<SEC-DOCUMENT>0001628280-22-010922.txt : 20220428
<SEC-HEADER>0001628280-22-010922.hdr.sgml : 20220428
<ACCEPTANCE-DATETIME>20220428072120
ACCESSION NUMBER:		0001628280-22-010922
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		112
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220428
DATE AS OF CHANGE:		20220428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BAXTER INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000010456
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				360781620
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04448
		FILM NUMBER:		22862181

	BUSINESS ADDRESS:	
		STREET 1:		ONE BAXTER PKWY
		STREET 2:		DF2-1W
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015
		BUSINESS PHONE:		8479482000

	MAIL ADDRESS:	
		STREET 1:		ONE BAXTER PARKWAY
		STREET 2:		DF2-1W
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAXTER TRAVENOL LABORATORIES INC
		DATE OF NAME CHANGE:	19880522

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAXTER LABORATORIES INC
		DATE OF NAME CHANGE:	19760608
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bax-20220331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:3113e683-fb48-43e6-a6e8-6a2e99588fde,g:c1ee1bb8-6f43-4e7f-a20c-1c092f3191f3,d:8787971997a742729b9820f85443271c--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:bax="http://www.baxter.com/20220331" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:country="http://xbrl.sec.gov/country/2021" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bax-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180L2ZyYWc6YzMxYWFkMDdjODk2NDQwMDllMWM1NmZmYmI3MDFmOGUvdGFibGU6YjQ1M2YzOTEwN2FkNGVkZGEyMWYwZmU0OWMyMThhNjEvdGFibGVyYW5nZTpiNDUzZjM5MTA3YWQ0ZWRkYTIxZjBmZTQ5YzIxOGE2MV8yLTEtMS0xLTc3MDMy_4d127bda-07b7-4e48-a3a5-8f492aef4cc8">false</ix:nonNumeric><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180L2ZyYWc6YzMxYWFkMDdjODk2NDQwMDllMWM1NmZmYmI3MDFmOGUvdGFibGU6YjQ1M2YzOTEwN2FkNGVkZGEyMWYwZmU0OWMyMThhNjEvdGFibGVyYW5nZTpiNDUzZjM5MTA3YWQ0ZWRkYTIxZjBmZTQ5YzIxOGE2MV8zLTEtMS0xLTc3MDMy_5dbe8011-4ab6-44b6-9e4e-7eeafb469bbb">2022</ix:nonNumeric><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180L2ZyYWc6YzMxYWFkMDdjODk2NDQwMDllMWM1NmZmYmI3MDFmOGUvdGFibGU6YjQ1M2YzOTEwN2FkNGVkZGEyMWYwZmU0OWMyMThhNjEvdGFibGVyYW5nZTpiNDUzZjM5MTA3YWQ0ZWRkYTIxZjBmZTQ5YzIxOGE2MV80LTEtMS0xLTc3MDMy_2d5c6bd7-b448-4d69-a2f0-51029b1b471e">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180L2ZyYWc6YzMxYWFkMDdjODk2NDQwMDllMWM1NmZmYmI3MDFmOGUvdGFibGU6YjQ1M2YzOTEwN2FkNGVkZGEyMWYwZmU0OWMyMThhNjEvdGFibGVyYW5nZTpiNDUzZjM5MTA3YWQ0ZWRkYTIxZjBmZTQ5YzIxOGE2MV81LTEtMS0xLTc3MDMy_c130c74c-0099-4e56-a133-43439f8e1736">0000010456</ix:nonNumeric><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180L2ZyYWc6YzMxYWFkMDdjODk2NDQwMDllMWM1NmZmYmI3MDFmOGUvdGFibGU6YjQ1M2YzOTEwN2FkNGVkZGEyMWYwZmU0OWMyMThhNjEvdGFibGVyYW5nZTpiNDUzZjM5MTA3YWQ0ZWRkYTIxZjBmZTQ5YzIxOGE2MV82LTEtMS0xLTc3MDMy_6da8ad42-6deb-4172-b6a7-4393e80b3a99">December 31</ix:nonNumeric><ix:nonNumeric contextRef="iac99a77dafa6431aab1c9441a22e537d_D20220101-20220331" name="bax:RevenueRecognizedContractPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNTA4Nw_f4e1f64e-f3c7-40c4-adcb-4328bb369ec4">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i810a45506ef9437c9a949870b37a194d_D20220101-20220331" name="bax:RevenueRecognizedContractPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNTY3NA_35dd3245-1f9f-4af5-81c9-d418989e3bbf">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i15c4aa9c7adc46609c75b8e4977a7bf5_I20220331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182NC9mcmFnOjg0MTZkZDMxZThmZDRlOTQ4YWY2YjFiMTc5OTFjOWU2L3RhYmxlOmE2ODcxNzNjNWE2OTRlYWU4ZWYyOTBmYTlkMjM5YTcyL3RhYmxlcmFuZ2U6YTY4NzE3M2M1YTY5NGVhZThlZjI5MGZhOWQyMzlhNzJfNC0xLTEtMS03NzAzMg_30abf8fc-5da7-41f3-98be-83bcecc1d8d4">9</ix:nonNumeric><ix:nonNumeric contextRef="i7dcc13e1767b4b20b08c82100616f090_I20220331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182NC9mcmFnOjg0MTZkZDMxZThmZDRlOTQ4YWY2YjFiMTc5OTFjOWU2L3RhYmxlOmE2ODcxNzNjNWE2OTRlYWU4ZWYyOTBmYTlkMjM5YTcyL3RhYmxlcmFuZ2U6YTY4NzE3M2M1YTY5NGVhZThlZjI5MGZhOWQyMzlhNzJfOC0xLTEtMS03NzAzMg_4bc1e35a-de0f-4bcc-a2ef-ae9358d9c51e">1</ix:nonNumeric><ix:nonNumeric contextRef="i149befa1f6404f1a97e608ad7a766348_I20220331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182NC9mcmFnOjg0MTZkZDMxZThmZDRlOTQ4YWY2YjFiMTc5OTFjOWU2L3RhYmxlOmE2ODcxNzNjNWE2OTRlYWU4ZWYyOTBmYTlkMjM5YTcyL3RhYmxlcmFuZ2U6YTY4NzE3M2M1YTY5NGVhZThlZjI5MGZhOWQyMzlhNzJfMTItMS0xLTEtNzcwMzI_f0da642f-fb70-4268-9176-72f93d298183">1</ix:nonNumeric><ix:nonNumeric contextRef="i7a469160b4ca45ceadc4df51de1bb9cd_I20220331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182NC9mcmFnOjg0MTZkZDMxZThmZDRlOTQ4YWY2YjFiMTc5OTFjOWU2L3RhYmxlOmE2ODcxNzNjNWE2OTRlYWU4ZWYyOTBmYTlkMjM5YTcyL3RhYmxlcmFuZ2U6YTY4NzE3M2M1YTY5NGVhZThlZjI5MGZhOWQyMzlhNzJfMTYtMS0xLTEtNzcwMzI_c6c9968b-4213-4dbc-b4c8-2011cae70ee1">1</ix:nonNumeric><ix:nonNumeric contextRef="i9f7a3b322d1541a28d6394b8562f85c1_I20220331" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182NC9mcmFnOjg0MTZkZDMxZThmZDRlOTQ4YWY2YjFiMTc5OTFjOWU2L3RhYmxlOmE2ODcxNzNjNWE2OTRlYWU4ZWYyOTBmYTlkMjM5YTcyL3RhYmxlcmFuZ2U6YTY4NzE3M2M1YTY5NGVhZThlZjI5MGZhOWQyMzlhNzJfMjAtMS0xLTEtNzcwMzI_b0363d2d-404b-4a59-bf6e-7788588abc2b"></ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bax-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a1624c56a6a4a3ab408fcb91225c59b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock100PerValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcb949de1f814a178d481b3618695860_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock100PerValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id98bd2c91c6d4e6db09e848a1ffdc8ab_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes04Due2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0509cd1ed8da470cab9a5bf85f1163aa_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2656e08f5e424363abb7ce8183383849_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6014262f0e9a44a2a58239a775cebe82_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes395Due2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ebeac25fbe44973800aa9db7f716eef_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes173Due2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08eaeee42e7a46eba61253ef057e42f5_I20220421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i1d4414eacf9648f9881e2e9dc42887af_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i9ad9afe3b705496a92217df29836a764_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i395c6d3fa47e43da801c740c4d0887d7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if62e913b0b0a496fae643c8af329597d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c50a6a898e74098976cf374bd92b5e3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cd0958ec6fe414297bf307609abf3b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie34009f3951740878e77b11e09660114_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafd810efc2234fb28217dc3a7f888066_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8aae1fa5b1449a79ef7b9912c57ca4f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f9fad2bb9874183aa490c07099b7007_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5f2d514381a4dae9fc8a99b95a414f7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3973bc554e71432ca8e07d7389490ea5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9d65a1c9ede4680974e4714437a55cd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40118e5765794906b7e238aa4c853768_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09965c96a10e480bbb6f1ffe8f35d49f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5e603c381fe4230aa663f494e69bfa6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d39e97f9bfc4d4a9af9dd344a9c0030_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1366da7fa3d545c8a056d8f11c73b8cf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9beb8849a787405a83fca7e87da30f32_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f9cbc6f08c446859633447e2e55616f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5abd3be1de0741caa08ee8a7bb927d49_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bc27871ead541a8a3f407cbc7b88e20_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i949d8647f73e4aab90b5a25fe2d56799_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2261098af7c3484dbb3074e0f50487ad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i968ed9c39ec74c9ba1af9f66763f82f5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73e5010e5e0241299ccdb8b1c93f7144_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6cac065ec6544838c98a84ff5fe15d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2562cb466738456fb044cb3fe9e1de27_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8300ea835fae4b28bcfd6760cd7604c8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i238ac34b0aab41be8134d8a775d08e2d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i401b2c604f694027b1c4dac9b79e2995_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5730d0771f684643b95bbc057538e077_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a31b884457e403e9ff8ac44f5eb8b7b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i334dc65857104da8bf45462dbc5304e8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b3a8f0389c44c1f970975d4fd28fd40_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4078e49ac5b14aba9f645b46af62a911_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e57d971a44a4a3f949731983ffafba1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia19d724121ef4d3794c045dd65c77f7b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd8d7f5c9b384bc1a8366b6af711f1c8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84fd6f93f3d74fcb85ae2bf1c449792d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib20ef40d3e874271b4203597bb847021_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc051d99f31b4d40b60823ffb0ce2ab4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i059198fbccc048f8afbe074a190f2478_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4edbb47a30cf46afbff865ead00dd98c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i969c52a42b424c649a401568d787c03d_I20211213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76d012ba0e6842c4bc044efa2367e442_D20211213-20211213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-13</xbrli:startDate><xbrli:endDate>2021-12-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0627724177f1427fb42008e3261d78c0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21e54c53c46c4b708c6f8469337d00f5_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">bax:ZosynMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaad890641b794c4ab677efe29d43bfc3_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">bax:ZosynMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i893821e416354e0681636831227afbcb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66457192cf5d4d76ab71f467bee6bca2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31a852f840a74cb8b2c787ac3741588a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i097b8af344b1429eabe401c1d86d6631_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide5f5c25f88f48b5af91862d33456fa9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i292b133325264c6597bd7b9662bb2dda_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d463df4bdbb45f0aa2538354d127517_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b0ebff960224f8ca45f13ec5e67356e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5a44ba447e844ac8ef93eebe8c514e2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i694baf88defe4467b0cc59ac6509b10c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib929fbd76df144d399a18b57db4d9ae3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1022ad8302e440da3f4e203175d4b10_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e4572eced80425baf027140478315ba_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52fbf2a8bbe449269339aa45b6bad70d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf3044fdced045cba1b544760a38b3b8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89a1452b79a447f2975f350bd948e3bf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bax:DevelopedTechnologyIncludingPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2638eb542e340638a844744dc8b8b41_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i824274fce6e34d36bcccea3b05be564e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdd214bbcad84d1c8ac9a757a0f976d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0abc73e3f8c249ac83f98f1ca79104ea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bax:DevelopedTechnologyIncludingPatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i656117b8223c4bdebeeb85ef817606b6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73e389fa92f548b49505eb62019ce7d9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77dc49641a924470949595f2087ee86d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:SeniorThreeYearTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia86774add006466498b0f2c3cba5e477_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:SeniorFiveYearTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00c553d814c644128d07318aded98980_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i9e9d2cef94014f91bd8867177e914d40_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="if45530e3d7994ceb8d8e400dc2ac33a7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12680af003b340588584061646eb80dd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="site"><xbrli:measure>bax:site</xbrli:measure></xbrli:unit><xbrli:context id="id2c66b1b9fe445a18da652d3450d08cf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i469c791f58204bae88a589c56467141f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bdf0bb5959445a281c014f161f85723_D20210112-20210112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-12</xbrli:startDate><xbrli:endDate>2021-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb864a5832494db0acdd2afdf1be2d00_D20220218-20220218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-18</xbrli:startDate><xbrli:endDate>2022-02-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d85a7b845f24d1fa695e4f71457e0c3_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>bax:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="ia62b9d54444c46208ba00c7b3a49f393_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ae5d43fac584f33a0a42a5f3c28e0d2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7189af185d184892889584811bd86919_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia90c948e8be245b98f70fa8267c58925_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23a86ccd6a744d46bea2df7cf193e7a3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id23b4ba90dd44f68a4a2fa4b53a355be_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47aa6b12f49d4f8f8e8e0b9146e3b922_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95a7419792054ae5bed8d890b5b8bec6_I20120731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2012-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6021c0283dc64cf58f4e8ce023f20cae_I20180228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05b8c7054b9d4d0883b6419ce2e08fe4_I20161130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2016-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6abadaa7a994ae19160f417f168acaf_I20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf18cf43e1fd42ea80e5bb10c70d8237_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i069285eebd5843f2856c7c3908c92f47_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f93d1d2dd2a457d996a157cd4e92b5d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6486fe1e58ef467195bd61197a081ab8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e7a72924e714ac6b891716ee10b193d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f2552f5c4054d1ebea374b3f2beb06b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3a1622bd0814078a54a920dde602168_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia612cf65ceaf4a1c9b76bfe56c4d3eb6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64a3e01103e34f1bbc3c8156b5ba0946_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17e2945361e24710af7f8a4b2bbd461b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id86e90917ec146d3ac68e2eb8b21f865_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia486f1301af041c9869fe8a3575fe4d4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5eefd1d44a344bdfbaad16b8a0fb4dc3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7fd2a0dc3844abbb371f105039e5020_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50951858332c4e6ca7aad9f12094ecea_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2419a534ffa472a893eb08ecd31d17a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61c25aa049c1446ba8f2b89559430b59_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc0dbb505a0a4fafbdccf76d617c81c1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b269065bdfa4003b5dac0551818244c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ae39c69af424944bc29e123b13ba03b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3f9dfaa202f43d7a4787a519244421f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c6117fdfad44c57ae71d0e2075129f2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbf3ffd3fcfe4c25bb7c73ac77cbbf80_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0174772e0bd41bd8c295a1a6f03a7f7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36f11ee6ccdd4c119f7e56f86d04836f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0b8fdc874934cd28547447f24fd547a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0f2358ba16e4eb2b4231007c968aafc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49849093a147487baaab59084a514458_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71a9302da0e54c3b8f8926e72835a876_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic40887eaba864beb99dfb7e8f5598fc9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ca753b742a8455c879cba08a880b703_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45b7e42abce84defb3a21a449abd0bbd_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd4fbdb722de41c680320b1de71522a7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bef5949b41742f0b1ba1cc2daeb9ab6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ba7828d1de048e19f12a0c301c05c70_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia377d8629c5a4a0fb71104100423c61c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54bb1c348a9847b582b458754fce46a2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb3cc6fd8ab54e7f919c3a7ef1e7de2d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15c4aa9c7adc46609c75b8e4977a7bf5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dcc13e1767b4b20b08c82100616f090_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i149befa1f6404f1a97e608ad7a766348_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a469160b4ca45ceadc4df51de1bb9cd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f7a3b322d1541a28d6394b8562f85c1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b4412787ecf4be9abb299cd553bdecb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac99a77dafa6431aab1c9441a22e537d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d4d3ad9a6744778b3c632ef51c41f3d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i810a45506ef9437c9a949870b37a194d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ConsumableMedicalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00a69787b49d45f98aca3e29cdef6cf9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ConsumableMedicalProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12862cd99e2648e6bcf32aac284bdb6a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a5af68d1dfd41d9b397bace193b7f2e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bbff8045db1420896d97da8621b4b0d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c59a85af92949bfa44911ac3ec56888_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44ec8a3cf51442cbaa0c996617cff9a4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:BundledEquipmentAndConsumableMedicalProductsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecf1812385b54a46ac8f5d89b0b93371_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:BundledEquipmentAndConsumableMedicalProductsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54f8a4bbd0174868969d5ea2762b4cba_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic17bdfd4421546eca4d7ae434aa0244e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8945826fd444f19b4c61de098d12163_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07b784c1178047b48ce2e8b3a5a7dbfd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6baa8e29dc1a4812ba336959185b5ed9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bax:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18dcbee3985a482faff83f708556a86d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bax:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i399bd9e6d7704a0f8494daa78d8321fc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae692eee99a04c67905eefc0ccfb948d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd0420526d1646c5ba9c811a0b9fc84f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae2bd6024f3b4290867ed42a20b57c42_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ebc0f71dfcc4d94b6422c836bb4d493_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41d12d31c3674b509c0fc670781c32d1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd2c69af596c4eb8afab548b28116f64_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic47301316276400fa58cbac0a27edd76_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0637d58240be4e3b84ee15a2869f6212_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie88685342da44b43aca2e889001b33df_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6257773f46f4406a950d9da284eeff8f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99fd85b9b1294818a42d590249ac0254_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1eb8a8cea96743978e1c34863c629e7e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccd3fe9f4eff41108f7f8233c7b8bec5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c50ddabc65d4775b4f0dd32b7866a0c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea7f19b9978a4f479a01e23692a3b391_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5de90053a7bb47eba9d7c5dff40cb4da_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5285bc00e83945fb8961453197a19fed_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic32465a108574d1ca7bae73c9b778aff_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i973336e83bc3453eb20073659da885b5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaad663d6e174f3f994c5b7b5c1706cd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i793ab633078c493c9736d462d4058098_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5bea1b0e28d4928871f812e9f5c7f6b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7795ac9bd9604206a6016440b538aac0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b930265e49a44e0943d8103a8b0b529_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5d5a261cd76428fbedae996f8d1907e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8e8d8c02c024de689ede733470259ff_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic88569bfa2d84d02bb251a96bb20f794_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if243ce5e748b4bd59093b5179090fb3f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fa2b02e71bf4d45b6db7e096d2650cb_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f5cb5974e244ecba9653d56940192c0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2913c2e1a7a24276acc5b6213dae5262_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i779714d757cf402f9776a2ccdec9726a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23f88c8a0df54c6884b9d01b2aaf82bf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44c9c2a4bb7449619ad2573dafa85bbf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8126141e4675434f839f8755c88b8ba3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0845bc16f68464e8379919be0e7b8fe_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fc7fd14f1844726a492dc5c657acbf8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i876dae9a11fe4141a783d8c2a6b92dec_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb9737600ddd4964a91212e64caf3594_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5745c41ec404c25a1bde3188976ef38_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c8442c959fa4529b57209c078253476_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i285d483ea5b047c587d620462e947359_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b3f80e5d38f4c1abc4cd1ab9a5b569a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e787427fc1d4863ab700a326101e439_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7467c8869654bcdb29ec9bef8eb852c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie34a3ea8d30f42b6a3c8f3f80e0898fd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacd83fad5f6042788153d814f190dd66_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedcbe041ae2a4606afe97260832fde83_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcc9eca3b12249c28c1c568c4b0ff3db_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ea4cbf5f08646e39f3d3ff3c49f24f2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23972f3969514c8ebbb4ed813b640924_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd3a87d60d1c4c0e9e235738abd249b4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18b82a0e238f4965bce3b3d3da7bc457_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab72e78e33e84f74af908d9272c9918b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c2a93a6dd094c51bfe994c44cd157c0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib694fa97d14d4be381e04aa9ddf846c1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0628696d6604d5b9f829e16a4b411ea_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8389d4f265c0420ea78f8103b6fc49ff_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69b44fa6f007430891d8a0fa04607c5a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f19fbe0743f48108c85afdca64f480d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97bb457dd66d4192aba9ecb5379b09e3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibebdfc914173408d98947b502a387897_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b8b91e94ed143eebd3f096088cfeac3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5945f9a9cad447da92a87bf81903df9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib32b8ba9994c4c05b40746ba26de0276_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f1ac0c71dc74295a156d768668f9a2a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7a8130be2624c9a8048123bf1f31901_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib93cd39c2a80489ba522e10fce6b0e92_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae185801a2824043b923695260987bdc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85d0b3b6424a4f239ced374f948ac74a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d6282669ad443c49c55d8ac91b9f5e7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b9e15e802c2455fb04ea04eb4db2322_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i522261ab58db4575939d49828d4c748e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if86b2c8277034f9e961edc5d828e8065_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:BusinessOptimizationProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9311558f896a40b688cfc17aa08d2304_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:BusinessOptimizationProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11a40960ca1f4fa5b6e685c5e17a27e1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffeac49ece2f4f0099db2b6316bc2a6b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia27cfb043f884dbd9667969290a6e989_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07f45e9451124a38a8618085deaa0bad_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac5d8d62119742ed9ba5ea4e4194307b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i290805ec99d64042be64af58b8ffd3b7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7223eebf6ed94d309d0faa7ad432bbbd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd1cb136a26b44cba87fb2a70901faa7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7d79d5f91f94bcab33cf772a3b3063d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0379f97ea684a719bc4b38d54e0efde_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i879c4d6181ea43c099235e39734a646e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63e5679fd4e5469d85730434afe1d238_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib68997075a33458898c6e14a36eebeb9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ef7f560cf624875bf9c35c67df33547_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62dc3391e9264db98a1f3fe40474e64b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5718c50c86d740d098ff8d49b559feaf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ee68bc6af754a66b0a50a9468a8588a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i312b43d90c8849b8b19bdd30e36c95c1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32aeda1131ad47a9a728d691bcb5e02b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6acac91985d749cbbb8a0f1ece842c1d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d49bf9ceb394ee397eb421a3a4ea0e7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9451246f53f4b13b9c1078a4785af23_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63b9c16382b045218cfce2166bcdcd3e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebe3c987e85b400bac19095e21ca736c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1701fe482b3a4c3183852a3aa9fe0c87_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d7dca14db914da8ad561a51aee21848_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i786ae4d3319c471ab517a03677b933e3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88c2ae6f33f64b45936b4dcd18b5d612_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5c7bf2bab574ab28206bdde47eed8d5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ef157d694c2423bb871181ca6e1ef94_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5dc8f540120419bb40e18be629ff121_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0744bc26d8d4427bc7a38006ba71623_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i760ce24b4a13497aa499059071c1bf88_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i536e66a57732404691a7c9d746a9c77a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i557d8b940ffb46fea7a0ffbea9c8628e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i922227aeddd24ee2b5e427b08c34c08d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39dea52d46d64c63b911fc2fec7d9fa9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if99e9e9771eb4da2a299bf355a486649_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93c6321b74e54dc7ac6d3673ec476dd1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61964dbdf7e84be88705f093c0802196_I20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2197ddaf305b41748d421ed313216345_I20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12a714234c6e4e9eb4d18197fbcce84c_I20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacacd738d13b471191092dfc7ad4dea7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71a1b7a14751464f96d1e33c2d439a5a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i792cbe33e35d445f91ea87aaf0e146b6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54c2d01d93ca4760941fa4a68b4b08b6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03f7bde8ea3b46179c1c8a7c608bd403_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c56206e8fd2421181da55d3c02a8854_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55ff25312dce4820b856d1dfd634ca60_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15e37ef8d94a4fe0b71f0876df3d6ee2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21388d336c1f433c8ceded9265e245d2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i979180e5f4714629b4784cf1025dd9c6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40ca9abc862645c4a33f3d2218f9f2a7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5b3d67eccd142a6939834d39b716b4f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67f9b129d87944fa85b837dac860fb75_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f8128091c9b4323ac693e2f73552a3e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6d8a8344b6145c39ccd9339d15cc4d9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04f11ec5ea644541baa8aa7176602e10_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fdf8bf9a08147fab31750ea1f96c4f5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec4b84b3fc74452c9f24e03eaad33954_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3f91e0124ba4fa4ac402434dc93e87b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9783d9bb5346424386c830791c5bd9af_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ebea270340c48ee9999faf277ae4c89_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1eb9fbfcc3ce4d20837be295da12469a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1229bd8de1424b6cafbefda84c89f17f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b481b445da94740a0c83504d45ed0c1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad0696204cae46f4a2dd949869b8a0a2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b1f513dd2f84554beda8f0654d39157_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97b20784595f4505a4473852b0d24361_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1dc1bf720b14af7be2658f5b9411099_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i010ba63179714c00a597d4434cdda0e3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied8dcdf39e2c4956942ba609511fb42c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied7ae06c0d764442a36e7ee405df5bae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4a1aa577cc642b1b122761aa34a02dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e2f63de943c437cbf78e59b19e61166_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia57b4248164c447fa78ab9e72dae9482_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i488bf22168054382b33a870cea5e12cf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0847c8d0a513447ab785792887cef7be_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a479dd0e9e04335a78d838743107def_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d57b720176840b084b62f8a521d47d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0699d0c72b624afcb5f0a2f67dead789_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i792e4039270545aba120425226791181_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i904ebe57a03f41a19cccabe5981567e2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1adb4c593b09447c8976d8d028dcd78c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i776aa6f56b4f4c128350b62839f20e93_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e0990c5545d42eea9be6143b97da502_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02f792b41f554f2c98ec32ac34f7d2c8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26c43bcaa7314a6b967da3c9bbca9100_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a4f6c720ee44c6ba4c1e80998b3d43c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i811d8be2a7d740bebdca3c2d962061e9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if73a3426d20d40529c001dbc761d4b8a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ae0b3674bb74050ac9785fa17b2f5e0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1eabca8696d4c27a96d88b08c1bf0a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>bax:segment</xbrli:measure></xbrli:unit><xbrli:context id="i5b628cec409b4e0aa786971fa2453bd0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36cc35bd29cf4b25b9ed69436f211f3d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AmericasSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb4a5d3c9d55448999d5cb714ebf69f3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AmericasSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36c28755553f4b3caaab97024026e4e6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:EMEASegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ea902d4e19b444db537a186c0a779f6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:EMEASegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae63df0c85ca44cd98106826bb67c91f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AsiaPacificSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i525d0111f09240c2b13835c305549821_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AsiaPacificSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id80baa04c95740de8f4bebecb32003d3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i904e310ddad74453ba7dc2d7fe323e01_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica5497822c874fda93fa60cb6aee725c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic57b38264d9d4bfcb8a0f926e4426cba_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib16764b626684350a430fa1f03cb037f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82348ec896cc42a891600e853ebccd95_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzktMi0xLTEtNzcwMzI_0eea4050-8459-42cf-9271-ac04667e54c9 id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzgtMS0xLTEtNzcwMzI_13f35301-dea9-413f-b5f7-9ed6808fa9ae id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzktMS0xLTEtNzcwMzI_4cc77988-0a14-47a5-baa8-271ce71b1caf id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzgtMi0xLTEtNzcwMzI_81b199f8-46cb-499e-87ef-81115911ecd7" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RleHRyZWdpb246ZWZlN2RlZmJlM2Q2NDVhMGIzNjA1ZWQ4Y2Q5ZDU1ZThfNDkz_b349bd57-b23c-414e-a785-abb60d23a955" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i8787971997a742729b9820f85443271c_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.850%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:15.5pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:15.5pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:15.5pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGV4dHJlZ2lvbjpmNmJhOTVjZjUzMmE0MDQ2YTQ3M2UxZGNjMDhjZGM0N18xNjY_97f3e5b2-ff08-499c-a911-79d10ce4c0dd">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.491%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.309%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MGZkZjhhNjU1YmY4NDA0NzljYmQxNWMzMGU5MjkwNDAvdGFibGVyYW5nZTowZmRmOGE2NTViZjg0MDQ3OWNiZDE1YzMwZTkyOTA0MF8wLTAtMS0xLTc3MDMy_1206d487-c018-49c2-a71f-c5715aa9f7fd">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGV4dHJlZ2lvbjpmNmJhOTVjZjUzMmE0MDQ2YTQ3M2UxZGNjMDhjZGM0N18yODM_6f47123b-681a-421f-a413-6b7beac0379b">March&#160;31, 2022</ix:nonNumeric> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.491%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.309%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MGI3NWExNWRjMzFlNGMzY2IzMDA4MzFlNTlhOGI5NDkvdGFibGVyYW5nZTowYjc1YTE1ZGMzMWU0YzNjYjMwMDgzMWU1OWE4Yjk0OV8wLTAtMS0xLTc3MDMy_4765ea19-c787-4388-8f4e-441336f61cbc">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Commission file number  <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGV4dHJlZ2lvbjpmNmJhOTVjZjUzMmE0MDQ2YTQ3M2UxZGNjMDhjZGM0N18zNzA_1ec4999a-538a-47c9-974a-0351840622aa">1-4448</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________________________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:21.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGV4dHJlZ2lvbjpmNmJhOTVjZjUzMmE0MDQ2YTQ3M2UxZGNjMDhjZGM0N180NTU_ee14d509-5877-4566-96aa-d8657df6e3d5">BAXTER INTERNATIONAL INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.608%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6ZjY0ZWMzZDhiNzBiNDFlN2I3MTQ1NzY1ODg3YWJiYzcvdGFibGVyYW5nZTpmNjRlYzNkOGI3MGI0MWU3YjcxNDU3NjU4ODdhYmJjN18wLTAtMS0xLTc3MDMy_61c59fa2-3deb-48b3-abb7-f0b044c4010d">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6ZjY0ZWMzZDhiNzBiNDFlN2I3MTQ1NzY1ODg3YWJiYzcvdGFibGVyYW5nZTpmNjRlYzNkOGI3MGI0MWU3YjcxNDU3NjU4ODdhYmJjN18wLTQtMS0xLTc3MDMy_8e70e749-3c71-4a80-9253-d904c21cd59e">36-0781620</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6ZjY0ZWMzZDhiNzBiNDFlN2I3MTQ1NzY1ODg3YWJiYzcvdGFibGVyYW5nZTpmNjRlYzNkOGI3MGI0MWU3YjcxNDU3NjU4ODdhYmJjN18zLTAtMS0xLTc3MDMy_a1245627-0732-4c56-828c-697971c2b781">One Baxter Parkway,</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6ZjY0ZWMzZDhiNzBiNDFlN2I3MTQ1NzY1ODg3YWJiYzcvdGFibGVyYW5nZTpmNjRlYzNkOGI3MGI0MWU3YjcxNDU3NjU4ODdhYmJjN18zLTEtMS0xLTc3MDMy_99fa437c-624b-4e42-bc77-f941723ef60e">Deerfield,</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6ZjY0ZWMzZDhiNzBiNDFlN2I3MTQ1NzY1ODg3YWJiYzcvdGFibGVyYW5nZTpmNjRlYzNkOGI3MGI0MWU3YjcxNDU3NjU4ODdhYmJjN18zLTItMS0xLTc3MDMy_2ab97fba-2121-4925-9e5c-ccaf7fd43d57">Illinois</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6ZjY0ZWMzZDhiNzBiNDFlN2I3MTQ1NzY1ODg3YWJiYzcvdGFibGVyYW5nZTpmNjRlYzNkOGI3MGI0MWU3YjcxNDU3NjU4ODdhYmJjN18zLTQtMS0xLTc3MDMy_b3cac72f-b965-4b60-a3ce-b77fb0ab9a84">60015</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.679%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6YTI0ZTEzNjVhODBhNDA2Yzg4MDYzYWE3ZWEwNjE5NTgvdGFibGVyYW5nZTphMjRlMTM2NWE4MGE0MDZjODgwNjNhYTdlYTA2MTk1OF8wLTItMS0xLTc3MDMy_3b62a633-9ad7-4790-852f-08a2650f2f0b">224.</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6YTI0ZTEzNjVhODBhNDA2Yzg4MDYzYWE3ZWEwNjE5NTgvdGFibGVyYW5nZTphMjRlMTM2NWE4MGE0MDZjODgwNjNhYTdlYTA2MTk1OF8wLTMtMS0xLTc3MDMy_e54048b2-7453-4395-8e59-f05a94e76e34">948.2000</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Registrant&#8217;s telephone number, including area code)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________________________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.503%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1a1624c56a6a4a3ab408fcb91225c59b_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8xLTAtMS0xLTc3MDMy_979105ef-4b7a-4a75-9f09-09de98e4414a"><ix:nonNumeric contextRef="ibcb949de1f814a178d481b3618695860_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8xLTAtMS0xLTc3MDMy_ba9e171c-f0d4-436f-b4e3-3064f52723a5">Common Stock, $1.00 par value</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1a1624c56a6a4a3ab408fcb91225c59b_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8xLTItMS0xLTc3MDMy_0cbcbc5e-8007-4d88-8a42-60dc945bf0dc"><ix:nonNumeric contextRef="ibcb949de1f814a178d481b3618695860_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8xLTItMS0xLTc3MDMy_14bc37a7-5451-4935-88a3-a0c312f8e751">BAX (NYSE)</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1a1624c56a6a4a3ab408fcb91225c59b_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8xLTQtMS0xLTc3MDMy_89365ee8-f7cf-4539-b71f-f19a2052490c">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibcb949de1f814a178d481b3618695860_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8yLTQtMS0xLTc3MDMy_9e2f4845-4358-485f-a390-75db0a5a6b39">Chicago Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id98bd2c91c6d4e6db09e848a1ffdc8ab_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8zLTAtMS0xLTc3MDMy_6cf6d22b-4972-4540-b8e9-1813ff58476e">0.4% Global Notes due 2024</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id98bd2c91c6d4e6db09e848a1ffdc8ab_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8zLTItMS0xLTc3MDMy_eec7f193-a3b4-456a-b454-4f5989d99cdc">BAX 24</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id98bd2c91c6d4e6db09e848a1ffdc8ab_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8zLTQtMS0xLTc3MDMy_178251bd-1c65-4514-a922-b5ef3215e9b8">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0509cd1ed8da470cab9a5bf85f1163aa_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV80LTAtMS0xLTc3MDMy_3f0060a9-838e-4325-8520-1828d8fc6ac8">1.3% Global Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0509cd1ed8da470cab9a5bf85f1163aa_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV80LTItMS0xLTc3MDMy_28a89e15-a8cd-4c5c-a574-3739eadfbaba">BAX 25</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0509cd1ed8da470cab9a5bf85f1163aa_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV80LTQtMS0xLTc3MDMy_4b932601-7d00-4dcf-be86-178f2c41a4fa">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2656e08f5e424363abb7ce8183383849_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV81LTAtMS0xLTc3MDMy_b483d0ec-50df-4463-8e9f-d5dd014cc84c">1.3% Global Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2656e08f5e424363abb7ce8183383849_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV81LTItMS0xLTc3MDMy_e1a95d85-7064-4388-8629-b19fcde87b6a">BAX 29</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2656e08f5e424363abb7ce8183383849_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV81LTQtMS0xLTc3MDMy_33aaf278-aa12-4cc2-9001-2d6b99442628">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6014262f0e9a44a2a58239a775cebe82_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV82LTAtMS0xLTc3MDMy_c5dd63fd-54d0-4a3a-92e4-2531c08f3645">3.95% Global Notes due 2030</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6014262f0e9a44a2a58239a775cebe82_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV82LTItMS0xLTc3MDMy_2f8f0ef9-0bbc-46b7-a544-6cefde375847">BAX 30</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6014262f0e9a44a2a58239a775cebe82_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV82LTQtMS0xLTc3MDMy_37c77137-fb09-40e8-8198-fcc8bad29683">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8ebeac25fbe44973800aa9db7f716eef_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV83LTAtMS0xLTc3MDMy_e5c41043-a46c-42bb-a677-214bcede16da">1.73% Global Notes due 2031</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8ebeac25fbe44973800aa9db7f716eef_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV83LTItMS0xLTc3MDMy_f66f71e5-1509-4321-a63b-7ac7f5017653">BAX 31</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8ebeac25fbe44973800aa9db7f716eef_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV83LTQtMS0xLTc3MDMy_9c4a1305-60de-4a5a-a00a-aeff5b52f514">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGV4dHJlZ2lvbjpmNmJhOTVjZjUzMmE0MDQ2YTQ3M2UxZGNjMDhjZGM0N18xMDg2_f4283517-a5f7-4c36-bb2f-49171a242f0e">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGV4dHJlZ2lvbjpmNmJhOTVjZjUzMmE0MDQ2YTQ3M2UxZGNjMDhjZGM0N18xMzc4_80f246e7-fb5e-439e-9f45-a08a0c9d31ed">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> &#160;No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.463%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.014%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.957%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6YTRmZGEzODc0MmU5NDFlMTkxZDM0YWUyZThhMWY3NTkvdGFibGVyYW5nZTphNGZkYTM4NzQyZTk0MWUxOTFkMzRhZTJlOGExZjc1OV8wLTAtMS0xLTc3MDMy_98c38d65-e10e-4e92-b94a-70c35dc36b63">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6YTRmZGEzODc0MmU5NDFlMTkxZDM0YWUyZThhMWY3NTkvdGFibGVyYW5nZTphNGZkYTM4NzQyZTk0MWUxOTFkMzRhZTJlOGExZjc1OV8xLTQtMS0xLTc3MDMy_47d14f67-a361-4ed2-bbfd-2ecb8fbf30fb">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6YTRmZGEzODc0MmU5NDFlMTkxZDM0YWUyZThhMWY3NTkvdGFibGVyYW5nZTphNGZkYTM4NzQyZTk0MWUxOTFkMzRhZTJlOGExZjc1OV8yLTEtMS0xLTc3MDMy_1df7774c-8188-40e6-a37d-ef06303844c2">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). &#160;&#160;&#160;&#160;Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGV4dHJlZ2lvbjpmNmJhOTVjZjUzMmE0MDQ2YTQ3M2UxZGNjMDhjZGM0N18yMjM3_5a0af2f7-c256-4828-b122-51b87696d880">x</ix:nonNumeric></span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s Common Stock, par value $1.00 per share, outstanding as of April&#160;21, 2022 was <ix:nonFraction unitRef="shares" contextRef="i08eaeee42e7a46eba61253ef057e42f5_I20220421" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGV4dHJlZ2lvbjpmNmJhOTVjZjUzMmE0MDQ2YTQ3M2UxZGNjMDhjZGM0N18yMjI2_bdc4bfc4-3097-480d-93e0-0da05a32cf74">503,528,678</ix:nonFraction> shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i8787971997a742729b9820f85443271c_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">BAXTER INTERNATIONAL INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">For the quarterly period ended March&#160;31, 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.662%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page Number</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_10">PART I.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_10">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_10">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_13">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_16">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_16">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_19">Condensed Consolidated Statements of Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_22">Condensed Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_22">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_25">Condensed Consolidated Statements of Changes in Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_28">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_28">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_31">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_88">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_88">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_88">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_112">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_112">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_112">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_115">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_115">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_115">41</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_118">PART II.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_118">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_118">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_121">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_121">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_121">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_124">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_121">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_127">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_127">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_127">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_130">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_130">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_130">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8787971997a742729b9820f85443271c_133">Signature</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i8787971997a742729b9820f85443271c_133">44</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i8787971997a742729b9820f85443271c_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div id="i8787971997a742729b9820f85443271c_13"></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Financial Statements</span></div><div id="i8787971997a742729b9820f85443271c_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Balance Sheets (unaudited) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions, except share information)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMi0xLTEtMS03NzAzMg_f0281d5d-9fe1-49b8-991a-30752c5ab5e9">2,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMi0yLTEtMS03NzAzMg_6e7d8fd0-8f3d-42c5-bbd1-8b32626773df">2,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMy0wLTEtMS03NzAzMi90ZXh0cmVnaW9uOjcxNjYwNDc4NmQ2YTRkNWE4Y2I1OTBhOTRiMzI3Y2ZhXzQ2_d65710ae-e5d1-424f-951d-151bafc373bc">129</ix:nonFraction> in 2022 and $<ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMy0wLTEtMS03NzAzMi90ZXh0cmVnaW9uOjcxNjYwNDc4NmQ2YTRkNWE4Y2I1OTBhOTRiMzI3Y2ZhXzU5_cfbd5ab0-0293-4e1d-ba2d-f5e49b64eed2">122</ix:nonFraction> in 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMy0xLTEtMS03NzAzMg_14f07b9f-b5cc-4168-b86f-5dff66ca6aeb">2,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMy0yLTEtMS03NzAzMg_3513f614-64ad-45b7-b292-cc3566c50821">2,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfNC0xLTEtMS03NzAzMg_b1104f24-2d84-48be-9c57-9b311dc0486a">2,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfNC0yLTEtMS03NzAzMg_cd828a87-c957-4ab6-b12d-83408f2d9aed">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfNS0xLTEtMS03NzAzMg_bfa1653e-7072-469b-b12c-c1da9a6f65c5">860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfNS0yLTEtMS03NzAzMg_a589de3e-318b-43b8-8d5b-231823b46989">839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfNi0xLTEtMS03NzAzMg_692d6a6e-083b-4906-8d27-be9a8369747c">8,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfNi0yLTEtMS03NzAzMg_c7f615c4-7f1c-4482-9ee3-db4dc2c4dc63">8,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfNy0xLTEtMS03NzAzMg_7cb3548a-3439-4c51-839c-eae2efac56c2">5,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfNy0yLTEtMS03NzAzMg_13604c3e-2ed6-4077-b15a-2bb5acdb02b0">5,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfOC0xLTEtMS03NzAzMg_7c24cecc-c687-4652-91ee-ee7921e6d9ec">9,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfOC0yLTEtMS03NzAzMg_ee132ee4-8529-432a-89a7-54f90a11651e">9,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfOS0xLTEtMS03NzAzMg_18c2a36b-58a4-4b96-b62b-784ae854d28a">7,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfOS0yLTEtMS03NzAzMg_108f1082-03aa-406c-bc7b-b9bcca7ca04f">7,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTAtMS0xLTEtNzcwMzI_ba5561d6-da35-4dd7-abf5-0656ad46e4c1">609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTAtMi0xLTEtNzcwMzI_49a9b8b2-fc88-456f-9380-7bb6c1682482">630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTEtMS0xLTEtNzcwMzI_0a25e299-8079-4173-8090-ad60bc8bb8b6">1,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTEtMi0xLTEtNzcwMzI_d3b6f00f-3b16-49b7-adcc-0583a251501c">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTItMS0xLTEtNzcwMzI_8bd61a64-fbfe-419f-851a-1b283989f027">32,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTItMi0xLTEtNzcwMzI_28bded13-0132-46e6-aa2a-082ab0334d67">33,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTQtMS0xLTEtNzcwMzI_b832f0d1-e1f2-4fbf-b38d-37c983724eed">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTQtMi0xLTEtNzcwMzI_5ef553ed-bfde-4e6f-8223-2a37b37c8c34">301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTUtMS0xLTEtNzcwMzI_2b2c7130-4a6e-422e-91df-5fd328dd2602">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTUtMi0xLTEtNzcwMzI_b23c87e3-d0cf-4ecd-b263-91f6514a4d0e">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTYtMS0xLTEtNzcwMzI_3fc094a5-65ac-49ef-9bb8-7da3d98ff4bb">1,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTYtMi0xLTEtNzcwMzI_1af4f5bd-ecb0-41db-be3a-92c15948054e">1,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTctMS0xLTEtNzcwMzI_0611a528-3f2b-4816-963c-0e8eb8be8282">2,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTctMi0xLTEtNzcwMzI_803d5de4-3138-46d9-87b5-421d9dbc8ab6">2,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTgtMS0xLTEtNzcwMzI_4ae9aac3-9082-44f8-8b8c-af6749659b9b">3,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTgtMi0xLTEtNzcwMzI_741be30e-2c78-435e-b317-ccaebe22a084">4,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations, less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTktMS0xLTEtNzcwMzI_cd50971e-0217-4c21-8be1-0d5ec4c6cda4">16,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTktMi0xLTEtNzcwMzI_2721d116-91d0-4a31-bcc5-a232964ca582">17,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjAtMS0xLTEtNzcwMzI_db9d0a22-b6fd-43c2-a885-186161dd5005">508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjAtMi0xLTEtNzcwMzI_54c9d62c-15a6-417b-8c6a-d2a11d357c13">522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjEtMS0xLTEtNzcwMzI_2377dfce-941c-4bd0-81ef-81bd8d219f1c">2,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjEtMi0xLTEtNzcwMzI_f3b2d298-20b3-488c-94e6-8c701e80c782">2,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjItMS0xLTEtNzcwMzI_42d14e1e-ab14-4f06-8c21-0525896da818">23,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjItMi0xLTEtNzcwMzI_3d1947cf-2c71-4c7e-afae-d51de5993454">24,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjMtMS0xLTEtNzcwMzI_9b2febef-d10b-4640-8a9a-76db12948f11"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjMtMi0xLTEtNzcwMzI_30c6e3f7-f15b-43d8-9a66-08a3de4af520"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjUtMC0xLTEtNzcwMzIvdGV4dHJlZ2lvbjpiY2VmYTFlZjZmNmE0NjhjYjFlMTcwMmU0NTllOGY4Ml8xOA_3e323363-86e8-47e6-99c4-62d64e56cec2"><ix:nonFraction unitRef="usdPerShare" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjUtMC0xLTEtNzcwMzIvdGV4dHJlZ2lvbjpiY2VmYTFlZjZmNmE0NjhjYjFlMTcwMmU0NTllOGY4Ml8xOA_ca03eff3-a527-4361-bafd-f1685b18f173">1</ix:nonFraction></ix:nonFraction> par value, authorized <ix:nonFraction unitRef="shares" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjUtMC0xLTEtNzcwMzIvdGV4dHJlZ2lvbjpiY2VmYTFlZjZmNmE0NjhjYjFlMTcwMmU0NTllOGY4Ml80Mw_45c0fc3b-e6d5-4709-844a-426c8ac9ae4c"><ix:nonFraction unitRef="shares" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjUtMC0xLTEtNzcwMzIvdGV4dHJlZ2lvbjpiY2VmYTFlZjZmNmE0NjhjYjFlMTcwMmU0NTllOGY4Ml80Mw_6ca80d25-55bb-4cf9-8252-a2a3f844020d">2,000,000,000</ix:nonFraction></ix:nonFraction> shares, issued <ix:nonFraction unitRef="shares" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjUtMC0xLTEtNzcwMzIvdGV4dHJlZ2lvbjpiY2VmYTFlZjZmNmE0NjhjYjFlMTcwMmU0NTllOGY4Ml82MQ_44d8e1aa-fa71-4ac2-b7ec-8de9d7e0e275"><ix:nonFraction unitRef="shares" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjUtMC0xLTEtNzcwMzIvdGV4dHJlZ2lvbjpiY2VmYTFlZjZmNmE0NjhjYjFlMTcwMmU0NTllOGY4Ml82MQ_b700eef9-8476-4264-9cec-95a791318a92">683,494,944</ix:nonFraction></ix:nonFraction> shares in 2022 and 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjUtMS0xLTEtNzcwMzI_b5e9effb-e85b-44f2-ab40-ecabeab74796">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjUtMi0xLTEtNzcwMzI_afd5c928-a47a-46cc-adeb-9c3c41e30b55">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock in treasury, at cost,<ix:nonFraction unitRef="shares" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjYtMC0xLTEtNzcwMzIvdGV4dHJlZ2lvbjo4NDhiY2U0YjEwMWY0MWY2YTk4ZGJjOGU5ZjE5YWMxZF8zOA_42ecc1f4-81cd-4b7f-b87d-769e0f66247d">180,058,105</ix:nonFraction> shares in 2022 and <ix:nonFraction unitRef="shares" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjYtMC0xLTEtNzcwMzIvdGV4dHJlZ2lvbjo4NDhiY2U0YjEwMWY0MWY2YTk4ZGJjOGU5ZjE5YWMxZF81OA_4709805b-79de-4af0-b4b1-03973bc82928">181,879,516</ix:nonFraction> shares in 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjYtMS0xLTEtNzcwMzI_bd4ec071-a1b5-4eef-9a7e-8451d66a9ad8">11,422</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjYtMi0xLTEtNzcwMzI_53d96e3c-abde-441a-841a-92dd2a56f0d7">11,488</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional contributed capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjctMS0xLTEtNzcwMzI_5bdce1d0-f7f1-462b-89f5-a783ed6bfc13">6,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjctMi0xLTEtNzcwMzI_0ae03b09-087c-4686-be03-46b3f8eedad7">6,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjgtMS0xLTEtNzcwMzI_e90f8c07-960b-4ff6-8a87-7366d0eecf67">16,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjgtMi0xLTEtNzcwMzI_9328fde4-b41b-44bf-b1a3-ac964d5057fa">17,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjktMS0xLTEtNzcwMzI_6e2a57f2-2ce7-4bf3-9e19-d5649537b43f">3,387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjktMi0xLTEtNzcwMzI_209ca1d7-1356-4c51-945d-434aa3a1c6f3">3,380</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMzAtMS0xLTEtNzcwMzI_2fc8c399-127a-4c85-bdff-ff50b81e843e">9,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMzAtMi0xLTEtNzcwMzI_606049cb-bcc3-41c4-9f43-98a1a7fda01f">9,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMzEtMS0xLTEtNzcwMzI_84c715b3-75cd-45e1-b5bc-5819c82cc366">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMzEtMi0xLTEtNzcwMzI_c27641eb-71e3-43fe-9ffb-7db1dbaa1b19">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMzItMS0xLTEtNzcwMzI_b0df16e6-e027-4763-a454-852bd672f495">9,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMzItMi0xLTEtNzcwMzI_8e3b5fa7-c3f5-47c0-84a9-3d024ce7bc5c">9,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMzMtMS0xLTEtNzcwMzI_d4a01f36-5bfb-4deb-86a4-bdf7fd1053cb">32,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMzMtMi0xLTEtNzcwMzI_05b22219-fde2-4468-963f-3d2d26c54393">33,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i8787971997a742729b9820f85443271c_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Income (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions, except per share data)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.275%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMi0xLTEtMS03NzAzMg_25c53d4b-ad5a-425d-9042-7fb83fb9b8a1">3,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMi0yLTEtMS03NzAzMg_26b48f0d-4577-4980-bb25-fd048bf77b8e">2,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMy0xLTEtMS03NzAzMg_11ff183f-9ef6-4a88-93c5-ef0fd4cdf091">2,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMy0yLTEtMS03NzAzMg_98190462-da11-452f-bdce-3fb8f887f14a">1,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfNC0xLTEtMS03NzAzMg_179d886f-ea93-4048-b35c-15e2e7eb027c">1,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfNC0yLTEtMS03NzAzMg_51b24b30-e7f1-4bfc-b1ee-a1e42882f41b">1,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfNS0xLTEtMS03NzAzMg_70dbec48-a122-4e8d-a65c-3a94cea1af7c">1,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfNS0yLTEtMS03NzAzMg_9e72092e-1231-4633-aa6f-60dd5a3f9258">627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfNi0xLTEtMS03NzAzMg_bba0a800-b3f4-44a5-a3f6-73a8a5618011">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfNi0yLTEtMS03NzAzMg_d488fb3a-ad16-4122-9fcf-05d43e6ef91b">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfNy0xLTEtMS03NzAzMg_f6717021-51e7-4aa4-91e2-275ee83832cf">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfNy0yLTEtMS03NzAzMg_25e339fb-60b7-4fac-8099-06865f1f6d80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfOC0xLTEtMS03NzAzMg_8144e02b-bcd2-40fd-85b6-fa17a4a97c36">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfOC0yLTEtMS03NzAzMg_2a45a760-3778-47f1-a06f-0e630dff5571">390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfOS0xLTEtMS03NzAzMg_a45ca199-af06-4227-bcd1-345f13722912">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfOS0yLTEtMS03NzAzMg_7e86320c-dea8-4bca-aff4-aa68446c16c1">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTAtMS0xLTEtNzcwMzI_0b6f880e-b686-43f0-9075-8cc8dda3ed46">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTAtMi0xLTEtNzcwMzI_723a222d-1d52-4d1a-9fcd-456dccae982a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTEtMS0xLTEtNzcwMzI_40f8ec9e-9664-41e4-a595-8921bdfa4a50">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTEtMi0xLTEtNzcwMzI_47d18aff-5f87-4d78-a1bd-d131a17f5346">351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTItMS0xLTEtNzcwMzI_c8355c91-dd15-457c-adea-5874abb4e822">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTItMi0xLTEtNzcwMzI_f5a20ae9-1bde-41f4-a796-6eb60d328c0b">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income   </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTMtMS0xLTEtNzcwMzI_f2bdd71d-78a1-4917-9ff2-b502cc4c8fc9">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTMtMi0xLTEtNzcwMzI_852f2f26-07b3-468e-af8f-a5364f3e41ed">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTQtMS0xLTEtNzcwMzI_b48b8eea-59ed-42de-9237-c49a67738277">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTQtMi0xLTEtNzcwMzI_bc15a9bc-7443-44da-9be9-72c6ffae1828">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Baxter stockholders</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTUtMS0xLTEtNzcwMzI_efad750e-efb2-4217-a215-6bebe05a670a">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTUtMi0xLTEtNzcwMzI_a2d48909-b18b-4821-bdce-76f159b9ab09">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTctMS0xLTEtNzcwMzI_61e9f695-1290-4bc4-80cf-f62c9612dde1">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTctMi0xLTEtNzcwMzI_86e22aef-7a1e-46b3-a0d4-70e69c5ee08f">0.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTgtMS0xLTEtNzcwMzI_f1e0f1b1-a388-4a69-8f59-30b66c0faa41">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTgtMi0xLTEtNzcwMzI_d3e71ac2-d021-4713-8e69-932825083202">0.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average number of shares outstanding</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMjAtMS0xLTEtNzcwMzI_4086f176-b2c5-4459-8445-18ea947a2b86">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMjAtMi0xLTEtNzcwMzI_83522db2-9324-4125-bcb9-94770785a607">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMjEtMS0xLTEtNzcwMzI_c4a45ee4-3b79-482f-beca-21bf1acfb56f">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMjEtMi0xLTEtNzcwMzI_30e075c7-c071-4960-9673-ccdaee1ba054">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i8787971997a742729b9820f85443271c_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Comprehensive Income (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfMi0xLTEtMS03NzAzMg_419e76af-6149-40e0-9dfe-92e2664ea949">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfMi0yLTEtMS03NzAzMg_162182d6-1e7f-40eb-a072-a936606fb52d">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments, net of tax expense (benefit) of ($<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNC0wLTEtMS03NzAzMi90ZXh0cmVnaW9uOjg5Yjg4ZGY4OGRkODQ2NzZhNGI5YWU4NGFhZDVlZTY1Xzcw_daf90287-0908-4849-83a9-b11efa6a54bc">11</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNC0wLTEtMS03NzAzMi90ZXh0cmVnaW9uOjg5Yjg4ZGY4OGRkODQ2NzZhNGI5YWU4NGFhZDVlZTY1Xzc3_5b7f0a2d-b1f2-49e3-a76f-667a6a4b5ac1">17</ix:nonFraction> for the three months ended March 31, 2022 and 2021, respectively.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNC0xLTEtMS03NzAzMg_fff2c350-12eb-4436-8bc7-a3cb600b46cc">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNC0yLTEtMS03NzAzMg_c769f6dd-0e49-4950-b669-6e5d95892bce">208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefits, net of tax expense of $<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNS0wLTEtMS03NzAzMi90ZXh0cmVnaW9uOmM0ZDM4NWE2NzA1OTRkMGFhYTBhNjc3NDJiODI2YTg5XzY5_f9dde9ed-c045-4c39-af87-8dca302e695e">3</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNS0wLTEtMS03NzAzMi90ZXh0cmVnaW9uOmM0ZDM4NWE2NzA1OTRkMGFhYTBhNjc3NDJiODI2YTg5Xzc2_5bd58b30-d5c6-41c7-80a1-b75883cf76b6">8</ix:nonFraction> for the three months ended March 31, 2022 and 2021, respectively.</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNS0xLTEtMS03NzAzMg_39720666-65d5-4b8d-8805-04ce91190815">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNS0yLTEtMS03NzAzMg_f85453dc-7327-43c1-8e06-6cb70a0ce649">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedging activities, net of tax expense (benefit) of ($<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNi0wLTEtMS03NzAzMi90ZXh0cmVnaW9uOmU5NDRhMzdkMWZiNTQ3ZmRiMzgzZGRmNmNhNGJmYzEzXzU2_e403fc2c-92e3-4bb2-a61e-31a79f59a8c8">1</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNi0wLTEtMS03NzAzMi90ZXh0cmVnaW9uOmU5NDRhMzdkMWZiNTQ3ZmRiMzgzZGRmNmNhNGJmYzEzXzYz_7c9c1a2d-a585-4587-99f9-95f5f9a373db">3</ix:nonFraction> for the three months ended March 31, 2022 and 2021, respectively.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNi0xLTEtMS03NzAzMg_e0989c22-70ec-4cbd-a3d5-916d19ad3158">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNi0yLTEtMS03NzAzMg_0ca729dd-4637-4e8e-b920-0194d4fb727e">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities, net of tax expense of $<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNy0wLTEtMS04NDkzOS90ZXh0cmVnaW9uOjMzNmM2ZDcxODBlNDRjYzA4MDg4MzhjNjc4NjJhNDMyXzEwOTk1MTE2Mjc4OTk_de659d7b-0c3c-4fac-a1c7-636d5752639f">1</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNy0wLTEtMS04NDkzOS90ZXh0cmVnaW9uOjMzNmM2ZDcxODBlNDRjYzA4MDg4MzhjNjc4NjJhNDMyXzEwOTk1MTE2Mjc5Mjg_d3c177ae-9ad5-4350-9c80-814c1cdbb14a">zero</ix:nonFraction> for the three months ended March 31, 2022 and 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNy0xLTEtMS04NDk3OQ_19defee0-3e27-4a63-a621-acc1d5298564">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNy0yLTEtMS04Nzc3Nw_b5197f40-287a-4772-b1fe-664634f0df28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNy0xLTEtMS03NzAzMg_7c2a936d-585d-423f-81ff-e98d7920e8af">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNy0yLTEtMS03NzAzMg_8804b66f-a106-4457-a453-9b5640067a82">166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfOC0xLTEtMS03NzAzMg_4ea0213c-ecb5-45aa-ab91-3cfdd3c48e52">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfOC0yLTEtMS03NzAzMg_979d73b6-64d5-4914-ab0c-ef9afc45ea4a">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfOS0xLTEtMS03NzAzMg_d9b9ab79-9205-435f-a6f0-7aae1f88d042">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfOS0yLTEtMS03NzAzMg_ad483565-5825-4936-83d2-09a33af6bbe5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to Baxter stockholders</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfMTAtMS0xLTEtNzcwMzI_706c5391-355c-4db1-b31a-215c159e0419">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfMTAtMi0xLTEtNzcwMzI_9fcb3e09-2f74-4a3d-a8dd-02e39959ac2a">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i8787971997a742729b9820f85443271c_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Changes in Equity (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.329%"><tr><td style="width:1.0%"></td><td style="width:23.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">For the three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Baxter International Inc. stockholders' equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock shares<br/>in treasury</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock in<br/>treasury</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional contributed capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accumulated other comprehensive<br/>income (loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total Baxter stockholders' equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i395c6d3fa47e43da801c740c4d0887d7_I20211231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy0xLTEtMS03NzAzMg_9c95d20e-2a95-4148-a869-f1a090d52243">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i395c6d3fa47e43da801c740c4d0887d7_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy0yLTEtMS03NzAzMg_0d0f632c-66d2-4556-beb4-8681eda6db4a">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if62e913b0b0a496fae643c8af329597d_I20211231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy0zLTEtMS03NzAzMg_0147c0e7-c90c-49d9-b0e9-7c68e117fb42">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if62e913b0b0a496fae643c8af329597d_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy00LTEtMS03NzAzMg_5717e2f6-339a-4374-9045-66cac1764ee8">11,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c50a6a898e74098976cf374bd92b5e3_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy01LTEtMS03NzAzMg_661b3804-da4e-404c-bb85-c7e4b86ad04f">6,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd0958ec6fe414297bf307609abf3b5_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy02LTEtMS03NzAzMg_3944d402-efbe-4b60-8ae0-afaaf4b18ade">17,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie34009f3951740878e77b11e09660114_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy03LTEtMS03NzAzMg_3bef6231-f8c5-4033-9bbe-dd18a53cf34a">3,380</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd810efc2234fb28217dc3a7f888066_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy04LTEtMS03NzAzMg_cc1c7582-a4ea-4c72-a145-a35be4dcea05">9,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8aae1fa5b1449a79ef7b9912c57ca4f_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy05LTEtMS03NzAzMg_b3e944eb-3bd8-4738-8c03-8cc961c51d75">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy0xMC0xLTEtNzcwMzI_97cd1802-3d51-4c38-911f-45f9f0d5b573">9,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f9fad2bb9874183aa490c07099b7007_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfNS02LTEtMS03NzAzMg_026ab311-af30-474b-aafc-f8abc598dc38">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f2d514381a4dae9fc8a99b95a414f7_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfNS04LTEtMS03NzAzMg_d3019f28-4805-4d6b-beb8-3f16ea838c8e">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3973bc554e71432ca8e07d7389490ea5_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfNS05LTEtMS03NzAzMg_fe69af16-23bc-44e5-8f81-08a8d707c636">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfNS0xMC0xLTEtNzcwMzI_208244c0-38b1-4ce6-90cb-bbe5b83e69f3">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9d65a1c9ede4680974e4714437a55cd_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfNi03LTEtMS03NzAzMg_7f22a579-1c28-4540-88b7-590dd051c238">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5f2d514381a4dae9fc8a99b95a414f7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfNi04LTEtMS03NzAzMg_724bf028-15b1-49c9-ad36-2de03037a61e">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfNi0xMC0xLTEtNzcwMzI_eebbb562-763b-40a8-bbba-05afe711f468">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock issued under employee benefit plans and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i40118e5765794906b7e238aa4c853768_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfOC0zLTEtMS03NzAzMg_5e405a33-6063-4742-9ab7-3de8c240dd17">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40118e5765794906b7e238aa4c853768_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfOC00LTEtMS03NzAzMg_ceecd0fb-29ae-4442-9d92-8ab2b40be239">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09965c96a10e480bbb6f1ffe8f35d49f_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfOC01LTEtMS03NzAzMg_ff82b3b1-a35f-412c-941e-e28f7f0d9c28">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f2d514381a4dae9fc8a99b95a414f7_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfOC04LTEtMS03NzAzMg_0c7d5ed6-14d9-4270-8cab-336d10597a27">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfOC0xMC0xLTEtNzcwMzI_497bb1cd-98db-40de-afaf-4be5760432c1">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared on common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f9fad2bb9874183aa490c07099b7007_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfOS02LTEtMS03NzAzMg_80198ecb-fa67-4213-ad38-500f0f0e3add">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5f2d514381a4dae9fc8a99b95a414f7_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfOS04LTEtMS03NzAzMg_99b69a64-2e84-41ce-a722-ba93f0aae1cb">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfOS0xMC0xLTEtNzcwMzI_38a8998e-ea3d-4035-89d7-9f04c34b7fe4">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3973bc554e71432ca8e07d7389490ea5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTAtOS0xLTEtNzcwMzI_00fb9f0b-9271-46f9-b68c-320e1adeb286">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTAtMTAtMS0xLTc3MDMy_38ae8b63-e970-4334-9d11-d4d4a52f3245">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance as of March&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5e603c381fe4230aa663f494e69bfa6_I20220331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtMS0xLTEtNzcwMzI_57c884f4-2284-4ec6-a1cb-df73e1bee089">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5e603c381fe4230aa663f494e69bfa6_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtMi0xLTEtNzcwMzI_4f64a959-b02c-4d28-8cf3-36bd232a7064">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d39e97f9bfc4d4a9af9dd344a9c0030_I20220331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtMy0xLTEtNzcwMzI_6db5b19f-e30c-4bfa-a893-531c64ed60b5">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d39e97f9bfc4d4a9af9dd344a9c0030_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtNC0xLTEtNzcwMzI_cd268067-0644-495a-be35-8d2dd6d5a08c">11,422</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1366da7fa3d545c8a056d8f11c73b8cf_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtNS0xLTEtNzcwMzI_46bbb78a-4341-4cbd-a9ab-3e0ff4cde9a1">6,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9beb8849a787405a83fca7e87da30f32_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtNi0xLTEtNzcwMzI_18a166b6-15a1-4203-9470-d528d7665675">16,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f9cbc6f08c446859633447e2e55616f_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtNy0xLTEtNzcwMzI_2feea9c9-258d-4c99-9972-4713dc77b666">3,387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5abd3be1de0741caa08ee8a7bb927d49_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtOC0xLTEtNzcwMzI_8156f66c-0cfc-4a66-b8d5-9d70526bfcd3">9,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc27871ead541a8a3f407cbc7b88e20_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtOS0xLTEtNzcwMzI_7b004231-8c05-407e-98cc-3f2b63ca399d">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtMTAtMS0xLTc3MDMy_12c5581c-bada-4d26-9ecb-91b918666768">9,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.329%"><tr><td style="width:1.0%"></td><td style="width:23.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.260%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.329%"><tr><td style="width:1.0%"></td><td style="width:23.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">For the three months ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Baxter International Inc. stockholders' equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock shares in treasury</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common stock in treasury</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional contributed capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total Baxter stockholders' equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i949d8647f73e4aab90b5a25fe2d56799_I20201231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy0xLTEtMS03NzAzMg_07bca04d-c688-4caa-9823-f15bd177d759">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949d8647f73e4aab90b5a25fe2d56799_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy0yLTEtMS03NzAzMg_3ee90cf2-6613-4ae1-9d76-e91fab8f6164">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2261098af7c3484dbb3074e0f50487ad_I20201231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy0zLTEtMS03NzAzMg_f8941123-301f-4dc2-adea-bd52cb54c60a">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2261098af7c3484dbb3074e0f50487ad_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy00LTEtMS03NzAzMg_22708234-f7be-4af8-9f5c-98ea6d29e0d3">11,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i968ed9c39ec74c9ba1af9f66763f82f5_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy01LTEtMS03NzAzMg_e503abdf-b148-4d98-bb74-188f810f46b1">6,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e5010e5e0241299ccdb8b1c93f7144_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy02LTEtMS03NzAzMg_d9948814-329a-464d-bb10-b7f7fb6442b7">16,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6cac065ec6544838c98a84ff5fe15d9_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy03LTEtMS03NzAzMg_0e0fe83a-1829-4626-a814-053db9c9bd66">3,314</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2562cb466738456fb044cb3fe9e1de27_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy04LTEtMS03NzAzMg_8b5fb359-e08d-4eb3-b4bf-cf24ece9366e">8,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8300ea835fae4b28bcfd6760cd7604c8_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy05LTEtMS03NzAzMg_6f0425be-c173-4b22-bbd5-12a7063deea6">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i238ac34b0aab41be8134d8a775d08e2d_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy0xMC0xLTEtNzcwMzI_d6ef4d18-2851-43b3-b171-930db4854c4d">8,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i401b2c604f694027b1c4dac9b79e2995_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNS02LTEtMS03NzAzMg_8654699f-3839-4b17-9de9-849eac016248">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5730d0771f684643b95bbc057538e077_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNS04LTEtMS03NzAzMg_9f4a5fee-a2f6-423a-9490-e5879d603f32">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a31b884457e403e9ff8ac44f5eb8b7b_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNS05LTEtMS03NzAzMg_aa1a0195-9a71-460e-b226-cb9b9b18a1ab">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNS0xMC0xLTEtNzcwMzI_c4f68654-05c3-4f24-aaa3-39a8274e51d0">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i334dc65857104da8bf45462dbc5304e8_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNi03LTEtMS03NzAzMg_35fa455b-03d6-49d0-bf94-f7ab586a135c">166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5730d0771f684643b95bbc057538e077_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNi04LTEtMS03NzAzMg_201d35e6-beea-4673-aafa-e3c01c5b5d30">166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNi0xMC0xLTEtNzcwMzI_829b9ace-17cb-4225-863e-ff881fa77142">166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b3a8f0389c44c1f970975d4fd28fd40_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNy0zLTEtMS03NzAzMg_128a891e-6c2b-451f-9b8b-919ae04396ba">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b3a8f0389c44c1f970975d4fd28fd40_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNy00LTEtMS03NzAzMg_d6e8cb96-bcbb-4add-a837-58f93f8b90d6">300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4078e49ac5b14aba9f645b46af62a911_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNy01LTEtMS03NzAzMg_47f4b329-3f20-44c8-bb06-652e29706aea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5730d0771f684643b95bbc057538e077_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNy04LTEtMS03NzAzMg_0fcae4ae-ae0e-424d-a2ec-c89891923d6a">300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNy0xMC0xLTEtNzcwMzI_02313e77-79ba-4ba5-b0cd-5d4d762cc342">300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock issued under employee benefit plans and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7b3a8f0389c44c1f970975d4fd28fd40_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfOC0zLTEtMS03NzAzMg_ccdb17b1-b7d7-468c-bae8-e5afaa67ac7f">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b3a8f0389c44c1f970975d4fd28fd40_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfOC00LTEtMS03NzAzMg_cc6a76b8-1e0a-4c01-8c46-bdb0edd4a28f">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4078e49ac5b14aba9f645b46af62a911_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfOC01LTEtMS03NzAzMg_2587d795-83b3-4da3-951d-eb251440f508">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5730d0771f684643b95bbc057538e077_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfOC04LTEtMS03NzAzMg_6789004a-fe2d-495b-ac7a-68aa6037a1c7">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfOC0xMC0xLTEtNzcwMzI_4a2573ab-96ea-4970-903d-256d7b5335e8">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared on common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i401b2c604f694027b1c4dac9b79e2995_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfOS02LTEtMS03NzAzMg_91268a82-0724-4c97-8398-94fd09e2d517">124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5730d0771f684643b95bbc057538e077_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfOS04LTEtMS03NzAzMg_200891cb-c9d3-48ae-b67e-c4ce809c2c93">124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfOS0xMC0xLTEtNzcwMzI_e1987d13-2dd1-4e1d-9a66-de3016f01a60">124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a31b884457e403e9ff8ac44f5eb8b7b_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTAtOS0xLTEtNzcwMzI_d7eb4520-7daa-4c79-800c-2b711710353c">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTAtMTAtMS0xLTc3MDMy_c16b05e2-8cd2-4174-9d63-819f9efbc203">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e57d971a44a4a3f949731983ffafba1_I20210331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtMS0xLTEtNzcwMzI_99734b14-4792-4cb0-a349-b0794077077d">683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e57d971a44a4a3f949731983ffafba1_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtMi0xLTEtNzcwMzI_2f814c61-851e-4469-a94d-2ea06c3ef885">683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia19d724121ef4d3794c045dd65c77f7b_I20210331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtMy0xLTEtNzcwMzI_6db13359-b3d3-4ee7-afbc-6d6095b95a39">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia19d724121ef4d3794c045dd65c77f7b_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtNC0xLTEtNzcwMzI_38568a64-510c-4944-8215-a9b12785b82f">11,296</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd8d7f5c9b384bc1a8366b6af711f1c8_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtNS0xLTEtNzcwMzI_72cd2948-b0f0-4bc9-a38b-d33283de80b5">6,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84fd6f93f3d74fcb85ae2bf1c449792d_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtNi0xLTEtNzcwMzI_ffe02b25-cd9c-4709-bba3-afde443f0ea9">16,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib20ef40d3e874271b4203597bb847021_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtNy0xLTEtNzcwMzI_d318698b-41f5-4fd4-874b-d47995270139">3,480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc051d99f31b4d40b60823ffb0ce2ab4_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtOC0xLTEtNzcwMzI_da86af8d-6bf7-446b-9310-84e375e6e83b">8,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059198fbccc048f8afbe074a190f2478_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtOS0xLTEtNzcwMzI_19774a31-ff34-424e-a32a-c2956ce19332">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4edbb47a30cf46afbff865ead00dd98c_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtMTAtMS0xLTc3MDMy_094cb617-c713-4b48-81e7-d1b8defbd81e">8,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.329%"><tr><td style="width:1.0%"></td><td style="width:23.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.260%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i8787971997a742729b9820f85443271c_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statements of Cash Flows (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in millions)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operations</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMy0xLTEtMS03NzAzMg_6cfa1ba9-13dd-4bd9-90a0-1f5643fd9301">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMy0yLTEtMS03NzAzMg_b5f36993-102d-4319-ac01-265542b870a8">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to cash flows from operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfNS0xLTEtMS03NzAzMg_84972fcf-79dd-425b-a40c-39059ca31d77">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfNS0yLTEtMS03NzAzMg_7636044f-56aa-4511-b971-bf68c374da81">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfNi0xLTEtMS03NzAzMg_129a5d70-d204-4998-a587-073cc5d2b8d1">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfNi0yLTEtMS03NzAzMg_17de347a-dfe8-4333-843b-5cc2025ba6e8">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfNy0xLTEtMS03NzAzMg_d2d87766-7152-4df4-b2d9-1b15523dfc25">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfNy0yLTEtMS03NzAzMg_6818c7c1-aab5-4f90-b966-1e988c20c189">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension and other postretirement costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfOC0xLTEtMS03NzAzMg_9cf706b6-29da-44dd-b1fc-4b01ff1feffb">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfOC0yLTEtMS03NzAzMg_00be7d2c-7622-45f5-a28d-5f8f82a5c3eb">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTAtMS0xLTEtNzcwMzI_9a64ce5c-ad82-4555-8c21-7aa7f9447015">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTAtMi0xLTEtNzcwMzI_1d7652a6-c101-4721-891d-7e6e966250c2">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in balance sheet items:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTItMS0xLTEtNzcwMzI_031adc4a-37ca-4b0c-9722-391ba1b6c6ca">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTItMi0xLTEtNzcwMzI_4d7b86e9-3a8b-4708-8a4d-7389ff86b1df">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTMtMS0xLTEtNzcwMzI_eadc9583-e96d-4f9f-aa24-362abf976d60">105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTMtMi0xLTEtNzcwMzI_dfd0931e-7cfd-4ace-9f59-caaa69864ead">129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTQtMS0xLTEtNzcwMzI_e31d8e9a-7907-46fb-a3f5-d7210777b475">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTQtMi0xLTEtNzcwMzI_b42c01a0-2dbe-40c7-a2a2-36e25de78647">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTUtMS0xLTEtNzcwMzI_2c642ac8-a33b-490e-a024-0b1ecff415a0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTUtMi0xLTEtNzcwMzI_afb23b3d-3c2a-4761-926f-abd96a37f389">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTYtMS0xLTEtNzcwMzI_ddd4bde6-436c-4358-8b7a-d6d277c0a88c">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTYtMi0xLTEtNzcwMzI_32bf17f6-534d-4897-8af7-56c7aa657a75">124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTctMS0xLTEtNzcwMzI_a9c99c3e-a1fb-4300-b736-326852343985">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTctMi0xLTEtNzcwMzI_99e0d780-ebf1-467e-943e-7393bf104090">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjAtMS0xLTEtNzcwMzI_f782ada7-2310-4741-80fa-1f83824b1c3a">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjAtMi0xLTEtNzcwMzI_bbdcdbf5-7927-46bf-b354-2be90ee22f81">377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjItMS0xLTEtNzcwMzI_bdbe2c34-0af9-4cc2-8cb8-dad3a58885b0">140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjItMi0xLTEtNzcwMzI_a55f5756-e7c1-4004-bd93-19a557566328">171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired, and investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjMtMS0xLTEtNzcwMzI_32f9c088-1de4-4504-a4e5-5356e44b1ec7">174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjMtMi0xLTEtNzcwMzI_86a7535a-0ae5-426b-8abe-314bf239e71c">381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investing activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjQtMS0xLTEtNzcwMzI_51375781-f2bc-4486-969a-dce332c73dcf">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjQtMi0xLTEtNzcwMzI_3da768a4-de38-4eb0-9c95-526fcc556ae1">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjUtMS0xLTEtNzcwMzI_1e21cfff-513a-46b6-9ce8-4687ba294e5f">304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjUtMi0xLTEtNzcwMzI_471277fe-1a66-4623-a507-838736b0ab6d">538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjctMS0xLTEtNzcwMzI_6a4b75ab-70c5-4b6d-8b2d-b0214d76a25a">404</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjctMi0xLTEtNzcwMzI_592ac7e8-ba50-470b-8332-e2917efaef3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decreases in debt with original maturities of three months or less</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjktMS0xLTEtNzcwMzI_84de2496-c431-45eb-bf50-682050adace0">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjktMi0xLTEtNzcwMzI_49023c5d-e3d3-4c58-8bd8-bce1955e04db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends on common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzAtMS0xLTEtNzcwMzI_4cc169bf-99dc-4388-a94a-c4f1c368f736">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzAtMi0xLTEtNzcwMzI_d9ca2198-5777-4521-a995-8162c00b0dc3">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from stock issued under employee benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzEtMS0xLTEtNzcwMzI_66e57965-8510-4c6e-83df-ebf83768c9ed">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzEtMi0xLTEtNzcwMzI_7a0ae195-bc66-4425-8182-383883e68dfd">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzItMS0xLTEtNzcwMzI_0f0bcbc5-8cfa-4268-8199-8afda6faf40a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzItMi0xLTEtNzcwMzI_96d784c2-d279-451e-834f-aa12eaebfedb">253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzQtMS0xLTEtNzcwMzI_0a2d0ce7-2799-4415-82e3-43101767b72e">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzQtMi0xLTEtNzcwMzI_d293e566-1b20-4510-8bf7-57b3f220ea6f">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzUtMS0xLTEtNzcwMzI_96d43bd0-c287-40e7-bc15-9c5bb11887ba">548</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzUtMi0xLTEtNzcwMzI_8a10fa7b-8eb3-4062-a4d7-fa41fb58c117">358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzYtMS0xLTEtNzcwMzI_a7a8bee8-f17b-4ecd-8b76-18976392a812">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzYtMi0xLTEtNzcwMzI_d83f4ed8-44ca-46c4-9a93-05ad41f60073">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzctMS0xLTEtNzcwMzI_699d4373-e64c-47b1-8ea5-4cc4734db0ea">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzctMi0xLTEtNzcwMzI_d6aefcd7-06da-4e61-b7b6-b892b7091c2e">550</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzgtMS0xLTEtNzcwMzI_13f35301-dea9-413f-b5f7-9ed6808fa9ae">2,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i238ac34b0aab41be8134d8a775d08e2d_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzgtMi0xLTEtNzcwMzI_81b199f8-46cb-499e-87ef-81115911ecd7">3,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzktMS0xLTEtNzcwMzI_4cc77988-0a14-47a5-baa8-271ce71b1caf">2,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4edbb47a30cf46afbff865ead00dd98c_I20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzktMi0xLTEtNzcwMzI_0eea4050-8459-42cf-9271-ac04667e54c9">3,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RleHRyZWdpb246ZWZlN2RlZmJlM2Q2NDVhMGIzNjA1ZWQ4Y2Q5ZDU1ZThfNDkz_b349bd57-b23c-414e-a785-abb60d23a955" continuedAt="ie16124001ba64f579d4a7e45a5a9c4e4" footnoteRole="http://www.xbrl.org/2003/role/footnote"> The following table provides a reconciliation of cash, cash equivalents and restricted cash shown above to the amounts reported within the condensed consolidated balance sheet as of March&#160;31, 2022, December&#160;31, 2021, and March&#160;31, 2021 (in millions):</ix:footnote></span><ix:continuation id="ie16124001ba64f579d4a7e45a5a9c4e4"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMS0xLTEtMS03NzAzMg_c1665869-6a34-40c2-8d8c-eb9759a4d704">2,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMS0yLTEtMS03NzAzMg_6b1452eb-3072-49ae-a6f4-f23256a61c8e">2,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4edbb47a30cf46afbff865ead00dd98c_I20210331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMS0zLTEtMS03NzAzMg_d67fefdf-61c5-4a97-b7e5-af49a870f844">3,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash included in prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMi0xLTEtMS03NzAzMg_8b0eb22c-074e-4cb9-908d-15d75a2f0dbe">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMi0yLTEtMS03NzAzMg_6de0f237-e050-402a-b23d-314bd33eb2d0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4edbb47a30cf46afbff865ead00dd98c_I20210331" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMi0zLTEtMS03NzAzMg_70ee2ddb-a40d-4898-a450-222235d33c9f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMy0xLTEtMS03NzAzMg_214f39c3-8ada-41ff-bf68-effd7537493a">2,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMy0yLTEtMS03NzAzMg_5f50c103-ff75-458f-b523-53632a5b6abe">2,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4edbb47a30cf46afbff865ead00dd98c_I20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMy0zLTEtMS03NzAzMg_bbad26d7-1915-463b-bd13-18342cb0b71e">3,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i8787971997a742729b9820f85443271c_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Baxter International Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Condensed Consolidated Financial Statements (unaudited)</span></div><div id="i8787971997a742729b9820f85443271c_34"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">1. <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNC9mcmFnOmVjNDIzMWFmOGM1NzRjZDhhYzIyNmFlZTQxMzdhNzhmL3RleHRyZWdpb246ZWM0MjMxYWY4YzU3NGNkOGFjMjI2YWVlNDEzN2E3OGZfNDE5OA_2d22be17-2b4b-4409-abad-269491864ec9" continuedAt="i26903780a4364d8e93b4ba75cb1fc0cf" escape="true">BASIS OF PRESENTATION</ix:nonNumeric></span></div><ix:continuation id="i26903780a4364d8e93b4ba75cb1fc0cf"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNC9mcmFnOmVjNDIzMWFmOGM1NzRjZDhhYzIyNmFlZTQxMzdhNzhmL3RleHRyZWdpb246ZWM0MjMxYWY4YzU3NGNkOGFjMjI2YWVlNDEzN2E3OGZfNDE5NQ_be28a3b9-cf0a-4c21-bb94-e1f9a2faf1b1" continuedAt="i8fb3c9bcf0d242c3ac1a803493e8e888" escape="true">The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (we or our) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) in the United States have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 (2021 Annual Report).</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8fb3c9bcf0d242c3ac1a803493e8e888">In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the current interim period are not necessarily indicative of the results of operations to be expected for the full year.</ix:continuation> </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="bax:RisksAndUncertaintiesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNC9mcmFnOmVjNDIzMWFmOGM1NzRjZDhhYzIyNmFlZTQxMzdhNzhmL3RleHRyZWdpb246ZWM0MjMxYWY4YzU3NGNkOGFjMjI2YWVlNDEzN2E3OGZfNDE5MQ_61d322a5-604d-4d69-a7a7-8461ad9138ea" continuedAt="ibbbc7cb8d11f46549fb883b4d8889285" escape="true">Risks and Uncertainties Related to COVID-19 and Global Economic Conditions </ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibbbc7cb8d11f46549fb883b4d8889285">Our global operations expose us to risks associated with public health crises and epidemics/pandemics, such as the novel strain of coronavirus (COVID-19). COVID-19 has had, and we expect will continue to have, an adverse impact on our operations, supply chains and distribution systems and has increased and we expect will continue to increase our expenses, including as a result of impacts associated with preventive and precautionary measures that we, other businesses and governments have taken and continue to take. Initial measures taken in 2020 led to unprecedented restrictions on, disruptions in, and other related impacts on business and personal activities, including a shift in healthcare priorities, which resulted in a significant decline in medical procedures in 2020. The pandemic has created significant volatility in the demand for our products. For further information about our revenues by product category, refer to Note 9. Significant uncertainty remains regarding the duration and overall impact of the COVID-19 pandemic.  For example, concerns remain regarding the pace of economic recovery due to virus resurgence across the globe from the Omicron variants, subvariants and other virus mutations as well as vaccine distribution and hesitancy. The U.S. and other governments may continue existing measures or implement new restrictions and other requirements in light of the continuing spread of the pandemic (including with respect to mandatory vaccinations for certain of our employees, moratoriums on elective procedures and mandatory quarantines and travel restrictions). Due to the uncertainty caused by the pandemic, our operating performance and financial results, particularly in the short term, may be subject to volatility.  We have experienced significant challenges, including lengthy delays, shortages and interruptions, posed by the pandemic and other exogenous factors (including significant weather events, disruptions to certain ports of call around the world and certain geopolitical events) to our global supply chain, including the cost and availability of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, and may experience these and other challenges in future periods.  Many of our manufacturing plant and distribution center personnel are currently unvaccinated, and we may also experience employee resistance in complying with current and future government vaccine and testing mandates, which may cause labor shortages significantly impacting manufacturing production and distribution center productivity.  We expect that these challenges as well as evolving governmental restrictions and requirements, among other factors, may continue to have an adverse effect on our business.</ix:continuation>  </span></div><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNC9mcmFnOmVjNDIzMWFmOGM1NzRjZDhhYzIyNmFlZTQxMzdhNzhmL3RleHRyZWdpb246ZWM0MjMxYWY4YzU3NGNkOGFjMjI2YWVlNDEzN2E3OGZfMjc0ODc3OTA4MDcwOQ_f2aaf75e-37ab-4b52-8dda-d4ae12adae94" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently adopted accounting pronouncements</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 1, 2022, we adopted Accounting Standards Update (ASU) 2021-05, Leases (Topic 842), which requires a lessor to classify a lease with variable lease payments (that do not depend on an index or rate) as an operating lease if (1) the lease would have been classified as a sales-type or direct financing lease, and (2) the lessor would have recognized a selling loss at lease commencement. These changes are intended to avoid recognizing a day-one loss for a lease with variable payments even though the lessor expects the arrangement will be profitable overall. The adoption of this ASU did not have a material impact on our condensed consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i8787971997a742729b9820f85443271c_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2. <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMTEzMzA_78c5a997-e8b3-4a53-b0e3-b7449f84b3f0" continuedAt="if15d567f550a42879f276828cd6048e5" escape="true">ACQUISITIONS AND OTHER ARRANGEMENTS</ix:nonNumeric></span></div><ix:continuation id="if15d567f550a42879f276828cd6048e5" continuedAt="i2133ab1c32684495afda9cec5fba0ad3"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Hillrom</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 13, 2021, we completed our acquisition of all outstanding equity interests of Hill-Rom Holdings, Inc. (Hillrom) for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-8" name="bax:BusinessCombinationCashConsideration" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDY3Ng_f42a02bf-9067-4cc6-87b4-f90c807ba0ce">10.5</ix:nonFraction>&#160;billion.  Including the assumption of Hillrom's outstanding debt, the enterprise value of the transaction was approximately $<ix:nonFraction unitRef="usd" contextRef="i76d012ba0e6842c4bc044efa2367e442_D20211213-20211213" decimals="-8" name="bax:BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDcwMA_e043646f-7f52-44ec-815b-2c084f384231">12.8</ix:nonFraction>&#160;billion.  Under the terms of the transaction agreement, Hillrom shareholders received $<ix:nonFraction unitRef="usdPerShare" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDY5MQ_f892bce7-20b4-47fc-8830-b232507ee5b5">156.00</ix:nonFraction> in cash per outstanding Hillrom common share. </span></div><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDc4OQ_b1d6dd4e-61de-40db-b36f-5db07747be23" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the total consideration paid:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration paid to Hillrom shareholders</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76d012ba0e6842c4bc044efa2367e442_D20211213-20211213" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmRmNGZjNjNlMTRiMzRiZmU4Y2M2ZmM3NmUzMjhjYjZhL3RhYmxlcmFuZ2U6ZGY0ZmM2M2UxNGIzNGJmZThjYzZmYzc2ZTMyOGNiNmFfMS0xLTEtMS04NTczNQ_b8619652-84a7-4ec3-b37f-73eaf5a0af36">10,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of equity awards issued to Hillrom equity award holders</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76d012ba0e6842c4bc044efa2367e442_D20211213-20211213" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmRmNGZjNjNlMTRiMzRiZmU4Y2M2ZmM3NmUzMjhjYjZhL3RhYmxlcmFuZ2U6ZGY0ZmM2M2UxNGIzNGJmZThjYzZmYzc2ZTMyOGNiNmFfMi0xLTEtMS04NTczNQ_ab6207d6-ecab-4a6a-a312-42bdd2cdc4bc">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76d012ba0e6842c4bc044efa2367e442_D20211213-20211213" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmRmNGZjNjNlMTRiMzRiZmU4Y2M2ZmM3NmUzMjhjYjZhL3RhYmxlcmFuZ2U6ZGY0ZmM2M2UxNGIzNGJmZThjYzZmYzc2ZTMyOGNiNmFfMy0xLTEtMS04NTczNQ_411fd4df-21f9-49bb-bdad-e2baff9f9269">10,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Represents cash consideration transferred of $<ix:nonFraction unitRef="usdPerShare" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDcxNQ_eef3545e-5eb8-4d08-9666-93227714fcd3">156.00</ix:nonFraction> per outstanding Hillrom common share to existing shareholders and holders of equity awards that vested at closing pursuant to their original terms.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Represents the pre-acquisition service portion of the fair value of <ix:nonFraction unitRef="shares" contextRef="i76d012ba0e6842c4bc044efa2367e442_D20211213-20211213" decimals="-3" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMTA5OTUxMTY1ODc5MA_f51e2a90-1e5a-49d6-a956-bed51683b3a2">668</ix:nonFraction>&#160;thousand replacement restricted stock units issued to Hillrom equity award holders at closing.</span></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation of assets acquired and liabilities assumed has not yet been finalized as of March 31, 2022. Finalization of the valuation during the measurement period could result in a change in the amounts recorded for acquired intangible assets, goodwill and income taxes among other items. The completion of the valuation will occur no later than one year from the acquisition date.<ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDc5MA_723a1a5c-7d9b-4f05-bdd3-0d43d909a059" continuedAt="i432a2515bc5e4d3d9f04e75f9041a093" escape="true">The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed as of the acquisition date:</ix:nonNumeric></span></div><div style="margin-top:3pt"><ix:continuation id="i432a2515bc5e4d3d9f04e75f9041a093"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets acquired and liabilities assumed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMi0xLTEtMS04NTg5Nw_0a0b1776-d7e9-4152-82c0-ae37115a43c9">399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMy0xLTEtMS04NTg5Nw_17919127-213e-483f-a23a-46c563a4567d">590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfNC0xLTEtMS04NTg5Nw_d8f11d84-4b6e-4e25-9a4d-10644c038e4d">557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfNS0xLTEtMS04NTg5Nw_6b92b40a-ae70-4c0c-bc1f-cfc5bbf9b996">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfNi0xLTEtMS04NTg5Nw_4accc985-4875-4dab-8244-ebca47a25309">502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfNy0xLTEtMS04NTg5Nw_1e032199-7403-468a-b474-36ab0197f716">6,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfOC0xLTEtMS04NTg5Nw_b52e8ee9-8b7a-46eb-80ce-ab791739d1eb">6,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-6" name="bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfOS0xLTEtMS04NTg5Nw_913a4cfc-f878-451c-bb0e-8131ee429c50">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMTAtMS0xLTEtODU4OTc_c6055368-bebf-4c65-8263-4f0e5d3d19f7">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-6" name="bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMTEtMS0xLTEtODU4OTc_3a422cf3-9732-4a11-aee1-8fbbcbf2e5c6">250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMTItMS0xLTEtODU4OTc_1c02d687-d29a-4ca5-98e3-ae6da8b9f146">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMTMtMS0xLTEtODU4OTc_2f611b86-9069-482f-b371-31f149c90b64">552</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMTQtMS0xLTEtODU4OTc_3a68a117-22a1-4165-8d75-5850d1f022a9">2,118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMTUtMS0xLTEtODU4OTc_7562dad1-c12b-4700-b3cd-326aceaa2ee1">57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMTYtMS0xLTEtODU4OTc_9723b396-6b3a-4b85-b510-91341577c03f">1,527</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired and liabilities assumed</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969c52a42b424c649a401568d787c03d_I20211213" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMTctMS0xLTEtODU4OTc_11e7e923-1658-4b80-8f37-4c3ff4efbb55">10,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we recorded measurement period adjustments to increase other intangible assets of $<ix:nonFraction unitRef="usd" contextRef="i0627724177f1427fb42008e3261d78c0_D20220101-20220331" decimals="-6" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDczOQ_14265054-7b20-4f3d-be28-01e24c44328d">7</ix:nonFraction>&#160;million, increase deferred income tax liabilities of $<ix:nonFraction unitRef="usd" contextRef="i0627724177f1427fb42008e3261d78c0_D20220101-20220331" decimals="-6" name="bax:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDcyNg_86e4e0cc-ab16-4330-ad75-117fcbc43f7c">11</ix:nonFraction>&#160;million, other individually insignificant adjustments for a net </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2133ab1c32684495afda9cec5fba0ad3"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decrease to assets acquired and liabilities assumed of $<ix:nonFraction unitRef="usd" contextRef="i0627724177f1427fb42008e3261d78c0_D20220101-20220331" decimals="-6" sign="-" name="bax:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDc1MQ_49acd62c-44e4-4739-ae2f-de94a8891dde">6</ix:nonFraction>&#160;million and a corresponding increase to goodwill of $<ix:nonFraction unitRef="usd" contextRef="i0627724177f1427fb42008e3261d78c0_D20220101-20220331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDc2Mw_e6f5a3b9-ced4-4130-828e-43188c76396c">10</ix:nonFraction>&#160;million. The measurement period adjustments did not have a significant impact our results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill, which is not deductible for tax purposes, includes the value of an assembled workforce as well as the overall strategic benefits provided to our product portfolio and is included in the Hillrom segment. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2022, we recognized $<ix:nonFraction unitRef="usd" contextRef="i0627724177f1427fb42008e3261d78c0_D20220101-20220331" decimals="-6" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDc3Ng_6e99ad59-86b3-40e1-a06e-b3c85ffda110">159</ix:nonFraction>&#160;million of incremental costs of sales from the fair value step-ups on acquired Hillrom inventory that was sold in the current period. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Other Business Development Activities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2022, we entered into an agreement with a subsidiary of Pfizer Inc. to acquire the rights to Zosyn, a premixed frozen piperacillin-tazobactam product, in the U.S. and Canada. Zosyn is used for the treatment of intra-abdominal infections, nosocomial pneumonia, skin and skin structure infections, female pelvic infections and community-acquired pneumonia. Under the terms of the acquisition, we paid the acquisition price of $<ix:nonFraction unitRef="usd" contextRef="i21e54c53c46c4b708c6f8469337d00f5_D20220301-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMTA5OTUxMTY3MzM4OA_a1f1ba47-798d-41bc-98ce-4ab351fc04ff">122</ix:nonFraction> million currently, received specified intellectual property, including patent rights, in the current period and will receive additional intellectual property, including the product rights to Zosyn, in one year.  Under the arrangement, we are entitled to receive profit sharing payments from sales of Zosyn until the product rights transfer to us in March 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The transaction has been accounted for as an asset acquisition, as substantially all of the fair value of the assets being acquired under the arrangement was concentrated in the product rights that we will receive, which we classify as a developed technology intangible asset. Accordingly, the $<ix:nonFraction unitRef="usd" contextRef="i21e54c53c46c4b708c6f8469337d00f5_D20220301-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMTA5OTUxMTY1NjE3OA_a1f1ba47-798d-41bc-98ce-4ab351fc04ff">122</ix:nonFraction> million purchase price was primarily allocated to the developed technology intangible asset class and will be amortized over an estimated useful life of <ix:nonNumeric contextRef="iaad890641b794c4ab677efe29d43bfc3_D20220301-20220331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMTA5OTUxMTY1NjU1Mg_3d22e2bf-21d0-4444-b056-7506efc1da4e">9</ix:nonNumeric> years.</span></div></ix:continuation><div id="i8787971997a742729b9820f85443271c_40"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">3. <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfNzE2_cbdc5f48-cb07-4418-84e9-5e352b894c0c" continuedAt="i2edb3a1206ff4b48935b62ff41e42aa7" escape="true">SUPPLEMENTAL FINANCIAL INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i2edb3a1206ff4b48935b62ff41e42aa7" continuedAt="i172655e468994ac0ad481b7e201ed770"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfNzE5_8f89a839-b318-4a40-a6c6-7f45fe9bee77" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Doubtful Accounts</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the changes in our allowance for doubtful accounts for the three months ended March&#160;31, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.263%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfMi0xLTEtMS03NzAzMg_4f0e0b9e-2d80-4523-b59a-cc7941fc37d1">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i238ac34b0aab41be8134d8a775d08e2d_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfMi0yLTEtMS03NzAzMg_f37953a6-99c9-47e8-9870-df7f298481e9">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfNC0xLTEtMS03NzAzMg_91a38572-eb0a-45ba-86ef-f989f813bf72">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfNC0yLTEtMS03NzAzMg_7dc289b6-b5f6-4eff-b301-12e8297e52f3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfNS0xLTEtMS03NzAzMg_2180abcb-4e25-41ce-a55d-cb4b4bc741c4">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfNS0yLTEtMS03NzAzMg_8e8447f8-485b-481a-ba4a-e14d13f4827e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfNi0xLTEtMS03NzAzMg_97bb27f9-573b-4b01-a05b-030557f44f8f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfNi0yLTEtMS03NzAzMg_4f1349c3-8307-472c-a0b9-18c84d472208">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfNy0xLTEtMS03NzAzMg_a803b867-5b0c-48d0-a022-503099279174">129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4edbb47a30cf46afbff865ead00dd98c_I20210331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfNy0yLTEtMS03NzAzMg_28d416fd-e5e8-4c5d-962a-3ccee0bb70f3">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:13pt"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfNzEz_40b7f702-7292-4cca-aaaa-050d0db54bd4" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:InventoryRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmFjNTFmMmE2OWRkYjQyNDRhM2E0YWNjMDZlNzQyMzUzL3RhYmxlcmFuZ2U6YWM1MWYyYTY5ZGRiNDI0NGEzYTRhY2MwNmU3NDIzNTNfMS0xLTEtMS03NzAzMg_13f8df30-5c3f-48e7-b676-d4e7af642913">656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:InventoryRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmFjNTFmMmE2OWRkYjQyNDRhM2E0YWNjMDZlNzQyMzUzL3RhYmxlcmFuZ2U6YWM1MWYyYTY5ZGRiNDI0NGEzYTRhY2MwNmU3NDIzNTNfMS0yLTEtMS03NzAzMg_6778fa8e-b974-4489-9838-4d947cbf49bb">591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:InventoryWorkInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmFjNTFmMmE2OWRkYjQyNDRhM2E0YWNjMDZlNzQyMzUzL3RhYmxlcmFuZ2U6YWM1MWYyYTY5ZGRiNDI0NGEzYTRhY2MwNmU3NDIzNTNfMi0xLTEtMS03NzAzMg_45b76788-1f96-4a45-bffd-026b979eda16">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:InventoryWorkInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmFjNTFmMmE2OWRkYjQyNDRhM2E0YWNjMDZlNzQyMzUzL3RhYmxlcmFuZ2U6YWM1MWYyYTY5ZGRiNDI0NGEzYTRhY2MwNmU3NDIzNTNfMi0yLTEtMS03NzAzMg_adce6530-50f4-45a0-a539-01d898cc3b0d">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmFjNTFmMmE2OWRkYjQyNDRhM2E0YWNjMDZlNzQyMzUzL3RhYmxlcmFuZ2U6YWM1MWYyYTY5ZGRiNDI0NGEzYTRhY2MwNmU3NDIzNTNfMy0xLTEtMS03NzAzMg_c1f19c2a-459a-4498-a347-933f7de7273a">1,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmFjNTFmMmE2OWRkYjQyNDRhM2E0YWNjMDZlNzQyMzUzL3RhYmxlcmFuZ2U6YWM1MWYyYTY5ZGRiNDI0NGEzYTRhY2MwNmU3NDIzNTNfMy0yLTEtMS03NzAzMg_03f9f340-2e57-4e94-bf8f-ba38c6e1fefa">1,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmFjNTFmMmE2OWRkYjQyNDRhM2E0YWNjMDZlNzQyMzUzL3RhYmxlcmFuZ2U6YWM1MWYyYTY5ZGRiNDI0NGEzYTRhY2MwNmU3NDIzNTNfNC0xLTEtMS03NzAzMg_6752b0ad-6e70-4e65-a6da-3d7f2b96b3fe">2,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmFjNTFmMmE2OWRkYjQyNDRhM2E0YWNjMDZlNzQyMzUzL3RhYmxlcmFuZ2U6YWM1MWYyYTY5ZGRiNDI0NGEzYTRhY2MwNmU3NDIzNTNfNC0yLTEtMS03NzAzMg_65301810-cab3-48f9-8db4-8eda75d0a16b">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:13pt"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfNzE0_b61b39ac-be5f-4641-bb0e-58fbf4bcd998" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment, Net </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjY2YzVmNjg1ZWRiNjRlZjI4M2Q0NjcyM2NjOGQ2ZmM4L3RhYmxlcmFuZ2U6NjZjNWY2ODVlZGI2NGVmMjgzZDQ2NzIzY2M4ZDZmYzhfMS0xLTEtMS03NzAzMg_17760211-9c8d-424d-b18e-0bc8aaf85176">11,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjY2YzVmNjg1ZWRiNjRlZjI4M2Q0NjcyM2NjOGQ2ZmM4L3RhYmxlcmFuZ2U6NjZjNWY2ODVlZGI2NGVmMjgzZDQ2NzIzY2M4ZDZmYzhfMS0yLTEtMS03NzAzMg_c7bb818e-1a65-4c06-86bc-5af2d47198e0">11,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjY2YzVmNjg1ZWRiNjRlZjI4M2Q0NjcyM2NjOGQ2ZmM4L3RhYmxlcmFuZ2U6NjZjNWY2ODVlZGI2NGVmMjgzZDQ2NzIzY2M4ZDZmYzhfMi0xLTEtMS03NzAzMg_eda28ffa-852f-4974-ad8b-6a3ade506786">6,643</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjY2YzVmNjg1ZWRiNjRlZjI4M2Q0NjcyM2NjOGQ2ZmM4L3RhYmxlcmFuZ2U6NjZjNWY2ODVlZGI2NGVmMjgzZDQ2NzIzY2M4ZDZmYzhfMi0yLTEtMS03NzAzMg_fb80b48e-cd81-4035-85b0-9cf484706ba8">6,550</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjY2YzVmNjg1ZWRiNjRlZjI4M2Q0NjcyM2NjOGQ2ZmM4L3RhYmxlcmFuZ2U6NjZjNWY2ODVlZGI2NGVmMjgzZDQ2NzIzY2M4ZDZmYzhfMy0xLTEtMS03NzAzMg_465ae587-2035-4198-a6f9-02c7f9ada2c6">5,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjY2YzVmNjg1ZWRiNjRlZjI4M2Q0NjcyM2NjOGQ2ZmM4L3RhYmxlcmFuZ2U6NjZjNWY2ODVlZGI2NGVmMjgzZDQ2NzIzY2M4ZDZmYzhfMy0yLTEtMS03NzAzMg_2d031dad-9694-480f-8fb3-c4fb855d27d9">5,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i172655e468994ac0ad481b7e201ed770"><div style="margin-top:13pt"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfMjc0ODc3OTA3MDgzMw_c0e292ca-5820-4796-97a5-8174f0232ffe" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Interest Expense, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.263%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net of capitalized interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjg5MGViYWQ1MjgxMDRkZTZiOGI4ZTg2ZjVhYmZiMzMwL3RhYmxlcmFuZ2U6ODkwZWJhZDUyODEwNGRlNmI4YjhlODZmNWFiZmIzMzBfMi0xLTEtMS04NjQ2OQ_097795c8-0531-4008-ad60-b5d544ac1b59">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjg5MGViYWQ1MjgxMDRkZTZiOGI4ZTg2ZjVhYmZiMzMwL3RhYmxlcmFuZ2U6ODkwZWJhZDUyODEwNGRlNmI4YjhlODZmNWFiZmIzMzBfMi0yLTEtMS04NjQ2OQ_db4ed46f-5ab5-4d1c-bd63-d9ffc32a81a9">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjg5MGViYWQ1MjgxMDRkZTZiOGI4ZTg2ZjVhYmZiMzMwL3RhYmxlcmFuZ2U6ODkwZWJhZDUyODEwNGRlNmI4YjhlODZmNWFiZmIzMzBfMy0xLTEtMS04NjQ2OQ_51febbc6-d641-4cd9-8470-6e89e6495363">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjg5MGViYWQ1MjgxMDRkZTZiOGI4ZTg2ZjVhYmZiMzMwL3RhYmxlcmFuZ2U6ODkwZWJhZDUyODEwNGRlNmI4YjhlODZmNWFiZmIzMzBfMy0yLTEtMS04NjQ2OQ_9dd4549f-7cdb-406b-ab07-af315c6b4ece">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjg5MGViYWQ1MjgxMDRkZTZiOGI4ZTg2ZjVhYmZiMzMwL3RhYmxlcmFuZ2U6ODkwZWJhZDUyODEwNGRlNmI4YjhlODZmNWFiZmIzMzBfNC0xLTEtMS04NjQ2OQ_dc5e63a8-6eea-4541-b3d4-bd477c61d35d">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjg5MGViYWQ1MjgxMDRkZTZiOGI4ZTg2ZjVhYmZiMzMwL3RhYmxlcmFuZ2U6ODkwZWJhZDUyODEwNGRlNmI4YjhlODZmNWFiZmIzMzBfNC0yLTEtMS04NjQ2OQ_6facdb5c-510f-4ed9-a7ae-2a26e9d69071">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-top:13pt"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfMjc0ODc3OTA3MDgzNA_f0fcf203-039b-455a-8286-cbfb8ca3a5e9" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Other (Income) Expense, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.263%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (gains) losses, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjYzMWUxNThjZTY4NjQ2MGE5MGY0MGExNzdhODAwZTU2L3RhYmxlcmFuZ2U6NjMxZTE1OGNlNjg2NDYwYTkwZjQwYTE3N2E4MDBlNTZfMi0xLTEtMS04NjQ3OQ_b9e37768-ba3e-4a83-9a89-efdf641fd40f">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjYzMWUxNThjZTY4NjQ2MGE5MGY0MGExNzdhODAwZTU2L3RhYmxlcmFuZ2U6NjMxZTE1OGNlNjg2NDYwYTkwZjQwYTE3N2E4MDBlNTZfMi0yLTEtMS04NjQ3OQ_4396b52a-bce3-4269-a05e-7632f9aa57c9">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjYzMWUxNThjZTY4NjQ2MGE5MGY0MGExNzdhODAwZTU2L3RhYmxlcmFuZ2U6NjMxZTE1OGNlNjg2NDYwYTkwZjQwYTE3N2E4MDBlNTZfMy0xLTEtMS04NjQ3OQ_53b5977c-7e8a-48a7-8d46-02054d9926b4">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjYzMWUxNThjZTY4NjQ2MGE5MGY0MGExNzdhODAwZTU2L3RhYmxlcmFuZ2U6NjMxZTE1OGNlNjg2NDYwYTkwZjQwYTE3N2E4MDBlNTZfMy0yLTEtMS04NjQ3OQ_ab03fccb-38c8-4244-9446-7d47537eec3f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingGainsLosses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjYzMWUxNThjZTY4NjQ2MGE5MGY0MGExNzdhODAwZTU2L3RhYmxlcmFuZ2U6NjMxZTE1OGNlNjg2NDYwYTkwZjQwYTE3N2E4MDBlNTZfNS0xLTEtMS04NjQ3OQ_e2fda737-512e-494d-940b-1dba110a2d54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjYzMWUxNThjZTY4NjQ2MGE5MGY0MGExNzdhODAwZTU2L3RhYmxlcmFuZ2U6NjMxZTE1OGNlNjg2NDYwYTkwZjQwYTE3N2E4MDBlNTZfNS0yLTEtMS04NjQ3OQ_b88b8db1-5f43-464f-a91e-33baecfaba82">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjYzMWUxNThjZTY4NjQ2MGE5MGY0MGExNzdhODAwZTU2L3RhYmxlcmFuZ2U6NjMxZTE1OGNlNjg2NDYwYTkwZjQwYTE3N2E4MDBlNTZfNi0xLTEtMS04NjQ3OQ_50497a5f-0861-4606-95af-5d6cb05bd2df">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjYzMWUxNThjZTY4NjQ2MGE5MGY0MGExNzdhODAwZTU2L3RhYmxlcmFuZ2U6NjMxZTE1OGNlNjg2NDYwYTkwZjQwYTE3N2E4MDBlNTZfNi0yLTEtMS04NjQ3OQ_ec24d4c8-3e5c-47a7-bf0b-ba369260bfb0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Non-Cash Operating and Investing Activities</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Right-of-use operating lease assets obtained in exchange for lease obligations for the three months ended March&#160;31, 2022 and 2021 were $<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfNDU0_74752b57-ca65-42c8-a896-bdc3002fd487">14</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfNDYx_58a0b72b-7d40-4ed9-9770-72dfd2566508">5</ix:nonFraction>&#160;million, respectively.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Purchases of property, plant and equipment included in accounts payable as of March&#160;31, 2022 and 2021 were $<ix:nonFraction unitRef="usd" contextRef="i893821e416354e0681636831227afbcb_D20220101-20220331" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfNjg5_4f9c9ef7-7266-48f8-bb1e-6214d688220d">53</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i66457192cf5d4d76ab71f467bee6bca2_D20210101-20210331" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfNjk2_1dce30ad-29b3-4ea8-a098-05cad7e080c8">63</ix:nonFraction> million, respectively. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There were <ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="INF" name="bax:OtherLiabilitiesCurrentUnsettledShareRepurchase" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfMjc0ODc3OTA3MDU2Nw_1ce89eef-3559-4295-8886-ce8014f0c8e1">no</ix:nonFraction> unsettled share repurchases as of March&#160;31, 2022. Unsettled share repurchases included in accrued expenses and other current liabilities were $<ix:nonFraction unitRef="usd" contextRef="i4edbb47a30cf46afbff865ead00dd98c_I20210331" decimals="-6" name="bax:OtherLiabilitiesCurrentUnsettledShareRepurchase" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfMjc0ODc3OTA3MDU2OQ_2e771fda-3628-416d-991e-933679cddc7a">47</ix:nonFraction>&#160;million as of March&#160;31, 2021.</span></div></ix:continuation><div id="i8787971997a742729b9820f85443271c_43"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">4. <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RleHRyZWdpb246YmJjYWM3MzBhODNiNDA2MWI4YmRkYzI5MTJiOTdjNGVfMTQ2MQ_ae5812f5-48b0-46d5-b9d5-0d9acd857548" continuedAt="idb4fb5dd26c74bd6a8a3ada8c5aaa542" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS, NET</ix:nonNumeric></span></div><ix:continuation id="idb4fb5dd26c74bd6a8a3ada8c5aaa542" continuedAt="i2e430653bd9f43bc8baf88af66fe8806"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:9pt"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RleHRyZWdpb246YmJjYWM3MzBhODNiNDA2MWI4YmRkYzI5MTJiOTdjNGVfMTQ2NQ_982369c5-fa67-4619-b933-8c8b124a76c2" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:40.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31a852f840a74cb8b2c787ac3741588a_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfMS0xLTEtMS03NzAzMg_df64d2c8-86f7-4410-9301-5631c769f6a0">2,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i097b8af344b1429eabe401c1d86d6631_I20211231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfMS0yLTEtMS03NzAzMg_570555b7-a48e-40db-928f-28aa9bf3cc4c">309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide5f5c25f88f48b5af91862d33456fa9_I20211231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfMS0zLTEtMS03NzAzMg_4b6163f0-15dd-4c75-8831-6a0b51de989e">224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i292b133325264c6597bd7b9662bb2dda_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfMS00LTEtMS03NzMxMg_ebcfd0a5-10b9-406d-8256-e6dcfb9476c2">6,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfMS00LTEtMS03NzAzMg_5bf6f248-af43-41f8-9e1c-8701a98c145b">9,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d463df4bdbb45f0aa2538354d127517_D20220101-20220331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNC0xLTEtMS03NzAzMg_a9ed13d3-cafb-414a-a3a1-323070ea5b22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b0ebff960224f8ca45f13ec5e67356e_D20220101-20220331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNC0yLTEtMS03NzAzMg_5c5291a1-9ddc-44aa-928c-cf3ed717fc80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5a44ba447e844ac8ef93eebe8c514e2_D20220101-20220331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNC0zLTEtMS03NzAzMg_004275a4-2aed-4364-9bbe-ae475577c406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i694baf88defe4467b0cc59ac6509b10c_D20220101-20220331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNC00LTEtMS04MjUzMw_fc1fd01f-8ede-4601-9aaf-53350aa20745">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNC00LTEtMS03NzAzMg_03a2dce8-57e2-4a1e-a9c6-a09d7c3fe360">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d463df4bdbb45f0aa2538354d127517_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNS0xLTEtMS03NzAzMg_2e382ca0-f66c-4ca8-bf20-e497f51fe380">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b0ebff960224f8ca45f13ec5e67356e_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNS0yLTEtMS03NzAzMg_242daa9d-4514-4af2-a1b4-d70b10ae3550">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5a44ba447e844ac8ef93eebe8c514e2_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNS0zLTEtMS03NzAzMg_7b666286-f0fb-4d77-a32b-859a4d075eac">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i694baf88defe4467b0cc59ac6509b10c_D20220101-20220331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNS00LTEtMS03NzMyOA_7b132f53-d1e5-4221-8cb4-e0672f015866">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNS00LTEtMS03NzAzMg_62fa4d85-3340-44aa-99fb-8296c3bb9adf">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib929fbd76df144d399a18b57db4d9ae3_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNi0xLTEtMS03NzAzMg_998b6934-e663-4f86-8a99-3632be060260">2,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1022ad8302e440da3f4e203175d4b10_I20220331" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNi0yLTEtMS03NzAzMg_8cbef742-c02d-432c-9979-a6d97fadb148">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e4572eced80425baf027140478315ba_I20220331" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNi0zLTEtMS03NzAzMg_4dd8a4ca-6bb6-4620-b375-32955a253b9d">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52fbf2a8bbe449269339aa45b6bad70d_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNi00LTEtMS03NzMzNQ_9232af1f-6e8e-43e5-b1f0-5b22fa6f8086">6,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNi00LTEtMS03NzAzMg_eb574541-ffaf-4748-8a33-49eac6d790bf">9,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, there were <ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RleHRyZWdpb246YmJjYWM3MzBhODNiNDA2MWI4YmRkYzI5MTJiOTdjNGVfMTQ4_8ff29a6a-0094-4867-8a29-7cb9e8ee20be">no</ix:nonFraction> reductions in goodwill relating to impairment losses.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2e430653bd9f43bc8baf88af66fe8806"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other intangible assets, net</span></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="bax:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RleHRyZWdpb246YmJjYWM3MzBhODNiNDA2MWI4YmRkYzI5MTJiOTdjNGVfMTQ2OA_9a1c6b86-3081-421c-a9e9-ca80382ee4eb" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our other intangible assets.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology, including patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other amortized intangible assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3044fdced045cba1b544760a38b3b8_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMi0xLTEtMS03NzM4Mw_94ae33ee-062a-4f45-80d2-4b320bf944a8">3,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89a1452b79a447f2975f350bd948e3bf_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMi0xLTEtMS03NzAzMg_093504ba-ee3e-4643-80dd-eedd20e28dfa">3,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2638eb542e340638a844744dc8b8b41_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMi0yLTEtMS03NzAzMg_ed001d3c-b182-48a2-94d1-207f3ab6c907">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824274fce6e34d36bcccea3b05be564e_I20220331" decimals="-6" name="us-gaap:OtherIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMi0zLTEtMS03NzAzMg_f2e15189-3494-4d0f-8383-06aa4b8b3290">2,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMi00LTEtMS03NzAzMg_25d42429-7670-463f-b0e3-c7fbedeb7af9">9,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf3044fdced045cba1b544760a38b3b8_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMy0xLTEtMS03NzM4Mw_6ba5af9c-937c-48e9-a4a2-7e235af97a9f">262</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89a1452b79a447f2975f350bd948e3bf_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMy0xLTEtMS03NzAzMg_bec1ba07-a738-483f-ab26-b2e58128b8fb">1,638</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2638eb542e340638a844744dc8b8b41_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMy0yLTEtMS03NzAzMg_ca7c2482-9022-4a51-8ae1-67dbf31b713c">227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824274fce6e34d36bcccea3b05be564e_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMy0zLTEtMS03NzAzMg_4a80f738-8794-4472-8559-6fea598aca43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMy00LTEtMS03NzAzMg_d709248d-3b29-447c-9b82-bbbe0bf68335">2,127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3044fdced045cba1b544760a38b3b8_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNC0xLTEtMS03NzM4Mw_5bd90d48-c759-47d5-988a-5fc91ae894e8">3,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89a1452b79a447f2975f350bd948e3bf_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNC0xLTEtMS03NzAzMg_ebd73ff6-0e97-4241-8485-7ea4a8bde0b4">2,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2638eb542e340638a844744dc8b8b41_I20220331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNC0yLTEtMS03NzAzMg_52f574f6-3fcb-4871-a488-14ac66b95e55">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824274fce6e34d36bcccea3b05be564e_I20220331" decimals="-6" name="us-gaap:OtherIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNC0zLTEtMS03NzAzMg_ee3af085-3fdb-4545-80b4-b84f62077576">2,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNC00LTEtMS03NzAzMg_3edae60f-61a7-416b-9435-ab3dfed22043">7,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdd214bbcad84d1c8ac9a757a0f976d2_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNi0xLTEtMS03NzM5MA_6828da49-bf0f-4b46-bab9-34122a4c41a7">3,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abc73e3f8c249ac83f98f1ca79104ea_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNi0xLTEtMS03NzAzMg_80b0c066-272f-46e4-8e09-a73662fe2e6e">3,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656117b8223c4bdebeeb85ef817606b6_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNi0yLTEtMS03NzAzMg_d6f00ccb-4033-44ee-afc1-7431de68ed74">344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e389fa92f548b49505eb62019ce7d9_I20211231" decimals="-6" name="us-gaap:OtherIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNi0zLTEtMS03NzAzMg_09888ae4-dc9d-4824-89f6-0491eb3b0275">2,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNi00LTEtMS03NzAzMg_0f96b63e-1073-4bf9-8195-518582a198ca">9,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdd214bbcad84d1c8ac9a757a0f976d2_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNy0xLTEtMS03NzM5MA_53c5b5ea-a095-4370-9234-42ac038ab290">162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0abc73e3f8c249ac83f98f1ca79104ea_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNy0xLTEtMS03NzAzMg_f29df185-3b5e-4ba0-b6da-2ea6b259ea12">1,556</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i656117b8223c4bdebeeb85ef817606b6_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNy0yLTEtMS03NzAzMg_4c8f5613-8db5-4832-a526-535fae01130a">212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e389fa92f548b49505eb62019ce7d9_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNy0zLTEtMS03NzAzMg_e71fce14-e8ec-43e2-9f15-b7cc6ec05d1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNy00LTEtMS03NzAzMg_12ee8d26-6b08-49a2-a6d2-0a8a4211c1f9">1,930</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdd214bbcad84d1c8ac9a757a0f976d2_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfOC0xLTEtMS03NzM5MA_0116e174-2930-4068-82c8-cfac27c732f0">3,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abc73e3f8c249ac83f98f1ca79104ea_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfOC0xLTEtMS03NzAzMg_c0d98f33-8dd2-4b90-b07a-85147a9d09c0">2,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656117b8223c4bdebeeb85ef817606b6_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfOC0yLTEtMS03NzAzMg_d3a25991-59f1-488b-ac62-e3cbb684f6f7">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e389fa92f548b49505eb62019ce7d9_I20211231" decimals="-6" name="us-gaap:OtherIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfOC0zLTEtMS03NzAzMg_90e271cb-ced1-4a69-91c5-f999dcaf49f2">2,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfOC00LTEtMS03NzAzMg_681a3f68-180f-445c-9443-d1194751bfd8">7,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense was $<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RleHRyZWdpb246YmJjYWM3MzBhODNiNDA2MWI4YmRkYzI5MTJiOTdjNGVfNzc1_e574fa36-5253-4e04-bda5-c9d21a6d37ef">217</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RleHRyZWdpb246YmJjYWM3MzBhODNiNDA2MWI4YmRkYzI5MTJiOTdjNGVfNzgy_ed52e552-0a91-4cd8-b6de-9954285ab9e7">64</ix:nonFraction> million for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div></ix:continuation><div id="i8787971997a742729b9820f85443271c_46"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">5. <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMjQ1Mw_c871a2dd-04e4-4526-a256-bf1257b8c7ff" continuedAt="ibacd76aca2af4d12bc617c430a4ac549" escape="true">FINANCING ARRANGEMENTS</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="ibacd76aca2af4d12bc617c430a4ac549" continuedAt="ie5a69fe89cc24e89bd749f0bb689fe77"> </ix:continuation></span></div><ix:continuation id="ie5a69fe89cc24e89bd749f0bb689fe77"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Debt Activity</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, we repaid $<ix:nonFraction unitRef="usd" contextRef="i77dc49641a924470949595f2087ee86d_I20220331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMTY0OTI2NzQ0Nzk2Mw_b6450850-44d3-46c5-b2bb-a2ad3f3e8883">170</ix:nonFraction>&#160;million of our $<ix:nonFraction unitRef="usd" contextRef="i77dc49641a924470949595f2087ee86d_I20220331" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMTY0OTI2NzQ0ODIwOA_dba95062-9d7d-4bb2-a5e7-d2115ffda706">2.0</ix:nonFraction>&#160;billion <ix:nonNumeric contextRef="i77dc49641a924470949595f2087ee86d_I20220331" name="us-gaap:LongTermDebtTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMTY0OTI2NzQ0ODIyMQ_224969f6-464c-4e48-a4f0-9eec5a5469b5">three-year</ix:nonNumeric> term loan facility and $<ix:nonFraction unitRef="usd" contextRef="ia86774add006466498b0f2c3cba5e477_I20220331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMTY0OTI2NzQ0ODIzNQ_fac1be0e-3288-4a19-91ae-e4eb1ed76a79">175</ix:nonFraction>&#160;million of our $<ix:nonFraction unitRef="usd" contextRef="ia86774add006466498b0f2c3cba5e477_I20220331" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMTY0OTI2NzQ0ODI0OQ_56786bf1-1537-40bb-95d6-ae0c59250200">2.0</ix:nonFraction>&#160;billion <ix:nonNumeric contextRef="ia86774add006466498b0f2c3cba5e477_I20220331" name="us-gaap:LongTermDebtTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMTY0OTI2NzQ0ODI2Mg_de1c42d2-644d-4dff-847d-342df862ee28">five-year</ix:nonNumeric> term loan facility. The loss from the early extinguishment of this debt was not significant. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dollar-denominated revolving credit facility has a capacity of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="i00c553d814c644128d07318aded98980_I20220331" decimals="-8" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMTM1NA_f5b7f597-0e30-435c-a62e-a3a83938bfb9">2.5</ix:nonFraction>&#160;billion</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our Euro-denominated revolving credit facility has a capacity of &#8364;<ix:nonFraction unitRef="eur" contextRef="i00c553d814c644128d07318aded98980_I20220331" decimals="-6" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMTM5Nw_cc90d7e4-7b79-4498-9dbf-c7f50a49f781">200</ix:nonFraction> million. Each of the facilities matures in 2026. There were <ix:nonFraction unitRef="usd" contextRef="i00c553d814c644128d07318aded98980_I20220331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMjE0MQ_1fc80757-f439-4939-a685-8db0f3d789ee"><ix:nonFraction unitRef="usd" contextRef="i9e9d2cef94014f91bd8867177e914d40_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMjE0MQ_5ec37ca8-d886-478e-84ca-7f7cc0cf6723">no</ix:nonFraction></ix:nonFraction> borrowings outstanding under these credit facilities as of March&#160;31, 2022 or December&#160;31, 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Paper</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:CommercialPaperAverageOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfNDM5ODA0NjUxMzkxMQ_faac0cbe-ac88-425e-9de2-6bd1cec60f47">200</ix:nonFraction>&#160;million of commercial paper outstanding with a weighted-average interest rate of <ix:nonFraction unitRef="number" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="3" name="bax:CommercialPaperWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfNDM5ODA0NjUxMzkyNQ_693ab10a-6a9f-41c6-ad83-a06d5469f223">0.5</ix:nonFraction>% and an original weighted-average term of <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="bax:OriginalWeightedAverageTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMjc0ODc3OTA3NjEyOA_7f70bc4a-1c4d-44ff-b932-7fc730600f97">89</ix:nonNumeric> days. As of December&#160;31, 2021, we had $<ix:nonFraction unitRef="usd" contextRef="if45530e3d7994ceb8d8e400dc2ac33a7_D20210101-20211231" decimals="-6" name="us-gaap:CommercialPaperAverageOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfNDM5ODA0NjUxMzg4MA_b97d0015-b1c5-42b8-8c70-22a6014df204">300</ix:nonFraction> million of commercial paper outstanding with a weighted-average interest rate of <ix:nonFraction unitRef="number" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="4" name="bax:CommercialPaperWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfNDM5ODA0NjUxMzg5OA_a15e6c73-6f89-44cb-99a2-7d605efc4c57">0.27</ix:nonFraction>% and an original weighted-average term of <ix:nonNumeric contextRef="if45530e3d7994ceb8d8e400dc2ac33a7_D20210101-20211231" name="bax:OriginalWeightedAverageTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMjc0ODc3OTA3NjA1OA_7311f1ef-84fa-4bca-a552-0fafe87402a9">88</ix:nonNumeric> days.</span></div></ix:continuation><div id="i8787971997a742729b9820f85443271c_49"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">6. <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfODQ3Mw_bc54c6b6-e0ea-43bf-8cfe-9fcc13f40105" continuedAt="ia063166376e04780b32a898771d0d460" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="ia063166376e04780b32a898771d0d460" continuedAt="i380946106f964f5b9b9fa87df7f71ccc"> </ix:continuation></span></div><ix:continuation id="i380946106f964f5b9b9fa87df7f71ccc" continuedAt="i1f0a49fe3c5546eda7e64f07112842da"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in product liability, patent, commercial, and other legal matters that arise in the normal course of our business. We record a liability when a loss is considered probable and the amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range, and no amount within the range is a better estimate, the minimum amount in the range is accrued. If a loss is not probable or a probable loss cannot be reasonably estimated, no liability is recorded. As of March&#160;31, 2022 and December&#160;31, 2021, our total recorded reserves with respect to legal and environmental matters were $<ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfNjI2_0d61c781-5ca0-4a3e-888c-8079c244718c">57</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfNjMz_24fbd420-8f12-43b5-8f83-613e42e3ccd5">72</ix:nonFraction> million, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established reserves for certain of the matters discussed below. We are not able to estimate the amount or range of any loss for certain contingencies for which there is no reserve or additional loss for matters already reserved. While our liability in connection with these claims cannot be estimated and the resolution thereof in any reporting period could have a significant impact on our results of operations and cash flows for that period, the outcome of these legal proceedings is not expected to have a material adverse effect on our consolidated financial position. While we believe that we have valid defenses in the matters set forth below, litigation is inherently uncertain, excessive verdicts do occur, and we may incur material judgments or enter into material settlements of claims.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the matters described below, we remain subject to the risk of future administrative and legal actions. With respect to governmental and regulatory matters, these actions may lead to product recalls, injunctions, and other restrictions on our operations and monetary sanctions, including significant civil or criminal penalties. With respect to </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1f0a49fe3c5546eda7e64f07112842da" continuedAt="ica72778f0ed641e3b70126cd12cdfe65"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intellectual property, we may be exposed to significant litigation concerning the scope of our and others&#8217; rights. Such litigation could result in a loss of patent protection or the ability to market products, which could lead to a significant loss of sales, or otherwise materially affect future results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved as a potentially responsible party (PRP) for environmental clean-up costs at <ix:nonFraction unitRef="site" contextRef="i12680af003b340588584061646eb80dd_D20220101-20220331" decimals="INF" name="bax:SiteContingencyNumberOfSites" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfMjI5MQ_2d90daf5-062a-432c-a76e-b935d3b18c2d">six</ix:nonFraction> Superfund sites. Under the U.S. Superfund statute and many state laws, generators of hazardous waste sent to a disposal or recycling site are liable for site cleanup if contaminants from that property later leak into the environment. The laws generally provide that a PRP may be held jointly and severally liable for the costs of investigating and remediating the site. Separate from these Superfund cases noted above, we are involved in an ongoing environmental remediations associated with historic operations at certain of our facilities. As of March&#160;31, 2022 and December&#160;31, 2021, our environmental reserves, which are measured on an undiscounted basis, were $<ix:nonFraction unitRef="usd" contextRef="id2c66b1b9fe445a18da652d3450d08cf_I20211231" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfMjk0OQ_6d7bc1dd-321a-4c97-a435-48eb5c932787"><ix:nonFraction unitRef="usd" contextRef="i469c791f58204bae88a589c56467141f_I20220331" decimals="-6" name="us-gaap:AccrualForEnvironmentalLossContingencies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfMjk0OQ_d99ea309-8736-478d-b997-9ac5bad33aa9">18</ix:nonFraction></ix:nonFraction> million, respectively. After considering these reserves, the outcome of these matters is not expected to have a material adverse effect on our financial position or results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Litigation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2019, we were named in an amended complaint filed by Fayette County, Georgia in the MDL In re: National Prescription Opiate Litigation pending in the U.S. District Court, Northern District of Ohio. The complaint alleges that multiple manufacturers and distributors of opiate products improperly marketed and diverted these products, which caused harm to Fayette County. The complaint is limited in its allegations as to Baxter and does not distinguish between injectable opiate products and orally administered opiates. We manufactured generic injectable opiate products in our facility in Cherry Hill, NJ, which we divested in 2011.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2019, we and certain of our officers were named in a class action complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Ethan E. Silverman et al. v. Baxter International Inc. et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> that was filed in the United States District Court for the Northern District of Illinois.  The plaintiff, who allegedly purchased shares of our common stock during the specified class period, filed this putative class action on behalf of himself and shareholders who acquired Baxter common stock between February 21, 2019 and October 23, 2019.  The plaintiff alleged that we and certain officers violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by making allegedly false and misleading statements and failing to disclose material facts relating to certain intra-company transactions undertaken for the purpose of generating foreign exchange gains or avoiding foreign exchange losses, as well as our internal controls over financial reporting.  On January 29, 2020, the Court appointed Varma Mutual Pension Insurance Company and Louisiana Municipal Police Employees Retirement System as lead plaintiffs in the case. Plaintiffs filed an amended complaint on June 25, 2020 containing substantially the same allegations. On August 24, 2020, we filed a motion to dismiss the amended complaint. On January 12, 2021, the Court granted our motion to dismiss the amended complaint but gave plaintiffs an opportunity to file a further-amended complaint. The parties reached an agreement to settle the case for $<ix:nonFraction unitRef="usd" contextRef="i2bdf0bb5959445a281c014f161f85723_D20210112-20210112" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfNzA2NA_1e3fcdac-5183-4e93-b7f1-e533d071eb15">16</ix:nonFraction>&#160;million, subject to the completion of confirmatory discovery and final approval by the Court. The Court granted final approval of the settlement on August 11, 2021 and the settlement became effective on September 13, 2021. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As initially disclosed in our Form 8-K on October 24, 2019, we voluntarily advised the staff of the SEC of an internal investigation into certain intra-company transactions that impacted our previously reported non-operating foreign exchanges gains and losses. We also received a stockholder request for inspection of our books and records in connection with the October 24, 2019 announcement. The Company has cooperated with the staff of the SEC in its investigation into related matters, and on February 18, 2022, we reached a settlement with the SEC. Without admitting or denying the findings in the administrative order issued by the SEC, we agreed to pay a civil penalty of $<ix:nonFraction unitRef="usd" contextRef="icb864a5832494db0acdd2afdf1be2d00_D20220218-20220218" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfMjc0ODc3OTA5MDIwNQ_8eabc9dd-8c29-4dd6-b0c6-0027dfbe97ae">18</ix:nonFraction>&#160;million and to cease and desist from violations of specified provisions of the federal securities laws and related rules. In the order, the SEC acknowledged the Company&#8217;s cooperation. We paid the penalty in the first quarter of 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, <ix:nonFraction unitRef="lawsuit" contextRef="i8d85a7b845f24d1fa695e4f71457e0c3_I20200331" decimals="INF" name="bax:LossContingencyNumberOfLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfNzgyNw_a972157d-8f5f-4375-974d-949ff6799fb0">two</ix:nonFraction> lawsuits were filed against us in the Northern District of Illinois by plaintiffs alleging injuries as a result of exposure to ethylene oxide used in our manufacturing facility in Mountain Home, Arkansas to sterilize certain of our products. The plaintiffs sought damages, including compensatory and punitive damages in an unspecified amount, and unspecified injunctive and declaratory relief. The parties reached agreement to settle these lawsuits in the third quarter of 2021 for amounts that are not material to our financial results, which were paid in the fourth quarter of 2021. The settlement of these claims does not preclude potential future lawsuits.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In July 2021, Hill-Rom, Inc. received a subpoena (from the United States Office of Inspector General for the Department of Health and Human Services (the DHHS) requesting documents and information related to compliance </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ica72778f0ed641e3b70126cd12cdfe65"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">with the False Claims Act and the Anti-Kickback Statute. Hillrom has been working with the DHHS and the DOJ to provide information responsive to the subpoena. Hillrom also voluntarily began a related internal review and Hillrom and now Baxter have been cooperating fully with the DHHS and the DOJ with respect to these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DHHS often issues this type of subpoena when investigating alleged violations of the False Claims Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 28, 2021, Linet Americas, Inc. (Linet) filed a complaint against Hill-Rom Holdings, Inc., Hill-Rom Company, Inc., and Hill-Rom Services, Inc. in the United States District Court for the Northern District of Illinois, captioned Linet Americas, Inc. v. Hill-Rom Holdings, Inc.; Hill-Rom Company, Inc.; Hill-Rom Services, Inc. Linet alleges that Hillrom violated Sections 1, 2 and 3 of The Sherman Antitrust Act of 1890 and the Illinois Antitrust Act by allegedly engaging in anti-competitive conduct in alleged markets for standard, ICU and birthing beds. Hillrom filed an answer to the complaint on January 28, 2022.</span></div></ix:continuation><div id="i8787971997a742729b9820f85443271c_52"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">7. <ix:nonNumeric contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTYwNg_759f444a-ac6a-4e36-9ce1-bae5d95143f2" continuedAt="i6f071447f0b64c7c8d8588b4ecab538a" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="i6f071447f0b64c7c8d8588b4ecab538a" continuedAt="iedeb63a66cd34e2eaa67830493e0472f"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock compensation expense totaled $<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMjkzNw_ea8e90dc-75a8-44ef-8358-b0c6964d38a1">32</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMjk1Mg_de73e1f9-6e88-4ce4-833e-8b8c64c5d232">22</ix:nonFraction> million in the first quarter of 2022 and 2021, respectively.  Approximately <ix:nonFraction unitRef="number" contextRef="ia62b9d54444c46208ba00c7b3a49f393_D20220101-20220331" decimals="2" name="bax:ShareBasedCompensationAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMjk1OQ_90e76959-3d17-4c0c-8a67-b152681d9b46">75</ix:nonFraction>% of stock compensation expense is classified within selling, general and administrative (SG&amp;A) expense with the remainder classified in cost of sales and research and development (R&amp;D) expense. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We awarded stock compensation grants which consisted of <ix:nonFraction unitRef="shares" contextRef="i9ae5d43fac584f33a0a42a5f3c28e0d2_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMjk3Mw_40586943-3fa0-4ed9-a2d1-2c81970ea3e9">1.8</ix:nonFraction> million stock options, <ix:nonFraction unitRef="shares" contextRef="i7189af185d184892889584811bd86919_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMjk5MA_792fddce-539b-4c11-984d-acbcbbb770d8">1.2</ix:nonFraction> million restricted stock units (RSUs) and <ix:nonFraction unitRef="shares" contextRef="ia90c948e8be245b98f70fa8267c58925_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzAwNw_a93b3b37-1fe6-411f-8060-e7275dc9da96">0.4</ix:nonFraction> million performance stock units (PSUs) during the first quarter of 2022. The grant date fair values of stock options, RSUs and PSUs awarded in the first quarter of 2022 were $<ix:nonFraction unitRef="usd" contextRef="i9ae5d43fac584f33a0a42a5f3c28e0d2_D20220101-20220331" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzA1MA_d0650544-0afa-4200-98d6-9863d978dcec">33</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i7189af185d184892889584811bd86919_D20220101-20220331" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzA2Nw_3c6a0b30-f828-4675-8310-ebd0499acebe">102</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia90c948e8be245b98f70fa8267c58925_D20220101-20220331" decimals="-6" name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzA4NA_01bdfb94-d57c-4817-8b23-f9308ef616b7">34</ix:nonFraction> million, respectively. Stock options and RSUs generally vest in one-third increments over a three-year period. The vesting conditions for PSUs granted are equally divided based on our compound annual sales growth rate performance, our adjusted return on invested capital performance and on our stock performance relative to a specified peer group.  All of the PSUs vest at the end of the applicable three-year service period.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Options</span></div><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMzI5ODUzNDg4OTcwNg_6093ab73-58ba-4f5b-a728-3ee6f1464b1b" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average Black-Scholes assumptions used in establishing the fair value of stock options granted during the period, along with weighted-average grant date fair values, were as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfMi0xLTEtMS03NzUxNg_b4b76080-6705-47e0-8109-d041d39ce26d">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfMi0yLTEtMS03NzUwMg_6304fec3-39da-46ee-8428-df14287e0238">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfMy0xLTEtMS03NzUxNg_461bdd06-2011-433f-b357-8872cb3b6914">5.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfMy0yLTEtMS03NzUwMg_55098518-fe71-45c7-9ef8-9fa08a130800">5.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfNC0xLTEtMS03NzUxNg_90f17454-6019-4f01-918f-c6597af17602">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfNC0yLTEtMS03NzUwMg_67058b14-5ab9-4fb1-9f44-44418cf6bc38">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfNS0xLTEtMS03NzUxNg_fe8dc136-0462-46e0-acb8-3e7b768e179c">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfNS0yLTEtMS03NzUwMg_0d9fd011-39ab-4e40-865a-83b5a324ae1a">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value per stock option</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfNi0xLTEtMS03NzUxNg_ca28f9b4-6d3a-4fbd-ab39-1050c6ccfb06">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfNi0yLTEtMS03NzUwMg_1775113e-8400-4540-9a70-4bc0c7fc43d8">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised was $<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzY2NQ_eb5ffb28-17b3-42c8-b7ef-93c7c5f33e17">27</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzY3OA_38108186-5c4b-4af3-bbbe-8e7a0ebcccb1">21</ix:nonFraction> million during the first quarters of 2022 and 2021, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the unrecognized compensation cost related to all unvested stock options of $<ix:nonFraction unitRef="usd" contextRef="i23a86ccd6a744d46bea2df7cf193e7a3_I20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzY5MQ_1b798783-3bfb-4a93-b163-751b7d300021">80</ix:nonFraction> million is expected to be recognized as expense over a weighted-average period of <ix:nonNumeric contextRef="i9ae5d43fac584f33a0a42a5f3c28e0d2_D20220101-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzc0MA_005f3a8d-4b66-4011-b237-e248574b3d7b">1.9</ix:nonNumeric> years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">RSUs</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the unrecognized compensation cost related to all unvested RSUs of $<ix:nonFraction unitRef="usd" contextRef="id23b4ba90dd44f68a4a2fa4b53a355be_I20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzcxNw_105584e3-b760-40e5-83e5-9205b18381e6">163</ix:nonFraction> million is expected to be recognized as expense over a weighted-average period of <ix:nonNumeric contextRef="i7189af185d184892889584811bd86919_D20220101-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzc1Mw_246bdfe7-6be4-4f4f-b915-c6c10863d32f">2.2</ix:nonNumeric> years. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PSUs</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the unrecognized compensation cost related to all unvested PSUs of $<ix:nonFraction unitRef="usd" contextRef="i47aa6b12f49d4f8f8e8e0b9146e3b922_I20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzc2Ng_dd00dba0-10b2-4031-8d06-5854579df7a2">50</ix:nonFraction> million is expected to be recognized as expense over a weighted-average period of <ix:nonNumeric contextRef="ia90c948e8be245b98f70fa8267c58925_D20220101-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzc3OQ_9ea089fd-c711-420d-aadb-fab9810d8da4">1.9</ix:nonNumeric> years. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iedeb63a66cd34e2eaa67830493e0472f" continuedAt="i6c646bb0d7394002a4600e698d1571f3"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Dividends</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash dividends declared per share for the three months ended March&#160;31, 2022 and 2021 were $<ix:nonFraction unitRef="usdPerShare" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="3" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfOTA0_1450a7ae-d077-466b-937c-8bccd1db4301">0.28</ix:nonFraction> and  $<ix:nonFraction unitRef="usdPerShare" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="3" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfOTk1_0152ce53-3541-4337-a4e7-07fb2a219606">0.245</ix:nonFraction>, respectively. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Programs</span></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i6c646bb0d7394002a4600e698d1571f3">In July 2012, the Board of Directors authorized the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="i95a7419792054ae5bed8d890b5b8bec6_I20120731" decimals="-8" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTExOQ_4e7e968d-6d3b-4bad-9845-fcbdb1fe8d6b">2.0</ix:nonFraction> billion of our common stock. The Board of Directors increased this authority by an additional $<ix:nonFraction unitRef="usd" contextRef="i6021c0283dc64cf58f4e8ce023f20cae_I20180228" decimals="-8" name="bax:StockRepurchaseProgramAdditionalAuthorizedAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTIwOA_0cdf1888-ac5f-4504-9717-2a1039fc5409"><ix:nonFraction unitRef="usd" contextRef="i05b8c7054b9d4d0883b6419ce2e08fe4_I20161130" decimals="-8" name="bax:StockRepurchaseProgramAdditionalAuthorizedAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTIwOA_de70f8fc-adbf-43ef-84c9-bf22f9fbe9af">1.5</ix:nonFraction></ix:nonFraction> billion in each of November 2016 and February 2018, by an additional $<ix:nonFraction unitRef="usd" contextRef="ia6abadaa7a994ae19160f417f168acaf_I20181130" decimals="-8" name="bax:StockRepurchaseProgramAdditionalAuthorizedAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTI3Mg_8363980d-49df-48f0-b907-5e81b0368228">2.0</ix:nonFraction> billion in November 2018 and by an additional $<ix:nonFraction unitRef="usd" contextRef="idf18cf43e1fd42ea80e5bb10c70d8237_I20201031" decimals="-8" name="bax:StockRepurchaseProgramAdditionalAuthorizedAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTMxMw_782110b9-ec6b-4628-8d0b-7eeb29842084">1.5</ix:nonFraction>&#160;billion in October 2020. During the first quarter of 2022, we did not repurchase any shares under this authority.  During the first quarter of 2021, we repurchased <ix:nonFraction unitRef="shares" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzNDQ0Mw_64697b9c-17ad-4d57-b1a6-72a5d3101294">3.6</ix:nonFraction>&#160;million shares under this authority pursuant to a Rule 10b5-1 plan. We had $<ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTU0OA_5219ffd4-b5d9-4a80-b98f-eac8f5f93a31">1.3</ix:nonFraction> billion remaining available under the authorization as of March&#160;31, 2022.</ix:continuation>  </span></div><div id="i8787971997a742729b9820f85443271c_58"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">8. <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RleHRyZWdpb246MTdhNzU1NjJkNzk3NDJhNDg5Y2Y3ZTExZTg1M2IyMDJfMTAwNQ_e4b56212-8747-4ca3-b4a7-aba0ff8bf165" continuedAt="ib9db7969abc641468d8c9a0ca224cd8b" escape="true">ACCUMULATED OTHER COMPREHENSIVE INCOME</ix:nonNumeric></span></div><ix:continuation id="ib9db7969abc641468d8c9a0ca224cd8b" continuedAt="ibb3f94c98d634817bcb1436514326e5e"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income includes all changes in stockholders&#8217; equity that do not arise from transactions with stockholders, and consists of net income, currency translation adjustments (CTA), certain gains and losses from pension and other postretirement employee benefit (OPEB) plans and gains and losses on cash flow hedges. </span></div><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RleHRyZWdpb246MTdhNzU1NjJkNzk3NDJhNDg5Y2Y3ZTExZTg1M2IyMDJfMTAwNw_1b85ac62-80e3-42bc-a815-60c8d5ac8e61" escape="true"><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a net-of-tax summary of the changes in accumulated other comprehensive (loss) income (AOCI) by component for the three months ended March&#160;31, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.101%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.664%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i069285eebd5843f2856c7c3908c92f47_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMi0xLTEtMS03NzAzMg_c4356baf-64fe-4889-98f7-c8ee5a34db43">2,907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f93d1d2dd2a457d996a157cd4e92b5d_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMi0yLTEtMS03NzAzMg_11c8670f-ae9f-4ebc-a426-c08881b16f1f">347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6486fe1e58ef467195bd61197a081ab8_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMi0zLTEtMS03NzAzMg_1fe0fdf1-318f-4a16-b908-1412431c29c1">126</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e7a72924e714ac6b891716ee10b193d_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMi00LTEtMS04NDM5Nw_9808d17c-e693-4796-972c-4ce1f71abe3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f2552f5c4054d1ebea374b3f2beb06b_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMi00LTEtMS03NzAzMg_d8262933-8e6c-4194-ab9c-5e9bcf7771ca">3,380</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3a1622bd0814078a54a920dde602168_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMy0xLTEtMS03NzAzMg_95c497f6-ea5c-4a1c-b694-8ca933779a4b">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia612cf65ceaf4a1c9b76bfe56c4d3eb6_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMy0yLTEtMS03NzAzMg_6f69ae02-bfe5-4c3b-ae50-75bf0a4f8da4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64a3e01103e34f1bbc3c8156b5ba0946_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMy0zLTEtMS03NzAzMg_8ae30c55-209e-4323-afe4-066dcf4d0e2a">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17e2945361e24710af7f8a4b2bbd461b_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMy00LTEtMS04NDQwNw_f0d4a145-6609-400a-91ab-cbabffa96511">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMy00LTEtMS03NzAzMg_8557ad6f-96a0-409d-a558-d547dcbe2744">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3a1622bd0814078a54a920dde602168_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNC0xLTEtMS03NzAzMg_b54e3958-0eb6-459e-8966-5a4581a279f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia612cf65ceaf4a1c9b76bfe56c4d3eb6_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNC0yLTEtMS03NzAzMg_3d1c8d25-dd99-44e2-a331-b93696d9e126">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64a3e01103e34f1bbc3c8156b5ba0946_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNC0zLTEtMS03NzAzMg_74897436-8f8c-427b-af35-06f92add44d9">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17e2945361e24710af7f8a4b2bbd461b_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNC00LTEtMS04NDQzMg_84c7b540-356f-42ee-b56f-e71a71987e6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNC00LTEtMS03NzAzMg_9f22f88c-6d43-4741-a21b-e4059ab3f228">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3a1622bd0814078a54a920dde602168_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNS0xLTEtMS03NzAzMg_df0e8afc-a4ad-4cc2-a472-34d4089ef4ea">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia612cf65ceaf4a1c9b76bfe56c4d3eb6_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNS0yLTEtMS03NzAzMg_7eb1db73-d431-440e-b9b7-1ffb4e1402ca">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64a3e01103e34f1bbc3c8156b5ba0946_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNS0zLTEtMS03NzAzMg_9f4bb38b-0b14-4fe1-91e2-dd9f77d51c28">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17e2945361e24710af7f8a4b2bbd461b_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNS00LTEtMS04NDQwNw_3bec30d0-d27f-468e-8d61-6309299b5cbf">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNS00LTEtMS03NzAzMg_13fd1538-1ade-436e-9e68-12da1e5312e9">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id86e90917ec146d3ac68e2eb8b21f865_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNi0xLTEtMS03NzAzMg_28087dbb-9cd7-4ce2-9927-c258a847d322">2,922</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia486f1301af041c9869fe8a3575fe4d4_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNi0yLTEtMS03NzAzMg_32d1dd5a-89a1-47cd-8c7d-f225fff444b0">338</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5eefd1d44a344bdfbaad16b8a0fb4dc3_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNi0zLTEtMS03NzAzMg_48bf679a-24c9-47ac-8f79-d40fc44a7256">128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7fd2a0dc3844abbb371f105039e5020_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNi00LTEtMS04NDQwNw_c8c59f37-b2cd-4f29-82d6-b8e5e70c85bf">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50951858332c4e6ca7aad9f12094ecea_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNi00LTEtMS03NzAzMg_a1d9b778-11fd-4e48-93b0-e636e043f3aa">3,387</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2419a534ffa472a893eb08ecd31d17a_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfMi0xLTEtMS03NzAzMg_6250e1c6-a17f-4ae1-a520-d689b0b611aa">2,587</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61c25aa049c1446ba8f2b89559430b59_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfMi0yLTEtMS03NzAzMg_91803ce9-36d0-4f27-becc-2e9c630284f6">574</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc0dbb505a0a4fafbdccf76d617c81c1_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfMi0zLTEtMS03NzAzMg_6fd5b590-4eb7-4710-a5fd-a38efa49b5e2">153</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b269065bdfa4003b5dac0551818244c_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfMi00LTEtMS03NzAzMg_190ec7c9-6255-40fa-b79d-c64ed9b81cb9">3,314</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ae39c69af424944bc29e123b13ba03b_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNC0xLTEtMS03NzAzMg_8d89bd68-2a27-4420-a776-7429a15f5c3d">208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3f9dfaa202f43d7a4787a519244421f_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNC0yLTEtMS03NzAzMg_6cb3f59e-6ee1-494b-97c7-4546727500bf">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c6117fdfad44c57ae71d0e2075129f2_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNC0zLTEtMS03NzAzMg_eb1541b0-516b-438b-b565-92a2936f4fa2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNC00LTEtMS03NzAzMg_89e05c97-ea1f-406a-8e6e-c9f6992ef50e">192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ae39c69af424944bc29e123b13ba03b_D20210101-20210331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNS0xLTEtMS03NzAzMg_6ebba2fd-7c9c-42bb-9a23-b8527f168138">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3f9dfaa202f43d7a4787a519244421f_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNS0yLTEtMS03NzAzMg_6a6c5e78-0e89-420e-a0d0-6e54fb0e063a">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c6117fdfad44c57ae71d0e2075129f2_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNS0zLTEtMS03NzAzMg_1a4c4765-dfff-4f3e-9997-73fb16e0446f">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNS00LTEtMS03NzAzMg_a06b10b2-4253-4c7f-8e37-9646b21426a2">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ae39c69af424944bc29e123b13ba03b_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNi0xLTEtMS03NzAzMg_2070a01f-b662-4380-a470-3a66af86a8ed">208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3f9dfaa202f43d7a4787a519244421f_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNi0yLTEtMS03NzAzMg_c938de78-4be7-4f3f-b026-a72ebbb2ad0a">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c6117fdfad44c57ae71d0e2075129f2_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNi0zLTEtMS03NzAzMg_b5a2a8a5-b997-4ba5-baf8-baa63073b048">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNi00LTEtMS03NzAzMg_9227f11a-9cf6-448d-b5f1-f07f6c6abb64">166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbf3ffd3fcfe4c25bb7c73ac77cbbf80_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNy0xLTEtMS03NzAzMg_742b8de7-ef83-459d-8f28-1b95a05c7381">2,795</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0174772e0bd41bd8c295a1a6f03a7f7_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNy0yLTEtMS03NzAzMg_dcd4b158-c002-4189-ae3c-c71146a2134a">544</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36f11ee6ccdd4c119f7e56f86d04836f_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNy0zLTEtMS03NzAzMg_de589eeb-9217-4a7b-95d2-fe154c43f2d0">141</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0b8fdc874934cd28547447f24fd547a_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNy00LTEtMS03NzAzMg_8d8d7930-e2ab-4d78-b65d-ff98b9f456de">3,480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;See table below for details about these reclassifications.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibb3f94c98d634817bcb1436514326e5e"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RleHRyZWdpb246MTdhNzU1NjJkNzk3NDJhNDg5Y2Y3ZTExZTg1M2IyMDJfMTAwOQ_c24ee534-66e3-43f8-81d7-b2cae427a9b3" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the amounts reclassified from AOCI to net income during the three months ended March&#160;31, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:44.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.362%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.168%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of impact in income statement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and OPEB items</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs or credits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0f2358ba16e4eb2b4231007c968aafc_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfMy0xLTEtMS03NzAzMg_ab1031ad-235e-427c-93fe-1d60cf121ef8">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49849093a147487baaab59084a514458_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfMy0yLTEtMS03NzAzMg_5360ff90-eedd-4b7b-a8ac-65d7cada2a7f">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f2358ba16e4eb2b4231007c968aafc_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfNC0xLTEtMS03NzAzMg_1d9f1453-156a-4c26-baeb-886ba9d873ed">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49849093a147487baaab59084a514458_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfNC0yLTEtMS03NzAzMg_92599143-4e07-4c2c-bd24-4e255b0d2876">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0f2358ba16e4eb2b4231007c968aafc_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfNS0xLTEtMS03NzAzMg_5ac21f32-d189-424e-bb35-08bae289ac1b">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49849093a147487baaab59084a514458_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfNS0yLTEtMS03NzAzMg_02918e8e-afd9-4899-8489-cc10d905c9a3">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on hedging activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71a9302da0e54c3b8f8926e72835a876_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfNy0xLTEtMS03NzAzMg_3e529fd6-0c85-47e3-9bba-ff991f59fcf3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic40887eaba864beb99dfb7e8f5598fc9_D20210101-20210331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfNy0yLTEtMS03NzAzMg_ba906c34-1dd7-4077-a988-27ee1eaf7753">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ca753b742a8455c879cba08a880b703_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfOC0xLTEtMS03NzAzMg_cc42ba1a-a892-475f-87ca-d2a8af446d63">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45b7e42abce84defb3a21a449abd0bbd_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfOC0yLTEtMS03NzAzMg_9378891a-8832-48da-961d-5ee83f096d07">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd4fbdb722de41c680320b1de71522a7_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfOS0xLTEtMS03NzAzMg_feddf94e-ed1b-4ff4-9ab2-50fa7f784ad7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bef5949b41742f0b1ba1cc2daeb9ab6_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfOS0yLTEtMS03NzAzMg_eeb6fe3d-f740-407e-bff5-ea216c84a6f8">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd4fbdb722de41c680320b1de71522a7_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfMTAtMS0xLTEtNzcwMzI_17ffe23e-584f-4066-aaff-24b9dce77d52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bef5949b41742f0b1ba1cc2daeb9ab6_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfMTAtMi0xLTEtNzcwMzI_8ba4c234-9f1a-4752-a011-ffff60f9075b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd4fbdb722de41c680320b1de71522a7_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfMTEtMS0xLTEtNzcwMzI_38721f92-80ef-4208-9e3c-2965fa3e7bf1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bef5949b41742f0b1ba1cc2daeb9ab6_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfMTEtMi0xLTEtNzcwMzI_4d215985-46c7-4ae5-aa61-c9c7c0bbe117">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ba7828d1de048e19f12a0c301c05c70_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfMTItMS0xLTEtNzcwMzI_dbdb142e-49f9-4af1-8782-81b95f7fd79d">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia377d8629c5a4a0fb71104100423c61c_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfMTItMi0xLTEtNzcwMzI_037034e4-bab7-476a-aae4-3a83784e6cc3">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of tax</span></td></tr></table></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Amounts in parentheses indicate reductions to net income</span></div></ix:nonNumeric><div style="margin-top:1pt;padding-left:72pt;text-indent:-72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:44.564%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.362%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.168%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 11 for additional information regarding the amortization of pension and OPEB items and Note 14 for additional information regarding hedging activity.</span></div></ix:continuation><div id="i8787971997a742729b9820f85443271c_61"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">9. <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg5Nw_95026059-6ba0-4871-8507-f31661ac91c4" continuedAt="i2d4a2a67d6fb4bf4be4cb457a978f1d9" escape="true">REVENUES</ix:nonNumeric></span></div><ix:continuation id="i2d4a2a67d6fb4bf4be4cb457a978f1d9" continuedAt="i2fb5c3685c174b8caed569f28f91f298"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of our contracts have multiple performance obligations. For contracts with multiple performance obligations, we allocate the contract&#8217;s transaction price to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract. Our global payment terms are typically between <ix:nonNumeric contextRef="i54bb1c348a9847b582b458754fce46a2_D20220101-20220331" name="bax:RevenuePerformanceObligationPaymentTerms" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODA1_806f7434-58be-4596-9507-cb4b955005ac">30</ix:nonNumeric>-<ix:nonNumeric contextRef="ibb3cc6fd8ab54e7f919c3a7ef1e7de2d_D20220101-20220331" name="bax:RevenuePerformanceObligationPaymentTerms" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODA4_a8da4aa6-77ee-4ae8-8e1f-b53b86608a13">90</ix:nonNumeric> days.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our performance obligations are satisfied at a point in time. This includes sales of our broad portfolio of essential healthcare products across our geographic segments including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; hospital beds and services; surgical tables, lights and pendants; and patient monitoring and diagnostic technologies. For most of those sales, our performance obligation is satisfied upon delivery to the customer. Shipping and handling activities are considered to be fulfillment activities and are not considered to be a separate performance obligation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To a lesser extent, in all of our segments, we enter into other types of contracts including contract manufacturing   arrangements, equipment leases, and certain subscription software and licensing arrangements. We recognize revenue for these arrangements over time or at a point in time depending on our evaluation of when the customer obtains control of the promised goods or services. Revenue is recognized over time when we are creating or enhancing an asset that the customer controls as the asset is created or enhanced or our performance does not create an asset with an alternative use and we have an enforceable right to payment for performance completed.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfMjE1NQ_b2d1ee8f-933e-4aea-983f-52a7c3828f7f">8.2</ix:nonFraction> billion of transaction price allocated to remaining performance obligations related to executed contracts with an original duration of one year or more, which are primarily included in the Americas segment. Some contracts in the United States included in this amount contain index-dependent price increases, which are not known at this time. We expect to recognize approximately <ix:nonFraction unitRef="number" contextRef="i15c4aa9c7adc46609c75b8e4977a7bf5_I20220331" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfMjUyOQ_473307ea-a9ab-48e2-8f10-3db3aed66b37">30</ix:nonFraction>% of this amount as revenue over the remainder of 2022, <ix:nonFraction unitRef="number" contextRef="i7dcc13e1767b4b20b08c82100616f090_I20220331" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfMjU4NA_31f267ba-1e07-43e6-9580-8286fba0f3dd">30</ix:nonFraction>% in 2023, <ix:nonFraction unitRef="number" contextRef="i149befa1f6404f1a97e608ad7a766348_I20220331" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfMTA5OTUxMTY0MTAzMw_4a842c15-ccca-40d0-9129-a58d6b77f736">20</ix:nonFraction>% in 2024, <ix:nonFraction unitRef="number" contextRef="i7a469160b4ca45ceadc4df51de1bb9cd_I20220331" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfMjYxMg_6cfa7bf4-e9c1-473b-ad97-5cd1256d3b32">15</ix:nonFraction>% in 2025 and <ix:nonFraction unitRef="number" contextRef="i9f7a3b322d1541a28d6394b8562f85c1_I20220331" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfMTA5OTUxMTY0MTA3MQ_23b13405-ee73-4d28-954c-6f3bdf8ab75f">5</ix:nonFraction>% thereafter.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2fb5c3685c174b8caed569f28f91f298" continuedAt="if5e2d0077f9e4617991faa6af68274da"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Judgments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration primarily related to rebates and wholesaler chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales and are included in accrued expenses and other current liabilities and accounts receivable, net on the condensed consolidated balance sheets. Management's estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reflect our best estimates of the amount of consideration to which we are entitled based on the terms of the contract using the expected value method. The amount of variable consideration included in the net sales price is limited to the amount for which it is probable that a significant reversal in revenue will not occur when the related uncertainty is resolved. Revenue recognized during the three months ended March&#160;31, 2022 and 2021 related to performance obligations satisfied in prior periods was not material.  Additionally, our contracts with customers often include promises to transfer multiple products and services to a customer.  Determining whether products and services are considered distinct performance obligations that should be accounted for separately and determining the allocation of the transaction price may require significant judgement.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in the recognition of trade accounts receivable, unbilled receivables, contract assets and customer advances and deposits (contract liabilities) on our condensed consolidated balance sheets. Net trade accounts receivable was $<ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-8" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNDUwNw_34957680-68db-4b14-b3c5-740cd0379a06">2.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-8" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNDUxNA_a9034a38-b880-4a5e-993e-4ad69b95aa2c">2.4</ix:nonFraction> billion as of March&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contract manufacturing arrangements, revenue is primarily recognized throughout the production cycle, which typically lasts up to <ix:nonNumeric contextRef="i3b4412787ecf4be9abb299cd553bdecb_D20220101-20220331" name="bax:RevenueRecognizedContractPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNDY4Mg_f88b56d3-4415-4083-8bc5-a19caff26733">90</ix:nonNumeric> days, resulting in the recognition of contract assets until the related services are completed and the customers are billed. Additionally, for arrangements containing a performance obligation to deliver software that can be used with medical devices, we recognize revenue upon delivery of the software, which results in the recognition of contract assets when customers are billed over time, generally over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNTA4Nw_f4e1f64e-f3c7-40c4-adcb-4328bb369ec4">one</span> to <ix:nonNumeric contextRef="i1d4d3ad9a6744778b3c632ef51c41f3d_D20220101-20220331" name="bax:RevenueRecognizedContractPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNTA5Mw_e7eb8203-d740-4fd9-8d72-c03bdaf129d9">five years</ix:nonNumeric>. For bundled contracts involving equipment delivered up-front and consumable medical products to be delivered over time, total contract revenue is allocated between the equipment and consumable medical products. In certain of those arrangements, a contract asset is created for the difference between the amount of equipment revenue recognized upon delivery and the amount of consideration initially receivable from the customer. In those arrangements, the contract asset becomes a trade account receivable as consumable medical products are provided and billed, generally over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNTY3NA_35dd3245-1f9f-4af5-81c9-d418989e3bbf">one</span> to <ix:nonNumeric contextRef="i00a69787b49d45f98aca3e29cdef6cf9_D20220101-20220331" name="bax:RevenueRecognizedContractPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNTY4MA_660e5f69-98cf-492f-9d6a-68dc1c97e312">seven years</ix:nonNumeric>. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if5e2d0077f9e4617991faa6af68274da" continuedAt="i4b9d34056dd444db976ba7cdf2384dff"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg5OA_bc57f7cf-e3d4-4a80-b07c-c23086cd4833" continuedAt="i35f5a0b9525848e08009751ec02ce253" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract manufacturing services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12862cd99e2648e6bcf32aac284bdb6a_I20220331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg5NWE0NGQwMzI4NDQzMGNhMmVjNjA1YTY0ZDI1N2YzL3RhYmxlcmFuZ2U6ODk1YTQ0ZDAzMjg0NDMwY2EyZWM2MDVhNjRkMjU3ZjNfMS0xLTEtMS03NzAzMg_a57cc9e1-4830-44a5-add2-199f0a9434cb">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a5af68d1dfd41d9b397bace193b7f2e_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg5NWE0NGQwMzI4NDQzMGNhMmVjNjA1YTY0ZDI1N2YzL3RhYmxlcmFuZ2U6ODk1YTQ0ZDAzMjg0NDMwY2EyZWM2MDVhNjRkMjU3ZjNfMS0yLTEtMS03NzAzMg_111a2121-e693-4b4b-bfdf-3fd594be5f16">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bbff8045db1420896d97da8621b4b0d_I20220331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg5NWE0NGQwMzI4NDQzMGNhMmVjNjA1YTY0ZDI1N2YzL3RhYmxlcmFuZ2U6ODk1YTQ0ZDAzMjg0NDMwY2EyZWM2MDVhNjRkMjU3ZjNfMi0xLTEtMS03NzAzMg_6f9f612b-c26a-4b66-a807-9d6e34b4178b">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c59a85af92949bfa44911ac3ec56888_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg5NWE0NGQwMzI4NDQzMGNhMmVjNjA1YTY0ZDI1N2YzL3RhYmxlcmFuZ2U6ODk1YTQ0ZDAzMjg0NDMwY2EyZWM2MDVhNjRkMjU3ZjNfMi0yLTEtMS03NzAzMg_a43554ef-702d-4dae-9f18-0b8dddb5cad2">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bundled equipment and consumable medical products contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44ec8a3cf51442cbaa0c996617cff9a4_I20220331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg5NWE0NGQwMzI4NDQzMGNhMmVjNjA1YTY0ZDI1N2YzL3RhYmxlcmFuZ2U6ODk1YTQ0ZDAzMjg0NDMwY2EyZWM2MDVhNjRkMjU3ZjNfMy0xLTEtMS03NzAzMg_6057c1f3-24b4-4643-8e15-4e9371f00b80">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecf1812385b54a46ac8f5d89b0b93371_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg5NWE0NGQwMzI4NDQzMGNhMmVjNjA1YTY0ZDI1N2YzL3RhYmxlcmFuZ2U6ODk1YTQ0ZDAzMjg0NDMwY2EyZWM2MDVhNjRkMjU3ZjNfMy0yLTEtMS03NzAzMg_2fb4710d-59b5-4057-a50d-34665cb6b090">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg5NWE0NGQwMzI4NDQzMGNhMmVjNjA1YTY0ZDI1N2YzL3RhYmxlcmFuZ2U6ODk1YTQ0ZDAzMjg0NDMwY2EyZWM2MDVhNjRkMjU3ZjNfNC0xLTEtMS03NzAzMg_27ea48e0-494b-4ab8-b95f-8bb6326cc458">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg5NWE0NGQwMzI4NDQzMGNhMmVjNjA1YTY0ZDI1N2YzL3RhYmxlcmFuZ2U6ODk1YTQ0ZDAzMjg0NDMwY2EyZWM2MDVhNjRkMjU3ZjNfNC0yLTEtMS03NzAzMg_6b6dd774-8a2b-4990-a70f-fa84f501f900">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of contract assets and contract liabilities as reported in the condensed consolidated balance sheets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54f8a4bbd0174868969d5ea2762b4cba_I20220331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfMS0xLTEtMS03NzAzMg_5a1b898f-c185-4c8b-9cf6-007e30a84e3f">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic17bdfd4421546eca4d7ae434aa0244e_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfMS0yLTEtMS03NzAzMg_084800ff-7ea7-499e-839c-9741433da96f">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8945826fd444f19b4c61de098d12163_I20220331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfMi0xLTEtMS03NzAzMg_aaa9a06a-27c3-4e6b-b96d-7a5e19376f3a">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07b784c1178047b48ce2e8b3a5a7dbfd_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfMi0yLTEtMS03NzAzMg_85148310-b606-41cc-8ed1-6f1560443ef7">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfMy0xLTEtMS03NzAzMg_27ea48e0-494b-4ab8-b95f-8bb6326cc458">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfMy0yLTEtMS03NzAzMg_6b6dd774-8a2b-4990-a70f-fa84f501f900">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6baa8e29dc1a4812ba336959185b5ed9_I20220331" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfNS0xLTEtMS03NzAzMg_edc4c49f-7f8f-4e2d-a311-8bb416a31b94">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18dcbee3985a482faff83f708556a86d_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfNS0yLTEtMS03NzAzMg_04fb556d-58c5-4c34-a64b-1f517abd6b39">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i399bd9e6d7704a0f8494daa78d8321fc_I20220331" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfNi0xLTEtMS03NzAzMg_fa629255-354a-44d6-b836-ac8a4ff55275">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae692eee99a04c67905eefc0ccfb948d_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfNi0yLTEtMS03NzAzMg_2bc17075-328b-4f0f-b194-a40240294b6e">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfNy0xLTEtMS03NzAzMg_fc52afd7-d785-4b9e-9c56-b54f74215cbf">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfNy0yLTEtMS03NzAzMg_59c73b89-b345-4932-a07c-7bbc02fe5a14">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities represent deferred revenues that arise as a result of cash received from customers or where the timing of billing for services precedes satisfaction of our performance obligations. Such remaining performance obligations represent the portion of the contract price for which work has not been performed and are primarily related to our installation and service contracts. We expect to satisfy the majority of the remaining performance obligations and recognize revenue related to installation and service contracts within the next 12 months with most of the non-current performance obligations satisfied within 24 months. </span></div><ix:continuation id="i35f5a0b9525848e08009751ec02ce253"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes contract liability activity for the three months ended March 31, 2022.  The contract liability balance represents the transaction price allocated to the remaining performance obligations.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.658%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg2YWUwNjczYTlmNzQ3N2M5OTVkMjA1YzQxMzI5ZWM1L3RhYmxlcmFuZ2U6ODZhZTA2NzNhOWY3NDc3Yzk5NWQyMDVjNDEzMjllYzVfMS0xLTEtMS03Nzk3Mg_91b16911-6e17-4827-9ce0-4440fdc49204">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New revenue deferrals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="bax:ContractWithCustomerLiabilityDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg2YWUwNjczYTlmNzQ3N2M5OTVkMjA1YzQxMzI5ZWM1L3RhYmxlcmFuZ2U6ODZhZTA2NzNhOWY3NDc3Yzk5NWQyMDVjNDEzMjllYzVfMi0xLTEtMS03Nzk3Mg_2bfe01a0-8d61-403b-ad78-dbe0cc3019f5">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized upon satisfaction of performance obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg2YWUwNjczYTlmNzQ3N2M5OTVkMjA1YzQxMzI5ZWM1L3RhYmxlcmFuZ2U6ODZhZTA2NzNhOWY3NDc3Yzk5NWQyMDVjNDEzMjllYzVfMy0xLTEtMS03Nzk3Mg_254e8b86-4108-4183-9d1a-db0ff7065702">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg2YWUwNjczYTlmNzQ3N2M5OTVkMjA1YzQxMzI5ZWM1L3RhYmxlcmFuZ2U6ODZhZTA2NzNhOWY3NDc3Yzk5NWQyMDVjNDEzMjllYzVfNS0xLTEtMS03Nzk3Mg_86a44eaa-ed90-49ec-b06f-2c2eccedc063">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, the amount of revenue recognized that was included in contract liabilities as of December 31, 2020 was not significant.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Net Sales</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our acquisition of Hillrom in December 2021, we have added three new product categories: Patient Support Systems, Front Line Care and Surgical Solutions. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4b9d34056dd444db976ba7cdf2384dff" continuedAt="id2c0c48a8b9d4437b8af5b788a2803ec"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg5MQ_752248d8-2349-4b35-b070-82843cfe3268" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0420526d1646c5ba9c811a0b9fc84f_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMy0xLTEtMS03NzAzMg_dc34a4be-a933-473d-bdc5-4d62022d9810">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae2bd6024f3b4290867ed42a20b57c42_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMy0yLTEtMS03NzAzMg_c30bdf83-ca2e-4ca5-a614-29edb1eeb431">669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebc0f71dfcc4d94b6422c836bb4d493_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMy0zLTEtMS03NzAzMg_ceed20e7-16cf-472c-92e4-97882b8e8edb">894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41d12d31c3674b509c0fc670781c32d1_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMy00LTEtMS03NzAzMg_1d9ff522-7b44-4284-9b4e-2200709a708e">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd2c69af596c4eb8afab548b28116f64_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMy01LTEtMS03NzAzMg_35f1d5e6-9d9c-48ca-93c6-68c85e9015bb">706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47301316276400fa58cbac0a27edd76_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMy02LTEtMS03NzAzMg_ddadb3b5-5354-4d18-a3d4-440937028453">922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0637d58240be4e3b84ee15a2869f6212_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNC0xLTEtMS03NzAzMg_6fe519f3-268b-4ed7-95dd-4d23ce48eb38">472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88685342da44b43aca2e889001b33df_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNC0yLTEtMS03NzAzMg_32691f92-7de4-4609-a7c1-94554656a87d">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6257773f46f4406a950d9da284eeff8f_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNC0zLTEtMS03NzAzMg_e09e3d78-e5e2-421e-8758-59c6cb89960e">706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99fd85b9b1294818a42d590249ac0254_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNC00LTEtMS03NzAzMg_84eaece1-9c96-415d-bf22-94f9b2071ebd">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb8a8cea96743978e1c34863c629e7e_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNC01LTEtMS03NzAzMg_5b99f184-c28c-4db5-9259-a88041b65b65">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccd3fe9f4eff41108f7f8233c7b8bec5_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNC02LTEtMS03NzAzMg_93ff1ca6-c1b7-4bfe-8fa0-9ad412ded7d3">652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c50ddabc65d4775b4f0dd32b7866a0c_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNS0xLTEtMS03NzAzMg_266962f6-704b-404a-bea5-4bb6c813a36d">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea7f19b9978a4f479a01e23692a3b391_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNS0yLTEtMS03NzAzMg_bf43d6d7-c119-49d4-9b4a-2a81e5c4c192">364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5de90053a7bb47eba9d7c5dff40cb4da_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNS0zLTEtMS03NzAzMg_506cf6cd-3abf-48c0-a7ea-ffc7b2f1eda8">521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5285bc00e83945fb8961453197a19fed_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNS00LTEtMS03NzAzMg_042f3e4e-0fb4-43eb-862a-0ec1b0491796">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32465a108574d1ca7bae73c9b778aff_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNS01LTEtMS03NzAzMg_e1f3144f-e598-4219-82f5-ce0166282296">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973336e83bc3453eb20073659da885b5_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNS02LTEtMS03NzAzMg_d75f66c3-d081-432d-a301-0c038f027c27">552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaad663d6e174f3f994c5b7b5c1706cd_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNi0xLTEtMS03NzAzMg_dc4b70e8-7b12-407a-b17c-c787d3e3cc9f">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i793ab633078c493c9736d462d4058098_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNi0yLTEtMS03NzAzMg_42b5eebb-c9b2-4086-beb3-920175aba059">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5bea1b0e28d4928871f812e9f5c7f6b_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNi0zLTEtMS03NzAzMg_9a31102f-7e7e-440e-acc9-72b4ed48dae6">227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7795ac9bd9604206a6016440b538aac0_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNi00LTEtMS03NzAzMg_1f8200b7-ca2c-4dda-adcf-f78f01964ca8">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b930265e49a44e0943d8103a8b0b529_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNi01LTEtMS03NzAzMg_680c2e22-e25c-4a34-9673-ec62eb03fc7e">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5d5a261cd76428fbedae996f8d1907e_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNi02LTEtMS03NzAzMg_8ea6bf81-79a5-458e-a1d3-c1670ecad07e">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e8d8c02c024de689ede733470259ff_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNy0xLTEtMS03NzAzMg_c8e8c727-67a4-4666-8bd7-c4e1b9f275c9">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic88569bfa2d84d02bb251a96bb20f794_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNy0yLTEtMS03NzAzMg_3711d966-7dd5-4bb5-9be7-6521c677d18e">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if243ce5e748b4bd59093b5179090fb3f_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNy0zLTEtMS03NzAzMg_c5a69462-649b-4a75-89ff-96ba3a82f288">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fa2b02e71bf4d45b6db7e096d2650cb_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNy00LTEtMS03NzAzMg_86e7e93e-436b-444b-baff-be55165192c0">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f5cb5974e244ecba9653d56940192c0_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNy01LTEtMS03NzAzMg_5c8ee38b-e741-465b-bb23-652273b8e067">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2913c2e1a7a24276acc5b6213dae5262_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNy02LTEtMS03NzAzMg_4db0b167-e916-49d0-bea9-505bc90e37ac">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">6</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i779714d757cf402f9776a2ccdec9726a_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOC0xLTEtMS03NzAzMg_7df8f721-21fb-4d2a-bb4f-854e4a9bc59d">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23f88c8a0df54c6884b9d01b2aaf82bf_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOC0yLTEtMS03NzAzMg_5c5ab3b6-1880-4a73-affc-27bc3c818a15">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44c9c2a4bb7449619ad2573dafa85bbf_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOC0zLTEtMS03NzAzMg_5a25e892-4959-4f10-a8cc-8bbc105ffb96">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8126141e4675434f839f8755c88b8ba3_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOC00LTEtMS03NzAzMg_5d86fb03-5e7c-4cd6-9bde-c038b4b89881">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0845bc16f68464e8379919be0e7b8fe_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOC01LTEtMS03NzAzMg_146d467f-bab4-4a36-8c31-ba566846914d">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fc7fd14f1844726a492dc5c657acbf8_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOC02LTEtMS03NzAzMg_41f67715-e3db-4b4d-8a5e-845d75c8e6ed">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioPharma Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">7</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i876dae9a11fe4141a783d8c2a6b92dec_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOS0xLTEtMS03NzAzMg_60428a39-6a1a-41b8-a123-03797d33e22b">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb9737600ddd4964a91212e64caf3594_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOS0yLTEtMS03NzAzMg_3fd606e0-e628-428d-896e-efd2ed75ce59">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5745c41ec404c25a1bde3188976ef38_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOS0zLTEtMS03NzAzMg_68ce40a2-5ed5-425d-b5b6-71044683c290">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c8442c959fa4529b57209c078253476_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOS00LTEtMS03NzAzMg_4e0a1873-ab51-455c-9d11-82fc0d5e7dac">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i285d483ea5b047c587d620462e947359_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOS01LTEtMS03NzAzMg_103d5bf5-5091-49ae-80ee-2ac77cb4c966">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b3f80e5d38f4c1abc4cd1ab9a5b569a_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOS02LTEtMS03NzAzMg_07f2c448-2564-4a3f-9a3b-6a09fd8c49fd">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">8</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e787427fc1d4863ab700a326101e439_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtMS0xLTEtNzgwNDc_4afa23ba-e673-40c6-8f72-3f6c2843a73d">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7467c8869654bcdb29ec9bef8eb852c_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtMi0xLTEtNzgwNDc_b0266615-7ee6-47fa-815c-2820930b733e">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34a3ea8d30f42b6a3c8f3f80e0898fd_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtMy0xLTEtNzgwNDc_a904cf14-bbda-4827-998b-80f0246c7c07">383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacd83fad5f6042788153d814f190dd66_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtNC0xLTEtNzgwNTQ_e709a8ce-53bb-4d08-a415-d7db1ab91f31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedcbe041ae2a4606afe97260832fde83_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtNS0xLTEtNzgwNTQ_72a058c0-4eaa-40c2-a44e-c414e0ad535c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcc9eca3b12249c28c1c568c4b0ff3db_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtNi0xLTEtNzgwNTQ_9534216a-dfce-46eb-a3f1-ceb4f6179504">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">9</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ea4cbf5f08646e39f3d3ff3c49f24f2_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtMS0xLTEtNzgwNDc_092dbba4-e326-41e2-8020-c55e5252391e">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23972f3969514c8ebbb4ed813b640924_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtMi0xLTEtNzgwNDc_83b6c85a-95c3-4616-8731-50f1e60cb3e5">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd3a87d60d1c4c0e9e235738abd249b4_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtMy0xLTEtNzgwNDc_77e0e3c9-4444-4996-a3c3-996dd9adbcd3">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18b82a0e238f4965bce3b3d3da7bc457_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtNC0xLTEtNzgwNTQ_6afacc2f-9893-407f-8c90-83883ee3ff49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab72e78e33e84f74af908d9272c9918b_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtNS0xLTEtNzgwNTQ_9b836b84-917c-4c7e-a83c-4059d1b4ae5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c2a93a6dd094c51bfe994c44cd157c0_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtNi0xLTEtNzgwNTQ_6eefa1e5-e838-45ca-a5a2-2495817039be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">10</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib694fa97d14d4be381e04aa9ddf846c1_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTItMS0xLTEtNzgwNDc_05cfa3ad-0424-4cfa-b3f5-e196faf72d10">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0628696d6604d5b9f829e16a4b411ea_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTItMi0xLTEtNzgwNDc_99b8d704-b046-4554-bd38-2c34fe5b4a49">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8389d4f265c0420ea78f8103b6fc49ff_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTItMy0xLTEtNzgwNDc_1b92b437-bdc4-496a-a461-e338aff90835">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69b44fa6f007430891d8a0fa04607c5a_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTItNC0xLTEtNzgwNTQ_ed561369-2e13-47a6-a631-a785a834d21b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f19fbe0743f48108c85afdca64f480d_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTItNS0xLTEtNzgwNTQ_50b89bab-4a5d-4314-b280-02be6a0e6bd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97bb457dd66d4192aba9ecb5379b09e3_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTItNi0xLTEtNzgwNTQ_289b0c15-c852-4b54-94e1-e311e73efa93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">11</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibebdfc914173408d98947b502a387897_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtMS0xLTEtNzcwMzI_bb072e6f-093a-4ee0-bf4c-34811f2dc65a">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b8b91e94ed143eebd3f096088cfeac3_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtMi0xLTEtNzcwMzI_c5933016-bff8-4836-a653-30f1a44163de">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5945f9a9cad447da92a87bf81903df9_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtMy0xLTEtNzcwMzI_035cbfd4-0f35-48f6-8e20-c3d3e233d311">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib32b8ba9994c4c05b40746ba26de0276_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtNC0xLTEtNzcwMzI_56dd4fbb-2ce9-45a2-a2d7-9364ced47e83">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f1ac0c71dc74295a156d768668f9a2a_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtNS0xLTEtNzcwMzI_2d89c2c1-cbb3-4bd5-9407-2c4d5e670261">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7a8130be2624c9a8048123bf1f31901_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtNi0xLTEtNzcwMzI_56cab6c7-51f9-4c06-85e0-33fb5f657322">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib93cd39c2a80489ba522e10fce6b0e92_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtMS0xLTEtNzcwMzI_def29cdf-8a76-4471-bc2b-4747b4999e49">1,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae185801a2824043b923695260987bdc_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtMi0xLTEtNzcwMzI_d2bf93da-2b71-4d59-ac07-609764d6f3ce">1,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtMy0xLTEtNzcwMzI_25fd99e4-353c-4c45-9809-ca8217e118ad">3,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d0b3b6424a4f239ced374f948ac74a_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtNC0xLTEtNzcwMzI_20dac12c-4ed6-4dc3-8eb5-18643c844cee">1,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d6282669ad443c49c55d8ac91b9f5e7_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtNS0xLTEtNzcwMzI_c33871b0-8d39-4afb-aa01-60dfd7a5d83f">1,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtNi0xLTEtNzcwMzI_90ba2c01-e6c4-469c-9f48-d80c26deb960">2,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Medication Delivery includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Clinical Nutrition includes sales of our parenteral nutrition (PN) therapies and related products.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology vision screening and physical assessment.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Other includes sales of miscellaneous product and service offerings.</span></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease smart beds, such as bariatric, critical care, maternal, and home care beds, as well as other surfaces, to customers during periods of peak demand or for specialty purposes. We also lease medical equipment, such as renal dialysis equipment and infusion pumps, to customers, primarily in conjunction with arrangements to provide consumable medical products such as dialysis therapies, IV fluids and inhaled anesthetics. Certain of our equipment leases are classified as sales-type leases and the remainder are operating leases. The terms of the related contracts, including the proportion of fixed versus variable payments and any options to shorten or extend the lease term, vary by customer. We allocate revenue between equipment leases and medical products based on their standalone selling prices.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id2c0c48a8b9d4437b8af5b788a2803ec"><div style="margin-top:10pt"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg5NQ_45fd7e30-0743-4174-8846-fd0ba31e6b91" escape="true"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg5NQ_9c5959b1-5f27-4b42-9301-91425ad772ff" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of lease revenue for the three months ended March&#160;31, 2022 and 2021 were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.280%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:SalesTypeLeaseRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjIzYjc2N2UyNzkwYjQxMTU5NDk3YmJhNDFjODJmYzUxL3RhYmxlcmFuZ2U6MjNiNzY3ZTI3OTBiNDExNTk0OTdiYmE0MWM4MmZjNTFfMS0xLTEtMS03NzAzMg_42deaf92-3ac1-422e-a3ac-93456fbee647">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:SalesTypeLeaseRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjIzYjc2N2UyNzkwYjQxMTU5NDk3YmJhNDFjODJmYzUxL3RhYmxlcmFuZ2U6MjNiNzY3ZTI3OTBiNDExNTk0OTdiYmE0MWM4MmZjNTFfMS0yLTEtMS03NzAzMg_a61dc7c7-cf98-4261-bf8d-3a42f089b8c1">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjIzYjc2N2UyNzkwYjQxMTU5NDk3YmJhNDFjODJmYzUxL3RhYmxlcmFuZ2U6MjNiNzY3ZTI3OTBiNDExNTk0OTdiYmE0MWM4MmZjNTFfMi0xLTEtMS03NzAzMg_5b3996a7-78fc-4590-b700-d94f1c674908">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjIzYjc2N2UyNzkwYjQxMTU5NDk3YmJhNDFjODJmYzUxL3RhYmxlcmFuZ2U6MjNiNzY3ZTI3OTBiNDExNTk0OTdiYmE0MWM4MmZjNTFfMi0yLTEtMS03NzAzMg_82962d89-35c6-475a-9f5d-ed08030fcc83">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:VariableLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjIzYjc2N2UyNzkwYjQxMTU5NDk3YmJhNDFjODJmYzUxL3RhYmxlcmFuZ2U6MjNiNzY3ZTI3OTBiNDExNTk0OTdiYmE0MWM4MmZjNTFfMy0xLTEtMS03NzAzMg_493c47a8-e1ec-4bd9-9dd2-650b3b13cbe7">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:VariableLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjIzYjc2N2UyNzkwYjQxMTU5NDk3YmJhNDFjODJmYzUxL3RhYmxlcmFuZ2U6MjNiNzY3ZTI3OTBiNDExNTk0OTdiYmE0MWM4MmZjNTFfMy0yLTEtMS03NzAzMg_d8896140-babd-49d5-afac-f2e66f90d016">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:LeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjIzYjc2N2UyNzkwYjQxMTU5NDk3YmJhNDFjODJmYzUxL3RhYmxlcmFuZ2U6MjNiNzY3ZTI3OTBiNDExNTk0OTdiYmE0MWM4MmZjNTFfNC0xLTEtMS03NzAzMg_3768dd10-2b07-47ff-bcbd-4a740daf943e">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:LeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjIzYjc2N2UyNzkwYjQxMTU5NDk3YmJhNDFjODJmYzUxL3RhYmxlcmFuZ2U6MjNiNzY3ZTI3OTBiNDExNTk0OTdiYmE0MWM4MmZjNTFfNC0yLTEtMS03NzAzMg_1d449616-0568-4b49-8128-6acf90a30a52">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.137%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net investment in sales-type leases was $<ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:SalesTypeLeaseNetInvestmentInLease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODc4Ng_6a44fb54-3d65-4818-b394-fb7ee8ce5968">109</ix:nonFraction> million as of March&#160;31, 2022, of which $<ix:nonFraction unitRef="usd" contextRef="i2b9e15e802c2455fb04ea04eb4db2322_I20181231" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg0MQ_f8b4fcd4-1d31-4d17-8e5b-d8638cb41dac">38</ix:nonFraction> million originated in 2018 and prior, $<ix:nonFraction unitRef="usd" contextRef="i522261ab58db4575939d49828d4c748e_I20191231" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg1Mw_cea5bda1-5b7e-4647-b275-2040afbbd115">16</ix:nonFraction> million in 2019, $<ix:nonFraction unitRef="usd" contextRef="i238ac34b0aab41be8134d8a775d08e2d_I20201231" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg2NQ_59ef1050-1148-430d-94dc-f8bae08e18e7">28</ix:nonFraction>&#160;million in 2020, $<ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg4MA_911725c4-17e9-4673-aca3-2667d2f024ce">25</ix:nonFraction> million in 2021, and $<ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfMTA5OTUxMTYzOTk3Mg_62fef6c3-a972-4d37-b9af-dd31a557c578">2</ix:nonFraction>&#160;million in 2022.</span></div></ix:continuation><div id="i8787971997a742729b9820f85443271c_67"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">10. <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RleHRyZWdpb246ZDhhMjhlZWNiM2M4NGM1YjgyMmM4MmFlNjA5ODEwN2FfMjM5Nw_40b89f9a-0598-480e-abb4-feb8d10286b9" continuedAt="i8f0b4d7df04842ffa157d7ed720dc88a" escape="true">BUSINESS OPTIMIZATION CHARGES</ix:nonNumeric></span></div><ix:continuation id="i8f0b4d7df04842ffa157d7ed720dc88a" continuedAt="ia1d419e3ffd84cda82579e715e7c1e73"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, we have undertaken actions to transform our cost structure and enhance operational efficiency. These efforts include restructuring the organization, optimizing the manufacturing footprint, R&amp;D operations and supply chain network, employing disciplined cost management, and centralizing and streamlining certain support functions. In the current period, restructuring charges include actions taken in connection with our integration of Hillrom. From the commencement of our business optimization activities in the second half of 2015 through March&#160;31, 2022, we have incurred cumulative pre-tax costs of $<ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-8" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RleHRyZWdpb246ZDhhMjhlZWNiM2M4NGM1YjgyMmM4MmFlNjA5ODEwN2FfNTMy_eabec09c-32cc-4f65-bd7d-80edead9ba78">1.3</ix:nonFraction> billion related to these actions. The costs consisted primarily of employee termination costs, implementation costs, contract termination costs, asset impairments and accelerated depreciation. We currently expect to incur additional pre-tax costs of approximately $<ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RleHRyZWdpb246ZDhhMjhlZWNiM2M4NGM1YjgyMmM4MmFlNjA5ODEwN2FfNzkx_0f45fd03-d539-4128-8d3b-84025fc14afc">25</ix:nonFraction> million through the completion of the initiatives that are currently underway, primarily related to implementation costs. We continue to pursue cost savings initiatives and, to the extent further cost savings opportunities are identified, we may incur additional restructuring charges and costs to implement business optimization programs in future periods.</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="bax:BusinessOptimizationChargeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RleHRyZWdpb246ZDhhMjhlZWNiM2M4NGM1YjgyMmM4MmFlNjA5ODEwN2FfMjM5OA_e9d0e471-5709-4ac3-ae63-9cd53f8fd084" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022 and 2021, we recorded the following charges related to business optimization programs.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.987%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86b2c8277034f9e961edc5d828e8065_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOmJiOTYyZDdlZmM3ZTQwNjZiZmUzNDk2OTQ0YzdkOWNjL3RhYmxlcmFuZ2U6YmI5NjJkN2VmYzdlNDA2NmJmZTM0OTY5NDRjN2Q5Y2NfMi0xLTEtMS03NzAzMg_f1ba4647-5b33-46f5-ae75-7f186e01de25">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9311558f896a40b688cfc17aa08d2304_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOmJiOTYyZDdlZmM3ZTQwNjZiZmUzNDk2OTQ0YzdkOWNjL3RhYmxlcmFuZ2U6YmI5NjJkN2VmYzdlNDA2NmJmZTM0OTY5NDRjN2Q5Y2NfMi0yLTEtMS03NzAzMg_c27e217d-90f3-409b-b6f9-847580f0a6df">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs to implement business optimization programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86b2c8277034f9e961edc5d828e8065_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOmJiOTYyZDdlZmM3ZTQwNjZiZmUzNDk2OTQ0YzdkOWNjL3RhYmxlcmFuZ2U6YmI5NjJkN2VmYzdlNDA2NmJmZTM0OTY5NDRjN2Q5Y2NfMy0xLTEtMS03NzAzMg_3c5c4b35-f759-4499-a497-1ad503fe78df">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9311558f896a40b688cfc17aa08d2304_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostIncurredCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOmJiOTYyZDdlZmM3ZTQwNjZiZmUzNDk2OTQ0YzdkOWNjL3RhYmxlcmFuZ2U6YmI5NjJkN2VmYzdlNDA2NmJmZTM0OTY5NDRjN2Q5Y2NfMy0yLTEtMS03NzAzMg_1a5ece7f-6937-48cd-86c9-a58710d1a754">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total business optimization charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86b2c8277034f9e961edc5d828e8065_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOmJiOTYyZDdlZmM3ZTQwNjZiZmUzNDk2OTQ0YzdkOWNjL3RhYmxlcmFuZ2U6YmI5NjJkN2VmYzdlNDA2NmJmZTM0OTY5NDRjN2Q5Y2NfNS0xLTEtMS03NzAzMg_d65d43fa-20b8-4bab-b2bf-18bff19a9057">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9311558f896a40b688cfc17aa08d2304_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOmJiOTYyZDdlZmM3ZTQwNjZiZmUzNDk2OTQ0YzdkOWNjL3RhYmxlcmFuZ2U6YmI5NjJkN2VmYzdlNDA2NmJmZTM0OTY5NDRjN2Q5Y2NfNS0yLTEtMS03NzAzMg_7fc70eca-a71c-4531-86c3-2961733895e4">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For segment reporting purposes, business optimization charges are unallocated expenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs to implement business optimization programs for the three months ended March&#160;31, 2022 and 2021, respectively, consisted primarily of external consulting and transition costs, including employee compensation and related costs. These costs were primarily included within cost of sales and SG&amp;A expense.</span></div><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RleHRyZWdpb246ZDhhMjhlZWNiM2M4NGM1YjgyMmM4MmFlNjA5ODEwN2FfMjQwMA_567690e1-b37d-46b8-8582-8152189beb02" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022 and 2021, we recorded the following restructuring charges.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11a40960ca1f4fa5b6e685c5e17a27e1_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfMi0xLTEtMS03NzAzMg_4a48bd24-efed-40a6-a136-b1f67e65b781">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffeac49ece2f4f0099db2b6316bc2a6b_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfMi0yLTEtMS03NzAzMg_86194f73-ece1-44bf-bca5-8a906c4e4514">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia27cfb043f884dbd9667969290a6e989_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfMi0zLTEtMS03NzAzMg_3f987f9c-02ef-43b8-8211-daccab2d7f69">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f45e9451124a38a8618085deaa0bad_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfMi00LTEtMS03NzAzMg_bf794aa6-1514-4087-a295-3ad9811c4873">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5d8d62119742ed9ba5ea4e4194307b_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfMy0xLTEtMS03NzAzMg_3642461e-1e84-4929-8e31-4138436eed60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i290805ec99d64042be64af58b8ffd3b7_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfMy0yLTEtMS03NzAzMg_0d15f510-8999-422e-bac6-3afbb3caa1da">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7223eebf6ed94d309d0faa7ad432bbbd_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfMy0zLTEtMS03NzAzMg_3c1c4237-c7df-447c-ab1c-07e5c7a38688">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd1cb136a26b44cba87fb2a70901faa7_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfMy00LTEtMS03NzAzMg_26b7cd0e-4c19-4583-9ac7-eda22697f42d">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d79d5f91f94bcab33cf772a3b3063d_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfNC0xLTEtMS03NzAzMg_8c34d046-2e77-478d-b906-d62261941ff2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0379f97ea684a719bc4b38d54e0efde_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfNC0yLTEtMS03NzAzMg_00d145fa-8b1e-4ceb-9a8a-aa0ed5a59041">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i879c4d6181ea43c099235e39734a646e_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfNC0zLTEtMS03NzAzMg_26655e59-b466-4c3a-8204-72c28315a4cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63e5679fd4e5469d85730434afe1d238_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfNC00LTEtMS03NzAzMg_12e69352-65c4-485e-b9b6-1cbfe834f271">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68997075a33458898c6e14a36eebeb9_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfNS0xLTEtMS03NzAzMg_3ceed479-fc0e-48d3-aaf0-e78f238acd15">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia62b9d54444c46208ba00c7b3a49f393_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfNS0yLTEtMS03NzAzMg_6130be0a-487c-45e2-b8f6-d9af01b33577">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef7f560cf624875bf9c35c67df33547_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfNS0zLTEtMS03NzAzMg_e9509f38-357b-454f-afc6-677ba9011413">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfNS00LTEtMS03NzAzMg_33c0f1b8-7dd0-4c38-8fd3-d7ee089431f3">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62dc3391e9264db98a1f3fe40474e64b_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfMi0xLTEtMS03NzAzMg_7f6e4ffa-2138-4e14-8f34-56a3fc9a4bdb">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5718c50c86d740d098ff8d49b559feaf_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfMi0yLTEtMS03NzAzMg_32ee77a9-6d0c-4aea-bc06-586cec1f5ad5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ee68bc6af754a66b0a50a9468a8588a_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfMi0zLTEtMS03NzAzMg_4da65494-41ef-4541-808b-8b3993b6b1d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i312b43d90c8849b8b19bdd30e36c95c1_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfMi00LTEtMS03NzAzMg_d810e871-28ef-4172-9df3-64926ced67e9">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32aeda1131ad47a9a728d691bcb5e02b_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfNC0xLTEtMS03NzAzMg_6c948abe-58a1-42b4-bf95-f63097f8bbd1">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6acac91985d749cbbb8a0f1ece842c1d_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfNC0yLTEtMS03NzAzMg_9334a2de-9557-4650-b6f4-890047167356">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d49bf9ceb394ee397eb421a3a4ea0e7_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfNC0zLTEtMS03NzAzMg_001b0cc1-621b-41d5-aafb-586ceef552a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9451246f53f4b13b9c1078a4785af23_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfNC00LTEtMS03NzAzMg_2f468c22-e7ad-404e-ac8b-6b32f915c2a8">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63b9c16382b045218cfce2166bcdcd3e_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfNS0xLTEtMS03NzAzMg_f1a97250-7a3d-4cc0-b2b3-a46f144a253b">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebe3c987e85b400bac19095e21ca736c_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfNS0yLTEtMS03NzAzMg_9fcbbec3-9caf-438c-b419-17a8dfcc2051">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1701fe482b3a4c3183852a3aa9fe0c87_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfNS0zLTEtMS03NzAzMg_feede1b2-5489-495b-9434-01f43d17156a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfNS00LTEtMS03NzAzMg_129db8b1-3ef0-48b8-91ca-7697c1fdf69b">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><ix:continuation id="ia1d419e3ffd84cda82579e715e7c1e73"><div><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RleHRyZWdpb246ZDhhMjhlZWNiM2M4NGM1YjgyMmM4MmFlNjA5ODEwN2FfMjQwMQ_c8a0c8f2-40df-47ba-a3e4-8726ad2443c8" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity in the liability related to our restructuring initiatives.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.405%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d7dca14db914da8ad561a51aee21848_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjYyYjExYTFmZjEyZDRiMWQ4MzE2ZDI2OWY3MmRmMWMyL3RhYmxlcmFuZ2U6NjJiMTFhMWZmMTJkNGIxZDgzMTZkMjY5ZjcyZGYxYzJfMS0xLTEtMS03NzAzMg_2b1d0009-0616-458d-8aec-46ea9fad1a52">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i786ae4d3319c471ab517a03677b933e3_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjYyYjExYTFmZjEyZDRiMWQ4MzE2ZDI2OWY3MmRmMWMyL3RhYmxlcmFuZ2U6NjJiMTFhMWZmMTJkNGIxZDgzMTZkMjY5ZjcyZGYxYzJfMi0xLTEtMS03NzAzMg_2e395c10-5ab3-4146-a00a-a2140f89d7e2">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i786ae4d3319c471ab517a03677b933e3_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjYyYjExYTFmZjEyZDRiMWQ4MzE2ZDI2OWY3MmRmMWMyL3RhYmxlcmFuZ2U6NjJiMTFhMWZmMTJkNGIxZDgzMTZkMjY5ZjcyZGYxYzJfMy0xLTEtMS03NzAzMg_609a632d-551a-4ac8-b53e-d532cec0ea1b">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i786ae4d3319c471ab517a03677b933e3_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjYyYjExYTFmZjEyZDRiMWQ4MzE2ZDI2OWY3MmRmMWMyL3RhYmxlcmFuZ2U6NjJiMTFhMWZmMTJkNGIxZDgzMTZkMjY5ZjcyZGYxYzJfNS0xLTEtMS03NzAzMg_9c0a8ec6-fa87-423f-b991-bb39952bd948">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88c2ae6f33f64b45936b4dcd18b5d612_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjYyYjExYTFmZjEyZDRiMWQ4MzE2ZDI2OWY3MmRmMWMyL3RhYmxlcmFuZ2U6NjJiMTFhMWZmMTJkNGIxZDgzMTZkMjY5ZjcyZGYxYzJfNi0xLTEtMS03NzAzMg_6a6e66a6-a666-4d17-afd5-7d1cc1221703">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our restructuring liabilities as of March&#160;31, 2022 relate to employee termination costs, with the remaining liabilities attributable to contract termination costs. Substantially all of the cash payments for those liabilities are expected to be disbursed by the end of 2023.</span></div></ix:continuation><div id="i8787971997a742729b9820f85443271c_70"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">11. <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RleHRyZWdpb246MzhiZTY2OGI4YjM4NDZhZTg0ZmVhNTk0Y2RmM2FhNGVfMTU3_d22abdd9-fa95-49fe-9cd4-173a0f9cd48d" continuedAt="i0042b340910046bbbae4713d6b1537c3" escape="true">PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</ix:nonNumeric></span></div><div style="margin-top:10pt"><ix:continuation id="i0042b340910046bbbae4713d6b1537c3"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RleHRyZWdpb246MzhiZTY2OGI4YjM4NDZhZTg0ZmVhNTk0Y2RmM2FhNGVfMTU5_f71460bd-6d71-40cd-8c61-3e20a5a8bedb" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of net periodic benefit cost relating to our pension and OPEB plans.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.275%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Pension benefits</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c7bf2bab574ab28206bdde47eed8d5_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfMy0xLTEtMS03NzAzMg_717153aa-bdae-455d-8573-3fa250349f4c">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ef157d694c2423bb871181ca6e1ef94_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfMy0yLTEtMS03NzAzMg_47645128-43fd-4c03-9658-fb295e6614ae">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c7bf2bab574ab28206bdde47eed8d5_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfNC0xLTEtMS03NzAzMg_94091e00-3c08-45a0-adfb-5b43c132f9a9">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ef157d694c2423bb871181ca6e1ef94_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfNC0yLTEtMS03NzAzMg_3e824601-21ff-489f-9c1d-16fff9dd3e7a">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5c7bf2bab574ab28206bdde47eed8d5_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfNS0xLTEtMS03NzAzMg_35949348-9fc2-46a9-b955-2e1ad64809f0">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ef157d694c2423bb871181ca6e1ef94_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfNS0yLTEtMS03NzAzMg_e8536d87-ddb9-40c8-85c5-a1d7400306b1">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c7bf2bab574ab28206bdde47eed8d5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfNi0xLTEtMS03NzAzMg_069fbe7b-68e5-4b87-a07a-fa3cf4f25e5d">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ef157d694c2423bb871181ca6e1ef94_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfNi0yLTEtMS03NzAzMg_b0b013a1-8a74-42c3-8ed0-2d0aeade65e8">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c7bf2bab574ab28206bdde47eed8d5_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfNy0xLTEtMS03NzAzMg_b91659c5-296a-4026-bee6-061cd5e87a48">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ef157d694c2423bb871181ca6e1ef94_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfNy0yLTEtMS03NzAzMg_fc9a37c2-3c91-4640-833d-8d26afcd7281">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OPEB</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5dc8f540120419bb40e18be629ff121_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfOS0xLTEtMS03NzAzMg_2d4895c8-b2b7-4c80-94f0-119342065762">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0744bc26d8d4427bc7a38006ba71623_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfOS0yLTEtMS03NzAzMg_965ffb07-a75a-4f93-8487-835a2f7fd050">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net loss and prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5dc8f540120419bb40e18be629ff121_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfMTAtMS0xLTEtNzcwMzI_a8bf794a-5296-4fd8-837b-32edaab1c27c">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0744bc26d8d4427bc7a38006ba71623_D20210101-20210331" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfMTAtMi0xLTEtNzcwMzI_384b143b-c588-4c81-aee0-076564f5099f">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic OPEB cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5dc8f540120419bb40e18be629ff121_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfMTEtMS0xLTEtNzcwMzI_68e4f1ab-f20d-4682-b5f4-4ac3f07d7941">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0744bc26d8d4427bc7a38006ba71623_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfMTEtMi0xLTEtNzcwMzI_b29c6670-204b-4937-8428-318947161257">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="i8787971997a742729b9820f85443271c_73"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"> 12. <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183My9mcmFnOmU0NjYxMjY4M2MxMzQwMzQ5OGNmMWZkYTcxOWE5ODNlL3RleHRyZWdpb246ZTQ2NjEyNjgzYzEzNDAzNDk4Y2YxZmRhNzE5YTk4M2VfMTc3OA_c203044b-fe91-45e4-ac92-67b880d13678" continuedAt="i1c626c3724b5413dba1b71763deede97" escape="true">INCOME TAXES</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i1c626c3724b5413dba1b71763deede97" continuedAt="ib963bcf6d91249709e9143ad5cd6aee6"> </ix:continuation></span></div><ix:continuation id="ib963bcf6d91249709e9143ad5cd6aee6"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our effective income tax rate was <ix:nonFraction unitRef="number" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183My9mcmFnOmU0NjYxMjY4M2MxMzQwMzQ5OGNmMWZkYTcxOWE5ODNlL3RleHRyZWdpb246ZTQ2NjEyNjgzYzEzNDAzNDk4Y2YxZmRhNzE5YTk4M2VfNTg_fa086c92-e5dc-458e-889c-16e872be7b95">22.3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183My9mcmFnOmU0NjYxMjY4M2MxMzQwMzQ5OGNmMWZkYTcxOWE5ODNlL3RleHRyZWdpb246ZTQ2NjEyNjgzYzEzNDAzNDk4Y2YxZmRhNzE5YTk4M2VfNjU_1f772a6d-d9be-4691-b26e-0c6552bac482">14.5</ix:nonFraction>% for the three months ended March 31, 2022 and 2021, respectively. Our effective income tax rate can differ from the <ix:nonFraction unitRef="number" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="2" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183My9mcmFnOmU0NjYxMjY4M2MxMzQwMzQ5OGNmMWZkYTcxOWE5ODNlL3RleHRyZWdpb246ZTQ2NjEyNjgzYzEzNDAzNDk4Y2YxZmRhNzE5YTk4M2VfMTk4_92412cd7-824f-4042-8e41-6c0db9bfbeb5">21</ix:nonFraction>% U.S. federal statutory rate due to a number of factors, including foreign rate differences, tax incentives, increases or decreases in valuation allowances and liabilities for uncertain tax positions and excess tax benefits on stock compensation awards.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to discrete tax matters in various foreign jurisdictions, of which none are individually material, and an increase in our liabilities for uncertain tax positions, partially offset by excess tax benefits on stock compensation awards and a favorable geographic earnings mix.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to decreases in accrued withholding taxes in several foreign jurisdictions and a favorable geographic earnings mix.</span></div></ix:continuation><div id="i8787971997a742729b9820f85443271c_76"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">13. <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RleHRyZWdpb246MzI2YjJiZDAwYzhmNDczYzgxODkwYjU3MjZhZDZhZjJfOTUz_a61fd944-a3f8-4dd8-8be9-2bf6c60274a5" continuedAt="i22cfcf7e962f4fe586c51de1a5f2f3a9" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i22cfcf7e962f4fe586c51de1a5f2f3a9" continuedAt="i1ec706e6353942ab8ef72a6bbe37da0f">The numerator for both basic and diluted earnings per share (EPS) is net income attributable to Baxter stockholders. The denominator for basic EPS is the weighted-average number of shares outstanding during the period. The dilutive effect of outstanding stock options, RSUs and PSUs is reflected in the denominator for diluted EPS using the treasury stock method.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1ec706e6353942ab8ef72a6bbe37da0f"><div style="margin-top:10pt"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RleHRyZWdpb246MzI2YjJiZDAwYzhmNDczYzgxODkwYjU3MjZhZDZhZjJfOTU0_a87fa30d-845a-4027-977b-9432a515ffd3" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of basic shares to diluted shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.275%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RhYmxlOjBjNGZhNDcyZjcwZTQwNTlhNTk2YzNkZWE3NWNmMjNmL3RhYmxlcmFuZ2U6MGM0ZmE0NzJmNzBlNDA1OWE1OTZjM2RlYTc1Y2YyM2ZfMi0xLTEtMS03NzAzMg_f759f33f-ebae-4b20-a49f-df53ac463bca">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RhYmxlOjBjNGZhNDcyZjcwZTQwNTlhNTk2YzNkZWE3NWNmMjNmL3RhYmxlcmFuZ2U6MGM0ZmE0NzJmNzBlNDA1OWE1OTZjM2RlYTc1Y2YyM2ZfMi0yLTEtMS03NzAzMg_e759acac-49be-4797-b488-2404f3f547e9">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RhYmxlOjBjNGZhNDcyZjcwZTQwNTlhNTk2YzNkZWE3NWNmMjNmL3RhYmxlcmFuZ2U6MGM0ZmE0NzJmNzBlNDA1OWE1OTZjM2RlYTc1Y2YyM2ZfMy0xLTEtMS03NzAzMg_7ec10d28-071a-49d6-9c3b-7618982fc3e2">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RhYmxlOjBjNGZhNDcyZjcwZTQwNTlhNTk2YzNkZWE3NWNmMjNmL3RhYmxlcmFuZ2U6MGM0ZmE0NzJmNzBlNDA1OWE1OTZjM2RlYTc1Y2YyM2ZfMy0yLTEtMS03NzAzMg_21c8ab5a-d9eb-4d75-b17b-a96a30169db8">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RhYmxlOjBjNGZhNDcyZjcwZTQwNTlhNTk2YzNkZWE3NWNmMjNmL3RhYmxlcmFuZ2U6MGM0ZmE0NzJmNzBlNDA1OWE1OTZjM2RlYTc1Y2YyM2ZfNC0xLTEtMS03NzAzMg_d6840e7e-69a0-49fa-9d9c-7ec56fa7f5a2">509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RhYmxlOjBjNGZhNDcyZjcwZTQwNTlhNTk2YzNkZWE3NWNmMjNmL3RhYmxlcmFuZ2U6MGM0ZmE0NzJmNzBlNDA1OWE1OTZjM2RlYTc1Y2YyM2ZfNC0yLTEtMS03NzAzMg_72f14d15-87f0-4cc7-9449-0b7606dbc56a">511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of dilutive securities includes unexercised stock options, unvested RSUs and contingently issuable shares related to granted PSUs. The computation of diluted EPS excludes <ix:nonFraction unitRef="shares" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RleHRyZWdpb246MzI2YjJiZDAwYzhmNDczYzgxODkwYjU3MjZhZDZhZjJfNjUw_35370b25-874e-4d0e-8209-7d096ce0f961">4</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RleHRyZWdpb246MzI2YjJiZDAwYzhmNDczYzgxODkwYjU3MjZhZDZhZjJfMTA5OTUxMTYyODg5NA_eb933ffa-5095-4c8c-a1c4-e7b8ac469d01">7</ix:nonFraction> million equity awards for the three months ended March&#160;31, 2022 and 2021, respectively, because their inclusion would have had an anti-dilutive effect on diluted EPS.  Refer to Note 7 for additional information regarding items impacting basic and diluted shares.</span></div></ix:continuation><div id="i8787971997a742729b9820f85443271c_79"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">14. <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfODgxOA_0a235ab5-ff23-44e3-b509-dda240d27e11" continuedAt="icea488ead4e44ca0beba5b1c14660de2" escape="true">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</ix:nonNumeric></span></div><ix:continuation id="icea488ead4e44ca0beba5b1c14660de2" continuedAt="iaacd4d9880a24d8b99e89af6d5066f0f"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate on a global basis and are exposed to the risk that our earnings, cash flows and equity could be adversely impacted by fluctuations in foreign exchange and interest rates. Our hedging policy attempts to manage these risks to an acceptable level based on our judgment of the appropriate trade-off between risk, opportunity and costs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are primarily exposed to foreign exchange risk with respect to recognized assets and liabilities, forecasted transactions and net assets denominated in the Euro, British Pound, Chinese Renminbi, Korean Won, Australian Dollar, Canadian Dollar, Japanese Yen, Colombian Peso, Brazilian Real, Mexican Peso, Turkish Lira, Indian Rupee and Swedish Krona. We manage our foreign currency exposures on a consolidated basis, which allows us to net exposures and take advantage of any natural offsets. In addition, we use derivative and nonderivative instruments to further reduce the net exposure to foreign exchange risk. Gains and losses on the hedging instruments offset losses and gains on the hedged transactions and reduce the earnings and equity volatility resulting from changes in foreign exchange rates. Financial market and currency volatility may limit our ability to cost-effectively hedge these exposures.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exposed to the risk that our earnings and cash flows could be adversely impacted by fluctuations in interest rates. Our policy is to manage interest costs using the mix of fixed- and floating-rate debt that we believe is appropriate at that time. To manage this mix in a cost-efficient manner, we periodically enter into interest rate swaps in which we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not hold any instruments for trading purposes and none of our outstanding derivative instruments contain credit-risk-related contingent features.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are generally recognized as either assets or liabilities at fair value in the condensed consolidated balance sheets and are classified as short-term or long-term based on the scheduled maturity of the instrument. We designate certain of our derivatives and foreign-currency denominated debt as hedging instruments in cash flow, fair value, or net investment hedges.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Flow Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may use options, including collars and purchased options, forwards and cross-currency swaps to hedge the foreign exchange risk to earnings relating to forecasted transactions and recognized assets and liabilities. We periodically use treasury rate locks to hedge the risk to earnings associated with movements in interest rates relating to anticipated issuances of debt.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each derivative instrument that is designated and effective as a cash flow hedge, the gain or loss on the derivative is recorded in AOCI and then recognized in earnings consistent with the underlying hedged item. Option premiums or net premiums paid are initially recorded as assets and reclassified to other comprehensive income (OCI) over the life of the option, and then recognized in earnings consistent with the underlying hedged item. Cash flow hedges are classified in cost of sales and interest expense, net, and are primarily related to forecasted intra-company sales denominated in foreign currencies and forecasted interest payments on anticipated issuances of debt, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of foreign exchange contracts designated as cash flow hedges were $<ix:nonFraction unitRef="usd" contextRef="i760ce24b4a13497aa499059071c1bf88_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfMzU5Nw_ad811c99-9404-43e6-b154-c395f8bf56ff">402</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i536e66a57732404691a7c9d746a9c77a_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfMzYwNA_90eb30c8-dc64-46d2-879e-887c65c934ac">377</ix:nonFraction> million as of March&#160;31, 2022 and December&#160;31, 2021, respectively. The maximum term over which we have cash flow </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iaacd4d9880a24d8b99e89af6d5066f0f" continuedAt="i7e821a77196f4baf8865626bfc615498"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hedge contracts in place related to forecasted transactions at March&#160;31, 2022 is <ix:nonNumeric contextRef="i557d8b940ffb46fea7a0ffbea9c8628e_D20220101-20220331" name="us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfMzc1Mw_278b4544-6f9e-452f-a2ad-91f8b50dce8c">12</ix:nonNumeric> months for foreign exchange contracts. There were <ix:nonFraction unitRef="usd" contextRef="i922227aeddd24ee2b5e427b08c34c08d_I20220331" decimals="INF" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfMzc5OQ_20565cd6-422e-4cc1-832b-bcbb24ea7c95"><ix:nonFraction unitRef="usd" contextRef="i39dea52d46d64c63b911fc2fec7d9fa9_I20211231" decimals="INF" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfMzc5OQ_45fc459c-1df2-4604-8fcc-ad8c63ca7343">no</ix:nonFraction></ix:nonFraction> outstanding interest rate contracts designated as cash flow hedges as of March&#160;31, 2022 and December&#160;31, 2021. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically use interest rate swaps to convert a portion of our fixed-rate debt into variable-rate debt. These instruments hedge our earnings from changes in the fair value of debt due to fluctuations in the designated benchmark interest rate. For each derivative instrument that is designated and effective as a fair value hedge, the gain or loss on the derivative is recognized immediately to earnings, and offsets changes in fair value attributable to a particular risk, such as changes in interest rates, of the hedged item, which are also recognized in earnings. Changes in the fair value of hedge instruments designated as fair value hedges are classified in interest expense, net, as they hedge the interest rate risk associated with certain of our fixed-rate debt.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="if99e9e9771eb4da2a299bf355a486649_I20220331" decimals="INF" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNDY5Mw_57e7666d-8c3b-4bcc-9d97-92b085de2cc6"><ix:nonFraction unitRef="usd" contextRef="i93c6321b74e54dc7ac6d3673ec476dd1_I20211231" decimals="INF" name="us-gaap:DerivativeFairValueOfDerivativeNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNDY5Mw_6954c6c9-bdbe-4b9e-93ef-09207dd239c7">no</ix:nonFraction></ix:nonFraction> outstanding interest rate contracts designated as fair value hedges as of March&#160;31, 2022 and December&#160;31, 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net Investment Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, we issued &#8364;<ix:nonFraction unitRef="eur" contextRef="i61964dbdf7e84be88705f093c0802196_I20170531" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNDgyNg_95bdbdae-35ad-4479-9c4a-8a24a9e183f2">600</ix:nonFraction> million of senior notes due May 2025. In May 2019, we issued &#8364;<ix:nonFraction unitRef="eur" contextRef="i2197ddaf305b41748d421ed313216345_I20190531" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNDg3Ng_21d37c3a-f4c0-41ce-bfea-8711fff59540">750</ix:nonFraction> million of senior notes due May 2024 and &#8364;<ix:nonFraction unitRef="eur" contextRef="i12a714234c6e4e9eb4d18197fbcce84c_I20190531" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNDkwNg_93493392-2c4b-465f-be6b-5c36ae6c8750">750</ix:nonFraction> million of senior notes due May 2029. We have designated these debt obligations as hedges of our net investment in our European operations and, as a result, mark to spot rate adjustments on the outstanding debt balances are recorded as a component of AOCI. As of March&#160;31, 2022, we had an accumulated pre-tax unrealized translation loss in AOCI of $<ix:nonFraction unitRef="usd" contextRef="iacacd738d13b471191092dfc7ad4dea7_I20220331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNTIzMQ_0b50a0b0-7e94-49eb-8db3-c5b62e108e4e">4</ix:nonFraction> million related to the Euro-denominated senior notes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dedesignations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If it is determined that a derivative or nonderivative hedging instrument is no longer highly effective as a hedge, we discontinue hedge accounting prospectively. Gains or losses relating to terminations of effective cash flow hedges generally continue to be deferred and are recognized consistent with the loss or income recognition of the underlying hedged items. However, if it is probable that the hedged forecasted transactions will not occur, any gains or losses would be immediately reclassified from AOCI to earnings. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i4edbb47a30cf46afbff865ead00dd98c_I20210331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNTgzMw_0242cdcb-0dde-462e-a297-f93a7f0b20e6"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNTgzMw_56cc4d43-4e2e-4b3d-a49b-de2676024d74">no</ix:nonFraction></ix:nonFraction> hedge dedesignations in the first three months of 2022 or 2021 resulting from changes in our assessment of the probability that the hedged forecasted transactions would occur.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we terminate a fair value hedge, an amount equal to the cumulative fair value adjustment to the hedged item at the date of termination is amortized to earnings over the remaining term of the hedged item. There were <ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="INF" name="bax:DerivativeFairValueTerminated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNjIyMw_a33f2ad8-dc11-4c1c-b54a-3c35eab6449d"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="INF" name="bax:DerivativeFairValueTerminated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNjIyMw_cdcda04e-7ad3-4431-ae45-8f079d2128a5">no</ix:nonFraction></ix:nonFraction> fair value hedges terminated during the first three months of 2022 or 2021. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we remove a net investment hedge designation, any gains or losses recognized in AOCI are not reclassified to earnings until we sell, liquidate, or deconsolidate the foreign investments that were being hedged. There were <ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="INF" name="bax:DerivativeNetInvestmentTerminated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNjUxNQ_3d66ef83-c0d8-46b1-ae39-b8db77d724e1"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="INF" name="bax:DerivativeNetInvestmentTerminated" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNjUxNQ_bfbfb2a5-d82c-42e4-bc6f-85b894ad434e">no</ix:nonFraction></ix:nonFraction> net investment hedges terminated during the first three months of 2022 or 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Undesignated Derivative Instruments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use forward contracts to hedge earnings from the effects of foreign exchange relating to certain of our intra-company and third-party receivables and payables denominated in a foreign currency. These derivative instruments are generally not formally designated as hedges and the terms of these instruments generally do not exceed one month.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total notional amount of undesignated derivative instruments was $<ix:nonFraction unitRef="usd" contextRef="i71a1b7a14751464f96d1e33c2d439a5a_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNzA0MA_b122898b-7bd3-4a52-ad13-bee8f6c7b71f">940</ix:nonFraction>&#160;million as of March&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i792cbe33e35d445f91ea87aaf0e146b6_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNDk0NzgwMjMzNDEzMA_30412fc9-2320-4d1b-8c63-9d6e77cd61d2">851</ix:nonFraction> million as of December&#160;31, 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gains and Losses on Hedging Instruments and Undesignated Derivative Instruments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfODgxMQ_dcbbea87-7d46-4a4c-af50-b844c212444b" continuedAt="ie6ece69e38904f0286ff9fea08ed21a9" escape="true">The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the three months ended March&#160;31, 2022 and </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7e821a77196f4baf8865626bfc615498" continuedAt="i5e2314f23a5748708a1ceb59c32bfe17"><ix:continuation id="ie6ece69e38904f0286ff9fea08ed21a9"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:24.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss)<br/>in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) reclassified from AOCI into income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54c2d01d93ca4760941fa4a68b4b08b6_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfMy0xLTEtMS03NzAzMg_c6406294-a6b3-4c3e-a401-fe1b71ad34a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03f7bde8ea3b46179c1c8a7c608bd403_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfMy0zLTEtMS03NzAzMg_cecb6478-1f67-4f8f-9c44-410844796287">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c56206e8fd2421181da55d3c02a8854_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfMy02LTEtMS03NzAzMg_9bf6e158-5317-471d-8cb8-95e01c77829b">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55ff25312dce4820b856d1dfd634ca60_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfMy04LTEtMS03NzAzMg_880fe40f-7a7a-44b2-b81e-cda103d89f76">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i557d8b940ffb46fea7a0ffbea9c8628e_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNC0xLTEtMS03NzAzMg_5c47bbb6-c1b8-49b9-a29c-b46c95970002">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15e37ef8d94a4fe0b71f0876df3d6ee2_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNC0zLTEtMS03NzAzMg_2797c409-5212-446b-b05b-a5f9a136113f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21388d336c1f433c8ceded9265e245d2_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNC02LTEtMS03NzAzMg_6bc12ab1-b51b-4d9f-8eed-94280decb1e7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i979180e5f4714629b4784cf1025dd9c6_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNC04LTEtMS03NzAzMg_8a0e6a42-d4ed-40eb-b769-01eaad9c876c">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNS0xLTEtMS03NzAzMg_5f80a2fb-de41-41e3-9aa7-f4d966b5a529">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNS0zLTEtMS03NzAzMg_64b1dac8-59cf-4bb2-9daf-609dee7f6cc4">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40ca9abc862645c4a33f3d2218f9f2a7_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNS02LTEtMS03NzAzMg_3517dbd3-0fa9-4bcc-bf66-805d1f96f3ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5b3d67eccd142a6939834d39b716b4f_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNS04LTEtMS03NzAzMg_3b38dacf-42a2-41bc-8153-d167e2a98dc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNi0xLTEtMS03NzAzMg_c2b9f50b-d553-4399-bf31-bcfeb0f356d2">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNi0zLTEtMS03NzAzMg_7f5a7f49-93f3-4bd0-b001-03870d229dd2">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNi02LTEtMS03NzAzMg_4f2cce02-d1c0-4857-bcc4-2ea9595605aa">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNi04LTEtMS03NzAzMg_1ed3ebc8-3729-4f64-9950-ceeb4a4aa54b">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss) in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67f9b129d87944fa85b837dac860fb75_D20220101-20220331" decimals="-6" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjUxN2ZhYjRlN2VjZDRkNjJhNGMwMTQ3YjA0NjE5YjIwL3RhYmxlcmFuZ2U6NTE3ZmFiNGU3ZWNkNGQ2MmE0YzAxNDdiMDQ2MTliMjBfMy0yLTEtMS03NzAzMg_9c3e8895-1273-49ba-8663-31e70ee1f701">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f8128091c9b4323ac693e2f73552a3e_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjUxN2ZhYjRlN2VjZDRkNjJhNGMwMTQ3YjA0NjE5YjIwL3RhYmxlcmFuZ2U6NTE3ZmFiNGU3ZWNkNGQ2MmE0YzAxNDdiMDQ2MTliMjBfMy00LTEtMS03NzAzMg_b3a5c188-92cb-4a1b-a48c-9066bf5d9923">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.331%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNzU4MA_8675f236-300c-4aa9-beda-d2d77d6fa820">5</ix:nonFraction> million of deferred, net after-tax losses on derivative instruments included in AOCI are expected to be recognized in earnings during the next 12 months, coinciding with when the hedged items are expected to impact earnings.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivative Assets and Liabilities</span></div><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfODgyMQ_8a152b3f-3915-456d-8d38-967375cc2381" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of March&#160;31, 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d8a8344b6145c39ccd9339d15cc4d9_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjgyYTE0ODhhNjgxMjQ5NTZiMzMzODM1MzM0YjNhNzcyL3RhYmxlcmFuZ2U6ODJhMTQ4OGE2ODEyNDk1NmIzMzM4MzUzMzRiM2E3NzJfNC0yLTEtMS03NzAzMg_610fee13-37de-41f3-a507-979cb09f2d8f">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04f11ec5ea644541baa8aa7176602e10_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjgyYTE0ODhhNjgxMjQ5NTZiMzMzODM1MzM0YjNhNzcyL3RhYmxlcmFuZ2U6ODJhMTQ4OGE2ODEyNDk1NmIzMzM4MzUzMzRiM2E3NzJfNC01LTEtMS03NzAzMg_3b2e19a4-9167-4146-9422-c3c840471a00">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fdf8bf9a08147fab31750ea1f96c4f5_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjgyYTE0ODhhNjgxMjQ5NTZiMzMzODM1MzM0YjNhNzcyL3RhYmxlcmFuZ2U6ODJhMTQ4OGE2ODEyNDk1NmIzMzM4MzUzMzRiM2E3NzJfNi0yLTEtMS03NzAzMg_7afce1fc-153f-4dc5-82f2-ee72f8ddd676">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fdf8bf9a08147fab31750ea1f96c4f5_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjgyYTE0ODhhNjgxMjQ5NTZiMzMzODM1MzM0YjNhNzcyL3RhYmxlcmFuZ2U6ODJhMTQ4OGE2ODEyNDk1NmIzMzM4MzUzMzRiM2E3NzJfNi01LTEtMS03NzAzMg_7b1e12e6-a955-45fd-aa0f-bdcce52fe4b2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec4b84b3fc74452c9f24e03eaad33954_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjgyYTE0ODhhNjgxMjQ5NTZiMzMzODM1MzM0YjNhNzcyL3RhYmxlcmFuZ2U6ODJhMTQ4OGE2ODEyNDk1NmIzMzM4MzUzMzRiM2E3NzJfOC0yLTEtMS03NzAzMg_dc737a3d-f13f-48ad-b34b-e910797c0c5f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3f91e0124ba4fa4ac402434dc93e87b_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjgyYTE0ODhhNjgxMjQ5NTZiMzMzODM1MzM0YjNhNzcyL3RhYmxlcmFuZ2U6ODJhMTQ4OGE2ODEyNDk1NmIzMzM4MzUzMzRiM2E3NzJfOC01LTEtMS03NzAzMg_777058c5-7d58-4ce2-82e8-02af27f062ab">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjgyYTE0ODhhNjgxMjQ5NTZiMzMzODM1MzM0YjNhNzcyL3RhYmxlcmFuZ2U6ODJhMTQ4OGE2ODEyNDk1NmIzMzM4MzUzMzRiM2E3NzJfOS0yLTEtMS03NzAzMg_59e33da2-3c02-4222-b30d-69f0ffb21f31">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjgyYTE0ODhhNjgxMjQ5NTZiMzMzODM1MzM0YjNhNzcyL3RhYmxlcmFuZ2U6ODJhMTQ4OGE2ODEyNDk1NmIzMzM4MzUzMzRiM2E3NzJfOS01LTEtMS03NzAzMg_e0fd30de-3192-4f9c-87c4-7c22c60cccff">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of December&#160;31, 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.451%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9783d9bb5346424386c830791c5bd9af_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjQyZTYwN2I2ZjFkZjQ2YTNhMzM0Yjc2MjQ0NTM3N2M5L3RhYmxlcmFuZ2U6NDJlNjA3YjZmMWRmNDZhM2EzMzRiNzYyNDQ1Mzc3YzlfNC0yLTEtMS03NzAzMg_06da04ae-bd3c-416c-8159-65cf7dca5f48">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ebea270340c48ee9999faf277ae4c89_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjQyZTYwN2I2ZjFkZjQ2YTNhMzM0Yjc2MjQ0NTM3N2M5L3RhYmxlcmFuZ2U6NDJlNjA3YjZmMWRmNDZhM2EzMzRiNzYyNDQ1Mzc3YzlfNC01LTEtMS03NzAzMg_255b4b62-a988-4900-b19c-4a23d028b3fc">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb9fbfcc3ce4d20837be295da12469a_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjQyZTYwN2I2ZjFkZjQ2YTNhMzM0Yjc2MjQ0NTM3N2M5L3RhYmxlcmFuZ2U6NDJlNjA3YjZmMWRmNDZhM2EzMzRiNzYyNDQ1Mzc3YzlfNi0yLTEtMS03NzAzMg_083f2e8d-04af-42cc-8225-b131ca84c427">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb9fbfcc3ce4d20837be295da12469a_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjQyZTYwN2I2ZjFkZjQ2YTNhMzM0Yjc2MjQ0NTM3N2M5L3RhYmxlcmFuZ2U6NDJlNjA3YjZmMWRmNDZhM2EzMzRiNzYyNDQ1Mzc3YzlfNi01LTEtMS03NzAzMg_d8d182fc-d7e2-426a-a59a-a366883d4c18">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1229bd8de1424b6cafbefda84c89f17f_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjQyZTYwN2I2ZjFkZjQ2YTNhMzM0Yjc2MjQ0NTM3N2M5L3RhYmxlcmFuZ2U6NDJlNjA3YjZmMWRmNDZhM2EzMzRiNzYyNDQ1Mzc3YzlfOC0yLTEtMS03NzAzMg_8f7b9cef-5301-40f5-aa26-e169d65bca1a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b481b445da94740a0c83504d45ed0c1_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjQyZTYwN2I2ZjFkZjQ2YTNhMzM0Yjc2MjQ0NTM3N2M5L3RhYmxlcmFuZ2U6NDJlNjA3YjZmMWRmNDZhM2EzMzRiNzYyNDQ1Mzc3YzlfOC01LTEtMS03NzAzMg_3cdc1c63-8b9f-4d37-ba42-5b9191863085">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjQyZTYwN2I2ZjFkZjQ2YTNhMzM0Yjc2MjQ0NTM3N2M5L3RhYmxlcmFuZ2U6NDJlNjA3YjZmMWRmNDZhM2EzMzRiNzYyNDQ1Mzc3YzlfOS0yLTEtMS03NzAzMg_e428dc49-5503-40ed-b2d8-3d1e803a0b25">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjQyZTYwN2I2ZjFkZjQ2YTNhMzM0Yjc2MjQ0NTM3N2M5L3RhYmxlcmFuZ2U6NDJlNjA3YjZmMWRmNDZhM2EzMzRiNzYyNDQ1Mzc3YzlfOS01LTEtMS03NzAzMg_a527840a-b738-4bee-94ba-beb70271ebff">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5e2314f23a5748708a1ceb59c32bfe17"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While some of our derivatives are subject to master netting arrangements, we present our assets and liabilities related to derivative instruments on a gross basis within the condensed consolidated balance sheets. Additionally, we are not required to post collateral for any of our outstanding derivatives.</span></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="bax:ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfODgyMg_8b321b38-1b2f-4845-a619-587d3343dd44" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on our derivative positions as if they were presented on a net basis, allowing for the right of offset by counterparty.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.383%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amounts recognized in the condensed consolidated balance sheets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfMi0xLTEtMS03NzAzMg_a75f6b14-2995-4379-bacf-d3277244a00b">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfMi0yLTEtMS03NzAzMg_6febd03c-e131-4015-b52d-c2b150c54f09">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfMi00LTEtMS03NzAzMg_beb2dcdd-15f1-4c14-b50d-dc493c62fd54">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfMi01LTEtMS03NzAzMg_90258fbd-4012-454c-b55f-90d797452e4f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfMy0xLTEtMS03NzAzMg_20b20dd7-2c00-4007-a6e0-456d9a971912">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfMy0yLTEtMS03NzAzMg_b7804aad-4e2f-4fa7-80a8-895b7e8eade2">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfMy00LTEtMS03NzAzMg_acff28a4-8e36-4536-840e-d6098cab7ddd">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfMy01LTEtMS03NzAzMg_6cfdc7a4-e63f-4a48-a6f0-38e22d24487a">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="bax:DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfNC0xLTEtMS03NzAzMg_447fb5d3-5342-4585-a868-7363d8c3f395">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-6" name="bax:DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfNC0yLTEtMS03NzAzMg_924c0901-d080-4899-b233-ebc7bcc362bc">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="bax:DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfNC00LTEtMS03NzAzMg_dd7b39a4-33c3-4921-b130-3ed17c9f6149">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-6" name="bax:DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfNC01LTEtMS03NzAzMg_22a00a00-7386-4878-b5ec-71c738d70f8a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfODgxNQ_90311ccf-663f-4303-b7be-b38434c6220a" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the amounts recorded on the condensed consolidated balance sheet related to fair value hedges:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.281%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying amount of hedged item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative amount of fair value hedging adjustment included<br/>&#160;in the carrying amount of the hedged item (a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad0696204cae46f4a2dd949869b8a0a2_I20220331" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjNiMGU2YWEwOTc0ZTQwOTE4ZjMwOWUwYjZiMDkzYmFmL3RhYmxlcmFuZ2U6M2IwZTZhYTA5NzRlNDA5MThmMzA5ZTBiNmIwOTNiYWZfMi0xLTEtMS03NzAzMg_168069d3-5cdc-4a60-b34e-67cb0fd9c1db">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b1f513dd2f84554beda8f0654d39157_I20211231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjNiMGU2YWEwOTc0ZTQwOTE4ZjMwOWUwYjZiMDkzYmFmL3RhYmxlcmFuZ2U6M2IwZTZhYTA5NzRlNDA5MThmMzA5ZTBiNmIwOTNiYWZfMi0yLTEtMS03NzAzMg_655ef5ea-be8c-4cc5-b225-e7a126c438ce">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad0696204cae46f4a2dd949869b8a0a2_I20220331" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjNiMGU2YWEwOTc0ZTQwOTE4ZjMwOWUwYjZiMDkzYmFmL3RhYmxlcmFuZ2U6M2IwZTZhYTA5NzRlNDA5MThmMzA5ZTBiNmIwOTNiYWZfMi00LTEtMS03NzAzMg_84665e9a-bfb1-4710-8044-948824412a82">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b1f513dd2f84554beda8f0654d39157_I20211231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjNiMGU2YWEwOTc0ZTQwOTE4ZjMwOWUwYjZiMDkzYmFmL3RhYmxlcmFuZ2U6M2IwZTZhYTA5NzRlNDA5MThmMzA5ZTBiNmIwOTNiYWZfMi01LTEtMS03NzAzMg_35ff59ce-54ab-4579-b4fd-b0c722dffa73">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a) These fair value hedges were terminated in 2018 and earlier periods.</span></div></ix:nonNumeric></ix:continuation><div id="i8787971997a742729b9820f85443271c_82"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">15. <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMzMwMw_4711faa3-7b77-4c08-8b1c-399ea1ac2c22" continuedAt="i38402787061a483b9a23b3df7733c311" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div style="margin-top:10pt"><ix:continuation id="i38402787061a483b9a23b3df7733c311" continuedAt="i0af6db050e8f4e3bb40df350d9b7bcde"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMzI5OQ_6c321be4-6800-4548-8be1-57b34cef78f8" continuedAt="if04360b8d7d04c47a5267962621eab9d" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our assets and liabilities that are measured at fair value on a recurring basis.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b20784595f4505a4473852b0d24361_I20220331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMy0xLTEtMS03NzAzMg_7f3e3cca-70c7-4206-adfb-b185ec425a2e">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1dc1bf720b14af7be2658f5b9411099_I20220331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMy0yLTEtMS03NzAzMg_66cf15ea-b2f2-4419-abe2-b85125566535">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i010ba63179714c00a597d4434cdda0e3_I20220331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMy0zLTEtMS03NzAzMg_72fbc4f7-924c-4aa2-b3bb-41b4f739381b">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8dcdf39e2c4956942ba609511fb42c_I20220331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMy00LTEtMS03NzAzMg_c0d201f1-5cf6-4a34-9067-2236f0fcb60a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b20784595f4505a4473852b0d24361_I20220331" decimals="-6" name="us-gaap:DebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNS0xLTEtMS03NzAzMg_2270f037-6288-4848-a4b0-8837185d4ca3">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1dc1bf720b14af7be2658f5b9411099_I20220331" decimals="-6" name="us-gaap:DebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNS0yLTEtMS03NzAzMg_b1cc8218-97d6-47b1-983a-3fe857c4fd9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i010ba63179714c00a597d4434cdda0e3_I20220331" decimals="-6" name="us-gaap:DebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNS0zLTEtMS03NzAzMg_5e73c236-231b-457e-9e74-610469dba8de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8dcdf39e2c4956942ba609511fb42c_I20220331" decimals="-6" name="us-gaap:DebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNS00LTEtMS03NzAzMg_3da0fb81-4a57-46fa-8387-5ad6381c122b">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b20784595f4505a4473852b0d24361_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNi0xLTEtMS03NzAzMg_7879d644-324b-4154-a948-bb35bd74b553">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1dc1bf720b14af7be2658f5b9411099_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNi0yLTEtMS03NzAzMg_d550fbb6-fdb7-4d29-b0d5-2c7a30c72391">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i010ba63179714c00a597d4434cdda0e3_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNi0zLTEtMS03NzAzMg_77b26097-be47-4e04-a604-15ed90884d36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8dcdf39e2c4956942ba609511fb42c_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNi00LTEtMS03NzAzMg_0ee884f0-3533-4c0d-988e-94c0ee3d42da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b20784595f4505a4473852b0d24361_I20220331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNy0xLTEtMS03NzAzMg_49861203-b9bc-416c-9f16-637062d4a923">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1dc1bf720b14af7be2658f5b9411099_I20220331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNy0yLTEtMS03NzAzMg_ea72aa04-2d45-41a4-a72b-a5de2793000a">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i010ba63179714c00a597d4434cdda0e3_I20220331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNy0zLTEtMS03NzAzMg_5099eaa8-da50-4ede-bd00-5f1d8243c10c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8dcdf39e2c4956942ba609511fb42c_I20220331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNy00LTEtMS03NzAzMg_377f5813-65a1-44f6-bd0b-0130cae38e31">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b20784595f4505a4473852b0d24361_I20220331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfOS0xLTEtMS03NzAzMg_9ff02651-405a-4400-a029-6e1c1920a4ff">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1dc1bf720b14af7be2658f5b9411099_I20220331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfOS0yLTEtMS03NzAzMg_ef2564fc-5eca-4102-89d2-ec4e02a51e7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i010ba63179714c00a597d4434cdda0e3_I20220331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfOS0zLTEtMS03NzAzMg_f329ba7c-dce7-430b-916a-c05956db2906">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8dcdf39e2c4956942ba609511fb42c_I20220331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfOS00LTEtMS03NzAzMg_f10cec1a-8da5-4ca6-9661-bf77d68f273c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b20784595f4505a4473852b0d24361_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMTEtMS0xLTEtNzcwMzI_c9637db8-e801-4685-9270-ef242a48e0f8">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1dc1bf720b14af7be2658f5b9411099_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMTEtMi0xLTEtNzcwMzI_785111b9-91ee-4211-ac87-4d6b9dde653e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i010ba63179714c00a597d4434cdda0e3_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMTEtMy0xLTEtNzcwMzI_57a5b138-34f1-4fe8-bb2c-d978fcf6511a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8dcdf39e2c4956942ba609511fb42c_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMTEtNC0xLTEtNzcwMzI_90f2f8db-1025-484f-bb02-1f875998ba80">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b20784595f4505a4473852b0d24361_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMTItMS0xLTEtNzcwMzI_0051257d-a4e1-4e1a-b3e0-002468e829db">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1dc1bf720b14af7be2658f5b9411099_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMTItMi0xLTEtNzcwMzI_10c80af4-e088-4b35-950f-ecf9e473668f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i010ba63179714c00a597d4434cdda0e3_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMTItMy0xLTEtNzcwMzI_7f4d0b46-6e4d-4efc-bcd2-fda60e730d39">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied8dcdf39e2c4956942ba609511fb42c_I20220331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMTItNC0xLTEtNzcwMzI_ed5716fc-f727-4e7e-ba98-6bb55db9593d">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0af6db050e8f4e3bb40df350d9b7bcde" continuedAt="ib424b74cc2d64e0ba55ef583a09ef084"><div><ix:continuation id="if04360b8d7d04c47a5267962621eab9d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"></td><td style="width:49.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.513%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7ae06c0d764442a36e7ee405df5bae_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMy0xLTEtMS03NzAzMg_0175866d-b1ab-456f-af2b-9eb6fcd6bb51">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a1aa577cc642b1b122761aa34a02dd_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMy0yLTEtMS03NzAzMg_ec518984-982f-4b1c-8708-862f909a7e6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2f63de943c437cbf78e59b19e61166_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMy0zLTEtMS03NzAzMg_ce373b36-7ad3-4aed-b97a-f9886b39cde2">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57b4248164c447fa78ab9e72dae9482_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMy00LTEtMS03NzAzMg_908e75bc-9030-43bb-8ae8-e9d65d4bcffd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7ae06c0d764442a36e7ee405df5bae_I20211231" decimals="-6" name="us-gaap:DebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNS0xLTEtMS03NzAzMg_b861df53-b49c-440c-bfda-42c43f591b18">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a1aa577cc642b1b122761aa34a02dd_I20211231" decimals="-6" name="us-gaap:DebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNS0yLTEtMS03NzAzMg_c0994559-3722-477e-9920-82660af918b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2f63de943c437cbf78e59b19e61166_I20211231" decimals="-6" name="us-gaap:DebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNS0zLTEtMS03NzAzMg_e21d87fd-8ce3-4c9e-87a7-bb35aba280e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57b4248164c447fa78ab9e72dae9482_I20211231" decimals="-6" name="us-gaap:DebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNS00LTEtMS03NzAzMg_9273e9e2-c798-4840-8580-70c23b2fa6cf">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7ae06c0d764442a36e7ee405df5bae_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNi0xLTEtMS03NzAzMg_55133ecb-9142-4410-89e8-589e88eba03e">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a1aa577cc642b1b122761aa34a02dd_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNi0yLTEtMS03NzAzMg_4bdb09d8-6058-48de-bd56-415d5f395226">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2f63de943c437cbf78e59b19e61166_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNi0zLTEtMS03NzAzMg_72772104-1bf2-45c8-a865-ce408adf8cda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57b4248164c447fa78ab9e72dae9482_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNi00LTEtMS03NzAzMg_c18a935b-3eee-4927-b358-6cc7fd367cdd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7ae06c0d764442a36e7ee405df5bae_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNy0xLTEtMS03NzAzMg_ecf6b724-043f-46bc-a7c3-13861c142cdd">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a1aa577cc642b1b122761aa34a02dd_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNy0yLTEtMS03NzAzMg_5fa4ab6e-e525-4a4d-a445-9bc283c4ba9c">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2f63de943c437cbf78e59b19e61166_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNy0zLTEtMS03NzAzMg_7933162a-d0e0-4abc-a1e7-d027e944a96b">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57b4248164c447fa78ab9e72dae9482_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNy00LTEtMS03NzAzMg_d9a447a7-aa33-4301-8505-25257b45e219">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7ae06c0d764442a36e7ee405df5bae_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfOS0xLTEtMS03NzAzMg_2e4e3d6b-1462-4207-8557-1e999c1f61ef">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a1aa577cc642b1b122761aa34a02dd_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfOS0yLTEtMS03NzAzMg_bead3dbf-3e1e-46dc-b478-f4739ce2c375">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2f63de943c437cbf78e59b19e61166_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfOS0zLTEtMS03NzAzMg_c744abff-a6a6-4c78-b0a8-808728379bc3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57b4248164c447fa78ab9e72dae9482_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfOS00LTEtMS03NzAzMg_9fafcf25-139e-4b9e-89c7-be38b5de0bb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7ae06c0d764442a36e7ee405df5bae_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMTEtMS0xLTEtNzcwMzI_c7d62632-b1e0-4669-b59d-e89371b57d2c">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a1aa577cc642b1b122761aa34a02dd_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMTEtMi0xLTEtNzcwMzI_257dcc6f-66c9-43da-8d2e-d85b4d743771">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2f63de943c437cbf78e59b19e61166_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMTEtMy0xLTEtNzcwMzI_9751804e-d7b0-4e3f-9dfc-406fbd50d9ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57b4248164c447fa78ab9e72dae9482_I20211231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMTEtNC0xLTEtNzcwMzI_9a668cf3-4d6a-4baa-88ce-12f965ab0b55">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7ae06c0d764442a36e7ee405df5bae_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMTItMS0xLTEtNzcwMzI_f4c76269-6f0b-49ea-9e56-658d63bf173c">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a1aa577cc642b1b122761aa34a02dd_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMTItMi0xLTEtNzcwMzI_d63bd91d-203d-4c10-ac7a-e4f65437eb5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2f63de943c437cbf78e59b19e61166_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMTItMy0xLTEtNzcwMzI_ba46ca7a-3a56-4995-ab63-04b2cbad7313">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57b4248164c447fa78ab9e72dae9482_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMTItNC0xLTEtNzcwMzI_ae59592d-3865-4e9e-8e23-26b13108decf">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:continuation></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 and December&#160;31, 2021, cash and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331" decimals="-8" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMTk0_33b3d2a5-4984-47ca-b75b-6f878fd5bc5e">2.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i9ad9afe3b705496a92217df29836a764_I20211231" decimals="-8" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMjAx_1b8d0faf-b189-4343-8f02-c07f010d80e7">3.0</ix:nonFraction> billion, respectively, included money market and other short-term funds of approximately $<ix:nonFraction unitRef="usd" contextRef="i488bf22168054382b33a870cea5e12cf_I20220331" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMjg1_ef527014-cb4f-4615-aebb-f0ee6ea135eb">426</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0847c8d0a513447ab785792887cef7be_I20211231" decimals="-6" name="us-gaap:MoneyMarketFundsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMjky_1525dc3d-2b96-4ebc-bf5a-451b75e3f85f">816</ix:nonFraction> million, respectively, which are considered Level 2 in the fair value hierarchy.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For assets that are measured using quoted prices in active markets, the fair value is the published market price per unit multiplied by the number of units held, without consideration of transaction costs. The majority of the derivatives entered into by us are valued using internal valuation techniques as no quoted market prices exist for such instruments. The principal techniques used to value these instruments are discounted cash flow and Black-Scholes models. The key inputs, which are considered observable and vary depending on the type of derivative, include contractual terms, interest rate yield curves, foreign exchange rates and volatility.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities, which consist of convertible debt and convertible redeemable preferred shares issued by nonpublic entities, are measured using discounted cash flow and option pricing models. Those debt securities are classified as Level 3 fair value measurements when there are no observable transactions near the balance sheet date due to the lack of observable data over certain fair value inputs such as equity volatility. The fair values of debt securities increase when interest rates decrease, equity volatility increases, or the fair values of the equity shares underlying the conversion options increase.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent payments related to acquisitions, which consist of milestone payments and sales-based payments, are valued using discounted cash flow techniques. The fair value of milestone payments reflects management&#8217;s expectations of probability of payment, and increases as the probability of payment increases or the expected timing of payments is accelerated. The fair value of sales-based payments is based upon probability-weighted future revenue estimates, and increases as revenue estimates increase, probability weighting of higher revenue scenarios increases or the expected timing of payment is accelerated. </span></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMzMwMA_3b3f02e3-5b7d-45e6-a030-b1c384228b7c" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of recurring fair value measurements that use significant unobservable inputs (Level 3), which consist of contingent payments related to acquisitions and debt securities.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.138%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at beginning of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a479dd0e9e04335a78d838743107def_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfMi0xLTEtMS03NzAzMg_56e118be-fc73-40f8-850a-4f50c683d026">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d57b720176840b084b62f8a521d47d2_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfMy0yLTEtMS04NTI3Nw_b2647e1b-2082-478d-b111-e38fa2bcd7a9">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0699d0c72b624afcb5f0a2f67dead789_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfMi0yLTEtMS03NzAzMg_1bf74d1a-6694-4114-a552-77571e32820b">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i792e4039270545aba120425226791181_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfMy0xLTEtMS03NzAzMg_7033f6ff-a0f6-4231-9494-6f1b9e0c8289">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904ebe57a03f41a19cccabe5981567e2_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNC0yLTEtMS04NTI3Nw_70ff9cf4-720a-45b9-ba55-a21a7cf30d5a">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1adb4c593b09447c8976d8d028dcd78c_D20210101-20210331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfMy0yLTEtMS03NzAzMg_fc4e1971-87cf-48ce-b687-88b29ad13acd">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i792e4039270545aba120425226791181_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNS0xLTEtMS03NzAzMg_6e0ea990-78c8-4051-9080-ebc71021eb58">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904ebe57a03f41a19cccabe5981567e2_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNi0yLTEtMS04NTI4NA_d8b55fdc-7266-4bed-a0c0-902abe47e531">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1adb4c593b09447c8976d8d028dcd78c_D20210101-20210331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNS0yLTEtMS03NzAzMg_459821e2-f392-4084-9316-d103dc9c5d5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i792e4039270545aba120425226791181_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNy0xLTEtMS04NjMwNw_f23e1cb1-c372-4214-96cc-cd9a87a9ef4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904ebe57a03f41a19cccabe5981567e2_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNy0yLTEtMS04NTI4NA_60a7ad09-613e-45ea-a10b-24ffcbca0840">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1adb4c593b09447c8976d8d028dcd78c_D20210101-20210331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNy00LTEtMS04NTMwMA_be2b530c-2a4e-4c86-9bc3-3444b3eb54a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i792e4039270545aba120425226791181_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNi0xLTEtMS03NzAzMg_0d3b287e-dae9-4372-8cd4-2242e3faef3b">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904ebe57a03f41a19cccabe5981567e2_D20220101-20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfOC0yLTEtMS04NTI4NA_434f4064-1c73-43ec-9038-5b7460bfbf3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1adb4c593b09447c8976d8d028dcd78c_D20210101-20210331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNi0yLTEtMS03NzAzMg_3481d325-1f8f-47d5-aa98-2b6321b78d92">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i776aa6f56b4f4c128350b62839f20e93_I20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfOC0xLTEtMS03NzAzMg_bb0f6844-3045-4729-83f1-7360c27f951c">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e0990c5545d42eea9be6143b97da502_I20220331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfMTAtMi0xLTEtODUyOTI_7d9dfd66-d8d8-4d8e-9c7d-4eb19f28c560">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02f792b41f554f2c98ec32ac34f7d2c8_I20210331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfOC0yLTEtMS03NzAzMg_0f29207c-1234-442d-82f6-ee5c928c7186">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib424b74cc2d64e0ba55ef583a09ef084"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Instruments Not Measured at Fair Value</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the financial instruments that we are required to recognize at fair value in the condensed consolidated balance sheets, we have certain financial instruments that are recognized at amortized cost or some basis other than fair value. For these financial instruments, <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMzMwMQ_b88a9d79-426f-404d-98c2-e296ed569b7e" continuedAt="i57d14c2c86db4d50a9e6cb5b6484db06" escape="true">the following table provides the values recognized in the condensed consolidated balance sheets and the estimated fair values as of March&#160;31, 2022 and December&#160;31, 2021.</ix:nonNumeric></span><ix:continuation id="i57d14c2c86db4d50a9e6cb5b6484db06" continuedAt="ic8a3f1db2afe47ca99314b38e7697655"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.547%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Book values</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair values(a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c43bcaa7314a6b967da3c9bbca9100_I20220331" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfMy0xLTEtMS03NzAzMg_1c80fe7a-41b2-4712-8ec0-324dea86243f">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a4f6c720ee44c6ba4c1e80998b3d43c_I20211231" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfMy0yLTEtMS03NzAzMg_1d341b4b-e3b2-4757-b3ce-b54cd0340fd2">301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i811d8be2a7d740bebdca3c2d962061e9_I20220331" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfMy00LTEtMS03NzAzMg_2d921967-b57e-47df-94ef-0db13e7f049f">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if73a3426d20d40529c001dbc761d4b8a_I20211231" decimals="-6" name="us-gaap:ShorttermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfMy01LTEtMS03NzAzMg_9873be0c-03f9-4bd6-ac8e-fe439169da0c">301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c43bcaa7314a6b967da3c9bbca9100_I20220331" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfNC0xLTEtMS03NzAzMg_77f9c119-026c-4fd3-a995-7ea8f2fec8f2">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a4f6c720ee44c6ba4c1e80998b3d43c_I20211231" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfNC0yLTEtMS03NzAzMg_b9ced139-44ad-412d-8d45-6261e8bc82a4">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i811d8be2a7d740bebdca3c2d962061e9_I20220331" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfNC00LTEtMS03NzAzMg_0f2630ab-5a9c-49ef-b938-a35e8ccca202">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if73a3426d20d40529c001dbc761d4b8a_I20211231" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfNC01LTEtMS03NzAzMg_32cd8d19-14fc-4a77-ba89-633139281d9e">212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c43bcaa7314a6b967da3c9bbca9100_I20220331" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfNS0xLTEtMS03NzAzMg_07831b17-7f22-4d86-9b8f-afb1dc4dfcdd">16,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a4f6c720ee44c6ba4c1e80998b3d43c_I20211231" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfNS0yLTEtMS03NzAzMg_bbba0282-9443-48dc-b7aa-56b7a0622fb8">17,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i811d8be2a7d740bebdca3c2d962061e9_I20220331" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfNS00LTEtMS03NzAzMg_e1763619-b1c5-41dc-9c78-5832512d34ff">16,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if73a3426d20d40529c001dbc761d4b8a_I20211231" decimals="-6" name="bax:LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfNS01LTEtMS03NzAzMg_b7784990-9bcd-41d1-b1dd-44eaf48316f2">17,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:continuation></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="ic8a3f1db2afe47ca99314b38e7697655">(a)&#160;&#160;&#160;&#160;These fair value amounts are classified as Level 2 within the fair value hierarchy as they are estimated based on observable inputs.</ix:continuation></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of short-term debt approximates its fair value due to the short-term maturities of the obligations. The estimated fair values of current and long-term debt were computed by multiplying price by the notional amount of the respective debt instruments. Price is calculated using the stated terms of the respective debt instrument and yield curves commensurate with our credit risk. The carrying values of other financial instruments, such as accounts receivable and accounts payable, approximate their fair values due to the short-term maturities of most of those assets and liabilities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments not measured at fair value are comprised of other equity investments without readily determinable fair values and were $<ix:nonFraction unitRef="usd" contextRef="i4ae0b3674bb74050ac9785fa17b2f5e0_I20220331" decimals="-6" name="us-gaap:OtherInvestmentNotReadilyMarketableFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMzE3Mg_752ff1d3-8eb1-469a-84bc-84987df9a16b">110</ix:nonFraction> million at March&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ic1eabca8696d4c27a96d88b08c1bf0a8_I20211231" decimals="-6" name="us-gaap:OtherInvestmentNotReadilyMarketableFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMzE4NQ_fedbb0ef-918c-448b-9312-818956e53c1b">114</ix:nonFraction> million at December&#160;31, 2021. Those investments are included in Other non-current assets on our condensed consolidated balance sheets.</span></div></ix:continuation><div id="i8787971997a742729b9820f85443271c_85"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">16. <ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RleHRyZWdpb246ZWE1YzFjMzM3MWJkNDY3NmEwN2YxZmQ2ODFhN2IzODJfMjMyMg_b2d2a05b-72cb-4568-a2b8-49b2939efaec" continuedAt="i5f3563376d1f4728bf352473b51bb882" escape="true">SEGMENT INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i5f3563376d1f4728bf352473b51bb882" continuedAt="id277551a21244e08a7f852a78d3504d7"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We manage our business based on <ix:nonFraction unitRef="segment" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RleHRyZWdpb246ZWE1YzFjMzM3MWJkNDY3NmEwN2YxZmQ2ODFhN2IzODJfNjE_02e914b2-805c-4825-ac1e-19a684bacdcb">four</ix:nonFraction> segments, consisting of the following geographic segments related to our legacy Baxter business: Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia Pacific), and a new global segment for the acquired Hillrom business. The Americas, EMEA and APAC segments provide a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use operating income on a segment basis to make resource allocation decisions and assess the ongoing performance of our business segments. Intersegment sales are eliminated in consolidation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain items are maintained at Corporate and are not allocated to a segment. They primarily include corporate headquarters costs, certain R&amp;D costs, certain product category support costs, stock compensation expense, certain employee benefit plan costs, and certain gains, losses, and other charges (such as business optimization, acquisition and integration costs, intangible asset amortization and asset impairments). For the period from our acquisition of Hillrom on December 13, 2021 through December 31, 2021, we previously included all costs incurred by the Hillrom business within that segment, including the types of costs described in the preceding sentence that are maintained at Corporate for our legacy Baxter segments. In connection with our ongoing integration activities, beginning in the first quarter 2022, we have updated the measure of profitability for our Hillrom segment by excluding such unallocated costs, consistent with our legacy Baxter segments. Those unallocated costs related to Hillrom, which totaled $<ix:nonFraction unitRef="usd" contextRef="i5b628cec409b4e0aa786971fa2453bd0_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RleHRyZWdpb246ZWE1YzFjMzM3MWJkNDY3NmEwN2YxZmQ2ODFhN2IzODJfMjc0ODc3OTA3NzM4Mg_9859cb95-335c-415b-93fb-346eccbcb52f">219</ix:nonFraction>&#160;million for the three months ended March 31, 2022, are now presented within Corporate as well. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our chief operating decision maker does not receive any asset information by operating segment and, accordingly, we do not report asset information by operating segment.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id277551a21244e08a7f852a78d3504d7"><div style="margin-top:10pt"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RleHRyZWdpb246ZWE1YzFjMzM3MWJkNDY3NmEwN2YxZmQ2ODFhN2IzODJfMjMyMw_fb55c5c1-2ee5-45c4-984f-5e9ae793ad4e" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information for our segments is as follows.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.275%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36cc35bd29cf4b25b9ed69436f211f3d_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfMy0xLTEtMS03NzAzMg_50f20251-710b-48db-9acf-b70ce46dec0a">1,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4a5d3c9d55448999d5cb714ebf69f3_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfMy0yLTEtMS03NzAzMg_e4c9dbc1-7eec-4578-96ff-f35f55facc68">1,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36c28755553f4b3caaab97024026e4e6_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfNC0xLTEtMS03NzAzMg_9f7c7360-6226-47da-b10a-b3b64e3d47a9">699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ea902d4e19b444db537a186c0a779f6_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfNC0yLTEtMS03NzAzMg_9cbec945-94ac-4f9e-a527-3c796484ff94">738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae63df0c85ca44cd98106826bb67c91f_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfNS0xLTEtMS03NzAzMg_918f167d-4ddf-4132-a2b8-7925048b0db6">627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i525d0111f09240c2b13835c305549821_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfNS0yLTEtMS03NzAzMg_61783b8c-299b-41c4-9d28-b6012837a431">648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id80baa04c95740de8f4bebecb32003d3_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfNi0xLTEtMS03ODI1MQ_dbe6c138-19e5-4330-8dc6-3bd60abcb5ad">755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904e310ddad74453ba7dc2d7fe323e01_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfNi0yLTEtMS03ODI1MQ_227dec2c-5ea2-49bf-9b75-1fe9bbbd4fee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5497822c874fda93fa60cb6aee725c_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfNi0xLTEtMS03NzAzMg_d1c404ca-81fe-4f5d-a445-fb47fab28127">3,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic57b38264d9d4bfcb8a0f926e4426cba_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfNi0yLTEtMS03NzAzMg_9b1b7e63-0486-44f2-b0d1-ce44af28039f">2,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating income</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36cc35bd29cf4b25b9ed69436f211f3d_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfOC0xLTEtMS03NzAzMg_a9230c3d-4d31-4af2-ac18-c2341571ac48">610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4a5d3c9d55448999d5cb714ebf69f3_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfOC0yLTEtMS03NzAzMg_35f150e1-ae9b-4cdf-b126-5b472f786ade">599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36c28755553f4b3caaab97024026e4e6_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfOS0xLTEtMS03NzAzMg_58d8a82a-aff2-49d4-833b-0d838e8c34d6">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ea902d4e19b444db537a186c0a779f6_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfOS0yLTEtMS03NzAzMg_e8a00333-7e97-4d7d-9c61-0135ec38ae28">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae63df0c85ca44cd98106826bb67c91f_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfMTAtMS0xLTEtNzcwMzI_108f6731-e30c-4879-8c0a-e3caca2d8361">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i525d0111f09240c2b13835c305549821_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfMTAtMi0xLTEtNzcwMzI_0e220efe-788f-4823-b2e7-82faaec456fd">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id80baa04c95740de8f4bebecb32003d3_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfMTItMS0xLTEtNzgyNzM_3eca9c9c-c92d-41db-b416-9d702e780a25">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904e310ddad74453ba7dc2d7fe323e01_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfMTItMi0xLTEtNzgyNzM_10145b85-b955-4552-aac4-803a3a207d8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5497822c874fda93fa60cb6aee725c_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfMTEtMS0xLTEtNzcwMzI_31885de8-d27e-407f-bd91-1cbd65bd36f3">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic57b38264d9d4bfcb8a0f926e4426cba_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfMTEtMi0xLTEtNzcwMzI_9fec9d83-863a-4e59-929c-c27ceec6d8f5">872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><ix:nonNumeric contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RleHRyZWdpb246ZWE1YzFjMzM3MWJkNDY3NmEwN2YxZmQ2ODFhN2IzODJfMjMyNA_e9050bfa-1d5e-4c9f-97a7-4fd3425aed27" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of segment operating income to income before income taxes per the condensed consolidated statements of income.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.275%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica5497822c874fda93fa60cb6aee725c_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfMi0xLTEtMS03NzAzMg_c34cf4c3-3488-440e-b5b8-b3c5471f0847">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic57b38264d9d4bfcb8a0f926e4426cba_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfMi0yLTEtMS03NzAzMg_d2238558-97ad-4493-914f-7ac952caead0">872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib16764b626684350a430fa1f03cb037f_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfMy0xLTEtMS03NzAzMg_d4562376-12a3-4ac8-bc7f-6a7d61419ccc">917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82348ec896cc42a891600e853ebccd95_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfMy0yLTEtMS03NzAzMg_ad4f2995-b35e-4999-a307-6c4b3933f0eb">482</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfNC0xLTEtMS03NzAzMg_5aa5df0f-d8b3-4ea4-ade4-2920e89ed577">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfNC0yLTEtMS03NzAzMg_9f2f2292-cc42-4eec-ae2e-d566d64eebd3">390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfNS0xLTEtMS03NzAzMg_8bc4806c-9845-4326-aa24-32995012e050">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfNS0yLTEtMS03NzAzMg_10ce23b6-dd43-4ebb-a808-6bf17deb019a">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfNi0xLTEtMS03NzAzMg_a3fae88c-4627-4357-bb2d-3fa3bf32f1b7">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfNi0yLTEtMS03NzAzMg_544cdb9f-82b8-473b-bf21-5fe1f57191f9">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfNy0xLTEtMS03NzAzMg_608c9778-5c76-4a89-9acf-6d31387aa23a">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfNy0yLTEtMS03NzAzMg_0b528633-4e7f-46d9-8a11-3441bed59a84">351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 9 for additional information on Net Sales by product category.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i8787971997a742729b9820f85443271c_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to our Annual Report on Form 10-K for the year ended December&#160;31, 2021, for management&#8217;s discussion and analysis of our financial condition and results of operations. The following is management&#8217;s discussion and analysis of our financial condition and results of operations for the three months ended March&#160;31, 2022 and 2021.</span></div><div id="i8787971997a742729b9820f85443271c_91"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RESULTS OF OPERATIONS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to Baxter stockholders for the three months ended March&#160;31, 2022 totaled $71 million, or $0.14 per diluted share, compared to $298 million, or $0.58 per diluted share, for the three months ended March&#160;31, 2021. The first quarter of 2022 is the first full quarter reflecting Hillrom results of operations after the December 13, 2021 acquisition. Net income for the three months ended March&#160;31, 2022 included special items which decreased net income by $400&#160;million, or $0.79 per diluted share, respectively, as further discussed below. Net income for the three months ended March&#160;31, 2021 included special items which decreased net income by $88&#160;million, or $0.18 per diluted share, as further discussed below.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Items</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our special items and the related impact by line item on our results for the three months ended March&#160;31, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Margin</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business optimization items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European medical devices regulation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product-related items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(322)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact on Gross Margin Ratio</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6 pts)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1 pts)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selling, General and Administrative (SG&amp;A) Expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business optimization items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investigation and related costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact on SG&amp;A Ratio</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 pts</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 pts</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Research and Development (R&amp;D) Expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business optimization items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact on R&amp;D Ratio</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0 pts</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0 pts</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Operating Income, net</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income Tax Expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effects of special items</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">6</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Special Items</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact on Effective Tax Rate</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 pts</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5 pts)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense, which increased significantly from the prior year due to the Hillrom acquisition, is identified as a special item to facilitate an evaluation of current and past operating performance and is consistent </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with how management and our Board of Directors assess performance. Additional special items are identified above because they are highly variable, difficult to predict and of a size that may substantially impact our reported results of operations for the period. Management believes that providing the separate impact of those items may provide a more complete understanding and facilitate a fuller analysis of our results of operations, particularly in evaluating performance from one period to another.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">In 2022 and 2021, our results were impacted by costs associated with our execution of programs to optimize our organization and cost structure. These actions included streamlining our international operations, rationalizing our manufacturing and distribution facilities, reducing our general and administrative infrastructure, re-aligning certain R&amp;D activities and cancelling certain R&amp;D programs. In the current period, restructuring charges include actions taken in connection with our integration of Hill-Rom Holdings, Inc. (Hillrom), which we acquired in December 2021. Our results in 2022 and 2021 included business optimization charges of $81 million and $27 million, respectively. Refer to Note 10 in Item 1 of this Quarterly Report on Form 10-Q for further information regarding these charges and related liabilities. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Our results in 2022 included $171 million of acquisition and integration-related expenses. Those costs  included $188 million related to our acquisition of Hillrom, primarily reflecting $159 million of incremental cost of sales from the fair value step-ups on acquired Hillrom inventory that was sold in the current period.  We do not expect to incur significant incremental cost of sales from those inventory fair value step-ups after the first quarter 2022. Other integration expenses in the current period included third party consulting costs related to our integration and related cost savings activities. Those acquisition and integration-related expenses related to Hillrom were partially offset by a $17 million benefit from a change in the estimated fair value of contingent consideration liabilities assumed in the Hillrom acquisition. Our results in 2021 included $1 million of integration expenses related to our acquisition of the rights to Caelyx and Doxil for specified territories outside of the U.S. Refer to Note 2 in Item 1 of this Quarterly Report on Form 10-Q for further information regarding business development activities.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Our results in 2022 and 2021 included $11 million and $8 million, respectively, related to updating our quality systems and product labeling to comply with the new medical device reporting regulation and other requirements of the European Union&#8217;s regulations for medical devices that became effective in stages beginning in 2021. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Our results in 2021 included charges of $11 million for investigation and related cost for matters associated with our previously announced investigation of foreign exchange gains and losses. Refer to Note 6  in Item 1 of this Quarterly Report on Form 10-Q for further information regarding the investigation.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Our results in 2022 included charges of $23 million related to warranty and remediation activities arising from two field corrective actions on certain of our infusion pumps.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:30.44pt">Reflected in this item is the income tax impact of the special items identified in this table. The tax effect of each special item is based on the jurisdiction in which the item was incurred and the tax laws in effect for each such jurisdiction.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 and Global Economic Conditions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global operations expose us to risks associated with public health crises and epidemics/pandemics, such as the novel strain of coronavirus (COVID-19). COVID-19 has had, and we expect will continue to have, an adverse impact on our operations, supply chains and distribution systems and has increased and we expect will continue to increase our expenses, including as a result of impacts associated with preventive and precautionary measures that we, other businesses and governments have taken and continue to take. Initial measures taken in 2020 led to unprecedented restrictions on, disruptions in, and other related impacts on business and personal activities, including a shift in healthcare priorities, which resulted in a significant decline in medical procedures in 2020. Some of these disruptions and impacts (including the suspension or postponement of elective medical procedures) in certain of our principal markets have continued into 2021 and 2022. The pandemic has created significant volatility in the demand for our products. For further discussion, refer to the Product Category Net Sales Reporting section below. Significant uncertainty remains regarding the duration and overall impact of the COVID-19 pandemic. For example, concerns remain regarding the pace of economic recovery due to virus resurgence across the globe from the Omicron variants, sub variants and other virus mutations as well as vaccine distribution and hesitancy. The U.S. and other governments may continue existing measures or implement new restrictions and other requirements in light of the continuing spread of the pandemic (including with respect to mandatory vaccinations for certain of our employees, moratoriums on elective procedures and mandatory quarantines and travel restrictions). Due to the uncertainty caused by the pandemic, our operating performance and financial results, particularly in the short term, may be subject to volatility. We have experienced significant challenges, including lengthy delays, shortages and interruptions, posed by the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pandemic and other exogenous factors (including significant weather events, disruptions to certain ports of call around the world and certain geopolitical events) to our global supply chain, including the cost and availability of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, and may experience these and other challenges in future periods. Many of our manufacturing plant and distribution center personnel are currently unvaccinated, and we may also experience employee resistance in complying with current and future government vaccine and testing mandates, which may cause labor shortages significantly impacting manufacturing production and distribution center productivity.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that these challenges as well as evolving governmental restrictions and requirements, among other factors, may continue to have an adverse effect on our business.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results of operations are affected by economic conditions, including macroeconomic conditions and levels of business confidence. The war in Ukraine and the sanctions and other measures being imposed in response to this conflict have increased the levels of economic and political uncertainty. In response, we continue to monitor the developing situation with respect to ongoing business in Russia and are working on appropriate contingency plans that will support our desire to serving existing, chronically ill patient populations while remaining compliant with all applicable U.S. and European Union sanctions and regulations. While Russia and Ukraine do not constitute a material portion of our business, a significant escalation or expansion of economic disruption or the conflict&#8217;s current scope could have an adverse effect on our business. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion, please refer to Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NET SALES</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Percent change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At actual<br/>currency rates</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At constant currency rates</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,946&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.976%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our acquisition of Hillrom favorably impacted net sales by 26 percentage points during the first quarter of 2022 compared to the prior year period. Foreign currency unfavorably impacted net sales by 3 percentage points, during the first quarter of 2022 compared to the prior-year period, principally due to the strengthening of the U.S. Dollar relative to the Euro, Turkish Lira, Australian Dollar and Japanese Yen.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The comparisons presented at constant currency rates reflect local currency sales at the prior period&#8217;s foreign exchange rates. This measure provides information on the change in net sales assuming that foreign currency exchange rates had not changed between the prior and the current period. We believe that the non-GAAP measure of change in net sales at constant currency rates, when used in conjunction with the U.S. GAAP measure of change in net sales at actual currency rates, may provide a more complete understanding and facilitate a fuller analysis of our results of operations, particularly in evaluating performance from one period to another.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Product Category Net Sales Reporting </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our acquisition of Hillrom, we have added three new product categories: Patient Support Systems, Front Line Care and Surgical Solutions. Following these additions, our product categories include the following:</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Renal Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medication Delivery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmaceuticals </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clinical Nutrition </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our parenteral nutrition (PN) therapies and related products.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advanced Surgery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acute Therapies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BioPharma Solutions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.5pt">Patient Support Systems </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes sales of our connected care solutions: devices, software, communications and integration technologies.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.5pt">Front Line Care</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology, vision screening and physical assessment.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.5pt">Surgical Solutions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.</span></div><div style="padding-left:90pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes sales of other miscellaneous product and service offerings.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of net sales by product category: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Percent change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At actual currency rates</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">At constant currency rates</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioPharma Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,946&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:37.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.012%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.626%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care net sales decreased 3% in the first quarter of 2022, as compared to the prior-year period. That decrease was driven by a 4% negative impact from foreign exchange rate changes, as compared to the prior-year period, and lower in-center HD sales, partially offset by global patient growth in PD.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery net sales increased 8% in the first quarter of 2022, as compared to the prior-year period. That increase was driven by increased demand for IV administration sets and solutions, reflecting a recovery in hospital admission rates and elective surgeries, and by lower U.S. customer rebates in the current year period. Those items were partially offset by a 2% negative impact from foreign exchange rates as compared to the prior-year period.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals net sales decreased 6% in the first quarter of 2022, as compared to the prior-year period. That decrease was primarily driven by a 4% negative impact from foreign exchange rates, as compared to the prior-year period. Additionally, pharmaceuticals net sales were adversely impacted by new market entrants increasing competition for certain molecules and due to supply constraints driven, in part, by labor shortages at certain of our manufacturing facilities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition net sales decreased 3% in the first quarter of 2022, as compared to the prior-year period. That decrease was driven by a 4% negative impact from foreign exchange rate changes, as compared to the prior-year period and lower sales of vitamins resulting from supply constraints. Those decreases were partially offset by growth in the U.S. for our PN therapies and related products.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery net sales increased 5% in the first quarter of 2022, as compared to the prior-year period. That increase was driven by a partial recovery in elective surgeries and benefits from competitor supply constraints.  Partially offsetting that increase was a 3% negative impact from foreign exchange rates, as compared to the prior-year period. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies net sales decreased 9% in the first quarter of 2022, as compared to the prior-year period. That decrease was driven by lower COVID-related demand for our CRRT systems and a 2% negative impact from foreign exchange rate changes, as compared to the prior-year period.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioPharma Solutions net sales increased 16% in the first quarter of 2022, as compared to the prior-year period. That increase was driven by manufacturing services and supply packaging related to the production of COVID-19 vaccines on behalf of multiple pharmaceutical companies, partially offset by a 5% negative impact from foreign exchange rate changes, as compared to the prior-year period.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Patient Support Systems, Front Line Care and Surgical Solutions product categories were added in connection with our acquisition of Hillrom.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Margin and Expense Ratios</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.187%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% of net sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% of net sales</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$ change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">% change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.114%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.366%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gross Margin</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross margin ratio was 36.4% and 38.9% in the first quarter of 2022 and 2021, respectively. The special items identified above had an unfavorable impact of approximately 8.6 and 3.1 percentage points on the gross margin ratio in the first quarter of 2022 and 2021, respectively. Refer to the Special Items caption above for additional detail.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the impact of the special items, the gross margin ratio increased in the first quarter of 2022 compared to the prior-year period. The increase was due to a favorable product mix, primarily driven by our acquisition of Hillrom, which was partially offset by higher manufacturing and supply chain costs resulting from raw materials inflation and the continuing impact of the COVID-19 pandemic.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">SG&amp;A</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SG&amp;A expenses ratio was 28.4% and 21.3% in the first quarter of 2022 and 2021, respectively. The special items identified above had an unfavorable impact of approximately 5.3 and 0.6 percentage points on the SG&amp;A expenses ratio in the first quarter of 2022 and 2021, respectively. Refer to the Special Items caption above for additional detail.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the impact of the special items, the SG&amp;A expenses ratio increased in the first quarter of 2022 compared to the prior-year period primarily due to the acquisition of Hillrom and increased outbound freight costs. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">R&amp;D</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The R&amp;D expenses ratio was 4.0% and 4.3% in the first quarter of 2022 and 2021, respectively. The special items identified above had no impact on the R&amp;D expenses ratio in the first quarter of 2022 and 2021. Refer to the Special Items caption above for additional detail.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The R&amp;D expenses ratio decreased in the first quarter of 2022 compared to the prior-year period as a result of decreased project-related expenditures.&#160;&#160;&#160;&#160; </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Optimization Items</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, we have undertaken actions to transform our cost structure and enhance operational efficiency. These efforts include restructuring the organization, optimizing our manufacturing footprint, R&amp;D operations and supply chain network, employing disciplined cost management, and centralizing and streamlining certain support functions. In the current period, restructuring charges include actions taken in connection with our integration of Hillrom. From the commencement of our business optimization actions in the second half of 2015 through March&#160;31, 2022, we have incurred cumulative pre-tax costs of $1.3 billion related to these actions. The costs consisted primarily of employee termination costs, implementation costs, contract termination costs, asset impairments, and accelerated depreciation. We currently expect to incur additional pre-tax costs of approximately $25 million through the completion of the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">initiatives that are currently underway, primarily related to implementation costs. We continue to pursue cost savings initiatives and, to the extent further cost savings opportunities are identified, we may incur additional restructuring charges and costs to implement business optimization programs in future periods.  The reductions in our cost base from these actions in the aggregate are expected to provide cumulative annual pre-tax savings of more than $1.2 billion once the remaining actions are complete. The savings from these actions have reduced cost of sales, SG&amp;A expenses, and R&amp;D expenses. Approximately 99 percent of the expected annual pre-tax savings are expected to be realized by the end of 2022, with the remainder by the end of 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Operating Income, Net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating income, net was income of $17 million in the first quarter of 2022, which was comprised of changes in the estimated fair value of contingent consideration liabilities.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2013, we entered into an agreement with Celerity Pharmaceutical, LLC (Celerity) to develop certain acute care generic injectable premix and oncolytic products through regulatory approval. We transferred our rights in these products to Celerity and Celerity assumed ownership and responsibility for development of the products. We are obligated to purchase the individual product rights from Celerity if the products obtain regulatory approval. In December 2020, we entered into an agreement with a third party to divest one of the products that is currently being developed by Celerity if that product receives regulatory approval in the U.S. and/or European Union. If regulatory approval is obtained, we would incur a loss ranging from $30 million to $60 million for the difference between our purchase price and the divestiture proceeds in connection with that transaction.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense, Net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net was $85 million in the first quarter of 2022 and $34 million in the first quarter of 2021. The increase in 2022 was driven by higher average debt outstanding in connection with the Hillrom acquisition.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other (Income) Expense, Net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (income) expense, net was income of $16 million and expense of $5 million in the first quarter of 2022 and 2021, respectively. The increase in the first quarter of 2022 compared to the prior year was primarily due to higher foreign exchange gains in the current-year period, higher pension benefits and an investment impairment in the prior year.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, we began to wind down our operations in Argentina. Upon substantial liquidation of those operations in the future, we expect to reclassify currency translation adjustments (CTA) from accumulated other comprehensive (loss) income to other (income) expense, net and recognize a non-cash charge. As of March&#160;31, 2022, the CTA loss for our Argentina operations was in excess of $60 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our effective income tax rate was 22.3% and 14.5% in the first quarter 2022 and 2021, respectively. Our effective income tax rate can differ from the 21% U.S. federal statutory rate due to a number of factors, including foreign rate differences, tax incentives, increases or decreases in valuation allowances and liabilities for uncertain tax positions and excess tax benefits on stock compensation awards.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to discrete tax matters in various foreign jurisdictions, of which none are individually material, and an increase in our liabilities for uncertain tax positions, partially offset by excess tax benefits on stock compensation awards and a favorable geographic earnings mix.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the three months ended March&#160;31, 2021, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to decreases in accrued withholding taxes in several foreign jurisdictions and a favorable geographic earnings mix. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Segment Results</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage our global operations based on four segments, consisting of the following geographic segments related to legacy Baxter business: Americas, EMEA and APAC, and a new global segment for our recently acquired Hillrom business. We use net sales and operating income on a segment basis to make resource allocation decisions and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assess the ongoing performance of our segments. The following is a summary of financial information for our reportable segments:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.521%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating income (loss)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(917)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,946&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Americas</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net sales and operating income were $1.6 billion and $610 million, respectively, in the first quarter of 2022 and $1.6 billion and $599 million, respectively, in the first quarter of 2021. The increase in operating profit in the first quarter was due to favorable sales performance in our BioPharma Solutions, Medication Delivery and Advanced Surgery product categories, partially offset by unfavorable performance in Pharmaceuticals and higher supply chain costs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">EMEA</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net sales and operating income were $699 million and $119 million, respectively, in the first quarter of 2022 and $738 million and $135 million, respectively, in the first quarter of 2021. The decrease in operating profit in the first quarter was primarily due to an unfavorable impact of foreign exchange rates on results as compared to the prior-year period and higher supply chain costs, partially offset by having a full quarter of sales from our February 2021 acquisition of the rights to Caelyx and Doxil for specified territories outside the U.S. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">APAC</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net sales and operating income were $627 million and $151 million, respectively, in the first quarter of 2022 and $648 million and $138 million, respectively, in the first quarter of 2021. The increase in operating profit in the first quarter was due to improved gross margin, driven by a favorable product mix, and lower operating expenses, partially offset by the unfavorable impact of foreign exchange rates on results as compared to the prior year period.    </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Hillrom</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment net sales and operating income were $755 million and $200 million, respectively, in the first quarter of 2022. The increase in operating profit in the first quarter was due to the acquisition of Hillrom in December 2021.    </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate and Other</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain items are maintained at Corporate and are not allocated to a segment. They primarily include corporate headquarters costs, certain R&amp;D costs, certain product categories support costs, stock compensation expense, certain employee benefit plan costs, and certain gains, losses, and other charges (such as business optimization, acquisition and integration costs, intangible asset amortization and asset impairments). For the period from our acquisition of Hillrom on December 13, 2021 through December 31, 2021, we previously included all costs incurred by the Hillrom business within that segment, including the types of costs described in the preceding sentence that are maintained at Corporate for our legacy Baxter segments. In connection with our ongoing integration activities, beginning in the first quarter 2022, we have updated the measure of profitability for our Hillrom segment by excluding such unallocated costs, consistent with our legacy Baxter segments. Those unallocated costs related to Hillrom which totaled $219 million for the three months ended March 31, 2022, are now presented within Corporate as well.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate operating loss in the first quarter was significantly higher than the prior-year period primarily due to higher intangible asset amortization expense, acquisition and integration-related expenses and business optimization charges, all driven by the Hillrom acquisition.  </span></div><div id="i8787971997a742729b9820f85443271c_94"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the statement of cash flows for the three-month periods ended March&#160;31, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(548)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows from Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first three months of 2022, cash provided by operating activities was $208 million, as compared to cash provided by operating activities of $377 million in the first three months of 2021, a decrease of $169 million. The decrease was primarily due to a decrease in our net income in 2022 and higher annual payouts under our employee incentive compensation plans in the current year period, partially offset by favorable accounts receivable collection performance and a lower increase in inventories compared to the prior year period. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first three months of 2022, cash used for investing activities included payments for acquisitions and investments of $174 million, primarily related to our payment to acquire the rights to Zosyn, and capital expenditures of $140 million. In the first three months of 2021, cash used for investing activities included payments for acquisitions and investments of $381 million, primarily related to Caelyx and Doxil and Transderm Scop, and capital expenditures of $171 million. See Note 2 in Item 1 of this Quarterly Report on Form 10-Q for further information regarding business development activities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first three months of 2022, cash used in financing activities included debt repayments of $404 million, dividend payments of $140 million, and a $45 million net repayment of short-term borrowings, partially offset by proceeds from stock issued under employee benefit plans of $66 million. In the first three months of 2021, cash used for financing activities included payments for treasury stock repurchases of $253 million and dividend payments of $125 million, partially offset by proceeds from stock issued under employee benefit plans of $48 million. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As authorized by the Board of Directors, we repurchase our stock depending upon our cash flows, net debt levels and market conditions. In July 2012, the Board of Directors authorized the repurchase of up to $2.0 billion of our common stock. The Board of Directors increased this authority by an additional $1.5 billion in each of November 2016 and February 2018, by an additional $2.0 billion in November 2018 and by an additional $1.5 billion in October 2020. We did not repurchase any shares under this authority in the first three months of 2022. We had $1.3 billion remaining available under this authorization as of March&#160;31, 2022.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities and Access to Capital and Credit Ratings</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Facilities</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2022, our U.S. dollar-denominated revolving credit facility and Euro-denominated revolving credit facility had a maximum capacity of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.5 billion and &#8364;200 million, respectively. There were no borrowings outstanding under these credit facilities as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or December&#160;31, 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we were in compliance with the financial covenants in these agreements. The non-performance of any financial institution supporting either of the credit facilities would reduce the maximum capacity of these facilities by the institution&#8217;s respective commitment.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Access to Capital and Credit Ratings</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We intend to fund short-term and long-term obligations as they mature through cash on hand, future cash flows from operations or by issuing additional debt. We had $2.3 billion of cash and cash equivalents as of March&#160;31, 2022, with adequate cash available to meet operating requirements in each jurisdiction in which we operate. We invest our excess cash in money market and other funds and diversify the concentration of cash among different financial institutions. As of March&#160;31, 2022, we had approximately $17.2 billion of long-term debt and finance lease obligations, including current maturities, and short-term debt. Subject to market conditions, we regularly evaluate opportunities with respect to our capital structure.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to generate cash flows from operations, issue debt or enter into other financing arrangements on acceptable terms could be adversely affected if there is a material decline in the demand for our products or in the solvency of our customers or suppliers, deterioration in our key financial ratios or credit ratings or other significantly unfavorable changes in conditions, including global economic conditions. However, we believe we have sufficient financial flexibility to issue debt, enter into other financing arrangements and attract long-term capital on acceptable terms to support our growth objectives. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes to our investment grade credit ratings that we disclosed in our 2021 Annual Report. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">LIBOR Reform</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, the United Kingdom&#8217;s Financial Conduct Authority announced that after 2021 it would no longer compel banks to submit the rates required to calculate the London Interbank Offered Rate (LIBOR) and other interbank offered rates, which have been widely used as reference rates for various securities and financial contracts, including loans, debt and derivatives. This announcement indicated that the continuation of LIBOR on the current basis was not guaranteed after 2021. Regulators in the U.S. and other jurisdictions have been working to replace these rates with alternative reference interest rates that are supported by transactions in liquid and observable markets, such as the Secured Overnight Financing Rate (SOFR). In 2020, it was announced that certain U.S. dollar LIBOR tenors would not cease until 2023. Currently, our $2.5 billion U.S. dollar-denominated revolving credit facility, our </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8364;200 million Euro-denominated revolving credit facility and our $4.0 billion Term Loan Credit Agreement reference</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> LIBOR-based rates. The discontinuation of LIBOR will require these arrangements to be modified in order to replace LIBOR with an alternative reference interest rate, which could impact our cost of funds. Our credit facilities and term loan credit agreement include provisions related to the determination of a successor LIBOR rate.</span></div><div id="i8787971997a742729b9820f85443271c_97"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CRITICAL ACCOUNTING POLICIES</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and   judgments that affect the reported amounts of assets, liabilities, revenues and expenses. A summary of our significant accounting policies is included in Note 1 to our consolidated financial statements in our 2021 Annual Report. Certain of our accounting policies are considered critical, as these policies are the most important to the depiction of our financial statements and require significant, difficult or complex judgments by us, often employing the use of estimates about the effects of matters that are inherently uncertain. Such policies are summarized in the Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations section in our 2021 Annual Report. There have been no significant changes in the application of our critical accounting policies during the first three months of 2022.</span></div><div id="i8787971997a742729b9820f85443271c_100"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RECENT ACCOUNTING PRONOUNCEMENTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There are no accounting standards issued but not yet effective that we believe will have a material impact on our condensed consolidated financial statements.</span></div><div id="i8787971997a742729b9820f85443271c_103"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">LEGAL CONTINGENCIES</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 6 within Item 1 for a discussion of our legal contingencies. Upon resolution of any of these uncertainties, we may incur charges in excess of presently established liabilities. While our liability in connection with certain claims cannot be estimated with any certainty, and although the resolution in any reporting period of one or more of these matters could have a significant impact on our results of operations and cash flows for that period, the outcome of these legal proceedings is not expected to have a material adverse effect on our consolidated financial position. While we believe that we have valid defenses in these matters, litigation is inherently uncertain, excessive verdicts do occur, and we may in the future incur material judgments or enter into material settlements of claims.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i8787971997a742729b9820f85443271c_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTAIN REGULATORY MATTERS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Food and Drug Administration (FDA) commenced an inspection of Claris&#8217; facilities in Ahmedabad, India in July 2017, immediately prior to the closing of our acquisition of Claris Injectables Limited (Claris). FDA completed the inspection and subsequently issued a Warning Letter based on observations identified in the 2017 inspection (Claris Warning Letter).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Due to challenges with the ongoing COVID-19 pandemic, FDA has not yet re-inspected the facilities and management cannot speculate on when the Claris Warning Letter will be lifted. However, we are continuing to implement corrective and preventive actions to address FDA&#8217;s prior observations and other items we identified and management continues to pursue and implement other manufacturing locations, including contract manufacturing organizations, to support the production of new products for distribution in the U.S. As previously disclosed, we have secured alternative locations to produce a majority of the planned new products to be manufactured in Ahmedabad for distribution into the U.S. and are producing new products from those locations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Available online at https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm613538.htm</span></div><div id="i8787971997a742729b9820f85443271c_109"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">FORWARD-LOOKING INFORMATION</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This quarterly report on Form 10-Q includes forward-looking statements. Use of the words &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;potential,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;seeks,&#8221; &#8220;intends,&#8221; &#8220;evaluates,&#8221; &#8220;pursues,&#8221; &#8220;anticipates,&#8221; &#8220;continues,&#8221; &#8220;designs,&#8221; &#8220;impacts,&#8221; &#8220;affects,&#8221; &#8220;forecasts,&#8221; &#8220;target,&#8221; &#8220;outlook,&#8221; &#8220;initiative,&#8221; &#8220;objective,&#8221; &#8220;designed,&#8221; &#8220;priorities,&#8221; &#8220;goal,&#8221; or the negative of those words or other similar expressions is intended to identify forward-looking statements that represent our current judgment about possible future events. These forward-looking statements may include statements with respect to accounting estimates and assumptions, impacts of the COVID-19 pandemic, litigation-related matters including outcomes, impacts of the internal investigation related to foreign exchange gains and losses, future regulatory filings and our R&amp;D pipeline, strategic objectives, sales from new product offerings, credit exposure to foreign governments, potential developments with respect to credit ratings, investment of foreign earnings, estimates of liabilities including those related to uncertain tax positions, contingent payments, future pension plan contributions, costs, discount rates and rates of return, our exposure to financial market volatility and foreign currency and interest rate risks, potential tax liabilities associated with the separation of our biopharmaceuticals business from our medical products businesses, the impact of competition, future sales growth, business development activities (including the acquisitions of Cheetah, Seprafilm, certain outside of the U.S. (OUS) rights to Caelyx and Doxil, full U.S. and specific OUS rights to Transderm Scop, PerClot, Hillrom and certain rights to Zosyn in the U.S. and Canada), business optimization initiatives, cost saving initiatives, future capital and R&amp;D expenditures, future debt issuances, manufacturing expansion, the adequacy of credit facilities, tax provisions and reserves, the effective tax rate and all other statements that do not relate to historical facts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These forward-looking statements are based on certain assumptions and analyses made in light of our experience and perception of historical trends, current conditions, and expected future developments as well as other factors that we believe are appropriate in the circumstances. While these statements represent our judgment on what the future may hold, and we believe these judgments are reasonable, these statements are not guarantees of any events or financial results. Whether actual future results and developments will conform to expectations and predictions is subject to a number of risks and uncertainties, including the following factors, many of which are beyond our control:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">demand for and market acceptance risks for and competitive pressures related to new and existing products (including challenges with our ability to accurately predict changing customer preferences and needs and advances in technology and the resulting impact on customer inventory levels and the impact of reduced hospital admission rates and elective surgery volumes), and the impact of those products on quality and patient safety concerns;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">product development risks, including satisfactory clinical performance and obtaining required regulatory approvals, the ability to manufacture at appropriate scale, and the general unpredictability associated with the product development cycle;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">our ability to finance and develop new products or enhancements on commercially acceptable terms or at all;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the impact of global economic conditions (including, among other things, the ongoing war in Ukraine and the related economic sanctions being imposed globally in response to the conflict and potential trade wars) and continuing public health crises, pandemics and epidemics, such as the ongoing COVID-19 pandemic, on us and our employees, customers and suppliers, including foreign governments in countries in which we operate;</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the continuity, availability and pricing of acceptable raw materials and component parts, and the related continuity of our manufacturing and distribution (including impacts from COVID-19) and those of our suppliers;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">inability to create additional production capacity in a timely manner or the occurrence of other manufacturing, sterilization or supply difficulties (including as a result of natural disaster, public health crises and epidemics/pandemics, regulatory actions or otherwise);</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">our ability to identify business development and growth opportunities and to successfully execute on business development strategies (including the Hillrom acquisition and related integration and restructuring activities);</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">product quality or patient safety issues, leading to product recalls, withdrawals, launch delays, warning letters, import bans, sanctions, seizures, litigation, or declining sales;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">breaches or failures of our information technology systems or products, including by cyber-attack, data leakage, unauthorized access or theft (as a result of increased remote working arrangements or otherwise);</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">future actions of (or failures to act or delays in acting by) FDA, the European Medicines Agency or any other regulatory body or government authority (including the SEC, DOJ or the Attorney General of any State) that could delay, limit or suspend product development, manufacturing or sale or result in seizures, recalls, injunctions, monetary sanctions or criminal or civil liabilities, including the continued delay in lifting the warning letter at our Ahmedabad facility;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">failures with respect to our quality, compliance or ethics programs;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">future actions of third parties, including third-party payers and our customers and distributors (including group purchasing organizations and formed integrated delivery networks), the impact of healthcare reform and its implementation, suspension, repeal, replacement, amendment, modification and other similar actions undertaken by the United States or foreign governments, including with respect to pricing, reimbursement, taxation and rebate policies; legislation, regulation and other governmental pressures in the United States or globally, including the cost of compliance and potential penalties for purported noncompliance thereof, all of which may affect pricing, reimbursement, taxation and rebate policies of government agencies and private payers or other elements of our business, including new or amended laws, rules and regulations (such as the California Consumer Privacy Act of 2018, the European Union&#8217;s General Data Protection Regulation and proposed regulatory changes of the U.S. Department of Health and Human Services in kidney health policy and reimbursement, which may substantially change the U.S. end stage renal disease market and demand for our peritoneal dialysis products, necessitating significant multi-year capital expenditures, which are difficult to estimate in advance);</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the outcome of pending or future litigation, including the opioid litigation and current or future ethylene oxide litigation or other claims;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">failure to achieve our short- and long-term financial goals;</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the impact of competitive products and pricing, including generic competition, drug reimportation and disruptive technologies;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">global regulatory, trade and tax policies (including with respect to climate change and other sustainability matters);</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the ability to protect or enforce our owned or in-licensed patent or other proprietary rights (including trademarks, copyrights, trade secrets and know-how) or patents of third parties preventing or restricting our manufacture, sale or use of affected products or technology;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.367%"><tr><td style="width:1.0%"></td><td style="width:3.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.059%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the impact of any goodwill or other intangible asset impairments on our operating results;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">fluctuations in foreign exchange and interest rates;</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">any changes in law concerning the taxation of income (whether with respect to current or future tax reform), including income earned outside the United States and potential taxes associated with the Base Erosion and Anti-Abuse Tax or the Build Back Better framework;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">actions by tax authorities in connection with ongoing tax audits;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">loss of key employees, the occurrence of labor disruptions or the inability to identify and recruit new employees;</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.511%"><tr><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">other factors identified elsewhere in this report and other filings with the SEC, including those factors described in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021, all of which are available on our website.</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Actual results may differ materially from those projected in the forward-looking statements. We do not undertake to update our forward-looking statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i8787971997a742729b9820f85443271c_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency Risk</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are primarily exposed to foreign exchange risk with respect to revenues generated outside of the United States denominated in the Euro, British Pound, Chinese Renminbi, Korean Won, Australian Dollar, Canadian Dollar, Japanese Yen, Colombian Peso, Brazilian Real, Mexican Peso, Indian Rupee and Swedish Krona. We manage our foreign currency exposures on a consolidated basis, which allows us to net exposures and take advantage of any natural offsets. In addition, we use derivative and nonderivative financial instruments to further reduce the net exposure to foreign exchange. Gains and losses on the hedging instruments offset losses and gains on the hedged transactions and reduce the earnings and stockholders&#8217; equity volatility relating to foreign exchange. However, we don't hedge our entire foreign exchange exposure and are still subject to earnings and stockholders' equity volatility relating to foreign exchange risk.  Financial market and currency volatility may limit our ability to cost-effectively hedge these exposures.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use options and forwards to hedge the foreign exchange risk to earnings relating to forecasted transactions and recognized assets and liabilities denominated in foreign currencies. The maximum term over which we have cash flow hedge contracts in place related to foreign exchange risk on forecasted transactions as of March&#160;31, 2022 is 12 months. We also enter into derivative instruments to hedge foreign exchange risk on certain intra-company and third-party receivables and payables and debt denominated in foreign currencies.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our risk-management program, we perform sensitivity analyses to assess potential changes in the fair value of our foreign exchange instruments relating to hypothetical and reasonably possible near-term movements in foreign exchange rates.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A sensitivity analysis of changes in the fair value of foreign exchange contracts outstanding as of March&#160;31, 2022, while not predictive in nature, indicated that if the U.S. Dollar uniformly weakened by 10% against all currencies, the net pre-tax asset balance of $9 million with respect to those contracts would change by $55 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sensitivity analysis model recalculates the fair value of the foreign exchange contracts outstanding as of March&#160;31, 2022 by replacing the actual exchange rates as of March&#160;31, 2022 with exchange rates that are 10% weaker compared to the actual exchange rates for each applicable currency. All other factors are held constant. These sensitivity analyses disregard the possibility that currency exchange rates can move in opposite directions and that gains from one currency may or may not be offset by losses from another currency. The analyses also disregard the offsetting change in value of the underlying hedged transactions and balances.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the three-year cumulative inflation rate in Turkey exceeded 100 percent.  As a result, we will begin reporting the results of our subsidiary in that jurisdiction using highly inflationary accounting, which requires that the functional currency of the entity be changed to the reporting currency of its parent, effective April 1, 2022.  We are not able to quantify the anticipated impact of that change at the present time. As of March 31, 2022, our subsidiary in Turkey had net monetary assets of $43 million. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our subsidiary in Argentina is reported using highly inflationary accounting effective July 1, 2018. Changes in the value of the Argentine Peso applied to our peso-denominated net monetary asset positions are recorded in income at the time of the change. As of March&#160;31, 2022, our net monetary assets denominated in Argentine Pesos are not significant.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate and Other Risks</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the caption &#8220;Interest Rate and Other Risks&#8221; in the &#8220;Financial Instrument Market Risk&#8221; section of the 2021 Annual Report. There were no significant changes during the quarter ended March&#160;31, 2022. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i8787971997a742729b9820f85443271c_115"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) as of March&#160;31, 2022. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March&#160;31, 2022. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Chan</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es in Internal Control over Financial Reporting</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended March&#160;31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i8787971997a742729b9820f85443271c_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART II. OTHER INFORMATION</span></div><div id="i8787971997a742729b9820f85443271c_121"></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in Part I, Item 1, Note 6 is incorporated herein by reference.</span></div><div id="i8787971997a742729b9820f85443271c_124"></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 1A.  Risk Factors  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We do not believe that there have been any material changes to the risk factors previously disclosed in our 2021 Annual Report. </span></div><div id="i8787971997a742729b9820f85443271c_127"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.574%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2012, we announced that our Board of Directors authorized us to repurchase up to $2.0 billion of our common stock on the open market or in private transactions. The Board of Directors increased this authority by an additional $1.5 billion in each of November 2016 and February 2018, by an additional $2.0 billion in November 2018 and by an additional $1.5 billion in October 2020. During the first quarter of 2022, we did not repurchase any shares under this authority. We had $1.3 billion remaining under this program as of March&#160;31, 2022. This program does not have an expiration date.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i8787971997a742729b9820f85443271c_130"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 6.&#160;&#160;&#160;&#160;Exhibits</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit Index:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.614%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C10.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20220331xex101.htm">Form of Performance Stock Unit Grant Agreement under Baxter International Inc. 2021 Incentive Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C 10.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20220331xex102.htm">Form of Restricted Stock Unit Grant Agreement under Baxter International Inc. 2021 Incentive Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C 10.3*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20220331xex103.htm">Form of Stock Option Grant Agreement under Baxter International Inc. 2021 Incentive Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C 10.4*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20220331xex104.htm">Offer Letter between Baxter Healthcare (Asia) Pte Ltd and Andrew Frye, dated July 1, 2019</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C 10.5*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20220331xex105.htm">Equity Addendum to Offer Letter between Baxter Healthcare (Asia) Pte Ltd and Andrew Frye, dated July 1, 2019</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C 10.6*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20220331xex106.htm">Mobility Addendum to Offer Letter between Baxter Healthcare (Asia) Pte Ltd and Andrew Frye, dated July 9, 2019</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20220331xex311.htm">Certification of Chief Executive Officer Pursuant to Rules 13a-14 (a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:10pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20220331xex312.htm">Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:10pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20220331ex321.htm">Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:10pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20220331xex322.htm">Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained within the Inline XBRL Instance Document in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C &#160;&#160;&#160;&#160;Management contract or compensatory plan or arrangement.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i8787971997a742729b9820f85443271c_133"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Signature</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BAXTER INTERNATIONAL INC.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: April 28, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James K. Saccaro</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James K. Saccaro<br/>Executive Vice President and Chief Financial Officer<br/>(duly authorized officer and principal financial officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>bax-20220331xex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i7a726023efbe40e38c085f4723e7d162_1"></div><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:4.1pt;padding-left:155.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">BAXTER INTERNATIONAL INC.</font></div><div style="margin-top:0.7pt;padding-left:93.95pt;padding-right:93.75pt;text-indent:86.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:110%">2021 INCENTIVE PLAN</font></div><div style="margin-top:0.7pt;padding-left:93.95pt;padding-right:93.75pt;text-indent:86.35pt"><font><br></font></div><div style="margin-top:0.7pt;padding-left:93.95pt;padding-right:93.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:110%">PERFORMANCE SHARE UNIT AWARD GRANT NOTICE</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Baxter International Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), pursuant to the Baxter International Inc. 2021 Incentive Plan, as may be amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), hereby grants to the holder listed below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) the number of performance share units set forth below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The PSUs are subject to the terms and conditions set forth in this Performance Share Unit Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Performance Share Unit Award Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and the Plan, each of which is incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in the Grant Notice and the Agreement. The PSUs granted hereunder shall be designated as a Performance Compensation Award under Section 11 of the Plan. </font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:15.8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.407%"><tr><td style="width:1.0%"></td><td style="width:26.768%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.032%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participant&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 8.9pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2.7pt;padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participant ID&#58;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 8.9pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3.1pt;padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Date of Grant&#58;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 8.9pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:4.3pt;padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Target Number of PSUs&#58;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 8.9pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3.5pt;padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Performance Period&#58;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 8.9pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:4.3pt;padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Vesting Schedule&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.3pt;padding-left:7.9pt;padding-right:2.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Except as otherwise provided in the Agreement, the PSUs are subject to the three-year performance period shown above and shall vest in accordance with the terms set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%;text-decoration:underline">Addendum 1 to Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%"> following Committee certification. </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.5pt;padding-left:2.5pt;padding-right:10.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:117%">Applicable Recoupment Policy&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.6pt;padding-left:4.5pt;padding-right:2.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">The Incentive Compensation Recoupment Policy shall apply to Participants who are not designated officers of the Company and the Executive Compensation Recoupment Policy shall apply to all Participants who are designated officers of the Company either at the time of grant or vesting. Both polices are attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">.</font></div></td></tr></table></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By accepting this Award electronically through the stock plan administrator&#8217;s online grant acceptance procedure, the Participant agrees to be bound by the terms and conditions of the Plan, the Agreement, and the Grant Notice. If the Participant does not accept this Award through the online acceptance process, the Participant&#8217;s Award will be canceled, and the Participant will not be entitled to any benefits from the Award or to any compensation or benefits in lieu of the canceled Award. The Participant has reviewed the Agreement, the Plan, and the Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing the Grant Notice and fully understands all provisions of the Grant Notice, the Agreement, and the Plan. The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan, the Grant Notice, or the Agreement.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">If the Participant declines the Award, the Award will be canceled, and the Participant will not be entitled to any benefits from the Award or to any compensation or benefits in lieu of the canceled Award.</font></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i7a726023efbe40e38c085f4723e7d162_4"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-top:4.1pt;padding-left:87.85pt;padding-right:87.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-top:0.15pt;padding-left:87.87pt;padding-right:87.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">PERFORMANCE SHARE UNIT AWARD AGREEMENT</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.4pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Pursuant to the Grant Notice to which this Agreement is attached, the Company has granted to the Participant the number of PSUs set forth in the Grant Notice.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:87.62pt;padding-right:87.62pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE I.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:87.85pt;padding-right:87.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GENERAL</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan or the Grant Notice. For purposes of this Agreement&#58;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:113.95pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the member of the Company Group that employs the</font></div><div style="margin-top:0.15pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participant.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:113.95pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the three-year period beginning with the first day of</font></div><div style="margin-top:0.15pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the calendar year of the Grant Date and ending on the last day of the third calendar year thereafter.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:17.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Qualifying Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#8221; shall mean a Termination of a Participant who is at least 65 years of age, or at least 55 years of age with at least 10 years of active continuous service with a member of the Company Group.</font></div><div><font><br></font></div><div style="padding-left:6pt;padding-right:5.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Incorporation of Terms of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. The PSUs and the shares of Common Stock issued to the Participant hereunder (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#8221;) are subject to the terms and conditions set forth in this Agreement, the Grant Notice, and the Plan, which are incorporated herein by reference.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:87.62pt;padding-right:87.62pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE II.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:87.72pt;padding-right:87.72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AWARD OF PERFORMANCE SHARE UNITS</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:5.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Award of PSUs.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> In consideration of the Participant&#8217;s continued employment with or service to a member of the Company Group and for other good and valuable consideration, effective as of the Date of Grant, the Company has granted to the Participant the target number of PSUs set forth in the Grant Notice, upon the terms and conditions set forth in the Grant Notice, the Plan, and this Agreement, subject to adjustment as provided in Section 12 of the Plan. Except as otherwise provided herein, each PSU represents the right to receive Shares in the amounts, at the times and subject to the conditions set forth herein and in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Addendum 1 to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. However, unless and until the PSUs have vested and been earned in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Addendum 1 to Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Participant will have no right to the payment of any Shares subject thereto. Prior to the actual delivery of any Shares, the PSUs will represent an unsecured obligation of the Company.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Vesting and Earning of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. Subject to the Participant&#8217;s continued employment with or service to a member of the Company Group through the end of the Performance Period and subject to the terms of this Agreement, the PSUs shall vest on the date specified in the Grant Notice and be earned in accordance with the terms set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Addendum 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline"> Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> following Committee certification.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Impact of Termination on PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. In the event the Participant incurs a Termination prior to the end of the Performance Period, then any unvested PSUs shall be canceled and forfeited, except as may be otherwise provided herein, in the Grant Notice, by the Committee or as set forth in a written agreement between the Participant and the Company or Employer. For the avoidance of doubt, a transfer</font></div><div style="height:69.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></td></tr></table></div></div></div><div id="i7a726023efbe40e38c085f4723e7d162_7"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-top:4.1pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of employment within the Company Group will not constitute a Termination.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.85pt;text-decoration:underline">Qualifying Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event the Participant incurs a Termination as a result of a Qualifying Retirement for any reason other than for Cause, or by reason of the Participant&#8217;s death or Disability, then (i) if the date of such Termination is after the calendar year of the Date of Grant, the PSUs will remain eligible for payout at the end of the Performance Period on the terms (and in accordance with the timing) provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Addendum 1 to Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or (ii) if the date of such Termination is in the calendar year of the Date of Grant a pro-rata portion of the unearned PSUs shall remain eligible for payout at the end of the Performance Period on the terms provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Addendum 1 to Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For purposes of the foregoing, the pro-rata portion of the unearned PSUs shall be determined by multiplying (x) the Target Number of PSUs specified in the Grant Notice by (y) the percentage equal to the number of months worked in the applicable calendar year of the Date of Grant, rounded to the nearest whole month, divided by twelve (12).</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.23pt;text-decoration:underline">Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event the Participant incurs a Termination as a result of the Participant&#8217;s death or Disability, any unvested PSUs shall vest immediately as follows&#58; (i) if the date of such Termination is after the calendar year of the Date of Grant, the PSUs shall be paid out at 100% of the target PSUs awarded, or (ii) if the date of such Termination is in the calendar year of the Date of Grant, a pro-rata portion of the unearned PSUs shall immediately vest. For purposes of the foregoing, the pro-rata portion of the unearned PSUs that shall immediately vest shall be determined by multiplying (x) the Target Number of PSUs specified in the Grant Notice by (y) the percentage equal to the number of months worked in the applicable calendar year of the Date of Grant, rounded to the nearest whole month, divided by twelve (12). Settlement of the PSUs subject to vesting hereunder will occur within sixty (60) days following the Participant&#8217;s Termination due to death or Disability.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.8pt;text-decoration:underline">All Other Terminations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event the Participant incurs a Termination other than as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, except as may be otherwise provided herein or by the Committee or as set forth in a written agreement between the Participant and the Company or Employer, the Participant shall immediately forfeit any and all PSUs granted under this Agreement that have not vested or do not vest on or prior to the date on which such Termination occurs, and the Participant&#8217;s rights in any such PSUs that are not so vested shall lapse and expire.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.18pt;text-decoration:underline">Outside the United States</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For purposes of this Agreement, if the Participant is employed or providing services outside the United States, the Committee (or its delegate) may determine that the date the Participant incurs a Termination shall mean the date the Participant is no longer actively providing services to a member of the Company Group (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction in which the Participant is employed or providing services or the terms of the Participant&#8217;s employment agreement, if any) and that the Participant&#8217;s right to vest in and earn the PSUs under the Plan, if any, will terminate as of such date and will not be extended by any notice period (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">e.g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">., the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction in which the Participant is employed or providing service or the terms of the Participant&#8217;s employment or service agreement, if any)&#59; the Committee (or its delegate) shall have the exclusive discretion to determine when the Participant is no longer actively providing services for purposes of the PSUs (including whether the Participant may still be considered to be providing services while on a leave of absence).</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4.1pt;padding-left:6pt;padding-right:5.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Impact of a Change in Control on PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. In the event of a Change in Control, the treatment of PSUs shall be governed by Section 12(b) of the Plan.</font></div><div><font><br></font></div><div style="padding-left:42pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:17.85pt">Except as otherwise provided herein, the Participant&#8217;s PSUs shall be settled in Shares (either in book-entry form or otherwise). Following the end of the Performance Period, the Committee shall certify the PSU payout, which certification shall be final and binding. Shares earned will be delivered or otherwise made available to the Participant as soon as practical after the Committee makes its determination but not later than the March 15 after the end of the Performance Period. Notwithstanding the foregoing, the Company may delay settlement of PSUs if it reasonably determines that such settlement will violate U.S. federal securities laws or any other applicable law, including non-U.S. laws, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:117%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">that such settlement shall be made at the earliest date at which the Company reasonably determines that the making of settlement will not cause such violation, as required by U.S. Treasury Regulation Section 1.409A-2(b)(7)(ii), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:117%">provided further </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">that no settlement shall be delayed under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 2.5(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> if such delay will result in a violation of Code Section 409A.</font></div><div style="margin-top:10.7pt;padding-left:5.95pt;padding-right:5.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:17.23pt">All distributions shall be made by the Company in the form of whole Shares. Any fractional share may be distributed in cash or, at the discretion of the Committee, withheld to account for Tax-Related Items (as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">). The value of a fractional share shall be determined based on the Fair Market Value as of the date the PSUs are certified by the Committee, and if that date is not a trading day, the Fair Market Value on next trading day will be used.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.85pt">Notwithstanding the foregoing, if the Participant is a resident or employed outside of the United States, the Company, in its sole discretion, may settle the PSUs in the form of a cash payment to the extent settlement in Shares&#58; (i) is prohibited under applicable law&#59; (ii) would require the Participant or a member of the Company Group to obtain the approval of any governmental and&#47;or regulatory body in the Participant&#8217;s country&#59; (iii) would result in adverse tax consequences for the Participant or a member of the Company Group&#59; or (iv) is administratively burdensome. Alternatively, the Company, in its sole discretion, may settle the PSUs in the form of Shares but require the Participant to sell such Shares immediately or within a specified period following the Participant&#8217;s Termination (in which case, this Agreement shall give the Company authorization to issue sales instructions on the Participant&#8217;s behalf).</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:17.23pt">For the avoidance of doubt, this Award represents a right to receive Shares, and not a right to receive cash, and the Company shall only be authorized to deliver cash in settlement of all or any portion of the Award under the specific circumstances contemplated above in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.5(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.5(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> or in connection with a transaction or event contemplated by Section 12 of the Plan.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:5.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Conditions to Issuance of Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company shall not be required to issue or deliver any certificate or certificates for any Shares or to cause any Shares to be held in book-entry form prior to the fulfillment of all of the following conditions&#58; (a) the admission of the Shares to listing on all stock exchanges on which such Shares are then listed, (b) the completion of any registration or other qualification of the Shares under any U.S. state or federal law or under rulings or regulations of the U.S. Securities and Exchange Commission or other governmental regulatory body, which the Committee shall, in its absolute discretion, deem necessary or advisable, (c) the obtaining of any approval or other clearance from any U.S. state or federal governmental agency or non-U.S. regulatory agency that the Committee shall, in its absolute discretion, determine to be necessary or advisable, and (d) the receipt of full payment of any applicable tax withholding in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> by the member of the Company Group with respect to which the applicable withholding obligation arises.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4.1pt;padding-left:42pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding any other provision of this Agreement&#58;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.4pt;text-align:justify;text-indent:80.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.05pt">The provisions of Section 14(e) of the Plan are incorporated herein by reference and made a part hereof. The Participant acknowledges that he or she may be required to pay to the Company or, if different, the Employer, and that the Company, the Employer, or any Subsidiary shall have the right and are hereby authorized to withhold from any compensation or other amount owing to the Participant, applicable income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax- related items (including taxes that are imposed on the Company or the Employer as a result of the Participant&#8217;s participation in the Plan but are deemed by the Company or the Employer to be an appropriate charge to the Participant) (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tax-Related Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), with respect to any issuance, transfer, or other taxable event under this Agreement or under the Plan and to take such action as may be necessary in the opinion of the Company to satisfy all obligations for the payment of such Tax-Related Items. The Participant further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the PSUs, including, but not limited to the grant, vesting and&#47;or settlement of the PSUs and the subsequent sale of Shares acquired upon settlement of the vested PSUs&#59; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the PSUs to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve a particular tax result. Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.5pt;text-align:justify;text-indent:80.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.43pt">The Company shall withhold, or cause to be withheld, Shares otherwise vesting or issuable under the PSUs in satisfaction of any applicable tax withholding obligations, unless the Committee permits the Participant to elect to satisfy such obligations by (i) cash, wire transfer of immediately available funds or check&#59; (ii) delivering Shares (which are not subject to any pledge or other security interest) that have been held by the Participant for not less than six (6) months (or such other period as established from time to time by the Committee in order to avoid adverse accounting treatment applying GAAP) having a Fair Market Value equal to such withholding liability&#59; or (iii) if approved by the Committee, by delivery of a written or electronic notice that the Participant has placed a market sell order with a broker acceptable to the Company with respect to Shares then issuable upon settlement of the PSUs, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company in satisfaction of the aggregate applicable tax withholding obligations&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that payment of such proceeds is then made to the Company upon settlement of such sale in satisfaction of the applicable tax withholding obligations. Notwithstanding the foregoing, the Participant authorizes the Company to satisfy the applicable tax withholding obligations from proceeds of the sale of Shares issuable under the PSUs through a mandatory sale arranged by the Company (on the Participant&#8217;s behalf pursuant to this authorization) and&#47;or through withholding from any cash, other securities, or other property issuable or deliverable under any Award or from any compensation or other amounts owing to the Participant. If the obligation for Tax-Related Items is satisfied by withholding in Shares, the number of Shares that may be so withheld or surrendered shall be limited to the number of Shares that have a Fair Market Value on the date of withholding no greater than the aggregate amount of such obligations based on the maximum individual statutory withholding rates or other rates that will not have a negative accounting impact in the Participant&#8217;s applicable jurisdictions for U.S. federal, state, local and non-U.S. income tax and payroll tax purposes that are applicable to such taxable income, and the Participant is deemed to have been issued the full number of Shares subject to the vested and earned PSUs, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items. The Participant acknowledges that, regardless of any action taken by the Company, the Employer, or any Subsidiary the ultimate liability for all Tax-Related Items, is and remains the Participant&#8217;s responsibility and may exceed the amount, if any, actually withheld by the Company or the Employer.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4.1pt;padding-left:6pt;padding-right:5.55pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.85pt">Notwithstanding any other provision of this Agreement, the Company shall not be obligated to deliver any certificate representing Shares issuable with respect to the PSUs to, or to cause any such Shares to be held in book-entry form by, the Participant or the Participant&#8217;s legal representative unless and until the Participant or the Participant&#8217;s legal representative shall have paid the Tax-Related Items resulting from the grant, vesting or settlement of the PSUs or any other taxable event related to the PSUs.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rights as Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Neither the Participant nor any Person claiming under or through the Participant will have any of the rights or privileges of a stockholder of the Company in respect of any Shares deliverable hereunder unless and until certificates representing such Shares (which may be in book-entry form) will have been issued and recorded on the records of the Company or its transfer agents or registrars and delivered to the Participant (including through electronic delivery to a brokerage account). Except as otherwise provided herein, after such issuance, recordation and delivery, the Participant will have all the rights of a stockholder of the Company with respect to such Shares, including, without limitation, the right to receipt of dividends and distributions on such Shares. From and after the Date of Grant and until the earlier of (a) the time when the Shares are delivered in settlement of the PSUs and (b) the time when the Participant&#8217;s right to receive Shares in settlement of the PSUs is forfeited, on the date that the Company pays a dividend (if any) to holders of Shares generally, the Participant shall be permitted to receive additional PSUs with respect to the PSUs based on the dividends and distributions paid on Shares to the same extent as if each PSU were a Share (without adjustment prior to vesting for payment levels set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Addendum 1 to Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dividend Equivalent Unit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). These additional PSUs will be accrued through the Performance Period at target performance, then adjusted (upwards or downwards, as applicable) to reflect final actual Company performance certified in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Addendum 1 to Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Such Dividend Equivalent Units (if any) shall be subject to the same terms and conditions, including payment timing, Performance Goals, vesting, and the obligation to satisfy any tax withholding obligations, in the same manner and at the same time as the PSUs to which the Dividend Equivalent Units relate or as otherwise determined by the Company. For the avoidance of doubt, Dividend Equivalent Units shall not be eligible for the crediting of dividend equivalents or otherwise.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:87.32pt;padding-right:87.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE III.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:87.87pt;padding-right:87.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NATURE OF GRANT</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;In accepting the grant of the PSUs, the Participant acknowledges, understands, and agrees that&#58;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.7pt;padding-left:5.95pt;padding-right:5.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:17.85pt">the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended, or terminated by the Company at any time, to the extent permitted by the Plan&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.7pt;padding-left:5.95pt;padding-right:5.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:17.23pt">the grant of the PSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of an award, or benefits in lieu of an award, even if PSUs have been granted in the past&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:17.85pt">all decisions with respect to future grants of PSUs or other grants, if any, will be at the sole discretion of the Company&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:113.95pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.23pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:6.2pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:17.85pt">the PSUs and the Shares subject to the PSUs, and the income from and value of same, are not intended to replace any pension rights or compensation&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4.2pt;padding-left:5.95pt;padding-right:6.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:19.07pt">the PSUs and the Shares subject to the PSUs, and the income from and value of same, are not part of normal or expected compensation for purposes of, including but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, holiday pay, long-service awards, pension or retirement or welfare benefits or similar payments&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:17.23pt">unless otherwise agreed with the Company in writing, the PSUs and the Shares subject to the PSUs, and the income from and value of same, are not granted as consideration for, or in connection with, the service the Participant may provide as a director of a Subsidiary&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:17.23pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.9pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:19.73pt">no claim or entitlement to compensation or damages shall arise from forfeiture of the PSUs resulting from the Participant&#8217;s Termination (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any)&#59; and</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:5.65pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:19.73pt">neither the Company nor the Employer shall be liable for any foreign exchange rate fluctuation between the Participant&#8217;s local currency and the United States Dollar that may affect the value of the PSUs or of any amounts due to the Participant pursuant to the settlement of PSUs or the subsequent sale of any Shares acquired upon settlement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:87.25pt;padding-right:87.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE IV.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:183.2pt;padding-right:183.2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DATA PRIVACY</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:5.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company is processing personal data of the Participant for purposes related to Plan administration services, based on the appropriate legal basis, depending on the Participant&#8217;s country, as stipulated in the HR Privacy Notice shared with the Participant and as in force. The Company further shares such data with its affiliates or processors, as appropriate, and only on a &#8220;need to know basis&#8221;. That may also include human resources personnel, certain executives, managers, and employees at other worldwide affiliates of the Company Group, who may have access to certain of the Participant&#8217;s personal data. Some of those recipients may be located or may have relevant operations outside of the Participant&#8217;s country, such as in the United States, where the data protection laws may not provide a level of protection equivalent to the laws of the Participant&#8217;s country. The Company implements the appropriate legal, technical, and organizational measures and mechanisms in this regard.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:6.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">For further information about the HR Privacy Notice and the processing of the Participant&#8217;s data in relation to the Plan, the Participant may contact local HR or send an email to&#58; privacy&#64;baxter.com.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:87.25pt;padding-right:87.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE V.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:183.32pt;padding-right:183.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">OTHER PROVISIONS</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Committee (and its delegates) shall have the power to interpret the Plan, the Grant Notice, and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan, the Grant Notice, and this Agreement as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations and determinations made by the Committee will be final and binding upon the Participant, the Company, and all other interested Persons. To the extent allowable pursuant to applicable law, no member of the Committee or the Board will</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4.1pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">be personally liable for any action, determination or interpretation made with respect to the Plan, the Grant Notice, or this Agreement.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">PSUs Not Transferable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. The PSUs may not be sold, pledged, assigned, or transferred in any manner other than by will or the laws of descent and distribution, unless and until the Shares underlying the PSUs have been issued, and all restrictions applicable to such Shares have lapsed. No PSUs or any interest or right therein or part thereof shall be liable for the debts, contracts or engagements of the Participant or his or her successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no effect, except to the extent that such disposition is permitted by the preceding sentence. Notwithstanding the foregoing, with the consent of the Committee, the PSUs may be transferred as described in Section 14(b)(ii) of the Plan, pursuant to any such conditions and procedures the Committee may require.</font></div><div style="margin-top:10.7pt;padding-left:6pt;padding-right:5.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. The Participant acknowledges that the PSUs and the Shares subject to the PSUs are subject to adjustment, modification and termination in certain events as provided in this Agreement and the Plan, including Section 12 of the Plan.</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cooperation&#59; Repatriation and Compliance Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant agrees to cooperate with the Company and the Employer in taking any action reasonably necessary or advisable to consummate the transactions contemplated by this Agreement. Further, the Participant agrees to repatriate all payments attributable to the PSUs in accordance with local foreign exchange rules and regulations in the Participant&#8217;s country of residence (and country of employment, if different). In addition, the Participant agrees to take any and all actions, and consents to any and all actions taken by the Employer, the Company and its Subsidiaries as may be required to allow the Employer, the Company and its Subsidiaries to comply with applicable law in the Participant&#8217;s country of residence (and country of employment, if different). Finally, the Participant agrees to take any and all actions that may be required to comply with the Participant&#8217;s personal legal and tax obligations under local laws, rules, and regulations in the Participant&#8217;s country of residence (and country of employment, if different).</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-U.S. Addendum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding any provisions in this Agreement to the contrary, the PSUs shall be subject to any special terms and conditions set forth in the Non-U.S. Addendum to this Agreement for the Participant&#8217;s country of residence (and country of employment or service, if different) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Addendum 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Moreover, if the Participant relocates to another country, any special terms and conditions for such country will apply to the Participant, to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable for legal or administrative reasons (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate the Participant&#8217;s transfer). The Non-U.S. Addendum (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Addendum 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) constitutes part of this Agreement.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For the purpose of this Plan and this Agreement, notices and all other communications shall be in writing and shall be deemed to have been duly given when delivered or mailed by overnight courier or United States registered mail, return receipt requested, postage prepaid, addressed to the Plan to the General Counsel, Baxter International Inc., One Baxter Parkway, Deerfield, Illinois 60015, USA and to the Participant to the address set forth in the Company&#8217;s payroll records or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4.1pt;padding-left:5.95pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan, on the PSUs and on any Shares acquired under the Plan, to the extent the Company determines, in its sole discretion, it is necessary or advisable in order to comply with local law, rules and regulations or to facilitate the operation and administration of the PSUs and the Plan. Such requirements may include (but are not limited to) requiring the Participant to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant acknowledges that he or she is proficient in the English language, or has consulted with an advisor who is proficient in the English language, so as to enable the Participant to understand the provisions of this Agreement and the Plan. If the Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Delivery and Acceptance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company, in its sole discretion, may decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an online or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 5.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Titles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 5.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Governing Law&#59; Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. Except to the extent preempted by US federal law, the laws of the State of Illinois, USA shall govern the interpretation, validity, administration, enforcement, and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws. For any legal action relating to this Agreement, the parties to this Agreement consent to the exclusive jurisdiction and venue of the federal courts in Chicago, Illinois.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 5.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Non-Competition, Non-Solicitation, and Confidentiality Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> Notwithstanding any other provision in this Agreement or the Plan to the contrary, any grant hereunder shall be cancelled and no Awards will vest, be settled, or be exercisable if the Participant does not accept, sign, date and return, as directed by the Company, a Non-Competition, Non-Solicitation and Confidentiality Agreement, in such form as determined by the Company, within sixty (60) days of being provided a copy of such agreement.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 5.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Repayment of Proceeds&#59; Clawback and Offset Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. The Shares underlying the PSUs and all proceeds related to such Shares are subject to the Company&#8217;s Incentive Compensation Recoupment Policy or Executive Compensation Recoupment Policy, as specified in the Grant Notice, which are attached to Grant Notice as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:5.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Additionally, where applicable, if (i) the Participant&#8217;s employment with the Company Group terminates for any reason and (ii) such Participant violates (either during and&#47;or after employment with the Company Group) the terms of the Participant&#8217;s Non-Competition, Non-Solicitation and Confidentiality Agreement as described in and required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then any Awards that have not vested or are not exercisable as of the Termination date (including any Awards that would later be settled as a result of a Qualifying Retirement) shall be cancelled and shall not vest, be settled or be exercisable. Furthermore, any Awards that have vested or became exercisable within the 12 months preceding the Termination date shall be forfeited and shall be returned to the Company, and any Awards that vested after the Termination date as a result of a Qualifying Retirement shall be forfeited. If the Participant has exercised any such Awards or sold Shares underlying Awards, then the Participant shall make a cash payment to the Company in an amount equal to the amount of the net gain recognized from the exercise of such Awards or sale of such</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4.1pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Shares within 30 business days of written notice by the Company to the Participant.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Conformity to Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. The Participant acknowledges that the Plan, the Grant Notice, and this Agreement, are intended to conform to the extent necessary with all applicable laws, including, without limitation, the provisions of the Securities Act and the Exchange Act, and any and all regulations and rules promulgated thereunder by the Securities and Exchange Commission, and other applicable securities laws and regulations. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the PSUs are granted, only in such a manner as to conform to applicable laws. To the extent permitted by applicable laws, the Plan, the Grant Notice, and this Agreement, shall be deemed amended to the extent necessary to conform to applicable laws.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 5.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Amendment, Suspension and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Committee or the Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:117%">, provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">that, except as may otherwise be provided by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the PSUs in any material way without the prior written consent of the Participant.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 5.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> of this Agreement and the Plan, this Agreement shall be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Limitations Applicable to Section 16 Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding any other provision of the Plan or this Agreement, if the Participant is subject to Section 16 of the Exchange Act, the Plan, the PSUs, the Grant Notice, and this Agreement shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by applicable laws, this Agreement shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Not a Contract of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Nothing in this Agreement or in the Plan shall confer upon the Participant any right to continue to serve as an employee of any member of the Company Group or shall interfere with or restrict in any way the rights of any member of the Company Group, which rights are hereby expressly reserved, to discharge or terminate the services of the Participant at any time for any reason whatsoever, with or without cause, except to the extent (i) expressly provided otherwise in a written agreement between a Member of the Company Group and the Participant or (ii) where such provisions are not consistent with applicable foreign or local laws, in which case such applicable foreign or local laws shall control.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 5.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. The Plan, the Grant Notice, and this Agreement (including the Addenda attached hereto) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and the Participant with respect to the subject matter hereof. Except as specifically provided in the Grant Notice or this Agreement, in the event of any inconsistency between the Plan, the Grant Notice or this Agreement, the Plan will control.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:5.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 5.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. The intent of the parties is that the payments and benefits under this Agreement comply with or be exempt from Code Section 409A and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith or otherwise exempt. The Company may unilaterally amend the terms of this Agreement (or the Plan) to avoid the application of, or to comply with, Code Section 409A, in a particular circumstance or as necessary or</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4.1pt;padding-left:5.95pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">desirable to satisfy any of the requirements under Code Section 409A or to mitigate any additional tax, interest and&#47;or penalties that may apply under Code Section 409A if exemption or compliance is not practicable, but the Company or the Participant shall not be under any obligation to make any such amendment. Nothing in this Agreement (or the Plan) shall provide a basis for any person to take action against the Company or any Subsidiary based on matters covered by Code Section 409A, including the tax treatment of any amount paid under the Agreement, and neither the Company nor any of its Subsidiaries shall under any circumstances have any liability to the Participant or his estate or any other party for any taxes, penalties or interest due on amounts paid or payable under this Agreement, including taxes, penalties or interest imposed under Code Section 409A.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without limiting the generality of the foregoing and anything in the Agreement to the contrary notwithstanding, if PSUs payable on or by reference to the timing of the Participant&#8217;s Termination constitute non-qualified deferred compensation subject to Section 409A, as determined in the Company&#8217;s sole discretion, such PSUs shall not be paid unless and until the Participant experiences a &#8220;separation from service&#8221; (within the meaning of Code Section 409A), and if the Participant is a &#8220;specified employee&#8221; (within the meaning of Code Section 409A) as of the date of the separation from service (as determined in accordance with the methodology established by the Company as in effect on the date of Termination), shall instead be paid to the Participant on the first business day that immediately follows the earlier of (i) the date that is six (6) months following the date of the Participant&#8217;s separation from service or (ii) the date of the Participant&#8217;s death, to the extent such delayed payment is otherwise required in order to avoid a prohibited distribution under Code Section 409A(a)(2).</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 5.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Agreement Severable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. In the event that any provision of the Grant Notice or this Agreement is held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of the Grant Notice or this Agreement.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.55pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 5.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Limitation on the Participant&#8217;s Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. Participation in the Plan confers no rights or interests other than as herein provided. This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust. Neither the Plan nor any underlying program, in and of itself, has any assets. The Participant shall have only the rights of a general unsecured creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the PSUs.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt;padding-right:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 5.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. The Grant Notice may be executed in one or more counterparts, including by way of any electronic signature, subject to applicable law, each of which shall be deemed an original and all of which together shall constitute one instrument.</font></div><div><font><br></font></div><div style="padding-left:6pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Private Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If the Participant is a resident outside the United States, the grant of the PSUs is not intended to be a public offering of securities in the Participant&#8217;s country of residence (and country of employment, if different). The Company has not submitted any registration statement, prospectus, or other filing with the local securities authorities with respect to the grant of the PSUs unless otherwise required under local law. No employee of the Company is permitted to advise the Participant on whether the Participant should acquire Shares under the Plan or provide the Participant with any legal, tax or financial advice with respect to the grant of the PSUs. Investment in Shares involves a degree of risk. Before deciding to acquire Shares pursuant to the PSUs, the Participant should carefully consider all risk factors and tax considerations relevant to the acquisition of Shares under the Plan or the disposition of them. Further, the Participant should carefully review all of the materials related to the PSUs and the Plan, and the Participant should consult with the Participant&#8217;s personal legal, tax and financial advisors for professional advice in relation to the Participant&#8217;s personal circumstances.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4.1pt;padding-left:5.95pt;padding-right:5.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Control, Foreign Asset&#47;Account and&#47;or Tax Reporting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant acknowledges that there may be certain exchange control, foreign asset&#47;account and&#47;or tax reporting requirements that may affect the Participant&#8217;s ability to acquire or hold Shares or cash received from participating in the Plan (including the receipt of any dividends paid on Shares and the proceeds from the sale of Shares) in a brokerage or bank account outside the Participant&#8217;s country. The Participant may be required to report such accounts, assets or related transactions to the tax or other authorities in the Participant&#8217;s country. The Participant also may be required to repatriate sale proceeds or other funds received as a result of participating in the Plan to the Participant&#8217;s country within a certain time after receipt. The Participant acknowledges that it is the Participant&#8217;s responsibility to comply with such regulations and that the Participant should speak to his or her personal advisor on this matter.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:5.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.26</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Insider Trading&#47;Market Abuse</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant may be subject to insider trading restrictions and&#47;or market abuse laws based on the exchange on which the Shares are listed and in applicable jurisdictions, including the United States, the Participant&#8217;s country and the designated broker&#8217;s country (including any Company Group securities trading policy), which may affect the Participant&#8217;s ability to accept, acquire, sell or otherwise dispose of Shares, rights to Shares (e.g., the PSUs) or rights linked to the value of Shares under the Plan during such times that the Participant is considered to have &#8220;inside information&#8221; regarding the Company (as defined by the laws or regulations in the Participant&#8217;s country). Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Participant acknowledges that it is the Participant&#8217;s responsibility to comply with any applicable restrictions and that the Participant should speak to his or her personal advisor on this matter.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 5.27</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">. The waiver by the Company with respect to the Participant&#8217;s (or any other participant&#8217;s) compliance of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by such party of a provision of this Agreement.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 5.28</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Consent and Agreement With Respect to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:117%">The Participant (a) acknowledges that a copy of the Plan and the U.S. prospectus for the Plan has been available to the Participant&#59; (b) represents that he or she has read and is familiar with the terms and provisions thereof, has had an opportunity to obtain the advice of counsel of his or her choice prior to executing this Agreement and fully understands all provisions of this Agreement and the Plan&#59; (c) accepts the PSUs subject to all of the terms and provisions thereof&#59; and (d) agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan or this Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:5.4pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:132%">To the extent that the Company has established, either itself or through a third-party plan administrator, the ability to accept this award electronically, such acceptance shall constitute the Participant&#8217;s signature hereof.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Company&#58;&#160;&#160;&#160;&#160;Participant&#58;</font></div><div style="margin-top:0.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.318%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:294.75pt"><font><br></font></div><div style="margin-top:0.95pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; Sven Skillrud</font></div><div style="margin-top:1.75pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58; Vice President, Total Rewards</font></div><div style="margin-top:0.15pt;padding-left:220.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">* * * * *</font></div><div><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:4.1pt;padding-left:87.72pt;padding-right:87.72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ADDENDUM 1 TO</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:87.87pt;padding-right:87.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:220%">THE PERFORMANCE SHARE UNIT AWARD AGREEMENT </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:220%;text-decoration:underline">PERFORMANCE GOALS AND PAYOUT SCHEDULE</font></div><div style="margin-top:1.55pt;padding-left:6pt;padding-right:5.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Capitalized terms not specifically defined herein shall have the meanings specified in the Plan, the Grant Notice and&#47;or the Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:5.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">The target number of PSUs specified in the Grant Notice will be earned one-third under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> (&#8220;Total Shareholder Return&#8221;), one-third under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> (&#8220;Compound Annual Growth Rate&#8221;) and the remainder under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> (&#8220;Adjusted Return on Invested Capital&#8221;), as set forth below.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.7pt;padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Total Shareholder Return</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The PSUs earned under this Section 1 will be earned based on the rank of Baxter&#8217;s total shareholder return (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">TSR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) relative to the TSR of companies in the S&#38;P 500 Healthcare Equipment &#38; Services Index (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Index</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the applicable peer group selected by the Committee within the first ninety (90) days of the Performance Period  set forth in the Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">TSR PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). TSR will be measured based on the average closing stock prices over the last twenty (20) trading days of the Performance Period (plus reinvested dividends) divided       by the average closing stock prices over the twenty (20) trading days prior to the beginning of the Performance Period. Any companies in the Index who are no longer publicly traded as of the end of the Performance Period will not be included in the final assessment of the results.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">The TSR PSUs will pay out in Shares in a range of 0% to 200% of the number of target TSR PSUs awarded  to the Participant as follows&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:18.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.431%"><tr><td style="width:1.0%"></td><td style="width:54.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.908%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:55.25pt;text-indent:-52.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Baxter International Inc. TSR Percentile Rank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">(Relative to the Index)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.5pt;padding-left:14.32pt;padding-right:14.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Percentage of Target Grant Earned</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2.3pt;padding-left:51.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93; percentile or above</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2.3pt;padding-left:14.25pt;padding-right:14.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93;%</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:72.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93; percentile</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:14.25pt;padding-right:14.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93;%</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:72.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93; percentile</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:13.85pt;padding-right:13.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93;%</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:56.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">Below &#91;&#8226;&#93; percentile</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:14.25pt;padding-right:14.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">&#91;&#8226;&#93;%</font></div></td></tr></table></div><div><font><br></font></div><div style="padding-left:6pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">The PSUs will pay out linearly between each set of performance data points specified. If the Company&#8217;s absolute TSR, as measured for the Performance Period, is negative, then the PSUs earned will be based on the lesser of (a) actual performance against target or (b) 100%.</font></div><div><font><br></font></div><div style="padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Compound Annual Growth Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:5.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">The PSUs earned under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%"> will be earned based on the Company&#8217;s Compound Annual Growth Rate (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%;text-decoration:underline">CAGR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">&#8221;) performance for Net Sales (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%;text-decoration:underline">CAGR PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">&#8221;) over the Performance Period. CAGR will be calculated as follows&#58;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net Sales for the last calendar year of the Performance Period divided by Net Sales for the calendar year immediately preceding the Date of Grant, then raising the result to an exponent of one divided by the number of calendar years within the Performance Period.&#160;Subtract one from the subsequent result to arrive at the applicable CAGR.</font></div><div style="padding-right:5.75pt;text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="padding-left:6pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of the CAGR calculation, Net Sales means net sales of the Company that shall be (a) computed on a constant currency basis using the average foreign exchange rates in each applicable jurisdiction for the calendar year immediately preceding the Date of Grant, and (b) adjusted to exclude the revenue for any business or asset acquisition or divestiture with annualized revenue of greater than $75 million at the time of the acquisition or divestiture (determined based on the trailing four quarters preceding the acquisition or divestiture date) from all periods within the Performance Period (as well as the Net Sales for the calendar year immediately preceding the Date of Grant for divestitures).</font></div><div style="padding-left:6pt;padding-right:5.75pt;text-align:justify"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:5.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CAGR PSUs will be measured over the Performance Period, beginning with the first day of the Performance Period and ending on the last day of the Performance Period. The Committee will set a target CAGR performance within the first ninety (90) days of the Performance Period and assess performance relative to that target after the completion of the Performance Period, which shall be finalized in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.7pt;padding-left:6pt;padding-right:5.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">CAGR PSUs will pay out in Shares in a range of 0% to 200% of the number of target CAGR PSUs awarded to the Participant as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:19.85pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.961%"><tr><td style="width:1.0%"></td><td style="width:54.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:14.77pt;padding-right:14.77pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Baxter International Inc. CAGR Performance</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:14.55pt;padding-right:14.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Percentage of Target Grant Earned</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:14.7pt;padding-right:14.7pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93; percent and above</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:14.47pt;padding-right:14.47pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93;%</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:14.32pt;padding-right:14.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93; percent</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:14.47pt;padding-right:14.47pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93;%</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:14.32pt;padding-right:14.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93; percent</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:14.07pt;padding-right:14.07pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93;%</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:14.72pt;padding-right:14.72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">Below &#91;&#8226;&#93; percent</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:14.47pt;padding-right:14.47pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">&#91;&#8226;&#93;%</font></div></td></tr></table></div><div><font><br></font></div><div style="padding-left:6pt;padding-right:51.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:234%">CAGR PSUs will pay out linearly between each set of performance data points specified above. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:234%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:234%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:234%;text-decoration:underline">Adjusted Return on Invested Capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:234%">.</font></div><div style="margin-top:0.3pt;padding-left:6pt;padding-right:5.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">The PSUs earned under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%"> will be earned based on the Company&#8217;s adjusted return on invested capital (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%;text-decoration:underline">ROIC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">&#8221;) performance (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%;text-decoration:underline">ROIC PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">&#8221;) over the Performance Period, as specified below. </font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ROIC shall be calculated over the Performance Period based on each applicable individual calendar year&#8217;s adjusted operating income less adjusted income tax expense, divided by average invested capital. Average invested capital for a particular year shall be measured as the simple average of invested capital at the beginning and end of that year. For purposes of the ROIC calculation, average invested capital is defined as working capital plus the sum of net property, plant and equipment, capitalized operating leases, net intangible assets, and goodwill. Working capital shall be measured as current assets (defined as total current assets reported under U.S. GAAP less cash and cash equivalents) less current liabilities (defined as total current liabilities reported under U.S. GAAP less short-term debt and finance lease obligations and the current portion of long-term debt and finance lease obligations). Additionally, in order to present the numerator and denominator on a like-for-like basis, accrued restructuring liabilities are removed and present intangible assets are reported at cost. </font></div><div style="padding-left:6pt;padding-right:5.6pt;text-align:justify"><font><br></font></div><div style="padding-left:6pt;padding-right:5.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of the ROIC calculation, the adjusted operating income less adjusted income tax expense from any business or asset acquisition or divestiture with annualized revenue of greater than $75 million at the time of the acquisition or divestiture (determined based on the trailing four quarters immediately preceding the acquisition or divestiture date) shall be excluded from the numerator and the average invested capital related to such acquisition or divestiture shall be excluded from the denominator.</font></div><div style="padding-left:6pt;padding-right:5.6pt;text-align:justify"><font><br></font></div><div style="padding-left:6pt;padding-right:5.6pt;text-align:justify"><font><br></font></div><div style="padding-left:6pt;padding-right:5.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Final ROIC performance will be calculated by first determining the annual ROIC performance for each of the three individual calendar years in the Performance Period and then determining the three-year simple average. </font></div><div style="padding-left:6pt;padding-right:5.6pt;text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="padding-left:6pt;padding-right:5.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Committee will set a target ROIC performance within the first ninety (90) days of the Performance Period and assess performance relative to that target after the completion of the Performance Period, which shall be finalized in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement.</font></div><div><font><br></font></div><div style="margin-top:5.25pt;padding-left:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:110%">The ROIC PSUs will pay out in Shares in a range of 0% to 200% of the number of target ROIC PSUs awarded to the Participant as follows&#58;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:21.45pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.308%"><tr><td style="width:1.0%"></td><td style="width:54.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.559%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.42pt;padding-right:15.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Baxter International Inc. ROIC Performance</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:15.12pt;padding-right:15.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">Percentage of Target Grant Earned</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2.3pt;padding-left:14.95pt;padding-right:14.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93; percent and above</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2.3pt;padding-left:15.05pt;padding-right:15.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93;%</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:15.37pt;padding-right:15.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93; percent</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:15.05pt;padding-right:15.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93;%</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:15.37pt;padding-right:15.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93; percent</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:14.65pt;padding-right:14.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;&#8226;&#93;%</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:15.07pt;padding-right:15.07pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">Below &#91;&#8226;&#93; percent</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.9pt;padding-left:15.05pt;padding-right:15.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">&#91;&#8226;&#93;%</font></div></td></tr></table></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The ROIC PSUs will pay out linearly between each set of performance data points specified above.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Committee shall have sole and exclusive authority and discretion to make all determinations and resolve all ambiguities, questions and disputes relating to the calculation of Performance Goals and the level of vesting and earning of the PSUs. With respect to the determination of the achievement of any of the Performance Goals and the percentage of the target grant earned, the Committee, in its discretion, may modify or adjust such performance objectives or related level of achievement in accordance with the terms of the Plan.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-top:0.2pt"><font><br></font></div><div><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:4.1pt;padding-left:87.72pt;padding-right:87.72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ADDENDUM 2 TO</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:87.87pt;padding-right:87.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:169%">THE PERFORMANCE SHARE UNIT AWARD AGREEMENT </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:169%;text-decoration:underline">FOR NON-U.S. PARTICIPANTS</font></div><div style="margin-top:6.25pt;padding-left:5.95pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In addition to the terms of the Plan, the Grant Notice, and the Agreement, the PSUs are subject to the following additional terms, conditions, and provisions (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-U.S. Addendum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). All capitalized terms as contained in this Non-U.S. Addendum shall have the same meaning as set forth in the Plan, the Grant Notice and&#47;or the Agreement. Pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement, if the Participant transfers residence and&#47;or employment or service to another country reflected in this Non-U.S. Addendum, the special terms, conditions and provision for such country will apply to the Participant to the extent the Company determines, in its sole discretion, that the application of such terms, conditions and provisions is necessary for legal or administrative reasons (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate the Participant&#8217;s transfer).</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">AUSTRALIA</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Tax Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. The Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#8221;) applies (subject to the conditions in that Act).</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Australia Offer Document</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. This grant of PSUs is intended to comply with the provisions of the Corporations Act 2001, Australia Securities and Investments Commission (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">ASIC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#8221;) Regulatory Guide 49 and ASIC Class Order CO 14&#47;1000. Additional details are set forth in the Australia Offer Document, a copy of which is attached to the end of this section for Australia as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Annex 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4.1pt;padding-left:87.6pt;padding-right:87.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">ANNEX 1</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:182.95pt;padding-right:182.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">OFFER DOCUMENT</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:87.72pt;padding-right:87.72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Baxter International Inc.</font></div><div style="margin-top:0.15pt;padding-left:87.62pt;padding-right:87.62pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2021 Incentive Plan</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:128.02pt;padding-right:128.02pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:117%">OFFER OF PERFORMANCE SHARE UNITS TO AUSTRALIAN RESIDENT EMPLOYEES</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company is pleased to provide the Participant with this offer to participate in the Plan. This offer sets out information regarding the grant of PSUs to Australian resident employees of the Company and its parents, Subsidiaries and Subsidiaries (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Australian Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). This information is provided by the Company to ensure compliance of the Plan with Australian Securities and Investments Commission (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ASIC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) Class Order 14&#47;1000 and relevant provisions of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Corporations Act 2001</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">In addition to the information set out in the Agreement and the Non-U.S. Addendum, Australian Participants are also being provided with copies of the following documents&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:41.95pt;text-align:justify;text-indent:-17.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.4pt">the Plan&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:42pt;text-align:justify;text-indent:-17.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.83pt">the Plan prospectus&#59; and</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41.95pt;text-align:justify;text-indent:-17.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.4pt">Employee Information Supplement for Australia (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">The Additional Documents provide further information to help Australian Participants make an informed investment decision about participating in the Plan. Neither the Plan nor the Plan prospectus is a prospectus for the purposes of the Corporations Act 2001.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">Australian Participants should not rely upon any oral statements made in relation to this offer. Australian Participants should rely only upon the statements contained in the Agreement, including the Non-U.S. Addendum, and the Additional Documents when considering participation in the Plan.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:117%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. Investment in Shares involves a degree of risk. Eligible employees who elect to participate in the Plan should monitor their participation and consider all risk factors relevant to the acquisition of Shares under the Plan as set forth below and in the Additional Documents.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6pt;padding-right:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">The information herein is general information only. It is not advice or information that takes into account Australian Participants&#8217; objectives, financial situation and needs.</font></div><div><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Australian Participants should consider obtaining their own financial product advice from a person who is licensed by ASIC to give such advice.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Additional Risk Factors for Australian Residents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Australian Participants should have regard to risk factors relevant to investment in securities generally and, in particular, to holding Shares. For example, the price at which an individual Share is quoted on The New York Stock Exchange (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">NYSE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) may increase or decrease due to a number of factors. There is no guarantee that the price of a Share will increase. Factors that may affect the price of an individual Share include fluctuations in the domestic and international market for listed stocks, general economic conditions, including interest rates, inflation rates, commodity and oil prices, changes to government fiscal, monetary or regulatory policies, legislation or regulation, the nature</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4.1pt;padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of the markets in which the Company operates and general operational and business risks.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">More information about potential factors that could affect the Company&#8217;s business and financial results will be included in the Company&#8217;s most recent Annual Report on Form 10-K and the Company&#8217;s Quarterly Report on Form 10-Q. Copies of these reports are available at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">http&#58;&#47;&#47;www.sec.gov&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, on the Company&#8217;s investor&#8217;s page at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;investor.baxter.com&#47;investors&#47;investor-overview&#47;default.aspx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and upon request to the Company.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">In addition, Australian Participants should be aware that the Australian dollar (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%;text-decoration:underline">AUD</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">&#8221;) value of any Shares acquired under the Plan will be affected by the USD&#47;AUD exchange rate. Participation in the Plan involves certain risks related to fluctuations in this rate of exchange.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Common Stock in a U.S. Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Common stock of a U.S. corporation is analogous to ordinary shares of an Australian corporation. Each holder of a Share is entitled to one vote. Dividends may be paid on the Shares out of any funds of the Company legally available for dividends at the discretion of the Board. Further, Shares are not liable to any further calls for payment of capital or for other assessment by the Company and have no sinking fund provisions, pre-emptive rights, conversion rights or redemption provisions.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:117%;text-decoration:underline">Ascertaining the Market Price of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. Australian Participants may ascertain the current market price of an individual Share as traded on NYSE under the symbol &#8220;BAX&#8221; at&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">https&#58;&#47;&#47;www.nyse.com&#47;quote&#47;XNYS&#58;BAX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. The AUD equivalent of that price can be obtained at&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">https&#58;&#47;&#47;www.rba.gov.au&#47;statistics&#47;frequency&#47;exchange-rates.html</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:117%">Please note that this is not a prediction of what the market price of the Shares will be when PSUs vest or when Shares are issued to Australian Participants (or at any other time), or of the applicable exchange rate at such time.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4.1pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">BRAZIL</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:5.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:110%;text-decoration:underline">Compliance with the Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:110%">. By accepting the PSUs, the Participant acknowledges his or her agreement to comply with applicable Brazilian laws and to pay any and all applicable Tax-Related Items.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This provision supplements Article III (&#8220;Nature of Grant&#8221;) of the Agreement&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.75pt;padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">By accepting the PSUs, the Participant agrees that (i) the Participant is making an investment decision and</font></div><div style="padding-left:5.95pt;padding-right:5.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:16.63pt">the value of the underlying Shares is not fixed and may increase or decrease over the vesting period without compensation to the Participant.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">CANADA</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This provision supplements </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement&#58;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:6pt;padding-right:6.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Notwithstanding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 2.5(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> of the Agreement, the PSUs do not provide any right for the Participant to receive a cash payment and the PSUs will be settled only in Shares.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Forfeiture upon Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This provision supplements </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement&#58;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of the PSUs, notwithstanding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement, the Committee or its delegate may provide that the Participant&#8217;s Termination will occur as of the date the Participant is no longer actually employed or otherwise rendering services to the Service Recipient (regardless of the reason for such Termination and whether or not later found to be invalid or in breach of employment or other laws or otherwise rendering services or the terms of the Participant&#8217;s employment or other service agreement, if any). In such case, unless otherwise provided in the Agreement or extended by the Company, the Participant&#8217;s right to vest in and earn the PSUs under the Plan, if any, will terminate as of such date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Termination Date will not be extended by any common law notice period. Notwithstanding the foregoing, however, if applicable employment standards legislation specifically requires continued entitlement to vesting during a statutory notice period, the Participant&#8217;s right to vest in the PSUs under the Plan, if any will be allowed to continue for that minimum notice period but then immediately terminate effective as of the last day of the Participant&#8217;s minimum statutory notice period. In the event the date the Participant is no longer providing actual service cannot be reasonably determined under the terms of the Agreement and&#47;or the Plan, the Committee or its delegate shall have the exclusive discretion to determine when the Participant is no longer actively providing services for purposes of the PSUs (including whether the Participant may still be considered to be providing services while on a leave of absence). Unless the applicable employment standards legislation specifically requires, in the case of the Participant, the Participant will not earn or be entitled to any pro-rated vesting for that portion of time before the date on which his service relationship is terminated (as determined under this provision) nor will the Participant be entitled to any compensation for lost vesting.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. The Participant may not be permitted to sell within Canada Shares acquired under the Plan. The Participant may only be permitted to sell or dispose of any Shares acquired under the Plan if such sale or disposal takes place outside of Canada through the facilities of a stock exchange on which the Shares are listed (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:117%">i.e., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">the New York Stock Exchange).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">CHINA</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">The following provisions apply only to the Participants who are subject to exchange control restrictions imposed by the State Administration of Foreign Exchange (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">SAFE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#8221;), as determined by the Company in its sole discretion&#58;</font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18</font></div></td></tr></table></div></div></div><div id="i7a726023efbe40e38c085f4723e7d162_10"></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:4.75pt;padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting of PSUs</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">The Participant&#8217;s Employer must be registered with SAFE prior to settlement of the PSUs. If the Company is unable to obtain registration approval or is required to obtain further approvals on behalf of a member of the Company Group, the vesting or settlement of the PSUs may be suspended or delayed. Further, the Company is under no obligation to vest the PSUs and&#47;or issue Shares if the Company&#8217;s SAFE approval becomes invalid or ceases to be in effect by the time the PSUs vest.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.7pt;padding-left:5.95pt;padding-right:5.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant acknowledges and agrees that he or she must sell any Shares issued to him or her upon settlement of the PSUs as soon as practicable following the Participant&#8217;s Termination and in no event later than six (6) months following the Participant&#8217;s Termination. The Participant agrees that if he or she continues to hold any of such Shares after this time, the Shares may be sold by the Company&#8217;s designated broker on the Participant&#8217;s behalf at the instruction of the Corporation. Therefore, by accepting the PSUs, the Participant understands and agrees that the Company is authorized to, and may in its sole discretion, instruct its designated broker to assist with the mandatory sale of Shares (on the Participant&#8217;s behalf pursuant to this authorization) and that the Participant expressly authorizes the Company&#8217;s designated broker to complete the sale of such Shares. The Participant acknowledges that the Company&#8217;s designated broker is under no obligation to arrange for the sale of the Shares at any particular price. Upon the sale of the Shares, the proceeds, less any Tax-Related Items and brokerage fees or commissions will be remitted to the Participant pursuant to the procedures described in the &#8220;Exchange Control Information&#8221; section below.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Control Information</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.7pt;padding-left:5.95pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Shares issued to the Participant under the Plan must be maintained in an account with E*TRADE Corporate Financial Services Inc. or such other broker as may be designated by the Company until the Shares are sold through that broker. If the Company changes its broker, the Participant acknowledges and agrees that the Company may transfer any Shares issued under the Plan to the new designated broker if necessary for legal or administrative reasons. The Participant agrees to sign any documentation necessary to facilitate the transfer. In addition, the Participant may be required to sell any Shares obtained under the Plan if the Company determines that the application of such condition is necessary or advisable for China SAFE exchange control, legal or other administrative reasons.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant understands and agrees that, to facilitate compliance with exchange control requirements, the Participant will be required to immediately repatriate to China the cash proceeds from the sale of Shares acquired upon vesting of the PSUs or from any dividends. The Participant further understands that, under local law, such repatriation of the cash proceeds will be effectuated through a special exchange control account established by the Company or one of its Subsidiaries in China, and the Participant hereby consents and agrees that the cash proceeds related to the Participant&#8217;s participation in the Plan may be transferred to such special account prior to being delivered to the Participant. The Company may deliver the proceeds to the Participant in U.S. dollars or local currency at the Company&#8217;s discretion. If the proceeds are paid in U.S. dollars, the Participant understands that he or she will be required to set up a U.S. dollar bank account in China so that the proceeds may be deposited into this account. If the proceeds are converted to local currency, there may be delays in delivering the proceeds to the Participant. The Participant agrees to bear the risk of any currency fluctuation between the time the Shares are sold, either through voluntary sale or through a mandatory sale arranged by the Company, or proceeds are otherwise realized under the Plan and the time such proceeds are distributed to the Participant through the special exchange control account.</font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19</font></div></td></tr></table></div></div></div><div id="i7a726023efbe40e38c085f4723e7d162_13"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-top:4.1pt;padding-left:6pt;padding-right:5.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">The Participant further agrees to comply with any other requirements that may be imposed by the Company in the future to facilitate compliance with exchange control requirements in China.</font></div><div><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">COLOMBIA</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This provision supplements Article III (&#8220;Nature of Grant&#8221;) of the Agreement&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant acknowledges that, pursuant to Article 128 of the Colombian Labor Code, the PSUs and related benefits do not constitute a component of the Participant&#8217;s &#8220;salary&#8221; for any legal purpose. Therefore, the PSUs and related benefits will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as legal&#47;fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions and&#47;or any other labor-related amount which may be payable.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">The Shares are not and will not be registered in the Colombian registry of publicly traded securities (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">Registro Nacional de Valores y Emisores</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">) and, therefore, the Shares may not be offered to the public in Colombia. Nothing in this document should be construed as the making of a public offer of securities in Colombia.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">HONG KONG</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Important Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.75pt;padding-left:5.95pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Securities Warning</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58; The contents of the Grant Notice, the Agreement, this Non-U.S. Addendum, the Plan, and all other materials pertaining to the PSUs and&#47;or the Plan have not been reviewed by any regulatory authority in Hong Kong. The Participant is hereby advised to exercise caution in relation to the offer thereunder. If the Participant has any doubts about any of the contents of the aforesaid materials, the Participant should obtain independent professional advice. The PSUs and any Shares issued in respect of the PSUs do not constitute a public offering of securities under Hong Kong law and are available only to eligible employees under the Plan. The Grant Notice, the Agreement, including this Non-U.S. Addendum, the Plan and other incidental communication materials have not been prepared in accordance with and are not intended to constitute a &#8220;prospectus&#8221; for a public offering of securities under the applicable securities legislation in Hong Kong. The PSUs and any documentation related thereto are intended solely for the Participant&#8217;s personal use and may not be distributed to any other person.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">If, for any reason, Shares are issued to the Participant within six (6) months of the Date of Grant, the Participant agrees that he or she will not sell or otherwise dispose of any such Shares prior to the six-month anniversary of the Date of Grant.</font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20</font></div></td></tr></table></div></div></div><div id="i7a726023efbe40e38c085f4723e7d162_16"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-top:4.1pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Notwithstanding anything to the contrary in this the Grant Notice, the Agreement, this Non-U.S. Addendum or the Plan, the PSUs shall be settled only in Shares (and may not be settled in cash).</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">SINGAPORE</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The PSUs are being granted pursuant to the &#8220;Qualifying Person&#8221; exemption under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SFA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Plan has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore. Hence, statutory liability under the SFA in relation to the content of prospectuses will not apply. The Participant should note that the PSUs are subject to section 257 of the SFA and hence the PSUs may not be offered or sold, or made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore, unless such offer, sale or invitation is made (i) more than six (6) months from the Date of Grant, (ii) pursuant to the exemptions under Part XIII Division 1 Subdivision (4) (other than section 280) of the SFA, or</font></div><div style="margin-top:0.4pt;padding-left:25.95pt;text-align:justify;text-indent:-20.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:3.58pt">pursuant to, and in accordance with the conditions of, any other applicable provisions of the SFA.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">In addition, the Participant understands that he or she is permitted to sell Shares acquired under the Plan through the designated broker appointed under the Plan, if any, provided the resale of Shares acquired under the Plan takes place outside of Singapore through the facilities of a stock exchange on which the Shares are listed. The Shares are currently listed on the New York Stock Exchange (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">NYSE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;).</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Director Notification Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">If the Participant is a director, alternate director, substitute director or shadow director </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:117%;text-decoration:underline"><a href="#i7a726023efbe40e38c085f4723e7d162_16" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:117%;text-decoration:underline">1</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:117%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">of a Singapore Subsidiary, the Participant must notify the Singapore Subsidiary in writing within two (2) business days of</font></div><div style="padding-left:5.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:108%">(i) becoming the registered holder of or acquiring an interest (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:108%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:108%">, PSUs, Shares, etc.) in the Company or</font></div><div style="margin-top:0.15pt;padding-left:5.95pt;padding-right:5.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">any Subsidiary, or becoming an alternate director, substitute director or shadow director (as the case may be), whichever occurs last, or (ii) any change in a previously disclosed interest (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:117%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">, sale of Shares). If the Participant is the chief executive officer (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">CEO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#8221;) of a Singapore Subsidiary and the above notification requirements are determined to apply to the CEO of a Singapore Subsidiary, the above notification requirements also may apply to the Participant.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">SPAIN</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination and Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">This provision supplements </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> (&#8220;Impact of Termination on PSUs&#8221;) of the Agreement and Article III (&#8220;Nature of Grant&#8221;) of the Agreement&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">In accepting the grant of PSUs, the Participant consents to participation in the Plan and acknowledges that the Participant has received a copy of the Plan.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:5.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">The Participant understands and agrees that, unless otherwise provided in the Agreement, the Participant will forfeit any PSUs that have not vested as of the date the Participant&#8217;s Termination ends without</font></div><div style="padding-right:5.95pt;text-align:justify"><font><br></font></div><div style="margin-top:4.15pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:111%">1 A shadow director is an individual who is not on the board of directors of the Singapore Subsidiary but who has sufficient control so that the board of directors of the Singapore Subsidiary acts in accordance with the directions or instructions of the individual.</font></div><div style="height:69.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21</font></div></td></tr></table></div></div></div><div id="i7a726023efbe40e38c085f4723e7d162_19"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-top:4.1pt;padding-left:6pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">entitlement to the underlying Shares or to any amount of indemnification in the event of the Participant&#8217;s Termination for any reason including, but not limited to, resignation, retirement, disciplinary dismissal adjudged to be with cause, disciplinary dismissal adjudged or recognized to be without cause (i.e., subject to a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">despido improcedente</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), individual or collective dismissal on objective grounds, whether adjudged or recognized to be with or without cause, material modification of the terms of employment or service under Article 41 of the Workers&#8217; Statute, relocation under Article 40 of the Workers&#8217; Statute, and&#47;or Article 50 of the Workers&#8217; Statute, unilateral withdrawal by the Employer and under Article 10.3 of the Royal Decree 1382&#47;1985.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant understands that the Company has unilaterally, gratuitously and in its own discretion decided to grant PSUs under the Plan to certain individuals who may be employees of the Company or a Subsidiary throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not bind the Company or a Subsidiary, other than as set forth in the Agreement. Consequently, the Participant understands that the PSUs are granted on the assumption and condition that the PSUs and any Shares acquired upon vesting of the PSUs are not a part of any employment contract (either with the Company or a Subsidiary) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation), or any other right whatsoever. Further, the Participant understands that the PSUs would not be granted to the Participant but for the assumptions and conditions referred to above&#59; thus, the Participant acknowledges and freely accepts that should any or all of the assumptions be mistaken, or should any of the conditions not be met for any reason, any grant of or right to the PSUs shall be null and void.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No &#8220;offer of securities to the public,&#8221; as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the grant of PSUs under the Plan. Neither the Plan, the Agreement (which includes this Non-U.S. Addendum), nor the Grant Notice have been nor will they be registered with the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Comisi&#243;n Nacional del Mercado de Valores </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Spanish Securities Exchange Commission), and they do not constitute a public offering prospectus.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">SWEDEN</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The following provision supplements </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (&#8220;Tax Withholding&#8221;) of the Agreement&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5.95pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Without limiting the Company&#8217;s and the Employer&#8217;s authority to satisfy their withholding obligations for Tax-Related Items as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> of the Award Agreement, in accepting the grant of PSUs, the Participant authorizes the Company and&#47;or the Employer to withhold Shares or to sell Shares otherwise deliverable to the Participant upon vesting&#47;settlement to satisfy Tax-Related Items, regardless of whether the Company and&#47;or the Employer have an obligation to withhold such Tax-Related Items.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">SWITZERLAND</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:5.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Neither this document nor any other materials relating to the PSUs constitute a prospectus according to article 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">FinSA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and neither this document nor any other materials relating to the PSUs may be publicly distributed nor otherwise made publicly available in Switzerland to any person other than an employee of a member of the Company Group. Neither this document nor any other offering or marketing material relating to the PSUs have been or will be filed with,</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4.1pt;padding-left:6pt;padding-right:5.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">or approved or supervised by, any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority (in particular, the Swiss Financial Market Supervisory Authority (FINMA)).</font></div><div><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">TAIWAN</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:6pt;padding-right:6.35pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">The offer of participation in the Plan is available only for employees of the Company and its Subsidiaries. The offer of participation in the Plan is not a public offer of securities by a Taiwanese company.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">UNITED ARAB EMIRATES</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This provision supplements Article III (&#8220;Nature of Grant&#8221;) of the Agreement&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">The Participant acknowledges that the PSUs and related benefits do not constitute a component of the Participant&#8217;s &#8220;wages&#8221; for any legal purpose. Therefore, the PSUs and related benefits will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as social insurance contributions and&#47;or any other labor-related amounts which may be payable.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:5.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Agreement, the Grant Notice, the Plan and other incidental communication materials concerning the PSUs are intended for distribution only to employees of the Company or its Subsidiaries. The Dubai Creative Clusters Authority (formerly known as the Dubai Technology and Media Free Zone Authority), Emirates Securities and Commodities Authority and&#47;or the Central Bank of the United Arab Emirates has no responsibility for reviewing or verifying any documents in connection with the PSUs. Neither the Ministry of Economy nor the Dubai Department of Economic Development have approved these communications nor taken steps to verify the information set out in them, and have no responsibility for them.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Further, the Shares underlying the PSUs may be illiquid and&#47;or subject to restrictions on their resale. The Participant should conduct his or her own due diligence on the PSUs and the Shares. If the Participant is in any doubt about any of the contents of the grant or other incidental documents, the Participant should obtain independent professional advice.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">UNITED KINGDOM</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This provision supplements </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:6pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without limitation to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement, the Participant agrees that he or she is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or, if different, the Employer or by Her Majesty&#8217;s Revenue &#38; Customs (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">HMRC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (or any other tax authority or any other relevant authority). The Participant also agrees to indemnify and keep indemnified the Company and, if different, the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Participant&#8217;s behalf.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:5.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">Notwithstanding the foregoing, if the Participant is a director or executive officer (within the meaning of Section 13(k) of the Exchange Act), the Participant understands that he or she may not be able to indemnify</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4.1pt;padding-left:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Company for the amount of any income tax not collected from or paid by the Participant within ninety</font></div><div style="margin-top:0.15pt;padding-left:5.95pt;padding-right:5.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(90) days of the end of the U.K. tax year in which the event giving rise to the Tax-Related Items occurs, as it may be considered to be a loan and, therefore, it may constitute a benefit to the Participant on which additional income tax and National Insurance contributions (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">NICs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) may be payable. The Participant understands that he or she will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying to the Company and&#47;or the Employer (as appropriate) the amount of any NICs due on this additional benefit, which may also be recovered from the Participant by any of the means referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="text-align:center"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">24</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-top:4.1pt;padding-left:85.87pt;padding-right:85.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT B</font></div><div style="margin-top:0.15pt;padding-left:86.22pt;padding-right:86.22pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Baxter International Inc.</font></div><div style="padding-left:86.42pt;padding-right:86.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Incentive Compensation Recoupment Policy</font></div><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:10.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.0&#160;&#160;&#160;&#160;Introduction</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:10.75pt;padding-right:10.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">This policy applies to all cash bonuses paid by Baxter International Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;) and its subsidiaries under its 2007 Incentive Plan, or any successor Plan, and all grants of equity awarded by the Company to any person who is not designated as an officer by the Board of Directors of the Company. Cash bonuses and grants of equity made to such officers are covered by the Executive Compensation Recoupment Policy. Collectively such cash bonuses and equity awards will be referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Incentive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;. Equity awards are any compensatory awards under the company&#8217;s equity compensation plans in the form of common stock or any derivative of common stock, including stock options, stock awards, restricted stock, restricted stock units, and performance share units.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:46.8pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.3pt">Triggers&#59; Scope of Actions</font></div><div style="margin-top:9.65pt;padding-left:46.75pt;padding-right:14.3pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Following a restatement of the Company&#8217;s financial results requiring an amendment to any previously filed results, the Chairman and CEO (the &#8220;CEO&#8221;) will review the facts and circumstances that led to the requirement for the restatement and take any actions it deems appropriate with respect to Incentive Compensation. The CEO will consider whether an employee received compensation based on performance reported but not actually achieved or was accountable for the events that led to the restatement, including any misconduct.</font></div><div><font><br></font></div><div style="padding-left:46.8pt;padding-right:14.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">If an employee violates any of the restrictive covenants contained in any agreement between the employee and the Company, the Chairman and CEO will review the facts and circumstances related to the violation and take any actions it deems appropriate with respect to Incentive Compensation.</font></div><div><font><br></font></div><div style="padding-left:46.75pt;padding-right:13.7pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Actions that may be taken include&#58; recovery, reduction, or forfeiture of all or part of any Incentive Compensation previously provided or to be provided in the future&#59; disciplinary actions&#59; and the pursuit of any other remedies.</font></div><div style="margin-top:10.45pt;padding-left:10.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.0&#160;&#160;&#160;&#160;Documentation</font></div><div><font><br></font></div><div style="padding-left:10.75pt;padding-right:25.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Policy will apply to Equity Plans covering any employee beginning with the Company&#8217;s 2011 Equity Plans. In addition, this Policy will be incorporated into the Company&#8217;s Management Incentive Compensation Program (MICP) beginning with the Company&#8217;s 2011 MICP, as well as any resolutions adopted by the Board or Compensation Committee as a condition to approval of the payout of any cash bonus under the 2007 Incentive Plan, or any successor Plan, beginning with the cash bonuses paid by the Company in March 2012.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:4.1pt;padding-left:69.87pt;padding-right:69.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT B</font></div><div style="margin-top:2.55pt;padding-left:70.22pt;padding-right:70.22pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Baxter International Inc.</font></div><div style="margin-top:0.15pt;padding-left:133.92pt;padding-right:133.92pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:117%">Executive Compensation Recoupment Policy (As amended and restated on March 8, 2018)</font></div><div style="margin-top:0.1pt;text-align:center"><font><br></font></div><div style="margin-top:4.7pt;padding-left:12.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.0&#160;&#160;&#160;&#160;Introduction</font></div><div><font><br></font></div><div style="padding-left:11.55pt;padding-right:14.3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This policy (as amended and restated, this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) applies to all cash bonuses paid by Baxter International Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) under its 2007 Incentive Plan, or any successor Plan, and all grants of equity awarded by the Company to any person designated as an officer by the Board of Directors of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Collectively such bonuses and equity awards will be referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Executive Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;. Equity awards are any compensatory awards under the company&#8217;s equity compensation plans in the form of common stock or any derivative of common stock, including stock options, stock awards, restricted stock, restricted stock units, and performance share units. For the avoidance of doubt, this Policy shall apply to any person who is a designated officer either at the time of grant or the time of payment of the Executive Incentive Compensation.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:47.6pt;text-align:justify;text-indent:-35.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:21.45pt">Triggers&#59; Scope of Actions</font></div><div><font><br></font></div><div style="padding-left:48.35pt;padding-right:10.5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Following a restatement of the Company&#8217;s financial results requiring an amendment to any previously filed results, the Board will review the facts and circumstances that led to the requirement for the restatement and take any actions it deems appropriate with respect to Executive Incentive Compensation. The Board will consider whether an officer received compensation based on performance reported but not actually achieved or was accountable for the events that led to the restatement, including any misconduct.</font></div><div><font><br></font></div><div style="padding-left:48.35pt;padding-right:12.1pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">If an officer violates any of the restrictive covenants contained in any agreement between the officer and the Company, the Board will review the facts and circumstances related to the violation and take any actions it deems appropriate with respect to Executive Incentive Compensation.</font></div><div><font><br></font></div><div style="padding-left:48.4pt;padding-right:30.65pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:22.3pt">Actions the Board may take include&#58; recovery, reduction, or forfeiture of all or part of any Executive Incentive Compensation previously provided or to be provided in the future&#59; disciplinary actions&#59; and the pursuit of any other remedies.</font></div><div style="padding-right:16.5pt"><font><br></font></div><div style="padding-left:12.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.0&#160;&#160;&#160;&#160;Documentation</font></div><div><font><br></font></div><div style="padding-left:13.5pt;padding-right:5.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Policy will be incorporated into future Equity Plans covering any officer beginning with the Company&#8217;s 2009 Equity Plan as well as resolutions adopted by the Board or Compensation Committee as a condition to approval of the payout of any cash bonus under the 2007 Incentive Plan, or any successor Plan, to any officer beginning with the cash bonuses paid by the Company in March 2009. The Executive Compensation team will provide a copy of this Policy to each officer.</font></div><div style="padding-left:12.35pt"><font><br></font></div><div style="padding-left:12.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.0&#160;&#160;&#160;&#160;Disclosure</font></div><div><font><br></font></div><div style="padding-left:13.5pt;padding-right:7.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">In the event the Board recoups incentive compensation under this Policy, Company management intends to disclose the aggregate amount of incentive compensation recovered under this Policy, so long as the underlying event has already been publicly disclosed publicly by the Company. This disclosure would appear in the Company&#8217;s annual proxy statement following any such Board action and would provide the aggregate amount of recovery for each event if there is more than one applicable event.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:8.35pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:5.161%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">26</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>bax-20220331xex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i38194599f5f14638839e77048df11256_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">BAXTER INTERNATIONAL INC.<br>2021 INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><br>RESTRICTED STOCK UNIT AWARD GRANT NOTICE </font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Baxter International Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), pursuant to the Baxter International Inc. 2021 Incentive Plan, as may be amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), hereby grants to the holder listed below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) the number of Restricted Stock Units set forth below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The RSUs are subject to the terms and conditions set forth in this Restricted Stock Unit Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Restricted Stock Unit Award Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and the Plan, each of which is incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in the Grant Notice and the Agreement.</font></div><div style="padding-left:6.3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:27.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:70.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participant&#58; </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Participant ID&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Date of Grant&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Number of RSUs&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Vesting Schedule&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Applicable Recoupment Policy&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Incentive Compensation Recoupment Policy shall apply to Participants who are not designated officers of the Company and the Executive Compensation Recoupment Policy shall apply to all Participants who are designated officers of the Company either at the time of grant or vesting. Both polices are attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By accepting this Award electronically through the stock plan administrator&#8217;s online grant acceptance procedure, the Participant agrees to be bound by the terms and conditions of the Plan, the Agreement, and the Grant Notice. If the Participant does not accept this Award through the online acceptance process, the Participant&#8217;s Award will be canceled, and the Participant will not be entitled to any benefits from the Award or to any compensation or benefits in lieu of the canceled Award. The Participant has reviewed the Agreement, the Plan, and the Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing the Grant Notice and fully understands all provisions of the Grant Notice, the Agreement, and the Plan. The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan, the Grant Notice, or the Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If the Participant declines the Award, the Award will be canceled, and the Participant will not be entitled to any benefits from the Award or to any compensation or benefits in lieu of the canceled Award.</font></div><div id="i38194599f5f14638839e77048df11256_4"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pursuant to the Grant Notice to which this Agreement is attached, the Company has granted to the Participant the number of RSUs set forth in the Grant Notice. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:232%">ARTICLE I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%;padding-left:6.7pt"><br>GENERAL</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan or the Grant Notice. For purposes of this Agreement&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Delivery Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the date the Participant&#8217;s RSUs are settled in Shares, which shall be within a reasonable period of time following the Vesting Date and, in all cases, no later than 2 1&#47;2 months following the applicable Vesting Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the member of the Company Group that employs the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Qualifying Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a Termination of a Participant who is at least 65 years of age, or at least 55 years of age with at least 10 years of active continuous service with a member of the Company Group. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a date Shares are traded on the New York Stock Exchange or, if the Shares are not traded on the New York Stock Exchange, a date the Shares are traded or reported by an applicable automated quotation system or such other exchange or automated quotation system, if applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the applicable date(s) when the restrictions on the RSUs lapse as provided in the Grant Notice or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement. If RSUs would become earned and vested on a date that is not a Trading Day, the next Trading Day shall be the Vesting Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Incorporation of Terms of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The RSUs and the shares of Common Stock issued to the Participant hereunder (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) are subject to the terms and conditions set forth in this Agreement, the Grant Notice, and the Plan, which are incorporated herein by reference. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:232%">ARTICLE II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%;padding-left:2.04pt"><br>AWARD OF RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Award of RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In consideration of the Participant&#8217;s continued employment with or service to a member of the Company Group and for other good and valuable consideration, effective as of the Date of Grant, the Company has granted to the Participant the number of RSUs set forth in the Grant Notice, upon the terms and conditions set forth in the Grant Notice, the Plan, and this Agreement, subject to adjustment as provided in Section 12 of the Plan. Except as otherwise provided herein, each RSU represents the right to receive one Share at the times and subject to the conditions set forth herein. However, unless and until the RSUs have vested, the Participant will have no right to the payment of any Shares subject thereto. Prior to the actual delivery of any Shares, the RSUs will represent an unsecured obligation of the Company. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Vesting of RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Subject to the Participant&#8217;s continued employment with or service to a member of the Company Group on each applicable Vesting Date and subject to the terms of this Agreement, the RSUs shall vest in such amounts and at such times as are set forth in the Grant Notice or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Impact of Termination on RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event the Participant incurs a Termination prior to a Vesting Date set forth in the Grant Notice, then any unvested RSUs shall be canceled and forfeited, except as may be otherwise provided herein, in the Grant Notice, by the Committee or as set forth in a written agreement between the Participant and the Company or Employer. For the avoidance of doubt, a transfer of employment within the Company Group will not constitute a Termination.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Qualifying Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event the Participant incurs a Termination as a result of a Qualifying Retirement for any reason other than for Cause, or by reason of the Participant&#8217;s death or Disability, then (i)&#160;if the date of such Termination is after the calendar year of the Date of Grant, the RSUs will remain eligible for payout on the terms provided in the Grant Notice and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or (ii)&#160;if the date of such Termination is in the calendar year of the Date of Grant a pro-rata portion of the unvested RSUs shall remain eligible for payout on the terms provided in the Grant Notice and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For purposes of the foregoing, the pro-rata portion of the unvested RSUs shall be determined by multiplying (x) the Number of RSUs specified in the Grant Notice by (y) the percentage equal to the number of months worked in the applicable calendar year of the Date of Grant, rounded to the nearest whole month, divided by twelve (12). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event the Participant incurs a Termination as a result of the Participant&#8217;s death or Disability, any unvested RSUs shall vest as follows&#58; (i) if the date of such Termination is after the calendar year of the Date of Grant, all unvested RSUs shall immediately vest, or (ii) if the date of such Termination is in the calendar year of the Date of Grant, a pro-rata portion of the unvested RSUs shall immediately vest. For purposes of the foregoing, the pro-rata portion of the unvested RSUs that shall immediately vest shall be determined by multiplying (x) the Number of RSUs specified in the Grant Notice by (y) the percentage equal to the number of months worked in the applicable calendar year of the Date of Grant, rounded to the nearest whole month, divided by twelve (12). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">All Other Terminations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event the Participant incurs a Termination other than as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, except as may be otherwise provided herein or by the Committee or as set forth in a written agreement between the Participant and the Company or Employer, the Participant shall immediately forfeit any and all RSUs granted under this Agreement that have not vested or do not vest on or prior to the date on which such Termination occurs, and the Participant&#8217;s rights in any such RSUs that are not so vested shall lapse and expire.</font><font style="color:#0070c0;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Outside the United States</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For purposes of this Agreement, if the Participant is employed or providing services outside the United States, the Committee (or its delegate) may determine that the date the Participant incurs a Termination shall mean the date the Participant is no longer actively providing services to a member of the Company Group (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction in which the Participant is employed or providing services or the terms of the Participant&#8217;s employment agreement, if any) and that the Participant&#8217;s right to vest in the RSUs under the Plan, if any, will terminate as of such date and will not be extended by any notice period (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">e.g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">., the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction in which the Participant is employed or providing service or the terms of the Participant&#8217;s employment or service agreement, if any)&#59; the Committee (or its delegate) shall have the exclusive discretion to determine when the Participant is no longer actively providing services for purposes of the RSUs (including whether the Participant may still be considered to be providing services while on a leave of absence).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Impact of a Change in Control on RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event of a Change in Control, the treatment of RSUs shall be governed by Section 12(b) of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Settlement of RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt"> Except as otherwise provided herein (including Section 2.7), the Participant&#8217;s RSUs shall be settled in Shares (either in book-entry form or otherwise) on the Delivery Date applicable to the vested portion of the RSUs. Notwithstanding the foregoing, the Company may delay settlement of RSUs if it reasonably determines that such settlement will violate U.S. federal securities laws or any other applicable law, including non-U.S. laws, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such settlement shall be made at the earliest date at which the Company reasonably determines that the making of settlement will not cause such violation, as required by U.S. Treasury Regulation Section 1.409A-2(b)(7)(ii), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no settlement shall be delayed under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> if such delay will result in a violation of Code Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">All distributions shall be made by the Company in the form of whole Shares. Any fractional share may be distributed in cash or, at the discretion of the Committee, withheld to account </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">for Tax-Related Items (as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">). The value of a fractional share shall be determined based on the Fair Market Value as of the date(s) the RSUs vest.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Notwithstanding the foregoing, if the Participant is a resident or employed outside of the United States, the Company, in its sole discretion, may settle the RSUs in the form of a cash payment to the extent settlement in Shares&#58; (i)&#160;is prohibited under applicable law&#59; (ii)&#160;would require the Participant or a member of the Company Group to obtain the approval of any governmental and&#47;or regulatory body in the Participant&#8217;s country&#59; (iii)&#160;would result in adverse tax consequences for the Participant or a member of the Company Group&#59; or (iv)&#160;is administratively burdensome. Alternatively, the Company, in its sole discretion, may settle the RSUs in the form of Shares but require the Participant to sell such Shares immediately or within a specified period following the Participant&#8217;s Termination (in which case, this Agreement shall give the Company authorization to issue sales instructions on the Participant&#8217;s behalf).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">For the avoidance of doubt, this Award represents a right to receive Shares, and not a right to receive cash, and the Company shall only be authorized to deliver cash in settlement of all or any portion of the Award under the specific circumstances contemplated above in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or in connection with a transaction or event contemplated by Section 12 of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Conditions to Issuance of Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company shall not be required to issue or deliver any certificate or certificates for any Shares or to cause any Shares to be held in book-entry form prior to the fulfillment of all of the following conditions&#58; (a) the admission of the Shares to listing on all stock exchanges on which such Shares are then listed, (b) the completion of any registration or other qualification of the Shares under any U.S. state or federal law or under rulings or regulations of the U.S. Securities and Exchange Commission or other governmental regulatory body, which the Committee shall, in its absolute discretion, deem necessary or advisable, (c) the obtaining of any approval or other clearance from any U.S. state or federal governmental agency or non-U.S. regulatory agency that the Committee shall, in its absolute discretion, determine to be necessary or advisable, and (d) the receipt of full payment of any applicable Tax-Related Items in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> by the member of the Company Group with respect to which the applicable withholding obligation arises.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding any other provision of this Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.8pt">The provisions of Section 14(e) of the Plan are incorporated herein by reference and made a part hereof. The Participant acknowledges that he or she may be required to pay to the Company or, if different, the Employer, and that the Company, the Employer, or any Subsidiary shall have the right and are hereby authorized to withhold from any compensation or other amount owing to the Participant, applicable income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items (including taxes that are imposed on the Company or the Employer as a result of the Participant&#8217;s participation in the Plan but are deemed by the Company or the Employer to be an appropriate charge to the Participant) (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tax-Related Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), with respect to any issuance, transfer, or other taxable event under this Agreement or under the Plan and to take such action as may be necessary in the opinion of the Company to satisfy all obligations for the payment of such Tax-Related Items. The Participant further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including, but not limited to the grant, vesting and&#47;or settlement of the RSUs and the subsequent sale of Shares acquired upon settlement of the vested RSUs&#59; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve a particular tax result. Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.18pt">The Company shall withhold, or cause to be withheld, Shares otherwise vesting or issuable under the RSUs in satisfaction of any applicable tax withholding obligations, unless the Committee permits the Participant to elect to satisfy such obligations by (i) cash, wire transfer of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">immediately available funds or check&#59; (ii) delivering Shares (which are not subject to any pledge or other security interest) that have been held by the Participant for not less than six (6) months (or such other period as established from time to time by the Committee in order to avoid adverse accounting treatment applying GAAP) having a Fair Market Value equal to such withholding liability&#59; or (iii) if approved by the Committee, by delivery of a written or electronic notice that the Participant has placed a market sell order with a broker acceptable to the Company with respect to Shares then issuable upon settlement of the RSUs, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company in satisfaction of the aggregate applicable tax withholding obligations&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that payment of such proceeds is then made to the Company upon settlement of such sale in satisfaction of the applicable tax withholding obligations. Notwithstanding the foregoing, the Participant authorizes the Company to satisfy the applicable tax withholding obligations from proceeds of the sale of Shares issuable under the RSUs through a mandatory sale arranged by the Company (on the Participant&#8217;s behalf pursuant to this authorization) and&#47;or through withholding from any cash, other securities, or other property issuable or deliverable under any Award or from any compensation or other amounts owing to the Participant. If the obligation for Tax-Related Items is satisfied by withholding in Shares, the number of Shares that may be so withheld or surrendered shall be limited to the number of Shares that have a Fair Market Value on the date of withholding no greater than the aggregate amount of such obligations based on the maximum individual statutory withholding rates or other rates that will not have a negative accounting impact in the Participant&#8217;s applicable jurisdictions for U.S. federal, state, local and non-U.S. income tax and payroll tax purposes that are applicable to such taxable income, and the Participant is deemed to have been issued the full number of Shares subject to the vested RSUs, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items. The Participant acknowledges that, regardless of any action taken by the Company, the Employer, or any Subsidiary the ultimate liability for all Tax-Related Items, is and remains the Participant&#8217;s responsibility and may exceed the amount, if any, actually withheld by the Company or the Employer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Notwithstanding any other provision of this Agreement, the Company shall not be obligated to deliver any certificate representing Shares issuable with respect to the RSUs to, or to cause any such Shares to be held in book-entry form by, the Participant or the Participant&#8217;s legal representative unless and until the Participant or the Participant&#8217;s legal representative shall have paid the Tax-Related Items resulting from the grant, vesting or settlement of the RSUs or any other taxable event related to the RSUs. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Rights as Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Neither the Participant nor any Person claiming under or through the Participant will have any of the rights or privileges of a stockholder of the Company in respect of any Shares deliverable hereunder unless and until certificates representing such Shares (which may be in book-entry form) will have been issued and recorded on the records of the Company or its transfer agents or registrars and delivered to the Participant (including through electronic delivery to a brokerage account). Except as otherwise provided herein, after such issuance, recordation and delivery, the Participant will have all the rights of a stockholder of the Company with respect to such Shares, including, without limitation, the right to receipt of dividends and distributions on such Shares. From and after the Date of Grant and until the earlier of (a)&#160;the time when the Shares are delivered in settlement of the RSUs and (b)&#160;the time when the Participant&#8217;s right to receive Shares in settlement of the RSUs is forfeited, on the date that the Company pays a dividend (if any) to holders of Shares generally, the Participant shall be permitted to receive additional RSUs with respect to the RSUs based on the dividends and distributions paid on Shares to the same extent as if each RSU were a Share (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dividend Equivalent Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Such Dividend Equivalent Units (if any) shall be subject to the same terms and conditions, including payment timing, vesting and the obligation to satisfy any tax withholding obligations, in the same manner and at the same time as the RSUs to which the Dividend Equivalent Units relate.  For the avoidance of doubt, Dividend Equivalent Units shall not be eligible for the crediting of dividend equivalents or otherwise.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%">ARTICLE III.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NATURE OF GRANT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt">In accepting the grant of the RSUs, the Participant acknowledges, understands, and agrees that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended, or terminated by the Company at any time, to the extent permitted by the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the grant of the RSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of an award, or benefits in lieu of an award, even if RSUs have been granted in the past&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">all decisions with respect to future grants of RSUs or other grants, if any, will be at the sole discretion of the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the RSUs and the Shares subject to the RSUs, and the income from and value of same, are not intended to replace any pension rights or compensation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">the RSUs and the Shares subject to the RSUs, and the income from and value of same, are not part of normal or expected compensation for purposes of, including but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, holiday pay, long-service awards, pension or retirement or welfare benefits or similar payments&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">unless otherwise agreed with the Company in writing, the RSUs and the Shares subject to the RSUs, and the income from and value of same, are not granted as consideration for, or in connection with, the service the Participant may provide as a director of a Subsidiary&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs resulting from the Participant&#8217;s Termination (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">neither the Company nor the Employer shall be liable for any foreign exchange rate fluctuation between the Participant&#8217;s local currency and the United States Dollar that may affect the value of the RSUs or of any amounts due to the Participant pursuant to the settlement of RSUs or the subsequent sale of any Shares acquired upon settlement.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%">ARTICLE IV.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DATA PRIVACY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company is processing personal data of the Participant for purposes related to Plan administration services, based on the appropriate legal basis, depending on the Participant&#8217;s country, as stipulated in the HR Privacy Notice shared with the Participant and as in force. The Company further shares such data with its affiliates or processors, as appropriate, and only on a &#8220;need to know basis&#8221;. That may also include human resources personnel, certain executives, managers, and employees at other worldwide affiliates of the Company Group, who may have access to certain of the Participant&#8217;s personal data. Some of those recipients may be located or may have relevant operations outside of the Participant&#8217;s country, such as in the United States, where the data protection laws may not provide a level of protection </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">equivalent to the laws of the Participant&#8217;s country. The Company implements the appropriate legal, technical, and organizational measures and mechanisms in this regard. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For further information about the HR Privacy Notice and the processing of the Participant&#8217;s data in relation to the Plan, the Participant may contact local HR or send an email to&#58; privacy&#64;baxter.com.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%">ARTICLE V.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%">OTHER PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Committee (and its delegates) shall have the power to interpret the Plan, the Grant Notice, and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan, the Grant Notice, and this Agreement as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations and determinations made by the Committee will be final and binding upon the Participant, the Company, and all other interested Persons. To the extent allowable pursuant to applicable law, no member of the Committee or the Board will be personally liable for any action, determination or interpretation made with respect to the Plan, the Grant Notice, or this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">RSUs Not Transferable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The RSUs may not be sold, pledged, assigned, or transferred in any manner other than by will or the laws of descent and distribution, unless and until the Shares underlying the RSUs have been issued, and all restrictions applicable to such Shares have lapsed. No RSUs or any interest or right therein or part thereof shall be liable for the debts, contracts or engagements of the Participant or his or her successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no effect, except to the extent that such disposition is permitted by the preceding sentence. Notwithstanding the foregoing, with the consent of the Committee, the RSUs may be transferred as described in Section 14(b)(ii) of the Plan, pursuant to any such conditions and procedures the Committee may require.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant acknowledges that the RSUs and the Shares subject to the RSUs are subject to adjustment, modification and termination in certain events as provided in this Agreement and the Plan, including Section 12 of the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Cooperation&#59; Repatriation and Compliance Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant agrees to cooperate with the Company and the Employer in taking any action reasonably necessary or advisable to consummate the transactions contemplated by this Agreement. Further, the Participant agrees to repatriate all payments attributable to the RSUs in accordance with local foreign exchange rules and regulations in the Participant&#8217;s country of residence (and country of employment, if different). In addition, the Participant agrees to take any and all actions, and consents to any and all actions taken by the Employer, the Company and its Subsidiaries as may be required to allow the Employer, the Company and its Subsidiaries to comply with applicable law in the Participant&#8217;s country of residence (and country of employment, if different). Finally, the Participant agrees to take any and all actions that may be required to comply with the Participant&#8217;s personal legal and tax obligations under local laws, rules, and regulations in the Participant&#8217;s country of residence (and country of employment, if different).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Non-U.S. Addendum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding any provisions in this Agreement to the contrary, the RSUs shall be subject to any special terms and conditions set forth in the Non-U.S. Addendum to this Agreement for the Participant&#8217;s country of residence (and country of employment or service, if different). Moreover, if the Participant relocates to another country, any special terms and conditions for such country will apply to the Participant, to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable for legal or administrative reasons (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate the Participant&#8217;s transfer). The Non-U.S. Addendum constitutes part of this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For the purpose of the Plan and this Agreement, notices and all other communications shall be in writing and shall be deemed to have been duly given when delivered or mailed by overnight courier or United States registered mail, return receipt requested, postage prepaid (or similar foreign postal service), addressed to the Plan to the General Counsel, Baxter International Inc., One Baxter Parkway, Deerfield, Illinois 60015, USA and to the Participant to the address set forth in the Company&#8217;s payroll records or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines, in its sole discretion, it is necessary or advisable in order to comply with local law, rules and regulations or to facilitate the operation and administration of the RSUs and the Plan. Such requirements may include (but are not limited to) requiring the Participant to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant acknowledges that he or she is proficient in the English language, or has consulted with an advisor who is proficient in the English language, so as to enable the Participant to understand the provisions of this Agreement and the Plan. If the Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Electronic Delivery and Acceptance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company, in its sole discretion, may decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an online or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Titles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Governing Law&#59; Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Except to the extent preempted by US federal law, the laws of the State of Illinois, USA shall govern the interpretation, validity, administration, enforcement, and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws. For any legal action relating to this Agreement, the parties to this Agreement consent to the exclusive jurisdiction and venue of the federal courts in Chicago, Illinois.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Non-Competition, Non-Solicitation, and Confidentiality Agreement. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding any other provision in this Agreement or the Plan to the contrary, if determined to be applicable to the Participant in the Company&#8217;s sole discretion, any grant hereunder shall be cancelled and no Awards will vest, be settled, or be exercisable if the Participant does not accept, sign, date and return, as directed by the Company, a Non-Competition, Non-Solicitation and Confidentiality Agreement, in such form as determined by the Company, within sixty (60) days of being provided a copy of such agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Repayment of Proceeds&#59; Clawback and Offset Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Shares underlying the RSUs and all proceeds related to such Shares are subject to the Company&#8217;s Incentive Compensation Recoupment Policy or Executive Compensation Recoupment Policy, as specified in the Grant Notice, which are attached to the Grant Notice as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Additionally, where applicable, if (i) the Participant&#8217;s employment with the Company Group terminates for any reason and (ii) such Participant violates (either during and&#47;or after employment with the Company Group) the terms of the Participant&#8217;s Non-Competition, Non-Solicitation and Confidentiality Agreement as described in and required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then any Awards that have not vested or are not exercisable as of the Termination date (including any Awards that would later be settled as a result of a Qualifying Retirement) shall be cancelled and shall not vest, be settled or be exercisable. Furthermore, any Awards that have vested or became exercisable within the 12 months preceding the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Termination date shall be forfeited and shall be returned to the Company, and any Awards that vested after the Termination date as a result of a Qualifying Retirement shall be forfeited. If the Participant has exercised any such Awards or sold any Shares underlying Awards, then the Participant shall make a cash payment to the Company in an amount equal to the amount of the net gain recognized from the exercise of such Awards or sale of such Shares within 30 business days of written notice by the Company to the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Conformity to Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant acknowledges that the Plan, the Grant Notice, and this Agreement, are intended to conform to the extent necessary with all applicable laws, including, without limitation, the provisions of the Securities Act and the Exchange Act, and any and all regulations and rules promulgated thereunder by the Securities and Exchange Commission, and other applicable securities laws and regulations. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the RSUs are granted, only in such a manner as to conform to applicable laws. To the extent permitted by applicable laws, the Plan, the Grant Notice, and this Agreement, shall be deemed amended to the extent necessary to conform to applicable laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Amendment, Suspension and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Committee or the Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">, provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, except as may otherwise be provided by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the RSUs in any material way without the prior written consent of the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement and the Plan, this Agreement shall be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Limitations Applicable to Section 16 Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding any other provision of the Plan or this Agreement, if the Participant is subject to Section 16 of the Exchange Act, the Plan, the RSUs, the Grant Notice, and this Agreement shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by applicable laws, this Agreement shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Not a Contract of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Nothing in this Agreement or in the Plan shall confer upon the Participant any right to continue to serve as an employee of any member of the Company Group or shall interfere with or restrict in any way the rights of any member of the Company Group, which rights are hereby expressly reserved, to discharge or terminate the services of the Participant at any time for any reason whatsoever, with or without cause, except to the extent (i) expressly provided otherwise in a written agreement between a Member of the Company Group and the Participant or (ii) where such provisions are not consistent with applicable foreign or local laws, in which case such applicable foreign or local laws shall control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Plan, the Grant Notice, and this Agreement (including the Addenda attached&#160;hereto) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and the Participant with respect to the subject matter hereof.  Except as specifically provided in the Grant Notice or this Agreement, in the event of any inconsistency between the Plan, the Grant Notice or this Agreement, the Plan will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The intent of the parties is that the payments and benefits under this Agreement comply with or be exempt from Code Section 409A and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith or otherwise exempt. The Company may unilaterally amend the terms of this Agreement (or the Plan) to avoid the application of, or to comply with, Code Section 409A, in a particular circumstance or as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">necessary or desirable to satisfy any of the requirements under Code Section 409A or to mitigate any additional tax, interest and&#47;or penalties that may apply under Code Section 409A if exemption or compliance is not practicable, but the Company or the Participant shall not be under any obligation to make any such amendment. Nothing in this Agreement (or the Plan) shall provide a basis for any person to take action against the Company or any Subsidiary based on matters covered by Code Section 409A, including the tax treatment of any amount paid under the Agreement, and neither the Company nor any of its Subsidiaries shall under any circumstances have any liability to the Participant or his estate or any other party for any taxes, penalties or interest due on amounts paid or payable under this Agreement, including taxes, penalties or interest imposed under Code Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without limiting the generality of the foregoing and anything in the Agreement to the contrary notwithstanding, if RSUs payable on or by reference to the timing of the Participant&#8217;s Termination constitute non-qualified deferred compensation subject to Section 409A, as determined in the Company&#8217;s sole discretion, such RSUs shall not be paid unless and until the Participant experiences a &#8220;separation from service&#8221; (within the meaning of Code Section 409A), and if the Participant is a &#8220;specified employee&#8221; (within the meaning of Code Section 409A) as of the date of the separation from service (as determined in accordance with the methodology established by the Company as in effect on the date of Termination), shall instead be paid to the Participant on the first business day that immediately follows the earlier of (i)&#160;the date that is six (6) months following the date of the Participant&#8217;s separation from service or (ii) the date of the Participant&#8217;s death, to the extent such delayed payment is otherwise required in order to avoid a prohibited distribution under Code Section 409A(a)(2).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Agreement Severable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event that any provision of the Grant Notice or this Agreement is held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of the Grant Notice or this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Limitation on the Participant&#8217;s Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Participation in the Plan confers no rights or interests other than as herein provided. This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust. Neither the Plan nor any underlying program, in and of itself, has any assets. The Participant shall have only the rights of a general unsecured creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the RSUs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Grant Notice may be executed in one or more counterparts, including by way of any electronic signature, subject to applicable law, each of which shall be deemed an original and all of which together shall constitute one instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Private Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If the Participant is a resident outside the United States, the grant of the RSUs is not intended to be a public offering of securities in the Participant&#8217;s country of residence (and country of employment, if different). The Company has not submitted any registration statement, prospectus, or other filing with the local securities authorities with respect to the grant of the RSUs unless otherwise required under local law. No employee of the Company is permitted to advise the Participant on whether the Participant should acquire Shares under the Plan or provide the Participant with any legal, tax or financial advice with respect to the grant of the RSUs. Investment in Shares involves a degree of risk. Before deciding to acquire Shares pursuant to the RSUs, the Participant should carefully consider all risk factors and tax considerations relevant to the acquisition of Shares under the Plan or the disposition of them. Further, the Participant should carefully review all of the materials related to the RSUs and the Plan, and the Participant should consult with the Participant&#8217;s personal legal, tax and financial advisors for professional advice in relation to the Participant&#8217;s personal circumstances.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Exchange Control, Foreign Asset&#47;Account and&#47;or Tax Reporting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant acknowledges that there may be certain exchange control, foreign asset&#47;account and&#47;or tax reporting requirements that may affect the Participant&#8217;s ability to acquire or hold Shares or cash received from participating in the Plan (including the receipt of any dividends paid on Shares and the proceeds from the sale of Shares) in a brokerage or bank account outside the Participant&#8217;s country. The Participant may be required to report such accounts, assets or related transactions to the tax or other authorities in the Participant&#8217;s country. The Participant also may be required to repatriate sale proceeds or other funds </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">received as a result of participating in the Plan to the Participant&#8217;s country within a certain time after receipt. The Participant acknowledges that it is the Participant&#8217;s responsibility to comply with such regulations and that the Participant should speak to his or her personal advisor on this matter. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.26</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Insider Trading&#47;Market Abuse</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant may be subject to insider trading restrictions and&#47;or market abuse laws based on the exchange on which the Shares are listed and in applicable jurisdictions, including the United States, the Participant&#8217;s country and the designated broker&#8217;s country (including any Company Group securities trading policy), which may affect the Participant&#8217;s ability to accept, acquire, sell or otherwise dispose of Shares, rights to Shares (e.g., the RSUs) or rights linked to the value of Shares under the Plan during such times that the Participant is considered to have &#8220;inside information&#8221; regarding the Company (as defined by the laws or regulations in the Participant&#8217;s country). Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Participant acknowledges that it is the Participant&#8217;s responsibility to comply with any applicable restrictions and that the Participant should speak to his or her personal advisor on this matter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.27</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The waiver by the Company with respect to the Participant&#8217;s (or any other participant&#8217;s) compliance of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by such party of a provision of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.28</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Consent and Agreement With Respect to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> The Participant (a)&#160;acknowledges that a copy of the Plan and the U.S. prospectus for the Plan has been available to the Participant&#59; (b)&#160;represents that he or she has read and is familiar with the terms and provisions thereof, has had an opportunity to obtain the advice of counsel of his or her choice prior to executing this Agreement and fully understands all provisions of this Agreement and the Plan&#59; (c) accepts the RSUs subject to all of the terms and provisions thereof&#59; and (d) agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan or this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:152%">To the extent that the Company has established, either itself or through a third-party plan administrator, the ability to accept this award electronically, such acceptance shall constitute the Participant&#8217;s signature hereof.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:152%">Company&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Participant&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:152%">____________________                                                &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_____________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:152%">By&#58; Sven Skillrud</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:152%">Title&#58; Vice President, Total Rewards</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">* * * * *</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div></div></div><div id="i38194599f5f14638839e77048df11256_7"></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">ADDENDUM</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:700;line-height:133%;position:relative;top:-3.85pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">TO</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">THE RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">FOR NON-U.S. PARTICIPANTS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In addition to the terms of the Plan, the Grant Notice, and the Agreement, the RSUs are subject to the following additional terms, conditions, and provisions (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-U.S. Addendum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). All capitalized terms as contained in this Non-U.S. Addendum shall have the same meaning as set forth in the Plan, the Grant Notice and&#47;or the Agreement. Pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement, if the Participant transfers residence and&#47;or employment or service to another country reflected in this Non-U.S. Addendum, the special terms, conditions and provision for such country will apply to the Participant to the extent the Company determines, in its sole discretion, that the application of such terms, conditions and provisions is necessary for legal or administrative reasons (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate the Participant&#8217;s transfer).</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">AUSTRALIA</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) applies (subject to the conditions in that Act). </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Australia Offer Document</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This grant of RSUs is intended to comply with the provisions of the Corporations Act 2001, Australia Securities and Investments Commission (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ASIC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) Regulatory Guide 49 and ASIC Class Order CO 14&#47;1000. Additional details are set forth in the Australia Offer Document, a copy of which is attached to the end of this section for Australia as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Annex 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:10pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">ANNEX 1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">OFFER DOCUMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Baxter International Inc.<br>2021 Incentive Plan</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">OFFER OF RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TO AUSTRALIAN RESIDENT EMPLOYEES</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company is pleased to provide the Participant with this offer to participate in the Plan. This offer sets out information regarding the grant of RSUs to Australian resident employees of the Company and its parents, Subsidiaries and Subsidiaries (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Australian Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). This information is provided by the Company to ensure compliance of the Plan with Australian Securities and Investments Commission (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ASIC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) Class Order 14&#47;1000 and relevant provisions of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Corporations Act 2001</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In addition to the information set out in the Agreement and the Non-U.S. Addendum, Australian Participants are also being provided with copies of the following documents&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">the Plan&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">the Plan prospectus&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">Employee Information Supplement for Australia (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Additional Documents provide further information to help Australian Participants make an informed investment decision about participating in the Plan. Neither the Plan nor the Plan prospectus is a prospectus for the purposes of the Corporations Act 2001. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Australian Participants should not rely upon any oral statements made in relation to this offer. Australian Participants should rely only upon the statements contained in the Agreement, including the Non-U.S. Addendum, and the Additional Documents when considering participation in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Investment in Shares involves a degree of risk. Eligible employees who elect to participate in the Plan should monitor their participation and consider all risk factors relevant to the acquisition of Shares under the Plan as set forth below and in the Additional Documents.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The information herein is general information only. It is not advice or information that takes into account Australian Participants&#8217; objectives, financial situation and needs.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Australian Participants should consider obtaining their own financial product advice from a person who is licensed by ASIC to give such advice.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Additional Risk Factors for Australian Residents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Australian Participants should have regard to risk factors relevant to investment in securities generally and, in particular, to holding Shares. For example, the price at which an individual Share is quoted on The New York Stock Exchange (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">NYSE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) may increase or decrease due to a number of factors. There is no guarantee that the price of a Share will increase. Factors that may affect the price of an individual Share include fluctuations in the domestic and international market for listed stocks, general economic conditions, including interest rates, inflation rates, commodity and oil prices, changes to government fiscal, monetary or regulatory policies, legislation or regulation, the nature of the markets in which the Company operates and general operational and business risks.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">More information about potential factors that could affect the Company&#8217;s business and financial results will be included in the Company&#8217;s most recent Annual Report on Form 10-K and the Company&#8217;s Quarterly Report on Form 10-Q. Copies of these reports are available at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">http&#58;&#47;&#47;www.sec.gov&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, on the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Company&#8217;s investor&#8217;s page at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;investor.baxter.com&#47;investors&#47;investor-overview&#47;default.aspx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and upon request to the Company.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In addition, Australian Participants should be aware that the Australian dollar (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">AUD</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) value of any Shares acquired under the Plan will be affected by the USD&#47;AUD exchange rate. Participation in the Plan involves certain risks related to fluctuations in this rate of exchange.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Common Stock in a U.S. Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Common stock of a U.S. corporation is analogous to ordinary shares of an Australian corporation. Each holder of a Share is entitled to one vote. Dividends may be paid on the Shares out of any funds of the Company legally available for dividends at the discretion of the Board. Further, Shares are not liable to any further calls for payment of capital or for other assessment by the Company and have no sinking fund provisions, pre-emptive rights, conversion rights or redemption provisions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Ascertaining the Market Price of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Australian Participants may ascertain the current market price of an individual Share as traded on NYSE under the symbol &#8220;BAX&#8221; at&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;www.nyse.com&#47;quote&#47;XNYS&#58;BAX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The AUD equivalent of that price can be obtained at&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;www.rba.gov.au&#47;statistics&#47;frequency&#47;exchange-rates.html</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Please note that this is not a prediction of what the market price of the Shares will be on any applicable Vesting Date or when Shares are issued to Australian Participants (or at any other time), or of the applicable exchange rate at such time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">BRAZIL</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with the Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. By accepting the RSUs, the Participant acknowledges his or her agreement to comply with applicable Brazilian laws and to pay any and all applicable Tax-Related Items.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This provision supplements Article III (&#8220;Nature of Grant&#8221;) of the Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By accepting the RSUs, the Participant agrees that (i) the Participant is making an investment decision and (ii) the value of the underlying Shares is not fixed and may increase or decrease over the vesting period without compensation to the Participant. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">CANADA</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement of RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This provision supplements </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement, the RSUs do not provide any right for the Participant to receive a cash payment and the RSUs will be settled only in Shares. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Forfeiture upon Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This provision supplements </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of the RSUs, notwithstanding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement, the Committee or its delegate may provide that the Participant&#8217;s Termination will occur as of the date the Participant is no longer actually employed or otherwise rendering services to the Service Recipient (regardless of the reason for such Termination and whether or not later found to be invalid or in breach of employment or other laws or otherwise rendering services or the terms of the Participant&#8217;s employment or other service agreement, if any). In such case, unless otherwise provided in the Agreement or extended by the Company, the Participant&#8217;s right to vest in the RSUs under the Plan, if any, will terminate as of such date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Termination Date will not be extended by any common law notice period. Notwithstanding the foregoing, however, if applicable employment standards legislation specifically requires continued entitlement to vesting during a statutory notice period, the Participant&#8217;s right to vest in the RSUs under the Plan, if any will be allowed to continue for that minimum notice period but then immediately terminate effective as of the last day of the Participant&#8217;s minimum statutory notice period. In the event the date the Participant is no longer providing actual service cannot be reasonably determined under the terms of the Agreement and&#47;or the Plan, the Committee or its delegate shall have the exclusive discretion to determine when the Participant is no longer actively providing services for purposes of the RSUs (including whether the Participant may still be considered to be providing services while on a leave of absence). Unless the applicable employment standards legislation specifically requires, in the case of the Participant, the Participant will not earn or be entitled to any pro-rated vesting for that portion of time before the date on which his service relationship is terminated (as determined under this provision) nor will the Participant be entitled to any compensation for lost vesting. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant may not be permitted to sell within Canada Shares acquired under the Plan. The Participant may only be permitted to sell or dispose of any Shares acquired under the Plan if such sale or disposal takes place outside of Canada through the facilities of a stock exchange on which the Shares are listed (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">i.e.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the New York Stock Exchange).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">CHILE</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The offer of RSUs refers to securities not registered in the Registry of Securities or in the Registry of Foreign securities of the Chilean Commission for the Financial Market, and therefore&#58; (i) the Shares shall not be subject to public offering in Chile&#59; and (ii) the Company is not subject to the oversight of the Chilean Commission for the Financial Market nor to the continual information obligations that Chilean law and regulations require from registered issuers.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">CHINA</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The following provisions apply only to the Participants who are subject to exchange control restrictions imposed by the State Administration of Foreign Exchange (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SAFE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), as determined by the Company in its sole discretion&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting of RSUs</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant&#8217;s Employer must be registered with SAFE prior to settlement of the RSUs. If the Company is unable to obtain registration approval or is required to obtain further approvals on behalf of a member of the Company Group, the vesting or settlement of the RSUs may be suspended or delayed. Further, the Company is under no obligation to vest the RSUs and&#47;or issues Shares if the Company&#8217;s SAFE approval becomes invalid or ceases to be in effect by the time the RSUs vest. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant acknowledges and agrees that he or she must sell any Shares issued to him or her upon settlement of the RSUs as soon as practicable following the Participant&#8217;s Termination and in no event later than six (6) months following the Participant&#8217;s Termination. The Participant agrees that if he or she continues to hold any of such Shares after this time, the Shares may be sold by the Company&#8217;s designated broker on the Participant&#8217;s behalf at the instruction of the Corporation. Therefore, by accepting the RSUs, the Participant understands and agrees that the Company is authorized to, and may in its sole discretion, instruct its designated broker to assist with the mandatory sale of Shares (on the Participant&#8217;s behalf pursuant to this authorization) and that the Participant expressly authorizes the Company&#8217;s designated broker to complete the sale of such Shares. The Participant acknowledges that the Company&#8217;s designated broker is under no obligation to arrange for the sale of the Shares at any particular price. Upon the sale of the Shares, the proceeds, less any Tax-Related Items and brokerage fees or commissions will be remitted to the Participant pursuant to the procedures described in the &#8220;Exchange Control Information&#8221; section below.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Control Information</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Shares issued to the Participant under the Plan must be maintained in an account with E*TRADE Corporate Financial Services Inc. or such other broker as may be designated by the Company until the Shares are sold through that broker. If the Company changes its broker, the Participant acknowledges and agrees that the Company may transfer any Shares issued under the Plan to the new designated broker if necessary for legal or administrative reasons. The Participant agrees to sign any documentation necessary to facilitate the transfer. In addition, the Participant may be required to sell any Shares obtained under the Plan if the Company determines that the application of such condition is necessary or advisable for China SAFE exchange control, legal or other administrative reasons.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant understands and agrees that, to facilitate compliance with exchange control requirements, the Participant will be required to immediately repatriate to China the cash proceeds from the sale of Shares acquired upon vesting of the RSUs or from any dividends. The Participant further understands that, under local law, such repatriation of the cash proceeds will be effectuated through a special exchange control account established by the Company or one of its Subsidiaries in China, and the Participant hereby consents and agrees that the cash proceeds related to the Participant&#8217;s participation in the Plan may be transferred to such special account prior to being delivered to the Participant. The Company may deliver the proceeds to the Participant in U.S. dollars or local currency at the Company&#8217;s discretion. If the proceeds are paid in U.S. dollars, the Participant understands that he or she will be required to set up a U.S. dollar bank account in China so that the proceeds may be deposited into this account. If the proceeds are converted to local currency, there may be delays in delivering the proceeds to the Participant. The Participant agrees to bear the risk of any currency fluctuation between the time the Shares are sold, either through voluntary sale or through a mandatory sale arranged by the Company, or proceeds are otherwise realized under the Plan and the time such proceeds are distributed to the Participant through the special exchange control account.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant further agrees to comply with any other requirements that may be imposed by the Company in the future to facilitate compliance with exchange control requirements in China.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">COLOMBIA</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This provision supplements Article III (&#8220;Nature of Grant&#8221;) of the Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant acknowledges that, pursuant to Article 128 of the Colombian Labor Code, the RSUs and related benefits do not constitute a component of the Participant&#8217;s &#8220;salary&#8221; for any legal purpose. Therefore, the RSUs and related benefits will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as legal&#47;fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions and&#47;or any other labor-related amount which may be payable.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Shares are not and will not be registered in the Colombian registry of publicly traded securities (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Registro Nacional de Valores y Emisores</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) and, therefore, the Shares may not be offered to the public in Colombia. Nothing in this document should be construed as the making of a public offer of securities in Colombia.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">FRANCE</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Terms and Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Consent to Receive Information in English</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In accepting this award, the Participant confirms having read and understood the documents relating to this grant (the Plan and this Agreement), which were provided in the English language. The Participant accepts the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Consentement &#224; recevoir des informations en anglais</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">. En acceptant l'attribution, le participant confirme ainsi avoir lu et compris les documents relatifs &#224; cette attribution (le Plan U.S. et ce Contrat d&#8217;Attribution) qui ont &#233;t&#233; communiqu&#233;s en langue anglaise. Le participant accepte les termes en connaissance de cause.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">The following provisions apply only if the Participant is eligible to be granted a French-qualified Restricted Stock Unit (&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">French-qualified RSU</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#34;) under the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Rules of the Baxter International Inc. 2021 Incentive Plan for Stock Options and Restricted Stock Units Granted to Participants in France (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">French Sub-Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#8221;). If the Participant is ineligible to be granted a French-qualified RSU under the French Sub-Plan, the grant will not qualify for the special French tax and social security treatment under Sections L. 225-197-1 to L. 225-197-5 and Sections L. 22-10-59 to L. 22-10-60 of the French Commercial Code, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Type of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Restricted Stock Units are granted as French-qualified RSUs and are intended to qualify for special tax and social security treatment applicable to shares granted for no consideration under Sections L. 225-197-1 to L. 225-197-5 and Sections L. 22-10-59 to L. 22-10-60 of the French Commercial Code, as amended. The French-qualified RSUs are subject to the provisions below and the French Sub-Plan, which has been provided to the Participant and is incorporated herein. Capitalized terms below not otherwise defined in the Agreement and the Plan shall have the same definitions assigned to them in the French Sub-Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Certain events may affect the status of the Restricted Stock Units as French-qualified RSUs or the underlying Shares, and the French-qualified RSUs or the underlying Shares may be disqualified in the future. The Company does not make any undertaking or representation to maintain the qualified status of the French-qualified RSUs or of the underlying Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Termination Due to Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding anything in the Plan or the Agreement, in the event of the Participant&#8217;s Termination due to death prior to the satisfaction of the vesting conditions set forth in the vesting schedule of the Grant Notice, any portion of the French-qualified RSUs that has not vested as of such date shall become immediately transferable to the Participant&#8217;s heirs. The Company shall issue the Shares to the Participant&#8217;s heirs, at their request, provided the heirs contact the Company and request such transfer of the Shares within six (6) months following the Participant&#8217;s death. If the Participant&#8217;s heirs do not request the issuance of the Shares underlying the French-qualified RSUs within six (6) months after the Participant&#8217;s death, the French-qualified RSUs will be forfeited. The Participant&#8217;s heirs shall not be subject to the restrictions on the transfer of Shares set forth in Section III.1(b) of the French Sub-Plan. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Non-Transferability of French-qualified RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The French-qualified RSUs may not be sold, assigned, transferred, pledged, hypothecated or otherwise disposed of in any manner during the Participant&#8217;s lifetime, and upon death only in accordance with the French Sub-Plan, and only to the extent required by applicable laws (including the provisions of Sections L. 225-197-1 to L. 225-197-5 and Sections L. 22-10-59 to L. 22-10-60 of the French Commercial Code, as amended).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Minimum Vesting Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding anything to the contrary in this Agreement or the Plan, save in the case of death of the Participant, the French-qualified RSUs may not be settled before the first (1st) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">annual anniversary of the Grant Date (as defined in the French Sub-Plan) or such other period as is required to comply with the minimum mandatory vesting period applicable to Shares underlying French-qualified RSUs under Section L. 225-197-1 of the French Commercial Code, as amended, or by the French Tax Code or French Social Security Code, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Mandatory Holding Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding anything to the contrary in this Agreement or the Plan, any Shares issued to the Participant upon settlement of the French-qualified RSUs must be held (and cannot be sold or transferred) until the expiration of a period which can be no less than two years from the Grant Date (as defined in the French Sub-Plan), or such other period as is required to comply with the minimum mandatory holding period applicable to Shares underlying French-qualified RSUs under Section L. 225-197-1 of the French Commercial Code, as amended, or by the French Tax Code or French Social Security Code, as amended&#59; provided that if the Participant dies or Terminates due to Disability (as defined in the French Sub-Plan), this mandatory holding period will not apply. To enforce this provision, the Company may, in its discretion, issue appropriate &#8220;stop transfer&#8221; instructions to its transfer agent or hold the Shares until the expiration of the holding period set forth above (such Shares may be held by the Company, a transfer agent designated by the Company or with a broker designated by the Company).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Closed Periods</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participant may not sell any Shares issued upon vesting of the French-qualified RSUs during certain Closed Periods, to the extent applicable to the Shares underlying the French-qualified RSUs granted by the Company, as described in the French Sub-Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Holding Periods for Managing Corporate Officers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If on the Grant Date (as defined in the French Sub-Plan), Participant qualifies as a managing corporate officer under French law (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">mandataires sociaux</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) or any similar official capacity of the Company or a Subsidiary, the Participant may not sell 20% of the Shares acquired upon settlement of the French-qualified RSUs until the termination of such official capacity, as long as this restriction is applicable to French-qualified RSUs.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notifications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If the Participant is a French resident and holds Shares outside of France or maintains a foreign bank account, the Participant is required to report such account opened, held, used or closed abroad during all or part of an applicable fiscal year to the French tax authorities when filing the Participant&#8217;s tax return.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">HONG KONG</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Important Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Securities Warning</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58; The contents of the Grant Notice, the Agreement, this Non-U.S. Addendum, the Plan, and all other materials pertaining to the RSUs and&#47;or the Plan have not been reviewed by any regulatory authority in Hong Kong. The Participant is hereby advised to exercise caution in relation to the offer thereunder. If the Participant has any doubts about any of the contents of the aforesaid materials, the Participant should obtain independent professional advice. The RSUs and any Shares issued in respect of the RSUs do not constitute a public offering of securities under Hong Kong law and are available only to eligible employees under the Plan. The Grant Notice, the Agreement, including this Non-U.S. Addendum, the Plan and other incidental communication materials have not been prepared in accordance with and are not intended to constitute a &#8220;prospectus&#8221; for a public offering of securities under the applicable securities legislation in Hong Kong. The RSUs and any documentation related thereto are intended solely for the Participant&#8217;s personal use and may not be distributed to any other person.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If, for any reason, Shares are issued to the Participant within six (6) months of the Date of Grant, the Participant agrees that he or she will not sell or otherwise dispose of any such Shares prior to the six-month anniversary of the Date of Grant.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding anything to the contrary in this the Grant Notice, the Agreement, this Non-U.S. Addendum or the Plan, the RSUs shall be settled only in Shares (and may not be settled in cash).</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">INDONESIA</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Language Consent </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By accepting the RSUs, the Participant (i) confirms having read and understood the documents relating to the grant (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Plan and the Agreement) which were provided in the English language, (ii) accepts the terms of those documents accordingly, and (iii) agrees not to challenge the validity of this document based on Law No. 24 of 2009 on National Flag, Language, Coat of Arms and National Anthem or the implementing Presidential Regulation (when issued).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Persetujuan Bahasa</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Dengan menerima pemberian Unit Saham Terbatas, anda (i) memberikan konfirmasi bahwa anda telah membaca dan memahami dokumen-dokumen berkaitan dengan pemberian ini (yaitu, Program dan Perjanjian) yang disediakan dalam Bahasa Inggris, (ii) menerima persyaratan di dalam dokumen-dokumen tersebut, dan (iii) setuju untuk tidak mengajukan keberatan atas keberlakuan dari dokumen ini berdasarkan Undang-Undang No. 24 Tahun 2009 tentang Bendera, Bahasa dan Lambang Negara serta Lagu Kebangsaan ataupun Peraturan Presiden sebagai pelaksanaannya (ketika diterbitkan).</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">ISRAEL</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement of RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The following provision supplements </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If Shares are delivered to the Participant pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement, the Company reserves the right to require that the Participant sell all Shares underlying the RSUs, either immediately upon receipt of such Shares or upon the Participant&#8217;s Termination, to facilitate compliance with tax withholding obligations in Israel. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In this regard, the Participant agrees that the Company is authorized to instruct its designated broker to assist with any such mandatory sale of Shares (on the Participant&#8217;s behalf pursuant to this authorization), and the Participant expressly authorizes the designated broker to complete the sale of such Shares. The Participant also agrees to sign any agreements, forms and&#47;or consents that may be reasonably requested by the Company (or the designated broker) to effectuate the sale of the Shares and shall otherwise cooperate with the Company with respect to such matters, provided that the Participant shall not be permitted to exercise any influence over how, when or whether the sales occur. The Participant acknowledges that the designated broker is under no obligation to arrange for the sale of the Shares at any particular price. Due to fluctuations in the Share price and&#47;or applicable exchange rates between the date the Shares are delivered to the Participant and (if later) the date on which the Shares are sold, the amount of proceeds ultimately distributed to the Participant may be more or less than the market value of the Shares on the Vesting Date or the date the shares are delivered to the Participant. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Upon the sale of the Shares, the cash proceeds from the sale of Shares (less any applicable Tax-Related Items, brokerage fees or commissions) will be delivered to the Participant in accordance with applicable laws and regulations.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This offer of RSUs does not constitute a public offering under the Securities Law, 1968. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">ITALY</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan Document Acknowledgment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By accepting the RSUs, the Participant acknowledges that he or she has received a copy of the Plan, the Agreement and the Notice and has reviewed the Plan, the Agreement, including this Non-U.S. Addendum, and the Grant Notice in their entirety and fully understands and accepts all provisions of the Plan, the Agreement, including this Non-U.S. Addendum, and the Grant Notice.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant further acknowledges that he or she has read and specifically and expressly approves the following provisions of the Agreement&#58; (i) Impact of Termination on RSUs&#59; (ii)&#160;Distribution or Payment of RSUs&#59; (iii) Tax Withholding&#59; (iv) Governing Law&#59; Venue&#59; (v) Electronic Delivery and Acceptance&#59; (vi) the Nature of Grant&#59; (vii) Data Privacy and (vii) the Vesting Schedule in the Grant Notice.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">MEXICO</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan Document Acknowledgement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By accepting the RSUs, the Participant acknowledges that he or she has received a copy of the Plan, the Grant Notice, and the Agreement, including this Non-U.S. Addendum, which the Participant has reviewed. The Participant acknowledges further that he or she accepts all the provisions of the Plan, the Grant Notice, and the Agreement, including this Non-U.S. Addendum. The Participant also acknowledges that he or she has read and specifically and expressly approves the terms and conditions set forth in Article III (&#8220;Nature of Grant&#8221;) in the Agreement, which clearly provides as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;The Participant&#8217;s participation in the Plan does not constitute an acquired right&#59; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;The Plan and the Participant&#8217;s participation in it are offered by the Company on a wholly discretionary basis&#59; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;The Participant&#8217;s participation in the Plan is voluntary&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;No member of the Company Group is responsible for any decrease in the value of any Shares acquired at vesting and settlement of the RSUs. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Labor Law Policy and Acknowledgment</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By accepting the RSUs, the Participant expressly recognizes that the Company, with registered offices at One Baxter Parkway, Deerfield, Illinois, 60015, USA, is solely responsible for the administration of the Plan and that the Participant&#8217;s participation in the Plan and acquisition of Shares do not constitute an employment relationship between the Participant and the Company since the Participant is participating in the Plan on a wholly commercial basis and his or her sole employer is Baxter M&#233;xico, S. de R.L de C MEX (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Baxter Mexico</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Based on the foregoing, the Participant expressly recognizes that the Plan and the benefits that he or she may derive from participating in the Plan do not establish any rights between the Participant and the employer, Baxter Mexico, and do not form part of the employment conditions and&#47;or benefits provided by Baxter Mexico, and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of the Participant&#8217;s employment.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant further understands that his or her participation in the Plan is as a result of a unilateral and discretionary decision of the Company&#59; therefore, the Company reserves the absolute right to amend and&#47;or discontinue the Participant&#8217;s participation at any time without any liability to the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finally, the Participant hereby declares that he or she does not reserve to him- or herself any action or right to bring any claim against the Company for any compensation or damages regarding any provision of the Plan or the benefits derived under the Plan, and the Participant therefore grants a full and broad release to the Company, and its subsidiaries, branches, representative offices, shareholders, directors, officers, employees, agents, or legal representatives with respect to any claim that may arise.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Spanish Translation</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Reconocimiento del Documento del Plan</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Al aceptar las Unidades de Acciones Restringidas (RSUs, por sus siglas en ingl&#233;s), el Participante reconoce que ha recibido una copia del Plan, el Anuncio de la Subvenci&#243;n y el Acuerdo, con inclusi&#243;n de este Anexo A, que el Participante ha revisado. El Participante reconoce, adem&#225;s, que acepta todas las disposiciones del Plan, el Anuncio de la Subvenci&#243;n, y en el Acuerdo, incluyendo este Anexo A. El Participante tambi&#233;n reconoce que ha le&#237;do y que concretamente aprueba de forma expresa los t&#233;rminos y condiciones establecidos en la Secci&#243;n 1 (&#8220;Naturaleza de la Subvenci&#243;n&#8221;) del Acuerdo, que claramente dispone lo siguiente&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;La participaci&#243;n del Participante en el Plan no constituye un derecho adquirido&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;El Plan y la participaci&#243;n del Participante en el Plan se ofrecen por la Compa&#241;&#237;a en su discrecionalidad total&#59; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;Que la participaci&#243;n del Participante en el Plan es voluntaria&#59; y</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;La Compa&#241;&#237;a y sus Empresas Matrices, Subsidiarias y Afiliadas no son responsables de ninguna disminuci&#243;n en el valor de las acciones adquiridas al conferir las RSUs.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Pol&#237;tica Laboral y Reconocimiento</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Al aceptar las RSUs, el Participante expresamente reconoce que la Compa&#241;&#237;a, con sus oficinas registradas y ubicadas en One Baxter Parkway, Deerfield, Illinois, 60015, USA, es la &#250;nica responsable por la administraci&#243;n del Plan y que la participaci&#243;n del Participante en el Plan y en su caso la adquisici&#243;n de Acciones no constituyen una relaci&#243;n de trabajo entre el Participante y la Compa&#241;&#237;a, ya que el Participante participa en el Plan en un marco totalmente comercial y su &#250;nico patr&#243;n es Baxter M&#233;xico, S. de R.L de C MEX (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Baxter Mexico</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#8221;). Derivado de lo anterior, el Participante expresamente reconoce que el Plan y los beneficios que pudieran derivar de la participaci&#243;n en el Plan no establecen derecho alguno entre el Participante y el patr&#243;n, Baxter Mexico, y no forma parte de las condiciones de trabajo y&#47;o las prestaciones otorgadas por Baxter Mexico, y que cualquier modificaci&#243;n al Plan o su terminaci&#243;n no constituye un cambio o desmejora de los t&#233;rminos y condiciones de la relaci&#243;n de trabajo del Participante.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Asimismo, el Participante reconoce que su participaci&#243;n en el Plan se ha resultado de una decisi&#243;n unilateral y discrecional de la Compa&#241;&#237;a&#59; por lo tanto, la Compa&#241;&#237;a se reserva el derecho absoluto de modificar y&#47;o terminar la participaci&#243;n del Participante en cualquier momento y sin responsabilidad alguna frente el Participante.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Finalmente, el Participante por este medio declara que no se reserva ninguna derecho o acci&#243;n en contra de la Compa&#241;&#237;a por cualquier compensaci&#243;n o da&#241;os y perjuicios en relaci&#243;n de las disposiciones del Plan o de los beneficios derivados del Plan, y por lo tanto, el Participante otorga el m&#225;s amplio finiquito que en derecho proceda a la Compa&#241;&#237;a, y sus filiales, oficinas de representaci&#243;n, accionistas, directores, autoridades, empleados, agentes, o representantes legales en relaci&#243;n con cualquier demanda que pudiera surgir.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The RSUs granted, and any Shares acquired, under the Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico. In addition, the Plan, the Agreement and any other document relating to the RSUs may not be publicly distributed in Mexico. These materials are addressed to the Participant because of the Participant&#8217;s existing relationship with the Company and any Subsidiary, and these materials should not be reproduced or copied in any form. The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of Baxter Mexico made in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">PORTUGAL</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant hereby expressly declares that he or she has full knowledge of the English language and has read, understood and freely accepted and agreed with the terms and conditions established in the Plan and the Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Conhecimento da L&#237;ngua</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Pela presente, o Participante declara expressamente que tem pleno conhecimento da l&#237;ngua inglesa e que leu, compreendeu e livremente aceitou e concordou com os termos e condi&#231;&#245;es estabelecidas no Plano e no Acordo (Agreement em ingl&#233;s).</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">RUSSIA</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement, the Plan and all other materials the Participant may receive regarding participation in the Plan do not constitute advertising or an offering of securities in Russia. Absent any requirement under local law, the issuance of Shares under the Plan has not and will not be registered in Russia and hence the shares described in any Plan-related documents may not be offered or placed in public circulation in Russia. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Transaction</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant understands that the RSUs and any Shares under the Plan are to be issued and sold solely in the United States. Any Shares issued to the Participant upon vesting of the RSUs shall be delivered to the Participant&#8217;s brokerage account in the United States, where such Shares must be held until the time of sale. In no event will Shares be delivered to the Participant in Russia. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Information</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Anti-corruption laws prohibit certain public servants, their spouses and their dependent children from owning any foreign source financial instruments (e.g., shares of foreign companies such as the Corporation). Accordingly, the Participant should inform the Company if he or she is covered by these laws because the Participant should not hold Shares acquired under the Plan.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Labor Law Information</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If the Participant continues to hold Shares acquired at vesting of the RSUs after an involuntary Termination, he or she may not be eligible to receive unemployment benefits in Russia.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">SINGAPORE</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The RSUs are being granted pursuant to the &#8220;Qualifying Person&#8221; exemption under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SFA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Plan has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore. Hence, statutory liability under the SFA in relation to the content of prospectuses will not apply. The Participant should note that the RSUs are subject to section 257 of the SFA and hence the RSUs may not be offered or sold, or made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore, unless such offer, sale or invitation is made (i) more than six (6) months from the Date of Grant, (ii) pursuant to the exemptions under Part XIII Division 1 Subdivision (4) (other than section 280) of the SFA, or (iii)&#160;pursuant to, and in accordance with the conditions of, any other applicable provisions of the SFA. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In addition, the Participant understands that he or she is permitted to sell Shares acquired under the Plan through the designated broker appointed under the Plan, if any, provided the resale of Shares acquired </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">under the Plan takes place outside of Singapore through the facilities of a stock exchange on which the Shares are listed. The Shares are currently listed on the New York Stock Exchange (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">NYSE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Director Notification Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If the Participant is a director, alternate director, substitute director or shadow director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of a Singapore Subsidiary, the Participant must notify the Singapore Subsidiary in writing within two (2) business days of (i) becoming the registered holder of or acquiring an interest (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, RSUs, Shares, etc.) in the Company or any Subsidiary, or becoming an alternate director, substitute director or shadow director (as the case may be), whichever occurs last, or (ii) any change in a previously disclosed interest (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, sale of Shares). If the Participant is the chief executive officer (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">CEO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of a Singapore Subsidiary and the above notification requirements are determined to apply to the CEO of a Singapore Subsidiary, the above notification requirements also may apply to the Participant.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">SPAIN</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination and Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This provision supplements </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (&#8220;Impact of Termination on RSUs&#8221;) of the Agreement and Article III (&#8220;Nature of Grant&#8221;) of the Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In accepting the grant of RSUs, the Participant consents to participation in the Plan and acknowledges that the Participant has received a copy of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant understands and agrees that, unless otherwise provided in the Agreement, the Participant will forfeit any RSUs that have not vested as of the date the Participant&#8217;s Termination ends without entitlement to the underlying Shares or to any amount of indemnification in the event of the Participant&#8217;s Termination for any reason including, but not limited to, resignation, retirement, disciplinary dismissal adjudged to be with cause, disciplinary dismissal adjudged or recognized to be without cause (i.e., subject to a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">despido improcedente</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), individual or collective dismissal on objective grounds, whether adjudged or recognized to be with or without cause, material modification of the terms of employment or service under Article 41 of the Workers&#8217; Statute, relocation under Article 40 of the Workers&#8217; Statute, and&#47;or Article 50 of the Workers&#8217; Statute, unilateral withdrawal by the Employer and under Article 10.3 of the Royal Decree 1382&#47;1985.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant understands that the Company has unilaterally, gratuitously and in its own discretion decided to grant RSUs under the Plan to certain individuals who may be employees of the Company or a Subsidiary throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not bind the Company or a Subsidiary, other than as set forth in the Agreement. Consequently, the Participant understands that the RSUs are granted on the assumption and condition that the RSUs and any Shares acquired upon vesting of the RSUs are not a part of any employment contract (either with the Company or a Subsidiary) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation), or any other right whatsoever. Further, the Participant understands that the RSUs would not be granted to the Participant but for the assumptions and conditions referred to above&#59; thus, the Participant acknowledges and freely accepts that should any or all of the assumptions be mistaken, or should any of the conditions not be met for any reason, any grant of or right to the RSUs shall be null and void. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No &#8220;offer of securities to the public,&#8221; as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the grant of RSUs under the Plan. Neither the Plan, the Agreement (which includes this Non-U.S. Addendum), nor the Grant Notice have been nor will they be registered with the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Comisi&#243;n Nacional del Mercado de Valores</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (Spanish Securities Exchange Commission), and they do not constitute a public offering prospectus.</font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> A shadow director is an individual who is not on the board of directors of the Singapore Subsidiary but who has sufficient control so that the board of directors of the Singapore Subsidiary acts in accordance with the directions or instructions of the individual.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">SWEDEN</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The following provision supplements </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (&#8220;Tax Withholding&#8221;) of the Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without limiting the Company&#8217;s and the Employer&#8217;s authority to satisfy their withholding obligations for Tax-Related Items as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Award Agreement, in accepting the grant of RSUs, the Participant authorizes the Company and&#47;or the Employer to withhold Shares or to sell Shares otherwise deliverable to the Participant upon vesting&#47;settlement to satisfy Tax-Related Items, regardless of whether the Company and&#47;or the Employer have an obligation to withhold such Tax-Related Items.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">SWITZERLAND</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Neither this document nor any other materials relating to the RSUs constitute a prospectus according to article 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">FinSA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and neither this document nor any other materials relating to the RSUs may be publicly distributed nor otherwise made publicly available in Switzerland to any person other than an employee of a member of the Company Group. Neither this document nor any other offering or marketing material relating to the RSUs have been or will be filed with, or approved or supervised by, any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority (in particular, the Swiss Financial Market Supervisory Authority (FINMA)).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">TAIWAN</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The offer of participation in the Plan is available only for employees of the Company and its Subsidiaries. The offer of participation in the Plan is not a public offer of securities by a Taiwanese company.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">TURKEY</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The sale of Shares acquired under the Plan is not permitted within Turkey. The sale of Shares acquired under the Plan must occur outside Turkey and through the facilities of a stock exchange on which the Shares are listed. The Shares are currently listed on the New York Stock Exchange (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">NYSE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">UNITED ARAB EMIRATES</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This provision supplements Article III (&#8220;Nature of Grant&#8221;) of the Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant acknowledges that the RSUs and related benefits do not constitute a component of the Participant&#8217;s &#8220;wages&#8221; for any legal purpose. Therefore, the RSUs and related benefits will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as social insurance contributions and&#47;or any other labor-related amounts which may be payable.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Agreement, the Grant Notice, the Plan and other incidental communication materials concerning the RSUs are intended for distribution only to employees of the Company or its Subsidiaries. The Dubai Creative Clusters Authority (formerly known as the Dubai Technology and Media Free Zone Authority), Emirates Securities and Commodities Authority and&#47;or the Central Bank of the United Arab Emirates has no responsibility for reviewing or verifying any documents in connection with the RSUs. Neither the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Ministry of Economy nor the Dubai Department of Economic Development have approved these communications nor taken steps to verify the information set out in them, and have no responsibility for them.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Further, the Shares underlying the RSUs may be illiquid and&#47;or subject to restrictions on their resale. The Participant should conduct his or her own due diligence on the RSUs and the Shares. If the Participant is in any doubt about any of the contents of the grant or other incidental documents, the Participant should obtain independent professional advice.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">UNITED KINGDOM </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This provision supplements </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without limitation to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement, the Participant agrees that he or she is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or, if different, the Employer or by Her Majesty&#8217;s Revenue &#38; Customs (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">HMRC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (or any other tax authority or any other relevant authority). The Participant also agrees to indemnify and keep indemnified the Company and, if different, the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Participant&#8217;s behalf.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if the Participant is a director or executive officer (within the meaning of Section 13(k) of the Exchange Act), the Participant understands that he or she may not be able to indemnify the Company for the amount of any income tax not collected from or paid by the Participant within ninety (90) days of the end of the U.K. tax year in which the event giving rise to the Tax-Related Items occurs, as it may be considered to be a loan and, therefore, it may constitute a benefit to the Participant on which additional income tax and National Insurance contributions (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">NICs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) may be payable. The Participant understands that he or she will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying to the Company and&#47;or the Employer (as appropriate) the amount of any NICs due on this additional benefit, which may also be recovered from the Participant by any of the means referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="padding-left:123.35pt;padding-right:123.35pt;text-align:center"><font><br></font></div><div style="padding-left:123.35pt;padding-right:123.35pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="padding-left:123.35pt;padding-right:123.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT B</font></div><div style="padding-left:123.35pt;padding-right:123.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Baxter International Inc.</font></div><div style="padding-left:123.4pt;padding-right:123.4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Incentive Compensation Recoupment Policy</font></div><div style="padding-left:123.4pt;padding-right:123.4pt;text-align:center"><font><br></font></div><div style="margin-top:4.5pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.0&#160;&#160;&#160;&#160;Introduction</font></div><div style="padding-left:5pt;padding-right:4.45pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:4.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This policy applies to all cash bonuses paid by Baxter International Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and its subsidiaries under its 2007 Incentive Plan, or any successor Plan, and all grants of equity awarded by the Company to any person who is not designated as an officer by the Board of Directors of the Company. Cash bonuses and grants of equity made to such officers are covered by the Executive Compensation Recoupment Policy. Collectively such cash bonuses and equity awards will be referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;. Equity awards are any compensatory awards under the company&#8217;s equity compensation plans in the form of common stock or any derivative of common stock, including stock options, stock awards, restricted stock, restricted stock units, and performance share units.</font></div><div style="padding-left:41pt"><font><br></font></div><div style="padding-left:41pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.3pt">Triggers&#59; Scope of Actions</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.75pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.3pt">Following a restatement of the Company&#8217;s financial results requiring an amendment to any previously filed results, the Chairman and CEO (the &#8220;CEO&#8221;) will review the facts and circumstances that led to the requirement for the restatement and take any actions it deems appropriate with respect to Incentive Compensation. The CEO will consider whether an employee received compensation based on performance reported but not actually achieved or was accountable for the events that led to the restatement, including any misconduct.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.45pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.3pt">If an employee violates any of the restrictive covenants contained in any agreement between the employee and the Company, the Chairman and CEO will review the facts and circumstances related to the violation and take any actions it deems appropriate with respect to Incentive Compensation.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:41pt;padding-right:7.8pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.3pt">Actions that may be taken include&#58; recovery, reduction, or forfeiture of all or part of any Incentive Compensation previously provided or to be provided in the future&#59; disciplinary actions&#59; and the pursuit of any other remedies.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.0&#160;&#160;&#160;&#160;Documentation</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:5pt;padding-right:20.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Policy will apply to Equity Plans covering any employee beginning with the Company&#8217;s 2011 Equity Plans. In addition, this Policy will be incorporated into the Company&#8217;s Management Incentive Compensation Program (MICP) beginning with the Company&#8217;s 2011 MICP, as well as any resolutions adopted by the Board or Compensation Committee as a condition to approval of the payout of any cash bonus under the 2007 Incentive Plan, or any successor Plan, beginning with the cash bonuses paid by the Company in March 2012.</font></div><div style="margin-bottom:12pt;padding-left:5pt;padding-right:20.05pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:5pt;padding-right:20.05pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:5pt;padding-right:20.05pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:5pt;padding-right:20.05pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:5pt;padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:5pt;padding-right:4.5pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.12pt;padding-right:4.5pt;text-align:justify;text-indent:0.36pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-right:4.5pt;text-align:justify;text-indent:0.36pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-right:4.5pt;text-align:justify;text-indent:0.36pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-right:4.5pt;text-align:justify;text-indent:0.36pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-right:4.5pt;text-align:justify;text-indent:0.36pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-right:4.5pt;text-align:justify;text-indent:0.36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3pt;padding-left:81pt;padding-right:81pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT B</font></div><div style="margin-top:3pt;padding-left:81pt;padding-right:81pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Baxter International Inc.</font></div><div style="padding-left:81pt;padding-right:81pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Executive Compensation Recoupment Policy</font></div><div style="padding-left:81pt;padding-right:81pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> (As amended and restated on March 8, 2018)</font></div><div style="margin-top:4.5pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.0&#160;&#160;&#160;&#160;Introduction</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:5.95pt;padding-right:8.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This policy (as amended and restated, this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) applies to all cash bonuses paid by Baxter International Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) under its 2007 Incentive Plan, or any successor Plan, and all grants of equity awarded by the Company to any person designated as an officer by the Board of Directors of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Collectively such bonuses and equity awards will be referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Executive Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;. Equity awards are any compensatory awards under the company&#8217;s equity compensation plans in the form of common stock or any derivative of common stock, including stock options, stock awards, restricted stock, restricted stock units, and performance share units. For the avoidance of doubt, this Policy shall apply to any person who is a designated officer either at the time of grant or the time of payment of the Executive Incentive Compensation.</font></div><div style="padding-left:42pt;text-indent:-42pt"><font><br></font></div><div style="padding-left:42pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.25pt">Triggers&#59; Scope of Actions</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:42pt;padding-right:5.2pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Following a restatement of the Company&#8217;s financial results requiring an amendment to any previously filed results, the Board will review the facts and circumstances that led to the requirement for the restatement and take any actions it deems appropriate with respect to Executive Incentive Compensation. The Board will consider whether an officer received compensation based on performance reported but not actually achieved or was accountable for the events that led to the restatement, including any misconduct.</font></div><div style="margin-top:0.55pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:42pt;padding-right:6.7pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">If an officer violates any of the restrictive covenants contained in any agreement between   the officer and the Company, the Board will review the facts and circumstances related to  the violation and take any actions it deems appropriate with respect to Executive Incentive Compensation.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:42pt;padding-right:25pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Actions the Board may take include&#58; recovery, reduction, or forfeiture of all or part of any Executive Incentive Compensation previously provided or to be provided in the future&#59; disciplinary actions&#59; and the pursuit of any other remedies.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.0&#160;&#160;&#160;&#160;Documentation</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:9pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Policy will be incorporated into future Equity Plans covering any officer beginning with the Company&#8217;s 2009 Equity Plan as well as resolutions adopted by the Board or Compensation Committee as a condition to approval of the payout of any cash bonus under the 2007 Incentive Plan, or any successor Plan, to any officer beginning with the cash bonuses paid by the Company in March 2009. The Executive Compensation team will provide a copy of this Policy to each officer.</font></div><div style="margin-top:3pt;padding-left:6pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.0&#160;&#160;&#160;&#160;Disclosure</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:6pt;padding-right:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event the Board recoups incentive compensation under this Policy, Company management  intends to disclose the aggregate amount of incentive compensation recovered under this Policy, so long as the underlying event has already been publicly disclosed publicly by the Company. This disclosure would appear in the Company&#8217;s annual proxy statement following any such Board action and would provide the aggregate amount of recovery for each event if there is more  than one applicable event.</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>bax-20220331xex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ida090020c1a44a898a2aa33a020d6bbe_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10.3</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">BAXTER INTERNATIONAL INC.<br>2021 INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><br>STOCK OPTION AWARD GRANT NOTICE </font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Baxter International Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), pursuant to the Baxter International Inc. 2021 Incentive Plan, as may be amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), hereby grants to the holder listed below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) the number of stock options set forth below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Options are subject to the terms and conditions set forth in this Stock Option Award Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Stock Option Award Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and the Plan, each of which is incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in the Grant Notice and the Agreement.</font></div><div style="padding-left:6.3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:27.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:70.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Participant&#58; </font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Participant ID&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Date of Grant&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Number of Options&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Exercise Price</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Vesting Schedule&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Expiration Date&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;&#8226;&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Applicable Recoupment Policy&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Incentive Compensation Recoupment Policy shall apply to Participants who are not designated officers of the Company and the Executive Compensation Recoupment Policy shall apply to all Participants who are designated officers of the Company either at the time of grant or vesting. Both polices are attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By accepting this Award electronically through the stock plan administrator&#8217;s online grant acceptance procedure, the Participant agrees to be bound by the terms and conditions of the Plan, the Agreement, and the Grant Notice. If the Participant does not accept this Award through the online acceptance process, the Participant&#8217;s Award will be canceled, and the Participant will not be entitled to any benefits from the Award or to any compensation or benefits in lieu of the canceled Award. The Participant has reviewed the Agreement, the Plan, and the Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing the Grant Notice and fully understands all provisions of the Grant Notice, the Agreement, and the Plan. The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan, the Grant Notice, or the Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If the Participant declines the Award, the Award will be canceled, and the Participant will not be entitled to any benefits from the Award or to any compensation or benefits in lieu of the canceled Award.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div></div></div><div id="ida090020c1a44a898a2aa33a020d6bbe_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">STOCK OPTION AWARD AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pursuant to the Grant Notice to which this Agreement is attached, the Company has granted to the Participant the number of Options set forth in the Grant Notice. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:232%">ARTICLE I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%;padding-left:6.7pt"><br>GENERAL</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan or the Grant Notice. For purposes of this Agreement&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the member of the Company Group that employs the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Qualifying Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a Termination of a Participant who is at least 65 years of age, or at least 55 years of age with at least 10 years of active continuous service with a member of the Company Group. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a date Shares are traded on the New York Stock Exchange or, if the Shares are not traded on the New York Stock Exchange, a date the Shares are traded or reported by an applicable automated quotation system or such other exchange or automated quotation system, if applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the applicable date(s) when the restrictions on the Options lapse, as provided in the Grant Notice or herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Incorporation of Terms of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Options and the shares of Common Stock issued to the Participant hereunder (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) are subject to the terms and conditions set forth in this Agreement, the Grant Notice, and the Plan, which are incorporated herein by reference. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:232%">ARTICLE II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%;padding-left:2.04pt"><br>AWARD OF STOCK OPTIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Award of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In consideration of the Participant&#8217;s continued employment with or service to a member of the Company Group and for other good and valuable consideration, effective as of the Date of Grant, the Company has granted to the Participant the number of Options set forth in the Grant Notice, upon the terms and conditions set forth in the Grant Notice, the Plan, and this Agreement, subject to adjustment as provided in Section 12 of the Plan. Except as otherwise provided herein, each Option represents the right to receive one Share at the times and subject to the conditions set forth herein. However, unless and until the Options have vested, the Participant will have no right to the payment of any Shares subject thereto. Prior to the actual delivery of any Shares, the Options will represent an unsecured obligation of the Company. All Options granted hereunder are Nonqualified Stock Options. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Term of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Unless terminated earlier as provided below or otherwise pursuant to the Plan, the Options shall expire on the date set forth in the Grant Notice. If Options would expire on a date that is not a Trading Day (for any reason, including, without limitation, a Participant&#8217;s Termination for any reason or at the normal expiration date), they will expire at the close of trading on the last Trading Day preceding that date. If the Options would expire at a time when trading in the Shares is prohibited by the Company&#8217;s insider trading policy (or Company-imposed &#8220;blackout period&#8221;), then the expiration date shall be automatically extended under the earlier of (i) the thirtieth (30th) day following the expiration of such prohibition and (ii) the normal expiration date of the Options, as set forth in the Grant Notice. Under no circumstances may Options be exercised after they have expired. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Vesting of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Subject to the Participant&#8217;s continued employment with or service to a member of the Company Group on each applicable Vesting Date and subject to the terms of this Agreement, the Options shall vest in such amounts and at such times as are set forth in the Grant Notice or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement and become exercisable. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Impact of Termination on Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event the Participant incurs a Termination prior to a Vesting Date set forth in the Grant Notice, then any unvested Options shall be canceled and forfeited, except as may be otherwise provided herein, in the Grant Notice, by the Committee or as set forth in a written agreement between the Participant and the Company or Employer. For the avoidance of doubt, a transfer of employment within the Company Group will not constitute a Termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Qualifying Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event the Participant incurs a Termination as a result of a Qualifying Retirement for any reason other than for Cause, or by reason of the Participant&#8217;s death or Disability, then (i)&#160;if the date of such Termination is after the calendar year of the Date of Grant, the Options shall continue to become exercisable on the Vesting Date(s) specified in the Grant Notice, or (ii)&#160;if the date of such Termination is in the calendar year of the Date of Grant, a pro-rata portion of the unvested Options shall continue to become exercisable on the Vesting Date(s) specified in the Grant Notice. For purposes of the foregoing, the pro-rata portion of the unvested Options that shall continue to become exercisable shall be determined by multiplying (x) the Number of Options specified in the Grant Notice by (y) the percentage equal to the number of months worked in the applicable calendar year of the Date of Grant, rounded to the nearest whole month, divided by twelve (12). Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, such Options shall expire on the first to occur of the fifth anniversary of the Termination as a result of a Qualifying Retirement or the normal expiration date of the Options, as set forth in the Grant Notice.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event the Participant incurs a Termination as a result of the Participant&#8217;s death or Disability, any unvested Options shall vest as follows&#58; (i) if the date of such Termination is after the calendar year of the Date of Grant, all unvested Options shall immediately vest and become exercisable, or (ii) if the date of such Termination is in the calendar year of the Date of Grant, a pro-rata portion of the unvested Options shall immediately vest and become exercisable. For purposes of the foregoing, the pro-rata portion of the unvested Options that shall immediately vest and become exercisable shall be determined by multiplying (x) the Number of Options specified in the Grant Notice by (y) the percentage equal to the number of months worked in the applicable calendar year of the Date of Grant, rounded to the nearest whole month, divided by twelve (12). Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, such Options shall expire on the first to occur of the fifth anniversary of the Termination as a result of Participant's death or Disability or the normal expiration date of the Options, as set forth in the Grant Notice. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Termination for Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event the Participant incurs a Termination for Cause, except as may be otherwise provided by the Committee or as set forth in a written agreement between the Participant and the Company or Employer, the Participant shall immediately forfeit any and all Options granted under this Agreement (whether or not vested), the Participant&#8217;s rights in any such Options shall lapse and expire, and the Participant shall also be subject to the Executive Compensation Recoupment Policy or Incentive Compensation Recoupment Policy, as applicable. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">All Other Terminations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event the Participant incurs a Termination other than as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.4(a),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.4(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, except as may be otherwise provided herein or by the Committee or as set forth in a written agreement between the Participant and the Company or Employer, any unvested Options shall expire immediately and any vested Options that are exercisable will expire as of the first to occur of, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (i)&#160;ninety (90) days after the Participant incurs a Termination (or the prior trading day if the 90th day after Termination is a non-trading day) or (ii)&#160;the normal expiration date of the Option, as set forth in the Grant Notice. If the Participant dies or becomes disabled during the ninety (90) day period, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Options will expire on the first to occur of the fifth anniversary of the Termination (or the prior trading day if the fifth anniversary of the Termination is a non-trading day) or the normal expiration date of the Option, as set forth in the Grant Notice. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Outside the United States</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For purposes of this Agreement, if the Participant is employed or providing services outside the United States, the Committee (or its delegate) may determine </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that the date the Participant incurs a Termination shall mean the date the Participant is no longer actively providing services to a member of the Company Group (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction in which the Participant is employed or providing services or the terms of the Participant&#8217;s employment agreement, if any) and that the Participant&#8217;s right to vest in the Options under the Plan, if any, will terminate as of such date, the post-Termination exercise period (if any) with respect to vested Options will begin as of such date, and will not be extended by any notice period (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">e.g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">., the Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction in which the Participant is employed or providing service or the terms of the Participant&#8217;s employment or service agreement, if any)&#59; the Committee (or its delegate) shall have the exclusive discretion to determine when the Participant is no longer actively providing services for purposes of the Options (including whether the Participant may still be considered to be providing services while on a leave of absence).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Impact of a Change in Control on Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event of a Change in Control, the treatment of the Options shall be governed by Section 12(b) of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Exercise of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt"> Options that have become exercisable may be exercised in whole or in part (but with respect to whole Shares only) by delivery of written or electronic notice of exercise to the Company (or any other notice of exercise method provided by the Company, in its sole discretion), in such form and pursuant to such procedures as may be designated by the Company from time to time, indicating the number of Shares with respect to which the Options are being exercised, which notice shall be accompanied by payment in full for the Shares. If Options would become exercisable on a date that is not a Trading Day, they will become exercisable on the next Trading Day. The Exercise Price may be paid in accordance with Section 7(d) of the Plan, or by such other method as the Committee may permit, in its sole discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, the Committee may suspend or eliminate any of the specified methods of exercise, require payment in a particular or different method of exercise than those specified, may allow the Participant to exercise the Options only by means of a cashless exercise (either a cashless &#8220;sell all&#8221; exercise or a cashless &#8220;sell-to-cover&#8221; exercise) as it shall determine in its sole discretion, or may require the Participant to sell any Shares acquired under the Plan immediately or within a specified period following the Participant&#8217;s Termination (in which case, this Agreement shall give the Company the authority to issue sales instructions on the Participant&#8217;s behalf).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Except as the Committee otherwise may provide and in accordance with Section&#160;14(b) of the Plan, Options may be exercised only by the Participant, the Participant&#8217;s legal representative, or a person to whom the Participant&#8217;s rights in the Options are transferred by will or the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Following the exercise of Options hereunder, as promptly as practical after receipt of such notification and full payment of the Exercise Price and any required Tax-Related Items (as defined and provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof), the Company shall issue or transfer, or cause such issue or transfer, to the Participant the number of Shares with respect to which the Options have been so exercised. All distributions shall be made by the Company in the form of whole Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Conditions to Exercise and Issuance of Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company shall not be required to permit the Participant to exercise the Options in a manner that Committee determines would violate the Sarbanes-Oxley Act of 2002, as it may be amended from time to time, or issue or deliver any certificate or certificates for any Shares or to cause any Shares to be held in book-entry form prior to the fulfillment of all of the following conditions&#58; (a) the admission of the Shares to listing on all stock exchanges on which such Shares are then listed, (b) the completion of any registration or other qualification of the Shares under any U.S. state or federal law or under rulings or regulations of the U.S. Securities and Exchange Commission or other governmental regulatory body, which the Committee shall, in its absolute discretion, deem necessary or advisable, (c) the obtaining of any approval or other clearance from any U.S. state or federal governmental agency or non-U.S. regulatory agency that the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Committee shall, in its absolute discretion, determine to be necessary or advisable, and (d) the receipt of full payment of any applicable Tax-Related Items in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> by the member of the Company Group with respect to which the applicable withholding obligation arises.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding any other provision of this Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.8pt">The provisions of Section 14(e) of the Plan are incorporated herein by reference and made a part hereof. The Participant acknowledges that he or she may be required to pay to the Company or, if different, the Employer, and that the Company, the Employer, or any Subsidiary shall have the right and are hereby authorized to withhold from any compensation or other amount owing to the Participant, applicable income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items (including taxes that are imposed on the Company or the Employer as a result of the Participant&#8217;s participation in the Plan but are deemed by the Company or the Employer to be an appropriate charge to the Participant) (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tax-Related Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), with respect to any issuance, transfer, or other taxable event under this Agreement or under the Plan and to take such action as may be necessary in the opinion of the Company to satisfy all obligations for the payment of such Tax-Related Items. The Participant further acknowledges that the Company and&#47;or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Options, including, but not limited to the grant, exercise and&#47;or settlement of the Options and the subsequent sale of Shares acquired upon exercise of the Options&#59; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Options to reduce or eliminate the Participant&#8217;s liability for Tax-Related Items or achieve a particular tax result. Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.18pt">The Committee may permit the Participant to elect to satisfy such obligations by (i) cash, wire transfer of immediately available funds or check&#59; (ii) delivering Shares (which are not subject to any pledge or other security interest) that have been held by the Participant for not less than six (6) months (or such other period as established from time to time by the Committee in order to avoid adverse accounting treatment applying GAAP) having a Fair Market Value equal to such withholding liability&#59; (iii)&#160;delivery of a written or electronic notice that the Participant has placed a market sell order with a broker acceptable to the Company with respect to Shares then issuable upon exercise of the Options, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company in satisfaction of the aggregate applicable tax withholding obligations&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that payment of such proceeds is then made to the Company upon settlement of such sale in satisfaction of the applicable tax withholding obligations&#59; or (iv)&#160;the Company withholding, or causing to be withheld, Shares otherwise issuable under the Options&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the number of Shares that may be so withheld or surrendered shall be limited to the number of Shares that have a Fair Market Value on the date of withholding no greater than the aggregate amount of such obligations based on the maximum individual statutory withholding rates or other rates that will not have a negative accounting impact, in the Participant&#8217;s applicable jurisdictions for U.S. federal, state, local and non-U.S. income tax and payroll tax purposes that are applicable to such taxable income. Notwithstanding the foregoing, the Participant authorizes the Company to satisfy the applicable tax withholding obligations from proceeds of the sale of Shares issuable under the Options through a mandatory sale arranged by the Company (on the Participant&#8217;s behalf pursuant to this authorization) and&#47;or through withholding from any cash, other securities, or other property issuable or deliverable under any Award or from any compensation or other amounts owing to the Participant. If the obligation for Tax-Related Items is satisfied by withholding in Shares, the Participant is deemed to have been issued the full number of Shares subject to the exercised Options, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items. The Participant acknowledges that, regardless of any action taken by the Company, the Employer, or any Subsidiary the ultimate liability for all Tax-Related Items, is and remains the Participant&#8217;s responsibility and may exceed the amount, if any, actually withheld by the Company or the Employer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Notwithstanding any other provision of this Agreement, the Company shall not be obligated to deliver any certificate representing Shares issuable with respect to the Options to, or to cause any such Shares to be held in book-entry form by, the Participant or the Participant&#8217;s legal </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">representative unless and until the Participant or the Participant&#8217;s legal representative shall have paid the Tax-Related Items resulting from the grant, exercise or settlement of the Options or any other taxable event related to the Options.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Rights as Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Neither the Participant nor any Person claiming under or through the Participant will have any of the rights or privileges of a stockholder of the Company in respect of any Shares deliverable hereunder unless and until certificates representing such Shares (which may be in book-entry form) will have been issued and recorded on the records of the Company or its transfer agents or registrars and delivered to the Participant (including through electronic delivery to a brokerage account). Except as otherwise provided herein, after such issuance, recordation and delivery, the Participant will have all the rights of a stockholder of the Company with respect to such Shares, including, without limitation, the right to receipt of dividends and distributions on such Shares. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%">ARTICLE III.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NATURE OF GRANT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt">In accepting the grant of the Options, the Participant acknowledges, understands, and agrees that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended, or terminated by the Company at any time, to the extent permitted by the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the grant of the Options is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of an award, or benefits in lieu of an award, even if Options have been granted in the past&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">all decisions with respect to future grants of Options or other grants, if any, will be at the sole discretion of the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the Participant is voluntarily participating in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the Options and the Shares subject to the Options, and the income from and value of same, are not intended to replace any pension rights or compensation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">the Options and the Shares subject to the Options, and the income from and value of same, are not part of normal or expected compensation for purposes of, including but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, holiday pay, long-service awards, pension or retirement or welfare benefits or similar payments&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">unless otherwise agreed with the Company in writing, the Options and the Shares subject to the Options, and the income from and value of same, are not granted as consideration for, or in connection with, the service the Participant may provide as a director of a Subsidiary&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the future value of the underlying Shares is unknown, indeterminable and cannot be predicted with certainty&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">no claim or entitlement to compensation or damages shall arise from forfeiture of the Options resulting from the Participant&#8217;s Termination (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is employed or the terms of the Participant&#8217;s employment agreement, if any)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">neither the Company nor the Employer shall be liable for any foreign exchange rate fluctuation between the Participant&#8217;s local currency and the United States Dollar that may affect the value of the Options or of any amounts due to the Participant pursuant to the settlement of the Options upon exercise or the subsequent sale of any Shares acquired upon settlement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%">ARTICLE IV.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DATA PRIVACY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company is processing personal data of the Participant for purposes related to Plan administration services, based on the appropriate legal basis, depending on the Participant&#8217;s country, as stipulated in the HR Privacy Notice shared with the Participant and as in force. The Company further shares such data with its affiliates or processors, as appropriate, and only on a &#8220;need to know basis&#8221;. That may also include human resources personnel, certain executives, managers, and employees at other worldwide affiliates of the Company Group, who may have access to certain of the Participant&#8217;s personal data. Some of those recipients may be located or may have relevant operations outside of the Participant&#8217;s country, such as in the United States, where the data protection laws may not provide a level of protection equivalent to the laws of the Participant&#8217;s country. The Company implements the appropriate legal, technical, and organizational measures and mechanisms in this regard. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For further information about the HR Privacy Notice and the processing of the Participant&#8217;s data in relation to the Plan, the Participant may contact local HR or send an email to&#58; privacy&#64;baxter.com.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%">ARTICLE V.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:232%">OTHER PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Committee (and its delegates) shall have the power to interpret the Plan, the Grant Notice, and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan, the Grant Notice, and this Agreement as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations and determinations made by the Committee will be final and binding upon the Participant, the Company, and all other interested Persons. To the extent allowable pursuant to applicable law, no member of the Committee or the Board will be personally liable for any action, determination or interpretation made with respect to the Plan, the Grant Notice, or this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Options Not Transferable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Options may not be sold, pledged, assigned, or transferred in any manner other than by will or the laws of descent and distribution, unless and until the Shares underlying the Options have been issued, and all restrictions applicable to such Shares have lapsed. No Options or any interest or right therein or part thereof shall be liable for the debts, contracts or engagements of the Participant or his or her successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no effect, except to the extent that such disposition is permitted by the preceding sentence. Notwithstanding the foregoing, with the consent of the Committee, the Options may be transferred as described in Section 14(b)(ii) of the Plan, pursuant to any such conditions and procedures the Committee may require.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant acknowledges that the Options and the Shares subject to the Options are subject to adjustment, modification and termination in certain events as provided in this Agreement and the Plan, including Section 12 of the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Cooperation&#59; Repatriation and Compliance Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant agrees to cooperate with the Company and the Employer in taking any action reasonably necessary or advisable to consummate the transactions contemplated by this Agreement. Further, the Participant agrees to repatriate all payments attributable to the Options in accordance with local foreign exchange rules and regulations in the Participant&#8217;s country of residence (and country of employment, if different). In addition, the Participant agrees to take any and all actions, and consents to any and all actions taken by the Employer, the Company and its Subsidiaries as may be required to allow the Employer, the Company and its Subsidiaries to comply with applicable law in the Participant&#8217;s country of residence (and country of employment, if different). Finally, the Participant agrees to take any and all actions that may be required </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">to comply with the Participant&#8217;s personal legal and tax obligations under local laws, rules, and regulations in the Participant&#8217;s country of residence (and country of employment, if different).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Non-U.S. Addendum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding any provisions in this Agreement to the contrary, the Options shall be subject to any special terms and conditions set forth in the Non-U.S. Addendum to this Agreement for the Participant&#8217;s country of residence (and country of employment or service, if different). Moreover, if the Participant relocates to another country, any special terms and conditions for such country will apply to the Participant, to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable for legal or administrative reasons (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate the Participant&#8217;s transfer). The Non-U.S. Addendum constitutes part of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For the purpose of the Plan and this Agreement, notices and all other communications shall be in writing and shall be deemed to have been duly given when delivered or mailed by overnight courier or United States registered mail, return receipt requested, postage prepaid (or similar foreign postal service), addressed to the Plan to the General Counsel, Baxter International Inc., One Baxter Parkway, Deerfield, Illinois 60015, USA and to the Participant to the address set forth in the Company&#8217;s payroll records or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company reserves the right to impose other requirements on the Participant&#8217;s participation in the Plan, on the Options and on any Shares acquired under the Plan, to the extent the Company determines, in its sole discretion, it is necessary or advisable in order to comply with local law, rules and regulations or to facilitate the operation and administration of the Options and the Plan. Such requirements may include (but are not limited to) requiring the Participant to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant acknowledges that he or she is proficient in the English language, or has consulted with an advisor who is proficient in the English language, so as to enable the Participant to understand the provisions of this Agreement and the Plan. If the Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Electronic Delivery and Acceptance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company, in its sole discretion, may decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an online or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Titles</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Governing Law&#59; Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Except to the extent preempted by US federal law, the laws of the State of Illinois, USA shall govern the interpretation, validity, administration, enforcement, and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws. For any legal action relating to this Agreement, the parties to this Agreement consent to the exclusive jurisdiction and venue of the federal courts in Chicago, Illinois.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Non-Competition, Non-Solicitation, and Confidentiality Agreement. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding any other provision in this Agreement or the Plan to the contrary, if determined to be applicable to the Participant in the Company&#8217;s sole discretion, any grant hereunder shall be cancelled and no Awards will vest, be settled, or be exercisable if the Participant does not accept, sign, date and return, as directed by the Company, a Non-Competition, Non-Solicitation and Confidentiality Agreement, in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">such form as determined by the Company, within sixty (60) days of being provided a copy of such agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Repayment of Proceeds&#59; Clawback and Offset Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Shares underlying the Options and all proceeds related to such Shares are subject to the Company&#8217;s Incentive Compensation Recoupment Policy or Executive Compensation Recoupment Policy, as specified in the Grant Notice, which are attached to the Grant Notice as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Additionally, where applicable, if (i) the Participant&#8217;s employment with the Company Group terminates for any reason and (ii) such Participant violates (either during and&#47;or after employment with the Company Group) the terms of the Participant&#8217;s Non-Competition, Non-Solicitation and Confidentiality Agreement as described in and required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then any Awards that have not vested or are not exercisable as of the Termination date (including any Awards that would later vest as a result of a Qualifying Retirement) shall be cancelled and shall not vest, be settled, or be exercisable. Furthermore, any Awards which have vested or became exercisable within the 12 months preceding the Termination date shall be forfeited and shall be returned to the Company, and any Awards that vested after the Termination date as a result of a Qualifying Retirement shall be forfeited. If the Participant has sold or exercised any such Awards, then the Participant shall make a cash payment to the Company in an amount equal to the amount of the net gain recognized from the sale or exercise of such Awards within 30 business days of written notice by the Company to the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Conformity to Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant acknowledges that the Plan, the Grant Notice, and this Agreement, are intended to conform to the extent necessary with all applicable laws, including, without limitation, the provisions of the Securities Act and the Exchange Act, and any and all regulations and rules promulgated thereunder by the Securities and Exchange Commission, and other applicable securities laws and regulations. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the Options are granted, only in such a manner as to conform to applicable laws. To the extent permitted by applicable laws, the Plan, the Grant Notice, and this Agreement, shall be deemed amended to the extent necessary to conform to applicable laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Amendment, Suspension and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended, or terminated at any time or from time to time by the Committee or the Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">, provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, except as may otherwise be provided by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the Options in any material way without the prior written consent of the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement and the Plan, this Agreement shall be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Limitations Applicable to Section 16 Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding any other provision of the Plan or this Agreement, if the Participant is subject to Section 16 of the Exchange Act, the Plan, the Options, the Grant Notice, and this Agreement shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by applicable laws, this Agreement shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Not a Contract of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Nothing in this Agreement or in the Plan shall confer upon the Participant any right to continue to serve as an employee of any member of the Company Group or shall interfere with or restrict in any way the rights of any member of the Company Group, which rights are hereby expressly reserved, to discharge or terminate the services of the Participant at any time for any reason whatsoever, with or without cause, except to the extent (i) expressly provided otherwise in a written agreement between a Member of the Company Group and the Participant or (ii) where such provisions are not consistent with applicable foreign or local laws, in which case such applicable foreign or local laws shall control.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Plan, the Grant Notice, and this Agreement (including the Addenda attached&#160;hereto) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and the Participant with respect to the subject matter hereof.  Except as specifically provided in the Grant Notice or this Agreement, in the event of any inconsistency between the Plan, the Grant Notice or this Agreement, the Plan will control. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Agreement Severable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event that any provision of the Grant Notice or this Agreement is held invalid or unenforceable, such provision will be severable from, and such invalidity or unenforceability will not be construed to have any effect on, the remaining provisions of the Grant Notice or this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Limitation on the Participant&#8217;s Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Participation in the Plan confers no rights or interests other than as herein provided. This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust. Neither the Plan nor any underlying program, in and of itself, has any assets. The Participant shall have only the rights of a general unsecured creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the Options.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Grant Notice may be executed in one or more counterparts, including by way of any electronic signature, subject to applicable law, each of which shall be deemed an original and all of which together shall constitute one instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Private Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If the Participant is a resident outside the United States, the grant of the Options is not intended to be a public offering of securities in the Participant&#8217;s country of residence (and country of employment, if different). The Company has not submitted any registration statement, prospectus, or other filing with the local securities authorities with respect to the grant of the Options unless otherwise required under local law. No employee of the Company is permitted to advise the Participant on whether the Participant should acquire Shares under the Plan or provide the Participant with any legal, tax or financial advice with respect to the grant of the Options. Investment in Shares involves a degree of risk. Before deciding to acquire Shares pursuant to the Options, the Participant should carefully consider all risk factors and tax considerations relevant to the acquisition of Shares under the Plan or the disposition of them. Further, the Participant should carefully review all of the materials related to the Options and the Plan, and the Participant should consult with the Participant&#8217;s personal legal, tax and financial advisors for professional advice in relation to the Participant&#8217;s personal circumstances.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Exchange Control, Foreign Asset&#47;Account and&#47;or Tax Reporting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant acknowledges that there may be certain exchange control, foreign asset&#47;account and&#47;or tax reporting requirements that may affect the Participant&#8217;s ability to acquire or hold Shares or cash received from participating in the Plan (including the receipt of any dividends paid on Shares and the proceeds from the sale of Shares) in a brokerage or bank account outside the Participant&#8217;s country. The Participant may be required to report such accounts, assets or related transactions to the tax or other authorities in the Participant&#8217;s country. The Participant also may be required to repatriate sale proceeds or other funds received as a result of participating in the Plan to the Participant&#8217;s country within a certain time after receipt. The Participant acknowledges that it is the Participant&#8217;s responsibility to comply with such regulations and that the Participant should speak to his or her personal advisor on this matter. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Insider Trading&#47;Market Abuse</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant may be subject to insider trading restrictions and&#47;or market abuse laws based on the exchange on which the Shares are listed and in applicable jurisdictions, including the United States, the Participant&#8217;s country and the designated broker&#8217;s country (including any Company Group securities trading policy), which may affect the Participant&#8217;s ability to accept, acquire, sell or otherwise dispose of Shares, rights to Shares (e.g., the Options) or rights linked to the value of Shares under the Plan during such times that the Participant is considered to have &#8220;inside information&#8221; regarding the Company (as defined by the laws or regulations in the Participant&#8217;s country). Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Participant acknowledges that it is the Participant&#8217;s responsibility to comply with any applicable restrictions and that the Participant should speak to his or her personal advisor on this matter.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.26</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The waiver by the Company with respect to the Participant&#8217;s (or any other participant&#8217;s) compliance of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by such party of a provision of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.27</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.03pt;text-decoration:underline">Consent and Agreement With Respect to Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> The Participant (a)&#160;acknowledges that a copy of the Plan and the U.S. prospectus for the Plan has been available to the Participant&#59; (b)&#160;represents that he or she has read and is familiar with the terms and provisions thereof, has had an opportunity to obtain the advice of counsel of his or her choice prior to executing this Agreement and fully understands all provisions of this Agreement and the Plan&#59; (c) accepts the Options subject to all of the terms and provisions thereof&#59; and (d) agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan or this Agreement.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:152%">To the extent that the Company has established, either itself or through a third-party plan administrator, the ability to accept this award electronically, such acceptance shall constitute the Participant&#8217;s signature hereof.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:152%">Company&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Participant&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:152%">_____________________                                                             _____________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:152%">By&#58; Sven Skillrud</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:152%">Title&#58; Vice President, Total Rewards</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">* * * * *</font></div><div style="text-align:center"><font><br></font></div><div id="ida090020c1a44a898a2aa33a020d6bbe_7"></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><div id="ida090020c1a44a898a2aa33a020d6bbe_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">ADDENDUM</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:700;line-height:133%;position:relative;top:-3.85pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">TO</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">THE STOCK OPTION AWARD AGREEMENT</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FOR NON-U.S. PARTICIPANTS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In addition to the terms of the Plan, the Grant Notice and the Agreement, the Options are subject to the following additional terms, conditions, and provisions (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-U.S. Addendum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). All capitalized terms as contained in this Non-U.S. Addendum shall have the same meaning as set forth in the Plan, the Grant Notice and&#47;or the Agreement. Pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement, if the Participant transfers residence and&#47;or employment or service to another country reflected in this Non-U.S. Addendum, the special terms, conditions and provision for such country will apply to the Participant to the extent the Company determines, in its sole discretion, that the application of such terms, conditions and provisions is necessary for legal or administrative reasons (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate the Participant&#8217;s transfer).</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">AUSTRALIA</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) applies (subject to the conditions in that Act). </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Australia Offer Document</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This grant of Options is intended to comply with the provisions of the Corporations Act 2001, Australia Securities and Investments Commission (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ASIC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) Regulatory Guide 49 and ASIC Class Order CO 14&#47;1000. Additional details are set forth in the Australia Offer Document, a copy of which is attached to the end of this section for Australia as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Annex 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:10pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%;text-decoration:underline">ANNEX 1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">OFFER DOCUMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Baxter International Inc.<br>2021 Incentive Plan</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">OFFER OF STOCK OPTIONS</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TO AUSTRALIAN RESIDENT EMPLOYEES</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company is pleased to provide the Participant with this offer to participate in the Plan. This offer sets out information regarding the grant of Options to Australian resident employees of the Company and its parents, Subsidiaries and Subsidiaries (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Australian Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). This information is provided by the Company to ensure compliance of the Plan with Australian Securities and Investments Commission (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ASIC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) Class Order 14&#47;1000 and relevant provisions of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Corporations Act 2001</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In addition to the information set out in the Agreement and the Non-U.S. Addendum, Australian Participants are also being provided with copies of the following documents&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">the Plan&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt">the Plan prospectus&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt">Employee Information Supplement for Australia (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Additional Documents provide further information to help Australian Participants make an informed investment decision about participating in the Plan. Neither the Plan nor the Plan prospectus is a prospectus for the purposes of the Corporations Act 2001. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Australian Participants should not rely upon any oral statements made in relation to this offer. Australian Participants should rely only upon the statements contained in the Agreement, including the Non-U.S. Addendum, and the Additional Documents when considering participation in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Investment in Shares involves a degree of risk. Eligible employees who elect to participate in the Plan should monitor their participation and consider all risk factors relevant to the acquisition of Shares under the Plan as set forth below and in the Additional Documents.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The information herein is general information only. It is not advice or information that takes into account Australian Participants&#8217; objectives, financial situation and needs.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Australian Participants should consider obtaining their own financial product advice from a person who is licensed by ASIC to give such advice.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Additional Risk Factors for Australian Residents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Australian Participants should have regard to risk factors relevant to investment in securities generally and, in particular, to holding Shares. For example, the price at which an individual Share is quoted on The New York Stock Exchange (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">NYSE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) may increase or decrease due to a number of factors. There is no guarantee that the price of a Share will increase. Factors that may affect the price of an individual Share include fluctuations in the domestic and international market for listed stocks, general economic conditions, including interest rates, inflation rates, commodity and oil prices, changes to government fiscal, monetary or regulatory policies, legislation or regulation, the nature of the markets in which the Company operates and general operational and business risks.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">More information about potential factors that could affect the Company&#8217;s business and financial results will be included in the Company&#8217;s most recent Annual Report on Form 10-K and the Company&#8217;s Quarterly Report on Form 10-Q. Copies of these reports are available at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">http&#58;&#47;&#47;www.sec.gov&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, on the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Company&#8217;s investor&#8217;s page at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;investor.baxter.com&#47;investors&#47;investor-overview&#47;default.aspx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and upon request to the Company.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In addition, Australian Participants should be aware that the Australian dollar (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">AUD</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) value of any Shares acquired under the Plan will be affected by the USD&#47;AUD exchange rate. Participation in the Plan involves certain risks related to fluctuations in this rate of exchange.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Common Stock in a U.S. Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Common stock of a U.S. corporation is analogous to ordinary shares of an Australian corporation. Each holder of a Share is entitled to one vote. Dividends may be paid on the Shares out of any funds of the Company legally available for dividends at the discretion of the Board. Further, Shares are not liable to any further calls for payment of capital or for other assessment by the Company and have no sinking fund provisions, pre-emptive rights, conversion rights or redemption provisions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Ascertaining the Market Price of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Australian Participants may ascertain the current market price of an individual Share as traded on NYSE under the symbol &#8220;BAX&#8221; at&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;www.nyse.com&#47;quote&#47;XNYS&#58;BAX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The AUD equivalent of that price can be obtained at&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">https&#58;&#47;&#47;www.rba.gov.au&#47;statistics&#47;frequency&#47;exchange-rates.html</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Please note that this is not a prediction of what the market price of the Shares will be on any applicable Vesting Date or when Shares are issued to Australian Participants (or at any other time), or of the applicable exchange rate at such time.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">BELGIUM</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unless otherwise determined by the Company, the Participant may accept the Options only on or after the 61st day after the date the material terms of the Options are communicated to the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">BRAZIL</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with the Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. By accepting the Options, the Participant acknowledges his or her agreement to comply with applicable Brazilian laws and to pay any and all applicable Tax-Related Items.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This provision supplements Article III (&#8220;Nature of Grant&#8221;) of the Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By accepting the Options, the Participant agrees that (i) the Participant is making an investment decision and (ii) the value of the underlying Shares is not fixed and may increase or decrease over the vesting period without compensation to the Participant. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">CANADA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Forfeiture upon Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This provision supplements </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.4(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of the Options, notwithstanding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.4(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement, the Committee or its delegate may provide that the Participant&#8217;s Termination will occur as of the date the Participant is no longer actually employed or otherwise rendering services to the Service Recipient (regardless of the reason for such Termination and whether or not later found to be invalid or in breach of employment or other laws or otherwise rendering services or the terms of the Participant&#8217;s employment or other service agreement, if any). In such case, unless otherwise provided in the Agreement or extended by the Company, the Participant&#8217;s right to vest in and exercise the Options under the Plan, if any, will terminate as of such date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Termination Date will not be extended by any common law notice period. Notwithstanding the foregoing, however, if applicable employment standards legislation specifically requires continued entitlement to vesting during a statutory notice period, the Participant&#8217;s right to vest in and exercise the Options under the Plan, if any will be allowed to continue for that minimum notice period but then immediately terminate effective as of the last day of the Participant&#8217;s minimum statutory notice period. In the event the date the Participant is no longer providing actual service cannot be reasonably determined under the terms of the Agreement and&#47;or the Plan, the Committee or its delegate shall have the exclusive discretion to determine when the Participant is no longer actively providing services for purposes of the Options (including whether the Participant may still be considered to be providing services while on a leave of absence). Unless the applicable employment standards legislation specifically requires, in the case of the Participant, the Participant will not earn or be entitled to any pro-rated vesting for that portion of time before the date on which his service relationship is terminated (as determined under this provision) nor will the Participant be entitled to any compensation for lost vesting. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant may not be permitted to sell within Canada Shares acquired under the Plan. The Participant may only be permitted to sell or dispose of any Shares acquired under the Plan if such sale or disposal takes place outside of Canada through the facilities of a stock exchange on which the Shares are listed (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">i.e.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the New York Stock Exchange).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">CHILE</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The offer of Options refers to securities not registered in the Registry of Securities or in the Registry of Foreign securities of the Chilean Commission for the Financial Market, and therefore&#58; (i) the Shares shall not be subject to public offering in Chile&#59; and (ii) the Company is not subject to the oversight of the Chilean Commission for the Financial Market nor to the continual information obligations that Chilean law and regulations require from registered issuers.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">CHINA</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The following provisions apply only to the Participants who are subject to exchange control restrictions imposed by the State Administration of Foreign Exchange (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SAFE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), as determined by the Company in its sole discretion&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise of the Options</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant&#8217;s Employer must be registered with SAFE prior to exercise &#47; settlement of the Options. If the Company is unable to obtain registration approval or is required to obtain further approvals on behalf of a member of the Company Group, the exercise or settlement of the Options may be suspended or delayed. Further, the Company is under no obligation to vest the Options and&#47;or issue Shares upon exercise if the Company&#8217;s SAFE approval becomes invalid or ceases to be in effect by the time the Options are exercised. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding any provision in the Agreement or the Plan to the contrary, pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.6(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement, unless and until the Company determines otherwise, the method of exercise of the Option shall be limited to a mandatory cashless, sell-all exercise method.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding any provision in the Agreement or the Plan to the contrary, the Participant acknowledges and agrees that any vested Options that are exercisable at the time of the Participant&#8217;s Termination will expire 90 (ninety) days</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">after the Participant incurs a Termination. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Control Information</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant understands and agrees that, to facilitate compliance with exchange control requirements, the Participant will be required to immediately repatriate to China the cash proceeds from the cashless sell-all exercise of the Options. The Participant further understands that, under local law, such repatriation of the cash proceeds will be effectuated through a special exchange control account established by the Company or one of its Subsidiaries in China, and the Participant hereby consents and agrees that the cash proceeds related to the Participant&#8217;s participation in the Plan may be transferred to such special account prior to being delivered to the Participant. The Company may deliver the proceeds to the Participant in U.S. dollars or local currency at the Company&#8217;s discretion. If the proceeds are paid in U.S. dollars, the Participant understands that he or she will be required to set up a U.S. dollar bank account in China so that the proceeds may be deposited into this account. If the proceeds are converted to local currency, there may be delays in delivering the proceeds to the Participant. The Participant agrees to bear the risk of any currency fluctuation between the time the Shares are sold and the time such proceeds are distributed to the Participant through the special exchange control account.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant further agrees to comply with any other requirements that may be imposed by the Company in the future to facilitate compliance with exchange control requirements in China.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">COLOMBIA</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This provision supplements Article III (&#8220;Nature of Grant&#8221;) of the Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant acknowledges that, pursuant to Article 128 of the Colombian Labor Code, the Options and related benefits do not constitute a component of the Participant&#8217;s &#8220;salary&#8221; for any legal purpose. Therefore, the Options and related benefits will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as legal&#47;fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions and&#47;or any other labor-related amount which may be payable.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Shares are not and will not be registered in the Colombian registry of publicly traded securities (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Registro Nacional de Valores y Emisores</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) and, therefore, the Shares may not be offered to the public in Colombia. Nothing in this document should be construed as the making of a public offer of securities in Colombia.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">FRANCE</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Terms and Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Consent to Receive Information in English</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> In accepting the Options, the Participant confirms having read and understood the documents relating to this grant (the Plan and this Agreement), which were provided in the English language. The Participant accepts the terms of those documents accordingly.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Consentement &#224; recevoir des informations en anglais</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">. En acceptant l'Option, le participant confirme ainsi avoir lu et compris les documents relatifs &#224; cette attribution (le Plan U.S. et ce Contrat d&#8217;Attribution) qui ont &#233;t&#233; communiqu&#233;s en langue anglaise. Le participant accepte les termes en connaissance de cause.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">The following provisions apply only if the Participant is eligible to be granted French-qualified Options under the Rules of the Baxter International Inc. 2021 Incentive Plan for Stock Options and Restricted Stock Units Granted to Participants in France (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">French Sub-Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#8221;). If the Participant is ineligible to be granted French-qualified Options under the French Sub-Plan, the Options will not qualify for the special French tax and social security treatment under Sections L. 225-177 to L. 225-186 and Sections L. 22-10-56 to L. 22-10-58 of the French Commercial Code, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Type of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Options are granted as French-qualified Options and are intended to qualify for the special tax and social security treatment in France under Sections L. 225-177 to L. 225-186 and Sections L. 22-10-56 to L. 22-10-58 of the French Commercial Code, as amended. The French-qualified Options are granted subject to the French Sub-Plan. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Certain events may affect the status of the Options as French-qualified Options, and the French-qualified Options or the underlying Shares may be disqualified in the future. The Company does not make any undertaking or representation to maintain the qualified status of the French-qualified Options or of the underlying Shares. Capitalized terms not defined herein, in the Agreement or the Plan shall have the meanings ascribed to them in the French Sub-Plan. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:11pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Holding Periods for Managing Corporate Officers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If on the Effective Grant Date (as defined in the French Sub-Plan) the Participant qualifies as a managing corporate officer under French law (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">mandataires sociaux</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) or any similar official capacity of the Company or a qualifying related company, the Participant may not sell 20% of the Shares acquired upon exercise of the French-qualified Options until the termination of such official capacity, as long as this restriction is applicable to French-qualified Options.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">No Transfer of French-qualified Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The French-qualified Options may not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of in any manner during the Participant&#8217;s lifetime and upon death only in accordance with Section II.4 of the French Sub-Plan, and only to the extent required by applicable laws (including the provisions of Sections L. 225-177 to L. 225-186 and Sections L. 22-10-56 to L. 22-10-58 of the French Commercial Code, as amended).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Term of the Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding anything in the Plan or the Agreement, the French-qualified Options will expire nine (9) years and six (6) months from the Effective Grant Date (as defined in the French Sub-Plan), unless sooner terminated, forfeited, or canceled in accordance with the provisions of the Plan or the Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Termination Due to Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding anything in the Plan or the Agreement, in the event of the Participant&#8217;s Termination due to death prior to the satisfaction of the vesting conditions set forth in the vesting schedule of the Grant Notice, any portion of the French-qualified Options that have not vested as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of such date will immediately vest and the Participant&#8217;s rights under the French-qualified Options may be exercised by the Participant&#8217;s legal heirs within six (6) months of the date of death. If the Participant&#8217;s heirs do not exercise the unexercised portion of the French-qualified Options within six (6) months of the date of death, the unexercised portion of the French-qualified Options will terminate and be forfeited.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notifications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Foreign Asset&#47;Account Reporting Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If the Participant is a French resident and holds Shares outside of France or maintain a foreign bank account, the Participant is required to report such account opened, held, used or closed abroad during all or part of an applicable fiscal year to the French tax authorities when filing the Participant&#8217;s tax return.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">HONG KONG</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Important Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Securities Warning</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58; The contents of the Grant Notice, the Agreement, this Non-U.S. Addendum, the Plan, and all other materials pertaining to the Options and&#47;or the Plan have not been reviewed by any regulatory authority in Hong Kong. The Participant is hereby advised to exercise caution in relation to the offer thereunder. If the Participant has any doubts about any of the contents of the aforesaid materials, the Participant should obtain independent professional advice. The Options and any Shares issued in respect of the Options do not constitute a public offering of securities under Hong Kong law and are available only to eligible employees under the Plan. The Grant Notice, the Agreement, including this Non-U.S. Addendum, the Plan and other incidental communication materials have not been prepared in accordance with and are not intended to constitute a &#8220;prospectus&#8221; for a public offering of securities under the applicable securities legislation in Hong Kong. The Options and any documentation related thereto are intended solely for the Participant&#8217;s personal use and may not be distributed to any other person.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If, for any reason, Shares are issued to the Participant within six (6) months of the Date of Grant, the Participant agrees that he or she will not sell or otherwise dispose of any such Shares prior to the six-month anniversary of the Date of Grant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding anything to the contrary in this the Grant Notice, the Agreement, this Non-U.S. Addendum or the Plan, the Options shall be settled only in Shares (and may not be settled in cash).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">INDONESIA</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Language Consent </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By accepting the Options, the Participant (i) confirms having read and understood the documents relating to the grant (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Plan and the Agreement) which were provided in the English language, (ii) accepts the terms of those documents accordingly, and (iii) agrees not to challenge the validity of this document based on Law No. 24 of 2009 on National Flag, Language, Coat of Arms and National Anthem or the implementing Presidential Regulation (when issued).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Persetujuan Bahasa</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Dengan menerima pemberian Opsi Saham, anda (i) memberikan konfirmasi bahwa anda telah membaca dan memahami dokumen-dokumen berkaitan dengan pemberian ini (yaitu, Program dan Perjanjian) yang disediakan dalam Bahasa Inggris, (ii) menerima persyaratan di dalam dokumen-dokumen tersebut, dan (iii) setuju untuk tidak mengajukan keberatan atas keberlakuan dari dokumen ini berdasarkan Undang-Undang No. 24 Tahun 2009 tentang Bendera, Bahasa dan Lambang Negara serta Lagu Kebangsaan ataupun Peraturan Presiden sebagai pelaksanaannya (ketika diterbitkan).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">ISRAEL</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The following provision supplements </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.6(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If Shares are delivered to the Participant pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.6(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement, the Company reserves the right to require that the Participant sell all Shares underlying the Options, either immediately upon exercise of the Options or upon the Participant&#8217;s Termination, to facilitate compliance with tax withholding obligations in Israel. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In this regard, the Participant agrees that the Company is authorized to instruct its designated broker to assist with any such mandatory sale of Shares (on the Participant&#8217;s behalf pursuant to this authorization), and the Participant expressly authorizes the designated broker to complete the sale of such Shares. The Participant also agrees to sign any agreements, forms and&#47;or consents that may be reasonably requested by the Company (or the designated broker) to effectuate the sale of the Shares and shall otherwise cooperate with the Company with respect to such matters, provided that the Participant shall not be permitted to exercise any influence over how, when or whether the sales occur. The Participant acknowledges that the designated broker is under no obligation to arrange for the sale of the Shares at any particular price. Due to fluctuations in the Share price and&#47;or applicable exchange rates between the date the Shares are delivered to the Participant and (if later) the date on which the Shares are sold, the amount of proceeds ultimately distributed to the Participant may be more or less than the market value of the Shares on the exercise date or the date the shares are delivered to the Participant. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Upon the sale of the Shares, the cash proceeds from the sale of Shares (less any applicable Tax-Related Items, brokerage fees or commissions) will be delivered to the Participant in accordance with applicable laws and regulations.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This offer of Options does not constitute a public offering under the Securities Law, 1968. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">ITALY</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Method of Exercise of Options</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding any provision in the Agreement or the Plan to the contrary, pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.6(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement, unless and until the Company determines otherwise, the method of exercise of the Option shall be limited to a mandatory cashless, sell-all exercise method.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan Document Acknowledgment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By accepting the Options, the Participant acknowledges that he or she has received a copy of the Plan, the Agreement and the Notice and has reviewed the Plan, the Agreement, including this Non-U.S. Addendum, and the Grant Notice in their entirety and fully understands and accepts all provisions of the Plan, the Agreement, including this Non-U.S. Addendum, and the Grant Notice.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant further acknowledges that he or she has read and specifically and expressly approves the following provisions of the Agreement&#58; (i) Impact of Termination on the Options&#59; (ii)&#160;Exercise of  Options&#59; (iii) Tax Withholding&#59; (iv) Governing Law&#59; Venue&#59; (v) Electronic Delivery and Acceptance&#59; (vi)&#160;the Nature of Grant&#59; (vii) Data Privacy and (vii) the Vesting Schedule in the Grant Notice.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">MEXICO</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan Document Acknowledgement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By accepting the Options, the Participant acknowledges that he or she has received a copy of the Plan, the Grant Notice, and the Agreement, including this Non-U.S. Addendum, which the Participant has </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reviewed. The Participant acknowledges further that he or she accepts all the provisions of the Plan, the Grant Notice, and the Agreement, including this Non-U.S. Addendum. The Participant also acknowledges that he or she has read and specifically and expressly approves the terms and conditions set forth in Article III (&#8220;Nature of Grant&#8221;) in the Agreement, which clearly provides as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;The Participant&#8217;s participation in the Plan does not constitute an acquired right&#59; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;The Plan and the Participant&#8217;s participation in it are offered by the Company on a wholly discretionary basis&#59; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;The Participant&#8217;s participation in the Plan is voluntary&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;No member of the Company Group is responsible for any decrease in the value of any Shares acquired at exercise and settlement of the Options. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Labor Law Policy and Acknowledgment</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By accepting the Options, the Participant expressly recognizes that the Company, with registered offices at One Baxter Parkway, Deerfield, Illinois, 60015, USA, is solely responsible for the administration of the Plan and that the Participant&#8217;s participation in the Plan and acquisition of Shares do not constitute an employment relationship between the Participant and the Company since the Participant is participating in the Plan on a wholly commercial basis and his or her sole employer is Baxter M&#233;xico, S. de R.L de C MEX (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Baxter Mexico</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Based on the foregoing, the Participant expressly recognizes that the Plan and the benefits that he or she may derive from participating in the Plan do not establish any rights between the Participant and the employer, Baxter Mexico, and do not form part of the employment conditions and&#47;or benefits provided by Baxter Mexico, and any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of the Participant&#8217;s employment.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant further understands that his or her participation in the Plan is as a result of a unilateral and discretionary decision of the Company&#59; therefore, the Company reserves the absolute right to amend and&#47;or discontinue the Participant&#8217;s participation at any time without any liability to the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finally, the Participant hereby declares that he or she does not reserve to him- or herself any action or right to bring any claim against the Company for any compensation or damages regarding any provision of the Plan or the benefits derived under the Plan, and the Participant therefore grants a full and broad release to the Company, and its subsidiaries, branches, representative offices, shareholders, directors, officers, employees, agents, or legal representatives with respect to any claim that may arise.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Spanish Translation</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Reconocimiento del Documento del Plan</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Al aceptar las Opci&#243;n Sobre Acciones Restringidas (Options, por sus siglas en ingl&#233;s), el Participante reconoce que ha recibido una copia del Plan, el Anuncio de la Subvenci&#243;n y el Acuerdo, con inclusi&#243;n de este Anexo A, que el Participante ha revisado. El Participante reconoce, adem&#225;s, que acepta todas las disposiciones del Plan, el Anuncio de la Subvenci&#243;n, y en el Acuerdo, incluyendo este Anexo A. El Participante tambi&#233;n reconoce que ha le&#237;do y que concretamente aprueba de forma expresa los t&#233;rminos y condiciones establecidos en la Secci&#243;n 1 (&#8220;Naturaleza de la Subvenci&#243;n&#8221;) del Acuerdo, que claramente dispone lo siguiente&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;La participaci&#243;n del Participante en el Plan no constituye un derecho adquirido&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;El Plan y la participaci&#243;n del Participante en el Plan se ofrecen por la Compa&#241;&#237;a en su discrecionalidad total&#59; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;Que la participaci&#243;n del Participante en el Plan es voluntaria&#59; y</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;La Compa&#241;&#237;a y sus Empresas Matrices, Subsidiarias y Afiliadas no son responsables de ninguna disminuci&#243;n en el valor de las acciones adquiridas al conferir las Options.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Pol&#237;tica Laboral y Reconocimiento</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Al aceptar las Options, el Participante expresamente reconoce que la Compa&#241;&#237;a, con sus oficinas registradas y ubicadas en One Baxter Parkway, Deerfield, Illinois, 60015, USA, es la &#250;nica responsable por la administraci&#243;n del Plan y que la participaci&#243;n del Participante en el Plan y en su caso la adquisici&#243;n de Acciones no constituyen una relaci&#243;n de trabajo entre el Participante y la Compa&#241;&#237;a, ya que el Participante participa en el Plan en un marco totalmente comercial y su &#250;nico patr&#243;n es Baxter M&#233;xico, S. de R.L de C MEX (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Baxter Mexico</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#8221;). Derivado de lo anterior, el Participante expresamente reconoce que el Plan y los beneficios que pudieran derivar de la participaci&#243;n en el Plan no establecen derecho alguno entre el Participante y el patr&#243;n, Baxter Mexico, y no forma parte de las condiciones de trabajo y&#47;o las prestaciones otorgadas por Baxter Mexico, y que cualquier modificaci&#243;n al Plan o su terminaci&#243;n no constituye un cambio o desmejora de los t&#233;rminos y condiciones de la relaci&#243;n de trabajo del Participante.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Asimismo, el Participante reconoce que su participaci&#243;n en el Plan se ha resultado de una decisi&#243;n unilateral y discrecional de la Compa&#241;&#237;a&#59; por lo tanto, la Compa&#241;&#237;a se reserva el derecho absoluto de modificar y&#47;o terminar la participaci&#243;n del Participante en cualquier momento y sin responsabilidad alguna frente el Participante.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Finalmente, el Participante por este medio declara que no se reserva ninguna derecho o acci&#243;n en contra de la Compa&#241;&#237;a por cualquier compensaci&#243;n o da&#241;os y perjuicios en relaci&#243;n de las disposiciones del Plan o de los beneficios derivados del Plan, y por lo tanto, el Participante otorga el m&#225;s amplio finiquito que en derecho proceda a la Compa&#241;&#237;a, y sus filiales, oficinas de representaci&#243;n, accionistas, directores, autoridades, empleados, agentes, o representantes legales en relaci&#243;n con cualquier demanda que pudiera surgir.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Options granted, and any Shares acquired, under the Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico. In addition, the Plan, the Agreement and any other document relating to the Options may not be publicly distributed in Mexico. These materials are addressed to the Participant because of the Participant&#8217;s existing relationship with the Company and any Subsidiary, and these materials should not be reproduced or copied in any form. The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of Baxter Mexico made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">PORTUGAL</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Language Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Participant hereby expressly declares that he or she has full knowledge of the English language and has read, understood and freely accepted and agreed with the terms and conditions established in the Plan and the Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Conhecimento da L&#237;ngua</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Pela presente, o Participante declara expressamente que tem pleno conhecimento da l&#237;ngua inglesa e que leu, compreendeu e livremente aceitou e concordou com os termos e condi&#231;&#245;es estabelecidas no Plano e no Acordo (Agreement em ingl&#233;s).</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">RUSSIA</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement, the Plan and all other materials the Participant may receive regarding participation in the Plan do not constitute advertising or an offering of securities in Russia. Absent any requirement under </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">local law, the issuance of Shares under the Plan has not and will not be registered in Russia and hence the shares described in any Plan-related documents may not be offered or placed in public circulation in Russia. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Transaction</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant understands that the Options and any Shares under the Plan are to be issued and sold solely in the United States. Any Shares issued to the Participant upon exercise of the Options shall be delivered to the Participant&#8217;s brokerage account in the United States, where such Shares must be held until the time of sale. In no event will Shares be delivered to the Participant in Russia. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Information</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Anti-corruption laws prohibit certain public servants, their spouses and their dependent children from owning any foreign source financial instruments (e.g., shares of foreign companies such as the Corporation). Accordingly, the Participant should inform the Company if he or she is covered by these laws because the Participant should not hold Shares acquired under the Plan.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Labor Law Information</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If the Participant continues to hold Shares acquired at exercise of the Options after an involuntary Termination, he or she may not be eligible to receive unemployment benefits in Russia.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">SINGAPORE</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Options are being granted pursuant to the &#8220;Qualifying Person&#8221; exemption under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SFA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Plan has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore. Hence, statutory liability under the SFA in relation to the content of prospectuses will not apply. The Participant should note that the Options are subject to section 257 of the SFA and hence the Options may not be offered or sold, or made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore, unless such offer, sale or invitation is made (i) more than six (6) months from the Date of Grant, (ii) pursuant to the exemptions under Part XIII Division 1 Subdivision (4) (other than section 280) of the SFA, or (iii)&#160;pursuant to, and in accordance with the conditions of, any other applicable provisions of the SFA. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In addition, the Participant understands that he or she is permitted to sell Shares acquired under the Plan through the designated broker appointed under the Plan, if any, provided the resale of Shares acquired under the Plan takes place outside of Singapore through the facilities of a stock exchange on which the Shares are listed. The Shares are currently listed on the New York Stock Exchange (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">NYSE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Director Notification Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If the Participant is a director, alternate director, substitute director or shadow director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of a Singapore Subsidiary, the Participant must notify the Singapore Subsidiary in writing within two (2) business days of (i) becoming the registered holder of or acquiring an interest (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, Options, Shares, etc.) in the Company or any Subsidiary, or becoming an alternate director, substitute director or shadow director (as the case may be), whichever occurs last, or (ii) any change in a previously disclosed interest (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, sale of Shares). If the Participant is the chief executive officer (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">CEO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of a Singapore Subsidiary and the above notification requirements are determined to apply to the CEO of a Singapore Subsidiary, the above notification requirements also may apply to the Participant.</font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> A shadow director is an individual who is not on the board of directors of the Singapore Subsidiary but who has sufficient control so that the board of directors of the Singapore Subsidiary acts in accordance with the directions or instructions of the individual.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">SPAIN</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination and Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This provision supplements </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (&#8220;Impact of Termination on Options&#8221;) of the Agreement and Article III (&#8220;Nature of Grant&#8221;) of the Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In accepting the grant of Options, the Participant consents to participation in the Plan and acknowledges that the Participant has received a copy of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant understands and agrees that, unless otherwise provided in the Agreement, the Participant will forfeit any Options that have not vested as of the date of the Participant&#8217;s Termination ends without entitlement to the underlying Shares or to any amount of indemnification in the event of the Participant&#8217;s Termination for any reason including, but not limited to, resignation, retirement, disciplinary dismissal adjudged to be with cause, disciplinary dismissal adjudged or recognized to be without cause (i.e., subject to a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">despido improcedente</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), individual or collective dismissal on objective grounds, whether adjudged or recognized to be with or without cause, material modification of the terms of employment or service under Article 41 of the Workers&#8217; Statute, relocation under Article 40 of the Workers&#8217; Statute, and&#47;or Article 50 of the Workers&#8217; Statute, unilateral withdrawal by the Employer and under Article 10.3 of the Royal Decree 1382&#47;1985.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant understands that the Company has unilaterally, gratuitously and in its own discretion decided to grant Options under the Plan to certain individuals who may be employees of the Company or a Subsidiary throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not bind the Company or a Subsidiary, other than as set forth in the Agreement. Consequently, the Participant understands that the Options are granted on the assumption and condition that the Options and any Shares acquired upon exercise of the Options are not a part of any employment contract (either with the Company or a Subsidiary) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation), or any other right whatsoever. Further, the Participant understands that the Options would not be granted to the Participant but for the assumptions and conditions referred to above&#59; thus, the Participant acknowledges and freely accepts that should any or all of the assumptions be mistaken, or should any of the conditions not be met for any reason, any grant of or right to the Options shall be null and void. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No &#8220;offer of securities to the public,&#8221; as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the grant of Options under the Plan. Neither the Plan, the Agreement (which includes this Non-U.S. Addendum), nor the Grant Notice have been nor will they be registered with the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Comisi&#243;n Nacional del Mercado de Valores</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (Spanish Securities Exchange Commission), and they do not constitute a public offering prospectus.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">SWEDEN</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The following provision supplements </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (&#8220;Tax Withholding&#8221;) of the Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without limiting the Company&#8217;s and the Employer&#8217;s authority to satisfy their withholding obligations for Tax-Related Items as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Award Agreement, in accepting the grant of Options, the Participant authorizes the Company and&#47;or the Employer to withhold Shares or to sell Shares otherwise deliverable to the Participant upon exercise&#47;settlement to satisfy Tax-Related Items, regardless of whether the Company and&#47;or the Employer have an obligation to withhold such Tax-Related Items.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">SWITZERLAND</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Neither this document nor any other materials relating to the Options constitute a prospectus according to article 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">FinSA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and neither this document nor any other materials relating to the Options may be publicly distributed nor otherwise made publicly available in Switzerland to any person other than an employee of a member of the Company Group. Neither this document nor any other offering or marketing material relating to the Options have been or will be filed with, or approved or supervised by, any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority (in particular, the Swiss Financial Market Supervisory Authority (FINMA)).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">TAIWAN</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The offer of participation in the Plan is available only for employees of the Company and its Subsidiaries. The offer of participation in the Plan is not a public offer of securities by a Taiwanese company.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">TURKEY</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The sale of Shares acquired under the Plan is not permitted within Turkey. The sale of Shares acquired under the Plan must occur outside Turkey and through the facilities of a stock exchange on which the Shares are listed. The Shares are currently listed on the New York Stock Exchange (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">NYSE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">UNITED ARAB EMIRATES</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This provision supplements Article III (&#8220;Nature of Grant&#8221;) of the Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Participant acknowledges that the Options and related benefits do not constitute a component of the Participant&#8217;s &#8220;wages&#8221; for any legal purpose. Therefore, the Options and related benefits will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as social insurance contributions and&#47;or any other labor-related amounts which may be payable.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Agreement, the Grant Notice, the Plan and other incidental communication materials concerning the Options are intended for distribution only to employees of the Company or its Subsidiaries. The Dubai Creative Clusters Authority (formerly known as the Dubai Technology and Media Free Zone Authority), Emirates Securities and Commodities Authority and&#47;or the Central Bank of the United Arab Emirates has no responsibility for reviewing or verifying any documents in connection with the Options. Neither the Ministry of Economy nor the Dubai Department of Economic Development have approved these communications nor taken steps to verify the information set out in them, and have no responsibility for them.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Further, the Shares underlying the Options may be illiquid and&#47;or subject to restrictions on their resale. The Participant should conduct his or her own due diligence on the Options and the Shares. If the Participant is in any doubt about any of the contents of the grant or other incidental documents, the Participant should obtain independent professional advice.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">UNITED KINGDOM </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This provision supplements </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without limitation to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement, the Participant agrees that he or she is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company or, if different, the Employer or by Her Majesty&#8217;s Revenue &#38; Customs (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">HMRC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (or any other tax authority or any other relevant authority). The Participant also agrees to indemnify and keep indemnified the Company and, if different, the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Participant&#8217;s behalf.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if the Participant is a director or executive officer (within the meaning of Section 13(k) of the Exchange Act), the Participant understands that he or she may not be able to indemnify the Company for the amount of any income tax not collected from or paid by the Participant within ninety (90) days of the end of the U.K. tax year in which the event giving rise to the Tax-Related Items occurs, as it may be considered to be a loan and, therefore, it may constitute a benefit to the Participant on which additional income tax and National Insurance contributions (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">NICs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) may be payable. The Participant understands that he or she will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying to the Company and&#47;or the Employer (as appropriate) the amount of any NICs due on this additional benefit, which may also be recovered from the Participant by any of the means referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:123.35pt;padding-right:123.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT B</font></div><div style="padding-left:123.35pt;padding-right:123.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Baxter International Inc.</font></div><div style="padding-left:123.4pt;padding-right:123.4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Incentive Compensation Recoupment Policy</font></div><div style="margin-bottom:12pt;margin-top:0.15pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.0&#160;&#160;&#160;&#160;Introduction</font></div><div style="padding-left:5pt;padding-right:4.45pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:4.45pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This policy applies to all cash bonuses paid by Baxter International Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and its subsidiaries under its 2007 Incentive Plan, or any successor Plan, and all grants of equity awarded by the Company to any person who is not designated as an officer by the Board of Directors of the Company. Cash bonuses and grants of equity made to such officers are covered by the Executive Compensation Recoupment Policy. Collectively such cash bonuses and equity awards will be referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;. Equity awards are any compensatory awards under the company&#8217;s equity compensation plans in the form of common stock or any derivative of common stock, including stock options, stock awards, restricted stock, restricted   stock units, and performance share units.</font></div><div style="padding-left:5pt;padding-right:4.45pt;text-align:justify"><font><br></font></div><div style="padding-left:41pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:22.3pt">Triggers&#59; Scope of Actions</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.75pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.3pt">Following a restatement of the Company&#8217;s financial results requiring an amendment to any previously filed results, the Chairman and CEO (the &#8220;CEO&#8221;) will review the facts and circumstances that led to the requirement for the restatement and take any actions it deems appropriate with respect to Incentive Compensation. The CEO will consider whether an employee received compensation based on performance reported but not actually achieved or was accountable for the events that led to the restatement, including any misconduct.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.45pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.3pt">If an employee violates any of the restrictive covenants contained in any agreement between the employee and the Company, the Chairman and CEO will review the facts and circumstances related to the violation and take any actions it deems appropriate with respect to Incentive Compensation.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:41pt;padding-right:7.8pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.3pt">Actions that may be taken include&#58; recovery, reduction, or forfeiture of all or part of any Incentive Compensation previously provided or to be provided in the future&#59; disciplinary actions&#59; and the pursuit of any other remedies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.0&#160;&#160;&#160;&#160;Documentation</font></div><div style="padding-left:5pt;padding-right:20.05pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:20.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Policy will apply to Equity Plans covering any employee beginning with the Company&#8217;s 2011 Equity Plans. In addition, this Policy will be incorporated into the Company&#8217;s Management Incentive Compensation Program (MICP) beginning with the Company&#8217;s 2011 MICP, as well as any resolutions adopted by the Board or Compensation Committee as a condition to approval of the payout of any cash bonus under the 2007 Incentive Plan, or any successor Plan, beginning with the cash bonuses paid by the Company in March 2012.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3pt;padding-left:90pt;padding-right:90pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT B</font></div><div style="margin-top:3pt;padding-left:90pt;padding-right:90pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Baxter International Inc.</font></div><div style="padding-left:90pt;padding-right:90pt;text-align:center;text-indent:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Executive Compensation Recoupment Policy</font></div><div style="padding-left:90pt;padding-right:90pt;text-align:center;text-indent:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> (As amended and restated on March 8, 2018)</font></div><div style="padding-left:90pt;padding-right:90pt;text-align:center;text-indent:0.1pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.0&#160;&#160;&#160;&#160;Introduction</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:5.95pt;padding-right:8.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This policy (as amended and restated, this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) applies to all cash bonuses paid by Baxter International Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) under its 2007 Incentive Plan, or any successor Plan, and all grants of equity awarded by the Company to any person designated as an officer by the Board of Directors of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Collectively such bonuses and equity awards will be referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Executive Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;. Equity awards are any compensatory awards under the company&#8217;s equity compensation plans in the form of common stock or any derivative of common stock, including stock options, stock awards, restricted stock, restricted stock units, and performance share units. For the avoidance of doubt, this Policy shall apply to any person who is a designated officer either at the time of grant or the time of payment of the Executive Incentive Compensation.</font></div><div style="padding-left:5.95pt;padding-right:8.5pt;text-align:justify"><font><br></font></div><div style="padding-left:6pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.0  &#160;&#160;&#160;&#160;Triggers&#59; Scope of Actions</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:42pt;padding-right:5.2pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Following a restatement of the Company&#8217;s financial results requiring an amendment to any previously filed results, the Board will review the facts and circumstances that led to the requirement for the restatement and take any actions it deems appropriate with respect to Executive Incentive Compensation. The Board will consider whether an officer received compensation based on performance reported but not actually achieved or was accountable for the events that led to the restatement, including any misconduct.</font></div><div style="margin-top:0.55pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:42pt;padding-right:6.7pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">If an officer violates any of the restrictive covenants contained in any agreement between the officer and the Company, the Board will review the facts and circumstances related to the violation and take any actions it deems appropriate with respect to Executive Incentive Compensation.</font></div><div style="padding-left:6pt;padding-right:6.7pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:42pt;padding-right:6.7pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Actions the Board may take include&#58; recovery, reduction, or forfeiture of all or part of any Executive Incentive Compensation previously provided or to be provided in the future&#59; disciplinary actions&#59; and the pursuit of any other remedies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.0&#160;&#160;&#160;&#160;Documentation</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Policy will be incorporated into future Equity Plans covering any officer beginning with the Company&#8217;s 2009 Equity Plan as well as resolutions adopted by the Board or Compensation Committee as a condition to approval of the payout of any cash bonus under the 2007 Incentive Plan, or any successor Plan, to any officer beginning with the cash bonuses paid by the Company in March 2009. The Executive Compensation team will provide a copy of this Policy to each officer.</font></div><div style="padding-left:9pt;text-align:justify"><font><br></font></div><div style="margin-top:3pt;padding-left:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.0&#160;&#160;&#160;&#160;Disclosure</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:6pt;padding-right:8.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event the Board recoups incentive compensation under this Policy, Company management intends to disclose the aggregate amount of incentive compensation recovered under this Policy, so long as the underlying event has already been publicly disclosed publicly by the Company. This disclosure would appear in the Company&#8217;s annual proxy statement following any such Board action and would provide the aggregate amount of recovery for each event if there is more than one applicable event.</font></div><div style="margin-bottom:12pt;padding-left:9pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>bax-20220331xex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id757629646434207a722eb6d721dc502_1"></div><div style="min-height:72.72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10.4     </font></div></div><div style="padding-left:413.85pt"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:31px;margin-bottom:5pt;vertical-align:text-bottom;width:169px"></div><div style="margin-top:1.9pt;padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PRIVATE &#38; CONFIDENTIAL</font></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:72pt;padding-right:423.85pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Andrew Frye </font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:72pt;padding-right:461.85pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:400%">10 June 2019 Dear Andrew,</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employment Agreement</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:72pt;padding-right:63.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With reference to the recent discussion, Baxter Healthcare (Asia) Pte Ltd (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), is pleased to offer you employment under this Employment Agreement (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) and as follows&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.72pt">Conditions to Offer&#58;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:90pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This offer is contingent upon&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:101.75pt;text-indent:-11.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:2.91pt">your securing a valid work pass for employment in Singapore&#59; and</font></div><div style="padding-left:101.75pt;text-indent:-11.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:2.91pt">your resignation from your employment with Baxter Healthcare (Thailand) Co., Ltd.</font></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.72pt">Position and Report</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:90pt;padding-right:71.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Your job title is </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SVP &#38; President, APAC. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">During the term of your employment, the Company may assign you to different roles or position within the organization upon consultation with you.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:90pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">You will continue to report to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jose Almeida, Chairman, CEO &#38; President</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:90pt;padding-right:71.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Your normal place of work is at the Company's office in Singapore but this will vary from time to time depending on the nature of your duties or upon reasonable instruction or direction of the Company. The official hours of work for the Company are 9&#58;00 am to 6&#58;00 pm (including an hour of lunch break) from Monday to Friday inclusive, with Saturdays and Sundays being rest days although you acknowledge that you will be able to work such hours as may be required for the proper performance of your duties without any further remuneration apart from that provided for in this Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.72pt">Effective Transfer Date</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:90pt;padding-right:72.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to your receipt of a valid work pass to work for the Company in Singapore, your transfer to the Company shall be effective on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1 August 2019 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">or any date which is mutually agreed between the Company and you in writing (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:90pt;padding-right:71.95pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By your agreement to transfer to the Company on the Effective Date, you hereby accept and agree that your employment with Baxter Healthcare (Thailand) Co., Ltd. shall terminate by reason of your resignation on 31 July 2019.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:90pt;padding-right:71.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whilst your years of service with Baxter Healthcare (Thailand) Co., Ltd. will be recognized for the purposes of computing contractual and statutory benefits and entitlements under this Agreement, all contractual and statutory benefits and entitlements under your employment with Baxter Healthcare (Thailand) Co., Ltd. will cease with effect from 31 July 2019 and all contractual and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:101%">Baxter Healthcare (Asia) Pte Ltd&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:101%">initials </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:101%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:113%">150 Beach Road #30-01&#47;08, Gateway West, Singapore 189720</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">T </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6826 1900 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">F </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6222 9927&#160;&#160;&#160;&#160;Page 1 of 14</font></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="id757629646434207a722eb6d721dc502_4"></div><hr style="page-break-after:always"><div style="min-height:82.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:90pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">statutory benefits and entitlements are set out in this Agreement.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.72pt">Salary, Bonus, Transportation Allowance and Benefits</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.72pt">Basic Salary &#38; Annual Wage Supplement (AWS)&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:108pt;padding-right:71.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">You will be paid a salary of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S$71,923.00 per month</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Your annual basic salary shall be </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S$935,000.00 per annum</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, inclusive of a 13th month annual wage supplement (&#34;AWS&#34;). To qualify for the AWS of any given year, you are required to have been continuously and actively employed by the Company up through 1 January of the following year. For 2019, your AWS will be prorated based on the Effective Date.</font></div><div><font><br></font></div><div style="padding-left:108pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.18pt">Salary Review&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:108pt;padding-right:72.25pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Your annual basic salary shall be subject to an annual review in accordance with Company policy. Your next salary review is in April 2020 and each year in April thereafter, in accordance with the practice for all employees in Singapore.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.72pt">Transport Allowance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:108pt;padding-right:68.85pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">You will be eligible for transport allowance of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S$4,000.00 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per month or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S$48,000.00 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(per annum) and is subject to the Company&#8217;s transport allowance policy as may be amended by the Company from time to time. The transport allowance, being a fixed and regular amount, is compensation income subject to income tax or any other tax levied on compensation.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:108pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.18pt">MICP Plan&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:108pt;padding-right:72.3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">You will continue to be eligible to participate in the Management Incentive Compensation Program (MICP) with a </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">bonus target of 75% </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of your annual salary.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:108pt;padding-right:71.95pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To qualify for the MICP in any given year, you are required to have been continuously employed by the Company through 1st February of the following year. The actual bonus you will receive will vary depending on both business performance and your individual assessment for the year.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:108pt;padding-right:72.2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Your business region is </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Global Baxter</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Please note that any payout under the MICP is dependent on the satisfaction of certain conditions and shall be at the absolute discretion of the Company. Any decision made by the Company with regards to such payout in any given year or period shall be final and binding.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.72pt">CPF Special Allowance (in lieu of Singapore Social Security Contribution &#8211; CPF)&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:108pt;padding-right:71.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">You will receive a special ex-gratia monthly allowance equivalent to the employer&#8217;s contribution as specified under the rules, terms and conditions that define Central Provident Fund (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CPF</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) by way of payment of an additional 17% of your Salary capped at SGD 1,020 per month (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CPF Ex-Gratia</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;). This fixed monthly allowance is not subject to the annual merit cycle and will remain constant during your employment in Singapore. This allowance will be subject to Singapore Income Tax. Upon you attaining Singapore permanent residency or Singapore citizenship, the CPF Ex-Gratia will cease and the Company will instead make CPF contributions according to the prevailing CPF contribution rates as stipulated by applicable laws and regulations directly to your CPF Account and the Company shall be entitled to recover from you the employee&#8217;s share of the contribution amount permitted in accordance with the Central Provident Fund Act, (Cap. 36) (if applicable).</font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_2.jpg" src="image_2.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:67px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.565%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10.45pt;padding-left:5.75pt"><font><br></font></div><div style="margin-top:10.45pt;padding-left:5.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Page 2 of 14</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:33.252%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Baxter Healthcare (Asia) Pte Ltd</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:114%">150 Beach Road #30-01&#47;08, Gateway West, Singapore 189720</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">T </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6826 1900 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">F </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6222 9927</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:4.030%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">initials</font></div></td></tr></table></div></div></div><div id="id757629646434207a722eb6d721dc502_7"></div><hr style="page-break-after:always"><div style="min-height:82.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:108pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">f.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:11.95pt">Annual Leave&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:108pt;padding-right:71.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition to gazetted public holidays, your annual leave entitlement will be </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30 days</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. You will not be able to use your annual leave to offset notice periods unless approved by the Company. For the avoidance of doubt, any annual leave you were entitled to during your employment with Baxter Healthcare (Thailand) Co., Ltd. will cease upon your resignation with Baxter Healthcare (Thailand) Co., Ltd.</font></div><div><font><br></font></div><div style="padding-left:108pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">g.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.18pt">Other Benefits&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:108pt;padding-right:72.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">You will be eligible for employee benefits and other employment programs offered by the Company which includes life and medical insurance as per the attached Schedule. For the avoidance of doubt, any benefit or employment programs administered by the Company shall be subject to amendment by the Company from time to time and any change shall be effective when implemented by the Company. Please note that such implementation is usually effective when published on the Baxter intranet website and may not be personally notified to all employees.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:108pt;padding-right:72.35pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Save as expressly set out in this Agreement, you shall not be entitled to any other salary, compensation or benefit of any kind.</font></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.72pt">Deductions</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:90pt;padding-right:71.85pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To the extent permitted by law, the Company shall be entitled to deduct&#58; (a) any amounts owed to the Company by you from your Salary&#59; (b) any contributions to the Chinese Development Assistance Council Fund, the Eurasian Community Fund, the Mosque Building and Mendaki Fund and the Singapore Indian Development Association Fund (as may be applicable)&#59; (c) any other deductions which may be made as set out in the Employment Act, on termination of employment, you owe any money to the Company, the Company shall be entitled to deduct any such money from any Salary due to you to the extent permitted by law.</font></div><div><font><br></font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.72pt">Taxes</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:90pt;padding-right:72.3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">You shall be fully responsible for all income tax or any other tax levied on your compensation under this Agreement under any competent jurisdiction.</font></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.72pt">Company Policies</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:90pt;padding-right:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">You must also comply with all Company&#8217;s policies, including the Baxter Code of Conduct, which are applicable to all Affiliates of the Company, which shall be deemed to be incorporated by reference into this Agreement. You further acknowledge that Baxter and its Affiliates, being a leading health-care corporation, have a special obligation to ensure that our behavior as a company, and the actions of our employees meet the highest standards of business conduct. Please note that failure by you to comply with any such policy will be regarded as a breach of your employment under this Agreement and you may be subject to disciplinary or other actions of the Company. &#8220;Affiliates&#8221; means all companies under the common control of Baxter Corporation Inc.</font></div><div><font><br></font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.72pt">Employee Handbook</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:90pt;padding-right:72.35pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition to the terms in this Agreement, you are also bound by the terms of the Company&#8217;s Employee Handbook which may be amended from time to time without prior notice. In the event of a conflict, the terms of this Agreement shall take precedence.</font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_2.jpg" src="image_2.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:67px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:8.565%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10.45pt;padding-left:5.75pt"><font><br></font></div><div style="margin-top:10.45pt;padding-left:5.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Page 3 of 14</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:33.252%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Baxter Healthcare (Asia) Pte Ltd</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:114%">150 Beach Road #30-01&#47;08, Gateway West, Singapore 189720</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">T </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6826 1900 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">F </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6222 9927</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:4.030%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">initials</font></div></td></tr></table></div></div></div><div id="id757629646434207a722eb6d721dc502_10"></div><hr style="page-break-after:always"><div style="min-height:82.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:9.72pt">Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:126pt;padding-right:68.7pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:5.78pt">The Company and you may terminate this Agreement without assigning any reason by giving </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">three months&#8217; written notice or payment in lieu of notice. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event the Company terminates you in accordance with Section 19(d) herein assuming that you are not terminated pursuant to Section 9(b) below, you shall be entitled to 18 months of severance pay.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:126pt;padding-right:68.95pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:5.78pt">Despite the forgoing provisions, the Company reserves the right to terminate your employment without notice in the event the Company, after due inquiry (if required under the Employment Act (Cap. 91)) of Singapore), considers that you have committed any act of gross misconduct or serious breach of the terms of this Agreement including, but not limited to, the following reasons&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:144pt;padding-right:74.1pt;text-indent:-26.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.02pt">for your dishonest performance of duties or an intentional criminal offense against the Company&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:144pt;text-indent:-29.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.1pt">if you intentionally cause damage to the Company&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:144pt;padding-right:69.15pt;text-indent:-31.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.03pt">if you violate the Company&#8217;s work rules, regulations or lawful and justifiable orders and a written warning thereof has previously been given by the Company, except in a serious case where the warning is not necessary. The written warning shall be effective for a period of 1 year from the date of the commission of the violation by you&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:144pt;text-indent:-31.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.07pt">if your negligence causes serious damage to the Company&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:144pt;padding-right:69.1pt;text-indent:-29.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:17.99pt">if you are sentenced to imprisonment by a final judgment. In this case, if it is an offense committed through negligence or petty offense, it must be a case where such offense has caused damage to the Company&#59; and&#47;or</font></div><div><font><br></font></div><div style="padding-left:144pt;text-indent:-31.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.07pt">if you cease to have the right to work in Singapore.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:114.5pt;padding-right:72.1pt;text-indent:-28.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.44pt">In case that the Company terminates your employment for any reason other than provided in Section 9(b), the Company shall compensate you for&#58;</font></div><div><font><br></font></div><div style="padding-left:135pt;text-indent:-17.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.07pt">accrued annual leave for the previous year&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:135pt;text-indent:-20.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.1pt">unused annual leave calculated as of the termination date for the year of termination.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:114.5pt;padding-right:69.35pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding anything in this Agreement, the Company however will not compensate you for any annual leave accrued during your employment with Baxter Healthcare (Thailand) Co., Ltd.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:114.6pt;padding-right:71.2pt;text-indent:-28.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.23pt">You acknowledge and agree that your employment under this Agreement may be terminated according to the CIC Agreement (defined below).</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:114.6pt;padding-right:70.3pt;text-indent:-28.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16.23pt">For the avoidance of doubt, the payment of severance pay shall not affect your entitlement to any of the following&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:144pt;text-indent:-26.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.07pt">any accrued but unpaid salary&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:144pt;text-indent:-29.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.1pt">any payment in lieu of accrued but unused holiday&#59; or</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:135pt;padding-right:103.2pt;text-indent:-22.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.03pt">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the reimbursement of expenses, provided that all claims for reimbursement are submitted within four weeks after your termination from employment,</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in relation, in each case, to the period before your termination from employment.</font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:12.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:25.2pt"><font style="color:#000000;font-family:'Bookman Old Style',sans-serif;font-size:18pt;font-style:italic;font-weight:400;line-height:88%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:80%">initials</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Page 4 of 14</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:33.252%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Baxter Healthcare (Asia) Pte Ltd</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:114%">150 Beach Road #30-01&#47;08, Gateway West, Singapore 189720</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">T </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6826 1900 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">F </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6222 9927</font></div></td></tr></table></div></div></div><div id="id757629646434207a722eb6d721dc502_13"></div><hr style="page-break-after:always"><div style="min-height:82.08pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:108pt;padding-right:71.95pt;text-align:justify;text-indent:-22.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.02pt">Upon resignation or termination, all items belonging to the Company must be returned. Such items would include, but are not limited to, any drawings, notebooks, manuals, documents, computerization of technical data, customer lists, specifications files, memoranda or other records of any nature belonging to the Company or any reproduction thereof which may have been provided to you during the course of your employment with the Company, and you shall not undertake or cause any action or deed to be done which might in any way affect the Company&#8217;s reputation of good standing or those of its products or services.</font></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.16pt">No Pre-existing Restrictions</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:90pt;padding-right:71.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Your acceptance of employment under this Agreement confirms that you have no obligations, oral or in writing, with any of your former employers which restrict your ability to be employed by the Company. You understand that your continued employment is contingent upon this representation. Additionally, the Company has not made this offer of employment to you in order to obtain from you any confidential or trade secret information of your former employers, and the Company will not ask you to use or disclose such confidential and trade secret information in your Baxter employment. Indeed, you have a continuing obligation not to use or disclose the confidential and trade secret information of your former employers, and, by entering into Baxter employment, you acknowledge that you will not use or disclose any of the confidential and trade secret information of your former employers.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:9.25pt;padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.16pt">Confidentiality &#38; Restrictive Covenants</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:90pt;padding-right:71.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under this Agreement and after termination thereof, you agree to use any and all confidential information, with which you may or will become familiar as a result of your employment with the Company only for the benefit of the Company or its affiliates and not to disclose it to any third parties, except in the necessary course of business for and on behalf of the Company or its affiliates. All information relating to the Company or its affiliates that is not generally known to the public (including any product or pricing information, client contacts or other client related information, any information relating to the Company&#8217;s or its affiliate&#8217;s operations, business or market strategy) disclosed to you in the course of your employment in the Company remains the property of the Company and you must not use such information in any way other than in the discharge of your duties to the Company.</font></div><div><font><br></font></div><div style="padding-left:90pt;padding-right:71.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Given the confidential information with which you may or will become familiar as a result of your employment with the Company and the significant value of such information to the Company, you agree that, in the event of your leaving the Company&#8217;s employment for any reason, for a period of one year thereafter, within the geographic limits which, Baxter Asia Pacific, and any of their competitors are or would be in actual competition&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:126pt;padding-right:72.3pt;text-align:justify;text-indent:-14.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.06pt">not to directly or indirectly render services (either by employment or otherwise) to any such competitors of the Company or its affiliates&#59; and</font></div><div style="padding-left:126pt;padding-right:71.85pt;text-align:justify;text-indent:-16.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:8.99pt">not to directly or indirectly divert or seek to divert business from the Company, its affiliates and any of the customers of the Company and its affiliates&#59; and</font></div><div style="padding-left:126pt;padding-right:71.8pt;text-align:justify;text-indent:-18.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.07pt">not to induce, attempt to induce, or assist another to induce or attempt to induce any person to terminate his&#47;her employment with the Company or its affiliates or to work for you or for any other person or entity.</font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:119.5pt;text-indent:-29.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:17.33pt">Intellectual Property</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:148.55pt;padding-right:72.05pt;text-align:justify;text-indent:-41.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:36.06pt">The parties acknowledge that you may create Inventions (whether alone or jointly) in the course of your employment with the Company and that you have a special obligation to further the interests of the Company in relation to such Inventions.</font></div><div style="height:71.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:33.252%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Baxter Healthcare (Asia) Pte Ltd</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:114%">150 Beach Road #30-01&#47;08, Gateway West, Singapore 189720</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">T </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6826 1900 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">F </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6222 9927</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.099%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">initials </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:7.809%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Page 5 of 14</font></div></td></tr></table></div></div></div><div id="id757629646434207a722eb6d721dc502_16"></div><hr style="page-break-after:always"><div style="min-height:82.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:148.55pt;padding-right:71.85pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the terms of the Copyright Act (Cap. 63), the Patent Act (Cap. 221), the Registered Designs Act (Cap. 266) and any other relevant laws, you must, promptly following creation, disclose to the Company all such Inventions and works embodying Intellectual Property of the Company (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company Intellectual Property</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;).</font></div><div><font><br></font></div><div style="padding-left:144pt;padding-right:71.95pt;text-align:justify;text-indent:-43.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:35.99pt">You acknowledge that (except to the extent prohibited by or ineffective in law) all Company Intellectual Property and materials embodying them automatically belong to the Company as from creation for the full term of those rights and (except to the extent prohibited by or ineffective in law), you now assign, by way of present and future assignment, any and all the right, title and interest to the Company (or its nominee).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:144pt;padding-right:72pt;text-align:justify;text-indent:-45.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:36.07pt">To the extent that any Company Intellectual Property does not vest in the Company automatically pursuant to this clause 11(c) (and except to the extent prohibited by or ineffective in law), You hold such property on trust for the Company absolutely and hereby grant to the Company an exclusive, royalty free licence to use such property in its discretion until such Company Intellectual Property fully vests in the Company.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:144pt;padding-right:71.8pt;text-align:justify;text-indent:-46pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:36.01pt">To the extent that any Inventions created by you (whether alone or jointly) at any time during the course of your employment are prohibited by or prevented in law from automatically vesting with the Company pursuant to this clause 11. You must, immediately upon creation of such rights, grant the Company a right of first refusal, in writing, to acquire them on arm's length terms to be agreed between the parties.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:144pt;padding-right:71.85pt;text-align:justify;text-indent:-43.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:36.03pt">You confirm that you have disclosed all Prior Works to the Company. To the extent that no such disclosures have been made, you confirm there are no Prior Works.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:144pt;padding-right:71.75pt;text-align:justify;text-indent:-46pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:36.01pt">If in the course of your employment with the Company, you incorporate into a Company product, process or machine a Prior Work owned by you or in which you have an interest, the Company will have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license to make, have made, modify, use and sell such Prior Work as part of or in connection with such product, process or machine. you acknowledge that the Salary and other benefits that the Company provides to you include consideration for the granting of such license.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:144pt;padding-right:72.1pt;text-align:justify;text-indent:-48.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">vii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:36.04pt">If any Company Intellectual Property is considered by the Company to be patentable, you are obliged, at the Company's written request, to assist the Company in applying at the Company's expense for the necessary patents. You agree&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:180.05pt;padding-right:72.2pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.62pt">to execute all such documents, both during and after your employment, as the Company may require to vest in the Company all right, title and interest pursuant to this Agreement&#59;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:180.05pt;padding-right:72.1pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.62pt">to provide all such information and assistance and do all such further things as the Company may require to enable it to protect, maintain and exploit the Company Intellectual Property to the best advantage, including (without limitation), at the Company's request, applying for the protection of Inventions throughout the world&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:180.05pt;padding-right:72.1pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.06pt">to assist the Company in applying for the registration of any registrable Company Intellectual Property, enable it to enforce the Company Intellectual Property against third parties and to defend claims for infringement of third party Intellectual Property Rights&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:180.05pt;padding-right:72.1pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">D.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.06pt">not to apply or cause others to apply for the registration of any Company Intellectual Property in Singapore or any other part of the world without the prior written consent of the Company&#59; and</font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_2.jpg" src="image_2.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:67px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:7.935%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10.3pt;padding-left:1.9pt"><font><br></font></div><div style="margin-top:10.3pt;padding-left:1.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Page 6 of 14</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:33.252%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Baxter Healthcare (Asia) Pte Ltd</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:114%">150 Beach Road #30-01&#47;08, Gateway West, Singapore 189720</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">T </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6826 1900 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">F </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6222 9927</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:4.030%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">initials</font></div></td></tr></table></div></div></div><div id="id757629646434207a722eb6d721dc502_19"></div><hr style="page-break-after:always"><div style="min-height:82.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:180.05pt;padding-right:72pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.62pt">to keep confidential all Company Intellectual Property unless the Company has consented in writing to its disclosure by you.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:144pt;padding-right:72.15pt;text-align:justify;text-indent:-50.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">viii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:35.97pt">You acknowledge that, except as provided by any applicable laws, no further remuneration or compensation, other than that provided for in this Agreement, is or may become due to you in respect of your compliance with this clause.</font></div><div><font><br></font></div><div style="padding-left:144pt;padding-right:72.15pt;text-align:justify;text-indent:-46pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ix.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:36.01pt">You must do nothing (whether by act or omission) during your employment or at any time thereafter to affect or imperil the validity of any Company Intellectual Property or Inventions.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:144pt;padding-right:72.1pt;text-align:justify;text-indent:-43.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:36.03pt">Discretion as to prosecution, registration or exploitation of any Company Intellectual Property or Invention will be at the sole discretion of the Company. You agree without additional payment to do all such further things and execute (as a deed or otherwise) all such documents as the Company may reasonably require for the purposes of the prosecution of, or any proceedings concerning, any patent, Company Intellectual Property or Invention including, without limitation, the validity or infringement of it.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:144pt;padding-right:72.35pt;text-align:justify;text-indent:-46pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">xi.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:36.01pt">You irrevocably appoint the Company as your attorney in your name to sign, execute, do or deliver on your behalf any deed, document or other instrument and to use your name for the purpose of giving full effect to this clause.</font></div><div><font><br></font></div><div style="padding-left:144pt;padding-right:72.35pt;text-align:justify;text-indent:-48.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">xii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:36.04pt">Rights and obligations under this Agreement will continue in force after termination of this Agreement in respect of any Company Intellectual Property and will be binding on your representatives.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:144pt;padding-right:72.1pt;text-align:justify;text-indent:-50.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">xiii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:35.97pt">You voluntarily and unconditionally consent to all or any acts or omissions by the Company, or persons authorized by the Company, in relation to works which would otherwise infringe your moral rights.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:144pt;padding-right:71.9pt;text-align:justify;text-indent:-51pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">xiv.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:36.01pt">You waive any and all existing and future moral rights in the works as against the Company, its successors and assigns and any licensee.</font></div><div><font><br></font></div><div style="padding-left:144pt;padding-right:72.2pt;text-align:justify;text-indent:-48.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">xv.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:35.98pt">You acknowledge that you have given this consent voluntarily and without reliance on any statement or representation made by the Company or anyone acting on the Company's behalf.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:90pt;padding-right:71.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the purposes of this clause, the following definitions shall apply&#58; (I) &#34;Intellectual Property Rights&#34; means patents, Inventions, copyright and related rights, trademarks, trade names, service marks and domain names, rights in get-up, goodwill, rights to sue for passing off, design rights, semi-conductor topography rights, database rights, confidential information, moral rights, proprietary rights and any other Intellectual Property Rights in each case whether registered or unregistered and including all applications or rights to apply for, and renewals or extensions of such rights and all similar or equivalent rights or forms of protection which subsist or will subsist now or in the future in any part of the world&#59; (II) &#34;Inventions&#34; means any invention, idea, discovery, development, improvement or innovation, processes, formulae, models or prototypes, whether or not patentable or capable of registration, and whether or not recorded in any medium (including, without limitation, any improvement thereto) and (III) &#34;Prior Works&#34; mean all Inventions and any patents, inventions, original works of authorship, developments, improvements, and trade secrets which you discovered, created, or made prior to your employment with the Company relating to the Company's actual, proposed or anticipated business, products or research and development, and which you have not assigned to the Company.</font></div><div><font><br></font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.16pt">Personal Data</font></div><div><font><br></font></div><div style="padding-left:90pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the purposes of this Clause, &#8220;Personal Data&#8221; refers to all data, whether true or not, about an</font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_2.jpg" src="image_2.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:67px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:7.935%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10.3pt;padding-left:1.9pt"><font><br></font></div><div style="margin-top:10.3pt;padding-left:1.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Page 7 of 14</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:33.252%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Baxter Healthcare (Asia) Pte Ltd</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:114%">150 Beach Road #30-01&#47;08, Gateway West, Singapore 189720</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">T </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6826 1900 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">F </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6222 9927</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:4.030%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">initials</font></div></td></tr></table></div></div></div><div id="id757629646434207a722eb6d721dc502_22"></div><hr style="page-break-after:always"><div style="min-height:82.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:90pt;padding-right:69.4pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">individual who can be identified from that data or from that data and other information to which the Company has or is likely to have access. Such data includes but is not limited to contact information (e.g. name, address, telephone number and email address) and billing information (e.g. bank account details, NRIC, passport or other equivalent identification number).</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:90pt;padding-right:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company recognises and respects your privacy rights with regard to Personal Data acquired during the course of your employment and for the purposes of managing or terminating your employment relationship with the Company and you hereby consent to the Company's collection, use, disclosure and processing of your Personal Data.</font></div><div><font><br></font></div><div style="padding-left:90pt;padding-right:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As evidence of its commitment to privacy, the Company collects, uses, discloses and processes Personal Data in accordance with the Singapore Personal Data Protection Act (No. 26 of 2012), it's Personal Data Protection Policy and other policies and procedures to ensure that respect for privacy is a key part of Baxter company culture and operations.</font></div><div><font><br></font></div><div style="padding-left:90pt;padding-right:71.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company reserves the right to update and amend the terms of its Personal Data Protection Policy and other policies and procedures from time to time in compliance with local legislation and&#47;or to meet its global policy requirements and for any other purpose deemed reasonable by the Company. The Company will notify you of any amendments via announcements in an appropriate manner.</font></div><div><font><br></font></div><div style="padding-left:90pt;padding-right:72.25pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If you do not agree to the amended terms, you should inform the Company as soon as possible of the terms to which you do not consent. Pending such notice, if there is any inconsistency between these terms and the amended terms, the amended terms will prevail to the extent of the inconsistency.</font></div><div><font><br></font></div><div style="padding-left:90pt;padding-right:72.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If you would like to obtain a copy of the Company&#8217;s Personal Data Protection Policy, access your Personal Data, correct or update your Personal Data, or if you have any concerns or queries about the treatment of your Personal Data, or if you have any complaints about any of the foregoing matters, please contact the Company&#8217;s Human Resource Department or Baxter&#8217;s Data Protection Officer.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:90pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baxter&#8217;s Data Protection Officer may be contacted at</font></div><div><font><br></font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Baxter International Inc.</font></div><div style="padding-left:90pt;padding-right:229.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Chief Privacy Officer, Global Privacy Office </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One Baxter Parkway Deerfield, IL 60015-4625</font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Contact No.&#58; 1-800-294-5418</font></div><div style="margin-top:0.05pt;padding-left:90pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Email address&#58; </font><font style="color:#3333ff;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">privacy&#64;baxter.com</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.16pt">Continuing Effect</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:90pt;padding-right:71.95pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The termination of this Agreement howsoever arising shall not operate to affect such of the provisions hereof as are expressed to operate or have effect thereafter and shall be without prejudice to any other accrued rights or remedies of the parties.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.16pt">Entire Agreement</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:90pt;padding-right:71.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement, together with the prevailing Company policies, CIC Agreement and addendums, forms the entire agreement between you and the Company in relation to your employment with the Company.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:90pt;padding-right:71.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement supersedes and entirely extinguishes all other oral or written understandings and agreements, arrangements and representations, express or implied, relating to your employment with the Company that may have existed prior to the date of this Agreement. Any such oral or written understandings and agreements, arrangements and representations, express or implied, shall be deemed to have been terminated by mutual consent.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:12.973%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:163%">initials </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:163%;text-decoration:underline">  </font><font style="color:#000000;font-family:'Bookman Old Style',sans-serif;font-size:18pt;font-style:italic;font-weight:400;line-height:163%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:7.9pt;padding-left:32.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Page 8 of 14</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:33.252%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Baxter Healthcare (Asia) Pte Ltd</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:114%">150 Beach Road #30-01&#47;08, Gateway West, Singapore 189720</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">T </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6826 1900 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">F </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6222 9927</font></div></td></tr></table></div></div></div><div id="id757629646434207a722eb6d721dc502_25"></div><hr style="page-break-after:always"><div style="min-height:82.08pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.16pt">Severability</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:90pt;padding-right:71.85pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If any term in this Agreement is determined by a competent authority to be invalid, unlawful or unenforceable, then such term shall to that extent only be severed from the remaining terms and conditions in this Agreement which shall continue to be valid and enforceable to the fullest extent permitted by law.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.16pt">Rights of Third Parties</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:90pt;padding-right:71.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Save for any affiliate of the Company, no person other than you and the Company shall have any rights under the Contracts (Rights of Third Parties) Act (Cap. 53B) to enforce any of the terms in this Agreement.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.16pt">Remedies and Waivers</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:90pt;padding-right:71.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No failure on the part of any party hereto to exercise, and no delay in exercising any right under this Agreement will operate as a waiver thereof, nor will any single or partial exercise of any right under this Agreement preclude any other or further exercise thereof or of the exercise of any other right. The rights and remedies provided in this Agreement are cumulative and not exclusive of any rights or remedies provided by law.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:90pt;padding-right:72.3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any waiver or consent given by any party under this Agreement shall be in writing and may be given subject to such conditions as such party may impose. Any waiver or consent shall be effective only in the instance and for the purpose for which it is given.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.16pt">Governing Law and Dispute Resolution</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:90pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement shall be governed by and construed in accordance with the laws of Singapore.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:90pt;padding-right:72.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any dispute arising out of or in connection with this Agreement, including any question regarding its existence, validity or termination, shall be referred to and finally resolved by arbitration in Singapore in accordance with the Arbitration Rules of the Singapore International Arbitration Centre (&#34;SIAC Rules&#34;) for the time being in force, which rules are deemed to be incorporated by reference in this clause. The Tribunal shall consist of one arbitrator. The language of the arbitration shall be English.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:90pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:4.16pt">Other Provisions&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:126pt;padding-right:69.15pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:5.78pt">You will continue to be eligible for a special agreement in the event of a change in control of the Company (&#8220;CIC Agreement&#8221;). You will receive a new CIC Agreement based upon your Singapore employment.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:126pt;padding-right:68.65pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:5.78pt">If the CIC Agreement does not apply to the termination of your employment, if your employment is terminated by the Company, other than for any of the reasons listed in Section 9(b) herein or due to poor performance or disability, the Company will provide you not more than sixty days following your termination of employment with a lump sum separation payment equal to 18 months&#8217; base salary and bonus target (less any severance benefits payable under any applicable Baxter plan or benefit), provided that you have properly executed within forty-five days following the date of termination and not revoked a customary release of claims in a form reasonably acceptable to the Company. You hereby agree that this lump sum is inclusive of your statutory payments under Singapore laws, e.g. compensation in lieu of advance notice, severance pay, untaken annual leave, repatriation</font></div><div style="height:69.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:4.408%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="padding-left:1pt"><font><br></font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:33.252%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Baxter Healthcare (Asia) Pte Ltd</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:114%">150 Beach Road #30-01&#47;08, Gateway West, Singapore 189720</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">T </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6826 1900 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">F </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6222 9927</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.099%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">initials </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:7.809%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Page 9 of 14</font></div></td></tr></table></div></div></div><div id="id757629646434207a722eb6d721dc502_28"></div><hr style="page-break-after:always"><div style="min-height:97.2pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:126pt;padding-right:68.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">expenses, if any. You also agree that you, in accepting the benefits under this clause, shall have no right whatsoever to make any claim for any other payments or compensations from the Company and shall have no right to make any complaint to or bringing proceedings before any court or authority in respect of the Agreement against the Company including the claim in relation to unfair employment termination. The capitalized terms in this paragraph have the meanings provided in the CIC Agreement without regard to whether a change in control has occurred. This provision will remain effective unless and until the Company adopts a formal severance plan for the executive leadership team for which you are eligible.</font></div><div><font><br></font></div><div style="padding-left:126pt;padding-right:69.1pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">You will be required to own a minimum of Baxter stock equal to four times your base salary. You will have five years from your official Officer appointment to achieve this ownership level.</font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:72pt;padding-right:71.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are confident that you will continue to make a significant contribution to the team at Baxter and the Company as a whole. We look forward to working with you in expanding our businesses in this strategically important market. Please feel free to call us if you have any questions with regard to the terms of this offer.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:72pt;padding-right:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Please express your agreement and acceptance of the employment details, terms and conditions by signing the original copy of this letter and returning it to the Company. This employment offer expires on 17 June 2019 at 5pm.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:9.2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Yours faithfully,</font></div><div style="margin-top:0.05pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">for </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Baxter Healthcare (Asia) Pte Ltd</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><img alt="image_9.jpg" src="image_9.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:216px"></div><div style="padding-left:72pt;padding-right:380pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Human Resources SEA &#38; Global Functions - APAC</font></div><div><font><br></font></div><div style="margin-top:0.35pt"><img alt="image_10.jpg" src="image_10.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:602px"></div><div><font><br></font></div><div><img alt="image_11.jpg" src="image_11.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:610px"></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ACCEPTANCE &#38; ACKNOWLEDGEMENT BY&#58;</font></div><div><font><br></font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:72.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.574%"><tr><td style="width:1.0%"></td><td style="width:49.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">I have read this Agreement and accept employment on the terms and conditions stated above&#58;</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:8.5pt;padding-left:5.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Andrew R Frye</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:11.35pt;padding-left:5.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">July 1, 2018</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:5.25pt;padding-left:5.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Signature</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NRIC&#47; Passport No</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;</font></div></td></tr></table></div><div style="padding-right:72pt;text-align:justify"><font><br></font></div><div style="height:95.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><img alt="image_2.jpg" src="image_2.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:67px"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:13.603%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:26.9pt"><font><br></font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:80%">initials</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Page 10 of 14</font></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:33.126%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.7pt;padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:113%">Baxter Healthcare (Asia) Pte Ltd</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:113%">150 Beach Road #30-01&#47;08, Gateway West, Singapore 189720</font></div><div style="padding-left:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">T </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6826 1900 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">F </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(65) 6222 9927</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>bax-20220331xex105.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i138af41d1a3c46659e55b08be629aa04_1"></div><div style="min-height:49.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10.5</font></div></div><div><font><br></font></div><div style="padding-left:360pt"><img alt="image_0b.jpg" src="image_0b.jpg" style="height:31px;margin-bottom:5pt;vertical-align:text-bottom;width:169px"></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:20pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;&#160;&#160;&#160;&#160;June 10, 2019</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:20pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To&#58;&#160;&#160;&#160;&#160;Andrew Frye</font></div><div><font><br></font></div><div style="padding-left:20pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RE&#58;&#160;&#160;&#160;&#160;Baxter Equity</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:20pt;padding-right:4.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">You will continue to be eligible to participate in the Long-Term Incentive (LTI) Program for senior management in accordance with the terms of the LTI program. The next LTI grant is currently scheduled for March 2020. Your equity target will be USD 1,400,000. The LTI Program delivers this value through a mix of 50% stock options and 50% performance share units. The Company&#8217;s equity targets are assessed annually and are subject to change based on market competitiveness and the company&#8217;s financial performance. Therefore, your equity target in the future may be greater or less than what is stated in this letter. Your actual equity grant will be based on the equity target for your level and an assessment of your individual performance and potential.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:20pt;padding-right:21.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In order to receive these grants (both stock options and RSUs), you will need to sign a Singapore Non- Competition, Non-Solicitation and Confidentiality Agreement (&#8220;Agreement&#8221;) following the grants.</font></div><div><font><br></font></div><div style="margin-top:4.65pt;padding-left:20pt;padding-right:21.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The terms of this addendum are deemed incorporated to your employment agreement dated August 1, 2019.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:20pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have read this Agreement and accept the terms and conditions stated above&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:2.55pt;padding-left:77pt;text-indent:36pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:45.657%"><tr><td style="width:1.0%"></td><td style="width:51.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.251%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">July 1, 2019</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Andrew Frye</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date</font></td></tr></table></div><div style="margin-top:0.2pt;padding-left:20pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:6.05pt;padding-right:6.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div style="margin-top:0.1pt;padding-right:7.3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Initials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>7
<FILENAME>bax-20220331xex106.htm
<DESCRIPTION>EX-10.6
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1ccfdf94ce334413b228736fd2628e82_1"></div><div style="min-height:35.28pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit 10.6</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:403.5pt"><img alt="image_0.jpg" src="image_0.jpg" style="height:25px;margin-bottom:5pt;vertical-align:text-bottom;width:140px"></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.95pt;padding-left:9pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DATE&#58;&#160;&#160;&#160;&#160;June 10, 2019</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TO&#58;&#160;&#160;&#160;&#160;Andrew Frye</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:9pt"><font><br></font></div><div><font><br></font></div><div style="padding-left:9pt;padding-right:310.1pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:232%">Addendum to Singapore Employment Contract Dear Andy,</font></div><div style="padding-left:9pt;padding-right:19.45pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Congratulations on your upcoming International Transfer. This letter outlines the provisions relating to your relocation and general transition to Singapore.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">TRANSFER OF EMPLOYMENT</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.95pt;padding-left:27pt;padding-right:40.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">All conditions in the Company&#8217;s International Transfer Policy apply to your move unless otherwise specified in this letter.</font></div><div><font><br></font></div><div style="padding-left:27pt;padding-right:44.3pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Any employment contracts you may have had with a subsidiary, division or facility of Baxter outside do not transfer or otherwise apply to your Singapore employment (including, without limitation, your employment agreement with Baxter Healthcare (Thailand) Co. Ltd (the &#8220;Contract&#8221;) which terminated by reason of your resignation on July 31, 2019.</font></div><div><font><br></font></div><div style="padding-left:27pt;padding-right:38.05pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Your original hire date of July 1, 2017 under the Contract will be used for future service awards, severance calculations and any applicable contractual or statutory entitlements in Singapore, if applicable.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">TAX</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:27pt;padding-right:43.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">You will be responsible for Singapore taxes relating to any income received as of the effective date of your international transfer. You will also be responsible for Singapore and Thailand taxes relating to any compensation, awards, or benefits granted prior to the effective date of your international transfer, but received after the effective date. From a Baxter perspective, these items of income would include base salary, annual incentive payments, stock options income realized at exercise or sale, restricted stock and other equity awards, benefit plan distributions and other Company-earned income.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:27pt;padding-right:38.6pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">You will receive Singapore, U.S. and Thailand tax preparation services, as required, for the duration you are employed with Baxter Singapore. In the event, you separate from Baxter Singapore, you will receive tax preparation services for the tax year that aligns with the effective date of your separation.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:27pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additionally, you will receive tax consultations through Baxter&#8217;s designated tax preparation firm.</font></div><div><font><br></font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">RELOCATION</font></div><div><font><br></font></div><div style="padding-left:27pt;padding-right:42.9pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The Company will assist you with the relocation expenses listed below. Upon acceptance, a representative from our relocation vendor will be contacting you to initiate your relocation process. You and any eligible family members will have one year from the date of transfer to use these benefits.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:45pt;padding-right:45.85pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:15.08pt">Household Good Shipment Support &#8211; The Company will provide you a shipment of goods to include a sea shipment (up to two 40ft containers) and air shipment (equivalent up to 450 kg).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:45pt;padding-right:71.95pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:15.08pt">Immigration Support &#8211; The Company will assist with the documentation for you and your family members, where eligible, to live and work in Singapore.</font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:1.456%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div></td></tr></table></div></div></div><div id="i1ccfdf94ce334413b228736fd2628e82_4"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:45pt;padding-right:54.2pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:15.08pt">Settling-In Services &#8211; The Company will provide a program to help you settle into your new location, including finding a new rental, signing a lease, etc.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:45pt;padding-right:55.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:15.08pt">Taxes &#8211; The Company will pay any taxes assessed in your new country on these relocation benefits and services.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:27pt;padding-right:46.6pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The Company has committed considerable resources to develop a program that will benefit you during your relocation. You are asked to take part in this partnership and complete the relocation repayment agreement prior to beginning the relocation process. The Company&#8217;s Relocation Vendor, Aires, will collect the agreement electronically through their system.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">MOBILITY BENEFITS</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:27pt;padding-right:45.4pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The Company will provide you a monthly housing allowance of SGD 16,000 during your employment with Baxter in Singapore. You are responsible for maintaining your housing lease, making all rent payments, and paying for any other costs associated with the housing (i.e. utilities, security deposit, etc.) The Company&#8217;s designated relocation vendor will make the monthly rental payments to the bank account and currency of your choice. This allowance will not transition to any future Baxter employment outside of Singapore.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:27pt;padding-right:53pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The Company will reimburse actual registration, tuition fees, and transportation to&#47;from school for your child through high school graduation. No uniforms, books, lunches, field trips, tutoring or extracurricular</font></div><div style="padding-left:27pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:113%">activities will be reimbursed. The Company&#8217;s designated relocation vendor will make the reimbursement to</font></div><div style="padding-left:27pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:113%">the bank account and currency of your choice.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:27pt;padding-right:38.45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The Company will enroll you and your immediate family members in the Company&#8217;s Offshore medical and dental programs. Additionally, you will be enrolled in a life insurance and accidental death and dismemberment (AD&#38;D) program. The Company will pay the cost of the insurance premiums and you will be responsible for any copays and deductibles. Dependent children up to age 26 can be covered under the medical and dental program.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:27pt;padding-right:40.15pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">You hereby agree that these Mobility Benefits (i.e. housing allowance, schooling, and benefit coverage) are purely provided by the Company for your welfare and not in any way considered as wage under any applicable employment law.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:27pt;padding-right:55.95pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">The terms of this addendum are deemed incorporated to your employment agreement dated August 1, 2019.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:9pt;padding-left:11.5pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accepted By&#58;&#160;&#160;&#160;&#160;Date</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:2.1pt;padding-left:7.7pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:18pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Jul 9, 2019</font></div><div style="margin-top:0.45pt"><img alt="image_1.jpg" src="image_1.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:286px"></div><div style="margin-top:1.3pt;padding-left:9pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew Frye</font></div><div style="height:48.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:1.602%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>8
<FILENAME>bax-20220331xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="icfe6f4f43009446e92e827a8557fb3bd_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as Amended</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jos&#233; E. Almeida, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">I have reviewed this Quarterly Report on Form 10-Q of Baxter International Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><font><br></font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jos&#233; E. Almeida</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jos&#233; E. Almeida</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board and</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:58.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; April&#160;28, 2022</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>9
<FILENAME>bax-20220331xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3edfc654f1cc41f4baccd1cac257cfd9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Financial Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as Amended</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, James K. Saccaro, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">I have reviewed this Quarterly Report on Form 10-Q of Baxter International Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; James K. Saccaro</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James K. Saccaro</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Date&#58; April&#160;28, 2022</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>10
<FILENAME>bax-20220331ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i462022dc63c245b29e9517987a436423_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">as Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jos&#233; E. Almeida, as Chairman of the Board and Chief Executive Officer of Baxter International Inc. (the &#8220;Company&#8221;), certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the Company&#8217;s Quarterly Report on Form 10-Q for the quarterly period ended March&#160;31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:24.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.534%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jos&#233; E. Almeida</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jos&#233; E. Almeida</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board and</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-indent:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;28, 2022</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>11
<FILENAME>bax-20220331xex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i64e271d0c3e84856a2c4926240793d9e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">as Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">James K. Saccaro, as Executive Vice President and Chief Financial Officer of Baxter International Inc. (the &#8220;Company&#8221;), certifies, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the Company&#8217;s Quarterly Report on Form 10-Q for the quarterly period ended March&#160;31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:24.266%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.534%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; James K. Saccaro</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James K. Saccaro</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-indent:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;28, 2022</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>bax-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3113e683-fb48-43e6-a6e8-6a2e99588fde,g:c1ee1bb8-6f43-4e7f-a20c-1c092f3191f3-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bax="http://www.baxter.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.baxter.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.baxter.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsunaudited" roleURI="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsunauditedParenthetical" roleURI="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofIncomeunaudited" roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Income (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeunaudited" roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical" roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofChangesinEquityunaudited" roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Changes in Equity (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsunaudited" roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATION" roleURI="http://www.baxter.com/role/BASISOFPRESENTATION">
        <link:definition>2101101 - Disclosure - BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONPolicies" roleURI="http://www.baxter.com/role/BASISOFPRESENTATIONPolicies">
        <link:definition>2202201 - Disclosure - BASIS OF PRESENTATION (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDOTHERARRANGEMENTS" roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTS">
        <link:definition>2103102 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDOTHERARRANGEMENTSTables" roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSTables">
        <link:definition>2304301 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails" roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails">
        <link:definition>2405401 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails" roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails">
        <link:definition>2406402 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Schedule of Total Consideration for Hillrom (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails" roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails">
        <link:definition>2407403 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Summary of Fair Value of Assets Acquired and Liabilities Assumed for Hillrom (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails" roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails">
        <link:definition>2408404 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Other Business Development Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATION" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION">
        <link:definition>2109103 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONTables" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables">
        <link:definition>2310302 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails">
        <link:definition>2411405 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails">
        <link:definition>2412406 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails">
        <link:definition>2413407 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails">
        <link:definition>2414408 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails">
        <link:definition>2415409 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Expense, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails" roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails">
        <link:definition>2416410 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNET" roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET">
        <link:definition>2117104 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNETTables" roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables">
        <link:definition>2318303 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails" roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails">
        <link:definition>2419411 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails" roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails">
        <link:definition>2420412 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails">
        <link:definition>2421413 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCINGARRANGEMENTS" roleURI="http://www.baxter.com/role/FINANCINGARRANGEMENTS">
        <link:definition>2122105 - Disclosure - FINANCING ARRANGEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCINGARRANGEMENTSDetails" roleURI="http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails">
        <link:definition>2423414 - Disclosure - FINANCING ARRANGEMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2124106 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>2425415 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITY">
        <link:definition>2126107 - Disclosure - STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>2327304 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYStockOptionsFairValueAssumptionsDetails" roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITYStockOptionsFairValueAssumptionsDetails">
        <link:definition>2428416 - Disclosure - STOCKHOLDERS' EQUITY - Stock Options Fair Value Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeDetails" roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails">
        <link:definition>2429417 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOME" roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME">
        <link:definition>2130108 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables" roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables">
        <link:definition>2331305 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails" roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails">
        <link:definition>2432418 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Changes in AOCI by Component (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails" roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails">
        <link:definition>2433419 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Amounts Reclassification from AOCI to Net Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUES" roleURI="http://www.baxter.com/role/REVENUES">
        <link:definition>2134109 - Disclosure - REVENUES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESTables" roleURI="http://www.baxter.com/role/REVENUESTables">
        <link:definition>2335306 - Disclosure - REVENUES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESAdditionalInformationDetails" roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails">
        <link:definition>2436420 - Disclosure - REVENUES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESAdditionalInformationDetails_1" roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails_1">
        <link:definition>2436420 - Disclosure - REVENUES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESRemainingPerformanceObligationsDetails" roleURI="http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails">
        <link:definition>2437421 - Disclosure - REVENUES - Remaining Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESRemainingPerformanceObligationsDetails_1" roleURI="http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails_1">
        <link:definition>2437421 - Disclosure - REVENUES - Remaining Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESContractAssetsandContractLiabilitiesDetails" roleURI="http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails">
        <link:definition>2438422 - Disclosure - REVENUES - Contract Assets and Contract Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails" roleURI="http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails">
        <link:definition>2439423 - Disclosure - REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUESLeaseRevenueDetails" roleURI="http://www.baxter.com/role/REVENUESLeaseRevenueDetails">
        <link:definition>2440424 - Disclosure - REVENUES - Lease Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGES" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES">
        <link:definition>2141110 - Disclosure - BUSINESS OPTIMIZATION CHARGES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGESTables" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables">
        <link:definition>2342307 - Disclosure - BUSINESS OPTIMIZATION CHARGES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails">
        <link:definition>2443425 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails">
        <link:definition>2444426 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails">
        <link:definition>2445427 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails" roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails">
        <link:definition>2446428 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS" roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS">
        <link:definition>2147111 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables" roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables">
        <link:definition>2348308 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails">
        <link:definition>2449429 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.baxter.com/role/INCOMETAXES">
        <link:definition>2150112 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.baxter.com/role/INCOMETAXESDetails">
        <link:definition>2451430 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.baxter.com/role/EARNINGSPERSHARE">
        <link:definition>2152113 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.baxter.com/role/EARNINGSPERSHARETables">
        <link:definition>2353309 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails" roleURI="http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails">
        <link:definition>2454431 - Disclosure - EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREAdditionalInformationDetails" roleURI="http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails">
        <link:definition>2455432 - Disclosure - EARNINGS PER SHARE - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES">
        <link:definition>2156114 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables">
        <link:definition>2357310 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails">
        <link:definition>2458433 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails">
        <link:definition>2459434 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails">
        <link:definition>2460435 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails">
        <link:definition>2461436 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails" roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails">
        <link:definition>2462437 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>2163115 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2364311 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>2465438 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSAdditionalInformationDetails" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails">
        <link:definition>2466439 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails">
        <link:definition>2467440 - Disclosure - FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails" roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails">
        <link:definition>2468441 - Disclosure - FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATION" roleURI="http://www.baxter.com/role/SEGMENTINFORMATION">
        <link:definition>2169116 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONTables" roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONTables">
        <link:definition>2370312 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails" roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails">
        <link:definition>2471442 - Disclosure - SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails" roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails">
        <link:definition>2472443 - Disclosure - SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets" abstract="false" name="DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_DerivativeNetInvestmentTerminated" abstract="false" name="DerivativeNetInvestmentTerminated" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_FairValueDisclosuresTable" abstract="true" name="FairValueDisclosuresTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bax_ManufacturingArrangementsMember" abstract="true" name="ManufacturingArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_BusinessCombinationCashConsideration" abstract="false" name="BusinessCombinationCashConsideration" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" abstract="false" name="LongTermDebtAndFinanceLeaseObligationsNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" abstract="true" name="FairValueAndCarryingValueByBalanceSheetGroupingTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bax_ConsumableMedicalProductsMember" abstract="true" name="ConsumableMedicalProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_GlobalNotes13Due2025Member" abstract="true" name="GlobalNotes13Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_SuperfundSitesMember" abstract="true" name="SuperfundSitesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_SiteContingencyNumberOfSites" abstract="false" name="SiteContingencyNumberOfSites" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bax_EMEASegmentMember" abstract="true" name="EMEASegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_BusinessOptimizationChargeTableTextBlock" abstract="false" name="BusinessOptimizationChargeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_HillromMember" abstract="true" name="HillromMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_RisksAndUncertaintiesPolicyPolicyTextBlock" abstract="false" name="RisksAndUncertaintiesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bax_ZosynMember" abstract="true" name="ZosynMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_StockRepurchaseProgramAdditionalAuthorizedAmount" abstract="false" name="StockRepurchaseProgramAdditionalAuthorizedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_AcquisitionsAndCollaborationsLineItems" abstract="true" name="AcquisitionsAndCollaborationsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bax_DerivativeFairValueTerminated" abstract="false" name="DerivativeFairValueTerminated" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_AsiaPacificSegmentMember" abstract="true" name="AsiaPacificSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_ShareBasedCompensationAllocationPercentage" abstract="false" name="ShareBasedCompensationAllocationPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="bax_RevenueRecognizedContractPeriod" abstract="false" name="RevenueRecognizedContractPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bax_AcquisitionsAndCollaborationsTable" abstract="true" name="AcquisitionsAndCollaborationsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bax_CommonStock100PerValueMember" abstract="true" name="CommonStock100PerValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_PharmaceuticalsMember" abstract="true" name="PharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_IntangibleAssetExcludingGoodwillLineItems" abstract="true" name="IntangibleAssetExcludingGoodwillLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember" abstract="true" name="OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_SeniorFiveYearTermLoanMember" abstract="true" name="SeniorFiveYearTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_OtherLiabilitiesCurrentUnsettledShareRepurchase" abstract="false" name="OtherLiabilitiesCurrentUnsettledShareRepurchase" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_OriginalWeightedAverageTerm" abstract="false" name="OriginalWeightedAverageTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" abstract="true" name="AccruedExpensesAndOtherCurrentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_GlobalNotes13Due2029Member" abstract="true" name="GlobalNotes13Due2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember" abstract="true" name="ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_SeveranceAndOtherEmployeeRelatedCostsMember" abstract="true" name="SeveranceAndOtherEmployeeRelatedCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_AssetImpairmentMember" abstract="true" name="AssetImpairmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_MedicationDeliveryMember" abstract="true" name="MedicationDeliveryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" abstract="false" name="LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_ContractWithCustomerLiabilityDeferredRevenue" abstract="false" name="ContractWithCustomerLiabilityDeferredRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_StockholdersEquityNoteLineItems" abstract="true" name="StockholdersEquityNoteLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bax_RevenueFromContractWithCustomerLineItems" abstract="true" name="RevenueFromContractWithCustomerLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bax_RenalMember" abstract="true" name="RenalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_SoftwareArrangementsMember" abstract="true" name="SoftwareArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_LossContingencyNumberOfLawsuits" abstract="false" name="LossContingencyNumberOfLawsuits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bax_AmericasSegmentMember" abstract="true" name="AmericasSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_OtherProductOrServicesMember" abstract="true" name="OtherProductOrServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" abstract="true" name="FairValueAndCarryingValueByBalanceSheetGroupingLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember" abstract="true" name="OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_IntangibleAssetExcludingGoodwillTable" abstract="true" name="IntangibleAssetExcludingGoodwillTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bax_SurgicalSolutionsMember" abstract="true" name="SurgicalSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_PatientSupportSystemsMember" abstract="true" name="PatientSupportSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" abstract="false" name="IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_CommercialPaperWeightedAverageInterestRate" abstract="false" name="CommercialPaperWeightedAverageInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bax_SeniorThreeYearTermLoanMember" abstract="true" name="SeniorThreeYearTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_FairValueDisclosuresLineItems" abstract="true" name="FairValueDisclosuresLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" abstract="false" name="OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_GlobalNotes395Due2030Member" abstract="true" name="GlobalNotes395Due2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" abstract="false" name="ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bax_StockholdersEquityNoteTable" abstract="true" name="StockholdersEquityNoteTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bax_BioPharmaSolutionsMember" abstract="true" name="BioPharmaSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_ContractTerminationAndOtherCostsMember" abstract="true" name="ContractTerminationAndOtherCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_EnviromentalCleanUpMember" abstract="true" name="EnviromentalCleanUpMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability" abstract="false" name="DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_ClinicalNutritionMember" abstract="true" name="ClinicalNutritionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_FrontLineCareMember" abstract="true" name="FrontLineCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_GlobalNotes04Due2024Member" abstract="true" name="GlobalNotes04Due2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_RevenueFromContractWithCustomerTable" abstract="true" name="RevenueFromContractWithCustomerTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" abstract="false" name="OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" abstract="false" name="AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" abstract="false" name="BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_AcuteTherapiesMember" abstract="true" name="AcuteTherapiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" abstract="true" name="BundledEquipmentAndConsumableMedicalProductsContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_DevelopedTechnologyIncludingPatentsMember" abstract="true" name="DevelopedTechnologyIncludingPatentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_RevenueFromContractWithCustomerRollForward" abstract="true" name="RevenueFromContractWithCustomerRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bax_AdvancedSurgeryMember" abstract="true" name="AdvancedSurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure" abstract="false" name="LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" abstract="false" name="ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bax_GlobalNotes173Due2031Member" abstract="true" name="GlobalNotes173Due2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_RevenuePerformanceObligationPaymentTerms" abstract="false" name="RevenuePerformanceObligationPaymentTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="bax_BusinessOptimizationProgramsMember" abstract="true" name="BusinessOptimizationProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>bax-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3113e683-fb48-43e6-a6e8-6a2e99588fde,g:c1ee1bb8-6f43-4e7f-a20c-1c092f3191f3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="simple" xlink:href="bax-20220331.xsd#CondensedConsolidatedBalanceSheetsunaudited"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d55e6ca1-a6cd-48e8-9ee0-727f0c2fed85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6247f579-063a-4fe0-9d92-821ebace02a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d55e6ca1-a6cd-48e8-9ee0-727f0c2fed85" xlink:to="loc_us-gaap_AssetsCurrent_6247f579-063a-4fe0-9d92-821ebace02a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1b0b891a-61cf-4d88-b253-7173d90afaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d55e6ca1-a6cd-48e8-9ee0-727f0c2fed85" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1b0b891a-61cf-4d88-b253-7173d90afaaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6ef23f3e-4fbf-4d56-86e2-bfcc39bbfd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d55e6ca1-a6cd-48e8-9ee0-727f0c2fed85" xlink:to="loc_us-gaap_Goodwill_6ef23f3e-4fbf-4d56-86e2-bfcc39bbfd5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_78ccb3ad-c988-4b27-999f-06726ab8a921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d55e6ca1-a6cd-48e8-9ee0-727f0c2fed85" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_78ccb3ad-c988-4b27-999f-06726ab8a921" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a2d6cb9c-aeef-4b00-af1f-4f2b4ab66583" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d55e6ca1-a6cd-48e8-9ee0-727f0c2fed85" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a2d6cb9c-aeef-4b00-af1f-4f2b4ab66583" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_123a7e4c-64ec-439d-918e-e3e08bbe84e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d55e6ca1-a6cd-48e8-9ee0-727f0c2fed85" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_123a7e4c-64ec-439d-918e-e3e08bbe84e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_42a5fb51-9458-457e-8306-e3387c0a1865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0a1c18df-56b6-4d60-858c-9f786e6344b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_42a5fb51-9458-457e-8306-e3387c0a1865" xlink:to="loc_us-gaap_StockholdersEquity_0a1c18df-56b6-4d60-858c-9f786e6344b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_83675289-fde7-43ca-9653-f01ffaca4adb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_42a5fb51-9458-457e-8306-e3387c0a1865" xlink:to="loc_us-gaap_MinorityInterest_83675289-fde7-43ca-9653-f01ffaca4adb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_939268d8-72f8-46da-b76d-dacd7450425a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_435e8b32-4ef2-4f79-9a99-d4320935f4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_939268d8-72f8-46da-b76d-dacd7450425a" xlink:to="loc_us-gaap_Liabilities_435e8b32-4ef2-4f79-9a99-d4320935f4fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fdc2b811-215c-478e-bd0f-1cefd9633d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_939268d8-72f8-46da-b76d-dacd7450425a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fdc2b811-215c-478e-bd0f-1cefd9633d3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_bdf428f1-2a1f-415c-998e-73e1ced7a682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_939268d8-72f8-46da-b76d-dacd7450425a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_bdf428f1-2a1f-415c-998e-73e1ced7a682" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d3c39bdb-e245-4b11-bdd4-c8e154cdaff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_37914835-6022-4f1d-bd4b-c3421e1f17e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d3c39bdb-e245-4b11-bdd4-c8e154cdaff7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_37914835-6022-4f1d-bd4b-c3421e1f17e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_287bc156-479b-4231-bc1d-d0e9094d437a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d3c39bdb-e245-4b11-bdd4-c8e154cdaff7" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_287bc156-479b-4231-bc1d-d0e9094d437a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_56d120ee-edfb-45c5-8cd6-6d9aa5b87369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d3c39bdb-e245-4b11-bdd4-c8e154cdaff7" xlink:to="loc_us-gaap_InventoryNet_56d120ee-edfb-45c5-8cd6-6d9aa5b87369" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5c0c9b12-2f4d-4714-9b76-b5c3c10d30ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d3c39bdb-e245-4b11-bdd4-c8e154cdaff7" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5c0c9b12-2f4d-4714-9b76-b5c3c10d30ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1c6682d4-5945-4931-9945-ec3fc65b749f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0c09c1b3-874a-46b1-beab-47dbdc1dab87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1c6682d4-5945-4931-9945-ec3fc65b749f" xlink:to="loc_us-gaap_LiabilitiesCurrent_0c09c1b3-874a-46b1-beab-47dbdc1dab87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_e4222292-2518-41cb-9339-86483dcb93d6" xlink:href="bax-20220331.xsd#bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1c6682d4-5945-4931-9945-ec3fc65b749f" xlink:to="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_e4222292-2518-41cb-9339-86483dcb93d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e66efbad-8b4a-4dbb-be4b-f1269f67debf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1c6682d4-5945-4931-9945-ec3fc65b749f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e66efbad-8b4a-4dbb-be4b-f1269f67debf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4a4b1a5c-1750-4365-a2b5-20b2401613ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1c6682d4-5945-4931-9945-ec3fc65b749f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_4a4b1a5c-1750-4365-a2b5-20b2401613ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_550625b2-d85a-4597-b7c9-eb7b70fe8b16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_80a156c2-46c3-4d81-9976-f95db2666afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_550625b2-d85a-4597-b7c9-eb7b70fe8b16" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_80a156c2-46c3-4d81-9976-f95db2666afe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9abd6892-1b2f-4bde-827c-08bb291a3f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_550625b2-d85a-4597-b7c9-eb7b70fe8b16" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9abd6892-1b2f-4bde-827c-08bb291a3f52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_23b68f9d-b399-4a02-a9ea-c974fffb322a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_550625b2-d85a-4597-b7c9-eb7b70fe8b16" xlink:to="loc_us-gaap_CommonStockValue_23b68f9d-b399-4a02-a9ea-c974fffb322a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c559feb5-1191-4aaf-acd6-e2c2ee4ae05b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_550625b2-d85a-4597-b7c9-eb7b70fe8b16" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c559feb5-1191-4aaf-acd6-e2c2ee4ae05b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_6cfccbae-0f6e-4b13-bb24-ecd05bb87de5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_550625b2-d85a-4597-b7c9-eb7b70fe8b16" xlink:to="loc_us-gaap_TreasuryStockValue_6cfccbae-0f6e-4b13-bb24-ecd05bb87de5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_686eaca4-817a-407e-b77f-c0125b46545f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_0d8b974c-6870-4d58-904f-46288899c082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_686eaca4-817a-407e-b77f-c0125b46545f" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_0d8b974c-6870-4d58-904f-46288899c082" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_91476645-9760-48db-ae75-844d232ca0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_686eaca4-817a-407e-b77f-c0125b46545f" xlink:to="loc_us-gaap_AccountsPayableCurrent_91476645-9760-48db-ae75-844d232ca0ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_38aaf769-4e73-4c87-9f6e-5c9dea3bfa18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_686eaca4-817a-407e-b77f-c0125b46545f" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_38aaf769-4e73-4c87-9f6e-5c9dea3bfa18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_788ec6db-4e92-4d5f-88ae-7af315c1b674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_686eaca4-817a-407e-b77f-c0125b46545f" xlink:to="loc_us-gaap_ShortTermBorrowings_788ec6db-4e92-4d5f-88ae-7af315c1b674" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited" xlink:type="simple" xlink:href="bax-20220331.xsd#CondensedConsolidatedStatementsofIncomeunaudited"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d16dbefe-2ff4-4faf-a04c-9b375344b782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_37aedc43-294b-4c6f-86fa-1e33e982a3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d16dbefe-2ff4-4faf-a04c-9b375344b782" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_37aedc43-294b-4c6f-86fa-1e33e982a3e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1e400ff7-6c4e-47f2-9942-c11337cda2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d16dbefe-2ff4-4faf-a04c-9b375344b782" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1e400ff7-6c4e-47f2-9942-c11337cda2cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c95d56f5-7505-4c5d-a4ee-4d690437d6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4ac1e61a-88eb-4982-8cbe-c5ff103eeda0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c95d56f5-7505-4c5d-a4ee-4d690437d6ae" xlink:to="loc_us-gaap_OperatingIncomeLoss_4ac1e61a-88eb-4982-8cbe-c5ff103eeda0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_d3dc3924-b5f1-4cf3-8dca-cf8441272349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c95d56f5-7505-4c5d-a4ee-4d690437d6ae" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_d3dc3924-b5f1-4cf3-8dca-cf8441272349" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_fe1ff1b0-fb34-492d-8c35-80c1ade8bf11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c95d56f5-7505-4c5d-a4ee-4d690437d6ae" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_fe1ff1b0-fb34-492d-8c35-80c1ade8bf11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fba9770a-a7ee-4928-b2e7-93d8eadccf97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0d9243ab-6c43-4158-9773-c31e54390b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_fba9770a-a7ee-4928-b2e7-93d8eadccf97" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0d9243ab-6c43-4158-9773-c31e54390b65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bf881b2d-d7ab-4a3d-8f88-e913f7f3a4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_fba9770a-a7ee-4928-b2e7-93d8eadccf97" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bf881b2d-d7ab-4a3d-8f88-e913f7f3a4ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c643a583-77f6-4813-966d-c5ff24943f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_31fd1b89-dc49-45ad-93d0-a06758425a73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c643a583-77f6-4813-966d-c5ff24943f45" xlink:to="loc_us-gaap_GrossProfit_31fd1b89-dc49-45ad-93d0-a06758425a73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ec91e7d5-8d81-42b7-8d59-46989012dfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c643a583-77f6-4813-966d-c5ff24943f45" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ec91e7d5-8d81-42b7-8d59-46989012dfd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_8f8be1e2-95e6-48dc-916a-cb45985b04ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c643a583-77f6-4813-966d-c5ff24943f45" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_8f8be1e2-95e6-48dc-916a-cb45985b04ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_cc96e600-b065-4e94-8dab-ea2d338d1e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c643a583-77f6-4813-966d-c5ff24943f45" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_cc96e600-b065-4e94-8dab-ea2d338d1e1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4b12f2c6-50c4-4f6c-a1d4-336098515ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_46e10514-aa76-4460-b769-e466318e8d33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4b12f2c6-50c4-4f6c-a1d4-336098515ce8" xlink:to="loc_us-gaap_ProfitLoss_46e10514-aa76-4460-b769-e466318e8d33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1831094a-0745-4bc1-8efa-1c595fa16123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4b12f2c6-50c4-4f6c-a1d4-336098515ce8" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1831094a-0745-4bc1-8efa-1c595fa16123" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited" xlink:type="simple" xlink:href="bax-20220331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_86d5634b-6090-4340-8726-203bf62bdb5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2d857e7a-48ce-43e0-968a-8c3e59a178f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_86d5634b-6090-4340-8726-203bf62bdb5c" xlink:to="loc_us-gaap_ProfitLoss_2d857e7a-48ce-43e0-968a-8c3e59a178f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2892c27a-604e-4f49-8afd-866dd1b3e5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_86d5634b-6090-4340-8726-203bf62bdb5c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2892c27a-604e-4f49-8afd-866dd1b3e5d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_eb62343b-f9fe-4f78-ab2c-af584039a847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_d1a2ba78-e996-46f0-94a0-d1f0a43bfefd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_eb62343b-f9fe-4f78-ab2c-af584039a847" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_d1a2ba78-e996-46f0-94a0-d1f0a43bfefd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_aa92b083-066f-45c2-a473-72a791253234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_eb62343b-f9fe-4f78-ab2c-af584039a847" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_aa92b083-066f-45c2-a473-72a791253234" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1c8725c9-e1c8-4b65-8e26-e88d1b0aaa1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_eb62343b-f9fe-4f78-ab2c-af584039a847" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1c8725c9-e1c8-4b65-8e26-e88d1b0aaa1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c14090f8-1105-45db-8428-db623be7b7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_eb62343b-f9fe-4f78-ab2c-af584039a847" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c14090f8-1105-45db-8428-db623be7b7dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7e9f6c97-8d49-4b42-afb9-50c0443511c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3ee7a2ff-e7a2-422e-9a3e-50e6434c5ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_7e9f6c97-8d49-4b42-afb9-50c0443511c6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3ee7a2ff-e7a2-422e-9a3e-50e6434c5ca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b78b7b97-7926-480f-bc43-1627b378e3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_7e9f6c97-8d49-4b42-afb9-50c0443511c6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b78b7b97-7926-480f-bc43-1627b378e3b3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="bax-20220331.xsd#CondensedConsolidatedStatementsofCashFlowsunaudited"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bf392cd3-9365-4da1-b392-66a7b4502eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_468aa292-e1d4-4012-aa9e-9da52ba2cbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bf392cd3-9365-4da1-b392-66a7b4502eb4" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_468aa292-e1d4-4012-aa9e-9da52ba2cbfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_65d2c778-aec6-418b-8657-d8d987f9b2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bf392cd3-9365-4da1-b392-66a7b4502eb4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_65d2c778-aec6-418b-8657-d8d987f9b2cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_625e999d-a395-4065-8faf-5daa081cb85b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bf392cd3-9365-4da1-b392-66a7b4502eb4" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_625e999d-a395-4065-8faf-5daa081cb85b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_80311329-5321-4472-aec2-479a926642a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_49183672-1193-4c89-a20a-8913401ed89f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_80311329-5321-4472-aec2-479a926642a6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_49183672-1193-4c89-a20a-8913401ed89f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4137a880-5bb7-435f-a0e6-c83bca925f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_80311329-5321-4472-aec2-479a926642a6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4137a880-5bb7-435f-a0e6-c83bca925f41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8df636c0-a531-42a6-a75b-ae289912c743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_80311329-5321-4472-aec2-479a926642a6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8df636c0-a531-42a6-a75b-ae289912c743" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_7794015d-f690-4a6a-a209-f4d7939c04db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_80311329-5321-4472-aec2-479a926642a6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_7794015d-f690-4a6a-a209-f4d7939c04db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea6eecd4-5dba-4995-a40a-d6396022708a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_644e932a-45e0-42ce-9675-719032b372c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea6eecd4-5dba-4995-a40a-d6396022708a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_644e932a-45e0-42ce-9675-719032b372c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_64993205-a382-45cc-879f-7f865c4f09f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea6eecd4-5dba-4995-a40a-d6396022708a" xlink:to="loc_us-gaap_ShareBasedCompensation_64993205-a382-45cc-879f-7f865c4f09f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_fec4d303-0dc0-4add-86b1-04a17918c133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea6eecd4-5dba-4995-a40a-d6396022708a" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_fec4d303-0dc0-4add-86b1-04a17918c133" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_7f92e3d1-f768-40e3-86e3-459a17aa5359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea6eecd4-5dba-4995-a40a-d6396022708a" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_7f92e3d1-f768-40e3-86e3-459a17aa5359" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_e05fb10e-e268-49f1-bc5d-25e923cae90c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea6eecd4-5dba-4995-a40a-d6396022708a" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_e05fb10e-e268-49f1-bc5d-25e923cae90c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_cf2fda79-9524-4b24-a99e-0db3eaeafdf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea6eecd4-5dba-4995-a40a-d6396022708a" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_cf2fda79-9524-4b24-a99e-0db3eaeafdf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e0274391-27bb-4dc9-a515-d160f1b6ec2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea6eecd4-5dba-4995-a40a-d6396022708a" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e0274391-27bb-4dc9-a515-d160f1b6ec2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_92157155-6495-4d12-8a9d-d025849f49b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea6eecd4-5dba-4995-a40a-d6396022708a" xlink:to="loc_us-gaap_ProfitLoss_92157155-6495-4d12-8a9d-d025849f49b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_e8e18c1b-8da5-4272-804f-d383bbe27de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea6eecd4-5dba-4995-a40a-d6396022708a" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_e8e18c1b-8da5-4272-804f-d383bbe27de6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_2b17515c-f412-4c26-aa64-a450e8a042ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea6eecd4-5dba-4995-a40a-d6396022708a" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_2b17515c-f412-4c26-aa64-a450e8a042ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_2c944b67-1aba-4896-af09-7bcb8a1625ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea6eecd4-5dba-4995-a40a-d6396022708a" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_2c944b67-1aba-4896-af09-7bcb8a1625ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_1389abe5-b8f5-4e04-be79-39d3d1c6a330" xlink:href="bax-20220331.xsd#bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ea6eecd4-5dba-4995-a40a-d6396022708a" xlink:to="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_1389abe5-b8f5-4e04-be79-39d3d1c6a330" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3a0f125-a789-4eee-97df-e2a6f6805a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_f2f9d0fd-ec9c-4ac2-9898-882ea7ce548d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3a0f125-a789-4eee-97df-e2a6f6805a52" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_f2f9d0fd-ec9c-4ac2-9898-882ea7ce548d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_fecff02c-3421-4a90-b1f6-afdf04838304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3a0f125-a789-4eee-97df-e2a6f6805a52" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_fecff02c-3421-4a90-b1f6-afdf04838304" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_05a5b380-1b18-49f4-b17f-5b2e0dffcfae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3a0f125-a789-4eee-97df-e2a6f6805a52" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_05a5b380-1b18-49f4-b17f-5b2e0dffcfae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4c9c05e4-80a5-46e0-9851-1d6ff4a70819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3a0f125-a789-4eee-97df-e2a6f6805a52" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4c9c05e4-80a5-46e0-9851-1d6ff4a70819" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_fef4899e-3914-4e1c-8bc0-187573b89f49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3a0f125-a789-4eee-97df-e2a6f6805a52" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_fef4899e-3914-4e1c-8bc0-187573b89f49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_ac5d71b0-68cd-4183-a1ad-e56102e2cb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3a0f125-a789-4eee-97df-e2a6f6805a52" xlink:to="loc_us-gaap_RepaymentsOfDebt_ac5d71b0-68cd-4183-a1ad-e56102e2cb8c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fe899bbb-cb9c-4df4-a5d5-093eb2b69805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_572de5e9-5522-4a0d-a986-0e127b444a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fe899bbb-cb9c-4df4-a5d5-093eb2b69805" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_572de5e9-5522-4a0d-a986-0e127b444a04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_513fe471-5461-4ab9-a76e-739e102f5527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fe899bbb-cb9c-4df4-a5d5-093eb2b69805" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_513fe471-5461-4ab9-a76e-739e102f5527" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b7195a13-3b1b-4949-83a1-f37583a17efe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_5cc82016-362f-4799-a8e0-039684aa3b71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b7195a13-3b1b-4949-83a1-f37583a17efe" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_5cc82016-362f-4799-a8e0-039684aa3b71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_ef31e18d-29d9-4e12-b473-ca9994e1dd6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b7195a13-3b1b-4949-83a1-f37583a17efe" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_ef31e18d-29d9-4e12-b473-ca9994e1dd6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_f53dc525-1648-4100-80a1-41e7a63adac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b7195a13-3b1b-4949-83a1-f37583a17efe" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_f53dc525-1648-4100-80a1-41e7a63adac8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_0325a031-d8d6-4944-859a-50ba1d38e356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b7195a13-3b1b-4949-83a1-f37583a17efe" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_0325a031-d8d6-4944-859a-50ba1d38e356" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_a4f1abd7-9cce-49f1-9dc5-46254e6efcde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b7195a13-3b1b-4949-83a1-f37583a17efe" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_a4f1abd7-9cce-49f1-9dc5-46254e6efcde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1b283f35-5ea6-45e9-b92c-03dcbeee12b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b7195a13-3b1b-4949-83a1-f37583a17efe" xlink:to="loc_us-gaap_Goodwill_1b283f35-5ea6-45e9-b92c-03dcbeee12b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7e7553aa-faf8-439e-a00e-9345fa10e0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b7195a13-3b1b-4949-83a1-f37583a17efe" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7e7553aa-faf8-439e-a00e-9345fa10e0cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_51920cda-fa41-4eac-8391-3e627d296fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b7195a13-3b1b-4949-83a1-f37583a17efe" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_51920cda-fa41-4eac-8391-3e627d296fb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5c070166-68c7-4ce7-9e8a-5c1cc4969dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b7195a13-3b1b-4949-83a1-f37583a17efe" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5c070166-68c7-4ce7-9e8a-5c1cc4969dcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_e3bed9a2-da59-4ba8-956f-587674bf59e4" xlink:href="bax-20220331.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b7195a13-3b1b-4949-83a1-f37583a17efe" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_e3bed9a2-da59-4ba8-956f-587674bf59e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3c08b285-4522-434f-85de-55477c9aec6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b7195a13-3b1b-4949-83a1-f37583a17efe" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3c08b285-4522-434f-85de-55477c9aec6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_d7e3e72e-3c6c-425a-bf57-75dcdde87eb7" xlink:href="bax-20220331.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b7195a13-3b1b-4949-83a1-f37583a17efe" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_d7e3e72e-3c6c-425a-bf57-75dcdde87eb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_baae8bd2-a481-432b-9e89-9ea40243f8ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b7195a13-3b1b-4949-83a1-f37583a17efe" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_baae8bd2-a481-432b-9e89-9ea40243f8ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_709d73c8-3c72-4f41-8291-ef6b64f3e842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b7195a13-3b1b-4949-83a1-f37583a17efe" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_709d73c8-3c72-4f41-8291-ef6b64f3e842" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_dd70a85a-7802-47e0-81fa-d4c43bee1e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b7195a13-3b1b-4949-83a1-f37583a17efe" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_dd70a85a-7802-47e0-81fa-d4c43bee1e12" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d9144b15-052d-43e3-a828-76a6287826ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_81c8d986-33fc-45ec-8020-2da95c2d7ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d9144b15-052d-43e3-a828-76a6287826ab" xlink:to="loc_us-gaap_InventoryRawMaterials_81c8d986-33fc-45ec-8020-2da95c2d7ffc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_e35e0dd6-b184-4faf-afad-e10f3fef6fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d9144b15-052d-43e3-a828-76a6287826ab" xlink:to="loc_us-gaap_InventoryWorkInProcess_e35e0dd6-b184-4faf-afad-e10f3fef6fe9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_db7ee1e1-53f0-4cba-b6ef-e5ec299367b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d9144b15-052d-43e3-a828-76a6287826ab" xlink:to="loc_us-gaap_InventoryFinishedGoods_db7ee1e1-53f0-4cba-b6ef-e5ec299367b2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2a4a993c-8042-49ab-ace5-ecae6b9a4364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a37b00b5-5eda-4362-a424-f75d3b8686c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_2a4a993c-8042-49ab-ace5-ecae6b9a4364" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a37b00b5-5eda-4362-a424-f75d3b8686c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_71078ff1-4c53-4f12-8844-d871a4e1b1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_2a4a993c-8042-49ab-ace5-ecae6b9a4364" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_71078ff1-4c53-4f12-8844-d871a4e1b1c4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_702c55cd-a47e-4c4b-8dfb-3416c01b14cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_525e5630-17af-4435-a6cc-7707020f6a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_702c55cd-a47e-4c4b-8dfb-3416c01b14cd" xlink:to="loc_us-gaap_InterestExpense_525e5630-17af-4435-a6cc-7707020f6a8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_53ef076b-4eb5-4498-9018-a1b2a1d6c046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_702c55cd-a47e-4c4b-8dfb-3416c01b14cd" xlink:to="loc_us-gaap_InvestmentIncomeInterest_53ef076b-4eb5-4498-9018-a1b2a1d6c046" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_35a44ae0-7f05-436e-9fa8-44dcccedeb94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingGainsLosses_0ddbe3fc-c622-4cc7-876d-d8626c10156b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_35a44ae0-7f05-436e-9fa8-44dcccedeb94" xlink:to="loc_us-gaap_OtherNonoperatingGainsLosses_0ddbe3fc-c622-4cc7-876d-d8626c10156b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_25996a1e-8a46-42be-82ff-e147971941c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_35a44ae0-7f05-436e-9fa8-44dcccedeb94" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_25996a1e-8a46-42be-82ff-e147971941c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_4e3b483e-0241-4dba-8360-27437d06f4db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_35a44ae0-7f05-436e-9fa8-44dcccedeb94" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_4e3b483e-0241-4dba-8360-27437d06f4db" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b9a4e077-94e2-4d33-99d6-d049e8195ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_12d91b20-edfb-450a-8f0f-82c8bc380259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b9a4e077-94e2-4d33-99d6-d049e8195ba7" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_12d91b20-edfb-450a-8f0f-82c8bc380259" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e95731ae-9be4-42f9-8ae7-0234ad148a61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b9a4e077-94e2-4d33-99d6-d049e8195ba7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e95731ae-9be4-42f9-8ae7-0234ad148a61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b84c0959-de19-4680-ad31-ba0380cfd46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_14a801ec-8305-426d-8e3a-fc12dd979fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b84c0959-de19-4680-ad31-ba0380cfd46b" xlink:to="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_14a801ec-8305-426d-8e3a-fc12dd979fc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_979fafec-5bf5-4e43-b2a1-6fde3a736bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b84c0959-de19-4680-ad31-ba0380cfd46b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_979fafec-5bf5-4e43-b2a1-6fde3a736bf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9a01b79a-6fa7-47e9-a0eb-38b9c605b421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e5fa9aed-7c6d-4c97-aef9-6f01b3c4d312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9a01b79a-6fa7-47e9-a0eb-38b9c605b421" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e5fa9aed-7c6d-4c97-aef9-6f01b3c4d312" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d9e03c6e-a1b4-421a-b57d-cc6f20ee0665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9a01b79a-6fa7-47e9-a0eb-38b9c605b421" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d9e03c6e-a1b4-421a-b57d-cc6f20ee0665" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESLeaseRevenueDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#REVENUESLeaseRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/REVENUESLeaseRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseIncome_ed637f3c-dd2a-48be-bf80-30a8a72e6b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue_9e308ce7-2ca6-4905-8eec-4c1e98d72d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseIncome_ed637f3c-dd2a-48be-bf80-30a8a72e6b42" xlink:to="loc_us-gaap_SalesTypeLeaseRevenue_9e308ce7-2ca6-4905-8eec-4c1e98d72d7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseIncome_32c0abdd-c28f-402d-8160-7760443761e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseIncome_ed637f3c-dd2a-48be-bf80-30a8a72e6b42" xlink:to="loc_us-gaap_VariableLeaseIncome_32c0abdd-c28f-402d-8160-7760443761e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_3274e28d-8379-4ba5-a025-d74e34193a54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseIncome_ed637f3c-dd2a-48be-bf80-30a8a72e6b42" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_3274e28d-8379-4ba5-a025-d74e34193a54" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_0b33a22f-6f1b-4ca3-947f-030cc28d7246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a299aeb2-7270-4a18-ae0f-9bf2402d7d34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCosts_0b33a22f-6f1b-4ca3-947f-030cc28d7246" xlink:to="loc_us-gaap_RestructuringCharges_a299aeb2-7270-4a18-ae0f-9bf2402d7d34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_e7004544-6395-44c9-bb31-60b6c5623dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCosts_0b33a22f-6f1b-4ca3-947f-030cc28d7246" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_e7004544-6395-44c9-bb31-60b6c5623dc0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b1fc7f1d-5363-404f-b7ef-ebb2c0f0ddfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3f26cbe5-f4d6-43e4-92d8-4704e1e75277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b1fc7f1d-5363-404f-b7ef-ebb2c0f0ddfa" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_3f26cbe5-f4d6-43e4-92d8-4704e1e75277" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_38e14961-7f2a-4cc4-8f10-7f76e41743f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b1fc7f1d-5363-404f-b7ef-ebb2c0f0ddfa" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_38e14961-7f2a-4cc4-8f10-7f76e41743f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_c11f69c7-acf8-497d-b5fe-1347cd1ca3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b1fc7f1d-5363-404f-b7ef-ebb2c0f0ddfa" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_c11f69c7-acf8-497d-b5fe-1347cd1ca3a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_9e89c621-3788-4e99-886a-af66bb668ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b1fc7f1d-5363-404f-b7ef-ebb2c0f0ddfa" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_9e89c621-3788-4e99-886a-af66bb668ea4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dfe7276b-3606-496d-8186-67636ad31995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a8e2c756-3f1c-44b1-8bed-43e7576d2a06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dfe7276b-3606-496d-8186-67636ad31995" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a8e2c756-3f1c-44b1-8bed-43e7576d2a06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7d1618c6-f039-4fc3-b706-896bd80a3ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dfe7276b-3606-496d-8186-67636ad31995" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7d1618c6-f039-4fc3-b706-896bd80a3ca4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_53051223-52fb-4b92-a875-916aef30ffd6" xlink:href="bax-20220331.xsd#bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_fa8260d6-ef8b-4f2b-b863-0a9c33ee0673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_53051223-52fb-4b92-a875-916aef30ffd6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_fa8260d6-ef8b-4f2b-b863-0a9c33ee0673" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_7b9d2fb6-839a-4151-a806-b642b19d033d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_53051223-52fb-4b92-a875-916aef30ffd6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_7b9d2fb6-839a-4151-a806-b642b19d033d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_220175af-1ed6-485e-832d-5e0e44f71a70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_d06e4653-0be1-4664-a77c-3c2b718be2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_220175af-1ed6-485e-832d-5e0e44f71a70" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_d06e4653-0be1-4664-a77c-3c2b718be2ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_27e5f661-b4a7-4327-bccd-fabaeb59c3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_220175af-1ed6-485e-832d-5e0e44f71a70" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_27e5f661-b4a7-4327-bccd-fabaeb59c3eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecurities_9ab99f68-1121-41a5-8e1b-e40409cd6d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_220175af-1ed6-485e-832d-5e0e44f71a70" xlink:to="loc_us-gaap_DebtSecurities_9ab99f68-1121-41a5-8e1b-e40409cd6d87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_0144252a-ecbc-4ba6-aece-8d0ae601133e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_48318bdd-2ab3-4248-b93d-cd34f3016675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_0144252a-ecbc-4ba6-aece-8d0ae601133e" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_48318bdd-2ab3-4248-b93d-cd34f3016675" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8ef21fc9-ff76-40a8-9bb2-ba94e31df97d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_0144252a-ecbc-4ba6-aece-8d0ae601133e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8ef21fc9-ff76-40a8-9bb2-ba94e31df97d" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>bax-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3113e683-fb48-43e6-a6e8-6a2e99588fde,g:c1ee1bb8-6f43-4e7f-a20c-1c092f3191f3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.baxter.com/role/Cover" xlink:type="simple" xlink:href="bax-20220331.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/Cover" xlink:type="extended" id="i6e67c0c53c6c4827ba015c72eabd46d1_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_bffa4e72-440e-43b7-8142-1517e092bf01" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_DocumentType_bffa4e72-440e-43b7-8142-1517e092bf01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_3011b8c2-e050-4417-b1e5-478570437e2a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_DocumentQuarterlyReport_3011b8c2-e050-4417-b1e5-478570437e2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f844fb46-d8e7-4115-bb0b-c32fc7c43d1d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_DocumentPeriodEndDate_f844fb46-d8e7-4115-bb0b-c32fc7c43d1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_e1345515-c48c-474a-be02-4f5894139efc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_DocumentTransitionReport_e1345515-c48c-474a-be02-4f5894139efc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a4a9343d-cdff-4364-8262-00935ef5bc20" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityFileNumber_a4a9343d-cdff-4364-8262-00935ef5bc20" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e30b024c-611d-45ef-9ded-1312c4267452" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityRegistrantName_e30b024c-611d-45ef-9ded-1312c4267452" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_504a32b3-7bea-4d59-8f54-563dd274239f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityIncorporationStateCountryCode_504a32b3-7bea-4d59-8f54-563dd274239f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b6857ffa-49b1-49db-9520-da6b95377f58" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityTaxIdentificationNumber_b6857ffa-49b1-49db-9520-da6b95377f58" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_cfd74551-ecb2-4194-985b-2c906a2f569d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityAddressAddressLine1_cfd74551-ecb2-4194-985b-2c906a2f569d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_16357333-a78c-4bc2-85c3-72a69dfaef85" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityAddressCityOrTown_16357333-a78c-4bc2-85c3-72a69dfaef85" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_1b3a5e79-59b3-4302-adff-636a8c806696" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityAddressStateOrProvince_1b3a5e79-59b3-4302-adff-636a8c806696" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a679fa6e-1793-4049-8dff-f4d03f21f41c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityAddressPostalZipCode_a679fa6e-1793-4049-8dff-f4d03f21f41c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_56318cb3-0b52-41e6-a769-1655b094afe6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_CityAreaCode_56318cb3-0b52-41e6-a769-1655b094afe6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f2d4ca9c-48d1-47af-b069-1ef11f49ec54" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_LocalPhoneNumber_f2d4ca9c-48d1-47af-b069-1ef11f49ec54" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_027c2a30-c4a7-4eaf-9ca2-1f92ea28e4e3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_Security12bTitle_027c2a30-c4a7-4eaf-9ca2-1f92ea28e4e3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_5de257ad-fdeb-4cb1-aa62-428b3373bb0f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_TradingSymbol_5de257ad-fdeb-4cb1-aa62-428b3373bb0f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d6b52d1b-6698-4998-94ca-9a135004c5bc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_SecurityExchangeName_d6b52d1b-6698-4998-94ca-9a135004c5bc" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ef8e64c4-6f54-4cac-a973-2601e80f7507" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityCurrentReportingStatus_ef8e64c4-6f54-4cac-a973-2601e80f7507" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_24e2c3c4-f787-4607-935a-16098bff4cbd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityInteractiveDataCurrent_24e2c3c4-f787-4607-935a-16098bff4cbd" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_6fd1ebf9-1812-4eae-83dc-831773fd388d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityFilerCategory_6fd1ebf9-1812-4eae-83dc-831773fd388d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_91470af9-8e6b-4385-be59-096386b38c8b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntitySmallBusiness_91470af9-8e6b-4385-be59-096386b38c8b" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_b374d8e6-810b-4826-a1f1-c56b0e2b778f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityEmergingGrowthCompany_b374d8e6-810b-4826-a1f1-c56b0e2b778f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_491a9337-9e75-4fea-a351-5e4437ba8875" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityShellCompany_491a9337-9e75-4fea-a351-5e4437ba8875" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_9259086c-ac17-41ed-9e67-d31fbc16e368" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_9259086c-ac17-41ed-9e67-d31fbc16e368" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_40846a1f-e05c-41d8-b60c-004efb8bdc62" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_AmendmentFlag_40846a1f-e05c-41d8-b60c-004efb8bdc62" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_996c773d-1d85-438b-bc3e-8d801dcd4a34" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_DocumentFiscalYearFocus_996c773d-1d85-438b-bc3e-8d801dcd4a34" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_e3e8e315-d7aa-4083-ae72-34cbbdbab916" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_DocumentFiscalPeriodFocus_e3e8e315-d7aa-4083-ae72-34cbbdbab916" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_37f0a954-547a-48dd-85c9-8394267dec63" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityCentralIndexKey_37f0a954-547a-48dd-85c9-8394267dec63" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_0b223b06-c3a1-4a00-858f-36ccfcd489cd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_CurrentFiscalYearEndDate_0b223b06-c3a1-4a00-858f-36ccfcd489cd" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_a08a77ba-6ef4-4ec1-9601-939912d42cd0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_DocumentInformationTable_a08a77ba-6ef4-4ec1-9601-939912d42cd0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d5dd8c17-d5ce-485c-8662-bc17ce2e3553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_a08a77ba-6ef4-4ec1-9601-939912d42cd0" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d5dd8c17-d5ce-485c-8662-bc17ce2e3553" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d5dd8c17-d5ce-485c-8662-bc17ce2e3553_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d5dd8c17-d5ce-485c-8662-bc17ce2e3553" xlink:to="loc_us-gaap_ClassOfStockDomain_d5dd8c17-d5ce-485c-8662-bc17ce2e3553_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_13a2f74d-fcbf-43ab-b692-8e932544db17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d5dd8c17-d5ce-485c-8662-bc17ce2e3553" xlink:to="loc_us-gaap_ClassOfStockDomain_13a2f74d-fcbf-43ab-b692-8e932544db17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommonStock100PerValueMember_14754506-035f-415e-bf43-05c29a2e406b" xlink:href="bax-20220331.xsd#bax_CommonStock100PerValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_13a2f74d-fcbf-43ab-b692-8e932544db17" xlink:to="loc_bax_CommonStock100PerValueMember_14754506-035f-415e-bf43-05c29a2e406b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes04Due2024Member_d4847a81-5d14-4c7c-bd5b-2d0dd24971a3" xlink:href="bax-20220331.xsd#bax_GlobalNotes04Due2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_13a2f74d-fcbf-43ab-b692-8e932544db17" xlink:to="loc_bax_GlobalNotes04Due2024Member_d4847a81-5d14-4c7c-bd5b-2d0dd24971a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2025Member_7f3b048e-fa16-4a76-ada6-810c0a5977cf" xlink:href="bax-20220331.xsd#bax_GlobalNotes13Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_13a2f74d-fcbf-43ab-b692-8e932544db17" xlink:to="loc_bax_GlobalNotes13Due2025Member_7f3b048e-fa16-4a76-ada6-810c0a5977cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2029Member_8e75c7fd-8c9a-4f30-b44c-7fbd82caccc9" xlink:href="bax-20220331.xsd#bax_GlobalNotes13Due2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_13a2f74d-fcbf-43ab-b692-8e932544db17" xlink:to="loc_bax_GlobalNotes13Due2029Member_8e75c7fd-8c9a-4f30-b44c-7fbd82caccc9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes395Due2030Member_0ea50c72-8d34-486a-8566-3ee7511cdcfb" xlink:href="bax-20220331.xsd#bax_GlobalNotes395Due2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_13a2f74d-fcbf-43ab-b692-8e932544db17" xlink:to="loc_bax_GlobalNotes395Due2030Member_0ea50c72-8d34-486a-8566-3ee7511cdcfb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes173Due2031Member_2354b25d-72f1-4201-9d07-8cea391f4b08" xlink:href="bax-20220331.xsd#bax_GlobalNotes173Due2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_13a2f74d-fcbf-43ab-b692-8e932544db17" xlink:to="loc_bax_GlobalNotes173Due2031Member_2354b25d-72f1-4201-9d07-8cea391f4b08" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_a7c5e77f-49ea-499d-b21b-d10fdb659117" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_a08a77ba-6ef4-4ec1-9601-939912d42cd0" xlink:to="loc_dei_EntityListingsExchangeAxis_a7c5e77f-49ea-499d-b21b-d10fdb659117" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_a7c5e77f-49ea-499d-b21b-d10fdb659117_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_a7c5e77f-49ea-499d-b21b-d10fdb659117" xlink:to="loc_dei_ExchangeDomain_a7c5e77f-49ea-499d-b21b-d10fdb659117_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_06642d3e-5df5-4eff-bcc4-f1bd562e3c3d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_a7c5e77f-49ea-499d-b21b-d10fdb659117" xlink:to="loc_dei_ExchangeDomain_06642d3e-5df5-4eff-bcc4-f1bd562e3c3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_132b2e32-0e09-4a52-aaaa-f53e945968b2" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XNYS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_06642d3e-5df5-4eff-bcc4-f1bd562e3c3d" xlink:to="loc_exch_XNYS_132b2e32-0e09-4a52-aaaa-f53e945968b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XCHI_13d11f0f-f91c-4183-8dd9-09074765d410" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XCHI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_06642d3e-5df5-4eff-bcc4-f1bd562e3c3d" xlink:to="loc_exch_XCHI_13d11f0f-f91c-4183-8dd9-09074765d410" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited" xlink:type="simple" xlink:href="bax-20220331.xsd#CondensedConsolidatedStatementsofChangesinEquityunaudited"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited" xlink:type="extended" id="ib22bc5d7c29e4032991dde70b96cfd25_CondensedConsolidatedStatementsofChangesinEquityunaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_af0cd874-8d82-4f4b-b710-ee3f9816a6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_af0cd874-8d82-4f4b-b710-ee3f9816a6c2" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_052349ef-6ab6-4d23-bd65-4e0cb4104922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_CommonStockSharesIssued_052349ef-6ab6-4d23-bd65-4e0cb4104922" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6869321e-6189-404e-838b-03d47db83e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6869321e-6189-404e-838b-03d47db83e09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_42ec06f9-1bd2-408f-b196-3746dc0ec491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_TreasuryStockShares_42ec06f9-1bd2-408f-b196-3746dc0ec491" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1a4cbfa6-1d9e-498e-8cf7-d6c03492a613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_ProfitLoss_1a4cbfa6-1d9e-498e-8cf7-d6c03492a613" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_eaf5a039-7cad-4da9-8722-1ed86ff6b881" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_eaf5a039-7cad-4da9-8722-1ed86ff6b881" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_8aad48f9-4b29-4210-807c-e6a6e4b636e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_8aad48f9-4b29-4210-807c-e6a6e4b636e5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_684683b5-968d-4b0f-bb44-28518deed0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_684683b5-968d-4b0f-bb44-28518deed0b7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2c8abe6c-d011-438b-a283-397e8ae9b2af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2c8abe6c-d011-438b-a283-397e8ae9b2af" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_375f0306-e1b2-4c51-bb99-507ef6ce4dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_375f0306-e1b2-4c51-bb99-507ef6ce4dfc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_eb5b807e-e412-4d4b-9180-56219331c397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_DividendsCommonStock_eb5b807e-e412-4d4b-9180-56219331c397" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_02e89dfe-c46f-4848-b421-f4dceed7d892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_02e89dfe-c46f-4848-b421-f4dceed7d892" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_5486c73a-9206-419f-a603-c85e303e9c81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_40851ef8-ac6d-4b48-80a9-a8a944c38cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_d0fb22b4-c80c-48cb-a649-372b285a4aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d4b4df5d-7c21-402d-ab77-7f02fd271696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_af0cd874-8d82-4f4b-b710-ee3f9816a6c2" xlink:to="loc_us-gaap_StatementTable_d4b4df5d-7c21-402d-ab77-7f02fd271696" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f1be9c21-42ab-4642-ba78-63fb4075f250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d4b4df5d-7c21-402d-ab77-7f02fd271696" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f1be9c21-42ab-4642-ba78-63fb4075f250" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f1be9c21-42ab-4642-ba78-63fb4075f250_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f1be9c21-42ab-4642-ba78-63fb4075f250" xlink:to="loc_us-gaap_EquityComponentDomain_f1be9c21-42ab-4642-ba78-63fb4075f250_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_956e84bd-6e59-43b7-a11c-435122b1918e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f1be9c21-42ab-4642-ba78-63fb4075f250" xlink:to="loc_us-gaap_EquityComponentDomain_956e84bd-6e59-43b7-a11c-435122b1918e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_3b08009b-4ef3-4b54-be46-aa4c7340fba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_956e84bd-6e59-43b7-a11c-435122b1918e" xlink:to="loc_us-gaap_ParentMember_3b08009b-4ef3-4b54-be46-aa4c7340fba9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2b378209-e73c-4082-839f-cb03d7aa14ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_3b08009b-4ef3-4b54-be46-aa4c7340fba9" xlink:to="loc_us-gaap_CommonStockMember_2b378209-e73c-4082-839f-cb03d7aa14ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_3660238b-6188-4796-a9aa-c67b5f15ac1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_3b08009b-4ef3-4b54-be46-aa4c7340fba9" xlink:to="loc_us-gaap_TreasuryStockMember_3660238b-6188-4796-a9aa-c67b5f15ac1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_42fd3f73-1971-41ec-89a0-d9b8c366b71d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_3b08009b-4ef3-4b54-be46-aa4c7340fba9" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_42fd3f73-1971-41ec-89a0-d9b8c366b71d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_dd2b1866-8873-44e7-9615-b8b74e01995e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_3b08009b-4ef3-4b54-be46-aa4c7340fba9" xlink:to="loc_us-gaap_RetainedEarningsMember_dd2b1866-8873-44e7-9615-b8b74e01995e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_685f3e7b-695a-43c1-a4d7-0b1bf3711c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_3b08009b-4ef3-4b54-be46-aa4c7340fba9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_685f3e7b-695a-43c1-a4d7-0b1bf3711c4a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_94405329-beca-4657-9ac1-c203c8450658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_956e84bd-6e59-43b7-a11c-435122b1918e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_94405329-beca-4657-9ac1-c203c8450658" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="extended" id="i1371d2629d394aadbe0578d6c19ea61e_ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationCashConsideration_f95e1092-6f75-4c57-b9fa-b05f5666f569" xlink:href="bax-20220331.xsd#bax_BusinessCombinationCashConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_bax_BusinessCombinationCashConsideration_f95e1092-6f75-4c57-b9fa-b05f5666f569" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations_e4b33102-08c3-4a7d-b3c9-821b686288f4" xlink:href="bax-20220331.xsd#bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations_e4b33102-08c3-4a7d-b3c9-821b686288f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_7ed0672f-0abd-41fb-9cc1-97efda2fb6df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_7ed0672f-0abd-41fb-9cc1-97efda2fb6df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_7452faf7-9070-4253-b52a-2eab92887d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_7452faf7-9070-4253-b52a-2eab92887d1e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_be30ec57-adfc-4388-9c08-46b4f4bdb93b" xlink:href="bax-20220331.xsd#bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_be30ec57-adfc-4388-9c08-46b4f4bdb93b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed_3f54cd5a-c8d4-456f-b4ee-fd46fdfea75f" xlink:href="bax-20220331.xsd#bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed_3f54cd5a-c8d4-456f-b4ee-fd46fdfea75f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_5a83757b-1bf6-4aed-aab5-bc95e4668e95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_5a83757b-1bf6-4aed-aab5-bc95e4668e95" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_0e453b4a-13f6-4df8-90d2-77d7f1faf575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_0e453b4a-13f6-4df8-90d2-77d7f1faf575" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d20a408e-fcfe-4162-82b8-57d1314cbd48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d20a408e-fcfe-4162-82b8-57d1314cbd48" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cefaaa53-8862-48f4-8d0c-54412e323726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d20a408e-fcfe-4162-82b8-57d1314cbd48" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cefaaa53-8862-48f4-8d0c-54412e323726" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cefaaa53-8862-48f4-8d0c-54412e323726_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cefaaa53-8862-48f4-8d0c-54412e323726" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cefaaa53-8862-48f4-8d0c-54412e323726_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_db3c84a2-7b04-4944-82aa-33d6f211c811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cefaaa53-8862-48f4-8d0c-54412e323726" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_db3c84a2-7b04-4944-82aa-33d6f211c811" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_abac39a3-30ce-4813-b37b-2ea8ba7016f2" xlink:href="bax-20220331.xsd#bax_HillromMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_db3c84a2-7b04-4944-82aa-33d6f211c811" xlink:to="loc_bax_HillromMember_abac39a3-30ce-4813-b37b-2ea8ba7016f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ZosynMember_d7de1a8a-4053-4b19-829d-b7c684579ecc" xlink:href="bax-20220331.xsd#bax_ZosynMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_db3c84a2-7b04-4944-82aa-33d6f211c811" xlink:to="loc_bax_ZosynMember_d7de1a8a-4053-4b19-829d-b7c684579ecc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails" xlink:type="extended" id="ic5144c5237214ae79970a57a2269a99a_ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsLineItems_f661679f-6e81-4ae6-9c25-5e033e484da1" xlink:href="bax-20220331.xsd#bax_AcquisitionsAndCollaborationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_2b25ab33-e309-414c-9914-a9ee32ca6942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_f661679f-6e81-4ae6-9c25-5e033e484da1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_2b25ab33-e309-414c-9914-a9ee32ca6942" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_cef3bd30-219f-4ad4-bfdd-5621046d6c34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_f661679f-6e81-4ae6-9c25-5e033e484da1" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_cef3bd30-219f-4ad4-bfdd-5621046d6c34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_31a2386b-9093-4315-842e-83bcdfcdc4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_f661679f-6e81-4ae6-9c25-5e033e484da1" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_31a2386b-9093-4315-842e-83bcdfcdc4ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_90a697dc-0987-4aef-894b-16ebf0420cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_f661679f-6e81-4ae6-9c25-5e033e484da1" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_90a697dc-0987-4aef-894b-16ebf0420cf7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_52cf3869-8686-4a92-ac0a-81bc3f4e7b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_f661679f-6e81-4ae6-9c25-5e033e484da1" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_52cf3869-8686-4a92-ac0a-81bc3f4e7b60" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsTable_69fb80ee-6263-4174-ab62-7b99c2615dfe" xlink:href="bax-20220331.xsd#bax_AcquisitionsAndCollaborationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_f661679f-6e81-4ae6-9c25-5e033e484da1" xlink:to="loc_bax_AcquisitionsAndCollaborationsTable_69fb80ee-6263-4174-ab62-7b99c2615dfe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ba11fd5f-3c21-4a8a-9ffb-d66463837ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_AcquisitionsAndCollaborationsTable_69fb80ee-6263-4174-ab62-7b99c2615dfe" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ba11fd5f-3c21-4a8a-9ffb-d66463837ba0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ba11fd5f-3c21-4a8a-9ffb-d66463837ba0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ba11fd5f-3c21-4a8a-9ffb-d66463837ba0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ba11fd5f-3c21-4a8a-9ffb-d66463837ba0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7334044-29a9-4c29-879e-531ca6dcae68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ba11fd5f-3c21-4a8a-9ffb-d66463837ba0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7334044-29a9-4c29-879e-531ca6dcae68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_fcf86243-aeca-47af-8357-0d73facbbf5e" xlink:href="bax-20220331.xsd#bax_HillromMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7334044-29a9-4c29-879e-531ca6dcae68" xlink:to="loc_bax_HillromMember_fcf86243-aeca-47af-8357-0d73facbbf5e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails" xlink:type="extended" id="ib7ddb59a5b244c16b79a4e8414c38950_ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:href="bax-20220331.xsd#bax_AcquisitionsAndCollaborationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_aaeb29d5-63bf-4785-9e5e-9f7fd7c032d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_aaeb29d5-63bf-4785-9e5e-9f7fd7c032d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_0c15fbfb-da9b-4ce3-83c2-bffb94f8c1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_0c15fbfb-da9b-4ce3-83c2-bffb94f8c1f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c7450ca0-95ea-464a-af66-7237d2a503f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c7450ca0-95ea-464a-af66-7237d2a503f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0826f5c5-2aa4-4e3d-b62f-9905587e3988" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0826f5c5-2aa4-4e3d-b62f-9905587e3988" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_552fd26c-9d4e-4aee-a40b-06bd2ef42503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_552fd26c-9d4e-4aee-a40b-06bd2ef42503" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_72888df0-1d49-41f6-84a4-82430fbbb548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_Goodwill_72888df0-1d49-41f6-84a4-82430fbbb548" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_af1d47aa-8775-41cb-bd74-68c8baf7b567" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_af1d47aa-8775-41cb-bd74-68c8baf7b567" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_b80ddf56-6092-4123-83f0-2b396ac70a5a" xlink:href="bax-20220331.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_b80ddf56-6092-4123-83f0-2b396ac70a5a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8dbf6f39-585c-4373-8ee1-03b75e5175a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8dbf6f39-585c-4373-8ee1-03b75e5175a4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_eaa023d8-e663-41b8-8e47-695001d86bf1" xlink:href="bax-20220331.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_eaa023d8-e663-41b8-8e47-695001d86bf1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_393970bf-0907-4ec5-a733-0fa11b83db45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_393970bf-0907-4ec5-a733-0fa11b83db45" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_0254ec93-e93d-4461-abd4-735cee8c97b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_0254ec93-e93d-4461-abd4-735cee8c97b5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_2c409f66-cc5e-4259-9829-f3986920a482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_2c409f66-cc5e-4259-9829-f3986920a482" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_c6f3070e-35e0-4179-9e8d-e6ac6a336d59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_c6f3070e-35e0-4179-9e8d-e6ac6a336d59" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_79ff74db-2b17-4342-b05f-4a21ef85ab53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_79ff74db-2b17-4342-b05f-4a21ef85ab53" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4277905b-03a6-4b77-a59e-e77fa1b1f762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4277905b-03a6-4b77-a59e-e77fa1b1f762" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsTable_46a609ff-bb2d-4c5c-b395-2a1651f5a28c" xlink:href="bax-20220331.xsd#bax_AcquisitionsAndCollaborationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_bax_AcquisitionsAndCollaborationsTable_46a609ff-bb2d-4c5c-b395-2a1651f5a28c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_45635a29-32f0-44f9-97fb-19b87622ad9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_AcquisitionsAndCollaborationsTable_46a609ff-bb2d-4c5c-b395-2a1651f5a28c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_45635a29-32f0-44f9-97fb-19b87622ad9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45635a29-32f0-44f9-97fb-19b87622ad9f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_45635a29-32f0-44f9-97fb-19b87622ad9f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45635a29-32f0-44f9-97fb-19b87622ad9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8036b72b-25cf-416c-8250-dfe66d291538" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_45635a29-32f0-44f9-97fb-19b87622ad9f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8036b72b-25cf-416c-8250-dfe66d291538" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_851c10d8-70c9-4a97-97fd-87e9c62ffdd3" xlink:href="bax-20220331.xsd#bax_HillromMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8036b72b-25cf-416c-8250-dfe66d291538" xlink:to="loc_bax_HillromMember_851c10d8-70c9-4a97-97fd-87e9c62ffdd3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails" xlink:type="extended" id="i10459a50e68243b09bc44b25c8eb3791_ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_76256bbd-55a3-43ba-b972-f2740d963c53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_066654c5-b671-4c60-a7be-b7001f03b338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76256bbd-55a3-43ba-b972-f2740d963c53" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_066654c5-b671-4c60-a7be-b7001f03b338" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_da6d69cf-ecf2-4a37-ada6-19defbd6ba55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76256bbd-55a3-43ba-b972-f2740d963c53" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_da6d69cf-ecf2-4a37-ada6-19defbd6ba55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c7857fbe-a5e1-4c53-bb52-efd43474b969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76256bbd-55a3-43ba-b972-f2740d963c53" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c7857fbe-a5e1-4c53-bb52-efd43474b969" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_95ca844f-b861-4859-9f08-c8232afdb976" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c7857fbe-a5e1-4c53-bb52-efd43474b969" xlink:to="loc_us-gaap_AssetAcquisitionAxis_95ca844f-b861-4859-9f08-c8232afdb976" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_95ca844f-b861-4859-9f08-c8232afdb976_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_95ca844f-b861-4859-9f08-c8232afdb976" xlink:to="loc_us-gaap_AssetAcquisitionDomain_95ca844f-b861-4859-9f08-c8232afdb976_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_c17cd017-9d82-4f36-8d0b-fddbdd6f79c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_95ca844f-b861-4859-9f08-c8232afdb976" xlink:to="loc_us-gaap_AssetAcquisitionDomain_c17cd017-9d82-4f36-8d0b-fddbdd6f79c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ZosynMember_52a8db79-72f7-49ac-a69e-ea2f1eaf6b88" xlink:href="bax-20220331.xsd#bax_ZosynMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_c17cd017-9d82-4f36-8d0b-fddbdd6f79c0" xlink:to="loc_bax_ZosynMember_52a8db79-72f7-49ac-a69e-ea2f1eaf6b88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9fe1118-4cf4-40e5-834c-a9b5b748361f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c7857fbe-a5e1-4c53-bb52-efd43474b969" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9fe1118-4cf4-40e5-834c-a9b5b748361f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b9fe1118-4cf4-40e5-834c-a9b5b748361f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9fe1118-4cf4-40e5-834c-a9b5b748361f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b9fe1118-4cf4-40e5-834c-a9b5b748361f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_563aaef8-f2a8-40f6-a5d9-abef43920dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9fe1118-4cf4-40e5-834c-a9b5b748361f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_563aaef8-f2a8-40f6-a5d9-abef43920dc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_c33b9e6c-bc8d-4a07-8309-2a8f4eeec5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_563aaef8-f2a8-40f6-a5d9-abef43920dc3" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_c33b9e6c-bc8d-4a07-8309-2a8f4eeec5c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_7dd4d9d6-ce0f-4ae9-aa5d-29713e142e76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_563aaef8-f2a8-40f6-a5d9-abef43920dc3" xlink:to="loc_us-gaap_CustomerRelationshipsMember_7dd4d9d6-ce0f-4ae9-aa5d-29713e142e76" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails" xlink:type="extended" id="iac86aa85406e4e049728f0dd9e3a7885_SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_700fcb60-fbd7-44c6-9966-3068d4ad6216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2ffda8b2-9dbd-44b5-8952-117e3d02b969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_700fcb60-fbd7-44c6-9966-3068d4ad6216" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2ffda8b2-9dbd-44b5-8952-117e3d02b969" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_13aacbc7-7da1-4acb-9746-228a82c7b88d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_700fcb60-fbd7-44c6-9966-3068d4ad6216" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_13aacbc7-7da1-4acb-9746-228a82c7b88d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_b93dd4c8-c12e-446e-a858-26f6671bcb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_700fcb60-fbd7-44c6-9966-3068d4ad6216" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_b93dd4c8-c12e-446e-a858-26f6671bcb5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_8989b9c1-0652-49f1-9f74-3d425625db7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_700fcb60-fbd7-44c6-9966-3068d4ad6216" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_8989b9c1-0652-49f1-9f74-3d425625db7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherLiabilitiesCurrentUnsettledShareRepurchase_09134136-7b1a-4d2e-96b9-8c22afa7a6a2" xlink:href="bax-20220331.xsd#bax_OtherLiabilitiesCurrentUnsettledShareRepurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_700fcb60-fbd7-44c6-9966-3068d4ad6216" xlink:to="loc_bax_OtherLiabilitiesCurrentUnsettledShareRepurchase_09134136-7b1a-4d2e-96b9-8c22afa7a6a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_06073e9a-3367-4ef5-a8f0-2096b833c436" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_700fcb60-fbd7-44c6-9966-3068d4ad6216" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_06073e9a-3367-4ef5-a8f0-2096b833c436" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_85d1fedf-8d2b-401e-bf56-024e6a0f2f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_06073e9a-3367-4ef5-a8f0-2096b833c436" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_85d1fedf-8d2b-401e-bf56-024e6a0f2f7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_85d1fedf-8d2b-401e-bf56-024e6a0f2f7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_85d1fedf-8d2b-401e-bf56-024e6a0f2f7d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_85d1fedf-8d2b-401e-bf56-024e6a0f2f7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7ad658a5-5ca7-4313-a0e0-d52a07985b22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_85d1fedf-8d2b-401e-bf56-024e6a0f2f7d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7ad658a5-5ca7-4313-a0e0-d52a07985b22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_b516ca8b-aafc-4501-b636-a26eee5d8a70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7ad658a5-5ca7-4313-a0e0-d52a07985b22" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_b516ca8b-aafc-4501-b636-a26eee5d8a70" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails" xlink:type="extended" id="i8fd6fa4c6f524e7fb42aee5c99730252_GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_fed29a14-69d8-4101-9c4e-ffb8e0d8cbbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_0db0c76a-2bd5-4cd5-b178-68fc165b9a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_fed29a14-69d8-4101-9c4e-ffb8e0d8cbbe" xlink:to="loc_us-gaap_GoodwillRollForward_0db0c76a-2bd5-4cd5-b178-68fc165b9a63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b5814241-58fd-4daa-a5bf-b27a86bd40aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_0db0c76a-2bd5-4cd5-b178-68fc165b9a63" xlink:to="loc_us-gaap_Goodwill_b5814241-58fd-4daa-a5bf-b27a86bd40aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_a8073709-87a9-4d77-8a60-93cfd07a348c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_0db0c76a-2bd5-4cd5-b178-68fc165b9a63" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_a8073709-87a9-4d77-8a60-93cfd07a348c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9f87885f-818d-45f7-8c60-6ab094536232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_0db0c76a-2bd5-4cd5-b178-68fc165b9a63" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9f87885f-818d-45f7-8c60-6ab094536232" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_27a3d6f9-ce99-4283-bf8c-9fb832abf317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_98d58096-2f44-48ea-b614-9d6468e4cb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_fed29a14-69d8-4101-9c4e-ffb8e0d8cbbe" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_98d58096-2f44-48ea-b614-9d6468e4cb2c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_efe971ed-9770-43bb-a92b-cccfa9160cea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_98d58096-2f44-48ea-b614-9d6468e4cb2c" xlink:to="loc_srt_StatementGeographicalAxis_efe971ed-9770-43bb-a92b-cccfa9160cea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_efe971ed-9770-43bb-a92b-cccfa9160cea_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_efe971ed-9770-43bb-a92b-cccfa9160cea" xlink:to="loc_srt_SegmentGeographicalDomain_efe971ed-9770-43bb-a92b-cccfa9160cea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cb67aaf5-2b36-4538-80bb-ddf5475fffd1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_efe971ed-9770-43bb-a92b-cccfa9160cea" xlink:to="loc_srt_SegmentGeographicalDomain_cb67aaf5-2b36-4538-80bb-ddf5475fffd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_49a1d216-0d27-4f5d-ba81-5137597b853a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cb67aaf5-2b36-4538-80bb-ddf5475fffd1" xlink:to="loc_srt_AmericasMember_49a1d216-0d27-4f5d-ba81-5137597b853a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_8e2a67bc-9a50-4199-8d5c-af39b4adbe72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cb67aaf5-2b36-4538-80bb-ddf5475fffd1" xlink:to="loc_us-gaap_EMEAMember_8e2a67bc-9a50-4199-8d5c-af39b4adbe72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_b1dce789-757e-43de-81fe-247f91b5b1a8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cb67aaf5-2b36-4538-80bb-ddf5475fffd1" xlink:to="loc_srt_AsiaPacificMember_b1dce789-757e-43de-81fe-247f91b5b1a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_4d1c7a5c-1287-4e6f-bd01-a542f910a5d5" xlink:href="bax-20220331.xsd#bax_HillromMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cb67aaf5-2b36-4538-80bb-ddf5475fffd1" xlink:to="loc_bax_HillromMember_4d1c7a5c-1287-4e6f-bd01-a542f910a5d5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="extended" id="i56e76dfdb9a5439c85fe75ebeed589ff_GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillLineItems_89d162cc-f850-4187-9928-177cd4412447" xlink:href="bax-20220331.xsd#bax_IntangibleAssetExcludingGoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_51d9cc68-1f7c-4d08-a94b-9a1d23a38456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_89d162cc-f850-4187-9928-177cd4412447" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_51d9cc68-1f7c-4d08-a94b-9a1d23a38456" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_f9fe4009-483d-461c-9a9c-61e8c9797ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_89d162cc-f850-4187-9928-177cd4412447" xlink:to="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_f9fe4009-483d-461c-9a9c-61e8c9797ba1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dba66872-741b-4a9d-b49b-3a98542623dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_89d162cc-f850-4187-9928-177cd4412447" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dba66872-741b-4a9d-b49b-3a98542623dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_469890f6-7e58-4c6d-b818-9db8c335fe78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_89d162cc-f850-4187-9928-177cd4412447" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_469890f6-7e58-4c6d-b818-9db8c335fe78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_571133a6-108d-45bb-9ac0-be57b4ac5e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_89d162cc-f850-4187-9928-177cd4412447" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_571133a6-108d-45bb-9ac0-be57b4ac5e0c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6df31202-ca2d-43a2-a60e-a9c6a90ff483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_89d162cc-f850-4187-9928-177cd4412447" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6df31202-ca2d-43a2-a60e-a9c6a90ff483" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillTable_ba92ea3f-b389-460b-baff-f8a0a10525eb" xlink:href="bax-20220331.xsd#bax_IntangibleAssetExcludingGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_89d162cc-f850-4187-9928-177cd4412447" xlink:to="loc_bax_IntangibleAssetExcludingGoodwillTable_ba92ea3f-b389-460b-baff-f8a0a10525eb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb492db8-34c2-4841-a563-8ddb91de9004" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable_ba92ea3f-b389-460b-baff-f8a0a10525eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb492db8-34c2-4841-a563-8ddb91de9004" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fb492db8-34c2-4841-a563-8ddb91de9004_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb492db8-34c2-4841-a563-8ddb91de9004" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fb492db8-34c2-4841-a563-8ddb91de9004_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_874ba78d-1b3b-4b0d-8827-3f90951bb821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb492db8-34c2-4841-a563-8ddb91de9004" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_874ba78d-1b3b-4b0d-8827-3f90951bb821" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_fee1fbb7-e360-4ba9-b98c-2b2ca4076e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_874ba78d-1b3b-4b0d-8827-3f90951bb821" xlink:to="loc_us-gaap_CustomerRelationshipsMember_fee1fbb7-e360-4ba9-b98c-2b2ca4076e07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DevelopedTechnologyIncludingPatentsMember_fb5d777e-0357-49a8-9115-af8eeff90cef" xlink:href="bax-20220331.xsd#bax_DevelopedTechnologyIncludingPatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_874ba78d-1b3b-4b0d-8827-3f90951bb821" xlink:to="loc_bax_DevelopedTechnologyIncludingPatentsMember_fb5d777e-0357-49a8-9115-af8eeff90cef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_34430c91-1191-4385-baf5-ec51e85c7fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_874ba78d-1b3b-4b0d-8827-3f90951bb821" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_34430c91-1191-4385-baf5-ec51e85c7fe8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_05747da6-12d4-464f-bdf0-d70fcfffee28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable_ba92ea3f-b389-460b-baff-f8a0a10525eb" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_05747da6-12d4-464f-bdf0-d70fcfffee28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_05747da6-12d4-464f-bdf0-d70fcfffee28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_05747da6-12d4-464f-bdf0-d70fcfffee28" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_05747da6-12d4-464f-bdf0-d70fcfffee28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0b24c382-b036-4660-9e6a-d136243cd45a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_05747da6-12d4-464f-bdf0-d70fcfffee28" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0b24c382-b036-4660-9e6a-d136243cd45a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsMember_29bc1ca4-f2bf-40b0-b6d2-610af6268342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0b24c382-b036-4660-9e6a-d136243cd45a" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsMember_29bc1ca4-f2bf-40b0-b6d2-610af6268342" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#FINANCINGARRANGEMENTSDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails" xlink:type="extended" id="ibfe38eecb90541cda6e028e644db606d_FINANCINGARRANGEMENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_74278a5d-200a-45be-aa0d-e1cf8898186a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_us-gaap_LongTermDebt_74278a5d-200a-45be-aa0d-e1cf8898186a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_42c0ed11-5ee7-4893-b2ab-97790730877f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_42c0ed11-5ee7-4893-b2ab-97790730877f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm_a11e2d13-4c0d-4106-89cc-5e72391114ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_us-gaap_LongTermDebtTerm_a11e2d13-4c0d-4106-89cc-5e72391114ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_a010e202-1c7b-4f40-a22d-17d894b03713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_a010e202-1c7b-4f40-a22d-17d894b03713" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_49554567-80be-4ada-942a-57c5e359e834" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_us-gaap_LineOfCredit_49554567-80be-4ada-942a-57c5e359e834" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperAverageOutstanding_5a44a9e6-768e-4605-bf87-1f1257bc60a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperAverageOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_us-gaap_CommercialPaperAverageOutstanding_5a44a9e6-768e-4605-bf87-1f1257bc60a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommercialPaperWeightedAverageInterestRate_b56b3ee0-84f7-49f3-a2ff-8918d820cd1f" xlink:href="bax-20220331.xsd#bax_CommercialPaperWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_bax_CommercialPaperWeightedAverageInterestRate_b56b3ee0-84f7-49f3-a2ff-8918d820cd1f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OriginalWeightedAverageTerm_79f13f72-6083-467e-aec8-82d9c90950cc" xlink:href="bax-20220331.xsd#bax_OriginalWeightedAverageTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_bax_OriginalWeightedAverageTerm_79f13f72-6083-467e-aec8-82d9c90950cc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d5635b72-c11c-4390-b55f-8ce34b3b05fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_us-gaap_DebtInstrumentTable_d5635b72-c11c-4390-b55f-8ce34b3b05fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0cdf76ec-9647-422b-96be-cab58e8acf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d5635b72-c11c-4390-b55f-8ce34b3b05fb" xlink:to="loc_us-gaap_DebtInstrumentAxis_0cdf76ec-9647-422b-96be-cab58e8acf5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0cdf76ec-9647-422b-96be-cab58e8acf5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0cdf76ec-9647-422b-96be-cab58e8acf5d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0cdf76ec-9647-422b-96be-cab58e8acf5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f0a0c813-5c2f-445b-9f4c-95ba652fecdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0cdf76ec-9647-422b-96be-cab58e8acf5d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f0a0c813-5c2f-445b-9f4c-95ba652fecdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeniorThreeYearTermLoanMember_f84ba990-7640-4dd0-82ae-0756156b15cb" xlink:href="bax-20220331.xsd#bax_SeniorThreeYearTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0a0c813-5c2f-445b-9f4c-95ba652fecdb" xlink:to="loc_bax_SeniorThreeYearTermLoanMember_f84ba990-7640-4dd0-82ae-0756156b15cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeniorFiveYearTermLoanMember_06873f82-9f4c-4280-9d44-5699320d0516" xlink:href="bax-20220331.xsd#bax_SeniorFiveYearTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0a0c813-5c2f-445b-9f4c-95ba652fecdb" xlink:to="loc_bax_SeniorFiveYearTermLoanMember_06873f82-9f4c-4280-9d44-5699320d0516" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ebc0339b-b056-4810-a217-62eb5a277750" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d5635b72-c11c-4390-b55f-8ce34b3b05fb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ebc0339b-b056-4810-a217-62eb5a277750" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ebc0339b-b056-4810-a217-62eb5a277750_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ebc0339b-b056-4810-a217-62eb5a277750" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ebc0339b-b056-4810-a217-62eb5a277750_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c4f6a322-3617-4d02-ac0e-a5b60a072880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ebc0339b-b056-4810-a217-62eb5a277750" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c4f6a322-3617-4d02-ac0e-a5b60a072880" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_86aed1c8-ce4a-439f-9227-6d3aa45093b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c4f6a322-3617-4d02-ac0e-a5b60a072880" xlink:to="loc_us-gaap_SeniorNotesMember_86aed1c8-ce4a-439f-9227-6d3aa45093b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_fddca41e-be71-4421-bd06-77d97ce09bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d5635b72-c11c-4390-b55f-8ce34b3b05fb" xlink:to="loc_us-gaap_CreditFacilityAxis_fddca41e-be71-4421-bd06-77d97ce09bf8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fddca41e-be71-4421-bd06-77d97ce09bf8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_fddca41e-be71-4421-bd06-77d97ce09bf8" xlink:to="loc_us-gaap_CreditFacilityDomain_fddca41e-be71-4421-bd06-77d97ce09bf8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e4f09911-84c6-4c4e-a967-ce17c299dd98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_fddca41e-be71-4421-bd06-77d97ce09bf8" xlink:to="loc_us-gaap_CreditFacilityDomain_e4f09911-84c6-4c4e-a967-ce17c299dd98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b02aa3ea-1256-4723-854b-222c0c7edabe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_e4f09911-84c6-4c4e-a967-ce17c299dd98" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b02aa3ea-1256-4723-854b-222c0c7edabe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="i2b8e18f2c748421882ba89c35a511c7d_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_9058fc37-45ba-4f40-9830-1e4dfb3ede8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_08b67e32-78be-4332-8796-a5ecbaa9210c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9058fc37-45ba-4f40-9830-1e4dfb3ede8f" xlink:to="loc_us-gaap_LitigationReserve_08b67e32-78be-4332-8796-a5ecbaa9210c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SiteContingencyNumberOfSites_6191642b-82bd-4475-9215-beb81b4faa76" xlink:href="bax-20220331.xsd#bax_SiteContingencyNumberOfSites"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9058fc37-45ba-4f40-9830-1e4dfb3ede8f" xlink:to="loc_bax_SiteContingencyNumberOfSites_6191642b-82bd-4475-9215-beb81b4faa76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_38ce73ea-2b5c-44bd-a6ec-0497c6ddbafc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9058fc37-45ba-4f40-9830-1e4dfb3ede8f" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_38ce73ea-2b5c-44bd-a6ec-0497c6ddbafc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_8a15f5fa-6a94-4fe0-bff4-a3b195e36cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9058fc37-45ba-4f40-9830-1e4dfb3ede8f" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_8a15f5fa-6a94-4fe0-bff4-a3b195e36cd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_578acaaa-16ff-42a4-bf91-af41634f3a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9058fc37-45ba-4f40-9830-1e4dfb3ede8f" xlink:to="loc_us-gaap_LitigationSettlementExpense_578acaaa-16ff-42a4-bf91-af41634f3a62" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LossContingencyNumberOfLawsuits_48b1b19b-ce45-4040-a948-47c156a47621" xlink:href="bax-20220331.xsd#bax_LossContingencyNumberOfLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_9058fc37-45ba-4f40-9830-1e4dfb3ede8f" xlink:to="loc_bax_LossContingencyNumberOfLawsuits_48b1b19b-ce45-4040-a948-47c156a47621" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_438e865e-642f-4d22-b879-254713bcd088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_9058fc37-45ba-4f40-9830-1e4dfb3ede8f" xlink:to="loc_us-gaap_LossContingenciesTable_438e865e-642f-4d22-b879-254713bcd088" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteAxis_49741176-8766-44ee-9121-0e1b71cec5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EnvironmentalRemediationSiteAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_438e865e-642f-4d22-b879-254713bcd088" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteAxis_49741176-8766-44ee-9121-0e1b71cec5a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain_49741176-8766-44ee-9121-0e1b71cec5a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis_49741176-8766-44ee-9121-0e1b71cec5a0" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteDomain_49741176-8766-44ee-9121-0e1b71cec5a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain_8122d654-d1c3-408a-892c-cb6b215f7ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis_49741176-8766-44ee-9121-0e1b71cec5a0" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteDomain_8122d654-d1c3-408a-892c-cb6b215f7ccd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SuperfundSitesMember_a73bcd3a-74a3-465d-95a6-b9bf6426bed4" xlink:href="bax-20220331.xsd#bax_SuperfundSitesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteDomain_8122d654-d1c3-408a-892c-cb6b215f7ccd" xlink:to="loc_bax_SuperfundSitesMember_a73bcd3a-74a3-465d-95a6-b9bf6426bed4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyAxis_d95a5e56-caae-4bfb-b4bd-1917e2a90f13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EnvironmentalRemediationContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_438e865e-642f-4d22-b879-254713bcd088" xlink:to="loc_us-gaap_EnvironmentalRemediationContingencyAxis_d95a5e56-caae-4bfb-b4bd-1917e2a90f13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyDomain_d95a5e56-caae-4bfb-b4bd-1917e2a90f13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EnvironmentalRemediationContingencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyAxis_d95a5e56-caae-4bfb-b4bd-1917e2a90f13" xlink:to="loc_us-gaap_EnvironmentalRemediationContingencyDomain_d95a5e56-caae-4bfb-b4bd-1917e2a90f13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyDomain_04560c5d-da7c-4d90-a345-1225d29020c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EnvironmentalRemediationContingencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyAxis_d95a5e56-caae-4bfb-b4bd-1917e2a90f13" xlink:to="loc_us-gaap_EnvironmentalRemediationContingencyDomain_04560c5d-da7c-4d90-a345-1225d29020c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EnviromentalCleanUpMember_5cf659f5-17b7-4b47-b25e-067cc07b3dd5" xlink:href="bax-20220331.xsd#bax_EnviromentalCleanUpMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyDomain_04560c5d-da7c-4d90-a345-1225d29020c0" xlink:to="loc_bax_EnviromentalCleanUpMember_5cf659f5-17b7-4b47-b25e-067cc07b3dd5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended" id="ib0765298ad4848afbad723a3e6095292_STOCKHOLDERSEQUITYNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:href="bax-20220331.xsd#bax_StockholdersEquityNoteLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_aeb23f0f-79be-4cbe-9d60-29870b35bb72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_ShareBasedCompensation_aeb23f0f-79be-4cbe-9d60-29870b35bb72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ShareBasedCompensationAllocationPercentage_4d680a0b-c203-4411-ab02-7b452b213f2c" xlink:href="bax-20220331.xsd#bax_ShareBasedCompensationAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_bax_ShareBasedCompensationAllocationPercentage_4d680a0b-c203-4411-ab02-7b452b213f2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2d290129-dccc-429a-895c-ec9a1c6dbce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2d290129-dccc-429a-895c-ec9a1c6dbce0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e838c070-c8fc-4707-a495-3ab46262fae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e838c070-c8fc-4707-a495-3ab46262fae6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross_3979f957-bf93-4c34-a592-dde5c528a78b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross_3979f957-bf93-4c34-a592-dde5c528a78b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9fd3a93c-512e-4984-84a7-7faf399bbe1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9fd3a93c-512e-4984-84a7-7faf399bbe1c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6d445955-2bb5-4a24-a69b-8870d7ff7b79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6d445955-2bb5-4a24-a69b-8870d7ff7b79" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_73abea52-b395-41a6-8e8b-e55940def06d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_73abea52-b395-41a6-8e8b-e55940def06d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_b78c5022-3813-403d-ba43-02163c073067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_b78c5022-3813-403d-ba43-02163c073067" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_833b4ce4-ac93-4bf5-97bb-9c69beba93a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_833b4ce4-ac93-4bf5-97bb-9c69beba93a6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_20c88010-07c1-47d9-949e-bb2f75c42c3c" xlink:href="bax-20220331.xsd#bax_StockRepurchaseProgramAdditionalAuthorizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_20c88010-07c1-47d9-949e-bb2f75c42c3c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_d29606d4-ea4e-4fe1-a420-bf175858933f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_d29606d4-ea4e-4fe1-a420-bf175858933f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_14987c9a-e668-496e-93cc-dffcdf98e27d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_14987c9a-e668-496e-93cc-dffcdf98e27d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_StockholdersEquityNoteTable_cfd36a45-49d9-410b-8e69-2bd64ce4d245" xlink:href="bax-20220331.xsd#bax_StockholdersEquityNoteTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_bax_StockholdersEquityNoteTable_cfd36a45-49d9-410b-8e69-2bd64ce4d245" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_772feb5d-569a-4fa9-898e-dcfcfbdba693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_StockholdersEquityNoteTable_cfd36a45-49d9-410b-8e69-2bd64ce4d245" xlink:to="loc_us-gaap_AwardTypeAxis_772feb5d-569a-4fa9-898e-dcfcfbdba693" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_772feb5d-569a-4fa9-898e-dcfcfbdba693_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_772feb5d-569a-4fa9-898e-dcfcfbdba693" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_772feb5d-569a-4fa9-898e-dcfcfbdba693_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff2fa4d-d197-4ae8-a94e-61e89eef5119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_772feb5d-569a-4fa9-898e-dcfcfbdba693" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff2fa4d-d197-4ae8-a94e-61e89eef5119" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_da0e5f7c-be28-4f12-991f-ec78b264ce2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff2fa4d-d197-4ae8-a94e-61e89eef5119" xlink:to="loc_us-gaap_EmployeeStockOptionMember_da0e5f7c-be28-4f12-991f-ec78b264ce2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_448dd5dc-b356-42da-ad8b-dc537a2b1186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff2fa4d-d197-4ae8-a94e-61e89eef5119" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_448dd5dc-b356-42da-ad8b-dc537a2b1186" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_903bf630-d06e-488f-abbe-b67eeb85b4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff2fa4d-d197-4ae8-a94e-61e89eef5119" xlink:to="loc_us-gaap_PerformanceSharesMember_903bf630-d06e-488f-abbe-b67eeb85b4e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3e7affc5-88ff-414f-920b-4c5037293ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_StockholdersEquityNoteTable_cfd36a45-49d9-410b-8e69-2bd64ce4d245" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3e7affc5-88ff-414f-920b-4c5037293ffa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3e7affc5-88ff-414f-920b-4c5037293ffa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3e7affc5-88ff-414f-920b-4c5037293ffa" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3e7affc5-88ff-414f-920b-4c5037293ffa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_85473c60-44d6-42b0-be44-b08644c5341c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3e7affc5-88ff-414f-920b-4c5037293ffa" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_85473c60-44d6-42b0-be44-b08644c5341c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_76823256-f224-4e58-a69d-af4cf1907f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_85473c60-44d6-42b0-be44-b08644c5341c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_76823256-f224-4e58-a69d-af4cf1907f8b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails" xlink:type="extended" id="ie373a2424f264875bc78136b1530d961_ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1969dd37-2a4d-4da0-bd1b-be51ceee6da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_31b138c7-8376-4204-9060-6c1c187d573f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1969dd37-2a4d-4da0-bd1b-be51ceee6da3" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_31b138c7-8376-4204-9060-6c1c187d573f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0e21ca43-b5a6-49bc-9585-ff5cd5589e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_31b138c7-8376-4204-9060-6c1c187d573f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0e21ca43-b5a6-49bc-9585-ff5cd5589e27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_3fda3911-a2e5-4c82-95fd-d67449166c77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_31b138c7-8376-4204-9060-6c1c187d573f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_3fda3911-a2e5-4c82-95fd-d67449166c77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_0d04718b-bf25-4e82-8f60-5e48fe9772e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_31b138c7-8376-4204-9060-6c1c187d573f" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_0d04718b-bf25-4e82-8f60-5e48fe9772e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_904b6923-f0b7-45c9-a237-a43f04c6520d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_31b138c7-8376-4204-9060-6c1c187d573f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_904b6923-f0b7-45c9-a237-a43f04c6520d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_91a6cbea-0585-43ed-8da2-6ea1d9f304a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_06e7100e-ed86-4d7c-b7e3-91c397a41e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1969dd37-2a4d-4da0-bd1b-be51ceee6da3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_06e7100e-ed86-4d7c-b7e3-91c397a41e47" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_abfac9a8-0b97-4fdb-824e-357e3bfd06fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_06e7100e-ed86-4d7c-b7e3-91c397a41e47" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_abfac9a8-0b97-4fdb-824e-357e3bfd06fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_abfac9a8-0b97-4fdb-824e-357e3bfd06fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_abfac9a8-0b97-4fdb-824e-357e3bfd06fd" xlink:to="loc_us-gaap_EquityComponentDomain_abfac9a8-0b97-4fdb-824e-357e3bfd06fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cdcd614e-e83b-4225-9de5-f7814396e181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_abfac9a8-0b97-4fdb-824e-357e3bfd06fd" xlink:to="loc_us-gaap_EquityComponentDomain_cdcd614e-e83b-4225-9de5-f7814396e181" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_fba415e1-1df7-43d1-985c-a6ebd4011ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cdcd614e-e83b-4225-9de5-f7814396e181" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_fba415e1-1df7-43d1-985c-a6ebd4011ddb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_c9ad6109-8dc9-44be-b296-d3f09df2a9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cdcd614e-e83b-4225-9de5-f7814396e181" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_c9ad6109-8dc9-44be-b296-d3f09df2a9f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_38b356a8-9a5c-410a-9023-73c963c636c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cdcd614e-e83b-4225-9de5-f7814396e181" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_38b356a8-9a5c-410a-9023-73c963c636c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_d12971f3-d684-40f8-9125-141ee524c1ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cdcd614e-e83b-4225-9de5-f7814396e181" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_d12971f3-d684-40f8-9125-141ee524c1ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_30ba7feb-434d-4fb5-b1d8-820487602912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cdcd614e-e83b-4225-9de5-f7814396e181" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_30ba7feb-434d-4fb5-b1d8-820487602912" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails" xlink:type="extended" id="i4679153b975e450db62d907fa9ed0784_ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_742ec357-ae8e-4098-8e5b-b9b33314de21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_dadf3b19-c5c5-4fca-8562-97961277a67f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_742ec357-ae8e-4098-8e5b-b9b33314de21" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_dadf3b19-c5c5-4fca-8562-97961277a67f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_45150f41-1d48-4fc5-939a-f41399121bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_742ec357-ae8e-4098-8e5b-b9b33314de21" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_45150f41-1d48-4fc5-939a-f41399121bf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_2f5f753e-e522-4311-b89f-65edc42cdae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_742ec357-ae8e-4098-8e5b-b9b33314de21" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_2f5f753e-e522-4311-b89f-65edc42cdae0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_c4d53e80-b212-4125-b5d1-9896f02133d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_742ec357-ae8e-4098-8e5b-b9b33314de21" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_c4d53e80-b212-4125-b5d1-9896f02133d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_24353356-78ae-4732-b717-18a29c971b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_742ec357-ae8e-4098-8e5b-b9b33314de21" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_24353356-78ae-4732-b717-18a29c971b98" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e63563e9-f15d-4761-bbb2-d69517f1ba4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_742ec357-ae8e-4098-8e5b-b9b33314de21" xlink:to="loc_us-gaap_NetIncomeLoss_e63563e9-f15d-4761-bbb2-d69517f1ba4d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a5eba7e-2c6b-40e6-a970-75aaa8181d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_742ec357-ae8e-4098-8e5b-b9b33314de21" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a5eba7e-2c6b-40e6-a970-75aaa8181d51" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4bc04df0-6a71-4e54-8335-61b0d5c8e799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a5eba7e-2c6b-40e6-a970-75aaa8181d51" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4bc04df0-6a71-4e54-8335-61b0d5c8e799" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4bc04df0-6a71-4e54-8335-61b0d5c8e799_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4bc04df0-6a71-4e54-8335-61b0d5c8e799" xlink:to="loc_us-gaap_EquityComponentDomain_4bc04df0-6a71-4e54-8335-61b0d5c8e799_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3b1ede07-babb-4640-ae49-29bb2f0e4793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4bc04df0-6a71-4e54-8335-61b0d5c8e799" xlink:to="loc_us-gaap_EquityComponentDomain_3b1ede07-babb-4640-ae49-29bb2f0e4793" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_a9deeaf2-d8a6-4c01-9080-fb320eb96f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3b1ede07-babb-4640-ae49-29bb2f0e4793" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_a9deeaf2-d8a6-4c01-9080-fb320eb96f3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_15a0a8d4-d7ee-4c22-8a77-3cb0ad422ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3b1ede07-babb-4640-ae49-29bb2f0e4793" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_15a0a8d4-d7ee-4c22-8a77-3cb0ad422ad3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b0f14fb9-16fd-4a7a-9a2e-499df17bbca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a5eba7e-2c6b-40e6-a970-75aaa8181d51" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b0f14fb9-16fd-4a7a-9a2e-499df17bbca6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b0f14fb9-16fd-4a7a-9a2e-499df17bbca6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b0f14fb9-16fd-4a7a-9a2e-499df17bbca6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b0f14fb9-16fd-4a7a-9a2e-499df17bbca6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d0eb8eb6-cf93-4999-891e-d52e8a7586d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b0f14fb9-16fd-4a7a-9a2e-499df17bbca6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d0eb8eb6-cf93-4999-891e-d52e8a7586d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_95bd1ea4-c951-48bf-a013-337a822f54da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d0eb8eb6-cf93-4999-891e-d52e8a7586d2" xlink:to="loc_us-gaap_ForeignExchangeContractMember_95bd1ea4-c951-48bf-a013-337a822f54da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_59723b96-8fac-4817-a17b-4e7295f70dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d0eb8eb6-cf93-4999-891e-d52e8a7586d2" xlink:to="loc_us-gaap_InterestRateContractMember_59723b96-8fac-4817-a17b-4e7295f70dd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_50c27cb3-cf80-42da-8fa1-05ad623697d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a5eba7e-2c6b-40e6-a970-75aaa8181d51" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_50c27cb3-cf80-42da-8fa1-05ad623697d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_50c27cb3-cf80-42da-8fa1-05ad623697d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_50c27cb3-cf80-42da-8fa1-05ad623697d1" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_50c27cb3-cf80-42da-8fa1-05ad623697d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_6ae61da8-7e3b-4b07-b28f-e24af2a7552a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_50c27cb3-cf80-42da-8fa1-05ad623697d1" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_6ae61da8-7e3b-4b07-b28f-e24af2a7552a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_496ad480-b522-4969-86f0-5f2861f2e47d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_6ae61da8-7e3b-4b07-b28f-e24af2a7552a" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_496ad480-b522-4969-86f0-5f2861f2e47d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#REVENUESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/REVENUESAdditionalInformationDetails" xlink:type="extended" id="i6bf2a2db38b242c2a696e0ab4a0fb07d_REVENUESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenuePerformanceObligationPaymentTerms_04f2cdda-e04d-490e-9bd2-35a479177242" xlink:href="bax-20220331.xsd#bax_RevenuePerformanceObligationPaymentTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_bax_RevenuePerformanceObligationPaymentTerms_04f2cdda-e04d-490e-9bd2-35a479177242" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_52880d4f-029b-4f9f-85b2-9ee347323f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_us-gaap_AccountsReceivableNet_52880d4f-029b-4f9f-85b2-9ee347323f04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueRecognizedContractPeriod_e4dccffa-e67b-4406-84c1-3e960bb06a8b" xlink:href="bax-20220331.xsd#bax_RevenueRecognizedContractPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_bax_RevenueRecognizedContractPeriod_e4dccffa-e67b-4406-84c1-3e960bb06a8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_807d30c7-6154-4eb5-a266-87402a3eda78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_807d30c7-6154-4eb5-a266-87402a3eda78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_924ddf39-8310-4d73-a7fe-242cf058d308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_924ddf39-8310-4d73-a7fe-242cf058d308" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerTable_b9b6db2e-842f-4844-9556-77937464a460" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_bax_RevenueFromContractWithCustomerTable_b9b6db2e-842f-4844-9556-77937464a460" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_17f05422-9c10-47ee-bb18-ae911e0865b8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_b9b6db2e-842f-4844-9556-77937464a460" xlink:to="loc_srt_RangeAxis_17f05422-9c10-47ee-bb18-ae911e0865b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_17f05422-9c10-47ee-bb18-ae911e0865b8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_17f05422-9c10-47ee-bb18-ae911e0865b8" xlink:to="loc_srt_RangeMember_17f05422-9c10-47ee-bb18-ae911e0865b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_db112830-5a9c-486f-8eba-ad8820c480b8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_17f05422-9c10-47ee-bb18-ae911e0865b8" xlink:to="loc_srt_RangeMember_db112830-5a9c-486f-8eba-ad8820c480b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1166406b-5ad9-4591-8c22-06ec45f3b33f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_db112830-5a9c-486f-8eba-ad8820c480b8" xlink:to="loc_srt_MinimumMember_1166406b-5ad9-4591-8c22-06ec45f3b33f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5f13d71e-8c7c-4782-b3fd-0ac369129019" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_db112830-5a9c-486f-8eba-ad8820c480b8" xlink:to="loc_srt_MaximumMember_5f13d71e-8c7c-4782-b3fd-0ac369129019" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_60b62c51-f725-4e7d-bbb1-eeb5993d1cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_b9b6db2e-842f-4844-9556-77937464a460" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_60b62c51-f725-4e7d-bbb1-eeb5993d1cc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_60b62c51-f725-4e7d-bbb1-eeb5993d1cc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_60b62c51-f725-4e7d-bbb1-eeb5993d1cc2" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_60b62c51-f725-4e7d-bbb1-eeb5993d1cc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_b1d193a9-21c8-4e95-bf01-dc74ea7e6b93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_60b62c51-f725-4e7d-bbb1-eeb5993d1cc2" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_b1d193a9-21c8-4e95-bf01-dc74ea7e6b93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember_a1326b6f-6c9f-4e3c-8d89-f297462bc836" xlink:href="bax-20220331.xsd#bax_ManufacturingArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_b1d193a9-21c8-4e95-bf01-dc74ea7e6b93" xlink:to="loc_bax_ManufacturingArrangementsMember_a1326b6f-6c9f-4e3c-8d89-f297462bc836" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember_58a66e7f-ce42-4e71-849a-d1afca0bbe2c" xlink:href="bax-20220331.xsd#bax_SoftwareArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_b1d193a9-21c8-4e95-bf01-dc74ea7e6b93" xlink:to="loc_bax_SoftwareArrangementsMember_58a66e7f-ce42-4e71-849a-d1afca0bbe2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ConsumableMedicalProductsMember_f39ea650-31fb-4bb0-b2b5-aacb5ba00d62" xlink:href="bax-20220331.xsd#bax_ConsumableMedicalProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_b1d193a9-21c8-4e95-bf01-dc74ea7e6b93" xlink:to="loc_bax_ConsumableMedicalProductsMember_f39ea650-31fb-4bb0-b2b5-aacb5ba00d62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_6c107c8f-d4ef-49a6-8771-93d12e0492db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_b9b6db2e-842f-4844-9556-77937464a460" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_6c107c8f-d4ef-49a6-8771-93d12e0492db" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails_1" xlink:type="simple" xlink:href="bax-20220331.xsd#REVENUESAdditionalInformationDetails_1"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/REVENUESAdditionalInformationDetails_1" xlink:type="extended" id="i6d219a8789054a16a6dda6c128eed1ff_REVENUESAdditionalInformationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenuePerformanceObligationPaymentTerms_04f2cdda-e04d-490e-9bd2-35a479177242" xlink:href="bax-20220331.xsd#bax_RevenuePerformanceObligationPaymentTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_bax_RevenuePerformanceObligationPaymentTerms_04f2cdda-e04d-490e-9bd2-35a479177242" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_52880d4f-029b-4f9f-85b2-9ee347323f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_us-gaap_AccountsReceivableNet_52880d4f-029b-4f9f-85b2-9ee347323f04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueRecognizedContractPeriod_e4dccffa-e67b-4406-84c1-3e960bb06a8b" xlink:href="bax-20220331.xsd#bax_RevenueRecognizedContractPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_bax_RevenueRecognizedContractPeriod_e4dccffa-e67b-4406-84c1-3e960bb06a8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_807d30c7-6154-4eb5-a266-87402a3eda78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_807d30c7-6154-4eb5-a266-87402a3eda78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_924ddf39-8310-4d73-a7fe-242cf058d308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_924ddf39-8310-4d73-a7fe-242cf058d308" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerTable_b9b6db2e-842f-4844-9556-77937464a460" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_bax_RevenueFromContractWithCustomerTable_b9b6db2e-842f-4844-9556-77937464a460" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_17f05422-9c10-47ee-bb18-ae911e0865b8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_b9b6db2e-842f-4844-9556-77937464a460" xlink:to="loc_srt_RangeAxis_17f05422-9c10-47ee-bb18-ae911e0865b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_17f05422-9c10-47ee-bb18-ae911e0865b8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_17f05422-9c10-47ee-bb18-ae911e0865b8" xlink:to="loc_srt_RangeMember_17f05422-9c10-47ee-bb18-ae911e0865b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_db112830-5a9c-486f-8eba-ad8820c480b8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_17f05422-9c10-47ee-bb18-ae911e0865b8" xlink:to="loc_srt_RangeMember_db112830-5a9c-486f-8eba-ad8820c480b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1166406b-5ad9-4591-8c22-06ec45f3b33f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_db112830-5a9c-486f-8eba-ad8820c480b8" xlink:to="loc_srt_MinimumMember_1166406b-5ad9-4591-8c22-06ec45f3b33f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5f13d71e-8c7c-4782-b3fd-0ac369129019" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_db112830-5a9c-486f-8eba-ad8820c480b8" xlink:to="loc_srt_MaximumMember_5f13d71e-8c7c-4782-b3fd-0ac369129019" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_60b62c51-f725-4e7d-bbb1-eeb5993d1cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_b9b6db2e-842f-4844-9556-77937464a460" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_60b62c51-f725-4e7d-bbb1-eeb5993d1cc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_60b62c51-f725-4e7d-bbb1-eeb5993d1cc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_60b62c51-f725-4e7d-bbb1-eeb5993d1cc2" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_60b62c51-f725-4e7d-bbb1-eeb5993d1cc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_b1d193a9-21c8-4e95-bf01-dc74ea7e6b93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_60b62c51-f725-4e7d-bbb1-eeb5993d1cc2" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_b1d193a9-21c8-4e95-bf01-dc74ea7e6b93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember_a1326b6f-6c9f-4e3c-8d89-f297462bc836" xlink:href="bax-20220331.xsd#bax_ManufacturingArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_b1d193a9-21c8-4e95-bf01-dc74ea7e6b93" xlink:to="loc_bax_ManufacturingArrangementsMember_a1326b6f-6c9f-4e3c-8d89-f297462bc836" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember_58a66e7f-ce42-4e71-849a-d1afca0bbe2c" xlink:href="bax-20220331.xsd#bax_SoftwareArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_b1d193a9-21c8-4e95-bf01-dc74ea7e6b93" xlink:to="loc_bax_SoftwareArrangementsMember_58a66e7f-ce42-4e71-849a-d1afca0bbe2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ConsumableMedicalProductsMember_f39ea650-31fb-4bb0-b2b5-aacb5ba00d62" xlink:href="bax-20220331.xsd#bax_ConsumableMedicalProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_b1d193a9-21c8-4e95-bf01-dc74ea7e6b93" xlink:to="loc_bax_ConsumableMedicalProductsMember_f39ea650-31fb-4bb0-b2b5-aacb5ba00d62" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#REVENUESRemainingPerformanceObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails" xlink:type="extended" id="i1af5fb2bd91e469bb60b6267089da84e_REVENUESRemainingPerformanceObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerLineItems_cef58eef-c0e0-45ce-ab64-55cc46c3062f" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_44a8fbaf-0d34-41e6-9692-7c0755a1ccbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_cef58eef-c0e0-45ce-ab64-55cc46c3062f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_44a8fbaf-0d34-41e6-9692-7c0755a1ccbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1a9c037b-3490-4a02-a3f9-977544b372b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_cef58eef-c0e0-45ce-ab64-55cc46c3062f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1a9c037b-3490-4a02-a3f9-977544b372b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_7b32fcd7-a9c3-4a9c-bce3-42d52f00409d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_cef58eef-c0e0-45ce-ab64-55cc46c3062f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_7b32fcd7-a9c3-4a9c-bce3-42d52f00409d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerTable_8f638a2d-1410-4aea-9069-ad2efb9796c4" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_cef58eef-c0e0-45ce-ab64-55cc46c3062f" xlink:to="loc_bax_RevenueFromContractWithCustomerTable_8f638a2d-1410-4aea-9069-ad2efb9796c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0f96a923-ae1f-4e58-9ef3-8dfa0e28e43d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_8f638a2d-1410-4aea-9069-ad2efb9796c4" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0f96a923-ae1f-4e58-9ef3-8dfa0e28e43d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="bax-20220331.xsd#REVENUESRemainingPerformanceObligationsDetails_1"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails_1" xlink:type="extended" id="ifc4c621af1f54f4ab15d9056f7e9dca1_REVENUESRemainingPerformanceObligationsDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerLineItems_cef58eef-c0e0-45ce-ab64-55cc46c3062f" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_44a8fbaf-0d34-41e6-9692-7c0755a1ccbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_cef58eef-c0e0-45ce-ab64-55cc46c3062f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_44a8fbaf-0d34-41e6-9692-7c0755a1ccbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1a9c037b-3490-4a02-a3f9-977544b372b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_cef58eef-c0e0-45ce-ab64-55cc46c3062f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1a9c037b-3490-4a02-a3f9-977544b372b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_7b32fcd7-a9c3-4a9c-bce3-42d52f00409d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_cef58eef-c0e0-45ce-ab64-55cc46c3062f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_7b32fcd7-a9c3-4a9c-bce3-42d52f00409d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerTable_8f638a2d-1410-4aea-9069-ad2efb9796c4" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_cef58eef-c0e0-45ce-ab64-55cc46c3062f" xlink:to="loc_bax_RevenueFromContractWithCustomerTable_8f638a2d-1410-4aea-9069-ad2efb9796c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#REVENUESContractAssetsandContractLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails" xlink:type="extended" id="if7aa6698e5c2498a91a78866d67d5dca_REVENUESContractAssetsandContractLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerLineItems_7d231390-3c43-41df-818b-b50a2c9a82ec" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_e382ea68-96d1-43a1-b3b2-1b005c449105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_7d231390-3c43-41df-818b-b50a2c9a82ec" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_e382ea68-96d1-43a1-b3b2-1b005c449105" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_02aa8a91-d062-4a67-b552-903155abab04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_7d231390-3c43-41df-818b-b50a2c9a82ec" xlink:to="loc_us-gaap_ContractWithCustomerLiability_02aa8a91-d062-4a67-b552-903155abab04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerRollForward_d8d5cc9e-a97a-4ae6-afc1-91f29d2004d6" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_7d231390-3c43-41df-818b-b50a2c9a82ec" xlink:to="loc_bax_RevenueFromContractWithCustomerRollForward_d8d5cc9e-a97a-4ae6-afc1-91f29d2004d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_3b18df42-3f0c-4d52-b9b0-2884b00edcb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityDeferredRevenue_4d628c54-8083-4b17-89ec-5d38461445b0" xlink:href="bax-20220331.xsd#bax_ContractWithCustomerLiabilityDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_d8d5cc9e-a97a-4ae6-afc1-91f29d2004d6" xlink:to="loc_bax_ContractWithCustomerLiabilityDeferredRevenue_4d628c54-8083-4b17-89ec-5d38461445b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_15d82492-ba8d-4dcb-bf4f-9f922eb92541" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_d8d5cc9e-a97a-4ae6-afc1-91f29d2004d6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_15d82492-ba8d-4dcb-bf4f-9f922eb92541" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_7b8bf36e-ff85-4c8e-99b3-1b8cfed9839c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerTable_516aaeb6-09d2-4d6c-aa5f-ac52a7e96a0c" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_7d231390-3c43-41df-818b-b50a2c9a82ec" xlink:to="loc_bax_RevenueFromContractWithCustomerTable_516aaeb6-09d2-4d6c-aa5f-ac52a7e96a0c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_af72d555-9dc6-4780-89e1-1ac002388281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_516aaeb6-09d2-4d6c-aa5f-ac52a7e96a0c" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_af72d555-9dc6-4780-89e1-1ac002388281" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_af72d555-9dc6-4780-89e1-1ac002388281_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_af72d555-9dc6-4780-89e1-1ac002388281" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_af72d555-9dc6-4780-89e1-1ac002388281_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_65494537-a710-4d94-97d7-f1e8705d9bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_af72d555-9dc6-4780-89e1-1ac002388281" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_65494537-a710-4d94-97d7-f1e8705d9bcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember_30dcbbe0-3d00-43d2-bf4d-46a086ee337c" xlink:href="bax-20220331.xsd#bax_ManufacturingArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_65494537-a710-4d94-97d7-f1e8705d9bcd" xlink:to="loc_bax_ManufacturingArrangementsMember_30dcbbe0-3d00-43d2-bf4d-46a086ee337c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember_8fa6f82e-d376-4182-b141-25389410bd03" xlink:href="bax-20220331.xsd#bax_SoftwareArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_65494537-a710-4d94-97d7-f1e8705d9bcd" xlink:to="loc_bax_SoftwareArrangementsMember_8fa6f82e-d376-4182-b141-25389410bd03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_97d0d215-f8c9-469c-af5e-758be991765c" xlink:href="bax-20220331.xsd#bax_BundledEquipmentAndConsumableMedicalProductsContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_65494537-a710-4d94-97d7-f1e8705d9bcd" xlink:to="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_97d0d215-f8c9-469c-af5e-758be991765c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6dbcfbe9-e7e8-47a0-890a-f2f03e1bdc15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_516aaeb6-09d2-4d6c-aa5f-ac52a7e96a0c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6dbcfbe9-e7e8-47a0-890a-f2f03e1bdc15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6dbcfbe9-e7e8-47a0-890a-f2f03e1bdc15_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6dbcfbe9-e7e8-47a0-890a-f2f03e1bdc15" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6dbcfbe9-e7e8-47a0-890a-f2f03e1bdc15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_676b9ccb-e300-417f-bfe5-1ae50fc07fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6dbcfbe9-e7e8-47a0-890a-f2f03e1bdc15" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_676b9ccb-e300-417f-bfe5-1ae50fc07fb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_b394f9fe-1e72-4fdc-81c8-8c9380d42ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_676b9ccb-e300-417f-bfe5-1ae50fc07fb8" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_b394f9fe-1e72-4fdc-81c8-8c9380d42ba0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_c8231f4f-9fe2-40db-9406-8358c9efb45b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_676b9ccb-e300-417f-bfe5-1ae50fc07fb8" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_c8231f4f-9fe2-40db-9406-8358c9efb45b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_dab6a62c-c5a0-42fe-b546-678916479d2a" xlink:href="bax-20220331.xsd#bax_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_676b9ccb-e300-417f-bfe5-1ae50fc07fb8" xlink:to="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_dab6a62c-c5a0-42fe-b546-678916479d2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_f7ecef19-be83-472e-aeec-2acd99fcd581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_676b9ccb-e300-417f-bfe5-1ae50fc07fb8" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_f7ecef19-be83-472e-aeec-2acd99fcd581" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails" xlink:type="extended" id="ia2269cfe5a874b23afb2f8f0d2f2fcc0_REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerLineItems_7f36ebbe-806e-494d-8f29-ab0f11ccfcfe" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b6079ec5-9ae8-4569-8acf-4948839834a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_7f36ebbe-806e-494d-8f29-ab0f11ccfcfe" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b6079ec5-9ae8-4569-8acf-4948839834a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerTable_72f80afb-4f09-469a-8170-1ec8a8ceb93e" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_7f36ebbe-806e-494d-8f29-ab0f11ccfcfe" xlink:to="loc_bax_RevenueFromContractWithCustomerTable_72f80afb-4f09-469a-8170-1ec8a8ceb93e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9a184085-5d4e-4d8d-939d-074a51f3ca76" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_72f80afb-4f09-469a-8170-1ec8a8ceb93e" xlink:to="loc_srt_ProductOrServiceAxis_9a184085-5d4e-4d8d-939d-074a51f3ca76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9a184085-5d4e-4d8d-939d-074a51f3ca76_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9a184085-5d4e-4d8d-939d-074a51f3ca76" xlink:to="loc_srt_ProductsAndServicesDomain_9a184085-5d4e-4d8d-939d-074a51f3ca76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9a184085-5d4e-4d8d-939d-074a51f3ca76" xlink:to="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RenalMember_f5d2e2c6-76f4-4441-b2fc-cd67982496f0" xlink:href="bax-20220331.xsd#bax_RenalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_RenalMember_f5d2e2c6-76f4-4441-b2fc-cd67982496f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_MedicationDeliveryMember_b9a4b688-8a90-46bd-b888-88314f74d755" xlink:href="bax-20220331.xsd#bax_MedicationDeliveryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_MedicationDeliveryMember_b9a4b688-8a90-46bd-b888-88314f74d755" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PharmaceuticalsMember_4d68be57-c9ef-45e0-977c-0236e57e1490" xlink:href="bax-20220331.xsd#bax_PharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_PharmaceuticalsMember_4d68be57-c9ef-45e0-977c-0236e57e1490" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ClinicalNutritionMember_49a03909-cb44-4761-b761-eccc8acd22c0" xlink:href="bax-20220331.xsd#bax_ClinicalNutritionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_ClinicalNutritionMember_49a03909-cb44-4761-b761-eccc8acd22c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AdvancedSurgeryMember_0039c23c-b5fb-4481-9af8-0c8a60912190" xlink:href="bax-20220331.xsd#bax_AdvancedSurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_AdvancedSurgeryMember_0039c23c-b5fb-4481-9af8-0c8a60912190" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcuteTherapiesMember_60e9d1b3-ee58-4910-9e95-527dfb4c22b3" xlink:href="bax-20220331.xsd#bax_AcuteTherapiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_AcuteTherapiesMember_60e9d1b3-ee58-4910-9e95-527dfb4c22b3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BioPharmaSolutionsMember_13a9343b-cca8-4a45-b93d-12c4891d6ef4" xlink:href="bax-20220331.xsd#bax_BioPharmaSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_BioPharmaSolutionsMember_13a9343b-cca8-4a45-b93d-12c4891d6ef4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PatientSupportSystemsMember_661ac82a-f2f1-4c73-8eab-403ea906f65a" xlink:href="bax-20220331.xsd#bax_PatientSupportSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_PatientSupportSystemsMember_661ac82a-f2f1-4c73-8eab-403ea906f65a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FrontLineCareMember_a278b269-413a-4a52-9cb6-15228652c2ec" xlink:href="bax-20220331.xsd#bax_FrontLineCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_FrontLineCareMember_a278b269-413a-4a52-9cb6-15228652c2ec" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SurgicalSolutionsMember_2d2608a7-fcf7-45c2-a4f7-cf2e8e017a45" xlink:href="bax-20220331.xsd#bax_SurgicalSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_SurgicalSolutionsMember_2d2608a7-fcf7-45c2-a4f7-cf2e8e017a45" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherProductOrServicesMember_daacee83-e747-4c67-934f-203f5d74ff86" xlink:href="bax-20220331.xsd#bax_OtherProductOrServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_OtherProductOrServicesMember_daacee83-e747-4c67-934f-203f5d74ff86" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7036f889-34f1-49cd-af68-45d5c23bf618" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_72f80afb-4f09-469a-8170-1ec8a8ceb93e" xlink:to="loc_srt_StatementGeographicalAxis_7036f889-34f1-49cd-af68-45d5c23bf618" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7036f889-34f1-49cd-af68-45d5c23bf618_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_7036f889-34f1-49cd-af68-45d5c23bf618" xlink:to="loc_srt_SegmentGeographicalDomain_7036f889-34f1-49cd-af68-45d5c23bf618_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e392fdd1-136c-4a43-a161-054a40840b54" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_7036f889-34f1-49cd-af68-45d5c23bf618" xlink:to="loc_srt_SegmentGeographicalDomain_e392fdd1-136c-4a43-a161-054a40840b54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_af93891d-9e26-473c-8810-bdf2af285c6d" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e392fdd1-136c-4a43-a161-054a40840b54" xlink:to="loc_country_US_af93891d-9e26-473c-8810-bdf2af285c6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_3e4b888e-ca14-47d2-8d2f-93e84ac7a7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e392fdd1-136c-4a43-a161-054a40840b54" xlink:to="loc_us-gaap_NonUsMember_3e4b888e-ca14-47d2-8d2f-93e84ac7a7f4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="extended" id="i891e8cfae14247f196b167fc0b426ab2_BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_7a130564-88df-4431-9a52-0ab166c327b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_4909fe16-685b-40b4-ae61-9c380f62b296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7a130564-88df-4431-9a52-0ab166c327b7" xlink:to="loc_us-gaap_RestructuringCharges_4909fe16-685b-40b4-ae61-9c380f62b296" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_057bbb5d-1858-40b5-aca6-a2b06c3ab7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7a130564-88df-4431-9a52-0ab166c327b7" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_057bbb5d-1858-40b5-aca6-a2b06c3ab7b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_5eb20d19-9ab3-4614-888b-7150283ea340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7a130564-88df-4431-9a52-0ab166c327b7" xlink:to="loc_us-gaap_RestructuringCosts_5eb20d19-9ab3-4614-888b-7150283ea340" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f8f6c16-d144-42cc-88b5-c2e58d8e9d56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7a130564-88df-4431-9a52-0ab166c327b7" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f8f6c16-d144-42cc-88b5-c2e58d8e9d56" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_1e18caad-0654-4dc3-a271-8e792fbbeffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f8f6c16-d144-42cc-88b5-c2e58d8e9d56" xlink:to="loc_us-gaap_RestructuringPlanAxis_1e18caad-0654-4dc3-a271-8e792fbbeffb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_1e18caad-0654-4dc3-a271-8e792fbbeffb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_1e18caad-0654-4dc3-a271-8e792fbbeffb" xlink:to="loc_us-gaap_RestructuringPlanDomain_1e18caad-0654-4dc3-a271-8e792fbbeffb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_c1e6bd10-19e8-4a15-92db-f393cd711513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_1e18caad-0654-4dc3-a271-8e792fbbeffb" xlink:to="loc_us-gaap_RestructuringPlanDomain_c1e6bd10-19e8-4a15-92db-f393cd711513" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessOptimizationProgramsMember_e4d347af-d580-4260-824f-609baf80cc3b" xlink:href="bax-20220331.xsd#bax_BusinessOptimizationProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_c1e6bd10-19e8-4a15-92db-f393cd711513" xlink:to="loc_bax_BusinessOptimizationProgramsMember_e4d347af-d580-4260-824f-609baf80cc3b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails" xlink:type="extended" id="i859eec30f1764baba01d67f142f446ad_BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1f7cfb5c-ea0f-4916-8f50-4467c9c7d5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b3b62c29-0841-406f-9c9d-ff0fbe3677fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1f7cfb5c-ea0f-4916-8f50-4467c9c7d5ef" xlink:to="loc_us-gaap_RestructuringCharges_b3b62c29-0841-406f-9c9d-ff0fbe3677fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1c3a5051-8380-4595-ac49-18e4a9eb748c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1f7cfb5c-ea0f-4916-8f50-4467c9c7d5ef" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1c3a5051-8380-4595-ac49-18e4a9eb748c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_0067c170-924f-49bb-b335-339bc03bcc95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1c3a5051-8380-4595-ac49-18e4a9eb748c" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_0067c170-924f-49bb-b335-339bc03bcc95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_0067c170-924f-49bb-b335-339bc03bcc95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_0067c170-924f-49bb-b335-339bc03bcc95" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_0067c170-924f-49bb-b335-339bc03bcc95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_47bdd90c-e46a-478d-9824-a3a2e7485928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_0067c170-924f-49bb-b335-339bc03bcc95" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_47bdd90c-e46a-478d-9824-a3a2e7485928" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_add027fa-3909-4f0d-ab7b-14109d0f9a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_47bdd90c-e46a-478d-9824-a3a2e7485928" xlink:to="loc_us-gaap_EmployeeSeveranceMember_add027fa-3909-4f0d-ab7b-14109d0f9a5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractTerminationAndOtherCostsMember_0fe88d6c-d0c5-4c3d-bce6-273b17dfdecc" xlink:href="bax-20220331.xsd#bax_ContractTerminationAndOtherCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_47bdd90c-e46a-478d-9824-a3a2e7485928" xlink:to="loc_bax_ContractTerminationAndOtherCostsMember_0fe88d6c-d0c5-4c3d-bce6-273b17dfdecc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AssetImpairmentMember_986dc40b-2f3a-40e9-9b1e-7c2e1f9c0650" xlink:href="bax-20220331.xsd#bax_AssetImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_47bdd90c-e46a-478d-9824-a3a2e7485928" xlink:to="loc_bax_AssetImpairmentMember_986dc40b-2f3a-40e9-9b1e-7c2e1f9c0650" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1b812853-9396-40b2-9ee3-7c5d4b7c4fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1c3a5051-8380-4595-ac49-18e4a9eb748c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1b812853-9396-40b2-9ee3-7c5d4b7c4fb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1b812853-9396-40b2-9ee3-7c5d4b7c4fb6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1b812853-9396-40b2-9ee3-7c5d4b7c4fb6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1b812853-9396-40b2-9ee3-7c5d4b7c4fb6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a6fe9dda-bdf8-498e-8606-d7762f92e739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1b812853-9396-40b2-9ee3-7c5d4b7c4fb6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a6fe9dda-bdf8-498e-8606-d7762f92e739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_3de65c58-05c5-4ec2-bdf8-c84d1c51a250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a6fe9dda-bdf8-498e-8606-d7762f92e739" xlink:to="loc_us-gaap_CostOfSalesMember_3de65c58-05c5-4ec2-bdf8-c84d1c51a250" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_10025dad-51f0-4a63-9f59-d00858a74634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a6fe9dda-bdf8-498e-8606-d7762f92e739" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_10025dad-51f0-4a63-9f59-d00858a74634" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8420005b-ee82-49c7-9190-f31daf5b1dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a6fe9dda-bdf8-498e-8606-d7762f92e739" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8420005b-ee82-49c7-9190-f31daf5b1dcd" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails" xlink:type="extended" id="i25b333d966414f2b90e728d09483f4b4_BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_d3daef1c-2e09-4856-a91f-67a361a77411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_03cbf617-5c14-4da8-af79-6e53c8049f50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d3daef1c-2e09-4856-a91f-67a361a77411" xlink:to="loc_us-gaap_RestructuringReserveRollForward_03cbf617-5c14-4da8-af79-6e53c8049f50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_aa542cda-7f5f-4798-a07d-1bcc3e49ca11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_03cbf617-5c14-4da8-af79-6e53c8049f50" xlink:to="loc_us-gaap_RestructuringReserve_aa542cda-7f5f-4798-a07d-1bcc3e49ca11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a990931d-b144-4a0f-a733-8767c40e1dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_03cbf617-5c14-4da8-af79-6e53c8049f50" xlink:to="loc_us-gaap_RestructuringCharges_a990931d-b144-4a0f-a733-8767c40e1dc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_a4968acb-7638-4edf-974f-1666037aa132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_03cbf617-5c14-4da8-af79-6e53c8049f50" xlink:to="loc_us-gaap_PaymentsForRestructuring_a4968acb-7638-4edf-974f-1666037aa132" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_a8ded0aa-a906-46b7-97e4-77c4d8f04d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_03cbf617-5c14-4da8-af79-6e53c8049f50" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_a8ded0aa-a906-46b7-97e4-77c4d8f04d7e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2753d384-55e9-4737-ad4d-e27fcfbb7b13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_90886707-ecb1-4b9f-954a-245fbb3dc9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d3daef1c-2e09-4856-a91f-67a361a77411" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_90886707-ecb1-4b9f-954a-245fbb3dc9fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_cce2796f-113d-4eff-8604-faa4496a81b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_90886707-ecb1-4b9f-954a-245fbb3dc9fd" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_cce2796f-113d-4eff-8604-faa4496a81b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_cce2796f-113d-4eff-8604-faa4496a81b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_cce2796f-113d-4eff-8604-faa4496a81b2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_cce2796f-113d-4eff-8604-faa4496a81b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_72b7ebf3-ae4c-427a-bcaf-32d644b16ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_cce2796f-113d-4eff-8604-faa4496a81b2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_72b7ebf3-ae4c-427a-bcaf-32d644b16ef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember_f60400ec-b54f-465a-9a7d-22f36390b236" xlink:href="bax-20220331.xsd#bax_SeveranceAndOtherEmployeeRelatedCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_72b7ebf3-ae4c-427a-bcaf-32d644b16ef9" xlink:to="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember_f60400ec-b54f-465a-9a7d-22f36390b236" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="extended" id="id3d3a92dedc242aea091d95acd9e597e_PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f9d50b6-6100-487a-8ff1-e428a12e3c19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_22bc2931-d1f4-4bf1-8daa-1ad1afa2b047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f9d50b6-6100-487a-8ff1-e428a12e3c19" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_22bc2931-d1f4-4bf1-8daa-1ad1afa2b047" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_b9714cc9-fbac-4070-9bb7-4b7023dfd659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_22bc2931-d1f4-4bf1-8daa-1ad1afa2b047" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_b9714cc9-fbac-4070-9bb7-4b7023dfd659" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_546fdcc0-cf57-4063-b8ed-0affef516f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_22bc2931-d1f4-4bf1-8daa-1ad1afa2b047" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_546fdcc0-cf57-4063-b8ed-0affef516f10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_9b944cd9-2225-4da3-9b06-303584d24887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_22bc2931-d1f4-4bf1-8daa-1ad1afa2b047" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_9b944cd9-2225-4da3-9b06-303584d24887" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_529ce5e6-0993-453d-8bb6-7624aa0eec72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_22bc2931-d1f4-4bf1-8daa-1ad1afa2b047" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_529ce5e6-0993-453d-8bb6-7624aa0eec72" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3873c948-a812-4aa5-8e81-67260751db96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_22bc2931-d1f4-4bf1-8daa-1ad1afa2b047" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3873c948-a812-4aa5-8e81-67260751db96" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3e212df2-fe27-44ed-9a9f-53aaef68c88a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f9d50b6-6100-487a-8ff1-e428a12e3c19" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3e212df2-fe27-44ed-9a9f-53aaef68c88a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_e21e162e-4363-452c-804b-8f4c90bbb2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3e212df2-fe27-44ed-9a9f-53aaef68c88a" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_e21e162e-4363-452c-804b-8f4c90bbb2f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e21e162e-4363-452c-804b-8f4c90bbb2f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e21e162e-4363-452c-804b-8f4c90bbb2f5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e21e162e-4363-452c-804b-8f4c90bbb2f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b49811af-f7bc-4cb3-a709-3e27daf4a44b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e21e162e-4363-452c-804b-8f4c90bbb2f5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b49811af-f7bc-4cb3-a709-3e27daf4a44b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_7c31589f-e0b0-4a02-8f7c-7e154d93908b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b49811af-f7bc-4cb3-a709-3e27daf4a44b" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_7c31589f-e0b0-4a02-8f7c-7e154d93908b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_08e4e55b-4ad0-413a-8b1e-db032fe7b9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b49811af-f7bc-4cb3-a709-3e27daf4a44b" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_08e4e55b-4ad0-413a-8b1e-db032fe7b9a3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails" xlink:type="extended" id="i181d0cbd7a564e8c8b1433314eff156e_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_9208f7a9-3ccf-45a5-9ecf-4b28c72fa562" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_us-gaap_DerivativeNotionalAmount_9208f7a9-3ccf-45a5-9ecf-4b28c72fa562" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_cdc3da7d-1dc2-4b1a-b577-6546be45d195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_cdc3da7d-1dc2-4b1a-b577-6546be45d195" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_f111e6dc-e786-46d3-99e2-434c286dea18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_f111e6dc-e786-46d3-99e2-434c286dea18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1f51af0b-d7e2-4ed0-989f-20c344a34b45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1f51af0b-d7e2-4ed0-989f-20c344a34b45" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0115ee78-59de-43fe-8f69-44c65a0a3ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0115ee78-59de-43fe-8f69-44c65a0a3ccc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeFairValueTerminated_5692e768-544f-4780-bb13-1fad09b80391" xlink:href="bax-20220331.xsd#bax_DerivativeFairValueTerminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_bax_DerivativeFairValueTerminated_5692e768-544f-4780-bb13-1fad09b80391" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeNetInvestmentTerminated_114f2eb0-a6a8-4365-8c16-d684a715dee9" xlink:href="bax-20220331.xsd#bax_DerivativeNetInvestmentTerminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_bax_DerivativeNetInvestmentTerminated_114f2eb0-a6a8-4365-8c16-d684a715dee9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_2e996cb0-2ac9-48b5-a00a-19334161a136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_2e996cb0-2ac9-48b5-a00a-19334161a136" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_752fb7bc-e335-4492-8399-29c3ddd648d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_752fb7bc-e335-4492-8399-29c3ddd648d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e01e2807-61d8-4b5d-be09-73d2cbc59c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_752fb7bc-e335-4492-8399-29c3ddd648d3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e01e2807-61d8-4b5d-be09-73d2cbc59c9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e01e2807-61d8-4b5d-be09-73d2cbc59c9c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e01e2807-61d8-4b5d-be09-73d2cbc59c9c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e01e2807-61d8-4b5d-be09-73d2cbc59c9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bd2da3af-0e0c-473d-a29d-b393c2766ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e01e2807-61d8-4b5d-be09-73d2cbc59c9c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bd2da3af-0e0c-473d-a29d-b393c2766ea1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_9560fe37-6d06-47b1-8a94-c6dc5d356f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd2da3af-0e0c-473d-a29d-b393c2766ea1" xlink:to="loc_us-gaap_ForeignExchangeContractMember_9560fe37-6d06-47b1-8a94-c6dc5d356f9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_20b0cf7d-1c74-485d-9e03-ae02a394bdac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd2da3af-0e0c-473d-a29d-b393c2766ea1" xlink:to="loc_us-gaap_InterestRateContractMember_20b0cf7d-1c74-485d-9e03-ae02a394bdac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e30b9ab4-731d-4fbc-b0d9-444e4049a351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd2da3af-0e0c-473d-a29d-b393c2766ea1" xlink:to="loc_us-gaap_InterestRateSwapMember_e30b9ab4-731d-4fbc-b0d9-444e4049a351" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6553ad22-7be6-439f-806f-4dd58c809bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_752fb7bc-e335-4492-8399-29c3ddd648d3" xlink:to="loc_us-gaap_DebtInstrumentAxis_6553ad22-7be6-439f-806f-4dd58c809bd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6553ad22-7be6-439f-806f-4dd58c809bd2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6553ad22-7be6-439f-806f-4dd58c809bd2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6553ad22-7be6-439f-806f-4dd58c809bd2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_477c8c92-f028-4913-87bf-2629556e4e52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6553ad22-7be6-439f-806f-4dd58c809bd2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_477c8c92-f028-4913-87bf-2629556e4e52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember_0c2780af-44ff-4670-ad7e-c749cb41a34a" xlink:href="bax-20220331.xsd#bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_477c8c92-f028-4913-87bf-2629556e4e52" xlink:to="loc_bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember_0c2780af-44ff-4670-ad7e-c749cb41a34a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember_71bd050a-38e1-4994-a960-02c59e13bdca" xlink:href="bax-20220331.xsd#bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_477c8c92-f028-4913-87bf-2629556e4e52" xlink:to="loc_bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember_71bd050a-38e1-4994-a960-02c59e13bdca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember_2e660451-d16f-4f03-b792-7bf7b4d2d6cd" xlink:href="bax-20220331.xsd#bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_477c8c92-f028-4913-87bf-2629556e4e52" xlink:to="loc_bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember_2e660451-d16f-4f03-b792-7bf7b4d2d6cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_338522f3-707d-4304-af70-d2d85676c3d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_752fb7bc-e335-4492-8399-29c3ddd648d3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_338522f3-707d-4304-af70-d2d85676c3d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_338522f3-707d-4304-af70-d2d85676c3d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_338522f3-707d-4304-af70-d2d85676c3d1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_338522f3-707d-4304-af70-d2d85676c3d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a3757d81-b0f4-4479-8687-4eae8810c551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_338522f3-707d-4304-af70-d2d85676c3d1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a3757d81-b0f4-4479-8687-4eae8810c551" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_92c18a3e-d733-4ff3-833d-32bb309f4fed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a3757d81-b0f4-4479-8687-4eae8810c551" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_92c18a3e-d733-4ff3-833d-32bb309f4fed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_362dfc1c-2495-4f8c-80a4-23439810fe69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_752fb7bc-e335-4492-8399-29c3ddd648d3" xlink:to="loc_us-gaap_HedgingDesignationAxis_362dfc1c-2495-4f8c-80a4-23439810fe69" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_362dfc1c-2495-4f8c-80a4-23439810fe69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_362dfc1c-2495-4f8c-80a4-23439810fe69" xlink:to="loc_us-gaap_HedgingDesignationDomain_362dfc1c-2495-4f8c-80a4-23439810fe69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7eaeb844-8fce-4358-91e5-e043565b962a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_362dfc1c-2495-4f8c-80a4-23439810fe69" xlink:to="loc_us-gaap_HedgingDesignationDomain_7eaeb844-8fce-4358-91e5-e043565b962a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_33808d4c-4eb5-40ff-b825-8d115cc8166a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_7eaeb844-8fce-4358-91e5-e043565b962a" xlink:to="loc_us-gaap_NondesignatedMember_33808d4c-4eb5-40ff-b825-8d115cc8166a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="extended" id="i3367586ab3ac48f092669c2ffe236add_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e7aa694c-d6f2-4daf-8608-30fd3b153de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_acf588db-6725-43e6-9514-b7e9bf77f772" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e7aa694c-d6f2-4daf-8608-30fd3b153de2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_acf588db-6725-43e6-9514-b7e9bf77f772" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_3024a9f1-a43f-4d71-92f7-f8b81445d24d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e7aa694c-d6f2-4daf-8608-30fd3b153de2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_3024a9f1-a43f-4d71-92f7-f8b81445d24d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_993581fb-1d33-417f-bdf6-1b0108006cb1" xlink:href="bax-20220331.xsd#bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e7aa694c-d6f2-4daf-8608-30fd3b153de2" xlink:to="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_993581fb-1d33-417f-bdf6-1b0108006cb1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_a2e136b4-a6f4-4d3f-b1cc-8d7534a3c281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e7aa694c-d6f2-4daf-8608-30fd3b153de2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_a2e136b4-a6f4-4d3f-b1cc-8d7534a3c281" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_b9f028d5-6fde-4588-b91c-b776dbd9cb4e" xlink:href="bax-20220331.xsd#bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e7aa694c-d6f2-4daf-8608-30fd3b153de2" xlink:to="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_b9f028d5-6fde-4588-b91c-b776dbd9cb4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a7c45126-5dc5-47a1-b7a8-66a3f51df805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e7aa694c-d6f2-4daf-8608-30fd3b153de2" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a7c45126-5dc5-47a1-b7a8-66a3f51df805" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_55321523-0710-4d09-bda5-eadaf5404f50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e7aa694c-d6f2-4daf-8608-30fd3b153de2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_55321523-0710-4d09-bda5-eadaf5404f50" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2237f9c7-dddd-4a90-b68d-626209b445fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_55321523-0710-4d09-bda5-eadaf5404f50" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2237f9c7-dddd-4a90-b68d-626209b445fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2237f9c7-dddd-4a90-b68d-626209b445fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2237f9c7-dddd-4a90-b68d-626209b445fa" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2237f9c7-dddd-4a90-b68d-626209b445fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f6af21e0-c01a-4e1c-b9aa-c2b7ab6d461c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2237f9c7-dddd-4a90-b68d-626209b445fa" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f6af21e0-c01a-4e1c-b9aa-c2b7ab6d461c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_f987edef-e3df-4e2d-91ae-d04fec851bda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f6af21e0-c01a-4e1c-b9aa-c2b7ab6d461c" xlink:to="loc_us-gaap_InterestRateContractMember_f987edef-e3df-4e2d-91ae-d04fec851bda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f5a25aad-1dc0-4332-98e8-92129008b522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f6af21e0-c01a-4e1c-b9aa-c2b7ab6d461c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f5a25aad-1dc0-4332-98e8-92129008b522" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_07e53ea7-a771-4f60-9d34-836b27b03be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_55321523-0710-4d09-bda5-eadaf5404f50" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_07e53ea7-a771-4f60-9d34-836b27b03be1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_07e53ea7-a771-4f60-9d34-836b27b03be1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_07e53ea7-a771-4f60-9d34-836b27b03be1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_07e53ea7-a771-4f60-9d34-836b27b03be1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5c1ec7e0-01ab-4974-a201-ec3a9bb05d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_07e53ea7-a771-4f60-9d34-836b27b03be1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5c1ec7e0-01ab-4974-a201-ec3a9bb05d8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_28f50453-ae6d-4b96-b1b4-e3d99e8c2166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5c1ec7e0-01ab-4974-a201-ec3a9bb05d8c" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_28f50453-ae6d-4b96-b1b4-e3d99e8c2166" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_dd809d6a-4809-4b5c-badc-465fa5e7df22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_55321523-0710-4d09-bda5-eadaf5404f50" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_dd809d6a-4809-4b5c-badc-465fa5e7df22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dd809d6a-4809-4b5c-badc-465fa5e7df22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dd809d6a-4809-4b5c-badc-465fa5e7df22" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dd809d6a-4809-4b5c-badc-465fa5e7df22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c48010ef-f1da-4104-bbfe-6a42eb7d6b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dd809d6a-4809-4b5c-badc-465fa5e7df22" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c48010ef-f1da-4104-bbfe-6a42eb7d6b2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_7fcc6e0a-f585-4506-bace-e2aae3401b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c48010ef-f1da-4104-bbfe-6a42eb7d6b2d" xlink:to="loc_us-gaap_InterestExpenseMember_7fcc6e0a-f585-4506-bace-e2aae3401b9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_32b6f65e-3719-4eac-9ec3-1ced70d68901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c48010ef-f1da-4104-bbfe-6a42eb7d6b2d" xlink:to="loc_us-gaap_CostOfSalesMember_32b6f65e-3719-4eac-9ec3-1ced70d68901" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_6284fc73-267f-44ea-b8a8-450f8ece283c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c48010ef-f1da-4104-bbfe-6a42eb7d6b2d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_6284fc73-267f-44ea-b8a8-450f8ece283c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails" xlink:type="extended" id="i5cfe017b5aaa4b46a7f29e2b3e04df03_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_ae9ad857-1a75-467c-bee4-0b1bdb2f66e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_8067f529-045f-46fe-aa0e-d4bc07e2660e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ae9ad857-1a75-467c-bee4-0b1bdb2f66e7" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_8067f529-045f-46fe-aa0e-d4bc07e2660e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_c78a49c8-4ad1-4783-af80-fccc1edeb155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ae9ad857-1a75-467c-bee4-0b1bdb2f66e7" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_c78a49c8-4ad1-4783-af80-fccc1edeb155" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_934152d0-ce66-4bd3-9c8b-40bcd8847679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ae9ad857-1a75-467c-bee4-0b1bdb2f66e7" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_934152d0-ce66-4bd3-9c8b-40bcd8847679" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d6e837f0-efb1-420e-8137-bed8b3b99a10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_934152d0-ce66-4bd3-9c8b-40bcd8847679" xlink:to="loc_us-gaap_HedgingDesignationAxis_d6e837f0-efb1-420e-8137-bed8b3b99a10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d6e837f0-efb1-420e-8137-bed8b3b99a10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d6e837f0-efb1-420e-8137-bed8b3b99a10" xlink:to="loc_us-gaap_HedgingDesignationDomain_d6e837f0-efb1-420e-8137-bed8b3b99a10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_811ced80-766c-453a-b7a0-c8ec9f3a36f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d6e837f0-efb1-420e-8137-bed8b3b99a10" xlink:to="loc_us-gaap_HedgingDesignationDomain_811ced80-766c-453a-b7a0-c8ec9f3a36f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6ddb3f0c-7b24-496f-9de6-ec2fff413411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_811ced80-766c-453a-b7a0-c8ec9f3a36f3" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6ddb3f0c-7b24-496f-9de6-ec2fff413411" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_b8bdec0a-bb96-40a6-87d0-c09e32a38f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_811ced80-766c-453a-b7a0-c8ec9f3a36f3" xlink:to="loc_us-gaap_NondesignatedMember_b8bdec0a-bb96-40a6-87d0-c09e32a38f68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_587e4e10-2b0e-4f1a-80fd-2119c58a3c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_934152d0-ce66-4bd3-9c8b-40bcd8847679" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_587e4e10-2b0e-4f1a-80fd-2119c58a3c1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_587e4e10-2b0e-4f1a-80fd-2119c58a3c1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_587e4e10-2b0e-4f1a-80fd-2119c58a3c1b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_587e4e10-2b0e-4f1a-80fd-2119c58a3c1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_61952495-8746-4d58-bdf3-b2eaa013d653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_587e4e10-2b0e-4f1a-80fd-2119c58a3c1b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_61952495-8746-4d58-bdf3-b2eaa013d653" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_2a75aa86-c5ef-4d65-82bc-f245594b16dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_61952495-8746-4d58-bdf3-b2eaa013d653" xlink:to="loc_us-gaap_ForeignExchangeContractMember_2a75aa86-c5ef-4d65-82bc-f245594b16dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1aef575b-2b00-499e-b3c7-aea30f48a554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_934152d0-ce66-4bd3-9c8b-40bcd8847679" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1aef575b-2b00-499e-b3c7-aea30f48a554" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1aef575b-2b00-499e-b3c7-aea30f48a554_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1aef575b-2b00-499e-b3c7-aea30f48a554" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1aef575b-2b00-499e-b3c7-aea30f48a554_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_daa4e58f-5cbd-4b02-8752-fe0e0eeddff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1aef575b-2b00-499e-b3c7-aea30f48a554" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_daa4e58f-5cbd-4b02-8752-fe0e0eeddff6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_282ce71b-e4ba-4923-900f-24cd8915e39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_daa4e58f-5cbd-4b02-8752-fe0e0eeddff6" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_282ce71b-e4ba-4923-900f-24cd8915e39e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_ae01d084-3118-42f5-8ccb-df40f41e55fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_daa4e58f-5cbd-4b02-8752-fe0e0eeddff6" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_ae01d084-3118-42f5-8ccb-df40f41e55fc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails" xlink:type="extended" id="ief601a283f6e4599b482c4d0c2a845fb_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_24798bcb-da8a-4071-afc6-29cb8cf8fde9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge_fcebfc93-1613-4566-839c-28f25a1eb760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_24798bcb-da8a-4071-afc6-29cb8cf8fde9" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedge_fcebfc93-1613-4566-839c-28f25a1eb760" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_c2267233-86c9-4db9-bc2b-9927e009ba94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_24798bcb-da8a-4071-afc6-29cb8cf8fde9" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_c2267233-86c9-4db9-bc2b-9927e009ba94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_79871f7c-9b68-4d68-a5a5-802618d26351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_24798bcb-da8a-4071-afc6-29cb8cf8fde9" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_79871f7c-9b68-4d68-a5a5-802618d26351" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e7cf5515-770b-4010-86a6-3f9b7eb1a94e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_79871f7c-9b68-4d68-a5a5-802618d26351" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e7cf5515-770b-4010-86a6-3f9b7eb1a94e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e7cf5515-770b-4010-86a6-3f9b7eb1a94e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e7cf5515-770b-4010-86a6-3f9b7eb1a94e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e7cf5515-770b-4010-86a6-3f9b7eb1a94e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_538e1f3f-4e70-4a9a-bfc7-a957ffef3f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e7cf5515-770b-4010-86a6-3f9b7eb1a94e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_538e1f3f-4e70-4a9a-bfc7-a957ffef3f0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_d70e8a2d-0aa8-48a7-a759-4cdd065a04c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_538e1f3f-4e70-4a9a-bfc7-a957ffef3f0a" xlink:to="loc_us-gaap_LongTermDebtMember_d70e8a2d-0aa8-48a7-a759-4cdd065a04c2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="ia8a0c3404a1c476faf0460be12122ecd_FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_815aac2a-3761-4e0b-a573-8cc8099c95d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_f4ef884d-37d9-4b1f-b4d3-a35e85865cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_815aac2a-3761-4e0b-a573-8cc8099c95d4" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_f4ef884d-37d9-4b1f-b4d3-a35e85865cd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_76d8eb9a-d555-4d3f-a4e0-d513a4d27a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_f4ef884d-37d9-4b1f-b4d3-a35e85865cd1" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_76d8eb9a-d555-4d3f-a4e0-d513a4d27a67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecurities_eae4e58b-3537-48d2-91e8-e62e728f5f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_f4ef884d-37d9-4b1f-b4d3-a35e85865cd1" xlink:to="loc_us-gaap_DebtSecurities_eae4e58b-3537-48d2-91e8-e62e728f5f45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_3d5d9e54-79ac-4f98-b208-58917b979fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_f4ef884d-37d9-4b1f-b4d3-a35e85865cd1" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_3d5d9e54-79ac-4f98-b208-58917b979fa4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_129e04fd-2603-4ffe-ac4e-f8dd1f46485c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_f4ef884d-37d9-4b1f-b4d3-a35e85865cd1" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_129e04fd-2603-4ffe-ac4e-f8dd1f46485c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_127a61e0-edf4-4141-88a5-f9224da9617c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_815aac2a-3761-4e0b-a573-8cc8099c95d4" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_127a61e0-edf4-4141-88a5-f9224da9617c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_453aca33-e953-44b5-8053-a3eaa1097d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_127a61e0-edf4-4141-88a5-f9224da9617c" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_453aca33-e953-44b5-8053-a3eaa1097d20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_29dc3f9c-5397-4c57-9c0c-0887ff97a19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_127a61e0-edf4-4141-88a5-f9224da9617c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_29dc3f9c-5397-4c57-9c0c-0887ff97a19e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_d638b539-5daf-488f-963f-6f94c190b413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_127a61e0-edf4-4141-88a5-f9224da9617c" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_d638b539-5daf-488f-963f-6f94c190b413" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483035b9-6cfc-4804-b785-6dfe77ea42f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_815aac2a-3761-4e0b-a573-8cc8099c95d4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483035b9-6cfc-4804-b785-6dfe77ea42f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_43bbba4e-da44-4b3c-b5be-d915b03c2184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483035b9-6cfc-4804-b785-6dfe77ea42f5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_43bbba4e-da44-4b3c-b5be-d915b03c2184" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_43bbba4e-da44-4b3c-b5be-d915b03c2184_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_43bbba4e-da44-4b3c-b5be-d915b03c2184" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_43bbba4e-da44-4b3c-b5be-d915b03c2184_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8ad90fa7-b3eb-4e36-8689-ffb2854bf727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_43bbba4e-da44-4b3c-b5be-d915b03c2184" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8ad90fa7-b3eb-4e36-8689-ffb2854bf727" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4c76b3a3-1edf-4670-9b1e-7762ead0a9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8ad90fa7-b3eb-4e36-8689-ffb2854bf727" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4c76b3a3-1edf-4670-9b1e-7762ead0a9bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_30c1f00f-856f-487d-a97f-6f99b08ff13e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483035b9-6cfc-4804-b785-6dfe77ea42f5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_30c1f00f-856f-487d-a97f-6f99b08ff13e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_30c1f00f-856f-487d-a97f-6f99b08ff13e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_30c1f00f-856f-487d-a97f-6f99b08ff13e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_30c1f00f-856f-487d-a97f-6f99b08ff13e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f2af076-8157-43da-9448-f5a149d15f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_30c1f00f-856f-487d-a97f-6f99b08ff13e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f2af076-8157-43da-9448-f5a149d15f71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_24c48544-4134-4eed-a68e-ae102b2afe1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f2af076-8157-43da-9448-f5a149d15f71" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_24c48544-4134-4eed-a68e-ae102b2afe1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ac682694-b184-47cc-a70e-e782bd7a63cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f2af076-8157-43da-9448-f5a149d15f71" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ac682694-b184-47cc-a70e-e782bd7a63cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d1eedd97-398a-45df-b949-347a130e3077" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f2af076-8157-43da-9448-f5a149d15f71" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d1eedd97-398a-45df-b949-347a130e3077" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#FAIRVALUEMEASUREMENTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="extended" id="i78190da15b47406cb798d4a239f0e14c_FAIRVALUEMEASUREMENTSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresLineItems_7b2b89b8-f930-497f-af9e-f5cee038c3b7" xlink:href="bax-20220331.xsd#bax_FairValueDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6e7d4fe8-5705-4db6-bb04-6c37ed6d3539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueDisclosuresLineItems_7b2b89b8-f930-497f-af9e-f5cee038c3b7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6e7d4fe8-5705-4db6-bb04-6c37ed6d3539" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_61f31309-9e26-4f3d-96a5-ffdd1c9baaa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueDisclosuresLineItems_7b2b89b8-f930-497f-af9e-f5cee038c3b7" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_61f31309-9e26-4f3d-96a5-ffdd1c9baaa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_97d069c5-d11c-43c4-a15f-dcfe306c594d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueDisclosuresLineItems_7b2b89b8-f930-497f-af9e-f5cee038c3b7" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_97d069c5-d11c-43c4-a15f-dcfe306c594d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresTable_306a5cca-e8df-4530-b6f1-1a17e44e6df5" xlink:href="bax-20220331.xsd#bax_FairValueDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_FairValueDisclosuresLineItems_7b2b89b8-f930-497f-af9e-f5cee038c3b7" xlink:to="loc_bax_FairValueDisclosuresTable_306a5cca-e8df-4530-b6f1-1a17e44e6df5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9a928ae-a8e0-4554-ba7f-c4ddd6ece9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_FairValueDisclosuresTable_306a5cca-e8df-4530-b6f1-1a17e44e6df5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9a928ae-a8e0-4554-ba7f-c4ddd6ece9aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9a928ae-a8e0-4554-ba7f-c4ddd6ece9aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9a928ae-a8e0-4554-ba7f-c4ddd6ece9aa" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d9a928ae-a8e0-4554-ba7f-c4ddd6ece9aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82f5fd48-201f-4248-91e0-628ed2ed7249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9a928ae-a8e0-4554-ba7f-c4ddd6ece9aa" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82f5fd48-201f-4248-91e0-628ed2ed7249" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c7a5fc8b-44b4-49be-b672-f2ac2a67666f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82f5fd48-201f-4248-91e0-628ed2ed7249" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c7a5fc8b-44b4-49be-b672-f2ac2a67666f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7a58c3ad-2c7f-41fd-949f-4b7faf5acdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_FairValueDisclosuresTable_306a5cca-e8df-4530-b6f1-1a17e44e6df5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7a58c3ad-2c7f-41fd-949f-4b7faf5acdfe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7a58c3ad-2c7f-41fd-949f-4b7faf5acdfe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a58c3ad-2c7f-41fd-949f-4b7faf5acdfe" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7a58c3ad-2c7f-41fd-949f-4b7faf5acdfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1f4fc798-9d34-44f1-a4fd-7225b31b0f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a58c3ad-2c7f-41fd-949f-4b7faf5acdfe" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1f4fc798-9d34-44f1-a4fd-7225b31b0f3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_4f92942f-c6c1-49ba-958d-bec50050fa63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1f4fc798-9d34-44f1-a4fd-7225b31b0f3f" xlink:to="loc_us-gaap_OtherAssetsMember_4f92942f-c6c1-49ba-958d-bec50050fa63" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails" xlink:type="extended" id="ic1c8e456fd414166a3c8ff8cf25e50cf_FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresLineItems_cc27308c-f6d1-45bf-9345-27ecc3eeb5a6" xlink:href="bax-20220331.xsd#bax_FairValueDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_179a361b-b457-4dde-9d63-986e9fe41f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueDisclosuresLineItems_cc27308c-f6d1-45bf-9345-27ecc3eeb5a6" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_179a361b-b457-4dde-9d63-986e9fe41f87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fedeec6b-0a43-42a8-bedb-689ee74a424f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_179a361b-b457-4dde-9d63-986e9fe41f87" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fedeec6b-0a43-42a8-bedb-689ee74a424f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_46aa5db1-598a-4388-9b50-bb77b9e72d62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_179a361b-b457-4dde-9d63-986e9fe41f87" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_46aa5db1-598a-4388-9b50-bb77b9e72d62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_8bb26e7f-d44f-4ea9-bf22-dc5f35bd282a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_179a361b-b457-4dde-9d63-986e9fe41f87" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_8bb26e7f-d44f-4ea9-bf22-dc5f35bd282a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_adfd7f07-286b-4080-8e22-236c789f20ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_179a361b-b457-4dde-9d63-986e9fe41f87" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_adfd7f07-286b-4080-8e22-236c789f20ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_f40ab158-6e0a-4ec7-adba-4dd1c86fe784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_179a361b-b457-4dde-9d63-986e9fe41f87" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_f40ab158-6e0a-4ec7-adba-4dd1c86fe784" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8d3ed754-60a5-45d1-b8d6-ae3c48525d38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresTable_82e79cdb-7367-490d-a602-4bd8838c74dd" xlink:href="bax-20220331.xsd#bax_FairValueDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_FairValueDisclosuresLineItems_cc27308c-f6d1-45bf-9345-27ecc3eeb5a6" xlink:to="loc_bax_FairValueDisclosuresTable_82e79cdb-7367-490d-a602-4bd8838c74dd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_9f3c9b70-5942-49ca-80f8-a5c40c781371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_FairValueDisclosuresTable_82e79cdb-7367-490d-a602-4bd8838c74dd" xlink:to="loc_us-gaap_FinancialInstrumentAxis_9f3c9b70-5942-49ca-80f8-a5c40c781371" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f3c9b70-5942-49ca-80f8-a5c40c781371_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9f3c9b70-5942-49ca-80f8-a5c40c781371" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f3c9b70-5942-49ca-80f8-a5c40c781371_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0dd8b20-2403-4593-9c3d-d63abfb4195c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9f3c9b70-5942-49ca-80f8-a5c40c781371" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0dd8b20-2403-4593-9c3d-d63abfb4195c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_5cf6f184-ad6d-43b5-9412-53d121675a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0dd8b20-2403-4593-9c3d-d63abfb4195c" xlink:to="loc_us-gaap_DebtSecuritiesMember_5cf6f184-ad6d-43b5-9412-53d121675a0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_15f07e53-91c0-4543-a6f0-6ddb1a3de199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0dd8b20-2403-4593-9c3d-d63abfb4195c" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_15f07e53-91c0-4543-a6f0-6ddb1a3de199" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails" xlink:type="extended" id="ide0c01ed4650441298b135410b10417c_FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_f30bc4c5-cc6e-484f-aca4-83ad1b2eb83b" xlink:href="bax-20220331.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue_c24c9a2d-e509-4ae7-92aa-785c1e91d39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_f30bc4c5-cc6e-484f-aca4-83ad1b2eb83b" xlink:to="loc_us-gaap_ShorttermDebtFairValue_c24c9a2d-e509-4ae7-92aa-785c1e91d39d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_5f1b1518-69e4-43e7-b2e7-1cb7fd3e7ca1" xlink:href="bax-20220331.xsd#bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_f30bc4c5-cc6e-484f-aca4-83ad1b2eb83b" xlink:to="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_5f1b1518-69e4-43e7-b2e7-1cb7fd3e7ca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure_47eb73af-65c7-4c32-bae1-d23e11c69aaf" xlink:href="bax-20220331.xsd#bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_f30bc4c5-cc6e-484f-aca4-83ad1b2eb83b" xlink:to="loc_bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure_47eb73af-65c7-4c32-bae1-d23e11c69aaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_aab2ebc0-292c-4e3f-aa7e-fed0db98f2e6" xlink:href="bax-20220331.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_f30bc4c5-cc6e-484f-aca4-83ad1b2eb83b" xlink:to="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_aab2ebc0-292c-4e3f-aa7e-fed0db98f2e6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_ff873e3b-23eb-4775-8870-d5c18901b7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_aab2ebc0-292c-4e3f-aa7e-fed0db98f2e6" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_ff873e3b-23eb-4775-8870-d5c18901b7d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_ff873e3b-23eb-4775-8870-d5c18901b7d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_ff873e3b-23eb-4775-8870-d5c18901b7d5" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_ff873e3b-23eb-4775-8870-d5c18901b7d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_2793100a-ca27-452c-9f4e-d539594021a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_ff873e3b-23eb-4775-8870-d5c18901b7d5" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_2793100a-ca27-452c-9f4e-d539594021a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_44af2856-18e7-4adf-915e-06892610d7d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_2793100a-ca27-452c-9f4e-d539594021a8" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_44af2856-18e7-4adf-915e-06892610d7d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_bf19fc68-e5ba-4ce8-925f-3ecd3151edab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_2793100a-ca27-452c-9f4e-d539594021a8" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_bf19fc68-e5ba-4ce8-925f-3ecd3151edab" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails" xlink:type="extended" id="i6e530f2d7efe4b11a2cab33031c5459e_SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_797757b2-0206-4305-a300-c50aabc65b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_f15dd263-3b92-4bd5-875a-828663aaee0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_797757b2-0206-4305-a300-c50aabc65b5d" xlink:to="loc_us-gaap_NumberOfOperatingSegments_f15dd263-3b92-4bd5-875a-828663aaee0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5a3e4079-83b3-4010-85bf-568d5a6880db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_797757b2-0206-4305-a300-c50aabc65b5d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5a3e4079-83b3-4010-85bf-568d5a6880db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3048c502-4bb6-482f-bd7d-b8c47c0c0c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_797757b2-0206-4305-a300-c50aabc65b5d" xlink:to="loc_us-gaap_OperatingIncomeLoss_3048c502-4bb6-482f-bd7d-b8c47c0c0c46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6aa23b85-7936-4f00-890e-73ab3efd269b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_797757b2-0206-4305-a300-c50aabc65b5d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6aa23b85-7936-4f00-890e-73ab3efd269b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_737baa70-0303-4257-813c-eafaafb597da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6aa23b85-7936-4f00-890e-73ab3efd269b" xlink:to="loc_srt_ConsolidationItemsAxis_737baa70-0303-4257-813c-eafaafb597da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_737baa70-0303-4257-813c-eafaafb597da_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_737baa70-0303-4257-813c-eafaafb597da" xlink:to="loc_srt_ConsolidationItemsDomain_737baa70-0303-4257-813c-eafaafb597da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c9748140-c335-4ecc-b29a-1e1ed0b6d559" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_737baa70-0303-4257-813c-eafaafb597da" xlink:to="loc_srt_ConsolidationItemsDomain_c9748140-c335-4ecc-b29a-1e1ed0b6d559" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2d2de227-4830-47b7-9159-41ecd3432c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c9748140-c335-4ecc-b29a-1e1ed0b6d559" xlink:to="loc_us-gaap_OperatingSegmentsMember_2d2de227-4830-47b7-9159-41ecd3432c6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_471d3e16-6c07-4cc9-bd43-0d18d91d3cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6aa23b85-7936-4f00-890e-73ab3efd269b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_471d3e16-6c07-4cc9-bd43-0d18d91d3cd5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_471d3e16-6c07-4cc9-bd43-0d18d91d3cd5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_471d3e16-6c07-4cc9-bd43-0d18d91d3cd5" xlink:to="loc_us-gaap_SegmentDomain_471d3e16-6c07-4cc9-bd43-0d18d91d3cd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9de67a20-cb6b-4e5c-b5bf-a8249598bd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_471d3e16-6c07-4cc9-bd43-0d18d91d3cd5" xlink:to="loc_us-gaap_SegmentDomain_9de67a20-cb6b-4e5c-b5bf-a8249598bd7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AmericasSegmentMember_2e79a476-13c5-47c7-b11a-291e92286bd2" xlink:href="bax-20220331.xsd#bax_AmericasSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9de67a20-cb6b-4e5c-b5bf-a8249598bd7c" xlink:to="loc_bax_AmericasSegmentMember_2e79a476-13c5-47c7-b11a-291e92286bd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EMEASegmentMember_1152e046-c703-47b7-ba72-6e7514abfb5a" xlink:href="bax-20220331.xsd#bax_EMEASegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9de67a20-cb6b-4e5c-b5bf-a8249598bd7c" xlink:to="loc_bax_EMEASegmentMember_1152e046-c703-47b7-ba72-6e7514abfb5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AsiaPacificSegmentMember_28306b87-af74-478c-8fba-200024042348" xlink:href="bax-20220331.xsd#bax_AsiaPacificSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9de67a20-cb6b-4e5c-b5bf-a8249598bd7c" xlink:to="loc_bax_AsiaPacificSegmentMember_28306b87-af74-478c-8fba-200024042348" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_b012463f-7a7e-452b-8110-19175f57de67" xlink:href="bax-20220331.xsd#bax_HillromMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9de67a20-cb6b-4e5c-b5bf-a8249598bd7c" xlink:to="loc_bax_HillromMember_b012463f-7a7e-452b-8110-19175f57de67" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails" xlink:type="extended" id="i3bfc9406ce114a18906ac2be00e1212a_SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ded82048-c186-4e25-818e-3072b360014c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_78d4a76b-db87-4e31-bd86-5ecaaea87ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ded82048-c186-4e25-818e-3072b360014c" xlink:to="loc_us-gaap_OperatingIncomeLoss_78d4a76b-db87-4e31-bd86-5ecaaea87ee6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_7acec38b-8dda-4515-a115-acbb4af270ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ded82048-c186-4e25-818e-3072b360014c" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_7acec38b-8dda-4515-a115-acbb4af270ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_208b75e9-7bab-4095-96e0-a3223190998c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ded82048-c186-4e25-818e-3072b360014c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_208b75e9-7bab-4095-96e0-a3223190998c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ad3674e0-6e5e-468d-883b-cee1eaed541d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ded82048-c186-4e25-818e-3072b360014c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ad3674e0-6e5e-468d-883b-cee1eaed541d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_e2236a9a-ee0d-4eed-af8c-7173a3372211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ded82048-c186-4e25-818e-3072b360014c" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_e2236a9a-ee0d-4eed-af8c-7173a3372211" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f7dc01c8-6835-4a19-86c9-f8a737bbf038" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_e2236a9a-ee0d-4eed-af8c-7173a3372211" xlink:to="loc_srt_ConsolidationItemsAxis_f7dc01c8-6835-4a19-86c9-f8a737bbf038" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f7dc01c8-6835-4a19-86c9-f8a737bbf038_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_f7dc01c8-6835-4a19-86c9-f8a737bbf038" xlink:to="loc_srt_ConsolidationItemsDomain_f7dc01c8-6835-4a19-86c9-f8a737bbf038_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5cc50416-f2fa-4f56-af89-f0c7710f8bcf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_f7dc01c8-6835-4a19-86c9-f8a737bbf038" xlink:to="loc_srt_ConsolidationItemsDomain_5cc50416-f2fa-4f56-af89-f0c7710f8bcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_42f3e688-ef40-493d-84b2-4e2ad2a9f5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_5cc50416-f2fa-4f56-af89-f0c7710f8bcf" xlink:to="loc_us-gaap_OperatingSegmentsMember_42f3e688-ef40-493d-84b2-4e2ad2a9f5bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_62239a09-28e8-4587-b124-44a3654f045f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_5cc50416-f2fa-4f56-af89-f0c7710f8bcf" xlink:to="loc_us-gaap_CorporateNonSegmentMember_62239a09-28e8-4587-b124-44a3654f045f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_400998d5-fe34-4e0f-8565-cac35a1a8155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_e2236a9a-ee0d-4eed-af8c-7173a3372211" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_400998d5-fe34-4e0f-8565-cac35a1a8155" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_400998d5-fe34-4e0f-8565-cac35a1a8155_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_400998d5-fe34-4e0f-8565-cac35a1a8155" xlink:to="loc_us-gaap_SegmentDomain_400998d5-fe34-4e0f-8565-cac35a1a8155_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8f9f663b-6334-40ff-9ae9-68ebf027d828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_400998d5-fe34-4e0f-8565-cac35a1a8155" xlink:to="loc_us-gaap_SegmentDomain_8f9f663b-6334-40ff-9ae9-68ebf027d828" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_96ee305e-7595-45e5-95c3-b6db5e1d42f3" xlink:href="bax-20220331.xsd#bax_HillromMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8f9f663b-6334-40ff-9ae9-68ebf027d828" xlink:to="loc_bax_HillromMember_96ee305e-7595-45e5-95c3-b6db5e1d42f3" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>bax-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3113e683-fb48-43e6-a6e8-6a2e99588fde,g:c1ee1bb8-6f43-4e7f-a20c-1c092f3191f3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_exch_XCHI_54b07505-3d69-4fda-b244-8436ffab7927_terseLabel_en-US" xlink:label="lab_exch_XCHI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chicago Stock Exchange</link:label>
    <link:label id="lab_exch_XCHI_label_en-US" xlink:label="lab_exch_XCHI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHICAGO STOCK EXCHANGE, INC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XCHI" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XCHI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XCHI" xlink:to="lab_exch_XCHI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax_f47409d0-3957-4147-9ebd-8217d250a8c4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_a518e0fc-2e53-45f3-b7d2-331a73c6d25f_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3b17a17d-36e8-432e-a488-11e61ef489ff_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_029cbf04-1bfc-4742-806d-488ddbfcb456_terseLabel_en-US" xlink:label="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Current Liabilities [Member]</link:label>
    <link:label id="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_documentation_en-US" xlink:label="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:href="bax-20220331.xsd#bax_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:to="lab_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_77fe3b80-b6cb-4120-9789-3e86b5d434e4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FairValueDisclosuresLineItems_b8d32383-04b6-4c3b-a71d-4134cff3af69_terseLabel_en-US" xlink:label="lab_bax_FairValueDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Line Items]</link:label>
    <link:label id="lab_bax_FairValueDisclosuresLineItems_label_en-US" xlink:label="lab_bax_FairValueDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Line Items]</link:label>
    <link:label id="lab_bax_FairValueDisclosuresLineItems_documentation_en-US" xlink:label="lab_bax_FairValueDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value disclosure Line items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresLineItems" xlink:href="bax-20220331.xsd#bax_FairValueDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FairValueDisclosuresLineItems" xlink:to="lab_bax_FairValueDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_41f6d1be-c46b-4770-bfbe-f3d1a60f2ea6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalRemediationContingencyDomain_a5a1a6c8-bcf5-47c0-b7ce-e78b3c5140cb_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationContingencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Contingency</link:label>
    <link:label id="lab_us-gaap_EnvironmentalRemediationContingencyDomain_label_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationContingencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Contingency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EnvironmentalRemediationContingencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyDomain" xlink:to="lab_us-gaap_EnvironmentalRemediationContingencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9931544d-db17-463e-adfe-224527ea7176_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_da191aad-900d-4681-99b1-a221a1975f5c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_6acb36f3-56ec-433d-8d7d-ae87f3218fbf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decreases in debt with original maturities of three months or less</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_42e33161-d3a3-42dc-bf86-f9a1d1485b80_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_3f1655de-d379-4019-b41b-fa7499794f17_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Baxter stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_29f1e244-27cf-484a-a274-882fd3b0b5b9_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net of tax</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_587116fc-3c92-4a1f-a0ca-b03f6cb9045a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_1a96f3ba-62f8-4bdb-bada-5d5ecd983e0c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes04Due2024Member_b7467579-068f-4766-9149-d9795d822a38_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes04Due2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.4% Global Notes due 2024</link:label>
    <link:label id="lab_bax_GlobalNotes04Due2024Member_label_en-US" xlink:label="lab_bax_GlobalNotes04Due2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 0.4% due 2024 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes04Due2024Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes04Due2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 0.4% due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes04Due2024Member" xlink:href="bax-20220331.xsd#bax_GlobalNotes04Due2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes04Due2024Member" xlink:to="lab_bax_GlobalNotes04Due2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_71ea1965-f3b7-4e34-a2cd-8a9ddc74341e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_5767afae-3cf7-4e3d-95d6-2d4f56c26504_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_f3c5d863-38c9-481b-9ccb-84f539c44cef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_bd5672d1-bf1b-4f6a-9aad-abe9cb7cc8a0_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_34f22030-f7b8-4cd6-ac6a-f5d759243b6a_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_DevelopedTechnologyIncludingPatentsMember_a746518f-7974-4771-a3f4-41dc69b1f628_terseLabel_en-US" xlink:label="lab_bax_DevelopedTechnologyIncludingPatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology, including patents</link:label>
    <link:label id="lab_bax_DevelopedTechnologyIncludingPatentsMember_label_en-US" xlink:label="lab_bax_DevelopedTechnologyIncludingPatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Including Patents [Member]</link:label>
    <link:label id="lab_bax_DevelopedTechnologyIncludingPatentsMember_documentation_en-US" xlink:label="lab_bax_DevelopedTechnologyIncludingPatentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology including patents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DevelopedTechnologyIncludingPatentsMember" xlink:href="bax-20220331.xsd#bax_DevelopedTechnologyIncludingPatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_DevelopedTechnologyIncludingPatentsMember" xlink:to="lab_bax_DevelopedTechnologyIncludingPatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_b917a695-8498-47bf-9229-8d51ef0598be_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other amortized intangible assets</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_9a173d40-1cde-403f-b788-99a3fdbfb00f_terseLabel_en-US" xlink:label="lab_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_label_en-US" xlink:label="lab_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes</link:label>
    <link:label id="lab_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_documentation_en-US" xlink:label="lab_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:href="bax-20220331.xsd#bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:to="lab_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember_ab1b5797-20a6-4154-bfa5-cdb9c0f2dc3f_terseLabel_en-US" xlink:label="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and Other Employee Related Costs</link:label>
    <link:label id="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember_label_en-US" xlink:label="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance And Other Employee Related Costs [Member]</link:label>
    <link:label id="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember_documentation_en-US" xlink:label="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and other employee related costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:href="bax-20220331.xsd#bax_SeveranceAndOtherEmployeeRelatedCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:to="lab_bax_SeveranceAndOtherEmployeeRelatedCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_efcd3d6c-9ede-41bd-a1b8-8d64951f93c0_terseLabel_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]</link:label>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_label_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]</link:label>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_documentation_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value and carrying value by balance sheet grouping.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:href="bax-20220331.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:to="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_60e98e88-dea8-4258-976a-f9608d8b994f_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_56abcacb-2e1e-4030-8456-855e65ec5e77_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_c474332e-8d0a-410a-a6d1-812f069328ff_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_ba5ca177-583b-428f-8138-1da478791d8b_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_a5889fe5-4851-4bf6-b5f0-c2b2c59dc5d7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_6550a917-e364-4c46-be2d-292fd9a4b583_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_4ea6d6bb-3f42-47e8-849f-490620a4cecc_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_fa1e870f-ef64-49b1-9d07-1496f183c621_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional contributed capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_b46d4384-9572-4733-a964-32c74859929e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed_a6583d87-40c5-45ae-9bc6-5a0829e28c1a_negatedTerseLabel_en-US" xlink:label="lab_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment, assets acquired and liabilities assumed</link:label>
    <link:label id="lab_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed_label_en-US" xlink:label="lab_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed_documentation_en-US" xlink:label="lab_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired and Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed" xlink:href="bax-20220331.xsd#bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed" xlink:to="lab_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_331be94c-ad2a-4d2b-8163-45a5c481be4b_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_e849fc3e-1054-4300-b41e-1cdffed5867f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_1b24c61b-a8b6-4c31-87cb-d89515e0bf7f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_69942b10-03bd-43a4-ad98-ba031e84d9cd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_eded8cef-4b0d-4591-8391-cd405311092b_terseLabel_en-US" xlink:label="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bundled equipment and consumable medical products contracts</link:label>
    <link:label id="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_label_en-US" xlink:label="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bundled Equipment And Consumable Medical Products Contracts [Member]</link:label>
    <link:label id="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_documentation_en-US" xlink:label="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bundled Equipment And Consumable Medical Products Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:href="bax-20220331.xsd#bax_BundledEquipmentAndConsumableMedicalProductsContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:to="lab_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_f9f649cf-0ccd-41e1-8359-fbf8e1e003cf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_3361939c-f94c-4aad-874e-62c021823fc1_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_ab958ad8-5811-4bf3-bd34-4ad5b0e31ab8_terseLabel_en-US" xlink:label="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, additional authorized amount</link:label>
    <link:label id="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_label_en-US" xlink:label="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program Additional Authorized Amount</link:label>
    <link:label id="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_documentation_en-US" xlink:label="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program additional authorized amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:href="bax-20220331.xsd#bax_StockRepurchaseProgramAdditionalAuthorizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:to="lab_bax_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f0abc665-2125-41de-94b4-c8e67b4606f1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_cf28612e-0b6c-49e0-958a-203e660e4230_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_249d0823-5cb8-4dc7-836c-9661374c01a1_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_2b399870-3ff9-4dbd-916a-153b81429584_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock_5a61a199-6d41-46bc-8ef1-3a757ce5b96e_terseLabel_en-US" xlink:label="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets, Net</link:label>
    <link:label id="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock_label_en-US" xlink:label="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Intangible Assets Excluding Goodwill [Table Text Block]</link:label>
    <link:label id="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock_documentation_en-US" xlink:label="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Finite And Indefinite Lived Intangible Assets Excluding Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:href="bax-20220331.xsd#bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:to="lab_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_89fa265d-e687-4a1d-ba07-f8768cbf37a9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease revenue</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8ad62d0a-3e40-4773-9658-4744ebb712cf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_8348aab9-2cb3-4007-8dae-67cb0f03f070_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (Income) Expense, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_76adfb7e-d172-41a1-8f1d-8939f944c629_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_9aea21c5-89ff-43cb-b93f-18e3a4e635be_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value recognized in earnings</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1e58daf8-acc2-421d-8ee1-69ab5fcfcc2b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intrinsic value of stock options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_OriginalWeightedAverageTerm_544b7c28-c082-4aa6-8401-9280c0d35a36_terseLabel_en-US" xlink:label="lab_bax_OriginalWeightedAverageTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original weighted-average term</link:label>
    <link:label id="lab_bax_OriginalWeightedAverageTerm_label_en-US" xlink:label="lab_bax_OriginalWeightedAverageTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original Weighted-Average Term</link:label>
    <link:label id="lab_bax_OriginalWeightedAverageTerm_documentation_en-US" xlink:label="lab_bax_OriginalWeightedAverageTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original Weighted-Average Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OriginalWeightedAverageTerm" xlink:href="bax-20220331.xsd#bax_OriginalWeightedAverageTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_OriginalWeightedAverageTerm" xlink:to="lab_bax_OriginalWeightedAverageTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_a2dec589-11ea-4649-bf4f-df29444860fd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition accounting adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_b9a7d57a-23cc-42c9-ba08-3d07b0061c84_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Reclassification from AOCI to Net Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_8eeacbec-c95b-44a8-b84a-6c91e71a46d3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_2e18299e-e6a6-4d99-a4d0-ea74b2e55e22_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Civil settlement amount</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0f2fa891-ba79-490a-baa5-333e4eab93c8_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_a0a910df-8f4c-4108-9b1e-b80baddb34b1_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_e026e18f-6c50-4659-95cc-9f5c7b59af06_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Activity in Reserves Related to Restructuring Initiatives</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_fbdbdf1f-a501-40f0-abc8-63340253af01_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_888a99c8-ade3-46f3-bcbf-a81a5d0b7845_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_ae4922bf-3201-4df4-9569-311b6da02f43_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining value available under stock repurchase programs</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8848b296-c8b3-48e8-ac8c-54cf76ffbd83_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive securities excluded from computation of EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_d9b3a72c-9e8f-417a-b511-56151fdbaee8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_966d4288-5a0b-4491-bb95-aa980107ba14_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Amount Not Offset Against Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_62b3e98c-7058-4d6a-b432-a482cceda509_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized upon satisfaction of performance obligations</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes395Due2030Member_f0ab49b7-a3e0-42b4-ac3c-72059d8362de_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes395Due2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Global Notes due 2030</link:label>
    <link:label id="lab_bax_GlobalNotes395Due2030Member_label_en-US" xlink:label="lab_bax_GlobalNotes395Due2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 3.95% due 2030 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes395Due2030Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes395Due2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 3.95% due 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes395Due2030Member" xlink:href="bax-20220331.xsd#bax_GlobalNotes395Due2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes395Due2030Member" xlink:to="lab_bax_GlobalNotes395Due2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_d8e5dbe0-d699-4591-b16b-02e9c3d3ba4e_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AmericasSegmentMember_1aeefb34-6d05-4733-a0e0-ee031a47aa1d_terseLabel_en-US" xlink:label="lab_bax_AmericasSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_bax_AmericasSegmentMember_label_en-US" xlink:label="lab_bax_AmericasSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas Segment [Member]</link:label>
    <link:label id="lab_bax_AmericasSegmentMember_documentation_en-US" xlink:label="lab_bax_AmericasSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AmericasSegmentMember" xlink:href="bax-20220331.xsd#bax_AmericasSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AmericasSegmentMember" xlink:to="lab_bax_AmericasSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_12a515cc-c961-41dc-aa5f-620085b5dad7_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged item</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_8c68b45c-0aa0-4b7d-9fb0-3b59a873f059_terseLabel_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value And Carrying Value By Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value And Carrying Value By Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_documentation_en-US" xlink:label="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value And Carrying Value By Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:href="bax-20220331.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:to="lab_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedge_af7900b1-9315-4fed-8c4d-fb30f0a5484c_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of hedged item</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedge_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged Liability, Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedge" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_c09accad-8965-4ed1-858e-3aa0e798f547_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessCombinationCashConsideration_b9abba44-b7b2-48df-a2b0-9dcca567edf4_verboseLabel_en-US" xlink:label="lab_bax_BusinessCombinationCashConsideration" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration</link:label>
    <link:label id="lab_bax_BusinessCombinationCashConsideration_label_en-US" xlink:label="lab_bax_BusinessCombinationCashConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Cash Consideration</link:label>
    <link:label id="lab_bax_BusinessCombinationCashConsideration_documentation_en-US" xlink:label="lab_bax_BusinessCombinationCashConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Cash Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationCashConsideration" xlink:href="bax-20220331.xsd#bax_BusinessCombinationCashConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessCombinationCashConsideration" xlink:to="lab_bax_BusinessCombinationCashConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_6db17708-8a4d-411d-8ca0-6eaaab10247b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in income, undesignated derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bd76e92b-d815-476f-ba4b-2dcc565f6f4d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_49d89e73-0efb-4603-be07-4a8051dbe129_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_3e68a882-dd6c-4441-983d-6b4f25dd2cdc_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_34813333-c3d2-43e3-8b15-ed789d58622f_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes13Due2029Member_39973e1e-9a0c-4f65-8f09-8bc8078309e1_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes13Due2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Global Notes due 2029</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2029Member_label_en-US" xlink:label="lab_bax_GlobalNotes13Due2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.3% due 2029 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2029Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes13Due2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.3% due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2029Member" xlink:href="bax-20220331.xsd#bax_GlobalNotes13Due2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes13Due2029Member" xlink:to="lab_bax_GlobalNotes13Due2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_be7d72fe-2a4d-44a0-a6be-452a5c7803f2_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of net losses and prior service costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTerm_7c4c950a-e535-4605-9611-4eea06e60f12_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average term</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTerm_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTerm" xlink:to="lab_us-gaap_LongTermDebtTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_eebb63ce-25a9-4d92-8fb9-9e76af556d26_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_ad0cede5-d15e-47e8-8b13-7edd5162d1cf_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total business optimization charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dfb3761a-82b5-4e8b-a85a-5fe1b47f1526_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseRevenue_3f20a08d-9f30-4b78-b21b-b662bdb66fe9_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type lease revenue</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseRevenue_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseRevenue" xlink:to="lab_us-gaap_SalesTypeLeaseRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_c1b2fbd7-33dc-432d-b6f5-da88942a8e31_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS, NET</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c0f22b01-c72a-4d6b-934b-ced82d5f53e2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock issued under employee benefit plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_c4f4af9f-ecf8-4e22-ba3f-e02576e16cab_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_e37d5a06-b7ce-43cc-a55e-e6b851c3e429_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_23a59c03-2786-4759-9d19-f1ce804fa52c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_38d05d07-7a0d-4a4c-971f-0e8f2b366286_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember_f38f13fb-beb9-4439-88dd-9bcd6c321502_terseLabel_en-US" xlink:label="lab_bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.4% Senior Notes Due in May 2024</link:label>
    <link:label id="lab_bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember_label_en-US" xlink:label="lab_bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Point Four Percentage Senior Notes Due May Two Thousand Twenty Four [Member]</link:label>
    <link:label id="lab_bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember_documentation_en-US" xlink:label="lab_bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero point four percentage senior notes due May two thousand twenty four.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember" xlink:href="bax-20220331.xsd#bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember" xlink:to="lab_bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_b899848f-73c4-4bea-b30c-af01cb028c14_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure_0f82fef7-42e3-401d-ac89-68f62bd5c743_terseLabel_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and finance lease obligations</link:label>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure_label_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt And Finance Lease Obligations Fair Value Disclosure</link:label>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure_documentation_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and finance lease obligations, fair value disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure" xlink:href="bax-20220331.xsd#bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure" xlink:to="lab_bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_d8883cfd-8956-40f4-8ed0-872de31ba8e5_terseLabel_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right Of Use Assets</link:label>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right Of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:href="bax-20220331.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:to="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_713ba5b3-130c-4115-bb19-b3980aefd61b_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures incurred but not yet paid</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_65f156b8-5860-466d-aca3-6ab379b92d16_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset obtained in exchange for operating lease liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_d0cd245d-d626-4a53-b448-2406f3bd0f4a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_07ca6295-7476-4fde-aa47-af13057a70a7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_d6033c3e-cfae-4202-b7ac-144743cf4c51_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_bc5f1594-f9d8-47f4-ab5a-7dea20980b2f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_25511cab-8ba0-410b-8fa3-b785cd2f824b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e4758eb3-9134-4ad6-9710-c04ae942a45c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_35f64d0d-3144-4e0d-bc3d-10528772efcf_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember_67009e71-4f04-4786-95ed-d75a1fd6a0c1_terseLabel_en-US" xlink:label="lab_bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Senior Notes Due in May 2029</link:label>
    <link:label id="lab_bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember_label_en-US" xlink:label="lab_bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Point Three Percentage Senior Notes Due May Two Thousand Twenty Nine [Member]</link:label>
    <link:label id="lab_bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember_documentation_en-US" xlink:label="lab_bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One point three percentage senior notes due May two thousand twenty nine.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember" xlink:href="bax-20220331.xsd#bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember" xlink:to="lab_bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense_b547bc2c-887b-4364-90cc-56a3c7afd7a8_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefit plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Cost (Reversal of Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_58e30471-d337-493f-bd77-fda21b4f57b6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNetAbstract_5021fde9-e189-497c-8581-dc565559fcb1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income Expense Net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract" xlink:to="lab_us-gaap_InterestIncomeExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_2e3b3753-3c59-46e5-97a4-d9e1bb0b169c_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_e7c6e71c-38cb-4bd9-aa0c-9a7c54f2889d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_4e945fe0-4219-4b64-a249-67f9c6e38276_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2dd96f7d-0899-433a-9105-f7c5d623c3a7_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits, net of tax expense of $3 and $8 for the three months ended March 31, 2022 and 2021, respectively.</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_58ba6155-68d0-40b6-996c-4dc071f57de2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_70afa14f-657b-41ce-b9a1-19f0560c384c_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNYS_49782b67-7855-4526-9374-4783a6bba7f2_terseLabel_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York Stock Exchange</link:label>
    <link:label id="lab_exch_XNYS_label_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XNYS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNYS" xlink:to="lab_exch_XNYS" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_StockholdersEquityNoteLineItems_26cff71a-d016-4fa8-b273-7bb902739b82_terseLabel_en-US" xlink:label="lab_bax_StockholdersEquityNoteLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders Equity Note [Line Items]</link:label>
    <link:label id="lab_bax_StockholdersEquityNoteLineItems_label_en-US" xlink:label="lab_bax_StockholdersEquityNoteLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders Equity Note [Line Items]</link:label>
    <link:label id="lab_bax_StockholdersEquityNoteLineItems_documentation_en-US" xlink:label="lab_bax_StockholdersEquityNoteLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders equity note.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_StockholdersEquityNoteLineItems" xlink:href="bax-20220331.xsd#bax_StockholdersEquityNoteLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_StockholdersEquityNoteLineItems" xlink:to="lab_bax_StockholdersEquityNoteLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5a90114c-002e-4327-8ea1-b78db06c5ca5_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value at beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_96eafb08-ac25-4070-a875-2e24975659f2_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value at end of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_bdd93dfe-6c06-44d7-b3d5-8003c8575852_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ZosynMember_9d4328ad-fc8d-4105-aa9b-c0d42157c145_terseLabel_en-US" xlink:label="lab_bax_ZosynMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zosyn</link:label>
    <link:label id="lab_bax_ZosynMember_label_en-US" xlink:label="lab_bax_ZosynMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zosyn [Member]</link:label>
    <link:label id="lab_bax_ZosynMember_documentation_en-US" xlink:label="lab_bax_ZosynMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zosyn</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ZosynMember" xlink:href="bax-20220331.xsd#bax_ZosynMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ZosynMember" xlink:to="lab_bax_ZosynMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_d923b73b-8a38-4a4f-8189-88db7b5e407f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseIncome_afef8cbc-f150-4679-9d6a-262937c1babc_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease revenue</link:label>
    <link:label id="lab_us-gaap_VariableLeaseIncome_label_en-US" xlink:label="lab_us-gaap_VariableLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseIncome" xlink:to="lab_us-gaap_VariableLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SeniorThreeYearTermLoanMember_c13db0d9-ab74-4b5c-9e70-6d386102b0de_terseLabel_en-US" xlink:label="lab_bax_SeniorThreeYearTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Three Year Term Loan</link:label>
    <link:label id="lab_bax_SeniorThreeYearTermLoanMember_label_en-US" xlink:label="lab_bax_SeniorThreeYearTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Three Year Term Loan [Member]</link:label>
    <link:label id="lab_bax_SeniorThreeYearTermLoanMember_documentation_en-US" xlink:label="lab_bax_SeniorThreeYearTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Three Year Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeniorThreeYearTermLoanMember" xlink:href="bax-20220331.xsd#bax_SeniorThreeYearTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SeniorThreeYearTermLoanMember" xlink:to="lab_bax_SeniorThreeYearTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_7d9bdcd3-7f57-4d90-a783-92c245e6af96_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental costs of sales</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_b98f30bd-b95d-48ef-bbd2-41bc1427b95b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowances of $129 in 2022 and $122 in 2021</link:label>
    <link:label id="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts and Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="lab_us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_6c8d760d-71e0-42c6-b18b-1144f8a36911_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_fe2f6fe2-01e1-4cf3-bcde-60f7eb9bc274_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_c557ccbf-1076-497b-8611-4925a585d3a3_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_7580d02c-8e4e-4d0c-a8de-6aa4717b952a_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to costs and expenses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RevenueFromContractWithCustomerTable_bdb07524-37ac-48e8-99c2-fcfe17a520b8_terseLabel_en-US" xlink:label="lab_bax_RevenueFromContractWithCustomerTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer [Table]</link:label>
    <link:label id="lab_bax_RevenueFromContractWithCustomerTable_label_en-US" xlink:label="lab_bax_RevenueFromContractWithCustomerTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer [Table]</link:label>
    <link:label id="lab_bax_RevenueFromContractWithCustomerTable_documentation_en-US" xlink:label="lab_bax_RevenueFromContractWithCustomerTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from contract with customer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerTable" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RevenueFromContractWithCustomerTable" xlink:to="lab_bax_RevenueFromContractWithCustomerTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_7314ddb5-88ad-4f55-a494-2261385f7294_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a6066b73-fe08-4092-bd2c-865847208517_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt and finance lease obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_8a9fe766-8d09-4449-ab3d-4682ce83dcfa_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_21937ee3-ad44-46be-9aff-115f2f4271a7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repaid debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_d0e19ec5-7960-4648-bb52-a74a98d8def1_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_58d9dca2-3e3e-4a83-a0f7-de6604ba7a61_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted prices in active markets for identical assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_42480d53-4b81-4f80-8c30-533fc8f0f796_negatedLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange (gains) losses, net</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f76ff7f1-4715-4d8e-9479-14a1da214fbb_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_696e02b6-36f4-46f2-874c-260aae2c285e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_63e1f289-b1ca-47ce-b642-c6c0628c4e02_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_1a6f271e-e1d5-4996-a1a7-baa5bafc9f58_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_ccb6a2e6-a04e-45c6-8a69-62f3906df313_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_3ad67fe3-bcd5-444c-8023-ba83e560028f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_7cd3da01-bee2-414a-8634-c3e04db6e4f3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNet_74ac0991-1cac-47e8-924f-92b765fcecf2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net trade accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet" xlink:to="lab_us-gaap_AccountsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_69eab2cb-3b9f-40ca-b706-a12bbf05bb45_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging activities, net of tax expense (benefit) of ($1) and $3 for the three months ended March 31, 2022 and 2021, respectively.</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RevenueRecognizedContractPeriod_20105460-8865-44f1-a0a0-2a4483e3c868_terseLabel_en-US" xlink:label="lab_bax_RevenueRecognizedContractPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized contract period</link:label>
    <link:label id="lab_bax_RevenueRecognizedContractPeriod_label_en-US" xlink:label="lab_bax_RevenueRecognizedContractPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognized Contract Period</link:label>
    <link:label id="lab_bax_RevenueRecognizedContractPeriod_documentation_en-US" xlink:label="lab_bax_RevenueRecognizedContractPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized contract period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueRecognizedContractPeriod" xlink:href="bax-20220331.xsd#bax_RevenueRecognizedContractPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RevenueRecognizedContractPeriod" xlink:to="lab_bax_RevenueRecognizedContractPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_50f5530f-d480-4caa-ba92-aa662542511b_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsMember_04e2bf39-95cc-4f2f-94f4-c890fdd07bd1_terseLabel_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:to="lab_us-gaap_IndefinitelivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_991c2240-2dfe-4b94-8eec-683dc938a0f3_terseLabel_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), reclassification adjustment from AOCI, cash flow hedges and net investment hedges, net of tax</link:label>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_label_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from Accumulated Other Comprehensive Income, Cash Flow Hedges And Net Investment Hedges, Net of Tax</link:label>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_documentation_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from Accumulated Other Comprehensive Income, Cash Flow Hedges And Net Investment Hedges, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:href="bax-20220331.xsd#bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:to="lab_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_ffb7d3e2-7614-4532-962a-d03ff18084f2_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_03052c22-cb58-42d9-b47e-109c6d0b3602_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteAxis_e5b012c9-79d6-43a8-9a0c-058433b11c52_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site</link:label>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteAxis_label_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EnvironmentalRemediationSiteAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis" xlink:to="lab_us-gaap_EnvironmentalRemediationSiteAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_778b3cd0-8f86-4cfe-bed5-4f9ac9178b09_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_5824721c-61e6-44a2-9b48-13be7cb194fb_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Asset at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_9ceb4041-9466-4e99-b519-ee46f134c3c1_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_6b025182-1116-4ee4-81bc-e361385e9eba_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_d4d15cc3-96b8-4c53-a7e8-10c3428d5be2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_b69f2089-64ad-4ab6-85c6-fcb90e14469d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_63685c75-b304-454f-8e87-668a37c702ea_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_7d1ead09-015f-4a3a-9f15-12702184aee2_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsettled share repurchases, value (in usd)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_f7691d0d-dd4e-4ff8-a041-785edb7e412d_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_6fc452af-d244-4475-841c-1328972b3790_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL FINANCIAL INFORMATION</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_55998e12-a86e-4c7f-8635-45a5edd2586c_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_9b4f629d-6a6c-44ce-9e49-2e3c374ccf5d_terseLabel_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and finance lease obligations, less current portion</link:label>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_label_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt And Finance Lease Obligations Noncurrent</link:label>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_documentation_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and finance lease obligations noncurrent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:href="bax-20220331.xsd#bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:to="lab_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_72286179-ca09-40c1-89c3-9c9063838dbd_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SurgicalSolutionsMember_ebf06752-162a-495d-8e5a-c4a0834d1b07_terseLabel_en-US" xlink:label="lab_bax_SurgicalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical solutions</link:label>
    <link:label id="lab_bax_SurgicalSolutionsMember_label_en-US" xlink:label="lab_bax_SurgicalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical solutions [Member]</link:label>
    <link:label id="lab_bax_SurgicalSolutionsMember_documentation_en-US" xlink:label="lab_bax_SurgicalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SurgicalSolutionsMember" xlink:href="bax-20220331.xsd#bax_SurgicalSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SurgicalSolutionsMember" xlink:to="lab_bax_SurgicalSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_bf1036ed-559f-4074-89e9-e2dca21f95be_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_5fd6d6ec-251e-40a7-aae5-cb61aaddf119_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_613e1f7b-3e23-4d6d-a726-319502d213dd_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_f74a5301-c07d-4a72-a7bd-c5cc81c165c8_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_1cf92a54-3e5d-4e32-a058-a88931bd3d4a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_6383b7a5-75e7-4367-b4f7-eae7d78e61ca_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_CommercialPaperWeightedAverageInterestRate_08915e8c-8086-414d-a06f-cee770b73f22_terseLabel_en-US" xlink:label="lab_bax_CommercialPaperWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average interest rate</link:label>
    <link:label id="lab_bax_CommercialPaperWeightedAverageInterestRate_label_en-US" xlink:label="lab_bax_CommercialPaperWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Weighted-Average Interest Rate</link:label>
    <link:label id="lab_bax_CommercialPaperWeightedAverageInterestRate_documentation_en-US" xlink:label="lab_bax_CommercialPaperWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Weighted-Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommercialPaperWeightedAverageInterestRate" xlink:href="bax-20220331.xsd#bax_CommercialPaperWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_CommercialPaperWeightedAverageInterestRate" xlink:to="lab_bax_CommercialPaperWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_2f77958e-bda1-4bd4-8747-e1d1b083b154_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillTable_44945c3e-e016-46a9-9920-5a24def64adc_terseLabel_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Table]</link:label>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillTable_label_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Table]</link:label>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillTable_documentation_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillTable" xlink:href="bax-20220331.xsd#bax_IntangibleAssetExcludingGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable" xlink:to="lab_bax_IntangibleAssetExcludingGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_1d9da795-6172-47c3-9cf8-c515c1038859_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_28d03cd5-34cd-4ce9-b9d7-6e04e3339c19_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated pre-tax unrealized translation gain in AOCI</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_edccedc7-2ffb-4b82-bd9c-904182f52628_verboseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_1ca17388-0ac7-4206-af37-40be7cfaee1b_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve, beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_de6bc8df-2dbd-49db-941b-86588d091e74_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve, ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations_c353b13c-77e1-40c1-85e9-40d3352b5466_terseLabel_en-US" xlink:label="lab_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enterprise value</link:label>
    <link:label id="lab_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations_label_en-US" xlink:label="lab_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Receivable, Fair Value, Including Outstanding Debt Obligations</link:label>
    <link:label id="lab_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations_documentation_en-US" xlink:label="lab_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Receivable, Fair Value, Including Outstanding Debt Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" xlink:href="bax-20220331.xsd#bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" xlink:to="lab_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_8577da57-25f6-4e00-b8fe-4d3741baa23c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_DerivativeNetInvestmentTerminated_f840931d-1668-47e8-84d7-e504dadfd3a9_terseLabel_en-US" xlink:label="lab_bax_DerivativeNetInvestmentTerminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, net investment terminated</link:label>
    <link:label id="lab_bax_DerivativeNetInvestmentTerminated_label_en-US" xlink:label="lab_bax_DerivativeNetInvestmentTerminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Net Investment Terminated</link:label>
    <link:label id="lab_bax_DerivativeNetInvestmentTerminated_documentation_en-US" xlink:label="lab_bax_DerivativeNetInvestmentTerminated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Net Investment Terminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeNetInvestmentTerminated" xlink:href="bax-20220331.xsd#bax_DerivativeNetInvestmentTerminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_DerivativeNetInvestmentTerminated" xlink:to="lab_bax_DerivativeNetInvestmentTerminated" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ClinicalNutritionMember_3aea2856-be1e-46d1-907f-653571038aec_terseLabel_en-US" xlink:label="lab_bax_ClinicalNutritionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical Nutrition</link:label>
    <link:label id="lab_bax_ClinicalNutritionMember_label_en-US" xlink:label="lab_bax_ClinicalNutritionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical Nutrition [Member]</link:label>
    <link:label id="lab_bax_ClinicalNutritionMember_documentation_en-US" xlink:label="lab_bax_ClinicalNutritionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical nutrition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ClinicalNutritionMember" xlink:href="bax-20220331.xsd#bax_ClinicalNutritionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ClinicalNutritionMember" xlink:to="lab_bax_ClinicalNutritionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability_b1037590-a7f2-4714-96d8-883601b34438_terseLabel_en-US" xlink:label="lab_bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, asset</link:label>
    <link:label id="lab_bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Fair Value Of Derivative Assets Offset By Fair Value Of Derivative Liability</link:label>
    <link:label id="lab_bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability_documentation_en-US" xlink:label="lab_bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative fair value of derivative assets offset by fair value of derivative liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability" xlink:href="bax-20220331.xsd#bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability" xlink:to="lab_bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_79840c54-4249-4891-ae50-09d604750c68_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired, and investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_92b10745-40d9-4bae-b192-cfa56d0b7d54_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_cb257a62-7523-4da0-82d1-9107c8b7f671_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CTA</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_8e7591c6-fcab-4dc0-9aa4-37ada3f257d7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ARRANGEMENTS</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_045f402a-4493-42a8-a652-44d9a00a9c40_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_899a36cc-9ddb-40c5-971b-a70b306ebdc2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant unobservable inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_42728625-6482-4f01-9fc8-1445f6df7646_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends on common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostDomain_dc2b26c9-5420-4330-ba68-5d96a3226ecb_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostDomain_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostDomain" xlink:to="lab_us-gaap_CapitalizedContractCostDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_1493dd88-fdf4-45a9-9d49-878f25719350_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_69e1ed9f-0ad7-4fbe-9a6d-16fdb3f7f327_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_bfe8724a-4bc4-496a-b0ca-8ded725bd871_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Sales from Contracts with Customers by Global Business Unit</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_b714daf3-57f9-4ac1-bb80-9aa92d718e5a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_bc1cc731-9ec4-411a-91c5-9d186b1e6469_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:to="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_d66792dd-ff54-45c1-bd69-839b6205b54d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2022 and 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e416b90b-04b7-4bc4-9776-2719749c529c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period for all unvested stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_bb609773-e197-46fe-bbb0-3ad37bf5f4e6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPEB</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_3bf369ad-b103-42e6-86a3-0f6a924c7412_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_b9e46ad8-4daf-4906-86d3-e8e7b88af084_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c7e51055-bd59-4847-8214-9e84fd272f7d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_9d449ce4-509c-4005-8087-628f86773ae6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book Values and Fair Values of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_49e5de7d-ae52-4575-9b7d-8bda97bb4cdf_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ae2f19ea-c0f9-46e7-a82f-3c72b37fa095_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for accounts receivable, current</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_235aab8e-a7dc-4f10-a752-e8eafe1dd110_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS AND OTHER ARRANGEMENTS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_e79c30c1-bd2e-4376-96e0-c8811a3de29e_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_fe977dca-cd37-474f-ab8d-7e50ce9e4a1d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_9c53a051-9e6f-4822-8c99-629034a08ccd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4b2ccb51-ef63-4c87-ace3-0eda430dd108_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_fc5d0e3a-f2ff-4dd0-a53b-8de50cb07f9c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_OtherLiabilitiesCurrentUnsettledShareRepurchase_7cc4086f-0b09-4133-b846-a72fbf9eb20a_terseLabel_en-US" xlink:label="lab_bax_OtherLiabilitiesCurrentUnsettledShareRepurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Current, Unsettled Share Repurchase</link:label>
    <link:label id="lab_bax_OtherLiabilitiesCurrentUnsettledShareRepurchase_label_en-US" xlink:label="lab_bax_OtherLiabilitiesCurrentUnsettledShareRepurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Current, Unsettled Share Repurchase</link:label>
    <link:label id="lab_bax_OtherLiabilitiesCurrentUnsettledShareRepurchase_documentation_en-US" xlink:label="lab_bax_OtherLiabilitiesCurrentUnsettledShareRepurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Current, Unsettled Share Repurchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherLiabilitiesCurrentUnsettledShareRepurchase" xlink:href="bax-20220331.xsd#bax_OtherLiabilitiesCurrentUnsettledShareRepurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_OtherLiabilitiesCurrentUnsettledShareRepurchase" xlink:to="lab_bax_OtherLiabilitiesCurrentUnsettledShareRepurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_3bed4b33-36a7-4975-904d-9f54f6f97e41_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_d4e55e44-1cbf-4416-98ec-adeb5ed5fc36_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period, treasury (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_67d521c3-59e1-43a6-9e20-aecab1236c57_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period, treasury (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquisitionRelatedCostsMember_7bd2a261-4c6b-4c6a-8aaa-2d4fe5b4692b_terseLabel_en-US" xlink:label="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Costs</link:label>
    <link:label id="lab_us-gaap_AcquisitionRelatedCostsMember_label_en-US" xlink:label="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquisitionRelatedCostsMember" xlink:to="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_b02d13ec-3153-4763-872e-5521464d4948_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_4faab161-d72b-4392-bb99-c0255d31069b_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_c05a0a7a-83f9-4b79-a0e7-1e323441f6df_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AcuteTherapiesMember_3bf0f5e2-4cc6-4397-804d-8c97fa4bf0fd_terseLabel_en-US" xlink:label="lab_bax_AcuteTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acute Therapies</link:label>
    <link:label id="lab_bax_AcuteTherapiesMember_label_en-US" xlink:label="lab_bax_AcuteTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acute Therapies [Member]</link:label>
    <link:label id="lab_bax_AcuteTherapiesMember_documentation_en-US" xlink:label="lab_bax_AcuteTherapiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acute Therapies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcuteTherapiesMember" xlink:href="bax-20220331.xsd#bax_AcuteTherapiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AcuteTherapiesMember" xlink:to="lab_bax_AcuteTherapiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_1bea3071-fa1d-4a9b-af49-2d4a85b03333_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2037776c-9d2f-4047-a62d-105931b66689_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_6808a90c-d7fe-4b32-8a61-d65ffe7c5492_terseLabel_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt and finance lease obligations</link:label>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_label_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt And Finance Lease Obligations Current Fair Value Disclosure</link:label>
    <link:label id="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_documentation_en-US" xlink:label="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and finance lease obligations, current, fair value disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:href="bax-20220331.xsd#bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:to="lab_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d82048f9-8028-4897-8f60-5ffd98e11697_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RevenueFromContractWithCustomerRollForward_3de887fd-f38a-45ff-bc81-c60aef310224_terseLabel_en-US" xlink:label="lab_bax_RevenueFromContractWithCustomerRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer [Roll Forward]</link:label>
    <link:label id="lab_bax_RevenueFromContractWithCustomerRollForward_label_en-US" xlink:label="lab_bax_RevenueFromContractWithCustomerRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer [Roll Forward]</link:label>
    <link:label id="lab_bax_RevenueFromContractWithCustomerRollForward_documentation_en-US" xlink:label="lab_bax_RevenueFromContractWithCustomerRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerRollForward" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward" xlink:to="lab_bax_RevenueFromContractWithCustomerRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_5f01b818-5dfa-4948-b70a-946f4b08c31a_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_e53e8e6f-37a7-49cb-821e-7ddf87392695_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_8c0251fc-9dfc-479a-a39c-7e54d1d160bc_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SG&amp;A</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_af0aaa23-c6c7-4e56-85ca-a78cf4a2c219_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, equity interest issued or issuable (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_d28b5dd9-5a5a-47c2-90b1-3aa8aea26e8c_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4b136f3d-7f9c-4eae-9ea6-09ecab4c3278_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_89710289-11d8-46eb-a297-e2aeb9d8a9c9_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_CommonStock100PerValueMember_8517e792-3eea-455e-ab3d-15fee376507b_terseLabel_en-US" xlink:label="lab_bax_CommonStock100PerValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $1.00 par value</link:label>
    <link:label id="lab_bax_CommonStock100PerValueMember_label_en-US" xlink:label="lab_bax_CommonStock100PerValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $1.00 per Value [Member]</link:label>
    <link:label id="lab_bax_CommonStock100PerValueMember_documentation_en-US" xlink:label="lab_bax_CommonStock100PerValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $1.00 per Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommonStock100PerValueMember" xlink:href="bax-20220331.xsd#bax_CommonStock100PerValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_CommonStock100PerValueMember" xlink:to="lab_bax_CommonStock100PerValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SiteContingencyNumberOfSites_7d2c9f0e-85bf-4248-abdf-2cbf1c175b7c_terseLabel_en-US" xlink:label="lab_bax_SiteContingencyNumberOfSites" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of sites</link:label>
    <link:label id="lab_bax_SiteContingencyNumberOfSites_label_en-US" xlink:label="lab_bax_SiteContingencyNumberOfSites" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site Contingency Number Of Sites</link:label>
    <link:label id="lab_bax_SiteContingencyNumberOfSites_documentation_en-US" xlink:label="lab_bax_SiteContingencyNumberOfSites" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Site contingency, number of sites.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SiteContingencyNumberOfSites" xlink:href="bax-20220331.xsd#bax_SiteContingencyNumberOfSites"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SiteContingencyNumberOfSites" xlink:to="lab_bax_SiteContingencyNumberOfSites" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_8f5cca21-b837-4b7c-bc89-b72a57091d08_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_fa21fd56-8be2-4afe-85b7-9548e68458d1_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_63a0a01f-9d0f-46cf-859b-aa8dc3b87794_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_0b7ce2a4-812b-434b-a5f8-963144d7953a_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book values</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_f5871096-efcf-4f2f-ad44-58ab3229c417_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_8db35bca-6f53-42b1-959b-eccf57af347d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_c099f79a-e51e-4cad-867e-c5419a6cdd61_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_f80c5268-c8ca-4089-8edf-e1c45f4623e1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_a861be8e-a785-4ece-a51b-33faeca0e770_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ManufacturingArrangementsMember_77cd3b11-35ef-4d19-8bda-8902995b2954_terseLabel_en-US" xlink:label="lab_bax_ManufacturingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract manufacturing services</link:label>
    <link:label id="lab_bax_ManufacturingArrangementsMember_label_en-US" xlink:label="lab_bax_ManufacturingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Arrangements [Member]</link:label>
    <link:label id="lab_bax_ManufacturingArrangementsMember_documentation_en-US" xlink:label="lab_bax_ManufacturingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember" xlink:href="bax-20220331.xsd#bax_ManufacturingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ManufacturingArrangementsMember" xlink:to="lab_bax_ManufacturingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_57c2af4e-6383-4b00-82e8-6ca9d102b366_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_0c06991a-8d62-405d-87ee-4347bc3636a9_negatedLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_c6f64e06-2361-4a9d-a08b-64b71fec147c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_36c06ea8-2a44-4dd2-b916-9a0bd2c832ec_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_7ba23f9f-1f9d-456e-8f81-00136562c0d1_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_b68d4a39-7869-4323-a5a4-1fee7fa0200d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_210300c2-847a-46ee-91f9-100835bbfc92_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total segment operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_7f32a011-3820-4f4b-955a-52a2a69120e6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f0ff60f3-109e-4332-b44d-567d94269639_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_6101bcca-9505-467c-b0bf-1b5b4b1d902f_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d84d3fac-7274-4f24-a7f2-2140e276dc57_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses)</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_60495727-3d24-4479-8758-4dcc6b800794_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_dc7076c1-e24d-4257-8edc-452c4b4f5775_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_6227e97d-4239-4663-9487-514afc87c689_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_f90149f0-9114-41dc-a166-c4484e0c8be4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS OPTIMIZATION CHARGES</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e19e5232-012a-4be0-be39-9cf5c927128c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional contributed capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1b6f8215-471d-4fd4-b8c7-f3aa55767f58_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_c7691fa5-3dc5-4f75-b07f-e5e86254111e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_1d8b2823-d47e-4fdf-b12d-23664ed9677e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_bf197780-3a98-4c0e-98df-b2ca78ea8a88_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_51a29514-5435-4469-998e-13fea2a56569_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock in treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_dafafdbb-996a-4e2f-8da0-dc32cb006499_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_1b3ce0fa-fee0-4bc6-9056-d6666c861e40_negatedTerseLabel_en-US" xlink:label="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_label_en-US" xlink:label="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Accrued Expenses And Other Current Liabilities</link:label>
    <link:label id="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_documentation_en-US" xlink:label="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Accrued Expenses And Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:href="bax-20220331.xsd#bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:to="lab_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ContractTerminationAndOtherCostsMember_ec49091e-fd6c-4d10-b4fa-d4f06d6db1c0_terseLabel_en-US" xlink:label="lab_bax_ContractTerminationAndOtherCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract termination and other costs</link:label>
    <link:label id="lab_bax_ContractTerminationAndOtherCostsMember_label_en-US" xlink:label="lab_bax_ContractTerminationAndOtherCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Termination And Other Costs [Member]</link:label>
    <link:label id="lab_bax_ContractTerminationAndOtherCostsMember_documentation_en-US" xlink:label="lab_bax_ContractTerminationAndOtherCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract termination and other costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractTerminationAndOtherCostsMember" xlink:href="bax-20220331.xsd#bax_ContractTerminationAndOtherCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ContractTerminationAndOtherCostsMember" xlink:to="lab_bax_ContractTerminationAndOtherCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_35f588e2-0d52-49b3-98b9-c074da74fad8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteDomain_a819c029-51ee-4bc4-952a-9fa7e5590483_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site</link:label>
    <link:label id="lab_us-gaap_EnvironmentalRemediationSiteDomain_label_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationSiteDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Site [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteDomain" xlink:to="lab_us-gaap_EnvironmentalRemediationSiteDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_0232cec7-a96c-4b52-b6c0-38defcc374f8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_b500313f-dc37-4c40-9c86-8a5896465502_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_c4d961f4-ec15-46dc-9459-89ed0061e3fa_totalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_356e5c74-d9fa-4e2b-83c4-31eabff98fbb_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_324e2ed0-472f-44ef-9fe9-4d89c6b2d1e3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing activities, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_d54ba373-5101-4087-9221-14d2bf1f56a8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_a97e740f-1186-4518-bf0d-cdff7ce43975_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, fair value, net</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_631ac70f-3f63-46c6-9d1d-e2d6daddf988_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cd4b007c-0aec-4b87-bdde-a1207a163518_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_13e0e44d-e17e-4d5f-9668-4ccdbca9bdee_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AssetImpairmentMember_cfd438b0-b293-4200-ba76-44da6c45a63f_terseLabel_en-US" xlink:label="lab_bax_AssetImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments</link:label>
    <link:label id="lab_bax_AssetImpairmentMember_label_en-US" xlink:label="lab_bax_AssetImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment [Member]</link:label>
    <link:label id="lab_bax_AssetImpairmentMember_documentation_en-US" xlink:label="lab_bax_AssetImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AssetImpairmentMember" xlink:href="bax-20220331.xsd#bax_AssetImpairmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AssetImpairmentMember" xlink:to="lab_bax_AssetImpairmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_ab94022a-a396-4432-a8f7-245897a458b5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_d1bd586c-b359-4475-b076-576e1c59369c_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4e69feb0-2f4c-47ef-a429-e3320ecfcdee_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_894a66bc-a038-4bd3-af1e-5f78f3e57818_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_6e717fb6-cdda-49ad-8db0-8c536a337c82_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_494e5df5-fdf0-47db-a751-faad64c7ded8_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Baxter stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShorttermDebtFairValue_5229842d-92b4-42f5-8a9e-ca734fa46819_terseLabel_en-US" xlink:label="lab_us-gaap_ShorttermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShorttermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_ShorttermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShorttermDebtFairValue" xlink:to="lab_us-gaap_ShorttermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_167a2800-e650-477c-a8dd-d85632447173_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_9b6fc429-3c46-4bce-b3d8-20f574e57bb7_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_cab9ea99-31a0-420a-a2ae-4b19f623ba75_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_e9538761-141c-41bf-bfa0-685232e1b7fe_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_b2322c44-25cf-4067-905d-f9c6635b203f_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7fb5d246-b69d-4655-ad51-4c0a2f864656_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_dfaee712-ad5a-4317-bd19-63b24d4a2944_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments designated as hedges</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperAverageOutstanding_551a2701-f3d7-4224-9688-4e2f7c1b39ce_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperAverageOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper, average outstanding</link:label>
    <link:label id="lab_us-gaap_CommercialPaperAverageOutstanding_label_en-US" xlink:label="lab_us-gaap_CommercialPaperAverageOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Average Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperAverageOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperAverageOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperAverageOutstanding" xlink:to="lab_us-gaap_CommercialPaperAverageOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b238e3ab-b5ff-434e-bf59-aba3a0b15693_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_b37a08ce-6c9b-4bae-bac9-9c4e4cba779b_verboseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseIncome_954fd17c-c0e1-4228-8c64-ad1d027250f6_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease revenue</link:label>
    <link:label id="lab_us-gaap_LeaseIncome_label_en-US" xlink:label="lab_us-gaap_LeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseIncome" xlink:to="lab_us-gaap_LeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_29b3568e-c0ad-4dbf-9711-eeded62705c8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_ae39f541-4eab-4a57-9ce5-2472a66fe1ff_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration transferred (in usd per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7868eb30-0195-44c0-ad2f-66d28a1cf14d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in AOCI by Component</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_9bb697c6-a6d7-4374-9709-52f094b18db0_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RenalMember_633969cf-94ba-4e10-bbab-c155d93a700f_terseLabel_en-US" xlink:label="lab_bax_RenalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renal Care</link:label>
    <link:label id="lab_bax_RenalMember_label_en-US" xlink:label="lab_bax_RenalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renal [Member]</link:label>
    <link:label id="lab_bax_RenalMember_documentation_en-US" xlink:label="lab_bax_RenalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renal.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RenalMember" xlink:href="bax-20220331.xsd#bax_RenalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RenalMember" xlink:to="lab_bax_RenalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_9a14741a-2524-48a7-b886-278b32f3fcde_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_26cc00dc-61c1-4fac-b256-e90470f2e0a0_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE INCOME</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_a409fd57-6dd2-445e-8397-84a087495317_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_LossContingencyNumberOfLawsuits_95acb86b-c46a-430b-a78a-6178d8045a5d_terseLabel_en-US" xlink:label="lab_bax_LossContingencyNumberOfLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of lawsuits</link:label>
    <link:label id="lab_bax_LossContingencyNumberOfLawsuits_label_en-US" xlink:label="lab_bax_LossContingencyNumberOfLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Lawsuits</link:label>
    <link:label id="lab_bax_LossContingencyNumberOfLawsuits_documentation_en-US" xlink:label="lab_bax_LossContingencyNumberOfLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LossContingencyNumberOfLawsuits" xlink:href="bax-20220331.xsd#bax_LossContingencyNumberOfLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_LossContingencyNumberOfLawsuits" xlink:to="lab_bax_LossContingencyNumberOfLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_294f162a-328d-4f65-b59c-87b6872aff23_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BioPharmaSolutionsMember_0381f954-1d3f-45d4-a574-5e059bc87227_terseLabel_en-US" xlink:label="lab_bax_BioPharmaSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioPharma Solutions</link:label>
    <link:label id="lab_bax_BioPharmaSolutionsMember_label_en-US" xlink:label="lab_bax_BioPharmaSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioPharma Solutions [Member]</link:label>
    <link:label id="lab_bax_BioPharmaSolutionsMember_documentation_en-US" xlink:label="lab_bax_BioPharmaSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioPharma Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BioPharmaSolutionsMember" xlink:href="bax-20220331.xsd#bax_BioPharmaSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BioPharmaSolutionsMember" xlink:to="lab_bax_BioPharmaSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_cdacd19c-18e6-4c10-8d18-efd8283c6415_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_c7d2e9fd-3d0a-4da2-9c5e-4e244de006a7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net of capitalized interest</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_78ed0323-4b42-48b7-a99f-c31913a287ed_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic cost (income)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FairValueDisclosuresTable_335aa419-be6c-4a63-b92e-67fc8cdfcb9c_terseLabel_en-US" xlink:label="lab_bax_FairValueDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Table]</link:label>
    <link:label id="lab_bax_FairValueDisclosuresTable_label_en-US" xlink:label="lab_bax_FairValueDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Table]</link:label>
    <link:label id="lab_bax_FairValueDisclosuresTable_documentation_en-US" xlink:label="lab_bax_FairValueDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value disclosures table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresTable" xlink:href="bax-20220331.xsd#bax_FairValueDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FairValueDisclosuresTable" xlink:to="lab_bax_FairValueDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_3f88a8fc-880e-446b-addb-56be345fd4dd_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsAbstract_42801686-3894-4d26-a55b-03d98ba0914a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsAbstract" xlink:to="lab_us-gaap_DerivativeAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SuperfundSitesMember_24a8cca2-74ad-4746-8590-34973a48b572_terseLabel_en-US" xlink:label="lab_bax_SuperfundSitesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Superfund Sites</link:label>
    <link:label id="lab_bax_SuperfundSitesMember_label_en-US" xlink:label="lab_bax_SuperfundSitesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Superfund Sites [Member]</link:label>
    <link:label id="lab_bax_SuperfundSitesMember_documentation_en-US" xlink:label="lab_bax_SuperfundSitesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Superfund sites.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SuperfundSitesMember" xlink:href="bax-20220331.xsd#bax_SuperfundSitesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SuperfundSitesMember" xlink:to="lab_bax_SuperfundSitesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e67dbe02-d42e-4e54-a4e6-3995761ac17f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_5726072a-6d19-4be5-863b-ae382fb65f02_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d19136ba-3dfc-49a5-b281-4982dc8bde89_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_1d6c1212-a008-4abf-8c77-9945bb3c0024_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_5cf5dbda-4500-446c-b870-572c8c826974_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_0eae3df8-24a7-472f-991d-ce1a983e5bea_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_4c393dc7-b6d7-4eaf-8ffd-2962d568eb06_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_6fca50a6-b0df-4e6b-b74f-9f0a9621fd15_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_b999bcf0-cba3-419e-b1cf-a36a05ef0306_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_80e2562d-51ec-4c3e-b4d2-b56d0d3df2f8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging activities, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_a42ac73c-b4eb-48da-bb0e-6e0e90973614_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Gains and Losses on Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3d5ac7f6-7fe8-4508-aee4-9940a230a852_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_6bbdfda8-03b7-42eb-a2da-3599462e91bf_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_acd17d24-1c28-4730-92b6-a444f3696915_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_87403f53-ecc0-4623-b6f4-e59506d21107_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair values</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_c5ad502a-c5df-4910-b50e-c9c878cf9239_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0e5be7ed-ae7d-4c84-bdc0-5141429e55b3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_5512c0df-5c79-4604-8f6b-0197f3c29bfb_negatedTerseLabel_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_label_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Short Term Debt</link:label>
    <link:label id="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_documentation_en-US" xlink:label="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed current liabilities short-term debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" xlink:href="bax-20220331.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" xlink:to="lab_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecurities_bfd2ba6c-edc7-4496-8994-f96750ce8f3b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecurities_label_en-US" xlink:label="lab_us-gaap_DebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecurities" xlink:to="lab_us-gaap_DebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_ee46924d-9eec-450a-a9c7-7f676f8531d9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_b13c0ba9-75ff-4e7e-9742-9fcb5ee4503f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3063e477-19d6-4804-b657-548df2af07b1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_aff9cc3f-315c-458f-9158-249b29043205_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_cb684dff-e24c-4974-8e46-c443e1f5301c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_750d8d81-558c-4d84-b8ea-4110634ecd79_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_692f8b4d-bed4-4c61-8447-28bb19097693_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period (in usd)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7360a68f-4fca-4f78-bb58-9e7e0cea941f_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period (in usd)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_d539ea2a-7b82-4513-bb96-378c67dd196a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_f5ae2d41-10ca-4875-8afb-34c2ba4b8ad8_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APAC</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_c5dcbdb6-645b-4c28-b089-e2f607cc28d1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f8636c1f-7a9f-4f0d-a5fc-4c6b8455c9aa_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_46ceac52-6f61-4bcc-9c6b-4f578535924c_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_cf73b522-6c18-464d-a3ca-6546455c598f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_62815082-1bd2-469f-bf00-356d391d2210_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_4dc4b8c0-3f81-44f6-aef9-edfa7bac5c77_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_2060ff6f-c1fb-46fc-8afe-e6ccb6129ddb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic Shares to Diluted Shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_d855a023-1e6e-486a-b2ba-979459d689f1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_08e8fa22-de59-4523-9e08-058416117647_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8228bfb5-c07a-4be9-8718-10cebb164b92_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Financial Information for Our Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3ed8b07a-b8ac-4e43-a998-d35c64230758_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_5ba8baac-3a6c-4c47-aaba-c850cb6ed186_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_79a2a4ac-f5d6-439a-8236-f594abf4a497_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_6139b3c5-9987-4c29-a091-f24dbf4a67cd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_7c28dd40-cd7e-41e9-a4c9-2dcb12874fa4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_e526244a-6e28-40e5-87e7-638405ae7b9c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic Shares to Diluted Shares</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_8e04af8d-67eb-40e4-bd0b-4336c835ae27_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts Receivable [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_56371854-288f-45da-b7f0-ef1bd0eff138_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_PharmaceuticalsMember_88aeb15d-7650-456a-8987-b35074e0f7cc_terseLabel_en-US" xlink:label="lab_bax_PharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals</link:label>
    <link:label id="lab_bax_PharmaceuticalsMember_label_en-US" xlink:label="lab_bax_PharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals [Member]</link:label>
    <link:label id="lab_bax_PharmaceuticalsMember_documentation_en-US" xlink:label="lab_bax_PharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceuticals.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PharmaceuticalsMember" xlink:href="bax-20220331.xsd#bax_PharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_PharmaceuticalsMember" xlink:to="lab_bax_PharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets_42501e73-dfc4-42ce-bc44-8d3931e3065e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Indefinite-lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_OtherIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a2e5f3a7-3e91-4d4a-ab66-b389ac806f75_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value per stock option (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_bbc68eae-4ee6-42d3-a138-79f637905286_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SoftwareArrangementsMember_2a79433f-a7e3-44bf-bd8a-7c90c4ba642b_terseLabel_en-US" xlink:label="lab_bax_SoftwareArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software sales</link:label>
    <link:label id="lab_bax_SoftwareArrangementsMember_label_en-US" xlink:label="lab_bax_SoftwareArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Arrangements [Member]</link:label>
    <link:label id="lab_bax_SoftwareArrangementsMember_documentation_en-US" xlink:label="lab_bax_SoftwareArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember" xlink:href="bax-20220331.xsd#bax_SoftwareArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SoftwareArrangementsMember" xlink:to="lab_bax_SoftwareArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_3583efc7-d365-4870-b6f0-bde022ac014e_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued under employee benefit plans and other (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fb6bee65-ae00-47dd-8d71-dcd52b403dd4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments, net of tax expense (benefit) of ($11) and $17 for the three months ended March 31, 2022 and 2021, respectively.</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_OtherProductOrServicesMember_3f8f470c-6fcc-4ddf-8a07-03c65f4175c1_terseLabel_en-US" xlink:label="lab_bax_OtherProductOrServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_bax_OtherProductOrServicesMember_label_en-US" xlink:label="lab_bax_OtherProductOrServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Product Or Services [Member]</link:label>
    <link:label id="lab_bax_OtherProductOrServicesMember_documentation_en-US" xlink:label="lab_bax_OtherProductOrServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other product or services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherProductOrServicesMember" xlink:href="bax-20220331.xsd#bax_OtherProductOrServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_OtherProductOrServicesMember" xlink:to="lab_bax_OtherProductOrServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingGainsLosses_81883534-0216-40bb-9b6a-881ac9d55412_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingGainsLosses_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingGainsLosses" xlink:to="lab_us-gaap_OtherNonoperatingGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_a9d1f9bd-2ade-4ea3-92f7-338940cf64fd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of equity awards issued to Hillrom equity award holders</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_d6d9d7b8-1d21-4db2-a58f-ac16e7936c9a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_DerivativeFairValueTerminated_96c9cb6f-2aa8-4cf7-9d26-0738f08b4709_terseLabel_en-US" xlink:label="lab_bax_DerivativeFairValueTerminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, fair value, terminated</link:label>
    <link:label id="lab_bax_DerivativeFairValueTerminated_label_en-US" xlink:label="lab_bax_DerivativeFairValueTerminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Terminated</link:label>
    <link:label id="lab_bax_DerivativeFairValueTerminated_documentation_en-US" xlink:label="lab_bax_DerivativeFairValueTerminated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Terminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeFairValueTerminated" xlink:href="bax-20220331.xsd#bax_DerivativeFairValueTerminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_DerivativeFairValueTerminated" xlink:to="lab_bax_DerivativeFairValueTerminated" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessOptimizationChargeTableTextBlock_9997134a-8fa7-4603-a234-8554ef818e07_terseLabel_en-US" xlink:label="lab_bax_BusinessOptimizationChargeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Business Optimization Charges</link:label>
    <link:label id="lab_bax_BusinessOptimizationChargeTableTextBlock_label_en-US" xlink:label="lab_bax_BusinessOptimizationChargeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Charge [Table Text Block]</link:label>
    <link:label id="lab_bax_BusinessOptimizationChargeTableTextBlock_documentation_en-US" xlink:label="lab_bax_BusinessOptimizationChargeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business optimization charge.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessOptimizationChargeTableTextBlock" xlink:href="bax-20220331.xsd#bax_BusinessOptimizationChargeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessOptimizationChargeTableTextBlock" xlink:to="lab_bax_BusinessOptimizationChargeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_MedicationDeliveryMember_5bff1b35-bb3b-4342-b7cf-ea5f21ac6f0b_terseLabel_en-US" xlink:label="lab_bax_MedicationDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Delivery</link:label>
    <link:label id="lab_bax_MedicationDeliveryMember_label_en-US" xlink:label="lab_bax_MedicationDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication Delivery [Member]</link:label>
    <link:label id="lab_bax_MedicationDeliveryMember_documentation_en-US" xlink:label="lab_bax_MedicationDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medication delivery.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_MedicationDeliveryMember" xlink:href="bax-20220331.xsd#bax_MedicationDeliveryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_MedicationDeliveryMember" xlink:to="lab_bax_MedicationDeliveryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_b5b59b99-c3cb-4a1a-a05b-951fb5237215_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement to settle the case</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_6bcbe229-fb65-4da4-9a62-3f1cb87ac412_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction price allocated to remaining performance obligations</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_69a458da-950d-4873-ac66-52ee5ad7aa05_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs to implement business optimization programs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostIncurredCost_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Incurred Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:to="lab_us-gaap_RestructuringAndRelatedCostIncurredCost" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock_038fa677-0c3e-4a56-8bd5-b9bcd061afb5_terseLabel_en-US" xlink:label="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties Related to COVID-19 and Global Economic Conditions</link:label>
    <link:label id="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties Policy [Policy Text Block]</link:label>
    <link:label id="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:href="bax-20220331.xsd#bax_RisksAndUncertaintiesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:to="lab_bax_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_c50b9f35-891f-4449-a00f-2eaac6c78a81_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued under employee benefit plans and other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_eb8d0c74-23ea-4d21-94d3-0882a123128c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_0ffefde1-fb66-4649-b967-3beae03e92e2_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_1366939b-7d25-4a52-a9f6-c2558861fee5_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type leases, receivables</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_22b40455-022a-4321-ab21-c40945bd6cc2_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_eba6ffd2-cf14-45dc-9cb7-ef2cc272d8e2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1637a506-e167-4b81-aa74-46119a1e536f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_da3782a3-3cd6-46e0-a145-b0eff7cd43eb_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total before tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5f4c1c53-c96b-46dc-b312-61c91a39ac9a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_2917758e-c660-4381-abf5-f14ca53187ff_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant other observable inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_52b49586-0374-435d-92b5-8d9650cccbc8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_3598b859-3d76-4522-961f-4793cfcee495_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_fde356b9-2599-47cd-a085-f9ccf13cf226_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_cdc723ef-00f0-4cc1-9c00-572380814edb_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_6a334c7a-b0d5-4034-b109-1b2b9339a56e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_b5989409-e375-42b1-b4ab-812b823e15f2_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_57f5da2b-d248-4285-8a18-0b474650b3db_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b376bcd8-6965-4525-94ce-692476478b1a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_4a3c3bd1-65da-4d24-9506-2e782e728e36_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_EnviromentalCleanUpMember_1b2843e1-e66e-4ead-aad8-c6f9b261a9c6_terseLabel_en-US" xlink:label="lab_bax_EnviromentalCleanUpMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Clean-up</link:label>
    <link:label id="lab_bax_EnviromentalCleanUpMember_label_en-US" xlink:label="lab_bax_EnviromentalCleanUpMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enviromental Clean Up [Member]</link:label>
    <link:label id="lab_bax_EnviromentalCleanUpMember_documentation_en-US" xlink:label="lab_bax_EnviromentalCleanUpMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enviromental clean-up.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EnviromentalCleanUpMember" xlink:href="bax-20220331.xsd#bax_EnviromentalCleanUpMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_EnviromentalCleanUpMember" xlink:to="lab_bax_EnviromentalCleanUpMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_f9684203-6ad2-4741-a8df-8c0885c2ebb7_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds, at carrying value</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="lab_us-gaap_MoneyMarketFundsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_ce3b96d6-ad14-4ce6-9857-446e5d45944a_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred, net after-tax gains on derivative instruments</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5542d2b1-6760-4245-8360-c3e7562db6dd_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_BusinessOptimizationProgramsMember_aaaf769b-2c7e-4e7d-88ea-75ecf436d394_terseLabel_en-US" xlink:label="lab_bax_BusinessOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Programs</link:label>
    <link:label id="lab_bax_BusinessOptimizationProgramsMember_label_en-US" xlink:label="lab_bax_BusinessOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Programs [Member]</link:label>
    <link:label id="lab_bax_BusinessOptimizationProgramsMember_documentation_en-US" xlink:label="lab_bax_BusinessOptimizationProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Optimization Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessOptimizationProgramsMember" xlink:href="bax-20220331.xsd#bax_BusinessOptimizationProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_BusinessOptimizationProgramsMember" xlink:to="lab_bax_BusinessOptimizationProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RevenuePerformanceObligationPaymentTerms_f1f88f0c-9b21-4b5b-9d76-d7977306e260_terseLabel_en-US" xlink:label="lab_bax_RevenuePerformanceObligationPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global payment terms</link:label>
    <link:label id="lab_bax_RevenuePerformanceObligationPaymentTerms_label_en-US" xlink:label="lab_bax_RevenuePerformanceObligationPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Payment Terms</link:label>
    <link:label id="lab_bax_RevenuePerformanceObligationPaymentTerms_documentation_en-US" xlink:label="lab_bax_RevenuePerformanceObligationPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Payment Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenuePerformanceObligationPaymentTerms" xlink:href="bax-20220331.xsd#bax_RevenuePerformanceObligationPaymentTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RevenuePerformanceObligationPaymentTerms" xlink:to="lab_bax_RevenuePerformanceObligationPaymentTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_779fdb5f-4f2d-4955-aea8-bd2c6b76db9b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_4279e36a-726c-46bb-ab92-fe38d98e4624_totalLabel_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), cash flow hedge and net investment hedge, gain (loss), before reclassification, tax</link:label>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:label id="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_documentation_en-US" xlink:label="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:href="bax-20220331.xsd#bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:to="lab_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_bccb627a-9e23-426e-9145-26caa0a9361d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_4cb5c728-42de-4fea-a0da-cef4c6b4cd5d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillLineItems_ba4a3c38-6f10-4178-82db-c3007146e158_terseLabel_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Line Items]</link:label>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillLineItems_label_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Line Items]</link:label>
    <link:label id="lab_bax_IntangibleAssetExcludingGoodwillLineItems_documentation_en-US" xlink:label="lab_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Excluding Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:href="bax-20220331.xsd#bax_IntangibleAssetExcludingGoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:to="lab_bax_IntangibleAssetExcludingGoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_3a75236b-a61c-4300-847d-4fc6314f4e64_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected additional pre-tax costs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ConsumableMedicalProductsMember_0bdba744-a657-489c-88a8-33bced8ce7fa_terseLabel_en-US" xlink:label="lab_bax_ConsumableMedicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumable Medical Products</link:label>
    <link:label id="lab_bax_ConsumableMedicalProductsMember_label_en-US" xlink:label="lab_bax_ConsumableMedicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumable Medical Products [Member]</link:label>
    <link:label id="lab_bax_ConsumableMedicalProductsMember_documentation_en-US" xlink:label="lab_bax_ConsumableMedicalProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumable medical products [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ConsumableMedicalProductsMember" xlink:href="bax-20220331.xsd#bax_ConsumableMedicalProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ConsumableMedicalProductsMember" xlink:to="lab_bax_ConsumableMedicalProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_6ee3fb82-f1a7-4b17-9fb3-4ee8c014a91b_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_1cb2a11a-686c-4da6-b845-ee7494f5b1ba_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_3e9351d6-c9b9-473a-826b-3f05fba1f492_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_57a5fc4a-f2fe-43e7-a80e-292f2a51197f_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_e27048af-0284-48c6-b11a-2bf49163f3a2_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_445f7dbb-27d2-4780-8cbe-449db2f1ccdd_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_ea4366c7-3aad-4e0b-b370-220ad55bb379_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember_30c0069c-ffce-45fa-b345-ca80423d2462_terseLabel_en-US" xlink:label="lab_bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Senior Notes due May 2025</link:label>
    <link:label id="lab_bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember_label_en-US" xlink:label="lab_bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Point Three Zero Percentage Senior Notes Due May Two Thousand And Twenty Five [Member]</link:label>
    <link:label id="lab_bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember_documentation_en-US" xlink:label="lab_bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One point three zero percentage senior notes due may two thousand and twenty five.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember" xlink:href="bax-20220331.xsd#bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember" xlink:to="lab_bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8e161802-1540-4224-9ebc-801d535519dd_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_0123d64f-7ea3-45cb-9054-6f6bea97041e_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent payments related to acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_5218b9c5-1829-4bed-9f11-9ac7b4876c6f_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_01898d63-0cd1-4f20-b245-531b8a817b5f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_fa0effd9-5886-4962-9063-3259959be160_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligations period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_190d18d2-8424-41c2-9715-22c98e819572_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_22778690-811d-4936-a86e-dc952520edb4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operations</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_0d8610ad-0bf7-4a21-9516-2feeacffc3d8_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_768471bd-3b25-4f52-960d-b21f561f9bc9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ShareBasedCompensationAllocationPercentage_e4e33ce3-0d0e-499d-b6aa-ebf4252e65f2_terseLabel_en-US" xlink:label="lab_bax_ShareBasedCompensationAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation expense allocation percentage</link:label>
    <link:label id="lab_bax_ShareBasedCompensationAllocationPercentage_label_en-US" xlink:label="lab_bax_ShareBasedCompensationAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Allocation Percentage</link:label>
    <link:label id="lab_bax_ShareBasedCompensationAllocationPercentage_documentation_en-US" xlink:label="lab_bax_ShareBasedCompensationAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Allocation Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ShareBasedCompensationAllocationPercentage" xlink:href="bax-20220331.xsd#bax_ShareBasedCompensationAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ShareBasedCompensationAllocationPercentage" xlink:to="lab_bax_ShareBasedCompensationAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_300a885b-b35b-49d8-9813-b4fdff2bb1a5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAxis_a30a1a07-6aca-43d3-8074-120c1b43f922_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAxis_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAxis" xlink:to="lab_us-gaap_CapitalizedContractCostAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AcquisitionsAndCollaborationsLineItems_c43a4b71-59aa-4ebf-a073-6acc0bb6459d_terseLabel_en-US" xlink:label="lab_bax_AcquisitionsAndCollaborationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Collaborations [Line Items]</link:label>
    <link:label id="lab_bax_AcquisitionsAndCollaborationsLineItems_label_en-US" xlink:label="lab_bax_AcquisitionsAndCollaborationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Collaborations [Line Items]</link:label>
    <link:label id="lab_bax_AcquisitionsAndCollaborationsLineItems_documentation_en-US" xlink:label="lab_bax_AcquisitionsAndCollaborationsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Collaborations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsLineItems" xlink:href="bax-20220331.xsd#bax_AcquisitionsAndCollaborationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems" xlink:to="lab_bax_AcquisitionsAndCollaborationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_eeefab23-3d21-4b52-a916-579e7190f6ac_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_205815be-5d0b-4738-9f7b-95cdb9851e8c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_03b74948-e8b7-4869-939a-b815b17f1f0c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_879ca604-020d-4a32-b12a-edf39070aa22_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_6dbff9f9-d2dc-451e-beda-3fd6dfd59b11_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_925d0eaf-cb64-4b17-993e-5050b7b31d4c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_cc377f66-757c-44f4-ba8f-ce0fd6a3a48d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_68ca5264-4a7e-42c7-8c4f-f8f637668fbc_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment hedge</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_aa4481a2-9a8a-468b-8195-7cbe075e73ed_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_6d62fc49-42bd-4358-9b61-9c5c17ccb743_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5732fdc1-3e18-45d2-acdb-8b0d1c5644ac_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_03194a80-f74a-40c5-9e02-44e22eeb7332_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_c5fad684-8aba-476e-865f-ce74bd404d0e_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b92c153e-0324-4684-a835-69151d50b542_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_a2f844f5-2a3d-484a-8bb6-caaab54c3103_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Baxter stockholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_2c541e2f-8b30-4d4c-bed8-c11a8738ca4f_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_d3b81134-c5d0-46cd-ac8d-7bc6d62a9e2a_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_c6ebaece-4d0f-49c6-adc9-9fb7a5ce97d1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee termination costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_bee2c0e7-b169-4090-a5de-a07c8bcc6f49_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_e6e5b551-1722-4625-9a89-0895986afacf_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_c38c23c2-5939-4ba4-9351-2a39f2a2aebc_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_6aec0839-6830-4f3a-94b2-3465c0751b9d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b09bbae5-57ae-4095-97e0-104dda6d1c97_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_5be81b30-0d54-464f-83ed-67f9790df38e_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock in treasury, at cost,180,058,105 shares in 2022 and 181,879,516 shares in 2021</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_392021ce-2b3d-4986-a8cb-0fdad1710ee7_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_74946e9b-feaa-4acb-8068-ed3e95b48d95_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Amount Not Offset Against Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_af890933-2836-44a0-97a1-00cfa27a1987_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_ef58a509-82fe-4023-8a45-be140d7e5c44_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_865a55b7-8783-4ab9-aff5-1415c8a9a1f0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_6a5e44f1-cbf6-4624-a3a1-aac80063fe2c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other equity investments without readily determinable fair values</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue" xlink:to="lab_us-gaap_OtherInvestmentNotReadilyMarketableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_916d3357-0b9e-4985-a964-dbd614c22476_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AcquisitionsAndCollaborationsTable_d9e61d0a-b804-4c31-a726-605a9a2e5328_terseLabel_en-US" xlink:label="lab_bax_AcquisitionsAndCollaborationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Collaborations [Table]</link:label>
    <link:label id="lab_bax_AcquisitionsAndCollaborationsTable_label_en-US" xlink:label="lab_bax_AcquisitionsAndCollaborationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Collaborations [Table]</link:label>
    <link:label id="lab_bax_AcquisitionsAndCollaborationsTable_documentation_en-US" xlink:label="lab_bax_AcquisitionsAndCollaborationsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Collaborations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsTable" xlink:href="bax-20220331.xsd#bax_AcquisitionsAndCollaborationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AcquisitionsAndCollaborationsTable" xlink:to="lab_bax_AcquisitionsAndCollaborationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_ffb5d681-3091-4996-b5e9-ff910de2cfbf_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_793b3642-4982-4424-94a4-69db107bc454_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_b1ac803c-2fdc-4c64-8602-b0ee72b41249_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_78a823e1-09dc-4e4c-bc76-679a8a5b7f4b_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_b3075fc1-06c4-4e37-a513-1893964b8545_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Baxter stockholders' equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_723226df-ec48-408e-bd4e-c350a5acb1f1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_920d37e1-b1f9-474f-9b92-1c043484091b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_dc312b39-474d-4671-a11d-c264c317f505_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Financial Instruments Measured at Fair Value on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_8f9dae4f-13ba-42af-9b92-be5281cbee2d_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared on common stock</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_901fe9b8-2b6b-4c65-8c7b-3399dce1c340_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_555b6f34-2386-43f9-9f71-ab7dc1fc270b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_d78436d7-2b18-4682-a7c9-f3d30c8a485b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_24abbb64-21bd-43da-a913-f4cc3803c27c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_f46df7f6-3a6c-45e2-b734-0eb7544acd28_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1323761-2ef6-4c27-8290-15e4a7b0c323_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d428dd4c-bc75-4eaf-9983-227c14b68e02_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_961f2917-e92c-43b1-8a21-630c2c4193b6_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_14d1cfbf-1946-4c60-9327-2e80ebaf3064_negatedLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_b82b1d6c-a45c-49df-a4cc-fc138805b6cb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_46688895-cb4e-47a6-b56f-35dd4122bd82_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_cb84e334-7f8a-495d-a96c-7d17cef0ad5c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_afa1f6d8-5003-45eb-b66d-80ac1488fdd4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, net of tax expense of $1 and zero for the three months ended March 31, 2022 and 2021, respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes13Due2025Member_bb003a50-33f8-497d-8268-fead1a3e2f45_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes13Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Global Notes due 2025</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2025Member_label_en-US" xlink:label="lab_bax_GlobalNotes13Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.3% due 2025 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2025Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes13Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.3% due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2025Member" xlink:href="bax-20220331.xsd#bax_GlobalNotes13Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes13Due2025Member" xlink:to="lab_bax_GlobalNotes13Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_SeniorFiveYearTermLoanMember_abf7762b-e383-4e5b-b7de-ed9c0c27c55c_terseLabel_en-US" xlink:label="lab_bax_SeniorFiveYearTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Five Year Term Loan</link:label>
    <link:label id="lab_bax_SeniorFiveYearTermLoanMember_label_en-US" xlink:label="lab_bax_SeniorFiveYearTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Five Year Term Loan [Member]</link:label>
    <link:label id="lab_bax_SeniorFiveYearTermLoanMember_documentation_en-US" xlink:label="lab_bax_SeniorFiveYearTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Five Year Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeniorFiveYearTermLoanMember" xlink:href="bax-20220331.xsd#bax_SeniorFiveYearTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_SeniorFiveYearTermLoanMember" xlink:to="lab_bax_SeniorFiveYearTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments_5afb93f0-955d-4dab-9d81-1ddd029572d7_negatedLabel_en-US" xlink:label="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments_label_en-US" xlink:label="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Currency Translation Adjustments</link:label>
    <link:label id="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments_documentation_en-US" xlink:label="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Currency Translation Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:href="bax-20220331.xsd#bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:to="lab_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_40f32543-9a89-4149-8493-64e756f54d21_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_HillromMember_698f7144-eef5-43e6-ab93-a2b12561037d_terseLabel_en-US" xlink:label="lab_bax_HillromMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hillrom</link:label>
    <link:label id="lab_bax_HillromMember_label_en-US" xlink:label="lab_bax_HillromMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hillrom [Member]</link:label>
    <link:label id="lab_bax_HillromMember_documentation_en-US" xlink:label="lab_bax_HillromMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hillrom Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember" xlink:href="bax-20220331.xsd#bax_HillromMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_HillromMember" xlink:to="lab_bax_HillromMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_65015479-c99b-44ee-8286-145713d6ec6b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_78919ba8-54ee-4e8c-84e3-eea084526491_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_b073f1b4-2dca-473d-94eb-cd148f85c6bf_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_8779141f-b582-4272-9df7-8ca6e0b6c7f8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_c2e8f2df-1e03-4b1a-832a-5fa4177690b2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_9ec6cc1a-cc88-41b7-a057-1401cb984645_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_f3ee9e1c-fedb-4b94-b9ef-eeff9b16ec4f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity and Share-based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_39ff5571-4984-48c1-9589-96a8aba61925_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_6981a6ee-fc8e-442e-a2d8-1fe051cc4eb2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and finance lease obligations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_0d6bbd3d-a427-44be-b8aa-14d926623346_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets_a71f4cf4-3e80-4819-a05f-fcf680ea1f8d_terseLabel_en-US" xlink:label="lab_bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, liability</link:label>
    <link:label id="lab_bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets_label_en-US" xlink:label="lab_bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Fair Value Of Derivative Liability Offset By Fair Value Of Derivative Assets</link:label>
    <link:label id="lab_bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets_documentation_en-US" xlink:label="lab_bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative fair value of derivative liability offset by fair value of derivative assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets" xlink:href="bax-20220331.xsd#bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets" xlink:to="lab_bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_15765c84-0403-4961-a1c0-6227e8135586_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_72fec1f2-819a-4f66-8941-dfb6e675989f_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsettled share repurchases (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_2626241e-71e4-44b8-9feb-bfe25aae2c6f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_1a5807de-5938-4e53-93d9-cc647d4fd42f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_76d94bc4-d69a-42da-9623-ae9baf8a2ad8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock_bfeed6b6-b9f7-4d44-968c-539934ad1ce0_terseLabel_en-US" xlink:label="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Positions Presented On Net Basis</link:label>
    <link:label id="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock_label_en-US" xlink:label="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Derivative Positions Presented On Net Basis Table [Table Text Block]</link:label>
    <link:label id="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock_documentation_en-US" xlink:label="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of derivative positions presented on net basis.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:href="bax-20220331.xsd#bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:to="lab_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_bb21b69d-1f2c-41d2-8386-a0cda1b30c15_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_a989b35a-d149-4c00-bd27-2eece464b836_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_47049f16-ac2b-475a-9ca0-da225103d336_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_ea37cc12-1935-460f-8c17-abda4252c58c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining revenue performance obligation, percentage of revenue expected to be recognized</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_69fa4b9c-ab5b-46f8-a34b-f8f27b67788f_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from AOCI</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_32e51eb2-93ec-4386-b6ab-4aaf286846d0_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, current borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_FrontLineCareMember_1bb559f0-7303-414b-bd0f-4480dc339213_terseLabel_en-US" xlink:label="lab_bax_FrontLineCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front line care</link:label>
    <link:label id="lab_bax_FrontLineCareMember_label_en-US" xlink:label="lab_bax_FrontLineCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front line care [Member]</link:label>
    <link:label id="lab_bax_FrontLineCareMember_documentation_en-US" xlink:label="lab_bax_FrontLineCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front line care</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FrontLineCareMember" xlink:href="bax-20220331.xsd#bax_FrontLineCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_FrontLineCareMember" xlink:to="lab_bax_FrontLineCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_45d29a46-17de-478a-9a3c-8b8a1c9500aa_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_95e80262-8495-4b11-805a-f1a2a4f6fc01_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross_72dae0d5-a779-43eb-95bb-f2d59a98742f_terseLabel_en-US" xlink:label="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock granted, value, share-based compensation, gross</link:label>
    <link:label id="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross_label_en-US" xlink:label="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:to="lab_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_e539fe30-ef59-4dc0-a0d4-2caf7c231b7d_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_2fc40020-daea-4979-a13c-e4d7ba56dda6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_7603edcf-c37d-4279-8f78-ab0d5bedb6e4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_90b5b2b9-dc0b-4fd7-aca0-d3ea1b666acc_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_4e93d038-183f-42b2-8299-9e7c53685059_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_ContractWithCustomerLiabilityDeferredRevenue_0f1422cf-f9a1-4306-a6fb-5590a9c08b2a_terseLabel_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New revenue deferrals</link:label>
    <link:label id="lab_bax_ContractWithCustomerLiabilityDeferredRevenue_label_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Deferred Revenue</link:label>
    <link:label id="lab_bax_ContractWithCustomerLiabilityDeferredRevenue_documentation_en-US" xlink:label="lab_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:href="bax-20220331.xsd#bax_ContractWithCustomerLiabilityDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:to="lab_bax_ContractWithCustomerLiabilityDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes173Due2031Member_1eda40e5-400e-4db3-a0a8-eb0adf8c3c60_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes173Due2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.73% Global Notes due 2031</link:label>
    <link:label id="lab_bax_GlobalNotes173Due2031Member_label_en-US" xlink:label="lab_bax_GlobalNotes173Due2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.73% due 2031 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes173Due2031Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes173Due2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.73% due 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes173Due2031Member" xlink:href="bax-20220331.xsd#bax_GlobalNotes173Due2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes173Due2031Member" xlink:to="lab_bax_GlobalNotes173Due2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_e6ed9320-5f27-42a8-a26d-5f86f905ac00_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_39de1fe7-05dc-47ae-bf52-6c5e7469d382_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_PatientSupportSystemsMember_4ce3e1a1-fa09-40fb-8028-5d0249d654f2_terseLabel_en-US" xlink:label="lab_bax_PatientSupportSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient support systems</link:label>
    <link:label id="lab_bax_PatientSupportSystemsMember_label_en-US" xlink:label="lab_bax_PatientSupportSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient support systems [Member]</link:label>
    <link:label id="lab_bax_PatientSupportSystemsMember_documentation_en-US" xlink:label="lab_bax_PatientSupportSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient support systems</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PatientSupportSystemsMember" xlink:href="bax-20220331.xsd#bax_PatientSupportSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_PatientSupportSystemsMember" xlink:to="lab_bax_PatientSupportSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease_4bf64117-c8fd-4262-a6d6-bdad5a12876a_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type lease, net of investment in lease</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-Type Lease, Net Investment in Lease, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AsiaPacificSegmentMember_bd2e9cfe-f86c-42a4-a3cc-39e28ec38fad_terseLabel_en-US" xlink:label="lab_bax_AsiaPacificSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APAC</link:label>
    <link:label id="lab_bax_AsiaPacificSegmentMember_label_en-US" xlink:label="lab_bax_AsiaPacificSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific Segment [Member]</link:label>
    <link:label id="lab_bax_AsiaPacificSegmentMember_documentation_en-US" xlink:label="lab_bax_AsiaPacificSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AsiaPacificSegmentMember" xlink:href="bax-20220331.xsd#bax_AsiaPacificSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AsiaPacificSegmentMember" xlink:to="lab_bax_AsiaPacificSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b2276544-1ce6-4eb0-b7af-48aeadaccf6d_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_8e62e3a2-59d6-4b07-af21-200e01e8e015_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_de0f3a53-63dd-48e8-b21f-941448f7be35_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_EMEASegmentMember_dc3fb8b8-e053-4691-ace9-4616cdae2494_terseLabel_en-US" xlink:label="lab_bax_EMEASegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA</link:label>
    <link:label id="lab_bax_EMEASegmentMember_label_en-US" xlink:label="lab_bax_EMEASegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E M E A Segment [Member]</link:label>
    <link:label id="lab_bax_EMEASegmentMember_documentation_en-US" xlink:label="lab_bax_EMEASegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E M E A Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EMEASegmentMember" xlink:href="bax-20220331.xsd#bax_EMEASegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_EMEASegmentMember" xlink:to="lab_bax_EMEASegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1cbbe853-026e-45a0-a7af-b48af871f1b3_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e3bd1986-3d85-4ea0-9c90-69543a211597_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_0bc79d65-2080-452e-8c70-8c7f31683c3f_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_c497a409-2241-48b9-8a48-9f5386ffd4ba_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_feb50f14-211a-47e4-8a22-372cdd706304_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalRemediationContingencyAxis_0eed9927-bf7a-49e3-ad61-99ca46c990f1_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Contingency</link:label>
    <link:label id="lab_us-gaap_EnvironmentalRemediationContingencyAxis_label_en-US" xlink:label="lab_us-gaap_EnvironmentalRemediationContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Remediation Contingency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EnvironmentalRemediationContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyAxis" xlink:to="lab_us-gaap_EnvironmentalRemediationContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0902e5c2-b3b4-4d39-aca9-3d861b275f0d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_f481311a-35fb-4c9c-a866-4937de49c46f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_1108e03f-3311-49f5-8551-4e6a6b590aee_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_ee3722ba-aa8e-4b11-8a9f-04c5ee5ec3c6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross other intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_df3be861-063b-44fe-88cf-19d5fc284318_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_acbf8995-2c85-4cb6-bc56-0ee5b460a3dd_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_StockholdersEquityNoteTable_b9645d9c-db41-47e6-bf17-927fdef1333a_terseLabel_en-US" xlink:label="lab_bax_StockholdersEquityNoteTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders Equity Note [Table]</link:label>
    <link:label id="lab_bax_StockholdersEquityNoteTable_label_en-US" xlink:label="lab_bax_StockholdersEquityNoteTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders Equity Note [Table]</link:label>
    <link:label id="lab_bax_StockholdersEquityNoteTable_documentation_en-US" xlink:label="lab_bax_StockholdersEquityNoteTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders Equity Note [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_StockholdersEquityNoteTable" xlink:href="bax-20220331.xsd#bax_StockholdersEquityNoteTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_StockholdersEquityNoteTable" xlink:to="lab_bax_StockholdersEquityNoteTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_b4b04434-72cb-47f3-bac0-921367f0f3f9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8d531a0d-6374-4222-aebd-24ec58478ca8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_373850a0-ac6b-409e-ab14-a8558b8d0b43_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a8a1faf3-08d7-4fc1-b05f-323b8e78113f_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_719a2a4d-2efc-4dd4-bb27-4dae488daee0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_12243e36-4b6e-4a9c-a496-de23e34c6817_netLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_4fdede2e-9f89-46e1-9c10-48adfac25847_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_6d6b1aa3-dd7e-4128-b18c-66de2c5e4279_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation reserve</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_37d73d09-ac86-4c53-a13a-044487db9c44_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_eb00bd51-13f7-4be6-adbd-66afd24d58cb_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_b77c0914-69a4-4825-aee4-6ebdb6360436_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-offs</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_d30ad6d3-e924-4255-9782-ed2c289b3f98_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_d3475730-591c-4948-9e3e-928ff60b458e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging activities</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_8201bc9f-7d7d-452d-b8ac-260464c861ff_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) on hedging activities</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_1a9dcad6-9566-4947-9290-a5025adf9069_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_87a42c18-81e3-45ff-9256-a7ec5745ecc6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_1afbe7c2-c540-4647-bac1-0402ace8b091_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undesignated derivative instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_22d095a6-97a1-4a1c-9ad3-7e94ca7925c9_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_34b925ed-9296-412b-9fd7-a1a249266a9a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_794f0a1e-a541-421b-9e4c-7b4bf5ef6958_verboseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_5fbb38c5-ff9c-4f23-99c8-1a5fb845a0b7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_1da23e66-8eda-45dc-bf80-c8550c609945_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income to Income Before Income Taxes Reconciliation</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3101c7d2-d7b6-4446-b42b-5099ad569884_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in balance sheet items:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_77e38326-3d5c-49aa-8e78-31817c5d9920_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c87b6cff-394d-499c-8b78-421db122ce0c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operations</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_3055aaa4-24fb-43ad-a9af-2d7b74f9ecbd_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_0624e27f-1242-471a-b138-cfd60b303090_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_6764a310-503b-41ae-a993-84a7d97cba63_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_92410574-a946-4d7a-b002-3c1dcd183db1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_fcad6e25-16f9-4837-af1e-42581da442e3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_fadf183f-bc83-4cc1-be58-8f83a96fe25d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_c3d1e331-9045-4018-a7d8-f3f2ca30e803_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration paid to Hillrom shareholders</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_133639ae-3d5b-47de-8ab6-a31a9e57f0be_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_a3720df1-a0f5-4cab-8aa4-954d0c2c3085_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Lease Income</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_6bf60d48-1a0f-4b41-8578-df81cfd60caa_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_5788eacc-da9c-4d42-805e-4193bedabdec_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_0d578616-2e6e-4f01-9e7d-d5d48adc704b_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from AOCI</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_34735a65-a014-4a03-af8b-2bd5cc556a77_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_e99bac13-7c14-43d8-a904-475682889fe5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_18e24989-abe9-46e8-99bd-591642a9f67d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_26a89eb9-779d-451c-bb8d-fa5fcc8321d8_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_353846c2-c311-42a5-a57d-f5ffcb632a14_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_cc812f98-69a2-4edc-900b-6b02af22586c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Liability at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_5f54bdc3-edf3-4bd0-aea5-7032984cae7e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_81633dd8-c887-43a3-af05-abfcb6a7e78d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_ae814b6d-590a-454e-8e91-77d4df96d6e4_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental reserves</link:label>
    <link:label id="lab_us-gaap_AccrualForEnvironmentalLossContingencies_label_en-US" xlink:label="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Environmental Loss Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:to="lab_us-gaap_AccrualForEnvironmentalLossContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_acb0eeec-2d72-427b-842b-8550a2e2835e_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_08ef9dca-672e-41ac-912b-1fd4bfe8f74a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative pre-tax costs incurred</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_35145ac0-8a9b-4e2e-a450-766469886fbc_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_RevenueFromContractWithCustomerLineItems_278dfdba-3c91-43a2-a836-bf8cf2a15801_terseLabel_en-US" xlink:label="lab_bax_RevenueFromContractWithCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer [Line Items]</link:label>
    <link:label id="lab_bax_RevenueFromContractWithCustomerLineItems_label_en-US" xlink:label="lab_bax_RevenueFromContractWithCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer [Line Items]</link:label>
    <link:label id="lab_bax_RevenueFromContractWithCustomerLineItems_documentation_en-US" xlink:label="lab_bax_RevenueFromContractWithCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from contract with customer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerLineItems" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems" xlink:to="lab_bax_RevenueFromContractWithCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_0bc544ff-380c-475d-8938-1f071f9d7cca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7ce5ab00-1a7a-4a12-9c98-09535d11fb96_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to all unvested stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_AdvancedSurgeryMember_d32a7d3b-72a1-4145-ac6a-c5a1e9c2f945_terseLabel_en-US" xlink:label="lab_bax_AdvancedSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Surgery</link:label>
    <link:label id="lab_bax_AdvancedSurgeryMember_label_en-US" xlink:label="lab_bax_AdvancedSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Surgery [Member]</link:label>
    <link:label id="lab_bax_AdvancedSurgeryMember_documentation_en-US" xlink:label="lab_bax_AdvancedSurgeryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced surgery.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AdvancedSurgeryMember" xlink:href="bax-20220331.xsd#bax_AdvancedSurgeryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_AdvancedSurgeryMember" xlink:to="lab_bax_AdvancedSurgeryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_e70c4a9c-afb4-483e-96da-e37de5764dbc_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_4af187bc-a815-4e8b-825b-ab58d1572bee_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesAbstract_d25e7677-40df-4037-be4f-b7957e8f7313_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract" xlink:to="lab_us-gaap_DerivativeLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_4b60aef3-d205-46d6-bcdf-31144848aabe_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_bf254b2d-7684-40ae-841c-1b797962fd07_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_98d61928-979b-4358-8341-24a5dc2fc75c_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_9f181a52-9066-43a3-b540-aab13103c7b4_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_5a2dea03-bde6-48e2-b439-ee3aa6e53b70_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_21be1d74-538c-4ec6-a9de-df921a1f0c05_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_299e30b4-32eb-4f9b-b2b2-a2fa0bf226b2_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COGS</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_1a7a872a-68f0-4192-bc57-54de67cd5ead_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_a8168ae7-2bd1-4e6d-b6e3-6ed30efc8f25_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum length of time hedge in cash flow hedge</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time Hedged in Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:to="lab_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_85b6a9da-89ef-4d75-9937-a26cef004621_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e04bb4a-3807-4175-9745-53f36c3acdfb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to cash flows from operations:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_4ff3e8cf-c1ce-4859-920c-842dba7205ef_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension benefits</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_7efc9b4f-2d32-47a8-bb4d-2565bb93624a_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension and other postretirement costs</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_5326fd76-a475-46fa-ab55-750a292994b4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Classification and Fair Values of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_397811b1-b123-4ea3-a5fd-51c6f70c9371_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Intangible Asset</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_378db106-eed8-4f8e-88c1-007df0dc6f9a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and OPEB plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_5123428d-e3ab-422f-a0ce-a1682e57c7aa_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and OPEB items</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_1b7cab44-9613-4a17-9741-e5ea80a07c9d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>bax-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3113e683-fb48-43e6-a6e8-6a2e99588fde,g:c1ee1bb8-6f43-4e7f-a20c-1c092f3191f3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.baxter.com/role/Cover" xlink:type="simple" xlink:href="bax-20220331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_9b1bad35-e270-4b19-b405-b1d9414e62e0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_a08a77ba-6ef4-4ec1-9601-939912d42cd0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9b1bad35-e270-4b19-b405-b1d9414e62e0" xlink:to="loc_dei_DocumentInformationTable_a08a77ba-6ef4-4ec1-9601-939912d42cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d5dd8c17-d5ce-485c-8662-bc17ce2e3553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_a08a77ba-6ef4-4ec1-9601-939912d42cd0" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d5dd8c17-d5ce-485c-8662-bc17ce2e3553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_13a2f74d-fcbf-43ab-b692-8e932544db17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d5dd8c17-d5ce-485c-8662-bc17ce2e3553" xlink:to="loc_us-gaap_ClassOfStockDomain_13a2f74d-fcbf-43ab-b692-8e932544db17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommonStock100PerValueMember_14754506-035f-415e-bf43-05c29a2e406b" xlink:href="bax-20220331.xsd#bax_CommonStock100PerValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_13a2f74d-fcbf-43ab-b692-8e932544db17" xlink:to="loc_bax_CommonStock100PerValueMember_14754506-035f-415e-bf43-05c29a2e406b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes04Due2024Member_d4847a81-5d14-4c7c-bd5b-2d0dd24971a3" xlink:href="bax-20220331.xsd#bax_GlobalNotes04Due2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_13a2f74d-fcbf-43ab-b692-8e932544db17" xlink:to="loc_bax_GlobalNotes04Due2024Member_d4847a81-5d14-4c7c-bd5b-2d0dd24971a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2025Member_7f3b048e-fa16-4a76-ada6-810c0a5977cf" xlink:href="bax-20220331.xsd#bax_GlobalNotes13Due2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_13a2f74d-fcbf-43ab-b692-8e932544db17" xlink:to="loc_bax_GlobalNotes13Due2025Member_7f3b048e-fa16-4a76-ada6-810c0a5977cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2029Member_8e75c7fd-8c9a-4f30-b44c-7fbd82caccc9" xlink:href="bax-20220331.xsd#bax_GlobalNotes13Due2029Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_13a2f74d-fcbf-43ab-b692-8e932544db17" xlink:to="loc_bax_GlobalNotes13Due2029Member_8e75c7fd-8c9a-4f30-b44c-7fbd82caccc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes395Due2030Member_0ea50c72-8d34-486a-8566-3ee7511cdcfb" xlink:href="bax-20220331.xsd#bax_GlobalNotes395Due2030Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_13a2f74d-fcbf-43ab-b692-8e932544db17" xlink:to="loc_bax_GlobalNotes395Due2030Member_0ea50c72-8d34-486a-8566-3ee7511cdcfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes173Due2031Member_2354b25d-72f1-4201-9d07-8cea391f4b08" xlink:href="bax-20220331.xsd#bax_GlobalNotes173Due2031Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_13a2f74d-fcbf-43ab-b692-8e932544db17" xlink:to="loc_bax_GlobalNotes173Due2031Member_2354b25d-72f1-4201-9d07-8cea391f4b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_a7c5e77f-49ea-499d-b21b-d10fdb659117" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_a08a77ba-6ef4-4ec1-9601-939912d42cd0" xlink:to="loc_dei_EntityListingsExchangeAxis_a7c5e77f-49ea-499d-b21b-d10fdb659117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_06642d3e-5df5-4eff-bcc4-f1bd562e3c3d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_a7c5e77f-49ea-499d-b21b-d10fdb659117" xlink:to="loc_dei_ExchangeDomain_06642d3e-5df5-4eff-bcc4-f1bd562e3c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_132b2e32-0e09-4a52-aaaa-f53e945968b2" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XNYS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_06642d3e-5df5-4eff-bcc4-f1bd562e3c3d" xlink:to="loc_exch_XNYS_132b2e32-0e09-4a52-aaaa-f53e945968b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XCHI_13d11f0f-f91c-4183-8dd9-09074765d410" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XCHI"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_06642d3e-5df5-4eff-bcc4-f1bd562e3c3d" xlink:to="loc_exch_XCHI_13d11f0f-f91c-4183-8dd9-09074765d410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_a08a77ba-6ef4-4ec1-9601-939912d42cd0" xlink:to="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_bffa4e72-440e-43b7-8142-1517e092bf01" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_DocumentType_bffa4e72-440e-43b7-8142-1517e092bf01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_3011b8c2-e050-4417-b1e5-478570437e2a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_DocumentQuarterlyReport_3011b8c2-e050-4417-b1e5-478570437e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f844fb46-d8e7-4115-bb0b-c32fc7c43d1d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_DocumentPeriodEndDate_f844fb46-d8e7-4115-bb0b-c32fc7c43d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_e1345515-c48c-474a-be02-4f5894139efc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_DocumentTransitionReport_e1345515-c48c-474a-be02-4f5894139efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a4a9343d-cdff-4364-8262-00935ef5bc20" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityFileNumber_a4a9343d-cdff-4364-8262-00935ef5bc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e30b024c-611d-45ef-9ded-1312c4267452" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityRegistrantName_e30b024c-611d-45ef-9ded-1312c4267452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_504a32b3-7bea-4d59-8f54-563dd274239f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityIncorporationStateCountryCode_504a32b3-7bea-4d59-8f54-563dd274239f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b6857ffa-49b1-49db-9520-da6b95377f58" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityTaxIdentificationNumber_b6857ffa-49b1-49db-9520-da6b95377f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_cfd74551-ecb2-4194-985b-2c906a2f569d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityAddressAddressLine1_cfd74551-ecb2-4194-985b-2c906a2f569d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_16357333-a78c-4bc2-85c3-72a69dfaef85" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityAddressCityOrTown_16357333-a78c-4bc2-85c3-72a69dfaef85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_1b3a5e79-59b3-4302-adff-636a8c806696" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityAddressStateOrProvince_1b3a5e79-59b3-4302-adff-636a8c806696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a679fa6e-1793-4049-8dff-f4d03f21f41c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityAddressPostalZipCode_a679fa6e-1793-4049-8dff-f4d03f21f41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_56318cb3-0b52-41e6-a769-1655b094afe6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_CityAreaCode_56318cb3-0b52-41e6-a769-1655b094afe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f2d4ca9c-48d1-47af-b069-1ef11f49ec54" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_LocalPhoneNumber_f2d4ca9c-48d1-47af-b069-1ef11f49ec54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_027c2a30-c4a7-4eaf-9ca2-1f92ea28e4e3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_Security12bTitle_027c2a30-c4a7-4eaf-9ca2-1f92ea28e4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_5de257ad-fdeb-4cb1-aa62-428b3373bb0f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_TradingSymbol_5de257ad-fdeb-4cb1-aa62-428b3373bb0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d6b52d1b-6698-4998-94ca-9a135004c5bc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_SecurityExchangeName_d6b52d1b-6698-4998-94ca-9a135004c5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_ef8e64c4-6f54-4cac-a973-2601e80f7507" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityCurrentReportingStatus_ef8e64c4-6f54-4cac-a973-2601e80f7507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_24e2c3c4-f787-4607-935a-16098bff4cbd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityInteractiveDataCurrent_24e2c3c4-f787-4607-935a-16098bff4cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_6fd1ebf9-1812-4eae-83dc-831773fd388d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityFilerCategory_6fd1ebf9-1812-4eae-83dc-831773fd388d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_91470af9-8e6b-4385-be59-096386b38c8b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntitySmallBusiness_91470af9-8e6b-4385-be59-096386b38c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_b374d8e6-810b-4826-a1f1-c56b0e2b778f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityEmergingGrowthCompany_b374d8e6-810b-4826-a1f1-c56b0e2b778f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_491a9337-9e75-4fea-a351-5e4437ba8875" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityShellCompany_491a9337-9e75-4fea-a351-5e4437ba8875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_9259086c-ac17-41ed-9e67-d31fbc16e368" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_9259086c-ac17-41ed-9e67-d31fbc16e368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_40846a1f-e05c-41d8-b60c-004efb8bdc62" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_AmendmentFlag_40846a1f-e05c-41d8-b60c-004efb8bdc62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_996c773d-1d85-438b-bc3e-8d801dcd4a34" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_DocumentFiscalYearFocus_996c773d-1d85-438b-bc3e-8d801dcd4a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_e3e8e315-d7aa-4083-ae72-34cbbdbab916" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_DocumentFiscalPeriodFocus_e3e8e315-d7aa-4083-ae72-34cbbdbab916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_37f0a954-547a-48dd-85c9-8394267dec63" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_EntityCentralIndexKey_37f0a954-547a-48dd-85c9-8394267dec63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_0b223b06-c3a1-4a00-858f-36ccfcd489cd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_89aa2061-3ba0-4e8a-979c-db960bae1028" xlink:to="loc_dei_CurrentFiscalYearEndDate_0b223b06-c3a1-4a00-858f-36ccfcd489cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="simple" xlink:href="bax-20220331.xsd#CondensedConsolidatedBalanceSheetsunaudited"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_17571131-7c6f-4720-bd62-bf6cb824df48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_36037a2d-b92c-491e-b8e1-f2132fe70e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17571131-7c6f-4720-bd62-bf6cb824df48" xlink:to="loc_us-gaap_AssetsCurrentAbstract_36037a2d-b92c-491e-b8e1-f2132fe70e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_912f8d64-0bb4-42ca-ba46-3629c1f3d578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_36037a2d-b92c-491e-b8e1-f2132fe70e35" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_912f8d64-0bb4-42ca-ba46-3629c1f3d578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_fb605243-3ef5-4128-aa73-56f80d5d94ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_36037a2d-b92c-491e-b8e1-f2132fe70e35" xlink:to="loc_us-gaap_AccountsAndOtherReceivablesNetCurrent_fb605243-3ef5-4128-aa73-56f80d5d94ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e7d064b7-13ad-45d0-9772-958e9e4e1e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_36037a2d-b92c-491e-b8e1-f2132fe70e35" xlink:to="loc_us-gaap_InventoryNet_e7d064b7-13ad-45d0-9772-958e9e4e1e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4c66a541-2981-4e05-a73e-918edb3b21a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_36037a2d-b92c-491e-b8e1-f2132fe70e35" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4c66a541-2981-4e05-a73e-918edb3b21a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_162e4448-4d4a-4d67-a29a-98f18880b262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_36037a2d-b92c-491e-b8e1-f2132fe70e35" xlink:to="loc_us-gaap_AssetsCurrent_162e4448-4d4a-4d67-a29a-98f18880b262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_33fa6e90-b39e-4a3e-aa53-7097253d77b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17571131-7c6f-4720-bd62-bf6cb824df48" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_33fa6e90-b39e-4a3e-aa53-7097253d77b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_409cffb6-59d9-4264-8090-788eadd27ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17571131-7c6f-4720-bd62-bf6cb824df48" xlink:to="loc_us-gaap_Goodwill_409cffb6-59d9-4264-8090-788eadd27ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_16adab4a-0cf8-40e7-bf61-460268c48ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17571131-7c6f-4720-bd62-bf6cb824df48" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_16adab4a-0cf8-40e7-bf61-460268c48ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_cdecadad-9ac3-48a7-9815-58f38ca5ac0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17571131-7c6f-4720-bd62-bf6cb824df48" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_cdecadad-9ac3-48a7-9815-58f38ca5ac0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d5e71646-8e93-4956-9566-97489257c389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17571131-7c6f-4720-bd62-bf6cb824df48" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d5e71646-8e93-4956-9566-97489257c389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1e30a706-ff2c-45bf-b247-112c0aeb6f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17571131-7c6f-4720-bd62-bf6cb824df48" xlink:to="loc_us-gaap_Assets_1e30a706-ff2c-45bf-b247-112c0aeb6f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_59099802-e57f-46df-a5d7-c36fea7ccd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17571131-7c6f-4720-bd62-bf6cb824df48" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_59099802-e57f-46df-a5d7-c36fea7ccd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_3f8e2c92-be33-46e8-96fa-c96de053c436" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_59099802-e57f-46df-a5d7-c36fea7ccd4d" xlink:to="loc_us-gaap_ShortTermBorrowings_3f8e2c92-be33-46e8-96fa-c96de053c436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d806d5a8-8c76-4299-96b7-7cf97694eec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_59099802-e57f-46df-a5d7-c36fea7ccd4d" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d806d5a8-8c76-4299-96b7-7cf97694eec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ea75a880-1675-4e40-9f60-9d32f79e61d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_59099802-e57f-46df-a5d7-c36fea7ccd4d" xlink:to="loc_us-gaap_AccountsPayableCurrent_ea75a880-1675-4e40-9f60-9d32f79e61d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_886b3ce2-d5e4-4e63-ab69-0f67eaf89024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_59099802-e57f-46df-a5d7-c36fea7ccd4d" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_886b3ce2-d5e4-4e63-ab69-0f67eaf89024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_08fe9117-bbff-4995-b93b-b807c6f6a831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_59099802-e57f-46df-a5d7-c36fea7ccd4d" xlink:to="loc_us-gaap_LiabilitiesCurrent_08fe9117-bbff-4995-b93b-b807c6f6a831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_d79961b1-386f-42d8-b67c-49377a16d301" xlink:href="bax-20220331.xsd#bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17571131-7c6f-4720-bd62-bf6cb824df48" xlink:to="loc_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent_d79961b1-386f-42d8-b67c-49377a16d301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9020d9ce-f000-475e-8d2f-5e834d29d9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17571131-7c6f-4720-bd62-bf6cb824df48" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9020d9ce-f000-475e-8d2f-5e834d29d9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_cff0ff40-7815-4251-8498-f0a805cadc33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17571131-7c6f-4720-bd62-bf6cb824df48" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_cff0ff40-7815-4251-8498-f0a805cadc33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_bbaade77-4c9e-4855-9cee-495c3d40eca3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17571131-7c6f-4720-bd62-bf6cb824df48" xlink:to="loc_us-gaap_Liabilities_bbaade77-4c9e-4855-9cee-495c3d40eca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_1afbe6c1-113b-4ed7-9073-26ade7cf52e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17571131-7c6f-4720-bd62-bf6cb824df48" xlink:to="loc_us-gaap_CommitmentsAndContingencies_1afbe6c1-113b-4ed7-9073-26ade7cf52e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_beaf0daa-6d6e-4f0c-94ca-e4218cd745e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17571131-7c6f-4720-bd62-bf6cb824df48" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_beaf0daa-6d6e-4f0c-94ca-e4218cd745e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0472d1ea-c2b3-465b-b5a4-1ef99036c425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_beaf0daa-6d6e-4f0c-94ca-e4218cd745e2" xlink:to="loc_us-gaap_CommonStockValue_0472d1ea-c2b3-465b-b5a4-1ef99036c425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_2bff8cf4-e5cb-4735-8e57-09d2f9983883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_beaf0daa-6d6e-4f0c-94ca-e4218cd745e2" xlink:to="loc_us-gaap_TreasuryStockValue_2bff8cf4-e5cb-4735-8e57-09d2f9983883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0617bd7e-a262-4a2f-aa65-b6489b11f667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_beaf0daa-6d6e-4f0c-94ca-e4218cd745e2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_0617bd7e-a262-4a2f-aa65-b6489b11f667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_01e48c59-0f5e-4899-8469-8bf49f05ef73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_beaf0daa-6d6e-4f0c-94ca-e4218cd745e2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_01e48c59-0f5e-4899-8469-8bf49f05ef73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_124bff4d-62c9-47d3-b547-8ddb6886e1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_beaf0daa-6d6e-4f0c-94ca-e4218cd745e2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_124bff4d-62c9-47d3-b547-8ddb6886e1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_39f4ec2a-3835-4c68-95d2-3ed79fc85ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_beaf0daa-6d6e-4f0c-94ca-e4218cd745e2" xlink:to="loc_us-gaap_StockholdersEquity_39f4ec2a-3835-4c68-95d2-3ed79fc85ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d6f0670a-7e99-4aed-97e7-e2c8d8789137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_beaf0daa-6d6e-4f0c-94ca-e4218cd745e2" xlink:to="loc_us-gaap_MinorityInterest_d6f0670a-7e99-4aed-97e7-e2c8d8789137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_41236cdc-9ead-4213-a102-b6c6d34522bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_beaf0daa-6d6e-4f0c-94ca-e4218cd745e2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_41236cdc-9ead-4213-a102-b6c6d34522bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f3d2e184-ddfa-452d-af0d-630c94211c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17571131-7c6f-4720-bd62-bf6cb824df48" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_f3d2e184-ddfa-452d-af0d-630c94211c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="simple" xlink:href="bax-20220331.xsd#CondensedConsolidatedBalanceSheetsunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2cdd3b3b-123b-43cc-a1e7-8cc32c69d716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_792bf522-1e4b-4723-a229-d2b27fc98b73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2cdd3b3b-123b-43cc-a1e7-8cc32c69d716" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_792bf522-1e4b-4723-a229-d2b27fc98b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_e30b500e-4e6a-42d2-a90b-ced617d7b029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2cdd3b3b-123b-43cc-a1e7-8cc32c69d716" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_e30b500e-4e6a-42d2-a90b-ced617d7b029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_d0385821-099f-4577-a201-4a3ce6d84ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2cdd3b3b-123b-43cc-a1e7-8cc32c69d716" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_d0385821-099f-4577-a201-4a3ce6d84ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_daed3672-3c4b-4ebb-b8ff-1a8cc58edb09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2cdd3b3b-123b-43cc-a1e7-8cc32c69d716" xlink:to="loc_us-gaap_CommonStockSharesIssued_daed3672-3c4b-4ebb-b8ff-1a8cc58edb09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_43261ace-60d9-407a-936c-62d98e55f59a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2cdd3b3b-123b-43cc-a1e7-8cc32c69d716" xlink:to="loc_us-gaap_TreasuryStockShares_43261ace-60d9-407a-936c-62d98e55f59a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited" xlink:type="simple" xlink:href="bax-20220331.xsd#CondensedConsolidatedStatementsofIncomeunaudited"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1cadf981-6c6a-4be6-bb05-0afb8ff72b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1cadf981-6c6a-4be6-bb05-0afb8ff72b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_bc275d94-8268-4c80-9c17-074b54373222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_bc275d94-8268-4c80-9c17-074b54373222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_9981390f-3c48-41b9-87e7-d5a843d2dd23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:to="loc_us-gaap_GrossProfit_9981390f-3c48-41b9-87e7-d5a843d2dd23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3bd76661-3ec2-4505-a4e8-95a62bb89912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3bd76661-3ec2-4505-a4e8-95a62bb89912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_e55a5bde-e725-467b-bb4d-2046e13c2aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_e55a5bde-e725-467b-bb4d-2046e13c2aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_25ad3439-fbc3-4780-bf4b-5d41c498dc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_25ad3439-fbc3-4780-bf4b-5d41c498dc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9f151a34-7695-4899-bf63-b7c71ba91a03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:to="loc_us-gaap_OperatingIncomeLoss_9f151a34-7695-4899-bf63-b7c71ba91a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_a0be780d-dde4-4e1b-a7d2-6a540a9a403a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_a0be780d-dde4-4e1b-a7d2-6a540a9a403a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_527d8db0-fb5b-441a-aad4-a821c2066cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_527d8db0-fb5b-441a-aad4-a821c2066cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b1e120cb-c53d-45b0-9708-84926db5b4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b1e120cb-c53d-45b0-9708-84926db5b4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_798b6c13-89ac-4c9e-a9d6-22b28c7a0968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_798b6c13-89ac-4c9e-a9d6-22b28c7a0968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_23eaf1ec-5a45-4558-bfde-f08c61e8e7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:to="loc_us-gaap_ProfitLoss_23eaf1ec-5a45-4558-bfde-f08c61e8e7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0f9569ba-0d4a-4aa0-aea7-f5d5ececfa89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0f9569ba-0d4a-4aa0-aea7-f5d5ececfa89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3c0e7121-9418-40aa-b970-db9ad272e0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:to="loc_us-gaap_NetIncomeLoss_3c0e7121-9418-40aa-b970-db9ad272e0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_dde7937e-628e-4da0-8d3e-a4ec2ef64448" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:to="loc_us-gaap_EarningsPerShareAbstract_dde7937e-628e-4da0-8d3e-a4ec2ef64448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_add55b97-5c3f-46df-9564-353b85f3b43d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dde7937e-628e-4da0-8d3e-a4ec2ef64448" xlink:to="loc_us-gaap_EarningsPerShareBasic_add55b97-5c3f-46df-9564-353b85f3b43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b3477de5-a8a9-4335-be09-35616c5f51eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dde7937e-628e-4da0-8d3e-a4ec2ef64448" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b3477de5-a8a9-4335-be09-35616c5f51eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_860bc373-af32-43c7-aad8-12dda6a28ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fd1e4776-97cc-4e3c-99ee-e43fe4290690" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_860bc373-af32-43c7-aad8-12dda6a28ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9f64f4fb-9a12-4f00-bce0-3e6f1c6e8fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_860bc373-af32-43c7-aad8-12dda6a28ed4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9f64f4fb-9a12-4f00-bce0-3e6f1c6e8fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7c4338d3-9979-4715-b231-bc0554c8c48d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_860bc373-af32-43c7-aad8-12dda6a28ed4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7c4338d3-9979-4715-b231-bc0554c8c48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited" xlink:type="simple" xlink:href="bax-20220331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b9acd084-2538-4d1a-83e9-64aa57332d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bb739785-3fd0-4edc-9f66-a092b1531814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b9acd084-2538-4d1a-83e9-64aa57332d3a" xlink:to="loc_us-gaap_ProfitLoss_bb739785-3fd0-4edc-9f66-a092b1531814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b969cfd9-477e-4b0d-9210-6d4ea1fd7ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b9acd084-2538-4d1a-83e9-64aa57332d3a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b969cfd9-477e-4b0d-9210-6d4ea1fd7ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_568644ea-118e-450e-9fd3-a6f02426c177" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b969cfd9-477e-4b0d-9210-6d4ea1fd7ff1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_568644ea-118e-450e-9fd3-a6f02426c177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_986c9df6-3b4d-445f-b4ad-2195c17d6925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b969cfd9-477e-4b0d-9210-6d4ea1fd7ff1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_986c9df6-3b4d-445f-b4ad-2195c17d6925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7ccd3e8d-1ce5-4aaf-a8cd-d00f38a20d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b969cfd9-477e-4b0d-9210-6d4ea1fd7ff1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7ccd3e8d-1ce5-4aaf-a8cd-d00f38a20d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_30c28267-5315-4b27-935c-d4511f37f64e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b969cfd9-477e-4b0d-9210-6d4ea1fd7ff1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_30c28267-5315-4b27-935c-d4511f37f64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_21f80c44-4b7c-4a3f-9f5b-269fb9e8c83a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b969cfd9-477e-4b0d-9210-6d4ea1fd7ff1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_21f80c44-4b7c-4a3f-9f5b-269fb9e8c83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ebf71a1c-39f0-4453-b76a-e98cb4bc9cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b9acd084-2538-4d1a-83e9-64aa57332d3a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ebf71a1c-39f0-4453-b76a-e98cb4bc9cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_90075445-db09-411e-a17c-2064d60163d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b9acd084-2538-4d1a-83e9-64aa57332d3a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_90075445-db09-411e-a17c-2064d60163d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ab47520c-322a-4d91-a7e4-541cc9bc5513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b9acd084-2538-4d1a-83e9-64aa57332d3a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_ab47520c-322a-4d91-a7e4-541cc9bc5513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical" xlink:type="simple" xlink:href="bax-20220331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2a319c70-8f82-4977-b9ca-b6de94f98be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_5db7470e-13dc-429c-a674-b5a7c8efbbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2a319c70-8f82-4977-b9ca-b6de94f98be2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_5db7470e-13dc-429c-a674-b5a7c8efbbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_0b0704ee-cdc5-4578-8eba-ed05a24873c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2a319c70-8f82-4977-b9ca-b6de94f98be2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_0b0704ee-cdc5-4578-8eba-ed05a24873c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_431a1831-0af9-4e66-ac14-8137d8c816e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2a319c70-8f82-4977-b9ca-b6de94f98be2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_431a1831-0af9-4e66-ac14-8137d8c816e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax_bbec2902-c61d-4fa6-adc8-b573c66bab4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2a319c70-8f82-4977-b9ca-b6de94f98be2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax_bbec2902-c61d-4fa6-adc8-b573c66bab4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited" xlink:type="simple" xlink:href="bax-20220331.xsd#CondensedConsolidatedStatementsofChangesinEquityunaudited"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_105eb1b4-f9cc-4e28-945e-51a1821f42eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d4b4df5d-7c21-402d-ab77-7f02fd271696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_105eb1b4-f9cc-4e28-945e-51a1821f42eb" xlink:to="loc_us-gaap_StatementTable_d4b4df5d-7c21-402d-ab77-7f02fd271696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f1be9c21-42ab-4642-ba78-63fb4075f250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d4b4df5d-7c21-402d-ab77-7f02fd271696" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f1be9c21-42ab-4642-ba78-63fb4075f250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_956e84bd-6e59-43b7-a11c-435122b1918e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f1be9c21-42ab-4642-ba78-63fb4075f250" xlink:to="loc_us-gaap_EquityComponentDomain_956e84bd-6e59-43b7-a11c-435122b1918e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_3b08009b-4ef3-4b54-be46-aa4c7340fba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_956e84bd-6e59-43b7-a11c-435122b1918e" xlink:to="loc_us-gaap_ParentMember_3b08009b-4ef3-4b54-be46-aa4c7340fba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2b378209-e73c-4082-839f-cb03d7aa14ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_3b08009b-4ef3-4b54-be46-aa4c7340fba9" xlink:to="loc_us-gaap_CommonStockMember_2b378209-e73c-4082-839f-cb03d7aa14ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_3660238b-6188-4796-a9aa-c67b5f15ac1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_3b08009b-4ef3-4b54-be46-aa4c7340fba9" xlink:to="loc_us-gaap_TreasuryStockMember_3660238b-6188-4796-a9aa-c67b5f15ac1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_42fd3f73-1971-41ec-89a0-d9b8c366b71d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_3b08009b-4ef3-4b54-be46-aa4c7340fba9" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_42fd3f73-1971-41ec-89a0-d9b8c366b71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_dd2b1866-8873-44e7-9615-b8b74e01995e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_3b08009b-4ef3-4b54-be46-aa4c7340fba9" xlink:to="loc_us-gaap_RetainedEarningsMember_dd2b1866-8873-44e7-9615-b8b74e01995e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_685f3e7b-695a-43c1-a4d7-0b1bf3711c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_3b08009b-4ef3-4b54-be46-aa4c7340fba9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_685f3e7b-695a-43c1-a4d7-0b1bf3711c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_94405329-beca-4657-9ac1-c203c8450658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_956e84bd-6e59-43b7-a11c-435122b1918e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_94405329-beca-4657-9ac1-c203c8450658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_af0cd874-8d82-4f4b-b710-ee3f9816a6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d4b4df5d-7c21-402d-ab77-7f02fd271696" xlink:to="loc_us-gaap_StatementLineItems_af0cd874-8d82-4f4b-b710-ee3f9816a6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_af0cd874-8d82-4f4b-b710-ee3f9816a6c2" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_052349ef-6ab6-4d23-bd65-4e0cb4104922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_CommonStockSharesIssued_052349ef-6ab6-4d23-bd65-4e0cb4104922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6869321e-6189-404e-838b-03d47db83e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6869321e-6189-404e-838b-03d47db83e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_42ec06f9-1bd2-408f-b196-3746dc0ec491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_TreasuryStockShares_42ec06f9-1bd2-408f-b196-3746dc0ec491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1a4cbfa6-1d9e-498e-8cf7-d6c03492a613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_ProfitLoss_1a4cbfa6-1d9e-498e-8cf7-d6c03492a613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_eaf5a039-7cad-4da9-8722-1ed86ff6b881" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_eaf5a039-7cad-4da9-8722-1ed86ff6b881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_8aad48f9-4b29-4210-807c-e6a6e4b636e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_8aad48f9-4b29-4210-807c-e6a6e4b636e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_684683b5-968d-4b0f-bb44-28518deed0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_684683b5-968d-4b0f-bb44-28518deed0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2c8abe6c-d011-438b-a283-397e8ae9b2af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2c8abe6c-d011-438b-a283-397e8ae9b2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_375f0306-e1b2-4c51-bb99-507ef6ce4dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_375f0306-e1b2-4c51-bb99-507ef6ce4dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_eb5b807e-e412-4d4b-9180-56219331c397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_DividendsCommonStock_eb5b807e-e412-4d4b-9180-56219331c397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_02e89dfe-c46f-4848-b421-f4dceed7d892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_02e89dfe-c46f-4848-b421-f4dceed7d892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_5486c73a-9206-419f-a603-c85e303e9c81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_CommonStockSharesIssued_5486c73a-9206-419f-a603-c85e303e9c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_40851ef8-ac6d-4b48-80a9-a8a944c38cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_40851ef8-ac6d-4b48-80a9-a8a944c38cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_d0fb22b4-c80c-48cb-a649-372b285a4aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4b93f31a-958a-4f15-af3e-bd4e28f65d38" xlink:to="loc_us-gaap_TreasuryStockShares_d0fb22b4-c80c-48cb-a649-372b285a4aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="bax-20220331.xsd#CondensedConsolidatedStatementsofCashFlowsunaudited"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_6b314650-9f31-4bc2-9dd1-28f49e57b44b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_78b72f13-1175-433d-9859-f6092174f79c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6b314650-9f31-4bc2-9dd1-28f49e57b44b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_78b72f13-1175-433d-9859-f6092174f79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0df46838-b1e4-4212-8a52-776d4237f3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_78b72f13-1175-433d-9859-f6092174f79c" xlink:to="loc_us-gaap_ProfitLoss_0df46838-b1e4-4212-8a52-776d4237f3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2a308ae-d53e-4ff6-9e7c-864f9e55df23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_78b72f13-1175-433d-9859-f6092174f79c" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2a308ae-d53e-4ff6-9e7c-864f9e55df23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3b74ae89-0f41-4f57-b172-d43661c0d628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2a308ae-d53e-4ff6-9e7c-864f9e55df23" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3b74ae89-0f41-4f57-b172-d43661c0d628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_4253d70c-ffae-40c2-aee1-23c9652f0cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2a308ae-d53e-4ff6-9e7c-864f9e55df23" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_4253d70c-ffae-40c2-aee1-23c9652f0cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8a6b667c-ed9b-47c7-9012-423c234b8899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2a308ae-d53e-4ff6-9e7c-864f9e55df23" xlink:to="loc_us-gaap_ShareBasedCompensation_8a6b667c-ed9b-47c7-9012-423c234b8899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_9e49e844-6cc4-4e45-8ce1-3f03b5c2d883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2a308ae-d53e-4ff6-9e7c-864f9e55df23" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_9e49e844-6cc4-4e45-8ce1-3f03b5c2d883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_47c871d7-2678-47b1-aab0-07c089b5864d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2a308ae-d53e-4ff6-9e7c-864f9e55df23" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_47c871d7-2678-47b1-aab0-07c089b5864d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e60c4825-5719-4db6-8629-d9fa16a673c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b2a308ae-d53e-4ff6-9e7c-864f9e55df23" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e60c4825-5719-4db6-8629-d9fa16a673c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_bbc7dd87-f12b-430f-b94b-d67a1ad33f42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e60c4825-5719-4db6-8629-d9fa16a673c1" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_bbc7dd87-f12b-430f-b94b-d67a1ad33f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b623824d-422b-4f6e-b558-1f26176dc5af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e60c4825-5719-4db6-8629-d9fa16a673c1" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b623824d-422b-4f6e-b558-1f26176dc5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_95cadbdb-35a9-44e5-98d7-c40a7ce5ac3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e60c4825-5719-4db6-8629-d9fa16a673c1" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_95cadbdb-35a9-44e5-98d7-c40a7ce5ac3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e44a0f16-9494-4c9e-b611-8da96955947f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e60c4825-5719-4db6-8629-d9fa16a673c1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e44a0f16-9494-4c9e-b611-8da96955947f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_bce7efe4-dca7-4f9e-8932-192856c42531" xlink:href="bax-20220331.xsd#bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e60c4825-5719-4db6-8629-d9fa16a673c1" xlink:to="loc_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_bce7efe4-dca7-4f9e-8932-192856c42531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_418ed97c-17cd-4880-9601-336da22f5a54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e60c4825-5719-4db6-8629-d9fa16a673c1" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_418ed97c-17cd-4880-9601-336da22f5a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3320275-bf71-4d73-a96a-8c37064bee3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_78b72f13-1175-433d-9859-f6092174f79c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3320275-bf71-4d73-a96a-8c37064bee3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_628c3a08-05df-4599-aca6-c8dcc5246b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6b314650-9f31-4bc2-9dd1-28f49e57b44b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_628c3a08-05df-4599-aca6-c8dcc5246b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_6f9377ce-425f-43db-aaa1-05c514e21041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_628c3a08-05df-4599-aca6-c8dcc5246b6b" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_6f9377ce-425f-43db-aaa1-05c514e21041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_23b89818-eb02-4428-963f-f0fb1d10fbe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_628c3a08-05df-4599-aca6-c8dcc5246b6b" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_23b89818-eb02-4428-963f-f0fb1d10fbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_7250795f-cf0e-45f9-af22-e2209aecc2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_628c3a08-05df-4599-aca6-c8dcc5246b6b" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_7250795f-cf0e-45f9-af22-e2209aecc2b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3d7135fc-3eb5-49b3-8dad-5c06f6d0a4af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_628c3a08-05df-4599-aca6-c8dcc5246b6b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3d7135fc-3eb5-49b3-8dad-5c06f6d0a4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_edb1e64b-9f45-4cc0-a16d-5e96e6273d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6b314650-9f31-4bc2-9dd1-28f49e57b44b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_edb1e64b-9f45-4cc0-a16d-5e96e6273d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_282003ba-968f-4a7c-84b1-fdf97d86a3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_edb1e64b-9f45-4cc0-a16d-5e96e6273d7c" xlink:to="loc_us-gaap_RepaymentsOfDebt_282003ba-968f-4a7c-84b1-fdf97d86a3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_1e773c32-60e9-40d1-8b24-2cfc403599ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_edb1e64b-9f45-4cc0-a16d-5e96e6273d7c" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_1e773c32-60e9-40d1-8b24-2cfc403599ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_ae933240-d4c7-4e21-b33c-03f88157c46d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_edb1e64b-9f45-4cc0-a16d-5e96e6273d7c" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_ae933240-d4c7-4e21-b33c-03f88157c46d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_678448ff-77bb-4b38-b942-c72d5275f6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_edb1e64b-9f45-4cc0-a16d-5e96e6273d7c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_678448ff-77bb-4b38-b942-c72d5275f6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9ff4728f-229c-4316-9326-7f5e96325ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_edb1e64b-9f45-4cc0-a16d-5e96e6273d7c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9ff4728f-229c-4316-9326-7f5e96325ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_350d517d-af27-491e-9f5f-539343cec8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_edb1e64b-9f45-4cc0-a16d-5e96e6273d7c" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_350d517d-af27-491e-9f5f-539343cec8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_755cf21f-9601-4a79-814f-915ef1cf961b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_edb1e64b-9f45-4cc0-a16d-5e96e6273d7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_755cf21f-9601-4a79-814f-915ef1cf961b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_cb4c1d66-ae0a-4b14-98d3-d4cf99e27fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6b314650-9f31-4bc2-9dd1-28f49e57b44b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_cb4c1d66-ae0a-4b14-98d3-d4cf99e27fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_994d9546-46f1-42b1-9790-011e5d86875c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6b314650-9f31-4bc2-9dd1-28f49e57b44b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_994d9546-46f1-42b1-9790-011e5d86875c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_919db57f-07d8-4f21-8532-f04cf92af30a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6b314650-9f31-4bc2-9dd1-28f49e57b44b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_919db57f-07d8-4f21-8532-f04cf92af30a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_319ac7d4-ca4c-4609-a72c-1919b8691209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6b314650-9f31-4bc2-9dd1-28f49e57b44b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_319ac7d4-ca4c-4609-a72c-1919b8691209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_45c2a25f-6684-438c-9e0c-8200aa453dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6b314650-9f31-4bc2-9dd1-28f49e57b44b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_45c2a25f-6684-438c-9e0c-8200aa453dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_2c7e188c-c869-4607-8ead-45b06323a796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6b314650-9f31-4bc2-9dd1-28f49e57b44b" xlink:to="loc_us-gaap_RestrictedCash_2c7e188c-c869-4607-8ead-45b06323a796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BASISOFPRESENTATION" xlink:type="simple" xlink:href="bax-20220331.xsd#BASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_043c120f-1d1c-4d65-815f-a06e6c83ef2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_c5e5681b-de34-44a5-8cce-31bc27b454e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_043c120f-1d1c-4d65-815f-a06e6c83ef2d" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_c5e5681b-de34-44a5-8cce-31bc27b454e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BASISOFPRESENTATIONPolicies" xlink:type="simple" xlink:href="bax-20220331.xsd#BASISOFPRESENTATIONPolicies"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BASISOFPRESENTATIONPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a21c2f07-f5d2-49b3-899b-f34257d134c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_98091971-61df-4ce9-b598-6a20fd1e4505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a21c2f07-f5d2-49b3-899b-f34257d134c7" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_98091971-61df-4ce9-b598-6a20fd1e4505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RisksAndUncertaintiesPolicyPolicyTextBlock_b64b8615-fb28-4ae5-806e-9f7284d1ef25" xlink:href="bax-20220331.xsd#bax_RisksAndUncertaintiesPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a21c2f07-f5d2-49b3-899b-f34257d134c7" xlink:to="loc_bax_RisksAndUncertaintiesPolicyPolicyTextBlock_b64b8615-fb28-4ae5-806e-9f7284d1ef25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a3590c81-1001-43ab-8a14-726ea5d6e3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a21c2f07-f5d2-49b3-899b-f34257d134c7" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a3590c81-1001-43ab-8a14-726ea5d6e3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTS" xlink:type="simple" xlink:href="bax-20220331.xsd#ACQUISITIONSANDOTHERARRANGEMENTS"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_07726de3-a776-485b-841b-6f9bf2c4008d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_b124611b-49ca-4a0a-bbae-f4b65dd39554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_07726de3-a776-485b-841b-6f9bf2c4008d" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_b124611b-49ca-4a0a-bbae-f4b65dd39554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSTables" xlink:type="simple" xlink:href="bax-20220331.xsd#ACQUISITIONSANDOTHERARRANGEMENTSTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b7f5059d-6381-4ebd-8ecb-09e90005d6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_80d9ce54-03ad-4ade-a99e-4a0e235ca63f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b7f5059d-6381-4ebd-8ecb-09e90005d6fd" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_80d9ce54-03ad-4ade-a99e-4a0e235ca63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_91dd8bdf-620b-4aab-affc-ecdb8c106a80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b7f5059d-6381-4ebd-8ecb-09e90005d6fd" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_91dd8bdf-620b-4aab-affc-ecdb8c106a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_18dcca20-b65b-4853-ad91-18aef6c05fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d20a408e-fcfe-4162-82b8-57d1314cbd48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_18dcca20-b65b-4853-ad91-18aef6c05fa2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d20a408e-fcfe-4162-82b8-57d1314cbd48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cefaaa53-8862-48f4-8d0c-54412e323726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d20a408e-fcfe-4162-82b8-57d1314cbd48" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cefaaa53-8862-48f4-8d0c-54412e323726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_db3c84a2-7b04-4944-82aa-33d6f211c811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cefaaa53-8862-48f4-8d0c-54412e323726" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_db3c84a2-7b04-4944-82aa-33d6f211c811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_abac39a3-30ce-4813-b37b-2ea8ba7016f2" xlink:href="bax-20220331.xsd#bax_HillromMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_db3c84a2-7b04-4944-82aa-33d6f211c811" xlink:to="loc_bax_HillromMember_abac39a3-30ce-4813-b37b-2ea8ba7016f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ZosynMember_d7de1a8a-4053-4b19-829d-b7c684579ecc" xlink:href="bax-20220331.xsd#bax_ZosynMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_db3c84a2-7b04-4944-82aa-33d6f211c811" xlink:to="loc_bax_ZosynMember_d7de1a8a-4053-4b19-829d-b7c684579ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d20a408e-fcfe-4162-82b8-57d1314cbd48" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationCashConsideration_f95e1092-6f75-4c57-b9fa-b05f5666f569" xlink:href="bax-20220331.xsd#bax_BusinessCombinationCashConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_bax_BusinessCombinationCashConsideration_f95e1092-6f75-4c57-b9fa-b05f5666f569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations_e4b33102-08c3-4a7d-b3c9-821b686288f4" xlink:href="bax-20220331.xsd#bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations_e4b33102-08c3-4a7d-b3c9-821b686288f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_7ed0672f-0abd-41fb-9cc1-97efda2fb6df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_7ed0672f-0abd-41fb-9cc1-97efda2fb6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_7452faf7-9070-4253-b52a-2eab92887d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_7452faf7-9070-4253-b52a-2eab92887d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_be30ec57-adfc-4388-9c08-46b4f4bdb93b" xlink:href="bax-20220331.xsd#bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_be30ec57-adfc-4388-9c08-46b4f4bdb93b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed_3f54cd5a-c8d4-456f-b4ee-fd46fdfea75f" xlink:href="bax-20220331.xsd#bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed_3f54cd5a-c8d4-456f-b4ee-fd46fdfea75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_5a83757b-1bf6-4aed-aab5-bc95e4668e95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_5a83757b-1bf6-4aed-aab5-bc95e4668e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_0e453b4a-13f6-4df8-90d2-77d7f1faf575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_58f62b0d-58f8-45fb-a013-0d1d6529551c" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_0e453b4a-13f6-4df8-90d2-77d7f1faf575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0d3c79f9-86d3-413a-8933-8b1cabaffe8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsTable_69fb80ee-6263-4174-ab62-7b99c2615dfe" xlink:href="bax-20220331.xsd#bax_AcquisitionsAndCollaborationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0d3c79f9-86d3-413a-8933-8b1cabaffe8e" xlink:to="loc_bax_AcquisitionsAndCollaborationsTable_69fb80ee-6263-4174-ab62-7b99c2615dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ba11fd5f-3c21-4a8a-9ffb-d66463837ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsTable_69fb80ee-6263-4174-ab62-7b99c2615dfe" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ba11fd5f-3c21-4a8a-9ffb-d66463837ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7334044-29a9-4c29-879e-531ca6dcae68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ba11fd5f-3c21-4a8a-9ffb-d66463837ba0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7334044-29a9-4c29-879e-531ca6dcae68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_fcf86243-aeca-47af-8357-0d73facbbf5e" xlink:href="bax-20220331.xsd#bax_HillromMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7334044-29a9-4c29-879e-531ca6dcae68" xlink:to="loc_bax_HillromMember_fcf86243-aeca-47af-8357-0d73facbbf5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsLineItems_f661679f-6e81-4ae6-9c25-5e033e484da1" xlink:href="bax-20220331.xsd#bax_AcquisitionsAndCollaborationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsTable_69fb80ee-6263-4174-ab62-7b99c2615dfe" xlink:to="loc_bax_AcquisitionsAndCollaborationsLineItems_f661679f-6e81-4ae6-9c25-5e033e484da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_2b25ab33-e309-414c-9914-a9ee32ca6942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_f661679f-6e81-4ae6-9c25-5e033e484da1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_2b25ab33-e309-414c-9914-a9ee32ca6942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_cef3bd30-219f-4ad4-bfdd-5621046d6c34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_f661679f-6e81-4ae6-9c25-5e033e484da1" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_cef3bd30-219f-4ad4-bfdd-5621046d6c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_31a2386b-9093-4315-842e-83bcdfcdc4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_f661679f-6e81-4ae6-9c25-5e033e484da1" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_31a2386b-9093-4315-842e-83bcdfcdc4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_90a697dc-0987-4aef-894b-16ebf0420cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_f661679f-6e81-4ae6-9c25-5e033e484da1" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_90a697dc-0987-4aef-894b-16ebf0420cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_52cf3869-8686-4a92-ac0a-81bc3f4e7b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_f661679f-6e81-4ae6-9c25-5e033e484da1" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_52cf3869-8686-4a92-ac0a-81bc3f4e7b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_94392daa-1582-483b-8d79-69e80ab8cfc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsTable_46a609ff-bb2d-4c5c-b395-2a1651f5a28c" xlink:href="bax-20220331.xsd#bax_AcquisitionsAndCollaborationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_94392daa-1582-483b-8d79-69e80ab8cfc1" xlink:to="loc_bax_AcquisitionsAndCollaborationsTable_46a609ff-bb2d-4c5c-b395-2a1651f5a28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_45635a29-32f0-44f9-97fb-19b87622ad9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsTable_46a609ff-bb2d-4c5c-b395-2a1651f5a28c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_45635a29-32f0-44f9-97fb-19b87622ad9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8036b72b-25cf-416c-8250-dfe66d291538" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_45635a29-32f0-44f9-97fb-19b87622ad9f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8036b72b-25cf-416c-8250-dfe66d291538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_851c10d8-70c9-4a97-97fd-87e9c62ffdd3" xlink:href="bax-20220331.xsd#bax_HillromMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8036b72b-25cf-416c-8250-dfe66d291538" xlink:to="loc_bax_HillromMember_851c10d8-70c9-4a97-97fd-87e9c62ffdd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:href="bax-20220331.xsd#bax_AcquisitionsAndCollaborationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsTable_46a609ff-bb2d-4c5c-b395-2a1651f5a28c" xlink:to="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_aaeb29d5-63bf-4785-9e5e-9f7fd7c032d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_aaeb29d5-63bf-4785-9e5e-9f7fd7c032d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_0c15fbfb-da9b-4ce3-83c2-bffb94f8c1f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_0c15fbfb-da9b-4ce3-83c2-bffb94f8c1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c7450ca0-95ea-464a-af66-7237d2a503f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c7450ca0-95ea-464a-af66-7237d2a503f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0826f5c5-2aa4-4e3d-b62f-9905587e3988" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0826f5c5-2aa4-4e3d-b62f-9905587e3988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_552fd26c-9d4e-4aee-a40b-06bd2ef42503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_552fd26c-9d4e-4aee-a40b-06bd2ef42503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_72888df0-1d49-41f6-84a4-82430fbbb548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_Goodwill_72888df0-1d49-41f6-84a4-82430fbbb548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_af1d47aa-8775-41cb-bd74-68c8baf7b567" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_af1d47aa-8775-41cb-bd74-68c8baf7b567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_b80ddf56-6092-4123-83f0-2b396ac70a5a" xlink:href="bax-20220331.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_b80ddf56-6092-4123-83f0-2b396ac70a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8dbf6f39-585c-4373-8ee1-03b75e5175a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8dbf6f39-585c-4373-8ee1-03b75e5175a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_eaa023d8-e663-41b8-8e47-695001d86bf1" xlink:href="bax-20220331.xsd#bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt_eaa023d8-e663-41b8-8e47-695001d86bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_393970bf-0907-4ec5-a733-0fa11b83db45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_393970bf-0907-4ec5-a733-0fa11b83db45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_0254ec93-e93d-4461-abd4-735cee8c97b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_0254ec93-e93d-4461-abd4-735cee8c97b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_2c409f66-cc5e-4259-9829-f3986920a482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_2c409f66-cc5e-4259-9829-f3986920a482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_c6f3070e-35e0-4179-9e8d-e6ac6a336d59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_c6f3070e-35e0-4179-9e8d-e6ac6a336d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_79ff74db-2b17-4342-b05f-4a21ef85ab53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_79ff74db-2b17-4342-b05f-4a21ef85ab53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4277905b-03a6-4b77-a59e-e77fa1b1f762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_AcquisitionsAndCollaborationsLineItems_c1330820-6835-4353-8ff5-0d4504ce44a4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_4277905b-03a6-4b77-a59e-e77fa1b1f762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3a0d0721-a03c-4bda-aec8-fbbf1b994d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c7857fbe-a5e1-4c53-bb52-efd43474b969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3a0d0721-a03c-4bda-aec8-fbbf1b994d8c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c7857fbe-a5e1-4c53-bb52-efd43474b969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_95ca844f-b861-4859-9f08-c8232afdb976" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c7857fbe-a5e1-4c53-bb52-efd43474b969" xlink:to="loc_us-gaap_AssetAcquisitionAxis_95ca844f-b861-4859-9f08-c8232afdb976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_c17cd017-9d82-4f36-8d0b-fddbdd6f79c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_95ca844f-b861-4859-9f08-c8232afdb976" xlink:to="loc_us-gaap_AssetAcquisitionDomain_c17cd017-9d82-4f36-8d0b-fddbdd6f79c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ZosynMember_52a8db79-72f7-49ac-a69e-ea2f1eaf6b88" xlink:href="bax-20220331.xsd#bax_ZosynMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_c17cd017-9d82-4f36-8d0b-fddbdd6f79c0" xlink:to="loc_bax_ZosynMember_52a8db79-72f7-49ac-a69e-ea2f1eaf6b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9fe1118-4cf4-40e5-834c-a9b5b748361f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c7857fbe-a5e1-4c53-bb52-efd43474b969" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9fe1118-4cf4-40e5-834c-a9b5b748361f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_563aaef8-f2a8-40f6-a5d9-abef43920dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9fe1118-4cf4-40e5-834c-a9b5b748361f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_563aaef8-f2a8-40f6-a5d9-abef43920dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_c33b9e6c-bc8d-4a07-8309-2a8f4eeec5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_563aaef8-f2a8-40f6-a5d9-abef43920dc3" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_c33b9e6c-bc8d-4a07-8309-2a8f4eeec5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_7dd4d9d6-ce0f-4ae9-aa5d-29713e142e76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_563aaef8-f2a8-40f6-a5d9-abef43920dc3" xlink:to="loc_us-gaap_CustomerRelationshipsMember_7dd4d9d6-ce0f-4ae9-aa5d-29713e142e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_76256bbd-55a3-43ba-b972-f2740d963c53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c7857fbe-a5e1-4c53-bb52-efd43474b969" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_76256bbd-55a3-43ba-b972-f2740d963c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_066654c5-b671-4c60-a7be-b7001f03b338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76256bbd-55a3-43ba-b972-f2740d963c53" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_066654c5-b671-4c60-a7be-b7001f03b338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_da6d69cf-ecf2-4a37-ada6-19defbd6ba55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76256bbd-55a3-43ba-b972-f2740d963c53" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_da6d69cf-ecf2-4a37-ada6-19defbd6ba55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION" xlink:type="simple" xlink:href="bax-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATION"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b0c46740-66b4-4957-9308-27940b92393f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_126ff64e-38e6-4e5c-84ee-d844e3322a00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b0c46740-66b4-4957-9308-27940b92393f" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_126ff64e-38e6-4e5c-84ee-d844e3322a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables" xlink:type="simple" xlink:href="bax-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1f849a18-874c-4ab2-9011-01a13ab8f964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_b81b9022-42e9-4696-979b-f5a3eac64d57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1f849a18-874c-4ab2-9011-01a13ab8f964" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_b81b9022-42e9-4696-979b-f5a3eac64d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_ed3145ca-fa47-4571-8ff5-3d768eddceba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1f849a18-874c-4ab2-9011-01a13ab8f964" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_ed3145ca-fa47-4571-8ff5-3d768eddceba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_6d3dd9ff-133a-41d6-9c56-aef4d7ff2d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1f849a18-874c-4ab2-9011-01a13ab8f964" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_6d3dd9ff-133a-41d6-9c56-aef4d7ff2d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_d81c33a3-43bb-4cbb-bccc-ec5e09586a65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1f849a18-874c-4ab2-9011-01a13ab8f964" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_d81c33a3-43bb-4cbb-bccc-ec5e09586a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_7cf17f62-255b-4584-b200-a4947d7b8fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1f849a18-874c-4ab2-9011-01a13ab8f964" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_7cf17f62-255b-4584-b200-a4947d7b8fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e863898f-934b-485d-8913-ed59f3866a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_6a3146e7-4a95-4f2e-be22-6f7ec3e6d148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e863898f-934b-485d-8913-ed59f3866a9f" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_6a3146e7-4a95-4f2e-be22-6f7ec3e6d148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_331150d2-5040-40ac-b0b3-73351ce39f49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_6a3146e7-4a95-4f2e-be22-6f7ec3e6d148" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_331150d2-5040-40ac-b0b3-73351ce39f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_010ccdf1-c849-4b87-b895-fb5bbf11658a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_6a3146e7-4a95-4f2e-be22-6f7ec3e6d148" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_010ccdf1-c849-4b87-b895-fb5bbf11658a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_df801d78-02e5-4276-bd14-d81bb07722a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_6a3146e7-4a95-4f2e-be22-6f7ec3e6d148" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_df801d78-02e5-4276-bd14-d81bb07722a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments_c5291c7e-9cd3-4943-a42a-d8d25afdabac" xlink:href="bax-20220331.xsd#bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_6a3146e7-4a95-4f2e-be22-6f7ec3e6d148" xlink:to="loc_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments_c5291c7e-9cd3-4943-a42a-d8d25afdabac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_5409d4b4-01f0-4905-8c1e-861c0be41dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_6a3146e7-4a95-4f2e-be22-6f7ec3e6d148" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_5409d4b4-01f0-4905-8c1e-861c0be41dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c59532d2-1afd-4bea-8258-1ca9fe2609f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_56f2d12b-e753-4527-9a14-54305ec4e6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c59532d2-1afd-4bea-8258-1ca9fe2609f4" xlink:to="loc_us-gaap_InventoryRawMaterials_56f2d12b-e753-4527-9a14-54305ec4e6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_42bf6bb3-fc47-4637-a662-6eeb40a8f6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c59532d2-1afd-4bea-8258-1ca9fe2609f4" xlink:to="loc_us-gaap_InventoryWorkInProcess_42bf6bb3-fc47-4637-a662-6eeb40a8f6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_38f0b570-71cc-47a3-bec3-5df4200ed62e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c59532d2-1afd-4bea-8258-1ca9fe2609f4" xlink:to="loc_us-gaap_InventoryFinishedGoods_38f0b570-71cc-47a3-bec3-5df4200ed62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9c01c9ca-1f2b-4c09-aada-5662f696dc33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c59532d2-1afd-4bea-8258-1ca9fe2609f4" xlink:to="loc_us-gaap_InventoryNet_9c01c9ca-1f2b-4c09-aada-5662f696dc33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5b269c0c-7d6d-41ff-a109-9b310e596811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e81ccb3a-3eb5-4e0a-913d-9d83e1157b41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5b269c0c-7d6d-41ff-a109-9b310e596811" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e81ccb3a-3eb5-4e0a-913d-9d83e1157b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8f42bf16-c6c4-4d0c-93a9-861d4fbab56e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5b269c0c-7d6d-41ff-a109-9b310e596811" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8f42bf16-c6c4-4d0c-93a9-861d4fbab56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7acb9b2d-3442-48d1-bab5-86fb33f5f5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5b269c0c-7d6d-41ff-a109-9b310e596811" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7acb9b2d-3442-48d1-bab5-86fb33f5f5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3a88b231-a3f1-4990-b96a-c7d56c2b4d57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNetAbstract_474c733f-30c3-497a-bb5c-04d50a3b98ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3a88b231-a3f1-4990-b96a-c7d56c2b4d57" xlink:to="loc_us-gaap_InterestIncomeExpenseNetAbstract_474c733f-30c3-497a-bb5c-04d50a3b98ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e8df9e6e-04e7-4e82-ad11-4139d6ac9ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_474c733f-30c3-497a-bb5c-04d50a3b98ea" xlink:to="loc_us-gaap_InterestExpense_e8df9e6e-04e7-4e82-ad11-4139d6ac9ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_2d74c8c9-e00a-4ba9-8a4d-2002a53bb3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_474c733f-30c3-497a-bb5c-04d50a3b98ea" xlink:to="loc_us-gaap_InvestmentIncomeInterest_2d74c8c9-e00a-4ba9-8a4d-2002a53bb3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_6d7af4bd-e2b5-4713-926e-cf87dc905b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestIncomeExpenseNetAbstract_474c733f-30c3-497a-bb5c-04d50a3b98ea" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_6d7af4bd-e2b5-4713-926e-cf87dc905b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_21da3af2-0d70-4494-9f53-31adcb879044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3cc0dff3-a370-499d-a616-000d938527ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_21da3af2-0d70-4494-9f53-31adcb879044" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3cc0dff3-a370-499d-a616-000d938527ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_915ea15d-b533-432b-90af-18a892d5a21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3cc0dff3-a370-499d-a616-000d938527ce" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_915ea15d-b533-432b-90af-18a892d5a21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_c085a9cb-31a1-4af6-a4aa-c78657db6c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3cc0dff3-a370-499d-a616-000d938527ce" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitExpense_c085a9cb-31a1-4af6-a4aa-c78657db6c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingGainsLosses_dadc0e52-13bd-46e4-b7b4-1759b43a3797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3cc0dff3-a370-499d-a616-000d938527ce" xlink:to="loc_us-gaap_OtherNonoperatingGainsLosses_dadc0e52-13bd-46e4-b7b4-1759b43a3797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_36e06f32-4a0b-4abf-9895-c85027fa6d86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_3cc0dff3-a370-499d-a616-000d938527ce" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_36e06f32-4a0b-4abf-9895-c85027fa6d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e40f23c2-329e-48be-afc6-f741778fa3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_06073e9a-3367-4ef5-a8f0-2096b833c436" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e40f23c2-329e-48be-afc6-f741778fa3d3" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_06073e9a-3367-4ef5-a8f0-2096b833c436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_85d1fedf-8d2b-401e-bf56-024e6a0f2f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_06073e9a-3367-4ef5-a8f0-2096b833c436" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_85d1fedf-8d2b-401e-bf56-024e6a0f2f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7ad658a5-5ca7-4313-a0e0-d52a07985b22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_85d1fedf-8d2b-401e-bf56-024e6a0f2f7d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7ad658a5-5ca7-4313-a0e0-d52a07985b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_b516ca8b-aafc-4501-b636-a26eee5d8a70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7ad658a5-5ca7-4313-a0e0-d52a07985b22" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_b516ca8b-aafc-4501-b636-a26eee5d8a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_700fcb60-fbd7-44c6-9966-3068d4ad6216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_06073e9a-3367-4ef5-a8f0-2096b833c436" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_700fcb60-fbd7-44c6-9966-3068d4ad6216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2ffda8b2-9dbd-44b5-8952-117e3d02b969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_700fcb60-fbd7-44c6-9966-3068d4ad6216" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2ffda8b2-9dbd-44b5-8952-117e3d02b969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_13aacbc7-7da1-4acb-9746-228a82c7b88d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_700fcb60-fbd7-44c6-9966-3068d4ad6216" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_13aacbc7-7da1-4acb-9746-228a82c7b88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_b93dd4c8-c12e-446e-a858-26f6671bcb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_700fcb60-fbd7-44c6-9966-3068d4ad6216" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_b93dd4c8-c12e-446e-a858-26f6671bcb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_8989b9c1-0652-49f1-9f74-3d425625db7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_700fcb60-fbd7-44c6-9966-3068d4ad6216" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_8989b9c1-0652-49f1-9f74-3d425625db7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherLiabilitiesCurrentUnsettledShareRepurchase_09134136-7b1a-4d2e-96b9-8c22afa7a6a2" xlink:href="bax-20220331.xsd#bax_OtherLiabilitiesCurrentUnsettledShareRepurchase"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_700fcb60-fbd7-44c6-9966-3068d4ad6216" xlink:to="loc_bax_OtherLiabilitiesCurrentUnsettledShareRepurchase_09134136-7b1a-4d2e-96b9-8c22afa7a6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET" xlink:type="simple" xlink:href="bax-20220331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNET"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_500429fe-1d94-4b87-bb5e-db90cb756cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_51433adb-1e0b-48a2-bd2c-0a41dfc0c6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_500429fe-1d94-4b87-bb5e-db90cb756cd9" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_51433adb-1e0b-48a2-bd2c-0a41dfc0c6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables" xlink:type="simple" xlink:href="bax-20220331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_399a82f5-63c2-47cb-a252-75a2e0d2555f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_5167847f-5917-4821-ad9b-f9aaf9e62dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_399a82f5-63c2-47cb-a252-75a2e0d2555f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_5167847f-5917-4821-ad9b-f9aaf9e62dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock_d3f5b792-a7b7-41fa-a981-e2a50bea104a" xlink:href="bax-20220331.xsd#bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_399a82f5-63c2-47cb-a252-75a2e0d2555f" xlink:to="loc_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock_d3f5b792-a7b7-41fa-a981-e2a50bea104a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cd464481-3c9e-4d02-865d-d90bb8d36ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_98d58096-2f44-48ea-b614-9d6468e4cb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cd464481-3c9e-4d02-865d-d90bb8d36ae9" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_98d58096-2f44-48ea-b614-9d6468e4cb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_efe971ed-9770-43bb-a92b-cccfa9160cea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_98d58096-2f44-48ea-b614-9d6468e4cb2c" xlink:to="loc_srt_StatementGeographicalAxis_efe971ed-9770-43bb-a92b-cccfa9160cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cb67aaf5-2b36-4538-80bb-ddf5475fffd1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_efe971ed-9770-43bb-a92b-cccfa9160cea" xlink:to="loc_srt_SegmentGeographicalDomain_cb67aaf5-2b36-4538-80bb-ddf5475fffd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_49a1d216-0d27-4f5d-ba81-5137597b853a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cb67aaf5-2b36-4538-80bb-ddf5475fffd1" xlink:to="loc_srt_AmericasMember_49a1d216-0d27-4f5d-ba81-5137597b853a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_8e2a67bc-9a50-4199-8d5c-af39b4adbe72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cb67aaf5-2b36-4538-80bb-ddf5475fffd1" xlink:to="loc_us-gaap_EMEAMember_8e2a67bc-9a50-4199-8d5c-af39b4adbe72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_b1dce789-757e-43de-81fe-247f91b5b1a8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cb67aaf5-2b36-4538-80bb-ddf5475fffd1" xlink:to="loc_srt_AsiaPacificMember_b1dce789-757e-43de-81fe-247f91b5b1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_4d1c7a5c-1287-4e6f-bd01-a542f910a5d5" xlink:href="bax-20220331.xsd#bax_HillromMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cb67aaf5-2b36-4538-80bb-ddf5475fffd1" xlink:to="loc_bax_HillromMember_4d1c7a5c-1287-4e6f-bd01-a542f910a5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_fed29a14-69d8-4101-9c4e-ffb8e0d8cbbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_98d58096-2f44-48ea-b614-9d6468e4cb2c" xlink:to="loc_us-gaap_GoodwillLineItems_fed29a14-69d8-4101-9c4e-ffb8e0d8cbbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_0db0c76a-2bd5-4cd5-b178-68fc165b9a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_fed29a14-69d8-4101-9c4e-ffb8e0d8cbbe" xlink:to="loc_us-gaap_GoodwillRollForward_0db0c76a-2bd5-4cd5-b178-68fc165b9a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b5814241-58fd-4daa-a5bf-b27a86bd40aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0db0c76a-2bd5-4cd5-b178-68fc165b9a63" xlink:to="loc_us-gaap_Goodwill_b5814241-58fd-4daa-a5bf-b27a86bd40aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_a8073709-87a9-4d77-8a60-93cfd07a348c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0db0c76a-2bd5-4cd5-b178-68fc165b9a63" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_a8073709-87a9-4d77-8a60-93cfd07a348c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9f87885f-818d-45f7-8c60-6ab094536232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0db0c76a-2bd5-4cd5-b178-68fc165b9a63" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_9f87885f-818d-45f7-8c60-6ab094536232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_27a3d6f9-ce99-4283-bf8c-9fb832abf317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0db0c76a-2bd5-4cd5-b178-68fc165b9a63" xlink:to="loc_us-gaap_Goodwill_27a3d6f9-ce99-4283-bf8c-9fb832abf317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a76942c8-6f8b-493d-a5d7-851924c47ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_93e712a4-9b23-4e03-9fef-09f2622b204b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a76942c8-6f8b-493d-a5d7-851924c47ed9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_93e712a4-9b23-4e03-9fef-09f2622b204b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_c8970bb5-d840-4f5f-9756-a5cc1820bf94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a76942c8-6f8b-493d-a5d7-851924c47ed9" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_c8970bb5-d840-4f5f-9756-a5cc1820bf94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7e43a8c0-512c-44b7-87f6-a924319fe76e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillTable_ba92ea3f-b389-460b-baff-f8a0a10525eb" xlink:href="bax-20220331.xsd#bax_IntangibleAssetExcludingGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7e43a8c0-512c-44b7-87f6-a924319fe76e" xlink:to="loc_bax_IntangibleAssetExcludingGoodwillTable_ba92ea3f-b389-460b-baff-f8a0a10525eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb492db8-34c2-4841-a563-8ddb91de9004" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable_ba92ea3f-b389-460b-baff-f8a0a10525eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb492db8-34c2-4841-a563-8ddb91de9004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_874ba78d-1b3b-4b0d-8827-3f90951bb821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb492db8-34c2-4841-a563-8ddb91de9004" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_874ba78d-1b3b-4b0d-8827-3f90951bb821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_fee1fbb7-e360-4ba9-b98c-2b2ca4076e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_874ba78d-1b3b-4b0d-8827-3f90951bb821" xlink:to="loc_us-gaap_CustomerRelationshipsMember_fee1fbb7-e360-4ba9-b98c-2b2ca4076e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DevelopedTechnologyIncludingPatentsMember_fb5d777e-0357-49a8-9115-af8eeff90cef" xlink:href="bax-20220331.xsd#bax_DevelopedTechnologyIncludingPatentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_874ba78d-1b3b-4b0d-8827-3f90951bb821" xlink:to="loc_bax_DevelopedTechnologyIncludingPatentsMember_fb5d777e-0357-49a8-9115-af8eeff90cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_34430c91-1191-4385-baf5-ec51e85c7fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_874ba78d-1b3b-4b0d-8827-3f90951bb821" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_34430c91-1191-4385-baf5-ec51e85c7fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_05747da6-12d4-464f-bdf0-d70fcfffee28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable_ba92ea3f-b389-460b-baff-f8a0a10525eb" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_05747da6-12d4-464f-bdf0-d70fcfffee28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0b24c382-b036-4660-9e6a-d136243cd45a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_05747da6-12d4-464f-bdf0-d70fcfffee28" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0b24c382-b036-4660-9e6a-d136243cd45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsMember_29bc1ca4-f2bf-40b0-b6d2-610af6268342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0b24c382-b036-4660-9e6a-d136243cd45a" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsMember_29bc1ca4-f2bf-40b0-b6d2-610af6268342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_IntangibleAssetExcludingGoodwillLineItems_89d162cc-f850-4187-9928-177cd4412447" xlink:href="bax-20220331.xsd#bax_IntangibleAssetExcludingGoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillTable_ba92ea3f-b389-460b-baff-f8a0a10525eb" xlink:to="loc_bax_IntangibleAssetExcludingGoodwillLineItems_89d162cc-f850-4187-9928-177cd4412447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_51d9cc68-1f7c-4d08-a94b-9a1d23a38456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_89d162cc-f850-4187-9928-177cd4412447" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_51d9cc68-1f7c-4d08-a94b-9a1d23a38456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_f9fe4009-483d-461c-9a9c-61e8c9797ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_89d162cc-f850-4187-9928-177cd4412447" xlink:to="loc_us-gaap_OtherIndefiniteLivedIntangibleAssets_f9fe4009-483d-461c-9a9c-61e8c9797ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dba66872-741b-4a9d-b49b-3a98542623dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_89d162cc-f850-4187-9928-177cd4412447" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dba66872-741b-4a9d-b49b-3a98542623dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_469890f6-7e58-4c6d-b818-9db8c335fe78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_89d162cc-f850-4187-9928-177cd4412447" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_469890f6-7e58-4c6d-b818-9db8c335fe78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_571133a6-108d-45bb-9ac0-be57b4ac5e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_89d162cc-f850-4187-9928-177cd4412447" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_571133a6-108d-45bb-9ac0-be57b4ac5e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6df31202-ca2d-43a2-a60e-a9c6a90ff483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_IntangibleAssetExcludingGoodwillLineItems_89d162cc-f850-4187-9928-177cd4412447" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6df31202-ca2d-43a2-a60e-a9c6a90ff483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FINANCINGARRANGEMENTS" xlink:type="simple" xlink:href="bax-20220331.xsd#FINANCINGARRANGEMENTS"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FINANCINGARRANGEMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3f16a2ef-9c52-4dec-bb99-ca94f2a52ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_80e64f4d-ce8e-4d33-9581-e04d1cc1e53b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3f16a2ef-9c52-4dec-bb99-ca94f2a52ff2" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_80e64f4d-ce8e-4d33-9581-e04d1cc1e53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#FINANCINGARRANGEMENTSDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_899ab1cd-1959-4eb1-b173-b2f7f53cf1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d5635b72-c11c-4390-b55f-8ce34b3b05fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_899ab1cd-1959-4eb1-b173-b2f7f53cf1d4" xlink:to="loc_us-gaap_DebtInstrumentTable_d5635b72-c11c-4390-b55f-8ce34b3b05fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0cdf76ec-9647-422b-96be-cab58e8acf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d5635b72-c11c-4390-b55f-8ce34b3b05fb" xlink:to="loc_us-gaap_DebtInstrumentAxis_0cdf76ec-9647-422b-96be-cab58e8acf5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f0a0c813-5c2f-445b-9f4c-95ba652fecdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0cdf76ec-9647-422b-96be-cab58e8acf5d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f0a0c813-5c2f-445b-9f4c-95ba652fecdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeniorThreeYearTermLoanMember_f84ba990-7640-4dd0-82ae-0756156b15cb" xlink:href="bax-20220331.xsd#bax_SeniorThreeYearTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0a0c813-5c2f-445b-9f4c-95ba652fecdb" xlink:to="loc_bax_SeniorThreeYearTermLoanMember_f84ba990-7640-4dd0-82ae-0756156b15cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeniorFiveYearTermLoanMember_06873f82-9f4c-4280-9d44-5699320d0516" xlink:href="bax-20220331.xsd#bax_SeniorFiveYearTermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f0a0c813-5c2f-445b-9f4c-95ba652fecdb" xlink:to="loc_bax_SeniorFiveYearTermLoanMember_06873f82-9f4c-4280-9d44-5699320d0516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ebc0339b-b056-4810-a217-62eb5a277750" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d5635b72-c11c-4390-b55f-8ce34b3b05fb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ebc0339b-b056-4810-a217-62eb5a277750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c4f6a322-3617-4d02-ac0e-a5b60a072880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ebc0339b-b056-4810-a217-62eb5a277750" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c4f6a322-3617-4d02-ac0e-a5b60a072880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_86aed1c8-ce4a-439f-9227-6d3aa45093b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c4f6a322-3617-4d02-ac0e-a5b60a072880" xlink:to="loc_us-gaap_SeniorNotesMember_86aed1c8-ce4a-439f-9227-6d3aa45093b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_fddca41e-be71-4421-bd06-77d97ce09bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d5635b72-c11c-4390-b55f-8ce34b3b05fb" xlink:to="loc_us-gaap_CreditFacilityAxis_fddca41e-be71-4421-bd06-77d97ce09bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e4f09911-84c6-4c4e-a967-ce17c299dd98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_fddca41e-be71-4421-bd06-77d97ce09bf8" xlink:to="loc_us-gaap_CreditFacilityDomain_e4f09911-84c6-4c4e-a967-ce17c299dd98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b02aa3ea-1256-4723-854b-222c0c7edabe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e4f09911-84c6-4c4e-a967-ce17c299dd98" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b02aa3ea-1256-4723-854b-222c0c7edabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d5635b72-c11c-4390-b55f-8ce34b3b05fb" xlink:to="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_74278a5d-200a-45be-aa0d-e1cf8898186a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_us-gaap_LongTermDebt_74278a5d-200a-45be-aa0d-e1cf8898186a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_42c0ed11-5ee7-4893-b2ab-97790730877f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_42c0ed11-5ee7-4893-b2ab-97790730877f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm_a11e2d13-4c0d-4106-89cc-5e72391114ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_us-gaap_LongTermDebtTerm_a11e2d13-4c0d-4106-89cc-5e72391114ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_a010e202-1c7b-4f40-a22d-17d894b03713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_a010e202-1c7b-4f40-a22d-17d894b03713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_49554567-80be-4ada-942a-57c5e359e834" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_us-gaap_LineOfCredit_49554567-80be-4ada-942a-57c5e359e834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperAverageOutstanding_5a44a9e6-768e-4605-bf87-1f1257bc60a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperAverageOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_us-gaap_CommercialPaperAverageOutstanding_5a44a9e6-768e-4605-bf87-1f1257bc60a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommercialPaperWeightedAverageInterestRate_b56b3ee0-84f7-49f3-a2ff-8918d820cd1f" xlink:href="bax-20220331.xsd#bax_CommercialPaperWeightedAverageInterestRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_bax_CommercialPaperWeightedAverageInterestRate_b56b3ee0-84f7-49f3-a2ff-8918d820cd1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OriginalWeightedAverageTerm_79f13f72-6083-467e-aec8-82d9c90950cc" xlink:href="bax-20220331.xsd#bax_OriginalWeightedAverageTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_eef74787-bab0-40d8-8816-89665810a574" xlink:to="loc_bax_OriginalWeightedAverageTerm_79f13f72-6083-467e-aec8-82d9c90950cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="bax-20220331.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bd669fc1-894b-476f-a388-8ac73e4d7c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3d79fcaf-07db-471b-8db3-39bf670396d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bd669fc1-894b-476f-a388-8ac73e4d7c1a" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3d79fcaf-07db-471b-8db3-39bf670396d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_437ccec4-43db-4ebf-9f0e-8fc73ed503b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_438e865e-642f-4d22-b879-254713bcd088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_437ccec4-43db-4ebf-9f0e-8fc73ed503b3" xlink:to="loc_us-gaap_LossContingenciesTable_438e865e-642f-4d22-b879-254713bcd088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteAxis_49741176-8766-44ee-9121-0e1b71cec5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EnvironmentalRemediationSiteAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_438e865e-642f-4d22-b879-254713bcd088" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteAxis_49741176-8766-44ee-9121-0e1b71cec5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationSiteDomain_8122d654-d1c3-408a-892c-cb6b215f7ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EnvironmentalRemediationSiteDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteAxis_49741176-8766-44ee-9121-0e1b71cec5a0" xlink:to="loc_us-gaap_EnvironmentalRemediationSiteDomain_8122d654-d1c3-408a-892c-cb6b215f7ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SuperfundSitesMember_a73bcd3a-74a3-465d-95a6-b9bf6426bed4" xlink:href="bax-20220331.xsd#bax_SuperfundSitesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EnvironmentalRemediationSiteDomain_8122d654-d1c3-408a-892c-cb6b215f7ccd" xlink:to="loc_bax_SuperfundSitesMember_a73bcd3a-74a3-465d-95a6-b9bf6426bed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyAxis_d95a5e56-caae-4bfb-b4bd-1917e2a90f13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EnvironmentalRemediationContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_438e865e-642f-4d22-b879-254713bcd088" xlink:to="loc_us-gaap_EnvironmentalRemediationContingencyAxis_d95a5e56-caae-4bfb-b4bd-1917e2a90f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalRemediationContingencyDomain_04560c5d-da7c-4d90-a345-1225d29020c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EnvironmentalRemediationContingencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyAxis_d95a5e56-caae-4bfb-b4bd-1917e2a90f13" xlink:to="loc_us-gaap_EnvironmentalRemediationContingencyDomain_04560c5d-da7c-4d90-a345-1225d29020c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EnviromentalCleanUpMember_5cf659f5-17b7-4b47-b25e-067cc07b3dd5" xlink:href="bax-20220331.xsd#bax_EnviromentalCleanUpMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EnvironmentalRemediationContingencyDomain_04560c5d-da7c-4d90-a345-1225d29020c0" xlink:to="loc_bax_EnviromentalCleanUpMember_5cf659f5-17b7-4b47-b25e-067cc07b3dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_9058fc37-45ba-4f40-9830-1e4dfb3ede8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_438e865e-642f-4d22-b879-254713bcd088" xlink:to="loc_us-gaap_LossContingenciesLineItems_9058fc37-45ba-4f40-9830-1e4dfb3ede8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_08b67e32-78be-4332-8796-a5ecbaa9210c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9058fc37-45ba-4f40-9830-1e4dfb3ede8f" xlink:to="loc_us-gaap_LitigationReserve_08b67e32-78be-4332-8796-a5ecbaa9210c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SiteContingencyNumberOfSites_6191642b-82bd-4475-9215-beb81b4faa76" xlink:href="bax-20220331.xsd#bax_SiteContingencyNumberOfSites"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9058fc37-45ba-4f40-9830-1e4dfb3ede8f" xlink:to="loc_bax_SiteContingencyNumberOfSites_6191642b-82bd-4475-9215-beb81b4faa76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForEnvironmentalLossContingencies_38ce73ea-2b5c-44bd-a6ec-0497c6ddbafc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9058fc37-45ba-4f40-9830-1e4dfb3ede8f" xlink:to="loc_us-gaap_AccrualForEnvironmentalLossContingencies_38ce73ea-2b5c-44bd-a6ec-0497c6ddbafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_8a15f5fa-6a94-4fe0-bff4-a3b195e36cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9058fc37-45ba-4f40-9830-1e4dfb3ede8f" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_8a15f5fa-6a94-4fe0-bff4-a3b195e36cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_578acaaa-16ff-42a4-bf91-af41634f3a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9058fc37-45ba-4f40-9830-1e4dfb3ede8f" xlink:to="loc_us-gaap_LitigationSettlementExpense_578acaaa-16ff-42a4-bf91-af41634f3a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LossContingencyNumberOfLawsuits_48b1b19b-ce45-4040-a948-47c156a47621" xlink:href="bax-20220331.xsd#bax_LossContingencyNumberOfLawsuits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_9058fc37-45ba-4f40-9830-1e4dfb3ede8f" xlink:to="loc_bax_LossContingencyNumberOfLawsuits_48b1b19b-ce45-4040-a948-47c156a47621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="bax-20220331.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9367d4b1-86c0-4036-a86b-68c7e76fcdad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_266314ee-d091-434e-a5b4-3d62cfb73464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9367d4b1-86c0-4036-a86b-68c7e76fcdad" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_266314ee-d091-434e-a5b4-3d62cfb73464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="bax-20220331.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d7e96936-d05b-4428-b601-ff2a2c1ce025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_ef6acc3c-d948-48fd-b9b5-713efff8548a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d7e96936-d05b-4428-b601-ff2a2c1ce025" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_ef6acc3c-d948-48fd-b9b5-713efff8548a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITYStockOptionsFairValueAssumptionsDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#STOCKHOLDERSEQUITYStockOptionsFairValueAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/STOCKHOLDERSEQUITYStockOptionsFairValueAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_79434143-3f1a-45f8-983d-743c48c335a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5b1730f3-ca70-4bd2-b432-822d053fdf5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_79434143-3f1a-45f8-983d-743c48c335a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5b1730f3-ca70-4bd2-b432-822d053fdf5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1c83c7ff-91d9-4b1b-97c6-35244be8b9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5b1730f3-ca70-4bd2-b432-822d053fdf5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1c83c7ff-91d9-4b1b-97c6-35244be8b9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ae11f6e6-2206-48be-b082-1a6c125fe07c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5b1730f3-ca70-4bd2-b432-822d053fdf5e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ae11f6e6-2206-48be-b082-1a6c125fe07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a51d6b2d-d850-4405-b7be-53c2a7f36357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5b1730f3-ca70-4bd2-b432-822d053fdf5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a51d6b2d-d850-4405-b7be-53c2a7f36357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_31fec5fe-264e-4fd7-b22f-71ebdb5c1e42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5b1730f3-ca70-4bd2-b432-822d053fdf5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_31fec5fe-264e-4fd7-b22f-71ebdb5c1e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4941a237-e8ce-40fb-a662-3e70c6475425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_5b1730f3-ca70-4bd2-b432-822d053fdf5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4941a237-e8ce-40fb-a662-3e70c6475425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7c2d1208-c06c-48cc-85c8-ac3df3c752dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_StockholdersEquityNoteTable_cfd36a45-49d9-410b-8e69-2bd64ce4d245" xlink:href="bax-20220331.xsd#bax_StockholdersEquityNoteTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7c2d1208-c06c-48cc-85c8-ac3df3c752dd" xlink:to="loc_bax_StockholdersEquityNoteTable_cfd36a45-49d9-410b-8e69-2bd64ce4d245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_772feb5d-569a-4fa9-898e-dcfcfbdba693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_StockholdersEquityNoteTable_cfd36a45-49d9-410b-8e69-2bd64ce4d245" xlink:to="loc_us-gaap_AwardTypeAxis_772feb5d-569a-4fa9-898e-dcfcfbdba693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff2fa4d-d197-4ae8-a94e-61e89eef5119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_772feb5d-569a-4fa9-898e-dcfcfbdba693" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff2fa4d-d197-4ae8-a94e-61e89eef5119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_da0e5f7c-be28-4f12-991f-ec78b264ce2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff2fa4d-d197-4ae8-a94e-61e89eef5119" xlink:to="loc_us-gaap_EmployeeStockOptionMember_da0e5f7c-be28-4f12-991f-ec78b264ce2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_448dd5dc-b356-42da-ad8b-dc537a2b1186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff2fa4d-d197-4ae8-a94e-61e89eef5119" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_448dd5dc-b356-42da-ad8b-dc537a2b1186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_903bf630-d06e-488f-abbe-b67eeb85b4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ff2fa4d-d197-4ae8-a94e-61e89eef5119" xlink:to="loc_us-gaap_PerformanceSharesMember_903bf630-d06e-488f-abbe-b67eeb85b4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3e7affc5-88ff-414f-920b-4c5037293ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_StockholdersEquityNoteTable_cfd36a45-49d9-410b-8e69-2bd64ce4d245" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3e7affc5-88ff-414f-920b-4c5037293ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_85473c60-44d6-42b0-be44-b08644c5341c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3e7affc5-88ff-414f-920b-4c5037293ffa" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_85473c60-44d6-42b0-be44-b08644c5341c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_76823256-f224-4e58-a69d-af4cf1907f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_85473c60-44d6-42b0-be44-b08644c5341c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_76823256-f224-4e58-a69d-af4cf1907f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:href="bax-20220331.xsd#bax_StockholdersEquityNoteLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_StockholdersEquityNoteTable_cfd36a45-49d9-410b-8e69-2bd64ce4d245" xlink:to="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_aeb23f0f-79be-4cbe-9d60-29870b35bb72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_ShareBasedCompensation_aeb23f0f-79be-4cbe-9d60-29870b35bb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ShareBasedCompensationAllocationPercentage_4d680a0b-c203-4411-ab02-7b452b213f2c" xlink:href="bax-20220331.xsd#bax_ShareBasedCompensationAllocationPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_bax_ShareBasedCompensationAllocationPercentage_4d680a0b-c203-4411-ab02-7b452b213f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2d290129-dccc-429a-895c-ec9a1c6dbce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2d290129-dccc-429a-895c-ec9a1c6dbce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e838c070-c8fc-4707-a495-3ab46262fae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e838c070-c8fc-4707-a495-3ab46262fae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross_3979f957-bf93-4c34-a592-dde5c528a78b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross_3979f957-bf93-4c34-a592-dde5c528a78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9fd3a93c-512e-4984-84a7-7faf399bbe1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9fd3a93c-512e-4984-84a7-7faf399bbe1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6d445955-2bb5-4a24-a69b-8870d7ff7b79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6d445955-2bb5-4a24-a69b-8870d7ff7b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_73abea52-b395-41a6-8e8b-e55940def06d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_73abea52-b395-41a6-8e8b-e55940def06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_b78c5022-3813-403d-ba43-02163c073067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_b78c5022-3813-403d-ba43-02163c073067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_833b4ce4-ac93-4bf5-97bb-9c69beba93a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_833b4ce4-ac93-4bf5-97bb-9c69beba93a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_20c88010-07c1-47d9-949e-bb2f75c42c3c" xlink:href="bax-20220331.xsd#bax_StockRepurchaseProgramAdditionalAuthorizedAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_bax_StockRepurchaseProgramAdditionalAuthorizedAmount_20c88010-07c1-47d9-949e-bb2f75c42c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_d29606d4-ea4e-4fe1-a420-bf175858933f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_d29606d4-ea4e-4fe1-a420-bf175858933f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_14987c9a-e668-496e-93cc-dffcdf98e27d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_StockholdersEquityNoteLineItems_46bceafa-f9f9-49e0-a4f5-4ae7f0317b8b" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_14987c9a-e668-496e-93cc-dffcdf98e27d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="bax-20220331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1d1c3b8d-798a-4301-a3c1-97373fdd51c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_b6c2c461-f0da-4954-a9c5-5cc16dbef35b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1d1c3b8d-798a-4301-a3c1-97373fdd51c5" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_b6c2c461-f0da-4954-a9c5-5cc16dbef35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables" xlink:type="simple" xlink:href="bax-20220331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_19f2075c-2eed-4898-9ec5-3912d9529aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_57ebd3e1-c9b4-4b32-91fd-4b0ce07659f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_19f2075c-2eed-4898-9ec5-3912d9529aa1" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_57ebd3e1-c9b4-4b32-91fd-4b0ce07659f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_7c793bee-2f34-4b14-8fcb-1a9fd594f736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_19f2075c-2eed-4898-9ec5-3912d9529aa1" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_7c793bee-2f34-4b14-8fcb-1a9fd594f736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f47620d8-c0b4-4b98-bebd-45d250f3cbda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_06e7100e-ed86-4d7c-b7e3-91c397a41e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f47620d8-c0b4-4b98-bebd-45d250f3cbda" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_06e7100e-ed86-4d7c-b7e3-91c397a41e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_abfac9a8-0b97-4fdb-824e-357e3bfd06fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_06e7100e-ed86-4d7c-b7e3-91c397a41e47" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_abfac9a8-0b97-4fdb-824e-357e3bfd06fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cdcd614e-e83b-4225-9de5-f7814396e181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_abfac9a8-0b97-4fdb-824e-357e3bfd06fd" xlink:to="loc_us-gaap_EquityComponentDomain_cdcd614e-e83b-4225-9de5-f7814396e181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_fba415e1-1df7-43d1-985c-a6ebd4011ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cdcd614e-e83b-4225-9de5-f7814396e181" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_fba415e1-1df7-43d1-985c-a6ebd4011ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_c9ad6109-8dc9-44be-b296-d3f09df2a9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cdcd614e-e83b-4225-9de5-f7814396e181" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_c9ad6109-8dc9-44be-b296-d3f09df2a9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_38b356a8-9a5c-410a-9023-73c963c636c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cdcd614e-e83b-4225-9de5-f7814396e181" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_38b356a8-9a5c-410a-9023-73c963c636c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_d12971f3-d684-40f8-9125-141ee524c1ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cdcd614e-e83b-4225-9de5-f7814396e181" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_d12971f3-d684-40f8-9125-141ee524c1ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_30ba7feb-434d-4fb5-b1d8-820487602912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cdcd614e-e83b-4225-9de5-f7814396e181" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_30ba7feb-434d-4fb5-b1d8-820487602912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1969dd37-2a4d-4da0-bd1b-be51ceee6da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_06e7100e-ed86-4d7c-b7e3-91c397a41e47" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1969dd37-2a4d-4da0-bd1b-be51ceee6da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_31b138c7-8376-4204-9060-6c1c187d573f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1969dd37-2a4d-4da0-bd1b-be51ceee6da3" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_31b138c7-8376-4204-9060-6c1c187d573f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0e21ca43-b5a6-49bc-9585-ff5cd5589e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_31b138c7-8376-4204-9060-6c1c187d573f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0e21ca43-b5a6-49bc-9585-ff5cd5589e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_3fda3911-a2e5-4c82-95fd-d67449166c77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_31b138c7-8376-4204-9060-6c1c187d573f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_3fda3911-a2e5-4c82-95fd-d67449166c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_0d04718b-bf25-4e82-8f60-5e48fe9772e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_31b138c7-8376-4204-9060-6c1c187d573f" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_0d04718b-bf25-4e82-8f60-5e48fe9772e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_904b6923-f0b7-45c9-a237-a43f04c6520d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_31b138c7-8376-4204-9060-6c1c187d573f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_904b6923-f0b7-45c9-a237-a43f04c6520d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_91a6cbea-0585-43ed-8da2-6ea1d9f304a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_31b138c7-8376-4204-9060-6c1c187d573f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_91a6cbea-0585-43ed-8da2-6ea1d9f304a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_fd127866-e6aa-441b-987c-f024d430c688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a5eba7e-2c6b-40e6-a970-75aaa8181d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fd127866-e6aa-441b-987c-f024d430c688" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a5eba7e-2c6b-40e6-a970-75aaa8181d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4bc04df0-6a71-4e54-8335-61b0d5c8e799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a5eba7e-2c6b-40e6-a970-75aaa8181d51" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4bc04df0-6a71-4e54-8335-61b0d5c8e799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3b1ede07-babb-4640-ae49-29bb2f0e4793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4bc04df0-6a71-4e54-8335-61b0d5c8e799" xlink:to="loc_us-gaap_EquityComponentDomain_3b1ede07-babb-4640-ae49-29bb2f0e4793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_a9deeaf2-d8a6-4c01-9080-fb320eb96f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3b1ede07-babb-4640-ae49-29bb2f0e4793" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_a9deeaf2-d8a6-4c01-9080-fb320eb96f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_15a0a8d4-d7ee-4c22-8a77-3cb0ad422ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3b1ede07-babb-4640-ae49-29bb2f0e4793" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_15a0a8d4-d7ee-4c22-8a77-3cb0ad422ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b0f14fb9-16fd-4a7a-9a2e-499df17bbca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a5eba7e-2c6b-40e6-a970-75aaa8181d51" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b0f14fb9-16fd-4a7a-9a2e-499df17bbca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d0eb8eb6-cf93-4999-891e-d52e8a7586d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b0f14fb9-16fd-4a7a-9a2e-499df17bbca6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d0eb8eb6-cf93-4999-891e-d52e8a7586d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_95bd1ea4-c951-48bf-a013-337a822f54da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d0eb8eb6-cf93-4999-891e-d52e8a7586d2" xlink:to="loc_us-gaap_ForeignExchangeContractMember_95bd1ea4-c951-48bf-a013-337a822f54da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_59723b96-8fac-4817-a17b-4e7295f70dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d0eb8eb6-cf93-4999-891e-d52e8a7586d2" xlink:to="loc_us-gaap_InterestRateContractMember_59723b96-8fac-4817-a17b-4e7295f70dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_50c27cb3-cf80-42da-8fa1-05ad623697d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a5eba7e-2c6b-40e6-a970-75aaa8181d51" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_50c27cb3-cf80-42da-8fa1-05ad623697d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_6ae61da8-7e3b-4b07-b28f-e24af2a7552a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_50c27cb3-cf80-42da-8fa1-05ad623697d1" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_6ae61da8-7e3b-4b07-b28f-e24af2a7552a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_496ad480-b522-4969-86f0-5f2861f2e47d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_6ae61da8-7e3b-4b07-b28f-e24af2a7552a" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_496ad480-b522-4969-86f0-5f2861f2e47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_742ec357-ae8e-4098-8e5b-b9b33314de21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_2a5eba7e-2c6b-40e6-a970-75aaa8181d51" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_742ec357-ae8e-4098-8e5b-b9b33314de21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_dadf3b19-c5c5-4fca-8562-97961277a67f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_742ec357-ae8e-4098-8e5b-b9b33314de21" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_dadf3b19-c5c5-4fca-8562-97961277a67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_45150f41-1d48-4fc5-939a-f41399121bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_742ec357-ae8e-4098-8e5b-b9b33314de21" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_45150f41-1d48-4fc5-939a-f41399121bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_2f5f753e-e522-4311-b89f-65edc42cdae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_742ec357-ae8e-4098-8e5b-b9b33314de21" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_2f5f753e-e522-4311-b89f-65edc42cdae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_c4d53e80-b212-4125-b5d1-9896f02133d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_742ec357-ae8e-4098-8e5b-b9b33314de21" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_c4d53e80-b212-4125-b5d1-9896f02133d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_24353356-78ae-4732-b717-18a29c971b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_742ec357-ae8e-4098-8e5b-b9b33314de21" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_24353356-78ae-4732-b717-18a29c971b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e63563e9-f15d-4761-bbb2-d69517f1ba4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_742ec357-ae8e-4098-8e5b-b9b33314de21" xlink:to="loc_us-gaap_NetIncomeLoss_e63563e9-f15d-4761-bbb2-d69517f1ba4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUES" xlink:type="simple" xlink:href="bax-20220331.xsd#REVENUES"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1bb8ed8b-0718-4e1e-af68-e2bc5106a3e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_fca30b6a-ea5e-4dd5-ad0b-15fde8c03334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1bb8ed8b-0718-4e1e-af68-e2bc5106a3e7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_fca30b6a-ea5e-4dd5-ad0b-15fde8c03334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESTables" xlink:type="simple" xlink:href="bax-20220331.xsd#REVENUESTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eb793ff8-b697-482b-ba38-fe0d94127d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_3263e75f-d21d-4dfe-975a-d4d9eeaa1d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eb793ff8-b697-482b-ba38-fe0d94127d8c" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_3263e75f-d21d-4dfe-975a-d4d9eeaa1d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_cc1a4364-4e84-4208-b16b-fbaafb3ec3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eb793ff8-b697-482b-ba38-fe0d94127d8c" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_cc1a4364-4e84-4208-b16b-fbaafb3ec3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_4f00bf44-c061-4ddd-b8db-55c236ebd2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eb793ff8-b697-482b-ba38-fe0d94127d8c" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_4f00bf44-c061-4ddd-b8db-55c236ebd2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_7f7647d2-79af-4a5e-b665-1ed01f43461e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eb793ff8-b697-482b-ba38-fe0d94127d8c" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_7f7647d2-79af-4a5e-b665-1ed01f43461e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#REVENUESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_94a6623f-b093-4546-9346-7e2937f72e14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerTable_b9b6db2e-842f-4844-9556-77937464a460" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_94a6623f-b093-4546-9346-7e2937f72e14" xlink:to="loc_bax_RevenueFromContractWithCustomerTable_b9b6db2e-842f-4844-9556-77937464a460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_17f05422-9c10-47ee-bb18-ae911e0865b8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_b9b6db2e-842f-4844-9556-77937464a460" xlink:to="loc_srt_RangeAxis_17f05422-9c10-47ee-bb18-ae911e0865b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_db112830-5a9c-486f-8eba-ad8820c480b8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_17f05422-9c10-47ee-bb18-ae911e0865b8" xlink:to="loc_srt_RangeMember_db112830-5a9c-486f-8eba-ad8820c480b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1166406b-5ad9-4591-8c22-06ec45f3b33f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_db112830-5a9c-486f-8eba-ad8820c480b8" xlink:to="loc_srt_MinimumMember_1166406b-5ad9-4591-8c22-06ec45f3b33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5f13d71e-8c7c-4782-b3fd-0ac369129019" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_db112830-5a9c-486f-8eba-ad8820c480b8" xlink:to="loc_srt_MaximumMember_5f13d71e-8c7c-4782-b3fd-0ac369129019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_60b62c51-f725-4e7d-bbb1-eeb5993d1cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_b9b6db2e-842f-4844-9556-77937464a460" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_60b62c51-f725-4e7d-bbb1-eeb5993d1cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_b1d193a9-21c8-4e95-bf01-dc74ea7e6b93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_60b62c51-f725-4e7d-bbb1-eeb5993d1cc2" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_b1d193a9-21c8-4e95-bf01-dc74ea7e6b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember_a1326b6f-6c9f-4e3c-8d89-f297462bc836" xlink:href="bax-20220331.xsd#bax_ManufacturingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_b1d193a9-21c8-4e95-bf01-dc74ea7e6b93" xlink:to="loc_bax_ManufacturingArrangementsMember_a1326b6f-6c9f-4e3c-8d89-f297462bc836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember_58a66e7f-ce42-4e71-849a-d1afca0bbe2c" xlink:href="bax-20220331.xsd#bax_SoftwareArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_b1d193a9-21c8-4e95-bf01-dc74ea7e6b93" xlink:to="loc_bax_SoftwareArrangementsMember_58a66e7f-ce42-4e71-849a-d1afca0bbe2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ConsumableMedicalProductsMember_f39ea650-31fb-4bb0-b2b5-aacb5ba00d62" xlink:href="bax-20220331.xsd#bax_ConsumableMedicalProductsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_b1d193a9-21c8-4e95-bf01-dc74ea7e6b93" xlink:to="loc_bax_ConsumableMedicalProductsMember_f39ea650-31fb-4bb0-b2b5-aacb5ba00d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_6c107c8f-d4ef-49a6-8771-93d12e0492db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_b9b6db2e-842f-4844-9556-77937464a460" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_6c107c8f-d4ef-49a6-8771-93d12e0492db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_b9b6db2e-842f-4844-9556-77937464a460" xlink:to="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenuePerformanceObligationPaymentTerms_04f2cdda-e04d-490e-9bd2-35a479177242" xlink:href="bax-20220331.xsd#bax_RevenuePerformanceObligationPaymentTerms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_bax_RevenuePerformanceObligationPaymentTerms_04f2cdda-e04d-490e-9bd2-35a479177242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_52880d4f-029b-4f9f-85b2-9ee347323f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_us-gaap_AccountsReceivableNet_52880d4f-029b-4f9f-85b2-9ee347323f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueRecognizedContractPeriod_e4dccffa-e67b-4406-84c1-3e960bb06a8b" xlink:href="bax-20220331.xsd#bax_RevenueRecognizedContractPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_bax_RevenueRecognizedContractPeriod_e4dccffa-e67b-4406-84c1-3e960bb06a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_807d30c7-6154-4eb5-a266-87402a3eda78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_807d30c7-6154-4eb5-a266-87402a3eda78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_924ddf39-8310-4d73-a7fe-242cf058d308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_8ef79df6-8def-4189-ad8b-d221130fbf0e" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable_924ddf39-8310-4d73-a7fe-242cf058d308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESAdditionalInformationDetails_1" xlink:type="simple" xlink:href="bax-20220331.xsd#REVENUESAdditionalInformationDetails_1"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESAdditionalInformationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#REVENUESRemainingPerformanceObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a2abdd8a-3425-46af-9cd4-911d4822bf0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerTable_8f638a2d-1410-4aea-9069-ad2efb9796c4" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a2abdd8a-3425-46af-9cd4-911d4822bf0a" xlink:to="loc_bax_RevenueFromContractWithCustomerTable_8f638a2d-1410-4aea-9069-ad2efb9796c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0f96a923-ae1f-4e58-9ef3-8dfa0e28e43d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_8f638a2d-1410-4aea-9069-ad2efb9796c4" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0f96a923-ae1f-4e58-9ef3-8dfa0e28e43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerLineItems_cef58eef-c0e0-45ce-ab64-55cc46c3062f" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_8f638a2d-1410-4aea-9069-ad2efb9796c4" xlink:to="loc_bax_RevenueFromContractWithCustomerLineItems_cef58eef-c0e0-45ce-ab64-55cc46c3062f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_44a8fbaf-0d34-41e6-9692-7c0755a1ccbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_cef58eef-c0e0-45ce-ab64-55cc46c3062f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_44a8fbaf-0d34-41e6-9692-7c0755a1ccbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1a9c037b-3490-4a02-a3f9-977544b372b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_cef58eef-c0e0-45ce-ab64-55cc46c3062f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_1a9c037b-3490-4a02-a3f9-977544b372b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_7b32fcd7-a9c3-4a9c-bce3-42d52f00409d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_cef58eef-c0e0-45ce-ab64-55cc46c3062f" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_7b32fcd7-a9c3-4a9c-bce3-42d52f00409d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="bax-20220331.xsd#REVENUESRemainingPerformanceObligationsDetails_1"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#REVENUESContractAssetsandContractLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_533c3564-67f8-4e4a-98cd-94accb5100fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerTable_516aaeb6-09d2-4d6c-aa5f-ac52a7e96a0c" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_533c3564-67f8-4e4a-98cd-94accb5100fa" xlink:to="loc_bax_RevenueFromContractWithCustomerTable_516aaeb6-09d2-4d6c-aa5f-ac52a7e96a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_af72d555-9dc6-4780-89e1-1ac002388281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_516aaeb6-09d2-4d6c-aa5f-ac52a7e96a0c" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_af72d555-9dc6-4780-89e1-1ac002388281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_65494537-a710-4d94-97d7-f1e8705d9bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_af72d555-9dc6-4780-89e1-1ac002388281" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_65494537-a710-4d94-97d7-f1e8705d9bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ManufacturingArrangementsMember_30dcbbe0-3d00-43d2-bf4d-46a086ee337c" xlink:href="bax-20220331.xsd#bax_ManufacturingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_65494537-a710-4d94-97d7-f1e8705d9bcd" xlink:to="loc_bax_ManufacturingArrangementsMember_30dcbbe0-3d00-43d2-bf4d-46a086ee337c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SoftwareArrangementsMember_8fa6f82e-d376-4182-b141-25389410bd03" xlink:href="bax-20220331.xsd#bax_SoftwareArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_65494537-a710-4d94-97d7-f1e8705d9bcd" xlink:to="loc_bax_SoftwareArrangementsMember_8fa6f82e-d376-4182-b141-25389410bd03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_97d0d215-f8c9-469c-af5e-758be991765c" xlink:href="bax-20220331.xsd#bax_BundledEquipmentAndConsumableMedicalProductsContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_65494537-a710-4d94-97d7-f1e8705d9bcd" xlink:to="loc_bax_BundledEquipmentAndConsumableMedicalProductsContractsMember_97d0d215-f8c9-469c-af5e-758be991765c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6dbcfbe9-e7e8-47a0-890a-f2f03e1bdc15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_516aaeb6-09d2-4d6c-aa5f-ac52a7e96a0c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6dbcfbe9-e7e8-47a0-890a-f2f03e1bdc15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_676b9ccb-e300-417f-bfe5-1ae50fc07fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6dbcfbe9-e7e8-47a0-890a-f2f03e1bdc15" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_676b9ccb-e300-417f-bfe5-1ae50fc07fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_b394f9fe-1e72-4fdc-81c8-8c9380d42ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_676b9ccb-e300-417f-bfe5-1ae50fc07fb8" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_b394f9fe-1e72-4fdc-81c8-8c9380d42ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_c8231f4f-9fe2-40db-9406-8358c9efb45b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_676b9ccb-e300-417f-bfe5-1ae50fc07fb8" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_c8231f4f-9fe2-40db-9406-8358c9efb45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_dab6a62c-c5a0-42fe-b546-678916479d2a" xlink:href="bax-20220331.xsd#bax_AccruedExpensesAndOtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_676b9ccb-e300-417f-bfe5-1ae50fc07fb8" xlink:to="loc_bax_AccruedExpensesAndOtherCurrentLiabilitiesMember_dab6a62c-c5a0-42fe-b546-678916479d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_f7ecef19-be83-472e-aeec-2acd99fcd581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_676b9ccb-e300-417f-bfe5-1ae50fc07fb8" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_f7ecef19-be83-472e-aeec-2acd99fcd581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerLineItems_7d231390-3c43-41df-818b-b50a2c9a82ec" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_516aaeb6-09d2-4d6c-aa5f-ac52a7e96a0c" xlink:to="loc_bax_RevenueFromContractWithCustomerLineItems_7d231390-3c43-41df-818b-b50a2c9a82ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_e382ea68-96d1-43a1-b3b2-1b005c449105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_7d231390-3c43-41df-818b-b50a2c9a82ec" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_e382ea68-96d1-43a1-b3b2-1b005c449105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_02aa8a91-d062-4a67-b552-903155abab04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_7d231390-3c43-41df-818b-b50a2c9a82ec" xlink:to="loc_us-gaap_ContractWithCustomerLiability_02aa8a91-d062-4a67-b552-903155abab04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerRollForward_d8d5cc9e-a97a-4ae6-afc1-91f29d2004d6" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_7d231390-3c43-41df-818b-b50a2c9a82ec" xlink:to="loc_bax_RevenueFromContractWithCustomerRollForward_d8d5cc9e-a97a-4ae6-afc1-91f29d2004d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_3b18df42-3f0c-4d52-b9b0-2884b00edcb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_d8d5cc9e-a97a-4ae6-afc1-91f29d2004d6" xlink:to="loc_us-gaap_ContractWithCustomerLiability_3b18df42-3f0c-4d52-b9b0-2884b00edcb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractWithCustomerLiabilityDeferredRevenue_4d628c54-8083-4b17-89ec-5d38461445b0" xlink:href="bax-20220331.xsd#bax_ContractWithCustomerLiabilityDeferredRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_d8d5cc9e-a97a-4ae6-afc1-91f29d2004d6" xlink:to="loc_bax_ContractWithCustomerLiabilityDeferredRevenue_4d628c54-8083-4b17-89ec-5d38461445b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_15d82492-ba8d-4dcb-bf4f-9f922eb92541" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_d8d5cc9e-a97a-4ae6-afc1-91f29d2004d6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_15d82492-ba8d-4dcb-bf4f-9f922eb92541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_7b8bf36e-ff85-4c8e-99b3-1b8cfed9839c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerRollForward_d8d5cc9e-a97a-4ae6-afc1-91f29d2004d6" xlink:to="loc_us-gaap_ContractWithCustomerLiability_7b8bf36e-ff85-4c8e-99b3-1b8cfed9839c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_549f8247-feca-4859-bc85-cee704c0aae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerTable_72f80afb-4f09-469a-8170-1ec8a8ceb93e" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_549f8247-feca-4859-bc85-cee704c0aae9" xlink:to="loc_bax_RevenueFromContractWithCustomerTable_72f80afb-4f09-469a-8170-1ec8a8ceb93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9a184085-5d4e-4d8d-939d-074a51f3ca76" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_72f80afb-4f09-469a-8170-1ec8a8ceb93e" xlink:to="loc_srt_ProductOrServiceAxis_9a184085-5d4e-4d8d-939d-074a51f3ca76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9a184085-5d4e-4d8d-939d-074a51f3ca76" xlink:to="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RenalMember_f5d2e2c6-76f4-4441-b2fc-cd67982496f0" xlink:href="bax-20220331.xsd#bax_RenalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_RenalMember_f5d2e2c6-76f4-4441-b2fc-cd67982496f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_MedicationDeliveryMember_b9a4b688-8a90-46bd-b888-88314f74d755" xlink:href="bax-20220331.xsd#bax_MedicationDeliveryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_MedicationDeliveryMember_b9a4b688-8a90-46bd-b888-88314f74d755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PharmaceuticalsMember_4d68be57-c9ef-45e0-977c-0236e57e1490" xlink:href="bax-20220331.xsd#bax_PharmaceuticalsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_PharmaceuticalsMember_4d68be57-c9ef-45e0-977c-0236e57e1490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ClinicalNutritionMember_49a03909-cb44-4761-b761-eccc8acd22c0" xlink:href="bax-20220331.xsd#bax_ClinicalNutritionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_ClinicalNutritionMember_49a03909-cb44-4761-b761-eccc8acd22c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AdvancedSurgeryMember_0039c23c-b5fb-4481-9af8-0c8a60912190" xlink:href="bax-20220331.xsd#bax_AdvancedSurgeryMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_AdvancedSurgeryMember_0039c23c-b5fb-4481-9af8-0c8a60912190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AcuteTherapiesMember_60e9d1b3-ee58-4910-9e95-527dfb4c22b3" xlink:href="bax-20220331.xsd#bax_AcuteTherapiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_AcuteTherapiesMember_60e9d1b3-ee58-4910-9e95-527dfb4c22b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BioPharmaSolutionsMember_13a9343b-cca8-4a45-b93d-12c4891d6ef4" xlink:href="bax-20220331.xsd#bax_BioPharmaSolutionsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_BioPharmaSolutionsMember_13a9343b-cca8-4a45-b93d-12c4891d6ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_PatientSupportSystemsMember_661ac82a-f2f1-4c73-8eab-403ea906f65a" xlink:href="bax-20220331.xsd#bax_PatientSupportSystemsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_PatientSupportSystemsMember_661ac82a-f2f1-4c73-8eab-403ea906f65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FrontLineCareMember_a278b269-413a-4a52-9cb6-15228652c2ec" xlink:href="bax-20220331.xsd#bax_FrontLineCareMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_FrontLineCareMember_a278b269-413a-4a52-9cb6-15228652c2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SurgicalSolutionsMember_2d2608a7-fcf7-45c2-a4f7-cf2e8e017a45" xlink:href="bax-20220331.xsd#bax_SurgicalSolutionsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_SurgicalSolutionsMember_2d2608a7-fcf7-45c2-a4f7-cf2e8e017a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherProductOrServicesMember_daacee83-e747-4c67-934f-203f5d74ff86" xlink:href="bax-20220331.xsd#bax_OtherProductOrServicesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d3f48401-9ff2-41b2-b224-51d6c3a60e6b" xlink:to="loc_bax_OtherProductOrServicesMember_daacee83-e747-4c67-934f-203f5d74ff86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7036f889-34f1-49cd-af68-45d5c23bf618" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_72f80afb-4f09-469a-8170-1ec8a8ceb93e" xlink:to="loc_srt_StatementGeographicalAxis_7036f889-34f1-49cd-af68-45d5c23bf618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e392fdd1-136c-4a43-a161-054a40840b54" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_7036f889-34f1-49cd-af68-45d5c23bf618" xlink:to="loc_srt_SegmentGeographicalDomain_e392fdd1-136c-4a43-a161-054a40840b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_af93891d-9e26-473c-8810-bdf2af285c6d" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e392fdd1-136c-4a43-a161-054a40840b54" xlink:to="loc_country_US_af93891d-9e26-473c-8810-bdf2af285c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_3e4b888e-ca14-47d2-8d2f-93e84ac7a7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e392fdd1-136c-4a43-a161-054a40840b54" xlink:to="loc_us-gaap_NonUsMember_3e4b888e-ca14-47d2-8d2f-93e84ac7a7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_RevenueFromContractWithCustomerLineItems_7f36ebbe-806e-494d-8f29-ab0f11ccfcfe" xlink:href="bax-20220331.xsd#bax_RevenueFromContractWithCustomerLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerTable_72f80afb-4f09-469a-8170-1ec8a8ceb93e" xlink:to="loc_bax_RevenueFromContractWithCustomerLineItems_7f36ebbe-806e-494d-8f29-ab0f11ccfcfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b6079ec5-9ae8-4569-8acf-4948839834a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_RevenueFromContractWithCustomerLineItems_7f36ebbe-806e-494d-8f29-ab0f11ccfcfe" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b6079ec5-9ae8-4569-8acf-4948839834a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/REVENUESLeaseRevenueDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#REVENUESLeaseRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/REVENUESLeaseRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0d21a4fa-de59-4b27-a833-b346fa4abd72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue_3e38dd99-f7b1-4644-8cd0-b97e1dd8ce90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0d21a4fa-de59-4b27-a833-b346fa4abd72" xlink:to="loc_us-gaap_SalesTypeLeaseRevenue_3e38dd99-f7b1-4644-8cd0-b97e1dd8ce90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_c95ab634-261b-4f39-8014-e168faccab7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0d21a4fa-de59-4b27-a833-b346fa4abd72" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_c95ab634-261b-4f39-8014-e168faccab7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseIncome_87bb0025-33ee-4ce2-8d14-95822a0a9db2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0d21a4fa-de59-4b27-a833-b346fa4abd72" xlink:to="loc_us-gaap_VariableLeaseIncome_87bb0025-33ee-4ce2-8d14-95822a0a9db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseIncome_e52e38ba-de25-4946-a545-46ba70d3ec50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0d21a4fa-de59-4b27-a833-b346fa4abd72" xlink:to="loc_us-gaap_LeaseIncome_e52e38ba-de25-4946-a545-46ba70d3ec50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES" xlink:type="simple" xlink:href="bax-20220331.xsd#BUSINESSOPTIMIZATIONCHARGES"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5906a488-c4d5-40f0-8527-de903b83701e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_47f3fd63-60f9-4e8b-82bf-be1b942a4a81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5906a488-c4d5-40f0-8527-de903b83701e" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_47f3fd63-60f9-4e8b-82bf-be1b942a4a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables" xlink:type="simple" xlink:href="bax-20220331.xsd#BUSINESSOPTIMIZATIONCHARGESTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_12b1ad91-57fd-43ed-b743-0c767312ca87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessOptimizationChargeTableTextBlock_e539a203-cb92-45dc-a008-5f85349bb491" xlink:href="bax-20220331.xsd#bax_BusinessOptimizationChargeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_12b1ad91-57fd-43ed-b743-0c767312ca87" xlink:to="loc_bax_BusinessOptimizationChargeTableTextBlock_e539a203-cb92-45dc-a008-5f85349bb491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_12c97cb9-8abc-40b4-ace2-76540af649d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_12b1ad91-57fd-43ed-b743-0c767312ca87" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_12c97cb9-8abc-40b4-ace2-76540af649d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_d1b87a91-46cb-4c99-9203-42490c98db76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_12b1ad91-57fd-43ed-b743-0c767312ca87" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_d1b87a91-46cb-4c99-9203-42490c98db76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7644e6af-9b8d-4ea2-9424-87265b690149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_72a3a62b-a3b0-4ed3-9144-72eacd43b8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7644e6af-9b8d-4ea2-9424-87265b690149" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_72a3a62b-a3b0-4ed3-9144-72eacd43b8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_5bdfb2f1-b180-43cd-8d50-4a31d863a211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7644e6af-9b8d-4ea2-9424-87265b690149" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_5bdfb2f1-b180-43cd-8d50-4a31d863a211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9bfc6b1f-a790-478a-9bdb-a1c00a4993b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f8f6c16-d144-42cc-88b5-c2e58d8e9d56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9bfc6b1f-a790-478a-9bdb-a1c00a4993b6" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f8f6c16-d144-42cc-88b5-c2e58d8e9d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_1e18caad-0654-4dc3-a271-8e792fbbeffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f8f6c16-d144-42cc-88b5-c2e58d8e9d56" xlink:to="loc_us-gaap_RestructuringPlanAxis_1e18caad-0654-4dc3-a271-8e792fbbeffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_c1e6bd10-19e8-4a15-92db-f393cd711513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_1e18caad-0654-4dc3-a271-8e792fbbeffb" xlink:to="loc_us-gaap_RestructuringPlanDomain_c1e6bd10-19e8-4a15-92db-f393cd711513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_BusinessOptimizationProgramsMember_e4d347af-d580-4260-824f-609baf80cc3b" xlink:href="bax-20220331.xsd#bax_BusinessOptimizationProgramsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_c1e6bd10-19e8-4a15-92db-f393cd711513" xlink:to="loc_bax_BusinessOptimizationProgramsMember_e4d347af-d580-4260-824f-609baf80cc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_7a130564-88df-4431-9a52-0ab166c327b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f8f6c16-d144-42cc-88b5-c2e58d8e9d56" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_7a130564-88df-4431-9a52-0ab166c327b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_4909fe16-685b-40b4-ae61-9c380f62b296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7a130564-88df-4431-9a52-0ab166c327b7" xlink:to="loc_us-gaap_RestructuringCharges_4909fe16-685b-40b4-ae61-9c380f62b296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_057bbb5d-1858-40b5-aca6-a2b06c3ab7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7a130564-88df-4431-9a52-0ab166c327b7" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_057bbb5d-1858-40b5-aca6-a2b06c3ab7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_5eb20d19-9ab3-4614-888b-7150283ea340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7a130564-88df-4431-9a52-0ab166c327b7" xlink:to="loc_us-gaap_RestructuringCosts_5eb20d19-9ab3-4614-888b-7150283ea340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_cfbdee17-3219-425c-b183-375bacf86fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1c3a5051-8380-4595-ac49-18e4a9eb748c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_cfbdee17-3219-425c-b183-375bacf86fb0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1c3a5051-8380-4595-ac49-18e4a9eb748c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_0067c170-924f-49bb-b335-339bc03bcc95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1c3a5051-8380-4595-ac49-18e4a9eb748c" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_0067c170-924f-49bb-b335-339bc03bcc95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_47bdd90c-e46a-478d-9824-a3a2e7485928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_0067c170-924f-49bb-b335-339bc03bcc95" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_47bdd90c-e46a-478d-9824-a3a2e7485928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_add027fa-3909-4f0d-ab7b-14109d0f9a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_47bdd90c-e46a-478d-9824-a3a2e7485928" xlink:to="loc_us-gaap_EmployeeSeveranceMember_add027fa-3909-4f0d-ab7b-14109d0f9a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ContractTerminationAndOtherCostsMember_0fe88d6c-d0c5-4c3d-bce6-273b17dfdecc" xlink:href="bax-20220331.xsd#bax_ContractTerminationAndOtherCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_47bdd90c-e46a-478d-9824-a3a2e7485928" xlink:to="loc_bax_ContractTerminationAndOtherCostsMember_0fe88d6c-d0c5-4c3d-bce6-273b17dfdecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AssetImpairmentMember_986dc40b-2f3a-40e9-9b1e-7c2e1f9c0650" xlink:href="bax-20220331.xsd#bax_AssetImpairmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_47bdd90c-e46a-478d-9824-a3a2e7485928" xlink:to="loc_bax_AssetImpairmentMember_986dc40b-2f3a-40e9-9b1e-7c2e1f9c0650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1b812853-9396-40b2-9ee3-7c5d4b7c4fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1c3a5051-8380-4595-ac49-18e4a9eb748c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1b812853-9396-40b2-9ee3-7c5d4b7c4fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a6fe9dda-bdf8-498e-8606-d7762f92e739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1b812853-9396-40b2-9ee3-7c5d4b7c4fb6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a6fe9dda-bdf8-498e-8606-d7762f92e739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_3de65c58-05c5-4ec2-bdf8-c84d1c51a250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a6fe9dda-bdf8-498e-8606-d7762f92e739" xlink:to="loc_us-gaap_CostOfSalesMember_3de65c58-05c5-4ec2-bdf8-c84d1c51a250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_10025dad-51f0-4a63-9f59-d00858a74634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a6fe9dda-bdf8-498e-8606-d7762f92e739" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_10025dad-51f0-4a63-9f59-d00858a74634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8420005b-ee82-49c7-9190-f31daf5b1dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a6fe9dda-bdf8-498e-8606-d7762f92e739" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_8420005b-ee82-49c7-9190-f31daf5b1dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1f7cfb5c-ea0f-4916-8f50-4467c9c7d5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1c3a5051-8380-4595-ac49-18e4a9eb748c" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_1f7cfb5c-ea0f-4916-8f50-4467c9c7d5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b3b62c29-0841-406f-9c9d-ff0fbe3677fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1f7cfb5c-ea0f-4916-8f50-4467c9c7d5ef" xlink:to="loc_us-gaap_RestructuringCharges_b3b62c29-0841-406f-9c9d-ff0fbe3677fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_86d729fd-c689-4341-ba9a-2935e877ce1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_90886707-ecb1-4b9f-954a-245fbb3dc9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_86d729fd-c689-4341-ba9a-2935e877ce1a" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_90886707-ecb1-4b9f-954a-245fbb3dc9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_cce2796f-113d-4eff-8604-faa4496a81b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_90886707-ecb1-4b9f-954a-245fbb3dc9fd" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_cce2796f-113d-4eff-8604-faa4496a81b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_72b7ebf3-ae4c-427a-bcaf-32d644b16ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_cce2796f-113d-4eff-8604-faa4496a81b2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_72b7ebf3-ae4c-427a-bcaf-32d644b16ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember_f60400ec-b54f-465a-9a7d-22f36390b236" xlink:href="bax-20220331.xsd#bax_SeveranceAndOtherEmployeeRelatedCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_72b7ebf3-ae4c-427a-bcaf-32d644b16ef9" xlink:to="loc_bax_SeveranceAndOtherEmployeeRelatedCostsMember_f60400ec-b54f-465a-9a7d-22f36390b236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_d3daef1c-2e09-4856-a91f-67a361a77411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_90886707-ecb1-4b9f-954a-245fbb3dc9fd" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_d3daef1c-2e09-4856-a91f-67a361a77411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_03cbf617-5c14-4da8-af79-6e53c8049f50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d3daef1c-2e09-4856-a91f-67a361a77411" xlink:to="loc_us-gaap_RestructuringReserveRollForward_03cbf617-5c14-4da8-af79-6e53c8049f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_aa542cda-7f5f-4798-a07d-1bcc3e49ca11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_03cbf617-5c14-4da8-af79-6e53c8049f50" xlink:to="loc_us-gaap_RestructuringReserve_aa542cda-7f5f-4798-a07d-1bcc3e49ca11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a990931d-b144-4a0f-a733-8767c40e1dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_03cbf617-5c14-4da8-af79-6e53c8049f50" xlink:to="loc_us-gaap_RestructuringCharges_a990931d-b144-4a0f-a733-8767c40e1dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_a4968acb-7638-4edf-974f-1666037aa132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_03cbf617-5c14-4da8-af79-6e53c8049f50" xlink:to="loc_us-gaap_PaymentsForRestructuring_a4968acb-7638-4edf-974f-1666037aa132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_a8ded0aa-a906-46b7-97e4-77c4d8f04d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_03cbf617-5c14-4da8-af79-6e53c8049f50" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_a8ded0aa-a906-46b7-97e4-77c4d8f04d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2753d384-55e9-4737-ad4d-e27fcfbb7b13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_03cbf617-5c14-4da8-af79-6e53c8049f50" xlink:to="loc_us-gaap_RestructuringReserve_2753d384-55e9-4737-ad4d-e27fcfbb7b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS" xlink:type="simple" xlink:href="bax-20220331.xsd#PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5dc9593b-6014-42b4-b1ad-588f2afebe83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_fb60981d-d4f6-4a4f-9ba7-07ab82e40682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_5dc9593b-6014-42b4-b1ad-588f2afebe83" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_fb60981d-d4f6-4a4f-9ba7-07ab82e40682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables" xlink:type="simple" xlink:href="bax-20220331.xsd#PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a30bd157-4aea-4b78-b7b3-43660147b491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_d4a8ff1a-9c55-4ee7-a0e9-45d7258e251e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a30bd157-4aea-4b78-b7b3-43660147b491" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_d4a8ff1a-9c55-4ee7-a0e9-45d7258e251e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_434716dd-e175-4451-a017-296239a2a9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3e212df2-fe27-44ed-9a9f-53aaef68c88a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_434716dd-e175-4451-a017-296239a2a9a5" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3e212df2-fe27-44ed-9a9f-53aaef68c88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_e21e162e-4363-452c-804b-8f4c90bbb2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3e212df2-fe27-44ed-9a9f-53aaef68c88a" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_e21e162e-4363-452c-804b-8f4c90bbb2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b49811af-f7bc-4cb3-a709-3e27daf4a44b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e21e162e-4363-452c-804b-8f4c90bbb2f5" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b49811af-f7bc-4cb3-a709-3e27daf4a44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_7c31589f-e0b0-4a02-8f7c-7e154d93908b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b49811af-f7bc-4cb3-a709-3e27daf4a44b" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_7c31589f-e0b0-4a02-8f7c-7e154d93908b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_08e4e55b-4ad0-413a-8b1e-db032fe7b9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b49811af-f7bc-4cb3-a709-3e27daf4a44b" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_08e4e55b-4ad0-413a-8b1e-db032fe7b9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f9d50b6-6100-487a-8ff1-e428a12e3c19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_3e212df2-fe27-44ed-9a9f-53aaef68c88a" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f9d50b6-6100-487a-8ff1-e428a12e3c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_22bc2931-d1f4-4bf1-8daa-1ad1afa2b047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_5f9d50b6-6100-487a-8ff1-e428a12e3c19" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_22bc2931-d1f4-4bf1-8daa-1ad1afa2b047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_b9714cc9-fbac-4070-9bb7-4b7023dfd659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_22bc2931-d1f4-4bf1-8daa-1ad1afa2b047" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_b9714cc9-fbac-4070-9bb7-4b7023dfd659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_546fdcc0-cf57-4063-b8ed-0affef516f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_22bc2931-d1f4-4bf1-8daa-1ad1afa2b047" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_546fdcc0-cf57-4063-b8ed-0affef516f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_9b944cd9-2225-4da3-9b06-303584d24887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_22bc2931-d1f4-4bf1-8daa-1ad1afa2b047" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_9b944cd9-2225-4da3-9b06-303584d24887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_529ce5e6-0993-453d-8bb6-7624aa0eec72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_22bc2931-d1f4-4bf1-8daa-1ad1afa2b047" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_529ce5e6-0993-453d-8bb6-7624aa0eec72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3873c948-a812-4aa5-8e81-67260751db96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_22bc2931-d1f4-4bf1-8daa-1ad1afa2b047" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3873c948-a812-4aa5-8e81-67260751db96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/INCOMETAXES" xlink:type="simple" xlink:href="bax-20220331.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2bcf1de1-bf3e-46e6-9484-3e62c439fbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_314be4ac-49ae-4f40-84d1-18290ae4c57b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2bcf1de1-bf3e-46e6-9484-3e62c439fbf3" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_314be4ac-49ae-4f40-84d1-18290ae4c57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ef0488a4-8463-48ae-81c3-b73d37a072e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6c0791cd-177a-4d8c-b93a-c0a12b5bcc8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef0488a4-8463-48ae-81c3-b73d37a072e9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6c0791cd-177a-4d8c-b93a-c0a12b5bcc8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_a0a76d13-2021-4bdb-ad07-2f5655956d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ef0488a4-8463-48ae-81c3-b73d37a072e9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_a0a76d13-2021-4bdb-ad07-2f5655956d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="bax-20220331.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3dfbb7a0-c837-48f0-adc4-6f62c76fe957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_cfa8a136-b97b-4d5b-965f-5d1e0597d807" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3dfbb7a0-c837-48f0-adc4-6f62c76fe957" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_cfa8a136-b97b-4d5b-965f-5d1e0597d807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="bax-20220331.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_01d95010-bc94-40c6-be5f-1ef6e5347c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_227dc9f6-c6b8-4461-94be-6f7ef3a1001f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_01d95010-bc94-40c6-be5f-1ef6e5347c9a" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_227dc9f6-c6b8-4461-94be-6f7ef3a1001f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_51aaf02f-7c2f-40d5-a2e5-8ef8212cf394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a677acfc-547b-4f95-8623-afc732ad7dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_51aaf02f-7c2f-40d5-a2e5-8ef8212cf394" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a677acfc-547b-4f95-8623-afc732ad7dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0df09bec-43b2-4622-954c-f82d97779f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a677acfc-547b-4f95-8623-afc732ad7dd4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0df09bec-43b2-4622-954c-f82d97779f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_54b4b4b1-2092-40a9-b2ff-70ab5a7c88f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a677acfc-547b-4f95-8623-afc732ad7dd4" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_54b4b4b1-2092-40a9-b2ff-70ab5a7c88f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_de180d6f-aa5c-4cba-8a3c-0c9e07e43732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_a677acfc-547b-4f95-8623-afc732ad7dd4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_de180d6f-aa5c-4cba-8a3c-0c9e07e43732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#EARNINGSPERSHAREAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_53996aac-9f1f-4501-82bb-d0f659c803f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d7e7b09a-09d2-425a-826f-4b1f1af293e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_53996aac-9f1f-4501-82bb-d0f659c803f1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d7e7b09a-09d2-425a-826f-4b1f1af293e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="simple" xlink:href="bax-20220331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_185c8f3a-1589-42bf-9578-d00cf3f35015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_0c8b3932-be86-4df3-97f3-2fa7a2a55337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_185c8f3a-1589-42bf-9578-d00cf3f35015" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_0c8b3932-be86-4df3-97f3-2fa7a2a55337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="simple" xlink:href="bax-20220331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0d84a15a-c88a-45b3-a09c-7c1fdd8fc24f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_113e77b5-ae41-4b7b-bdc0-d92fc9b3fccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0d84a15a-c88a-45b3-a09c-7c1fdd8fc24f" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_113e77b5-ae41-4b7b-bdc0-d92fc9b3fccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_3c50bad9-0f83-47bc-9417-42cd52f7bf33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0d84a15a-c88a-45b3-a09c-7c1fdd8fc24f" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_3c50bad9-0f83-47bc-9417-42cd52f7bf33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock_13ad74e1-5d8b-4a5f-9884-d0a2e58124dc" xlink:href="bax-20220331.xsd#bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0d84a15a-c88a-45b3-a09c-7c1fdd8fc24f" xlink:to="loc_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock_13ad74e1-5d8b-4a5f-9884-d0a2e58124dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1c820361-dc0b-43e2-a282-d7e74391ebfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0d84a15a-c88a-45b3-a09c-7c1fdd8fc24f" xlink:to="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1c820361-dc0b-43e2-a282-d7e74391ebfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2b99f8ef-86dd-4dc2-aaa8-004e1df02c18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_752fb7bc-e335-4492-8399-29c3ddd648d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2b99f8ef-86dd-4dc2-aaa8-004e1df02c18" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_752fb7bc-e335-4492-8399-29c3ddd648d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e01e2807-61d8-4b5d-be09-73d2cbc59c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_752fb7bc-e335-4492-8399-29c3ddd648d3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e01e2807-61d8-4b5d-be09-73d2cbc59c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bd2da3af-0e0c-473d-a29d-b393c2766ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e01e2807-61d8-4b5d-be09-73d2cbc59c9c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bd2da3af-0e0c-473d-a29d-b393c2766ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_9560fe37-6d06-47b1-8a94-c6dc5d356f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd2da3af-0e0c-473d-a29d-b393c2766ea1" xlink:to="loc_us-gaap_ForeignExchangeContractMember_9560fe37-6d06-47b1-8a94-c6dc5d356f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_20b0cf7d-1c74-485d-9e03-ae02a394bdac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd2da3af-0e0c-473d-a29d-b393c2766ea1" xlink:to="loc_us-gaap_InterestRateContractMember_20b0cf7d-1c74-485d-9e03-ae02a394bdac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e30b9ab4-731d-4fbc-b0d9-444e4049a351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bd2da3af-0e0c-473d-a29d-b393c2766ea1" xlink:to="loc_us-gaap_InterestRateSwapMember_e30b9ab4-731d-4fbc-b0d9-444e4049a351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6553ad22-7be6-439f-806f-4dd58c809bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_752fb7bc-e335-4492-8399-29c3ddd648d3" xlink:to="loc_us-gaap_DebtInstrumentAxis_6553ad22-7be6-439f-806f-4dd58c809bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_477c8c92-f028-4913-87bf-2629556e4e52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6553ad22-7be6-439f-806f-4dd58c809bd2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_477c8c92-f028-4913-87bf-2629556e4e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember_0c2780af-44ff-4670-ad7e-c749cb41a34a" xlink:href="bax-20220331.xsd#bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_477c8c92-f028-4913-87bf-2629556e4e52" xlink:to="loc_bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember_0c2780af-44ff-4670-ad7e-c749cb41a34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember_71bd050a-38e1-4994-a960-02c59e13bdca" xlink:href="bax-20220331.xsd#bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_477c8c92-f028-4913-87bf-2629556e4e52" xlink:to="loc_bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember_71bd050a-38e1-4994-a960-02c59e13bdca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember_2e660451-d16f-4f03-b792-7bf7b4d2d6cd" xlink:href="bax-20220331.xsd#bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_477c8c92-f028-4913-87bf-2629556e4e52" xlink:to="loc_bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember_2e660451-d16f-4f03-b792-7bf7b4d2d6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_338522f3-707d-4304-af70-d2d85676c3d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_752fb7bc-e335-4492-8399-29c3ddd648d3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_338522f3-707d-4304-af70-d2d85676c3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a3757d81-b0f4-4479-8687-4eae8810c551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_338522f3-707d-4304-af70-d2d85676c3d1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a3757d81-b0f4-4479-8687-4eae8810c551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_92c18a3e-d733-4ff3-833d-32bb309f4fed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a3757d81-b0f4-4479-8687-4eae8810c551" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_92c18a3e-d733-4ff3-833d-32bb309f4fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_362dfc1c-2495-4f8c-80a4-23439810fe69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_752fb7bc-e335-4492-8399-29c3ddd648d3" xlink:to="loc_us-gaap_HedgingDesignationAxis_362dfc1c-2495-4f8c-80a4-23439810fe69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7eaeb844-8fce-4358-91e5-e043565b962a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_362dfc1c-2495-4f8c-80a4-23439810fe69" xlink:to="loc_us-gaap_HedgingDesignationDomain_7eaeb844-8fce-4358-91e5-e043565b962a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_33808d4c-4eb5-40ff-b825-8d115cc8166a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_7eaeb844-8fce-4358-91e5-e043565b962a" xlink:to="loc_us-gaap_NondesignatedMember_33808d4c-4eb5-40ff-b825-8d115cc8166a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_752fb7bc-e335-4492-8399-29c3ddd648d3" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_9208f7a9-3ccf-45a5-9ecf-4b28c72fa562" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_us-gaap_DerivativeNotionalAmount_9208f7a9-3ccf-45a5-9ecf-4b28c72fa562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_cdc3da7d-1dc2-4b1a-b577-6546be45d195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1_cdc3da7d-1dc2-4b1a-b577-6546be45d195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_f111e6dc-e786-46d3-99e2-434c286dea18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_f111e6dc-e786-46d3-99e2-434c286dea18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1f51af0b-d7e2-4ed0-989f-20c344a34b45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1f51af0b-d7e2-4ed0-989f-20c344a34b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0115ee78-59de-43fe-8f69-44c65a0a3ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0115ee78-59de-43fe-8f69-44c65a0a3ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeFairValueTerminated_5692e768-544f-4780-bb13-1fad09b80391" xlink:href="bax-20220331.xsd#bax_DerivativeFairValueTerminated"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_bax_DerivativeFairValueTerminated_5692e768-544f-4780-bb13-1fad09b80391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeNetInvestmentTerminated_114f2eb0-a6a8-4365-8c16-d684a715dee9" xlink:href="bax-20220331.xsd#bax_DerivativeNetInvestmentTerminated"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_bax_DerivativeNetInvestmentTerminated_114f2eb0-a6a8-4365-8c16-d684a715dee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_2e996cb0-2ac9-48b5-a00a-19334161a136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b8ef7aa5-cd3b-47e8-be73-d15b9d0b9ced" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_2e996cb0-2ac9-48b5-a00a-19334161a136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_da66edc3-cb06-40bd-914f-afcbd321c8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_55321523-0710-4d09-bda5-eadaf5404f50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_da66edc3-cb06-40bd-914f-afcbd321c8b0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_55321523-0710-4d09-bda5-eadaf5404f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2237f9c7-dddd-4a90-b68d-626209b445fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_55321523-0710-4d09-bda5-eadaf5404f50" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2237f9c7-dddd-4a90-b68d-626209b445fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f6af21e0-c01a-4e1c-b9aa-c2b7ab6d461c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2237f9c7-dddd-4a90-b68d-626209b445fa" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f6af21e0-c01a-4e1c-b9aa-c2b7ab6d461c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_f987edef-e3df-4e2d-91ae-d04fec851bda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f6af21e0-c01a-4e1c-b9aa-c2b7ab6d461c" xlink:to="loc_us-gaap_InterestRateContractMember_f987edef-e3df-4e2d-91ae-d04fec851bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f5a25aad-1dc0-4332-98e8-92129008b522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f6af21e0-c01a-4e1c-b9aa-c2b7ab6d461c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f5a25aad-1dc0-4332-98e8-92129008b522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_07e53ea7-a771-4f60-9d34-836b27b03be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_55321523-0710-4d09-bda5-eadaf5404f50" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_07e53ea7-a771-4f60-9d34-836b27b03be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5c1ec7e0-01ab-4974-a201-ec3a9bb05d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_07e53ea7-a771-4f60-9d34-836b27b03be1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5c1ec7e0-01ab-4974-a201-ec3a9bb05d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_28f50453-ae6d-4b96-b1b4-e3d99e8c2166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_5c1ec7e0-01ab-4974-a201-ec3a9bb05d8c" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_28f50453-ae6d-4b96-b1b4-e3d99e8c2166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_dd809d6a-4809-4b5c-badc-465fa5e7df22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_55321523-0710-4d09-bda5-eadaf5404f50" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_dd809d6a-4809-4b5c-badc-465fa5e7df22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c48010ef-f1da-4104-bbfe-6a42eb7d6b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dd809d6a-4809-4b5c-badc-465fa5e7df22" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c48010ef-f1da-4104-bbfe-6a42eb7d6b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_7fcc6e0a-f585-4506-bace-e2aae3401b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c48010ef-f1da-4104-bbfe-6a42eb7d6b2d" xlink:to="loc_us-gaap_InterestExpenseMember_7fcc6e0a-f585-4506-bace-e2aae3401b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_32b6f65e-3719-4eac-9ec3-1ced70d68901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c48010ef-f1da-4104-bbfe-6a42eb7d6b2d" xlink:to="loc_us-gaap_CostOfSalesMember_32b6f65e-3719-4eac-9ec3-1ced70d68901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_6284fc73-267f-44ea-b8a8-450f8ece283c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c48010ef-f1da-4104-bbfe-6a42eb7d6b2d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_6284fc73-267f-44ea-b8a8-450f8ece283c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e7aa694c-d6f2-4daf-8608-30fd3b153de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_55321523-0710-4d09-bda5-eadaf5404f50" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e7aa694c-d6f2-4daf-8608-30fd3b153de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_acf588db-6725-43e6-9514-b7e9bf77f772" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e7aa694c-d6f2-4daf-8608-30fd3b153de2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_acf588db-6725-43e6-9514-b7e9bf77f772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_3024a9f1-a43f-4d71-92f7-f8b81445d24d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e7aa694c-d6f2-4daf-8608-30fd3b153de2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_3024a9f1-a43f-4d71-92f7-f8b81445d24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_993581fb-1d33-417f-bdf6-1b0108006cb1" xlink:href="bax-20220331.xsd#bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e7aa694c-d6f2-4daf-8608-30fd3b153de2" xlink:to="loc_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax_993581fb-1d33-417f-bdf6-1b0108006cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_a2e136b4-a6f4-4d3f-b1cc-8d7534a3c281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e7aa694c-d6f2-4daf-8608-30fd3b153de2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_a2e136b4-a6f4-4d3f-b1cc-8d7534a3c281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_b9f028d5-6fde-4588-b91c-b776dbd9cb4e" xlink:href="bax-20220331.xsd#bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e7aa694c-d6f2-4daf-8608-30fd3b153de2" xlink:to="loc_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax_b9f028d5-6fde-4588-b91c-b776dbd9cb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a7c45126-5dc5-47a1-b7a8-66a3f51df805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e7aa694c-d6f2-4daf-8608-30fd3b153de2" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a7c45126-5dc5-47a1-b7a8-66a3f51df805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_abeb9508-228d-45cf-9134-1ae9a1782f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_934152d0-ce66-4bd3-9c8b-40bcd8847679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_abeb9508-228d-45cf-9134-1ae9a1782f0d" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_934152d0-ce66-4bd3-9c8b-40bcd8847679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d6e837f0-efb1-420e-8137-bed8b3b99a10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_934152d0-ce66-4bd3-9c8b-40bcd8847679" xlink:to="loc_us-gaap_HedgingDesignationAxis_d6e837f0-efb1-420e-8137-bed8b3b99a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_811ced80-766c-453a-b7a0-c8ec9f3a36f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d6e837f0-efb1-420e-8137-bed8b3b99a10" xlink:to="loc_us-gaap_HedgingDesignationDomain_811ced80-766c-453a-b7a0-c8ec9f3a36f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6ddb3f0c-7b24-496f-9de6-ec2fff413411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_811ced80-766c-453a-b7a0-c8ec9f3a36f3" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6ddb3f0c-7b24-496f-9de6-ec2fff413411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_b8bdec0a-bb96-40a6-87d0-c09e32a38f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_811ced80-766c-453a-b7a0-c8ec9f3a36f3" xlink:to="loc_us-gaap_NondesignatedMember_b8bdec0a-bb96-40a6-87d0-c09e32a38f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_587e4e10-2b0e-4f1a-80fd-2119c58a3c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_934152d0-ce66-4bd3-9c8b-40bcd8847679" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_587e4e10-2b0e-4f1a-80fd-2119c58a3c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_61952495-8746-4d58-bdf3-b2eaa013d653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_587e4e10-2b0e-4f1a-80fd-2119c58a3c1b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_61952495-8746-4d58-bdf3-b2eaa013d653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_2a75aa86-c5ef-4d65-82bc-f245594b16dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_61952495-8746-4d58-bdf3-b2eaa013d653" xlink:to="loc_us-gaap_ForeignExchangeContractMember_2a75aa86-c5ef-4d65-82bc-f245594b16dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1aef575b-2b00-499e-b3c7-aea30f48a554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_934152d0-ce66-4bd3-9c8b-40bcd8847679" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1aef575b-2b00-499e-b3c7-aea30f48a554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_daa4e58f-5cbd-4b02-8752-fe0e0eeddff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1aef575b-2b00-499e-b3c7-aea30f48a554" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_daa4e58f-5cbd-4b02-8752-fe0e0eeddff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_282ce71b-e4ba-4923-900f-24cd8915e39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_daa4e58f-5cbd-4b02-8752-fe0e0eeddff6" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_282ce71b-e4ba-4923-900f-24cd8915e39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_ae01d084-3118-42f5-8ccb-df40f41e55fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_daa4e58f-5cbd-4b02-8752-fe0e0eeddff6" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_ae01d084-3118-42f5-8ccb-df40f41e55fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_ae9ad857-1a75-467c-bee4-0b1bdb2f66e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_934152d0-ce66-4bd3-9c8b-40bcd8847679" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_ae9ad857-1a75-467c-bee4-0b1bdb2f66e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_8067f529-045f-46fe-aa0e-d4bc07e2660e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ae9ad857-1a75-467c-bee4-0b1bdb2f66e7" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_8067f529-045f-46fe-aa0e-d4bc07e2660e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_c78a49c8-4ad1-4783-af80-fccc1edeb155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_ae9ad857-1a75-467c-bee4-0b1bdb2f66e7" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_c78a49c8-4ad1-4783-af80-fccc1edeb155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3e3480c5-cf6a-4540-a0b4-e5bb0ddc018e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract_34ea225d-b6e2-41af-9083-62a4851d7d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3e3480c5-cf6a-4540-a0b4-e5bb0ddc018e" xlink:to="loc_us-gaap_DerivativeAssetsAbstract_34ea225d-b6e2-41af-9083-62a4851d7d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6d15bdf8-7eb2-4218-a8ab-02cc39ecb77d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_34ea225d-b6e2-41af-9083-62a4851d7d1a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6d15bdf8-7eb2-4218-a8ab-02cc39ecb77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_f45efc0b-f5a9-4a7c-a7cb-d32cf8d1c1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_34ea225d-b6e2-41af-9083-62a4851d7d1a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral_f45efc0b-f5a9-4a7c-a7cb-d32cf8d1c1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability_1332510b-f270-4845-b792-ee745435faf6" xlink:href="bax-20220331.xsd#bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_34ea225d-b6e2-41af-9083-62a4851d7d1a" xlink:to="loc_bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability_1332510b-f270-4845-b792-ee745435faf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract_00a3d5fa-51fd-47a3-bc7c-c9ac401a9038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3e3480c5-cf6a-4540-a0b4-e5bb0ddc018e" xlink:to="loc_us-gaap_DerivativeLiabilitiesAbstract_00a3d5fa-51fd-47a3-bc7c-c9ac401a9038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_23ca14c7-85a4-477a-8588-c1c452aeaddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_00a3d5fa-51fd-47a3-bc7c-c9ac401a9038" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_23ca14c7-85a4-477a-8588-c1c452aeaddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_56622df7-0da1-4014-a16b-988d630ad519" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_00a3d5fa-51fd-47a3-bc7c-c9ac401a9038" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral_56622df7-0da1-4014-a16b-988d630ad519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets_10836a13-c33d-461c-829e-cf687759354e" xlink:href="bax-20220331.xsd#bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_00a3d5fa-51fd-47a3-bc7c-c9ac401a9038" xlink:to="loc_bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets_10836a13-c33d-461c-829e-cf687759354e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_539d9a53-4358-49fe-89bd-860ecd7fc8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_79871f7c-9b68-4d68-a5a5-802618d26351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_539d9a53-4358-49fe-89bd-860ecd7fc8e8" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_79871f7c-9b68-4d68-a5a5-802618d26351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e7cf5515-770b-4010-86a6-3f9b7eb1a94e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_79871f7c-9b68-4d68-a5a5-802618d26351" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e7cf5515-770b-4010-86a6-3f9b7eb1a94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_538e1f3f-4e70-4a9a-bfc7-a957ffef3f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e7cf5515-770b-4010-86a6-3f9b7eb1a94e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_538e1f3f-4e70-4a9a-bfc7-a957ffef3f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_d70e8a2d-0aa8-48a7-a759-4cdd065a04c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_538e1f3f-4e70-4a9a-bfc7-a957ffef3f0a" xlink:to="loc_us-gaap_LongTermDebtMember_d70e8a2d-0aa8-48a7-a759-4cdd065a04c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_24798bcb-da8a-4071-afc6-29cb8cf8fde9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_79871f7c-9b68-4d68-a5a5-802618d26351" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_24798bcb-da8a-4071-afc6-29cb8cf8fde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge_fcebfc93-1613-4566-839c-28f25a1eb760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_24798bcb-da8a-4071-afc6-29cb8cf8fde9" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedge_fcebfc93-1613-4566-839c-28f25a1eb760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_c2267233-86c9-4db9-bc2b-9927e009ba94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_24798bcb-da8a-4071-afc6-29cb8cf8fde9" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_c2267233-86c9-4db9-bc2b-9927e009ba94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="bax-20220331.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3c275689-6d5e-4c47-ac48-48e85057ba7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_0fd9b31b-7040-410f-9768-6e8e8cc88aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3c275689-6d5e-4c47-ac48-48e85057ba7c" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_0fd9b31b-7040-410f-9768-6e8e8cc88aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="bax-20220331.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f25c1459-a3d5-4aa6-835a-b72284130d24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_43b5c454-52d5-4d6d-8e57-da1cfbdbacd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f25c1459-a3d5-4aa6-835a-b72284130d24" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_43b5c454-52d5-4d6d-8e57-da1cfbdbacd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_63db74ae-43b1-434f-8f1b-4ddc7ca46aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f25c1459-a3d5-4aa6-835a-b72284130d24" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_63db74ae-43b1-434f-8f1b-4ddc7ca46aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_6870f605-d085-47aa-b2ae-5fca667c45aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f25c1459-a3d5-4aa6-835a-b72284130d24" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_6870f605-d085-47aa-b2ae-5fca667c45aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c5a8c429-53bc-41fc-8bc7-aa30ead532e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483035b9-6cfc-4804-b785-6dfe77ea42f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c5a8c429-53bc-41fc-8bc7-aa30ead532e4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483035b9-6cfc-4804-b785-6dfe77ea42f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_43bbba4e-da44-4b3c-b5be-d915b03c2184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483035b9-6cfc-4804-b785-6dfe77ea42f5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_43bbba4e-da44-4b3c-b5be-d915b03c2184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8ad90fa7-b3eb-4e36-8689-ffb2854bf727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_43bbba4e-da44-4b3c-b5be-d915b03c2184" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8ad90fa7-b3eb-4e36-8689-ffb2854bf727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4c76b3a3-1edf-4670-9b1e-7762ead0a9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8ad90fa7-b3eb-4e36-8689-ffb2854bf727" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4c76b3a3-1edf-4670-9b1e-7762ead0a9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_30c1f00f-856f-487d-a97f-6f99b08ff13e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483035b9-6cfc-4804-b785-6dfe77ea42f5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_30c1f00f-856f-487d-a97f-6f99b08ff13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f2af076-8157-43da-9448-f5a149d15f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_30c1f00f-856f-487d-a97f-6f99b08ff13e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f2af076-8157-43da-9448-f5a149d15f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_24c48544-4134-4eed-a68e-ae102b2afe1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f2af076-8157-43da-9448-f5a149d15f71" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_24c48544-4134-4eed-a68e-ae102b2afe1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ac682694-b184-47cc-a70e-e782bd7a63cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f2af076-8157-43da-9448-f5a149d15f71" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ac682694-b184-47cc-a70e-e782bd7a63cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d1eedd97-398a-45df-b949-347a130e3077" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1f2af076-8157-43da-9448-f5a149d15f71" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d1eedd97-398a-45df-b949-347a130e3077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_815aac2a-3761-4e0b-a573-8cc8099c95d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_483035b9-6cfc-4804-b785-6dfe77ea42f5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_815aac2a-3761-4e0b-a573-8cc8099c95d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_f4ef884d-37d9-4b1f-b4d3-a35e85865cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_815aac2a-3761-4e0b-a573-8cc8099c95d4" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_f4ef884d-37d9-4b1f-b4d3-a35e85865cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_76d8eb9a-d555-4d3f-a4e0-d513a4d27a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_f4ef884d-37d9-4b1f-b4d3-a35e85865cd1" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue_76d8eb9a-d555-4d3f-a4e0-d513a4d27a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecurities_eae4e58b-3537-48d2-91e8-e62e728f5f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_f4ef884d-37d9-4b1f-b4d3-a35e85865cd1" xlink:to="loc_us-gaap_DebtSecurities_eae4e58b-3537-48d2-91e8-e62e728f5f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_3d5d9e54-79ac-4f98-b208-58917b979fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_f4ef884d-37d9-4b1f-b4d3-a35e85865cd1" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_3d5d9e54-79ac-4f98-b208-58917b979fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_129e04fd-2603-4ffe-ac4e-f8dd1f46485c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_f4ef884d-37d9-4b1f-b4d3-a35e85865cd1" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_129e04fd-2603-4ffe-ac4e-f8dd1f46485c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_127a61e0-edf4-4141-88a5-f9224da9617c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_815aac2a-3761-4e0b-a573-8cc8099c95d4" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_127a61e0-edf4-4141-88a5-f9224da9617c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_453aca33-e953-44b5-8053-a3eaa1097d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_127a61e0-edf4-4141-88a5-f9224da9617c" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue_453aca33-e953-44b5-8053-a3eaa1097d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_29dc3f9c-5397-4c57-9c0c-0887ff97a19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_127a61e0-edf4-4141-88a5-f9224da9617c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_29dc3f9c-5397-4c57-9c0c-0887ff97a19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_d638b539-5daf-488f-963f-6f94c190b413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_127a61e0-edf4-4141-88a5-f9224da9617c" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_d638b539-5daf-488f-963f-6f94c190b413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#FAIRVALUEMEASUREMENTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7429edf2-3cce-401c-a209-da57b3e8bf44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresTable_306a5cca-e8df-4530-b6f1-1a17e44e6df5" xlink:href="bax-20220331.xsd#bax_FairValueDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7429edf2-3cce-401c-a209-da57b3e8bf44" xlink:to="loc_bax_FairValueDisclosuresTable_306a5cca-e8df-4530-b6f1-1a17e44e6df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9a928ae-a8e0-4554-ba7f-c4ddd6ece9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_306a5cca-e8df-4530-b6f1-1a17e44e6df5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9a928ae-a8e0-4554-ba7f-c4ddd6ece9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82f5fd48-201f-4248-91e0-628ed2ed7249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d9a928ae-a8e0-4554-ba7f-c4ddd6ece9aa" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82f5fd48-201f-4248-91e0-628ed2ed7249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c7a5fc8b-44b4-49be-b672-f2ac2a67666f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_82f5fd48-201f-4248-91e0-628ed2ed7249" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c7a5fc8b-44b4-49be-b672-f2ac2a67666f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7a58c3ad-2c7f-41fd-949f-4b7faf5acdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_306a5cca-e8df-4530-b6f1-1a17e44e6df5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7a58c3ad-2c7f-41fd-949f-4b7faf5acdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1f4fc798-9d34-44f1-a4fd-7225b31b0f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a58c3ad-2c7f-41fd-949f-4b7faf5acdfe" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1f4fc798-9d34-44f1-a4fd-7225b31b0f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_4f92942f-c6c1-49ba-958d-bec50050fa63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1f4fc798-9d34-44f1-a4fd-7225b31b0f3f" xlink:to="loc_us-gaap_OtherAssetsMember_4f92942f-c6c1-49ba-958d-bec50050fa63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresLineItems_7b2b89b8-f930-497f-af9e-f5cee038c3b7" xlink:href="bax-20220331.xsd#bax_FairValueDisclosuresLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_306a5cca-e8df-4530-b6f1-1a17e44e6df5" xlink:to="loc_bax_FairValueDisclosuresLineItems_7b2b89b8-f930-497f-af9e-f5cee038c3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6e7d4fe8-5705-4db6-bb04-6c37ed6d3539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresLineItems_7b2b89b8-f930-497f-af9e-f5cee038c3b7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6e7d4fe8-5705-4db6-bb04-6c37ed6d3539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_61f31309-9e26-4f3d-96a5-ffdd1c9baaa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresLineItems_7b2b89b8-f930-497f-af9e-f5cee038c3b7" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_61f31309-9e26-4f3d-96a5-ffdd1c9baaa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_97d069c5-d11c-43c4-a15f-dcfe306c594d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresLineItems_7b2b89b8-f930-497f-af9e-f5cee038c3b7" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableFairValue_97d069c5-d11c-43c4-a15f-dcfe306c594d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_606f5092-3ec4-48e2-a923-0114120ce433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresTable_82e79cdb-7367-490d-a602-4bd8838c74dd" xlink:href="bax-20220331.xsd#bax_FairValueDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_606f5092-3ec4-48e2-a923-0114120ce433" xlink:to="loc_bax_FairValueDisclosuresTable_82e79cdb-7367-490d-a602-4bd8838c74dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_9f3c9b70-5942-49ca-80f8-a5c40c781371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_82e79cdb-7367-490d-a602-4bd8838c74dd" xlink:to="loc_us-gaap_FinancialInstrumentAxis_9f3c9b70-5942-49ca-80f8-a5c40c781371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0dd8b20-2403-4593-9c3d-d63abfb4195c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9f3c9b70-5942-49ca-80f8-a5c40c781371" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0dd8b20-2403-4593-9c3d-d63abfb4195c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_5cf6f184-ad6d-43b5-9412-53d121675a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0dd8b20-2403-4593-9c3d-d63abfb4195c" xlink:to="loc_us-gaap_DebtSecuritiesMember_5cf6f184-ad6d-43b5-9412-53d121675a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_15f07e53-91c0-4543-a6f0-6ddb1a3de199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c0dd8b20-2403-4593-9c3d-d63abfb4195c" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_15f07e53-91c0-4543-a6f0-6ddb1a3de199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueDisclosuresLineItems_cc27308c-f6d1-45bf-9345-27ecc3eeb5a6" xlink:href="bax-20220331.xsd#bax_FairValueDisclosuresLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresTable_82e79cdb-7367-490d-a602-4bd8838c74dd" xlink:to="loc_bax_FairValueDisclosuresLineItems_cc27308c-f6d1-45bf-9345-27ecc3eeb5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_179a361b-b457-4dde-9d63-986e9fe41f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueDisclosuresLineItems_cc27308c-f6d1-45bf-9345-27ecc3eeb5a6" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_179a361b-b457-4dde-9d63-986e9fe41f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fedeec6b-0a43-42a8-bedb-689ee74a424f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_179a361b-b457-4dde-9d63-986e9fe41f87" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fedeec6b-0a43-42a8-bedb-689ee74a424f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_46aa5db1-598a-4388-9b50-bb77b9e72d62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_179a361b-b457-4dde-9d63-986e9fe41f87" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_46aa5db1-598a-4388-9b50-bb77b9e72d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_8bb26e7f-d44f-4ea9-bf22-dc5f35bd282a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_179a361b-b457-4dde-9d63-986e9fe41f87" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_8bb26e7f-d44f-4ea9-bf22-dc5f35bd282a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_adfd7f07-286b-4080-8e22-236c789f20ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_179a361b-b457-4dde-9d63-986e9fe41f87" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_adfd7f07-286b-4080-8e22-236c789f20ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_f40ab158-6e0a-4ec7-adba-4dd1c86fe784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_179a361b-b457-4dde-9d63-986e9fe41f87" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_f40ab158-6e0a-4ec7-adba-4dd1c86fe784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8d3ed754-60a5-45d1-b8d6-ae3c48525d38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_179a361b-b457-4dde-9d63-986e9fe41f87" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8d3ed754-60a5-45d1-b8d6-ae3c48525d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b339f862-00b9-4578-b5d8-f6d666d84f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_aab2ebc0-292c-4e3f-aa7e-fed0db98f2e6" xlink:href="bax-20220331.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b339f862-00b9-4578-b5d8-f6d666d84f14" xlink:to="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_aab2ebc0-292c-4e3f-aa7e-fed0db98f2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_ff873e3b-23eb-4775-8870-d5c18901b7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_aab2ebc0-292c-4e3f-aa7e-fed0db98f2e6" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_ff873e3b-23eb-4775-8870-d5c18901b7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_2793100a-ca27-452c-9f4e-d539594021a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_ff873e3b-23eb-4775-8870-d5c18901b7d5" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_2793100a-ca27-452c-9f4e-d539594021a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_44af2856-18e7-4adf-915e-06892610d7d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_2793100a-ca27-452c-9f4e-d539594021a8" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_44af2856-18e7-4adf-915e-06892610d7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_bf19fc68-e5ba-4ce8-925f-3ecd3151edab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_2793100a-ca27-452c-9f4e-d539594021a8" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_bf19fc68-e5ba-4ce8-925f-3ecd3151edab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_f30bc4c5-cc6e-484f-aca4-83ad1b2eb83b" xlink:href="bax-20220331.xsd#bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingTable_aab2ebc0-292c-4e3f-aa7e-fed0db98f2e6" xlink:to="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_f30bc4c5-cc6e-484f-aca4-83ad1b2eb83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtFairValue_c24c9a2d-e509-4ae7-92aa-785c1e91d39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShorttermDebtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_f30bc4c5-cc6e-484f-aca4-83ad1b2eb83b" xlink:to="loc_us-gaap_ShorttermDebtFairValue_c24c9a2d-e509-4ae7-92aa-785c1e91d39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_5f1b1518-69e4-43e7-b2e7-1cb7fd3e7ca1" xlink:href="bax-20220331.xsd#bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_f30bc4c5-cc6e-484f-aca4-83ad1b2eb83b" xlink:to="loc_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure_5f1b1518-69e4-43e7-b2e7-1cb7fd3e7ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure_47eb73af-65c7-4c32-bae1-d23e11c69aaf" xlink:href="bax-20220331.xsd#bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems_f30bc4c5-cc6e-484f-aca4-83ad1b2eb83b" xlink:to="loc_bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure_47eb73af-65c7-4c32-bae1-d23e11c69aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATION" xlink:type="simple" xlink:href="bax-20220331.xsd#SEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6651232a-2593-4d0e-822f-263cd7bda67f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_66f3ddee-30c0-4f3f-894b-cbb642995e96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6651232a-2593-4d0e-822f-263cd7bda67f" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_66f3ddee-30c0-4f3f-894b-cbb642995e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="bax-20220331.xsd#SEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cb334d10-c964-41ae-a26b-a40e7e4d36d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_807498c9-cb23-4a7a-a283-a48cb6e1368b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cb334d10-c964-41ae-a26b-a40e7e4d36d2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_807498c9-cb23-4a7a-a283-a48cb6e1368b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_a153ece4-a722-45f0-ba4c-dfac21b886e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cb334d10-c964-41ae-a26b-a40e7e4d36d2" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_a153ece4-a722-45f0-ba4c-dfac21b886e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9419293d-bef1-4fd1-891a-eadfe5e65e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6aa23b85-7936-4f00-890e-73ab3efd269b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9419293d-bef1-4fd1-891a-eadfe5e65e1b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6aa23b85-7936-4f00-890e-73ab3efd269b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_737baa70-0303-4257-813c-eafaafb597da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6aa23b85-7936-4f00-890e-73ab3efd269b" xlink:to="loc_srt_ConsolidationItemsAxis_737baa70-0303-4257-813c-eafaafb597da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c9748140-c335-4ecc-b29a-1e1ed0b6d559" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_737baa70-0303-4257-813c-eafaafb597da" xlink:to="loc_srt_ConsolidationItemsDomain_c9748140-c335-4ecc-b29a-1e1ed0b6d559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2d2de227-4830-47b7-9159-41ecd3432c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c9748140-c335-4ecc-b29a-1e1ed0b6d559" xlink:to="loc_us-gaap_OperatingSegmentsMember_2d2de227-4830-47b7-9159-41ecd3432c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_471d3e16-6c07-4cc9-bd43-0d18d91d3cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6aa23b85-7936-4f00-890e-73ab3efd269b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_471d3e16-6c07-4cc9-bd43-0d18d91d3cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9de67a20-cb6b-4e5c-b5bf-a8249598bd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_471d3e16-6c07-4cc9-bd43-0d18d91d3cd5" xlink:to="loc_us-gaap_SegmentDomain_9de67a20-cb6b-4e5c-b5bf-a8249598bd7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AmericasSegmentMember_2e79a476-13c5-47c7-b11a-291e92286bd2" xlink:href="bax-20220331.xsd#bax_AmericasSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9de67a20-cb6b-4e5c-b5bf-a8249598bd7c" xlink:to="loc_bax_AmericasSegmentMember_2e79a476-13c5-47c7-b11a-291e92286bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_EMEASegmentMember_1152e046-c703-47b7-ba72-6e7514abfb5a" xlink:href="bax-20220331.xsd#bax_EMEASegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9de67a20-cb6b-4e5c-b5bf-a8249598bd7c" xlink:to="loc_bax_EMEASegmentMember_1152e046-c703-47b7-ba72-6e7514abfb5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_AsiaPacificSegmentMember_28306b87-af74-478c-8fba-200024042348" xlink:href="bax-20220331.xsd#bax_AsiaPacificSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9de67a20-cb6b-4e5c-b5bf-a8249598bd7c" xlink:to="loc_bax_AsiaPacificSegmentMember_28306b87-af74-478c-8fba-200024042348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_b012463f-7a7e-452b-8110-19175f57de67" xlink:href="bax-20220331.xsd#bax_HillromMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9de67a20-cb6b-4e5c-b5bf-a8249598bd7c" xlink:to="loc_bax_HillromMember_b012463f-7a7e-452b-8110-19175f57de67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_797757b2-0206-4305-a300-c50aabc65b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6aa23b85-7936-4f00-890e-73ab3efd269b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_797757b2-0206-4305-a300-c50aabc65b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_f15dd263-3b92-4bd5-875a-828663aaee0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_797757b2-0206-4305-a300-c50aabc65b5d" xlink:to="loc_us-gaap_NumberOfOperatingSegments_f15dd263-3b92-4bd5-875a-828663aaee0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5a3e4079-83b3-4010-85bf-568d5a6880db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_797757b2-0206-4305-a300-c50aabc65b5d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5a3e4079-83b3-4010-85bf-568d5a6880db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3048c502-4bb6-482f-bd7d-b8c47c0c0c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_797757b2-0206-4305-a300-c50aabc65b5d" xlink:to="loc_us-gaap_OperatingIncomeLoss_3048c502-4bb6-482f-bd7d-b8c47c0c0c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails" xlink:type="simple" xlink:href="bax-20220331.xsd#SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6f5ca883-5f0b-47c8-bce9-8daa62b04a00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_e2236a9a-ee0d-4eed-af8c-7173a3372211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6f5ca883-5f0b-47c8-bce9-8daa62b04a00" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_e2236a9a-ee0d-4eed-af8c-7173a3372211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f7dc01c8-6835-4a19-86c9-f8a737bbf038" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_e2236a9a-ee0d-4eed-af8c-7173a3372211" xlink:to="loc_srt_ConsolidationItemsAxis_f7dc01c8-6835-4a19-86c9-f8a737bbf038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5cc50416-f2fa-4f56-af89-f0c7710f8bcf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_f7dc01c8-6835-4a19-86c9-f8a737bbf038" xlink:to="loc_srt_ConsolidationItemsDomain_5cc50416-f2fa-4f56-af89-f0c7710f8bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_42f3e688-ef40-493d-84b2-4e2ad2a9f5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_5cc50416-f2fa-4f56-af89-f0c7710f8bcf" xlink:to="loc_us-gaap_OperatingSegmentsMember_42f3e688-ef40-493d-84b2-4e2ad2a9f5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_62239a09-28e8-4587-b124-44a3654f045f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_5cc50416-f2fa-4f56-af89-f0c7710f8bcf" xlink:to="loc_us-gaap_CorporateNonSegmentMember_62239a09-28e8-4587-b124-44a3654f045f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_400998d5-fe34-4e0f-8565-cac35a1a8155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_e2236a9a-ee0d-4eed-af8c-7173a3372211" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_400998d5-fe34-4e0f-8565-cac35a1a8155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8f9f663b-6334-40ff-9ae9-68ebf027d828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_400998d5-fe34-4e0f-8565-cac35a1a8155" xlink:to="loc_us-gaap_SegmentDomain_8f9f663b-6334-40ff-9ae9-68ebf027d828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_HillromMember_96ee305e-7595-45e5-95c3-b6db5e1d42f3" xlink:href="bax-20220331.xsd#bax_HillromMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8f9f663b-6334-40ff-9ae9-68ebf027d828" xlink:to="loc_bax_HillromMember_96ee305e-7595-45e5-95c3-b6db5e1d42f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ded82048-c186-4e25-818e-3072b360014c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_e2236a9a-ee0d-4eed-af8c-7173a3372211" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ded82048-c186-4e25-818e-3072b360014c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_78d4a76b-db87-4e31-bd86-5ecaaea87ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ded82048-c186-4e25-818e-3072b360014c" xlink:to="loc_us-gaap_OperatingIncomeLoss_78d4a76b-db87-4e31-bd86-5ecaaea87ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_7acec38b-8dda-4515-a115-acbb4af270ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ded82048-c186-4e25-818e-3072b360014c" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_7acec38b-8dda-4515-a115-acbb4af270ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_208b75e9-7bab-4095-96e0-a3223190998c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ded82048-c186-4e25-818e-3072b360014c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_208b75e9-7bab-4095-96e0-a3223190998c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ad3674e0-6e5e-468d-883b-cee1eaed541d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_ded82048-c186-4e25-818e-3072b360014c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ad3674e0-6e5e-468d-883b-cee1eaed541d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  V 2<# 2(  A$! Q$!_\0
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M_P#?-'*PYHFK115.^OK;3K66YNYX[>"(?-+*^Q5_X%2++7O2< 5SC?$/PP&
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MO>(]6M]/TV)>&D?YIF_NQKU9O]E:_,_]J']LC6/CAYN@Z/%)H7@Q9-_D;O\
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MRS;%Y=+#>SPO+S?X3A5ZU]*?\$_?!'_"7_M#6-]*I>WT.SEU$Y_O_P"J0?\
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M>3$43?\ ?;I7XM(/G%?K]^VUH=[XC_9E\:VEA UQ<)%;W)B1=S%8KB*5^/\
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MVOA[H>IV>H67B?Q=;WMM,DT%PEU:[HW0Y5A_HU%%>C_:>-_Y^O[SS/[,P?\
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<.I4;7:XZ&7X6G5]I"FDSW*BBBO-/4"BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_0a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !  5T# 2(  A$! Q$!_\0
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MW^\G]ROU$SS7Y'FN#E@\5-3^T>M2ESQ.'^,OC)?A[\*?%/B(/LFL-/EE@/\
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MO4OB_P"-]8L+BQO?%VMWEE.NR6WN-1E=)5_N,F^N0K]M/^%?>&/^A=TG_P
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M2&SL-R6=Q%=>1*J,Q;8WRONZU]+?\.]?A+_SPUC_ ,#_ /[&@_\ !/;X2_\
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MN_\ WG1:_3 _\$__ (1_] _4_P#P8/5G1_V%?A7HFK66I6EEJ:7=G.EQ"_\
M:#_*Z-N6OHY<1X/E]Q3,/82/?K&RBL+2"V@79#"BQ1I_=5>*N445^<G>%%%%
$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_0b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0b.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !  5T# 2(  A$! Q$!_\0
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MW^\G]ROU$SS7Y'FN#E@\5-3^T>M2ESQ.'^,OC)?A[\*?%/B(/LFL-/EE@/\
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MO4OB_P"-]8L+BQO?%VMWEE.NR6WN-1E=)5_N,F^N0K]M/^%?>&/^A=TG_P
M8O\ XFE_X5_X8_Z%S2?_  !B_P#B:\V'$4*?P44:_5_[Y^)5?H%\%&_X4M^P
MCKOB7)AO]4ANKV)OXA+(?(M__04;_@5?61\ >& /^1=TG_P!B_\ B:^5_P#@
MHQXIA\-_"[PUX2LECMDU*\\UHHEVHMO OW=O^]*G_?-9SS)YQ4I82,.7W@]G
M[&/,?GG1117WQP'W_P#\$U/!WV3PKXJ\3R("]Y>16$3=]L2;G_\ 'I5_[YK[
M7/6O'/V2_!X\%?L_^$;1E"W$]J+^?!_CG/F_^@NM>Q=S7X[F.(^LXNK/S/8I
MQY(V'T445PEGYW?\%(/B#%JWC#P[X3MIUD72H&N[I5?[LLOW$;_:VI_X_7QQ
M7ZHZ]^P[\,?%&MWNKZK%K%[J5Y*T\]Q+J3EF9JI_\.__ (19_P"0?JG_ (,'
MK[C 9S@\'AX4?>.&="4Y\Y^75;6A>./$?A:"6#1O$&J:1#*V^6'3[R6W1F_O
M_*]?I7_P[_\ A%_T#]4_\&#T?\._OA'_ - _4_\ P8/7=/B# U/C4Q>PD?G5
M_P +C\?_ /0\>)/_  ;3_P#Q=<YK&MZAXAO7O-5U"YU*[?[UQ=SM*[?\":OT
MW_X=_P#PC_Z!^I_^#!Z7_AW_ /"/_H'ZG_X,'K..?X&'PT__ "5!["1^75:G
MA?PUJGC/7[#1='M9+W4;N18X8XUX9J_3#_AW_P#",_\ ,/U/_P &#UZ5\,/@
M#X%^#WFOX8T.*SNI%V27LCM+.Z^A=LT5.)*$8?N8>^$<-(32?A);:?\  F'X
M=LR^2=#;2I9D[NT15W_[Z9FK\C_&O@G5_A]XGU#P_K=HUI?V<NV167[_ /MI
M_LO7[< 9&.M<)\1_@MX,^+=HL/BG0+;4WC7;%<G*S1_[DBX85\WE>;?4:DW5
M7-&9O5I<Y^,M>G?"+]HKQO\ !.UO;7PS>P16EX_FR6]W LJA_P"_7WO_ ,._
MOA#_ - _4_\ P8/2?\.__A%_SX:G_P"#!Z^DJY]EU>')6IF'L)'R>O\ P4 ^
M+D[(JSZ0[-\J(FG?>_\ 'Z\"\8:EJ^K^*M8OO$#2/KLMS*U]YJ;'\W?\]?J3
MX'_8R^%O@+Q%:ZYIVC37%_:MO@-[<O*L3_WPI_BJMXL_8E^%_C+Q+J6O:A87
MYU#49GN)_*O71"[?>^6N:AG678>K>C1Y0G1J3/RHKZ$_81\)6_BC]H72YKC;
MLTFUEOU1OXV7Y$_\>?=_P"OL#_A@#X1'II^I_P#@P>NH^&7[)_@#X2>)X?$/
MAR#4+748XGBS+>LZ,K?>5E[U>,S["UL/.E2YN:00H2C(]7US7=.\-:3<ZCJ=
MW#86%LN^:XN'V(B^I:O@;]H[]O.\\0&[\/\ PZEDTW3?]5/K;KMN)_\ KE_<
M7_:^]_NU]?\ Q8^ _AKXSK;Q^)I]3FLH.8[*WO7A@W?WRB_>:O.A_P $_OA%
M_P! _4__  8/7S>7U,#AW[3$+GD=53FDO=/S_P#A)\$O%WQV\1-::#:-,F_=
M>:G<?\>\'^TS?W_]C[U?I)\!_P!EKPE\#],WP0+J^OSQ[+K5;N/YW_O*J_PK
M7J/A/P?HO@;0;;1M!TZ#2M-@7;%;VZ[0./YUN,/>KS'-JV.]V/NP%3IQ@?DI
M^UE\%'^"_P 5KNSMHMF@:INO=,?^XK/\\7_ '_\ '=E>*U^Q_P 7_@1X3^.-
MOIL/BFUGG73V=[=X)VB9-V-W3_=6O-/^& ?A'_T#]3_\&#U]#@^(:-.A"&(5
MYG-*A+FO _+O_<K]5/V.?CBOQA^&,4.H3!O$NC;;6_#G+2K_ ,LIO^!C_P >
M5ZH?\.__ (1$?\@_5/\ P8/75?#']E7P+\'O$G]N>&4U.TO/+:)T>^9XI%;^
M%D/X5Q9KF6#Q]#EBI<Z-*5*4)'/?MO?"O4?BC\&W.C0M<ZMH]TNH16Z+EY5V
M,CJG^UM?=_P"ORQV,GWJ_=;=D5XA\1/V1/AE\3=5;5-2T0V>IR-NEN=-D,'F
M_P"^OW6_WMN:Y\ISE8"/LJOP%5*7/[Q^3%?4_P  _P!NB]^$'@FT\,:KX<_X
M2&SL-R6=Q%=>1*J,Q;8WRONZU]+?\.]?A+_SPUC_ ,#_ /[&@_\ !/;X2_\
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MN_\ WG1:_3 _\$__ (1_] _4_P#P8/5G1_V%?A7HFK66I6EEJ:7=G.EQ"_\
M:#_*Z-N6OHY<1X/E]Q3,/82/?K&RBL+2"V@79#"BQ1I_=5>*N445^<G>%%%%
$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_1.jpg
MB5!.1PT*&@H    -24A$4@  !=<    #" (   #^YZ&9    -4E$051X7NW8
MH0$ , S#L/[_=,8SN)5)V!=X!@   (#?<ND"    @'?]8%P8    @ W]8)(#
4_)TURZW#K3P     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_10.jpg
MB5!.1PT*&@H    -24A$4@  #$$    ," (   "X2=5G    LTE$051X7NW:
M00V 0! $P?-O F\860(\2!!P_:EZ349#KP,          " R,^O_ 0
M    [*)A @          &N=#PP0          #0T3           0$G#!
M        E#1,          ! 2<,$          "4-$P          $#I:YC>
M!0          L)^&"0          *-T-TP           '0N*HLL6 (>LQ(
+    245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_11.jpg
MB5!.1PT*&@H    -24A$4@  #&H    +" (    2\1WX    FTE$051X7NW:
M,1$ ( #$,/R;?HX5"TW&:N@Y            /=O^!           4&"? @
M        HNQ3          ! E'T*          "(LD\!          !1]BD
M         "#*/@4          $39IP          @"C[%           $/7V
@J0$          "1=X[XXT%L> KP     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_2.jpg
MB5!.1PT*&@H    -24A$4@   60    %" (   #]I@$\    +TE$051X7NW4
MH1$ 0 @#0?IO&L2KSR H8-=EXJ\*8-._O &>C$5L@)58 "=B 9P,V-Z6$\[V
..^[D     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image_9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_9.jpg
MB5!.1PT*&@H    -24A$4@  !&4    #" (   "U:B5=    )$E$051X7NW!
M,0$   P"(/N7U@)[]@,)        /!0  (#+ #3,(I5OV,@P     $E%3D2N
#0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010230496552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Apr. 21, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-4448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BAXTER INTERNATIONAL INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-0781620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Baxter Parkway,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Deerfield,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">224.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">948.2000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">503,528,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000010456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_CommonStock100PerValueMember', window );">Common Stock, $1.00 par value | New York Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $1.00 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX (NYSE)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_CommonStock100PerValueMember', window );">Common Stock, $1.00 par value | Chicago Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $1.00 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX (NYSE)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">CHX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes04Due2024Member', window );">0.4% Global Notes due 2024 | New York Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.4% Global Notes due 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member', window );">1.3% Global Notes due 2025 | New York Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.3% Global Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member', window );">1.3% Global Notes due 2029 | New York Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.3% Global Notes due 2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes395Due2030Member', window );">3.95% Global Notes due 2030 | New York Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.95% Global Notes due 2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes173Due2031Member', window );">1.73% Global Notes due 2031 | New York Stock Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.73% Global Notes due 2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_CommonStock100PerValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_CommonStock100PerValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNYS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNYS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XCHI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XCHI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes04Due2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes04Due2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes395Due2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes395Due2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes173Due2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes173Due2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010235058344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,294<span></span>
</td>
<td class="nump">$ 2,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Accounts receivable, net of allowances of $129 in 2022 and $122 in 2021</a></td>
<td class="nump">2,471<span></span>
</td>
<td class="nump">2,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">2,548<span></span>
</td>
<td class="nump">2,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">860<span></span>
</td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">8,173<span></span>
</td>
<td class="nump">8,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">5,114<span></span>
</td>
<td class="nump">5,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,816<span></span>
</td>
<td class="nump">9,836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">7,693<span></span>
</td>
<td class="nump">7,792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">609<span></span>
</td>
<td class="nump">630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">1,311<span></span>
</td>
<td class="nump">1,213<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">32,716<span></span>
</td>
<td class="nump">33,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current maturities of long-term debt and finance lease obligations</a></td>
<td class="nump">209<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,223<span></span>
</td>
<td class="nump">1,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">2,258<span></span>
</td>
<td class="nump">2,479<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,890<span></span>
</td>
<td class="nump">4,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent', window );">Long-term debt and finance lease obligations, less current portion</a></td>
<td class="nump">16,765<span></span>
</td>
<td class="nump">17,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">508<span></span>
</td>
<td class="nump">522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">2,434<span></span>
</td>
<td class="nump">2,493<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">23,597<span></span>
</td>
<td class="nump">24,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2022 and 2021</a></td>
<td class="nump">683<span></span>
</td>
<td class="nump">683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Common stock in treasury, at cost,180,058,105 shares in 2022 and 181,879,516 shares in 2021</a></td>
<td class="num">(11,422)<span></span>
</td>
<td class="num">(11,488)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional contributed capital</a></td>
<td class="nump">6,207<span></span>
</td>
<td class="nump">6,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">16,994<span></span>
</td>
<td class="nump">17,065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(3,387)<span></span>
</td>
<td class="num">(3,380)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Baxter stockholders&#8217; equity</a></td>
<td class="nump">9,075<span></span>
</td>
<td class="nump">9,077<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">9,119<span></span>
</td>
<td class="nump">9,121<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 32,716<span></span>
</td>
<td class="nump">$ 33,521<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term debt and finance lease obligations noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010231462328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for accounts receivable, current</a></td>
<td class="nump">$ 129<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">683,494,944<span></span>
</td>
<td class="nump">683,494,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">180,058,105<span></span>
</td>
<td class="nump">181,879,516<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010230539160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Income (unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,707<span></span>
</td>
<td class="nump">$ 2,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">2,359<span></span>
</td>
<td class="nump">1,801<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">1,348<span></span>
</td>
<td class="nump">1,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">1,052<span></span>
</td>
<td class="nump">627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating income, net</a></td>
<td class="num">(17)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">351<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Baxter stockholders</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="nump">$ 0.59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average number of shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">503<span></span>
</td>
<td class="nump">505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">509<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010235019640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustments, net of tax expense (benefit) of ($11) and $17 for the three months ended March 31, 2022 and 2021, respectively.</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(208)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and other postretirement benefits, net of tax expense of $3 and $8 for the three months ended March 31, 2022 and 2021, respectively.</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Hedging activities, net of tax expense (benefit) of ($1) and $3 for the three months ended March 31, 2022 and 2021, respectively.</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Debt securities, net of tax expense of $1 and zero for the three months ended March 31, 2022 and 2021, respectively</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive loss, net of tax</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(166)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Baxter stockholders</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010236372040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Currency translation adjustments, tax</a></td>
<td class="num">$ (11)<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Pension and other postretirement benefits, tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent', window );">Hedging activities, tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax', window );">Debt securities, tax</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010233961304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Equity (unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Baxter stockholders' equity</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Common stock in treasury</div></th>
<th class="th"><div>Additional contributed capital</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
<th class="th"><div>Noncontrolling interests</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance, beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd) at Dec. 31, 2020</a></td>
<td class="nump">$ 8,726<span></span>
</td>
<td class="nump">$ 8,689<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="num">$ (11,051)<span></span>
</td>
<td class="nump">$ 6,043<span></span>
</td>
<td class="nump">$ 16,328<span></span>
</td>
<td class="num">$ (3,314)<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, beginning of period, treasury (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(166)<span></span>
</td>
<td class="num">(166)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(166)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(300)<span></span>
</td>
<td class="num">(300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (300)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock issued under employee benefit plans and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock issued under employee benefit plans and other</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared on common stock</a></td>
<td class="num">(124)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Change in noncontrolling interests</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance, end of period (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd) at Mar. 31, 2021</a></td>
<td class="nump">$ 8,490<span></span>
</td>
<td class="nump">8,452<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="num">$ (11,296)<span></span>
</td>
<td class="nump">6,043<span></span>
</td>
<td class="nump">16,502<span></span>
</td>
<td class="num">(3,480)<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, end of period, treasury (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance, beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="nump">683,494,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd) at Dec. 31, 2021</a></td>
<td class="nump">$ 9,121<span></span>
</td>
<td class="nump">9,077<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="num">$ (11,488)<span></span>
</td>
<td class="nump">6,197<span></span>
</td>
<td class="nump">17,065<span></span>
</td>
<td class="num">(3,380)<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, beginning of period, treasury (in shares) at Dec. 31, 2021</a></td>
<td class="nump">181,879,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (7)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (in shares)</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock issued under employee benefit plans and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock issued under employee benefit plans and other</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared on common stock</a></td>
<td class="num">(142)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(142)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Change in noncontrolling interests</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance, end of period (in shares) at Mar. 31, 2022</a></td>
<td class="nump">683,494,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd) at Mar. 31, 2022</a></td>
<td class="nump">$ 9,119<span></span>
</td>
<td class="nump">$ 9,075<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="num">$ (11,422)<span></span>
</td>
<td class="nump">$ 6,207<span></span>
</td>
<td class="nump">$ 16,994<span></span>
</td>
<td class="num">$ (3,387)<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Balance, end of period, treasury (in shares) at Mar. 31, 2022</a></td>
<td class="nump">180,058,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010233859544">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operations</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to cash flows from operations:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">380<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">32<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash', window );">Net periodic pension and other postretirement costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in balance sheet items:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Accounts receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">153<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(105)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(13)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(221)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(43)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flows from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">208<span></span>
</td>
<td class="nump">377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(140)<span></span>
</td>
<td class="num">(171)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired, and investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(174)<span></span>
</td>
<td class="num">(381)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash flows from investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(304)<span></span>
</td>
<td class="num">(538)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(404)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess', window );">Net decreases in debt with original maturities of three months or less</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(45)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Cash dividends on common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(140)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from stock issued under employee benefit plans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">66<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(253)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash flows from financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(548)<span></span>
</td>
<td class="num">(358)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Decrease in cash, cash equivalents and restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(657)<span></span>
</td>
<td class="num">(550)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,956<span></span>
</td>
<td class="nump">3,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,299<span></span>
</td>
<td class="nump">3,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,294<span></span>
</td>
<td class="nump">3,182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash included in prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The following table provides a reconciliation of cash, cash equivalents and restricted cash shown above to the amounts reported within the condensed consolidated balance sheet as of March&#160;31, 2022, December&#160;31, 2021, and March&#160;31, 2021 (in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.974%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash included in prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,956&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,186&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Accrued Expenses And Other Current Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense (reversal of expense) for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232483912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">BASIS OF PRESENTATION</a></td>
<td class="text">BASIS OF PRESENTATION<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (we or our) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) in the United States have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 (2021 Annual Report).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the current interim period are not necessarily indicative of the results of operations to be expected for the full year. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks and Uncertainties Related to COVID-19 and Global Economic Conditions </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global operations expose us to risks associated with public health crises and epidemics/pandemics, such as the novel strain of coronavirus (COVID-19). COVID-19 has had, and we expect will continue to have, an adverse impact on our operations, supply chains and distribution systems and has increased and we expect will continue to increase our expenses, including as a result of impacts associated with preventive and precautionary measures that we, other businesses and governments have taken and continue to take. Initial measures taken in 2020 led to unprecedented restrictions on, disruptions in, and other related impacts on business and personal activities, including a shift in healthcare priorities, which resulted in a significant decline in medical procedures in 2020. The pandemic has created significant volatility in the demand for our products. For further information about our revenues by product category, refer to Note 9. Significant uncertainty remains regarding the duration and overall impact of the COVID-19 pandemic.  For example, concerns remain regarding the pace of economic recovery due to virus resurgence across the globe from the Omicron variants, subvariants and other virus mutations as well as vaccine distribution and hesitancy. The U.S. and other governments may continue existing measures or implement new restrictions and other requirements in light of the continuing spread of the pandemic (including with respect to mandatory vaccinations for certain of our employees, moratoriums on elective procedures and mandatory quarantines and travel restrictions). Due to the uncertainty caused by the pandemic, our operating performance and financial results, particularly in the short term, may be subject to volatility.  We have experienced significant challenges, including lengthy delays, shortages and interruptions, posed by the pandemic and other exogenous factors (including significant weather events, disruptions to certain ports of call around the world and certain geopolitical events) to our global supply chain, including the cost and availability of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, and may experience these and other challenges in future periods.  Many of our manufacturing plant and distribution center personnel are currently unvaccinated, and we may also experience employee resistance in complying with current and future government vaccine and testing mandates, which may cause labor shortages significantly impacting manufacturing production and distribution center productivity.  We expect that these challenges as well as evolving governmental restrictions and requirements, among other factors, may continue to have an adverse effect on our business.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently adopted accounting pronouncements</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 1, 2022, we adopted Accounting Standards Update (ASU) 2021-05, Leases (Topic 842), which requires a lessor to classify a lease with variable lease payments (that do not depend on an index or rate) as an operating lease if (1) the lease would have been classified as a sales-type or direct financing lease, and (2) the lessor would have recognized a selling loss at lease commencement. These changes are intended to avoid recognizing a day-one loss for a lease with variable payments even though the lessor expects the arrangement will be profitable overall. The adoption of this ASU did not have a material impact on our condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232417768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND OTHER ARRANGEMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITIONS AND OTHER ARRANGEMENTS</a></td>
<td class="text">ACQUISITIONS AND OTHER ARRANGEMENTS<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Hillrom</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 13, 2021, we completed our acquisition of all outstanding equity interests of Hill-Rom Holdings, Inc. (Hillrom) for a purchase price of $10.5&#160;billion.  Including the assumption of Hillrom's outstanding debt, the enterprise value of the transaction was approximately $12.8&#160;billion.  Under the terms of the transaction agreement, Hillrom shareholders received $156.00 in cash per outstanding Hillrom common share. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the total consideration paid:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration paid to Hillrom shareholders</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of equity awards issued to Hillrom equity award holders</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,476&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Represents cash consideration transferred of $156.00 per outstanding Hillrom common share to existing shareholders and holders of equity awards that vested at closing pursuant to their original terms.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Represents the pre-acquisition service portion of the fair value of 668&#160;thousand replacement restricted stock units issued to Hillrom equity award holders at closing.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation of assets acquired and liabilities assumed has not yet been finalized as of March 31, 2022. Finalization of the valuation during the measurement period could result in a change in the amounts recorded for acquired intangible assets, goodwill and income taxes among other items. The completion of the valuation will occur no later than one year from the acquisition date.The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed as of the acquisition date:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets acquired and liabilities assumed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,527)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired and liabilities assumed</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,476&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we recorded measurement period adjustments to increase other intangible assets of $7&#160;million, increase deferred income tax liabilities of $11&#160;million, other individually insignificant adjustments for a net </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decrease to assets acquired and liabilities assumed of $6&#160;million and a corresponding increase to goodwill of $10&#160;million. The measurement period adjustments did not have a significant impact our results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill, which is not deductible for tax purposes, includes the value of an assembled workforce as well as the overall strategic benefits provided to our product portfolio and is included in the Hillrom segment. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2022, we recognized $159&#160;million of incremental costs of sales from the fair value step-ups on acquired Hillrom inventory that was sold in the current period. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Other Business Development Activities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In March 2022, we entered into an agreement with a subsidiary of Pfizer Inc. to acquire the rights to Zosyn, a premixed frozen piperacillin-tazobactam product, in the U.S. and Canada. Zosyn is used for the treatment of intra-abdominal infections, nosocomial pneumonia, skin and skin structure infections, female pelvic infections and community-acquired pneumonia. Under the terms of the acquisition, we paid the acquisition price of $122 million currently, received specified intellectual property, including patent rights, in the current period and will receive additional intellectual property, including the product rights to Zosyn, in one year.  Under the arrangement, we are entitled to receive profit sharing payments from sales of Zosyn until the product rights transfer to us in March 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The transaction has been accounted for as an asset acquisition, as substantially all of the fair value of the assets being acquired under the arrangement was concentrated in the product rights that we will receive, which we classify as a developed technology intangible asset. Accordingly, the $122 million purchase price was primarily allocated to the developed technology intangible asset class and will be amortized over an estimated useful life of 9 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232322344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">SUPPLEMENTAL FINANCIAL INFORMATION</a></td>
<td class="text">SUPPLEMENTAL FINANCIAL INFORMATION<div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Doubtful Accounts</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the changes in our allowance for doubtful accounts for the three months ended March&#160;31, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.263%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,548&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment, Net </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,643)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,550)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,114&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Interest Expense, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.263%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net of capitalized interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Other (Income) Expense, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.263%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (gains) losses, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Non-Cash Operating and Investing Activities</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Right-of-use operating lease assets obtained in exchange for lease obligations for the three months ended March&#160;31, 2022 and 2021 were $14 million and $5&#160;million, respectively.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Purchases of property, plant and equipment included in accounts payable as of March&#160;31, 2022 and 2021 were $53 million and $63 million, respectively. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There were no unsettled share repurchases as of March&#160;31, 2022. Unsettled share repurchases included in accrued expenses and other current liabilities were $47&#160;million as of March&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232432376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS, NET</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS, NET<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:40.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,517&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,836&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,488&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,801&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,816&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, there were no reductions in goodwill relating to impairment losses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other intangible assets, net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our other intangible assets.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology, including patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other amortized intangible assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,638)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,195&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,693&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,930)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,245&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,792&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible asset amortization expense was $217 million and $64 million for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232779064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING ARRANGEMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">FINANCING ARRANGEMENTS</a></td>
<td class="text">FINANCING ARRANGEMENTS <div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Debt Activity</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, we repaid $170&#160;million of our $2.0&#160;billion three-year term loan facility and $175&#160;million of our $2.0&#160;billion five-year term loan facility. The loss from the early extinguishment of this debt was not significant. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dollar-denominated revolving credit facility has a capacity of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $2.5&#160;billion</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our Euro-denominated revolving credit facility has a capacity of &#8364;200 million. Each of the facilities matures in 2026. There were no borrowings outstanding under these credit facilities as of March&#160;31, 2022 or December&#160;31, 2021.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Paper</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we had $200&#160;million of commercial paper outstanding with a weighted-average interest rate of 0.5% and an original weighted-average term of 89 days. As of December&#160;31, 2021, we had $300 million of commercial paper outstanding with a weighted-average interest rate of 0.27% and an original weighted-average term of 88 days.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232759368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES <div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in product liability, patent, commercial, and other legal matters that arise in the normal course of our business. We record a liability when a loss is considered probable and the amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range, and no amount within the range is a better estimate, the minimum amount in the range is accrued. If a loss is not probable or a probable loss cannot be reasonably estimated, no liability is recorded. As of March&#160;31, 2022 and December&#160;31, 2021, our total recorded reserves with respect to legal and environmental matters were $57 million and $72 million, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established reserves for certain of the matters discussed below. We are not able to estimate the amount or range of any loss for certain contingencies for which there is no reserve or additional loss for matters already reserved. While our liability in connection with these claims cannot be estimated and the resolution thereof in any reporting period could have a significant impact on our results of operations and cash flows for that period, the outcome of these legal proceedings is not expected to have a material adverse effect on our consolidated financial position. While we believe that we have valid defenses in the matters set forth below, litigation is inherently uncertain, excessive verdicts do occur, and we may incur material judgments or enter into material settlements of claims.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the matters described below, we remain subject to the risk of future administrative and legal actions. With respect to governmental and regulatory matters, these actions may lead to product recalls, injunctions, and other restrictions on our operations and monetary sanctions, including significant civil or criminal penalties. With respect to </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intellectual property, we may be exposed to significant litigation concerning the scope of our and others&#8217; rights. Such litigation could result in a loss of patent protection or the ability to market products, which could lead to a significant loss of sales, or otherwise materially affect future results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved as a potentially responsible party (PRP) for environmental clean-up costs at six Superfund sites. Under the U.S. Superfund statute and many state laws, generators of hazardous waste sent to a disposal or recycling site are liable for site cleanup if contaminants from that property later leak into the environment. The laws generally provide that a PRP may be held jointly and severally liable for the costs of investigating and remediating the site. Separate from these Superfund cases noted above, we are involved in an ongoing environmental remediations associated with historic operations at certain of our facilities. As of March&#160;31, 2022 and December&#160;31, 2021, our environmental reserves, which are measured on an undiscounted basis, were $18 million, respectively. After considering these reserves, the outcome of these matters is not expected to have a material adverse effect on our financial position or results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Litigation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2019, we were named in an amended complaint filed by Fayette County, Georgia in the MDL In re: National Prescription Opiate Litigation pending in the U.S. District Court, Northern District of Ohio. The complaint alleges that multiple manufacturers and distributors of opiate products improperly marketed and diverted these products, which caused harm to Fayette County. The complaint is limited in its allegations as to Baxter and does not distinguish between injectable opiate products and orally administered opiates. We manufactured generic injectable opiate products in our facility in Cherry Hill, NJ, which we divested in 2011.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2019, we and certain of our officers were named in a class action complaint captioned </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Ethan E. Silverman et al. v. Baxter International Inc. et al.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> that was filed in the United States District Court for the Northern District of Illinois.  The plaintiff, who allegedly purchased shares of our common stock during the specified class period, filed this putative class action on behalf of himself and shareholders who acquired Baxter common stock between February 21, 2019 and October 23, 2019.  The plaintiff alleged that we and certain officers violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by making allegedly false and misleading statements and failing to disclose material facts relating to certain intra-company transactions undertaken for the purpose of generating foreign exchange gains or avoiding foreign exchange losses, as well as our internal controls over financial reporting.  On January 29, 2020, the Court appointed Varma Mutual Pension Insurance Company and Louisiana Municipal Police Employees Retirement System as lead plaintiffs in the case. Plaintiffs filed an amended complaint on June 25, 2020 containing substantially the same allegations. On August 24, 2020, we filed a motion to dismiss the amended complaint. On January 12, 2021, the Court granted our motion to dismiss the amended complaint but gave plaintiffs an opportunity to file a further-amended complaint. The parties reached an agreement to settle the case for $16&#160;million, subject to the completion of confirmatory discovery and final approval by the Court. The Court granted final approval of the settlement on August 11, 2021 and the settlement became effective on September 13, 2021. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As initially disclosed in our Form 8-K on October 24, 2019, we voluntarily advised the staff of the SEC of an internal investigation into certain intra-company transactions that impacted our previously reported non-operating foreign exchanges gains and losses. We also received a stockholder request for inspection of our books and records in connection with the October 24, 2019 announcement. The Company has cooperated with the staff of the SEC in its investigation into related matters, and on February 18, 2022, we reached a settlement with the SEC. Without admitting or denying the findings in the administrative order issued by the SEC, we agreed to pay a civil penalty of $18&#160;million and to cease and desist from violations of specified provisions of the federal securities laws and related rules. In the order, the SEC acknowledged the Company&#8217;s cooperation. We paid the penalty in the first quarter of 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, two lawsuits were filed against us in the Northern District of Illinois by plaintiffs alleging injuries as a result of exposure to ethylene oxide used in our manufacturing facility in Mountain Home, Arkansas to sterilize certain of our products. The plaintiffs sought damages, including compensatory and punitive damages in an unspecified amount, and unspecified injunctive and declaratory relief. The parties reached agreement to settle these lawsuits in the third quarter of 2021 for amounts that are not material to our financial results, which were paid in the fourth quarter of 2021. The settlement of these claims does not preclude potential future lawsuits.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In July 2021, Hill-Rom, Inc. received a subpoena (from the United States Office of Inspector General for the Department of Health and Human Services (the DHHS) requesting documents and information related to compliance </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">with the False Claims Act and the Anti-Kickback Statute. Hillrom has been working with the DHHS and the DOJ to provide information responsive to the subpoena. Hillrom also voluntarily began a related internal review and Hillrom and now Baxter have been cooperating fully with the DHHS and the DOJ with respect to these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DHHS often issues this type of subpoena when investigating alleged violations of the False Claims Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 28, 2021, Linet Americas, Inc. (Linet) filed a complaint against Hill-Rom Holdings, Inc., Hill-Rom Company, Inc., and Hill-Rom Services, Inc. in the United States District Court for the Northern District of Illinois, captioned Linet Americas, Inc. v. Hill-Rom Holdings, Inc.; Hill-Rom Company, Inc.; Hill-Rom Services, Inc. Linet alleges that Hillrom violated Sections 1, 2 and 3 of The Sherman Antitrust Act of 1890 and the Illinois Antitrust Act by allegedly engaging in anti-competitive conduct in alleged markets for standard, ICU and birthing beds. Hillrom filed an answer to the complaint on January 28, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232437544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock compensation expense totaled $32 million and $22 million in the first quarter of 2022 and 2021, respectively.  Approximately 75% of stock compensation expense is classified within selling, general and administrative (SG&amp;A) expense with the remainder classified in cost of sales and research and development (R&amp;D) expense. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We awarded stock compensation grants which consisted of 1.8 million stock options, 1.2 million restricted stock units (RSUs) and 0.4 million performance stock units (PSUs) during the first quarter of 2022. The grant date fair values of stock options, RSUs and PSUs awarded in the first quarter of 2022 were $33 million, $102 million and $34 million, respectively. Stock options and RSUs generally vest in one-third increments over a three-year period. The vesting conditions for PSUs granted are equally divided based on our compound annual sales growth rate performance, our adjusted return on invested capital performance and on our stock performance relative to a specified peer group.  All of the PSUs vest at the end of the applicable three-year service period.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Options</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average Black-Scholes assumptions used in establishing the fair value of stock options granted during the period, along with weighted-average grant date fair values, were as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.152%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value per stock option</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised was $27 million and $21 million during the first quarters of 2022 and 2021, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the unrecognized compensation cost related to all unvested stock options of $80 million is expected to be recognized as expense over a weighted-average period of 1.9 years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">RSUs</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the unrecognized compensation cost related to all unvested RSUs of $163 million is expected to be recognized as expense over a weighted-average period of 2.2 years. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PSUs</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the unrecognized compensation cost related to all unvested PSUs of $50 million is expected to be recognized as expense over a weighted-average period of 1.9 years. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Dividends</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash dividends declared per share for the three months ended March&#160;31, 2022 and 2021 were $0.28 and  $0.245, respectively. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Programs</span></div>In July 2012, the Board of Directors authorized the repurchase of up to $2.0 billion of our common stock. The Board of Directors increased this authority by an additional $1.5 billion in each of November 2016 and February 2018, by an additional $2.0 billion in November 2018 and by an additional $1.5&#160;billion in October 2020. During the first quarter of 2022, we did not repurchase any shares under this authority.  During the first quarter of 2021, we repurchased 3.6&#160;million shares under this authority pursuant to a Rule 10b5-1 plan. We had $1.3 billion remaining available under the authorization as of March&#160;31, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010313684760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE INCOME</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE INCOME<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income includes all changes in stockholders&#8217; equity that do not arise from transactions with stockholders, and consists of net income, currency translation adjustments (CTA), certain gains and losses from pension and other postretirement employee benefit (OPEB) plans and gains and losses on cash flow hedges. </span></div><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a net-of-tax summary of the changes in accumulated other comprehensive (loss) income (AOCI) by component for the three months ended March&#160;31, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.101%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.095%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,380)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,922)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,387)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(574)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,314)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,795)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(544)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,480)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;See table below for details about these reclassifications.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the amounts reclassified from AOCI to net income during the three months ended March&#160;31, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:44.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.168%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of impact in income statement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and OPEB items</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs or credits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on hedging activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of tax</span></td></tr></table></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Amounts in parentheses indicate reductions to net income</span></div><div style="margin-top:1pt;padding-left:72pt;text-indent:-72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:44.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.168%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 11 for additional information regarding the amortization of pension and OPEB items and Note 14 for additional information regarding hedging activity.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232328360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUES</a></td>
<td class="text">REVENUES<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of our contracts have multiple performance obligations. For contracts with multiple performance obligations, we allocate the contract&#8217;s transaction price to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract. Our global payment terms are typically between 30-90 days.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our performance obligations are satisfied at a point in time. This includes sales of our broad portfolio of essential healthcare products across our geographic segments including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; hospital beds and services; surgical tables, lights and pendants; and patient monitoring and diagnostic technologies. For most of those sales, our performance obligation is satisfied upon delivery to the customer. Shipping and handling activities are considered to be fulfillment activities and are not considered to be a separate performance obligation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To a lesser extent, in all of our segments, we enter into other types of contracts including contract manufacturing   arrangements, equipment leases, and certain subscription software and licensing arrangements. We recognize revenue for these arrangements over time or at a point in time depending on our evaluation of when the customer obtains control of the promised goods or services. Revenue is recognized over time when we are creating or enhancing an asset that the customer controls as the asset is created or enhanced or our performance does not create an asset with an alternative use and we have an enforceable right to payment for performance completed.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we had $8.2 billion of transaction price allocated to remaining performance obligations related to executed contracts with an original duration of one year or more, which are primarily included in the Americas segment. Some contracts in the United States included in this amount contain index-dependent price increases, which are not known at this time. We expect to recognize approximately 30% of this amount as revenue over the remainder of 2022, 30% in 2023, 20% in 2024, 15% in 2025 and 5% thereafter.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Judgments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration primarily related to rebates and wholesaler chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales and are included in accrued expenses and other current liabilities and accounts receivable, net on the condensed consolidated balance sheets. Management's estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reflect our best estimates of the amount of consideration to which we are entitled based on the terms of the contract using the expected value method. The amount of variable consideration included in the net sales price is limited to the amount for which it is probable that a significant reversal in revenue will not occur when the related uncertainty is resolved. Revenue recognized during the three months ended March&#160;31, 2022 and 2021 related to performance obligations satisfied in prior periods was not material.  Additionally, our contracts with customers often include promises to transfer multiple products and services to a customer.  Determining whether products and services are considered distinct performance obligations that should be accounted for separately and determining the allocation of the transaction price may require significant judgement.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in the recognition of trade accounts receivable, unbilled receivables, contract assets and customer advances and deposits (contract liabilities) on our condensed consolidated balance sheets. Net trade accounts receivable was $2.3 billion and $2.4 billion as of March&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contract manufacturing arrangements, revenue is primarily recognized throughout the production cycle, which typically lasts up to 90 days, resulting in the recognition of contract assets until the related services are completed and the customers are billed. Additionally, for arrangements containing a performance obligation to deliver software that can be used with medical devices, we recognize revenue upon delivery of the software, which results in the recognition of contract assets when customers are billed over time, generally over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNTA4Nw_f4e1f64e-f3c7-40c4-adcb-4328bb369ec4">one</span> to five years. For bundled contracts involving equipment delivered up-front and consumable medical products to be delivered over time, total contract revenue is allocated between the equipment and consumable medical products. In certain of those arrangements, a contract asset is created for the difference between the amount of equipment revenue recognized upon delivery and the amount of consideration initially receivable from the customer. In those arrangements, the contract asset becomes a trade account receivable as consumable medical products are provided and billed, generally over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNTY3NA_35dd3245-1f9f-4af5-81c9-d418989e3bbf">one</span> to seven years. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract manufacturing services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bundled equipment and consumable medical products contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of contract assets and contract liabilities as reported in the condensed consolidated balance sheets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities represent deferred revenues that arise as a result of cash received from customers or where the timing of billing for services precedes satisfaction of our performance obligations. Such remaining performance obligations represent the portion of the contract price for which work has not been performed and are primarily related to our installation and service contracts. We expect to satisfy the majority of the remaining performance obligations and recognize revenue related to installation and service contracts within the next 12 months with most of the non-current performance obligations satisfied within 24 months. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes contract liability activity for the three months ended March 31, 2022.  The contract liability balance represents the transaction price allocated to the remaining performance obligations.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.658%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New revenue deferrals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized upon satisfaction of performance obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, the amount of revenue recognized that was included in contract liabilities as of December 31, 2020 was not significant.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Net Sales</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our acquisition of Hillrom in December 2021, we have added three new product categories: Patient Support Systems, Front Line Care and Surgical Solutions. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">6</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioPharma Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">7</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">8</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">9</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">10</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">11</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,950&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,946&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Medication Delivery includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Clinical Nutrition includes sales of our parenteral nutrition (PN) therapies and related products.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology vision screening and physical assessment.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Other includes sales of miscellaneous product and service offerings.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease smart beds, such as bariatric, critical care, maternal, and home care beds, as well as other surfaces, to customers during periods of peak demand or for specialty purposes. We also lease medical equipment, such as renal dialysis equipment and infusion pumps, to customers, primarily in conjunction with arrangements to provide consumable medical products such as dialysis therapies, IV fluids and inhaled anesthetics. Certain of our equipment leases are classified as sales-type leases and the remainder are operating leases. The terms of the related contracts, including the proportion of fixed versus variable payments and any options to shorten or extend the lease term, vary by customer. We allocate revenue between equipment leases and medical products based on their standalone selling prices.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of lease revenue for the three months ended March&#160;31, 2022 and 2021 were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.279%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.280%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.137%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net investment in sales-type leases was $109 million as of March&#160;31, 2022, of which $38 million originated in 2018 and prior, $16 million in 2019, $28&#160;million in 2020, $25 million in 2021, and $2&#160;million in 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232417768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">BUSINESS OPTIMIZATION CHARGES</a></td>
<td class="text">BUSINESS OPTIMIZATION CHARGES<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, we have undertaken actions to transform our cost structure and enhance operational efficiency. These efforts include restructuring the organization, optimizing the manufacturing footprint, R&amp;D operations and supply chain network, employing disciplined cost management, and centralizing and streamlining certain support functions. In the current period, restructuring charges include actions taken in connection with our integration of Hillrom. From the commencement of our business optimization activities in the second half of 2015 through March&#160;31, 2022, we have incurred cumulative pre-tax costs of $1.3 billion related to these actions. The costs consisted primarily of employee termination costs, implementation costs, contract termination costs, asset impairments and accelerated depreciation. We currently expect to incur additional pre-tax costs of approximately $25 million through the completion of the initiatives that are currently underway, primarily related to implementation costs. We continue to pursue cost savings initiatives and, to the extent further cost savings opportunities are identified, we may incur additional restructuring charges and costs to implement business optimization programs in future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022 and 2021, we recorded the following charges related to business optimization programs.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.440%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.987%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs to implement business optimization programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total business optimization charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For segment reporting purposes, business optimization charges are unallocated expenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs to implement business optimization programs for the three months ended March&#160;31, 2022 and 2021, respectively, consisted primarily of external consulting and transition costs, including employee compensation and related costs. These costs were primarily included within cost of sales and SG&amp;A expense.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022 and 2021, we recorded the following restructuring charges.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity in the liability related to our restructuring initiatives.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our restructuring liabilities as of March&#160;31, 2022 relate to employee termination costs, with the remaining liabilities attributable to contract termination costs. Substantially all of the cash payments for those liabilities are expected to be disbursed by the end of 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232779624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</a></td>
<td class="text">PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS<span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of net periodic benefit cost relating to our pension and OPEB plans.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.152%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Pension benefits</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OPEB</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net loss and prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic OPEB cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232328360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES <div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our effective income tax rate was 22.3% and 14.5% for the three months ended March 31, 2022 and 2021, respectively. Our effective income tax rate can differ from the 21% U.S. federal statutory rate due to a number of factors, including foreign rate differences, tax incentives, increases or decreases in valuation allowances and liabilities for uncertain tax positions and excess tax benefits on stock compensation awards.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to discrete tax matters in various foreign jurisdictions, of which none are individually material, and an increase in our liabilities for uncertain tax positions, partially offset by excess tax benefits on stock compensation awards and a favorable geographic earnings mix.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to decreases in accrued withholding taxes in several foreign jurisdictions and a favorable geographic earnings mix.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232767064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHAREThe numerator for both basic and diluted earnings per share (EPS) is net income attributable to Baxter stockholders. The denominator for basic EPS is the weighted-average number of shares outstanding during the period. The dilutive effect of outstanding stock options, RSUs and PSUs is reflected in the denominator for diluted EPS using the treasury stock method.<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of basic shares to diluted shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.152%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of dilutive securities includes unexercised stock options, unvested RSUs and contingently issuable shares related to granted PSUs. The computation of diluted EPS excludes 4 million and 7 million equity awards for the three months ended March&#160;31, 2022 and 2021, respectively, because their inclusion would have had an anti-dilutive effect on diluted EPS.  Refer to Note 7 for additional information regarding items impacting basic and diluted shares.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232487896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</a></td>
<td class="text">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate on a global basis and are exposed to the risk that our earnings, cash flows and equity could be adversely impacted by fluctuations in foreign exchange and interest rates. Our hedging policy attempts to manage these risks to an acceptable level based on our judgment of the appropriate trade-off between risk, opportunity and costs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are primarily exposed to foreign exchange risk with respect to recognized assets and liabilities, forecasted transactions and net assets denominated in the Euro, British Pound, Chinese Renminbi, Korean Won, Australian Dollar, Canadian Dollar, Japanese Yen, Colombian Peso, Brazilian Real, Mexican Peso, Turkish Lira, Indian Rupee and Swedish Krona. We manage our foreign currency exposures on a consolidated basis, which allows us to net exposures and take advantage of any natural offsets. In addition, we use derivative and nonderivative instruments to further reduce the net exposure to foreign exchange risk. Gains and losses on the hedging instruments offset losses and gains on the hedged transactions and reduce the earnings and equity volatility resulting from changes in foreign exchange rates. Financial market and currency volatility may limit our ability to cost-effectively hedge these exposures.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exposed to the risk that our earnings and cash flows could be adversely impacted by fluctuations in interest rates. Our policy is to manage interest costs using the mix of fixed- and floating-rate debt that we believe is appropriate at that time. To manage this mix in a cost-efficient manner, we periodically enter into interest rate swaps in which we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not hold any instruments for trading purposes and none of our outstanding derivative instruments contain credit-risk-related contingent features.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivative instruments are generally recognized as either assets or liabilities at fair value in the condensed consolidated balance sheets and are classified as short-term or long-term based on the scheduled maturity of the instrument. We designate certain of our derivatives and foreign-currency denominated debt as hedging instruments in cash flow, fair value, or net investment hedges.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Flow Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may use options, including collars and purchased options, forwards and cross-currency swaps to hedge the foreign exchange risk to earnings relating to forecasted transactions and recognized assets and liabilities. We periodically use treasury rate locks to hedge the risk to earnings associated with movements in interest rates relating to anticipated issuances of debt.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each derivative instrument that is designated and effective as a cash flow hedge, the gain or loss on the derivative is recorded in AOCI and then recognized in earnings consistent with the underlying hedged item. Option premiums or net premiums paid are initially recorded as assets and reclassified to other comprehensive income (OCI) over the life of the option, and then recognized in earnings consistent with the underlying hedged item. Cash flow hedges are classified in cost of sales and interest expense, net, and are primarily related to forecasted intra-company sales denominated in foreign currencies and forecasted interest payments on anticipated issuances of debt, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts of foreign exchange contracts designated as cash flow hedges were $402 million and $377 million as of March&#160;31, 2022 and December&#160;31, 2021, respectively. The maximum term over which we have cash flow </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hedge contracts in place related to forecasted transactions at March&#160;31, 2022 is 12 months for foreign exchange contracts. There were no outstanding interest rate contracts designated as cash flow hedges as of March&#160;31, 2022 and December&#160;31, 2021. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically use interest rate swaps to convert a portion of our fixed-rate debt into variable-rate debt. These instruments hedge our earnings from changes in the fair value of debt due to fluctuations in the designated benchmark interest rate. For each derivative instrument that is designated and effective as a fair value hedge, the gain or loss on the derivative is recognized immediately to earnings, and offsets changes in fair value attributable to a particular risk, such as changes in interest rates, of the hedged item, which are also recognized in earnings. Changes in the fair value of hedge instruments designated as fair value hedges are classified in interest expense, net, as they hedge the interest rate risk associated with certain of our fixed-rate debt.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no outstanding interest rate contracts designated as fair value hedges as of March&#160;31, 2022 and December&#160;31, 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Net Investment Hed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">es</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, we issued &#8364;600 million of senior notes due May 2025. In May 2019, we issued &#8364;750 million of senior notes due May 2024 and &#8364;750 million of senior notes due May 2029. We have designated these debt obligations as hedges of our net investment in our European operations and, as a result, mark to spot rate adjustments on the outstanding debt balances are recorded as a component of AOCI. As of March&#160;31, 2022, we had an accumulated pre-tax unrealized translation loss in AOCI of $4 million related to the Euro-denominated senior notes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dedesignations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If it is determined that a derivative or nonderivative hedging instrument is no longer highly effective as a hedge, we discontinue hedge accounting prospectively. Gains or losses relating to terminations of effective cash flow hedges generally continue to be deferred and are recognized consistent with the loss or income recognition of the underlying hedged items. However, if it is probable that the hedged forecasted transactions will not occur, any gains or losses would be immediately reclassified from AOCI to earnings. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no hedge dedesignations in the first three months of 2022 or 2021 resulting from changes in our assessment of the probability that the hedged forecasted transactions would occur.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we terminate a fair value hedge, an amount equal to the cumulative fair value adjustment to the hedged item at the date of termination is amortized to earnings over the remaining term of the hedged item. There were no fair value hedges terminated during the first three months of 2022 or 2021. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we remove a net investment hedge designation, any gains or losses recognized in AOCI are not reclassified to earnings until we sell, liquidate, or deconsolidate the foreign investments that were being hedged. There were no net investment hedges terminated during the first three months of 2022 or 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Undesignated Derivative Instruments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use forward contracts to hedge earnings from the effects of foreign exchange relating to certain of our intra-company and third-party receivables and payables denominated in a foreign currency. These derivative instruments are generally not formally designated as hedges and the terms of these instruments generally do not exceed one month.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total notional amount of undesignated derivative instruments was $940&#160;million as of March&#160;31, 2022 and $851 million as of December&#160;31, 2021.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Gains and Losses on Hedging Instruments and Undesignated Derivative Instruments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the three months ended March&#160;31, 2022 and </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:24.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.415%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss)<br/>in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) reclassified from AOCI into income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.308%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.785%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss) in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.331%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, $5 million of deferred, net after-tax losses on derivative instruments included in AOCI are expected to be recognized in earnings during the next 12 months, coinciding with when the hedged items are expected to impact earnings.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivative Assets and Liabilities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of March&#160;31, 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.216%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of December&#160;31, 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While some of our derivatives are subject to master netting arrangements, we present our assets and liabilities related to derivative instruments on a gross basis within the condensed consolidated balance sheets. Additionally, we are not required to post collateral for any of our outstanding derivatives.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on our derivative positions as if they were presented on a net basis, allowing for the right of offset by counterparty.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.254%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.383%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amounts recognized in the condensed consolidated balance sheets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the amounts recorded on the condensed consolidated balance sheet related to fair value hedges:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.281%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying amount of hedged item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative amount of fair value hedging adjustment included<br/>&#160;in the carrying amount of the hedged item (a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a) These fair value hedges were terminated in 2018 and earlier periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232483912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our assets and liabilities that are measured at fair value on a recurring basis.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.624%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"/><td style="width:49.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.513%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 and December&#160;31, 2021, cash and cash equivalents of $2.3 billion and $3.0 billion, respectively, included money market and other short-term funds of approximately $426 million and $816 million, respectively, which are considered Level 2 in the fair value hierarchy.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For assets that are measured using quoted prices in active markets, the fair value is the published market price per unit multiplied by the number of units held, without consideration of transaction costs. The majority of the derivatives entered into by us are valued using internal valuation techniques as no quoted market prices exist for such instruments. The principal techniques used to value these instruments are discounted cash flow and Black-Scholes models. The key inputs, which are considered observable and vary depending on the type of derivative, include contractual terms, interest rate yield curves, foreign exchange rates and volatility.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities, which consist of convertible debt and convertible redeemable preferred shares issued by nonpublic entities, are measured using discounted cash flow and option pricing models. Those debt securities are classified as Level 3 fair value measurements when there are no observable transactions near the balance sheet date due to the lack of observable data over certain fair value inputs such as equity volatility. The fair values of debt securities increase when interest rates decrease, equity volatility increases, or the fair values of the equity shares underlying the conversion options increase.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent payments related to acquisitions, which consist of milestone payments and sales-based payments, are valued using discounted cash flow techniques. The fair value of milestone payments reflects management&#8217;s expectations of probability of payment, and increases as the probability of payment increases or the expected timing of payments is accelerated. The fair value of sales-based payments is based upon probability-weighted future revenue estimates, and increases as revenue estimates increase, probability weighting of higher revenue scenarios increases or the expected timing of payment is accelerated. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of recurring fair value measurements that use significant unobservable inputs (Level 3), which consist of contingent payments related to acquisitions and debt securities.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.138%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at beginning of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Instruments Not Measured at Fair Value</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the financial instruments that we are required to recognize at fair value in the condensed consolidated balance sheets, we have certain financial instruments that are recognized at amortized cost or some basis other than fair value. For these financial instruments, the following table provides the values recognized in the condensed consolidated balance sheets and the estimated fair values as of March&#160;31, 2022 and December&#160;31, 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Book values</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair values(a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,765&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,149&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,568&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;These fair value amounts are classified as Level 2 within the fair value hierarchy as they are estimated based on observable inputs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of short-term debt approximates its fair value due to the short-term maturities of the obligations. The estimated fair values of current and long-term debt were computed by multiplying price by the notional amount of the respective debt instruments. Price is calculated using the stated terms of the respective debt instrument and yield curves commensurate with our credit risk. The carrying values of other financial instruments, such as accounts receivable and accounts payable, approximate their fair values due to the short-term maturities of most of those assets and liabilities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity investments not measured at fair value are comprised of other equity investments without readily determinable fair values and were $110 million at March&#160;31, 2022 and $114 million at December&#160;31, 2021. Those investments are included in Other non-current assets on our condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232297688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text">SEGMENT INFORMATION<div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We manage our business based on four segments, consisting of the following geographic segments related to our legacy Baxter business: Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia Pacific), and a new global segment for the acquired Hillrom business. The Americas, EMEA and APAC segments provide a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use operating income on a segment basis to make resource allocation decisions and assess the ongoing performance of our business segments. Intersegment sales are eliminated in consolidation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain items are maintained at Corporate and are not allocated to a segment. They primarily include corporate headquarters costs, certain R&amp;D costs, certain product category support costs, stock compensation expense, certain employee benefit plan costs, and certain gains, losses, and other charges (such as business optimization, acquisition and integration costs, intangible asset amortization and asset impairments). For the period from our acquisition of Hillrom on December 13, 2021 through December 31, 2021, we previously included all costs incurred by the Hillrom business within that segment, including the types of costs described in the preceding sentence that are maintained at Corporate for our legacy Baxter segments. In connection with our ongoing integration activities, beginning in the first quarter 2022, we have updated the measure of profitability for our Hillrom segment by excluding such unallocated costs, consistent with our legacy Baxter segments. Those unallocated costs related to Hillrom, which totaled $219&#160;million for the three months ended March 31, 2022, are now presented within Corporate as well. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our chief operating decision maker does not receive any asset information by operating segment and, accordingly, we do not report asset information by operating segment.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information for our segments is as follows.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.152%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,946&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating income</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of segment operating income to income before income taxes per the condensed consolidated statements of income.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.152%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(917)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 9 for additional information on Net Sales by product category.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010237199160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (we or our) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) in the United States have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 (2021 Annual Report).In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the current interim period are not necessarily indicative of the results of operations to be expected for the full year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RisksAndUncertaintiesPolicyPolicyTextBlock', window );">Risks and Uncertainties Related to COVID-19 and Global Economic Conditions</a></td>
<td class="text">Risks and Uncertainties Related to COVID-19 and Global Economic Conditions Our global operations expose us to risks associated with public health crises and epidemics/pandemics, such as the novel strain of coronavirus (COVID-19). COVID-19 has had, and we expect will continue to have, an adverse impact on our operations, supply chains and distribution systems and has increased and we expect will continue to increase our expenses, including as a result of impacts associated with preventive and precautionary measures that we, other businesses and governments have taken and continue to take. Initial measures taken in 2020 led to unprecedented restrictions on, disruptions in, and other related impacts on business and personal activities, including a shift in healthcare priorities, which resulted in a significant decline in medical procedures in 2020. The pandemic has created significant volatility in the demand for our products. For further information about our revenues by product category, refer to Note 9. Significant uncertainty remains regarding the duration and overall impact of the COVID-19 pandemic.  For example, concerns remain regarding the pace of economic recovery due to virus resurgence across the globe from the Omicron variants, subvariants and other virus mutations as well as vaccine distribution and hesitancy. The U.S. and other governments may continue existing measures or implement new restrictions and other requirements in light of the continuing spread of the pandemic (including with respect to mandatory vaccinations for certain of our employees, moratoriums on elective procedures and mandatory quarantines and travel restrictions). Due to the uncertainty caused by the pandemic, our operating performance and financial results, particularly in the short term, may be subject to volatility.  We have experienced significant challenges, including lengthy delays, shortages and interruptions, posed by the pandemic and other exogenous factors (including significant weather events, disruptions to certain ports of call around the world and certain geopolitical events) to our global supply chain, including the cost and availability of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, and may experience these and other challenges in future periods.  Many of our manufacturing plant and distribution center personnel are currently unvaccinated, and we may also experience employee resistance in complying with current and future government vaccine and testing mandates, which may cause labor shortages significantly impacting manufacturing production and distribution center productivity.  We expect that these challenges as well as evolving governmental restrictions and requirements, among other factors, may continue to have an adverse effect on our business.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently adopted accounting pronouncements</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 1, 2022, we adopted Accounting Standards Update (ASU) 2021-05, Leases (Topic 842), which requires a lessor to classify a lease with variable lease payments (that do not depend on an index or rate) as an operating lease if (1) the lease would have been classified as a sales-type or direct financing lease, and (2) the lessor would have recognized a selling loss at lease commencement. These changes are intended to avoid recognizing a day-one loss for a lease with variable payments even though the lessor expects the arrangement will be profitable overall. The adoption of this ASU did not have a material impact on our condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_RisksAndUncertaintiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risks and Uncertainties Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_RisksAndUncertaintiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010236217592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND OTHER ARRANGEMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the total consideration paid:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash consideration paid to Hillrom shareholders</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of equity awards issued to Hillrom equity award holders</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Consideration</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,476&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Represents cash consideration transferred of $156.00 per outstanding Hillrom common share to existing shareholders and holders of equity awards that vested at closing pursuant to their original terms.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Represents the pre-acquisition service portion of the fair value of 668&#160;thousand replacement restricted stock units issued to Hillrom equity award holders at closing.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text">The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed as of the acquisition date:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.136%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets acquired and liabilities assumed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,527)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired and liabilities assumed</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,476&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010233416200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Allowance for Doubtful Accounts</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Doubtful Accounts</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the changes in our allowance for doubtful accounts for the three months ended March&#160;31, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.263%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,548&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment, Net</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment, Net </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,643)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,550)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,114&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Interest Expense, Net</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Interest Expense, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.263%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net of capitalized interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Other (Income) Expense, Net</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Other (Income) Expense, Net</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.263%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (gains) losses, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232303144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Goodwill</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of goodwill by business segment.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:40.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,517&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,836&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,488&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,801&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,816&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock', window );">Other Intangible Assets, Net</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our other intangible assets.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed technology, including patents</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other amortized intangible assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,638)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,195&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,693&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,930)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,245&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,792&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Finite And Indefinite Lived Intangible Assets Excluding Goodwill</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232286136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average Black-Scholes assumptions used in establishing the fair value of stock options granted during the period, along with weighted-average grant date fair values, were as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.152%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value per stock option</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010236210840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Summary of Changes in AOCI by Component</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a net-of-tax summary of the changes in accumulated other comprehensive (loss) income (AOCI) by component for the three months ended March&#160;31, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.101%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.095%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.664%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,380)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,922)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,387)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CTA</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension and OPEB plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedging activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(574)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,314)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before<br/>reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,795)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(544)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,480)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;See table below for details about these reclassifications.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Summary of Reclassification from AOCI to Net Income</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the amounts reclassified from AOCI to net income during the three months ended March&#160;31, 2022 and 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:44.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.168%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI (a)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of impact in income statement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and OPEB items</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs or credits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains (losses) on hedging activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total before tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Tax effect</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net of tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications for the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net of tax</span></td></tr></table></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Amounts in parentheses indicate reductions to net income</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010233625048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract with Customer, Contract Asset</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contract assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract manufacturing services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bundled equipment and consumable medical products contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification of contract assets and contract liabilities as reported in the condensed consolidated balance sheets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.269%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes contract liability activity for the three months ended March 31, 2022.  The contract liability balance represents the transaction price allocated to the remaining performance obligations.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.658%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New revenue deferrals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized upon satisfaction of performance obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Net Sales from Contracts with Customers by Global Business Unit</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Renal Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication Delivery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmaceuticals </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Nutrition </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Surgery </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acute Therapies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">6</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioPharma Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">7</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient Support Systems </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">8</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front Line Care </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">9</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical Solutions </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">10</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">11</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Baxter</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,950&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,946&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.934%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Medication Delivery includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Clinical Nutrition includes sales of our parenteral nutrition (PN) therapies and related products.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt">Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology vision screening and physical assessment.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt">Other includes sales of miscellaneous product and service offerings.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock', window );">Sales-type Lease, Lease Income</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of lease revenue for the three months ended March&#160;31, 2022 and 2021 were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.279%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.280%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock', window );">Operating Lease, Lease Income</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of lease revenue for the three months ended March&#160;31, 2022 and 2021 were:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.279%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.280%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity of undiscounted cash flows to be received on annual basis for sales-type and direct financing leases receivable. Includes, but is not limited to, reconciliation to lease receivable recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010235179176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_BusinessOptimizationChargeTableTextBlock', window );">Summary of Business Optimization Charges</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022 and 2021, we recorded the following charges related to business optimization programs.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.440%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.987%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs to implement business optimization programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total business optimization charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Components of Restructuring Charges</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022 and 2021, we recorded the following restructuring charges.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract termination and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Summary of Activity in Reserves Related to Restructuring Initiatives</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes activity in the liability related to our restructuring initiatives.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability balance as of March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_BusinessOptimizationChargeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business optimization charge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_BusinessOptimizationChargeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232779624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of net periodic benefit cost relating to our pension and OPEB plans.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.152%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Pension benefits</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net losses and prior service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OPEB</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net loss and prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic OPEB cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010313706456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Reconciliation of Basic Shares to Diluted Shares</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of basic shares to diluted shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.152%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010313781784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Summary of Gains and Losses on Derivative Instruments</a></td>
<td class="text">The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the three months ended March&#160;31, 2022 and <div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:24.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.799%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.415%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss)<br/>in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) reclassified from AOCI into income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow hedges</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net investment hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.308%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.785%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of gain (loss) in income statement</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Classification and Fair Values of Derivative Instruments</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of March&#160;31, 2022.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.216%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.164%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of December&#160;31, 2021.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.014%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.451%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in asset positions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in liability positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet location</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Undesignated derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total derivative instruments</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock', window );">Derivative Positions Presented On Net Basis</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on our derivative positions as if they were presented on a net basis, allowing for the right of offset by counterparty.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.254%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.383%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amounts recognized in the condensed consolidated balance sheets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the amounts recorded on the condensed consolidated balance sheet related to fair value hedges:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.512%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.281%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Carrying amount of hedged item</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cumulative amount of fair value hedging adjustment included<br/>&#160;in the carrying amount of the hedged item (a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a) These fair value hedges were terminated in 2018 and earlier periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of derivative positions presented on net basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010233443512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of Financial Instruments Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our assets and liabilities that are measured at fair value on a recurring basis.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.624%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.395%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"/><td style="width:49.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.513%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basis of fair value measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted prices in active markets for identical assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant other<br/>observable inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Significant<br/>unobservable inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of recurring fair value measurements that use significant unobservable inputs (Level 3), which consist of contingent payments related to acquisitions and debt securities.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.138%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent payments related to acquisitions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at beginning of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value recognized in AOCI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Book Values and Fair Values of Financial Instruments</a></td>
<td class="text">the following table provides the values recognized in the condensed consolidated balance sheets and the estimated fair values as of March&#160;31, 2022 and December&#160;31, 2021.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Book values</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair values(a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,765&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,149&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,568&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table>(a)&#160;&#160;&#160;&#160;These fair value amounts are classified as Level 2 within the fair value hierarchy as they are estimated based on observable inputs.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232303144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Financial Information for Our Segments</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information for our segments is as follows.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.152%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,946&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Operating income</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hillrom</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Operating Income to Income Before Income Taxes Reconciliation</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of segment operating income to income before income taxes per the condensed consolidated statements of income.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.152%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(917)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010228875464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND OTHER ARRANGEMENTS - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 13, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember', window );">Hillrom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_BusinessCombinationCashConsideration', window );">Cash consideration</a></td>
<td class="nump">$ 10,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations', window );">Enterprise value</a></td>
<td class="nump">$ 12,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Cash consideration transferred (in usd per share)</a></td>
<td class="nump">$ 156.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed', window );">Adjustment, assets acquired and liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory', window );">Incremental costs of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 159<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Acquired Receivable, Fair Value, Including Outstanding Debt Obligations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_BusinessCombinationCashConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Cash Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_BusinessCombinationCashConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired and Liabilities Assumed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bax_HillromMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010230367160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS AND OTHER ARRANGEMENTS - Schedule of Total Consideration for Hillrom (Details) - Hillrom<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 13, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_AcquisitionsAndCollaborationsLineItems', window );"><strong>Acquisitions And Collaborations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration paid to Hillrom shareholders</a></td>
<td class="nump">$ 10,474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Fair value of equity awards issued to Hillrom equity award holders</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total Consideration</a></td>
<td class="nump">$ 10,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Cash consideration transferred (in usd per share) | $ / shares</a></td>
<td class="nump">$ 156.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, equity interest issued or issuable (in shares) | shares</a></td>
<td class="nump">668<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_AcquisitionsAndCollaborationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisitions And Collaborations [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_AcquisitionsAndCollaborationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bax_HillromMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010234045352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS AND OTHER ARRANGEMENTS - Summary of Fair Value of Assets Acquired and Liabilities Assumed for Hillrom (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 13, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_AcquisitionsAndCollaborationsLineItems', window );"><strong>Acquisitions And Collaborations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 9,816<span></span>
</td>
<td class="nump">$ 9,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember', window );">Hillrom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_AcquisitionsAndCollaborationsLineItems', window );"><strong>Acquisitions And Collaborations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">557<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt', window );">Short-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(250)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(140)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(552)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Long-term debt and finance lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,118)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,527)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total assets acquired and liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,476<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_AcquisitionsAndCollaborationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisitions And Collaborations [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_AcquisitionsAndCollaborationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed current liabilities short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right Of Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease obligation assumed in business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bax_HillromMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bax_HillromMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010236499464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND OTHER ARRANGEMENTS - Other Business Development Activities (Details) - Zosyn<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="nump">$ 122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=bax_ZosynMember', window );">Developed Technology Intangible Asset</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average useful life</a></td>
<td class="text">9 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=bax_ZosynMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=bax_ZosynMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010228876200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Allowance for Doubtful Accounts Receivable [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at beginning of period</a></td>
<td class="nump">$ 122<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Charged to costs and expenses</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-offs</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments', window );">Currency translation adjustments</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at end of period</a></td>
<td class="nump">$ 129<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Allowance for Credit Loss, Currency Translation Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010235091256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 656<span></span>
</td>
<td class="nump">$ 591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">1,607<span></span>
</td>
<td class="nump">1,562<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 2,548<span></span>
</td>
<td class="nump">$ 2,453<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010235055304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">$ 11,757<span></span>
</td>
<td class="nump">$ 11,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(6,643)<span></span>
</td>
<td class="num">(6,550)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 5,114<span></span>
</td>
<td class="nump">$ 5,178<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010235055304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNetAbstract', window );"><strong>Interest Income Expense Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net of capitalized interest</a></td>
<td class="nump">$ 88<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010233416200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Other Expense, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign exchange (gains) losses, net</a></td>
<td class="num">$ (11)<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitExpense', window );">Pension and other postretirement benefit plans</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingGainsLosses', window );">Other, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7,9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost (reversal of cost) for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010230311560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details) - USD ($)<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use asset obtained in exchange for operating lease liability</a></td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Unsettled share repurchases (in shares)</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Unsettled share repurchases, value (in usd)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_OtherLiabilitiesCurrentUnsettledShareRepurchase', window );">Other Liabilities Current, Unsettled Share Repurchase</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">47,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures incurred but not yet paid</a></td>
<td class="nump">$ 53,000,000<span></span>
</td>
<td class="nump">$ 63,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_OtherLiabilitiesCurrentUnsettledShareRepurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities Current, Unsettled Share Repurchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_OtherLiabilitiesCurrentUnsettledShareRepurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010228786552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 9,836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting adjustments</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">9,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">2,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">2,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">EMEA</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">APAC</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">221<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bax_HillromMember', window );">Hillrom</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">6,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Acquisition accounting adjustments</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 6,801<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bax_HillromMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bax_HillromMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010313738760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Intangible asset amortization expense</a></td>
<td class="nump">$ 217,000,000<span></span>
</td>
<td class="nump">$ 64,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010234078632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">$ (2,127)<span></span>
</td>
<td class="num">$ (1,930)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross other intangible assets</a></td>
<td class="nump">9,820<span></span>
</td>
<td class="nump">9,722<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">7,693<span></span>
</td>
<td class="nump">7,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember', window );">Indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIndefiniteLivedIntangibleAssets', window );">Other intangible assets</a></td>
<td class="nump">2,140<span></span>
</td>
<td class="nump">2,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">3,457<span></span>
</td>
<td class="nump">3,437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(262)<span></span>
</td>
<td class="num">(162)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="nump">3,195<span></span>
</td>
<td class="nump">3,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bax_DevelopedTechnologyIncludingPatentsMember', window );">Developed technology, including patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">3,883<span></span>
</td>
<td class="nump">3,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(1,638)<span></span>
</td>
<td class="num">(1,556)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="nump">2,245<span></span>
</td>
<td class="nump">2,245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other amortized intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_IntangibleAssetExcludingGoodwillLineItems', window );"><strong>Intangible Asset Excluding Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">340<span></span>
</td>
<td class="nump">344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(227)<span></span>
</td>
<td class="num">(212)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_IntangibleAssetExcludingGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible Asset Excluding Goodwill [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_IntangibleAssetExcludingGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after impairment of indefinite-lived intangible assets classified as other. Excludes financial assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_IndefinitelivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bax_DevelopedTechnologyIncludingPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bax_DevelopedTechnologyIncludingPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010228802824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCING ARRANGEMENTS (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommercialPaperAverageOutstanding', window );">Commercial paper, average outstanding</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_CommercialPaperWeightedAverageInterestRate', window );">Weighted-average interest rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.27%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_OriginalWeightedAverageTerm', window );">Original weighted-average term</a></td>
<td class="text">89 days<span></span>
</td>
<td class="text">88 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of credit, current borrowing capacity</a></td>
<td class="nump">$ 2,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Borrowings outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_SeniorThreeYearTermLoanMember', window );">Senior Three Year Term Loan | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Repaid debt</a></td>
<td class="nump">170,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTerm', window );">Weighted-average term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_SeniorFiveYearTermLoanMember', window );">Senior Five Year Term Loan | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Repaid debt</a></td>
<td class="nump">$ 175,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTerm', window );">Weighted-average term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_CommercialPaperWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commercial Paper, Weighted-Average Interest Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_CommercialPaperWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_OriginalWeightedAverageTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Original Weighted-Average Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_OriginalWeightedAverageTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaperAverageOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average amount outstanding of commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (a)<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (b)<br> -Subparagraph (1)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaperAverageOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_SeniorThreeYearTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_SeniorThreeYearTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_SeniorFiveYearTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_SeniorFiveYearTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010233975224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 18, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 12, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>site</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>lawsuit</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Litigation reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Agreement to settle the case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Civil settlement amount</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_LossContingencyNumberOfLawsuits', window );">Number of lawsuits | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EnvironmentalRemediationSiteAxis=bax_SuperfundSitesMember', window );">Superfund Sites | Environmental Clean-up</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_SiteContingencyNumberOfSites', window );">Number of sites | site</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Environmental reserves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_LossContingencyNumberOfLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_LossContingencyNumberOfLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_SiteContingencyNumberOfSites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Site contingency, number of sites.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_SiteContingencyNumberOfSites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForEnvironmentalLossContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs accrued as of the balance sheet date for environmental loss contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6395460&amp;loc=d3e13647-108346<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13207-110859<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForEnvironmentalLossContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EnvironmentalRemediationSiteAxis=bax_SuperfundSitesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EnvironmentalRemediationSiteAxis=bax_SuperfundSitesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EnvironmentalRemediationContingencyAxis=bax_EnviromentalCleanUpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EnvironmentalRemediationContingencyAxis=bax_EnviromentalCleanUpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010234083160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Stock Options Fair Value Assumptions (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value per stock option (in usd per share)</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010229880792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Narrative (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2012 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of stock options exercised</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.28<span></span>
</td>
<td class="nump">$ 0.245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_StockRepurchaseProgramAdditionalAuthorizedAmount', window );">Stock repurchase program, additional authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (in shares) | shares</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining value available under stock repurchase programs</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_ShareBasedCompensationAllocationPercentage', window );">Stock compensation expense allocation percentage</a></td>
<td class="nump">0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Gross stock options (in shares) | shares</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross', window );">Stock granted, value, share-based compensation, gross</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to all unvested stock options</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for all unvested stock options</a></td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants in period (in shares) | shares</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross', window );">Stock granted, value, share-based compensation, gross</a></td>
<td class="nump">$ 102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to all unvested stock options</a></td>
<td class="nump">$ 163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for all unvested stock options</a></td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Grants in period (in shares) | shares</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross', window );">Stock granted, value, share-based compensation, gross</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to all unvested stock options</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for all unvested stock options</a></td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_ShareBasedCompensationAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Allocation Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_ShareBasedCompensationAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_StockRepurchaseProgramAdditionalAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock repurchase program additional authorized amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_StockRepurchaseProgramAdditionalAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_StockholdersEquityNoteLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stockholders equity note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_StockholdersEquityNoteLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010231196120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Changes in AOCI by Component (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="nump">$ 9,121<span></span>
</td>
<td class="nump">$ 8,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(192)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net other comprehensive income (loss)</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(166)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="nump">9,119<span></span>
</td>
<td class="nump">8,490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">CTA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="num">(2,907)<span></span>
</td>
<td class="num">(2,587)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(208)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net other comprehensive income (loss)</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(208)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="num">(2,922)<span></span>
</td>
<td class="num">(2,795)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension and OPEB plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="num">(347)<span></span>
</td>
<td class="num">(574)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net other comprehensive income (loss)</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="num">(338)<span></span>
</td>
<td class="num">(544)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Hedging activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="num">(126)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net other comprehensive income (loss)</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="num">(128)<span></span>
</td>
<td class="num">(141)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net other comprehensive income (loss)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Gains (losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, beginning of period (in usd)</a></td>
<td class="num">(3,380)<span></span>
</td>
<td class="num">(3,314)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, end of period (in usd)</a></td>
<td class="num">$ (3,387)<span></span>
</td>
<td class="num">$ (3,480)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010233747304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Amounts Reclassification from AOCI to Net Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(2,359)<span></span>
</td>
<td class="num">(1,801)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total before tax</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">351<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total net of tax</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Amounts reclassified from AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total net of tax</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension and OPEB items | Amounts reclassified from AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total net of tax</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gains (losses) on hedging activities | Amounts reclassified from AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total before tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Total net of tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gains (losses) on hedging activities | Foreign exchange contracts | Amounts reclassified from AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gains (losses) on hedging activities | Interest rate contracts | Amounts reclassified from AOCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense, net</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010229867416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Net trade accounts receivable</a></td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLease', window );">Sales-type lease, net of investment in lease</a></td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable', window );">Sales-type leases, receivables</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenuePerformanceObligationPaymentTerms', window );">Global payment terms</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Software sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueRecognizedContractPeriod', window );">Revenue recognized contract period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Consumable Medical Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueRecognizedContractPeriod', window );">Revenue recognized contract period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenuePerformanceObligationPaymentTerms', window );">Global payment terms</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Contract manufacturing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueRecognizedContractPeriod', window );">Revenue recognized contract period</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Software sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueRecognizedContractPeriod', window );">Revenue recognized contract period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Consumable Medical Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueRecognizedContractPeriod', window );">Revenue recognized contract period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_RevenueFromContractWithCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_RevenueFromContractWithCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_RevenuePerformanceObligationPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue, Performance Obligation, Payment Terms</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_RevenuePerformanceObligationPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_RevenueRecognizedContractPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue recognized contract period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_RevenueRecognizedContractPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123366838&amp;loc=d3e3073-115593<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type and direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919391-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of net investment in sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_SoftwareArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_SoftwareArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_ConsumableMedicalProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_ConsumableMedicalProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_ManufacturingArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_ManufacturingArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010231416696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUES - Remaining Performance Obligations (Details)<br> $ in Billions</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Transaction price allocated to remaining performance obligations</a></td>
<td class="nump">$ 8.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-04-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-04-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining revenue performance obligation, percentage of revenue expected to be recognized</a></td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations period</a></td>
<td class="text">9 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining revenue performance obligation, percentage of revenue expected to be recognized</a></td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining revenue performance obligation, percentage of revenue expected to be recognized</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining revenue performance obligation, percentage of revenue expected to be recognized</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2026-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining revenue performance obligation, percentage of revenue expected to be recognized</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations period</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_RevenueFromContractWithCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_RevenueFromContractWithCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-04-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-04-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010231360008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES - Contract Assets and Contract Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerRollForward', window );"><strong>Revenue From Contract With Customer [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at beginning of period</a></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_ContractWithCustomerLiabilityDeferredRevenue', window );">New revenue deferrals</a></td>
<td class="nump">116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized upon satisfaction of performance obligations</a></td>
<td class="num">(122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at end of period</a></td>
<td class="nump">240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=bax_AccruedExpensesAndOtherCurrentLiabilitiesMember', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">166<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerRollForward', window );"><strong>Revenue From Contract With Customer [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at beginning of period</a></td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at end of period</a></td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerRollForward', window );"><strong>Revenue From Contract With Customer [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at beginning of period</a></td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at end of period</a></td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAxis=bax_ManufacturingArrangementsMember', window );">Contract manufacturing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAxis=bax_SoftwareArrangementsMember', window );">Software sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAxis=bax_BundledEquipmentAndConsumableMedicalProductsContractsMember', window );">Bundled equipment and consumable medical products contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">$ 111<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_ContractWithCustomerLiabilityDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Deferred Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_ContractWithCustomerLiabilityDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_RevenueFromContractWithCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_RevenueFromContractWithCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_RevenueFromContractWithCustomerRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_RevenueFromContractWithCustomerRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=bax_AccruedExpensesAndOtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=bax_AccruedExpensesAndOtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_ManufacturingArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_ManufacturingArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_SoftwareArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_SoftwareArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=bax_BundledEquipmentAndConsumableMedicalProductsContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=bax_BundledEquipmentAndConsumableMedicalProductsContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010229082632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 3,707<span></span>
</td>
<td class="nump">$ 2,946<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,757<span></span>
</td>
<td class="nump">1,180<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,950<span></span>
</td>
<td class="nump">1,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_RenalMember', window );">Renal Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">894<span></span>
</td>
<td class="nump">922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_RenalMember', window );">Renal Care | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_RenalMember', window );">Renal Care | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">669<span></span>
</td>
<td class="nump">706<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_MedicationDeliveryMember', window );">Medication Delivery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">706<span></span>
</td>
<td class="nump">652<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_MedicationDeliveryMember', window );">Medication Delivery | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">472<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_MedicationDeliveryMember', window );">Medication Delivery | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">234<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PharmaceuticalsMember', window );">Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">521<span></span>
</td>
<td class="nump">552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PharmaceuticalsMember', window );">Pharmaceuticals | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PharmaceuticalsMember', window );">Pharmaceuticals | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">364<span></span>
</td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_ClinicalNutritionMember', window );">Clinical Nutrition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_ClinicalNutritionMember', window );">Clinical Nutrition | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_ClinicalNutritionMember', window );">Clinical Nutrition | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember', window );">Advanced Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember', window );">Advanced Surgery | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember', window );">Advanced Surgery | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AcuteTherapiesMember', window );">Acute Therapies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AcuteTherapiesMember', window );">Acute Therapies | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_AcuteTherapiesMember', window );">Acute Therapies | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember', window );">BioPharma Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember', window );">BioPharma Solutions | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember', window );">BioPharma Solutions | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember', window );">Patient support systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember', window );">Patient support systems | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember', window );">Patient support systems | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_FrontLineCareMember', window );">Front line care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_FrontLineCareMember', window );">Front line care | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_FrontLineCareMember', window );">Front line care | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember', window );">Surgical solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember', window );">Surgical solutions | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember', window );">Surgical solutions | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember', window );">Other | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember', window );">Other | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_RevenueFromContractWithCustomerLineItems', window );"><strong>Revenue From Contract With Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_RevenueFromContractWithCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_RevenueFromContractWithCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_RenalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_RenalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_MedicationDeliveryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_MedicationDeliveryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_PharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_PharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_ClinicalNutritionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_ClinicalNutritionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_AcuteTherapiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_AcuteTherapiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_FrontLineCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_FrontLineCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010228888824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUES - Lease Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseRevenue', window );">Sales-type lease revenue</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Operating lease revenue</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseIncome', window );">Variable lease revenue</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseIncome', window );">Total lease revenue</a></td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease income from operating, direct financing, and sales-type leases. Includes, but is not limited to, variable lease payments, interest income, profit (loss) recognized at commencement, and lease payments paid and payable to lessor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919311-209978<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sales-type lease revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease payments from operating, direct financing, and sales-type leases, excluding amount included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010231459544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Cumulative pre-tax costs incurred</a></td>
<td class="nump">$ 1,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected additional pre-tax costs</a></td>
<td class="nump">$ 25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010231293256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bax_BusinessOptimizationProgramsMember', window );">Business Optimization Programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostIncurredCost', window );">Costs to implement business optimization programs</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Total business optimization charges</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostIncurredCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostIncurredCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bax_BusinessOptimizationProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bax_BusinessOptimizationProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010228992616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">COGS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee termination costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee termination costs | COGS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee termination costs | SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee termination costs | R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember', window );">Contract termination and other costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember', window );">Contract termination and other costs | COGS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember', window );">Contract termination and other costs | SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember', window );">Contract termination and other costs | R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember', window );">Asset impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember', window );">Asset impairments | COGS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember', window );">Asset impairments | SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember', window );">Asset impairments | R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bax_ContractTerminationAndOtherCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bax_AssetImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010231388920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=bax_SeveranceAndOtherEmployeeRelatedCostsMember', window );">Severance and Other Employee Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve, beginning balance</a></td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Currency translation</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve, ending balance</a></td>
<td class="nump">$ 137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bax_SeveranceAndOtherEmployeeRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bax_SeveranceAndOtherEmployeeRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010233821784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net losses and prior service costs</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic cost (income)</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">OPEB</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Net periodic benefit cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net losses and prior service costs</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic cost (income)</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232457608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">22.30%<span></span>
</td>
<td class="nump">14.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. Federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232395064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Reconciliation of Basic Shares to Diluted Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">503<span></span>
</td>
<td class="nump">505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">509<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010232352824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Additional Information (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of EPS (in shares)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010226636824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_DerivativeFairValueTerminated', window );">Derivative, fair value, terminated</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_DerivativeNetInvestmentTerminated', window );">Derivative, net investment terminated</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Deferred, net after-tax gains on derivative instruments</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Undesignated derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">940,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 851,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net investment hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Accumulated pre-tax unrealized translation gain in AOCI</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember', window );">1.30% Senior Notes due May 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember', window );">0.4% Senior Notes Due in May 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember', window );">1.3% Senior Notes Due in May 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 402,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">377,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1', window );">Maximum length of time hedge in cash flow hedge</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_DerivativeFairValueTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative, Fair Value, Terminated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_DerivativeFairValueTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_DerivativeNetInvestmentTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative, Net Investment Terminated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_DerivativeNetInvestmentTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010228941688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax', window );">Other comprehensive income (loss), cash flow hedge and net investment hedge, gain (loss), before reclassification, tax</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax', window );">Other comprehensive income (loss), reclassification adjustment from AOCI, cash flow hedges and net investment hedges, net of tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate contracts | Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange contracts | Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange contracts | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Gain (loss) recognized in income, undesignated derivative instruments</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">$ (22)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), before Reclassification, Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Reclassification Adjustment from Accumulated Other Comprehensive Income, Cash Flow Hedges And Net Investment Hedges, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010233806008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivative instruments designated as hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivative instruments designated as hedges | Foreign exchange contracts | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivative instruments designated as hedges | Foreign exchange contracts | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Undesignated derivative instruments | Foreign exchange contracts | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Undesignated derivative instruments | Foreign exchange contracts | Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010236246072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsAbstract', window );"><strong>Asset</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral', window );">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability', window );">Total, asset</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesAbstract', window );"><strong>Liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability, fair value</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral', window );">Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets', window );">Total, liability</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative fair value of derivative assets offset by fair value of derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative fair value of derivative liability offset by fair value of derivative assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226006-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226006-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010423394392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details) - Long-term debt - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedge', window );">Carrying amount of hedged item</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease', window );">Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged item</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability hedged in fair value hedging relationship.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109999712-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109999712-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010230251768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details) - Fair Value, Measurements, Recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecurities', window );">Debt securities</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments related to acquisitions</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Quoted prices in active markets for identical assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments related to acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant other observable inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments related to acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant unobservable inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecurities', window );">Debt securities</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue', window );">Foreign exchange contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent payments related to acquisitions</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">$ 124<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity), and investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivative assets designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivative liabilities designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010231389768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,294<span></span>
</td>
<td class="nump">$ 2,951<span></span>
</td>
<td class="nump">$ 3,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInvestmentNotReadilyMarketableFairValue', window );">Other equity investments without readily determinable fair values</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant other observable inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_FairValueDisclosuresLineItems', window );"><strong>Fair Value Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money market funds, at carrying value</a></td>
<td class="nump">$ 426<span></span>
</td>
<td class="nump">$ 816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_FairValueDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value disclosure Line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_FairValueDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestmentNotReadilyMarketableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the other investment not readily marketable determined by management based upon fair value methods, including pricing of similar securities and valuation techniques, that was used to record the investment for financial reporting purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 820<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35710923&amp;loc=d3e45360-110995<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestmentNotReadilyMarketableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010228994152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value at beginning of period</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Additions</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value recognized in earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome', window );">Change in fair value recognized in AOCI</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value at end of period</a></td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AcquisitionRelatedCostsMember', window );">Acquisition-related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value at beginning of period</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value recognized in earnings</a></td>
<td class="num">(17)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome', window );">Change in fair value recognized in AOCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value at end of period</a></td>
<td class="nump">$ 124<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AcquisitionRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AcquisitionRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010231389192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Book values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems', window );"><strong>Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShorttermDebtFairValue', window );">Short-term debt</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure', window );">Current maturities of long-term debt and finance lease obligations</a></td>
<td class="nump">209<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure', window );">Long-term debt and finance lease obligations</a></td>
<td class="nump">16,765<span></span>
</td>
<td class="nump">17,149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems', window );"><strong>Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShorttermDebtFairValue', window );">Short-term debt</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure', window );">Current maturities of long-term debt and finance lease obligations</a></td>
<td class="nump">209<span></span>
</td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure', window );">Long-term debt and finance lease obligations</a></td>
<td class="nump">$ 16,221<span></span>
</td>
<td class="nump">$ 17,568<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value and carrying value by balance sheet grouping.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term debt and finance lease obligations, current, fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term debt and finance lease obligations, fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bax_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShorttermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShorttermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010233778520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">$ 3,707<span></span>
</td>
<td class="nump">$ 2,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">390<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">3,707<span></span>
</td>
<td class="nump">2,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">1,080<span></span>
</td>
<td class="nump">872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">1,626<span></span>
</td>
<td class="nump">1,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">610<span></span>
</td>
<td class="nump">599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | EMEA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">699<span></span>
</td>
<td class="nump">738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | APAC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">627<span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Hillrom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales</a></td>
<td class="nump">755<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total segment operating income</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bax_AmericasSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bax_AmericasSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bax_EMEASegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bax_EMEASegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bax_AsiaPacificSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bax_AsiaPacificSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bax_HillromMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bax_HillromMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010230313624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">$ 163<span></span>
</td>
<td class="nump">$ 390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(16)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">351<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">1,080<span></span>
</td>
<td class="nump">872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Hillrom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="num">(917)<span></span>
</td>
<td class="num">$ (482)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate and other | Hillrom</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">$ 219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bax_HillromMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bax_HillromMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140010313741096">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCash</td>
<td class="nump">$ 5,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>bax-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bax="http://www.baxter.com/20220331"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:exch="http://xbrl.sec.gov/exch/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bax-20220331.xsd" xlink:type="simple"/>
    <context id="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1a1624c56a6a4a3ab408fcb91225c59b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock100PerValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibcb949de1f814a178d481b3618695860_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock100PerValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id98bd2c91c6d4e6db09e848a1ffdc8ab_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes04Due2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0509cd1ed8da470cab9a5bf85f1163aa_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2656e08f5e424363abb7ce8183383849_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6014262f0e9a44a2a58239a775cebe82_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes395Due2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8ebeac25fbe44973800aa9db7f716eef_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes173Due2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i08eaeee42e7a46eba61253ef057e42f5_I20220421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2022-04-21</instant>
        </period>
    </context>
    <context id="i1d4414eacf9648f9881e2e9dc42887af_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9ad9afe3b705496a92217df29836a764_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i395c6d3fa47e43da801c740c4d0887d7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if62e913b0b0a496fae643c8af329597d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c50a6a898e74098976cf374bd92b5e3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6cd0958ec6fe414297bf307609abf3b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie34009f3951740878e77b11e09660114_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iafd810efc2234fb28217dc3a7f888066_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia8aae1fa5b1449a79ef7b9912c57ca4f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7f9fad2bb9874183aa490c07099b7007_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic5f2d514381a4dae9fc8a99b95a414f7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3973bc554e71432ca8e07d7389490ea5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic9d65a1c9ede4680974e4714437a55cd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i40118e5765794906b7e238aa4c853768_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i09965c96a10e480bbb6f1ffe8f35d49f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic5e603c381fe4230aa663f494e69bfa6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7d39e97f9bfc4d4a9af9dd344a9c0030_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1366da7fa3d545c8a056d8f11c73b8cf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9beb8849a787405a83fca7e87da30f32_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6f9cbc6f08c446859633447e2e55616f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5abd3be1de0741caa08ee8a7bb927d49_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1bc27871ead541a8a3f407cbc7b88e20_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i949d8647f73e4aab90b5a25fe2d56799_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2261098af7c3484dbb3074e0f50487ad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i968ed9c39ec74c9ba1af9f66763f82f5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i73e5010e5e0241299ccdb8b1c93f7144_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib6cac065ec6544838c98a84ff5fe15d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2562cb466738456fb044cb3fe9e1de27_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8300ea835fae4b28bcfd6760cd7604c8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i238ac34b0aab41be8134d8a775d08e2d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i401b2c604f694027b1c4dac9b79e2995_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5730d0771f684643b95bbc057538e077_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5a31b884457e403e9ff8ac44f5eb8b7b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i334dc65857104da8bf45462dbc5304e8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7b3a8f0389c44c1f970975d4fd28fd40_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4078e49ac5b14aba9f645b46af62a911_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3e57d971a44a4a3f949731983ffafba1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia19d724121ef4d3794c045dd65c77f7b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibd8d7f5c9b384bc1a8366b6af711f1c8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i84fd6f93f3d74fcb85ae2bf1c449792d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib20ef40d3e874271b4203597bb847021_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifc051d99f31b4d40b60823ffb0ce2ab4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i059198fbccc048f8afbe074a190f2478_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4edbb47a30cf46afbff865ead00dd98c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i969c52a42b424c649a401568d787c03d_I20211213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-13</instant>
        </period>
    </context>
    <context id="i76d012ba0e6842c4bc044efa2367e442_D20211213-20211213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-13</startDate>
            <endDate>2021-12-13</endDate>
        </period>
    </context>
    <context id="i0627724177f1427fb42008e3261d78c0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i21e54c53c46c4b708c6f8469337d00f5_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">bax:ZosynMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaad890641b794c4ab677efe29d43bfc3_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">bax:ZosynMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i893821e416354e0681636831227afbcb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i66457192cf5d4d76ab71f467bee6bca2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i31a852f840a74cb8b2c787ac3741588a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i097b8af344b1429eabe401c1d86d6631_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide5f5c25f88f48b5af91862d33456fa9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i292b133325264c6597bd7b9662bb2dda_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4d463df4bdbb45f0aa2538354d127517_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7b0ebff960224f8ca45f13ec5e67356e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if5a44ba447e844ac8ef93eebe8c514e2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i694baf88defe4467b0cc59ac6509b10c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib929fbd76df144d399a18b57db4d9ae3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib1022ad8302e440da3f4e203175d4b10_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7e4572eced80425baf027140478315ba_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i52fbf2a8bbe449269339aa45b6bad70d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icf3044fdced045cba1b544760a38b3b8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i89a1452b79a447f2975f350bd948e3bf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bax:DevelopedTechnologyIncludingPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia2638eb542e340638a844744dc8b8b41_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i824274fce6e34d36bcccea3b05be564e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifdd214bbcad84d1c8ac9a757a0f976d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0abc73e3f8c249ac83f98f1ca79104ea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bax:DevelopedTechnologyIncludingPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i656117b8223c4bdebeeb85ef817606b6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i73e389fa92f548b49505eb62019ce7d9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:IndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i77dc49641a924470949595f2087ee86d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:SeniorThreeYearTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia86774add006466498b0f2c3cba5e477_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:SeniorFiveYearTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i00c553d814c644128d07318aded98980_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9e9d2cef94014f91bd8867177e914d40_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if45530e3d7994ceb8d8e400dc2ac33a7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i12680af003b340588584061646eb80dd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id2c66b1b9fe445a18da652d3450d08cf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i469c791f58204bae88a589c56467141f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationContingencyAxis">bax:EnviromentalCleanUpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EnvironmentalRemediationSiteAxis">bax:SuperfundSitesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2bdf0bb5959445a281c014f161f85723_D20210112-20210112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2021-01-12</startDate>
            <endDate>2021-01-12</endDate>
        </period>
    </context>
    <context id="icb864a5832494db0acdd2afdf1be2d00_D20220218-20220218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2022-02-18</startDate>
            <endDate>2022-02-18</endDate>
        </period>
    </context>
    <context id="i8d85a7b845f24d1fa695e4f71457e0c3_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia62b9d54444c46208ba00c7b3a49f393_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9ae5d43fac584f33a0a42a5f3c28e0d2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7189af185d184892889584811bd86919_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia90c948e8be245b98f70fa8267c58925_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i23a86ccd6a744d46bea2df7cf193e7a3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id23b4ba90dd44f68a4a2fa4b53a355be_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i47aa6b12f49d4f8f8e8e0b9146e3b922_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i95a7419792054ae5bed8d890b5b8bec6_I20120731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2012-07-31</instant>
        </period>
    </context>
    <context id="i6021c0283dc64cf58f4e8ce023f20cae_I20180228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2018-02-28</instant>
        </period>
    </context>
    <context id="i05b8c7054b9d4d0883b6419ce2e08fe4_I20161130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2016-11-30</instant>
        </period>
    </context>
    <context id="ia6abadaa7a994ae19160f417f168acaf_I20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="idf18cf43e1fd42ea80e5bb10c70d8237_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i069285eebd5843f2856c7c3908c92f47_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f93d1d2dd2a457d996a157cd4e92b5d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6486fe1e58ef467195bd61197a081ab8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9e7a72924e714ac6b891716ee10b193d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f2552f5c4054d1ebea374b3f2beb06b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic3a1622bd0814078a54a920dde602168_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia612cf65ceaf4a1c9b76bfe56c4d3eb6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i64a3e01103e34f1bbc3c8156b5ba0946_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i17e2945361e24710af7f8a4b2bbd461b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id86e90917ec146d3ac68e2eb8b21f865_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia486f1301af041c9869fe8a3575fe4d4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5eefd1d44a344bdfbaad16b8a0fb4dc3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib7fd2a0dc3844abbb371f105039e5020_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i50951858332c4e6ca7aad9f12094ecea_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie2419a534ffa472a893eb08ecd31d17a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i61c25aa049c1446ba8f2b89559430b59_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idc0dbb505a0a4fafbdccf76d617c81c1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b269065bdfa4003b5dac0551818244c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ae39c69af424944bc29e123b13ba03b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie3f9dfaa202f43d7a4787a519244421f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8c6117fdfad44c57ae71d0e2075129f2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifbf3ffd3fcfe4c25bb7c73ac77cbbf80_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia0174772e0bd41bd8c295a1a6f03a7f7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i36f11ee6ccdd4c119f7e56f86d04836f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie0b8fdc874934cd28547447f24fd547a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic0f2358ba16e4eb2b4231007c968aafc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i49849093a147487baaab59084a514458_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i71a9302da0e54c3b8f8926e72835a876_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic40887eaba864beb99dfb7e8f5598fc9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3ca753b742a8455c879cba08a880b703_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i45b7e42abce84defb3a21a449abd0bbd_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icd4fbdb722de41c680320b1de71522a7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8bef5949b41742f0b1ba1cc2daeb9ab6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8ba7828d1de048e19f12a0c301c05c70_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia377d8629c5a4a0fb71104100423c61c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i54bb1c348a9847b582b458754fce46a2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibb3cc6fd8ab54e7f919c3a7ef1e7de2d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i15c4aa9c7adc46609c75b8e4977a7bf5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7dcc13e1767b4b20b08c82100616f090_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i149befa1f6404f1a97e608ad7a766348_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7a469160b4ca45ceadc4df51de1bb9cd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9f7a3b322d1541a28d6394b8562f85c1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3b4412787ecf4be9abb299cd553bdecb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iac99a77dafa6431aab1c9441a22e537d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1d4d3ad9a6744778b3c632ef51c41f3d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i810a45506ef9437c9a949870b37a194d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ConsumableMedicalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i00a69787b49d45f98aca3e29cdef6cf9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ConsumableMedicalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i12862cd99e2648e6bcf32aac284bdb6a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9a5af68d1dfd41d9b397bace193b7f2e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:ManufacturingArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6bbff8045db1420896d97da8621b4b0d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4c59a85af92949bfa44911ac3ec56888_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:SoftwareArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i44ec8a3cf51442cbaa0c996617cff9a4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:BundledEquipmentAndConsumableMedicalProductsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iecf1812385b54a46ac8f5d89b0b93371_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">bax:BundledEquipmentAndConsumableMedicalProductsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i54f8a4bbd0174868969d5ea2762b4cba_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic17bdfd4421546eca4d7ae434aa0244e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia8945826fd444f19b4c61de098d12163_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i07b784c1178047b48ce2e8b3a5a7dbfd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6baa8e29dc1a4812ba336959185b5ed9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bax:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i18dcbee3985a482faff83f708556a86d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">bax:AccruedExpensesAndOtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i399bd9e6d7704a0f8494daa78d8321fc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iae692eee99a04c67905eefc0ccfb948d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibd0420526d1646c5ba9c811a0b9fc84f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iae2bd6024f3b4290867ed42a20b57c42_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3ebc0f71dfcc4d94b6422c836bb4d493_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i41d12d31c3674b509c0fc670781c32d1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibd2c69af596c4eb8afab548b28116f64_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic47301316276400fa58cbac0a27edd76_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:RenalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0637d58240be4e3b84ee15a2869f6212_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie88685342da44b43aca2e889001b33df_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6257773f46f4406a950d9da284eeff8f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i99fd85b9b1294818a42d590249ac0254_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1eb8a8cea96743978e1c34863c629e7e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iccd3fe9f4eff41108f7f8233c7b8bec5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:MedicationDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1c50ddabc65d4775b4f0dd32b7866a0c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iea7f19b9978a4f479a01e23692a3b391_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5de90053a7bb47eba9d7c5dff40cb4da_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5285bc00e83945fb8961453197a19fed_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic32465a108574d1ca7bae73c9b778aff_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i973336e83bc3453eb20073659da885b5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iaaad663d6e174f3f994c5b7b5c1706cd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i793ab633078c493c9736d462d4058098_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id5bea1b0e28d4928871f812e9f5c7f6b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7795ac9bd9604206a6016440b538aac0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9b930265e49a44e0943d8103a8b0b529_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib5d5a261cd76428fbedae996f8d1907e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:ClinicalNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if8e8d8c02c024de689ede733470259ff_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic88569bfa2d84d02bb251a96bb20f794_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if243ce5e748b4bd59093b5179090fb3f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8fa2b02e71bf4d45b6db7e096d2650cb_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6f5cb5974e244ecba9653d56940192c0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2913c2e1a7a24276acc5b6213dae5262_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AdvancedSurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i779714d757cf402f9776a2ccdec9726a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i23f88c8a0df54c6884b9d01b2aaf82bf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i44c9c2a4bb7449619ad2573dafa85bbf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8126141e4675434f839f8755c88b8ba3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie0845bc16f68464e8379919be0e7b8fe_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3fc7fd14f1844726a492dc5c657acbf8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:AcuteTherapiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i876dae9a11fe4141a783d8c2a6b92dec_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idb9737600ddd4964a91212e64caf3594_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic5745c41ec404c25a1bde3188976ef38_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6c8442c959fa4529b57209c078253476_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i285d483ea5b047c587d620462e947359_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8b3f80e5d38f4c1abc4cd1ab9a5b569a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:BioPharmaSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8e787427fc1d4863ab700a326101e439_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic7467c8869654bcdb29ec9bef8eb852c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie34a3ea8d30f42b6a3c8f3f80e0898fd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iacd83fad5f6042788153d814f190dd66_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iedcbe041ae2a4606afe97260832fde83_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idcc9eca3b12249c28c1c568c4b0ff3db_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:PatientSupportSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2ea4cbf5f08646e39f3d3ff3c49f24f2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i23972f3969514c8ebbb4ed813b640924_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idd3a87d60d1c4c0e9e235738abd249b4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i18b82a0e238f4965bce3b3d3da7bc457_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iab72e78e33e84f74af908d9272c9918b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6c2a93a6dd094c51bfe994c44cd157c0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:FrontLineCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib694fa97d14d4be381e04aa9ddf846c1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie0628696d6604d5b9f829e16a4b411ea_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8389d4f265c0420ea78f8103b6fc49ff_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i69b44fa6f007430891d8a0fa04607c5a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5f19fbe0743f48108c85afdca64f480d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i97bb457dd66d4192aba9ecb5379b09e3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:SurgicalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibebdfc914173408d98947b502a387897_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3b8b91e94ed143eebd3f096088cfeac3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id5945f9a9cad447da92a87bf81903df9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib32b8ba9994c4c05b40746ba26de0276_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2f1ac0c71dc74295a156d768668f9a2a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if7a8130be2624c9a8048123bf1f31901_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bax:OtherProductOrServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib93cd39c2a80489ba522e10fce6b0e92_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iae185801a2824043b923695260987bdc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i85d0b3b6424a4f239ced374f948ac74a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0d6282669ad443c49c55d8ac91b9f5e7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2b9e15e802c2455fb04ea04eb4db2322_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i522261ab58db4575939d49828d4c748e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if86b2c8277034f9e961edc5d828e8065_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:BusinessOptimizationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9311558f896a40b688cfc17aa08d2304_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bax:BusinessOptimizationProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i11a40960ca1f4fa5b6e685c5e17a27e1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iffeac49ece2f4f0099db2b6316bc2a6b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia27cfb043f884dbd9667969290a6e989_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i07f45e9451124a38a8618085deaa0bad_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iac5d8d62119742ed9ba5ea4e4194307b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i290805ec99d64042be64af58b8ffd3b7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7223eebf6ed94d309d0faa7ad432bbbd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icd1cb136a26b44cba87fb2a70901faa7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:ContractTerminationAndOtherCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia7d79d5f91f94bcab33cf772a3b3063d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie0379f97ea684a719bc4b38d54e0efde_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i879c4d6181ea43c099235e39734a646e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i63e5679fd4e5469d85730434afe1d238_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib68997075a33458898c6e14a36eebeb9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6ef7f560cf624875bf9c35c67df33547_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i62dc3391e9264db98a1f3fe40474e64b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5718c50c86d740d098ff8d49b559feaf_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0ee68bc6af754a66b0a50a9468a8588a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i312b43d90c8849b8b19bdd30e36c95c1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i32aeda1131ad47a9a728d691bcb5e02b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6acac91985d749cbbb8a0f1ece842c1d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8d49bf9ceb394ee397eb421a3a4ea0e7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id9451246f53f4b13b9c1078a4785af23_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:AssetImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i63b9c16382b045218cfce2166bcdcd3e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iebe3c987e85b400bac19095e21ca736c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1701fe482b3a4c3183852a3aa9fe0c87_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4d7dca14db914da8ad561a51aee21848_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i786ae4d3319c471ab517a03677b933e3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i88c2ae6f33f64b45936b4dcd18b5d612_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bax:SeveranceAndOtherEmployeeRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if5c7bf2bab574ab28206bdde47eed8d5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3ef157d694c2423bb871181ca6e1ef94_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if5dc8f540120419bb40e18be629ff121_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if0744bc26d8d4427bc7a38006ba71623_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i760ce24b4a13497aa499059071c1bf88_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i536e66a57732404691a7c9d746a9c77a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i557d8b940ffb46fea7a0ffbea9c8628e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i922227aeddd24ee2b5e427b08c34c08d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i39dea52d46d64c63b911fc2fec7d9fa9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if99e9e9771eb4da2a299bf355a486649_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i93c6321b74e54dc7ac6d3673ec476dd1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i61964dbdf7e84be88705f093c0802196_I20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="i2197ddaf305b41748d421ed313216345_I20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="i12a714234c6e4e9eb4d18197fbcce84c_I20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bax:OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="iacacd738d13b471191092dfc7ad4dea7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i71a1b7a14751464f96d1e33c2d439a5a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i792cbe33e35d445f91ea87aaf0e146b6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i54c2d01d93ca4760941fa4a68b4b08b6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i03f7bde8ea3b46179c1c8a7c608bd403_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2c56206e8fd2421181da55d3c02a8854_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i55ff25312dce4820b856d1dfd634ca60_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i15e37ef8d94a4fe0b71f0876df3d6ee2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i21388d336c1f433c8ceded9265e245d2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i979180e5f4714629b4784cf1025dd9c6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i40ca9abc862645c4a33f3d2218f9f2a7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id5b3d67eccd142a6939834d39b716b4f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i67f9b129d87944fa85b837dac860fb75_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8f8128091c9b4323ac693e2f73552a3e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib6d8a8344b6145c39ccd9339d15cc4d9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i04f11ec5ea644541baa8aa7176602e10_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7fdf8bf9a08147fab31750ea1f96c4f5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iec4b84b3fc74452c9f24e03eaad33954_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie3f91e0124ba4fa4ac402434dc93e87b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9783d9bb5346424386c830791c5bd9af_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9ebea270340c48ee9999faf277ae4c89_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1eb9fbfcc3ce4d20837be295da12469a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1229bd8de1424b6cafbefda84c89f17f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3b481b445da94740a0c83504d45ed0c1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iad0696204cae46f4a2dd949869b8a0a2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9b1f513dd2f84554beda8f0654d39157_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i97b20784595f4505a4473852b0d24361_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id1dc1bf720b14af7be2658f5b9411099_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i010ba63179714c00a597d4434cdda0e3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ied8dcdf39e2c4956942ba609511fb42c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ied7ae06c0d764442a36e7ee405df5bae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id4a1aa577cc642b1b122761aa34a02dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2e2f63de943c437cbf78e59b19e61166_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia57b4248164c447fa78ab9e72dae9482_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i488bf22168054382b33a870cea5e12cf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0847c8d0a513447ab785792887cef7be_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2a479dd0e9e04335a78d838743107def_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4d57b720176840b084b62f8a521d47d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0699d0c72b624afcb5f0a2f67dead789_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i792e4039270545aba120425226791181_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i904ebe57a03f41a19cccabe5981567e2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1adb4c593b09447c8976d8d028dcd78c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i776aa6f56b4f4c128350b62839f20e93_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0e0990c5545d42eea9be6143b97da502_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i02f792b41f554f2c98ec32ac34f7d2c8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i26c43bcaa7314a6b967da3c9bbca9100_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5a4f6c720ee44c6ba4c1e80998b3d43c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i811d8be2a7d740bebdca3c2d962061e9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if73a3426d20d40529c001dbc761d4b8a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ae0b3674bb74050ac9785fa17b2f5e0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic1eabca8696d4c27a96d88b08c1bf0a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5b628cec409b4e0aa786971fa2453bd0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i36cc35bd29cf4b25b9ed69436f211f3d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AmericasSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ieb4a5d3c9d55448999d5cb714ebf69f3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AmericasSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i36c28755553f4b3caaab97024026e4e6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:EMEASegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1ea902d4e19b444db537a186c0a779f6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:EMEASegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iae63df0c85ca44cd98106826bb67c91f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AsiaPacificSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i525d0111f09240c2b13835c305549821_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:AsiaPacificSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id80baa04c95740de8f4bebecb32003d3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i904e310ddad74453ba7dc2d7fe323e01_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bax:HillromMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ica5497822c874fda93fa60cb6aee725c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic57b38264d9d4bfcb8a0f926e4426cba_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib16764b626684350a430fa1f03cb037f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i82348ec896cc42a891600e853ebccd95_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="site">
        <measure>bax:site</measure>
    </unit>
    <unit id="lawsuit">
        <measure>bax:lawsuit</measure>
    </unit>
    <unit id="segment">
        <measure>bax:segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180L2ZyYWc6YzMxYWFkMDdjODk2NDQwMDllMWM1NmZmYmI3MDFmOGUvdGFibGU6YjQ1M2YzOTEwN2FkNGVkZGEyMWYwZmU0OWMyMThhNjEvdGFibGVyYW5nZTpiNDUzZjM5MTA3YWQ0ZWRkYTIxZjBmZTQ5YzIxOGE2MV8yLTEtMS0xLTc3MDMy_4d127bda-07b7-4e48-a3a5-8f492aef4cc8">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180L2ZyYWc6YzMxYWFkMDdjODk2NDQwMDllMWM1NmZmYmI3MDFmOGUvdGFibGU6YjQ1M2YzOTEwN2FkNGVkZGEyMWYwZmU0OWMyMThhNjEvdGFibGVyYW5nZTpiNDUzZjM5MTA3YWQ0ZWRkYTIxZjBmZTQ5YzIxOGE2MV8zLTEtMS0xLTc3MDMy_5dbe8011-4ab6-44b6-9e4e-7eeafb469bbb">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180L2ZyYWc6YzMxYWFkMDdjODk2NDQwMDllMWM1NmZmYmI3MDFmOGUvdGFibGU6YjQ1M2YzOTEwN2FkNGVkZGEyMWYwZmU0OWMyMThhNjEvdGFibGVyYW5nZTpiNDUzZjM5MTA3YWQ0ZWRkYTIxZjBmZTQ5YzIxOGE2MV80LTEtMS0xLTc3MDMy_2d5c6bd7-b448-4d69-a2f0-51029b1b471e">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180L2ZyYWc6YzMxYWFkMDdjODk2NDQwMDllMWM1NmZmYmI3MDFmOGUvdGFibGU6YjQ1M2YzOTEwN2FkNGVkZGEyMWYwZmU0OWMyMThhNjEvdGFibGVyYW5nZTpiNDUzZjM5MTA3YWQ0ZWRkYTIxZjBmZTQ5YzIxOGE2MV81LTEtMS0xLTc3MDMy_c130c74c-0099-4e56-a133-43439f8e1736">0000010456</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180L2ZyYWc6YzMxYWFkMDdjODk2NDQwMDllMWM1NmZmYmI3MDFmOGUvdGFibGU6YjQ1M2YzOTEwN2FkNGVkZGEyMWYwZmU0OWMyMThhNjEvdGFibGVyYW5nZTpiNDUzZjM5MTA3YWQ0ZWRkYTIxZjBmZTQ5YzIxOGE2MV82LTEtMS0xLTc3MDMy_6da8ad42-6deb-4172-b6a7-4393e80b3a99">--12-31</dei:CurrentFiscalYearEndDate>
    <bax:RevenueRecognizedContractPeriod
      contextRef="iac99a77dafa6431aab1c9441a22e537d_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNTA4Nw_f4e1f64e-f3c7-40c4-adcb-4328bb369ec4">P1Y</bax:RevenueRecognizedContractPeriod>
    <bax:RevenueRecognizedContractPeriod
      contextRef="i810a45506ef9437c9a949870b37a194d_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNTY3NA_35dd3245-1f9f-4af5-81c9-d418989e3bbf">P1Y</bax:RevenueRecognizedContractPeriod>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i15c4aa9c7adc46609c75b8e4977a7bf5_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182NC9mcmFnOjg0MTZkZDMxZThmZDRlOTQ4YWY2YjFiMTc5OTFjOWU2L3RhYmxlOmE2ODcxNzNjNWE2OTRlYWU4ZWYyOTBmYTlkMjM5YTcyL3RhYmxlcmFuZ2U6YTY4NzE3M2M1YTY5NGVhZThlZjI5MGZhOWQyMzlhNzJfNC0xLTEtMS03NzAzMg_30abf8fc-5da7-41f3-98be-83bcecc1d8d4">P9M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i7dcc13e1767b4b20b08c82100616f090_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182NC9mcmFnOjg0MTZkZDMxZThmZDRlOTQ4YWY2YjFiMTc5OTFjOWU2L3RhYmxlOmE2ODcxNzNjNWE2OTRlYWU4ZWYyOTBmYTlkMjM5YTcyL3RhYmxlcmFuZ2U6YTY4NzE3M2M1YTY5NGVhZThlZjI5MGZhOWQyMzlhNzJfOC0xLTEtMS03NzAzMg_4bc1e35a-de0f-4bcc-a2ef-ae9358d9c51e">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i149befa1f6404f1a97e608ad7a766348_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182NC9mcmFnOjg0MTZkZDMxZThmZDRlOTQ4YWY2YjFiMTc5OTFjOWU2L3RhYmxlOmE2ODcxNzNjNWE2OTRlYWU4ZWYyOTBmYTlkMjM5YTcyL3RhYmxlcmFuZ2U6YTY4NzE3M2M1YTY5NGVhZThlZjI5MGZhOWQyMzlhNzJfMTItMS0xLTEtNzcwMzI_f0da642f-fb70-4268-9176-72f93d298183">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i7a469160b4ca45ceadc4df51de1bb9cd_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182NC9mcmFnOjg0MTZkZDMxZThmZDRlOTQ4YWY2YjFiMTc5OTFjOWU2L3RhYmxlOmE2ODcxNzNjNWE2OTRlYWU4ZWYyOTBmYTlkMjM5YTcyL3RhYmxlcmFuZ2U6YTY4NzE3M2M1YTY5NGVhZThlZjI5MGZhOWQyMzlhNzJfMTYtMS0xLTEtNzcwMzI_c6c9968b-4213-4dbc-b4c8-2011cae70ee1">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i9f7a3b322d1541a28d6394b8562f85c1_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182NC9mcmFnOjg0MTZkZDMxZThmZDRlOTQ4YWY2YjFiMTc5OTFjOWU2L3RhYmxlOmE2ODcxNzNjNWE2OTRlYWU4ZWYyOTBmYTlkMjM5YTcyL3RhYmxlcmFuZ2U6YTY4NzE3M2M1YTY5NGVhZThlZjI5MGZhOWQyMzlhNzJfMjAtMS0xLTEtNzcwMzI_b0363d2d-404b-4a59-bf6e-7788588abc2b"
      xsi:nil="true"/>
    <dei:DocumentType
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGV4dHJlZ2lvbjpmNmJhOTVjZjUzMmE0MDQ2YTQ3M2UxZGNjMDhjZGM0N18xNjY_97f3e5b2-ff08-499c-a911-79d10ce4c0dd">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MGZkZjhhNjU1YmY4NDA0NzljYmQxNWMzMGU5MjkwNDAvdGFibGVyYW5nZTowZmRmOGE2NTViZjg0MDQ3OWNiZDE1YzMwZTkyOTA0MF8wLTAtMS0xLTc3MDMy_1206d487-c018-49c2-a71f-c5715aa9f7fd">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGV4dHJlZ2lvbjpmNmJhOTVjZjUzMmE0MDQ2YTQ3M2UxZGNjMDhjZGM0N18yODM_6f47123b-681a-421f-a413-6b7beac0379b">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MGI3NWExNWRjMzFlNGMzY2IzMDA4MzFlNTlhOGI5NDkvdGFibGVyYW5nZTowYjc1YTE1ZGMzMWU0YzNjYjMwMDgzMWU1OWE4Yjk0OV8wLTAtMS0xLTc3MDMy_4765ea19-c787-4388-8f4e-441336f61cbc">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGV4dHJlZ2lvbjpmNmJhOTVjZjUzMmE0MDQ2YTQ3M2UxZGNjMDhjZGM0N18zNzA_1ec4999a-538a-47c9-974a-0351840622aa">1-4448</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGV4dHJlZ2lvbjpmNmJhOTVjZjUzMmE0MDQ2YTQ3M2UxZGNjMDhjZGM0N180NTU_ee14d509-5877-4566-96aa-d8657df6e3d5">BAXTER INTERNATIONAL INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6ZjY0ZWMzZDhiNzBiNDFlN2I3MTQ1NzY1ODg3YWJiYzcvdGFibGVyYW5nZTpmNjRlYzNkOGI3MGI0MWU3YjcxNDU3NjU4ODdhYmJjN18wLTAtMS0xLTc3MDMy_61c59fa2-3deb-48b3-abb7-f0b044c4010d">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6ZjY0ZWMzZDhiNzBiNDFlN2I3MTQ1NzY1ODg3YWJiYzcvdGFibGVyYW5nZTpmNjRlYzNkOGI3MGI0MWU3YjcxNDU3NjU4ODdhYmJjN18wLTQtMS0xLTc3MDMy_8e70e749-3c71-4a80-9253-d904c21cd59e">36-0781620</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6ZjY0ZWMzZDhiNzBiNDFlN2I3MTQ1NzY1ODg3YWJiYzcvdGFibGVyYW5nZTpmNjRlYzNkOGI3MGI0MWU3YjcxNDU3NjU4ODdhYmJjN18zLTAtMS0xLTc3MDMy_a1245627-0732-4c56-828c-697971c2b781">One Baxter Parkway,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6ZjY0ZWMzZDhiNzBiNDFlN2I3MTQ1NzY1ODg3YWJiYzcvdGFibGVyYW5nZTpmNjRlYzNkOGI3MGI0MWU3YjcxNDU3NjU4ODdhYmJjN18zLTEtMS0xLTc3MDMy_99fa437c-624b-4e42-bc77-f941723ef60e">Deerfield,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6ZjY0ZWMzZDhiNzBiNDFlN2I3MTQ1NzY1ODg3YWJiYzcvdGFibGVyYW5nZTpmNjRlYzNkOGI3MGI0MWU3YjcxNDU3NjU4ODdhYmJjN18zLTItMS0xLTc3MDMy_2ab97fba-2121-4925-9e5c-ccaf7fd43d57">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6ZjY0ZWMzZDhiNzBiNDFlN2I3MTQ1NzY1ODg3YWJiYzcvdGFibGVyYW5nZTpmNjRlYzNkOGI3MGI0MWU3YjcxNDU3NjU4ODdhYmJjN18zLTQtMS0xLTc3MDMy_b3cac72f-b965-4b60-a3ce-b77fb0ab9a84">60015</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6YTI0ZTEzNjVhODBhNDA2Yzg4MDYzYWE3ZWEwNjE5NTgvdGFibGVyYW5nZTphMjRlMTM2NWE4MGE0MDZjODgwNjNhYTdlYTA2MTk1OF8wLTItMS0xLTc3MDMy_3b62a633-9ad7-4790-852f-08a2650f2f0b">224.</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6YTI0ZTEzNjVhODBhNDA2Yzg4MDYzYWE3ZWEwNjE5NTgvdGFibGVyYW5nZTphMjRlMTM2NWE4MGE0MDZjODgwNjNhYTdlYTA2MTk1OF8wLTMtMS0xLTc3MDMy_e54048b2-7453-4395-8e59-f05a94e76e34">948.2000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i1a1624c56a6a4a3ab408fcb91225c59b_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8xLTAtMS0xLTc3MDMy_979105ef-4b7a-4a75-9f09-09de98e4414a">Common Stock, $1.00 par value</dei:Security12bTitle>
    <dei:Security12bTitle
      contextRef="ibcb949de1f814a178d481b3618695860_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8xLTAtMS0xLTc3MDMy_ba9e171c-f0d4-436f-b4e3-3064f52723a5">Common Stock, $1.00 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i1a1624c56a6a4a3ab408fcb91225c59b_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8xLTItMS0xLTc3MDMy_0cbcbc5e-8007-4d88-8a42-60dc945bf0dc">BAX (NYSE)</dei:TradingSymbol>
    <dei:TradingSymbol
      contextRef="ibcb949de1f814a178d481b3618695860_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8xLTItMS0xLTc3MDMy_14bc37a7-5451-4935-88a3-a0c312f8e751">BAX (NYSE)</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i1a1624c56a6a4a3ab408fcb91225c59b_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8xLTQtMS0xLTc3MDMy_89365ee8-f7cf-4539-b71f-f19a2052490c">NYSE</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="ibcb949de1f814a178d481b3618695860_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8yLTQtMS0xLTc3MDMy_9e2f4845-4358-485f-a390-75db0a5a6b39">CHX</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="id98bd2c91c6d4e6db09e848a1ffdc8ab_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8zLTAtMS0xLTc3MDMy_6cf6d22b-4972-4540-b8e9-1813ff58476e">0.4% Global Notes due 2024</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id98bd2c91c6d4e6db09e848a1ffdc8ab_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8zLTItMS0xLTc3MDMy_eec7f193-a3b4-456a-b454-4f5989d99cdc">BAX 24</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id98bd2c91c6d4e6db09e848a1ffdc8ab_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV8zLTQtMS0xLTc3MDMy_178251bd-1c65-4514-a922-b5ef3215e9b8">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i0509cd1ed8da470cab9a5bf85f1163aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV80LTAtMS0xLTc3MDMy_3f0060a9-838e-4325-8520-1828d8fc6ac8">1.3% Global Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0509cd1ed8da470cab9a5bf85f1163aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV80LTItMS0xLTc3MDMy_28a89e15-a8cd-4c5c-a574-3739eadfbaba">BAX 25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0509cd1ed8da470cab9a5bf85f1163aa_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV80LTQtMS0xLTc3MDMy_4b932601-7d00-4dcf-be86-178f2c41a4fa">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i2656e08f5e424363abb7ce8183383849_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV81LTAtMS0xLTc3MDMy_b483d0ec-50df-4463-8e9f-d5dd014cc84c">1.3% Global Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i2656e08f5e424363abb7ce8183383849_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV81LTItMS0xLTc3MDMy_e1a95d85-7064-4388-8629-b19fcde87b6a">BAX 29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i2656e08f5e424363abb7ce8183383849_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV81LTQtMS0xLTc3MDMy_33aaf278-aa12-4cc2-9001-2d6b99442628">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i6014262f0e9a44a2a58239a775cebe82_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV82LTAtMS0xLTc3MDMy_c5dd63fd-54d0-4a3a-92e4-2531c08f3645">3.95% Global Notes due 2030</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i6014262f0e9a44a2a58239a775cebe82_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV82LTItMS0xLTc3MDMy_2f8f0ef9-0bbc-46b7-a544-6cefde375847">BAX 30</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6014262f0e9a44a2a58239a775cebe82_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV82LTQtMS0xLTc3MDMy_37c77137-fb09-40e8-8198-fcc8bad29683">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i8ebeac25fbe44973800aa9db7f716eef_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV83LTAtMS0xLTc3MDMy_e5c41043-a46c-42bb-a677-214bcede16da">1.73% Global Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8ebeac25fbe44973800aa9db7f716eef_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV83LTItMS0xLTc3MDMy_f66f71e5-1509-4321-a63b-7ac7f5017653">BAX 31</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8ebeac25fbe44973800aa9db7f716eef_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6MzZmZDJlMzcxYzc2NDk1MDg1ZGQzYjk1NDAwMjcyOWUvdGFibGVyYW5nZTozNmZkMmUzNzFjNzY0OTUwODVkZDNiOTU0MDAyNzI5ZV83LTQtMS0xLTc3MDMy_9c4a1305-60de-4a5a-a00a-aeff5b52f514">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGV4dHJlZ2lvbjpmNmJhOTVjZjUzMmE0MDQ2YTQ3M2UxZGNjMDhjZGM0N18xMDg2_f4283517-a5f7-4c36-bb2f-49171a242f0e">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGV4dHJlZ2lvbjpmNmJhOTVjZjUzMmE0MDQ2YTQ3M2UxZGNjMDhjZGM0N18xMzc4_80f246e7-fb5e-439e-9f45-a08a0c9d31ed">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6YTRmZGEzODc0MmU5NDFlMTkxZDM0YWUyZThhMWY3NTkvdGFibGVyYW5nZTphNGZkYTM4NzQyZTk0MWUxOTFkMzRhZTJlOGExZjc1OV8wLTAtMS0xLTc3MDMy_98c38d65-e10e-4e92-b94a-70c35dc36b63">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6YTRmZGEzODc0MmU5NDFlMTkxZDM0YWUyZThhMWY3NTkvdGFibGVyYW5nZTphNGZkYTM4NzQyZTk0MWUxOTFkMzRhZTJlOGExZjc1OV8xLTQtMS0xLTc3MDMy_47d14f67-a361-4ed2-bbfd-2ecb8fbf30fb">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGFibGU6YTRmZGEzODc0MmU5NDFlMTkxZDM0YWUyZThhMWY3NTkvdGFibGVyYW5nZTphNGZkYTM4NzQyZTk0MWUxOTFkMzRhZTJlOGExZjc1OV8yLTEtMS0xLTc3MDMy_1df7774c-8188-40e6-a37d-ef06303844c2">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGV4dHJlZ2lvbjpmNmJhOTVjZjUzMmE0MDQ2YTQ3M2UxZGNjMDhjZGM0N18yMjM3_5a0af2f7-c256-4828-b122-51b87696d880">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i08eaeee42e7a46eba61253ef057e42f5_I20220421"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xL2ZyYWc6ZjZiYTk1Y2Y1MzJhNDA0NmE0NzNlMWRjYzA4Y2RjNDcvdGV4dHJlZ2lvbjpmNmJhOTVjZjUzMmE0MDQ2YTQ3M2UxZGNjMDhjZGM0N18yMjI2_bdc4bfc4-3097-480d-93e0-0da05a32cf74"
      unitRef="shares">503528678</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMi0xLTEtMS03NzAzMg_f0281d5d-9fe1-49b8-991a-30752c5ab5e9"
      unitRef="usd">2294000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMi0yLTEtMS03NzAzMg_6e7d8fd0-8f3d-42c5-bbd1-8b32626773df"
      unitRef="usd">2951000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMy0wLTEtMS03NzAzMi90ZXh0cmVnaW9uOjcxNjYwNDc4NmQ2YTRkNWE4Y2I1OTBhOTRiMzI3Y2ZhXzQ2_d65710ae-e5d1-424f-951d-151bafc373bc"
      unitRef="usd">129000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMy0wLTEtMS03NzAzMi90ZXh0cmVnaW9uOjcxNjYwNDc4NmQ2YTRkNWE4Y2I1OTBhOTRiMzI3Y2ZhXzU5_cfbd5ab0-0293-4e1d-ba2d-f5e49b64eed2"
      unitRef="usd">122000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMy0xLTEtMS03NzAzMg_14f07b9f-b5cc-4168-b86f-5dff66ca6aeb"
      unitRef="usd">2471000000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMy0yLTEtMS03NzAzMg_3513f614-64ad-45b7-b292-cc3566c50821"
      unitRef="usd">2629000000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfNC0xLTEtMS03NzAzMg_b1104f24-2d84-48be-9c57-9b311dc0486a"
      unitRef="usd">2548000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfNC0yLTEtMS03NzAzMg_cd828a87-c957-4ab6-b12d-83408f2d9aed"
      unitRef="usd">2453000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfNS0xLTEtMS03NzAzMg_bfa1653e-7072-469b-b12c-c1da9a6f65c5"
      unitRef="usd">860000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfNS0yLTEtMS03NzAzMg_a589de3e-318b-43b8-8d5b-231823b46989"
      unitRef="usd">839000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfNi0xLTEtMS03NzAzMg_692d6a6e-083b-4906-8d27-be9a8369747c"
      unitRef="usd">8173000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfNi0yLTEtMS03NzAzMg_c7f615c4-7f1c-4482-9ee3-db4dc2c4dc63"
      unitRef="usd">8872000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfNy0xLTEtMS03NzAzMg_7cb3548a-3439-4c51-839c-eae2efac56c2"
      unitRef="usd">5114000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfNy0yLTEtMS03NzAzMg_13604c3e-2ed6-4077-b15a-2bb5acdb02b0"
      unitRef="usd">5178000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfOC0xLTEtMS03NzAzMg_7c24cecc-c687-4652-91ee-ee7921e6d9ec"
      unitRef="usd">9816000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfOC0yLTEtMS03NzAzMg_ee132ee4-8529-432a-89a7-54f90a11651e"
      unitRef="usd">9836000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfOS0xLTEtMS03NzAzMg_18c2a36b-58a4-4b96-b62b-784ae854d28a"
      unitRef="usd">7693000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfOS0yLTEtMS03NzAzMg_108f1082-03aa-406c-bc7b-b9bcca7ca04f"
      unitRef="usd">7792000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTAtMS0xLTEtNzcwMzI_ba5561d6-da35-4dd7-abf5-0656ad46e4c1"
      unitRef="usd">609000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTAtMi0xLTEtNzcwMzI_49a9b8b2-fc88-456f-9380-7bb6c1682482"
      unitRef="usd">630000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTEtMS0xLTEtNzcwMzI_0a25e299-8079-4173-8090-ad60bc8bb8b6"
      unitRef="usd">1311000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTEtMi0xLTEtNzcwMzI_d3b6f00f-3b16-49b7-adcc-0583a251501c"
      unitRef="usd">1213000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTItMS0xLTEtNzcwMzI_8bd61a64-fbfe-419f-851a-1b283989f027"
      unitRef="usd">32716000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTItMi0xLTEtNzcwMzI_28bded13-0132-46e6-aa2a-082ab0334d67"
      unitRef="usd">33521000000</us-gaap:Assets>
    <us-gaap:ShortTermBorrowings
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTQtMS0xLTEtNzcwMzI_b832f0d1-e1f2-4fbf-b38d-37c983724eed"
      unitRef="usd">200000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTQtMi0xLTEtNzcwMzI_5ef553ed-bfde-4e6f-8223-2a37b37c8c34"
      unitRef="usd">301000000</us-gaap:ShortTermBorrowings>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTUtMS0xLTEtNzcwMzI_2b2c7130-4a6e-422e-91df-5fd328dd2602"
      unitRef="usd">209000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTUtMi0xLTEtNzcwMzI_b23c87e3-d0cf-4ecd-b263-91f6514a4d0e"
      unitRef="usd">210000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTYtMS0xLTEtNzcwMzI_3fc094a5-65ac-49ef-9bb8-7da3d98ff4bb"
      unitRef="usd">1223000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTYtMi0xLTEtNzcwMzI_1af4f5bd-ecb0-41db-be3a-92c15948054e"
      unitRef="usd">1246000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTctMS0xLTEtNzcwMzI_0611a528-3f2b-4816-963c-0e8eb8be8282"
      unitRef="usd">2258000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTctMi0xLTEtNzcwMzI_803d5de4-3138-46d9-87b5-421d9dbc8ab6"
      unitRef="usd">2479000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTgtMS0xLTEtNzcwMzI_4ae9aac3-9082-44f8-8b8c-af6749659b9b"
      unitRef="usd">3890000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTgtMi0xLTEtNzcwMzI_741be30e-2c78-435e-b317-ccaebe22a084"
      unitRef="usd">4236000000</us-gaap:LiabilitiesCurrent>
    <bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTktMS0xLTEtNzcwMzI_cd50971e-0217-4c21-8be1-0d5ec4c6cda4"
      unitRef="usd">16765000000</bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent>
    <bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMTktMi0xLTEtNzcwMzI_2721d116-91d0-4a31-bcc5-a232964ca582"
      unitRef="usd">17149000000</bax:LongTermDebtAndFinanceLeaseObligationsNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjAtMS0xLTEtNzcwMzI_db9d0a22-b6fd-43c2-a885-186161dd5005"
      unitRef="usd">508000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjAtMi0xLTEtNzcwMzI_54c9d62c-15a6-417b-8c6a-d2a11d357c13"
      unitRef="usd">522000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjEtMS0xLTEtNzcwMzI_2377dfce-941c-4bd0-81ef-81bd8d219f1c"
      unitRef="usd">2434000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjEtMi0xLTEtNzcwMzI_f3b2d298-20b3-488c-94e6-8c701e80c782"
      unitRef="usd">2493000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjItMS0xLTEtNzcwMzI_42d14e1e-ab14-4f06-8c21-0525896da818"
      unitRef="usd">23597000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjItMi0xLTEtNzcwMzI_3d1947cf-2c71-4c7e-afae-d51de5993454"
      unitRef="usd">24400000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjMtMS0xLTEtNzcwMzI_9b2febef-d10b-4640-8a9a-76db12948f11"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjMtMi0xLTEtNzcwMzI_30c6e3f7-f15b-43d8-9a66-08a3de4af520"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjUtMC0xLTEtNzcwMzIvdGV4dHJlZ2lvbjpiY2VmYTFlZjZmNmE0NjhjYjFlMTcwMmU0NTllOGY4Ml8xOA_3e323363-86e8-47e6-99c4-62d64e56cec2"
      unitRef="usdPerShare">1</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjUtMC0xLTEtNzcwMzIvdGV4dHJlZ2lvbjpiY2VmYTFlZjZmNmE0NjhjYjFlMTcwMmU0NTllOGY4Ml8xOA_ca03eff3-a527-4361-bafd-f1685b18f173"
      unitRef="usdPerShare">1</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjUtMC0xLTEtNzcwMzIvdGV4dHJlZ2lvbjpiY2VmYTFlZjZmNmE0NjhjYjFlMTcwMmU0NTllOGY4Ml80Mw_45c0fc3b-e6d5-4709-844a-426c8ac9ae4c"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjUtMC0xLTEtNzcwMzIvdGV4dHJlZ2lvbjpiY2VmYTFlZjZmNmE0NjhjYjFlMTcwMmU0NTllOGY4Ml80Mw_6ca80d25-55bb-4cf9-8252-a2a3f844020d"
      unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjUtMC0xLTEtNzcwMzIvdGV4dHJlZ2lvbjpiY2VmYTFlZjZmNmE0NjhjYjFlMTcwMmU0NTllOGY4Ml82MQ_44d8e1aa-fa71-4ac2-b7ec-8de9d7e0e275"
      unitRef="shares">683494944</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjUtMC0xLTEtNzcwMzIvdGV4dHJlZ2lvbjpiY2VmYTFlZjZmNmE0NjhjYjFlMTcwMmU0NTllOGY4Ml82MQ_b700eef9-8476-4264-9cec-95a791318a92"
      unitRef="shares">683494944</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjUtMS0xLTEtNzcwMzI_b5e9effb-e85b-44f2-ab40-ecabeab74796"
      unitRef="usd">683000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjUtMi0xLTEtNzcwMzI_afd5c928-a47a-46cc-adeb-9c3c41e30b55"
      unitRef="usd">683000000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockShares
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjYtMC0xLTEtNzcwMzIvdGV4dHJlZ2lvbjo4NDhiY2U0YjEwMWY0MWY2YTk4ZGJjOGU5ZjE5YWMxZF8zOA_42ecc1f4-81cd-4b7f-b87d-769e0f66247d"
      unitRef="shares">180058105</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjYtMC0xLTEtNzcwMzIvdGV4dHJlZ2lvbjo4NDhiY2U0YjEwMWY0MWY2YTk4ZGJjOGU5ZjE5YWMxZF81OA_4709805b-79de-4af0-b4b1-03973bc82928"
      unitRef="shares">181879516</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjYtMS0xLTEtNzcwMzI_bd4ec071-a1b5-4eef-9a7e-8451d66a9ad8"
      unitRef="usd">11422000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjYtMi0xLTEtNzcwMzI_53d96e3c-abde-441a-841a-92dd2a56f0d7"
      unitRef="usd">11488000000</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjctMS0xLTEtNzcwMzI_5bdce1d0-f7f1-462b-89f5-a783ed6bfc13"
      unitRef="usd">6207000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjctMi0xLTEtNzcwMzI_0ae03b09-087c-4686-be03-46b3f8eedad7"
      unitRef="usd">6197000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjgtMS0xLTEtNzcwMzI_e90f8c07-960b-4ff6-8a87-7366d0eecf67"
      unitRef="usd">16994000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjgtMi0xLTEtNzcwMzI_9328fde4-b41b-44bf-b1a3-ac964d5057fa"
      unitRef="usd">17065000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjktMS0xLTEtNzcwMzI_6e2a57f2-2ce7-4bf3-9e19-d5649537b43f"
      unitRef="usd">-3387000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMjktMi0xLTEtNzcwMzI_209ca1d7-1356-4c51-945d-434aa3a1c6f3"
      unitRef="usd">-3380000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMzAtMS0xLTEtNzcwMzI_2fc8c399-127a-4c85-bdff-ff50b81e843e"
      unitRef="usd">9075000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMzAtMi0xLTEtNzcwMzI_606049cb-bcc3-41c4-9f43-98a1a7fda01f"
      unitRef="usd">9077000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMzEtMS0xLTEtNzcwMzI_84c715b3-75cd-45e1-b5bc-5819c82cc366"
      unitRef="usd">44000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMzEtMi0xLTEtNzcwMzI_c27641eb-71e3-43fe-9ffb-7db1dbaa1b19"
      unitRef="usd">44000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMzItMS0xLTEtNzcwMzI_b0df16e6-e027-4763-a454-852bd672f495"
      unitRef="usd">9119000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMzItMi0xLTEtNzcwMzI_8e3b5fa7-c3f5-47c0-84a9-3d024ce7bc5c"
      unitRef="usd">9121000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMzMtMS0xLTEtNzcwMzI_d4a01f36-5bfb-4deb-86a4-bdf7fd1053cb"
      unitRef="usd">32716000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xNi9mcmFnOjcxZDZhNTFhMWVkNzRlMDI4ZjAxOGVkN2Y5MDg0MzIzL3RhYmxlOmQzZmQxOWQ3ZWQwMTQzOWJhODY0MmJkZGZmMjk1NDVlL3RhYmxlcmFuZ2U6ZDNmZDE5ZDdlZDAxNDM5YmE4NjQyYmRkZmYyOTU0NWVfMzMtMi0xLTEtNzcwMzI_05b22219-fde2-4468-963f-3d2d26c54393"
      unitRef="usd">33521000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMi0xLTEtMS03NzAzMg_25c53d4b-ad5a-425d-9042-7fb83fb9b8a1"
      unitRef="usd">3707000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMi0yLTEtMS03NzAzMg_26b48f0d-4577-4980-bb25-fd048bf77b8e"
      unitRef="usd">2946000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMy0xLTEtMS03NzAzMg_11ff183f-9ef6-4a88-93c5-ef0fd4cdf091"
      unitRef="usd">2359000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMy0yLTEtMS03NzAzMg_98190462-da11-452f-bdce-3fb8f887f14a"
      unitRef="usd">1801000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfNC0xLTEtMS03NzAzMg_179d886f-ea93-4048-b35c-15e2e7eb027c"
      unitRef="usd">1348000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfNC0yLTEtMS03NzAzMg_51b24b30-e7f1-4bfc-b1ee-a1e42882f41b"
      unitRef="usd">1145000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfNS0xLTEtMS03NzAzMg_70dbec48-a122-4e8d-a65c-3a94cea1af7c"
      unitRef="usd">1052000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfNS0yLTEtMS03NzAzMg_9e72092e-1231-4633-aa6f-60dd5a3f9258"
      unitRef="usd">627000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfNi0xLTEtMS03NzAzMg_bba0a800-b3f4-44a5-a3f6-73a8a5618011"
      unitRef="usd">150000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfNi0yLTEtMS03NzAzMg_d488fb3a-ad16-4122-9fcf-05d43e6ef91b"
      unitRef="usd">128000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfNy0xLTEtMS03NzAzMg_f6717021-51e7-4aa4-91e2-275ee83832cf"
      unitRef="usd">17000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfNy0yLTEtMS03NzAzMg_25e339fb-60b7-4fac-8099-06865f1f6d80"
      unitRef="usd">0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfOC0xLTEtMS03NzAzMg_8144e02b-bcd2-40fd-85b6-fa17a4a97c36"
      unitRef="usd">163000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfOC0yLTEtMS03NzAzMg_2a45a760-3778-47f1-a06f-0e630dff5571"
      unitRef="usd">390000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfOS0xLTEtMS03NzAzMg_a45ca199-af06-4227-bcd1-345f13722912"
      unitRef="usd">-85000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfOS0yLTEtMS03NzAzMg_7e86320c-dea8-4bca-aff4-aa68446c16c1"
      unitRef="usd">-34000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTAtMS0xLTEtNzcwMzI_0b6f880e-b686-43f0-9075-8cc8dda3ed46"
      unitRef="usd">16000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTAtMi0xLTEtNzcwMzI_723a222d-1d52-4d1a-9fcd-456dccae982a"
      unitRef="usd">-5000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTEtMS0xLTEtNzcwMzI_40f8ec9e-9664-41e4-a595-8921bdfa4a50"
      unitRef="usd">94000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTEtMi0xLTEtNzcwMzI_47d18aff-5f87-4d78-a1bd-d131a17f5346"
      unitRef="usd">351000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTItMS0xLTEtNzcwMzI_c8355c91-dd15-457c-adea-5874abb4e822"
      unitRef="usd">21000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTItMi0xLTEtNzcwMzI_f5a20ae9-1bde-41f4-a796-6eb60d328c0b"
      unitRef="usd">51000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTMtMS0xLTEtNzcwMzI_f2bdd71d-78a1-4917-9ff2-b502cc4c8fc9"
      unitRef="usd">73000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTMtMi0xLTEtNzcwMzI_852f2f26-07b3-468e-af8f-a5364f3e41ed"
      unitRef="usd">300000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTQtMS0xLTEtNzcwMzI_b48b8eea-59ed-42de-9237-c49a67738277"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTQtMi0xLTEtNzcwMzI_bc15a9bc-7443-44da-9be9-72c6ffae1828"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTUtMS0xLTEtNzcwMzI_efad750e-efb2-4217-a215-6bebe05a670a"
      unitRef="usd">71000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTUtMi0xLTEtNzcwMzI_a2d48909-b18b-4821-bdce-76f159b9ab09"
      unitRef="usd">298000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTctMS0xLTEtNzcwMzI_61e9f695-1290-4bc4-80cf-f62c9612dde1"
      unitRef="usdPerShare">0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTctMi0xLTEtNzcwMzI_86e22aef-7a1e-46b3-a0d4-70e69c5ee08f"
      unitRef="usdPerShare">0.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTgtMS0xLTEtNzcwMzI_f1e0f1b1-a388-4a69-8f59-30b66c0faa41"
      unitRef="usdPerShare">0.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMTgtMi0xLTEtNzcwMzI_d3e71ac2-d021-4713-8e69-932825083202"
      unitRef="usdPerShare">0.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMjAtMS0xLTEtNzcwMzI_4086f176-b2c5-4459-8445-18ea947a2b86"
      unitRef="shares">503000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMjAtMi0xLTEtNzcwMzI_83522db2-9324-4125-bcb9-94770785a607"
      unitRef="shares">505000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMjEtMS0xLTEtNzcwMzI_c4a45ee4-3b79-482f-beca-21bf1acfb56f"
      unitRef="shares">509000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18xOS9mcmFnOjc3NjgyNmZjMmQzMjRjNzVhMDhjNGMzMGJiZjk2ZTljL3RhYmxlOmExZDMyYzk1YTFkNDQyYTJhM2M0MjYwZjI4YmEwMTgxL3RhYmxlcmFuZ2U6YTFkMzJjOTVhMWQ0NDJhMmEzYzQyNjBmMjhiYTAxODFfMjEtMi0xLTEtNzcwMzI_30e075c7-c071-4960-9673-ccdaee1ba054"
      unitRef="shares">511000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfMi0xLTEtMS03NzAzMg_419e76af-6149-40e0-9dfe-92e2664ea949"
      unitRef="usd">73000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfMi0yLTEtMS03NzAzMg_162182d6-1e7f-40eb-a072-a936606fb52d"
      unitRef="usd">300000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNC0wLTEtMS03NzAzMi90ZXh0cmVnaW9uOjg5Yjg4ZGY4OGRkODQ2NzZhNGI5YWU4NGFhZDVlZTY1Xzcw_daf90287-0908-4849-83a9-b11efa6a54bc"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNC0wLTEtMS03NzAzMi90ZXh0cmVnaW9uOjg5Yjg4ZGY4OGRkODQ2NzZhNGI5YWU4NGFhZDVlZTY1Xzc3_5b7f0a2d-b1f2-49e3-a76f-667a6a4b5ac1"
      unitRef="usd">17000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNC0xLTEtMS03NzAzMg_fff2c350-12eb-4436-8bc7-a3cb600b46cc"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNC0yLTEtMS03NzAzMg_c769f6dd-0e49-4950-b669-6e5d95892bce"
      unitRef="usd">-208000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNS0wLTEtMS03NzAzMi90ZXh0cmVnaW9uOmM0ZDM4NWE2NzA1OTRkMGFhYTBhNjc3NDJiODI2YTg5XzY5_f9dde9ed-c045-4c39-af87-8dca302e695e"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNS0wLTEtMS03NzAzMi90ZXh0cmVnaW9uOmM0ZDM4NWE2NzA1OTRkMGFhYTBhNjc3NDJiODI2YTg5Xzc2_5bd58b30-d5c6-41c7-80a1-b75883cf76b6"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNS0xLTEtMS03NzAzMg_39720666-65d5-4b8d-8805-04ce91190815"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNS0yLTEtMS03NzAzMg_f85453dc-7327-43c1-8e06-6cb70a0ce649"
      unitRef="usd">-30000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNi0wLTEtMS03NzAzMi90ZXh0cmVnaW9uOmU5NDRhMzdkMWZiNTQ3ZmRiMzgzZGRmNmNhNGJmYzEzXzU2_e403fc2c-92e3-4bb2-a61e-31a79f59a8c8"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNi0wLTEtMS03NzAzMi90ZXh0cmVnaW9uOmU5NDRhMzdkMWZiNTQ3ZmRiMzgzZGRmNmNhNGJmYzEzXzYz_7c9c1a2d-a585-4587-99f9-95f5f9a373db"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNi0xLTEtMS03NzAzMg_e0989c22-70ec-4cbd-a3d5-916d19ad3158"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNi0yLTEtMS03NzAzMg_0ca729dd-4637-4e8e-b920-0194d4fb727e"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNy0wLTEtMS04NDkzOS90ZXh0cmVnaW9uOjMzNmM2ZDcxODBlNDRjYzA4MDg4MzhjNjc4NjJhNDMyXzEwOTk1MTE2Mjc4OTk_de659d7b-0c3c-4fac-a1c7-636d5752639f"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNy0wLTEtMS04NDkzOS90ZXh0cmVnaW9uOjMzNmM2ZDcxODBlNDRjYzA4MDg4MzhjNjc4NjJhNDMyXzEwOTk1MTE2Mjc5Mjg_d3c177ae-9ad5-4350-9c80-814c1cdbb14a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNy0xLTEtMS04NDk3OQ_19defee0-3e27-4a63-a621-acc1d5298564"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNy0yLTEtMS04Nzc3Nw_b5197f40-287a-4772-b1fe-664634f0df28"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNy0xLTEtMS03NzAzMg_7c2a936d-585d-423f-81ff-e98d7920e8af"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfNy0yLTEtMS03NzAzMg_8804b66f-a106-4457-a453-9b5640067a82"
      unitRef="usd">-166000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfOC0xLTEtMS03NzAzMg_4ea0213c-ecb5-45aa-ab91-3cfdd3c48e52"
      unitRef="usd">66000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfOC0yLTEtMS03NzAzMg_979d73b6-64d5-4914-ab0c-ef9afc45ea4a"
      unitRef="usd">134000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfOS0xLTEtMS03NzAzMg_d9b9ab79-9205-435f-a6f0-7aae1f88d042"
      unitRef="usd">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfOS0yLTEtMS03NzAzMg_ad483565-5825-4936-83d2-09a33af6bbe5"
      unitRef="usd">2000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfMTAtMS0xLTEtNzcwMzI_706c5391-355c-4db1-b31a-215c159e0419"
      unitRef="usd">64000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yMi9mcmFnOjBhMTM1Y2ZlMTY4ZTRjYTM4NzViMmVhZTQyZTE3NzMyL3RhYmxlOmZlZTljYWM3YjNiMTQ1Zjc5MjNmN2Y3M2U4OTE2Zjk5L3RhYmxlcmFuZ2U6ZmVlOWNhYzdiM2IxNDVmNzkyM2Y3ZjczZTg5MTZmOTlfMTAtMi0xLTEtNzcwMzI_9fcb3e09-2f74-4a3d-a8dd-02e39959ac2a"
      unitRef="usd">132000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="i395c6d3fa47e43da801c740c4d0887d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy0xLTEtMS03NzAzMg_9c95d20e-2a95-4148-a869-f1a090d52243"
      unitRef="shares">683000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i395c6d3fa47e43da801c740c4d0887d7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy0yLTEtMS03NzAzMg_0d0f632c-66d2-4556-beb4-8681eda6db4a"
      unitRef="usd">683000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="if62e913b0b0a496fae643c8af329597d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy0zLTEtMS03NzAzMg_0147c0e7-c90c-49d9-b0e9-7c68e117fb42"
      unitRef="shares">182000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if62e913b0b0a496fae643c8af329597d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy00LTEtMS03NzAzMg_5717e2f6-339a-4374-9045-66cac1764ee8"
      unitRef="usd">-11488000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5c50a6a898e74098976cf374bd92b5e3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy01LTEtMS03NzAzMg_661b3804-da4e-404c-bb85-c7e4b86ad04f"
      unitRef="usd">6197000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6cd0958ec6fe414297bf307609abf3b5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy02LTEtMS03NzAzMg_3944d402-efbe-4b60-8ae0-afaaf4b18ade"
      unitRef="usd">17065000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie34009f3951740878e77b11e09660114_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy03LTEtMS03NzAzMg_3bef6231-f8c5-4033-9bbe-dd18a53cf34a"
      unitRef="usd">-3380000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iafd810efc2234fb28217dc3a7f888066_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy04LTEtMS03NzAzMg_cc1c7582-a4ea-4c72-a145-a35be4dcea05"
      unitRef="usd">9077000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia8aae1fa5b1449a79ef7b9912c57ca4f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy05LTEtMS03NzAzMg_b3e944eb-3bd8-4738-8c03-8cc961c51d75"
      unitRef="usd">44000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMy0xMC0xLTEtNzcwMzI_97cd1802-3d51-4c38-911f-45f9f0d5b573"
      unitRef="usd">9121000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i7f9fad2bb9874183aa490c07099b7007_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfNS02LTEtMS03NzAzMg_026ab311-af30-474b-aafc-f8abc598dc38"
      unitRef="usd">71000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic5f2d514381a4dae9fc8a99b95a414f7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfNS04LTEtMS03NzAzMg_d3019f28-4805-4d6b-beb8-3f16ea838c8e"
      unitRef="usd">71000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3973bc554e71432ca8e07d7389490ea5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfNS05LTEtMS03NzAzMg_fe69af16-23bc-44e5-8f81-08a8d707c636"
      unitRef="usd">2000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfNS0xMC0xLTEtNzcwMzI_208244c0-38b1-4ce6-90cb-bbe5b83e69f3"
      unitRef="usd">73000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic9d65a1c9ede4680974e4714437a55cd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfNi03LTEtMS03NzAzMg_7f22a579-1c28-4540-88b7-590dd051c238"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic5f2d514381a4dae9fc8a99b95a414f7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfNi04LTEtMS03NzAzMg_724bf028-15b1-49c9-ad36-2de03037a61e"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfNi0xMC0xLTEtNzcwMzI_eebbb562-763b-40a8-bbba-05afe711f468"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i40118e5765794906b7e238aa4c853768_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfOC0zLTEtMS03NzAzMg_5e405a33-6063-4742-9ab7-3de8c240dd17"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i40118e5765794906b7e238aa4c853768_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfOC00LTEtMS03NzAzMg_ceecd0fb-29ae-4442-9d92-8ab2b40be239"
      unitRef="usd">66000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i09965c96a10e480bbb6f1ffe8f35d49f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfOC01LTEtMS03NzAzMg_ff82b3b1-a35f-412c-941e-e28f7f0d9c28"
      unitRef="usd">10000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic5f2d514381a4dae9fc8a99b95a414f7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfOC04LTEtMS03NzAzMg_0c7d5ed6-14d9-4270-8cab-336d10597a27"
      unitRef="usd">76000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfOC0xMC0xLTEtNzcwMzI_497bb1cd-98db-40de-afaf-4be5760432c1"
      unitRef="usd">76000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:DividendsCommonStock
      contextRef="i7f9fad2bb9874183aa490c07099b7007_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfOS02LTEtMS03NzAzMg_80198ecb-fa67-4213-ad38-500f0f0e3add"
      unitRef="usd">142000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ic5f2d514381a4dae9fc8a99b95a414f7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfOS04LTEtMS03NzAzMg_99b69a64-2e84-41ce-a722-ba93f0aae1cb"
      unitRef="usd">142000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfOS0xMC0xLTEtNzcwMzI_38a8998e-ea3d-4035-89d7-9f04c34b7fe4"
      unitRef="usd">142000000</us-gaap:DividendsCommonStock>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i3973bc554e71432ca8e07d7389490ea5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTAtOS0xLTEtNzcwMzI_00fb9f0b-9271-46f9-b68c-320e1adeb286"
      unitRef="usd">-2000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTAtMTAtMS0xLTc3MDMy_38ae8b63-e970-4334-9d11-d4d4a52f3245"
      unitRef="usd">-2000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic5e603c381fe4230aa663f494e69bfa6_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtMS0xLTEtNzcwMzI_57c884f4-2284-4ec6-a1cb-df73e1bee089"
      unitRef="shares">683000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5e603c381fe4230aa663f494e69bfa6_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtMi0xLTEtNzcwMzI_4f64a959-b02c-4d28-8cf3-36bd232a7064"
      unitRef="usd">683000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i7d39e97f9bfc4d4a9af9dd344a9c0030_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtMy0xLTEtNzcwMzI_6db5b19f-e30c-4bfa-a893-531c64ed60b5"
      unitRef="shares">180000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d39e97f9bfc4d4a9af9dd344a9c0030_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtNC0xLTEtNzcwMzI_cd268067-0644-495a-be35-8d2dd6d5a08c"
      unitRef="usd">-11422000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1366da7fa3d545c8a056d8f11c73b8cf_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtNS0xLTEtNzcwMzI_46bbb78a-4341-4cbd-a9ab-3e0ff4cde9a1"
      unitRef="usd">6207000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9beb8849a787405a83fca7e87da30f32_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtNi0xLTEtNzcwMzI_18a166b6-15a1-4203-9470-d528d7665675"
      unitRef="usd">16994000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f9cbc6f08c446859633447e2e55616f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtNy0xLTEtNzcwMzI_2feea9c9-258d-4c99-9972-4713dc77b666"
      unitRef="usd">-3387000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5abd3be1de0741caa08ee8a7bb927d49_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtOC0xLTEtNzcwMzI_8156f66c-0cfc-4a66-b8d5-9d70526bfcd3"
      unitRef="usd">9075000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1bc27871ead541a8a3f407cbc7b88e20_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtOS0xLTEtNzcwMzI_7b004231-8c05-407e-98cc-3f2b63ca399d"
      unitRef="usd">44000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmMyZThlZWQ1ZDFlZTRkMzVhMGI1MGU2YTc4OGM0YWIwL3RhYmxlcmFuZ2U6YzJlOGVlZDVkMWVlNGQzNWEwYjUwZTZhNzg4YzRhYjBfMTEtMTAtMS0xLTc3MDMy_12c5581c-bada-4d26-9ecb-91b918666768"
      unitRef="usd">9119000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesIssued
      contextRef="i949d8647f73e4aab90b5a25fe2d56799_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy0xLTEtMS03NzAzMg_07bca04d-c688-4caa-9823-f15bd177d759"
      unitRef="shares">683000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i949d8647f73e4aab90b5a25fe2d56799_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy0yLTEtMS03NzAzMg_3ee90cf2-6613-4ae1-9d76-e91fab8f6164"
      unitRef="usd">683000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i2261098af7c3484dbb3074e0f50487ad_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy0zLTEtMS03NzAzMg_f8941123-301f-4dc2-adea-bd52cb54c60a"
      unitRef="shares">179000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2261098af7c3484dbb3074e0f50487ad_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy00LTEtMS03NzAzMg_22708234-f7be-4af8-9f5c-98ea6d29e0d3"
      unitRef="usd">-11051000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i968ed9c39ec74c9ba1af9f66763f82f5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy01LTEtMS03NzAzMg_e503abdf-b148-4d98-bb74-188f810f46b1"
      unitRef="usd">6043000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73e5010e5e0241299ccdb8b1c93f7144_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy02LTEtMS03NzAzMg_d9948814-329a-464d-bb10-b7f7fb6442b7"
      unitRef="usd">16328000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib6cac065ec6544838c98a84ff5fe15d9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy03LTEtMS03NzAzMg_0e0fe83a-1829-4626-a814-053db9c9bd66"
      unitRef="usd">-3314000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2562cb466738456fb044cb3fe9e1de27_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy04LTEtMS03NzAzMg_8b5fb359-e08d-4eb3-b4bf-cf24ece9366e"
      unitRef="usd">8689000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8300ea835fae4b28bcfd6760cd7604c8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy05LTEtMS03NzAzMg_6f0425be-c173-4b22-bbd5-12a7063deea6"
      unitRef="usd">37000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i238ac34b0aab41be8134d8a775d08e2d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMy0xMC0xLTEtNzcwMzI_d6ef4d18-2851-43b3-b171-930db4854c4d"
      unitRef="usd">8726000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i401b2c604f694027b1c4dac9b79e2995_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNS02LTEtMS03NzAzMg_8654699f-3839-4b17-9de9-849eac016248"
      unitRef="usd">298000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5730d0771f684643b95bbc057538e077_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNS04LTEtMS03NzAzMg_9f4a5fee-a2f6-423a-9490-e5879d603f32"
      unitRef="usd">298000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5a31b884457e403e9ff8ac44f5eb8b7b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNS05LTEtMS03NzAzMg_aa1a0195-9a71-460e-b226-cb9b9b18a1ab"
      unitRef="usd">2000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNS0xMC0xLTEtNzcwMzI_c4f68654-05c3-4f24-aaa3-39a8274e51d0"
      unitRef="usd">300000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i334dc65857104da8bf45462dbc5304e8_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNi03LTEtMS03NzAzMg_35fa455b-03d6-49d0-bf94-f7ab586a135c"
      unitRef="usd">-166000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5730d0771f684643b95bbc057538e077_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNi04LTEtMS03NzAzMg_201d35e6-beea-4673-aafa-e3c01c5b5d30"
      unitRef="usd">-166000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNi0xMC0xLTEtNzcwMzI_829b9ace-17cb-4225-863e-ff881fa77142"
      unitRef="usd">-166000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i7b3a8f0389c44c1f970975d4fd28fd40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNy0zLTEtMS03NzAzMg_128a891e-6c2b-451f-9b8b-919ae04396ba"
      unitRef="shares">4000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i7b3a8f0389c44c1f970975d4fd28fd40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNy00LTEtMS03NzAzMg_d6e8cb96-bcbb-4add-a837-58f93f8b90d6"
      unitRef="usd">300000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i4078e49ac5b14aba9f645b46af62a911_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNy01LTEtMS03NzAzMg_47f4b329-3f20-44c8-bb06-652e29706aea"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i5730d0771f684643b95bbc057538e077_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNy04LTEtMS03NzAzMg_0fcae4ae-ae0e-424d-a2ec-c89891923d6a"
      unitRef="usd">300000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfNy0xMC0xLTEtNzcwMzI_02313e77-79ba-4ba5-b0cd-5d4d762cc342"
      unitRef="usd">300000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i7b3a8f0389c44c1f970975d4fd28fd40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfOC0zLTEtMS03NzAzMg_ccdb17b1-b7d7-468c-bae8-e5afaa67ac7f"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7b3a8f0389c44c1f970975d4fd28fd40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfOC00LTEtMS03NzAzMg_cc6a76b8-1e0a-4c01-8c46-bdb0edd4a28f"
      unitRef="usd">55000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4078e49ac5b14aba9f645b46af62a911_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfOC01LTEtMS03NzAzMg_2587d795-83b3-4da3-951d-eb251440f508"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5730d0771f684643b95bbc057538e077_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfOC04LTEtMS03NzAzMg_6789004a-fe2d-495b-ac7a-68aa6037a1c7"
      unitRef="usd">55000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfOC0xMC0xLTEtNzcwMzI_4a2573ab-96ea-4970-903d-256d7b5335e8"
      unitRef="usd">55000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:DividendsCommonStock
      contextRef="i401b2c604f694027b1c4dac9b79e2995_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfOS02LTEtMS03NzAzMg_91268a82-0724-4c97-8398-94fd09e2d517"
      unitRef="usd">124000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i5730d0771f684643b95bbc057538e077_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfOS04LTEtMS03NzAzMg_200891cb-c9d3-48ae-b67e-c4ce809c2c93"
      unitRef="usd">124000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfOS0xMC0xLTEtNzcwMzI_e1987d13-2dd1-4e1d-9a66-de3016f01a60"
      unitRef="usd">124000000</us-gaap:DividendsCommonStock>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i5a31b884457e403e9ff8ac44f5eb8b7b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTAtOS0xLTEtNzcwMzI_d7eb4520-7daa-4c79-800c-2b711710353c"
      unitRef="usd">-1000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTAtMTAtMS0xLTc3MDMy_c16b05e2-8cd2-4174-9d63-819f9efbc203"
      unitRef="usd">-1000000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3e57d971a44a4a3f949731983ffafba1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtMS0xLTEtNzcwMzI_99734b14-4792-4cb0-a349-b0794077077d"
      unitRef="shares">683000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e57d971a44a4a3f949731983ffafba1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtMi0xLTEtNzcwMzI_2f814c61-851e-4469-a94d-2ea06c3ef885"
      unitRef="usd">683000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="ia19d724121ef4d3794c045dd65c77f7b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtMy0xLTEtNzcwMzI_6db13359-b3d3-4ee7-afbc-6d6095b95a39"
      unitRef="shares">181000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia19d724121ef4d3794c045dd65c77f7b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtNC0xLTEtNzcwMzI_38568a64-510c-4944-8215-a9b12785b82f"
      unitRef="usd">-11296000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd8d7f5c9b384bc1a8366b6af711f1c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtNS0xLTEtNzcwMzI_72cd2948-b0f0-4bc9-a38b-d33283de80b5"
      unitRef="usd">6043000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i84fd6f93f3d74fcb85ae2bf1c449792d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtNi0xLTEtNzcwMzI_ffe02b25-cd9c-4709-bba3-afde443f0ea9"
      unitRef="usd">16502000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib20ef40d3e874271b4203597bb847021_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtNy0xLTEtNzcwMzI_d318698b-41f5-4fd4-874b-d47995270139"
      unitRef="usd">-3480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifc051d99f31b4d40b60823ffb0ce2ab4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtOC0xLTEtNzcwMzI_da86af8d-6bf7-446b-9310-84e375e6e83b"
      unitRef="usd">8452000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i059198fbccc048f8afbe074a190f2478_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtOS0xLTEtNzcwMzI_19774a31-ff34-424e-a32a-c2956ce19332"
      unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4edbb47a30cf46afbff865ead00dd98c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yNS9mcmFnOmJkMjg3ZGM3MDI0OTRiMmZiMWNjNDIwZWFmNTQ3MmVmL3RhYmxlOmRmNzk5NzMxZWZhMzQ1MGVhMWU3ZjdkNmMzODAxN2NiL3RhYmxlcmFuZ2U6ZGY3OTk3MzFlZmEzNDUwZWExZTdmN2Q2YzM4MDE3Y2JfMTEtMTAtMS0xLTc3MDMy_094cb617-c713-4b48-81e7-d1b8defbd81e"
      unitRef="usd">8490000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMy0xLTEtMS03NzAzMg_6cfa1ba9-13dd-4bd9-90a0-1f5643fd9301"
      unitRef="usd">73000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMy0yLTEtMS03NzAzMg_b5f36993-102d-4319-ac01-265542b870a8"
      unitRef="usd">300000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfNS0xLTEtMS03NzAzMg_84972fcf-79dd-425b-a40c-39059ca31d77"
      unitRef="usd">380000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfNS0yLTEtMS03NzAzMg_7636044f-56aa-4511-b971-bf68c374da81"
      unitRef="usd">217000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfNi0xLTEtMS03NzAzMg_129a5d70-d204-4998-a587-073cc5d2b8d1"
      unitRef="usd">-55000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfNi0yLTEtMS03NzAzMg_17de347a-dfe8-4333-843b-5cc2025ba6e8"
      unitRef="usd">-25000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:ShareBasedCompensation
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfNy0xLTEtMS03NzAzMg_d2d87766-7152-4df4-b2d9-1b15523dfc25"
      unitRef="usd">32000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfNy0yLTEtMS03NzAzMg_6818c7c1-aab5-4f90-b966-1e988c20c189"
      unitRef="usd">22000000</us-gaap:ShareBasedCompensation>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfOC0xLTEtMS03NzAzMg_9cf706b6-29da-44dd-b1fc-4b01ff1feffb"
      unitRef="usd">14000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfOC0yLTEtMS03NzAzMg_00be7d2c-7622-45f5-a28d-5f8f82a5c3eb"
      unitRef="usd">26000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTAtMS0xLTEtNzcwMzI_9a64ce5c-ad82-4555-8c21-7aa7f9447015"
      unitRef="usd">12000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTAtMi0xLTEtNzcwMzI_1d7652a6-c101-4721-891d-7e6e966250c2"
      unitRef="usd">-14000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTItMS0xLTEtNzcwMzI_031adc4a-37ca-4b0c-9722-391ba1b6c6ca"
      unitRef="usd">-153000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTItMi0xLTEtNzcwMzI_4d7b86e9-3a8b-4708-8a4d-7389ff86b1df"
      unitRef="usd">-51000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTMtMS0xLTEtNzcwMzI_eadc9583-e96d-4f9f-aa24-362abf976d60"
      unitRef="usd">105000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTMtMi0xLTEtNzcwMzI_dfd0931e-7cfd-4ace-9f59-caaa69864ead"
      unitRef="usd">129000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTQtMS0xLTEtNzcwMzI_e31d8e9a-7907-46fb-a3f5-d7210777b475"
      unitRef="usd">13000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTQtMi0xLTEtNzcwMzI_b42c01a0-2dbe-40c7-a2a2-36e25de78647"
      unitRef="usd">-2000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTUtMS0xLTEtNzcwMzI_2c642ac8-a33b-490e-a024-0b1ecff415a0"
      unitRef="usd">5000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTUtMi0xLTEtNzcwMzI_afb23b3d-3c2a-4761-926f-abd96a37f389"
      unitRef="usd">22000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTYtMS0xLTEtNzcwMzI_ddd4bde6-436c-4358-8b7a-d6d277c0a88c"
      unitRef="usd">221000000</bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities>
    <bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTYtMi0xLTEtNzcwMzI_32bf17f6-534d-4897-8af7-56c7aa657a75"
      unitRef="usd">124000000</bax:IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTctMS0xLTEtNzcwMzI_a9c99c3e-a1fb-4300-b736-326852343985"
      unitRef="usd">-43000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMTctMi0xLTEtNzcwMzI_99e0d780-ebf1-467e-943e-7393bf104090"
      unitRef="usd">1000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjAtMS0xLTEtNzcwMzI_f782ada7-2310-4741-80fa-1f83824b1c3a"
      unitRef="usd">208000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjAtMi0xLTEtNzcwMzI_bbdcdbf5-7927-46bf-b354-2be90ee22f81"
      unitRef="usd">377000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjItMS0xLTEtNzcwMzI_bdbe2c34-0af9-4cc2-8cb8-dad3a58885b0"
      unitRef="usd">140000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjItMi0xLTEtNzcwMzI_a55f5756-e7c1-4004-bd93-19a557566328"
      unitRef="usd">171000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjMtMS0xLTEtNzcwMzI_32f9c088-1de4-4504-a4e5-5356e44b1ec7"
      unitRef="usd">174000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjMtMi0xLTEtNzcwMzI_86a7535a-0ae5-426b-8abe-314bf239e71c"
      unitRef="usd">381000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjQtMS0xLTEtNzcwMzI_51375781-f2bc-4486-969a-dce332c73dcf"
      unitRef="usd">-10000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjQtMi0xLTEtNzcwMzI_3da768a4-de38-4eb0-9c95-526fcc556ae1"
      unitRef="usd">-14000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjUtMS0xLTEtNzcwMzI_1e21cfff-513a-46b6-9ce8-4687ba294e5f"
      unitRef="usd">-304000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjUtMi0xLTEtNzcwMzI_471277fe-1a66-4623-a507-838736b0ab6d"
      unitRef="usd">-538000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfDebt
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjctMS0xLTEtNzcwMzI_6a4b75ab-70c5-4b6d-8b2d-b0214d76a25a"
      unitRef="usd">404000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjctMi0xLTEtNzcwMzI_592ac7e8-ba50-470b-8332-e2917efaef3d"
      unitRef="usd">0</us-gaap:RepaymentsOfDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjktMS0xLTEtNzcwMzI_84de2496-c431-45eb-bf50-682050adace0"
      unitRef="usd">-45000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMjktMi0xLTEtNzcwMzI_49023c5d-e3d3-4c58-8bd8-bce1955e04db"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzAtMS0xLTEtNzcwMzI_4cc169bf-99dc-4388-a94a-c4f1c368f736"
      unitRef="usd">140000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzAtMi0xLTEtNzcwMzI_d9ca2198-5777-4521-a995-8162c00b0dc3"
      unitRef="usd">125000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzEtMS0xLTEtNzcwMzI_66e57965-8510-4c6e-83df-ebf83768c9ed"
      unitRef="usd">66000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzEtMi0xLTEtNzcwMzI_7a0ae195-bc66-4425-8182-383883e68dfd"
      unitRef="usd">48000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzItMS0xLTEtNzcwMzI_0f0bcbc5-8cfa-4268-8199-8afda6faf40a"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzItMi0xLTEtNzcwMzI_96d784c2-d279-451e-834f-aa12eaebfedb"
      unitRef="usd">253000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzQtMS0xLTEtNzcwMzI_0a2d0ce7-2799-4415-82e3-43101767b72e"
      unitRef="usd">-25000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzQtMi0xLTEtNzcwMzI_d293e566-1b20-4510-8bf7-57b3f220ea6f"
      unitRef="usd">-28000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzUtMS0xLTEtNzcwMzI_96d43bd0-c287-40e7-bc15-9c5bb11887ba"
      unitRef="usd">-548000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzUtMi0xLTEtNzcwMzI_8a10fa7b-8eb3-4062-a4d7-fa41fb58c117"
      unitRef="usd">-358000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzYtMS0xLTEtNzcwMzI_a7a8bee8-f17b-4ecd-8b76-18976392a812"
      unitRef="usd">-13000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzYtMi0xLTEtNzcwMzI_d83f4ed8-44ca-46c4-9a93-05ad41f60073"
      unitRef="usd">-31000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzctMS0xLTEtNzcwMzI_699d4373-e64c-47b1-8ea5-4cc4734db0ea"
      unitRef="usd">-657000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzctMi0xLTEtNzcwMzI_d6aefcd7-06da-4e61-b7b6-b892b7091c2e"
      unitRef="usd">-550000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzgtMS0xLTEtNzcwMzI_13f35301-dea9-413f-b5f7-9ed6808fa9ae"
      unitRef="usd">2956000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i238ac34b0aab41be8134d8a775d08e2d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzgtMi0xLTEtNzcwMzI_81b199f8-46cb-499e-87ef-81115911ecd7"
      unitRef="usd">3736000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzktMS0xLTEtNzcwMzI_4cc77988-0a14-47a5-baa8-271ce71b1caf"
      unitRef="usd">2299000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4edbb47a30cf46afbff865ead00dd98c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzktMi0xLTEtNzcwMzI_0eea4050-8459-42cf-9271-ac04667e54c9"
      unitRef="usd">3186000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMS0xLTEtMS03NzAzMg_c1665869-6a34-40c2-8d8c-eb9759a4d704"
      unitRef="usd">2294000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMS0yLTEtMS03NzAzMg_6b1452eb-3072-49ae-a6f4-f23256a61c8e"
      unitRef="usd">2951000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4edbb47a30cf46afbff865ead00dd98c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMS0zLTEtMS03NzAzMg_d67fefdf-61c5-4a97-b7e5-af49a870f844"
      unitRef="usd">3182000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMi0xLTEtMS03NzAzMg_8b0eb22c-074e-4cb9-908d-15d75a2f0dbe"
      unitRef="usd">5000000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMi0yLTEtMS03NzAzMg_6de0f237-e050-402a-b23d-314bd33eb2d0"
      unitRef="usd">5000000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i4edbb47a30cf46afbff865ead00dd98c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMi0zLTEtMS03NzAzMg_70ee2ddb-a40d-4898-a450-222235d33c9f"
      unitRef="usd">4000000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMy0xLTEtMS03NzAzMg_214f39c3-8ada-41ff-bf68-effd7537493a"
      unitRef="usd">2299000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMy0yLTEtMS03NzAzMg_5f50c103-ff75-458f-b523-53632a5b6abe"
      unitRef="usd">2956000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4edbb47a30cf46afbff865ead00dd98c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOjViMzUwOTk2Y2U3MTQ2NmM4ZjJlOWRhNmM3NjhjYTE0L3RhYmxlcmFuZ2U6NWIzNTA5OTZjZTcxNDY2YzhmMmU5ZGE2Yzc2OGNhMTRfMy0zLTEtMS03NzAzMg_bbad26d7-1915-463b-bd13-18342cb0b71e"
      unitRef="usd">3186000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNC9mcmFnOmVjNDIzMWFmOGM1NzRjZDhhYzIyNmFlZTQxMzdhNzhmL3RleHRyZWdpb246ZWM0MjMxYWY4YzU3NGNkOGFjMjI2YWVlNDEzN2E3OGZfNDE5OA_2d22be17-2b4b-4409-abad-269491864ec9">BASIS OF PRESENTATION&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (we or our) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) in the United States have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 (2021 Annual Report).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the current interim period are not necessarily indicative of the results of operations to be expected for the full year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Risks and Uncertainties Related to COVID-19 and Global Economic Conditions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our global operations expose us to risks associated with public health crises and epidemics/pandemics, such as the novel strain of coronavirus (COVID-19). COVID-19 has had, and we expect will continue to have, an adverse impact on our operations, supply chains and distribution systems and has increased and we expect will continue to increase our expenses, including as a result of impacts associated with preventive and precautionary measures that we, other businesses and governments have taken and continue to take. Initial measures taken in 2020 led to unprecedented restrictions on, disruptions in, and other related impacts on business and personal activities, including a shift in healthcare priorities, which resulted in a significant decline in medical procedures in 2020. The pandemic has created significant volatility in the demand for our products. For further information about our revenues by product category, refer to Note 9. Significant uncertainty remains regarding the duration and overall impact of the COVID-19 pandemic.  For example, concerns remain regarding the pace of economic recovery due to virus resurgence across the globe from the Omicron variants, subvariants and other virus mutations as well as vaccine distribution and hesitancy. The U.S. and other governments may continue existing measures or implement new restrictions and other requirements in light of the continuing spread of the pandemic (including with respect to mandatory vaccinations for certain of our employees, moratoriums on elective procedures and mandatory quarantines and travel restrictions). Due to the uncertainty caused by the pandemic, our operating performance and financial results, particularly in the short term, may be subject to volatility.  We have experienced significant challenges, including lengthy delays, shortages and interruptions, posed by the pandemic and other exogenous factors (including significant weather events, disruptions to certain ports of call around the world and certain geopolitical events) to our global supply chain, including the cost and availability of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, and may experience these and other challenges in future periods.  Many of our manufacturing plant and distribution center personnel are currently unvaccinated, and we may also experience employee resistance in complying with current and future government vaccine and testing mandates, which may cause labor shortages significantly impacting manufacturing production and distribution center productivity.  We expect that these challenges as well as evolving governmental restrictions and requirements, among other factors, may continue to have an adverse effect on our business.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently adopted accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January 1, 2022, we adopted Accounting Standards Update (ASU) 2021-05, Leases (Topic 842), which requires a lessor to classify a lease with variable lease payments (that do not depend on an index or rate) as an operating lease if (1) the lease would have been classified as a sales-type or direct financing lease, and (2) the lessor would have recognized a selling loss at lease commencement. These changes are intended to avoid recognizing a day-one loss for a lease with variable payments even though the lessor expects the arrangement will be profitable overall. The adoption of this ASU did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNC9mcmFnOmVjNDIzMWFmOGM1NzRjZDhhYzIyNmFlZTQxMzdhNzhmL3RleHRyZWdpb246ZWM0MjMxYWY4YzU3NGNkOGFjMjI2YWVlNDEzN2E3OGZfNDE5NQ_be28a3b9-cf0a-4c21-bb94-e1f9a2faf1b1">The unaudited interim condensed consolidated financial statements of Baxter International Inc. and its subsidiaries (we or our) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) in the United States have been condensed or omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 (2021 Annual Report).In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented. All such adjustments, unless otherwise noted herein, are of a normal, recurring nature. The results of operations for the current interim period are not necessarily indicative of the results of operations to be expected for the full year.</us-gaap:ConsolidationPolicyTextBlock>
    <bax:RisksAndUncertaintiesPolicyPolicyTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNC9mcmFnOmVjNDIzMWFmOGM1NzRjZDhhYzIyNmFlZTQxMzdhNzhmL3RleHRyZWdpb246ZWM0MjMxYWY4YzU3NGNkOGFjMjI2YWVlNDEzN2E3OGZfNDE5MQ_61d322a5-604d-4d69-a7a7-8461ad9138ea">Risks and Uncertainties Related to COVID-19 and Global Economic Conditions Our global operations expose us to risks associated with public health crises and epidemics/pandemics, such as the novel strain of coronavirus (COVID-19). COVID-19 has had, and we expect will continue to have, an adverse impact on our operations, supply chains and distribution systems and has increased and we expect will continue to increase our expenses, including as a result of impacts associated with preventive and precautionary measures that we, other businesses and governments have taken and continue to take. Initial measures taken in 2020 led to unprecedented restrictions on, disruptions in, and other related impacts on business and personal activities, including a shift in healthcare priorities, which resulted in a significant decline in medical procedures in 2020. The pandemic has created significant volatility in the demand for our products. For further information about our revenues by product category, refer to Note 9. Significant uncertainty remains regarding the duration and overall impact of the COVID-19 pandemic.  For example, concerns remain regarding the pace of economic recovery due to virus resurgence across the globe from the Omicron variants, subvariants and other virus mutations as well as vaccine distribution and hesitancy. The U.S. and other governments may continue existing measures or implement new restrictions and other requirements in light of the continuing spread of the pandemic (including with respect to mandatory vaccinations for certain of our employees, moratoriums on elective procedures and mandatory quarantines and travel restrictions). Due to the uncertainty caused by the pandemic, our operating performance and financial results, particularly in the short term, may be subject to volatility.  We have experienced significant challenges, including lengthy delays, shortages and interruptions, posed by the pandemic and other exogenous factors (including significant weather events, disruptions to certain ports of call around the world and certain geopolitical events) to our global supply chain, including the cost and availability of raw materials and component parts (including resins and electromechanical devices) and higher transportation costs, and may experience these and other challenges in future periods.  Many of our manufacturing plant and distribution center personnel are currently unvaccinated, and we may also experience employee resistance in complying with current and future government vaccine and testing mandates, which may cause labor shortages significantly impacting manufacturing production and distribution center productivity.  We expect that these challenges as well as evolving governmental restrictions and requirements, among other factors, may continue to have an adverse effect on our business.</bax:RisksAndUncertaintiesPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNC9mcmFnOmVjNDIzMWFmOGM1NzRjZDhhYzIyNmFlZTQxMzdhNzhmL3RleHRyZWdpb246ZWM0MjMxYWY4YzU3NGNkOGFjMjI2YWVlNDEzN2E3OGZfMjc0ODc3OTA4MDcwOQ_f2aaf75e-37ab-4b52-8dda-d4ae12adae94">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently adopted accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January 1, 2022, we adopted Accounting Standards Update (ASU) 2021-05, Leases (Topic 842), which requires a lessor to classify a lease with variable lease payments (that do not depend on an index or rate) as an operating lease if (1) the lease would have been classified as a sales-type or direct financing lease, and (2) the lessor would have recognized a selling loss at lease commencement. These changes are intended to avoid recognizing a day-one loss for a lease with variable payments even though the lessor expects the arrangement will be profitable overall. The adoption of this ASU did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMTEzMzA_78c5a997-e8b3-4a53-b0e3-b7449f84b3f0">ACQUISITIONS AND OTHER ARRANGEMENTS&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Hillrom&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 13, 2021, we completed our acquisition of all outstanding equity interests of Hill-Rom Holdings, Inc. (Hillrom) for a purchase price of $10.5&#160;billion.  Including the assumption of Hillrom's outstanding debt, the enterprise value of the transaction was approximately $12.8&#160;billion.  Under the terms of the transaction agreement, Hillrom shareholders received $156.00 in cash per outstanding Hillrom common share. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of the total consideration paid:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash consideration paid to Hillrom shareholders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of equity awards issued to Hillrom equity award holders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Represents cash consideration transferred of $156.00 per outstanding Hillrom common share to existing shareholders and holders of equity awards that vested at closing pursuant to their original terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Represents the pre-acquisition service portion of the fair value of 668&#160;thousand replacement restricted stock units issued to Hillrom equity award holders at closing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation of assets acquired and liabilities assumed has not yet been finalized as of March 31, 2022. Finalization of the valuation during the measurement period could result in a change in the amounts recorded for acquired intangible assets, goodwill and income taxes among other items. The completion of the valuation will occur no later than one year from the acquisition date.The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed as of the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2022, we recorded measurement period adjustments to increase other intangible assets of $7&#160;million, increase deferred income tax liabilities of $11&#160;million, other individually insignificant adjustments for a net &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;decrease to assets acquired and liabilities assumed of $6&#160;million and a corresponding increase to goodwill of $10&#160;million. The measurement period adjustments did not have a significant impact our results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The goodwill, which is not deductible for tax purposes, includes the value of an assembled workforce as well as the overall strategic benefits provided to our product portfolio and is included in the Hillrom segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2022, we recognized $159&#160;million of incremental costs of sales from the fair value step-ups on acquired Hillrom inventory that was sold in the current period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"&gt;Other Business Development Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In March 2022, we entered into an agreement with a subsidiary of Pfizer Inc. to acquire the rights to Zosyn, a premixed frozen piperacillin-tazobactam product, in the U.S. and Canada. Zosyn is used for the treatment of intra-abdominal infections, nosocomial pneumonia, skin and skin structure infections, female pelvic infections and community-acquired pneumonia. Under the terms of the acquisition, we paid the acquisition price of $122 million currently, received specified intellectual property, including patent rights, in the current period and will receive additional intellectual property, including the product rights to Zosyn, in one year.  Under the arrangement, we are entitled to receive profit sharing payments from sales of Zosyn until the product rights transfer to us in March 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The transaction has been accounted for as an asset acquisition, as substantially all of the fair value of the assets being acquired under the arrangement was concentrated in the product rights that we will receive, which we classify as a developed technology intangible asset. Accordingly, the $122 million purchase price was primarily allocated to the developed technology intangible asset class and will be amortized over an estimated useful life of 9 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <bax:BusinessCombinationCashConsideration
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDY3Ng_f42a02bf-9067-4cc6-87b4-f90c807ba0ce"
      unitRef="usd">10500000000</bax:BusinessCombinationCashConsideration>
    <bax:BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations
      contextRef="i76d012ba0e6842c4bc044efa2367e442_D20211213-20211213"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDcwMA_e043646f-7f52-44ec-815b-2c084f384231"
      unitRef="usd">12800000000</bax:BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDY5MQ_f892bce7-20b4-47fc-8830-b232507ee5b5"
      unitRef="usdPerShare">156.00</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDc4OQ_b1d6dd4e-61de-40db-b36f-5db07747be23">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of the total consideration paid:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash consideration paid to Hillrom shareholders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of equity awards issued to Hillrom equity award holders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Represents cash consideration transferred of $156.00 per outstanding Hillrom common share to existing shareholders and holders of equity awards that vested at closing pursuant to their original terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Represents the pre-acquisition service portion of the fair value of 668&#160;thousand replacement restricted stock units issued to Hillrom equity award holders at closing.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i76d012ba0e6842c4bc044efa2367e442_D20211213-20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmRmNGZjNjNlMTRiMzRiZmU4Y2M2ZmM3NmUzMjhjYjZhL3RhYmxlcmFuZ2U6ZGY0ZmM2M2UxNGIzNGJmZThjYzZmYzc2ZTMyOGNiNmFfMS0xLTEtMS04NTczNQ_b8619652-84a7-4ec3-b37f-73eaf5a0af36"
      unitRef="usd">10474000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i76d012ba0e6842c4bc044efa2367e442_D20211213-20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmRmNGZjNjNlMTRiMzRiZmU4Y2M2ZmM3NmUzMjhjYjZhL3RhYmxlcmFuZ2U6ZGY0ZmM2M2UxNGIzNGJmZThjYzZmYzc2ZTMyOGNiNmFfMi0xLTEtMS04NTczNQ_ab6207d6-ecab-4a6a-a312-42bdd2cdc4bc"
      unitRef="usd">2000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i76d012ba0e6842c4bc044efa2367e442_D20211213-20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmRmNGZjNjNlMTRiMzRiZmU4Y2M2ZmM3NmUzMjhjYjZhL3RhYmxlcmFuZ2U6ZGY0ZmM2M2UxNGIzNGJmZThjYzZmYzc2ZTMyOGNiNmFfMy0xLTEtMS04NTczNQ_411fd4df-21f9-49bb-bdad-e2baff9f9269"
      unitRef="usd">10476000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDcxNQ_eef3545e-5eb8-4d08-9666-93227714fcd3"
      unitRef="usdPerShare">156.00</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i76d012ba0e6842c4bc044efa2367e442_D20211213-20211213"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMTA5OTUxMTY1ODc5MA_f51e2a90-1e5a-49d6-a956-bed51683b3a2"
      unitRef="shares">668000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDc5MA_723a1a5c-7d9b-4f05-bdd3-0d43d909a059">The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed as of the acquisition date:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.136%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMi0xLTEtMS04NTg5Nw_0a0b1776-d7e9-4152-82c0-ae37115a43c9"
      unitRef="usd">399000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMy0xLTEtMS04NTg5Nw_17919127-213e-483f-a23a-46c563a4567d"
      unitRef="usd">590000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfNC0xLTEtMS04NTg5Nw_d8f11d84-4b6e-4e25-9a4d-10644c038e4d"
      unitRef="usd">557000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfNS0xLTEtMS04NTg5Nw_6b92b40a-ae70-4c0c-bc1f-cfc5bbf9b996"
      unitRef="usd">49000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfNi0xLTEtMS04NTg5Nw_4accc985-4875-4dab-8244-ebca47a25309"
      unitRef="usd">502000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:Goodwill
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfNy0xLTEtMS04NTg5Nw_1e032199-7403-468a-b474-36ab0197f716"
      unitRef="usd">6795000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfOC0xLTEtMS04NTg5Nw_b52e8ee9-8b7a-46eb-80ce-ab791739d1eb"
      unitRef="usd">6029000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfOS0xLTEtMS04NTg5Nw_913a4cfc-f878-451c-bb0e-8131ee429c50"
      unitRef="usd">74000000</bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMTAtMS0xLTEtODU4OTc_c6055368-bebf-4c65-8263-4f0e5d3d19f7"
      unitRef="usd">125000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMTEtMS0xLTEtODU4OTc_3a422cf3-9732-4a11-aee1-8fbbcbf2e5c6"
      unitRef="usd">250000000</bax:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMTItMS0xLTEtODU4OTc_1c02d687-d29a-4ca5-98e3-ae6da8b9f146"
      unitRef="usd">140000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMTMtMS0xLTEtODU4OTc_2f611b86-9069-482f-b371-31f149c90b64"
      unitRef="usd">552000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMTQtMS0xLTEtODU4OTc_3a68a117-22a1-4165-8d75-5850d1f022a9"
      unitRef="usd">2118000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMTUtMS0xLTEtODU4OTc_7562dad1-c12b-4700-b3cd-326aceaa2ee1"
      unitRef="usd">57000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMTYtMS0xLTEtODU4OTc_9723b396-6b3a-4b85-b510-91341577c03f"
      unitRef="usd">1527000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i969c52a42b424c649a401568d787c03d_I20211213"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RhYmxlOmZkYjA3MDFhNzRkZDRhYzFiM2MwNmY5YmI0ZjRmOWFkL3RhYmxlcmFuZ2U6ZmRiMDcwMWE3NGRkNGFjMWIzYzA2ZjliYjRmNGY5YWRfMTctMS0xLTEtODU4OTc_11e7e923-1658-4b80-8f37-4c3ff4efbb55"
      unitRef="usd">10476000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles
      contextRef="i0627724177f1427fb42008e3261d78c0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDczOQ_14265054-7b20-4f3d-be28-01e24c44328d"
      unitRef="usd">7000000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
    <bax:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes
      contextRef="i0627724177f1427fb42008e3261d78c0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDcyNg_86e4e0cc-ab16-4330-ad75-117fcbc43f7c"
      unitRef="usd">11000000</bax:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes>
    <bax:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed
      contextRef="i0627724177f1427fb42008e3261d78c0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDc1MQ_49acd62c-44e4-4739-ae2f-de94a8891dde"
      unitRef="usd">-6000000</bax:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i0627724177f1427fb42008e3261d78c0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDc2Mw_e6f5a3b9-ced4-4130-828e-43188c76396c"
      unitRef="usd">10000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory
      contextRef="i0627724177f1427fb42008e3261d78c0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMjc0ODc3OTExNDc3Ng_6e99ad59-86b3-40e1-a06e-b3c85ffda110"
      unitRef="usd">159000000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i21e54c53c46c4b708c6f8469337d00f5_D20220301-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMTA5OTUxMTY3MzM4OA_a1f1ba47-798d-41bc-98ce-4ab351fc04ff"
      unitRef="usd">122000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i21e54c53c46c4b708c6f8469337d00f5_D20220301-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMTA5OTUxMTY1NjE3OA_a1f1ba47-798d-41bc-98ce-4ab351fc04ff"
      unitRef="usd">122000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iaad890641b794c4ab677efe29d43bfc3_D20220301-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18zNy9mcmFnOjk1ZDkwMGI3MDdkMjQ0Mzg4Yjk3YTdlMWNiMTIxZjIxL3RleHRyZWdpb246OTVkOTAwYjcwN2QyNDQzODhiOTdhN2UxY2IxMjFmMjFfMTA5OTUxMTY1NjU1Mg_3d22e2bf-21d0-4444-b056-7506efc1da4e">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfNzE2_cbdc5f48-cb07-4418-84e9-5e352b894c0c">SUPPLEMENTAL FINANCIAL INFORMATION&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the changes in our allowance for doubtful accounts for the three months ended March&#160;31, 2022 and 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment, Net &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Interest Expense, Net&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net of capitalized interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Other (Income) Expense, Net&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange (gains) losses, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and other postretirement benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Non-Cash Operating and Investing Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Right-of-use operating lease assets obtained in exchange for lease obligations for the three months ended March&#160;31, 2022 and 2021 were $14 million and $5&#160;million, respectively.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Purchases of property, plant and equipment included in accounts payable as of March&#160;31, 2022 and 2021 were $53 million and $63 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;There were no unsettled share repurchases as of March&#160;31, 2022. Unsettled share repurchases included in accrued expenses and other current liabilities were $47&#160;million as of March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfNzE5_8f89a839-b318-4a40-a6c6-7f45fe9bee77">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the changes in our allowance for doubtful accounts for the three months ended March&#160;31, 2022 and 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfMi0xLTEtMS03NzAzMg_4f0e0b9e-2d80-4523-b59a-cc7941fc37d1"
      unitRef="usd">122000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i238ac34b0aab41be8134d8a775d08e2d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfMi0yLTEtMS03NzAzMg_f37953a6-99c9-47e8-9870-df7f298481e9"
      unitRef="usd">125000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfNC0xLTEtMS03NzAzMg_91a38572-eb0a-45ba-86ef-f989f813bf72"
      unitRef="usd">6000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfNC0yLTEtMS03NzAzMg_7dc289b6-b5f6-4eff-b301-12e8297e52f3"
      unitRef="usd">1000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfNS0xLTEtMS03NzAzMg_2180abcb-4e25-41ce-a55d-cb4b4bc741c4"
      unitRef="usd">1000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfNS0yLTEtMS03NzAzMg_8e8447f8-485b-481a-ba4a-e14d13f4827e"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfNi0xLTEtMS03NzAzMg_97bb27f9-573b-4b01-a05b-030557f44f8f"
      unitRef="usd">-2000000</bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments>
    <bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfNi0yLTEtMS03NzAzMg_4f1349c3-8307-472c-a0b9-18c84d472208"
      unitRef="usd">6000000</bax:AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfNy0xLTEtMS03NzAzMg_a803b867-5b0c-48d0-a022-503099279174"
      unitRef="usd">129000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i4edbb47a30cf46afbff865ead00dd98c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmZkMjBjMzljNTRjODQ5Zjc5YzkwM2IxYWYzNmY0YjI3L3RhYmxlcmFuZ2U6ZmQyMGMzOWM1NGM4NDlmNzljOTAzYjFhZjM2ZjRiMjdfNy0yLTEtMS03NzAzMg_28d416fd-e5e8-4c5d-962a-3ccee0bb70f3"
      unitRef="usd">120000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfNzEz_40b7f702-7292-4cca-aaaa-050d0db54bd4">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmFjNTFmMmE2OWRkYjQyNDRhM2E0YWNjMDZlNzQyMzUzL3RhYmxlcmFuZ2U6YWM1MWYyYTY5ZGRiNDI0NGEzYTRhY2MwNmU3NDIzNTNfMS0xLTEtMS03NzAzMg_13f8df30-5c3f-48e7-b676-d4e7af642913"
      unitRef="usd">656000000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmFjNTFmMmE2OWRkYjQyNDRhM2E0YWNjMDZlNzQyMzUzL3RhYmxlcmFuZ2U6YWM1MWYyYTY5ZGRiNDI0NGEzYTRhY2MwNmU3NDIzNTNfMS0yLTEtMS03NzAzMg_6778fa8e-b974-4489-9838-4d947cbf49bb"
      unitRef="usd">591000000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmFjNTFmMmE2OWRkYjQyNDRhM2E0YWNjMDZlNzQyMzUzL3RhYmxlcmFuZ2U6YWM1MWYyYTY5ZGRiNDI0NGEzYTRhY2MwNmU3NDIzNTNfMi0xLTEtMS03NzAzMg_45b76788-1f96-4a45-bffd-026b979eda16"
      unitRef="usd">285000000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmFjNTFmMmE2OWRkYjQyNDRhM2E0YWNjMDZlNzQyMzUzL3RhYmxlcmFuZ2U6YWM1MWYyYTY5ZGRiNDI0NGEzYTRhY2MwNmU3NDIzNTNfMi0yLTEtMS03NzAzMg_adce6530-50f4-45a0-a539-01d898cc3b0d"
      unitRef="usd">300000000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmFjNTFmMmE2OWRkYjQyNDRhM2E0YWNjMDZlNzQyMzUzL3RhYmxlcmFuZ2U6YWM1MWYyYTY5ZGRiNDI0NGEzYTRhY2MwNmU3NDIzNTNfMy0xLTEtMS03NzAzMg_c1f19c2a-459a-4498-a347-933f7de7273a"
      unitRef="usd">1607000000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmFjNTFmMmE2OWRkYjQyNDRhM2E0YWNjMDZlNzQyMzUzL3RhYmxlcmFuZ2U6YWM1MWYyYTY5ZGRiNDI0NGEzYTRhY2MwNmU3NDIzNTNfMy0yLTEtMS03NzAzMg_03f9f340-2e57-4e94-bf8f-ba38c6e1fefa"
      unitRef="usd">1562000000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmFjNTFmMmE2OWRkYjQyNDRhM2E0YWNjMDZlNzQyMzUzL3RhYmxlcmFuZ2U6YWM1MWYyYTY5ZGRiNDI0NGEzYTRhY2MwNmU3NDIzNTNfNC0xLTEtMS03NzAzMg_6752b0ad-6e70-4e65-a6da-3d7f2b96b3fe"
      unitRef="usd">2548000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOmFjNTFmMmE2OWRkYjQyNDRhM2E0YWNjMDZlNzQyMzUzL3RhYmxlcmFuZ2U6YWM1MWYyYTY5ZGRiNDI0NGEzYTRhY2MwNmU3NDIzNTNfNC0yLTEtMS03NzAzMg_65301810-cab3-48f9-8db4-8eda75d0a16b"
      unitRef="usd">2453000000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfNzE0_b61b39ac-be5f-4641-bb0e-58fbf4bcd998">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment, Net &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,550)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjY2YzVmNjg1ZWRiNjRlZjI4M2Q0NjcyM2NjOGQ2ZmM4L3RhYmxlcmFuZ2U6NjZjNWY2ODVlZGI2NGVmMjgzZDQ2NzIzY2M4ZDZmYzhfMS0xLTEtMS03NzAzMg_17760211-9c8d-424d-b18e-0bc8aaf85176"
      unitRef="usd">11757000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjY2YzVmNjg1ZWRiNjRlZjI4M2Q0NjcyM2NjOGQ2ZmM4L3RhYmxlcmFuZ2U6NjZjNWY2ODVlZGI2NGVmMjgzZDQ2NzIzY2M4ZDZmYzhfMS0yLTEtMS03NzAzMg_c7bb818e-1a65-4c06-86bc-5af2d47198e0"
      unitRef="usd">11728000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjY2YzVmNjg1ZWRiNjRlZjI4M2Q0NjcyM2NjOGQ2ZmM4L3RhYmxlcmFuZ2U6NjZjNWY2ODVlZGI2NGVmMjgzZDQ2NzIzY2M4ZDZmYzhfMi0xLTEtMS03NzAzMg_eda28ffa-852f-4974-ad8b-6a3ade506786"
      unitRef="usd">6643000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjY2YzVmNjg1ZWRiNjRlZjI4M2Q0NjcyM2NjOGQ2ZmM4L3RhYmxlcmFuZ2U6NjZjNWY2ODVlZGI2NGVmMjgzZDQ2NzIzY2M4ZDZmYzhfMi0yLTEtMS03NzAzMg_fb80b48e-cd81-4035-85b0-9cf484706ba8"
      unitRef="usd">6550000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjY2YzVmNjg1ZWRiNjRlZjI4M2Q0NjcyM2NjOGQ2ZmM4L3RhYmxlcmFuZ2U6NjZjNWY2ODVlZGI2NGVmMjgzZDQ2NzIzY2M4ZDZmYzhfMy0xLTEtMS03NzAzMg_465ae587-2035-4198-a6f9-02c7f9ada2c6"
      unitRef="usd">5114000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjY2YzVmNjg1ZWRiNjRlZjI4M2Q0NjcyM2NjOGQ2ZmM4L3RhYmxlcmFuZ2U6NjZjNWY2ODVlZGI2NGVmMjgzZDQ2NzIzY2M4ZDZmYzhfMy0yLTEtMS03NzAzMg_2d031dad-9694-480f-8fb3-c4fb855d27d9"
      unitRef="usd">5178000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfMjc0ODc3OTA3MDgzMw_c0e292ca-5820-4796-97a5-8174f0232ffe">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Interest Expense, Net&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net of capitalized interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:InterestExpense
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjg5MGViYWQ1MjgxMDRkZTZiOGI4ZTg2ZjVhYmZiMzMwL3RhYmxlcmFuZ2U6ODkwZWJhZDUyODEwNGRlNmI4YjhlODZmNWFiZmIzMzBfMi0xLTEtMS04NjQ2OQ_097795c8-0531-4008-ad60-b5d544ac1b59"
      unitRef="usd">88000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjg5MGViYWQ1MjgxMDRkZTZiOGI4ZTg2ZjVhYmZiMzMwL3RhYmxlcmFuZ2U6ODkwZWJhZDUyODEwNGRlNmI4YjhlODZmNWFiZmIzMzBfMi0yLTEtMS04NjQ2OQ_db4ed46f-5ab5-4d1c-bd63-d9ffc32a81a9"
      unitRef="usd">37000000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjg5MGViYWQ1MjgxMDRkZTZiOGI4ZTg2ZjVhYmZiMzMwL3RhYmxlcmFuZ2U6ODkwZWJhZDUyODEwNGRlNmI4YjhlODZmNWFiZmIzMzBfMy0xLTEtMS04NjQ2OQ_51febbc6-d641-4cd9-8470-6e89e6495363"
      unitRef="usd">3000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjg5MGViYWQ1MjgxMDRkZTZiOGI4ZTg2ZjVhYmZiMzMwL3RhYmxlcmFuZ2U6ODkwZWJhZDUyODEwNGRlNmI4YjhlODZmNWFiZmIzMzBfMy0yLTEtMS04NjQ2OQ_9dd4549f-7cdb-406b-ab07-af315c6b4ece"
      unitRef="usd">3000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjg5MGViYWQ1MjgxMDRkZTZiOGI4ZTg2ZjVhYmZiMzMwL3RhYmxlcmFuZ2U6ODkwZWJhZDUyODEwNGRlNmI4YjhlODZmNWFiZmIzMzBfNC0xLTEtMS04NjQ2OQ_dc5e63a8-6eea-4541-b3d4-bd477c61d35d"
      unitRef="usd">-85000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjg5MGViYWQ1MjgxMDRkZTZiOGI4ZTg2ZjVhYmZiMzMwL3RhYmxlcmFuZ2U6ODkwZWJhZDUyODEwNGRlNmI4YjhlODZmNWFiZmIzMzBfNC0yLTEtMS04NjQ2OQ_6facdb5c-510f-4ed9-a7ae-2a26e9d69071"
      unitRef="usd">-34000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfMjc0ODc3OTA3MDgzNA_f0fcf203-039b-455a-8286-cbfb8ca3a5e9">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Other (Income) Expense, Net&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange (gains) losses, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and other postretirement benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjYzMWUxNThjZTY4NjQ2MGE5MGY0MGExNzdhODAwZTU2L3RhYmxlcmFuZ2U6NjMxZTE1OGNlNjg2NDYwYTkwZjQwYTE3N2E4MDBlNTZfMi0xLTEtMS04NjQ3OQ_b9e37768-ba3e-4a83-9a89-efdf641fd40f"
      unitRef="usd">11000000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjYzMWUxNThjZTY4NjQ2MGE5MGY0MGExNzdhODAwZTU2L3RhYmxlcmFuZ2U6NjMxZTE1OGNlNjg2NDYwYTkwZjQwYTE3N2E4MDBlNTZfMi0yLTEtMS04NjQ3OQ_4396b52a-bce3-4269-a05e-7632f9aa57c9"
      unitRef="usd">3000000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjYzMWUxNThjZTY4NjQ2MGE5MGY0MGExNzdhODAwZTU2L3RhYmxlcmFuZ2U6NjMxZTE1OGNlNjg2NDYwYTkwZjQwYTE3N2E4MDBlNTZfMy0xLTEtMS04NjQ3OQ_53b5977c-7e8a-48a7-8d46-02054d9926b4"
      unitRef="usd">-5000000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitExpense
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjYzMWUxNThjZTY4NjQ2MGE5MGY0MGExNzdhODAwZTU2L3RhYmxlcmFuZ2U6NjMxZTE1OGNlNjg2NDYwYTkwZjQwYTE3N2E4MDBlNTZfMy0yLTEtMS04NjQ3OQ_ab03fccb-38c8-4244-9446-7d47537eec3f"
      unitRef="usd">4000000</us-gaap:PensionAndOtherPostretirementBenefitExpense>
    <us-gaap:OtherNonoperatingGainsLosses
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjYzMWUxNThjZTY4NjQ2MGE5MGY0MGExNzdhODAwZTU2L3RhYmxlcmFuZ2U6NjMxZTE1OGNlNjg2NDYwYTkwZjQwYTE3N2E4MDBlNTZfNS0xLTEtMS04NjQ3OQ_e2fda737-512e-494d-940b-1dba110a2d54"
      unitRef="usd">0</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:OtherNonoperatingGainsLosses
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjYzMWUxNThjZTY4NjQ2MGE5MGY0MGExNzdhODAwZTU2L3RhYmxlcmFuZ2U6NjMxZTE1OGNlNjg2NDYwYTkwZjQwYTE3N2E4MDBlNTZfNS0yLTEtMS04NjQ3OQ_b88b8db1-5f43-464f-a91e-33baecfaba82"
      unitRef="usd">-4000000</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjYzMWUxNThjZTY4NjQ2MGE5MGY0MGExNzdhODAwZTU2L3RhYmxlcmFuZ2U6NjMxZTE1OGNlNjg2NDYwYTkwZjQwYTE3N2E4MDBlNTZfNi0xLTEtMS04NjQ3OQ_50497a5f-0861-4606-95af-5d6cb05bd2df"
      unitRef="usd">16000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RhYmxlOjYzMWUxNThjZTY4NjQ2MGE5MGY0MGExNzdhODAwZTU2L3RhYmxlcmFuZ2U6NjMxZTE1OGNlNjg2NDYwYTkwZjQwYTE3N2E4MDBlNTZfNi0yLTEtMS04NjQ3OQ_ec24d4c8-3e5c-47a7-bf0b-ba369260bfb0"
      unitRef="usd">-5000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfNDU0_74752b57-ca65-42c8-a896-bdc3002fd487"
      unitRef="usd">14000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfNDYx_58a0b72b-7d40-4ed9-9770-72dfd2566508"
      unitRef="usd">5000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i893821e416354e0681636831227afbcb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfNjg5_4f9c9ef7-7266-48f8-bb1e-6214d688220d"
      unitRef="usd">53000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i66457192cf5d4d76ab71f467bee6bca2_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfNjk2_1dce30ad-29b3-4ea8-a098-05cad7e080c8"
      unitRef="usd">63000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <bax:OtherLiabilitiesCurrentUnsettledShareRepurchase
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfMjc0ODc3OTA3MDU2Nw_1ce89eef-3559-4295-8886-ce8014f0c8e1"
      unitRef="usd">0</bax:OtherLiabilitiesCurrentUnsettledShareRepurchase>
    <bax:OtherLiabilitiesCurrentUnsettledShareRepurchase
      contextRef="i4edbb47a30cf46afbff865ead00dd98c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180MC9mcmFnOmZkOTEzNmNiY2NkNDQyOTBiMTViZDNjNDEwYmQ5NDAwL3RleHRyZWdpb246ZmQ5MTM2Y2JjY2Q0NDI5MGIxNWJkM2M0MTBiZDk0MDBfMjc0ODc3OTA3MDU2OQ_2e771fda-3628-416d-991e-933679cddc7a"
      unitRef="usd">47000000</bax:OtherLiabilitiesCurrentUnsettledShareRepurchase>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RleHRyZWdpb246YmJjYWM3MzBhODNiNDA2MWI4YmRkYzI5MTJiOTdjNGVfMTQ2MQ_ae5812f5-48b0-46d5-b9d5-0d9acd857548">GOODWILL AND OTHER INTANGIBLE ASSETS, NET&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of goodwill by business segment.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, there were no reductions in goodwill relating to impairment losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our other intangible assets.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.428%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology, including patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,638)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible asset amortization expense was $217 million and $64 million for the three months ended March&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RleHRyZWdpb246YmJjYWM3MzBhODNiNDA2MWI4YmRkYzI5MTJiOTdjNGVfMTQ2NQ_982369c5-fa67-4619-b933-8c8b124a76c2">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of goodwill by business segment.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i31a852f840a74cb8b2c787ac3741588a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfMS0xLTEtMS03NzAzMg_df64d2c8-86f7-4410-9301-5631c769f6a0"
      unitRef="usd">2517000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i097b8af344b1429eabe401c1d86d6631_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfMS0yLTEtMS03NzAzMg_570555b7-a48e-40db-928f-28aa9bf3cc4c"
      unitRef="usd">309000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ide5f5c25f88f48b5af91862d33456fa9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfMS0zLTEtMS03NzAzMg_4b6163f0-15dd-4c75-8831-6a0b51de989e"
      unitRef="usd">224000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i292b133325264c6597bd7b9662bb2dda_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfMS00LTEtMS03NzMxMg_ebcfd0a5-10b9-406d-8256-e6dcfb9476c2"
      unitRef="usd">6786000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfMS00LTEtMS03NzAzMg_5bf6f248-af43-41f8-9e1c-8701a98c145b"
      unitRef="usd">9836000000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i4d463df4bdbb45f0aa2538354d127517_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNC0xLTEtMS03NzAzMg_a9ed13d3-cafb-414a-a3a1-323070ea5b22"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i7b0ebff960224f8ca45f13ec5e67356e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNC0yLTEtMS03NzAzMg_5c5291a1-9ddc-44aa-928c-cf3ed717fc80"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="if5a44ba447e844ac8ef93eebe8c514e2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNC0zLTEtMS03NzAzMg_004275a4-2aed-4364-9bbe-ae475577c406"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i694baf88defe4467b0cc59ac6509b10c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNC00LTEtMS04MjUzMw_fc1fd01f-8ede-4601-9aaf-53350aa20745"
      unitRef="usd">10000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNC00LTEtMS03NzAzMg_03a2dce8-57e2-4a1e-a9c6-a09d7c3fe360"
      unitRef="usd">10000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i4d463df4bdbb45f0aa2538354d127517_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNS0xLTEtMS03NzAzMg_2e382ca0-f66c-4ca8-bf20-e497f51fe380"
      unitRef="usd">-29000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i7b0ebff960224f8ca45f13ec5e67356e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNS0yLTEtMS03NzAzMg_242daa9d-4514-4af2-a1b4-d70b10ae3550"
      unitRef="usd">-3000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="if5a44ba447e844ac8ef93eebe8c514e2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNS0zLTEtMS03NzAzMg_7b666286-f0fb-4d77-a32b-859a4d075eac"
      unitRef="usd">-3000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i694baf88defe4467b0cc59ac6509b10c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNS00LTEtMS03NzMyOA_7b132f53-d1e5-4221-8cb4-e0672f015866"
      unitRef="usd">5000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNS00LTEtMS03NzAzMg_62fa4d85-3340-44aa-99fb-8296c3bb9adf"
      unitRef="usd">-30000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ib929fbd76df144d399a18b57db4d9ae3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNi0xLTEtMS03NzAzMg_998b6934-e663-4f86-8a99-3632be060260"
      unitRef="usd">2488000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib1022ad8302e440da3f4e203175d4b10_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNi0yLTEtMS03NzAzMg_8cbef742-c02d-432c-9979-a6d97fadb148"
      unitRef="usd">306000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7e4572eced80425baf027140478315ba_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNi0zLTEtMS03NzAzMg_4dd8a4ca-6bb6-4620-b375-32955a253b9d"
      unitRef="usd">221000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i52fbf2a8bbe449269339aa45b6bad70d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNi00LTEtMS03NzMzNQ_9232af1f-6e8e-43e5-b1f0-5b22fa6f8086"
      unitRef="usd">6801000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOjQ3NjUwY2U3MjVjZTRmZWY5MTEyMGM2MWExYWQ2YTM1L3RhYmxlcmFuZ2U6NDc2NTBjZTcyNWNlNGZlZjkxMTIwYzYxYTFhZDZhMzVfNi00LTEtMS03NzAzMg_eb574541-ffaf-4748-8a33-49eac6d790bf"
      unitRef="usd">9816000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RleHRyZWdpb246YmJjYWM3MzBhODNiNDA2MWI4YmRkYzI5MTJiOTdjNGVfMTQ4_8ff29a6a-0094-4867-8a29-7cb9e8ee20be"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <bax:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RleHRyZWdpb246YmJjYWM3MzBhODNiNDA2MWI4YmRkYzI5MTJiOTdjNGVfMTQ2OA_9a1c6b86-3081-421c-a9e9-ca80382ee4eb">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our other intangible assets.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.428%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed technology, including patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,638)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</bax:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icf3044fdced045cba1b544760a38b3b8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMi0xLTEtMS03NzM4Mw_94ae33ee-062a-4f45-80d2-4b320bf944a8"
      unitRef="usd">3457000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i89a1452b79a447f2975f350bd948e3bf_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMi0xLTEtMS03NzAzMg_093504ba-ee3e-4643-80dd-eedd20e28dfa"
      unitRef="usd">3883000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia2638eb542e340638a844744dc8b8b41_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMi0yLTEtMS03NzAzMg_ed001d3c-b182-48a2-94d1-207f3ab6c907"
      unitRef="usd">340000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:OtherIndefiniteLivedIntangibleAssets
      contextRef="i824274fce6e34d36bcccea3b05be564e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMi0zLTEtMS03NzAzMg_f2e15189-3494-4d0f-8383-06aa4b8b3290"
      unitRef="usd">2140000000</us-gaap:OtherIndefiniteLivedIntangibleAssets>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMi00LTEtMS03NzAzMg_25d42429-7670-463f-b0e3-c7fbedeb7af9"
      unitRef="usd">9820000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icf3044fdced045cba1b544760a38b3b8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMy0xLTEtMS03NzM4Mw_6ba5af9c-937c-48e9-a4a2-7e235af97a9f"
      unitRef="usd">262000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i89a1452b79a447f2975f350bd948e3bf_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMy0xLTEtMS03NzAzMg_bec1ba07-a738-483f-ab26-b2e58128b8fb"
      unitRef="usd">1638000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia2638eb542e340638a844744dc8b8b41_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMy0yLTEtMS03NzAzMg_ca7c2482-9022-4a51-8ae1-67dbf31b713c"
      unitRef="usd">227000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i824274fce6e34d36bcccea3b05be564e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMy0zLTEtMS03NzAzMg_4a80f738-8794-4472-8559-6fea598aca43"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfMy00LTEtMS03NzAzMg_d709248d-3b29-447c-9b82-bbbe0bf68335"
      unitRef="usd">2127000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="icf3044fdced045cba1b544760a38b3b8_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNC0xLTEtMS03NzM4Mw_5bd90d48-c759-47d5-988a-5fc91ae894e8"
      unitRef="usd">3195000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i89a1452b79a447f2975f350bd948e3bf_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNC0xLTEtMS03NzAzMg_ebd73ff6-0e97-4241-8485-7ea4a8bde0b4"
      unitRef="usd">2245000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia2638eb542e340638a844744dc8b8b41_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNC0yLTEtMS03NzAzMg_52f574f6-3fcb-4871-a488-14ac66b95e55"
      unitRef="usd">113000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherIndefiniteLivedIntangibleAssets
      contextRef="i824274fce6e34d36bcccea3b05be564e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNC0zLTEtMS03NzAzMg_ee3af085-3fdb-4545-80b4-b84f62077576"
      unitRef="usd">2140000000</us-gaap:OtherIndefiniteLivedIntangibleAssets>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNC00LTEtMS03NzAzMg_3edae60f-61a7-416b-9435-ab3dfed22043"
      unitRef="usd">7693000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ifdd214bbcad84d1c8ac9a757a0f976d2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNi0xLTEtMS03NzM5MA_6828da49-bf0f-4b46-bab9-34122a4c41a7"
      unitRef="usd">3437000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0abc73e3f8c249ac83f98f1ca79104ea_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNi0xLTEtMS03NzAzMg_80b0c066-272f-46e4-8e09-a73662fe2e6e"
      unitRef="usd">3801000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i656117b8223c4bdebeeb85ef817606b6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNi0yLTEtMS03NzAzMg_d6f00ccb-4033-44ee-afc1-7431de68ed74"
      unitRef="usd">344000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:OtherIndefiniteLivedIntangibleAssets
      contextRef="i73e389fa92f548b49505eb62019ce7d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNi0zLTEtMS03NzAzMg_09888ae4-dc9d-4824-89f6-0491eb3b0275"
      unitRef="usd">2140000000</us-gaap:OtherIndefiniteLivedIntangibleAssets>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNi00LTEtMS03NzAzMg_0f96b63e-1073-4bf9-8195-518582a198ca"
      unitRef="usd">9722000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifdd214bbcad84d1c8ac9a757a0f976d2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNy0xLTEtMS03NzM5MA_53c5b5ea-a095-4370-9234-42ac038ab290"
      unitRef="usd">162000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0abc73e3f8c249ac83f98f1ca79104ea_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNy0xLTEtMS03NzAzMg_f29df185-3b5e-4ba0-b6da-2ea6b259ea12"
      unitRef="usd">1556000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i656117b8223c4bdebeeb85ef817606b6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNy0yLTEtMS03NzAzMg_4c8f5613-8db5-4832-a526-535fae01130a"
      unitRef="usd">212000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i73e389fa92f548b49505eb62019ce7d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNy0zLTEtMS03NzAzMg_e71fce14-e8ec-43e2-9f15-b7cc6ec05d1f"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfNy00LTEtMS03NzAzMg_12ee8d26-6b08-49a2-a6d2-0a8a4211c1f9"
      unitRef="usd">1930000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ifdd214bbcad84d1c8ac9a757a0f976d2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfOC0xLTEtMS03NzM5MA_0116e174-2930-4068-82c8-cfac27c732f0"
      unitRef="usd">3275000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0abc73e3f8c249ac83f98f1ca79104ea_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfOC0xLTEtMS03NzAzMg_c0d98f33-8dd2-4b90-b07a-85147a9d09c0"
      unitRef="usd">2245000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i656117b8223c4bdebeeb85ef817606b6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfOC0yLTEtMS03NzAzMg_d3a25991-59f1-488b-ac62-e3cbb684f6f7"
      unitRef="usd">132000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherIndefiniteLivedIntangibleAssets
      contextRef="i73e389fa92f548b49505eb62019ce7d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfOC0zLTEtMS03NzAzMg_90e271cb-ced1-4a69-91c5-f999dcaf49f2"
      unitRef="usd">2140000000</us-gaap:OtherIndefiniteLivedIntangibleAssets>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RhYmxlOmU1OTMyYmVjZDBhNTQyYjhiZjBiZGZlOWY4MzlkYjg4L3RhYmxlcmFuZ2U6ZTU5MzJiZWNkMGE1NDJiOGJmMGJkZmU5ZjgzOWRiODhfOC00LTEtMS03NzAzMg_681a3f68-180f-445c-9443-d1194751bfd8"
      unitRef="usd">7792000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RleHRyZWdpb246YmJjYWM3MzBhODNiNDA2MWI4YmRkYzI5MTJiOTdjNGVfNzc1_e574fa36-5253-4e04-bda5-c9d21a6d37ef"
      unitRef="usd">217000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180My9mcmFnOmJiY2FjNzMwYTgzYjQwNjFiOGJkZGMyOTEyYjk3YzRlL3RleHRyZWdpb246YmJjYWM3MzBhODNiNDA2MWI4YmRkYzI5MTJiOTdjNGVfNzgy_ed52e552-0a91-4cd8-b6de-9954285ab9e7"
      unitRef="usd">64000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMjQ1Mw_c871a2dd-04e4-4526-a256-bf1257b8c7ff">FINANCING ARRANGEMENTS &lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Significant Debt Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, we repaid $170&#160;million of our $2.0&#160;billion three-year term loan facility and $175&#160;million of our $2.0&#160;billion five-year term loan facility. The loss from the early extinguishment of this debt was not significant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Credit Facilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our U.S. dollar-denominated revolving credit facility has a capacity of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $2.5&#160;billion&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and our Euro-denominated revolving credit facility has a capacity of &#x20ac;200 million. Each of the facilities matures in 2026. There were no borrowings outstanding under these credit facilities as of March&#160;31, 2022 or December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, we had $200&#160;million of commercial paper outstanding with a weighted-average interest rate of 0.5% and an original weighted-average term of 89 days. As of December&#160;31, 2021, we had $300 million of commercial paper outstanding with a weighted-average interest rate of 0.27% and an original weighted-average term of 88 days.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i77dc49641a924470949595f2087ee86d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMTY0OTI2NzQ0Nzk2Mw_b6450850-44d3-46c5-b2bb-a2ad3f3e8883"
      unitRef="usd">170000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i77dc49641a924470949595f2087ee86d_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMTY0OTI2NzQ0ODIwOA_dba95062-9d7d-4bb2-a5e7-d2115ffda706"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtTerm
      contextRef="i77dc49641a924470949595f2087ee86d_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMTY0OTI2NzQ0ODIyMQ_224969f6-464c-4e48-a4f0-9eec5a5469b5">P3Y</us-gaap:LongTermDebtTerm>
    <us-gaap:LongTermDebt
      contextRef="ia86774add006466498b0f2c3cba5e477_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMTY0OTI2NzQ0ODIzNQ_fac1be0e-3288-4a19-91ae-e4eb1ed76a79"
      unitRef="usd">175000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia86774add006466498b0f2c3cba5e477_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMTY0OTI2NzQ0ODI0OQ_56786bf1-1537-40bb-95d6-ae0c59250200"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtTerm
      contextRef="ia86774add006466498b0f2c3cba5e477_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMTY0OTI2NzQ0ODI2Mg_de1c42d2-644d-4dff-847d-342df862ee28">P5Y</us-gaap:LongTermDebtTerm>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i00c553d814c644128d07318aded98980_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMTM1NA_f5b7f597-0e30-435c-a62e-a3a83938bfb9"
      unitRef="usd">2500000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i00c553d814c644128d07318aded98980_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMTM5Nw_cc90d7e4-7b79-4498-9dbf-c7f50a49f781"
      unitRef="eur">200000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i00c553d814c644128d07318aded98980_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMjE0MQ_1fc80757-f439-4939-a685-8db0f3d789ee"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i9e9d2cef94014f91bd8867177e914d40_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMjE0MQ_5ec37ca8-d886-478e-84ca-7f7cc0cf6723"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:CommercialPaperAverageOutstanding
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfNDM5ODA0NjUxMzkxMQ_faac0cbe-ac88-425e-9de2-6bd1cec60f47"
      unitRef="usd">200000000</us-gaap:CommercialPaperAverageOutstanding>
    <bax:CommercialPaperWeightedAverageInterestRate
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfNDM5ODA0NjUxMzkyNQ_693ab10a-6a9f-41c6-ad83-a06d5469f223"
      unitRef="number">0.005</bax:CommercialPaperWeightedAverageInterestRate>
    <bax:OriginalWeightedAverageTerm
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMjc0ODc3OTA3NjEyOA_7f70bc4a-1c4d-44ff-b932-7fc730600f97">P89D</bax:OriginalWeightedAverageTerm>
    <us-gaap:CommercialPaperAverageOutstanding
      contextRef="if45530e3d7994ceb8d8e400dc2ac33a7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfNDM5ODA0NjUxMzg4MA_b97d0015-b1c5-42b8-8c70-22a6014df204"
      unitRef="usd">300000000</us-gaap:CommercialPaperAverageOutstanding>
    <bax:CommercialPaperWeightedAverageInterestRate
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfNDM5ODA0NjUxMzg5OA_a15e6c73-6f89-44cb-99a2-7d605efc4c57"
      unitRef="number">0.0027</bax:CommercialPaperWeightedAverageInterestRate>
    <bax:OriginalWeightedAverageTerm
      contextRef="if45530e3d7994ceb8d8e400dc2ac33a7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180Ni9mcmFnOmJjZTYxYmYzMmZkODQ4YTY4ZDJlYjNjMTA5YjYzOWNkL3RleHRyZWdpb246YmNlNjFiZjMyZmQ4NDhhNjhkMmViM2MxMDliNjM5Y2RfMjc0ODc3OTA3NjA1OA_7311f1ef-84fa-4bca-a552-0fafe87402a9">P88D</bax:OriginalWeightedAverageTerm>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfODQ3Mw_bc54c6b6-e0ea-43bf-8cfe-9fcc13f40105">COMMITMENTS AND CONTINGENCIES &lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are involved in product liability, patent, commercial, and other legal matters that arise in the normal course of our business. We record a liability when a loss is considered probable and the amount can be reasonably estimated. If the reasonable estimate of a probable loss is a range, and no amount within the range is a better estimate, the minimum amount in the range is accrued. If a loss is not probable or a probable loss cannot be reasonably estimated, no liability is recorded. As of March&#160;31, 2022 and December&#160;31, 2021, our total recorded reserves with respect to legal and environmental matters were $57 million and $72 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have established reserves for certain of the matters discussed below. We are not able to estimate the amount or range of any loss for certain contingencies for which there is no reserve or additional loss for matters already reserved. While our liability in connection with these claims cannot be estimated and the resolution thereof in any reporting period could have a significant impact on our results of operations and cash flows for that period, the outcome of these legal proceedings is not expected to have a material adverse effect on our consolidated financial position. While we believe that we have valid defenses in the matters set forth below, litigation is inherently uncertain, excessive verdicts do occur, and we may incur material judgments or enter into material settlements of claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the matters described below, we remain subject to the risk of future administrative and legal actions. With respect to governmental and regulatory matters, these actions may lead to product recalls, injunctions, and other restrictions on our operations and monetary sanctions, including significant civil or criminal penalties. With respect to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;intellectual property, we may be exposed to significant litigation concerning the scope of our and others&#x2019; rights. Such litigation could result in a loss of patent protection or the ability to market products, which could lead to a significant loss of sales, or otherwise materially affect future results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Environmental&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are involved as a potentially responsible party (PRP) for environmental clean-up costs at six Superfund sites. Under the U.S. Superfund statute and many state laws, generators of hazardous waste sent to a disposal or recycling site are liable for site cleanup if contaminants from that property later leak into the environment. The laws generally provide that a PRP may be held jointly and severally liable for the costs of investigating and remediating the site. Separate from these Superfund cases noted above, we are involved in an ongoing environmental remediations associated with historic operations at certain of our facilities. As of March&#160;31, 2022 and December&#160;31, 2021, our environmental reserves, which are measured on an undiscounted basis, were $18 million, respectively. After considering these reserves, the outcome of these matters is not expected to have a material adverse effect on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;General Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In August 2019, we were named in an amended complaint filed by Fayette County, Georgia in the MDL In re: National Prescription Opiate Litigation pending in the U.S. District Court, Northern District of Ohio. The complaint alleges that multiple manufacturers and distributors of opiate products improperly marketed and diverted these products, which caused harm to Fayette County. The complaint is limited in its allegations as to Baxter and does not distinguish between injectable opiate products and orally administered opiates. We manufactured generic injectable opiate products in our facility in Cherry Hill, NJ, which we divested in 2011.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In November 2019, we and certain of our officers were named in a class action complaint captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Ethan E. Silverman et al. v. Baxter International Inc. et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; that was filed in the United States District Court for the Northern District of Illinois.  The plaintiff, who allegedly purchased shares of our common stock during the specified class period, filed this putative class action on behalf of himself and shareholders who acquired Baxter common stock between February 21, 2019 and October 23, 2019.  The plaintiff alleged that we and certain officers violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by making allegedly false and misleading statements and failing to disclose material facts relating to certain intra-company transactions undertaken for the purpose of generating foreign exchange gains or avoiding foreign exchange losses, as well as our internal controls over financial reporting.  On January 29, 2020, the Court appointed Varma Mutual Pension Insurance Company and Louisiana Municipal Police Employees Retirement System as lead plaintiffs in the case. Plaintiffs filed an amended complaint on June 25, 2020 containing substantially the same allegations. On August 24, 2020, we filed a motion to dismiss the amended complaint. On January 12, 2021, the Court granted our motion to dismiss the amended complaint but gave plaintiffs an opportunity to file a further-amended complaint. The parties reached an agreement to settle the case for $16&#160;million, subject to the completion of confirmatory discovery and final approval by the Court. The Court granted final approval of the settlement on August 11, 2021 and the settlement became effective on September 13, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As initially disclosed in our Form 8-K on October 24, 2019, we voluntarily advised the staff of the SEC of an internal investigation into certain intra-company transactions that impacted our previously reported non-operating foreign exchanges gains and losses. We also received a stockholder request for inspection of our books and records in connection with the October 24, 2019 announcement. The Company has cooperated with the staff of the SEC in its investigation into related matters, and on February 18, 2022, we reached a settlement with the SEC. Without admitting or denying the findings in the administrative order issued by the SEC, we agreed to pay a civil penalty of $18&#160;million and to cease and desist from violations of specified provisions of the federal securities laws and related rules. In the order, the SEC acknowledged the Company&#x2019;s cooperation. We paid the penalty in the first quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, two lawsuits were filed against us in the Northern District of Illinois by plaintiffs alleging injuries as a result of exposure to ethylene oxide used in our manufacturing facility in Mountain Home, Arkansas to sterilize certain of our products. The plaintiffs sought damages, including compensatory and punitive damages in an unspecified amount, and unspecified injunctive and declaratory relief. The parties reached agreement to settle these lawsuits in the third quarter of 2021 for amounts that are not material to our financial results, which were paid in the fourth quarter of 2021. The settlement of these claims does not preclude potential future lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In July 2021, Hill-Rom, Inc. received a subpoena (from the United States Office of Inspector General for the Department of Health and Human Services (the DHHS) requesting documents and information related to compliance &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;with the False Claims Act and the Anti-Kickback Statute. Hillrom has been working with the DHHS and the DOJ to provide information responsive to the subpoena. Hillrom also voluntarily began a related internal review and Hillrom and now Baxter have been cooperating fully with the DHHS and the DOJ with respect to these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The DHHS often issues this type of subpoena when investigating alleged violations of the False Claims Act.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 28, 2021, Linet Americas, Inc. (Linet) filed a complaint against Hill-Rom Holdings, Inc., Hill-Rom Company, Inc., and Hill-Rom Services, Inc. in the United States District Court for the Northern District of Illinois, captioned Linet Americas, Inc. v. Hill-Rom Holdings, Inc.; Hill-Rom Company, Inc.; Hill-Rom Services, Inc. Linet alleges that Hillrom violated Sections 1, 2 and 3 of The Sherman Antitrust Act of 1890 and the Illinois Antitrust Act by allegedly engaging in anti-competitive conduct in alleged markets for standard, ICU and birthing beds. Hillrom filed an answer to the complaint on January 28, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LitigationReserve
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfNjI2_0d61c781-5ca0-4a3e-888c-8079c244718c"
      unitRef="usd">57000000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfNjMz_24fbd420-8f12-43b5-8f83-613e42e3ccd5"
      unitRef="usd">72000000</us-gaap:LitigationReserve>
    <bax:SiteContingencyNumberOfSites
      contextRef="i12680af003b340588584061646eb80dd_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfMjI5MQ_2d90daf5-062a-432c-a76e-b935d3b18c2d"
      unitRef="site">6</bax:SiteContingencyNumberOfSites>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="id2c66b1b9fe445a18da652d3450d08cf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfMjk0OQ_6d7bc1dd-321a-4c97-a435-48eb5c932787"
      unitRef="usd">18000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies
      contextRef="i469c791f58204bae88a589c56467141f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfMjk0OQ_d99ea309-8736-478d-b997-9ac5bad33aa9"
      unitRef="usd">18000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i2bdf0bb5959445a281c014f161f85723_D20210112-20210112"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfNzA2NA_1e3fcdac-5183-4e93-b7f1-e533d071eb15"
      unitRef="usd">16000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementExpense
      contextRef="icb864a5832494db0acdd2afdf1be2d00_D20220218-20220218"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfMjc0ODc3OTA5MDIwNQ_8eabc9dd-8c29-4dd6-b0c6-0027dfbe97ae"
      unitRef="usd">18000000</us-gaap:LitigationSettlementExpense>
    <bax:LossContingencyNumberOfLawsuits
      contextRef="i8d85a7b845f24d1fa695e4f71457e0c3_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY180OS9mcmFnOmNiZTEzZjkxNTllMzQ2MzNhYWJiZjY0YmUzNGIwODNlL3RleHRyZWdpb246Y2JlMTNmOTE1OWUzNDYzM2FhYmJmNjRiZTM0YjA4M2VfNzgyNw_a972157d-8f5f-4375-974d-949ff6799fb0"
      unitRef="lawsuit">2</bax:LossContingencyNumberOfLawsuits>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTYwNg_759f444a-ac6a-4e36-9ce1-bae5d95143f2">STOCKHOLDERS&#x2019; EQUITY&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock compensation expense totaled $32 million and $22 million in the first quarter of 2022 and 2021, respectively.  Approximately 75% of stock compensation expense is classified within selling, general and administrative (SG&amp;amp;A) expense with the remainder classified in cost of sales and research and development (R&amp;amp;D) expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We awarded stock compensation grants which consisted of 1.8 million stock options, 1.2 million restricted stock units (RSUs) and 0.4 million performance stock units (PSUs) during the first quarter of 2022. The grant date fair values of stock options, RSUs and PSUs awarded in the first quarter of 2022 were $33 million, $102 million and $34 million, respectively. Stock options and RSUs generally vest in one-third increments over a three-year period. The vesting conditions for PSUs granted are equally divided based on our compound annual sales growth rate performance, our adjusted return on invested capital performance and on our stock performance relative to a specified peer group.  All of the PSUs vest at the end of the applicable three-year service period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average Black-Scholes assumptions used in establishing the fair value of stock options granted during the period, along with weighted-average grant date fair values, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value per stock option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total intrinsic value of stock options exercised was $27 million and $21 million during the first quarters of 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the unrecognized compensation cost related to all unvested stock options of $80 million is expected to be recognized as expense over a weighted-average period of 1.9 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;RSUs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the unrecognized compensation cost related to all unvested RSUs of $163 million is expected to be recognized as expense over a weighted-average period of 2.2 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;PSUs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the unrecognized compensation cost related to all unvested PSUs of $50 million is expected to be recognized as expense over a weighted-average period of 1.9 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash dividends declared per share for the three months ended March&#160;31, 2022 and 2021 were $0.28 and  $0.245, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Repurchase Programs&lt;/span&gt;&lt;/div&gt;In July 2012, the Board of Directors authorized the repurchase of up to $2.0 billion of our common stock. The Board of Directors increased this authority by an additional $1.5 billion in each of November 2016 and February 2018, by an additional $2.0 billion in November 2018 and by an additional $1.5&#160;billion in October 2020. During the first quarter of 2022, we did not repurchase any shares under this authority.  During the first quarter of 2021, we repurchased 3.6&#160;million shares under this authority pursuant to a Rule 10b5-1 plan. We had $1.3 billion remaining available under the authorization as of March&#160;31, 2022.</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMjkzNw_ea8e90dc-75a8-44ef-8358-b0c6964d38a1"
      unitRef="usd">32000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMjk1Mg_de73e1f9-6e88-4ce4-833e-8b8c64c5d232"
      unitRef="usd">22000000</us-gaap:ShareBasedCompensation>
    <bax:ShareBasedCompensationAllocationPercentage
      contextRef="ia62b9d54444c46208ba00c7b3a49f393_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMjk1OQ_90e76959-3d17-4c0c-8a67-b152681d9b46"
      unitRef="number">0.75</bax:ShareBasedCompensationAllocationPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i9ae5d43fac584f33a0a42a5f3c28e0d2_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMjk3Mw_40586943-3fa0-4ed9-a2d1-2c81970ea3e9"
      unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i7189af185d184892889584811bd86919_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMjk5MA_792fddce-539b-4c11-984d-acbcbbb770d8"
      unitRef="shares">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ia90c948e8be245b98f70fa8267c58925_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzAwNw_a93b3b37-1fe6-411f-8060-e7275dc9da96"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross
      contextRef="i9ae5d43fac584f33a0a42a5f3c28e0d2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzA1MA_d0650544-0afa-4200-98d6-9863d978dcec"
      unitRef="usd">33000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross
      contextRef="i7189af185d184892889584811bd86919_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzA2Nw_3c6a0b30-f828-4675-8310-ebd0499acebe"
      unitRef="usd">102000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross
      contextRef="ia90c948e8be245b98f70fa8267c58925_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzA4NA_01bdfb94-d57c-4817-8b23-f9308ef616b7"
      unitRef="usd">34000000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMzI5ODUzNDg4OTcwNg_6093ab73-58ba-4f5b-a728-3ee6f1464b1b">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average Black-Scholes assumptions used in establishing the fair value of stock options granted during the period, along with weighted-average grant date fair values, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value per stock option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfMi0xLTEtMS03NzUxNg_b4b76080-6705-47e0-8109-d041d39ce26d"
      unitRef="number">0.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfMi0yLTEtMS03NzUwMg_6304fec3-39da-46ee-8428-df14287e0238"
      unitRef="number">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfMy0xLTEtMS03NzUxNg_461bdd06-2011-433f-b357-8872cb3b6914">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfMy0yLTEtMS03NzUwMg_55098518-fe71-45c7-9ef8-9fa08a130800">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfNC0xLTEtMS03NzUxNg_90f17454-6019-4f01-918f-c6597af17602"
      unitRef="number">0.018</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfNC0yLTEtMS03NzUwMg_67058b14-5ab9-4fb1-9f44-44418cf6bc38"
      unitRef="number">0.008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfNS0xLTEtMS03NzUxNg_fe8dc136-0462-46e0-acb8-3e7b768e179c"
      unitRef="number">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfNS0yLTEtMS03NzUwMg_0d9fd011-39ab-4e40-865a-83b5a324ae1a"
      unitRef="number">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfNi0xLTEtMS03NzUxNg_ca28f9b4-6d3a-4fbd-ab39-1050c6ccfb06"
      unitRef="usdPerShare">18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RhYmxlOmQ4NzJmYjFhYjRiNTQ1ZWI5ZjFiNWFhYzkzMGFjZmEwL3RhYmxlcmFuZ2U6ZDg3MmZiMWFiNGI1NDVlYjlmMWI1YWFjOTMwYWNmYTBfNi0yLTEtMS03NzUwMg_1775113e-8400-4540-9a70-4bc0c7fc43d8"
      unitRef="usdPerShare">16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzY2NQ_eb5ffb28-17b3-42c8-b7ef-93c7c5f33e17"
      unitRef="usd">27000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzY3OA_38108186-5c4b-4af3-bbbe-8e7a0ebcccb1"
      unitRef="usd">21000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i23a86ccd6a744d46bea2df7cf193e7a3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzY5MQ_1b798783-3bfb-4a93-b163-751b7d300021"
      unitRef="usd">80000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i9ae5d43fac584f33a0a42a5f3c28e0d2_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzc0MA_005f3a8d-4b66-4011-b237-e248574b3d7b">P1Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="id23b4ba90dd44f68a4a2fa4b53a355be_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzcxNw_105584e3-b760-40e5-83e5-9205b18381e6"
      unitRef="usd">163000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i7189af185d184892889584811bd86919_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzc1Mw_246bdfe7-6be4-4f4f-b915-c6c10863d32f">P2Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i47aa6b12f49d4f8f8e8e0b9146e3b922_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzc2Ng_dd00dba0-10b2-4031-8d06-5854579df7a2"
      unitRef="usd">50000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ia90c948e8be245b98f70fa8267c58925_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzMzc3OQ_9ea089fd-c711-420d-aadb-fab9810d8da4">P1Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfOTA0_1450a7ae-d077-466b-937c-8bccd1db4301"
      unitRef="usdPerShare">0.28</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfOTk1_0152ce53-3541-4337-a4e7-07fb2a219606"
      unitRef="usdPerShare">0.245</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i95a7419792054ae5bed8d890b5b8bec6_I20120731"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTExOQ_4e7e968d-6d3b-4bad-9845-fcbdb1fe8d6b"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <bax:StockRepurchaseProgramAdditionalAuthorizedAmount
      contextRef="i6021c0283dc64cf58f4e8ce023f20cae_I20180228"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTIwOA_0cdf1888-ac5f-4504-9717-2a1039fc5409"
      unitRef="usd">1500000000</bax:StockRepurchaseProgramAdditionalAuthorizedAmount>
    <bax:StockRepurchaseProgramAdditionalAuthorizedAmount
      contextRef="i05b8c7054b9d4d0883b6419ce2e08fe4_I20161130"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTIwOA_de70f8fc-adbf-43ef-84c9-bf22f9fbe9af"
      unitRef="usd">1500000000</bax:StockRepurchaseProgramAdditionalAuthorizedAmount>
    <bax:StockRepurchaseProgramAdditionalAuthorizedAmount
      contextRef="ia6abadaa7a994ae19160f417f168acaf_I20181130"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTI3Mg_8363980d-49df-48f0-b907-5e81b0368228"
      unitRef="usd">2000000000</bax:StockRepurchaseProgramAdditionalAuthorizedAmount>
    <bax:StockRepurchaseProgramAdditionalAuthorizedAmount
      contextRef="idf18cf43e1fd42ea80e5bb10c70d8237_I20201031"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTMxMw_782110b9-ec6b-4628-8d0b-7eeb29842084"
      unitRef="usd">1500000000</bax:StockRepurchaseProgramAdditionalAuthorizedAmount>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTA5OTUxMTYzNDQ0Mw_64697b9c-17ad-4d57-b1a6-72a5d3101294"
      unitRef="shares">3600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181Mi9mcmFnOjcwZDM1ZjM3ZmE4ODRmYzNhMjEzNTBmNjY1ODM4MDMwL3RleHRyZWdpb246NzBkMzVmMzdmYTg4NGZjM2EyMTM1MGY2NjU4MzgwMzBfMTU0OA_5219ffd4-b5d9-4a80-b98f-eac8f5f93a31"
      unitRef="usd">1300000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RleHRyZWdpb246MTdhNzU1NjJkNzk3NDJhNDg5Y2Y3ZTExZTg1M2IyMDJfMTAwNQ_e4b56212-8747-4ca3-b4a7-aba0ff8bf165">ACCUMULATED OTHER COMPREHENSIVE INCOME&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income includes all changes in stockholders&#x2019; equity that do not arise from transactions with stockholders, and consists of net income, currency translation adjustments (CTA), certain gains and losses from pension and other postretirement employee benefit (OPEB) plans and gains and losses on cash flow hedges. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a net-of-tax summary of the changes in accumulated other comprehensive (loss) income (AOCI) by component for the three months ended March&#160;31, 2022 and 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension and OPEB plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,380)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,922)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension and OPEB plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,795)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;padding-left:72pt;text-indent:-72pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;See table below for details about these reclassifications.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the amounts reclassified from AOCI to net income during the three months ended March&#160;31, 2022 and 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of impact in income statement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and OPEB items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net losses and prior service costs or credits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) on hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Amounts in parentheses indicate reductions to net income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:72pt;text-indent:-72pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 11 for additional information regarding the amortization of pension and OPEB items and Note 14 for additional information regarding hedging activity.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RleHRyZWdpb246MTdhNzU1NjJkNzk3NDJhNDg5Y2Y3ZTExZTg1M2IyMDJfMTAwNw_1b85ac62-80e3-42bc-a815-60c8d5ac8e61">&lt;div style="margin-bottom:6pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a net-of-tax summary of the changes in accumulated other comprehensive (loss) income (AOCI) by component for the three months ended March&#160;31, 2022 and 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension and OPEB plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,380)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,922)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CTA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension and OPEB plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,795)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;padding-left:72pt;text-indent:-72pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;See table below for details about these reclassifications.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i069285eebd5843f2856c7c3908c92f47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMi0xLTEtMS03NzAzMg_c4356baf-64fe-4889-98f7-c8ee5a34db43"
      unitRef="usd">-2907000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4f93d1d2dd2a457d996a157cd4e92b5d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMi0yLTEtMS03NzAzMg_11c8670f-ae9f-4ebc-a426-c08881b16f1f"
      unitRef="usd">-347000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6486fe1e58ef467195bd61197a081ab8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMi0zLTEtMS03NzAzMg_1fe0fdf1-318f-4a16-b908-1412431c29c1"
      unitRef="usd">-126000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e7a72924e714ac6b891716ee10b193d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMi00LTEtMS04NDM5Nw_9808d17c-e693-4796-972c-4ce1f71abe3f"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f2552f5c4054d1ebea374b3f2beb06b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMi00LTEtMS03NzAzMg_d8262933-8e6c-4194-ab9c-5e9bcf7771ca"
      unitRef="usd">-3380000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic3a1622bd0814078a54a920dde602168_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMy0xLTEtMS03NzAzMg_95c497f6-ea5c-4a1c-b694-8ca933779a4b"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia612cf65ceaf4a1c9b76bfe56c4d3eb6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMy0yLTEtMS03NzAzMg_6f69ae02-bfe5-4c3b-ae50-75bf0a4f8da4"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i64a3e01103e34f1bbc3c8156b5ba0946_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMy0zLTEtMS03NzAzMg_8ae30c55-209e-4323-afe4-066dcf4d0e2a"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i17e2945361e24710af7f8a4b2bbd461b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMy00LTEtMS04NDQwNw_f0d4a145-6609-400a-91ab-cbabffa96511"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfMy00LTEtMS03NzAzMg_8557ad6f-96a0-409d-a558-d547dcbe2744"
      unitRef="usd">-13000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic3a1622bd0814078a54a920dde602168_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNC0xLTEtMS03NzAzMg_b54e3958-0eb6-459e-8966-5a4581a279f9"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia612cf65ceaf4a1c9b76bfe56c4d3eb6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNC0yLTEtMS03NzAzMg_3d1c8d25-dd99-44e2-a331-b93696d9e126"
      unitRef="usd">-7000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i64a3e01103e34f1bbc3c8156b5ba0946_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNC0zLTEtMS03NzAzMg_74897436-8f8c-427b-af35-06f92add44d9"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i17e2945361e24710af7f8a4b2bbd461b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNC00LTEtMS04NDQzMg_84c7b540-356f-42ee-b56f-e71a71987e6b"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNC00LTEtMS03NzAzMg_9f22f88c-6d43-4741-a21b-e4059ab3f228"
      unitRef="usd">-6000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic3a1622bd0814078a54a920dde602168_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNS0xLTEtMS03NzAzMg_df0e8afc-a4ad-4cc2-a472-34d4089ef4ea"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia612cf65ceaf4a1c9b76bfe56c4d3eb6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNS0yLTEtMS03NzAzMg_7eb1db73-d431-440e-b9b7-1ffb4e1402ca"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i64a3e01103e34f1bbc3c8156b5ba0946_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNS0zLTEtMS03NzAzMg_9f4bb38b-0b14-4fe1-91e2-dd9f77d51c28"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i17e2945361e24710af7f8a4b2bbd461b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNS00LTEtMS04NDQwNw_3bec30d0-d27f-468e-8d61-6309299b5cbf"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNS00LTEtMS03NzAzMg_13fd1538-1ade-436e-9e68-12da1e5312e9"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id86e90917ec146d3ac68e2eb8b21f865_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNi0xLTEtMS03NzAzMg_28087dbb-9cd7-4ce2-9927-c258a847d322"
      unitRef="usd">-2922000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia486f1301af041c9869fe8a3575fe4d4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNi0yLTEtMS03NzAzMg_32d1dd5a-89a1-47cd-8c7d-f225fff444b0"
      unitRef="usd">-338000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5eefd1d44a344bdfbaad16b8a0fb4dc3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNi0zLTEtMS03NzAzMg_48bf679a-24c9-47ac-8f79-d40fc44a7256"
      unitRef="usd">-128000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib7fd2a0dc3844abbb371f105039e5020_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNi00LTEtMS04NDQwNw_c8c59f37-b2cd-4f29-82d6-b8e5e70c85bf"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i50951858332c4e6ca7aad9f12094ecea_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQxOTM1NTU4ZmZlZDRjMTA5NTcyNzc4YWUyZTViZTY3L3RhYmxlcmFuZ2U6NDE5MzU1NThmZmVkNGMxMDk1NzI3NzhhZTJlNWJlNjdfNi00LTEtMS03NzAzMg_a1d9b778-11fd-4e48-93b0-e636e043f3aa"
      unitRef="usd">-3387000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie2419a534ffa472a893eb08ecd31d17a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfMi0xLTEtMS03NzAzMg_6250e1c6-a17f-4ae1-a520-d689b0b611aa"
      unitRef="usd">-2587000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i61c25aa049c1446ba8f2b89559430b59_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfMi0yLTEtMS03NzAzMg_91803ce9-36d0-4f27-becc-2e9c630284f6"
      unitRef="usd">-574000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idc0dbb505a0a4fafbdccf76d617c81c1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfMi0zLTEtMS03NzAzMg_6fd5b590-4eb7-4710-a5fd-a38efa49b5e2"
      unitRef="usd">-153000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2b269065bdfa4003b5dac0551818244c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfMi00LTEtMS03NzAzMg_190ec7c9-6255-40fa-b79d-c64ed9b81cb9"
      unitRef="usd">-3314000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0ae39c69af424944bc29e123b13ba03b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNC0xLTEtMS03NzAzMg_8d89bd68-2a27-4420-a776-7429a15f5c3d"
      unitRef="usd">-208000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie3f9dfaa202f43d7a4787a519244421f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNC0yLTEtMS03NzAzMg_6cb3f59e-6ee1-494b-97c7-4546727500bf"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8c6117fdfad44c57ae71d0e2075129f2_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNC0zLTEtMS03NzAzMg_eb1541b0-516b-438b-b565-92a2936f4fa2"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNC00LTEtMS03NzAzMg_89e05c97-ea1f-406a-8e6e-c9f6992ef50e"
      unitRef="usd">-192000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0ae39c69af424944bc29e123b13ba03b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNS0xLTEtMS03NzAzMg_6ebba2fd-7c9c-42bb-9a23-b8527f168138"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie3f9dfaa202f43d7a4787a519244421f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNS0yLTEtMS03NzAzMg_6a6c5e78-0e89-420e-a0d0-6e54fb0e063a"
      unitRef="usd">-17000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8c6117fdfad44c57ae71d0e2075129f2_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNS0zLTEtMS03NzAzMg_1a4c4765-dfff-4f3e-9997-73fb16e0446f"
      unitRef="usd">-9000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNS00LTEtMS03NzAzMg_a06b10b2-4253-4c7f-8e37-9646b21426a2"
      unitRef="usd">-26000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0ae39c69af424944bc29e123b13ba03b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNi0xLTEtMS03NzAzMg_2070a01f-b662-4380-a470-3a66af86a8ed"
      unitRef="usd">-208000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie3f9dfaa202f43d7a4787a519244421f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNi0yLTEtMS03NzAzMg_c938de78-4be7-4f3f-b026-a72ebbb2ad0a"
      unitRef="usd">30000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8c6117fdfad44c57ae71d0e2075129f2_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNi0zLTEtMS03NzAzMg_b5a2a8a5-b997-4ba5-baf8-baa63073b048"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNi00LTEtMS03NzAzMg_9227f11a-9cf6-448d-b5f1-f07f6c6abb64"
      unitRef="usd">-166000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifbf3ffd3fcfe4c25bb7c73ac77cbbf80_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNy0xLTEtMS03NzAzMg_742b8de7-ef83-459d-8f28-1b95a05c7381"
      unitRef="usd">-2795000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia0174772e0bd41bd8c295a1a6f03a7f7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNy0yLTEtMS03NzAzMg_dcd4b158-c002-4189-ae3c-c71146a2134a"
      unitRef="usd">-544000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36f11ee6ccdd4c119f7e56f86d04836f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNy0zLTEtMS03NzAzMg_de589eeb-9217-4a7b-95d2-fe154c43f2d0"
      unitRef="usd">-141000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0b8fdc874934cd28547447f24fd547a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjdkNmNmMWE1MjY2YzQ3N2ZhNWE0MGUxMTZmMTlhNDcwL3RhYmxlcmFuZ2U6N2Q2Y2YxYTUyNjZjNDc3ZmE1YTQwZTExNmYxOWE0NzBfNy00LTEtMS03NzAzMg_8d8d7930-e2ab-4d78-b65d-ff98b9f456de"
      unitRef="usd">-3480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RleHRyZWdpb246MTdhNzU1NjJkNzk3NDJhNDg5Y2Y3ZTExZTg1M2IyMDJfMTAwOQ_c24ee534-66e3-43f8-81d7-b2cae427a9b3">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the amounts reclassified from AOCI to net income during the three months ended March&#160;31, 2022 and 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.564%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of impact in income statement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and OPEB items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net losses and prior service costs or credits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gains (losses) on hedging activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total before tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications for the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net of tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-72pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Amounts in parentheses indicate reductions to net income&lt;/span&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic0f2358ba16e4eb2b4231007c968aafc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfMy0xLTEtMS03NzAzMg_ab1031ad-235e-427c-93fe-1d60cf121ef8"
      unitRef="usd">-9000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i49849093a147487baaab59084a514458_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfMy0yLTEtMS03NzAzMg_5360ff90-eedd-4b7b-a8ac-65d7cada2a7f"
      unitRef="usd">-21000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic0f2358ba16e4eb2b4231007c968aafc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfNC0xLTEtMS03NzAzMg_1d9f1453-156a-4c26-baeb-886ba9d873ed"
      unitRef="usd">-2000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i49849093a147487baaab59084a514458_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfNC0yLTEtMS03NzAzMg_92599143-4e07-4c2c-bd24-4e255b0d2876"
      unitRef="usd">-4000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ic0f2358ba16e4eb2b4231007c968aafc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfNS0xLTEtMS03NzAzMg_5ac21f32-d189-424e-bb35-08bae289ac1b"
      unitRef="usd">-7000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i49849093a147487baaab59084a514458_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfNS0yLTEtMS03NzAzMg_02918e8e-afd9-4899-8489-cc10d905c9a3"
      unitRef="usd">-17000000</us-gaap:NetIncomeLoss>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i71a9302da0e54c3b8f8926e72835a876_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfNy0xLTEtMS03NzAzMg_3e529fd6-0c85-47e3-9bba-ff991f59fcf3"
      unitRef="usd">-2000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic40887eaba864beb99dfb7e8f5598fc9_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfNy0yLTEtMS03NzAzMg_ba906c34-1dd7-4077-a988-27ee1eaf7753"
      unitRef="usd">10000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i3ca753b742a8455c879cba08a880b703_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfOC0xLTEtMS03NzAzMg_cc42ba1a-a892-475f-87ca-d2a8af446d63"
      unitRef="usd">-1000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i45b7e42abce84defb3a21a449abd0bbd_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfOC0yLTEtMS03NzAzMg_9378891a-8832-48da-961d-5ee83f096d07"
      unitRef="usd">-1000000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icd4fbdb722de41c680320b1de71522a7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfOS0xLTEtMS03NzAzMg_feddf94e-ed1b-4ff4-9ab2-50fa7f784ad7"
      unitRef="usd">1000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8bef5949b41742f0b1ba1cc2daeb9ab6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfOS0yLTEtMS03NzAzMg_eeb6fe3d-f740-407e-bff5-ea216c84a6f8"
      unitRef="usd">-11000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="icd4fbdb722de41c680320b1de71522a7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfMTAtMS0xLTEtNzcwMzI_17ffe23e-584f-4066-aaff-24b9dce77d52"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8bef5949b41742f0b1ba1cc2daeb9ab6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfMTAtMi0xLTEtNzcwMzI_8ba4c234-9f1a-4752-a011-ffff60f9075b"
      unitRef="usd">-2000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="icd4fbdb722de41c680320b1de71522a7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfMTEtMS0xLTEtNzcwMzI_38721f92-80ef-4208-9e3c-2965fa3e7bf1"
      unitRef="usd">1000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8bef5949b41742f0b1ba1cc2daeb9ab6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfMTEtMi0xLTEtNzcwMzI_4d215985-46c7-4ae5-aa61-c9c7c0bbe117"
      unitRef="usd">-9000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8ba7828d1de048e19f12a0c301c05c70_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfMTItMS0xLTEtNzcwMzI_dbdb142e-49f9-4af1-8782-81b95f7fd79d"
      unitRef="usd">-6000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia377d8629c5a4a0fb71104100423c61c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY181OC9mcmFnOjE3YTc1NTYyZDc5NzQyYTQ4OWNmN2UxMWU4NTNiMjAyL3RhYmxlOjQ5NzMyYmY1MDNjNzQ1MjZiN2E2ZTBlNGY2ODBlZDI1L3RhYmxlcmFuZ2U6NDk3MzJiZjUwM2M3NDUyNmI3YTZlMGU0ZjY4MGVkMjVfMTItMi0xLTEtNzcwMzI_037034e4-bab7-476a-aae4-3a83784e6cc3"
      unitRef="usd">-26000000</us-gaap:NetIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg5Nw_95026059-6ba0-4871-8507-f31661ac91c4">REVENUES&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. A contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of our contracts have multiple performance obligations. For contracts with multiple performance obligations, we allocate the contract&#x2019;s transaction price to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract. Our global payment terms are typically between 30-90 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Most of our performance obligations are satisfied at a point in time. This includes sales of our broad portfolio of essential healthcare products across our geographic segments including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; hospital beds and services; surgical tables, lights and pendants; and patient monitoring and diagnostic technologies. For most of those sales, our performance obligation is satisfied upon delivery to the customer. Shipping and handling activities are considered to be fulfillment activities and are not considered to be a separate performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To a lesser extent, in all of our segments, we enter into other types of contracts including contract manufacturing   arrangements, equipment leases, and certain subscription software and licensing arrangements. We recognize revenue for these arrangements over time or at a point in time depending on our evaluation of when the customer obtains control of the promised goods or services. Revenue is recognized over time when we are creating or enhancing an asset that the customer controls as the asset is created or enhanced or our performance does not create an asset with an alternative use and we have an enforceable right to payment for performance completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, we had $8.2 billion of transaction price allocated to remaining performance obligations related to executed contracts with an original duration of one year or more, which are primarily included in the Americas segment. Some contracts in the United States included in this amount contain index-dependent price increases, which are not known at this time. We expect to recognize approximately 30% of this amount as revenue over the remainder of 2022, 30% in 2023, 20% in 2024, 15% in 2025 and 5% thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from product sales are recorded at the net sales price (transaction price), which includes estimates of variable consideration primarily related to rebates and wholesaler chargebacks. These reserves are based on estimates of the amounts earned or to be claimed on the related sales and are included in accrued expenses and other current liabilities and accounts receivable, net on the condensed consolidated balance sheets. Management's estimates take into consideration historical experience, current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves reflect our best estimates of the amount of consideration to which we are entitled based on the terms of the contract using the expected value method. The amount of variable consideration included in the net sales price is limited to the amount for which it is probable that a significant reversal in revenue will not occur when the related uncertainty is resolved. Revenue recognized during the three months ended March&#160;31, 2022 and 2021 related to performance obligations satisfied in prior periods was not material.  Additionally, our contracts with customers often include promises to transfer multiple products and services to a customer.  Determining whether products and services are considered distinct performance obligations that should be accounted for separately and determining the allocation of the transaction price may require significant judgement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in the recognition of trade accounts receivable, unbilled receivables, contract assets and customer advances and deposits (contract liabilities) on our condensed consolidated balance sheets. Net trade accounts receivable was $2.3 billion and $2.4 billion as of March&#160;31, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contract manufacturing arrangements, revenue is primarily recognized throughout the production cycle, which typically lasts up to 90 days, resulting in the recognition of contract assets until the related services are completed and the customers are billed. Additionally, for arrangements containing a performance obligation to deliver software that can be used with medical devices, we recognize revenue upon delivery of the software, which results in the recognition of contract assets when customers are billed over time, generally over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNTA4Nw_f4e1f64e-f3c7-40c4-adcb-4328bb369ec4"&gt;one&lt;/span&gt; to five years. For bundled contracts involving equipment delivered up-front and consumable medical products to be delivered over time, total contract revenue is allocated between the equipment and consumable medical products. In certain of those arrangements, a contract asset is created for the difference between the amount of equipment revenue recognized upon delivery and the amount of consideration initially receivable from the customer. In those arrangements, the contract asset becomes a trade account receivable as consumable medical products are provided and billed, generally over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNTY3NA_35dd3245-1f9f-4af5-81c9-d418989e3bbf"&gt;one&lt;/span&gt; to seven years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our contract assets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract manufacturing services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bundled equipment and consumable medical products contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification of contract assets and contract liabilities as reported in the condensed consolidated balance sheets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities represent deferred revenues that arise as a result of cash received from customers or where the timing of billing for services precedes satisfaction of our performance obligations. Such remaining performance obligations represent the portion of the contract price for which work has not been performed and are primarily related to our installation and service contracts. We expect to satisfy the majority of the remaining performance obligations and recognize revenue related to installation and service contracts within the next 12 months with most of the non-current performance obligations satisfied within 24 months. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes contract liability activity for the three months ended March 31, 2022.  The contract liability balance represents the transaction price allocated to the remaining performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New revenue deferrals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized upon satisfaction of performance obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2021, the amount of revenue recognized that was included in contract liabilities as of December 31, 2020 was not significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Disaggregation of Net Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with our acquisition of Hillrom in December 2021, we have added three new product categories: Patient Support Systems, Front Line Care and Surgical Solutions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Renal Care &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medication Delivery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pharmaceuticals &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Clinical Nutrition &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advanced Surgery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acute Therapies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BioPharma Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient Support Systems &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;8&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Front Line Care &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;9&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;11&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Baxter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Medication Delivery includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Clinical Nutrition includes sales of our parenteral nutrition (PN) therapies and related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology vision screening and physical assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt"&gt;Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt"&gt;Other includes sales of miscellaneous product and service offerings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease smart beds, such as bariatric, critical care, maternal, and home care beds, as well as other surfaces, to customers during periods of peak demand or for specialty purposes. We also lease medical equipment, such as renal dialysis equipment and infusion pumps, to customers, primarily in conjunction with arrangements to provide consumable medical products such as dialysis therapies, IV fluids and inhaled anesthetics. Certain of our equipment leases are classified as sales-type leases and the remainder are operating leases. The terms of the related contracts, including the proportion of fixed versus variable payments and any options to shorten or extend the lease term, vary by customer. We allocate revenue between equipment leases and medical products based on their standalone selling prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The components of lease revenue for the three months ended March&#160;31, 2022 and 2021 were:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our net investment in sales-type leases was $109 million as of March&#160;31, 2022, of which $38 million originated in 2018 and prior, $16 million in 2019, $28&#160;million in 2020, $25 million in 2021, and $2&#160;million in 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <bax:RevenuePerformanceObligationPaymentTerms
      contextRef="i54bb1c348a9847b582b458754fce46a2_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODA1_806f7434-58be-4596-9507-cb4b955005ac">P30D</bax:RevenuePerformanceObligationPaymentTerms>
    <bax:RevenuePerformanceObligationPaymentTerms
      contextRef="ibb3cc6fd8ab54e7f919c3a7ef1e7de2d_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODA4_a8da4aa6-77ee-4ae8-8e1f-b53b86608a13">P90D</bax:RevenuePerformanceObligationPaymentTerms>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfMjE1NQ_b2d1ee8f-933e-4aea-983f-52a7c3828f7f"
      unitRef="usd">8200000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i15c4aa9c7adc46609c75b8e4977a7bf5_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfMjUyOQ_473307ea-a9ab-48e2-8f10-3db3aed66b37"
      unitRef="number">0.30</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i7dcc13e1767b4b20b08c82100616f090_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfMjU4NA_31f267ba-1e07-43e6-9580-8286fba0f3dd"
      unitRef="number">0.30</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i149befa1f6404f1a97e608ad7a766348_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfMTA5OTUxMTY0MTAzMw_4a842c15-ccca-40d0-9129-a58d6b77f736"
      unitRef="number">0.20</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i7a469160b4ca45ceadc4df51de1bb9cd_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfMjYxMg_6cfa7bf4-e9c1-473b-ad97-5cd1256d3b32"
      unitRef="number">0.15</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i9f7a3b322d1541a28d6394b8562f85c1_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfMTA5OTUxMTY0MTA3MQ_23b13405-ee73-4d28-954c-6f3bdf8ab75f"
      unitRef="number">0.05</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:AccountsReceivableNet
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNDUwNw_34957680-68db-4b14-b3c5-740cd0379a06"
      unitRef="usd">2300000000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNDUxNA_a9034a38-b880-4a5e-993e-4ad69b95aa2c"
      unitRef="usd">2400000000</us-gaap:AccountsReceivableNet>
    <bax:RevenueRecognizedContractPeriod
      contextRef="i3b4412787ecf4be9abb299cd553bdecb_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNDY4Mg_f88b56d3-4415-4083-8bc5-a19caff26733">P90D</bax:RevenueRecognizedContractPeriod>
    <bax:RevenueRecognizedContractPeriod
      contextRef="i1d4d3ad9a6744778b3c632ef51c41f3d_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNTA5Mw_e7eb8203-d740-4fd9-8d72-c03bdaf129d9">P5Y</bax:RevenueRecognizedContractPeriod>
    <bax:RevenueRecognizedContractPeriod
      contextRef="i00a69787b49d45f98aca3e29cdef6cf9_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfNTY4MA_660e5f69-98cf-492f-9d6a-68dc1c97e312">P7Y</bax:RevenueRecognizedContractPeriod>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg5OA_bc57f7cf-e3d4-4a80-b07c-c23086cd4833">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our contract assets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract manufacturing services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bundled equipment and consumable medical products contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification of contract assets and contract liabilities as reported in the condensed consolidated balance sheets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.269%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes contract liability activity for the three months ended March 31, 2022.  The contract liability balance represents the transaction price allocated to the remaining performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New revenue deferrals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue recognized upon satisfaction of performance obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i12862cd99e2648e6bcf32aac284bdb6a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg5NWE0NGQwMzI4NDQzMGNhMmVjNjA1YTY0ZDI1N2YzL3RhYmxlcmFuZ2U6ODk1YTQ0ZDAzMjg0NDMwY2EyZWM2MDVhNjRkMjU3ZjNfMS0xLTEtMS03NzAzMg_a57cc9e1-4830-44a5-add2-199f0a9434cb"
      unitRef="usd">47000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i9a5af68d1dfd41d9b397bace193b7f2e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg5NWE0NGQwMzI4NDQzMGNhMmVjNjA1YTY0ZDI1N2YzL3RhYmxlcmFuZ2U6ODk1YTQ0ZDAzMjg0NDMwY2EyZWM2MDVhNjRkMjU3ZjNfMS0yLTEtMS03NzAzMg_111a2121-e693-4b4b-bfdf-3fd594be5f16"
      unitRef="usd">50000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i6bbff8045db1420896d97da8621b4b0d_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg5NWE0NGQwMzI4NDQzMGNhMmVjNjA1YTY0ZDI1N2YzL3RhYmxlcmFuZ2U6ODk1YTQ0ZDAzMjg0NDMwY2EyZWM2MDVhNjRkMjU3ZjNfMi0xLTEtMS03NzAzMg_6f9f612b-c26a-4b66-a807-9d6e34b4178b"
      unitRef="usd">42000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i4c59a85af92949bfa44911ac3ec56888_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg5NWE0NGQwMzI4NDQzMGNhMmVjNjA1YTY0ZDI1N2YzL3RhYmxlcmFuZ2U6ODk1YTQ0ZDAzMjg0NDMwY2EyZWM2MDVhNjRkMjU3ZjNfMi0yLTEtMS03NzAzMg_a43554ef-702d-4dae-9f18-0b8dddb5cad2"
      unitRef="usd">45000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i44ec8a3cf51442cbaa0c996617cff9a4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg5NWE0NGQwMzI4NDQzMGNhMmVjNjA1YTY0ZDI1N2YzL3RhYmxlcmFuZ2U6ODk1YTQ0ZDAzMjg0NDMwY2EyZWM2MDVhNjRkMjU3ZjNfMy0xLTEtMS03NzAzMg_6057c1f3-24b4-4643-8e15-4e9371f00b80"
      unitRef="usd">111000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="iecf1812385b54a46ac8f5d89b0b93371_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg5NWE0NGQwMzI4NDQzMGNhMmVjNjA1YTY0ZDI1N2YzL3RhYmxlcmFuZ2U6ODk1YTQ0ZDAzMjg0NDMwY2EyZWM2MDVhNjRkMjU3ZjNfMy0yLTEtMS03NzAzMg_2fb4710d-59b5-4057-a50d-34665cb6b090"
      unitRef="usd">100000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg5NWE0NGQwMzI4NDQzMGNhMmVjNjA1YTY0ZDI1N2YzL3RhYmxlcmFuZ2U6ODk1YTQ0ZDAzMjg0NDMwY2EyZWM2MDVhNjRkMjU3ZjNfNC0xLTEtMS03NzAzMg_27ea48e0-494b-4ab8-b95f-8bb6326cc458"
      unitRef="usd">200000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg5NWE0NGQwMzI4NDQzMGNhMmVjNjA1YTY0ZDI1N2YzL3RhYmxlcmFuZ2U6ODk1YTQ0ZDAzMjg0NDMwY2EyZWM2MDVhNjRkMjU3ZjNfNC0yLTEtMS03NzAzMg_6b6dd774-8a2b-4990-a70f-fa84f501f900"
      unitRef="usd">195000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i54f8a4bbd0174868969d5ea2762b4cba_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfMS0xLTEtMS03NzAzMg_5a1b898f-c185-4c8b-9cf6-007e30a84e3f"
      unitRef="usd">84000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ic17bdfd4421546eca4d7ae434aa0244e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfMS0yLTEtMS03NzAzMg_084800ff-7ea7-499e-839c-9741433da96f"
      unitRef="usd">84000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ia8945826fd444f19b4c61de098d12163_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfMi0xLTEtMS03NzAzMg_aaa9a06a-27c3-4e6b-b96d-7a5e19376f3a"
      unitRef="usd">116000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i07b784c1178047b48ce2e8b3a5a7dbfd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfMi0yLTEtMS03NzAzMg_85148310-b606-41cc-8ed1-6f1560443ef7"
      unitRef="usd">111000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfMy0xLTEtMS03NzAzMg_27ea48e0-494b-4ab8-b95f-8bb6326cc458"
      unitRef="usd">200000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfMy0yLTEtMS03NzAzMg_6b6dd774-8a2b-4990-a70f-fa84f501f900"
      unitRef="usd">195000000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i6baa8e29dc1a4812ba336959185b5ed9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfNS0xLTEtMS03NzAzMg_edc4c49f-7f8f-4e2d-a311-8bb416a31b94"
      unitRef="usd">166000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i18dcbee3985a482faff83f708556a86d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfNS0yLTEtMS03NzAzMg_04fb556d-58c5-4c34-a64b-1f517abd6b39"
      unitRef="usd">162000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i399bd9e6d7704a0f8494daa78d8321fc_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfNi0xLTEtMS03NzAzMg_fa629255-354a-44d6-b836-ac8a4ff55275"
      unitRef="usd">74000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="iae692eee99a04c67905eefc0ccfb948d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfNi0yLTEtMS03NzAzMg_2bc17075-328b-4f0f-b194-a40240294b6e"
      unitRef="usd">84000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfNy0xLTEtMS03NzAzMg_fc52afd7-d785-4b9e-9c56-b54f74215cbf"
      unitRef="usd">240000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjMwZDE1MDM3MDc2MDQwZWFhNDQ2ODFmMTYzYTY5Yjc3L3RhYmxlcmFuZ2U6MzBkMTUwMzcwNzYwNDBlYWE0NDY4MWYxNjNhNjliNzdfNy0yLTEtMS03NzAzMg_59c73b89-b345-4932-a07c-7bbc02fe5a14"
      unitRef="usd">246000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg2YWUwNjczYTlmNzQ3N2M5OTVkMjA1YzQxMzI5ZWM1L3RhYmxlcmFuZ2U6ODZhZTA2NzNhOWY3NDc3Yzk5NWQyMDVjNDEzMjllYzVfMS0xLTEtMS03Nzk3Mg_91b16911-6e17-4827-9ce0-4440fdc49204"
      unitRef="usd">246000000</us-gaap:ContractWithCustomerLiability>
    <bax:ContractWithCustomerLiabilityDeferredRevenue
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg2YWUwNjczYTlmNzQ3N2M5OTVkMjA1YzQxMzI5ZWM1L3RhYmxlcmFuZ2U6ODZhZTA2NzNhOWY3NDc3Yzk5NWQyMDVjNDEzMjllYzVfMi0xLTEtMS03Nzk3Mg_2bfe01a0-8d61-403b-ad78-dbe0cc3019f5"
      unitRef="usd">116000000</bax:ContractWithCustomerLiabilityDeferredRevenue>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg2YWUwNjczYTlmNzQ3N2M5OTVkMjA1YzQxMzI5ZWM1L3RhYmxlcmFuZ2U6ODZhZTA2NzNhOWY3NDc3Yzk5NWQyMDVjNDEzMjllYzVfMy0xLTEtMS03Nzk3Mg_254e8b86-4108-4183-9d1a-db0ff7065702"
      unitRef="usd">122000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjg2YWUwNjczYTlmNzQ3N2M5OTVkMjA1YzQxMzI5ZWM1L3RhYmxlcmFuZ2U6ODZhZTA2NzNhOWY3NDc3Yzk5NWQyMDVjNDEzMjllYzVfNS0xLTEtMS03Nzk3Mg_86a44eaa-ed90-49ec-b06f-2c2eccedc063"
      unitRef="usd">240000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg5MQ_752248d8-2349-4b35-b070-82843cfe3268">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables disaggregate our net sales from contracts with customers by product category between the U.S. and international:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Renal Care &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medication Delivery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pharmaceuticals &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Clinical Nutrition &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advanced Surgery &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acute Therapies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BioPharma Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient Support Systems &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;8&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Front Line Care &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;9&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;11&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Baxter&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Renal Care includes sales of our peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Medication Delivery includes sales of our intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Pharmaceuticals includes sales of our premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Clinical Nutrition includes sales of our parenteral nutrition (PN) therapies and related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Advanced Surgery includes sales of our biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Acute Therapies includes sales of our continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;BioPharma Solutions includes sales of contracted services we provide to various pharmaceutical and biopharmaceutical companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Patient Support Systems includes sales of our connected care solutions: devices, software, communications and integration technologies.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.56pt"&gt;Front Line Care includes sales of our integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology vision screening and physical assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt"&gt;Surgical Solutions includes sales of our surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.12pt"&gt;Other includes sales of miscellaneous product and service offerings.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd0420526d1646c5ba9c811a0b9fc84f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMy0xLTEtMS03NzAzMg_dc34a4be-a933-473d-bdc5-4d62022d9810"
      unitRef="usd">225000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae2bd6024f3b4290867ed42a20b57c42_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMy0yLTEtMS03NzAzMg_c30bdf83-ca2e-4ca5-a614-29edb1eeb431"
      unitRef="usd">669000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ebc0f71dfcc4d94b6422c836bb4d493_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMy0zLTEtMS03NzAzMg_ceed20e7-16cf-472c-92e4-97882b8e8edb"
      unitRef="usd">894000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i41d12d31c3674b509c0fc670781c32d1_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMy00LTEtMS03NzAzMg_1d9ff522-7b44-4284-9b4e-2200709a708e"
      unitRef="usd">216000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd2c69af596c4eb8afab548b28116f64_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMy01LTEtMS03NzAzMg_35f1d5e6-9d9c-48ca-93c6-68c85e9015bb"
      unitRef="usd">706000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic47301316276400fa58cbac0a27edd76_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMy02LTEtMS03NzAzMg_ddadb3b5-5354-4d18-a3d4-440937028453"
      unitRef="usd">922000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0637d58240be4e3b84ee15a2869f6212_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNC0xLTEtMS03NzAzMg_6fe519f3-268b-4ed7-95dd-4d23ce48eb38"
      unitRef="usd">472000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie88685342da44b43aca2e889001b33df_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNC0yLTEtMS03NzAzMg_32691f92-7de4-4609-a7c1-94554656a87d"
      unitRef="usd">234000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6257773f46f4406a950d9da284eeff8f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNC0zLTEtMS03NzAzMg_e09e3d78-e5e2-421e-8758-59c6cb89960e"
      unitRef="usd">706000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99fd85b9b1294818a42d590249ac0254_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNC00LTEtMS03NzAzMg_84eaece1-9c96-415d-bf22-94f9b2071ebd"
      unitRef="usd">411000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1eb8a8cea96743978e1c34863c629e7e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNC01LTEtMS03NzAzMg_5b99f184-c28c-4db5-9259-a88041b65b65"
      unitRef="usd">241000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iccd3fe9f4eff41108f7f8233c7b8bec5_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNC02LTEtMS03NzAzMg_93ff1ca6-c1b7-4bfe-8fa0-9ad412ded7d3"
      unitRef="usd">652000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c50ddabc65d4775b4f0dd32b7866a0c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNS0xLTEtMS03NzAzMg_266962f6-704b-404a-bea5-4bb6c813a36d"
      unitRef="usd">157000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea7f19b9978a4f479a01e23692a3b391_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNS0yLTEtMS03NzAzMg_bf43d6d7-c119-49d4-9b4a-2a81e5c4c192"
      unitRef="usd">364000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5de90053a7bb47eba9d7c5dff40cb4da_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNS0zLTEtMS03NzAzMg_506cf6cd-3abf-48c0-a7ea-ffc7b2f1eda8"
      unitRef="usd">521000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5285bc00e83945fb8961453197a19fed_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNS00LTEtMS03NzAzMg_042f3e4e-0fb4-43eb-862a-0ec1b0491796"
      unitRef="usd">200000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic32465a108574d1ca7bae73c9b778aff_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNS01LTEtMS03NzAzMg_e1f3144f-e598-4219-82f5-ce0166282296"
      unitRef="usd">352000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i973336e83bc3453eb20073659da885b5_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNS02LTEtMS03NzAzMg_d75f66c3-d081-432d-a301-0c038f027c27"
      unitRef="usd">552000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaaad663d6e174f3f994c5b7b5c1706cd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNi0xLTEtMS03NzAzMg_dc4b70e8-7b12-407a-b17c-c787d3e3cc9f"
      unitRef="usd">84000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i793ab633078c493c9736d462d4058098_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNi0yLTEtMS03NzAzMg_42b5eebb-c9b2-4086-beb3-920175aba059"
      unitRef="usd">143000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id5bea1b0e28d4928871f812e9f5c7f6b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNi0zLTEtMS03NzAzMg_9a31102f-7e7e-440e-acc9-72b4ed48dae6"
      unitRef="usd">227000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7795ac9bd9604206a6016440b538aac0_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNi00LTEtMS03NzAzMg_1f8200b7-ca2c-4dda-adcf-f78f01964ca8"
      unitRef="usd">83000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b930265e49a44e0943d8103a8b0b529_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNi01LTEtMS03NzAzMg_680c2e22-e25c-4a34-9673-ec62eb03fc7e"
      unitRef="usd">151000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5d5a261cd76428fbedae996f8d1907e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNi02LTEtMS03NzAzMg_8ea6bf81-79a5-458e-a1d3-c1670ecad07e"
      unitRef="usd">234000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8e8d8c02c024de689ede733470259ff_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNy0xLTEtMS03NzAzMg_c8e8c727-67a4-4666-8bd7-c4e1b9f275c9"
      unitRef="usd">136000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic88569bfa2d84d02bb251a96bb20f794_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNy0yLTEtMS03NzAzMg_3711d966-7dd5-4bb5-9be7-6521c677d18e"
      unitRef="usd">92000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if243ce5e748b4bd59093b5179090fb3f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNy0zLTEtMS03NzAzMg_c5a69462-649b-4a75-89ff-96ba3a82f288"
      unitRef="usd">228000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8fa2b02e71bf4d45b6db7e096d2650cb_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNy00LTEtMS03NzAzMg_86e7e93e-436b-444b-baff-be55165192c0"
      unitRef="usd">126000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f5cb5974e244ecba9653d56940192c0_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNy01LTEtMS03NzAzMg_5c8ee38b-e741-465b-bb23-652273b8e067"
      unitRef="usd">91000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2913c2e1a7a24276acc5b6213dae5262_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfNy02LTEtMS03NzAzMg_4db0b167-e916-49d0-bea9-505bc90e37ac"
      unitRef="usd">217000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i779714d757cf402f9776a2ccdec9726a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOC0xLTEtMS03NzAzMg_7df8f721-21fb-4d2a-bb4f-854e4a9bc59d"
      unitRef="usd">68000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23f88c8a0df54c6884b9d01b2aaf82bf_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOC0yLTEtMS03NzAzMg_5c5ab3b6-1880-4a73-affc-27bc3c818a15"
      unitRef="usd">120000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44c9c2a4bb7449619ad2573dafa85bbf_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOC0zLTEtMS03NzAzMg_5a25e892-4959-4f10-a8cc-8bbc105ffb96"
      unitRef="usd">188000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8126141e4675434f839f8755c88b8ba3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOC00LTEtMS03NzAzMg_5d86fb03-5e7c-4cd6-9bde-c038b4b89881"
      unitRef="usd">81000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0845bc16f68464e8379919be0e7b8fe_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOC01LTEtMS03NzAzMg_146d467f-bab4-4a36-8c31-ba566846914d"
      unitRef="usd">126000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fc7fd14f1844726a492dc5c657acbf8_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOC02LTEtMS03NzAzMg_41f67715-e3db-4b4d-8a5e-845d75c8e6ed"
      unitRef="usd">207000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i876dae9a11fe4141a783d8c2a6b92dec_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOS0xLTEtMS03NzAzMg_60428a39-6a1a-41b8-a123-03797d33e22b"
      unitRef="usd">52000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb9737600ddd4964a91212e64caf3594_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOS0yLTEtMS03NzAzMg_3fd606e0-e628-428d-896e-efd2ed75ce59"
      unitRef="usd">104000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5745c41ec404c25a1bde3188976ef38_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOS0zLTEtMS03NzAzMg_68ce40a2-5ed5-425d-b5b6-71044683c290"
      unitRef="usd">156000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c8442c959fa4529b57209c078253476_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOS00LTEtMS03NzAzMg_4e0a1873-ab51-455c-9d11-82fc0d5e7dac"
      unitRef="usd">44000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i285d483ea5b047c587d620462e947359_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOS01LTEtMS03NzAzMg_103d5bf5-5091-49ae-80ee-2ac77cb4c966"
      unitRef="usd">91000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b3f80e5d38f4c1abc4cd1ab9a5b569a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfOS02LTEtMS03NzAzMg_07f2c448-2564-4a3f-9a3b-6a09fd8c49fd"
      unitRef="usd">135000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e787427fc1d4863ab700a326101e439_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtMS0xLTEtNzgwNDc_4afa23ba-e673-40c6-8f72-3f6c2843a73d"
      unitRef="usd">295000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7467c8869654bcdb29ec9bef8eb852c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtMi0xLTEtNzgwNDc_b0266615-7ee6-47fa-815c-2820930b733e"
      unitRef="usd">88000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie34a3ea8d30f42b6a3c8f3f80e0898fd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtMy0xLTEtNzgwNDc_a904cf14-bbda-4827-998b-80f0246c7c07"
      unitRef="usd">383000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iacd83fad5f6042788153d814f190dd66_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtNC0xLTEtNzgwNTQ_e709a8ce-53bb-4d08-a415-d7db1ab91f31"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iedcbe041ae2a4606afe97260832fde83_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtNS0xLTEtNzgwNTQ_72a058c0-4eaa-40c2-a44e-c414e0ad535c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idcc9eca3b12249c28c1c568c4b0ff3db_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtNi0xLTEtNzgwNTQ_9534216a-dfce-46eb-a3f1-ceb4f6179504"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ea4cbf5f08646e39f3d3ff3c49f24f2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtMS0xLTEtNzgwNDc_092dbba4-e326-41e2-8020-c55e5252391e"
      unitRef="usd">207000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23972f3969514c8ebbb4ed813b640924_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtMi0xLTEtNzgwNDc_83b6c85a-95c3-4616-8731-50f1e60cb3e5"
      unitRef="usd">87000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idd3a87d60d1c4c0e9e235738abd249b4_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtMy0xLTEtNzgwNDc_77e0e3c9-4444-4996-a3c3-996dd9adbcd3"
      unitRef="usd">294000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18b82a0e238f4965bce3b3d3da7bc457_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtNC0xLTEtNzgwNTQ_6afacc2f-9893-407f-8c90-83883ee3ff49"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab72e78e33e84f74af908d9272c9918b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtNS0xLTEtNzgwNTQ_9b836b84-917c-4c7e-a83c-4059d1b4ae5b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c2a93a6dd094c51bfe994c44cd157c0_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtNi0xLTEtNzgwNTQ_6eefa1e5-e838-45ca-a5a2-2495817039be"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib694fa97d14d4be381e04aa9ddf846c1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTItMS0xLTEtNzgwNDc_05cfa3ad-0424-4cfa-b3f5-e196faf72d10"
      unitRef="usd">37000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0628696d6604d5b9f829e16a4b411ea_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTItMi0xLTEtNzgwNDc_99b8d704-b046-4554-bd38-2c34fe5b4a49"
      unitRef="usd">41000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8389d4f265c0420ea78f8103b6fc49ff_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTItMy0xLTEtNzgwNDc_1b92b437-bdc4-496a-a461-e338aff90835"
      unitRef="usd">78000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69b44fa6f007430891d8a0fa04607c5a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTItNC0xLTEtNzgwNTQ_ed561369-2e13-47a6-a631-a785a834d21b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f19fbe0743f48108c85afdca64f480d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTItNS0xLTEtNzgwNTQ_50b89bab-4a5d-4314-b280-02be6a0e6bd4"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97bb457dd66d4192aba9ecb5379b09e3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTItNi0xLTEtNzgwNTQ_289b0c15-c852-4b54-94e1-e311e73efa93"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibebdfc914173408d98947b502a387897_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtMS0xLTEtNzcwMzI_bb072e6f-093a-4ee0-bf4c-34811f2dc65a"
      unitRef="usd">24000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b8b91e94ed143eebd3f096088cfeac3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtMi0xLTEtNzcwMzI_c5933016-bff8-4836-a653-30f1a44163de"
      unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id5945f9a9cad447da92a87bf81903df9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtMy0xLTEtNzcwMzI_035cbfd4-0f35-48f6-8e20-c3d3e233d311"
      unitRef="usd">32000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib32b8ba9994c4c05b40746ba26de0276_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtNC0xLTEtNzcwMzI_56dd4fbb-2ce9-45a2-a2d7-9364ced47e83"
      unitRef="usd">19000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f1ac0c71dc74295a156d768668f9a2a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtNS0xLTEtNzcwMzI_2d89c2c1-cbb3-4bd5-9407-2c4d5e670261"
      unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7a8130be2624c9a8048123bf1f31901_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTAtNi0xLTEtNzcwMzI_56cab6c7-51f9-4c06-85e0-33fb5f657322"
      unitRef="usd">27000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib93cd39c2a80489ba522e10fce6b0e92_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtMS0xLTEtNzcwMzI_def29cdf-8a76-4471-bc2b-4747b4999e49"
      unitRef="usd">1757000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae185801a2824043b923695260987bdc_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtMi0xLTEtNzcwMzI_d2bf93da-2b71-4d59-ac07-609764d6f3ce"
      unitRef="usd">1950000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtMy0xLTEtNzcwMzI_25fd99e4-353c-4c45-9809-ca8217e118ad"
      unitRef="usd">3707000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i85d0b3b6424a4f239ced374f948ac74a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtNC0xLTEtNzcwMzI_20dac12c-4ed6-4dc3-8eb5-18643c844cee"
      unitRef="usd">1180000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d6282669ad443c49c55d8ac91b9f5e7_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtNS0xLTEtNzcwMzI_c33871b0-8d39-4afb-aa01-60dfd7a5d83f"
      unitRef="usd">1766000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjk0ZWM5N2VkZDE2MDQ0NDU5ZDRjNmJiOGU5MjI5OWMxL3RhYmxlcmFuZ2U6OTRlYzk3ZWRkMTYwNDQ0NTlkNGM2YmI4ZTkyMjk5YzFfMTEtNi0xLTEtNzcwMzI_90ba2c01-e6c4-469c-9f48-d80c26deb960"
      unitRef="usd">2946000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg5NQ_45fd7e30-0743-4174-8846-fd0ba31e6b91">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The components of lease revenue for the three months ended March&#160;31, 2022 and 2021 were:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg5NQ_9c5959b1-5f27-4b42-9301-91425ad772ff">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The components of lease revenue for the three months ended March&#160;31, 2022 and 2021 were:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.279%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjIzYjc2N2UyNzkwYjQxMTU5NDk3YmJhNDFjODJmYzUxL3RhYmxlcmFuZ2U6MjNiNzY3ZTI3OTBiNDExNTk0OTdiYmE0MWM4MmZjNTFfMS0xLTEtMS03NzAzMg_42deaf92-3ac1-422e-a3ac-93456fbee647"
      unitRef="usd">3000000</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjIzYjc2N2UyNzkwYjQxMTU5NDk3YmJhNDFjODJmYzUxL3RhYmxlcmFuZ2U6MjNiNzY3ZTI3OTBiNDExNTk0OTdiYmE0MWM4MmZjNTFfMS0yLTEtMS03NzAzMg_a61dc7c7-cf98-4261-bf8d-3a42f089b8c1"
      unitRef="usd">6000000</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjIzYjc2N2UyNzkwYjQxMTU5NDk3YmJhNDFjODJmYzUxL3RhYmxlcmFuZ2U6MjNiNzY3ZTI3OTBiNDExNTk0OTdiYmE0MWM4MmZjNTFfMi0xLTEtMS03NzAzMg_5b3996a7-78fc-4590-b700-d94f1c674908"
      unitRef="usd">122000000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjIzYjc2N2UyNzkwYjQxMTU5NDk3YmJhNDFjODJmYzUxL3RhYmxlcmFuZ2U6MjNiNzY3ZTI3OTBiNDExNTk0OTdiYmE0MWM4MmZjNTFfMi0yLTEtMS03NzAzMg_82962d89-35c6-475a-9f5d-ed08030fcc83"
      unitRef="usd">34000000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:VariableLeaseIncome
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjIzYjc2N2UyNzkwYjQxMTU5NDk3YmJhNDFjODJmYzUxL3RhYmxlcmFuZ2U6MjNiNzY3ZTI3OTBiNDExNTk0OTdiYmE0MWM4MmZjNTFfMy0xLTEtMS03NzAzMg_493c47a8-e1ec-4bd9-9dd2-650b3b13cbe7"
      unitRef="usd">20000000</us-gaap:VariableLeaseIncome>
    <us-gaap:VariableLeaseIncome
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjIzYjc2N2UyNzkwYjQxMTU5NDk3YmJhNDFjODJmYzUxL3RhYmxlcmFuZ2U6MjNiNzY3ZTI3OTBiNDExNTk0OTdiYmE0MWM4MmZjNTFfMy0yLTEtMS03NzAzMg_d8896140-babd-49d5-afac-f2e66f90d016"
      unitRef="usd">17000000</us-gaap:VariableLeaseIncome>
    <us-gaap:LeaseIncome
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjIzYjc2N2UyNzkwYjQxMTU5NDk3YmJhNDFjODJmYzUxL3RhYmxlcmFuZ2U6MjNiNzY3ZTI3OTBiNDExNTk0OTdiYmE0MWM4MmZjNTFfNC0xLTEtMS03NzAzMg_3768dd10-2b07-47ff-bcbd-4a740daf943e"
      unitRef="usd">145000000</us-gaap:LeaseIncome>
    <us-gaap:LeaseIncome
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RhYmxlOjIzYjc2N2UyNzkwYjQxMTU5NDk3YmJhNDFjODJmYzUxL3RhYmxlcmFuZ2U6MjNiNzY3ZTI3OTBiNDExNTk0OTdiYmE0MWM4MmZjNTFfNC0yLTEtMS03NzAzMg_1d449616-0568-4b49-8128-6acf90a30a52"
      unitRef="usd">57000000</us-gaap:LeaseIncome>
    <us-gaap:SalesTypeLeaseNetInvestmentInLease
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODc4Ng_6a44fb54-3d65-4818-b394-fb7ee8ce5968"
      unitRef="usd">109000000</us-gaap:SalesTypeLeaseNetInvestmentInLease>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="i2b9e15e802c2455fb04ea04eb4db2322_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg0MQ_f8b4fcd4-1d31-4d17-8e5b-d8638cb41dac"
      unitRef="usd">38000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="i522261ab58db4575939d49828d4c748e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg1Mw_cea5bda1-5b7e-4647-b275-2040afbbd115"
      unitRef="usd">16000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="i238ac34b0aab41be8134d8a775d08e2d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg2NQ_59ef1050-1148-430d-94dc-f8bae08e18e7"
      unitRef="usd">28000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfODg4MA_911725c4-17e9-4673-aca3-2667d2f024ce"
      unitRef="usd">25000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182MS9mcmFnOjhmYTA3OTExN2I0NTRjNzY5ZTBhZDQ3MjQxNzJkMzg5L3RleHRyZWdpb246OGZhMDc5MTE3YjQ1NGM3NjllMGFkNDcyNDE3MmQzODlfMTA5OTUxMTYzOTk3Mg_62fef6c3-a972-4d37-b9af-dd31a557c578"
      unitRef="usd">2000000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivable>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RleHRyZWdpb246ZDhhMjhlZWNiM2M4NGM1YjgyMmM4MmFlNjA5ODEwN2FfMjM5Nw_40b89f9a-0598-480e-abb4-feb8d10286b9">BUSINESS OPTIMIZATION CHARGES&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In recent years, we have undertaken actions to transform our cost structure and enhance operational efficiency. These efforts include restructuring the organization, optimizing the manufacturing footprint, R&amp;amp;D operations and supply chain network, employing disciplined cost management, and centralizing and streamlining certain support functions. In the current period, restructuring charges include actions taken in connection with our integration of Hillrom. From the commencement of our business optimization activities in the second half of 2015 through March&#160;31, 2022, we have incurred cumulative pre-tax costs of $1.3 billion related to these actions. The costs consisted primarily of employee termination costs, implementation costs, contract termination costs, asset impairments and accelerated depreciation. We currently expect to incur additional pre-tax costs of approximately $25 million through the completion of the initiatives that are currently underway, primarily related to implementation costs. We continue to pursue cost savings initiatives and, to the extent further cost savings opportunities are identified, we may incur additional restructuring charges and costs to implement business optimization programs in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2022 and 2021, we recorded the following charges related to business optimization programs.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.440%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs to implement business optimization programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total business optimization charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For segment reporting purposes, business optimization charges are unallocated expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs to implement business optimization programs for the three months ended March&#160;31, 2022 and 2021, respectively, consisted primarily of external consulting and transition costs, including employee compensation and related costs. These costs were primarily included within cost of sales and SG&amp;amp;A expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2022 and 2021, we recorded the following restructuring charges.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;COGS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract termination and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;COGS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity in the liability related to our restructuring initiatives.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all of our restructuring liabilities as of March&#160;31, 2022 relate to employee termination costs, with the remaining liabilities attributable to contract termination costs. Substantially all of the cash payments for those liabilities are expected to be disbursed by the end of 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RleHRyZWdpb246ZDhhMjhlZWNiM2M4NGM1YjgyMmM4MmFlNjA5ODEwN2FfNTMy_eabec09c-32cc-4f65-bd7d-80edead9ba78"
      unitRef="usd">1300000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RleHRyZWdpb246ZDhhMjhlZWNiM2M4NGM1YjgyMmM4MmFlNjA5ODEwN2FfNzkx_0f45fd03-d539-4128-8d3b-84025fc14afc"
      unitRef="usd">25000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <bax:BusinessOptimizationChargeTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RleHRyZWdpb246ZDhhMjhlZWNiM2M4NGM1YjgyMmM4MmFlNjA5ODEwN2FfMjM5OA_e9d0e471-5709-4ac3-ae63-9cd53f8fd084">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2022 and 2021, we recorded the following charges related to business optimization programs.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.440%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs to implement business optimization programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total business optimization charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</bax:BusinessOptimizationChargeTableTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="if86b2c8277034f9e961edc5d828e8065_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOmJiOTYyZDdlZmM3ZTQwNjZiZmUzNDk2OTQ0YzdkOWNjL3RhYmxlcmFuZ2U6YmI5NjJkN2VmYzdlNDA2NmJmZTM0OTY5NDRjN2Q5Y2NfMi0xLTEtMS03NzAzMg_f1ba4647-5b33-46f5-ae75-7f186e01de25"
      unitRef="usd">67000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9311558f896a40b688cfc17aa08d2304_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOmJiOTYyZDdlZmM3ZTQwNjZiZmUzNDk2OTQ0YzdkOWNjL3RhYmxlcmFuZ2U6YmI5NjJkN2VmYzdlNDA2NmJmZTM0OTY5NDRjN2Q5Y2NfMi0yLTEtMS03NzAzMg_c27e217d-90f3-409b-b6f9-847580f0a6df"
      unitRef="usd">25000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="if86b2c8277034f9e961edc5d828e8065_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOmJiOTYyZDdlZmM3ZTQwNjZiZmUzNDk2OTQ0YzdkOWNjL3RhYmxlcmFuZ2U6YmI5NjJkN2VmYzdlNDA2NmJmZTM0OTY5NDRjN2Q5Y2NfMy0xLTEtMS03NzAzMg_3c5c4b35-f759-4499-a497-1ad503fe78df"
      unitRef="usd">14000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringAndRelatedCostIncurredCost
      contextRef="i9311558f896a40b688cfc17aa08d2304_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOmJiOTYyZDdlZmM3ZTQwNjZiZmUzNDk2OTQ0YzdkOWNjL3RhYmxlcmFuZ2U6YmI5NjJkN2VmYzdlNDA2NmJmZTM0OTY5NDRjN2Q5Y2NfMy0yLTEtMS03NzAzMg_1a5ece7f-6937-48cd-86c9-a58710d1a754"
      unitRef="usd">2000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
    <us-gaap:RestructuringCosts
      contextRef="if86b2c8277034f9e961edc5d828e8065_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOmJiOTYyZDdlZmM3ZTQwNjZiZmUzNDk2OTQ0YzdkOWNjL3RhYmxlcmFuZ2U6YmI5NjJkN2VmYzdlNDA2NmJmZTM0OTY5NDRjN2Q5Y2NfNS0xLTEtMS03NzAzMg_d65d43fa-20b8-4bab-b2bf-18bff19a9057"
      unitRef="usd">81000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i9311558f896a40b688cfc17aa08d2304_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOmJiOTYyZDdlZmM3ZTQwNjZiZmUzNDk2OTQ0YzdkOWNjL3RhYmxlcmFuZ2U6YmI5NjJkN2VmYzdlNDA2NmJmZTM0OTY5NDRjN2Q5Y2NfNS0yLTEtMS03NzAzMg_7fc70eca-a71c-4531-86c3-2961733895e4"
      unitRef="usd">27000000</us-gaap:RestructuringCosts>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RleHRyZWdpb246ZDhhMjhlZWNiM2M4NGM1YjgyMmM4MmFlNjA5ODEwN2FfMjQwMA_567690e1-b37d-46b8-8582-8152189beb02">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2022 and 2021, we recorded the following restructuring charges.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;COGS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract termination and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;COGS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="i11a40960ca1f4fa5b6e685c5e17a27e1_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfMi0xLTEtMS03NzAzMg_4a48bd24-efed-40a6-a136-b1f67e65b781"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iffeac49ece2f4f0099db2b6316bc2a6b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfMi0yLTEtMS03NzAzMg_86194f73-ece1-44bf-bca5-8a906c4e4514"
      unitRef="usd">47000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia27cfb043f884dbd9667969290a6e989_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfMi0zLTEtMS03NzAzMg_3f987f9c-02ef-43b8-8211-daccab2d7f69"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i07f45e9451124a38a8618085deaa0bad_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfMi00LTEtMS03NzAzMg_bf794aa6-1514-4087-a295-3ad9811c4873"
      unitRef="usd">49000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iac5d8d62119742ed9ba5ea4e4194307b_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfMy0xLTEtMS03NzAzMg_3642461e-1e84-4929-8e31-4138436eed60"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i290805ec99d64042be64af58b8ffd3b7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfMy0yLTEtMS03NzAzMg_0d15f510-8999-422e-bac6-3afbb3caa1da"
      unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7223eebf6ed94d309d0faa7ad432bbbd_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfMy0zLTEtMS03NzAzMg_3c1c4237-c7df-447c-ab1c-07e5c7a38688"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="icd1cb136a26b44cba87fb2a70901faa7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfMy00LTEtMS03NzAzMg_26b7cd0e-4c19-4583-9ac7-eda22697f42d"
      unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia7d79d5f91f94bcab33cf772a3b3063d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfNC0xLTEtMS03NzAzMg_8c34d046-2e77-478d-b906-d62261941ff2"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie0379f97ea684a719bc4b38d54e0efde_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfNC0yLTEtMS03NzAzMg_00d145fa-8b1e-4ceb-9a8a-aa0ed5a59041"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i879c4d6181ea43c099235e39734a646e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfNC0zLTEtMS03NzAzMg_26655e59-b466-4c3a-8204-72c28315a4cf"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i63e5679fd4e5469d85730434afe1d238_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfNC00LTEtMS03NzAzMg_12e69352-65c4-485e-b9b6-1cbfe834f271"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib68997075a33458898c6e14a36eebeb9_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfNS0xLTEtMS03NzAzMg_3ceed479-fc0e-48d3-aaf0-e78f238acd15"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia62b9d54444c46208ba00c7b3a49f393_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfNS0yLTEtMS03NzAzMg_6130be0a-487c-45e2-b8f6-d9af01b33577"
      unitRef="usd">65000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6ef7f560cf624875bf9c35c67df33547_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfNS0zLTEtMS03NzAzMg_e9509f38-357b-454f-afc6-677ba9011413"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjMzZmViMmVmZTM2YzQ0ZDE4ODBjNTI1ZTM3NjMwYTQ0L3RhYmxlcmFuZ2U6MzNmZWIyZWZlMzZjNDRkMTg4MGM1MjVlMzc2MzBhNDRfNS00LTEtMS03NzAzMg_33c0f1b8-7dd0-4c38-8fd3-d7ee089431f3"
      unitRef="usd">67000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i62dc3391e9264db98a1f3fe40474e64b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfMi0xLTEtMS03NzAzMg_7f6e4ffa-2138-4e14-8f34-56a3fc9a4bdb"
      unitRef="usd">16000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5718c50c86d740d098ff8d49b559feaf_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfMi0yLTEtMS03NzAzMg_32ee77a9-6d0c-4aea-bc06-586cec1f5ad5"
      unitRef="usd">5000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i0ee68bc6af754a66b0a50a9468a8588a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfMi0zLTEtMS03NzAzMg_4da65494-41ef-4541-808b-8b3993b6b1d0"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i312b43d90c8849b8b19bdd30e36c95c1_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfMi00LTEtMS03NzAzMg_d810e871-28ef-4172-9df3-64926ced67e9"
      unitRef="usd">21000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i32aeda1131ad47a9a728d691bcb5e02b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfNC0xLTEtMS03NzAzMg_6c948abe-58a1-42b4-bf95-f63097f8bbd1"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6acac91985d749cbbb8a0f1ece842c1d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfNC0yLTEtMS03NzAzMg_9334a2de-9557-4650-b6f4-890047167356"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8d49bf9ceb394ee397eb421a3a4ea0e7_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfNC0zLTEtMS03NzAzMg_001b0cc1-621b-41d5-aafb-586ceef552a0"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id9451246f53f4b13b9c1078a4785af23_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfNC00LTEtMS03NzAzMg_2f468c22-e7ad-404e-ac8b-6b32f915c2a8"
      unitRef="usd">4000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i63b9c16382b045218cfce2166bcdcd3e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfNS0xLTEtMS03NzAzMg_f1a97250-7a3d-4cc0-b2b3-a46f144a253b"
      unitRef="usd">20000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iebe3c987e85b400bac19095e21ca736c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfNS0yLTEtMS03NzAzMg_9fcbbec3-9caf-438c-b419-17a8dfcc2051"
      unitRef="usd">5000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i1701fe482b3a4c3183852a3aa9fe0c87_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfNS0zLTEtMS03NzAzMg_feede1b2-5489-495b-9434-01f43d17156a"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjE4ZmIwY2FlNTUwMjRhODM4Mjc1NTNiMDJhNGJjMjJhL3RhYmxlcmFuZ2U6MThmYjBjYWU1NTAyNGE4MzgyNzU1M2IwMmE0YmMyMmFfNS00LTEtMS03NzAzMg_129db8b1-3ef0-48b8-91ca-7697c1fdf69b"
      unitRef="usd">25000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RleHRyZWdpb246ZDhhMjhlZWNiM2M4NGM1YjgyMmM4MmFlNjA5ODEwN2FfMjQwMQ_c8a0c8f2-40df-47ba-a3e4-8726ad2443c8">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes activity in the liability related to our restructuring initiatives.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.405%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i4d7dca14db914da8ad561a51aee21848_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjYyYjExYTFmZjEyZDRiMWQ4MzE2ZDI2OWY3MmRmMWMyL3RhYmxlcmFuZ2U6NjJiMTFhMWZmMTJkNGIxZDgzMTZkMjY5ZjcyZGYxYzJfMS0xLTEtMS03NzAzMg_2b1d0009-0616-458d-8aec-46ea9fad1a52"
      unitRef="usd">109000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i786ae4d3319c471ab517a03677b933e3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjYyYjExYTFmZjEyZDRiMWQ4MzE2ZDI2OWY3MmRmMWMyL3RhYmxlcmFuZ2U6NjJiMTFhMWZmMTJkNGIxZDgzMTZkMjY5ZjcyZGYxYzJfMi0xLTEtMS03NzAzMg_2e395c10-5ab3-4146-a00a-a2140f89d7e2"
      unitRef="usd">61000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i786ae4d3319c471ab517a03677b933e3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjYyYjExYTFmZjEyZDRiMWQ4MzE2ZDI2OWY3MmRmMWMyL3RhYmxlcmFuZ2U6NjJiMTFhMWZmMTJkNGIxZDgzMTZkMjY5ZjcyZGYxYzJfMy0xLTEtMS03NzAzMg_609a632d-551a-4ac8-b53e-d532cec0ea1b"
      unitRef="usd">31000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i786ae4d3319c471ab517a03677b933e3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjYyYjExYTFmZjEyZDRiMWQ4MzE2ZDI2OWY3MmRmMWMyL3RhYmxlcmFuZ2U6NjJiMTFhMWZmMTJkNGIxZDgzMTZkMjY5ZjcyZGYxYzJfNS0xLTEtMS03NzAzMg_9c0a8ec6-fa87-423f-b991-bb39952bd948"
      unitRef="usd">-2000000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i88c2ae6f33f64b45936b4dcd18b5d612_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY182Ny9mcmFnOmQ4YTI4ZWVjYjNjODRjNWI4MjJjODJhZTYwOTgxMDdhL3RhYmxlOjYyYjExYTFmZjEyZDRiMWQ4MzE2ZDI2OWY3MmRmMWMyL3RhYmxlcmFuZ2U6NjJiMTFhMWZmMTJkNGIxZDgzMTZkMjY5ZjcyZGYxYzJfNi0xLTEtMS03NzAzMg_6a6e66a6-a666-4d17-afd5-7d1cc1221703"
      unitRef="usd">137000000</us-gaap:RestructuringReserve>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RleHRyZWdpb246MzhiZTY2OGI4YjM4NDZhZTg0ZmVhNTk0Y2RmM2FhNGVfMTU3_d22abdd9-fa95-49fe-9cd4-173a0f9cd48d">PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of net periodic benefit cost relating to our pension and OPEB plans.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net losses and prior service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;OPEB&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net loss and prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic OPEB cost (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RleHRyZWdpb246MzhiZTY2OGI4YjM4NDZhZTg0ZmVhNTk0Y2RmM2FhNGVfMTU5_f71460bd-6d71-40cd-8c61-3e20a5a8bedb">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of net periodic benefit cost relating to our pension and OPEB plans.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Pension benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net losses and prior service costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;OPEB&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net loss and prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic OPEB cost (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="if5c7bf2bab574ab28206bdde47eed8d5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfMy0xLTEtMS03NzAzMg_717153aa-bdae-455d-8573-3fa250349f4c"
      unitRef="usd">19000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i3ef157d694c2423bb871181ca6e1ef94_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfMy0yLTEtMS03NzAzMg_47645128-43fd-4c03-9658-fb295e6614ae"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if5c7bf2bab574ab28206bdde47eed8d5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfNC0xLTEtMS03NzAzMg_94091e00-3c08-45a0-adfb-5b43c132f9a9"
      unitRef="usd">24000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i3ef157d694c2423bb871181ca6e1ef94_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfNC0yLTEtMS03NzAzMg_3e824601-21ff-489f-9c1d-16fff9dd3e7a"
      unitRef="usd">18000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="if5c7bf2bab574ab28206bdde47eed8d5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfNS0xLTEtMS03NzAzMg_35949348-9fc2-46a9-b955-2e1ad64809f0"
      unitRef="usd">39000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i3ef157d694c2423bb871181ca6e1ef94_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfNS0yLTEtMS03NzAzMg_e8536d87-ddb9-40c8-85c5-a1d7400306b1"
      unitRef="usd">36000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="if5c7bf2bab574ab28206bdde47eed8d5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfNi0xLTEtMS03NzAzMg_069fbe7b-68e5-4b87-a07a-fa3cf4f25e5d"
      unitRef="usd">-12000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i3ef157d694c2423bb871181ca6e1ef94_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfNi0yLTEtMS03NzAzMg_b0b013a1-8a74-42c3-8ed0-2d0aeade65e8"
      unitRef="usd">-23000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if5c7bf2bab574ab28206bdde47eed8d5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfNy0xLTEtMS03NzAzMg_b91659c5-296a-4026-bee6-061cd5e87a48"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i3ef157d694c2423bb871181ca6e1ef94_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfNy0yLTEtMS03NzAzMg_fc9a37c2-3c91-4640-833d-8d26afcd7281"
      unitRef="usd">27000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if5dc8f540120419bb40e18be629ff121_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfOS0xLTEtMS03NzAzMg_2d4895c8-b2b7-4c80-94f0-119342065762"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if0744bc26d8d4427bc7a38006ba71623_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfOS0yLTEtMS03NzAzMg_965ffb07-a75a-4f93-8487-835a2f7fd050"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="if5dc8f540120419bb40e18be629ff121_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfMTAtMS0xLTEtNzcwMzI_a8bf794a-5296-4fd8-837b-32edaab1c27c"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="if0744bc26d8d4427bc7a38006ba71623_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfMTAtMi0xLTEtNzcwMzI_384b143b-c588-4c81-aee0-076564f5099f"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if5dc8f540120419bb40e18be629ff121_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfMTEtMS0xLTEtNzcwMzI_68e4f1ab-f20d-4682-b5f4-4ac3f07d7941"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if0744bc26d8d4427bc7a38006ba71623_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183MC9mcmFnOjM4YmU2NjhiOGIzODQ2YWU4NGZlYTU5NGNkZjNhYTRlL3RhYmxlOjE4ZDFiOWUwNzM4YzRiNGRhODE5N2MxOGE5NjJlMmUwL3RhYmxlcmFuZ2U6MThkMWI5ZTA3MzhjNGI0ZGE4MTk3YzE4YTk2MmUyZTBfMTEtMi0xLTEtNzcwMzI_b29c6670-204b-4937-8428-318947161257"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183My9mcmFnOmU0NjYxMjY4M2MxMzQwMzQ5OGNmMWZkYTcxOWE5ODNlL3RleHRyZWdpb246ZTQ2NjEyNjgzYzEzNDAzNDk4Y2YxZmRhNzE5YTk4M2VfMTc3OA_c203044b-fe91-45e4-ac92-67b880d13678">INCOME TAXES &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our effective income tax rate was 22.3% and 14.5% for the three months ended March 31, 2022 and 2021, respectively. Our effective income tax rate can differ from the 21% U.S. federal statutory rate due to a number of factors, including foreign rate differences, tax incentives, increases or decreases in valuation allowances and liabilities for uncertain tax positions and excess tax benefits on stock compensation awards.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2022, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to discrete tax matters in various foreign jurisdictions, of which none are individually material, and an increase in our liabilities for uncertain tax positions, partially offset by excess tax benefits on stock compensation awards and a favorable geographic earnings mix.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2021, the difference between our effective income tax rate and the U.S. federal statutory rate was primarily attributable to decreases in accrued withholding taxes in several foreign jurisdictions and a favorable geographic earnings mix.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183My9mcmFnOmU0NjYxMjY4M2MxMzQwMzQ5OGNmMWZkYTcxOWE5ODNlL3RleHRyZWdpb246ZTQ2NjEyNjgzYzEzNDAzNDk4Y2YxZmRhNzE5YTk4M2VfNTg_fa086c92-e5dc-458e-889c-16e872be7b95"
      unitRef="number">0.223</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183My9mcmFnOmU0NjYxMjY4M2MxMzQwMzQ5OGNmMWZkYTcxOWE5ODNlL3RleHRyZWdpb246ZTQ2NjEyNjgzYzEzNDAzNDk4Y2YxZmRhNzE5YTk4M2VfNjU_1f772a6d-d9be-4691-b26e-0c6552bac482"
      unitRef="number">0.145</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183My9mcmFnOmU0NjYxMjY4M2MxMzQwMzQ5OGNmMWZkYTcxOWE5ODNlL3RleHRyZWdpb246ZTQ2NjEyNjgzYzEzNDAzNDk4Y2YxZmRhNzE5YTk4M2VfMTk4_92412cd7-824f-4042-8e41-6c0db9bfbeb5"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RleHRyZWdpb246MzI2YjJiZDAwYzhmNDczYzgxODkwYjU3MjZhZDZhZjJfOTUz_a61fd944-a3f8-4dd8-8be9-2bf6c60274a5">EARNINGS PER SHAREThe numerator for both basic and diluted earnings per share (EPS) is net income attributable to Baxter stockholders. The denominator for basic EPS is the weighted-average number of shares outstanding during the period. The dilutive effect of outstanding stock options, RSUs and PSUs is reflected in the denominator for diluted EPS using the treasury stock method.&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of basic shares to diluted shares.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effect of dilutive securities includes unexercised stock options, unvested RSUs and contingently issuable shares related to granted PSUs. The computation of diluted EPS excludes 4 million and 7 million equity awards for the three months ended March&#160;31, 2022 and 2021, respectively, because their inclusion would have had an anti-dilutive effect on diluted EPS.  Refer to Note 7 for additional information regarding items impacting basic and diluted shares.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RleHRyZWdpb246MzI2YjJiZDAwYzhmNDczYzgxODkwYjU3MjZhZDZhZjJfOTU0_a87fa30d-845a-4027-977b-9432a515ffd3">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of basic shares to diluted shares.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RhYmxlOjBjNGZhNDcyZjcwZTQwNTlhNTk2YzNkZWE3NWNmMjNmL3RhYmxlcmFuZ2U6MGM0ZmE0NzJmNzBlNDA1OWE1OTZjM2RlYTc1Y2YyM2ZfMi0xLTEtMS03NzAzMg_f759f33f-ebae-4b20-a49f-df53ac463bca"
      unitRef="shares">503000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RhYmxlOjBjNGZhNDcyZjcwZTQwNTlhNTk2YzNkZWE3NWNmMjNmL3RhYmxlcmFuZ2U6MGM0ZmE0NzJmNzBlNDA1OWE1OTZjM2RlYTc1Y2YyM2ZfMi0yLTEtMS03NzAzMg_e759acac-49be-4797-b488-2404f3f547e9"
      unitRef="shares">505000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RhYmxlOjBjNGZhNDcyZjcwZTQwNTlhNTk2YzNkZWE3NWNmMjNmL3RhYmxlcmFuZ2U6MGM0ZmE0NzJmNzBlNDA1OWE1OTZjM2RlYTc1Y2YyM2ZfMy0xLTEtMS03NzAzMg_7ec10d28-071a-49d6-9c3b-7618982fc3e2"
      unitRef="shares">6000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RhYmxlOjBjNGZhNDcyZjcwZTQwNTlhNTk2YzNkZWE3NWNmMjNmL3RhYmxlcmFuZ2U6MGM0ZmE0NzJmNzBlNDA1OWE1OTZjM2RlYTc1Y2YyM2ZfMy0yLTEtMS03NzAzMg_21c8ab5a-d9eb-4d75-b17b-a96a30169db8"
      unitRef="shares">6000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RhYmxlOjBjNGZhNDcyZjcwZTQwNTlhNTk2YzNkZWE3NWNmMjNmL3RhYmxlcmFuZ2U6MGM0ZmE0NzJmNzBlNDA1OWE1OTZjM2RlYTc1Y2YyM2ZfNC0xLTEtMS03NzAzMg_d6840e7e-69a0-49fa-9d9c-7ec56fa7f5a2"
      unitRef="shares">509000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RhYmxlOjBjNGZhNDcyZjcwZTQwNTlhNTk2YzNkZWE3NWNmMjNmL3RhYmxlcmFuZ2U6MGM0ZmE0NzJmNzBlNDA1OWE1OTZjM2RlYTc1Y2YyM2ZfNC0yLTEtMS03NzAzMg_72f14d15-87f0-4cc7-9449-0b7606dbc56a"
      unitRef="shares">511000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RleHRyZWdpb246MzI2YjJiZDAwYzhmNDczYzgxODkwYjU3MjZhZDZhZjJfNjUw_35370b25-874e-4d0e-8209-7d096ce0f961"
      unitRef="shares">4000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183Ni9mcmFnOjMyNmIyYmQwMGM4ZjQ3M2M4MTg5MGI1NzI2YWQ2YWYyL3RleHRyZWdpb246MzI2YjJiZDAwYzhmNDczYzgxODkwYjU3MjZhZDZhZjJfMTA5OTUxMTYyODg5NA_eb933ffa-5095-4c8c-a1c4-e7b8ac469d01"
      unitRef="shares">7000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfODgxOA_0a235ab5-ff23-44e3-b509-dda240d27e11">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate on a global basis and are exposed to the risk that our earnings, cash flows and equity could be adversely impacted by fluctuations in foreign exchange and interest rates. Our hedging policy attempts to manage these risks to an acceptable level based on our judgment of the appropriate trade-off between risk, opportunity and costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are primarily exposed to foreign exchange risk with respect to recognized assets and liabilities, forecasted transactions and net assets denominated in the Euro, British Pound, Chinese Renminbi, Korean Won, Australian Dollar, Canadian Dollar, Japanese Yen, Colombian Peso, Brazilian Real, Mexican Peso, Turkish Lira, Indian Rupee and Swedish Krona. We manage our foreign currency exposures on a consolidated basis, which allows us to net exposures and take advantage of any natural offsets. In addition, we use derivative and nonderivative instruments to further reduce the net exposure to foreign exchange risk. Gains and losses on the hedging instruments offset losses and gains on the hedged transactions and reduce the earnings and equity volatility resulting from changes in foreign exchange rates. Financial market and currency volatility may limit our ability to cost-effectively hedge these exposures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are also exposed to the risk that our earnings and cash flows could be adversely impacted by fluctuations in interest rates. Our policy is to manage interest costs using the mix of fixed- and floating-rate debt that we believe is appropriate at that time. To manage this mix in a cost-efficient manner, we periodically enter into interest rate swaps in which we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not hold any instruments for trading purposes and none of our outstanding derivative instruments contain credit-risk-related contingent features.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All derivative instruments are generally recognized as either assets or liabilities at fair value in the condensed consolidated balance sheets and are classified as short-term or long-term based on the scheduled maturity of the instrument. We designate certain of our derivatives and foreign-currency denominated debt as hedging instruments in cash flow, fair value, or net investment hedges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Cash Flow Hed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;g&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;es&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may use options, including collars and purchased options, forwards and cross-currency swaps to hedge the foreign exchange risk to earnings relating to forecasted transactions and recognized assets and liabilities. We periodically use treasury rate locks to hedge the risk to earnings associated with movements in interest rates relating to anticipated issuances of debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each derivative instrument that is designated and effective as a cash flow hedge, the gain or loss on the derivative is recorded in AOCI and then recognized in earnings consistent with the underlying hedged item. Option premiums or net premiums paid are initially recorded as assets and reclassified to other comprehensive income (OCI) over the life of the option, and then recognized in earnings consistent with the underlying hedged item. Cash flow hedges are classified in cost of sales and interest expense, net, and are primarily related to forecasted intra-company sales denominated in foreign currencies and forecasted interest payments on anticipated issuances of debt, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts of foreign exchange contracts designated as cash flow hedges were $402 million and $377 million as of March&#160;31, 2022 and December&#160;31, 2021, respectively. The maximum term over which we have cash flow &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;hedge contracts in place related to forecasted transactions at March&#160;31, 2022 is 12 months for foreign exchange contracts. There were no outstanding interest rate contracts designated as cash flow hedges as of March&#160;31, 2022 and December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Fair Value Hed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;g&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;es&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We periodically use interest rate swaps to convert a portion of our fixed-rate debt into variable-rate debt. These instruments hedge our earnings from changes in the fair value of debt due to fluctuations in the designated benchmark interest rate. For each derivative instrument that is designated and effective as a fair value hedge, the gain or loss on the derivative is recognized immediately to earnings, and offsets changes in fair value attributable to a particular risk, such as changes in interest rates, of the hedged item, which are also recognized in earnings. Changes in the fair value of hedge instruments designated as fair value hedges are classified in interest expense, net, as they hedge the interest rate risk associated with certain of our fixed-rate debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no outstanding interest rate contracts designated as fair value hedges as of March&#160;31, 2022 and December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Net Investment Hed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;g&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;es&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, we issued &#x20ac;600 million of senior notes due May 2025. In May 2019, we issued &#x20ac;750 million of senior notes due May 2024 and &#x20ac;750 million of senior notes due May 2029. We have designated these debt obligations as hedges of our net investment in our European operations and, as a result, mark to spot rate adjustments on the outstanding debt balances are recorded as a component of AOCI. As of March&#160;31, 2022, we had an accumulated pre-tax unrealized translation loss in AOCI of $4 million related to the Euro-denominated senior notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Dedesignations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If it is determined that a derivative or nonderivative hedging instrument is no longer highly effective as a hedge, we discontinue hedge accounting prospectively. Gains or losses relating to terminations of effective cash flow hedges generally continue to be deferred and are recognized consistent with the loss or income recognition of the underlying hedged items. However, if it is probable that the hedged forecasted transactions will not occur, any gains or losses would be immediately reclassified from AOCI to earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no hedge dedesignations in the first three months of 2022 or 2021 resulting from changes in our assessment of the probability that the hedged forecasted transactions would occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If we terminate a fair value hedge, an amount equal to the cumulative fair value adjustment to the hedged item at the date of termination is amortized to earnings over the remaining term of the hedged item. There were no fair value hedges terminated during the first three months of 2022 or 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If we remove a net investment hedge designation, any gains or losses recognized in AOCI are not reclassified to earnings until we sell, liquidate, or deconsolidate the foreign investments that were being hedged. There were no net investment hedges terminated during the first three months of 2022 or 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Undesignated Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use forward contracts to hedge earnings from the effects of foreign exchange relating to certain of our intra-company and third-party receivables and payables denominated in a foreign currency. These derivative instruments are generally not formally designated as hedges and the terms of these instruments generally do not exceed one month.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total notional amount of undesignated derivative instruments was $940&#160;million as of March&#160;31, 2022 and $851 million as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Gains and Losses on Hedging Instruments and Undesignated Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the three months ended March&#160;31, 2022 and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of gain (loss)&lt;br/&gt;in income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) reclassified from AOCI into income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of gain (loss) in income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, $5 million of deferred, net after-tax losses on derivative instruments included in AOCI are expected to be recognized in earnings during the next 12 months, coinciding with when the hedged items are expected to impact earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivative Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of March&#160;31, 2022.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in asset positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in liability positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of December&#160;31, 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in asset positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in liability positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While some of our derivatives are subject to master netting arrangements, we present our assets and liabilities related to derivative instruments on a gross basis within the condensed consolidated balance sheets. Additionally, we are not required to post collateral for any of our outstanding derivatives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information on our derivative positions as if they were presented on a net basis, allowing for the right of offset by counterparty.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amounts recognized in the condensed consolidated balance sheets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the amounts recorded on the condensed consolidated balance sheet related to fair value hedges:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.281%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying amount of hedged item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cumulative amount of fair value hedging adjustment included&lt;br/&gt;&#160;in the carrying amount of the hedged item (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a) These fair value hedges were terminated in 2018 and earlier periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i760ce24b4a13497aa499059071c1bf88_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfMzU5Nw_ad811c99-9404-43e6-b154-c395f8bf56ff"
      unitRef="usd">402000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i536e66a57732404691a7c9d746a9c77a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfMzYwNA_90eb30c8-dc64-46d2-879e-887c65c934ac"
      unitRef="usd">377000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1
      contextRef="i557d8b940ffb46fea7a0ffbea9c8628e_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfMzc1Mw_278b4544-6f9e-452f-a2ad-91f8b50dce8c">P12M</us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i922227aeddd24ee2b5e427b08c34c08d_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfMzc5OQ_20565cd6-422e-4cc1-832b-bcbb24ea7c95"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i39dea52d46d64c63b911fc2fec7d9fa9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfMzc5OQ_45fc459c-1df2-4604-8fcc-ad8c63ca7343"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="if99e9e9771eb4da2a299bf355a486649_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNDY5Mw_57e7666d-8c3b-4bcc-9d97-92b085de2cc6"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i93c6321b74e54dc7ac6d3673ec476dd1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNDY5Mw_6954c6c9-bdbe-4b9e-93ef-09207dd239c7"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i61964dbdf7e84be88705f093c0802196_I20170531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNDgyNg_95bdbdae-35ad-4479-9c4a-8a24a9e183f2"
      unitRef="eur">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2197ddaf305b41748d421ed313216345_I20190531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNDg3Ng_21d37c3a-f4c0-41ce-bfea-8711fff59540"
      unitRef="eur">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i12a714234c6e4e9eb4d18197fbcce84c_I20190531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNDkwNg_93493392-2c4b-465f-be6b-5c36ae6c8750"
      unitRef="eur">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iacacd738d13b471191092dfc7ad4dea7_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNTIzMQ_0b50a0b0-7e94-49eb-8db3-c5b62e108e4e"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i4edbb47a30cf46afbff865ead00dd98c_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNTgzMw_0242cdcb-0dde-462e-a297-f93a7f0b20e6"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNTgzMw_56cc4d43-4e2e-4b3d-a49b-de2676024d74"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <bax:DerivativeFairValueTerminated
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNjIyMw_a33f2ad8-dc11-4c1c-b54a-3c35eab6449d"
      unitRef="usd">0</bax:DerivativeFairValueTerminated>
    <bax:DerivativeFairValueTerminated
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNjIyMw_cdcda04e-7ad3-4431-ae45-8f079d2128a5"
      unitRef="usd">0</bax:DerivativeFairValueTerminated>
    <bax:DerivativeNetInvestmentTerminated
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNjUxNQ_3d66ef83-c0d8-46b1-ae39-b8db77d724e1"
      unitRef="usd">0</bax:DerivativeNetInvestmentTerminated>
    <bax:DerivativeNetInvestmentTerminated
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNjUxNQ_bfbfb2a5-d82c-42e4-bc6f-85b894ad434e"
      unitRef="usd">0</bax:DerivativeNetInvestmentTerminated>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i71a1b7a14751464f96d1e33c2d439a5a_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNzA0MA_b122898b-7bd3-4a52-ad13-bee8f6c7b71f"
      unitRef="usd">940000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i792cbe33e35d445f91ea87aaf0e146b6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNDk0NzgwMjMzNDEzMA_30412fc9-2320-4d1b-8c63-9d6e77cd61d2"
      unitRef="usd">851000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfODgxMQ_dcbbea87-7d46-4a4c-af50-b844c212444b">The following tables summarize the gains and losses on our hedging instruments and the classification of those gains and losses within our condensed consolidated financial statements for the three months ended March&#160;31, 2022 and &lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of gain (loss)&lt;br/&gt;in income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) reclassified from AOCI into income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location of gain (loss) in income statement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i54c2d01d93ca4760941fa4a68b4b08b6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfMy0xLTEtMS03NzAzMg_c6406294-a6b3-4c3e-a401-fe1b71ad34a8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i03f7bde8ea3b46179c1c8a7c608bd403_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfMy0zLTEtMS03NzAzMg_cecb6478-1f67-4f8f-9c44-410844796287"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i2c56206e8fd2421181da55d3c02a8854_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfMy02LTEtMS03NzAzMg_9bf6e158-5317-471d-8cb8-95e01c77829b"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i55ff25312dce4820b856d1dfd634ca60_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfMy04LTEtMS03NzAzMg_880fe40f-7a7a-44b2-b81e-cda103d89f76"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i557d8b940ffb46fea7a0ffbea9c8628e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNC0xLTEtMS03NzAzMg_5c47bbb6-c1b8-49b9-a29c-b46c95970002"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i15e37ef8d94a4fe0b71f0876df3d6ee2_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNC0zLTEtMS03NzAzMg_2797c409-5212-446b-b05b-a5f9a136113f"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i21388d336c1f433c8ceded9265e245d2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNC02LTEtMS03NzAzMg_6bc12ab1-b51b-4d9f-8eed-94280decb1e7"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i979180e5f4714629b4784cf1025dd9c6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNC04LTEtMS03NzAzMg_8a0e6a42-d4ed-40eb-b769-01eaad9c876c"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNS0xLTEtMS03NzAzMg_5f80a2fb-de41-41e3-9aa7-f4d966b5a529"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNS0zLTEtMS03NzAzMg_64b1dac8-59cf-4bb2-9daf-609dee7f6cc4"
      unitRef="usd">114000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i40ca9abc862645c4a33f3d2218f9f2a7_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNS02LTEtMS03NzAzMg_3517dbd3-0fa9-4bcc-bf66-805d1f96f3ab"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="id5b3d67eccd142a6939834d39b716b4f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNS04LTEtMS03NzAzMg_3b38dacf-42a2-41bc-8153-d167e2a98dc7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNi0xLTEtMS03NzAzMg_c2b9f50b-d553-4399-bf31-bcfeb0f356d2"
      unitRef="usd">39000000</bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax>
    <bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNi0zLTEtMS03NzAzMg_7f5a7f49-93f3-4bd0-b001-03870d229dd2"
      unitRef="usd">118000000</bax:OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax>
    <bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNi02LTEtMS03NzAzMg_4f2cce02-d1c0-4857-bcc4-2ea9595605aa"
      unitRef="usd">1000000</bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax>
    <bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmE1MzYzOTE3NmU5ZTRkYmM4NjhkZWU1MTYwMTVhNjBiL3RhYmxlcmFuZ2U6YTUzNjM5MTc2ZTllNGRiYzg2OGRlZTUxNjAxNWE2MGJfNi04LTEtMS03NzAzMg_1ed3ebc8-3729-4f64-9950-ceeb4a4aa54b"
      unitRef="usd">-11000000</bax:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i67f9b129d87944fa85b837dac860fb75_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjUxN2ZhYjRlN2VjZDRkNjJhNGMwMTQ3YjA0NjE5YjIwL3RhYmxlcmFuZ2U6NTE3ZmFiNGU3ZWNkNGQ2MmE0YzAxNDdiMDQ2MTliMjBfMy0yLTEtMS03NzAzMg_9c3e8895-1273-49ba-8663-31e70ee1f701"
      unitRef="usd">3000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i8f8128091c9b4323ac693e2f73552a3e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjUxN2ZhYjRlN2VjZDRkNjJhNGMwMTQ3YjA0NjE5YjIwL3RhYmxlcmFuZ2U6NTE3ZmFiNGU3ZWNkNGQ2MmE0YzAxNDdiMDQ2MTliMjBfMy00LTEtMS03NzAzMg_b3a5c188-92cb-4a1b-a48c-9066bf5d9923"
      unitRef="usd">-22000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfNzU4MA_8675f236-300c-4aa9-beda-d2d77d6fa820"
      unitRef="usd">5000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfODgyMQ_8a152b3f-3915-456d-8d38-967375cc2381">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of March&#160;31, 2022.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in asset positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in liability positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the classification and fair values of derivative instruments reported in the condensed consolidated balance sheet as of December&#160;31, 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in asset positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Derivatives in liability positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance sheet location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments designated as hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Undesignated derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total derivative instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib6d8a8344b6145c39ccd9339d15cc4d9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjgyYTE0ODhhNjgxMjQ5NTZiMzMzODM1MzM0YjNhNzcyL3RhYmxlcmFuZ2U6ODJhMTQ4OGE2ODEyNDk1NmIzMzM4MzUzMzRiM2E3NzJfNC0yLTEtMS03NzAzMg_610fee13-37de-41f3-a507-979cb09f2d8f"
      unitRef="usd">12000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i04f11ec5ea644541baa8aa7176602e10_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjgyYTE0ODhhNjgxMjQ5NTZiMzMzODM1MzM0YjNhNzcyL3RhYmxlcmFuZ2U6ODJhMTQ4OGE2ODEyNDk1NmIzMzM4MzUzMzRiM2E3NzJfNC01LTEtMS03NzAzMg_3b2e19a4-9167-4146-9422-c3c840471a00"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i7fdf8bf9a08147fab31750ea1f96c4f5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjgyYTE0ODhhNjgxMjQ5NTZiMzMzODM1MzM0YjNhNzcyL3RhYmxlcmFuZ2U6ODJhMTQ4OGE2ODEyNDk1NmIzMzM4MzUzMzRiM2E3NzJfNi0yLTEtMS03NzAzMg_7afce1fc-153f-4dc5-82f2-ee72f8ddd676"
      unitRef="usd">12000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7fdf8bf9a08147fab31750ea1f96c4f5_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjgyYTE0ODhhNjgxMjQ5NTZiMzMzODM1MzM0YjNhNzcyL3RhYmxlcmFuZ2U6ODJhMTQ4OGE2ODEyNDk1NmIzMzM4MzUzMzRiM2E3NzJfNi01LTEtMS03NzAzMg_7b1e12e6-a955-45fd-aa0f-bdcce52fe4b2"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iec4b84b3fc74452c9f24e03eaad33954_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjgyYTE0ODhhNjgxMjQ5NTZiMzMzODM1MzM0YjNhNzcyL3RhYmxlcmFuZ2U6ODJhMTQ4OGE2ODEyNDk1NmIzMzM4MzUzMzRiM2E3NzJfOC0yLTEtMS03NzAzMg_dc737a3d-f13f-48ad-b34b-e910797c0c5f"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie3f91e0124ba4fa4ac402434dc93e87b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjgyYTE0ODhhNjgxMjQ5NTZiMzMzODM1MzM0YjNhNzcyL3RhYmxlcmFuZ2U6ODJhMTQ4OGE2ODEyNDk1NmIzMzM4MzUzMzRiM2E3NzJfOC01LTEtMS03NzAzMg_777058c5-7d58-4ce2-82e8-02af27f062ab"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjgyYTE0ODhhNjgxMjQ5NTZiMzMzODM1MzM0YjNhNzcyL3RhYmxlcmFuZ2U6ODJhMTQ4OGE2ODEyNDk1NmIzMzM4MzUzMzRiM2E3NzJfOS0yLTEtMS03NzAzMg_59e33da2-3c02-4222-b30d-69f0ffb21f31"
      unitRef="usd">16000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjgyYTE0ODhhNjgxMjQ5NTZiMzMzODM1MzM0YjNhNzcyL3RhYmxlcmFuZ2U6ODJhMTQ4OGE2ODEyNDk1NmIzMzM4MzUzMzRiM2E3NzJfOS01LTEtMS03NzAzMg_e0fd30de-3192-4f9c-87c4-7c22c60cccff"
      unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9783d9bb5346424386c830791c5bd9af_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjQyZTYwN2I2ZjFkZjQ2YTNhMzM0Yjc2MjQ0NTM3N2M5L3RhYmxlcmFuZ2U6NDJlNjA3YjZmMWRmNDZhM2EzMzRiNzYyNDQ1Mzc3YzlfNC0yLTEtMS03NzAzMg_06da04ae-bd3c-416c-8159-65cf7dca5f48"
      unitRef="usd">6000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9ebea270340c48ee9999faf277ae4c89_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjQyZTYwN2I2ZjFkZjQ2YTNhMzM0Yjc2MjQ0NTM3N2M5L3RhYmxlcmFuZ2U6NDJlNjA3YjZmMWRmNDZhM2EzMzRiNzYyNDQ1Mzc3YzlfNC01LTEtMS03NzAzMg_255b4b62-a988-4900-b19c-4a23d028b3fc"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1eb9fbfcc3ce4d20837be295da12469a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjQyZTYwN2I2ZjFkZjQ2YTNhMzM0Yjc2MjQ0NTM3N2M5L3RhYmxlcmFuZ2U6NDJlNjA3YjZmMWRmNDZhM2EzMzRiNzYyNDQ1Mzc3YzlfNi0yLTEtMS03NzAzMg_083f2e8d-04af-42cc-8225-b131ca84c427"
      unitRef="usd">6000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1eb9fbfcc3ce4d20837be295da12469a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjQyZTYwN2I2ZjFkZjQ2YTNhMzM0Yjc2MjQ0NTM3N2M5L3RhYmxlcmFuZ2U6NDJlNjA3YjZmMWRmNDZhM2EzMzRiNzYyNDQ1Mzc3YzlfNi01LTEtMS03NzAzMg_d8d182fc-d7e2-426a-a59a-a366883d4c18"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1229bd8de1424b6cafbefda84c89f17f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjQyZTYwN2I2ZjFkZjQ2YTNhMzM0Yjc2MjQ0NTM3N2M5L3RhYmxlcmFuZ2U6NDJlNjA3YjZmMWRmNDZhM2EzMzRiNzYyNDQ1Mzc3YzlfOC0yLTEtMS03NzAzMg_8f7b9cef-5301-40f5-aa26-e169d65bca1a"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i3b481b445da94740a0c83504d45ed0c1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjQyZTYwN2I2ZjFkZjQ2YTNhMzM0Yjc2MjQ0NTM3N2M5L3RhYmxlcmFuZ2U6NDJlNjA3YjZmMWRmNDZhM2EzMzRiNzYyNDQ1Mzc3YzlfOC01LTEtMS03NzAzMg_3cdc1c63-8b9f-4d37-ba42-5b9191863085"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjQyZTYwN2I2ZjFkZjQ2YTNhMzM0Yjc2MjQ0NTM3N2M5L3RhYmxlcmFuZ2U6NDJlNjA3YjZmMWRmNDZhM2EzMzRiNzYyNDQ1Mzc3YzlfOS0yLTEtMS03NzAzMg_e428dc49-5503-40ed-b2d8-3d1e803a0b25"
      unitRef="usd">8000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjQyZTYwN2I2ZjFkZjQ2YTNhMzM0Yjc2MjQ0NTM3N2M5L3RhYmxlcmFuZ2U6NDJlNjA3YjZmMWRmNDZhM2EzMzRiNzYyNDQ1Mzc3YzlfOS01LTEtMS03NzAzMg_a527840a-b738-4bee-94ba-beb70271ebff"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <bax:ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfODgyMg_8b321b38-1b2f-4845-a619-587d3343dd44">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information on our derivative positions as if they were presented on a net basis, allowing for the right of offset by counterparty.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amounts recognized in the condensed consolidated balance sheets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</bax:ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfMi0xLTEtMS03NzAzMg_a75f6b14-2995-4379-bacf-d3277244a00b"
      unitRef="usd">16000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfMi0yLTEtMS03NzAzMg_6febd03c-e131-4015-b52d-c2b150c54f09"
      unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfMi00LTEtMS03NzAzMg_beb2dcdd-15f1-4c14-b50d-dc493c62fd54"
      unitRef="usd">8000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfMi01LTEtMS03NzAzMg_90258fbd-4012-454c-b55f-90d797452e4f"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfMy0xLTEtMS03NzAzMg_20b20dd7-2c00-4007-a6e0-456d9a971912"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfMy0yLTEtMS03NzAzMg_b7804aad-4e2f-4fa7-80a8-895b7e8eade2"
      unitRef="usd">3000000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfMy00LTEtMS03NzAzMg_acff28a4-8e36-4536-840e-d6098cab7ddd"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral>
    <us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfMy01LTEtMS03NzAzMg_6cfdc7a4-e63f-4a48-a6f0-38e22d24487a"
      unitRef="usd">2000000</us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral>
    <bax:DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfNC0xLTEtMS03NzAzMg_447fb5d3-5342-4585-a868-7363d8c3f395"
      unitRef="usd">13000000</bax:DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability>
    <bax:DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfNC0yLTEtMS03NzAzMg_924c0901-d080-4899-b233-ebc7bcc362bc"
      unitRef="usd">4000000</bax:DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets>
    <bax:DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfNC00LTEtMS03NzAzMg_dd7b39a4-33c3-4921-b130-3ed17c9f6149"
      unitRef="usd">6000000</bax:DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability>
    <bax:DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOmJmYmNkNmFmOGJjMjQ0YWNiODYwMDFmNDMyZDBkNTMyL3RhYmxlcmFuZ2U6YmZiY2Q2YWY4YmMyNDRhY2I4NjAwMWY0MzJkMGQ1MzJfNC01LTEtMS03NzAzMg_22a00a00-7386-4878-b5ec-71c738d70f8a"
      unitRef="usd">3000000</bax:DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets>
    <us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RleHRyZWdpb246MWRmM2ViODQyZWE4NGFmZWIwNzQ1MGE5OGI1YmQ4N2VfODgxNQ_90311ccf-663f-4303-b7be-b38434c6220a">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the amounts recorded on the condensed consolidated balance sheet related to fair value hedges:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.512%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.281%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Carrying amount of hedged item&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cumulative amount of fair value hedging adjustment included&lt;br/&gt;&#160;in the carrying amount of the hedged item (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a) These fair value hedges were terminated in 2018 and earlier periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:HedgedLiabilityFairValueHedge
      contextRef="iad0696204cae46f4a2dd949869b8a0a2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjNiMGU2YWEwOTc0ZTQwOTE4ZjMwOWUwYjZiMDkzYmFmL3RhYmxlcmFuZ2U6M2IwZTZhYTA5NzRlNDA5MThmMzA5ZTBiNmIwOTNiYWZfMi0xLTEtMS03NzAzMg_168069d3-5cdc-4a60-b34e-67cb0fd9c1db"
      unitRef="usd">101000000</us-gaap:HedgedLiabilityFairValueHedge>
    <us-gaap:HedgedLiabilityFairValueHedge
      contextRef="i9b1f513dd2f84554beda8f0654d39157_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjNiMGU2YWEwOTc0ZTQwOTE4ZjMwOWUwYjZiMDkzYmFmL3RhYmxlcmFuZ2U6M2IwZTZhYTA5NzRlNDA5MThmMzA5ZTBiNmIwOTNiYWZfMi0yLTEtMS03NzAzMg_655ef5ea-be8c-4cc5-b225-e7a126c438ce"
      unitRef="usd">101000000</us-gaap:HedgedLiabilityFairValueHedge>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="iad0696204cae46f4a2dd949869b8a0a2_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjNiMGU2YWEwOTc0ZTQwOTE4ZjMwOWUwYjZiMDkzYmFmL3RhYmxlcmFuZ2U6M2IwZTZhYTA5NzRlNDA5MThmMzA5ZTBiNmIwOTNiYWZfMi00LTEtMS03NzAzMg_84665e9a-bfb1-4710-8044-948824412a82"
      unitRef="usd">4000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="i9b1f513dd2f84554beda8f0654d39157_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY183OS9mcmFnOjFkZjNlYjg0MmVhODRhZmViMDc0NTBhOThiNWJkODdlL3RhYmxlOjNiMGU2YWEwOTc0ZTQwOTE4ZjMwOWUwYjZiMDkzYmFmL3RhYmxlcmFuZ2U6M2IwZTZhYTA5NzRlNDA5MThmMzA5ZTBiNmIwOTNiYWZfMi01LTEtMS03NzAzMg_35ff59ce-54ab-4579-b4fd-b0c722dffa73"
      unitRef="usd">4000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMzMwMw_4711faa3-7b77-4c08-8b1c-399ea1ac2c22">FAIR VALUE MEASUREMENTS&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our assets and liabilities that are measured at fair value on a recurring basis.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quoted prices in active markets for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant other&lt;br/&gt;observable inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant&lt;br/&gt;unobservable inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.513%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quoted prices in active markets for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant other&lt;br/&gt;observable inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant&lt;br/&gt;unobservable inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022 and December&#160;31, 2021, cash and cash equivalents of $2.3 billion and $3.0 billion, respectively, included money market and other short-term funds of approximately $426 million and $816 million, respectively, which are considered Level 2 in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For assets that are measured using quoted prices in active markets, the fair value is the published market price per unit multiplied by the number of units held, without consideration of transaction costs. The majority of the derivatives entered into by us are valued using internal valuation techniques as no quoted market prices exist for such instruments. The principal techniques used to value these instruments are discounted cash flow and Black-Scholes models. The key inputs, which are considered observable and vary depending on the type of derivative, include contractual terms, interest rate yield curves, foreign exchange rates and volatility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities, which consist of convertible debt and convertible redeemable preferred shares issued by nonpublic entities, are measured using discounted cash flow and option pricing models. Those debt securities are classified as Level 3 fair value measurements when there are no observable transactions near the balance sheet date due to the lack of observable data over certain fair value inputs such as equity volatility. The fair values of debt securities increase when interest rates decrease, equity volatility increases, or the fair values of the equity shares underlying the conversion options increase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent payments related to acquisitions, which consist of milestone payments and sales-based payments, are valued using discounted cash flow techniques. The fair value of milestone payments reflects management&#x2019;s expectations of probability of payment, and increases as the probability of payment increases or the expected timing of payments is accelerated. The fair value of sales-based payments is based upon probability-weighted future revenue estimates, and increases as revenue estimates increase, probability weighting of higher revenue scenarios increases or the expected timing of payment is accelerated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of recurring fair value measurements that use significant unobservable inputs (Level 3), which consist of contingent payments related to acquisitions and debt securities.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value recognized in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Instruments Not Measured at Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the financial instruments that we are required to recognize at fair value in the condensed consolidated balance sheets, we have certain financial instruments that are recognized at amortized cost or some basis other than fair value. For these financial instruments, the following table provides the values recognized in the condensed consolidated balance sheets and the estimated fair values as of March&#160;31, 2022 and December&#160;31, 2021.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Book values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair values(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-term debt and finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;These fair value amounts are classified as Level 2 within the fair value hierarchy as they are estimated based on observable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of short-term debt approximates its fair value due to the short-term maturities of the obligations. The estimated fair values of current and long-term debt were computed by multiplying price by the notional amount of the respective debt instruments. Price is calculated using the stated terms of the respective debt instrument and yield curves commensurate with our credit risk. The carrying values of other financial instruments, such as accounts receivable and accounts payable, approximate their fair values due to the short-term maturities of most of those assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity investments not measured at fair value are comprised of other equity investments without readily determinable fair values and were $110 million at March&#160;31, 2022 and $114 million at December&#160;31, 2021. Those investments are included in Other non-current assets on our condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMzI5OQ_6c321be4-6800-4548-8be1-57b34cef78f8">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our assets and liabilities that are measured at fair value on a recurring basis.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quoted prices in active markets for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant other&lt;br/&gt;observable inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant&lt;br/&gt;unobservable inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.513%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basis of fair value measurement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quoted prices in active markets for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant other&lt;br/&gt;observable inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Significant&lt;br/&gt;unobservable inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="i97b20784595f4505a4473852b0d24361_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMy0xLTEtMS03NzAzMg_7f3e3cca-70c7-4206-adfb-b185ec425a2e"
      unitRef="usd">16000000</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="id1dc1bf720b14af7be2658f5b9411099_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMy0yLTEtMS03NzAzMg_66cf15ea-b2f2-4419-abe2-b85125566535"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="i010ba63179714c00a597d4434cdda0e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMy0zLTEtMS03NzAzMg_72fbc4f7-924c-4aa2-b3bb-41b4f739381b"
      unitRef="usd">16000000</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="ied8dcdf39e2c4956942ba609511fb42c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMy00LTEtMS03NzAzMg_c0d201f1-5cf6-4a34-9067-2236f0fcb60a"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:DebtSecurities
      contextRef="i97b20784595f4505a4473852b0d24361_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNS0xLTEtMS03NzAzMg_2270f037-6288-4848-a4b0-8837185d4ca3"
      unitRef="usd">53000000</us-gaap:DebtSecurities>
    <us-gaap:DebtSecurities
      contextRef="id1dc1bf720b14af7be2658f5b9411099_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNS0yLTEtMS03NzAzMg_b1cc8218-97d6-47b1-983a-3fe857c4fd9c"
      unitRef="usd">0</us-gaap:DebtSecurities>
    <us-gaap:DebtSecurities
      contextRef="i010ba63179714c00a597d4434cdda0e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNS0zLTEtMS03NzAzMg_5e73c236-231b-457e-9e74-610469dba8de"
      unitRef="usd">0</us-gaap:DebtSecurities>
    <us-gaap:DebtSecurities
      contextRef="ied8dcdf39e2c4956942ba609511fb42c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNS00LTEtMS03NzAzMg_3da0fb81-4a57-46fa-8387-5ad6381c122b"
      unitRef="usd">53000000</us-gaap:DebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i97b20784595f4505a4473852b0d24361_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNi0xLTEtMS03NzAzMg_7879d644-324b-4154-a948-bb35bd74b553"
      unitRef="usd">8000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id1dc1bf720b14af7be2658f5b9411099_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNi0yLTEtMS03NzAzMg_d550fbb6-fdb7-4d29-b0d5-2c7a30c72391"
      unitRef="usd">8000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i010ba63179714c00a597d4434cdda0e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNi0zLTEtMS03NzAzMg_77b26097-be47-4e04-a604-15ed90884d36"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ied8dcdf39e2c4956942ba609511fb42c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNi00LTEtMS03NzAzMg_0ee884f0-3533-4c0d-988e-94c0ee3d42da"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i97b20784595f4505a4473852b0d24361_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNy0xLTEtMS03NzAzMg_49861203-b9bc-416c-9f16-637062d4a923"
      unitRef="usd">77000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id1dc1bf720b14af7be2658f5b9411099_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNy0yLTEtMS03NzAzMg_ea72aa04-2d45-41a4-a72b-a5de2793000a"
      unitRef="usd">8000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i010ba63179714c00a597d4434cdda0e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNy0zLTEtMS03NzAzMg_5099eaa8-da50-4ede-bd00-5f1d8243c10c"
      unitRef="usd">16000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ied8dcdf39e2c4956942ba609511fb42c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfNy00LTEtMS03NzAzMg_377f5813-65a1-44f6-bd0b-0130cae38e31"
      unitRef="usd">53000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="i97b20784595f4505a4473852b0d24361_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfOS0xLTEtMS03NzAzMg_9ff02651-405a-4400-a029-6e1c1920a4ff"
      unitRef="usd">7000000</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="id1dc1bf720b14af7be2658f5b9411099_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfOS0yLTEtMS03NzAzMg_ef2564fc-5eca-4102-89d2-ec4e02a51e7f"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="i010ba63179714c00a597d4434cdda0e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfOS0zLTEtMS03NzAzMg_f329ba7c-dce7-430b-916a-c05956db2906"
      unitRef="usd">7000000</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="ied8dcdf39e2c4956942ba609511fb42c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfOS00LTEtMS03NzAzMg_f10cec1a-8da5-4ca6-9661-bf77d68f273c"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i97b20784595f4505a4473852b0d24361_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMTEtMS0xLTEtNzcwMzI_c9637db8-e801-4685-9270-ef242a48e0f8"
      unitRef="usd">124000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id1dc1bf720b14af7be2658f5b9411099_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMTEtMi0xLTEtNzcwMzI_785111b9-91ee-4211-ac87-4d6b9dde653e"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i010ba63179714c00a597d4434cdda0e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMTEtMy0xLTEtNzcwMzI_57a5b138-34f1-4fe8-bb2c-d978fcf6511a"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ied8dcdf39e2c4956942ba609511fb42c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMTEtNC0xLTEtNzcwMzI_90f2f8db-1025-484f-bb02-1f875998ba80"
      unitRef="usd">124000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i97b20784595f4505a4473852b0d24361_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMTItMS0xLTEtNzcwMzI_0051257d-a4e1-4e1a-b3e0-002468e829db"
      unitRef="usd">131000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id1dc1bf720b14af7be2658f5b9411099_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMTItMi0xLTEtNzcwMzI_10c80af4-e088-4b35-950f-ecf9e473668f"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i010ba63179714c00a597d4434cdda0e3_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMTItMy0xLTEtNzcwMzI_7f4d0b46-6e4d-4efc-bcd2-fda60e730d39"
      unitRef="usd">7000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ied8dcdf39e2c4956942ba609511fb42c_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjkxMGI5MzExN2QxNTQ2YzE5NmFiNzEyY2Q3YmUzMTFkL3RhYmxlcmFuZ2U6OTEwYjkzMTE3ZDE1NDZjMTk2YWI3MTJjZDdiZTMxMWRfMTItNC0xLTEtNzcwMzI_ed5716fc-f727-4e7e-ba98-6bb55db9593d"
      unitRef="usd">124000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="ied7ae06c0d764442a36e7ee405df5bae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMy0xLTEtMS03NzAzMg_0175866d-b1ab-456f-af2b-9eb6fcd6bb51"
      unitRef="usd">8000000</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="id4a1aa577cc642b1b122761aa34a02dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMy0yLTEtMS03NzAzMg_ec518984-982f-4b1c-8708-862f909a7e6c"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="i2e2f63de943c437cbf78e59b19e61166_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMy0zLTEtMS03NzAzMg_ce373b36-7ad3-4aed-b97a-f9886b39cde2"
      unitRef="usd">8000000</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue
      contextRef="ia57b4248164c447fa78ab9e72dae9482_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMy00LTEtMS03NzAzMg_908e75bc-9030-43bb-8ae8-e9d65d4bcffd"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue>
    <us-gaap:DebtSecurities
      contextRef="ied7ae06c0d764442a36e7ee405df5bae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNS0xLTEtMS03NzAzMg_b861df53-b49c-440c-bfda-42c43f591b18"
      unitRef="usd">30000000</us-gaap:DebtSecurities>
    <us-gaap:DebtSecurities
      contextRef="id4a1aa577cc642b1b122761aa34a02dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNS0yLTEtMS03NzAzMg_c0994559-3722-477e-9920-82660af918b0"
      unitRef="usd">0</us-gaap:DebtSecurities>
    <us-gaap:DebtSecurities
      contextRef="i2e2f63de943c437cbf78e59b19e61166_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNS0zLTEtMS03NzAzMg_e21d87fd-8ce3-4c9e-87a7-bb35aba280e4"
      unitRef="usd">0</us-gaap:DebtSecurities>
    <us-gaap:DebtSecurities
      contextRef="ia57b4248164c447fa78ab9e72dae9482_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNS00LTEtMS03NzAzMg_9273e9e2-c798-4840-8580-70c23b2fa6cf"
      unitRef="usd">30000000</us-gaap:DebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ied7ae06c0d764442a36e7ee405df5bae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNi0xLTEtMS03NzAzMg_55133ecb-9142-4410-89e8-589e88eba03e"
      unitRef="usd">10000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id4a1aa577cc642b1b122761aa34a02dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNi0yLTEtMS03NzAzMg_4bdb09d8-6058-48de-bd56-415d5f395226"
      unitRef="usd">10000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i2e2f63de943c437cbf78e59b19e61166_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNi0zLTEtMS03NzAzMg_72772104-1bf2-45c8-a865-ce408adf8cda"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia57b4248164c447fa78ab9e72dae9482_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNi00LTEtMS03NzAzMg_c18a935b-3eee-4927-b358-6cc7fd367cdd"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ied7ae06c0d764442a36e7ee405df5bae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNy0xLTEtMS03NzAzMg_ecf6b724-043f-46bc-a7c3-13861c142cdd"
      unitRef="usd">48000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id4a1aa577cc642b1b122761aa34a02dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNy0yLTEtMS03NzAzMg_5fa4ab6e-e525-4a4d-a445-9bc283c4ba9c"
      unitRef="usd">10000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2e2f63de943c437cbf78e59b19e61166_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNy0zLTEtMS03NzAzMg_7933162a-d0e0-4abc-a1e7-d027e944a96b"
      unitRef="usd">8000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia57b4248164c447fa78ab9e72dae9482_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfNy00LTEtMS03NzAzMg_d9a447a7-aa33-4301-8505-25257b45e219"
      unitRef="usd">30000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="ied7ae06c0d764442a36e7ee405df5bae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfOS0xLTEtMS03NzAzMg_2e4e3d6b-1462-4207-8557-1e999c1f61ef"
      unitRef="usd">5000000</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="id4a1aa577cc642b1b122761aa34a02dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfOS0yLTEtMS03NzAzMg_bead3dbf-3e1e-46dc-b478-f4739ce2c375"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="i2e2f63de943c437cbf78e59b19e61166_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfOS0zLTEtMS03NzAzMg_c744abff-a6a6-4c78-b0a8-808728379bc3"
      unitRef="usd">5000000</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue
      contextRef="ia57b4248164c447fa78ab9e72dae9482_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfOS00LTEtMS03NzAzMg_9fafcf25-139e-4b9e-89c7-be38b5de0bb8"
      unitRef="usd">0</us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ied7ae06c0d764442a36e7ee405df5bae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMTEtMS0xLTEtNzcwMzI_c7d62632-b1e0-4669-b59d-e89371b57d2c"
      unitRef="usd">143000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id4a1aa577cc642b1b122761aa34a02dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMTEtMi0xLTEtNzcwMzI_257dcc6f-66c9-43da-8d2e-d85b4d743771"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2e2f63de943c437cbf78e59b19e61166_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMTEtMy0xLTEtNzcwMzI_9751804e-d7b0-4e3f-9dfc-406fbd50d9ad"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia57b4248164c447fa78ab9e72dae9482_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMTEtNC0xLTEtNzcwMzI_9a668cf3-4d6a-4baa-88ce-12f965ab0b55"
      unitRef="usd">143000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ied7ae06c0d764442a36e7ee405df5bae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMTItMS0xLTEtNzcwMzI_f4c76269-6f0b-49ea-9e56-658d63bf173c"
      unitRef="usd">148000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id4a1aa577cc642b1b122761aa34a02dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMTItMi0xLTEtNzcwMzI_d63bd91d-203d-4c10-ac7a-e4f65437eb5c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2e2f63de943c437cbf78e59b19e61166_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMTItMy0xLTEtNzcwMzI_ba46ca7a-3a56-4995-ab63-04b2cbad7313"
      unitRef="usd">5000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia57b4248164c447fa78ab9e72dae9482_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjgxNDQ3NTgyY2I1YTQ4MWZiODg2NGQyNWJhZjQxYmNhL3RhYmxlcmFuZ2U6ODE0NDc1ODJjYjVhNDgxZmI4ODY0ZDI1YmFmNDFiY2FfMTItNC0xLTEtNzcwMzI_ae59592d-3865-4e9e-8e23-26b13108decf"
      unitRef="usd">143000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1d4414eacf9648f9881e2e9dc42887af_I20220331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMTk0_33b3d2a5-4984-47ca-b75b-6f878fd5bc5e"
      unitRef="usd">2300000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9ad9afe3b705496a92217df29836a764_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMjAx_1b8d0faf-b189-4343-8f02-c07f010d80e7"
      unitRef="usd">3000000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i488bf22168054382b33a870cea5e12cf_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMjg1_ef527014-cb4f-4615-aebb-f0ee6ea135eb"
      unitRef="usd">426000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="i0847c8d0a513447ab785792887cef7be_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMjky_1525dc3d-2b96-4ebc-bf5a-451b75e3f85f"
      unitRef="usd">816000000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMzMwMA_3b3f02e3-5b7d-45e6-a030-b1c384228b7c">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of recurring fair value measurements that use significant unobservable inputs (Level 3), which consist of contingent payments related to acquisitions and debt securities.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent payments related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value recognized in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i2a479dd0e9e04335a78d838743107def_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfMi0xLTEtMS03NzAzMg_56e118be-fc73-40f8-850a-4f50c683d026"
      unitRef="usd">143000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i4d57b720176840b084b62f8a521d47d2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfMy0yLTEtMS04NTI3Nw_b2647e1b-2082-478d-b111-e38fa2bcd7a9"
      unitRef="usd">30000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i0699d0c72b624afcb5f0a2f67dead789_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfMi0yLTEtMS03NzAzMg_1bf74d1a-6694-4114-a552-77571e32820b"
      unitRef="usd">30000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i792e4039270545aba120425226791181_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfMy0xLTEtMS03NzAzMg_7033f6ff-a0f6-4231-9494-6f1b9e0c8289"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i904ebe57a03f41a19cccabe5981567e2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNC0yLTEtMS04NTI3Nw_70ff9cf4-720a-45b9-ba55-a21a7cf30d5a"
      unitRef="usd">21000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i1adb4c593b09447c8976d8d028dcd78c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfMy0yLTEtMS03NzAzMg_fc4e1971-87cf-48ce-b687-88b29ad13acd"
      unitRef="usd">24000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i792e4039270545aba120425226791181_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNS0xLTEtMS03NzAzMg_6e0ea990-78c8-4051-9080-ebc71021eb58"
      unitRef="usd">-17000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i904ebe57a03f41a19cccabe5981567e2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNi0yLTEtMS04NTI4NA_d8b55fdc-7266-4bed-a0c0-902abe47e531"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i1adb4c593b09447c8976d8d028dcd78c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNS0yLTEtMS03NzAzMg_459821e2-f392-4084-9316-d103dc9c5d5a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="i792e4039270545aba120425226791181_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNy0xLTEtMS04NjMwNw_f23e1cb1-c372-4214-96cc-cd9a87a9ef4a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="i904ebe57a03f41a19cccabe5981567e2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNy0yLTEtMS04NTI4NA_60a7ad09-613e-45ea-a10b-24ffcbca0840"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="i1adb4c593b09447c8976d8d028dcd78c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNy00LTEtMS04NTMwMA_be2b530c-2a4e-4c86-9bc3-3444b3eb54a6"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i792e4039270545aba120425226791181_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNi0xLTEtMS03NzAzMg_0d3b287e-dae9-4372-8cd4-2242e3faef3b"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i904ebe57a03f41a19cccabe5981567e2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfOC0yLTEtMS04NTI4NA_434f4064-1c73-43ec-9038-5b7460bfbf3a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i1adb4c593b09447c8976d8d028dcd78c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfNi0yLTEtMS03NzAzMg_3481d325-1f8f-47d5-aa98-2b6321b78d92"
      unitRef="usd">16000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i776aa6f56b4f4c128350b62839f20e93_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfOC0xLTEtMS03NzAzMg_bb0f6844-3045-4729-83f1-7360c27f951c"
      unitRef="usd">124000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i0e0990c5545d42eea9be6143b97da502_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfMTAtMi0xLTEtODUyOTI_7d9dfd66-d8d8-4d8e-9c7d-4eb19f28c560"
      unitRef="usd">53000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i02f792b41f554f2c98ec32ac34f7d2c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjZjMjcwNTVlMDFkNTQwNWViM2M4ZTFhNTM0MmNiOWFjL3RhYmxlcmFuZ2U6NmMyNzA1NWUwMWQ1NDA1ZWIzYzhlMWE1MzQyY2I5YWNfOC0yLTEtMS03NzAzMg_0f29207c-1234-442d-82f6-ee5c928c7186"
      unitRef="usd">38000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMzMwMQ_b88a9d79-426f-404d-98c2-e296ed569b7e">the following table provides the values recognized in the condensed consolidated balance sheets and the estimated fair values as of March&#160;31, 2022 and December&#160;31, 2021.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Book values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fair values(a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current maturities of long-term debt and finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt and finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;(a)&#160;&#160;&#160;&#160;These fair value amounts are classified as Level 2 within the fair value hierarchy as they are estimated based on observable inputs.</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:ShorttermDebtFairValue
      contextRef="i26c43bcaa7314a6b967da3c9bbca9100_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfMy0xLTEtMS03NzAzMg_1c80fe7a-41b2-4712-8ec0-324dea86243f"
      unitRef="usd">200000000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:ShorttermDebtFairValue
      contextRef="i5a4f6c720ee44c6ba4c1e80998b3d43c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfMy0yLTEtMS03NzAzMg_1d341b4b-e3b2-4757-b3ce-b54cd0340fd2"
      unitRef="usd">301000000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:ShorttermDebtFairValue
      contextRef="i811d8be2a7d740bebdca3c2d962061e9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfMy00LTEtMS03NzAzMg_2d921967-b57e-47df-94ef-0db13e7f049f"
      unitRef="usd">200000000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:ShorttermDebtFairValue
      contextRef="if73a3426d20d40529c001dbc761d4b8a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfMy01LTEtMS03NzAzMg_9873be0c-03f9-4bd6-ac8e-fe439169da0c"
      unitRef="usd">301000000</us-gaap:ShorttermDebtFairValue>
    <bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure
      contextRef="i26c43bcaa7314a6b967da3c9bbca9100_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfNC0xLTEtMS03NzAzMg_77f9c119-026c-4fd3-a995-7ea8f2fec8f2"
      unitRef="usd">209000000</bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure>
    <bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure
      contextRef="i5a4f6c720ee44c6ba4c1e80998b3d43c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfNC0yLTEtMS03NzAzMg_b9ced139-44ad-412d-8d45-6261e8bc82a4"
      unitRef="usd">210000000</bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure>
    <bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure
      contextRef="i811d8be2a7d740bebdca3c2d962061e9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfNC00LTEtMS03NzAzMg_0f2630ab-5a9c-49ef-b938-a35e8ccca202"
      unitRef="usd">209000000</bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure>
    <bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure
      contextRef="if73a3426d20d40529c001dbc761d4b8a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfNC01LTEtMS03NzAzMg_32cd8d19-14fc-4a77-ba89-633139281d9e"
      unitRef="usd">212000000</bax:LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure>
    <bax:LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure
      contextRef="i26c43bcaa7314a6b967da3c9bbca9100_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfNS0xLTEtMS03NzAzMg_07831b17-7f22-4d86-9b8f-afb1dc4dfcdd"
      unitRef="usd">16765000000</bax:LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure>
    <bax:LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure
      contextRef="i5a4f6c720ee44c6ba4c1e80998b3d43c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfNS0yLTEtMS03NzAzMg_bbba0282-9443-48dc-b7aa-56b7a0622fb8"
      unitRef="usd">17149000000</bax:LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure>
    <bax:LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure
      contextRef="i811d8be2a7d740bebdca3c2d962061e9_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfNS00LTEtMS03NzAzMg_e1763619-b1c5-41dc-9c78-5832512d34ff"
      unitRef="usd">16221000000</bax:LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure>
    <bax:LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure
      contextRef="if73a3426d20d40529c001dbc761d4b8a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RhYmxlOjBiMjUxNWE2YWQ0MjQ1NmQ5M2RkNmI0YTRmYmY1Mjg2L3RhYmxlcmFuZ2U6MGIyNTE1YTZhZDQyNDU2ZDkzZGQ2YjRhNGZiZjUyODZfNS01LTEtMS03NzAzMg_b7784990-9bcd-41d1-b1dd-44eaf48316f2"
      unitRef="usd">17568000000</bax:LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure>
    <us-gaap:OtherInvestmentNotReadilyMarketableFairValue
      contextRef="i4ae0b3674bb74050ac9785fa17b2f5e0_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMzE3Mg_752ff1d3-8eb1-469a-84bc-84987df9a16b"
      unitRef="usd">110000000</us-gaap:OtherInvestmentNotReadilyMarketableFairValue>
    <us-gaap:OtherInvestmentNotReadilyMarketableFairValue
      contextRef="ic1eabca8696d4c27a96d88b08c1bf0a8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184Mi9mcmFnOmRkOTQ4Nzk5NmNiMjQ4OGRiOWY5ZTZjNjZhZGI2ZTRjL3RleHRyZWdpb246ZGQ5NDg3OTk2Y2IyNDg4ZGI5ZjllNmM2NmFkYjZlNGNfMzE4NQ_fedbb0ef-918c-448b-9312-818956e53c1b"
      unitRef="usd">114000000</us-gaap:OtherInvestmentNotReadilyMarketableFairValue>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RleHRyZWdpb246ZWE1YzFjMzM3MWJkNDY3NmEwN2YxZmQ2ODFhN2IzODJfMjMyMg_b2d2a05b-72cb-4568-a2b8-49b2939efaec">SEGMENT INFORMATION&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We manage our business based on four segments, consisting of the following geographic segments related to our legacy Baxter business: Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia Pacific), and a new global segment for the acquired Hillrom business. The Americas, EMEA and APAC segments provide a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use operating income on a segment basis to make resource allocation decisions and assess the ongoing performance of our business segments. Intersegment sales are eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Certain items are maintained at Corporate and are not allocated to a segment. They primarily include corporate headquarters costs, certain R&amp;amp;D costs, certain product category support costs, stock compensation expense, certain employee benefit plan costs, and certain gains, losses, and other charges (such as business optimization, acquisition and integration costs, intangible asset amortization and asset impairments). For the period from our acquisition of Hillrom on December 13, 2021 through December 31, 2021, we previously included all costs incurred by the Hillrom business within that segment, including the types of costs described in the preceding sentence that are maintained at Corporate for our legacy Baxter segments. In connection with our ongoing integration activities, beginning in the first quarter 2022, we have updated the measure of profitability for our Hillrom segment by excluding such unallocated costs, consistent with our legacy Baxter segments. Those unallocated costs related to Hillrom, which totaled $219&#160;million for the three months ended March 31, 2022, are now presented within Corporate as well. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our chief operating decision maker does not receive any asset information by operating segment and, accordingly, we do not report asset information by operating segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information for our segments is as follows.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of segment operating income to income before income taxes per the condensed consolidated statements of income.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 9 for additional information on Net Sales by product category.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RleHRyZWdpb246ZWE1YzFjMzM3MWJkNDY3NmEwN2YxZmQ2ODFhN2IzODJfNjE_02e914b2-805c-4825-ac1e-19a684bacdcb"
      unitRef="segment">4</us-gaap:NumberOfOperatingSegments>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5b628cec409b4e0aa786971fa2453bd0_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RleHRyZWdpb246ZWE1YzFjMzM3MWJkNDY3NmEwN2YxZmQ2ODFhN2IzODJfMjc0ODc3OTA3NzM4Mg_9859cb95-335c-415b-93fb-346eccbcb52f"
      unitRef="usd">219000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RleHRyZWdpb246ZWE1YzFjMzM3MWJkNDY3NmEwN2YxZmQ2ODFhN2IzODJfMjMyMw_fb55c5c1-2ee5-45c4-984f-5e9ae793ad4e">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information for our segments is as follows.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Operating income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hillrom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36cc35bd29cf4b25b9ed69436f211f3d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfMy0xLTEtMS03NzAzMg_50f20251-710b-48db-9acf-b70ce46dec0a"
      unitRef="usd">1626000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb4a5d3c9d55448999d5cb714ebf69f3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfMy0yLTEtMS03NzAzMg_e4c9dbc1-7eec-4578-96ff-f35f55facc68"
      unitRef="usd">1560000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36c28755553f4b3caaab97024026e4e6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfNC0xLTEtMS03NzAzMg_9f7c7360-6226-47da-b10a-b3b64e3d47a9"
      unitRef="usd">699000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ea902d4e19b444db537a186c0a779f6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfNC0yLTEtMS03NzAzMg_9cbec945-94ac-4f9e-a527-3c796484ff94"
      unitRef="usd">738000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae63df0c85ca44cd98106826bb67c91f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfNS0xLTEtMS03NzAzMg_918f167d-4ddf-4132-a2b8-7925048b0db6"
      unitRef="usd">627000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i525d0111f09240c2b13835c305549821_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfNS0yLTEtMS03NzAzMg_61783b8c-299b-41c4-9d28-b6012837a431"
      unitRef="usd">648000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id80baa04c95740de8f4bebecb32003d3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfNi0xLTEtMS03ODI1MQ_dbe6c138-19e5-4330-8dc6-3bd60abcb5ad"
      unitRef="usd">755000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i904e310ddad74453ba7dc2d7fe323e01_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfNi0yLTEtMS03ODI1MQ_227dec2c-5ea2-49bf-9b75-1fe9bbbd4fee"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ica5497822c874fda93fa60cb6aee725c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfNi0xLTEtMS03NzAzMg_d1c404ca-81fe-4f5d-a445-fb47fab28127"
      unitRef="usd">3707000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic57b38264d9d4bfcb8a0f926e4426cba_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfNi0yLTEtMS03NzAzMg_9b1b7e63-0486-44f2-b0d1-ce44af28039f"
      unitRef="usd">2946000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i36cc35bd29cf4b25b9ed69436f211f3d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfOC0xLTEtMS03NzAzMg_a9230c3d-4d31-4af2-ac18-c2341571ac48"
      unitRef="usd">610000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieb4a5d3c9d55448999d5cb714ebf69f3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfOC0yLTEtMS03NzAzMg_35f150e1-ae9b-4cdf-b126-5b472f786ade"
      unitRef="usd">599000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i36c28755553f4b3caaab97024026e4e6_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfOS0xLTEtMS03NzAzMg_58d8a82a-aff2-49d4-833b-0d838e8c34d6"
      unitRef="usd">119000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1ea902d4e19b444db537a186c0a779f6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfOS0yLTEtMS03NzAzMg_e8a00333-7e97-4d7d-9c61-0135ec38ae28"
      unitRef="usd">135000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iae63df0c85ca44cd98106826bb67c91f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfMTAtMS0xLTEtNzcwMzI_108f6731-e30c-4879-8c0a-e3caca2d8361"
      unitRef="usd">151000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i525d0111f09240c2b13835c305549821_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfMTAtMi0xLTEtNzcwMzI_0e220efe-788f-4823-b2e7-82faaec456fd"
      unitRef="usd">138000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id80baa04c95740de8f4bebecb32003d3_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfMTItMS0xLTEtNzgyNzM_3eca9c9c-c92d-41db-b416-9d702e780a25"
      unitRef="usd">200000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i904e310ddad74453ba7dc2d7fe323e01_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfMTItMi0xLTEtNzgyNzM_10145b85-b955-4552-aac4-803a3a207d8c"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ica5497822c874fda93fa60cb6aee725c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfMTEtMS0xLTEtNzcwMzI_31885de8-d27e-407f-bd91-1cbd65bd36f3"
      unitRef="usd">1080000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic57b38264d9d4bfcb8a0f926e4426cba_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIxNjA1OTYxNTI0OTQwM2Q5MTU5MjgwMjk0NjA5YjQ1L3RhYmxlcmFuZ2U6YjE2MDU5NjE1MjQ5NDAzZDkxNTkyODAyOTQ2MDliNDVfMTEtMi0xLTEtNzcwMzI_9fec9d83-863a-4e59-929c-c27ceec6d8f5"
      unitRef="usd">872000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RleHRyZWdpb246ZWE1YzFjMzM3MWJkNDY3NmEwN2YxZmQ2ODFhN2IzODJfMjMyNA_e9050bfa-1d5e-4c9f-97a7-4fd3425aed27">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of segment operating income to income before income taxes per the condensed consolidated statements of income.&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="ica5497822c874fda93fa60cb6aee725c_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfMi0xLTEtMS03NzAzMg_c34cf4c3-3488-440e-b5b8-b3c5471f0847"
      unitRef="usd">1080000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic57b38264d9d4bfcb8a0f926e4426cba_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfMi0yLTEtMS03NzAzMg_d2238558-97ad-4493-914f-7ac952caead0"
      unitRef="usd">872000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib16764b626684350a430fa1f03cb037f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfMy0xLTEtMS03NzAzMg_d4562376-12a3-4ac8-bc7f-6a7d61419ccc"
      unitRef="usd">-917000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i82348ec896cc42a891600e853ebccd95_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfMy0yLTEtMS03NzAzMg_ad4f2995-b35e-4999-a307-6c4b3933f0eb"
      unitRef="usd">-482000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfNC0xLTEtMS03NzAzMg_5aa5df0f-d8b3-4ea4-ade4-2920e89ed577"
      unitRef="usd">163000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfNC0yLTEtMS03NzAzMg_9f2f2292-cc42-4eec-ae2e-d566d64eebd3"
      unitRef="usd">390000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfNS0xLTEtMS03NzAzMg_8bc4806c-9845-4326-aa24-32995012e050"
      unitRef="usd">-85000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfNS0yLTEtMS03NzAzMg_10ce23b6-dd43-4ebb-a808-6bf17deb019a"
      unitRef="usd">-34000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfNi0xLTEtMS03NzAzMg_a3fae88c-4627-4357-bb2d-3fa3bf32f1b7"
      unitRef="usd">16000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfNi0yLTEtMS03NzAzMg_544cdb9f-82b8-473b-bf21-5fe1f57191f9"
      unitRef="usd">-5000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0b7b723524ed4f1789829f72199711c8_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfNy0xLTEtMS03NzAzMg_608c9778-5c76-4a89-9acf-6d31387aa23a"
      unitRef="usd">94000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY184NS9mcmFnOmVhNWMxYzMzNzFiZDQ2NzZhMDdmMWZkNjgxYTdiMzgyL3RhYmxlOmIwODYxZjM2YzAyYzQzOGE4YzNhOTQzZGY3NDBmZTg3L3RhYmxlcmFuZ2U6YjA4NjFmMzZjMDJjNDM4YThjM2E5NDNkZjc0MGZlODdfNy0yLTEtMS03NzAzMg_0b528633-4e7f-46d9-8a11-3441bed59a84"
      unitRef="usd">351000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzgtMS0xLTEtNzcwMzI_13f35301-dea9-413f-b5f7-9ed6808fa9ae"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzgtMS0xLTEtNzcwMzI_13f35301-dea9-413f-b5f7-9ed6808fa9ae"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzktMi0xLTEtNzcwMzI_0eea4050-8459-42cf-9271-ac04667e54c9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzktMi0xLTEtNzcwMzI_0eea4050-8459-42cf-9271-ac04667e54c9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzktMS0xLTEtNzcwMzI_4cc77988-0a14-47a5-baa8-271ce71b1caf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzktMS0xLTEtNzcwMzI_4cc77988-0a14-47a5-baa8-271ce71b1caf"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzgtMi0xLTEtNzcwMzI_81b199f8-46cb-499e-87ef-81115911ecd7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzgtMi0xLTEtNzcwMzI_81b199f8-46cb-499e-87ef-81115911ecd7"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RleHRyZWdpb246ZWZlN2RlZmJlM2Q2NDVhMGIzNjA1ZWQ4Y2Q5ZDU1ZThfNDkz_b349bd57-b23c-414e-a785-abb60d23a955" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RleHRyZWdpb246ZWZlN2RlZmJlM2Q2NDVhMGIzNjA1ZWQ4Y2Q5ZDU1ZThfNDkz_b349bd57-b23c-414e-a785-abb60d23a955" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"> The following table provides a reconciliation of cash, cash equivalents and restricted cash shown above to the amounts reported within the condensed consolidated balance sheet as of March&#160;31, 2022, December&#160;31, 2021, and March&#160;31, 2021 (in millions):<xhtml:table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><xhtml:tr><xhtml:td style="width:1.0%"/><xhtml:td style="width:57.520%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:11.974%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:14.129%"/><xhtml:td style="width:0.1%"/><xhtml:td style="width:1.0%"/><xhtml:td style="width:11.977%"/><xhtml:td style="width:0.1%"/></xhtml:tr><xhtml:tr><xhtml:td colspan="3" style="padding:0 1pt"/><xhtml:td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2022</xhtml:span></xhtml:td><xhtml:td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</xhtml:span></xhtml:td><xhtml:td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2021</xhtml:span></xhtml:td></xhtml:tr><xhtml:tr><xhtml:td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,294&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,951&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,182&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></xhtml:tr><xhtml:tr><xhtml:td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash included in prepaid expenses and other current assets</xhtml:span></xhtml:td><xhtml:td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></xhtml:tr><xhtml:tr><xhtml:td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,299&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,956&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><xhtml:span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,186&#160;</xhtml:span></xhtml:td><xhtml:td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></xhtml:tr></xhtml:table></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzgtMS0xLTEtNzcwMzI_13f35301-dea9-413f-b5f7-9ed6808fa9ae"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RleHRyZWdpb246ZWZlN2RlZmJlM2Q2NDVhMGIzNjA1ZWQ4Y2Q5ZDU1ZThfNDkz_b349bd57-b23c-414e-a785-abb60d23a955"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzktMi0xLTEtNzcwMzI_0eea4050-8459-42cf-9271-ac04667e54c9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RleHRyZWdpb246ZWZlN2RlZmJlM2Q2NDVhMGIzNjA1ZWQ4Y2Q5ZDU1ZThfNDkz_b349bd57-b23c-414e-a785-abb60d23a955"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzktMS0xLTEtNzcwMzI_4cc77988-0a14-47a5-baa8-271ce71b1caf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RleHRyZWdpb246ZWZlN2RlZmJlM2Q2NDVhMGIzNjA1ZWQ4Y2Q5ZDU1ZThfNDkz_b349bd57-b23c-414e-a785-abb60d23a955"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RhYmxlOmU1Mjk1NzdlZjJlODQ1OWQ4ZmZjN2RjYmIyMTc4ODNiL3RhYmxlcmFuZ2U6ZTUyOTU3N2VmMmU4NDU5ZDhmZmM3ZGNiYjIxNzg4M2JfMzgtMi0xLTEtNzcwMzI_81b199f8-46cb-499e-87ef-81115911ecd7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjg3ODc5NzE5OTdhNzQyNzI5Yjk4MjBmODU0NDMyNzFjL3NlYzo4Nzg3OTcxOTk3YTc0MjcyOWI5ODIwZjg1NDQzMjcxY18yOC9mcmFnOmVmZTdkZWZiZTNkNjQ1YTBiMzYwNWVkOGNkOWQ1NWU4L3RleHRyZWdpb246ZWZlN2RlZmJlM2Q2NDVhMGIzNjA1ZWQ4Y2Q5ZDU1ZThfNDkz_b349bd57-b23c-414e-a785-abb60d23a955"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>107
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *4ZG%0'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "E.IQ4K#'4W.\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M3L,P#(9?!>7>NLT80E&7"X@32$A, G&+'&^+:-HH,6KW]J1EZX3@ 3C&_O/Y
ML^0&@\(^TG/L T5VE*Y&WW9)8=B( W-0  D/Y$TJ<Z++S5T?O>'\C'L(!C_,
MGD!6U0UX8F,-&YB 15B(0C<6%48RW,<3WN*"#Y^QG6$6@5KRU'&"NJQ!Z&EB
M.(YM Q? !&.*/GT7R"[$N?HG=NZ ."7'Y);4, SEL)IS>8<:WIX>7^9U"]<E
M-AU2_I6<XF.@C3A/?EW=W6\?A):5E$5U7<C;;5TK6:GU^GUR_>%W$?:]=3OW
MCXW/@KJ!7W>AOP!02P,$%     @ I3J<5)E<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" "E.IQ4.M,2 < &  !!)@  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;+6:74_C1A2&K[>_8A2U4E>"Q!Y_ "M "@%VH[+9+*'MTJH7@SU)+&Q/.IX0
M(O7']XSS,0$Y9PP$+DB<^+Q^?>;X.3..CV="WA=CSA5YS-*\.&F,E9I\:K6*
M:,PS5C3%A.?PS5#(C"G8E*-6,9&<Q650EK:HXX2MC"5YX_2X_*PO3X_%5*5)
MSON2%-,L8W)^QE,Q.VFXC=4'U\EHK/0'K=/C"1OQ 5>_3_H2MEIKE3C)>%XD
M(B>2#T\:;?=3)_1U0+G''PF?%1OOB3Z5.R'N]48W/FDXVA%/>:2T!(.7!][A
M::J5P,>_2]'&^I@Z<//]2OVR/'DXF3M6\(Y(_TQB-3YI'#9(S(=LFJIK,?O"
MER<4:+U(I$7YG\P6^P9A@T330HEL&0P.LB1?O++'92(V CQG2P!=!M!G :Z_
M)<!;!GCEB2Z<E:=USA0[/99B1J3>&]3TFS(W932<39+K81PH"=\F$*=..^*!
M2[)/BC&3O#AN*=#4W[2B9?S9(IYNB??(5Y&K<4$N\IC'3^-;X&5MB*X,G5%4
M\"N33>*Y>X0ZE%;XZ>#A[0F$T\KP)W:\=7Z\4L_;HG<NHBE4K2+=?''-Z-K[
M^PKV(EW%L^(?Y!C^^AA^>0S?=HR;^817#0$>[CK[WQ$7P=I%4,_%]RF3BLMT
M3J[Y1$A5Y0B74G+*$4?AVE%8SU&?RT3$NL0(%'EEBG"E55']].&#I2X.UMX.
M:HZ99,"TLBRVIPO7&K*TP/)UN/9TB.I<Y"I1<W*9I)STIMD=EU5>< UWW_?]
M0\3,T=K,41TSUWR4% IRI$B/995#A^N<M7_<7%R3;@_^]]HWW6^]]A5L=9J(
M1]<Q]'/JN.SFD9 P>.7EO4<&"JJ,"$DZ8IHK.8?7N-*Z1?W\ C.Y@6BWCLD;
M]DBZ,=1<,DRB!8BVC[)%T@OWG8-#-Z0.YI :A[2.PW8<0Q,I]E9O2,G);WEU
M[G!)B")G[!% 1/I,WL_8? ^S:GCN>B^RVM%;,-0W8I97VL3ESCF7PX2G,>K.
M= (79_ES=^M*[$OQD.11=29QS>X59LVT!Q>'^G-K?5$HEI*_DLGVRP-7#!W'
M#3!OIE&X.-_+06S#-':[%5R 4A\%BFD++L[R*Q%!4OICD6,,MH@<^8=-F(>C
MUZ9I"FZMKM"92JG[U:)))?FHK*UI]90/5[Q]/E%\ZLQT"+=6B^CF<)$OIO.Z
MO;.5U4IGN"+NC)JV0&NU!=U)H0G )3@2<E[EQZ)SQ>2(DW84P;(%F@N/%Y*8
M1],5:*VN,,A8FI*S:0%?%Y6C:=&QS3ZHZ0*T5A>XR+@<Z0+[# IJ#)=D-F%Y
M=?IP0:LU0WU:B_J#,:P744.XC-60 3VM!7JPDD$?'R@1W0/MRT48^395@-8\
MAAQ6+H 6RD&IK)?I#Z>!XP7T,#R B=M#E2T#>8HCN0USVKB<UUZFK.KH9Q8!
M:X8,TVG-V?]E4FBFWG(FR25\6%WD%K[CLWYJ^$YKSON7KI9+D^V^<+GO+N;*
M,)[68SP8DV"J"VOQ1_(;KRYQ7,K1?Z[C!R'FS#">XD1>M9W-0<36<1:Y_7V7
M[GM8TCP#>0^'\]-K[V>WZ3AD O8>6#KEY#_2XS-R*^3]8@]R\1B-63["BMLS
M\/;<=[NMX!D@>S@_;Q(%2T$Q)"[]]>XC&?!H*J%.JO)N44)SA7G=N,^"HQ76
MT7$Y*YEG=R*MM(@+P$*1_-J['5Q\Q/P80'LXH%?)6H_[UO6K14A;PAP9-GLX
M6FWUVAG#LG D7E"NAL5>^'[E:MCJX3!\2;GB2J\N5T-<#\=DC7+%!>J5J^&L
MAX/Q!>5J ?:7']@M34-7'Z>KT_1_(9]3<0?4[PD%TYH8JA3ZL/\JM/H&K?[[
MH=4W:/5WAE:+TO9$848-5_VW<M4BH L5][)QGWM73+4(69CJ&Z;Z.%/=IE>=
M_.!U56J(ZK\?47U#5']G1+4H;4\49M3@U'\K3BT"996B7@Q*_5VAU")DJ=+
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M,9=Z!_A^*& PEQOZ .NGQD[_!U!+ P04    " "E.IQ4P;ZI[&0&  "@&0
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MD2_'H\!4,(]$2C:H($L789M70R?<0O@!.6B<]\'<MEL6R(B^_.2;_\K^C?*
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M+\GS GSG:Z;N@17T5^^7_P502P,$%     @ I3J<5'!E@@*R"   DQ4  !D
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M ),*F>=X[)U'B'2Y$@IO_4;HTBNKG'>TAC2,;J'BB\EID1N*JS(>B[U&];X
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M8=2%>!#'3^ -&Z>' 6_X';P;NQ5:?A9<%UV8&^V,DIFHRD1GL++H4/OJA=G
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M!8GGX3F A?Y(*L9*,OG8IV,T7F**^1IMV-R*/<T 3TA".0(9)V-Z)L^)+8U
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M+R8]B^F<4R]K0L_JT.2-T#'<*&D+ W.9L_RE?P]AMEC)#NN,O!OPANHNQ%$
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ML83\:X$7)Z:= 7Y?*65W'9>@O8I-_P902P,$%     @ I3J<5(6K]GIH P
M&@@  !D   !X;"]W;W)K<VAE971S+W-H965T,3,N>&ULM5;!<MLV$/V5'3;M
M*28E2K*55-*,;,NI#U8]5M(>.CU Y%+$! 188&E:?]\%*-%J$GNFZ?0B$L"^
MA_>6BX5FK;&?78E(\%0I[>91252_3Q*7E5@)%YL:-:\4QE:">&AWB:LMBCR
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M@UETK4X^[(HZQSGX60;[H$46T/;2:E!E=-MBJ76?X%)>..XP.#$%FP5D!!R
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MTZ8Y9FLP=Z$- R,R@QR8PAU+BD:A"SR5R3H9YT8.JJ4R(3^_(M.Z<9(R ;Y
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M['IUO4-969'V3(A[:/7C(=&8B?HP/)?,N+7#0:LWG3-J]DBL$:IG>0K $(:
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M0'H-UHC;8J_?^XIL@^'#Z3:-9IO^69@A-'Q 9BTQ6P3 E'"(G+&$)K7<OAC
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M ??B@6_#:,2MB[#HC5O9BP_Z 5P_0TS+B.=G@40#4N5/"F&,S&0B?.QUPV$
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ML,K:RG_6"$Q"4XEY9ZTE.<&@_BS)NXERGQ(*#HVII"[Y[]!Y,0K;0.WZDP/
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M8RU?%$@A0-8KY_@X" G&;Y3-5U!+ P04    " "E.IQ4P:@W;;D#  !/"
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MS2P!U[2O9A)L%5L&73C4@.*PH(Z/CC?0]]Q2U.V$'?3_0RQ_ %!+ P04
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MK=-0\;_9L?3M68/$IA?L!4\AY$E^@XCZC;PFK':/N[S!)X7DL"<#5*TP:GN
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M@.\;@QB;%S+0_<_%Z7\!4$L#!!0    ( *4ZG%3PHD>>! H  ,T8   9
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M#<&6_!-'B%PY6H#O=''7/I""[G\P+O\-4$L#!!0    ( *4ZG%1<!T.HC00
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MZ "AP,0Z"8Q^*[Q"(9P@@O&[EADT*AUC>[V1_MW;3K;,F<$K)?[AJ<W.@Y,
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MMU%9 _I_+:79?]@ =0,__0]02P,$%     @ I3J<5(SLZ?+G P  !PD  !D
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M(RIL[9^Z?F+5TCTOY\K28]4-,_IU@)H/T'ZJE*TGK*#YO7'Z+U!+ P04
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MJ+ 1Y%(Y+H$DQTX+/>>8\J238&U3X#M8XJ96+X.8JKDV+ _!")':YK6![E#
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MRW<+^DJ@=@!:WRMEVX$3Z+X[T[]02P,$%     @ I3J<5&"$#2)V @  0@4
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MM ;F?BF$WF^L@_H?$/T!4$L#!!0    ( *4ZG%1M;O5^ZP(  -T'   9
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MCB]6PO@GK#>VE0#BE;$JVX!)0<9E_F:OFSSL (BG'!!M -$^X.(#0&T#J/E
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M+J_0+E6UN6IB9.DZQ8LTV'?<,,<_ R@;@/L+*<UV8@]H_C7Q'U!+ P04
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M8J>4<C\,@JZ?$B:\8=^=S=6P+W/#F:!S!3I/4Z)>+RB7VX'7\MX.[M@F,?;
M'_8SLJ$+:AZRN<*=7UF)64J%9E* HNN!-VJ=CUN!57 2/QC=ZITU6"I+*1_M
M9A(/O, BHIRNC#5!\/%,QY1S:PEQ/)5&O<JG5=Q=OUF_=N21S))H.I;\)XM-
M,O!./8CIFN3<W,GM=UH2ZEA[*\FU^X=M*1MXL,JUD6FIC A2)HHG>2D#L:.
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M!,>$YR^HYPO&Y.XB3U#_BS'Z#5!+ P04    " "E.IQ4D8?@X8D"  #7!0
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M"AL_3F FF'+_4#6Q@0?91FE1-F"CH*2\_I*7YAQV (9G/R!L .%;0/<#0-0
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M6XBQ;/$$F'ZSYB+&2D_%QI:) +S*0#&U/<?IVC$FS!H-LF>/8C3@J:*$P:-
M,HUC+'[= >7[H>5:[P^>R&:KS -[-$CP!A:@7I)'H6=VR;(B,3!).$,"UD/K
MUKV9N(X!9!%?">SEP1B9I2PY?S63Z6IH.<814(B4H<#ZMH, *#5,VL?/@M0J
M-0WP</S./LD6KQ>SQ!("3K^1E=H.K;Z%5K#&*55/?/\9B@7YAB_B5&97M,]C
M_8Z%HE0J'A=@[2 F++_CMR(1!P#/K0%X!< [%] N .U_ 7X-H%, .N<J^ 7
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M*W\7\6>ZOR=E0MTLWI)&+/\+]J6MW0'+'>,T+IV%@CA,BO_^K[(0-0<11^V
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M_@K%@%H97RAB97[)-H\-,#A<*RV2 HP5)#S-_]EK(<0! 'GJ ;0 T)\!S1,
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MV125VV#OSZ0TFXD[9U>?24:_ %!+ P04    " "E.IQ4%7\*^:$$  "X%0
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M-HN=-AM-N>K6"SV4C12S^[H0Z5Q4;8#\_V-9-F\;[0%V:\[._P=02P,$%
M  @ I3J<5"/6/=68 @  ^ 8  !D   !X;"]W;W)K<VAE971S+W-H965T-C$N
M>&ULC57?;]HP$/Y7K*@/K;0V)"&P52%2H4R;M&X(UNYAVH,A!['JV)EMH/WO
M=W9"QN_V);'/]WWWW5U\2=92/>L<P)"7@@O=\W)CREO?U[,<"JIO9 D"3^92
M%=3@5BU\72J@F0,5W ];K8Y?4":\-'&VD4H3N32<"1@IHI=%0=5K'[A<][S
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MIHO54M6<K39&EFY43:7!Z^*6.?Z:0%D'/)]+:38;&Z#YV:7_ %!+ P04
M" "E.IQ4R+845CX"  "4!   &0   'AL+W=O<FMS:&5E=',O<VAE970V,BYX
M;6Q]5-U/VS 0_U=.$0\@#9*F!3:41NH'&WT JH9NTJ8]N,FUM7#LS';:[K_?
MV2E9V2@OB<^^^WW89R=;I9_-&M'"KA32](.UM=5-&)I\C24S%ZI"22M+I4MF
M*=2KT%0:6>&+2A'&4705EHS+($W\W%2GB:JMX!*G&DQ=EDS_'J)0VW[0"5XF
M9GRUMFXB3).*K3!#.Z^FFJ*P12EXB=)P)4'CLA\,.C?#GLOW"5\Y;LW!&)R3
MA5+/+I@4_2!R@E!@;AT"H]\&1RB$ R(9O_:804OI"@_'+^B?O7?RLF &1TI\
MXX5=]X./ 12X9+6P,[6]P[V?2X>7*V'\%[9-[O6G /+:6%7NBTE!R67S9[O]
M/AP4Q)TC!?&^(/:Z&R*O<LPL2Q.MMJ!=-J&Y@;?JJTD<E^Y0,JMIE5.=38?S
M;/)PFV7P.'V:W$^^#YXFCP\PNAO,OMQF< Z#HN!N^YB B6QZP&WFZ1@MX\*<
MP0EP"?=<")HV26A)DT,.\SW_L.&/C_#?,WT!W<X'B*,XGF=C.#TY>XT2DJ/6
M5MS:BCUL]PCL#(W5=6YKS>4*F"Q@AH)9+&#@VH LH8$?@P5E45_\?(>QVS)V
M/6/O"..H+FMBH!8#NAWGENT@5\8:VIZ\UAJ+M_:F@;SRD.[Z;-).-XJ2</.&
MD%XKI/>ND-M=11U/3MG?HWNEZ"TAO?^$Q)?_R @/FLS=5SJY%9<&!"ZI*+JX
MO@Q -W>@":RJ?-\ME*4N]L,U/1NH70*M+Y6R+X%KY?8A2O\ 4$L#!!0    (
M *4ZG%1[A2*TT0(  !D(   9    >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM
M;+U676_:,!3]*U=1'UII:R!\5X $M-N01HM(NTF;]F 20ZSZ([,=Z/;K9SLA
MHWQ$?9CV0FSGGG///8[NI;\5\EDE&&MX892K@9=HG=[XOHH2S)"Z%BGFYLU*
M2(:TV<JUKU*)4>Q C/I!K=;V&2+<&_;=V5P.^R+3E' \EZ RQI#\-<94; =>
MW=L=+,@ZT?; '_93M,8AUD_I7)J=7[+$A&&NB. @\6K@C>HWDYZ-=P%?"-ZJ
MO3782I9"/-O--!YX-2L(4QQIRX#,8X,GF%)+9&3\+#B],J4%[J]W[!]<[::6
M)5)X(NA7$NMDX'4]B/$*950OQ/83+NII6;Y(4.5^85O$UCR(,J4%*\!& 2,\
M?Z*7PH<]@.$Y#0@*0' (:)X!- I PQ6:*W-EW2*-AGTIMB!MM&&S"^>-0YMJ
M"+>W&&IIWA*#T\/Q4SB]OPM#>)@_3F?3;Z/'Z<,]3#Z-%A_O0G@/87Z[(%8P
MSI0!*P4/J2:,_$;N'B8)DFNLX/(6:T2HNC*@I_ 6+B^NX ((AQFAU 2JOJ^-
M7IO5CPIMXUQ;<$9; V:"ZT3!'8]Q_!KOFSK+8H-=L>.@DG"&Y#4TZN\@J 7!
M"3V3M\/K%7(:I?<-Q]<XP[? 2LLLTIDD? T3H30@'H,YQG*#X?MG$P]3C9GZ
M49&M669KNFS--V6+\FL[=2DY3=O1V":P&;8[?7^S[]-Q2- J0UZI:Y7J6I7J
M3G]<<RG6$C%547Z[3-#^#V9WRFR=?V-V3M.J,OLXY)S9W5)=MU*=K5Z!%D!8
M2K'IR1J6.__%OO_I2?]SY=TC6?7F@?+CD."T\%XIO%<I_%%H1,]HK3"Y=_2Y
M=NL'4H]#@LZ!5G^ORS)L<MGAHR 2&==Y#RI/R_DV<FW]X'QLYEX^IO[2Y$/3
M=)@UX0HH7AG*VG7'>"?S091OM$A=+U\*;2:#6R9F=F-I \S[E1!ZM[$)RG\#
MPS]02P,$%     @ I3J<5.(IN=*0!   41H  !D   !X;"]W;W)K<VAE971S
M+W-H965T-C0N>&ULO9E1CZ,V$,>_BH5.U9W4+F [)-DFD9+L=B]2<[O:W+92
MJSZPB9.@ YS:SN9.ZH>O#2Q. A@>$"\)AIGQS!_K!X-')\J^\3TA GR/PIB/
MK;T0AUO;YNL]B7Q^0P\DEE>VE$6^D$.VL_F!$7^3.$6A#1W'LR,_B*W)*#GW
MQ"8C>A1A$),G!O@QBGSV8T9">AI;KO5^XCG8[84Z84]&!W]'5D2\')Z8'-EY
ME$T0D9@'- :,;,?6U+V=XZ%R2"S^",B)GQT#5<HKI=_48+$96X[*B(1D+50(
M7_Z]D3D)0Q5)YO%O%M3*YU2.Y\?OT7]+BI?%O/J<S&GX9[ 1^[$UL,"&;/UC
M*)[IZ3/)"NJI>&L:\N07G#);QP+K(Q<TRIQE!E$0I__^]TR(,P<9I]P!9@[P
MV@%7.*#, 26%IIDE9=WYPI^,&#T!IJQE-'60:)-XRVJ"6-W&E6#R:B#]Q&3V
MLEI\N5^MP./3U\5R\=?TZ^+Q"YA_GCX_W*_ +V!.HP.-22PXH%OP3+A@Q[4X
MLB#>@?G>9SO"P<<[(OP@Y)^D_<OJ#GS\\ E\ $$,ED$8RGO%1[:0J:H)[766
MUBQ-"U:DA<"2QF+/P7V\(9M+?UN6F-<)W^N<06/ I<]N ')_!M"!L"2?>7-W
MUY .RF5'23Q4$>]*2,H%\..-TI>P-P+^_EW:@X4@$?_',!O.9\/);+C1;.OT
MMI7=E#2,EX11 'B;>/V1_7:N4]$$]G*3B^QZ>78]8W;SQX>5H4@O#^-U(&D_
MGZW?CJ1IF-ZY7E>*EE@XY8H.\N0&QN16#S_YT>'7J:'.81YJV(&JKJ-QY+2C
M:Q;G7#:O=Z5LB4W%6G7/>.F:$TRDO3,5"W4LV(6X&CHN:DE<5!#.N=;69'*9
MG\:4:^;4?70(Z0]"@"!,/NO\Y$&_EK)P4_F:,VZO"[DUD%RO);F]@I9X>*UW
MT48]B4H%UQ!SS12K%AS\!VJX[&H:N8,N=-?(<H<MZ3ZLA7.)B>N5RPXUY* 9
M<D;9&\ ;:EI!MP/IH28:A.U(G\6Y6/+7KQHE-A7XAAJ!T(Q H_3U;(>:91!W
MH;R&&S2_1357OE?+=J/)97X:AM ,P[E\GV>R:;L07BE"Q9ZP6LI#S338[T)X
M33=H?MEJ+OR@B!)8(:MF'32SKHFL]2Q'&EW(Z4!=I &&:EZWFJJ;Q6FP9I&F
M&3+3K*&X#8B-SAK#+CI#I#F%6NH-LSA-EB_2U$(UO5\SA>O!C#2(4!=](M(\
M0BUUBJC8"%:M8 TG9(;3E',B0! =_(!%ZBN.J20-'=1%4X@U='!+32$N:0JO
MOU\437"YREA#"ILA55"YGKA80PAWT21B#2#<4I.(ZYO$$I,JL<^^99F!529V
M P)CS23<19N(-9!P2VTB+K: A=5=-*E@"-8 PV: E0E>#V2L&86[: ^QIA=N
MJ3W,XGBF!6XR2?.SSS[.1T3.I?8LN'RT'6.1?K_.S^;[(M-D-^#J_,R]G:>[
M&SI,NMFRE"4$,0<AV<J0SDU?WG^6[E^D T$/R1; *Q6"1LGAGO@;PI2!O+ZE
M5+P/U 3Y+M+D?U!+ P04    " "E.IQ4E:T5V <#  !^"   &0   'AL+W=O
M<FMS:&5E=',O<VAE970V-2YX;6RU5EU/(C$4_2LW$Q\T4>=+0 V0 +HK#RIA
M=#?9S3Z4F0O3V&G9MH#\^VT[XX@*K-ED7YCV3L\Y]Z/<.^V5D$\J1]3P7#"N
M.EZN]?S2]U6:8T'4J9@C-V^F0A9$FZV<^6HND60.5# _"H*F7Q#*O6[;V4:R
MVQ8+S2C'D02U* HBUWUD8M7Q0N_%,*:S7%N#WVW/R0P3U(_SD30[OV;):(%<
M4<%!XK3C]<++0>@ [L0WBBNUL08;RD2()[L99ATOL!XAPU1;"F(>2QP@8Y;)
M^/&[(O5J30O<7+^P?W'!FV F1.% L.\TTWG'._<@PRE9,#T6JQNL FI8OE0P
MY7YA59T-/$@72HNB AL/"LK+)WFN$K$!,#S; 5$%B-X#SG8 X@H0NT!+SUQ8
M5T23;EN*%4A[VK#9A<N-0YMH*+=E3+0T;ZG!Z6[_,1G>72<)W(\>AK?#'[V'
MX?T=#&YZXZ_7"9Q 4I87Q!1Z-N-4KX%R&*-"N41E%HQHS$ +:]-RD>J%I'P&
M0TXU);9&"@ZO4!/*U)$A?$RNX/#@" XLS2UES!13M7UM8K$>^6GE=[_T.]KA
M=PRW@NM<P37/,'N+]TT.ZD1$+XGH1WL);XD\A3@\ABB(HBW^##X/#_>X$]=U
MB1U?O(/O;3*K=,//L6 ,S/U=$9G]VB-S5LN<.9FS'3*#G,@9;LU_"6PZH&T&
MRVZSU?:7FRGY>"1JU$?>^-.H_6GL]2?!)4K"4P3",[C7.4JX+N9,K!'KNS80
M2JL]P3=KL>;_S'&KEFGMC:DB/H8)SBCG5FM"F UR6]I+KL9&3L/@8GM2SVL'
MSO^UR.<?U)KA=K&+6NQBK]B(K$V7?U^?4NWB@]I)O$,N#%X;6+ _NH64R-,U
M:'-QE+DAIJ%L[2?!1_5HA_A&]PP_5UODV5\*6S%M_EO"N/7. 7^CDQ=HJF8'
MG()4++@N>UEMK8=HSXV.=_:^':YN0KS2E)/9="IS#14PG!K*X+1E,B++85=N
MM)B[>3$1VDP?M\S-!P)*>\"\GPJA7S96H/[DZ/X!4$L#!!0    ( *4ZG%1U
M1X?E=@,   L+   9    >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;*U648_:
M.!#^*U;4AUWINB&!!;8")&#3*P] !/3NV4L&L)K8.=O MK_^QDX($$)4J?L"
MMC/?YV]F[/'TCD+^4#L 3=Z3F*N^L],Z_>*Z:KV#A*HGD0+'+QLA$ZIQ*K>N
M2B70R(*2V/4;C;:;4,:=0<^NA7+0$WL=,PZA)&J?)%3^'$$LCGW'<TX+"[;=
M:;/@#GHIW<(2]/<TE#AS"Y:()< 5$YQ(V/2=H?=E[+4,P%K\P^"H+L;$N/(F
MQ \SF41]IV$400QK;2@H_AU@#'%LF%#'?SFI4^QI@)?C$_M7ZSPZ\T85C$7\
M+XOTKN]T'1+!ANYCO1#';Y []&SXUB)6]I<<<]N&0]9[I462@U%!PGCV3]_S
M0%P D*<:X.< OPQHW0$T<T#3.IHILVZ]4DT'/2F.1!IK9#,#&QN+1F\8-VE<
M:HE?&>+T( QFR\E\1H:S5S)??0L6))PO5XM@-5D$TV"V(J-@%GR=K$BXF/^]
M&$Z7Y#.9X>D*03(1L349 8<-TV0LE"8+B*EF?$NT0(LLUY1'9*YW($F()I"D
ML?B)YT"3P X!"HHPIER1AU?0E,7J$7?ZOGPE#Y\>R2?".)FR.$9"U7,U.F[D
MN^O<R5'FI'_'R2:9"JYWB@0\@N@:[V+ BJCYIZB-_%K"*95/I.G]1?R&[U?H
M&?\^W*N1TRR2V+1\K7M)S$/]E@52U5"V"LJ6I6S>H30Y3D\YSGG)&A-8P_U<
M<#_7REV"/+ U5-!EL<_0;8LV9>@P\%YZ[N$ROK<F)@^'"E'M0E2[5M2$:Y"@
MJIS,5&7PY\LM6R55MR9>MUI5IU#5J545O*=8[R#"BJGWDA-,<HJWA%"EH)SG
M3&;G1L/G9CEZ53;M:J'=0FBW5N@P$5*S7]369K$A',]/+%"EL@4@Q9.$C\=%
MXBO%=V\#Z)>TWYKXS6KI+X7TEUKI5T?=2",/C*]% H]5$E]N);9+$F]-_$ZU
M1*]Q+M.-6I'S,!C57#WOHMY['WZQ/?_,[O_9+<KQ5_$KA:_6Y%K7N4!Z]17R
M8XYGOLGUQ2FKK["Y4YJ\<S'V6A]X1'.R=K6$7&:%33G*[D5;D8#<VFY+X?Y[
MKK.WLE@M.KJA[6-*ZR/3Z=EVY4R3M8GX$FX9/OHQ;)"R\=3!N,FL\\HF6J2V
M>7D3&ELA.]QAMPK2&.#WC1#Z-#$;%/WOX']02P,$%     @ I3J<5))LJ^!"
M @  K 4  !D   !X;"]W;W)K<VAE971S+W-H965T-C<N>&ULC51M;YLP$/XK
M%M*D39J 0+)-%8F4MVK]T"UJVFW2M \.',&JL9E]C/3?SS:$I5&"]@7[SO<\
M]]QA7])(]:P+ "2'D@L]]0K$ZB8(=%I 2;4O*Q#F))>JI&A,M0]TI8!F#E3R
M( K##T%)F?!FB?-MU"R1-7(F8*.(KLN2JI<%<-E,O9%W=#RP?8'6$<R2BNYA
M"_A4;92Q@IXE8R4(S:0@"O*I-Q_=+"<VW@5\8]#HDSVQE>RD?+;&73;U0BL(
M.*1H&:A9_L 2.+=$1L;OCM/K4UK@Z?[(?NMJ-[7LJ(:EY-]9AL74^^21#'):
M<WR0S6?HZG$"4\FU^Y*FC8UCCZ2U1EEV8*.@9*)=Z:'KPPG \%P&1!T@.@>,
MKP#B#A"[0EMEKJP513I+E&R(LM&&S6Y<;QS:5,.$_8M;5.:4&1S.[KXLO]ZO
MR>/\QWI+WJX *>/Z71*@X;810=KQ+%J>Z I/3.ZEP$*3M<@@>XT/C*9>6'04
MMH@&">^I\DD\>D^B,(HNZ%G^/WPT("?N^Q0[OOA:GT0J2R"/]$!63*=<ZEH!
M^3G?:53F*OX:2#'N4XQ=BO&5%.L\!W>I"6N3H4FF*,*EOS%,%45^'+ZYU+5A
MW&CL3\YQKVJ9]+5,!HF>_*U/;B$#13G12+%&J5ZN5C-,%HW\\+*JX.3BEZ#V
M;AYHDLI:8'O5>F\_<N;NI9WY%V84M9/C'TT[Q\Q%VC.A"8?<4(;^1Z-5M;.A
M-5!6[GGM))K'ZK:%&:>@;( YSZ7$HV$3] -Z]A=02P,$%     @ I3J<5! E
M\OMY @  F08  !D   !X;"]W;W)K<VAE971S+W-H965T-C@N>&ULE55-<YLP
M$/TK&D[)3!LP&+?-8&;\U28'9SSVM#TKL!A-A.1*PD[_?5<"4\>U:7M!TFK?
MV[<KM$H.4KWH$L"0UXH+/?9*8W;WOJ^S$BJJ[^0.!.X44E74X%)M?;U30','
MJK@?!L'(KR@37IHXVTJEB:P-9P)6BNBZJJCZ.04N#V-OX!T-:[8MC37X:;*C
M6]B ^;I;*5SY'4O.*A":24$4%&-O,KB?C:R_<_C&X*!/YL1F\BSEBUT\YF,O
ML(* 0V8L \5A#S/@W!*AC!\MI]>%M,#3^9']L\L=<WFF&F:2?V>Y*<?>1X_D
M4-":F[4\/$";3VSY,LFU^Y)#ZQMX)*NUD54+1@45$\U(7]LZG "0YS(@; 'A
M.6!X!1"U@,@EVBAS:<VIH6FBY($HZXUL=N)JX]"8#1/V%#=&X2Y#G$D7D_73
MX].7#5DMUF3S,%DOR'NRADR*C'%&7:EE0:94LXQL2JI $R/)G/':0'ZTW,S!
M4,;U+8)U8VH')LB2<8XT.O$-"K9A_:P5-VW$A5?$160IA2DU68@<\K=X'Q/M
ML@V/V4[#7L(E57<D&KPC81"&%_3,_AT^Z)$3=<6/'%]TA>]_Z]P3<MB%'+J0
MPRLAFP W>"S- =U>.I6&(G84M@WLTSB($G]_6JE+/G'G\T9;W&F+>[4MB@(O
MMRU#;M/&ZTTT9+5BAME_K%]S_(>>T9GB/H\W>D>=WE&OWN/A_$79Z$*E/IUI
MN^ S&)RI\T]N>05JZYJ?)IFLA6FN0&?M^NO$M94S^Q3[;M,F?],T31M_\"T3
MFG HD#*X^X"*5-,(FX61.]=+GJ7!SN2F);X=H*P#[A=2FN/"!NA>H_074$L#
M!!0    ( *4ZG%1-\78N8 (  $X%   9    >&PO=V]R:W-H965T<R]S:&5E
M=#8Y+GAM;(U4P6[;, S]%<*G%ECKQ$[7H7 ,.&FV]M B2+#M,.R@V'0L5)8\
M26[:OQ\E.U[6)<4NEBCQ/3V2)I.=TD^F0K3P4@MIID%E;7,3AB:OL&;F4C4H
MZ:94NF:63+T-3:.1%1Y4BS :C3Z&->,R2!-_MM1IHEHKN,2E!M/6-=.O,Q1J
M-PW&P?Y@Q;>5=0=AFC1LBVNT7YNE)BL<6 I>HS1<2=!83H-L?#.?.'_O\(WC
MSASLP46R4>K)&??%-!@Y02@PMXZ!T?*,<Q3"$9&,7SUG,#SI@(?[/?MG'SO%
MLF$&YTI\YX6MIL&G  HL62OL2NWNL(_GRO'E2AC_A5WO.PH@;XU5=0\F!367
MW<I>^CP< (CG."#J =%;P.0$(.X!L0^T4^;#NF66I8E6.]#.F]C<QN?&HRD:
M+ET5UU;3+2><31?9ZO'^\<L:EHL5K.^RU0(N("L*[I+,!-S+[D]Q*3^[1<NX
M,.?D8BJFT>P7+N&!"T%.)@DMR7+D8=Y+F'42HA,28GA0TE8&%K+ XF]\2.$,
M,47[F&;1NX0/3%]"//X T2B*CNB9_S]\_(Z<>$AQ[/GB4REF6G*Y-;!$#6N7
M,/B1;8S5] O_?(=_,O!///_D!'\F+;\HN&A=0X#!O-54/:H*ON2BI91"J54-
MN:J;UG:55"4LEFLXH[IU%3P_5K;NV2O_K)L&S^DD"9\/$_FOQ_7@T<42'OR:
M->JM[UA#8EIINXH.I\-0R'POO#F?T;#H>OL/33=IJ%Y;+@T(+(ER='E->G37
MO9UA5>,;8*,LM9/?5C3P4#L'NB^5LGO#/3",T/0W4$L#!!0    ( *4ZG%2Q
M2;7PZ00  +D5   9    >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;,58:V_B
M.!3]*Q;[4$>::1*'9Y<BT4*G2 M;E;;[8;4?7&+ FL1A; <ZJ_WQ>YVX,;1@
MLE(E^J'DX7MR?'Q]KNWN)A7?Y))2A5Z2F,O+VE*IU87GR=F2)D2>IRO*X<T\
M%0E1<"L6GEP)2J(\*(D][/M-+R&,UWK=_-F=Z'733,6,TSN!9)8D1/RXHG&Z
MN:P%M=<']VRQ5/J!U^NNR().J7I<W0FX\TJ4B"642Y9R).C\LM8/+FY"K /R
M%D^,;N36-=)=>4[3;_IF%%W6?,V(QG2F- 2!GS6]IG&LD8#'=P-:*[^I [>O
M7]%O\LY#9YZ)I-=I_">+U/*RUJZAB,Y)%JO[='-+38<:&F^6QC+_CS:FK5]#
MLTRJ-#'!P"!AO/@E+T:(K0 <' C )@!7#0A-0%@UH&X"ZF\##O6A80(:50.:
M)J"9:U^(E2L]((KTNB+=(*%; YJ^R(<KCP:!&=>9-54"WC*(4[W!\'[TU'\8
M/0W1:#)]N'\<#R</4]2?#-#M</!U-/F*^M?P>O0P&D[1%]2/(J93@L1HQ(O$
MU@ER-J"*L%A^0K_^U Z;]=\0XVC,XAA>RJZG@*G^GC<SK*X*5O@ JQ"-4ZZ6
M$@UY1*/=> ]Z6'83OW;S"CL!QT2<HS#XC+"/\>-T@,Y^_K2'UG5UE. PRL"-
M,J"S*BC#8UQ^&)"@,WR\1V=&^'U0-Y6A6@ZH'>'#,K_"'#L\V%G!UD2[!^2+
M5"(#5U(2$1ZA6QHM&%^@OC872"HJT8#)69S*3,#U7[\#%!HIFLB_'43J)9%Z
M3J1^E,AGQ%.3PB1),Z[VY6<!ULS!M#NO>W[76V^GBJO%#L-&R;!1F>&<,('6
M),[@6E$!$Y^HMQ.A(%I@-AQ$72UVB#9+HLWJ4D+Q8WQ-I=(#>X1K\RC79E51
M6R77UA&N<RH$C0JF9 X$ORCR@A90="4"YXIL@C*;H/O8M]ZQ;_CYWWZ&[9)A
MV\GP$2Q.LD4N6B4V.U_IE%_IG'8>!KZM./Y'SD2#MJU[I^Z_4;[P7=-T.WW:
MC< U2,%6G0R<K">[B;X$T:A+#FR!\8E'QGIU$#K[V)_-LB2+\TR$=6H^43(.
M"]:8_0./E"!<QD7!U_-'U_C^']>CO:,6OANUNG,@K(\';B,/SD/_%S2EG*4"
M35(%0D091;J(04%MN(2P3APT3CPFUFL#M]F:CO*\H_^^+J_V%7D#U-F2O'E0
M;NN?@=M _?/Z&[4'&<U7=X7@=5<OK0<&[1,+;HTRZ'R,X$,#M"UXJW% <&SM
M$;OM$?+;*7C'M1RV=H:#TPJ.K0%B_$&"&Z!J@EO7PV[7@QTJ[#\YHB^S)>$+
MBF:P]Q"PY77576S]"M=/K+2U-5Q]A5FA\AJTYHZ'X[V5%[]?9(:MELOPL75
M['; ,7EA29:@F/*%6J)TCA1+:%&!];R8$;E$\QA@]Q1ETQ/W%P*,DGR_Z5+9
M.B9V.^:(PR(3U@E(0"&MEDS6)_&)?1);G\1NGSRT78%U]MXAZ!S;40U,DPH[
ME="Z:>AVT]W!D!NR<FUJK7V&)[;/T-IGZ+;/_SD.!LTU#LXF!4MOZ\0IH6*1
MGPU*2':PDN)4IGQ:GC_V\U.W-\^O@HOKXA31PA2'FF,B%GJ/%M,Y0/KG+<@+
M49P3%C<J7>7G6L^I4FF27RXI@1V4;@#OYRE4%'.C/U">UO;^ U!+ P04
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M,"9KIB=B^X2YG[KE"P53Z1.V>6S%@7"MM$ARL%&04)Z]R7N>ASU M78"X.4
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MJM;9TH.L-UFTKH;%Z3#.E-#?,AVG)G>7]T_@Y?+A^19,;R]GST^WT]M_?\_
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MDG"&!"1#9^S=AGV#MX!G ENYMT9&R8KS%[-YB(=.RQ0$%")E(F!]*6 "E)I
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M7=^D3J97^W2@Q<'=CC="F[NV^]R;YQ!(:V#6MT+H\\!ND#^PQO\!4$L#!!0
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M7Z1(MF;^YST0H;$FL?I5(J.:RZB6)A5MA-0WFL@8/H&Y+MJDE""T!.;?L.O
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M^CY@FQM]90-A#/3W%>?JT#$3%)? Z4]02P,$%     @ I3J<5$:T9B^^ 0
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M]16-.IXF1;JL1?=GM\]0,\QNK^'FL2@FZEA0SJLD.SQU='ABZO-_4$L#!!0
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( *4ZG%0ZTQ(!P 8  $$F   8
M          " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " "E.IQ4P;ZI[&0&  "@&0  &               @($$#P  >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ I3J<5!;^[<O3 @  B@<
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M965T-RYX;6Q02P$"% ,4    " "E.IQ4OS\+U& '  !O'@  &
M    @($F*P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
MI3J<5&U8^7'$"0  AA<  !@              ("!O#(  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( *4ZG%1P98("L@@  ),5   9
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M970Q-"YX;6Q02P$"% ,4    " "E.IQ4\2W[[W %  #@#0  &0
M    @('"80  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M *4ZG%3GPR]Z;@4  -\-   9              " @6EG  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ I3J<5%:^<]H+$0  OR\  !D
M             ("!#FT  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    " "E.IQ4]^'=_C,&  "V$   &0              @(%0?@  >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( *4ZG%2)F<U^W (
M ( &   9              " @;J$  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ I3J<5,1_H?IT P  KP@  !D              ("!
MS8<  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " "E.IQ4
MP:@W;;D#  !/"   &0              @(%XBP  >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( *4ZG%3)3)<VMPX  %XP   9
M      " @6B/  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ I3J<5%PT1+X_"0  X!H  !D              ("!5IX  'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "E.IQ4(MWI $T'  #%$
M&0              @(',IP  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+
M 0(4 Q0    ( *4ZG%3PHD>>! H  ,T8   9              " @5"O  !X
M;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ I3J<5%P'0ZB-
M!   M@H  !D              ("!B[D  'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6Q02P$"% ,4    " "E.IQ45)6'>WP$  #,"P  &0
M@(%/O@  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( *4Z
MG%2,[.GRYP,   <)   9              " @0+#  !X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L! A0#%     @ I3J<5%4E4N#^ @  ,P8  !D
M         ("!(,<  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
M    " "E.IQ4I:6]>=@$  ![#   &0              @(%5R@  >&PO=V]R
M:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( *4ZG%3=O"'@/0@  '$6
M   9              " @63/  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL
M4$L! A0#%     @ I3J<5*KJ*AK? P  H0H  !D              ("!V-<
M 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " "E.IQ4?]+2
M"P #  "#!@  &0              @('NVP  >&PO=V]R:W-H965T<R]S:&5E
M=#,S+GAM;%!+ 0(4 Q0    ( *4ZG%1@A TB=@(  $(%   9
M  " @27?  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @
MI3J<5#%:N?;M!0  C1,  !D              ("!TN$  'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6Q02P$"% ,4    " "E.IQ4\ ]GR!X%  #*#@  &0
M            @('VYP  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4
M Q0    ( *4ZG%1NN/E9?0,  "D(   9              " @4OM  !X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ I3J<5![E;3H] P
M:PD  !D              ("!__   'AL+W=O<FMS:&5E=',O<VAE970S."YX
M;6Q02P$"% ,4    " "E.IQ4:__UB^0"  #T!@  &0              @(%S
M]   >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( *4ZG%1Q
MY^E1+@0  $$.   9              " @8[W  !X;"]W;W)K<VAE971S+W-H
M965T-# N>&UL4$L! A0#%     @ I3J<5,NWJ-": @  #P8  !D
M     ("!\_L  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
M" "E.IQ4;6[U?NL"  #=!P  &0              @('$_@  >&PO=V]R:W-H
M965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( *4ZG%0\&64ZG0(  '8&   9
M              " @>8! 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L!
M A0#%     @ I3J<5"3%S>*: @  ,P8  !D              ("!N@0! 'AL
M+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " "E.IQ4%,4$984"
M  !W!@  &0              @(&+!P$ >&PO=V]R:W-H965T<R]S:&5E=#0U
M+GAM;%!+ 0(4 Q0    ( *4ZG%2RB\R!NP(  !<'   9              "
M@4<* 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ I3J<
M5!5<HY]) P  ]P@  !D              ("!.0T! 'AL+W=O<FMS:&5E=',O
M<VAE970T-RYX;6Q02P$"% ,4    " "E.IQ4N55>SM$#  #1$   &0
M        @(&Y$ $ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0
M   ( *4ZG%21A^#AB0(  -<%   9              " @<$4 0!X;"]W;W)K
M<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ I3J<5+31C"OL P  MA
M !D              ("!@1<! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q0
M2P$"% ,4    " "E.IQ4Q0Z8+><#  #Q#@  &0              @(&D&P$
M>&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( *4ZG%3@;!Y$
M!P,  $()   9              " @<(? 0!X;"]W;W)K<VAE971S+W-H965T
M-3(N>&UL4$L! A0#%     @ I3J<5)U[8QL+ P  O0@  !D
M ("! ",! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " "E
M.IQ4D%')QIP%  "I%P  &0              @(%")@$ >&PO=V]R:W-H965T
M<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( *4ZG%39<?S(*P4  !@:   9
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M970U.2YX;6Q02P$"% ,4    " "E.IQ4?F X6JP'  !_-@  &0
M    @('H0@$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    (
M *4ZG%0CUCW5F (  /@&   9              " @<M* 0!X;"]W;W)K<VAE
M971S+W-H965T-C$N>&UL4$L! A0#%     @ I3J<5,BV%%8^ @  E 0  !D
M             ("!FDT! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"
M% ,4    " "E.IQ4>X4BM-$"   9"   &0              @($/4 $ >&PO
M=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( *4ZG%3B*;G2D 0
M %$:   9              " @1=3 0!X;"]W;W)K<VAE971S+W-H965T-C0N
M>&UL4$L! A0#%     @ I3J<5)6M%=@' P  ?@@  !D              ("!
MWE<! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " "E.IQ4
M=4>'Y78#   +"P  &0              @($<6P$ >&PO=V]R:W-H965T<R]S
M:&5E=#8V+GAM;%!+ 0(4 Q0    ( *4ZG%22;*O@0@(  *P%   9
M      " @<E> 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%
M  @ I3J<5! E\OMY @  F08  !D              ("!0F$! 'AL+W=O<FMS
M:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " "E.IQ43?%V+F "  !.!0
M&0              @('R8P$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+
M 0(4 Q0    ( *4ZG%2Q2;7PZ00  +D5   9              " @8EF 0!X
M;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ I3J<5/D[SU-(
M!   61(  !D              ("!J6L! 'AL+W=O<FMS:&5E=',O<VAE970W
M,2YX;6Q02P$"% ,4    " "E.IQ4:R;L\X(#  "V#@  &0
M@($H< $ >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( *4Z
MG%2"OW4+]0(  *X(   9              " @>%S 0!X;"]W;W)K<VAE971S
M+W-H965T-S,N>&UL4$L! A0#%     @ I3J<5.TIR\^? @  X04  !D
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M=#<X+GAM;%!+ 0(4 Q0    ( *4ZG%0KI%E)[@,  /00   9
M  " @3F) 0!X;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @
MI3J<5/A&;BFD P  $ X  !D              ("!7HT! 'AL+W=O<FMS:&5E
M=',O<VAE970X,"YX;6Q02P$"% ,4    " "E.IQ41K1F+[X!  #F P  &0
M            @($YD0$ >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4
M Q0    ( *4ZG%3*#0<W0@,   H4   -              "  2Z3 0!X;"]S
M='EL97,N>&UL4$L! A0#%     @ I3J<5)>*NQS     $P(   L
M     ( !FY8! %]R96QS+RYR96QS4$L! A0#%     @ I3J<5&/HO%X3!@
MM34   \              ( !A)<! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( *4ZG%2KG#%+;@(  -HO   :              "  <2= 0!X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( *4ZG%1$Y-]8'@(  )<N
M   3              "  6J@ 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0  !9 %D 9A@  +FB 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>345</ContextCount>
  <ElementCount>334</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>104</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Income (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Income (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Changes in Equity (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Equity (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BASISOFPRESENTATION</Role>
      <ShortName>BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTS</Role>
      <ShortName>ACQUISITIONS AND OTHER ARRANGEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2109103 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2117104 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2122105 - Disclosure - FINANCING ARRANGEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FINANCINGARRANGEMENTS</Role>
      <ShortName>FINANCING ARRANGEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2124106 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2126107 - Disclosure - STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2130108 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2134109 - Disclosure - REVENUES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUES</Role>
      <ShortName>REVENUES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2141110 - Disclosure - BUSINESS OPTIMIZATION CHARGES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2147111 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS</Role>
      <ShortName>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2150112 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2152113 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2156114 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2163115 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2169116 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SEGMENTINFORMATION</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - BASIS OF PRESENTATION (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BASISOFPRESENTATIONPolicies</Role>
      <ShortName>BASIS OF PRESENTATION (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSTables</Role>
      <ShortName>ACQUISITIONS AND OTHER ARRANGEMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTS</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2310302 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2318303 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2327304 - Disclosure - STOCKHOLDERS??? EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS??? EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2331305 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2335306 - Disclosure - REVENUES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUESTables</Role>
      <ShortName>REVENUES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/REVENUES</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2342307 - Disclosure - BUSINESS OPTIMIZATION CHARGES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2348308 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables</Role>
      <ShortName>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2353309 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2357310 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2364311 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2370312 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SEGMENTINFORMATIONTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.baxter.com/role/SEGMENTINFORMATION</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails</Role>
      <ShortName>ACQUISITIONS AND OTHER ARRANGEMENTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Schedule of Total Consideration for Hillrom (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails</Role>
      <ShortName>ACQUISITIONS AND OTHER ARRANGEMENTS - Schedule of Total Consideration for Hillrom (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Summary of Fair Value of Assets Acquired and Liabilities Assumed for Hillrom (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails</Role>
      <ShortName>ACQUISITIONS AND OTHER ARRANGEMENTS - Summary of Fair Value of Assets Acquired and Liabilities Assumed for Hillrom (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Other Business Development Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails</Role>
      <ShortName>ACQUISITIONS AND OTHER ARRANGEMENTS - Other Business Development Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2414408 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2415409 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Expense, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Other Expense, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2416410 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2419411 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2420412 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2421413 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2423414 - Disclosure - FINANCING ARRANGEMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails</Role>
      <ShortName>FINANCING ARRANGEMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.baxter.com/role/FINANCINGARRANGEMENTS</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2425415 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2428416 - Disclosure - STOCKHOLDERS' EQUITY - Stock Options Fair Value Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/STOCKHOLDERSEQUITYStockOptionsFairValueAssumptionsDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Stock Options Fair Value Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2429417 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2432418 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Changes in AOCI by Component (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Changes in AOCI by Component (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2433419 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Amounts Reclassification from AOCI to Net Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Amounts Reclassification from AOCI to Net Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2436420 - Disclosure - REVENUES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUESAdditionalInformationDetails</Role>
      <ShortName>REVENUES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2437421 - Disclosure - REVENUES - Remaining Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails</Role>
      <ShortName>REVENUES - Remaining Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2438422 - Disclosure - REVENUES - Contract Assets and Contract Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails</Role>
      <ShortName>REVENUES - Contract Assets and Contract Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2439423 - Disclosure - REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails</Role>
      <ShortName>REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2440424 - Disclosure - REVENUES - Lease Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/REVENUESLeaseRevenueDetails</Role>
      <ShortName>REVENUES - Lease Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2443425 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2444426 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2445427 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2446428 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails</Role>
      <ShortName>BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2449429 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails</Role>
      <ShortName>PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2451430 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.baxter.com/role/INCOMETAXES</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2454431 - Disclosure - EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails</Role>
      <ShortName>EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2455432 - Disclosure - EARNINGS PER SHARE - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails</Role>
      <ShortName>EARNINGS PER SHARE - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2458433 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2459434 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2460435 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2461436 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2462437 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2465438 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2466439 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2467440 - Disclosure - FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2468441 - Disclosure - FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2471442 - Disclosure - SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails</Role>
      <ShortName>SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2472443 - Disclosure - SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails</Role>
      <ShortName>SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="bax-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - bax-20220331.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - bax-20220331.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="bax-20220331.htm">bax-20220331.htm</File>
    <File>bax-20220331.xsd</File>
    <File>bax-20220331_cal.xml</File>
    <File>bax-20220331_def.xml</File>
    <File>bax-20220331_lab.xml</File>
    <File>bax-20220331_pre.xml</File>
    <File>bax-20220331ex321.htm</File>
    <File>bax-20220331xex101.htm</File>
    <File>bax-20220331xex102.htm</File>
    <File>bax-20220331xex103.htm</File>
    <File>bax-20220331xex104.htm</File>
    <File>bax-20220331xex105.htm</File>
    <File>bax-20220331xex106.htm</File>
    <File>bax-20220331xex311.htm</File>
    <File>bax-20220331xex312.htm</File>
    <File>bax-20220331xex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="914">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="47">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>113
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bax-20220331.htm": {
   "axisCustom": 0,
   "axisStandard": 34,
   "contextCount": 345,
   "dts": {
    "calculationLink": {
     "local": [
      "bax-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bax-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bax-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bax-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bax-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bax-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd"
     ]
    }
   },
   "elementCount": 594,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 5,
    "http://www.baxter.com/20220331": 2,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 12
   },
   "keyCustom": 31,
   "keyStandard": 303,
   "memberCustom": 39,
   "memberStandard": 63,
   "nsprefix": "bax",
   "nsuri": "http://www.baxter.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.baxter.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS",
     "role": "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTS",
     "shortName": "ACQUISITIONS AND OTHER ARRANGEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109103 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117104 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET",
     "role": "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122105 - Disclosure - FINANCING ARRANGEMENTS",
     "role": "http://www.baxter.com/role/FINANCINGARRANGEMENTS",
     "shortName": "FINANCING ARRANGEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124106 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126107 - Disclosure - STOCKHOLDERS\u2019 EQUITY",
     "role": "http://www.baxter.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "ife7be5d8b6b942a4a8046c17c53c3f40_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130108 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME",
     "role": "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134109 - Disclosure - REVENUES",
     "role": "http://www.baxter.com/role/REVENUES",
     "shortName": "REVENUES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141110 - Disclosure - BUSINESS OPTIMIZATION CHARGES",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES",
     "shortName": "BUSINESS OPTIMIZATION CHARGES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147111 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS",
     "role": "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS",
     "shortName": "PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets (unaudited)",
     "role": "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccountsAndOtherReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150112 - Disclosure - INCOME TAXES",
     "role": "http://www.baxter.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152113 - Disclosure - EARNINGS PER SHARE",
     "role": "http://www.baxter.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2156114 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2163115 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2169116 - Disclosure - SEGMENT INFORMATION",
     "role": "http://www.baxter.com/role/SEGMENTINFORMATION",
     "shortName": "SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - BASIS OF PRESENTATION (Policies)",
     "role": "http://www.baxter.com/role/BASISOFPRESENTATIONPolicies",
     "shortName": "BASIS OF PRESENTATION (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS (Tables)",
     "role": "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSTables",
     "shortName": "ACQUISITIONS AND OTHER ARRANGEMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310302 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION (Tables)",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318303 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)",
     "role": "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327304 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)",
     "role": "http://www.baxter.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)",
     "role": "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331305 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)",
     "role": "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2335306 - Disclosure - REVENUES (Tables)",
     "role": "http://www.baxter.com/role/REVENUESTables",
     "shortName": "REVENUES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bax:BusinessOptimizationChargeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342307 - Disclosure - BUSINESS OPTIMIZATION CHARGES (Tables)",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables",
     "shortName": "BUSINESS OPTIMIZATION CHARGES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bax:BusinessOptimizationChargeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348308 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)",
     "role": "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables",
     "shortName": "PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353309 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://www.baxter.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2357310 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2364311 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2370312 - Disclosure - SEGMENT INFORMATION (Tables)",
     "role": "http://www.baxter.com/role/SEGMENTINFORMATIONTables",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillPurchaseAccountingAdjustments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Additional Information (Details)",
     "role": "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
     "shortName": "ACQUISITIONS AND OTHER ARRANGEMENTS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i969c52a42b424c649a401568d787c03d_I20211213",
      "decimals": "-8",
      "lang": "en-US",
      "name": "bax:BusinessCombinationCashConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i76d012ba0e6842c4bc044efa2367e442_D20211213-20211213",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Schedule of Total Consideration for Hillrom (Details)",
     "role": "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails",
     "shortName": "ACQUISITIONS AND OTHER ARRANGEMENTS - Schedule of Total Consideration for Hillrom (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i76d012ba0e6842c4bc044efa2367e442_D20211213-20211213",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Income (unaudited)",
     "role": "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited",
     "shortName": "Condensed Consolidated Statements of Income (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Summary of Fair Value of Assets Acquired and Liabilities Assumed for Hillrom (Details)",
     "role": "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails",
     "shortName": "ACQUISITIONS AND OTHER ARRANGEMENTS - Summary of Fair Value of Assets Acquired and Liabilities Assumed for Hillrom (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i969c52a42b424c649a401568d787c03d_I20211213",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i21e54c53c46c4b708c6f8469337d00f5_D20220301-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - ACQUISITIONS AND OTHER ARRANGEMENTS - Other Business Development Activities (Details)",
     "role": "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails",
     "shortName": "ACQUISITIONS AND OTHER ARRANGEMENTS - Other Business Development Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i21e54c53c46c4b708c6f8469337d00f5_D20220301-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i9ad9afe3b705496a92217df29836a764_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details)",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Allowance for Doubtful Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i9ad9afe3b705496a92217df29836a764_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details)",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details)",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Property, Plant and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414408 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details)",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Interest Expense, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossUnrealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415409 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Other Expense, Net (Details)",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Other Expense, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossUnrealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416410 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details)",
     "role": "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i9ad9afe3b705496a92217df29836a764_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419411 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)",
     "role": "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420412 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details)",
     "role": "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited)",
     "role": "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bax:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421413 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details)",
     "role": "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bax:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommercialPaperAverageOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423414 - Disclosure - FINANCING ARRANGEMENTS (Details)",
     "role": "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails",
     "shortName": "FINANCING ARRANGEMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommercialPaperAverageOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425415 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428416 - Disclosure - STOCKHOLDERS' EQUITY - Stock Options Fair Value Assumptions (Details)",
     "role": "http://www.baxter.com/role/STOCKHOLDERSEQUITYStockOptionsFairValueAssumptionsDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Stock Options Fair Value Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429417 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)",
     "role": "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i9ad9afe3b705496a92217df29836a764_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432418 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Changes in AOCI by Component (Details)",
     "role": "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Changes in AOCI by Component (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433419 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Amounts Reclassification from AOCI to Net Income (Details)",
     "role": "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME - Summary of Amounts Reclassification from AOCI to Net Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i8ba7828d1de048e19f12a0c301c05c70_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436420 - Disclosure - REVENUES - Additional Information (Details)",
     "role": "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
     "shortName": "REVENUES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437421 - Disclosure - REVENUES - Remaining Performance Obligations (Details)",
     "role": "http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails",
     "shortName": "REVENUES - Remaining Performance Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438422 - Disclosure - REVENUES - Contract Assets and Contract Liabilities (Details)",
     "role": "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails",
     "shortName": "REVENUES - Contract Assets and Contract Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)",
     "role": "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439423 - Disclosure - REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details)",
     "role": "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails",
     "shortName": "REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "ib93cd39c2a80489ba522e10fce6b0e92_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
       "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeLeaseRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440424 - Disclosure - REVENUES - Lease Revenue (Details)",
     "role": "http://www.baxter.com/role/REVENUESLeaseRevenueDetails",
     "shortName": "REVENUES - Lease Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
       "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeLeaseRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostCostIncurredToDate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443425 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails",
     "shortName": "BUSINESS OPTIMIZATION CHARGES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostCostIncurredToDate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444426 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details)",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails",
     "shortName": "BUSINESS OPTIMIZATION CHARGES - Summary of Business Optimization Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bax:BusinessOptimizationChargeTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "if86b2c8277034f9e961edc5d828e8065_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445427 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details)",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
     "shortName": "BUSINESS OPTIMIZATION CHARGES - Components of Restructuring Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "ib68997075a33458898c6e14a36eebeb9_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446428 - Disclosure - BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details)",
     "role": "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails",
     "shortName": "BUSINESS OPTIMIZATION CHARGES - Summary of Activity in Reserves Related to Restructuring Initiatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i4d7dca14db914da8ad561a51aee21848_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "if5c7bf2bab574ab28206bdde47eed8d5_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449429 - Disclosure - PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details)",
     "role": "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails",
     "shortName": "PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS - Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "if5c7bf2bab574ab28206bdde47eed8d5_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451430 - Disclosure - INCOME TAXES (Details)",
     "role": "http://www.baxter.com/role/INCOMETAXESDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454431 - Disclosure - EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details)",
     "role": "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails",
     "shortName": "EARNINGS PER SHARE - Reconciliation of Basic Shares to Diluted Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455432 - Disclosure - EARNINGS PER SHARE - Additional Information (Details)",
     "role": "http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails",
     "shortName": "EARNINGS PER SHARE - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i949d8647f73e4aab90b5a25fe2d56799_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Changes in Equity (unaudited)",
     "role": "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited",
     "shortName": "Condensed Consolidated Statements of Changes in Equity (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i949d8647f73e4aab90b5a25fe2d56799_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DerivativeNotionalAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458433 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DerivativeNotionalAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459434 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details)",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Summary of Gains and Losses on Hedging Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460435 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details)",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Classification and Fair Value Amounts of Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i7fdf8bf9a08147fab31750ea1f96c4f5_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461436 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details)",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Positions Presented On Net Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bax:ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "iad0696204cae46f4a2dd949869b8a0a2_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462437 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details)",
     "role": "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "iad0696204cae46f4a2dd949869b8a0a2_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i97b20784595f4505a4473852b0d24361_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465438 - Disclosure - FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i97b20784595f4505a4473852b0d24361_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i1d4414eacf9648f9881e2e9dc42887af_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466439 - Disclosure - FAIR VALUE MEASUREMENTS - Additional Information (Details)",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i4ae0b3674bb74050ac9785fa17b2f5e0_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherInvestmentNotReadilyMarketableFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i4d57b720176840b084b62f8a521d47d2_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467440 - Disclosure - FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details)",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i4d57b720176840b084b62f8a521d47d2_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i26c43bcaa7314a6b967da3c9bbca9100_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShorttermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468441 - Disclosure - FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details)",
     "role": "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Book Values and Fair Values of Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i26c43bcaa7314a6b967da3c9bbca9100_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShorttermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471442 - Disclosure - SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)",
     "role": "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails",
     "shortName": "SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)",
     "role": "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472443 - Disclosure - SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details)",
     "role": "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
     "shortName": "SEGMENT INFORMATION - Operating Income to Income Before Income Taxes Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "ib16764b626684350a430fa1f03cb037f_D20220101-20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - BASIS OF PRESENTATION",
     "role": "http://www.baxter.com/role/BASISOFPRESENTATION",
     "shortName": "BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i0b7b723524ed4f1789829f72199711c8_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i9ad9afe3b705496a92217df29836a764_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - bax-20220331.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - bax-20220331.htm",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220331.htm",
      "contextRef": "i9ad9afe3b705496a92217df29836a764_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 104,
   "tag": {
    "bax_AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Allowance for Credit Loss, Currency Translation Adjustments",
        "label": "Accounts Receivable, Allowance for Credit Loss, Currency Translation Adjustments",
        "negatedLabel": "Currency translation adjustments"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossCurrencyTranslationAdjustments",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_AccruedExpensesAndOtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Expenses And Other Current Liabilities",
        "label": "Accrued Expenses And Other Current Liabilities [Member]",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedExpensesAndOtherCurrentLiabilitiesMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AcquisitionsAndCollaborationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisitions And Collaborations [Line Items]",
        "label": "Acquisitions And Collaborations [Line Items]",
        "terseLabel": "Acquisitions And Collaborations [Line Items]"
       }
      }
     },
     "localname": "AcquisitionsAndCollaborationsLineItems",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_AcquisitionsAndCollaborationsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisitions And Collaborations [Table]",
        "label": "Acquisitions And Collaborations [Table]",
        "terseLabel": "Acquisitions And Collaborations [Table]"
       }
      }
     },
     "localname": "AcquisitionsAndCollaborationsTable",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_AcuteTherapiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acute Therapies.",
        "label": "Acute Therapies [Member]",
        "terseLabel": "Acute Therapies"
       }
      }
     },
     "localname": "AcuteTherapiesMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AdvancedSurgeryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advanced surgery.",
        "label": "Advanced Surgery [Member]",
        "terseLabel": "Advanced Surgery"
       }
      }
     },
     "localname": "AdvancedSurgeryMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AmericasSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Americas Segment",
        "label": "Americas Segment [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasSegmentMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AsiaPacificSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asia Pacific Segment",
        "label": "Asia Pacific Segment [Member]",
        "terseLabel": "APAC"
       }
      }
     },
     "localname": "AsiaPacificSegmentMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_AssetImpairmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairment",
        "label": "Asset Impairment [Member]",
        "terseLabel": "Asset impairments"
       }
      }
     },
     "localname": "AssetImpairmentMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_BioPharmaSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BioPharma Solutions",
        "label": "BioPharma Solutions [Member]",
        "terseLabel": "BioPharma Solutions"
       }
      }
     },
     "localname": "BioPharmaSolutionsMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_BundledEquipmentAndConsumableMedicalProductsContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bundled Equipment And Consumable Medical Products Contracts",
        "label": "Bundled Equipment And Consumable Medical Products Contracts [Member]",
        "terseLabel": "Bundled equipment and consumable medical products contracts"
       }
      }
     },
     "localname": "BundledEquipmentAndConsumableMedicalProductsContractsMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Acquired Receivable, Fair Value, Including Outstanding Debt Obligations",
        "label": "Business Combination, Acquired Receivable, Fair Value, Including Outstanding Debt Obligations",
        "terseLabel": "Enterprise value"
       }
      }
     },
     "localname": "BusinessCombinationAcquiredReceivableFairValueIncludingOutstandingDebtObligations",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_BusinessCombinationCashConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Cash Consideration",
        "label": "Business Combination, Cash Consideration",
        "verboseLabel": "Cash consideration"
       }
      }
     },
     "localname": "BusinessCombinationCashConsideration",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired and Liabilities Assumed",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired and Liabilities Assumed",
        "negatedTerseLabel": "Adjustment, assets acquired and liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquiredAndLiabilitiesAssumed",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current liabilities short-term debt.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Short Term Debt",
        "negatedTerseLabel": "Short-term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesShortTermDebt",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right Of Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right Of Use Assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_BusinessOptimizationChargeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business optimization charge.",
        "label": "Business Optimization Charge [Table Text Block]",
        "terseLabel": "Summary of Business Optimization Charges"
       }
      }
     },
     "localname": "BusinessOptimizationChargeTableTextBlock",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bax_BusinessOptimizationProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Optimization Programs",
        "label": "Business Optimization Programs [Member]",
        "terseLabel": "Business Optimization Programs"
       }
      }
     },
     "localname": "BusinessOptimizationProgramsMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ClinicalNutritionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical nutrition.",
        "label": "Clinical Nutrition [Member]",
        "terseLabel": "Clinical Nutrition"
       }
      }
     },
     "localname": "ClinicalNutritionMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_CommercialPaperWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Paper, Weighted-Average Interest Rate",
        "label": "Commercial Paper, Weighted-Average Interest Rate",
        "terseLabel": "Weighted-average interest rate"
       }
      }
     },
     "localname": "CommercialPaperWeightedAverageInterestRate",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bax_CommonStock100PerValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, $1.00 per Value",
        "label": "Common Stock, $1.00 per Value [Member]",
        "terseLabel": "Common Stock, $1.00 par value"
       }
      }
     },
     "localname": "CommonStock100PerValueMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ConsumableMedicalProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumable medical products [Member].",
        "label": "Consumable Medical Products [Member]",
        "terseLabel": "Consumable Medical Products"
       }
      }
     },
     "localname": "ConsumableMedicalProductsMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ContractTerminationAndOtherCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract termination and other costs.",
        "label": "Contract Termination And Other Costs [Member]",
        "terseLabel": "Contract termination and other costs"
       }
      }
     },
     "localname": "ContractTerminationAndOtherCostsMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ContractWithCustomerLiabilityDeferredRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Deferred Revenue",
        "label": "Contract With Customer, Liability, Deferred Revenue",
        "terseLabel": "New revenue deferrals"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityDeferredRevenue",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative fair value of derivative assets offset by fair value of derivative liability.",
        "label": "Derivative Fair Value Of Derivative Assets Offset By Fair Value Of Derivative Liability",
        "terseLabel": "Total, asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAssetsOffsetByFairValueOfDerivativeLiability",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative fair value of derivative liability offset by fair value of derivative assets.",
        "label": "Derivative Fair Value Of Derivative Liability Offset By Fair Value Of Derivative Assets",
        "terseLabel": "Total, liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiabilityOffsetByFairValueOfDerivativeAssets",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_DerivativeFairValueTerminated": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Fair Value, Terminated",
        "label": "Derivative, Fair Value, Terminated",
        "terseLabel": "Derivative, fair value, terminated"
       }
      }
     },
     "localname": "DerivativeFairValueTerminated",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_DerivativeNetInvestmentTerminated": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Net Investment Terminated",
        "label": "Derivative, Net Investment Terminated",
        "terseLabel": "Derivative, net investment terminated"
       }
      }
     },
     "localname": "DerivativeNetInvestmentTerminated",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_DevelopedTechnologyIncludingPatentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed technology including patents.",
        "label": "Developed Technology Including Patents [Member]",
        "terseLabel": "Developed technology, including patents"
       }
      }
     },
     "localname": "DevelopedTechnologyIncludingPatentsMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_EMEASegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "E M E A Segment",
        "label": "E M E A Segment [Member]",
        "terseLabel": "EMEA"
       }
      }
     },
     "localname": "EMEASegmentMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_EnviromentalCleanUpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Enviromental clean-up.",
        "label": "Enviromental Clean Up [Member]",
        "terseLabel": "Environmental Clean-up"
       }
      }
     },
     "localname": "EnviromentalCleanUpMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_FairValueAndCarryingValueByBalanceSheetGroupingLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value and carrying value by balance sheet grouping.",
        "label": "Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]",
        "terseLabel": "Fair Value And Carrying Value By Balance Sheet Grouping [Line Items]"
       }
      }
     },
     "localname": "FairValueAndCarryingValueByBalanceSheetGroupingLineItems",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_FairValueAndCarryingValueByBalanceSheetGroupingTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value And Carrying Value By Balance Sheet Grouping [Table]",
        "label": "Fair Value And Carrying Value By Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value And Carrying Value By Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueAndCarryingValueByBalanceSheetGroupingTable",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_FairValueDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value disclosure Line items.",
        "label": "Fair Value Disclosures [Line Items]",
        "terseLabel": "Fair Value Disclosures [Line Items]"
       }
      }
     },
     "localname": "FairValueDisclosuresLineItems",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_FairValueDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value disclosures table.",
        "label": "Fair Value Disclosures [Table]",
        "terseLabel": "Fair Value Disclosures [Table]"
       }
      }
     },
     "localname": "FairValueDisclosuresTable",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_FrontLineCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Front line care",
        "label": "Front line care [Member]",
        "terseLabel": "Front line care"
       }
      }
     },
     "localname": "FrontLineCareMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes04Due2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Notes 0.4% due 2024",
        "label": "Global Notes 0.4% due 2024 [Member]",
        "terseLabel": "0.4% Global Notes due 2024"
       }
      }
     },
     "localname": "GlobalNotes04Due2024Member",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes13Due2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Notes 1.3% due 2025",
        "label": "Global Notes 1.3% due 2025 [Member]",
        "terseLabel": "1.3% Global Notes due 2025"
       }
      }
     },
     "localname": "GlobalNotes13Due2025Member",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes13Due2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Notes 1.3% due 2029",
        "label": "Global Notes 1.3% due 2029 [Member]",
        "terseLabel": "1.3% Global Notes due 2029"
       }
      }
     },
     "localname": "GlobalNotes13Due2029Member",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes173Due2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Notes 1.73% due 2031",
        "label": "Global Notes 1.73% due 2031 [Member]",
        "terseLabel": "1.73% Global Notes due 2031"
       }
      }
     },
     "localname": "GlobalNotes173Due2031Member",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes395Due2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Notes 3.95% due 2030",
        "label": "Global Notes 3.95% due 2030 [Member]",
        "terseLabel": "3.95% Global Notes due 2030"
       }
      }
     },
     "localname": "GlobalNotes395Due2030Member",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_HillromMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hillrom Member",
        "label": "Hillrom [Member]",
        "terseLabel": "Hillrom"
       }
      }
     },
     "localname": "HillromMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Accrued Expenses And Other Current Liabilities",
        "label": "Increase (Decrease) In Accrued Expenses And Other Current Liabilities",
        "negatedTerseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_IntangibleAssetExcludingGoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Asset Excluding Goodwill [Line Items]",
        "label": "Intangible Asset Excluding Goodwill [Line Items]",
        "terseLabel": "Intangible Asset Excluding Goodwill [Line Items]"
       }
      }
     },
     "localname": "IntangibleAssetExcludingGoodwillLineItems",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_IntangibleAssetExcludingGoodwillTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Asset Excluding Goodwill [Table]",
        "label": "Intangible Asset Excluding Goodwill [Table]",
        "terseLabel": "Intangible Asset Excluding Goodwill [Table]"
       }
      }
     },
     "localname": "IntangibleAssetExcludingGoodwillTable",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt and finance lease obligations, current, fair value disclosure.",
        "label": "Long Term Debt And Finance Lease Obligations Current Fair Value Disclosure",
        "terseLabel": "Current maturities of long-term debt and finance lease obligations"
       }
      }
     },
     "localname": "LongTermDebtAndFinanceLeaseObligationsCurrentFairValueDisclosure",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt and finance lease obligations, fair value disclosure.",
        "label": "Long Term Debt And Finance Lease Obligations Fair Value Disclosure",
        "terseLabel": "Long-term debt and finance lease obligations"
       }
      }
     },
     "localname": "LongTermDebtAndFinanceLeaseObligationsFairValueDisclosure",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_LongTermDebtAndFinanceLeaseObligationsNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt and finance lease obligations noncurrent.",
        "label": "Long Term Debt And Finance Lease Obligations Noncurrent",
        "terseLabel": "Long-term debt and finance lease obligations, less current portion"
       }
      }
     },
     "localname": "LongTermDebtAndFinanceLeaseObligationsNoncurrent",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_LossContingencyNumberOfLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Lawsuits",
        "label": "Loss Contingency, Number Of Lawsuits",
        "terseLabel": "Number of lawsuits"
       }
      }
     },
     "localname": "LossContingencyNumberOfLawsuits",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bax_ManufacturingArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing arrangements.",
        "label": "Manufacturing Arrangements [Member]",
        "terseLabel": "Contract manufacturing services"
       }
      }
     },
     "localname": "ManufacturingArrangementsMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_MedicationDeliveryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medication delivery.",
        "label": "Medication Delivery [Member]",
        "terseLabel": "Medication Delivery"
       }
      }
     },
     "localname": "MedicationDeliveryMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One point three percentage senior notes due May two thousand twenty nine.",
        "label": "One Point Three Percentage Senior Notes Due May Two Thousand Twenty Nine [Member]",
        "terseLabel": "1.3% Senior Notes Due in May 2029"
       }
      }
     },
     "localname": "OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One point three zero percentage senior notes due may two thousand and twenty five.",
        "label": "One Point Three Zero Percentage Senior Notes Due May Two Thousand And Twenty Five [Member]",
        "terseLabel": "1.30% Senior Notes due May 2025"
       }
      }
     },
     "localname": "OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_OriginalWeightedAverageTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Original Weighted-Average Term",
        "label": "Original Weighted-Average Term",
        "terseLabel": "Original weighted-average term"
       }
      }
     },
     "localname": "OriginalWeightedAverageTerm",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), before Reclassification, Tax",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge And Net Investment Hedge, Gain (Loss), before Reclassification, Tax",
        "totalLabel": "Other comprehensive income (loss), cash flow hedge and net investment hedge, gain (loss), before reclassification, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Reclassification Adjustment from Accumulated Other Comprehensive Income, Cash Flow Hedges And Net Investment Hedges, Net of Tax",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from Accumulated Other Comprehensive Income, Cash Flow Hedges And Net Investment Hedges, Net of Tax",
        "terseLabel": "Other comprehensive income (loss), reclassification adjustment from AOCI, cash flow hedges and net investment hedges, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAccumulatedOtherComprehensiveIncomeCashFlowHedgesAndNetInvestmentHedgesNetOfTax",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_OtherLiabilitiesCurrentUnsettledShareRepurchase": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Liabilities Current, Unsettled Share Repurchase",
        "label": "Other Liabilities Current, Unsettled Share Repurchase",
        "terseLabel": "Other Liabilities Current, Unsettled Share Repurchase"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentUnsettledShareRepurchase",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_OtherProductOrServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other product or services.",
        "label": "Other Product Or Services [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherProductOrServicesMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_PatientSupportSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient support systems",
        "label": "Patient support systems [Member]",
        "terseLabel": "Patient support systems"
       }
      }
     },
     "localname": "PatientSupportSystemsMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_PharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmaceuticals.",
        "label": "Pharmaceuticals [Member]",
        "terseLabel": "Pharmaceuticals"
       }
      }
     },
     "localname": "PharmaceuticalsMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_RenalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Renal.",
        "label": "Renal [Member]",
        "terseLabel": "Renal Care"
       }
      }
     },
     "localname": "RenalMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_RevenueFromContractWithCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from contract with customer.",
        "label": "Revenue From Contract With Customer [Line Items]",
        "terseLabel": "Revenue From Contract With Customer [Line Items]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerLineItems",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails",
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails",
      "http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_RevenueFromContractWithCustomerRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer",
        "label": "Revenue From Contract With Customer [Roll Forward]",
        "terseLabel": "Revenue From Contract With Customer [Roll Forward]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerRollForward",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_RevenueFromContractWithCustomerTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from contract with customer.",
        "label": "Revenue From Contract With Customer [Table]",
        "terseLabel": "Revenue From Contract With Customer [Table]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTable",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails",
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails",
      "http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_RevenuePerformanceObligationPaymentTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Performance Obligation, Payment Terms",
        "label": "Revenue, Performance Obligation, Payment Terms",
        "terseLabel": "Global payment terms"
       }
      }
     },
     "localname": "RevenuePerformanceObligationPaymentTerms",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bax_RevenueRecognizedContractPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue recognized contract period.",
        "label": "Revenue Recognized Contract Period",
        "terseLabel": "Revenue recognized contract period"
       }
      }
     },
     "localname": "RevenueRecognizedContractPeriod",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "bax_RisksAndUncertaintiesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risks and Uncertainties Policy",
        "label": "Risks and Uncertainties Policy [Policy Text Block]",
        "terseLabel": "Risks and Uncertainties Related to COVID-19 and Global Economic Conditions"
       }
      }
     },
     "localname": "RisksAndUncertaintiesPolicyPolicyTextBlock",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bax_ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of derivative positions presented on net basis.",
        "label": "Schedule Of Derivative Positions Presented On Net Basis Table [Table Text Block]",
        "terseLabel": "Derivative Positions Presented On Net Basis"
       }
      }
     },
     "localname": "ScheduleOfDerivativePositionsPresentedOnNetBasisTableTableTextBlock",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bax_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Finite And Indefinite Lived Intangible Assets Excluding Goodwill",
        "label": "Schedule Of Finite And Indefinite Lived Intangible Assets Excluding Goodwill [Table Text Block]",
        "terseLabel": "Other Intangible Assets, Net"
       }
      }
     },
     "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillTableTextBlock",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bax_SeniorFiveYearTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Five Year Term Loan",
        "label": "Senior Five Year Term Loan [Member]",
        "terseLabel": "Senior Five Year Term Loan"
       }
      }
     },
     "localname": "SeniorFiveYearTermLoanMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_SeniorThreeYearTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Three Year Term Loan",
        "label": "Senior Three Year Term Loan [Member]",
        "terseLabel": "Senior Three Year Term Loan"
       }
      }
     },
     "localname": "SeniorThreeYearTermLoanMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_SeveranceAndOtherEmployeeRelatedCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Severance and other employee related costs.",
        "label": "Severance And Other Employee Related Costs [Member]",
        "terseLabel": "Severance and Other Employee Related Costs"
       }
      }
     },
     "localname": "SeveranceAndOtherEmployeeRelatedCostsMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ShareBasedCompensationAllocationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Allocation Percentage",
        "label": "Share-based Compensation Allocation Percentage",
        "terseLabel": "Stock compensation expense allocation percentage"
       }
      }
     },
     "localname": "ShareBasedCompensationAllocationPercentage",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "bax_SiteContingencyNumberOfSites": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Site contingency, number of sites.",
        "label": "Site Contingency Number Of Sites",
        "terseLabel": "Number of sites"
       }
      }
     },
     "localname": "SiteContingencyNumberOfSites",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bax_SoftwareArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Software arrangements.",
        "label": "Software Arrangements [Member]",
        "terseLabel": "Software sales"
       }
      }
     },
     "localname": "SoftwareArrangementsMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_StockRepurchaseProgramAdditionalAuthorizedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock repurchase program additional authorized amount.",
        "label": "Stock Repurchase Program Additional Authorized Amount",
        "terseLabel": "Stock repurchase program, additional authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAdditionalAuthorizedAmount",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bax_StockholdersEquityNoteLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockholders equity note.",
        "label": "Stockholders Equity Note [Line Items]",
        "terseLabel": "Stockholders Equity Note [Line Items]"
       }
      }
     },
     "localname": "StockholdersEquityNoteLineItems",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_StockholdersEquityNoteTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockholders Equity Note [Table]",
        "label": "Stockholders Equity Note [Table]",
        "terseLabel": "Stockholders Equity Note [Table]"
       }
      }
     },
     "localname": "StockholdersEquityNoteTable",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bax_SuperfundSitesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Superfund sites.",
        "label": "Superfund Sites [Member]",
        "terseLabel": "Superfund Sites"
       }
      }
     },
     "localname": "SuperfundSitesMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_SurgicalSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical solutions",
        "label": "Surgical solutions [Member]",
        "terseLabel": "Surgical solutions"
       }
      }
     },
     "localname": "SurgicalSolutionsMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zero point four percentage senior notes due May two thousand twenty four.",
        "label": "Zero Point Four Percentage Senior Notes Due May Two Thousand Twenty Four [Member]",
        "terseLabel": "0.4% Senior Notes Due in May 2024"
       }
      }
     },
     "localname": "ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_ZosynMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zosyn",
        "label": "Zosyn [Member]",
        "terseLabel": "Zosyn"
       }
      }
     },
     "localname": "ZosynMember",
     "nsuri": "http://www.baxter.com/20220331",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "verboseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "verboseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "verboseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r743"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]",
        "terseLabel": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]",
        "terseLabel": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "exch_XCHI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHICAGO STOCK EXCHANGE, INC [Member]",
        "terseLabel": "Chicago Stock Exchange"
       }
      }
     },
     "localname": "XCHI",
     "nsuri": "http://xbrl.sec.gov/exch/2021",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "exch_XNYS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]",
        "terseLabel": "New York Stock Exchange"
       }
      }
     },
     "localname": "XNYS",
     "nsuri": "http://xbrl.sec.gov/exch/2021",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Americas [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "APAC"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r128",
      "r168",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r188",
      "r192",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r301",
      "r303",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r128",
      "r168",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r188",
      "r192",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r301",
      "r303",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r309",
      "r342",
      "r457",
      "r462",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r657",
      "r706",
      "r709",
      "r728",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r309",
      "r342",
      "r457",
      "r462",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r657",
      "r706",
      "r709",
      "r728",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r195",
      "r369",
      "r373",
      "r659",
      "r705",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r195",
      "r369",
      "r373",
      "r659",
      "r705",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r309",
      "r342",
      "r401",
      "r457",
      "r462",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r657",
      "r706",
      "r709",
      "r728",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r309",
      "r342",
      "r401",
      "r457",
      "r462",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r657",
      "r706",
      "r709",
      "r728",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r196",
      "r197",
      "r369",
      "r374",
      "r708",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails",
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r196",
      "r197",
      "r369",
      "r374",
      "r708",
      "r716",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails",
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsAndOtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.",
        "label": "Accounts and Other Receivables, Net, Current",
        "terseLabel": "Accounts receivable, net of allowances of $129 in 2022 and $122 in 2021"
       }
      }
     },
     "localname": "AccountsAndOtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.",
        "label": "Accounts Payable and Accrued Liabilities [Member]",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r36",
      "r625"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNet": {
     "auth_ref": [
      "r19",
      "r686",
      "r717"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "terseLabel": "Net trade accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForEnvironmentalLossContingencies": {
     "auth_ref": [
      "r257",
      "r278",
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies.",
        "label": "Accrual for Environmental Loss Contingencies",
        "terseLabel": "Environmental reserves"
       }
      }
     },
     "localname": "AccrualForEnvironmentalLossContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r64",
      "r70",
      "r78",
      "r79",
      "r80",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Pension and OPEB plans",
        "verboseLabel": "Pension and OPEB items"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r34",
      "r250"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r70",
      "r78",
      "r79",
      "r80",
      "r81",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Hedging activities",
        "verboseLabel": "Gains (losses) on hedging activities"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r61",
      "r62",
      "r63",
      "r70",
      "r78",
      "r79",
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r22",
      "r67",
      "r69",
      "r70",
      "r691",
      "r714",
      "r715"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r78",
      "r79",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r66",
      "r70",
      "r78",
      "r79",
      "r80",
      "r129",
      "r130",
      "r131",
      "r536",
      "r710",
      "r711",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r59",
      "r70",
      "r78",
      "r79",
      "r80",
      "r536",
      "r599",
      "r600",
      "r601",
      "r602",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "CTA"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted-average useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AcquisitionRelatedCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of acquisition-related costs allocated to (included in) reported pro forma earnings (supplemental pro forma information).",
        "label": "Acquisition-related Costs [Member]",
        "terseLabel": "Acquisition-related Costs"
       }
      }
     },
     "localname": "AcquisitionRelatedCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "SUPPLEMENTAL FINANCIAL INFORMATION"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional contributed capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r480",
      "r481",
      "r482",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional contributed capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to cash flows from operations:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r201",
      "r213",
      "r215",
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r26",
      "r201",
      "r213"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for accounts receivable, current"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Allowance for Doubtful Accounts Receivable [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Write-offs"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r113",
      "r238",
      "r245"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Intangible asset amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive securities excluded from computation of EPS (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/EARNINGSPERSHAREAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r66",
      "r70",
      "r78",
      "r79",
      "r80",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r125",
      "r176",
      "r183",
      "r190",
      "r211",
      "r291",
      "r292",
      "r293",
      "r295",
      "r296",
      "r297",
      "r298",
      "r300",
      "r302",
      "r304",
      "r305",
      "r529",
      "r537",
      "r593",
      "r623",
      "r625",
      "r666",
      "r687"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r51",
      "r125",
      "r211",
      "r291",
      "r292",
      "r293",
      "r295",
      "r296",
      "r297",
      "r298",
      "r300",
      "r302",
      "r304",
      "r305",
      "r529",
      "r537",
      "r593",
      "r623",
      "r625"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r204"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Accumulated pre-tax unrealized translation gain in AOCI"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r466",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r547",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r453",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r453",
      "r458",
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Business acquisition, equity interest issued or issuable (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Cash consideration transferred (in usd per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r512",
      "r513",
      "r515"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "totalLabel": "Total Consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r512",
      "r513"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Fair value of equity awards issued to Hillrom equity award holders"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r511",
      "r514",
      "r518"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Contingent payments related to acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "ACQUISITIONS AND OTHER ARRANGEMENTS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory",
        "terseLabel": "Incremental costs of sales"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease obligation assumed in business combination.",
        "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation",
        "negatedTerseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedTerseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "negatedTerseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r505",
      "r506"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 15.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt",
        "negatedTerseLabel": "Long-term debt and finance lease obligations"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedTerseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r505",
      "r506"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total assets acquired and liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r117",
      "r118",
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Capital expenditures incurred but not yet paid"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAxis": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cost capitalized in obtaining or fulfilling contract with customer.",
        "label": "Capitalized Contract Cost [Axis]",
        "terseLabel": "Capitalized Contract Cost"
       }
      }
     },
     "localname": "CapitalizedContractCostAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalizedContractCostDomain": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost capitalized in obtaining and fulfilling contract with customer.",
        "label": "Capitalized Contract Cost [Domain]",
        "terseLabel": "Capitalized Contract Cost"
       }
      }
     },
     "localname": "CapitalizedContractCostDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r591",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Book values"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r5",
      "r32",
      "r115"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r110",
      "r115",
      "r120"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r110",
      "r597"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Decrease in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r569"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "terseLabel": "Deferred, net after-tax gains on derivative instruments"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r123",
      "r125",
      "r144",
      "r145",
      "r146",
      "r148",
      "r150",
      "r160",
      "r161",
      "r162",
      "r211",
      "r291",
      "r296",
      "r297",
      "r298",
      "r304",
      "r305",
      "r340",
      "r341",
      "r343",
      "r344",
      "r593",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperAverageOutstanding": {
     "auth_ref": [
      "r736",
      "r737"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average amount outstanding of commercial paper.",
        "label": "Commercial Paper, Average Outstanding",
        "terseLabel": "Commercial paper, average outstanding"
       }
      }
     },
     "localname": "CommercialPaperAverageOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r43",
      "r279",
      "r671",
      "r696"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r275",
      "r276",
      "r277",
      "r287",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r129",
      "r130",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Balance, end of period (in shares)",
        "periodStartLabel": "Balance, beginning of period (in shares)",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r18",
      "r625"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2022 and 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r74",
      "r76",
      "r77",
      "r88",
      "r677",
      "r701"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Baxter stockholders"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r74",
      "r76",
      "r87",
      "r527",
      "r528",
      "r541",
      "r676",
      "r700"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r74",
      "r76",
      "r86",
      "r526",
      "r541",
      "r675",
      "r699"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r85",
      "r97",
      "r674",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE INCOME"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r121",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract with Customer, Contract Asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r355",
      "r357",
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "terseLabel": "Contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r355",
      "r356",
      "r370"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "verboseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "negatedTerseLabel": "Revenue recognized upon satisfaction of performance obligations"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r192",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate and other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r92",
      "r659"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedLabel": "Cost of sales",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "COGS",
        "verboseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r122",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r323",
      "r330",
      "r331",
      "r333",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "FINANCING ARRANGEMENTS"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r124",
      "r128",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r335",
      "r336",
      "r337",
      "r338",
      "r610",
      "r667",
      "r668",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r306",
      "r335",
      "r336",
      "r608",
      "r610",
      "r611"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Senior notes"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r41",
      "r124",
      "r128",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r335",
      "r336",
      "r337",
      "r338",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r41",
      "r124",
      "r128",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r332",
      "r335",
      "r336",
      "r337",
      "r338",
      "r347",
      "r348",
      "r349",
      "r350",
      "r607",
      "r608",
      "r610",
      "r611",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity), and investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Debt Securities",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r379",
      "r417",
      "r441",
      "r447",
      "r448"
     ],
     "calculation": {
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Amortization of net losses and prior service costs"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r379",
      "r416",
      "r440",
      "r447",
      "r448"
     ],
     "calculation": {
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r379",
      "r383",
      "r415",
      "r439",
      "r447",
      "r448"
     ],
     "calculation": {
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r413",
      "r437",
      "r447",
      "r448"
     ],
     "calculation": {
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic cost (income)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r381",
      "r414",
      "r438",
      "r447",
      "r448"
     ],
     "calculation": {
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r113",
      "r171"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Asset [Abstract]",
        "terseLabel": "Asset"
       }
      }
     },
     "localname": "DerivativeAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r52",
      "r55",
      "r56",
      "r549",
      "r639"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Derivative asset, fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral": {
     "auth_ref": [
      "r53",
      "r54",
      "r57",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Amount Not Offset Against Collateral",
        "negatedLabel": "Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r52",
      "r55",
      "r56",
      "r549",
      "r639"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Derivative liability, fair value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral": {
     "auth_ref": [
      "r53",
      "r54",
      "r57",
      "r566"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Amount Not Offset Against Collateral",
        "negatedLabel": "Gross amount subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r590"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "terseLabel": "Derivative, fair value, net"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r55",
      "r548",
      "r550",
      "r556",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r571",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r546",
      "r548",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r546",
      "r548",
      "r556",
      "r562",
      "r563",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r555",
      "r557"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Gain (loss) recognized in income, undesignated derivative instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Liability [Abstract]",
        "terseLabel": "Liability"
       }
      }
     },
     "localname": "DerivativeLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativePositionsPresentedOnNetBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivative instruments designated as hedges"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed Technology Intangible Asset"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r351",
      "r683"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedLabel": "Dividends declared on common stock"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r89",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r142",
      "r144",
      "r148",
      "r149",
      "r150",
      "r155",
      "r156",
      "r573",
      "r574",
      "r678",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r89",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r144",
      "r148",
      "r149",
      "r150",
      "r155",
      "r156",
      "r573",
      "r574",
      "r678",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r151",
      "r153",
      "r154",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r597"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "terseLabel": "Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r126",
      "r488",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. Federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r477"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost related to all unvested stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period for all unvested stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee termination costs"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EnvironmentalRemediationContingencyAxis": {
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r257",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of environmental remediation contingency.",
        "label": "Environmental Remediation Contingency [Axis]",
        "terseLabel": "Environmental Remediation Contingency"
       }
      }
     },
     "localname": "EnvironmentalRemediationContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EnvironmentalRemediationContingencyDomain": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Environmental remediation contingency, for example, but not limited to, asbestos, air emissions and mercury emissions.",
        "label": "Environmental Remediation Contingency [Domain]",
        "terseLabel": "Environmental Remediation Contingency"
       }
      }
     },
     "localname": "EnvironmentalRemediationContingencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EnvironmentalRemediationSiteAxis": {
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r257",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location or named area designated for environmental remediation.",
        "label": "Environmental Remediation Site [Axis]",
        "terseLabel": "Environmental Remediation Site"
       }
      }
     },
     "localname": "EnvironmentalRemediationSiteAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EnvironmentalRemediationSiteDomain": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location or named area designated for environmental remediation.",
        "label": "Environmental Remediation Site [Domain]",
        "terseLabel": "Environmental Remediation Site"
       }
      }
     },
     "localname": "EnvironmentalRemediationSiteDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r78",
      "r79",
      "r80",
      "r129",
      "r130",
      "r131",
      "r133",
      "r139",
      "r141",
      "r159",
      "r212",
      "r346",
      "r351",
      "r480",
      "r481",
      "r482",
      "r492",
      "r493",
      "r572",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r605",
      "r710",
      "r711",
      "r712",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r589"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Marketable equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r321",
      "r335",
      "r336",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair values"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r576",
      "r577",
      "r578",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r582",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Fair Value Measurements that Use Significant Unobservable Inputs"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r576",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r576",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Book Values and Fair Values of Financial Instruments"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r321",
      "r335",
      "r336",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r447",
      "r577",
      "r629",
      "r630",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r576",
      "r577",
      "r580",
      "r581",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r321",
      "r402",
      "r404",
      "r409",
      "r447",
      "r577",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted prices in active markets for identical assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r321",
      "r335",
      "r336",
      "r402",
      "r404",
      "r409",
      "r447",
      "r577",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant other observable inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r321",
      "r335",
      "r336",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r447",
      "r577",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant unobservable inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r583"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in fair value recognized in earnings"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome": {
     "auth_ref": [
      "r584"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Change in fair value recognized in AOCI"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "auth_ref": [
      "r585"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r585"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r582"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value at end of period",
        "periodStartLabel": "Fair value at beginning of period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r321",
      "r335",
      "r336",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r447",
      "r629",
      "r630",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r586",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r547",
      "r552",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r205",
      "r206",
      "r208",
      "r209",
      "r210",
      "r214",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r332",
      "r345",
      "r571",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r244"
     ],
     "calculation": {
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r239",
      "r241",
      "r244",
      "r247",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r244",
      "r661"
     ],
     "calculation": {
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross other intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r239",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r244",
      "r660"
     ],
     "calculation": {
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeAssetAtFairValue": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivative assets designated as cash flow hedging instruments.",
        "label": "Foreign Currency Cash Flow Hedge Asset at Fair Value",
        "terseLabel": "Foreign exchange contracts"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivative liabilities designated as cash flow hedging instruments.",
        "label": "Foreign Currency Cash Flow Hedge Liability at Fair Value",
        "terseLabel": "Foreign exchange contracts"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r114",
      "r594",
      "r596"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "negatedLabel": "Foreign exchange (gains) losses, net"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r55",
      "r402",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign exchange contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r228",
      "r230",
      "r625",
      "r665"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSSummaryofFairValueofAssetsAcquiredandLiabilitiesAssumedforHillromDetails",
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r232"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r113",
      "r229",
      "r231",
      "r235"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill, impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r233",
      "r502"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Acquisition accounting adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r91",
      "r125",
      "r176",
      "r182",
      "r186",
      "r189",
      "r192",
      "r211",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r298",
      "r300",
      "r302",
      "r304",
      "r305",
      "r593"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgedLiabilityFairValueHedge": {
     "auth_ref": [
      "r564"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability hedged in fair value hedging relationship.",
        "label": "Hedged Liability, Fair Value Hedge",
        "terseLabel": "Carrying amount of hedged item"
       }
      }
     },
     "localname": "HedgedLiabilityFairValueHedge",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.",
        "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)",
        "terseLabel": "Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged item"
       }
      }
     },
     "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r546",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r83",
      "r176",
      "r182",
      "r186",
      "r189",
      "r192",
      "r662",
      "r672",
      "r681",
      "r703"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before income taxes",
        "totalLabel": "Income before income taxes",
        "verboseLabel": "Total before tax"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited",
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r252",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails",
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails",
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r126",
      "r489",
      "r490",
      "r491",
      "r494",
      "r497",
      "r499",
      "r500",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r127",
      "r140",
      "r141",
      "r174",
      "r487",
      "r495",
      "r498",
      "r704"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax expense",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in balance sheet items:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Gains (losses)"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefinitelivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Member]",
        "terseLabel": "Indefinite-lived intangible assets"
       }
      }
     },
     "localname": "IndefinitelivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Gross other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r237",
      "r242"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets, net",
        "totalLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r82",
      "r170",
      "r606",
      "r609",
      "r680"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense, net of capitalized interest"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.",
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "terseLabel": "Interest Expense, Net"
       }
      }
     },
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r679"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "negatedLabel": "Interest expense, net",
        "negatedTerseLabel": "Interest expense, net",
        "negatedTotalLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited",
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Income (Expense), Net [Abstract]",
        "terseLabel": "Interest Income Expense Net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r55",
      "r402",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "terseLabel": "Interest rate contracts"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest rate swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r6",
      "r50",
      "r625"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r94",
      "r169"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "negatedLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONInterestExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseIncome": {
     "auth_ref": [
      "r621"
     ],
     "calculation": {
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease income from operating, direct financing, and sales-type leases. Includes, but is not limited to, variable lease payments, interest income, profit (loss) recognized at commencement, and lease payments paid and payable to lessor.",
        "label": "Lease Income",
        "totalLabel": "Total lease revenue"
       }
      }
     },
     "localname": "LeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.",
        "label": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Operating Lease, Lease Income"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r38",
      "r125",
      "r184",
      "r211",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r298",
      "r300",
      "r302",
      "r304",
      "r305",
      "r530",
      "r537",
      "r538",
      "r593",
      "r623",
      "r624"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r25",
      "r125",
      "r211",
      "r593",
      "r625",
      "r670",
      "r694"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r40",
      "r125",
      "r211",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r298",
      "r300",
      "r302",
      "r304",
      "r305",
      "r530",
      "r537",
      "r538",
      "r593",
      "r623",
      "r624",
      "r625"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSSummaryofFinancialInstrumentsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r15",
      "r668",
      "r685"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Borrowings outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Line of credit, current borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r43",
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Litigation reserve"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Agreement to settle the case"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Civil settlement amount"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r15",
      "r320",
      "r334",
      "r335",
      "r336",
      "r668",
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Repaid debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "terseLabel": "Current maturities of long-term debt and finance lease obligations"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtTerm": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Long-term Debt, Term",
        "terseLabel": "Weighted-average term"
       }
      }
     },
     "localname": "LongTermDebtTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r41",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r288",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MaximumLengthOfTimeHedgedInCashFlowHedge1": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum length of time over which the entity is hedging its exposure to the variability in future cash flows for forecasted transactions, excluding those forecasted transactions related to the payment of variable interest on existing financial instruments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Length of Time Hedged in Cash Flow Hedge",
        "terseLabel": "Maximum length of time hedge in cash flow hedge"
       }
      }
     },
     "localname": "MaximumLengthOfTimeHedgedInCashFlowHedge1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r46",
      "r125",
      "r211",
      "r291",
      "r296",
      "r297",
      "r298",
      "r304",
      "r305",
      "r593",
      "r669",
      "r693"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Change in noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money Market Funds, at Carrying Value",
        "terseLabel": "Money market funds, at carrying value"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r110",
      "r111",
      "r114"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Cash flows from operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operations"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r3",
      "r72",
      "r75",
      "r80",
      "r84",
      "r114",
      "r125",
      "r132",
      "r134",
      "r135",
      "r136",
      "r137",
      "r140",
      "r141",
      "r147",
      "r176",
      "r182",
      "r186",
      "r189",
      "r192",
      "r211",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r298",
      "r300",
      "r302",
      "r304",
      "r305",
      "r574",
      "r593",
      "r673",
      "r697"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to Baxter stockholders",
        "verboseLabel": "Total net of tax"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r72",
      "r75",
      "r80",
      "r140",
      "r141",
      "r533",
      "r540"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging",
        "verboseLabel": "Net investment hedge"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r351",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Undesignated derivative instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAdditionalInformationDetails",
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r176",
      "r182",
      "r186",
      "r189",
      "r192"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Total operating income",
        "totalLabel": "Operating income",
        "verboseLabel": "Total segment operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited",
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "auth_ref": [
      "r158",
      "r616",
      "r621"
     ],
     "calculation": {
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.",
        "label": "Operating Lease, Lease Income",
        "terseLabel": "Operating lease revenue"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r613"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r612"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r4",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r547",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r61",
      "r62",
      "r67"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Debt securities, net of tax expense of $1 and zero for the three months ended March 31, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax": {
     "auth_ref": [
      "r68"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, Tax",
        "terseLabel": "Debt securities, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r70",
      "r78",
      "r79",
      "r81",
      "r598",
      "r600",
      "r605"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r60",
      "r67"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Hedging activities, net of tax expense (benefit) of ($1) and $3 for the three months ended March 31, 2022 and 2021, respectively."
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent": {
     "auth_ref": [
      "r68"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent",
        "terseLabel": "Hedging activities, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "terseLabel": "Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r67",
      "r71",
      "r554"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Currency translation adjustments, net of tax expense (benefit) of ($11) and $17 for the three months ended March 31, 2022 and 2021, respectively."
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r58",
      "r68",
      "r595",
      "r604"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "terseLabel": "Currency translation adjustments, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r558"
     ],
     "calculation": {
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "bax_OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossBeforeReclassificationTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r73",
      "r76",
      "r78",
      "r79",
      "r81",
      "r85",
      "r346",
      "r598",
      "r603",
      "r605",
      "r674",
      "r698"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "netLabel": "Net other comprehensive income (loss)",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Total other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r65",
      "r67"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Pension and other postretirement benefits, net of tax expense of $3 and $8 for the three months ended March 31, 2022 and 2021, respectively."
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r65",
      "r68",
      "r526"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "negatedLabel": "Pension and other postretirement benefits, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r246"
     ],
     "calculation": {
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after impairment of indefinite-lived intangible assets classified as other. Excludes financial assets and goodwill.",
        "label": "Other Indefinite-lived Intangible Assets",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "OtherIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other amortized intangible assets"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETOtherIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestmentNotReadilyMarketableFairValue": {
     "auth_ref": [
      "r663"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the other investment not readily marketable determined by management based upon fair value methods, including pricing of similar securities and valuation techniques, that was used to record the investment for financial reporting purposes.",
        "label": "Other Investment Not Readily Marketable, Fair Value",
        "terseLabel": "Other equity investments without readily determinable fair values"
       }
      }
     },
     "localname": "OtherInvestmentNotReadilyMarketableFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingGainsLosses": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Gains (Losses)",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other (income) expense, net",
        "totalLabel": "Other (income) expense, net",
        "verboseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited",
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other Income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESSummaryofGainsandLossesonHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedLabel": "Other operating income, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r377",
      "r378",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r430",
      "r434",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "OPEB"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Baxter stockholders' equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r98",
      "r101"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other investing activities, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r108",
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Cash dividends on common stock"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r99",
      "r516"
     ],
     "calculation": {
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to Acquire Businesses, Gross",
        "verboseLabel": "Cash consideration paid to Hillrom shareholders"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSScheduleofTotalConsiderationforHillromDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash acquired, and investments"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r100",
      "r520",
      "r521",
      "r522"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Cost (Reversal of Cost)",
        "terseLabel": "Pension and other postretirement benefit plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r401",
      "r403",
      "r409",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r447",
      "r449",
      "r450",
      "r451",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "PENSION AND OTHER POSTRETIREMENT BENEFIT PROGRAMS"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense (reversal of expense) for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash",
        "terseLabel": "Net periodic pension and other postretirement costs"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r376",
      "r378",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r430",
      "r434",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r451",
      "r452",
      "r458",
      "r459",
      "r460",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension benefits"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r7",
      "r30",
      "r31"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESClassificationandFairValueAmountsofDerivativeInstrumentsDetails",
      "http://www.baxter.com/role/REVENUESContractAssetsandContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r102",
      "r479"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from stock issued under employee benefit plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r104",
      "r107"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": {
     "auth_ref": [
      "r103",
      "r106",
      "r116"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.",
        "label": "Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less",
        "terseLabel": "Net decreases in debt with original maturities of three months or less"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r3",
      "r72",
      "r75",
      "r80",
      "r109",
      "r125",
      "r132",
      "r140",
      "r141",
      "r176",
      "r182",
      "r186",
      "r189",
      "r192",
      "r211",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r298",
      "r300",
      "r302",
      "r304",
      "r305",
      "r526",
      "r532",
      "r534",
      "r540",
      "r541",
      "r574",
      "r593",
      "r681"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r34",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r33",
      "r249"
     ],
     "calculation": {
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r10",
      "r11",
      "r251",
      "r625",
      "r682",
      "r695"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONPropertyPlantandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r10",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r10",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r90",
      "r216"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Charged to costs and expenses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r70",
      "r78",
      "r79",
      "r81",
      "r598",
      "r602",
      "r605"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedLabel": "Amounts reclassified from AOCI"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Amounts reclassified from AOCI"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "terseLabel": "Summary of Reclassification from AOCI to Net Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r182",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r182",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Operating Income to Income Before Income Taxes Reconciliation"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedTerseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r486",
      "r658",
      "r730"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "R&amp;D"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r120",
      "r664",
      "r690"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash included in prepaid expenses and other current assets"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r259",
      "r261",
      "r264",
      "r273",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "BUSINESS OPTIMIZATION CHARGES"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r260",
      "r263",
      "r270",
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Cumulative pre-tax costs incurred"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r260",
      "r263",
      "r270",
      "r272"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected additional pre-tax costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostIncurredCost": {
     "auth_ref": [
      "r260",
      "r263",
      "r270",
      "r272"
     ],
     "calculation": {
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.",
        "label": "Restructuring and Related Cost, Incurred Cost",
        "terseLabel": "Costs to implement business optimization programs"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostIncurredCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r113",
      "r258",
      "r267",
      "r270"
     ],
     "calculation": {
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Charges",
        "verboseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r260",
      "r261",
      "r270",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "totalLabel": "Total business optimization charges"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r261",
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Reserve, ending balance",
        "periodStartLabel": "Reserve, beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveTranslationAdjustment": {
     "auth_ref": [
      "r261",
      "r271"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.",
        "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency translation"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r21",
      "r351",
      "r483",
      "r625",
      "r692",
      "r713",
      "r715"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r129",
      "r130",
      "r131",
      "r133",
      "r139",
      "r141",
      "r212",
      "r480",
      "r481",
      "r482",
      "r492",
      "r493",
      "r572",
      "r710",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r376",
      "r377",
      "r378",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r430",
      "r434",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r458",
      "r459",
      "r460",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r376",
      "r377",
      "r378",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r430",
      "r434",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r458",
      "r459",
      "r460",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r167",
      "r168",
      "r181",
      "r187",
      "r188",
      "r195",
      "r196",
      "r199",
      "r368",
      "r369",
      "r659"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales",
        "verboseLabel": "Total net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited",
      "http://www.baxter.com/role/REVENUESNetSalesfromContractswithCustomersbyGlobalBusinessUnitDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r366",
      "r367",
      "r372",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUES"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Transaction price allocated to remaining performance obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Remaining performance obligations period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails",
      "http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Remaining revenue performance obligation, percentage of revenue expected to be recognized"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESRemainingPerformanceObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r614",
      "r615"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use asset obtained in exchange for operating lease liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable": {
     "auth_ref": [
      "r617",
      "r622"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type and direct financing leases.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable",
        "terseLabel": "Sales-type leases, receivables"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock": {
     "auth_ref": [
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received on annual basis for sales-type and direct financing leases receivable. Includes, but is not limited to, reconciliation to lease receivable recognized in statement of financial position.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block]",
        "terseLabel": "Sales-type Lease, Lease Income"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLease": {
     "auth_ref": [
      "r202",
      "r213",
      "r220",
      "r622"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of net investment in sales-type lease.",
        "label": "Sales-Type Lease, Net Investment in Lease, before Allowance for Credit Loss",
        "terseLabel": "Sales-type lease, net of investment in lease"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseRevenue": {
     "auth_ref": [
      "r158",
      "r619"
     ],
     "calculation": {
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sales-type lease revenue.",
        "label": "Sales-type Lease, Revenue",
        "terseLabel": "Sales-type lease revenue"
       }
      }
     },
     "localname": "SalesTypeLeaseRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r70",
      "r603",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Summary of Changes in AOCI by Component"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSAdditionalInformationDetails",
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSOtherBusinessDevelopmentActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r433",
      "r434",
      "r435",
      "r436",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSNetPeriodicBenefitCostRelatingtoPensionandOtherPostemploymentEmployeeBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r548",
      "r556",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Summary of Gains and Losses on Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Classification and Fair Values of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Net Sales from Contracts with Customers by Global Business Unit"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary of Financial Instruments Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Amounts Recorded on Condensed Consolidated Balance Sheet Related to Fair Value Hedges"
       }
      }
     },
     "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r234",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r234",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r9",
      "r27",
      "r28",
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Net Periodic Benefit Cost Relating to Pension and Other Postemployment Employee Benefit Plans"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/PENSIONANDOTHERPOSTRETIREMENTBENEFITPROGRAMSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "terseLabel": "Other (Income) Expense, Net"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r34",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACQUISITIONSANDOTHERARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r263",
      "r270",
      "r271",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofBusinessOptimizationChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r265",
      "r266",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Components of Restructuring Charges"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r261",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Summary of Activity in Reserves Related to Restructuring Initiatives"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r176",
      "r179",
      "r185",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r176",
      "r179",
      "r185",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Financial Information for Our Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Reconciliation of Basic Shares to Diluted Shares"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r163",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r192",
      "r199",
      "r263",
      "r272",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r163",
      "r165",
      "r166",
      "r176",
      "r180",
      "r186",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r198",
      "r199",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
        "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "SG&amp;A"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FINANCINGARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Grants in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYStockOptionsFairValueAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYStockOptionsFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYStockOptionsFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYStockOptionsFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r470"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of stock options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Gross stock options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Fair value per stock option (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYStockOptionsFairValueAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r464",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r472",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYStockOptionsFairValueAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r354",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-based Payments [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r12",
      "r625",
      "r667",
      "r688"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShorttermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.",
        "label": "Short-term Debt, Fair Value",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShorttermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSBookValuesandFairValuesofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r163",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r192",
      "r199",
      "r234",
      "r253",
      "r263",
      "r272",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/SEGMENTINFORMATIONOperatingIncometoIncomeBeforeIncomeTaxesReconciliationDetails",
      "http://www.baxter.com/role/SEGMENTINFORMATIONSummaryofFinancialInformationforOurSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r123",
      "r125",
      "r144",
      "r145",
      "r146",
      "r148",
      "r150",
      "r160",
      "r161",
      "r162",
      "r211",
      "r291",
      "r296",
      "r297",
      "r298",
      "r304",
      "r305",
      "r340",
      "r341",
      "r343",
      "r344",
      "r346",
      "r593",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r45",
      "r78",
      "r79",
      "r80",
      "r129",
      "r130",
      "r131",
      "r133",
      "r139",
      "r141",
      "r159",
      "r212",
      "r346",
      "r351",
      "r480",
      "r481",
      "r482",
      "r492",
      "r493",
      "r572",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r605",
      "r710",
      "r711",
      "r712",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofAmountsReclassificationfromAOCItoNetIncomeDetails",
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r159",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture",
        "terseLabel": "Stock granted, value, share-based compensation, gross"
       }
      }
     },
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r17",
      "r18",
      "r346",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "negatedLabel": "Stock issued under employee benefit plans and other (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r17",
      "r18",
      "r351",
      "r465",
      "r469"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock issued under employee benefit plans and other"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining value available under stock repurchase programs"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r18",
      "r23",
      "r24",
      "r125",
      "r203",
      "r211",
      "r593",
      "r625"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Baxter stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r79",
      "r125",
      "r129",
      "r130",
      "r131",
      "r133",
      "r139",
      "r211",
      "r212",
      "r351",
      "r480",
      "r481",
      "r482",
      "r492",
      "r493",
      "r524",
      "r525",
      "r539",
      "r572",
      "r593",
      "r598",
      "r599",
      "r605",
      "r711",
      "r712",
      "r744"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance, end of period (in usd)",
        "periodStartLabel": "Balance, beginning of period (in usd)",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMESummaryofChangesinAOCIbyComponentDetails",
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r205",
      "r206",
      "r208",
      "r209",
      "r210",
      "r332",
      "r345",
      "r571",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESAmountsRecordedonCondensedConsolidatedBalanceSheetRelatedtoFairValueHedgesDetails",
      "http://www.baxter.com/role/FAIRVALUEMEASUREMENTSReconciliationofFairValueMeasurementsthatUseSignificantUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r44",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Common stock in treasury"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r44",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "periodEndLabel": "Balance, end of period, treasury (in shares)",
        "periodStartLabel": "Balance, beginning of period, treasury (in shares)",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r18",
      "r346",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Purchases of treasury stock (in shares)",
        "verboseLabel": "Unsettled share repurchases (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited",
      "http://www.baxter.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r44",
      "r352",
      "r353"
     ],
     "calculation": {
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Common stock in treasury, at cost,180,058,105 shares in 2022 and 181,879,516 shares in 2021"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r346",
      "r351",
      "r352"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Purchases of treasury stock",
        "terseLabel": "Unsettled share repurchases, value (in usd)"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofChangesinEquityunaudited",
      "http://www.baxter.com/role/SUPPLEMENTALFINANCIALINFORMATIONAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r260",
      "r261",
      "r270",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESComponentsofRestructuringChargesDetails",
      "http://www.baxter.com/role/BUSINESSOPTIMIZATIONCHARGESSummaryofActivityinReservesRelatedtoRestructuringInitiativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeaseIncome": {
     "auth_ref": [
      "r620"
     ],
     "calculation": {
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease payments from operating, direct financing, and sales-type leases, excluding amount included in measurement of lease receivable.",
        "label": "Variable Lease, Income",
        "terseLabel": "Variable lease revenue"
       }
      }
     },
     "localname": "VariableLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/REVENUESLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r143",
      "r150"
     ],
     "calculation": {
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited",
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average number of shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r142",
      "r150"
     ],
     "calculation": {
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/CondensedConsolidatedStatementsofIncomeunaudited",
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Reconciliation of Basic Shares to Diluted Shares"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/EARNINGSPERSHAREReconciliationofBasicSharestoDilutedSharesDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3098-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=SL77927221-108306"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123353750&loc=SL49131252-203054"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13283-110859"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13296-110859"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6395460&loc=d3e13647-108346"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB TOPIC 5.Y.Q2)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=SL65897772-128472"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109999712-113959"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109999712-113959"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226006-175313"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123420820&loc=SL77919311-209978"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919391-209981"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919379-209981"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "820",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=35710923&loc=d3e45360-110995"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123366838&loc=d3e3073-115593"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r731": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r732": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r733": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r734": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r735": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r736": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r737": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r738": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r739": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r740": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r741": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r742": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r743": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7,9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>114
<FILENAME>0001628280-22-010922-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-010922-xbrl.zip
M4$L#!!0    ( *4ZG%0^M*MDC4\" ,)M&@ 0    8F%X+3(P,C(P,S,Q+FAT
M;>R]:W=3N;(N_'W_BKSL\9ZS]QC+H$OIQNK%&8$$.GVP R$T._G2HR25DAD<
M.\MV(,FO/R4G 0)T<VDG]G3"6@VVYT5SZJG+4U*I],O_.3GLK[RCT;@9#OYU
M3]X7]U;^SZ-?_K].YW\>;SU?61NFXT,:3%:>C @GE%?>-Y/]E3>9QF]7RFAX
MN/)F.'K;O,-.9WK-D^'1Z:C9VY^L**'49P='#[64FJS7G1+!=X _=]"2[UA4
M%(+QOF3ZQ][#)(EDC/Q[ =T!<J6#2J2.3"*HHF601?\C/_3.N^!D" X=**="
M#%Z)X@V 5DZFVNS^A-^.WW P?G@R;OYU;W\R.7KXX,'[]^_OO]?WAZ.]!TH(
M^>!_NL]?I7TZQ$XS&$]PD.C>Q57'X\X>XM&'*PN.X_2ZBP-\O9(=(3M:7E[2
MG%QIYR2.^A<M2?V@&?2; =6^O3R]'F_^[ I1K[CZ1,W)Y.MG?[SU@\D(!^,R
M'!WBA&&MSR@Z0G6DNKS)>#3Y\I7XQZ^\#IVD_0_G3AL;4[J_-WSWH!Z97O#A
M5?@!WGZMDQFD\&!Z]/+4+\Z\^M+U<,3QIR_=X6:O7''Y&'_UWM)TA/_D92)>
M!8>_3VAT/PT/ZXLHH3^!<3P$)=U?(7-^QL4%?_[>50@_13LW5_OSXH;VP?G!
MRU,S-5_O=SXP[?9_P^6I:7@\F(Q.OW[ZQ<&/2#WLXV#O7_=HT'G]ZA[K"&%^
M],LA37"E7MZA?Q\W[_YU[\EP,&'-[VR?'C$,Z?S;O^Y-Z&3R8/I&#Q[]QW_\
MQR^39M*G1]R/G<L._.7!^6^_/#B_<QSFTT>_Y.;=RGARVJ=_W<O-^*B/IP\'
MPP%Q^\W)PWHBC<X_-CG38/J1C_?8^HR:=-[\R62+RK_N-2*ZZ)0V"BA#D<ZS
MWH?B5#4%4B;_Q]KT422+\4=0!WA8FZ;FX2H;M%R-VM,^[MU;:3+?,NO?3^/:
M\-USM?5N1W>/\\'ZN]UGX6#S8$]OKB73.ULWF]MYOW?V\K1WMF%V#MY"]^#Q
MX>;::]%;Z_)O3P^>ZUY_YVP(O3.^9CN=;&Z_U3O;270/TNGFFPVSN;;Q?O=@
M3_;67I[Q;R<[THOG:O=TYTVR.V?=DYTW3]]VU_+!YMI;Q>>\[Z[U^]TW7=D[
MW#W<.=S0W;6GAYO/7K_+SYXV\=EKNW/P4G;5SMGF]OK[GGKZMO?L][>[S]9/
MNV]VWN\>OA:;;[JGW>W]_1Z_R_DUOW-;9K"[?=3TUEZ?[1YT37=[5>^\>2EV
MWVR]W=G>.-GE=]K=?FEVSC9.-I^MJ^[O_O3Y]OJD^TJ</-]._ S=TS\@2^5B
MQHY@'-@^LRU'C:;C"P2%5" E?^]1P?Z8?GEP!<?KA/7253UMQ@G[.X2CI_S+
M^ [@;P%\]@7 )D?R0LH.8+0= /XK$%#'$2&[;AMBC/<>51#FAN\+OO\PWR'\
M70B++Q!6V20;L^M$J$PLV\ 4JXB.D8)YE(S@))OFE_(&\5T?L-LX?<((C["_
M,<AT\G_I] [;;V$KO\ V22V2@]01(@0VSX99MM1,I#7H4#Q)I^V]1Z+^D0*,
MO4&,GQR/1E=,]/H@KW%<<6_EG+1Q"R>3AYE_Z1QRL_OURD[&TPX-[B3A6Y*@
MOI $F]%C!M6QF6('I%.=:)%=M@Z:#7S4&,*]1VN4Z##2:$7_D+IC"@&=RUC0
M@I:(4:8 (%$I,MKEOQ %9HL/M^@=#8YIB])P;]"<4:Y\<X1I<F[9YPNWZKX*
MA^GPZ6#S8/]PA[N>H3OIJ0W1V]XZZ)WMF-WMQ_N[:R]U]^#E2>_LM[?=LSWS
M7&_UZ=>MT]TW^2@JL)O/=O>[_(S=[75=1:#WK*M[!RPJSU@$UM)I;VU==P]?
MGFVN]4MO>Q5Z[_\H0+)8]K1%)X9)).A@3@R=5CY&;0,EN/?HA=SY$:"\% C&
M"$LE@'8I8(#@'</O4 :X ^K'@-K1O=4_M,E9*S =64)AFE28_;+X=S)(-HF!
M=(SEAX&2)@%B2(XQ!VL%?S+1$P3GT,5B_MCX')^+08B/&!UB,V@&>PS-U* .
M$FW&?K,W#8?73XXH32AO-X=\RF9YQ;^."P/)Q\ZQE%?L< VX'^;CT=02SQGF
MWI-+F/=$=WOW[>Y:]V1W>_]P=VVKO[G]$G;>[*B=@Z=-=SMQ^T\/-M^\5@SS
M_L[A27_S<%WQLS'\O8/>&_Z\O=7?>?,:=M_LG&YN/V:QZ;_MLHGE9SB]O(;;
M.MY5;+JW=_@Y&7[5E?S9L.G>YW;[NP<;ILMBL_GFY6GWK,_O^UOI/:FF=VJ"
M=>]L]:R[]X<6&(LOJ6-R-;NRZ$[PD3I>QT0IR>PSZW/X$2%QF:_3[,2MBQ"5
MB,(GKZ005MHB@IB3D)RR,[^3D6_*R.:7,@(Q2=(&.YD$FY*8$E-Q*AVDH(W/
M(9E*Q7_(-4L(D0I65R*8I6%P9 4S 38CUFKP=S*RR#+2W=ZXH''KD]Y9>M\]
MV_BCB,PL2Y5.B4YT0%G?"6P".DZ5H+,*7GK]@T+BD -Y:46$Q/0@474ZN1B9
MZ]A[2/E.2!9;2':^$))DF9);SW1120[W<DP<WB?/K(Y#,R0GB.0/"@G'=JBC
M5BI+4ZF]SU8'B-Y85;Q)\E,A.1DW#P=-_U_W)J-CNCZ9N1.-;XG&P>H7HA&%
MMFPG,L<4P/*!)G1BL=1QSGOC/<:DXKU'7TC&@ZL#\B,JQ/%[HO%7IA'JE,W#
M\706C65G93K;\W!R>L1",&X.C_IU+F?ZV_ZHBM:G,P;W3\:YMG[U%N?-?VSS
MXA'&P^/1]-MTXNSAA;B>B\7/#$]<WHBFXT^7WYI<OY>&P^+I ]%7IYZ>;/S?
MJR,IGU_\Z/*GJW<_F@KSY;?Q!$>3.@PR'5*MLV]"7E[W\=B'Q\R?G*H[6GYL
MXOS(Y??+1AY<Z:BO]IM$:14D8]$BH,8(@EEK#%(IDTR(<^BWB]>GO3KF>_XU
M<V,G1_TF-9/N^8A%;OCH^<SUI:%Y->$^J-<\Z>-XS#9D,DQO5T^:\;TZ2?7P
MR?"0XYGIC\R9V:C\COUC.K_=+P^^VLIW-/YQ_/)Y,YZP[1JOGZ1]5@\Z;[G.
ME#[\G][.JS]MXL%G[]L*L8DL(A"8,!0O 5G=,G@9M97>!N.MN!.;68C-DU\W
MEDML,L? 6:4@D\U -D<1R(/G>*7DQ+YH><3F67\8L=\;3F@L8.V8^'7@SM;\
ME- ((S@HD91]1G B80QH(I/0(J75B$LI-%*?"XVY$YJ?$AIEC26F,H9  3-@
MC-$EJL&R]MI#6&JA"7="\U-"8X4$Q?&MH(  J-!XI>M4ETD4R:NE%!H=S%1J
MM+B3FI^2&L^R@4F9$@D@..V%0 PYNN*D)2I+*372G=L:+>^DYN=8C2<D8N]$
M=3B6(EJIC*8BC.,?/TSY@5J$<8KS3.3)10] 1WWH@<LCW]<#QX/F_/7'^SBB
M\8<W.R0<'X_HT04 TX.7M[@\=OF]WN/K0QD90 *K8@D6? G>2U(4<@+EO</R
MR8CEHO7HIS+UDSUZ/!U(N]IE%VG*#U^_6OOAW@R8 Q;2T0D#P6)0?*=<5/#:
MHK,P[4TIU:+UINQ(-9/>Y%#_517$#Z^7FW?\6)^>.ATMQ<EP]),=_\7U]<<U
M&@P/F\'7;ON]ZG'E%@^N/OVW<"_D(IGLHXT!% )Z 39)EXQ.NL#YR(Z\]&9R
M0=3IBCV7WV_/Y<SL.=.H9+,N'*(2Z,S=)I.K>3Q9L/7)[N;TY6\[__5_']=\
MS.'AT7# 7\?G?OCRM$\&Q+[A^G_"+\]*D:^*M&4W('4442";LH)D02>/1:M@
M@LM+ \WV:&H,3ML$CDE&H$4?/+&Z!!^<344[B#FH:$@O#3BK.3=U.A/[+[#)
M&X,G>-1,L-\2F&S*(AA/R19BEJ6"BT4+9T5 _A#-TL"T11-L!I37<51GJ\<M
MP8<T"!$*>R'):N0=:Y.+4I((U@HI;Y"N7;<:I71\>-RO2U(W)_LTJN>-:+_>
M[1UM#-+P\%N3,XL"&9;LI:"2E-)0HO*58">-KGCOA;5+ ]D+K*G_;4'%(Y(L
M:*($".@"%1=#D"H9EQ#*TJ#2&P[JBX^&_3[;N0WN HXJVH*2*Z%@5C$&[T!Z
MC4SL1!).A, !JW!M''.;MU^:_YA8,D5E(T%[B9"10F&6SH@&@\PYRA*B>EVF
M<?Y8ZN!T3,8 .094)?0D. S6/K"F$IKEP_*F#.K\L4TA6X,R!<H$UHO@@(!A
M!NW0F/35=47MQG8NK'/^0 .'#IZ,L\95M;71D=),D"!YHYV=1U;E-0-]S4,H
M\X>4&9(U*5CDT .\B#':(DLA7[3)$%HY6[D@ R_S!S<9LD(GYD^%0&F!:*TN
M$(!LB 7MS4V!73.F-S4(_;?FYJY&+%D'"ARWQ)(@ P8L(6<-_"D)H<720'-S
M@]"S T=J:S.Z@CH;,!QT"&.S+U(F)K$^W>#4\;+8PFN!*42*WM=1&8[ZA4&O
M2T)'WF74HFBU-##=Z"#T[/"Q):28;!$^ <<%)EC-!HXY(QE3%RDO#3[S'H2>
M'60&8]:19.;H'&1"%)[(HXLQ*,=\<&D@NX%!Z!GZHY@4VSA)F.OB2X\U\\*Q
M;CFV?Z26ARS,81!ZANX(0O867'&: #$&$0TJ4TAE8UTXUQVQ!%,%-\6VQ<SF
M!Y2R4@2/Q24-'G*,FNT;B6($>(=Y::"Y.;8].W""]91#XGBH%BL+$27'0L5:
MQ[&JOTQ]709PYL&V9P<36S7#74>&A *I0D@I1U]K?>E2!WN7!J8;9=NSPR?:
MA$E80\D: *]]8H/GH13V0-+DY7$_\V;;,W1+QJH4@4V=]MR7)0J %'6A4!FX
M<DL#V0VP[=FAXK40A%Z;@@11^9A*9F<D4N:_(/FE064.;'N&NJ,],IF+@IDV
MR$A>:LB^+L[+'+.J&Z1T\^H!$#*JQ")9; "A'+MBR,@$R@5B]VSFD)K?>L\\
M_X4#QFF1A7.R6 \6= PFQB2,,[JF3+CE0_5&DE[F@R5J64>HH2[B$YI"*6RT
M (HA9LXN+A^6<TEZF<\"'W8WS+2]<=S7&7TL8,"J')/1 L@O'[;S3WJ9"] N
M:O1%:!]8<Y,LP8G ) -*5K[DN:R NV:@;S+I92Z0@G"UFC*FFM6-$4.Q8#@.
MPV(5!BF7#]+Y)+W,QS"3<3DX64MV .H2:A$&&;PN!4O$\TJ5RX#IS:V\G-4,
M"<J071T\E%0@:Q<@<=_E;$URKC ?6A9H;G+EY:S B=EG5PS'C]K74M3HM;61
M;:*3LLB+88]E &<^*R]G!9-GXF%+T$5G!R5%;Y!49(!JL9EP,>ZQ###=\,K+
MF:F1$FS<1-;DZV:4,H(2V@07HP?'#2T-/O,>AI\=9"4)(W,(A:-U8$8?K?"*
MZ4(4B11&6!K(;F3EY:Q0$28P:RLQ)28)OG@F;S4IB3F$* K<\OBCN:R\G!5*
M0#E&<*A%*C6 BJ5X:PBS$#D'GVX.I7GU0+ A&86@V-)#LAQ6@I#&,IGR+@G]
MH9R(U(LJIX^/Q^QHQ^/5Q'(ZGG*CCT7>?FWZ_='P\/H7 DL] S"<S4*JB(*L
M!Y68QPH *JBT=01P7K)Q"D;G#I6OH?)9_'X%E[^.WZ^<^G=6)%GE:I#($:%D
M E4J@1*>M+*252JUJ9;X D XGVJ[D@S4"F%@606=\,D6#S9H[=@OE,O%OKH%
M$*Z.QS3Y*GZ[P_'IX/K1TS>.'F+V05B0L0[0U)U_G:-"*F30L21]:]#[[F:>
M-H-F0L\Y[LE,WW"PU\0^3=L>/S[MXL%P-"V@>I7VK=$[Z@^/*&]3VA\,^\.]
MTZUF;W]R Z4<;EZF?-">K0)(JPV0L)X_6*^E4HXY8VI3I?\7(P9M-#E]T6>.
MLCK(E=P?U7L\/MT^/:+/(JX_.WD9S;ZU8)P,*A63(3N+T4D."EPDLC&A:M&T
M2BM GL_TBD1O%+MS@0Y2]%$E#G0P:0>R;B"UN 61QJ/)QY#\&0WW1GBTWR3L
MGZ-9#Z].M[O"ME1Y$\'%6K<2(-8:?(21./:LNXG:;*V6K<7B4K/6N^NK+<$B
MDRFFEGWWOH"/!DN0WJJL=<WLQ=!:+*9Z,6[P!29N(+4$#A54E%IK992%9.L
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M@BP+VF (:A5^XTBD\SPRL7A%%\1,PKD^OA\?-Y.O$H&+8S_,!="J&+(!_I/
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M262CH-"67*9;.&6 )+WQ0J*J.XJ#CJ'N[6:4%8&Y6[YE2Q9:":$W6<2:$*8
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M!N[1*QHTPU%O.*'QVC%U\73[_7![?W@\QD%>'>3M]WS:Z5,&_#I!E*XCS&Q
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M*E$Q'-E>L(,P;.6*B9UP759Z]HO]=:XK:^QEG?U9G*XW=[H.CV.W>SE[6K_
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MA1<;VUKB!ED3!6&U+?,%8;4C;'J!MT*;$ %AC&B'.',:Z2 <@K'1E#F G#:
M,/80[/6?QZU=;16A6[29*_]!?V2[=2SR2_7+0R&GVAS^W]-0,4)JXJC9$"UI
M:)!61H0U XXR6 )'485<-!96%*.X\L!1FT35980LQQ0K=@0\+GC6MAE0X+DB
M>,[X"%221'B.5"(><:XI,C$R%!P/GGKX(5F&IU:S>]--A.==QT3=I<N@_QD:
M<;[9^MRU63KT0A6J_CF?J1L'/Q5GP:J<!>.N_S-W/%@RSRZ[O7@PZV2GV:@
MY1T37%O$.#.(>T$06#,>10OCF*P7TM.-;;%)R*WCNXL3H8E"H"#OCI WK0L(
MDYA[%A&-02*.%2AV(BRBS@GK@\/4X0IYZM:[= UP+C1_]7_1[X<OG6[W9FO\
M ]Z5K&N-O^S@PBIUL<K^[-Z_\I3[Z#WR4BO$I0!K@\2(8E2&DBB#B7YCVVQJ
M(ANT(UE05MMZ7E"V I1-K]TQ$D9CY$@+"JJ948NTL0H)G@RVA$A!8H4RUB24
M/5S+O=KX:G5Z(]O[T,EI2,9>_V*SKS:>[[*[Q\Y$,!B>G?GN:>ZPPD*UL]#L
M]C_1GEHF'1+:<L2=D<A)ZI#2W$8M>*#:;FRK36EN[?@OMGL3U_J"P#M&X(P-
MCW6"?RG"S%JPX:5'SBN'G''>6^4MYBDC$+1W@Q#X<&WX2;W[WH=6-]IA;%6=
M@?H)G0YC#9$ #Y&+ZE(#7[O^W[GG7^?&[*>_AF-F*CRSS,&A@YW,,=5JOW?A
MOT ;WCLKA"1!HF"90#P$A:Q+ F$II U<1N[)QK;$MXY#*D9]$Q?Z JY:P=7Y
M'ES<6..THRAYK1$7,B'#-$;*.>F)U)1K"N!BMPZC+;;\PK8\]#+Z/H2OV/&K
M6KF_10WO]7N^A 35S3C/9I9S;*F(U!BDL3*($\7@-X.1#1([KQVPD=S8)IN,
ME+/XC<)<;0MZP=S*,3>UR@?F9,(X(>:(S)D,04('[Q$6F@$<B< DYR':I*1)
MWK(2S)^#^:]1 "L,#6[(XR^=_7'!1UYS&J[WD$+AW?IX]^6,UM$N2&(E1\FE
M"%K')*0%L8@XJIG1)N%<PY/1355;2,+*SR<4XGFDQ%/O\8M"/+42SY3@H\ \
M,1"&,&'Y='24R%IJ$=;4.E@;>)"9>-BFH'7EG&WFR8LKK6+PU:%_FD,DUJ_R
M0[=C7:=;U>:NJ_S##_JCIA(0BW[#H\BR]>:X/QBA41R< #NZV="<DK3] :R1
M=8GS:K(<P%SYO3\8]+] ]PS+FKC4FOAJ=A]1,YIP("B2!&LB2'+DF Z(*0\2
M1M&<)W=CF^(F;7447G@8O%"7=BZ\4 ,O3&EE$9,0+ ;D4@ C/4HPTBEEB%JF
M')"#]HR#5L8/L#A#LQ73I?8]R47G*^F;2RYT^[T/5V14/JB<JC*@<1+XU'?0
MX*H^8\EOMB)Y\F\8@\Q"NS "56V9SYV1[58!&OO?>K_D8;H)0?TU(URHHUX1
MAA'/F4XXI1$9$A(2*3"J0Z 2TRQ<FI2(J8"MMC6_@&VE8)M2 XXRKU7.48)]
M C7@01=0R0!Q20K"+0\X MA(D_(*/@K_R=>B3)_M>55NN40SK[9<R9_C?BYY
MDFIGG<.9)9XECPVW DEA/>(F)F2<TT@%RX+1*7'GJ@ -VJ1DR@5TM1<H*:!;
M(>BFEGIB$T_"!12] W%-@D,N,HL,]408KF%$8P4Z_@!/,C=^L1^<QA]F,+^R
M(U;,_)4I@3P*__[6TX67:N<E/QLA+0FQ@FK$$G6(:R*1D<PC''5TVD5-\YD,
MNDE%D[(C%=S5*08*[NX =U-Z0&,61(@<,<(TXC(8I)43B%,23'!>VWPR(5<)
M;)*GK41)7TUY?D45W,I!<&WO+!3(N(;<5=O60"&M%9+6AQFQP&TTUGJ&3,[%
MP'G22#OMD4U2P1HDC#-N8YMM:E-77,/"T"A)T!NL,0I.5XS3*7&A.'&1X8BH
M5R NF(C(,:*0]S:Z2*G%FF]L\TU:6]JT9@;D-C_D]M]+!!ALPDO#X5?U\;D_
MR"\7?T2]VL+9L^E=T.?C$9G>!2T'2E?!9I]F5(</ AM%(H*U1B'N*0'5$0G"
M043/O?3! IL1N:FD:)"M5+!X:_U0L'CO6)P^ZZ,H"20["4G(,4*,(.>]0)8R
M"GSKK<CN0J(V"7\(?HOF"XCI3&RWW:EXP-NGJ\G =FG;G%^EH,(RB[/,Q]DL
M;,&9@"VER,D4P'[Q%%FM!2):$DD"Z $L-K8%+F75&P6PU61A*P"K 6#3QQ"X
M-T%2CXBP,N=%<DA[:5&@EI# A/*$ <!H7972BA-@N4QLM]Y9>,!&1:WIV*YX
M)HL)L0KNF<W)1IF"1<%'9'BNT^C CH 13/##!1TH,2GGAZ*;G)5*:(T"7JTY
MV0KP5@^\J44_,4<#C!:BV#'$M?8 P2AAY5>81(V]&H?Z\$:5,2@A!SGD8.6A
M!@^2L5809U HJCZ*FLUAQFF \2(164<XXBF76,_^?BRHT$8&JXD&BF*;PJBU
MV+DL\+S;\(("SUKA.:4@6""&*Y]R7 %!W"L :K(1!4%"%,8P+CC DV_RVA*;
M-#.P8.%6-5!0/.V?G'1&N?+P^*1#AB2T./;\C_8,;M,I5_OE,A?7:A;QLV'G
M2:_3_;\;H\%IG*:)*P^>CS9??>S"!POP07MFN3:.INC =@\$.\0E!U/>&HN4
M#(Y0 Z-%2(;:%!,T:78MLP:5V;7:V36]VF O(TL*)2)@=K&@D;%2(JPM"Y';
M)"B^=G:MW&QL(+/GDO*C\YNE;%SX\6^4KO%F=[]KCW_H_'UY[\DM4+[^B:Q.
M+M[Y(MW/W]7WGS9;__@1H?T9!V^.[2#6(JY?[CV?1VS]WIO<DC_M8'_P9F1'
M,;RUW=/X[:LGPAH7JEN ZOX:M9]^1W5_AQ=O>?A_?W2/:/=O]_%SYY"^/3D\
M>-X]^GATLG?R#.]]//YX^/%YMWT UY_ ?0ZZW?T7A[S=U6?[.^]99)0QR9"6
M42.NHD3&>(XD#9)'(7WT],>KXC63Z&8.E#*)UG$2>8L9L"=#5E %RZTDR-D4
M8/656C@"6DZQC>W9Q'0S+[0^VT'K[SRTFRU[.CKN#X#X0NO:Z3?,HS^\@YE7
M3;/ASM<F+>8L*-/QSJ<C;G]YSX7'R3.'H@P". T;I#FWB%/IM?7&1NY_P&ES
M)]4JUL0RJ=9H4DEO-0Y4("$<F!1 +DA309&EEB687ICBG)9W$R3=Y;\+\-UX
MKFVV.L/A:8.([F75G#(?&SH?:?O5>\Z#CL1:,!VR0]5ZBIR*'ND ,T!%'*D2
MS2&Y,J$:/Z%@T#'8P'FM5#*OE1P94/_("*L,843#=-C8EIIM<L,W#9\-L;F.
MWEJ=7BLS4>4SSC/HJYL!S.82)%/WEO,5\%564MF[6A98TQGY130PZ4!/ZNQ-
MY E6?<<QBMZZ:)WBRL@*&0V*?2EXJFV/N.#IMGB:\L[;%(0W5"/+%5AETGMD
M0W2PW##/2638"=$T/-WU,;"&.I3S4CX:1#L\'9QOMNP(^F(XVKPGL^5@TI K
M.K,HS/J >_@3A0G/O'L,*O,O?/CQV9?V._C^=X?T\. 3/WKQQ\?]%W^)HX_/
MQ.&[]MG1<WVQO_.>T^@]21QIX@/B3B7DM I(21-QDI)R!28TT6 \"[U)\.R1
M['F"\IY,G#+YUF?RD3SY%#8:@WY3)I=/L0DCQQU!F!G%G-<4%J0\^<BF5F93
MS"ET^OWDNXT1LVX'^7ZY!ROF.WQ-=%<)T*L17M-&3N#18T60)3F78,RIO:V*
M2'-!@@2BM"'C@VSR.4?[?BW'9N\';779. 5M*T;;]"E:%HR,# P?EU<C3BP
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MX"[=RA?:LN'CZ7!4.1:O3IROE4U^<>.: +_F-W[Y1R,*N5<0^,X%>J6B4G\
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M-$Q!8=Z==^/-J>+X;XF%\QF[V%"/79 (H!"PD!/0/VA@B#/8/%FD;0X)"ZL
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MOK%]F'2V!$ PT.Y92/S13GY#X)9A.S-?2&IR0I<I)DACO[CW?X:F9](H1]\
M7"?8GIXM8/3V<%(7:9H: :P26 ))3T]J?1J&D]T8>IDC,E5T_"7[-^N>Z_D
MI>G NNZU)LP&YAW87*#1MM?S9@$) 9T<CU;G@CF!D+^&$OD2$H.-#P^ZS,F
M_ZU62%TPI]$F?3(X @H&T#I+5)@>: Y'"Y&5Z3',K2<[87ZF4W00?G:![KM
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M!]6[\MXUNATW[2VOT&F1V(*]K<&XE@W,E\/<OKD""\$*A6RP$<%>"Z1HP5)
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MYEL50BV$4%_F$$J*@GKC"7*$6L0EQJ!Z.8\8+8P+QM 0"*A>\RDTE>9US\>
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MV$OEA2NJNP'5G34.OZDB\("=0\:2 G'&,#+)*TR(C,XZSJ)T('_([\ANC&N
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M6$1<!8EL(0OD>8"M*3C5!&R-0MPY^K9*V*KPYFEEC%9XLP2\F?5M%%*J:%1
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M]30">RJ@>;E L_06P!70W EHSF: QMLD 8J(A+$"<4\<LKY@R.L8':-&$0-
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M/#!C+-%.J.!X,&!M+F[B66<?/P"FM^=\<<9H)PT#Q4E*AG@"LT5;8Q"38+*
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M.4)]I)DT@ ]KN,*(&P^E(6N@5]_'X!1F[F7637W;<EM9#Z5YFE,V7H\&\$0
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MVA2]"_+EAV6":7='Y4@K+"RGHY56@!" $E9QJJAQ !PX:0'2(FO.NUR^>#0
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MW#5?7KU]WL:_>R!@VK:;+^^V??LH?Z,'*!,;FX!MO9,(Q_LA#MO]LO>-CR>
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M<6DA#^K5W#G/-LQ]9#"[8AA=XT,\&@$N@5[7^*??V^O;P\$-U(7'G%9\R?#
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M-?"M)/#=2/'#1A M-&/4\RB]5:#YF40H-CSZ:&N_X//!QXE6:$DP3BF-"$F
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M.__C)__:N>RME^\&_]WN[LIN<):)1TI1%-@$BNE2]L0YY;(R7$-T#[$;?%F
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M!=5D,\;;R=[D9'_I/?_@+!7@A"'>X(R#DXE86^UW166]E<[Q4"8;OC'95VV
M5LM@%Z>B>&8N?(4_D?2*7H5&^6 U;+XAO'X^N',E6.%BJ,+D;*O^O$%SJD"A
MUC2>?T3I/EON^B_.^7;"21B<;LN=A4\.4&^>=N9'10/Y5NB=\,B17!N=0HFJ
MMLY[;FV(4@J/Z]M_7^C=F].6+N7M'Y4"UD;<+8#R'DKY#6-\<5,2''))@!I!
MC$=6=,P&E\O.A;@ZYN[90L:7M7.YE%\5VLAB_<%%L_2B<KF(B:C-L'.Q'0MC
MN-(+ME?TY>I,R_E E\7N;+6DKXJLPC6X"*4Z"[2I]%74((NR.B^*01WZG&)E
M<B[BUZKXA_68FXO!6<L0Y<63EUCXMDJT.EB5>7/9 )S%RSRKX^(J>%4?7B"2
MLKI)_PLYZ$?4='[Z<=;VWG- B9\AE3VP1+(H&?5H .)B0-DON/%>*)L";.V,
M1\M,!'_'2ZB[15%$NM( 6AM4'Y3@*4L6@&7QG2'!U^*EX_$D3M/H1^.FO>>R
M>_PAZ>0-#B.)5>V0'"TQ47,2*,H!EQFWT6[MY!*,5>)!IJL<58=<^ODH#BY$
ME_1'G\>#SX4=SJ+Q%LBMHBQ)GHQ'=>QHL0SFPTK37]+ J6E<>]O.;CP'REF5
M!^04S^<DZ5F8S/(P0>6,.6W'W[QTN_-R=!HM>!I'>E%NNQ4B.1\ M\RS%_LY
M8Z,+)YYOQYGGYZQ%DW77R46N6U+U5?ZJ?F&XBJ'.V4V5A_9B_.K+T:7=N>"_
MJCOD4\D?4DX"73#,SC_?3;\Y=XN0Z,_]N) U-;&V='HY'-^+$L@@8Q0<)&'9
MYI*A31+#@B41F+'&HIGC\W7HE%*G+&IY'FP$B::P"TXDCHI>R@KMXY9.-S=_
MT'W^02F:9%:66!-P_BS/Q$;EBCT<<!YU$HQO[4S+L%[%I^V&Y?=O6*J&;UC^
M[0;DRH9EJ0U3=KQ5C  0O=7*.QUBYL) S/DT"_Y='9:^[(3T\R(/GH_B?Q?^
MO9.]PO<_\KGI5\\_H/VFLT:,)Q$!B=I0XJD.)'!!C0H1#-IT*[,K9):.>BNY
M-& 2-91:+5D*E(?$I5@]-]T4;T;Q4N<Q*E7'U<9!G?1K/BS>BJ]I>F$K96%6
M_;1$R/UF"$.T;M,:L==-$:;I-KN+%&%B&\W[NWFLO4XNK[_+F_4 :4S_-BE>
MG;@3E?!A[2Z<KN5MO%Z':M'U\%VJ_)T=P9Y5PJ10\=/HU])?>[YK;)/YVA]K
M1O;3S<B+KN"E6^Z&V4A_S.S$CS3_\'6V+[E1/$1K$U>H)B@?LN#.!6[ 1Z_<
M%=N7:T6+KM3EJHVM9N0>OJGZML@]_%'VWKV@O=]>EWS 4#WWM]Y!=_C78>_P
M.7N_]YZ6O,,]_O[K:N[A5[N?\/O7^/US;,O'TH?C]_P%JH1=WMW]ZZ!W^.93
M]_!/L7_8R]WUBMI.ZA!L8@3U/$H G"2X CE!53M39T% \%L[H#=4<:Y!&=-;
MUGF:K&.=+&9I9#%'8-%Z836.2F)6>)UYNF(?O66=.V2=U4+?C#''&6<D*2L(
M>/#$YYB)R%%:\$EFIK9VY/J)EX:RSDUK0C9?XWN[W.ZL0C9O5-SZDKX^E0*[
MRON<#059E2.AQJIH=72H]C!<T_2*<U0MU]P=U_37-!R5;5:,>Q*X<L@UI7ZU
MH;JXLY. 4NC.% WGUC5U+X?TG9:N?L+(@B"M,RC)+2_E"+,#L"@T@DA!*F-,
M*\7O'UFK4MR!D!)2)IKR2""Z5,I6&T*]B3%Z&5SDB*SU<VT/AZR;^FV:+ZA_
M7D0N?'=TP%F,PXVD^B4#\V2X!U(P3H0L&0 /WCD:K%6*Z9"S==!*]?OFGI-U
MJ4ZE#BP+PE&$$U @2OH_22!9H5FFR$%T:P?MC V9$/<IUI\PM%)  8%2VT@O
MP8%RP609C?746X$3UXKU^X?6JECGV8-F-!)I?8GRE9HXB7\*4$H&KSRU!5IT
M4];Y0QK@-ZPP]@CT@=.MFGHC^X9UGV\U,$_#?[K) 7GD['W#\V@M>]\5>_=^
M65.,N$ZNQ.00L. ).&](J8E+C/=*<!4"2%.2"=V:O3?+H!O?[&EYK.6Q#1^U
M;'GL#GEL50M57L6H-1#C./*8M90X33.N& -94I8M+5JHW91WZ2%Y[%K%7IL4
M,5D=MQB@AEDE4[CJ:-K"$;5VN+[.7%G2T9]E!_FN<_9M5&8;E=E&9;91F6U4
M9C4P?R")NOXW4W)=TPG01DK]")%2$K)QX'VD3(-1QBH;97)<*^XA^#8^\TP-
M[A[O[[Y@W=VNZ.X&5%]?'^^_^_4 G\]?[?XZ[.Z]_XJJ,+8UB%4UN/OUYT_=
MO3]1?0['^)[CWN[/@_=%I2XI%=Z]_]([[*$J/.CWOL;+XC.E8]Y8DTE@1A((
MQA,;LB*4ZB0HZL))E S\ZZE)&AHIU;+.C\XZ@6E?0C.!,PDJ!0=1NP0"G*,<
MH(W/? #6636^J0%#:<Y$)Z>+\9V($380JX&!$-%9]:A8Y^G&9[ZJU#R< O)M
M5>]'CR=SQH(T7!7B@<PL*CB*Q42MB8PS)5I=Y[Y99SU2TSE7\NHYPG40!)+R
MQ%L5B7:R1.]KE84K,1VJ00%E+;3Z5'MM(#"F#07MP83$D_'"2:>CS[$5Z/</
MK56!;B0#(Q@E7E%%@(5 3(J,J,RDH@ B9;V1<*D&Q&K^B%$;U^KZCV$W/2FC
MJ8V\:!K'KH>DWEODQ75Y[MX=-2W;/&ZV:>,CFL<V#Q8?<2]LL]#U5O+!,5Z%
M.URA_YTU:#5:8]DB6MISF:7VT$]YNL>0GE^K/-!M0L6?E%QY2M)#>>=,XJB<
M,M2'&/=."&6E9>701XKV-KKJ:>J^5GQ<0WSTUO<5$YH. 6PF.IM,(/%(G&"L
M**O %/[J+92\E+?VM6WV_%1+$$^ ()B)P:<DK)%($#R[G(W(FAHIE3/J5@[#
MEB!N2!!K6X"0/<Y')-*$$G@@@#B%=BW+DFGGH_+"%H*X==Z$!IP":[Y:M;[-
M]PTMZD??D!#6^FB30O.(@J/9@(7HG#;1",YR:!60>^>7]<V^[!2W7$HB)#@"
M$!7Q1BCB@G&0LY1<RZT=?>L0@W:O;Z/;Z$E9GE*RUE$(2ELJD;T##2&CPFA:
MT?T0T%H[P.T#TU0CM+CQ!#+-Q#.+\ALHQ_\L>)4V$;W3G+V^IWQ^^Q;NDO;P
MXUT,R".G\+O<2FPI_$84OKZ7F(/D+D=-HBYAW]XF8H-$%4E"UB5R-I3R.<CF
MF_7N-^X4=TMD+9$]Q"YE2V0W)+)5753:H(4WEG@!2&16<.)*>1GM?: \)^D8
M%"+;E)^Y8<>X5XIB->58]V7*93F*/4G3NKYA3I-)55.]*ILVK8N=NDE_6A7+
M<XO:I-5A[U+)O:ZE5TH&EDI]9U5(QY-2E[0JEGJ^/ORB%'Q58/"TI.M1>4C$
M7Z9NUI_F!?[QZE*6Y_*ZK-/MSMMY52EUN*C@>L5UY_I651\>3TXKRY\O&'B$
M<Y2J5M456(_'DT^= ^SP:%SJ"*;1\OF+.H!U8<"S:L=UD=K9N&IR?S2=N<&@
M/A5?KE[T]"SOXG;G7:HV2O'5>%/=[Y.J24-W.)X@_2R;^/<]+&]8+S1[KDU_
MWYZJ@NWB'/X(5WZ'\<X0OSR8+FK;CJ>S98/.NR*O:E+=H?ZB-"X^F,/B>:O%
MX2ZM.?:W5:8: Z>_R9*PEOO@I%-6]^?RR[+&YNQ@DM)RM-.H5)H\/<==%1+?
M[G3VSJ_5LV<M<R.<KO$Z+P->-IHN4%0O[+-RHK@<OFM57:<H^:/)Q6#8MI)F
M\TD3U#8#OLFD"=\1>/((CNWO52N[6Z_L%Y>L[+L]PO\(7#T_+P#LBI!!((P6
M8O*HJDW:QH"W49FMO7/=M%7\_;L_CWN' >V:P1#;)GJ\B^W\ZU.WI*WZ^OI+
M%]NZ_Z[+UM-6[1_L[SWGO:^]@U?OWHO>;A#OOWZ2O7>O3[J[?QWV=E]@&P?8
MG[]6SNM_$FCO6.:9LHP1E9@F8+@F-I28< ":8P#+Z5W8.W<;EOD$-]1[Z?A4
M2:[-'41+NY&^@3J\EU%/*<']3=K975B<BSK=+0M=AX7Z:RS$?4Z4.4I,5(P
M%9ZXJ V)/M$0!&4VRZ:=I'VZ,=%O3HWQ9?7YSOP(D;?JZ+C""/LARC/\XR%H
MZ;LTHL7LO3F=O):<KD-.)^OD)"$9;\HQ9&KPAQ'$1N:0G&C.FBJI*4=RXNN1
MA6L)^AH05+AT:& [T[=M]<NN;//6?\,83N7HR+7-X#;Q<YOXN8U]>"SRH;=N
M0AOE .?(D11M.4R= O%49<(#3\CK,5 E-A+[T,S,S_]:V0QIS"[';EWL_5N[
M%?4$+!R[^+-<ZX8XYM6^T61=#Z[V%8_=M-,?A<$\UGF@K\H5C8\XGP.VO(-6
M-Y?MN2D.;I6%>C2[SJ[%70R?OGSX^E/W\>,D?3S-D]U+L\[;"V55O]%>>\^S
M_;*:AU&J.;7:_RN[FB[\[[P_[2^[\)_^8%"V?''63J>FGOKCU#EPGW'Z8ZSF
MN2R843I>EI_KE(VHC^,)3NU/G3]P2,I&XMOY4=F:[;P]F<[2</JL\^L$V]GY
M+S:N\TO9;"W;EF_G.":ED-W;\6"^V 6^.(#?1-"BDU!VF8[&=4]^JK9)^Y_3
MV>;2_[VXN[@@!WIVB_/3\OZK;UG;BEF9OBOYZ&[GE>F5P3KW\^#T /:1^YB(
MGR3WB;B,;?_)#8[=R73K7Q>7)Z[-\^.Y.A1UAW>J9,V7O?72;5_P-@J@4L62
MJBUZJY5W.L3,A8&8<RW2\9X4G\^*=.6!!C#.X'T 0GOCLO3:&,<-%2F<*@B+
M((P-V)(7E8&WX2#%^2"]RB^P7;.3=_V87HXJ2[[T:F$_XE(>OOB"0SER@Z7*
M,/WYY(]%-<;GH_AV$0FQAXW[>3 .GQZG^C!(_WESLO\N'GD.ZM5O^P==;&-W
M[X5X?_B:]7[KBAZ*_NYOOWY"M> $50'1';[^^FIWD%_M?I3=UQ^TY!Q,-(0+
ML 2\D"C^-26&&Q A)\&5V>HDU+&."LHF\]3H0(!I)YX1?ZHX=(2\7Y737H3+
M7(B_.!<]XT]6V?*DX]/LN 2B%,GZY_;;[8H2^Z-J7975Y@:/KS@"M]M6W$%Q
M!+HM;/O81_=8=2\Q%,RL9N]8K/9K50!X#$$6UXFO^-MALY?E/-G D.%C[G.\
MOED5X^GT\5KE,9Y<K98;N4&;@N@BW)]Z'U^>UUN>>F?WQK.GW\EVU3ZQSJZO
MVB846:HEZ:F'X7Z,NS<)Y[OV0RT'9 ,O5]OR.]Y^B:NJ#"01VY<89]Y-4WG
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MGBKHDM.96=0C=:F&#-HZRA(7RG(GO+"L!5WS0+?J9?891%11HT;"+ $;J_A
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MLE 3S2!JJ4,&RK/52) \!.0_J[EJSQ$WC1Q?K>=EUC&;K#G.$,N^9&-VJ)!
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MHV8A4' @@DE$1<-)J8/4IDH@^QU<P;\K34(UXD8;;779K'$:N.;6HP9!LY$
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MW'D;B'1/K9+?6*A^IL3Y54'G.Q8Z9YM3Z+Q&Z*-7.M\KE/H#^W,-JYE?-I:
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M"/0=(9-525B:[;W9;G /LO>6 S2K<MY4_+YR[T[%[\OA]VEM2M%$>" ":96
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M<@^ 8!/-A"MW)M%OJU8#4HV]C)J-[B#65#'-+"CS4FP+7E!22WY%+WZ#E>3
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MP^F&5I(8R8,+247-7=1:89$P@!_60+Y&9I@C\+=?WRNXP56JPSOK-RJ=:?4
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M-!E?.[$E>8?SWNYU/@U@Y_+?]M-E';^_8J]@W(Y_T:5XZQ^^!N]<QD2D I>
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M$=="@=[N.:+1&F&$Q,+:>2E"E;RH,+O"[$</2UR"\CX5EEBA]P:C][3KG<3
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MA8:%!^4CV&%DB^/[68VKCZ^F9$OB1[BMR'MPMV%_H:+^TD24FQ2E?"4<LBH
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M>%IP^^5$1H<)GZ3A -@65O\C=F DV)7"9.G/6<S,=RX_?GUMD>78HR4<P\_
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M=?K7LCK=JN\H(;6);*@>MG51-=FAOB+KFA%0XEB:H8>H:Y_<[>!)%PHY>W>
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MY-65:"<8!.2HB.B/8EC52%[%EHADB]JZ*:TE/".%J@!F*?+-_4$+XI9% 7O
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MX$C<NNC>NOI\=TD.2+3<]P'G_C9*B@Q8C\1Q4H"!'\R-"2^%46 !"+5")0S
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M9R=L[T\^G7P0>,)Z4XKYB5$K8X@?6",?HCN'YGSIWY6CL_A0D36[!K-XUUQ
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M/<$3[]KYK+57=9F:03!F2Z5!'3]D,/;KR<FGDM^QAE9,.*=S7^\;E3#U9,R
M'AE- GT2#(0H<+,@9"X=/YWD\ ^.;R'.FEF) "P<$W$7BOF8@"PT+L2(91$
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M.V]4],)P'S/L1.R#F#B;QJ8!WRZWWNYNY=R!EFF]"$GD W0YGZ)OZ03CT([
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MSS]5F/R.01?FV4K_\L/_ U!+ P04    " "E.IQ47#]%]L$D  #N;0$ %
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MAD@#,<(!FHR,Q#::^_\=RH:4C-D9WJJJZS$-?!%L]V667_IQ]X>?G*-I6Q8
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MZE+Q%:,AUNB$#IGF.C+*E&Z39_\654.*ZRIBYK[[.;=6S$YOH+KDG"OGM&=
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M7/WZYUN__X=H?ILYYWYJ?OKU5V?#;;^('\M^^O??WES$#W#MR7 \F_MQ_#8
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MAY:YXL3C_TA6 IQ43MO0)EFD?. JXH1?-30V)'X=Z+#73UVD/.DBHAY#"TL
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MW]&Y8N^)GG]LLN+&5V_**V[OAU<?YN?Y]]GJGPZ"I2EEI8DNW?HDX\61Q6V
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M A:SM<XRJ^N<I3=1''YCZH/KS7UE;[E6R+O\?GZ_^ @GUZ4APT#R2"$Q1A2
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M="Z9(9I#4)X;8U2=%UNVH3D6BZZSI&O<"FQ@6K<8;8&JJD6W'=?CV'/=>7M
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M_O;R[.VOK]^>GKWND&K>XD,[)YSO"GPC[9P'"\QF'HVTN-*MY<%;%X7R"@T
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M*B]SW,#43'B$AELJTS];5A@T7P^H,B$$E0BSY:J!EK=[H]?$\T"+!Q],J'-
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M?CZU@G<.8+1,=#6Y8@K3+A F[C(3,26%=)7 $'MCA>; G-A795O0H9.\FS^
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ME? OT\EL]OMXBG Q^G_T2Q+W&R1+%K_"/^=<"(-$=V9"KM&>@N1RV\"T3M8
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M\+J,]Y/+Z78K6,&GOW_UJD'$S T'ICP*DB#Y7! L9UR2IX]"Q9RV85</4%X
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M70(%';]_WV/VR[?)=#Y?S<.]>6J<I$ZACL1%PP/3@(X%"<"<-TE@$%F%-H_
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MI$5:S:6_I\4\B@3W2>Q $E("D>LY,(GB!/H\#DG D(^XT?+GOD8FI_P*(^B
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M4"C4]AY257OC"'$8>E0R'WN^H*Y955"3YGL$)PV^_U=C!7D%%F1+\"POZ+5
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M@G8JK_QU?<D7_%K-\7_'.5LG[%81=L_JKJ(=Y=ZGWU+&E^RK]%+GPL&$AF$
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M.& .B6(4&"UOG %F:L/77[?/BKQ44,%"8C5<\SBGBS171$8B?NCUDG:PJ.V
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M')=%&,!8.(G\]FGL1+'O)%RK%-CQ9J;VX;L_^WNSE7A)K]P;VZ2>WH"V0]7
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M:5Z=PWE7AT]\D1U?*!_+\9W DU-12$D00^2Q!!(4<>@Z"0V90_S0\7J4I+8
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MS$?K+8P_/TAO<Y./K@]UE?1/<K]B82RB1/MM290F &8H 3B+)4BUIP$1%)!
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MY2[V<Y7R/;K+4Q?B=A^[)Q1?H9?34=VZNO,A;W:2WDT#Z$S5KJE+[&MU:!J
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MQF9W,X6 0JE]&T+2#$641YE3>;MAD4MCN$;C0-8J.]<_&<+8SMGQB]S$/'@
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MVK2#XG<RFTC7>:>P:0$_F[@F%C>VPKX)_!U6=(<T5]-K(Q,Q!!&/]=(H2T)
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M&"<@DD@"B!$%+&84D(S E B$B7+:Z&X_?&F\VNCF7#3H!6(AEEC1. 9"I@3
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MB3-T[\CHJ^F67'9"KHH;:B&[P^&/-]5Y_N*8972L#\)28KKE$2"33--5S"+
M(&4 1S'#VN6)4N64&CA6D:51V.?WG[[>W7\*;C^]"^Z__>/]E^#S_==O7]Y_
MN_OR_O?WG[X%;]Y_>O_A[EOP^<O];U]N?__J&*X=.UZ6,=P91F%RPCN<(FL4
M#OZTJ9;C'MB]$BR_T=ZQRLP; KX2LK.X\+7/&QD-NEAOH55YX\WS\9*Z,$=9
M1=:T"=ANBM_TA?OB;E.5<"@SNE=IIE)!8P9$#+$F5)P"3",,0@8SB-*0)6Y+
MQ0ET7!K75F<9BK(BS;;2.O@EWP1%62S%<8]]BC&UC&"][DA-'?QJU:AIV]<N
M5!.PY\NU;(R5-T%MISF\8BP-]!!7MM;'63S&T*8;"K_AMPGTG#=R-QW09T&_
M"46-G#[X#RF>UO)>->UC;OD_G_XO=^_6W#B.I8O^%3R<B:F*,'KS I+ O#EO
MU1D[*YTGTS5]9O># E=;W;+HD617NG_]!GB1*$NB  J@.2<FIMIIDUQK?2 _
M+ #K,E_7-5[>O73^5761F;&TR!D7&.;$5 +/D@P2Q*7^9X**'!68Q6YM31T5
MF!KQM_KO=>KJFG!E&*7SBZ;;E.O)A.LX6?)]0/1#D[EWX-TI>B!Z?OG758EQ
MR74@1 ?,.?0Y%\:5ZB>;2)SW"ZHEF@ D1%.>,A'#7+O(IF@8,C7%<YC( NO_
M3[!,G0Y93TJ:&M'5$4F5>@,C1@^PM.,H+P@%)J,..-Z#ML[:'R8R]$#:V\2%
MGC+Z9%3HR1O<RW1_7#[/M6:F]._B_4+2Y1^/3=!0S!*,4AE#F><2(DD%I%0[
M13Q7A"5Y3 FW8H%>*5-C@%K19:TIJ%2%3X_V)9]/P]E/!-Y "DP"71UK>, ?
MCP/ZWIW&R;X2MA>\1BI\O8<;;UXK3[WOSN+04]_Z]+VCE;,^JWZW>O7YBX<Y
M0[^72_GR.UW]4VX^/2W%^GKSGJY6+_/E746X,T5RC#1T,*<B@:A ,:18*(AY
MA''&$\F85;]F2WE3H\5*7?!0Z0N44?@*T W@C<[@V2CMYC*=0]S.<?*(8V#F
MK"&L506?MA"VZM9Y./X\*DM@O/I5YV2.ZEU9 O#:Q[*];6#8.UW??UJ4?_Y5
MBCOY&YTO3<+A;?G.5+XRSMQ<S:4PU43GR]L_Y>)9:G4V]^L9ERDCN<@A%:8R
M#)<Y)#@K($*YS 3*"$)..U(#]9@:+7V02II6-5=@J3^JJOHZW-"?X$Y;M 95
ME]G5_%E/[<\F)="<[IN9PW%M-W3,[ ALA)$(3&S& F!, )4-P!C1IG1O2L"J
MVGU;4ZJ*S?J"VAA06^,Q;/\R./T&]0_49=R0_\L .T@(N/!Q;K0JY'SVP]15
MGF]>XH3=SC<+.<LRE @3(),7)B<Z01G$J?Z)I[+(\D2P7 @;KCSV\*D18*64
MV1V.DU_8KZ!5UX[@CJ+7SUJ78A*8BESAL*:7/KN/<,9:\K_<E<__2]]6T<5_
M(_,CK'^L..+H T?Y\/M,:;_FWFO<]YC:[>R;3OO%;TWWQ6;53RE514X83'AA
M-IL* 3&6%!:9Y JEN4@)LMUL.B]N:I_Q]FRGJS+XYM2@TA+H\]M0?N$+_,7W
M(S=@8\H"0OL=*K]0CK15-?!E=-JRL@>F9^_*XB&C;6+9&]3=S7*XRYUUF][$
M1UL2-W$7MW+UL)ZI6&&L(@Z)J7V,6,8@,;G7HB!%D4:Y3/+(NOVFI="I,7#3
M3/.QB83:&!T=&CW:0GV>?4, &)B#MYW,3_4O;^/+;@.AZM \,P"Z8[7.](.R
M6RM-1[CZ&FG:/FJ\-IJ.QNTUT72]=]AV85V">E841 F6*8A4(B B60:II!@R
MD?"<%;E@A+E4<JT?ZT3!(Q1=K2MR#JDZW\!DM^'F;GQ@^KSNM]AY"VS?0*\[
M6LVC1]V@VC?G]7[3J[^Z>TE5(H.)5%W)>Y/=\"QWE0#W-K.NE^*KW'Q>/LOU
MQGS?>SM<=6W W1X7IW64UL\92@HBTURO9).<0Y0S!BDC"50RQ8)@B?($V7R[
M(^@Z-4*HS 6\:V];T_67A=E>O@+<[#TKL_=\7^T]FUQ+<Q0PWYI>_^&J.A+8
MWM:4$UV]PN#*OA#P&*_.>6=Q0B]$8)*LWX4]4\%>]=@K\/H<0ML,M-%@9W7]
MAZON"<7V77AM_I6I,CN==\'>Q9W0.S&29SRQ=\/)PQYIM'H<\] :C.;/CP1E
M=QDPELBA76;JT_%.R6*MA_[?]_J7<^TP,\Y9GA04$IFD$"6YA,2T$-">"J41
M)6D>6YV4V0J<VJ9/J^\%E>+/8FRW*/&)7."9> M:MQA[Y7CIGT"CK\^>-';(
M>.Y.<T;HR'UJ[" X[%AC>=_0$IX/#^7RATD'KA+ZUM=/F_MR-?^7%#/$6<:+
MQ"16"PF1DA322%#(I4(\9XB+S(E9>F1-C51J5>LTZ2M MWH.3Y7N ]J.7CS!
M%YA9&N1^U,C5BH*=ICYK>YZ%PW-US]/R1J[O>=;PPPJ?YV]QWW5YU67OH+_>
MEVV5*$:K;#0,<Q5'$,4%AC@1#/(TBHH8Y3+.K&J1.TF=&J>\;BP)#OM)#JC6
MY380YW<C@L ;F'.F@*S]VCX(PB.MTKTA[;2^=D:L9Z5L_ZS1UKS.YG57K^XW
M>ZC'6-546]"-*0^QUC(?)6]^CF<I+;(DS1FD><PAT@P/,2J$]A]YGL9((9E;
M!8&Y"IX:W;?* 2I$E>YM(A-6L@IMYUIAQS6J-?YVSF0(5(-'*'2K,M8%&2NE
MJPJ-5V +N/EGH+J,%DB%J\W8)_SMZC-:0-);H]'F?G??]'VY7#\]F (+O^ME
M,J>+;ZM2:)%M^%_$!*,%0IJE3 8.)AQB3#%,4\:EP%P6RBH7QT+6U(AIIRYH
M] 6MPO:.T3E\SSN:'E$+OJ0]"=B V-1SR-D[DAX1',E]["#YT"#Y^!I)3_G4
MEN#T>(KGGC":?VAI2M<KM+W%C5C7JTW;#N W:0)<'^_-LYL*\[F4J6(X@2JF
MIE5U7$"B6 J1E)A',:(DMBK&V"ME:F3:U=". _I![.=-;] $9LRN<AXK\UN9
MW^=_Z0=T?"_]K]=^5[^$4;YX*R/;;]WNXH'5%.;+TN0.M1U0ZUI^GY=\)>E:
M?I#U_\YBSA(:QQ3FV,1&"9I#AE$&I2P002IC,7/*:K83.S4>>']O*B.:*IO+
M_8;&\\8,Q^6>)?AVBSW_D ;FCQ--H:^:$J:@51W\TBI_^C3&O>B"$UI^:R_8
MB1ZW!(,3' >5&-SN=L\<_M!XKJ8/R2R5),UBD4-.F&DLEE*(DYS!5$698C16
MB%@5V'_]X*FQ3:M;U<+4/D]X#ZM^ZK@$@<#D8&>\4U;P,4L'9P3O/6RT;.!C
M)G0S@8_^W=W];]<1UTOQ0ZZ>YURN&\\U*VBF.*)0)4I"E,H"4AQ)F)!$)32+
M8U)8=3'OE3*U#[%1M-J-;#2U7P6<QO+\*L +0H$_U"/@>%X,G$7AXL7 :0FC
M+0;.&ME=#)R_>-AB8-\C:V?S9LM*)D6$,%4P2C"""'.]!# K@H3I"3?.4Y52
MI[XV?<*FQ@!?O;C[O?#:.?F^0'L;USY \U\;0+QZ[[T"1_79;4Q_[:E;W3/X
M[%CJF^XU*7V0SW)15FW(S5'/4J]A$<I4(1B#25%59<01Q)QI%P(1P1(5<VY7
MZL=*VM3HHU6VFB3%3ET@:WW=3XE[D+8C$F_X!6:2/>@ZFH)&5:]'P.<1\7WN
MVR-Q[,/>\\8?.>&UN&EH1D1;#O"]X2O*JS5-XSE+BM(\YP5,*140R8A!EA81
M3)*(BBQC^A_$+1OBM+"I<<E.5] JZYH'T8.L'7GXPBOT'L(A5 $Z"-N X3GE
MH4?@R.D.YTT_3'6PN&= <OA2?BNU7WZKH9;_1Z[*;U*_1<L-O9,_Y')>KKZ6
M&[U*>I*_TY?;/\O;^_)IK:<4DV7QI[[LY9-6J/'$TXA'44XX5(IK!R535+,+
MRB"G.$))*A*46RUT_*HU-1Z*_Y)&_P9J(T!E!1!/$F@[@'YO,X=\7'\CU\]>
M;S<>@7E.&P4JJT!E%C!V@9UA^X/TH1DD;1UHS:N2;&L#@;%P0,"+QU%T2*!^
MD]$<*U=:C^IC-:J;:E3_94;U<3>JZWI4E]M/[T&/ZD:/ZJ8=5?/_FWI4E;;4
M4\R-?]#[4I[]"1LON]D[0'N)S/Z?/G"ST&1)MRG4UYO-:LZ>-B88Z;8\OLLP
MPS+.8QPE,,Z0*?=KFE5)QB&.8I&E6183MST 9PVF-H=^K>J?5+FYM*.^J<7M
M)\# ?8PLMR%#(A]Z;[(J)M&I.0&N7V%_8O?2XZ;E4/C\[F0Z:S'N]N90D [V
M/ <_:!@QMJ5"WY</;+ZLO 2SU-$"-/^:F,VY?E;UZR]SRN:+^>9E%L5Z89$C
M!0M)4[WFX R2*$,P5SF3E!01BN7L6:Y8:4N. [1P^4B[N@0,N-IJW-;[7(-5
MDP^B/U3::;KH1HQ#QLB.&@/C'I@<MQ6%.^I?@<XP[%EP!;8V^"/'"P#T2H]#
M]!B5("\ ZC5%7O*HH:=%S^7B60NH*UQ\HKQZ:K,$S)(8,\(S&..$0,2D@$3%
M,224%PSA(N>Y59B)E;2I>85;99L2+:!5U_64J ]AVU,B3[@%/R4Z 5F $V<K
M3#R?$_5)'/F<R,+XPW,BFYL&UMWEO'S2;L$W^F)<.KW,U;]9/4G1$M5<;K,!
M8TRPR%,8<1&; KT19*;E3);&#%,<%RQS(A5[T5-CF$;/[?%SM5-4UC4\GU8K
M,\\O=C8X5OBU'Q [#@H#<V!":I4&C=85PBWL'<4#\),[7GX+#]N+'[<XL3,L
M!P6,W9\PV#<R)<N_2W,FIFGS:.WR-H?Z=OZ@+[E1/_1OUXKRJJYY%7\?SQ2-
MI%*"P SC'"*2)WI5J0DP33)",L)D;-<NPK=B4^/#K4%F?WU;L;_<FK0VO]>*
M.SM@?H;1VE<;?7#"NW5U(X7= )UJJ;"M"U%;9CJ+=6UKDXJ\NH%>X?;M,?I1
M;FSGTBND1_Q0O\\?1N^?Z'Q5=:A]IUU@NGY:2;.Q]6DE__M)+OG+]<_Y>A:3
M2,18)!"C!$$4<\W<19S!).$$2QR3K' *MK:0.352[N@)MHJZ,; -TG;DZAF_
MP+QY%#KP=Z.E1T?3 1.OY&8C=U3><@#B-26YW#KXF-;4M_ZV*I_G0HIW+W^L
M39W9F\=J0V]Y=ZV9[;GR76=)4A0X)Q'$<6R:UZ0YI#B74'"2)5D22<&L&F"X
MBW;BGA'Z6;QOFU6L@1EN4#XVVY_NYZ^VX%L?O : =(03UPK15FW 7L O1G,P
M7_X*MLJ#G?9>SUH=$?-]R&HK?NS354=8CARKNCYA&(/]N"]758^N=^5J5?ZI
M'[V>10+G<40%C)@J(*(:>Y+%.4R4E)0KQ5-A56NV1\;4_*%*16C:'0(AF6/0
M]S$,[1CG0F0"4TL'E ]]H#C31H_97OGAF)Q1B:#'T-=??-^E%RZ%ZN9@U\O]
MO;3*(1(WR^^FP7531O!KN5RU_WQ'U_/UK=F,FQ4Y1D7,!$Q9DD&D,KU@RB,!
M61*K+(\58=PI)<2;9E.C$6,8J"P#'8]S;?98&MVKO>JN,>#OE266T<#^Q]9Q
MB3;FB 6FM]U@730^PY=VOK ,LP"\6+NW62;Z O7D8M*; /<\G*KS@'Z2*>[Z
M8$X7JV73]:)ZY^HMM"9:>2:13%,N4QB)2.KE)M%LG5,*)5-(+S=EGBGK/!M[
ML5/CXZI?0]4ZL=6Z/98%=*M^)^[?/B7#82CZ&38<P,&]0ZTT9$9KT%4;[/3N
MY,D$0=8^F24,PB,EJWA"VBD1Q1VPGD03AX>-EDCB;F W463 W4-3M=GF\](4
M^ZY*3U4N6QI%%./,Y&7K_R B,"0X3B%#2BB5,!;3S"U#^T#&Y(B<WTOQM)#F
MZ/%+N;S;K4K!3O/U,%_Z&,1V7O&%P(4F:#^8#<C9/HF*YU3M0SDC9VB?-/0P
M,?OTI0/;SM''^88N3 .J-M?;5/ROCMUH&M&81@7,*:<0I2*%."H0C).(QPRE
MBB1.!YP]LJ9&%!U5=W4)>MM9.*-KQPV>, O,$2?A\GZ@:8&'WV9S/?+&;39W
MWO"#9G,6M[BO'J\["3UZ=?J^7.B_E,W1VY=M&RZ.4HI8$<.,Z/4BT@M&J*DD
M-5S"(\9RE!&K1%)[D5/CD*[65?;^OMX#&Z%9PG]^M>@?U, D\Z9XVJ\1_>,Z
MTOK0"[Y.JT,WJ'I6AI8/&FU5Z&98=T7H>.> MB'Z-9*OVQ14#HF44E&6I# 5
M>BI$+$L@)7$.LX+((B:1TM1MW3;DE)2ID?3 MB$G0>SG76_0!*;:_;8AGEPX
M*^,O;QIR4L)X34/.&;G7-.3LQ1<>VZYWU;S6[^C"1-+^N)=R\Z798WKW<KS<
MU[N7OTIQ-U_>?9#K^5V=<%KO:B11AN.,29B)B)GB_A@253!(,BX8P5DLL151
MA%=U:FRS.RM<@XZM5Z"Q%E3F@M;>*Q.$=:Q"GC'ZPA-?_Z^%W8)V&H,=F#]'
M'>?A)\?!AB#,4;)_==_F;#D8["</F\-)'#8Y_4W.[^XW4EP_RQ6]DU^?3$;>
MC:J.0]8W3YOUABY%<]S-9U'*3 <K#"5FID5H3B!)"87,S$)QH6(5.<TW3M*G
M-H542H%?YDNPKO0]W6_) _*X()SF$8)1$@F(:)I %B<42J%2$A41I4GB5O(F
M&/;C%+L9%7V["348HH'GR%9OT"@.:LVKK,!*=]!1WLR<6GU_<^ @U+Q.:VX:
MC#I3#0+G]>0S["'#YI./=&62!=??Y*IZ_H?YXDF+GN6"*444@2(1'"*],H%,
M"@I3)7*A1$98'+O,'"?D3&V.:-2J>$J8':15E1U=<Y8C99V"UHZ</  6F(9:
M#4WH2TT\5Z#1TA_;G('!*Z^<DC4J@YPQ^#57G+M\8%)*W8^U*9M/DDQ$DBK(
M68Z:KL@DE3"+LH@5+(T%<O(B]YX^-09HE'-,A=L'S.X+'PQ#X.^Z12! -X&C
M)OO-.-F3,&ZNR3'C#K),CE[D<2W8$,"!LW M_O&TWAC9,\[3HE!Y#HNLT',[
M4@@RBO7G+2,]N].4(NQ4J7B@'E/[\C\J)?G&>-'"Z&ZVD]8F>KPN9>1WY6(Q
M2A>L8?QB_T:KF=85.US2@)T=@9<U]D"&7^!8Z/+V2QU[P*P6/0Z/NZ#,^[.L
MG]7LV#7UVW+,:988AX<6$J*$%Q!SI*#"*D^+/,>*<;<=G-/"IK==4Q=O;Y4%
M]UI;RQ0""V@I10C'-(&$8@I1CADT15]@P9F,BDP6J70OE7\QL&/5Q-^I"AI=
MO0%K-V?X@2OPM' <J1 ]-L^BX;\N_7%QXQ>@[S7[:*7Y_CN&IEBH^5**=W*I
M?]A\TZ]!T_?7Q%S.<I$GBB.B*9@)B-(,0\+R&!*>\;C@G!4H=4NVZ)$V-;YH
M>TYSYP#J?E#MB,(;5(&YHM$3-(H"H^G5ME]W;_#Y@.0*"TP\IUGT21PYX<+"
M^,/4"YN;+FVDV<FH^4TOK4TWC.T9['?35,&$ =[/'ZM8LZQ($R6XAEK&&*),
M))!RH;T0%HF89SE"=@%[EZDQ-;)IY]BNGD.[;SH-ART;A08Y,$T=P]=[FL=E
M* 5JY>FDRALU^1P"U^GVGX.>-HP#V\8^36OBMAY\&A-$<015@?0:*^(9)#)*
M($(R2:1D19HZI: =E3(U!FN5;(L,7(&E=/2;CJ-IQU 78Q28@+;P- H&6$WU
M0N"578Y+&I4\>HU]S0W]%P_<OBJ7?[3]!GBFJ,@Q@I@R_<$7N80XS\RN?H&8
M0!$2D73:5-D]>Y*?>1U39YM[< PQR]V283B$WAXIS?^&V XY--?O_D?G^>-N
M>!P:=K##<>22@0?H3>K_C?HNC2/ -T]-3:+O=8,WL_9I"H QDO X2R6,4E,-
MVWS"%*<9S$F<Q2*+6(:<9FH'V5/[L+L5$_:4KZJ"->I7"_J!I29<QL6.'@*A
M'9@^? +M'@7@#IG?& $'^>-&$+@#<Q!?,. 1 ^M?E ^/*WFO?9EJN6-:D'Z5
MFQMU2W_.:*(P0BJ#"4T%1%BO0#!C.>244DUG/(VCU*76=H\L)PH;H[AV5]53
M_8_?T9\;$U5HJJ/=EPL-NF.\41_X=KSE"=+ /+6/YEYCXRM@CH@T?VF-KPZZ
M''^C*Z_A 19P^:V>T2-OW.H9YPT_J)YA<<O@K0[]=LQ-?ZJJ"*1^[,>??/%D
M8@)^*TOQYWRQF"4\0[%,E*:<-()((&Y"ES'D<4QQD6).D5,G/!NA4W.D;JIV
M=_.MYH!6J@_;#SD/N4@9CN,409X)#7G.!:0<"U@P;H[O*)$)=>%[[Y"/0/PC
M0VZ](^45R/ ;5"UZUPUZAN1_V>H,6J5/!^$-V;*RQLCW#M9YP6-O:%E#<61_
MR_[>@<DJ#X^+\D7*']($B6F+VJVO7#(JN=1D'RF(",\A%9Q HEA!,RY)(=R2
M58[+F1K)MVH"4U>P:6Q=10HX.I.G8+6C& ]@!6:5+4Y;%0/LFYV!P6^BR@E9
MXR:J]!M\D*ARYO*AB] ZY?IO\\W]^R>]GGJ0JVT3]QF3,N&1+""+<P)11")(
M,R%-.36.&>>Y0L0MA+-7GLLK/TX4Y[8<PN"&Q_T RUQF+,MB&!=)HOV^)#,A
MG01&F&0$YU11KF9U=]$?&[K:C SR:\GA@&ZK4] -8/)NOEPV73J'=%;MAYSK
M!4R2\@1F)-7O-*,(DE2/0$)3HA*:4,EX _G'I7@3P%NYH\ M37/O$$#;;J-X
M@B[X1DK#!']J14&KZ=6V6_?IWI,#MDHL(/&\6=(G<>3M$@OC#S=,;&[RVB'Q
MD_87EWR_25^N?>@(:U;)L=DX42F%!+$$IBC/>%1D,3.%1R_ND'A$]-36\J\[
M)*I694#/-_&[=!CLB"<,N(%9Z$ROQ*WR8_9*[$%LC%Z)Q\1/H5=B#RR6O1+[
MGC",RZHMMB.[R^8\H-UAKKM8Z]^O)%W+#[+^WVNVKAAVQB+"&)49S HJS9)
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M02YBA!7.M.NHG'*63\N:&A^WJH)55U?'3-L>:.VXUA-@@8ESB]6>F@'*^EO
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MV*7(60X9405$ B%-'9C#+"4D153$7$;6Y<4OUV=J#-/97MU: K:F@)NE2?
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M+WEXED(:IQ1&""%<"$8X<BI9TB=L:I_\YZ_O;W[_"&ZO_[^>LE[ND-I]][Z
M"DP!G<ZQW6HC1E50Z>K17["!Q'.@8X_ D0,<SYM^&-AH<<] ?Z!<WNDO\.&#
M9!O3G:PJ6B%9%#&1Q3!.50$1DSFD@@GM$E E$B0RS)F32W!$R-0HPN@(C9+
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M8\%%C%/!G+(DPZDZ-4IOE0.+N9)5A\8725>NG9P"#JT=@T]CP +3>V4!K$P
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M^9-F'NS$G[YRV"?>. SKV[(IRM.6\I'KWU;E>CWCJ8AEFL:01"B#*(HQI(7
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M'*5W5XNDFA/.<H0RA)A+HDX),$QA/$4LERE+']CA!5?W5^TG>5T-& <)M0E
M?$@7PU)\-IZ_<Y=ID#CQA(D BM(( DD&&U,$RBD+@BDMY#9)B&U <7?E?O+8
ME8%Q@'"; ,?I.$RF:.@60EG4#KV<7(WGTV\O)S$-)!&.,\]!^Y*HB]*"R5*
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MDYCBR9<T=1?IW=6E3].SO*QV/;N:S^9NO*@+6\O,*.(#UQQ<YJP4U.J2PS-
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M5SW/TR<"VMX 6[%K"=$2N832M X$I0D<Q9W/B!)1$:IXK/.T]D#"FVD]V"?
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M$)Y:9!XC*:^#,D)JFT+80N&W/K*-R+%[=>\KM3:/#XR0TND\7<X&TF3%/(F
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M8SQ%U8\0.56QP;MJ['EZO/?*LJOZN8^O=90\^E:,-N73<F>,9YR"XYF"L):
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MA1("(<1#J;.*A(%1,D*TQ'L3N7+I!PA@-AP/BPM*:Z(TQ"I@6:!;;9(#KZ@
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MX("7VSZ*.0Z\W4SP5=JP1,<GA^6X2L\H7E8:Z+#J+#P3+!W6CWI$8I^&;2^
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MI0TB<N[:K)M\EJS.'V0.C<7A5-@!'BE@+[/YUS!-N!3BS7PASV0L1C+(S%"
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M(N_%,#"))^YLUK91V>B6A!Y%BG!'U#R>N==,A1T@]#$SNUP?YPP%3[7Q).I
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M.)FM[K"SV<75<I+-S6)F&;Q4,D)*@7@(2@/%Q1FX2,IYD@J63>;C/O7Y&V'
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M%P8!%"\H<%88'8UG7+4:5#-N5%S/6/W_V]5<]?QI]II^FY];$60P(D*0D9%
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M$, 3C,\6RT#[39C,_Q4NKN[7NR?-8L@>6'$25!VOXA6W4-<$:5%L++)-H\7
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MOE@L\')QVUDM$EH> 54,)#!!)X^Q D+1P?-<H_38!%J;T]@?U'9!Q>P@*NH
M?"]26KYC?@@_JFTGSNAWYE=$QR3$R<7RK>6:LX",9^8488,[4*+4Z=(I0BZ*
M#BM'K4NC'0<;TSANJ-H(?(U4U 'X[GDFM^[*7:U(?;;+3EO@Y*&",C9!1%3
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ME4%W*+J>;>.M<ER1WR*EKF\&$D3A W#DF%DT6>N=A@<=B*,QFY2&DNR30#F
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MI;GO\IWW\N9:?R5PWRMV_P)02P,$%     @ I3J<5/"[PR5Y?0  V,T# !8
M  !B87@M,C R,C S,S%X97@Q,#$N:'1M['UI<^-6EN7W^148>]HC=3!I4;OL
M:D?0DC*M**<R6U*6J_K+!$@\BJ@$ 1J+E*Q?/W=Y*P"2D%(2H"SV3+A2) @\
MO.6NYY[[E_]]]N'TYA\?S[UI/HN\CY]^_?WBU/ONS8\__K%W^N./9S=GWF\W
M[W_W]OL[ ^\F]>,LS,,D]J,??SR__,[[;IKG\Y]^_/'^_KY_O]=/TML?;ZY^
MQ%OM_Q@E22;Z01Y\]\M?\!/XK_"#7_[77_[WFS?>63(N9B+.O7$J_%P$7I&%
M\:WW1R"RS]Z;-_*JTV2^2,/;:>[M[NSN>G\DZ>?PSN?O\S"/Q"_J/G_YD?_^
MRX_TD+^,DF#QRU^"\,X+@__Z+CSRCW8/=W;WQ&0D]G?$WO%XY_A@LG\$GQP%
M@\/=_S> 0?X(E_-OLGP1B?_Z;A;&;Z8"G__3X5'_\'B>_WP?!OGTI\'.SG]\
MYUR:BR_Y&S\*;^.?:,#P[22!UY-?CY,H27_Z?H?^[V?\YLW$GX71XJ?_>Q/.
M1.9=BGOO*IGY\?_M93#);S*1AA.^, O_)7X:#.#A].<]#V@?[A.%L5 #Y"&=
M?YF&HS#W!CO]P5]^Q.O5:U5?SD]OX?WR9/[3?A_O/O># -;@320F<+N#@_[A
M_/E?XZCV-7X=_OWF_,J[N(3_7@YO+CY<#G^'OT[[[CO5O\U._ZC\-B=[_9,#
MZT-:(OST"#^EM0OC +;13\>'_;V#-MY[@.\-NWR [WE^>7/QMW/OX^_#RQ=^
M8S@YZ2_/\<R69O3C^=7;#U?OAS"GWO5OPZMS[]/EQ8TW_&-X=>:]NQI>WGB7
M'VXN3L^;O?-^PXERYN6P,B=PMO0RL-#X9Y'EX63AK,S>2QS >CGRJ_\E%ZEW
M$<-_8Y\E/OPU[O<\WSL3D7_OI\(;)^D\2>EK;RN?"N^'[X]W=W=^5M/R\B/G
M^0O$6 [KIP*F,L6KOOOE-)G-_7C1WN"^^X7F9_#S=L^;%VE6^#""//%PYI9.
MN,<R(1[#C@COA/<Q\F-8A,R;^0MO)#P?M%\ ^G.2)C,OA\'2'?%_N[\B^"[=
M6(ZI2,5HX=V"@9-G:DVF201#]:(P0P-E)*+D_C5,JI_FX3B$K9YW86YI)N-B
M-H*93";>7*23)(6[CX6735&(%'$(4YZ)W(,O\NGKF>?K3UD7)KCOW<!4X6@\
MG,ZL&/U3C+5< 7$R@R_B (1U')#M;D]V&,-58>9]M);EFI;E$RR+]P[/@W>9
MP(9Z#?+$'FX7EJ9'2[!D;H>@0@-O>)L*08Z0G^?^> J"!F41K!Z(^&[.LO(Q
MAFU.\2O8C7IIN[ 52030;B3[0<!60W%\/PWA'R  PE@9<W('@F0 A9B*"?P;
M=FX?-FTDLLQ+X";I?9@)+Q 3>)RZNF>)&_4-21=^) K[*/*F/I@P^%D&=HN^
M;B;\&(SC3/W $3MJX'HZ+8%'^EH.@69>/F:$]\[ KJ;7@9/D.Z<0+4$19VRX
M\CGD7U^#Y,3/!@.<'#7VOM?,.6CL1I4\[?XQ_2[W1Y%0EXR2% ;T!K9)Y,\S
M\9/ZQ\]!F,TC?_%3&--BTX]^EL,8)7F>S'Y"U^).H!7@1]*]H&W*7\L0QLE!
M?W_G"*,8.8PT#]2#98"C3P&.'_.@^MWN8?_H\'CIUSO]P=+O5MWV"+[<VVUT
MVQ]IR#QLF)@,;)W_^F[ON]+T_K0[_^+!*?'P?_?Z)8<+Y[XR2\F\I8"'9;3]
M\/W!L99H:BH:ON5Q_Z0;;[E,&)T,?B:)= C_<[+GON;#5K796]8?U=UJ[&*W
MWTJ,HKSXWL69N_X<N]OL@F?8!7O5J&>;N^ ,=!5J'5)^FTWP0IM@O[_7I4UP
M R,#Y^Q2^\MHYFPVPXM)A(,N;0;;9(5_ATFPV0G_GF+A;R++,3UZC0&"(A)?
MM0^^9EX&U7DYHAWEYC=V7R:)5ME#@WW*@8X%[';?]E7G:7(7!L8EU<ZD#-$L
MBYY-X;(W"^&G3N!R3H<1?,WD/O;\47+'7BK[GG>P5O@8?PP>=4#7WX?YU'*/
MG?!;2\$!F*F5L8L@$'%0S+P!3D7;$1]:5IBR*$KN\1B _SX+\UP(;XQ;=P*;
M%U^@[*>_L,P8+-$>I;,QL+.(+YD.16=_.)]'\#H8:+B"A2_F%'K\F,"'BQ:%
MRF%YXO9K)F[W1>:M?O-AQ,GDX)SX464>I1SP8:H7>'HL]R[S[J<)"9HXR>T0
M53*!32S23(6=9*Y2![_.OXAQ\8AGXQ^USV_P;!&B^/3\G$47IA3A"@JY>4E*
M<@X6I^_]"F+6F^/C!0O1[D2RUT@Y)==^;5.N]9<)K1\IMK<NZ/BHF..C$0D'
MA/!H"Y2P0*4*NAUU *6M.'8K(E#9:1*CN,%M/TV3XI85;I8GX\_>' /0?C +
MXS#+81LD*9J8@Z.?8<]3&%7N:KX[J_@T&8.IE0II(%@A&A]M!TH2CX0W2F _
M8:1\:;+-"B3WRK:'.MYVP+OO74PJSPP2>"+*#!ZB_?;VZ\JW*;]'EE7>0D\
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MC8SZ07%J*N]LECS-UD'V7\_91N\2/\JT(V9"TR64D4*78<9J%>1 1N)I6/"
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M@]IL9[E)=4?GM]LPMOKT<OU^[L9TK\:$L+G2%M2M?C;W:Z=SO]/SV3EHR&M
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M.C@6XYR[=-HS@GPQJ9@E=[*1JGIB95_(*^7\P8X?)UF^0J!^G6C\EL1N,Z'
M_:4>*S%5"])7CW]:CCA:BX72DDG"PP(#\G7/C@UJJ\A@W=4]4;V+ECYVQ0.M
MX_D54*C6CL@W=?R(KXH.G M(JIA!8&Q(Q)3<LWKK<3%,Y1YH9Y!9I%JL35.Q
MW# RK8CK(4Z$C"\_FF[YANT7QTQI2?1N8.D;6/KSP]+WFL62OVU8>J>DZ#K
M9XU\W0 ^-X#/1S25.7"I)5KMN3506U^'O9X,RFGN^!50SOIZ\$?U>ANH)G$O
MC/$\Z>_M/*IGX\%^?W=_.8[S*S">!P<GW<-X'O3W:Q+L\M,.)(4?C?'D@] Z
MQA-,O=KY';R.^>TVQK.>@*^F&$=]VH$)[S+*LVX^#]R")[V!=SH]G]U#,AWT
M]VK0-_+3SLYCUS!,F]VXV8W=V8W[7.-9T37ERL]NS6(7=V,=6O:@.VC95X3R
M[+R$_$J4Y]/YIG7!L?U.U6RO"!$\"2BT><'[MSJ[)O9H]2[-DD@PY $3<!E1
M]A3Y-$G#?,%9\C ;IQP/S!-OYG\61):@DBQ6)C\5<+,[_MJ?C<+;@O+C/>_/
M O-]ZC(,>Q0Y(0DB3M#*J(V5RZ4>G];"ODO\R, %(G$G(KR$\H@*20(N6FCU
M?8%=U/?^P/@CC OV0JX>XXS<I%^G(=Q5-6/!+'!-]-,=QMSQ%W/3I_26?$;&
M /;<1DF$30AA>YII[<&D+KQ9$L#NH(PSI:@Y<VIO[F3T3PQ9W@G*2ZL<JYX+
M^PUJ@K T/&ILJ]XK\N.'!1J;'(NO$+JGL&?2T/^Z??Z?R^#-C_CB:4*%FXS@
M)B/8C8S@_C><$7PP[\6@O##'1W7E5^K3]OO,\Q0.S\[.+\\^O?=VO9L/3]NI
MMCP;QU4W17W:@=DXQ/S"S6_GGMVX_OJWX=6Y]^GRXL8;_C&\.O.&[Z[.S]^?
M7]Z\4!*R;IBK0LXP<N_RP^4;0E%^'%[=7)Q>?!Q>WEPW6=K#I5F^SM*HTQZ^
M .M$PC6535:Q3'J5/I ];7?I/&G/D)LCLC(KR$)2]^2L'YF'&AS*#^HA8QM_
M)+&Z\S2Y"S,R4;>HR*73_28ODYAWS## OHK%K!N-)X=1Y*"E>5$1V@PW\0F^
M2&@&F-[*&]@N">&S_1G!HQDHGE5;A-9O$ES,'[[?/_I94K&9E+KWL4BS J^$
M[='-956(!#BNG8(C@,\RJ:35<YCU;()P4W"OL+VG._EB-H^2!;M38$-P-UXF
MJ$W@5BGLB2+.TP7\>B)[RB[=&[S,Y,_7G6#W !.@D'PG]00*)6#1Q:(.'B _
M@E51(''%^JA1MYEVVLA9MCTWAM 8?EOE4M( UHPTXV8-8Y%E/@P3QQV)6WA#
M\@$1OYCE*8-UP.S*2#;);:V&B(XCN,!@O84(]X]D8OA."50J + >G]$O1L)Z
M+#T,!D0> *X/^(TS<$:1F[ T5Z;5M5S[%12%3] C\R5(Q^J,K)7EJ)^N;ZZ&
MOU\,7SJ:U)GBT-6]%&_\+]Y%3"$+_*K-;I-,L(AJ L^93\4]N,$9N79=C!!A
M3!+C>&_XYE1)O0NN"\ 7&9K^O$,P*P8G)T?>UFD^W>Y$C>'JA8 !MSGYNKJ0
MY"+6%I6,,TLJD=SW:8Z;"I2G*R[LBF&\;CD+U 51Z'L?)B!XO;-D7,RL1$Q;
M!PQ.%@<[,5Z+=GB(ZPFJ5(+Q"$RZ,!%(2_EICN5T+E\XHV.VN[,SZ'GFA<$J
M*E)9: 7JC*O_\=TSCJIF=(;;+I1>LWS7[15*.\?Q2MQBA#T!Q?^N *O-VS^A
M6<4!>J>1GV7>!RJ<._W@#?;)F .5N&/7UZ%=Y(>1=+G*9OFRC=HCFNPY1=59
M J-0SG-_/#6P35T,&J+!;ZBOS4W]]N@'UJQP'(LOWJ#5\]@D*+^I4]E$I;L5
ME3[XAJ/27WD UP:LJQ:-_+ # =IUGM3EY?G?C<!\L@2D"Q YWJU%R*J/7W":
MZ(X_46QLW"#._^'MV_,K[^S#Z2>,7C=F&7KHMJIC^'\=B9"E8/CF(8GJ<:I]
M[<,NO?;NSNX 7Q-;V=ZQ>_N<H8C![G%_IP;3KS[NP+20[</'Y</;)=F@:^_F
M@Z=C-Y?>U?GUQ1EFA<[??_S]PS_.SQOE6QY L=\H)],5W],&"%%8$<SO.9%L
M!$R@D2"13"5R*IVZ$%VYB>3:4%_GPH[32T^1+R,B#"[\TG$B+Q6W?JII"ER7
M$NZK'8!819MS&6$6U6X]Z,]@L!8&@UYB#V,]\)O03Y4/Z7S0LN>X3DV:-[?F
MOBWFJ%+"AU;57D;<.+Q;=+LYW4,I ?<.R6XX)A RI,DD_'@[6:_[*OS^=:O7
MGM_O+)7CVEM^O83M1>(.#UPU.//,8U]J$RWIZE,7*FIS>AO:&OM/%JT\[HK*
M(*5;D\>WA0'A<[G UTDGZCQ^3:)OB;BC6),?98DW$J@DM) AH3%.YJ%1 R;M
M'\C8TT,*?Q^GX?<'%7]"+@U_%,:HLGYZ,SAJIY4.[=96J]S+*)5]G 8E^V%]
M3AJN3V,S=HV34R[Y7;I<K=3,\WJ-.K->^_WC/7O!\  2IKK(:.WP2#>4A=_N
M\1IW9KGD\3J7%K*=D07;=PZV/<EA-[2^A1%5!I@CA5[[&<YUMI7)2*@D0S?,
MXF=$97;=DR2S #W)NL71CN2D2 D"9!L+8#],131?:@!PW4DL?T-H(>4/>+ _
M.)'OC]#>,$XHD_]9;NBE".G)6H[%B?6'$6H2,6#^5JT]*TUEZTS2ACO@475<
M2W9 9^ A2"V\; VS:5)$ <PYM@F/%EXQQS7#2IL425%S/Q>\469^0/$#3C0I
MZU)%$/I+-XE\ -T\B=43"#QF;EX"([HXMQA)"%48HL8^U1#4NOU]C^1SV L8
M-CF1A%H[D<B]5]3=/)V,J.T'V\[VJ(O5K0% *I?_=_^>()T3":IK%^A@@@\.
M7=$=EKNAI @$[B$4"FF8?>Y[YS#-Q/MJ@E3WT\03D43 +(F3J0T\2^(P9XD3
MIJ5=)"%]M,>HT@Z?Z$W\,?P@,[Z\],<<YLV)&KDB\Y=/=>"U1/+-,;1XZ59_
M89A.5UC<M'JS-1?H$Q%2Z.M6Q (EF?TMBB'8/SEA/4'P(=82 U\E[<=,;)]I
M5TD09H&PLWI!)X&85D5@3Y(C(T 6EKLP>R46(JA9KZ=2/)U:FC5Z01^;9(0:
M0(IY.&')?6S-'ZC]H!CKI6)68*S$S&!*\1C#4D;P39QQE).P,[!HMYB08;Y;
M^N53M^WM*I;MP9E?(U"N4':]E;++<4=B[TH&^ELUZM?:&E2PP-D+W -+A7'H
M:)#,*#HI-"+*6Q#0W'#N]\@L3B*R2%AV,S^^^.(C26-/8NJH\"&7N"HRD@/%
MGDN_PAW[9Y'DS!Q]0TWK[[U_).EG[SI/QI^]\R_C*?'N=3N<?OF/Z_,NN'B$
MH@=;,64B^A0]$/YW4#"(WN(JE+N!X,B\%#'(BL+'')<0IH* EQ$+N>6B4=V"
M>DI?'Q/Z 0[ !V-X7/YMW>*340N"+$+V>M\"W<)XDQF6T(^EPK=SZ2"D/K-5
M -*.Z+TSW"N@:I2>@S5"ANZQ4TUE3&BZ'=S=@X7D&HJ)-.?E!UQHH'@&DC#B
M]\!O:#=2ZN\6&VO$'*\(L[$?]= \$KFL74@-H'&>@%0FOH%(W(:9(A+0UVB*
M>'C%(A5+Y>P&+;=!RW46+7>X0<L]#BW7%4.5)E%&CUC$DC!FW6TGS+E_A<Q^
M*Y$KFUJ0@,;/=:<*-#R:NF5/%E;H2MB1YO1]DKJ.F8P&)EC8AW;]Q%:@8[+>
M+!5:[LZF9]9TG@FIM4561'FF6Q](Y:J]Y?)M9@DJ0$%TET/9 H$:P* E!J;<
MS!OLO/FKCBN5?_[?W-,#K,/JK_Z[#Y=;F<],]9:1Z=([/XQ()\#KKK&:)I-6
M[+EIGL\I-TN !/K/_?U]'ZSC/JA]^KM-<Z^WK',?&_.):=.%@K7;TYR5YEF]
M0G]$.,H^V&+.YYGSUQLTPNY"<4^?!F+BPR'H^]G\2[OK@\>&8KRI((XI%?:2
M"_;4G%]K<LI=%I$4F+< &\NA%M*Q!=F&I.J6@V+]($!S,FW;6US39G'XZ:R]
M@5G.XIT?%4*1BLD(+,5E4ZNOJ@;!L5IAQ610=)^NS^CHP3LA41L[ZV@>],WB
ME9,,)D ]!H/7QWP*&@EV=Z:J2PCN*=X6AZN>TT)"LROYBC6"%7&(F%*G& IU
M+Z!TD944;#=V)<='?CM'%FA\8S,^2G2",9G<)@6YVPFB<-&WSGBC<DS!.OK6
MC_O>.?(P8H"*0QV^"3>AS95'O,O 7??N$MRK9]22,@XT#\'<#W4W,WDTT&B3
MAV52X*4E>"]Q)&"X3-LW$^XI)N\LI95%6RAO\&OBIT'?>\O9YYX^BC!@C,QC
M1S])@4"/YAPUN(D1AR;G_D*Q ZH^9_ I?L.$%KZI%B]!7U%+49PP3CPP*JD5
M)+Z:!;CL8:.V-V(V9[H'7$5FC@"]2ZEM_HBC&0%=E\36[U^<W;(K)W1=668F
M99_*Z;[GJ-9'%3#C3=!N=G$YY@'VCGH!IT^FC,VM#/OYQ-,1<,P7(Z>6KLD6
MLU$2*7S/K\._2V4%AX?LQ+8,V36K66?(HL,0+S*A+5@*=-.__@YO35?#"[9=
M* _F$ZINW8=5-[WE-1S#"HZ$3$Q1;]#7N [IR$?'K>\7]!&"+D*,+K,S,2$C
M/1XOZ"]E7;RA($=_FL^B;A9//T%&>YF5\]+.0?,:1)J3C]QH%Y2C]@+"3">R
M46,%X5AIV'OE)I1EDZ7:E75+0!FJ[4'W$I4:?6(IY##+"C8>E@E'I$+R<X8/
M,:8+)F.[AS=3E+ZFS[9C,N//F)\)?K$IFM^D 5YA&N!HDP9X=!J@<V[DKU?#
M_[GX_5$0G4=$I/;;V+6#M8ZT*@G45$&_^_=M&03L/?^Z0!R6F.?*=T"-U:OV
M%QQ_CI-[<'4Q84T@U=0C?U#7.Y5XD"R]]&OJ_RLDW1;Y]Y)8/J&V!\IO]"5W
MH?S!C?_ES96,WUSD8M;4\7M4V45;M10K(2"4NT<53[2?[<97J/[5,$]FNK0B
M\X:X06#!+BXN=)BT-'8=("SS;3Z@7*TQLZ(C%8]J!44GPM2[2.W0\.#A?,ET
MWE:X7?D^I*H!;@]17RZPHFBIB?W>K6K,K3!LJP )W467-N*P?Z@+QG3\&__@
MH[PP@#;E3TS"+X*[%B\%5V$2BFZBVG[,N=4Q2E6,&J*0%7%FE0PX&^*YJW4[
M9U><#B^'9\_.5-J% ["66#G/(]W;!:5)9_5&-X&7=J_L-LL<:\BI'Z(LGZ@:
MH5N@]\LD1P&8Y2 [42AVDQ^Q$SN(YJN&WEQW$0@2TD6J4!&-<%IS7?]78@Y'
M8 ]US/+&?C;5*2*%YC&=S$9$E4D),2I,TU5$3>..W[!T?IND$Q&2:4Q8CAO3
MG6LCIA\IIO>V@G\O,=TM($']I&#E1KF F%V;N!LR_/5NKU*7/:JOPR9[ M$"
MN2"?PO"8R4Q%76L#2_BPY$[&XP*3^^J1=8T19%%'E,2W&/A!2 TB%&3Q9^ I
MC,!]2!C-6)8'RZX8F?)5KF67C"MP4.<A*I(MKBR*$(<JG\^M($R7"WO J'?N
MIX+2(? ]H1I\9$F<8'@<'T.(57#(PH!+$#T, \-=$.[C=.S@G I%I=:-7JI&
MMX5/S=36/4 U!O&=7B.@=[>QZ%;V\0#?KP>.(\^"'HGF *KP"U&!E.0@=Z$8
ME2""'ARK>9@ARDB%L6XI:12Y"]52 ^WQ-E$M)87<*C1RVBL=Z!6PYES;6^@,
MAMR%$BO.F9='QG.-^WHDG#5&2VW,:"?8LW@%[BJ.#_2]LHG,-%%PMA+XJ^=-
MDWMQAX@@7%$K:6CV*_T2#F+FE!;)#K-C.NR8W XQGH'\ F&,V4N)@5(Q8!6U
M" HZ/SZ1$A14NN2,]P&;=,W>-'!"I,12C/P\/&G28BU9&(>S8N8.PAL5)"1C
M+YS-1!#"Y&/_'+W+!0$4R?;5AS[R852!OU@E!-3#EKP[G7JB@K]3[7C6"UR6
M!#2G)'JU5!G[L=PK+#5A6:VV/C;XTA%>#E.9W4W*])Q:KFE*?:Q,5UVWCZX>
M!:>^URD4(N6Q7E0+W\D2F\+;,H5X2B64'X)*$;8D;Q%5'"V4GJAYV/TTA'.!
MB@;. ;XA0H]&&?9^@@/[B25T.?7^J%/44[M[3(&_RGZJ1H.U9""A#;."$L("
M(>)Q@%<BN$F@SZ(^!%@WH;""(,_@UR@@S 9,5(D.]R;@_:7X2;)I.,<ET\<C
M\+;\K&ZGV0[%-K'/L/8HO4S-V)W@)A5E8F6)?(_G]"([;EF_5DJ1FYK#*(75
M''=-+B':F8#]@=H+#L2I'_N!OP9#7G]KBCK4WIO LQD*D(88]5!:-YD?"?-K
M[,Q&!!;SR$?@3Y&C.,%;RE'GTS0I;CFW._''8<2K0K!A1BAKE$YBU\-9J"!9
MA[S5&5I26LNP+_J]%L-NG&594M'?E([LT?'_[F4]?KNX;)CT>&Q6O+M5/HJ@
MQI"@6J2^W .1)$$U.\8,1:4VJOI$HM68)E3^F*<,^LO ,D2IH7VL:^38\H96
MYT+6IV]!D<*L=(9D8IW&&+YMBV3"Z=74\UP3HE144-^1<G68;8--W& 3G]V#
M'QP_')N(KQ4&__5=>.0?[1[N[.Z)R4CL[XB]X_'.\<%D_P@^.0H&A[O_;[#S
MW=<#&H_V^\==[DW?77S.&MW[-^E6E;+LWWA1TG(U7!<!D:R\J3>#X7%LXA;M
MVE31F:,"0OA\DK*-;F,7E'O?]R[<JK@08T"J@(W+2.2-I2(&Y0^6 !>M89&G
MD,:]N5R5O*DK,[3#1V+J1Q.VTF="<1K93WX'\FW><W YU/&Y;MBJ["\KP.NG
MV!WA>T#:"[LRK_)BZ'_$.%!85PWOH2"8OK,5JJ'B 0TO<D:K5X$F6<_)2&#3
MU\R.C8\1<I3IF+D,>"DM3#$"_6P<R;\;$+,F2_LT=+>N)"P+PF4TA%VQP'4O
MG:4084+U6M#%*3G1&5;.H$ @G]SRPDTES#2<*6PQY<F7'#%D\TP28O6<IQ@Z
M',LB6>41-$E]2?Y/.',<B.4T$HP7'AM^\;8.MY&%*Y]F#[MO-39ASP0<53,9
M*DZ=*0X\+O61L0<5%)CD*JR&)[)G!PR4J,&?NK:S'ED@,M@L%*\;I<EGE&V5
M4*PAA&%)*'.'80R2M=#53WQWJS+Z!LG>,(38H_1$ S@KG2T*D5;W2$D@^D4^
M35+8D+@O>A9HLKY)O1JK#%27WQD#C%D&FL)@[V<8J*7H/ =Y-'/LUOH)FA=I
M5F@*6FNT-#/;$AQ33<&"LSF'1V18VJW>+VNX; IA+V2J0(W:VBLU6\\^E>5I
M7O&PY1K)3U-R<!5:2 W##F-QR9KA>.1"N;[W25-55WZD:!Z3,7*Y(KT=T1(M
MJM4 S E%PT1&FHG@].Q8]TLR<*14F#A@>27<)92/#@H</TS'. U')NTJ?7GM
MW)_*2('5<T 5%ZN6OD0QO $^_;)JSCJ@4[MB39-*K6C#6O%I@M3*N)Z!96OH
MWI'L6E(KDZP[_\^;J^'9N1;=PGNKF;ZN5=8+FTIZ"F[!L 4I"7RM96PIX<9I
MX%EA5 YDDU(R 7$0"GS'BEFOB#!1<O,E:PJ05FD.'"NX W&&;?BJ)D9I!N4<
MQ[!^-3)P E_ Y&1(%4+9*&3EP%GRK?C?G4J\UDE?.4BDQ+CE-@"J7Q/+4W-_
M)*KAA(%*!:NWH'2QH32J2W"2J#.^3MF\TA7WU22'/74Z#F=-JTQR*A. L2J*
M"94RN/H-:%[NPDS3E9Q.89^Q$U*.L?;,7$IBD?H9?5HPW9I"PF6-1[HD(LH[
M;(5!U2OMJ7&I_K F[DU;:,8-)6MSSZ6-9L,F4C'W\S2DW9O(M9?)[:G6ZTPT
M;EL E3P<F@AW)L2B37[DH2&6<MRIB@BG>N24@V]/#,\&;_XH&<.^B_S['F]F
M/6S+R'6'K%Z<G>."::6D6/,YLX\\P>795#(87@5.1 CF?D5LXNZ/:190]#D-
M.S$1BE-HNG'8+XEV]VA!< 9"ZM8)1/<E+#ZL9:;MTD8>2L0H@:2D#.5'Y>NK
MM]4A'>YA%X@(CG-:^V!>.UMNRZL=2[!.#<+8B..)&=IH:_"R,G7,>.$MLW.U
MPZ"5D'X.JBQB:BK=?;434_)NZPX)MITHYHJ72K+*C?SXLYXTM=B@,CV+*EL.
M3&M?RDN0CM=>!]^@_F686$DNNCL_]$ZI,+>._ 7M.;D"RHE;L0BKE-U(^+R(
MQ!0O$^YZ;2P^-K@ROQ<2&J3#324;HN?IAD9\Z.Z2"%[:UXY;:AW'DE,GG94J
M1#))W<FRP9\@Y_]559;J'-(P:>\[-PA0>86C8HFW80,#UHF,Y5IOD]O:Y+:>
M/[=U\JRYK;TGR&VU1-:QGGR[LRW+:I(U)A>B!;?#X*!)AVR[T-.=&3!CX&(C
MK*P]X9\**G?Z"B-4*\8G:.W3213/A]\_O/_UXIF!/)T+"76)WN)YBVI;<Q+;
MINSX]M+=ZW->[&7:864UV8/=8Y,_B9+9",EP?O='&"-) F'5YLI6]1R%$K&8
M4#:#"W;1V\O#O,BI%!?D*/B.5EJLQJ.3ZPN6,!C+*D"-D1E-,:M@]4XN9_5H
M[.H4W1C 2DQ;&/LR;A_LH3$UJ2&Z$L/]$]%4J"=(Q]S/>(B25C%$)6$NN?,Y
M*$4@^D#,8@+:]K Z&;0(PG2_X)]90I9V&&=%2DJ'U R:Z0P6-,,VZHY&\T:]
MMS_C2"I!=36A[P(-H:?FVEC/<]4Y4=X]Y/F#Q/K3=:7K2I!P<"#%5(GXF:HF
MK9-KX7%T4P\EF22DAA+1\V(4@0Q;*)I=JZE;AQ#J^-)7/.K$NP1KDWK'!,+[
MFP_#@:<NO/-9F"4MLB#C$+>Y_5WNBEHKE2\7ASH FS@"KP$9PW*-J-IOJCL_
MAYE.*UB=#4A?I)CT\#.9\/XL@ZJ^NB<]B0+[9EWMYSSS.>J<1?[;A\MWWE_A
M/_]F)OG%#&O#T&RYI$K%5R"\'Y<6[FK29ZFPJ]O!CM[]PT^1^+W=>F:D\;Z1
M@";R,Z152@Z%W%,]UYOHL>"JZ3^N0JX];2"R839#?%:(F,VYQ7>?U,(C==A6
M]B1 N2I0M6&#'U-.;756E'B<G.(7OR5PZ[_"?ZIA;ABS3+]0MI/%M/@BTC%&
MC\=^H=(G;F-W*=59^-/)TU%[)[/C9S)-7(PPL4/MO20H+*^98!_U2(9I"ST[
MU82%U D2 HOV,@%3*5V33 2!9C"'PQU]^8V5_5]-H=.K80S;A>35>2FVEI&J
MQU(T'&#74TU%[?1(I[&7*N41U7;C=36!*W><*1=>M_>X6R=M._@1]>C%_$DR
MFQ6QRH>;_>ANLCGF%*5EA2']-##Q+O5^>#'V#B5\,%>LFVF3?ALL#DUSD3F^
M6Z-9M7+W%+(WW]MER34[W5YW%ZN@4XBX@W,NH]*O@'B\:%%'(67RB]1<&F:Q
MR(2&\TF+IY0],<X8_^B)5<)KQ%']CJD57.HKJSKM%:CI;R\21+'TBTE/1U(8
MK-*KI_:OPBBHRKD$,):"]$QVI2(AMIH,MI1SQG.D*IU-+K-4\VRCBG6BGC*2
MX9<W-!*X+,8$, -Z:@:UR4UN<I,MYB9W=YXU-WGX#><F.Z?1+,):S13Y"A3:
MTS'W';Y\<YP'D:R"RN @D]02%#M'Q:""3H_T\+RDS#1$5B>3"BTE$?6V2C:C
MN@RN0*Q;4Q*(QQJ)G8M575]<OAM^_'!U_LR&6 <%QVM..CR.>GU9F*HK L2D
M1\F!3(4$@-ZB>(!#6JZVD2[N?Q<P[@DQY7\D3T]YNN*+ZO_(_JPJJ]D]VML:
M;&]-=';:V@PH']X2Z"3SAN/<VSJ=^G.LG=L]/NEYNSL[A]YYT-]NFYICW>Y^
M.VPWEF=S$\H06F:"&^5$4I0$MUSB;*64,(CEF?"%J;E[G\2"D)M#'6U###BL
MOS]/4M'W?D.>M9YGF/.P8RF"AQ968 .FJ"[ )F-CE+;2SQ96QIJX8:H1/1D>
MLUO 6?O88HK1F_#@2&\_& JU/L5QFQ_6)'/06R,T:X*1S$#6\,F;J_:6=V%N
MR,_@2ZQ#XV/ J?3QE'A"%=E=$*;PZVC!/*?J+P+^<^"$LCEZ>C7!*%?YX,!Z
M&D-K/9R:BL (L>'(C!GB:FIB%9*_Y+1BBX[*<=?'6<6G</Z]OR,*Y2R4,)4!
M(N #]=?6/AQ4V?2.GJ[F_GAGVYI\G,[&N1K7)MZ5,K4J/OFCD$*D/[W9=73G
M2Y]'F,[66IZ@I'(=O_[!,<Z$M;P]549=CG3*$\F50ACAZ%EA/2LT:7$WF65]
M[H!?I<M-1]0HI8E7EGNM*#X(LQKFNS4\=S8NO5H!!\N4A*2_E_$":X)B@ON+
MI54]I:?6D^AI0>4]&8\>2WOK8]E=.%HHHCU9D;R$6JX+S,:P*5;"*?]QW1J7
MUX%M,7R#6,I5\WY&ZA;.GNV >%<&O_P*G)%OL0V!C,]7J\;0* WDHH$RBL!6
M)9IG\QE:7#(+ISYDX>H'R;WY:,W"/JYA]=%74OK]Q?>FJ9C\UW??-PIT=F;<
M@[_\Z/_R+$>ER<B^^Z554E-2:$;MZ1+0*HD_%_LCC_A$,E'6_ KML'OTAI$0
MFQ--^7WB;>UN>Z,BP\KN#+G+49$^Z*AWX5CO'),UO,T\5JI"T7(ZD3^'P6R8
MER/+0_=%Q"M@^KH#6:2W$7U#:MW&;/8D2X]B8!'YN+]M\*"J2+DY"+ 1M*I;
M'24)WV(=.P*BRPV&,)#':XDM";LD=G=&CF_WV%;%3@S<="6CA@+T6'*<#1\&
M^52();D+DP()@[!X.:)ZJP[N9YK+%O<S/;]78A78KH58R<3%>!J*"08FQ@51
M3B03L.%@6;I-W'MZ_J$+O+W>4L6EZZ3]4<*@*&,;.[5]5#1MF'\1]4/4S3)B
M!"^Z_"&]9D^(LH0.GG/CAS=+[6[FY,$IHX_#B\NGA3:_PJ*5,@?@ZZM'?#I0
M5;>4<?>:$3;N^+G7:KM/I;0NP&;C=(*]R>'_HZ&WM+"33L$+588>/%WZLRO(
M30XXQ"4"3,I\*I+HJCNGN7LP5[.4>8>0N+44CF70N.S2&E!MZ-RTIT)@]-.R
M$#Z.1:LS?F0M%<)*&JWF7?F6L&9-N/DK&?>4'N3 O0*-(]L5)TU7M%^L9;!%
M"BS5&7[M06JV$@\HIJEZ?,^A[7>H%F?UDB)F<N -*RX8AORHX 'YPK!I&K;_
M"#F;+>/^H\1/ YQX]2.3AJJS;K%C'-X$CUQ6H,M /2P5>X5-X/3 .X/<SI;E
MT?@.G"-+;5I>?4OSCFL1NH<G_>/]#4)W@]!]'H3NX%D1NB??,$*W]2+$E0M;
M:O2)0H<-84)O*:;15)7O2-X$Y#9D?@;MHX=V\\L5[!6VHG-++4P=5X\$,O4
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M50_X^1T*S\E_)JOY[-/_4$L#!!0    ( *4ZG%2"W:ZQGX$  %J' P 6
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M)-*LVLF[;%'F:??Q>X^458;X1FF>72+S&L%I0#1U=.3.0/,6J-ZJB)EF?")
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M(,U1%8)QAWVX';D,_Q&R#I!;693I0(\Q6;.\L4#NELG':.OYMN&+V0KKBDG
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M]8Z4<GDH/2!5\U+'R$@19$<:P4&2C^%APEB*3@,,3U?,3MKI_B2[5(\P'&P
M9R4'!2[!AF*%O\-- U?@#L9_.'-*7!/$H^TUJ"O; <;2F)TD42VK(FQJ;6+9
M\!++H6DF%T/9XWHVDD X3[0)1+M$43 U$$8E<0/VJ_BOU!X6CZ19\!%:9-T
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M**FKJ=D(K?&QQ(BN#1W%;3]UTW#$AC /+?'R"YP@^?4"AO5"<]A;!+.4V;)
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M^=&_*:QAL_[3YH;:T<06=3G@NI;Z5@O"V+ABV\>WBB'8 #!T@.'1 \O5_K2
M\(.XIC*ME@=V9FN'Z,?<7@QG:8FE63$7KZ PRTA L8S I$#EDF=]2QMJD[)[
M#X45APA6['I"H&=TYA8R'JAKW71?Y^4ONED^FB?;EA*T7ON(<XS^5@\QVAJ5
M9W>A#YNR3Q=A (4J+:MKE:0+:C0PT_S62-YN"4!:E0RYS)\2/11>A<.2J,(Y
MF5UM>@\[5''J&P,6IHH#IG-TZ-29',GYB*U/=+ZS7YDJNE Y9?S3.V''TQQ_
MY[0]+''(G.^D,;4H4]C)[FH=EI&%S=^GV*&,S'A;E-#2.>+]:+%SWB_K/S^,
MZ+SC;:]2&C\:):G0MPQ0OIK:,L8=G])K,%@B#6_6E_+S%(6(3&A@;B.J?2W*
M7%(20TQ',.,KR-4OF$6\_-%?7<ZW]ORS?>0+;E3W56$V!A'P.HSQP-3A9L0/
MSY*4SXNHY-T.GY)S$@BN&%,NH:>6%<6SK) /UT-!,*N]<:Y*R<0V8&$A'-A@
M*$R.:VL6ELW05Y?\-!$63?_LY6L6>_W_;RBR7[[^A&'NTQ3\3\?_HA7_M^H0
M=KWS?WHR'C_Q:HS.K^&\/K]*TK2HXYZTC<HC<O-^Q=/WO0&<#**+O(+#Z4P3
MQ_9*RZYO$8G_&\G_6^& NM?A\\W%=ESYT79P!YN;Q/_]7?+DY=ZKI\]>O9H\
MF^P]??[DY<LGK_2+%[M/7\:3O;W]9\__Y\5W?SX@].S%\/GG# GMACK)5QKE
MEC+QY D6I3DZ.CX]^O#+%S%B7@SWGMVC%1WKN<KG/^P\&;[$VZ\U'EDJE>%"
MIS?;AU^) +)[X"[>W7.'X]*1;[!7S_LQ^5QYXN_'T=GQ^<79R>'%\5%T?O'N
M\!_1A].3B^C@MX.SH^C@Y[/CXU^.3R_NZFJ_.K;,I_#FW5ET^NYTARS>]P=G
M%R>')^\/3B_.5SY9[GT>K3?D>Q+ZV)V!Z?D!%K/LZ":KBV6?;U1<<\E_?HH]
MOH@L4?Y*2&0]LW:+; F):/23SQ7K4]%J85:A>K9.9Y.$># $@W:5FA-M-U8N
M$:\!18RDR+G)_V_UP,_J8%#.S&7%J@:GY.)%$J"7_*4".\M#7?9S6IU/=(V@
M.D/3J^^@'C7\QZ4'A_8&WZO-AEXVR:2EB!H[TDW,M="3E*N0+EP;/,V42-VU
M@\,-3(Y"LOD=&$2*@'22)50-UX7S6M@<:J:OPQ2@5G*Z=75T,8G>T5(&J5N*
M$6PW4Q5CN,.K0(V$GT0C6%JR#)^!QSI6(I7"&S.^PWGL_->7)G09,)M03,\X
M41&&-IOEL5KB&3%SO[VJH_E0S49%HO[D^ES]A/L,_KG>J0T''T!+.GA[<M#S
M?JTJ!1%M>^(0!.L/7I(GF=)1Y@(_8[C'>3U"M"D)G9=/#G8.C> \R6 +:8(-
M(ZZX+$D,(I/QWJM7+Z*MPVJZC6J&[K>6 0WN@U[!HA61+@W]SA-L='0H&N/M
M/PN*Z]V&.*CQ'$@3Q<E:T5$^KOM APE;PJ;+F)RKL$"7PZ,(\KJ1=G^8%_/<
M9*O@_MC?W=T;1*[#C5I8+A6G],IA15O]WD;G)X>]V$=G#'[*X=#_N4:<UM-7
M',>&!F)![K*,WA'UR.&[:.\I*7+PA%W2PXSY!#J12E(#GFJHY(L6ZL"+\[+H
M1&G:J#ZM.0F<-,!2%&%4B=Q#>UN2^B#+],=HC20DJQ2D7N;I>W3WAN[>+P'E
M?[B>VZ5;Y/3T^%_1WI?S:'WI?M,3NRJ2=;LQW[UY<WP6';T[_+#45]G[;B_M
MY$_J(R94G&1B=M() <KO$%N_O[N_AQ^0E/I:!Y"H!S8,/-?OWG3[K1=[<9=K
MH^OUPK^+K'EYBOTZ.8)E'!W_\O[MNW\?'W]JG]9<U+J1I9YJRE4 _6-I)CEI
M),070)?:M"3M>R)%'^;+.'NOKGP@? ,!'RK.\%RKYF2.],"DV'=2M3,C#9(+
ME(.00A1_#;[HN7[L>NZ-_5H)6IQ+FV;5G\:D;%5Q].IFZZRLB:[%1R-;-!HM
M)Z^[C];-9[1N? /&LUZD"K(0(;1-T'X5,NTTB#?#KNB5J.^(,/J;&"U7EL]A
MH,-&&#M"$ O$%%G"E#T]TI9;$(4#;7:P>A,GOEU ,A;+N&3LT2IC'"#6GSSO
M'/4 2[JS]W)M#,A;:KLOX/YG0QJ&$ +]< =^U*.!WPM&W@/U6^CXPYV'<8_F
M@8;AV/ V>3$64!?GH Z3" Q];EO04@S/@@E'54=Z'[-PKDKC?>R')KF1QRA:
M3%TC:@VF"1-"!8<K)H[J=+[PP)0:$7(/Q?TMP9;) XG4",_GA1P0"SA&.T2,
M!.[:>43SNL#LW>6QB U5?Q8-O23X8N)C@?3J-I$F1[Y42SF'<Q1W4& 9 W>X
M<&[E!?1PXF:UU2.]AS?00'I!_8AN-<QBP+J6Y<U4"M=CQC5I8XMX=_N^'U<%
M WBFY%MU0V"HB<!1ULTNOAI[WC$,<T+5;JWSXV::<U+/$O^+67FS/".BWXH*
MXH73+V"8!1QZGT26%P#31AJT>T,BL&B-]GWA+3X(?!DO1-08 1:R9?]7W/DP
M\Y4AX32ICXUS@J!3<!A0U#BW_%H+9(N CZ*<, !<PMWQ^<%$U6Z6,Z2HVLR1
MOD.RVO7+F:4B*&&IYS>9-QQPWL7UV(X\LUN8\DFXGQ)D!QGKK&0W%H6 80XN
MT57/"7-T9]_'<&7,E-N19[CYW\CF#Y3>#%.YR0.[9I;H.]8"8679K4Q4;8ND
M61*(8(_&1O9N>LOU!9%9WA;2HQ(F2-.'2XR%WQ#9$B/]48%DU@.!=!#FMI*P
M/FEUQ,"'E/-T%ZZT/^J\8E(@E",X//_.BZOHO,K'5ZY<>[_]G*?_/C_N@R%!
M $[0DA 1JKDLG?P=<P5N%66U*?DLJX%@;(54?HLN:X7!!ZT=>)6GD3@I>-((
M,FO>,K3;I(OTT=W;-?FDSH$ 2NNQ"&A+YQ/G,\S>'LN)Z<<0A5:*$+',$%7B
M6@&);XX;F*,LG\'-/I#?*8^VT%C!%%%P[H@B*U\PQA5SB*GX0))R/_ 76HT4
MD[G$"G$96\5).48F6= O="6PV<+A:8C4)\';4R1QEG<%A$.\822AV'+B8C]+
M5QS;#R<(-0G'!DR_^4MAJL7B!*9\$N[^#3WR?LF+4+L0XR]'1#:>9A-_^8V9
M'-HMP&8!,3LD(>,O,PN6MNZ,+,V%=<AF.2X?/2;H9I;5E Q*;)W00A"$LVAO
M=^<?UAYIWOY/V&45%KOHN.N?0[C<<PP3U39>)-YDRVD!W;U#YDPF:Y&&TZJ:
M2X[YTQ?\GYN;FR&<+4/8-/1YG<)R8 CH'K%,9DCVPZ'H)Y:I5V*IN:-9C<H=
M:R".5K^W:-G8HZ8+PQ$A=X9P"@;?E\&G'3S^D,:=OHWU1($ ':IR_G&]>YNJ
M/<X)4D$$,,9BEPG;S$/0BU@NCC6*XH^%+&[PI+ *G'=#G*=8![O?VO3!AZ->
M*-.6$Y.*!0LOZ3BH>N&A-UAQ8-7#P3\^G!\Q<?R'(T=XBIK;LK)?U@-F"(I)
M?_-+([159E#?"ZD^:=[3][6^JGV.L!<,1Y%E2 3.Y/[U?//KM<BE?62-L+U$
M[1N[]E&\ ;3S_#*OR8C($?2%%D,I=/=D*7D;UKMY&!TC52":W<([Z(QHU(6K
ME-<&EEBZSG&%'5FZ>TGL,ZSW'M$N*M.RQ)FLO8$FHZ1#= )8O1,-K]@^662,
M2WLT#_@I5T7L507QB'W1[8<UJB6GD%[-H2)D99*R&U((%2G1.&N8RK0X3GN7
M.]4L2IN)]P/,65#VK]#DPZYY^!XLFZ-WJ +ZM2D/1ZF8<*91A,E5VX.];BJE
MN_L?VLXZ*$72F-B*T%&_-^8[3UX_'5[D<B@MESOF?M4%0A^-IV"I$T(Q83-[
MH-"/XTGV\G8VRE,3T_[IX%^&L%A5(32G_\H=&F#9;:FM5D=N-_KK7]!KNAHZ
MN.ZL,5!6\*"$,Q8.7]G^I,?P'(YA!D&,L7L;B5@W<AZ*D4)#>*AJ^@J#GPGZ
MNEC!GI#BFHUOZ9,YRW?(VS.<5K.T%]RA?1-\*V9@O"=X-QY$5D].;%DX1 1H
MH9?GK#0YY)KRQ#M&C?XG(7./7?M7]&."6#T2)F$*0WN'85*64IMXD8 CAN/*
MHQE&!O9M0RCL\0M09-17,O$VR]G^>>;N\R7+/S[I\4D/_4G]4?%^.COX?R=O
M^T[_=(?Y9_(F;-;X6W6S7I7EIUMACS6:<W>YQH#<VN-U5A9<WBS1X"3Z3X7Z
M3T*G A6JH)@"0EUN(V/M**&PD1LNU,>=,_$5G%1ZML1<^<0ML &KY=3&TH@!
M:MV*K<D,(NNRM(#:,CK 10*3=G)R8MURC;9;AU23>JF;$/=AS"U2P]YO:PFG
M."II6\EVZW<J0W+%57NZT:1(3I[(G=;GAQ^\BO0&F\8:XB3Y*(6)%@;<T3W.
M3Q3];PZCD'/F!_I<<+/KK%Q40W0)MO03Y_6;"VH]"8?B,:CU9URO!Z<'1P^-
M2^I<5Y7D-4BN;6]/B7X&:@PEX?[PV5I363I8"9<?C1WKU2.&[=/Z13K/"L\,
MJN2!Y\CC4EB9H-+RP,8Y'=\F087JM^&MKGY,R/THY4>1H0B+$)N8A('UT#.-
MYZ<D:1)S9H-%LV]DCLA2/N*\F.B$]%,*LU\0"V8/HF\;+#V?;,7]VC(K2\^>
M+%Q:GJWD+;8;L@V3H[U;%(-&H:6<2O2 Q8,AXHJKRCNNE'8%20N-\D0&2\]\
M/*XQHFM>V44O*_CD-,\NT6^"Z <,2TLB4!R61BV09I KEC*WL*V+?BY<PV=@
M_<T3%.9;#))/$10J[V="7<<5[#<89?_-5),?'GZG4+9"HJ-)7K-GAN"C8$<F
M,2>UF!I_B,P(>(_9F6^JCRYMO1Q/(1%ZQ]!VO<#0*ZN L1G.OFU,P!(V9#!9
M!V#O\BC8EEB^@A87 F']A<TQC+\O+KG+1RV,$)K$YI%TAH9@&M.^ :^.2D9?
MRPJA!M,2Z3]+JK]R, #4!UP3QUF;+>.QQN4\TL'4HI(T9F0++%6\@BK1D3=C
M&#6U4V:R@"V54TVW:7ZCKQ']@3/J!:G<,J4[L8I. (XG.N\)%^DB)%^"WA?,
M#4TRC)8)WL5X3HV/1<H4*THHK0E\'[3W\ZU-!_A"U@Y#:<K-$VT2LR&2+)G5
ML[ 1T:@FV9A%R6RFXP0&'\G'[2K7!"$CM=/N]51!JV)UNVSOFY<MZ#MM=N+2
MO#9<YG?+618 -*8D<:TP&:M,U@H+2YA6CQ/=A\<%,BL@4_&I^!UA_^(#IE$$
M0'\TY0(]\!%,@VT%AUKO.D>(O,#KJ)6YDP6JA%\(W)P$S9?@60A+DI=(6!)[
MI+M>=C--4HX>PS[ 'B)<950B<3YLV \LF)NAWD_:10.SNL>JU!WKJ>UAM9)!
MJR*38K@^X$P*ZA)$(;9[T6X"S%TPN#"09W W"@BW &WY=R9WY?5E<LO+:3*G
M0M=F>\12%[RUTGSM?YL2_OGT:'2FH^V!*Y;2BC"[0_JQF@'74R_"1B:'7W3L
M*9$Y<YS\2K"PI89IQD,(UO6ARE2L[@#K=C^:[/;.9Q/>L40Y<$\P<")*2JE2
M[>[&ZA24T#Q/%>)'Z@JE CY26FW*7-(9JL98Q5+2@)2 2BVX(_=SPCPPB23$
M;?6+N"P9ZN%@K;9,M3BUM/?L*RO[ZO]^\O:XYWUZ,$)J \>9"1N8C-1PC!::
MBO60Q+,CS4PPERA2"F<#GM$W!:FBWK2PJ=N\X V<]-!?_ZD&7XX*#\A*C\O2
M.&'?V+1,AB%;7I>"- >&?)I0KP@_U@WE>/!*0<SK$<@H[JW0!-&;O;K4)O3K
ML;_B<QKU)'*"AJ.1L'H'F'[(UJ5 (Z%)B@&MO)1T#E*:S-/1Y&*22I,J7!I-
MCHD;_ E")&'QX,#I(,].%X<>>[6I'(>CQR7*Q:5(O6C'^9G IE&?SA[SN%B*
MG-*3JX(!J258C:B*6+?+.7(G10=>22C6M<W6VQ *A?.#-[V@4!A$H7G12"[I
M+O7UJ96I^S/\!J7<"(2O5-*X'^)E\>[L<IH(X6$1S:!Y[,ZP\I2 >+@N$?'-
M$KP,( /&(S",3B;-(Z3.3'X39RO(@V5_@DP  <$Y38F5Z+%WN<F(,E>6J/./
M-!QS$[8(9MH0>?AO_AE,B/D@ !Y1A;VN9INLL+(NY^SN(P!3JFZUG[C5ZAC:
M.EGNG5G6;V:?['EWZ%0J+8 J:*Z=!AIE.R@CC26R2M^-/D9056G=Z^(D,[N3
M_ KVY=B4)9K9-P>$>MHK(%3?)%]' /M3"[GW2L2%F&.""7M(R2DY)DI,:D'!
M1WX.S[/ADE*FR<R E2G>OT"4(-==GA/GW;Q K^I8<D6-0G2?8*"PXX%L81\U
M!]:@O?#:Y&.T]7P;*7:J:;G:<]O^'G\D0"*YP3 N_-(07''6C?ASC*-E4AF/
M(PJ>@6^'&)&*MX:J@VU9K,&.8%?FJ,BO4(:WO-2.KX8EOD13DPQ.D-HF)O'3
MO03A"V,C#2AR<P_T+&T$\AZWUTA#\*NZFN8%U^[-!Q[ZM;OXJ6FK^/";?4;?
M*UA-9>7 _#/T85/@@AUGEE=QZ^X!FGOU>VEF3&MI9+;%@FP'I4'7GL,K2LQP
M-OTK[SEM!K*O*U.5F%OMK96.I>?ORN8P+WG9XI-7%07I]\;Z-,WP78.</>8(
MW#B';1A]L RLK9L,AUL^1KY$Y*XBUJ3;=GH!<TU1,Y'T9*+9'3"VAK$#217:
M^5:;,Q%.H;PZKK'],!SC(ADY)X28,M:V.11#R:.M-KFZIEP<$7"V;>--4M*7
M=??!:>RMDZA3=#FGNU'@9Z ].P9AI&$5ZE"2,\?_]^+LX.C8BDW?67-N@G%8
MI2HRX \&4<@N=#62_1T:FHCPKB1M.N;I0' .?MB0_,26Z6 8YE!J\B5W9!,M
MD]K85E..N>-X;XR@C'$&\]<A?R:K5:->?.@B*\,EI\F:2A<LR]SSD>&$ R F
M0FUZ05%LQX73%7<E,>/LJ:9J8Y/'VT$;?^A<?>]H:1EO2S$8UNL."F?C<!U.
M89VQG=-T[PS<6 JW1?>(;N0V;JZ")0K'H#'OXT;"7X=;C*9YQF6N.L/6C<7@
M(RX*/5=5D= *RV5^)"X^M><>.UG]$[(5^\,C]-JY3ZQ*C'0E1*V+J\GPI;2W
MA3'T_8'AT> %FN9C6!NINAGP@K/-]I3 L,FFXVPCU\P9)*)',2@ 23*;HVGD
MI"T9WQ9MN$(S&@443T$9,7:L9\J1L/N=1+UT=$M("$+D=@FML!,>V=$BU6\A
M?[L1 T9H&$E ,5GIONFM=>UPA9Y8I[#EBLX7\]SYLE6N#C2EKJ,*VD940$R_
M14N#IY692L:WT2(]T"K4]J"P[\%CA0A]&D]?KN0WK+^N38*DY?7<T!<)9=A(
M95=VT,QDP[$6>3RQTC![0I*KA,YAJY7S [H[P_P[,NGA^ PX_.,>G:I;6G,R
M \;(63()RPZDD58\B423+$%^.S<>V19<6=UH0159KU/CG!]$MOP$;[KK/(5.
M*VO8%-YV;!@]HLRW095Y$0Z6#Q<%.?^?]H%F]B$UD]9^\( 8#YAD5"_0QGTP
MPETBXV&<3-;C:I=%D)!MV3?\4R>RI,?HE@P#,U[(@! =-25-_(DCSFZ[OH_W
MRA&^=V_?_?+3R4/++^Q5"OH&CBUNT37DS?=[0.[P)@T"-XH9I+W]E\Y?F.:S
M$;))O%4CM$OR6'L9<E(0DRT_G>D)>>\X;0ZUMRJIZHH2XD!R@2[HW,!=&IK,
M"YQL</@9APQ:0Y99T"!L ]_E\M;X0'7+T^T%G#RX;1/""RK%F& 4Q ;@R#-2
M&@KS!E&T5<E-%%:N!,6RN^1:L2%(>-I8SS)"MPPP1Q#D-D+]/N+',J>3,\'2
MKR3F2;#CL<O8 -=L=\!0:W9,O]6,O1<$][,\CK=H6"X^![ZY&->S7L6X^B]*
M'L%V7U-D-[A/*8?,DV)MD)V3TH6'IF,P6WIK&"L]5%W/$+^" <RC4]!UJ1Y%
MK*-?%30'WGH;'<^2,E\SH>@VU[6IPF/'"^/)Y!!TT-E( BA$55SFB)*@IK8&
M85):MZ9'R4UG9X%.5U5*L.M*'$8J "F28]'-J_^>GB__5;7^-V<'IX</#:A\
M0=E.N,$/;>V91\+./RM0EM/"D4\1]^>9T#7XQ6MA QUGE^C.[)>$'*XQ 9T+
M"GCH /3,W:BBG1^)<FN2X)*>JFN\%I0G)KX2GV*>LY/)UBR7S"U\K/C\+M$6
MXUQ=SR\%/UA[;'L@ZNT-^OB:2<<R?: 69Y<U:'!=,77L"LM5+]T0$W9<N]!7
MA6SKEVE_BT!\[DW!.)V__F5__^EK(C.YSA.$^)4^^!S9XV%2+E.5?&E1M?(>
M.3;K%*<Y_2]56=L)@V8N N!6*MBF8&PED:*NIG6DF6NMP**&NFPMU$EIQF>L
M*V+,M:^(ME)9LN0(QP=)Z%U542Q&[H&[?COZHTZBG$?\R9/7%?]#0(@Z2_ZH
M^3.--RUF;88=UO3;L#?<:TU-QB6MZ2[H8P:7EV1)QA@RJ<O^EGE8<;;O Z!/
M6KX&JGY@RL(R/)0$#FI:T1MTX$]W_JBA"9,$OCH3(#W\R5E@'\!N1__1DZ=?
M&A?_V?9VNU/G'_K4=L32PW!NNWC$6E/_^C4T9W7J<J!^HD)+H*[XY0T)?+*_
MN[^'?V&J\K4((71F\:)]-[?>H^X57;(#E*V6(-L$SM0W[(CZBN09GWGI8^!Y
M!X>D3\WV^35..J44W'!_.77^P0OG-;K-6AJK5=:-P/?>.A2@Q.SDWDI]I.4B
M_DBQ,-&3H!7SH?+KA'^HC-["(MQ_MK/WZL7.'K;7^_R,GA1>N;.WN_/LE;T0
M/S[?->M<VH"9<KJ@][/7&4QA-:/,@X=QABTU#&_G7RT4M%&F"![["X08^LOL
M)BD[=XE 2:A&J'#6P!KT-X/9"'?O (]: U$0[ DR[Y\0V9,-+K!QN=X]0W;0
M@D$)$PH%&F$4*E>+OE.Z"!N'P@MUYNRQ#I0 (?91M)DZ57 9EW\?1H=<MHD!
MXV25\7M16CGT0JPG!JL9Q.@<C C/O@;U2PE#P'<F<A*6B"FT;9R9QS7ZUELQ
ML[S6I)0VHJ2(LEEBF>A^'$'-@IVT:/?(:=%BNAXTEL=][[,(G:1T=P0(B!!%
M%>>2:#Y35TS(28^LQ#N*: O$YUN,*,RO ?C2,]U+PG%8V.I%U-Z]71J?[P3R
M&;^X'/@1B+Y'OYCW]B:=&2Q(S[4OPDC6OD>,F/C,6DOBX?X42$7V&*? H1!9
MNE5)B66M/82G 9BZBN8$TX-3">Z6UYMKRO%4Q[7+YR"5@\)X8SQ ,!'$HV1:
MN%D8*:AX>^*S^10.&/A8+G.^9DAG)M!+<YHN&A$8?2E!;T4"/Y,@ZGY(YJZ'
M# 1#F12F].O .[K@3KJ*XN\J+ XN, ,N%\OED@QFOEGDB4B&5LY%HSGN,@O"
M'AB<A:U<.^7J4&2NA2WQQ-?B">QNKLE>6]+4P=*',F!TPCS 1@U9W*E%S!P$
MM_1Y#203R1][0^[AKW3#D'IR<C+<VQIM-Q0F>]3W-EK\V03Z:9[M7-A]AI!"
MYESIFK>>"?F__F7O^3J9*-CLZ%[A7NR7T;Q&N1SX@'(0+@2[@C^FMW/49\>D
M_09,KD(;%A-BGE->H.$9+&YAJERT#:$]FG-+;3UK/B@,NSA',\)B2"U%'N_U
M>4>(UK-R6.]14*B.B&@];L.&T<!T/^LP=/K+T/79MO(OPMUI:#C>$V5GSS9M
M/S4SCU>I0(B] 6$$7,5&=QN <G6MFPR8LK464&'>+26$^=\CMIS R5=%6WME
MM?U(1&'G\/DC2&_%$8/# JG"X!_,<N',0E^I)^9F)D0-W"B-HV"[D<TJ1,2J
M;)+/^!D/A%(2N>2R5!KEK$*?65L[[=X\@=\L/$WN?2I02HRD6LC5%^HC78:_
MF!'();57O'W?GN/Y%SMU?P=MIK>'R[J:TUT?^$$<=9U\+JW<P&Y2EP6'GN38
M3W6*/,R@Z#D><,IPQ_<['7G;RX77'^>)(Z=3MAP>^9JEKC?R<C//-6:CW^31
MK<9L29N"NYK,&WP^H3>5G?- A!Z37WK.$:;!:2Z-6'@]C=<*T3/B-\3$=C8X
M[S41M$H7#J>-81+08QA=Y)%&>-)81R&M=\A%!AK8P+#/!,0SY#DB,K$YIW>;
M-)0JG]OE:;)1/$H=\C'ATQQEPJ5LJBG3-WC^E^YU37ZFL'?.>:%&.>B>6SZ5
MD'C+:3\U,SY5LQV+*2>([!S?8-@:%E[Z#=A2ARF9W'S*]<WQT:]C;OUNF"Z"
M]P5D9%U$"]V25IPK8XF;A0MBT/"&A,)\51^K"0^W-F\':=&F!",_VTX,%4ZN
MJ 'JJ+K$+QT#S[O))(&YZMM67?_F.)D8I_BJFH^_K<R*I2@P$0[P!-B0/2:>
MX 2(AB)/0^;I?E,&LT*AJ#00H3KJCWU@$(XDF;-,X"6JX-%%?6RLYFHL3OK&
MZ:T<F4J[@%8H&/=W_T^3W2V@HKFO+N]4F,J+2IKH7JO1)-*P:@XG,)$*;8,W
M1 \8R-'.=_96XGUR ,9E1CYF^7S1H\2PF1^4L+XI9?I N&C.-$6S86%VL.'U
MH5OK]IQWHU$-Z!2W,5)3,> *;1?+U>Q5J!',,$@J@[[!)TQD4GQNH+;T:EC;
M!<V7I-C+'.9S3?$UM(,&45UR'&W,>IL"FT;%MK8;%^3!7 DFZO$%SP3,0)!9
MMT3GD_MG(Z'_F."3\BJI--@$3-@E03B\!XS*NNBOJO:)J9=_?W?Z<_0/^$_?
M68V7=>)DA@O)05MZFIN^<"3[0RN]HM7H\0/\IHH,MM!ZU2XL!W,A?E%"2';B
MGAJ0+5)A$$%!N5T',;+SU;-!X#YE<A#V'LZ0BSI!'OXYFY6>0[9)>6^18@18
M9?^HQE3^ZT3?N*J:4M,%/6)&-)%/]^^H9?TCQ]ISS4S'I#14>L0NR1)5?T1O
M84GI8";GU=3/L^5K*+<<>Z)I"W4F*2#8BT&9]0A!HR,X 0P!=M4QP H/@!(I
MZ.SHM,6_Y,!+60/D2J%B T2]ET\T$01CB"N^)D;B"V\\.YP U#6$=(?TXUT,
M-<W2/V%B/=LZ=JAMH1U$3JMK!9K[B HR,GK"9FY(O6'=K O*#5^ZXGQDQ?*U
MQ\ -6G9P$YW.J(ES&J'PC[KU&"ZR.?)#"I-$$R1B^H<7^W#Y8-C$Y(/)H6&N
MRX"WYUZC2FO#G<K>[WYURO9*#^8]Y(:U=)"X@JL\1/PC]WCJ4E\ZN2)U4=(Z
M ^7"4I=+Y*+!A.>(>/BFQ8?_!HCV3SQ;WZHY0R/./(3>XP'[A?3S@>7$8JK?
M@4\8LSATUXWO%+%XQ(X=%DD=%-*=M2!L),;4O6Q!V0PYIA_$",'+R<<=:DD7
M:"%HU&??5]\<GN9%+_$T/=E8RQFNK(\,$<6TC!^E6S_ #)^HN8?0!ZL8F@0%
M"](S %I36J2A"YC+X KDHUX2+OW$B=E,A\')Z=&[T^/SE2A:>[?KWPJ!3&0H
M@_J_>WZZ7Q4?+(;Z9YEZ3$9YSYCDL';T.D5SPRH+9-'V*K1% ZXTNRI7T< 4
MJ<5[66E#4856&XHVC:RDE/R%E?)L<,DGH1LI\J=F0N8XC/:?XD7[N[NO\-M3
M0SSQ)E67@^BM;>YAKLC(/C",9O;* U#OM)6XR4Q(>2G4:]S)&#LZLT5KHRUR
MN+(N^_F%:D_VZS+A\Q[VH*[JWVM82#^IJ2K5)@_"BIOX")8IEF70&3QQAN _
MK%V)]);$OW,.XS%#F-E(58I3CQ7)-*YQF5S!A5<LWE29P(*>WBB^J (1-J7+
MU%A%,;UCAD]+8/U?X?K?D7_A<"^N%+08,VFH-:X1299$6[?P8SV !9R#')S1
MLV#.?E?9[PD"J&\55H= EUNBL#VQ2N$JGLGH)+N\+))2MKC7S:*\5; 6\/I$
M;FFVJ\*%,:I!L<%7\D;GE8(AVOHJJI)87>%#+]7O-0V%'FE^* X7?TS554VM
M*FS/J5OP4PPM+*YHK.$-ESO\CY$$%VI:9RP,T+>'O_R$7I5"#4SO8B*+AB'&
MN_0E= @:6%0*OKRLHW]H_*%4W)QZ7M.X(1,WCJ"( [AAI"Y5 D,"+87%!9=G
MMS#)5[J"Z871@6$8)14T\U'E$I7K_.S@^&W/._4G#*]&I>&UF%U?Y.4OAGO/
M[C-,;1=%E<]_V'DR?(FW8R649*Q2F5 \Q'D(>YO7^BGD;@&E?S]11@:PO3]\
MMC7>7BN5V<.I8W R\5V<RXHN!?4,^K]"5+]62(B81R*5XEJS\5'@?0S(('!&
MU%D>E;&X\'_=H%@V1Z7<D<__0% T9!Q-YE6S?FXNI807Q6H\EHR[2L(A1 /_
M,)A[5QF5J.Y.RD+IM+]4 '=Q] K.[K*3FO>^I7I7K,1KO?M?L!QO=Y&XA:5X
M/U?IW;3,NZI0*K-;2@K$S()8OBU9YU=ZXC"-&E$502+K:.=D;(EYW&K\-@64
M;6V^H/T^JA.YRJ86@$!!F'&>SS5!=FVRDGD=?6%"XZ;8W4Q5:%X,&KD^[1"]
M1]$QQ]UG:O1:: $7LIJDM28<&!:]F^8W \918?K)5%=3[0H0PRX?C^OBOO6/
MOU:]8^$]\BJZE<9?0[?R=4%9%A?'ML6Y"LJ%\DO!Q68B[WNJL5-GPB7.M]TS
MH(OL4VH\C)DH*+#.]6"P'(0IYU:G53)CN7M'53=9OS/,4Z<:KC;;#O/>P$S4
M%7J2ZN: RHXW] 0<QRO"KI?WZ_J&2N,[*V7?KVSHEBVC[2VL5D7MP?)RVMN6
MA6?I&NM"@#3H/ICYR'CI'AQ N[>5;*BPF:WW(1 F<>TN!3$Y@$W8MT&T]^KY
MR][OK96=(!<';__="X_GI[I],7!P9%SQ!_;PPX\/*^+\S:$O7CZB+SY#Z+*M
M#SHX$N)1"Z[I$E/)P;E%$KDP?YLQEG$#G,] 3Q#8[8+[[H/,-(_V@0FB."9%
MA.&N0E=,)#BIT_2V7>9<PGZH:(>D6I^Y50\UMK:D7N^=*T@"X<0$C><_3A!^
MX1F<R!9@/".=12@Z?6\4I#H! XSAR#Z])_Q_7/!,M8!A(4XG/3+Z.5U30(=N
M?6^XO1R>B\0.OSG?AOGI>COZ&>TO J##R<_?_ZJS6LLE<,5Q"F9@D6>@.ARQ
MBL@]/I!B*F-[;<+&1ZMTJOP*/X.RKZ+W17*MQOP0_MJW!\X-XVB2??D%N0:D
MR:IJRR_'_SHY?->G'GPNO47[BDM/E<SUGD=-MMUX=;GN/ #-[ QSEMWA5S&B
ML=%^_Q#"IR\[B/YT-Q;YWSZWM*YLQ;U%W,BKE(INTM";R8#[50&O%D<:Y=+S
M.5%N;A1F:T].I?9_&W/G\BC,=R:%PZ*C.NW7S"6G4[R!SY7-'*S]Y8/E(\3N
M-7))1;XR4U^T2>D#3X.UEZ?LU!-V(P3*CE29E)L\D$\^XZH#R7,-YF)648%Q
M'!.<@\T<EZ<+Q^4T%RA4DSKBYR*OYYQA7<ZQ- EE04LR"9SL&*BP6IEU['II
M=79[JLIRZY#T;;%($('#*B/;.YV&"]ZC(_!]GB9CHQ%WN60V:N'<4[-QYR?H
M,/EE)N&U,'HX,($D6Y&:R6$HIO(NLS7+X,%7-TC =J1U,4DH;_\DA;;E"(-[
MOKN[]VP0?3@_0#HVDY_77*,4S8B1;:^L0@HU3YBVPU7WD IL<</*9I^2YW_O
M2!3-)*ESQMS8X@J?)O,@PM,,WOB[L$RRL6Z[WX,6-FM(>.)][/C^2+:SYR(A
MKS]J<3A\)O&4 F,R![]P/<F/R3@?1*!YQ3#SP[?XSV$$%DC/V7M,)S2VOP^\
M/4,85T%*LQ< -D$.\[;J3@HT@9'.]"2I6JHN!N)@*+"X'X6*%J\46;$@F]6(
M .6$Y,#VEW<N4+-H!E$PVJS/RX,QXFWI--Q-M!L\C=H+B=H^V:@RZ"X=+R"2
MQCRV(9=@=\-S:%@\EXD+0P<A$ FZX@VPW;#$JSN4.I7_)0587-\V,=2UV ?F
MNQMYI3GQL51Y(DHP6,QURG0J\*2$8M+$.ATW5$_8R0S;"]405KRP(<2 O@1T
M9)S[#GU$E*3^ZL(WYIA,4+=$Z@+)+]%^K)= IY=A+4@30U+:$87>R.E_ ULE
M33L8PH04 N8GY6(YH;2QMIE,!@[(-)GMR!(I=<I*H:DY5+CY&162M0<FL$IF
M$:*XLS)$'!F%$R$Y.BN5>4BL9@K-?$8PF><X\&=#'@3RDH5CW*!9Z 8.V97'
M*4Q$352GO("9/ B.==*$92$XFD:L7P<WE(9]+=$4?%?9>(I_^=7'K@U1'GQ/
M6 =TS!*Z)@8->ESE^*=0Z2$HSC!%#)B^M1PPXN(2=E;XV+(%WG'#;5%'T+1E
MI9Z_N>C;JUY&WQX*W=HY; _4-:B\4!H )AYLG\_@VRP?)[,$UC469DNM YP_
M^26'-WH4OOOQ (0C18) (H$*\"%+8H5>3; =#L9C&!CXFZD_LDOXJ8RVV*:<
M$Z5ZB=A)O(^2C"Y3J6N_#4(O]06S)OT8QA3K-*)[%S\GHP0TSSHC_WFB[,C2
MS0=9G<'KL1TI<6)>:_@,SW_ZY'46W=(EXUH7,:B88])FQFE=V@O@-L1BPF/T
MQSP"XQ-?VVP3-0-.(!7GP^AX08-!:,=Z!L_=?_:ZY.?P@(%XQO' WC,E1B+#
M=?]^#+ C6= 7ZL<M:$)YT(%V^RHU&R4\WEEK=%.-O[QX#4^YI>_@9]3>4,="
M57I>U'J$(TY*OQ([!N[+06/@AZ(V#I]N69^6KK'M 5,7YS3GV"4]=O.R%[K5
M5:K_H[J[;OWLL=][:BHH+M).&M<,;B>,;HW;4:_L9)^K&#6.G51/JA^>/._<
MCOQ50FQ4/^S@1;W9H$M<\V^5TW_'WM)OK!1>8:1;98[BZ19+GZ)RI<=3T#-B
M]/[!M*[N3M[T\5WLS3^64;O%];OB2!-!#H8(,Q*5\ !2-?'6O=>\.15>7]9B
M68TIHQJE+P@6:'R__?JK#O)B3_\_:_T)PZN=MS]1/%2WW]*B71PA>-NYTF[I
ML#Z>D9@OHU\4<GFA16+9IA.%POX F5!53+5>HS+/C*L6I3XI!0@VP2,;%BT<
M$+6;+9Z<:Y6BN:?I6%1&@3#2!;]+B9\"!H(5CE79H'LR!4L1$WG*PXYIFQ'%
M&I"*-@K5R@>RLQOZHZ2!-3<NJQ=\J >Z2J=<9(VNI!K>\(R,P "7%!N(:976
M(QC9F-7.3PI%( $A$ASN/]M]C42*_C(W\MH%)!HBB8^$/SY);MV*S!^K,N>7
M4&S"O]GIW<%IG9&FC(9\<#$T;Z1^QSHY5='6<&\7#?"MZM2(;6\"68NOQIR0
M<<Y'$\\C5GKF6 4*%S>8.3RE*JQ8Z%N0XK-M\Z\9MEAQ4[I QA$ZS\"^(9&,
M[B3D"LV+5;:H6[IH';!;#A9H23_.ZSC1!5%IX(M$]'?MBE +-8:$]E30% Z6
MQ0L9OO'652N.@;Q=8LS@R[4Y@WSKQ=LNM^QDIDNPXY62:_(J+RY)MJ 8:+V$
M#)1:I;!KD0I88AJNETJZB&EW)J3A?FVIWV,TXO((IZ><Z=]AE?%$+;?">(P7
MBH*F_.FMAWO5HP;K:)2S_ [G @S\\N57BN6/H0[9&J314$C#7.]%/VX##5U&
MORU4I98:'AX@)Z%=T-!NM;_4XGY7V":[_MGA2NTQ"ZNP"U764K'"F>.O4_9=
M48#:G74)FQNT\50$U@K=^# 7#P5,2+JUEP_.&3E;,&L]E]@)'Y"H!;O9LLJO
M3%E.*JZWQ)C#<.$2H3>Y:3%1$O<(>+G<09M^KHO?:Q:V.FMO^,6NIR@W<L23
MU[&<!;Z'ZK:Q8)M#P^(0OS8NL$AAXCW(6E".H!NPJNB0<'*<,A]C4&T6ZAZD
MVI&AD6J*E(B2%VLO'N(YR=B. %5,>2$6"J? =BG88<EA%HW=DS +/=I[('[#
M41?=,9RH<;J9B37EO/M''#0:UGO1V_WPT!(C-W"<.2KO5X-S\(<&RF[0"&>V
M"@18U)7-[[>D>V?R(X&9W/29>BP.04IJB_*(_7Y2V97!]7EW'MJ$XBBLY&H0
MJ7G!15TY!Y5I4UDG&D8G<%/,@ N_9D([(<NQJ5M"PB;O9+.>NGV?G\SNO1N&
MN]0> 3Y1]L<Q0G*Z$Z%'>JSJ4B\%AGQ,&/P8 ,!:+ MV7KUJ71*1#IHD10^D
M0RB-\K@>2UF;?)X(/S_'S@4JS^G >)8HK[A;\-C[Y0B'E/PP?$A8,.5GRUT8
M(I_CN8#G( A$B_3T;G1#&D#QB5 $-F82U]BDFRF3\8N\]0HDP-,"11KZ$1,6
M]3&(;03'WNYC%'O%(6LR&G3GL1@9Z(F[7YC=@G+ES386&!T+95/WCC=1P(F"
M_#B7F6[6M^Z'!_,3<]3>OSN[^/#SP6*&P0V@!V@R.J^;U*$3E.70HHO@69CW
M1( EFQIEUG&31-A+:E9&FV!J9TH]AH,W-6!PS=\1N9&G3W0B)BVXU-$7=S,>
MKY+,&012O#A*?]*-%QJ3JZY#6'Y3."(%*J*BMVSUX)SUJ^#S%Z]$N*)]_EZC
M8X-5!XV&6V"&&I-<=I"X*=$ZJ_0,]!;-GK5@Z%,W](1-07R#!!UT/2#C&]8R
M3%T-7Z?)=:$%'#'68-7BEPB:@",&_H:+HYPQRFB+\X[!YY-9^_39:X.-T 2.
MX/ 9;IP\(A_" 3TGVG(:,33;!\Q\B[G19Q_.-[R.0,-X[B@[NE$:%7$1-1@C
M719-1P&\+E(Q28OVH+[+,D5;-DQ,=+<E62^()5YDS,!CSFI0QM0P.AB5;&/>
M&@9+VF&LRZ4YU@%-4=?#UR+O/!<PG01$EKXASH85]ME602+3S9KD]MU\"&N3
M\R.\9T&Y=VP5/G?'U"USW/Z>H>L9VF2$T:UBS8V38ER[2FFFUYN\;R@]G!"E
MC#/?T-T2+OY6YH7U:#1\0(T%AS8SPNMM@2_*ND1WBV3+R8Y!@GSX]1SI3TM8
M]:V*B!W^#F)7-=F<?IE$6PUG&6^<X_*T''2F3F]7FX@#$AD*/8;7&4P1O@;K
M^?J%QC%# S>T2C6YD/"@O,9=2UM.;KX'K=U#V T',"P[AWE1U'/:Y)M^C%!_
MQJX_Q"\(EODT&24@[+EHJI%N%%BAG AF4"KG>5T*Z2E_X\J$CJ=)&A=8KAD3
MY?*;S"22F/+395X78RS^G(&,1V0"$]ZRN-W2P\OAP AI6'SFKC&Y]/!0X5+4
MI3CZBKE,UO80,1FN#DMS'8J/+Z%Y"[R$R<0S[A*,1E][*?ZE<"\:K^2"Y^(9
M@1DFK4SM1N'13=X#+B-[TU=_1S5=D\5&9,.=,^GEW/M2FIQ\$=4EL=P&(2EV
MF$<JVH2M44N<WJR.U9F7S6ESJYP$[=/B6=60.#\Y_?G@_;NSXPU<,(^QN:\>
MFT.%:Z1QKTF4KD%2KDWEXW_6T.X)4=R_IP+ I@"R_@B;B<XV<1@;WO\73[;V
MMK<FVY86V NBP('VID:N(;"QQE6T=3A5<]S>^R]?#;#LSO/H.!YN]SQ7__S-
MP3J7G@.V733M-8J;-HVV-(\OV:SRS#?%,2]3U=IY1'_),TTB]L 684<S$>9?
M@2H BNK?T=0#%0+4W9KX\%UBL4?'^^:@J^ZZE$P7NFYY-V5\2G.1D?FV[3MV
M2H!NFA6D:X]^-SSO9A$^>V&7'S0E-%&;$=9&A)<R4RDZ1_:L/)R(8O ,2J0&
M]X22OT9HYLY-BB_LH3',A1Y8!GA&:H !@PG[F?E$A1RXGC:=/W9XT8E-G-@N
M_#(0TNS"?WE2<@NI+%C.Y2I:M8\MZW:C^C&5Y6IN=[N=C6V&XQ_]"UG"CA+)
M4-[#2&]L/FT]A8V:&V:US(W]R]UM;_!I.(G#D;'YWHLEX[A-S"UKQ5$8#+S(
MN<?:W0YUP0LW5#2W,03+[.I HPZ*%%"-DN5:,OQ1Y/4ECW.[V  ,<)[0F=!,
M-T\H,3XHH$# L)#5W;[U,;1M0]M[CZ'M%8>LN635%3R;'(-17E=81R\XF((U
M+35R$K9Q%30]'U^YBA6+RDJD>#H*FZ3W-:@O" M-;^4"PXF#'?UW7EQ%Y_3X
M8_/X+4]]ZJ<&<_KO\^-^J#!],KE6'<4C06$&1DETYMSOCP;*Y_ <("^/1;R"
M(I""9,3SROL.]3 )GI@O^7A4<7YCO]K$^H9[ZUQ#+#R=B/5Q?JVP%SJY,]P(
MC+OLN@M5O1LT!<&81#T/'>@W>;2UOQV-ZA)>#XIO# <>OA<UVQ%LNYFA\?.,
M%Z::P:LP/$;:!GM!(U1;,).E;W6[T>VZWKK=G)1H2O3H:CRT]+Z69+5HH3F)
MWTPF <,TG[SWHBUQ*8]5J:7PTK;0"6NLGT4%LHA)HC(6PS8S__"ABE8"8B.N
MD[PNA04VS4N*$C[.>?><AWHYG+;=TI6F99KH"1J!X]KC=BIZ[HDY/'[7!S5F
ML9RTF#$URAG;[A0%+TYOZH1Q@A/;<>0*L11=Q^_N$L9WO@'YQHD[RW_P)Y+
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M#'F:,N5841J# 2,:?H_0H_$8ZD_.;9&5DCNE BH%]TPB)XA@VJ'EW))>I?Z
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M9#XM<G1^\;,;W[:@$<ETJN,$+D_GTJ!.J]@>S*LT[FN>R2NV]ZN=LRN^_^'
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MKV/RJPTP/Z!.C!1[]( Z^6)C><?M8IP5+!P7[1RB-HRW!2)BE>JF^BQ[R62
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MH,B.+5=AC8K5>Z6$$/U.B]H=0"7[$O&@ !&@RVH[ +7IC%VY[6 R+5&2B%2
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M.LYYZQ,>H0!)4]$%LYRK/95LFUV#KCB@*"ZQ4!CZ4T-HP=ZOMLUJB5>9K7E
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M."A3UW'=]-MWHY0[@6%.J/20=7[<3').%EKB@C$K;YIGQ(1;$:]^./V"@UG
M*O=9]'$!)FVH0;LW5 R+UFC?%][B@\"7\<+4C,%?82/V?\6=#S-?&7Y*DY_8
M."<(-06' 46+<TLWM4"V".XHRBG\SR7U'+T=3%3M9CE#QJ;-'.E;)*M=OYS^
M*8(2EGI^DWG# >==7(_LR#-'B%!AT'Y*D&-EI+.2W5@4^H4YN$(G/2?BT9U]
M'\,[PZ7<CCS'S?]:-G^@]&:8;TT>V#5S*-^R%@@FRYYE8BY;),V20 1[?$"R
M=U-R*!.\D05FG:J"JE(A:QTN,19^NT@>&.E/"B2S-M7K"6Y;23B?M#J$0\7(
MR4YWX4K[=YU7S*Z$<@2'YU]Y\3&ZJ/+11U<[K]]^SK-_79STP9 @["9H20@&
M)9$*S>6_8RZ'IJ*L-O6W9#40@HVG(H,]7BN,/VCM<*L\C40<P9-&:%GSEEV[
M3;HX$-V]79-/ZAP(H+0>B8"VI$AQ/L7\ZI&<F'[T4/BY" S+5%LEKA60^.:X
M@3G*\BG<[&/XG?)H*@Q$!7-MP;DCBJQ\P?!6S$TF=OXDY7[@+[0:*29SE5]#
MH]@J3LH1$JN"?J$K0<P6#D=#U$B)%']-2GE70-O$&T82E2U++/:S=)7*_'""
M\(=P;,#TF[\4XE9D[Z]+Q":7M/LW],A[FQ>A=B'&7XY@;#S-QO[R&S%ILEN
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MG(LFAUQ3GGC'J-'_)&#N,93_AEY,$*O'0O9+06CO,$S*4DKW+A)P1$)<>4S
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MI,S73'JUS<SK57CNR$QY&%+" SD[25!"J([+'%&^P\16R4E*6V+.HXVDP[/
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M[E)/K6EDFVT,]ZLBG9NH )$-LI91;FY8>6M?U(?V?QMSMT))V$Y'7.;8^BB
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MV2^'[]^=GVS@HGD(U:TC5(>ZUU#C$2)!NT9=!FT*P/^CAJ:/J;+'>RJ";NK
MPY:=\A$GD0=#<_OLT=;^]M9XVQ*A>P$5.-=>U\A(!,;ZJ(JVCB9JACO\X/F+
M =9\>QJ=Q+O;/4_EOWA]N,[5YZ!NETWKC<*H31,NS>,K-K(\8TYQ_"NG',RZ
M=*[UMWFF2<H><J$-KMMY ?.O0", ??57-/Q DP"MMR8J7Y=W[+&/OSZ,DLR&
M$GW:9FTK%,B[*2%4FHL<]/-V$,+I KK#R""M>_B'J6YAUN&39W8%0FM"F[4C
MYMH(^U+Z*L7KR,:5YQ.I#!Y&6',&WS*F_+PAFKXSDP<,.VD$,Z('MO0%(SC
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M*Y:>5'_  QQ>\1S3@VODM7ST_&5T!"LVG_8=J_#KV_.C/CASHZW [5"I3U[
M.\SATJF^]C"$8"ZUM5"B<3+K*[?IW&QW?=1ZYC*\=9C8!Q<LG7YUI9!_AQK4
M7IC&!S4G$U28I6*S-'.'3R6E&&V-F4IBBR_ B^!:G)0_-2!&L^XLNJ(G*AUO
MHK<&4X0J'$!*RS/&#/K9KG+*JT]N8<;$<>L@;S,\BQ-,;U.9E!4S<G3_T=9'
MZT.U(9K#4;5])QIACP_;X%+=JO07H,T7M&0$5/$C SM7TS)@]R7EDZ-W@VJ6
M%+R.1)*%G O4.>B51O?$B[UMRQ^)E^HLMAZ"W;_OT@OF6A7$0VE#7,Q[<)5<
M4Q5C!/D(5*:] YBAD$1M4AD+TW-B<OZZBM*<?3TTB,9;*G<$SEGQ8W8!>6T8
MSA [DW?3#I30_/#WIPN\GOT6SV>G1VO-A++BN>'K;0G<)2O?(*>L2T6.]D+/
M\J(R]</AR<;!Y$TA^@M(EB6E/\EF35CV=R,T7<"WU.EX1Y7E_VOO6IH3QX'P
M7W'M:;*5\3J&$'*9JDDF4\LAM:F:.>Q5,0Y0!39K0S+\^U4_)$O8!IN7S227
MG0T/(<G=K59_W5_+VSKW!A]!<R@LF$5U61D97]N2MX&6$\-.\V0B9?VB0$'A
M26V9[J41-\<#"C=%]>[1;/)6 ?'*#&Z =;*KA3]J%FIZH<?F&BTMB2QNN+OK
MI;UNO.9>S)ZEZ.ZWF7]2@X'\?W=XH^JZO8I]H=]?T*S;PJ#9'(Q>-/H\#5_D
M//V.VP&Z4/5J0M-7+Y]^)^L&V![^_7MP-_CIW)6*W1DN^(\O=^(7= 8:1$13
MK?RCH/Q.D%MFMW"5W18M4JX'V+]>Z7!7A"#RCA[$2P*3GF)IHU=U#+#!V.L1
MI_VAVMH;(W==4X1PQZ\;"CY+*^-Z929\ (RWP^7F?JOKRU@3FJ[;+=[%2INV
MY^#-9/.@T%&/'8I-0+PJ$.G8>8XC;-FD;G*E:GH&W5/8H6[%U47E:Z<&G,\7
M!7C9][P;)[,6Q-G! 99T&03R B'_HI=5A@VBBL2E]M\2 7BHB<V'$NT:%X-\
MVF@*A#%)'8S@ >X4=_2W=>YH'MIU[DV9@8GE)D4]MF+=ZPI^@!-2K7ZASH..
MB6RVE<!=I7CLIBL:-UB?AKDCJ7'Y,RB.TG8+;_'1T0)9=IT':W/A46+S!S5-
MK!.B][*;<+!65L\/R.3) C(<ZI3&$;49YI=!KDG$N<^L$7+0R:O@^)GUB4O'
M8..BKZCJ;_J3)G:I\PFD,/ 7C5<<_O RPM0UC R$"29M0.P&N^S2FQ6]E:,>
M.MTK-1 ?^)\[/==K[KCVW1,UPRGTI*VM\7VW _OP4V[Z"/D<@=+L1Q#/47*^
M4CY)C=R)W1RK_..RA:'OWE3PXQI_K'Z#EK+PL7[71"\"U5<>92ISJXC*(VN=
M+3^\G"Y2QD94QQSYW:&B7\ 3,VMA0P67_#4*N=^/Q00, F7$/?QC.43R;WWT
MX^E#J6RJK&/!['N3)%C.(& 9* ARFG'X&2U!=#S>7"5F*@&)& 8-.34*XI$A
MHI-9I)"2XB#RR<E4Q6<+Q5-A)3AC%2[/N&"-DEA-/VT9<.C!@74EIK6D""N<
M\TPX+*>Z!.I/^3_C2<AEJV^"ZK.A![2*S>J@?]'>Z'TP33[LQ&R2<MY7G:2H
M8REVB95OEV)WVJ;8@Q=+VJ063C%5U A#ZX3 U]" WP%6$<C$QQEZ0G/>/8>+
M-RBC1JE2(ZML/S85)9I=58-5ACH+*4U;D:(>5%4;E^P;MW\&@MU@BX5BP6:/
M@^P9PUF4*,QE%YB>I "9%7BE'-W ZR#3UG.!#3*J)A8G;DG R3C)-%,^<1<]
MY[GS7["#-[E*%HL["RZ]HS0'._U.] 14-L L'$+"^GX _P%$MSGIZY1'K;YQ
MUJ_8)VSE>ZA;1XI;;1V]D< 510#('NO>:'P=?<+;(^J-<@6TF7\.I;!%JIUE
MH7/H>U=7UE"NL]:L>>WWJ50J3N9P>5<DWT4C/XI(C.@,*E'/IR0>)6+F?'H<
MW#]=5)XM?!IS'-Z @$RDS(>,V!'EL@_E[3>+L' \)[%_')E$%PLX#%,L0]/<
MW3%7.0A-W#P7*\A 9%W/HB[&1;].)*M@H85!2#.:)8W4HTB",6R!7]F^?"!X
M90C>=0L1/ .(Z*S#$+=>SE;A2^V ?/8#\LYWW7OC>9679_D$GGO5V/E>-5[]
MNZ[?^?0UI9@)U0JK.SD& ,A$]R_!2O<O3K4%^\";O;.%-X_C-[NW>:>P[[;/
M)60L$Y/C"H21';=60SVVG6@6IOR A$^VUTV@OWM#OF?PC'$-;7C"14CU[P52
M9S[0!US='%Q=&:QVOJNR#FA[A&]#9W H8K<#'-0G24=8\NDCPK0DRH8PT0(3
MX"P@TUT.KXO?S1?G8F4B==ODJ"K,OH/34L,GZJWC[)[K->=_^Z[G.&6.8ZL
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M5YXO]!<TEI+_C!>SZ9?_ 5!+ P04    " "E.IQ46S,SBU4X   FH0$ %@
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MDOJ/L3VXIO,%MSR.#^;$F<)-X^Q5T)RS50J:$D.RPULM1\QPE'WSYWSF'*G
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M);O#$?<VP(QO:*OO=M#/#WY^MA<Z8)_W!?N\7TJOUVQU6P>=MQ/1,^4G]TG
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MBIZI#.8#=S?< _V=4.FG%?@,*1&-X1O(BKPR1L'0 :!4JSGD2\.0E3:6 2M
M+P4USI208(>QSM11<S44E\90(7PT0^'7C#6._OFXVUY*MNX/+)HO@<46%E>:
M#F!C K; 4?G1@J8@K^@MFP^]T58 [D6$TSS&;\#J:(J&BE;)1B/F*?BR-%\-
MOGPN/E%EW%\R0<-4W,T)VFGA%=:P!4PE+$ZMTRGL'J@,(348<;!9R$YB= ^)
MY/ U3-N:YPH9@G.;[GRD+![-4W$@A181>&/KVQ(F,<+"YQ4<#GZ5*Q9IN5EI
M3D068O2%GI21(<6@C(;:C=,X1BR"9XA L$1"M2-%5%/"NR8B*<)#>S T!/4
M]A1AMTQZZ,<1R6@(RX.,E>0>RL',1HEJ?T_8OS.,$ K16;F1!(0.L01.@]V7
ML&GFV%BT"@ELK,-'9&%3!'P0!*[VM9T7P]_.\*T2SWJQK\Z5LV1I8"TLH0;P
M"Z\*RD'1 $%?)/,KVE;1"OS,CL/HE)91(O/G(KUI4@Z9B[&>&S@R'2C""GHQ
ML'^TH,499LP<_^M8+)G" 3G65U0 !J'KH:GAYP[S3TN"3Z[+SUFR.?)]>RL2
MYFMD"^%0FH7*QDLJD"(;%T=99J"^#:_9LLJ,N(P>(<+^:0.?+V<?+T^.!N>7
M%T^3*S><_1=HVPC:!M/2B TKTA2\EE5K:^\S94-VB_$"R":$49@UPJ.)0[XF
M6%+T/)8HS!< ZF 2:'0*LJ<:*30T+=0@ <%\ )PBIL(D G((#$]P>8@U> R6
MAA"S6+U,I "X2DTX5.0C#&#*A$%:A"1BT1"""$-?Y_PB9@;6-#<:?2V E8D\
MK IID0TXBBCH2?&LU5Y6X+;3_<&H_!M00XKIC^KN?J?5^,ETM^W4M2S>"SBJ
M0$ ,^$X(GUP%/-$EDJLL <>G=.W#=?MD2<EUC=QGQN62M)@'>C &0JE1/1-5
MPF,V,^1-EN@@>")(JSXRQ24*W,ITU^@AES.#T=G?0 0)OYMYK7:=7(]WGS+;
M7:%.>ZZI,K^HTYWJ=!Y%?&P]\+TJ9'&RQ$C?MB98!PZPEEMHTM@U#TD5,H$\
M@)6(54'="!$F<<)$R.NY6LEZ=;&;:G>=9@./79AKG)[)\V[84@=#,=%>>]>G
M4^@P%6&FEJ<<'BA=XREG2O#C53BND"8IZQ6_]"';@:PG[_%8RUM/>M MN]-J
M=W!M!2JO_&+=XJ%FJZ;\Y6?[76>_OOYQW7'+9S5-V]"'#:1PKG_L-,L^@2'U
MKL<0M,5^U:KE2/\I%*?72&Z)6UB4V0CJTN+FS+YV[K3P61J8K#+Y3&&*N]""
M4<JIIH]ROC5CJHF;==RTRK:)0$YA:\RJ0\B\KZNZ*-"CX83FZ8*XIETYG3VG
MLU57SEWHVEQQ\;8".MLMI_&"G/<AYQ53> ,]KD)N>E7DDO=Z7XJ_ >#JN_Z
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MZCK[G?^?N_).O?$+W97/8^P3^-+-++FQ_55YS?P?%?I_RSC\+U!+ P04
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M8(@HKBI/=0E=(9"L1:L.@"EBE0(Q)G@2;+5>X:\*O;NS-" N0I)8IQZE1@>
MS@ 983D7[$FY&[-,FYE;(-+*D7+>DF9R^C':#2OK:\!R"V,VK'W1V.H]%VQ=
MW0K$JYV#3K)_Y"KT5').1]_$Y"N$Z))Q*P,8$%PUU)*"QB00.-3*C:D[=9N
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M,BYH=&W55]MRVS80?>]7;.2I8\^(=^I&R9IQ9&?B-*F=6*G;IPY$@!(F$,&
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M !               ( !     &)A>"TR,#(R,#,S,2YH=&U02P$"% ,4
M" "E.IQ4]6?Z.F,7  "E]P  $               @ &[3P( 8F%X+3(P,C(P
M,S,Q+GAS9%!+ 0(4 Q0    ( *4ZG%1</T7VP20  .YM 0 4
M  "  4QG @!B87@M,C R,C S,S%?8V%L+GAM;%!+ 0(4 Q0    ( *4ZG%2;
M4\P($G4  *<@!0 4              "  3^, @!B87@M,C R,C S,S%?9&5F
M+GAM;%!+ 0(4 Q0    ( *4ZG%2SGD=W/!P! !*D"P 4              "
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M+FAT;5!+ 0(4 Q0    ( *4ZG%37YPCI] <   XE   6              "
M ;*<!@!B87@M,C R,C S,S%X97@S,3(N:'1M4$L! A0#%     @ I3J<5'79
M S5R!   #1   !8              ( !VJ0& &)A>"TR,#(R,#,S,7AE>#,R
;,BYH=&U02P4&     !  $  K!   @*D&

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
